data_2kb1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kb1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.894 0.378 . . . . 1.0 110.663 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 6' ' ' ARG . 97.7 m-20 -67.25 -14.27 62.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.525 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.665 ' H ' ' HD1' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -83.76 -35.03 24.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.895 0.379 . . . . 1.0 110.286 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.16 -44.52 88.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.808 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 3' ' ' ASP . 39.0 ptt180 -66.85 -38.51 86.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.247 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.69 -43.14 80.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.289 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.93 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.245 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.44 -39.72 94.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.333 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -62.19 -38.82 90.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.28 74.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.972 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.09 -39.47 86.24 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.588 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.43 -33.76 76.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.47 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.78 -36.3 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.596 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.02 -40.87 97.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 1.0 110.339 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -33.7 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.29 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -60.62 -43.09 97.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.055 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.07 -41.53 93.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.448 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.37 -41.65 89.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.121 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.34 -49.59 77.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.631 -0.427 . . . . 1.0 109.996 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.37 -38.18 86.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.024 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.83 94.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.752 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.428 ' OG ' ' OG ' ' A' ' 48' ' ' SER . 38.7 m -53.65 -36.35 61.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' VAL . 64.9 tttm -77.57 -78.29 0.14 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.835 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 24' ' ' LYS . 74.0 mmtt -36.19 -35.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.29 87.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.612 -0.435 . . . . 1.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 1.8 m -63.08 -47.8 90.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.201 -0.6 . . . . 1.0 110.564 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.9 tm-20 -70.1 -42.92 72.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.916 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 66' ' ' GLU . . . -59.48 -31.42 69.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.931 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -97.19 -33.05 11.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.605 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 27' ' ' VAL . 23.6 tpt180 -77.55 97.63 5.1 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.286 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 -14.02 7.98 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.88 42.57 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.93 142.72 28.45 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.111 1.874 . . . . 1.0 112.318 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.18 7.69 84.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.021 -0.831 . . . . 1.0 111.021 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.33 147.28 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 1.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.38 10.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' ILE . 6.7 tt -83.8 -71.08 0.52 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.358 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 40' ' ' SER . 45.0 pt 37.51 -162.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 39' ' ' ILE . 4.0 m 55.15 128.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.361 0.601 . . . . 1.0 111.055 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.423 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 23.2 m-85 -77.66 -55.68 1.23 Allowed Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.781 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.4 Cg_endo -60.28 -20.52 62.85 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.701 1.601 . . . . 1.0 112.348 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -89.0 -24.97 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.004 -0.278 . . . . 1.0 110.951 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.85 -37.84 85.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 tp -63.89 -43.51 97.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.437 ' CD1' ' CG2' ' B' ' 64' ' ' THR . 0.3 OUTLIER -60.13 -42.11 94.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.117 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 18.1 t90 -60.68 -41.95 96.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.428 ' OG ' ' OG ' ' A' ' 23' ' ' SER . 52.9 p -76.64 69.63 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.384 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -152.39 -80.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.047 0.451 . . . . 1.0 110.476 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 57' ' ' TYR . 16.7 pt-20 -60.45 -20.87 61.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 52' ' ' ALA . 15.1 t -65.18 -43.73 90.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.137 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 54' ' ' THR . . . -56.1 -50.05 72.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.481 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.0 OUTLIER -79.82 37.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.362 0.601 . . . . 1.0 109.437 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 19.2 p 60.28 -117.95 0.8 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.388 -0.824 . . . . 1.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.537 ' N ' ' OG1' ' A' ' 54' ' ' THR . 2.5 t 69.87 -54.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.13 -1.91 88.27 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 59' ' ' ASP . 3.2 m-85 -90.58 34.49 0.89 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.45 -9.78 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 57' ' ' TYR . 11.6 t0 74.29 9.36 4.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.422 . . . . 1.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -145.08 -162.13 1.44 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 13.2 p90 -167.88 98.32 0.59 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.094 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.99 150.23 77.74 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.453 1.435 . . . . 1.0 112.122 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.724 ' CG2' ' H ' ' A' ' 64' ' ' THR . 14.3 p -87.64 -136.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.724 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 29.7 m -107.19 -44.28 4.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.524 0.33 . . . . 1.0 110.907 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.726 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.0 tt0 -56.17 -41.64 75.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.807 0.337 . . . . 1.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -65.13 24.94 0.02 OUTLIER 'General case' 0 C--O 1.264 1.856 0 CA-C-O 123.625 1.679 . . . . 1.0 109.8 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.726 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 42.97 65.9 1.29 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 117.968 -1.462 . . . . 1.0 111.487 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 56.3 ttm-85 -24.33 -34.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.161 0.981 . . . . 1.0 110.833 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 67' ' ' GLY . 73.4 mmtt -48.15 -19.03 0.24 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.145 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.3 t -61.19 -47.49 93.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 119.662 -0.815 . . . . 1.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.59 -41.8 19.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.854 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -52.71 -48.29 66.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.685 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.87 -40.3 97.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.97 -46.48 96.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.177 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.11 -43.22 99.06 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.99 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.81 -41.06 94.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.61 -36.34 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.386 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.56 94.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.07 -43.73 98.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.653 0.263 . . . . 1.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -62.51 -46.17 89.65 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.33 -49.35 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.929 0.395 . . . . 1.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -69.0 -27.88 66.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.905 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -84.54 -28.03 26.94 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.006 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.41 -45.98 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.335 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.4 m -57.41 -18.55 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.361 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.1 m -38.16 -31.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.101 0.477 . . . . 1.0 110.442 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -58.95 -51.1 71.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.338 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -61.88 -29.61 70.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.034 0.445 . . . . 1.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.8 mm? -70.86 -35.38 72.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -65.73 -50.45 64.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.088 0.47 . . . . 1.0 111.432 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -4.54 0.64 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.714 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.0 m-20 -55.28 -66.08 0.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.305 . . . . 1.0 111.129 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.5 p90 -62.76 -39.61 94.69 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.337 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 70.9 t -43.47 -31.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.55 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.26 -22.1 66.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 1.0 111.345 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.538 HH12 ' HG1' ' B' ' 91' ' ' THR . 29.6 ptt180 -59.95 -34.28 73.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.711 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.961 -179.749 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 4' ' ' HIS . 52.7 p-10 . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.768 0.318 . . . . 1.0 110.726 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 3' ' ' ASP . 15.8 p-80 -83.69 -26.3 29.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.531 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.31 -42.69 87.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -64.28 -42.53 96.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.567 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.2 -40.16 84.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 1.0 109.868 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.88 97.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.729 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.69 -37.95 87.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 1.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.74 -39.48 91.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.76 -36.8 79.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.788 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.68 -36.92 85.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 1.0 110.518 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.289 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -64.08 -37.22 86.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.546 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.89 -41.46 99.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.421 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.45 -38.12 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.791 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.474 ' NZ ' ' OE1' ' B' ' 21' ' ' GLU . 25.8 ttpp -61.07 -43.1 99.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.54 -41.78 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.66 -41.35 90.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.1 mt-10 -63.06 -44.05 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.474 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 47.8 mt-10 -70.08 -33.96 72.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.023 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' B' ' 26' ' ' ALA . . . -63.6 -39.93 95.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.413 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.1 p -59.3 -43.59 92.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.07 -63.85 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.413 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -59.88 -39.61 85.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.564 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 22' ' ' ALA . . . -51.8 -51.38 56.92 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.941 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.99 -47.18 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.141 -0.624 . . . . 1.0 110.943 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -64.37 -39.53 94.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.763 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.11 91.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' B' ' 36' ' ' ALA . 79.5 mm-40 -67.48 -42.45 82.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.789 0.328 . . . . 1.0 111.16 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -52.62 102.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 1.0 110.805 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 113.3 -9.13 24.62 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.51 138.27 23.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.834 -0.215 . . . . 1.0 110.672 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.59 141.55 25.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.91 1.74 . . . . 1.0 112.341 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.18 26.82 68.13 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -47.16 -58.3 4.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 1.0 110.794 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.42 -20.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.383 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' B' ' 36' ' ' ALA . 24.4 tp -110.6 119.51 39.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.1 pt -154.89 168.92 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.627 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.5 OUTLIER 80.22 135.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.0 110.989 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.626 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 4.1 t80 -72.12 -41.82 8.93 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.912 -0.585 . . . . 1.0 111.564 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.5 Cg_endo -58.22 -32.7 96.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.494 1.463 . . . . 1.0 112.794 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.527 ' CG ' HH12 ' B' ' 60' ' ' ARG . 35.4 p-10 -99.05 -7.45 26.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.54 -44.11 91.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 1.0 110.406 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -64.49 -33.58 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.683 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.404 ' NE1' ' CB ' ' C' ' 68' ' ' ARG . 0.3 OUTLIER -61.17 -46.8 89.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.515 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.404 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.1 OUTLIER -71.01 -28.36 64.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.404 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -68.49 -35.4 77.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.589 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.6 ' CG1' HH12 ' C' ' 68' ' ' ARG . 47.2 t -60.47 -48.4 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.856 0.317 . . . . 1.0 111.856 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.426 ' HB3' HH21 ' C' ' 68' ' ' ARG . 6.3 pt-20 -68.96 -28.84 66.99 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.472 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -62.28 -47.19 85.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.155 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.55 -36.74 69.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.476 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.539 ' C ' ' H ' ' B' ' 55' ' ' VAL . 82.1 p -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 53' ' ' THR . 2.7 p 66.09 -6.7 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.302 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' B' ' 57' ' ' TYR . 69.5 t -65.33 -47.34 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.922 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 67.43 -34.8 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.579 ' H ' ' C ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER 61.88 -73.08 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.803 0.335 . . . . 1.0 110.604 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 57' ' ' TYR . . . 158.72 29.94 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.69 -62.41 1.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 1.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.527 HH12 ' CG ' ' B' ' 43' ' ' ASP . 81.5 mtm180 -147.43 -170.24 3.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.394 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -173.82 136.72 0.67 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.12 -171.73 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.576 1.518 . . . . 1.0 112.138 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.485 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.0 t -118.06 -135.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.155 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.437 ' CG2' ' CD1' ' A' ' 46' ' ' TRP . 26.2 m -114.39 -37.12 4.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.541 -0.299 . . . . 1.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.651 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.8 tt0 -66.49 -34.1 77.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.509 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.485 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -71.19 32.02 0.05 OUTLIER 'General case' 0 C--O 1.267 2.016 0 CA-C-O 123.709 1.718 . . . . 1.0 109.972 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.98 63.91 1.62 Allowed Glycine 0 C--O 1.214 -1.127 0 CA-C-N 113.916 -1.493 . . . . 1.0 111.14 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' B' ' 67' ' ' GLY . 58.8 ttm-85 -23.95 -33.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.384 1.092 . . . . 1.0 110.91 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 99.0 mttt -48.27 -18.48 0.22 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' B' ' 67' ' ' GLY . 53.6 t -61.93 -46.91 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 C-N-CA 119.953 -0.699 . . . . 1.0 109.754 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -48.16 38.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.457 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.45 -45.11 12.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.275 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.01 -46.93 87.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.686 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.0 -46.01 82.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.456 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.09 -44.12 97.34 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.72 -37.74 85.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.376 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.16 -41.23 96.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.674 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.2 -42.25 94.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.41 HG21 HD12 ' B' ' 79' ' ' ILE . 97.2 mt -62.53 -43.55 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.071 -0.252 . . . . 1.0 111.075 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.76 -40.39 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 1.0 110.797 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.07 -46.92 94.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.151 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -74.7 0.79 14.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.018 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -106.31 -37.6 6.49 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -62.98 -39.99 96.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.057 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -52.62 -8.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.005 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.7 m -61.35 -21.54 64.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.54 -23.32 49.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.49 -10.83 18.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.533 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 38.6 mt -99.14 -25.89 14.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.953 0.406 . . . . 1.0 110.293 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -13.55 60.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.891 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.538 ' HG1' HH12 ' A' ' 96' ' ' ARG . 0.1 OUTLIER -100.37 -4.46 29.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.122 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.19 -43.56 98.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 4.7 p90 -70.5 -32.64 70.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.153 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.79 -27.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.711 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.61 -22.98 64.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.441 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -59.49 -37.09 77.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 1.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.986 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.9 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.866 0.365 . . . . 1.0 110.457 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.619 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 4.5 p80 -69.04 -36.55 77.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.644 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.44 -36.32 83.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -62.91 -38.3 90.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.835 0.35 . . . . 1.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.33 -42.22 98.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.021 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.0 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.63 -39.57 93.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.398 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.12 -41.33 98.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.333 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.88 88.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.52 -39.89 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 1.0 111.106 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.69 -34.67 78.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.742 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.44 -36.16 82.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.538 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.17 -41.21 98.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.345 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.26 -39.15 78.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.23 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.63 -38.48 87.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.852 0.358 . . . . 1.0 110.828 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.75 -40.52 84.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.672 -0.411 . . . . 1.0 109.944 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.428 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.0 mm-40 -56.94 -45.43 82.79 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.96 -37.1 78.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.033 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.52 94.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.415 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 90.2 p -61.41 -35.78 78.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' C' ' 26' ' ' ALA . 88.2 tttt -73.79 -77.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.106 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' C' ' 29' ' ' ALA . 14.6 mptt -38.98 -25.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' C' ' 24' ' ' LYS . . . -64.88 -41.61 95.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.74 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' C' ' 28' ' ' GLU . 1.7 m -63.73 -47.63 90.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.029 0.442 . . . . 1.0 110.366 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.556 ' C ' ' H ' ' C' ' 30' ' ' GLU . 96.8 mt-10 -71.64 -36.58 70.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.428 -0.805 . . . . 1.0 110.365 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' LYS . . . -70.91 29.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' C' ' 28' ' ' GLU . 3.6 tp10 -153.46 -38.98 0.1 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.954 0.407 . . . . 1.0 110.283 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -65.36 86.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.065 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.4 20.42 2.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.4 151.49 39.71 Favored Pre-proline 0 N--CA 1.466 0.373 0 O-C-N 122.886 -0.185 . . . . 1.0 110.685 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.55 115.8 4.15 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.167 1.245 . . . . 1.0 111.106 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 82.5 18.08 67.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.259 -0.736 . . . . 1.0 111.259 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . -42.35 167.98 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.919 0.39 . . . . 1.0 110.472 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.95 -30.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.436 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.59 101.31 13.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.104 0.478 . . . . 1.0 110.225 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' C' ' 40' ' ' SER . 42.2 pt -128.83 161.25 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.217 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.8 OUTLIER 80.81 140.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 1.0 110.604 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 46.0 t80 -79.65 -41.96 1.51 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.188 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.5 Cg_endo -59.92 -29.9 90.51 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.489 1.459 . . . . 1.0 112.453 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' C' ' 44' ' ' ALA . 2.8 p-10 -93.56 -23.22 18.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.719 0.295 . . . . 1.0 111.198 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' C' ' 43' ' ' ASP . . . -63.55 -33.27 75.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.864 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 tp -65.38 -41.11 90.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.91 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -42.93 99.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.811 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.535 ' NE1' ' OH ' ' B' ' 57' ' ' TYR . 3.7 t90 -59.61 -40.04 86.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' C' ' 51' ' ' THR . 15.5 m -58.27 -33.1 69.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.99 -44.89 92.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.482 ' OE1' ' NH1' ' D' ' 68' ' ' ARG . 9.0 pt-20 -87.51 73.11 9.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.693 0.282 . . . . 1.0 111.289 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' C' ' 48' ' ' SER . 0.6 OUTLIER -177.0 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.171 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.041 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -92.16 20.5 5.89 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p 57.5 33.5 23.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.873 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.2 t -132.5 87.14 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.119 0.485 . . . . 1.0 110.112 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.89 79.14 1.65 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.536 ' CZ ' ' O ' ' D' ' 60' ' ' ARG . 0.8 OUTLIER -60.08 -47.34 86.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.931 0.396 . . . . 1.0 110.523 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 147.31 -85.58 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.729 -0.949 . . . . 1.0 110.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.459 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 92.4 m-20 41.61 -89.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 1.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' C' ' 58' ' ' GLY . 84.2 mtm180 -127.8 150.85 49.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.887 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -153.41 147.51 18.81 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.74 156.94 62.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.254 1.969 . . . . 1.0 112.04 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.22 -132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.157 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.511 ' C ' ' H ' ' C' ' 66' ' ' GLU . 99.4 m -115.3 -56.96 2.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.833 0.349 . . . . 1.0 110.703 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -52.85 -10.08 0.15 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 10.7 mp0 -108.28 47.04 0.92 Allowed 'General case' 0 C--O 1.272 2.261 0 CA-C-O 124.747 2.213 . . . . 1.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 37.4 60.99 1.07 Allowed Glycine 0 C--O 1.218 -0.905 0 CA-C-N 112.432 -2.167 . . . . 1.0 111.128 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.6 HH12 ' CG1' ' B' ' 49' ' ' VAL . 60.9 ttt-85 -25.18 -32.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.738 0.769 . . . . 1.0 111.074 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.718 ' N ' ' O ' ' C' ' 67' ' ' GLY . 52.4 mtmt -55.4 -9.08 0.41 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.702 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.0 t -58.32 -45.64 89.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 118.617 -1.233 . . . . 1.0 110.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.97 38.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 1.0 111.15 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -56.89 -46.02 82.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.067 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.87 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.414 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.12 -44.02 91.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.653 -0.419 . . . . 1.0 111.395 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.14 -41.25 99.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.126 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.99 -35.49 75.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.708 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.46 74.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.357 . . . . 1.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -36.63 88.18 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.07 -44.01 97.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.678 -0.307 . . . . 1.0 110.729 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.76 -43.85 87.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.814 -0.354 . . . . 1.0 111.099 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.0 -48.66 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.517 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -73.98 -14.44 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.084 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.0 -32.14 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 1.0 110.171 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.2 tt -66.45 -39.61 88.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.483 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 m -47.93 -9.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.055 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' C' ' 84' ' ' LEU . 27.1 m -57.4 -38.88 75.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.411 . . . . 1.0 110.024 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -51.3 -23.25 3.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.088 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.0 -11.54 26.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.85 -49.39 7.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.318 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.37 -13.97 4.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.975 0.417 . . . . 1.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.2 OUTLIER -101.02 -5.37 25.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.165 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.09 -47.85 84.39 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 36.9 p90 -78.35 -36.62 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.35 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 86.9 t -46.51 -34.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.763 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -62.33 -20.65 64.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.713 0.292 . . . . 1.0 111.242 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -49.48 -38.96 32.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.51 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.256 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.902 0.382 . . . . 1.0 110.451 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -66.8 -21.93 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.657 ' H ' ' ND1' ' D' ' 4' ' ' HIS . 1.0 OUTLIER -65.07 -41.7 94.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.267 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.45 -37.91 88.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.553 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -62.98 -42.53 99.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.354 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.51 -44.98 69.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.47 -43.85 89.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.704 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.41 -38.01 89.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.567 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -39.18 92.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.711 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.99 73.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . 0.409 ' OE2' ' CE1' ' D' ' 82' ' ' PHE . 79.7 mm-40 -65.48 -33.73 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.23 -40.98 97.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.887 0.375 . . . . 1.0 110.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.91 -30.43 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.97 -42.12 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.324 . . . . 1.0 110.486 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -62.23 -40.14 95.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.59 -41.65 92.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.35 -41.77 94.33 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.181 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.9 mt-10 -62.7 -48.12 80.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -69.83 -42.23 73.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 1.0 110.49 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.06 85.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.085 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -58.98 -43.58 91.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.85 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.54 -32.37 73.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.649 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -78.5 -38.26 41.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.849 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.81 75.88 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.166 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 9.9 p -63.11 -45.15 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 1.0 110.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 83.7 tt0 -66.26 -42.85 87.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.511 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.44 97.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.279 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -64.98 -32.99 74.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.811 -0.356 . . . . 1.0 110.451 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.02 130.58 41.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.953 0.406 . . . . 1.0 110.454 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.07 -10.38 63.8 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.25 148.98 36.63 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.59 137.6 22.94 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.87 1.713 . . . . 1.0 112.208 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.57 74.42 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 138.52 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.979 0.419 . . . . 1.0 110.442 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.84 -30.98 4.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.311 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 tt -97.38 76.39 2.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 1.0 110.166 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -101.97 -2.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.417 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 10.6 p -76.44 148.15 37.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 0.7 OUTLIER -104.43 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.11 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.3 Cg_endo -57.98 -31.67 93.4 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.612 1.541 . . . . 1.0 111.744 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.37 -0.79 57.7 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.195 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.7 89.21 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.819 0.343 . . . . 1.0 110.39 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.48 -38.39 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.468 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.44 -46.45 80.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.064 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -65.47 -38.64 90.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.17 -35.14 80.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.786 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.13 -48.79 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.834 -0.347 . . . . 1.0 110.919 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' D' ' 53' ' ' THR . 13.8 pt-20 -67.78 -29.35 68.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.075 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.4 m -63.04 -44.84 94.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.39 70.61 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.462 ' C ' ' HG1' ' D' ' 54' ' ' THR . 23.2 p -80.76 8.93 7.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.34 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.462 ' HG1' ' C ' ' D' ' 53' ' ' THR . 73.1 p 41.26 70.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.444 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' D' ' 57' ' ' TYR . 0.2 OUTLIER -146.78 -42.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.334 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.56 -38.8 0.6 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' D' ' 55' ' ' VAL . 1.6 t80 66.12 -68.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 1.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . 146.0 32.21 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.0 m-20 -85.44 -58.49 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.536 ' O ' ' CZ ' ' C' ' 57' ' ' TYR . 94.1 mtt-85 -141.0 -179.39 6.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -158.01 137.09 8.13 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.697 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.66 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.3 2.0 . . . . 1.0 112.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.424 ' CG1' ' H ' ' D' ' 64' ' ' THR . 2.0 t -89.4 -140.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.814 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.424 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 5.1 m -114.68 -32.54 5.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' D' ' 67' ' ' GLY . 79.9 tt0 -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.926 0.394 . . . . 1.0 110.576 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.413 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.2 OUTLIER -77.49 24.88 0.19 Allowed 'General case' 0 C--O 1.262 1.758 0 CA-C-O 123.715 1.722 . . . . 1.0 109.219 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.87 62.22 3.06 Favored Glycine 0 C--O 1.213 -1.181 0 CA-C-N 113.87 -1.514 . . . . 1.0 109.439 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.482 ' NH1' ' OE1' ' C' ' 50' ' ' GLU . 58.6 ttm-85 -25.21 -30.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.216 0.598 . . . . 1.0 110.985 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.725 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.1 mttp -51.2 -24.63 4.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.351 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' D' ' 67' ' ' GLY . 74.8 t -62.37 -49.47 83.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.039 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -39.29 72.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.476 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -61.35 -37.03 81.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.848 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.01 -41.67 99.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.411 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.43 -43.24 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.267 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -58.82 -45.92 88.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.081 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -65.58 -38.36 89.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 1.0 110.576 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.26 84.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.499 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.67 -39.27 86.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.33 -43.44 97.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.414 -0.463 . . . . 1.0 111.19 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.65 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.82 -50.31 81.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.457 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . 0.409 ' CE1' ' OE2' ' D' ' 12' ' ' GLU . 24.6 m-85 -66.97 -41.38 86.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.11 78.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.313 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' D' ' 86' ' ' THR . 7.7 tt -61.79 -42.15 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -50.21 -15.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -54.73 -19.5 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.119 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -62.24 -62.97 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.827 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.86 75.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.139 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.06 -47.47 68.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.899 0.38 . . . . 1.0 110.732 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.457 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -61.45 -25.39 67.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 1.3 m -84.01 -3.55 58.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.319 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.62 -46.76 89.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.147 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 9.0 p90 -65.54 -32.29 73.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.615 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.51 -42.74 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.181 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -52.96 -22.12 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -50.42 -37.34 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 1.0 110.459 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.876 -179.317 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 120.544 0.211 . . . . 1.0 110.568 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 59.54 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 2' ' ' ALA . 31.1 p80 -56.75 -40.2 75.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 1.0 110.663 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.441 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 43.7 tt0 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.315 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -64.43 -38.52 91.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.178 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.04 -40.0 90.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.68 88.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.49 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -62.21 -39.61 93.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.18 -37.67 88.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.422 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.97 79.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.59 -37.8 88.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 1.0 110.524 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -64.75 -35.97 82.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.914 0.387 . . . . 1.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.62 -33.22 75.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.29 -42.0 98.98 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.628 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.34 -37.71 86.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.153 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -61.9 -41.64 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.723 0.297 . . . . 1.0 110.98 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.53 -42.03 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.467 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.49 -40.94 88.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.055 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.66 -48.59 81.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.684 -0.407 . . . . 1.0 109.935 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.039 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.99 90.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.577 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -59.67 -43.05 94.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.129 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -58.28 -64.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.56 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.97 -37.8 80.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.648 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.94 -49.41 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.861 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.74 -43.18 90.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.526 -0.469 . . . . 1.0 110.179 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -61.33 -42.62 98.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.724 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.46 -53.37 58.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -65.02 -19.58 66.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.157 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -82.53 89.41 6.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.887 -0.325 . . . . 1.0 111.249 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.58 6.12 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 116.192 -0.458 . . . . 1.0 112.012 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.94 144.55 29.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.807 0.304 . . . . 1.0 110.287 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.45 142.03 26.06 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.954 1.77 . . . . 1.0 112.231 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.47 12.14 80.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.1 138.14 57.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 1.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.77 -58.66 1.94 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.612 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.53 99.21 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.976 0.417 . . . . 1.0 110.427 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 pt -135.5 55.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.457 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 3.4 m -156.54 132.66 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.061 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 91.6 m-85 -67.19 -44.22 47.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.578 0.584 . . . . 1.0 112.578 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.5 Cg_endo -60.04 -32.44 94.85 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 121.272 1.315 . . . . 1.0 112.76 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.9 p-10 -99.8 -1.1 38.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 121.017 -0.273 . . . . 1.0 110.948 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.431 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -66.16 -43.78 85.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 1.0 110.495 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 tt -66.69 -38.73 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.653 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -56.52 -46.07 80.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE3' ' N ' ' A' ' 48' ' ' SER . 1.6 t90 -67.36 -39.01 85.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.906 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.472 ' O ' ' CG2' ' A' ' 51' ' ' THR . 1.1 m -55.74 -25.51 40.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.163 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.93 -44.81 78.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.414 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.485 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 99.5 mt-10 -79.7 69.02 5.93 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.408 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -174.65 -46.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.4 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.4 65.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.528 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 54' ' ' THR . 33.0 p -92.44 -0.79 57.32 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 53' ' ' THR . 16.5 p 57.14 76.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.207 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -148.77 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.688 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.4 89.85 0.8 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.546 -0.622 . . . . 1.0 111.546 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -63.93 -42.87 97.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 1.0 110.948 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.76 15.61 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.67 -68.65 0.35 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.638 0.256 . . . . 1.0 110.904 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -134.14 159.49 40.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.13 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' D' ' 57' ' ' TYR . 20.3 t80 -172.34 137.8 0.91 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.46 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.13 -172.63 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.804 1.669 . . . . 1.0 112.013 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' A' ' 64' ' ' THR . 11.1 p -117.75 -121.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.613 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 36.4 m -111.31 -61.77 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.658 0.266 . . . . 1.0 111.098 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.6 tt0 -49.06 -20.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.149 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 44.9 mt-10 -87.87 36.4 0.76 Allowed 'General case' 0 C--O 1.265 1.921 0 CA-C-O 124.433 2.063 . . . . 1.0 109.032 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.65 63.43 1.21 Allowed Glycine 0 C--O 1.212 -1.261 0 CA-C-N 112.937 -1.938 . . . . 1.0 111.11 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.528 HH12 ' CG ' ' D' ' 59' ' ' ASP . 62.2 ttm-85 -24.92 -33.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.025 0.913 . . . . 1.0 111.055 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 67' ' ' GLY . 70.9 mmtt -49.93 -18.27 0.5 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.48 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -62.41 -47.56 92.43 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 119.288 -0.965 . . . . 1.0 110.449 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.62 69.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.307 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.32 -37.96 88.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.823 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.1 -43.99 82.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.848 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -44.57 92.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.41 -41.58 98.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.57 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.35 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.87 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.568 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.52 94.99 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 79' ' ' ILE . 96.2 mt -62.4 -43.37 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.627 0.251 . . . . 1.0 110.429 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.71 -43.45 97.81 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.265 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.58 -49.25 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.002 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.37 -13.85 61.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.392 . . . . 1.0 111.086 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.39 -35.54 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 1.0 110.715 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.88 -42.17 97.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ALA . 11.4 m -59.42 -23.14 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.421 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.7 m -36.71 -28.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 1.0 110.624 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.35 -49.01 79.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.269 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -63.48 -32.4 73.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.284 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 4.2 mm? -66.48 -40.22 89.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.555 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.28 -45.12 84.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.842 0.353 . . . . 1.0 110.955 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.97 -3.22 34.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.258 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.42 -48.65 76.51 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.582 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.8 p90 -73.62 -37.06 65.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 1.0 111.451 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 95.3 t -48.29 -27.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.592 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -66.25 -21.44 66.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 67.5 t0 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.69 0.281 . . . . 1.0 110.657 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.497 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 7.3 p80 -79.3 -22.19 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.532 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.22 -37.81 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.74 -39.85 95.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.15 -40.55 90.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.935 0.398 . . . . 1.0 110.05 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.72 90.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -65.34 -41.26 94.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -63.6 -36.4 83.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.483 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.0 86.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.965 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.03 -37.25 73.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 1.0 110.613 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.3 -32.97 74.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.194 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.18 -39.52 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.389 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.9 tp -61.89 -42.79 99.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.273 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -53.95 -39.75 66.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.97 -37.77 86.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.527 -0.306 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.19 -41.83 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.36 -48.07 83.31 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.456 ' O ' ' OG ' ' B' ' 23' ' ' SER . 81.0 mm-40 -64.68 -41.96 95.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.233 0.539 . . . . 1.0 109.745 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.64 -26.69 68.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.51 87.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.248 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 97.9 p -58.86 -45.36 90.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.556 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.66 -30.75 71.49 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.45 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 29' ' ' ALA . 29.1 mmtp -79.3 -42.88 24.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.45 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.17 -47.99 77.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.441 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 8.3 p -61.75 -45.88 97.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.509 . . . . 1.0 109.971 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.484 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -71.18 -21.22 62.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -58.49 -40.47 82.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.963 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 27.3 mp0 -65.93 -36.4 83.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 1.0 110.294 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -66.79 90.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.431 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 126.72 -15.31 6.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.28 19.17 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 87.2 Cg_endo -76.42 118.42 4.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.075 1.85 . . . . 1.0 112.235 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.8 37.68 1.13 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.89 143.34 32.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.64 -51.3 0.09 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.232 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' B' ' 39' ' ' ILE . 5.0 tt -60.96 -60.29 4.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.981 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' B' ' 40' ' ' SER . 44.9 pt 31.56 -145.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 123.436 0.46 . . . . 1.0 110.729 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.464 ' O ' ' O ' ' B' ' 39' ' ' ILE . 19.3 m 57.39 144.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.331 0.586 . . . . 1.0 111.162 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.443 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 2.7 m-85 -100.58 -64.37 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.763 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 23.3 Cg_endo -58.85 -23.49 67.53 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.293 1.995 . . . . 1.0 112.432 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -90.76 -21.18 21.67 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.677 0.275 . . . . 1.0 110.697 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.69 88.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.841 0.353 . . . . 1.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -61.8 -36.49 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.216 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.504 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.6 OUTLIER -67.77 -43.16 80.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.421 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.464 ' CD1' ' OE2' ' B' ' 50' ' ' GLU . 19.5 t90 -61.6 -41.6 97.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.731 0.3 . . . . 1.0 110.669 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 m -60.94 -38.11 84.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.475 -0.49 . . . . 1.0 110.581 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.75 -44.41 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.464 ' OE2' ' CD1' ' B' ' 47' ' ' TRP . 5.0 pt-20 -55.78 -38.9 70.52 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.709 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.654 ' C ' ' H ' ' B' ' 53' ' ' THR . 6.0 t -87.34 -152.44 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.216 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 58.94 -9.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.475 0.179 . . . . 1.0 110.663 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.654 ' H ' ' C ' ' B' ' 51' ' ' THR . 67.0 p -113.06 15.32 19.6 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.648 0.261 . . . . 1.0 110.937 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.07 66.5 1.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.916 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' B' ' 56' ' ' GLY . 9.9 p -147.56 -46.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.758 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.471 ' N ' ' CG1' ' B' ' 55' ' ' VAL . . . 44.73 78.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.415 ' OH ' ' OG1' ' C' ' 51' ' ' THR . 0.2 OUTLIER -61.98 -45.23 94.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.681 0.277 . . . . 1.0 110.502 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.65 3.63 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.644 -0.983 . . . . 1.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 99.5 m-20 -62.51 -41.43 98.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.363 . . . . 1.0 110.688 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -117.11 -173.17 2.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -139.57 99.4 7.77 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.615 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.12 160.52 48.39 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.375 1.383 . . . . 1.0 112.285 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' B' ' 34' ' ' PRO . 0.9 OUTLIER -79.24 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.588 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 66' ' ' GLU . 1.8 m -115.35 -67.82 0.97 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.288 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' B' ' 32' ' ' GLY . 80.7 tt0 -34.02 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.224 0.535 . . . . 1.0 110.701 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.867 ' O ' ' N ' ' B' ' 68' ' ' ARG . 91.8 mt-10 -147.85 -107.07 0.09 Allowed 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.549 -0.75 . . . . 1.0 109.359 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.06 -56.54 0.0 OUTLIER Glycine 0 N--CA 1.478 1.49 0 O-C-N 124.635 1.209 . . . . 1.0 114.355 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.867 ' N ' ' O ' ' B' ' 66' ' ' GLU . 36.6 ttt180 -72.13 -46.09 57.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.16 -34.2 77.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.832 -1.173 . . . . 1.0 107.832 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.71 -44.66 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.96 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.6 76.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.234 -0.439 . . . . 1.0 109.936 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -52.39 -50.47 62.4 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.898 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.47 -48.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.516 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 78.2 mtm -61.52 -47.62 84.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.785 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' B' ' 80' ' ' GLU . 51.6 tttp -66.44 -40.51 89.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.521 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.7 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.78 94.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.55 -43.17 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.001 -0.28 . . . . 1.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -58.59 -47.39 84.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.061 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.84 -50.37 75.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.619 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -67.9 -37.21 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.689 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.03 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.32 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' B' ' 86' ' ' THR . 3.6 tt -61.59 -42.03 98.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' B' ' 87' ' ' ALA . 26.2 t -49.09 -21.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.406 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.5 m -48.77 -21.07 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' B' ' 91' ' ' THR . . . -58.55 -54.52 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 1.0 111.024 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.71 89.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.828 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.0 mm? -63.04 -42.75 99.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.412 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -64.35 -35.74 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.437 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -82.57 -4.36 57.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.535 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -57.93 -48.75 78.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.57 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 10.7 p90 -67.14 -32.44 73.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.008 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.68 -43.71 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.76 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -57.37 -21.62 37.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.487 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -58.97 -33.07 70.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.068 0.461 . . . . 1.0 109.936 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.836 -178.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.883 0.373 . . . . 1.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 15.2 p80 -66.83 -37.48 84.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.7 tt0 -62.69 -35.69 80.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.677 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.04 -39.7 95.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.01 -40.15 94.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.323 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.78 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.368 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.25 -36.54 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.371 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.42 -38.69 88.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.35 85.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.11 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.53 -39.49 93.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 1.0 111.011 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -63.55 -38.72 92.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.644 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.98 -32.38 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.28 -38.52 89.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 1.0 110.315 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.62 -33.44 74.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.202 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.55 -46.95 83.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.697 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 m -63.86 -37.6 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.81 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.15 -41.87 98.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.279 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.0 mt-10 -64.49 -43.22 94.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.35 -39.41 71.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.313 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.4 84.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.0 p -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.413 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -65.56 -39.93 92.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.236 0.541 . . . . 1.0 109.965 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.2 mttp -66.8 -43.97 82.45 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.054 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -54.39 -53.56 52.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.748 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.12 -44.81 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.66 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.34 -33.88 75.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.405 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' C' ' 26' ' ' ALA . 4.5 mp0 -81.79 -13.17 58.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.657 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.74 89.62 0.11 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.842 0.354 . . . . 1.0 110.425 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.08 20.05 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.3 140.47 72.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.26 141.34 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.936 1.758 . . . . 1.0 112.33 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.01 65.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.228 -0.749 . . . . 1.0 111.228 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 134.37 44.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.885 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.41 -22.73 16.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.356 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 tp -107.37 112.15 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.9 pt -139.26 -3.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.263 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -76.36 154.62 34.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.512 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -96.18 -63.17 0.12 Allowed Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.28 -36.12 95.52 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.99 1.794 . . . . 1.0 112.528 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.402 ' O ' ' NH1' ' C' ' 60' ' ' ARG . 90.8 m-20 -81.39 -7.11 59.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.257 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.47 87.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 1.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -65.5 -38.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.591 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -48.82 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.226 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -61.64 -41.18 97.14 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.682 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.2 t -68.39 60.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.645 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -150.66 -56.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.085 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.36 -30.55 71.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.584 -0.446 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.415 ' OG1' ' OH ' ' B' ' 57' ' ' TYR . 98.9 m -62.31 -46.62 87.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.25 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.48 -26.31 66.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.66 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' C' ' 54' ' ' THR . 47.3 p -91.21 5.25 49.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.96 0.41 . . . . 1.0 110.076 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 53' ' ' THR . 43.4 p 52.4 74.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.24 -68.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.294 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.13 75.23 0.48 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -59.95 -45.98 90.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.69 0.281 . . . . 1.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.43 10.57 1.87 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' D' ' 61' ' ' TYR . 99.4 m-20 -60.02 -46.77 88.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 1.0 110.405 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' C' ' 43' ' ' ASP . 53.6 mtm180 -143.01 166.86 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.02 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -156.65 127.24 3.47 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.599 -0.44 . . . . 1.0 110.542 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.67 152.57 64.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.802 1.668 . . . . 1.0 112.236 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.445 ' C ' ' OE2' ' C' ' 66' ' ' GLU . 2.4 t -84.28 -134.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.24 -0.436 . . . . 1.0 109.949 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.431 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 72.3 m -114.59 -37.97 4.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.734 0.302 . . . . 1.0 110.721 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.608 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.2 tt0 -66.55 -28.2 68.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.469 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.445 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -72.17 26.05 0.05 Allowed 'General case' 0 C--O 1.264 1.82 0 CA-C-O 123.509 1.623 . . . . 1.0 110.36 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.44 64.06 1.93 Allowed Glycine 0 C--O 1.214 -1.095 0 CA-C-O 117.889 -1.506 . . . . 1.0 111.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' B' ' 59' ' ' ASP . 58.9 ttm-85 -24.41 -31.52 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.961 0.881 . . . . 1.0 111.368 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' C' ' 67' ' ' GLY . 14.5 mptt -49.5 -21.53 0.98 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.791 -0.641 . . . . 1.0 109.354 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' C' ' 67' ' ' GLY . 76.8 t -61.72 -49.52 83.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.9 -36.25 69.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.029 0.442 . . . . 1.0 110.696 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.34 -42.09 86.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.913 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.02 -41.1 97.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.086 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.31 -43.6 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.39 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 20.7 mtm -60.9 -44.08 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.125 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.57 -38.41 89.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.59 90.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.668 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.19 95.15 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.714 -0.554 . . . . 1.0 111.714 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.29 -43.14 97.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.51 -0.406 . . . . 1.0 110.982 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.97 -50.37 74.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.809 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 m -61.84 -49.45 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.918 -0.313 . . . . 1.0 111.363 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -69.34 -40.13 77.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.019 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -64.94 -36.09 83.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 1.0 110.614 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.7 tt -62.55 -41.08 98.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.53 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -46.37 -19.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.533 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' C' ' 83' ' ' ALA . 25.9 m -51.94 -40.36 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.469 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -49.35 -27.48 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.243 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.58 -16.63 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.612 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' C' ' 86' ' ' THR . 55.3 mt -87.86 -44.07 11.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.164 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.15 -23.84 50.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.936 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -85.93 -4.42 59.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.898 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.07 -45.27 93.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.698 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.421 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 7.1 p90 -76.03 -28.6 57.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.067 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.81 -42.61 89.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.468 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -55.66 -21.8 19.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.198 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 42.6 ptt85 -50.74 -41.84 56.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 1.0 110.474 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 9.4 tm-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.694 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.428 ' O ' ' NH1' ' D' ' 6' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.866 0.365 . . . . 1.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 16.6 p-10 -77.01 -37.74 54.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.129 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.472 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.3 p80 -65.59 -34.83 79.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.01 -38.84 92.8 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.573 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' D' ' 2' ' ' ALA . 84.2 mtt85 -64.24 -38.98 92.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.598 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -66.2 -40.15 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.175 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.85 92.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.772 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.84 -40.43 91.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 1.0 110.56 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.73 -35.66 81.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.516 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.68 79.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.966 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.16 -39.53 94.2 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.683 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.22 -36.44 83.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.65 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -63.99 -36.05 82.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.427 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -62.4 -41.38 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.643 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.86 -44.78 78.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.699 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.4 -40.09 96.28 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.204 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -49.02 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.98 -30.19 62.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.415 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -66.26 -49.92 65.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.669 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.17 -40.42 95.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' D' ' 26' ' ' ALA . . . -65.45 -34.15 77.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.823 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' D' ' 48' ' ' SER . 26.0 m -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.814 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -63.68 -39.07 93.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.46 -0.496 . . . . 1.0 110.036 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.73 -18.25 44.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.135 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -58.6 -50.23 74.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.382 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.65 -43.8 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.54 -30.76 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.32 -34.11 71.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.535 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' D' ' 32' ' ' GLY . 79.0 mm-40 -63.83 -46.87 83.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -46.21 95.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.433 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 126.93 -5.7 7.38 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.52 32.94 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.912 0.356 . . . . 1.0 110.32 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.64 117.34 4.73 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.113 1.875 . . . . 1.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' D' ' 37' ' ' ALA . . . 103.52 -22.67 35.23 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' D' ' 37' ' ' ALA . . . 46.93 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.694 0.283 . . . . 1.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' D' ' 35' ' ' GLY . . . 82.44 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -73.07 53.21 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.89 0.376 . . . . 1.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' D' ' 39' ' ' ILE . 18.8 tt -105.16 111.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.065 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.546 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 17.3 t 179.45 -118.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.125 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.7 m-85 177.27 -66.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.298 -0.26 . . . . 1.0 110.298 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -59.03 -31.16 95.15 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.024 1.816 . . . . 1.0 111.666 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -84.21 -9.19 58.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.32 99.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.87 0.367 . . . . 1.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -67.68 -39.3 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.691 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -46.95 86.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.441 ' CD2' ' C ' ' D' ' 47' ' ' TRP . 0.3 OUTLIER -70.78 -20.76 62.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.232 -0.587 . . . . 1.0 109.604 178.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' D' ' 23' ' ' SER . 22.8 t -74.56 -40.49 61.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.106 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.89 -47.76 91.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -66.78 -37.61 84.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.118 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -62.45 -44.57 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.008 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.7 -25.42 62.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -97.77 9.81 41.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.203 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p 43.88 44.62 5.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.225 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.83 -54.57 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.843 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.57 57.15 3.37 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.616 ' CG ' ' CD1' ' A' ' 61' ' ' TYR . 5.6 t80 -61.91 -41.79 98.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 1.0 110.491 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.19 -14.63 0.22 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.528 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -40.43 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.886 0.375 . . . . 1.0 110.958 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -132.39 156.62 46.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.103 -0.498 . . . . 1.0 109.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.51 ' CD2' ' OD1' ' C' ' 59' ' ' ASP . 5.6 p90 -149.3 153.28 37.32 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.81 160.04 51.3 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.299 1.999 . . . . 1.0 111.993 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 18.2 t -90.05 -116.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.578 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 60.7 m -116.23 -77.55 0.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.815 0.341 . . . . 1.0 110.95 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -46.92 120.77 3.21 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.064 -0.717 . . . . 1.0 109.064 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.871 ' O ' ' N ' ' D' ' 68' ' ' ARG . 96.9 mt-10 55.09 -96.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.91 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.19 -55.68 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 O-C-N 125.086 1.491 . . . . 1.0 114.085 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.871 ' N ' ' O ' ' D' ' 66' ' ' GLU . 57.7 ttm-85 -80.04 -58.5 3.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.539 . . . . 1.0 109.87 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' D' ' 66' ' ' GLU . 99.0 mttt -43.46 -40.78 3.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.71 -46.9 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.536 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -49.84 68.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -44.18 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.863 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -67.14 -40.28 86.69 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.937 -0.305 . . . . 1.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.98 -47.65 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.509 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 18.5 ptp -62.6 -39.46 93.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.264 . . . . 1.0 111.083 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.61 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.667 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.597 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.87 -41.25 95.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.568 -0.613 . . . . 1.0 111.568 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.78 -43.55 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.652 0.226 . . . . 1.0 111.394 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.38 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.072 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.48 -46.07 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.42 -8.41 50.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.801 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -102.36 -27.22 12.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.81 0.338 . . . . 1.0 110.147 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' D' ' 86' ' ' THR . 6.0 tt -65.03 -37.55 87.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.275 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.8 -5.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.462 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.591 ' H ' ' C ' ' D' ' 84' ' ' LEU . 65.5 m -58.82 -42.91 90.33 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.954 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -42.39 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.767 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -102.97 -32.33 9.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.174 0.511 . . . . 1.0 110.028 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' D' ' 86' ' ' THR . 58.2 mt -69.76 -39.34 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.715 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.576 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.28 -49.51 77.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.707 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -11.83 43.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.66 -49.33 78.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.786 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 17.2 p90 -76.24 -22.56 55.04 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.38 -42.64 94.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.776 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -50.41 -21.78 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.723 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -55.58 -43.57 76.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.252 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.323 . . . . 1.0 110.476 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -162.67 -37.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.461 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.602 ' HE2' HH22 ' A' ' 95' ' ' ARG . 20.5 p-80 -81.08 -26.6 36.14 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.605 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.62 -32.49 73.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.592 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -60.38 -42.68 96.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.192 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -63.29 -45.34 91.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.072 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.71 88.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.393 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 57.2 tt0 -64.55 -39.83 94.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.59 -36.78 85.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.96 66.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.226 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 1.0 110.722 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 57.3 mp0 -66.23 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.436 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.572 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.31 -42.44 99.37 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.95 -33.06 72.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.068 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -61.58 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.269 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.74 -40.94 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.52 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.28 -41.24 88.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 23' ' ' SER . 72.3 mm-40 -61.31 -47.02 87.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.624 -0.43 . . . . 1.0 109.86 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.69 -34.2 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.008 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.793 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 92.1 p -59.41 -44.0 92.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 1.0 109.968 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.25 -40.19 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 29' ' ' ALA . 70.1 mmtt -66.83 -42.48 85.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.14 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.922 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.2 p -62.02 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.477 -0.489 . . . . 1.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 98.2 mt-10 -67.25 -39.54 86.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.429 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -62.02 -49.24 76.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.113 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 38' ' ' LEU . 5.8 tm-20 -69.67 -41.41 75.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.059 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -54.71 90.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.604 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 121.2 3.7 10.46 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.65 122.99 45.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 122.689 -0.301 . . . . 1.0 110.55 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.44 141.96 26.0 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.881 1.721 . . . . 1.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.71 15.4 81.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.15 -162.06 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 1.0 110.545 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 38' ' ' LEU . . . -171.65 -4.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.616 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 4.9 tt -99.1 89.03 4.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.034 0.445 . . . . 1.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 17.4 pt -122.76 165.66 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 81.98 135.55 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.442 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.527 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.5 t80 -75.12 -45.95 4.7 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.763 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.7 Cg_endo -60.31 -27.25 84.49 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.554 1.503 . . . . 1.0 112.501 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.73 -27.95 19.72 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.011 -0.275 . . . . 1.0 110.898 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.66 -42.07 94.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.881 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.109 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.539 ' CD1' ' OE2' ' A' ' 50' ' ' GLU . 26.6 t90 -60.09 -39.82 87.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -56.09 -36.7 68.43 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.598 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.55 71.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.843 0.354 . . . . 1.0 111.293 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE2' ' CD1' ' A' ' 47' ' ' TRP . 10.6 pt-20 -173.96 -40.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.175 0.512 . . . . 1.0 109.668 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -68.8 -39.74 79.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.148 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.0 51.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.481 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 50' ' ' GLU . 72.0 p -86.41 -3.16 58.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 53' ' ' THR . 69.4 p 52.49 38.84 26.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.084 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -102.76 -35.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.631 -0.259 . . . . 1.0 110.883 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.0 73.82 0.37 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.457 ' HH ' ' HE1' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -62.4 -44.08 97.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.336 . . . . 1.0 110.415 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.66 20.38 5.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.514 -1.034 . . . . 1.0 110.514 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.7 m-20 -62.8 -40.09 96.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.297 . . . . 1.0 110.411 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -132.3 164.41 26.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 109.923 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 12.5 p90 -151.66 90.83 3.89 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.675 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.69 166.53 27.19 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.736 1.624 . . . . 1.0 112.271 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.75 -124.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.231 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 p -114.33 -37.18 4.43 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -57.94 -26.04 61.74 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.61 -0.436 . . . . 1.0 109.87 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -87.33 29.64 0.84 Allowed 'General case' 0 C--O 1.26 1.645 0 CA-C-O 123.678 1.704 . . . . 1.0 109.199 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 38.16 65.21 0.72 Allowed Glycine 0 C--O 1.212 -1.258 0 CA-C-N 113.494 -1.685 . . . . 1.0 111.714 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.632 ' NH2' ' CE3' ' D' ' 46' ' ' TRP . 0.0 OUTLIER -22.93 -31.2 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.028 0.914 . . . . 1.0 111.507 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.2 mttt -56.79 -12.3 1.84 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.241 -0.89 . . . . 1.0 108.973 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 67' ' ' GLY . 41.3 t -60.35 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 119.507 -0.877 . . . . 1.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.91 -38.4 66.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.591 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -56.19 -39.63 72.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.577 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.38 -42.2 92.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.249 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.81 -46.52 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.296 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 63.0 mtm -63.35 -40.79 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.721 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.43 -45.0 96.14 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.439 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.11 96.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -43.08 96.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.665 0.269 . . . . 1.0 110.418 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.62 -41.66 90.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.462 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.81 -55.31 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.699 -0.4 . . . . 1.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.07 -41.21 99.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.068 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.74 -37.4 87.46 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.008 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.2 tt -62.99 -41.23 99.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.53 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.18 -10.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.44 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 84' ' ' LEU . 70.8 m -51.72 -44.22 63.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.354 . . . . 1.0 110.078 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.97 -20.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.827 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.15 -33.44 8.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.857 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.8 mt -69.8 -39.24 76.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.216 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.65 -49.84 75.89 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.256 0.55 . . . . 1.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -3.38 1.48 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.686 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 90' ' ' ALA . 64.4 t0 -60.25 -42.83 96.13 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.569 ' CG ' ' OG1' ' B' ' 91' ' ' THR . 31.2 p90 -85.25 -26.04 26.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.635 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -55.23 -29.51 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.239 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.602 HH22 ' HE2' ' A' ' 4' ' ' HIS . 84.2 mtt85 -65.79 -21.16 66.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 1.0 110.937 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.453 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.0 ptt-85 -50.34 -42.82 53.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.642 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.453 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 82.0 tt0 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.795 0.331 . . . . 1.0 110.648 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.585 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 7.9 p-80 -65.31 -32.33 73.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.437 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.06 -35.99 82.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.07 -39.19 93.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.26 -40.65 96.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.82 99.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.614 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.77 -37.72 82.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.44 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -61.75 -38.5 88.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.65 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.54 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.33 -40.9 97.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 1.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.01 -38.62 91.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 1.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -62.69 -32.18 73.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.57 -42.03 99.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -57.88 -39.62 78.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.774 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.65 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.73 -34.3 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.905 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.02 -40.39 93.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.91 -47.5 85.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -70.63 -32.09 69.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.054 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.13 80.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.265 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.9 t -60.18 -43.34 95.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.799 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.62 -55.55 33.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.137 0.494 . . . . 1.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.46 -44.11 97.19 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.082 -0.647 . . . . 1.0 110.639 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.47 -48.72 78.38 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.704 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.8 OUTLIER -65.61 -42.52 93.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.424 . . . . 1.0 110.375 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.413 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 95.5 mt-10 -69.67 -43.34 72.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.128 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.17 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -72.91 -22.4 60.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -77.88 122.25 25.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.955 0.407 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.15 2.79 57.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.377 -0.689 . . . . 1.0 111.377 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.7 149.46 37.13 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.533 -0.173 . . . . 1.0 110.533 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.27 143.41 28.21 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.073 1.849 . . . . 1.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.71 28.9 74.07 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.284 -0.726 . . . . 1.0 111.284 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 139.43 57.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 1.0 110.278 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.82 -40.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.999 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 tp -68.02 -21.73 65.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.28 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' CB ' ' B' ' 40' ' ' SER . 12.5 tt -43.27 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.52 ' O ' ' N ' ' B' ' 44' ' ' ALA . 1.8 p 163.85 109.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.557 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.7 m-85 -56.72 -60.27 9.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.087 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.8 Cg_endo -57.84 -35.51 98.75 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.058 1.839 . . . . 1.0 112.771 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.73 -20.53 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.526 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' B' ' 40' ' ' SER . . . -62.36 -39.3 92.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.951 0.405 . . . . 1.0 109.988 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.02 -37.82 80.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.663 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.409 ' CD1' ' NE ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -46.89 79.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.422 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.457 ' HE1' ' HH ' ' A' ' 57' ' ' TYR . 3.1 t90 -62.78 -40.45 97.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.26 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 44' ' ' ALA . 6.7 m -50.9 -22.76 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.755 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.88 -21.04 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.809 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -93.79 16.97 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.73 -39.02 1.65 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.744 0.307 . . . . 1.0 111.14 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.17 70.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.294 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' B' ' 54' ' ' THR . 18.7 p -90.31 9.11 30.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 1.0 110.734 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.8 p 51.32 42.04 28.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' B' ' 56' ' ' GLY . 19.0 m -97.29 -44.78 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.673 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' B' ' 55' ' ' VAL . . . 41.31 64.57 1.3 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.534 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.1 t80 -60.97 -47.13 87.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 1.0 110.907 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.4 10.68 1.24 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -57.51 -66.1 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.388 . . . . 1.0 110.568 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.43 HH21 ' NH2' ' C' ' 68' ' ' ARG . 52.4 mtm180 -137.04 142.42 42.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.991 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' B' ' 61' ' ' TYR . 6.1 p90 -126.31 136.24 28.31 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.297 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.52 164.67 33.42 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.889 1.726 . . . . 1.0 112.063 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.4 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 22.2 m -91.98 -140.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.223 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -114.1 -40.74 3.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.749 0.309 . . . . 1.0 111.129 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.667 ' C ' ' H ' ' B' ' 67' ' ' GLY . 79.4 tt0 -66.71 -32.72 74.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 67' ' ' GLY . 0.2 OUTLIER -70.38 30.35 0.04 OUTLIER 'General case' 0 C--O 1.261 1.672 0 CA-C-O 123.715 1.721 . . . . 1.0 110.03 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.42 63.94 1.27 Allowed Glycine 0 C--O 1.21 -1.344 0 CA-C-N 113.972 -1.467 . . . . 1.0 111.585 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.5 ttm-85 -25.0 -33.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.323 1.062 . . . . 1.0 110.862 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.0 mttp -48.5 -18.59 0.25 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' B' ' 67' ' ' GLY . 59.8 t -64.09 -45.55 96.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.724 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.85 -36.2 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.69 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -57.17 -41.12 78.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.947 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -64.18 -42.8 96.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.03 -47.29 88.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.251 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.668 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.03 -38.36 90.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 1.0 110.47 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.87 92.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.535 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.32 -40.92 91.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.406 HD13 HG21 ' B' ' 79' ' ' ILE . 96.5 mt -61.93 -43.29 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.838 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.8 -42.45 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.384 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.24 -47.93 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.157 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.51 -11.23 60.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.912 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.08 -25.91 13.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.81 -41.53 97.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.94 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 87' ' ' ALA . 30.8 m -46.69 -26.66 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 32.4 m -34.53 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -50.49 -65.36 0.57 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.035 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.85 -20.54 35.4 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.48 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 -44.01 97.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.595 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.32 -60.93 2.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.766 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.569 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -50.21 -5.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.84 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' B' ' 90' ' ' ALA . 51.0 t0 -60.78 -40.31 92.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 93' ' ' PHE . 1.6 p90 -65.19 -33.56 76.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 1.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.77 -44.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.458 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' B' ' 97' ' ' GLU . 10.5 tpt180 -47.05 -21.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.851 -0.34 . . . . 1.0 111.207 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -46.2 -20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.377 . . . . 1.0 110.217 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' C ' ' B' ' 95' ' ' ARG . 97.0 mt-10 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.138 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.743 0.306 . . . . 1.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 7.2 p80 -172.51 -34.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.627 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 79.8 tt0 -67.31 -41.13 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.745 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -62.28 -42.59 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.55 -39.65 91.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.104 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.98 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.477 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.08 -40.69 82.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.19 -38.16 90.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.311 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.58 78.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.044 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.17 -37.72 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 1.0 110.894 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.84 -35.5 80.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.648 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.06 -36.35 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.676 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.07 -41.01 97.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.342 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -62.59 -40.63 97.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.54 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.14 -38.63 89.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.815 0.341 . . . . 1.0 111.116 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.38 -40.79 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -59.29 -41.35 88.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.19 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.65 -48.7 80.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.869 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.85 -32.73 71.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.13 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.29 93.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -60.27 -44.11 95.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.508 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.11 -39.14 92.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 1.0 110.12 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -72.46 -47.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.09 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.57 73.16 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.359 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 7.4 p -60.8 -44.8 98.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.961 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.453 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 42.7 tp10 -68.05 -36.98 80.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.55 86.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.3 -44.48 68.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.399 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -52.93 97.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.348 . . . . 1.0 110.701 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.63 0.15 15.63 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.176 -0.769 . . . . 1.0 111.176 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.83 140.46 21.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 1.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 143.69 25.71 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.918 1.746 . . . . 1.0 112.338 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 24.39 69.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.51 140.82 58.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.379 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.08 -34.76 4.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.422 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' C' ' 40' ' ' SER . 1.1 mt -72.2 -2.05 17.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.213 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.428 ' O ' ' OG ' ' C' ' 40' ' ' SER . 12.4 tt -46.92 90.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 1.0 110.627 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.519 ' N ' ' O ' ' C' ' 38' ' ' LEU . 70.4 m -167.04 -127.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.008 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.407 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 6.9 t80 174.39 -58.29 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.346 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.7 Cg_endo -58.86 -38.28 89.3 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.835 1.69 . . . . 1.0 112.376 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 14.6 p-10 -91.91 2.97 56.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.5 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.74 98.29 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.771 -0.371 . . . . 1.0 110.507 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 tt -68.21 -31.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.378 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.59 ' CZ2' ' O ' ' D' ' 63' ' ' VAL . 10.4 t90 -57.91 -47.17 83.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.993 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.0 OUTLIER -76.17 -22.33 55.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.404 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 6.0 t -67.5 -42.7 82.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.436 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 76.0 t -61.09 -47.9 91.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.74 -31.63 71.67 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.88 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -58.96 -44.94 91.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.2 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.23 70.89 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.759 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' C' ' 54' ' ' THR . 68.8 p -75.18 -6.81 51.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' C' ' 53' ' ' THR . 13.2 p 59.33 24.15 12.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' C' ' 56' ' ' GLY . 18.5 m -87.54 -47.5 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.611 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . 0.449 ' N ' ' CG2' ' C' ' 55' ' ' VAL . . . 38.43 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.37 -39.88 95.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.793 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.8 16.29 1.29 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.119 -0.793 . . . . 1.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.04 -41.65 99.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 1.0 110.572 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -145.44 176.3 9.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -163.67 127.7 1.87 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.593 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.27 160.02 51.0 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.918 1.745 . . . . 1.0 112.382 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.422 ' CG1' ' H ' ' C' ' 64' ' ' THR . 2.0 t -86.99 -140.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.092 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.422 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 54.0 m -114.81 -34.48 5.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' C' ' 67' ' ' GLY . 76.0 tt0 -67.17 -31.52 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -69.57 31.61 0.03 OUTLIER 'General case' 0 C--O 1.262 1.75 0 CA-C-O 123.48 1.61 . . . . 1.0 110.347 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.07 64.72 1.42 Allowed Glycine 0 C--O 1.212 -1.255 0 CA-C-N 114.103 -1.408 . . . . 1.0 111.234 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' C' ' 67' ' ' GLY . 49.6 ttm-85 -23.49 -33.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 117.848 0.824 . . . . 1.0 111.174 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.6 mptm? -49.66 -19.33 0.59 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' C' ' 67' ' ' GLY . 78.1 t -62.94 -46.64 95.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 119.23 -0.988 . . . . 1.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.34 69.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 1.0 110.628 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.75 -44.28 77.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.786 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.21 -43.09 99.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.518 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.73 -47.96 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.738 -0.385 . . . . 1.0 111.129 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.38 -42.64 96.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.593 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 55.2 tttm -64.68 -39.55 93.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.604 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.49 93.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 1.0 110.47 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.63 -42.1 93.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.747 -0.541 . . . . 1.0 111.747 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.401 HD12 HG22 ' C' ' 79' ' ' ILE . 96.6 mt -62.0 -44.0 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.84 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 98.0 mt-10 -63.52 -40.32 96.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.279 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 63.9 t -64.05 -49.05 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.094 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -67.85 -37.72 82.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.347 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -66.42 -36.02 81.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.0 110.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.7 tt -61.78 -40.05 93.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.81 -3.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.719 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.561 ' H ' ' C ' ' C' ' 84' ' ' LEU . 66.8 m -59.33 -40.93 87.87 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.685 0.279 . . . . 1.0 110.271 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.35 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.259 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.13 -11.29 38.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.69 -61.12 1.8 Allowed 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.578 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -42.93 -52.34 5.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.819 0.343 . . . . 1.0 111.045 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.38 -13.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.002 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' C' ' 90' ' ' ALA . 96.8 m-20 -63.52 -47.52 81.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.277 . . . . 1.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 2.2 p90 -67.98 -33.3 74.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 1.0 110.847 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -43.06 94.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.773 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -58.67 -22.44 56.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.394 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . 0.446 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 37.9 ptt85 -50.39 -43.11 54.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 1.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 46.9 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.362 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.878 0.37 . . . . 1.0 110.593 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 15.2 p-10 -77.73 -41.7 36.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.287 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' D' ' 4' ' ' HIS . 6.7 p80 -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.873 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -63.75 -37.2 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.693 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.49 -41.51 97.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.666 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -65.81 -37.46 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 1.0 110.059 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.77 -39.56 93.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.499 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.21 -37.61 87.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.554 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.93 91.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.074 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.23 -38.84 92.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 1.0 110.757 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.06 -36.35 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.626 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.78 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.581 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.67 -41.57 99.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.794 -0.362 . . . . 1.0 110.418 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.05 -36.31 74.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.834 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -60.89 -41.91 96.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.715 0.293 . . . . 1.0 111.042 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.32 -37.43 79.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.89 -41.65 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.19 -47.47 84.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.016 0.436 . . . . 1.0 110.149 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.48 -34.2 77.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.895 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.11 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.715 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -60.94 -45.99 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.09 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -78.08 -35.8 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 1.0 111.064 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -72.39 -44.87 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.163 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -62.16 -49.76 74.53 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 11.4 p -61.44 -43.62 97.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 1.0 109.868 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 42.1 tp10 -69.28 -20.78 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.041 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.04 85.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.077 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 24.0 mp0 -63.97 -38.15 90.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.802 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -57.93 93.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.18 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -9.12 6.9 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.1 146.65 32.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.752 0.276 . . . . 1.0 110.353 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.72 116.47 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.766 1.644 . . . . 1.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.09 37.71 4.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.74 98.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.816 0.341 . . . . 1.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.63 -72.6 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.13 61.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 1.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 tt -90.38 -8.37 10.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.928 0.394 . . . . 1.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -65.69 140.13 58.44 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 0.8 OUTLIER -97.68 -61.44 0.12 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.67 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.447 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.5 Cg_endo -57.85 -32.04 93.97 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.558 1.505 . . . . 1.0 111.888 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.81 -3.27 58.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 1.0 110.574 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . 0.415 ' O ' ' OG ' ' D' ' 48' ' ' SER . 0.0 OUTLIER -66.3 -32.24 57.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.287 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.632 ' CE3' ' NH2' ' A' ' 68' ' ' ARG . 1.7 t-105 -61.18 -47.3 86.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.008 -178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.413 ' CE3' ' N ' ' D' ' 48' ' ' SER . 0.8 OUTLIER -69.86 -37.88 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 25.3 p -47.12 -34.57 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 1.0 110.323 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.2 -44.71 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.412 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.3 52.84 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.73 -0.471 . . . . 1.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.9 m -156.21 -48.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.468 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.91 -23.62 46.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.021 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.2 p -93.5 8.37 40.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.281 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.5 p 48.72 32.6 3.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.898 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.47 -39.49 85.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.101 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -91.21 0.64 Allowed Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' D' ' 57' ' ' TYR . 43.7 p90 -62.91 114.66 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.263 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' D' ' 60' ' ' ARG . . . -126.47 28.24 4.8 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t0 63.76 -6.74 0.22 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.755 0.312 . . . . 1.0 110.789 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' D' ' 58' ' ' GLY . 73.4 mtt-85 -145.87 128.41 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 8.2 p90 -118.55 141.44 29.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.852 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.81 156.78 62.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.314 2.009 . . . . 1.0 112.512 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.59 ' O ' ' CZ2' ' C' ' 46' ' ' TRP . 12.3 t -77.94 -120.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.057 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 54.6 m -116.9 -72.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.961 0.41 . . . . 1.0 110.227 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -56.16 127.34 30.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' D' ' 68' ' ' ARG . 94.5 mt-10 58.28 -94.5 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.054 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 24.63 -57.18 0.0 OUTLIER Glycine 0 N--CA 1.48 1.57 0 O-C-N 124.483 1.114 . . . . 1.0 114.193 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.5 ttp85 -83.19 -59.48 2.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -41.08 -36.35 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.49 -46.59 80.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.949 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -66.46 -34.79 78.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.828 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.12 -48.1 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.905 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.82 -38.1 88.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.946 -0.302 . . . . 1.0 111.716 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -62.86 -46.38 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.39 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.77 -39.89 95.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.613 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.5 98.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.567 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.11 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.332 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.42 94.91 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.692 -0.563 . . . . 1.0 111.692 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.423 HG22 HD13 ' D' ' 79' ' ' ILE . 95.6 mt -62.3 -43.43 98.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.621 0.248 . . . . 1.0 111.148 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.21 -38.63 91.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.899 -0.321 . . . . 1.0 111.36 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.18 -49.65 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.277 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -67.17 -40.7 86.64 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.692 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.92 -33.71 76.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.234 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.4 tt -60.95 -41.53 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.086 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.02 -14.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 1.0 110.258 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.505 ' H ' ' C ' ' D' ' 84' ' ' LEU . 39.6 m -49.6 -39.59 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.071 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.59 -26.98 14.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.63 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.92 -10.76 32.75 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.158 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.4 -59.85 2.1 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.181 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 92' ' ' ASP . . . -42.22 -53.74 3.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 1.0 111.056 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.746 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' D' ' 90' ' ' ALA . 80.1 m-20 -62.0 -45.11 95.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.313 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 0.1 OUTLIER -53.56 -37.14 62.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 1.0 110.489 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' D' ' 97' ' ' GLU . 61.4 t -61.05 -43.66 96.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.135 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -50.92 -21.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.745 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -55.47 -44.04 76.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.137 -0.32 . . . . 1.0 110.137 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' D' ' 97' ' ' GLU . 55.1 mp0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.857 0.361 . . . . 1.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -159.94 -61.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.413 ' HD1' ' CB ' ' A' ' 88' ' ' ALA . 8.7 p80 -77.42 -23.88 50.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.836 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -67.11 -37.79 84.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.803 0.335 . . . . 1.0 110.239 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -60.76 -43.23 98.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.87 -38.89 90.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.085 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.14 99.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.331 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.09 -37.41 85.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.377 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -61.32 -41.96 97.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.283 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.2 83.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.842 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.32 -35.6 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.566 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.43 -37.16 86.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.387 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.19 -32.11 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.637 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.11 -41.73 98.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 1.0 110.504 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.22 -40.43 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.154 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -63.51 -39.85 95.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.864 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -63.11 -42.57 97.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.24 -41.41 93.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.319 -0.4 . . . . 1.0 109.944 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.81 -45.68 92.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -69.56 -34.11 73.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.107 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.79 94.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.459 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -43.35 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.21 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.92 -59.68 5.07 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.14 -45.07 96.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.154 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.69 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.483 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.43 -47.23 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.257 -0.577 . . . . 1.0 110.338 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.92 -41.57 67.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.837 -0.62 . . . . 1.0 111.35 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -35.08 65.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.804 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 5.5 mp0 -89.89 -10.18 46.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.632 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -75.24 108.52 8.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.63 61.28 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.504 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.91 142.94 26.11 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.33 143.55 28.18 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.111 1.874 . . . . 1.0 112.443 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.74 -4.44 21.87 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.91 143.25 52.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.846 0.355 . . . . 1.0 110.568 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.17 -26.76 2.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.568 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.66 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.892 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.42 ' O ' ' CB ' ' A' ' 40' ' ' SER . 14.5 tt -116.79 89.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.226 0.536 . . . . 1.0 110.439 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 0.3 OUTLIER 166.98 134.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.766 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.484 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 66.8 m-85 -69.58 -49.41 21.84 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.043 -0.526 . . . . 1.0 112.403 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.3 Cg_endo -60.19 -34.92 93.73 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.486 1.457 . . . . 1.0 113.188 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.7 p-10 -90.5 -24.28 20.7 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 121.062 -0.255 . . . . 1.0 111.08 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . . . -65.1 -38.29 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 1.0 110.581 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 tp -63.35 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.98 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.538 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.3 OUTLIER -62.49 -45.64 92.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.934 179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 51' ' ' THR . 3.7 t90 -57.53 -39.91 77.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -65.44 -34.78 79.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.4 -46.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.475 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.11 -8.23 56.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.062 0.458 . . . . 1.0 110.428 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 24.2 m -80.61 -45.63 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.328 . . . . 1.0 111.195 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.57 88.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.609 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -75.12 0.29 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.71 60.98 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.73 -44.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.682 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 36.12 89.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.731 -0.548 . . . . 1.0 111.731 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.89 -44.42 97.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.343 . . . . 1.0 110.704 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.12 15.76 0.68 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 98.4 m-20 -59.92 -50.39 73.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.337 . . . . 1.0 110.636 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 43' ' ' ASP . 0.9 OUTLIER -138.75 156.28 47.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.976 -0.557 . . . . 1.0 109.875 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -144.08 131.6 10.61 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.674 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.58 -171.62 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.827 1.685 . . . . 1.0 112.198 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.672 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.2 p -128.82 -136.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.222 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.672 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 66.4 m -112.62 -40.23 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.628 0.251 . . . . 1.0 111.341 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.636 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.3 tt0 -64.48 -36.12 83.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.461 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 1.2 pp20? -72.66 32.18 0.06 Allowed 'General case' 0 C--O 1.262 1.763 0 CA-C-O 124.537 2.113 . . . . 1.0 109.721 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.25 63.98 1.43 Allowed Glycine 0 C--O 1.212 -1.242 0 CA-C-N 113.612 -1.631 . . . . 1.0 111.098 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.471 HH21 HH22 ' D' ' 60' ' ' ARG . 56.8 ttm-85 -24.12 -34.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.95 0.875 . . . . 1.0 111.334 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.8 mtmt -50.5 -14.25 0.17 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.609 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' GLY . 43.2 t -60.95 -47.68 92.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.156 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -42.48 68.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.353 . . . . 1.0 111.161 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -52.09 -39.64 60.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.85 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -68.97 -41.33 78.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.615 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.96 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.398 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.1 ptp -63.62 -39.55 94.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.773 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -62.73 -42.63 99.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.446 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.96 86.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.361 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -36.73 93.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -26.93 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.135 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.14 -49.76 18.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.724 0.297 . . . . 1.0 111.412 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.4 m -62.21 -48.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.32 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -66.0 -40.79 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.707 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.09 -36.61 84.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 1.0 111.064 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.6 tt -62.16 -41.59 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.346 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.6 t -46.47 -13.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.559 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 84' ' ' LEU . 94.9 m -55.31 -23.83 25.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -62.28 -29.67 70.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.111 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.413 ' CB ' ' HD1' ' A' ' 4' ' ' HIS . . . -92.52 -11.84 33.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.777 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.27 -47.63 9.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.655 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.89 -24.12 49.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.959 0.409 . . . . 1.0 111.016 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -89.17 -3.73 58.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.706 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.89 -46.48 89.2 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.384 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -81.76 -19.18 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.31 -28.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.405 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 97' ' ' GLU . 96.4 mtt180 -63.59 -28.91 70.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -42.41 -23.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.845 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 95' ' ' ARG . 44.1 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 1.0 110.04 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . 0.471 ' OD1' ' NH2' ' B' ' 6' ' ' ARG . 78.8 m-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.637 0.256 . . . . 1.0 110.436 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.572 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 2.2 m80 -60.97 -45.52 94.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.21 -48.99 75.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.592 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' B' ' 3' ' ' ASP . 88.7 mtm180 -65.42 -41.07 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 1.0 110.768 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.9 -40.24 87.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.166 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.44 96.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.521 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -65.49 -38.03 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.05 -39.07 93.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.684 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.44 67.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.903 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.85 -35.36 80.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 1.0 110.505 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.236 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.15 -37.55 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.599 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.49 -40.92 98.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 1.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.66 -39.34 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.812 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.37 -43.21 99.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.61 -40.84 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.49 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.444 ' O ' ' OG ' ' B' ' 23' ' ' SER . 32.7 mt -59.03 -42.81 91.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.46 -37.71 85.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.37 -53.11 39.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.415 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -65.93 -43.97 86.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' B' ' 48' ' ' SER . 75.2 m -56.22 -43.91 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.128 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.34 -32.84 74.69 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.25 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.98 -34.81 50.71 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.09 -0.244 . . . . 1.0 111.239 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.43 67.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.483 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' B' ' 28' ' ' GLU . 2.6 m -61.52 -49.08 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.406 -0.517 . . . . 1.0 110.496 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 80.6 tt0 -76.35 -35.8 58.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.605 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.97 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.215 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -107.82 61.41 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.762 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -141.8 80.04 1.7 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 1.0 111.105 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.06 4.41 27.54 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.7 57.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.35 139.6 23.57 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.008 1.806 . . . . 1.0 112.244 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 19.04 74.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.05 166.02 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.753 0.311 . . . . 1.0 110.458 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.07 -11.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.642 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' B' ' 40' ' ' SER . 0.9 OUTLIER -87.6 33.26 0.7 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.223 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 pt -71.84 46.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.65 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.447 ' H ' ' C ' ' B' ' 38' ' ' LEU . 58.3 m -130.96 151.31 51.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.099 0.475 . . . . 1.0 111.065 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.439 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 3.0 m-85 -97.54 -64.5 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.015 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -58.52 -28.03 84.27 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 122.213 1.942 . . . . 1.0 112.525 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -87.56 -2.18 58.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 1.0 110.643 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.02 95.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 1.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.79 -39.29 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.765 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -49.49 77.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.415 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -40.78 95.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.465 ' CB ' ' OG ' ' B' ' 23' ' ' SER . 15.2 m -63.15 -39.62 95.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.53 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -59.5 -47.31 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.812 0.301 . . . . 1.0 111.812 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.482 ' CD ' HH12 ' C' ' 68' ' ' ARG . 15.0 pt-20 -65.41 -30.03 70.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -64.39 -44.75 90.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.615 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -25.54 61.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.286 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.465 ' C ' ' H ' ' B' ' 55' ' ' VAL . 33.3 p -90.65 4.08 52.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.805 0.336 . . . . 1.0 110.583 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' B' ' 53' ' ' THR . 17.9 p 54.42 9.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.635 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' B' ' 53' ' ' THR . 67.6 t -63.97 -45.85 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.698 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.31 57.61 5.59 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -60.4 -49.29 78.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.371 . . . . 1.0 110.938 -178.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 158.73 -92.46 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 69.1 m-20 44.16 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.614 0.245 . . . . 1.0 110.611 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.593 ' NH2' ' NH2' ' C' ' 68' ' ' ARG . 1.1 mpp_? -114.87 161.52 18.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 16.6 p90 -141.58 105.1 5.89 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.384 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 163.21 38.62 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.525 1.483 . . . . 1.0 112.308 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.69 ' CG2' ' H ' ' B' ' 64' ' ' THR . 9.6 p -106.03 -154.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.352 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.69 ' H ' ' CG2' ' B' ' 63' ' ' VAL . 9.9 m -88.7 -53.45 4.62 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.65 0.262 . . . . 1.0 111.632 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.3 tt0 -42.09 -36.36 1.13 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.776 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.576 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -72.73 22.85 0.06 Allowed 'General case' 0 C--O 1.267 1.974 0 CA-C-O 124.283 1.992 . . . . 1.0 109.782 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.728 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 42.99 65.46 1.41 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.704 -1.609 . . . . 1.0 111.463 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.576 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -26.66 -28.55 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.067 0.934 . . . . 1.0 110.863 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.3 mttt -45.43 -26.31 0.53 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 67' ' ' GLY . 3.8 p -63.13 -43.63 98.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.627 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -79.37 -37.91 36.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.608 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -58.59 -40.19 82.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -63.71 -44.04 94.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.502 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 95.2 t -63.17 -48.23 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.891 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.1 mtm -63.03 -43.71 97.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.281 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -64.51 -40.84 96.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.161 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.23 97.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.729 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.86 95.84 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.09 -43.75 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.781 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.14 -42.99 99.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 1.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.63 -46.91 93.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.908 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -74.98 -4.16 36.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.851 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.45 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.02 -31.69 10.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.881 0.372 . . . . 1.0 110.052 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -64.98 -39.52 93.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.025 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.02 -5.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.206 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' B' ' 84' ' ' LEU . 53.9 m -58.54 -41.43 85.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -42.23 -54.07 3.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.599 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.96 68.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 86' ' ' THR . 70.0 mt -88.2 -17.63 30.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -70.94 -37.15 72.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.441 ' HG1' ' HE ' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -66.8 -24.86 66.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.225 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -49.42 -43.79 44.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.656 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -59.74 -46.49 88.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.946 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.75 -42.32 89.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.441 ' HE ' ' HG1' ' B' ' 91' ' ' THR . 95.6 mtt-85 -49.41 -21.51 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.539 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -50.29 -39.25 44.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 1.0 110.281 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 -179.615 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' C' ' 6' ' ' ARG . 55.0 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.827 0.346 . . . . 1.0 111.074 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 7.1 p-80 -40.97 -31.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.22 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 20.4 pt-20 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 1.0 110.632 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' C' ' 3' ' ' ASP . 73.5 ttp85 -60.63 -43.1 97.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.299 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.08 -38.27 90.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.036 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.89 92.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.629 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.03 -40.98 95.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.52 -37.27 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.495 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.22 93.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.086 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.13 -38.7 89.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 1.0 110.847 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -65.82 -32.16 73.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -61.66 -40.64 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -39.58 94.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.53 -30.93 71.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.873 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.49 -42.35 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -59.86 -40.32 88.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.359 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.4 mm-40 -54.59 -48.88 71.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.849 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.78 -33.46 74.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.897 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.51 82.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 91.0 p -61.78 -46.95 87.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.445 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.56 -36.33 80.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.227 0.536 . . . . 1.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.72 -46.5 53.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.504 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -64.46 -48.46 75.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.395 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 8.3 p -59.32 -44.88 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.221 -0.591 . . . . 1.0 109.685 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 82.4 tt0 -68.37 -26.96 65.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.37 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.409 ' O ' ' OE1' ' C' ' 66' ' ' GLU . . . -56.16 -51.01 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.14 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 33.3 mp0 -67.54 -36.94 81.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -72.89 92.23 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.89 -19.54 5.81 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.662 . . . . 1.0 111.444 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.51 154.03 39.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.1 150.59 37.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.264 1.976 . . . . 1.0 112.193 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.28 61.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.21 143.51 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 1.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 -39.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.539 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' C' ' 39' ' ' ILE . 3.5 tt -57.94 -79.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.994 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' C' ' 38' ' ' LEU . 95.4 mt 51.57 167.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' C' ' 39' ' ' ILE . 1.8 t 81.65 124.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.453 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.475 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 53.4 t80 -88.28 -49.89 0.42 Allowed Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.254 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.9 Cg_endo -60.05 -28.49 87.15 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.343 1.362 . . . . 1.0 112.529 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.48 -13.2 24.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.53 0.205 . . . . 1.0 111.216 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -37.46 84.44 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.532 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.32 -34.69 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.404 ' NE1' ' CB ' ' D' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -48.11 75.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.149 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.524 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 7.6 t90 -61.18 -40.2 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.414 -0.514 . . . . 1.0 109.733 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.09 45.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.842 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' C' ' 47' ' ' TRP . 71.0 t -137.25 -50.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.535 0.207 . . . . 1.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -69.45 -27.16 65.0 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -51.83 68.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.337 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.66 -25.37 53.55 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.849 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -90.94 14.21 14.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.799 0.333 . . . . 1.0 110.408 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' C' ' 54' ' ' THR . 0.1 OUTLIER 35.42 77.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.403 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -145.78 -78.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . 0.403 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 75.54 84.73 0.37 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -63.93 -40.98 97.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.622 0.248 . . . . 1.0 110.608 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.99 22.23 0.6 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 99.8 m-20 -61.83 -43.59 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 1.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 77.7 mtt-85 -144.14 -167.58 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.617 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 89.2 m-85 -157.77 123.36 2.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.72 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.86 168.39 21.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.643 1.562 . . . . 1.0 112.255 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.66 -167.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.088 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -101.88 -67.81 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.246 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -38.37 -31.7 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.801 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.8 mt-10 -138.62 -107.62 0.17 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.39 -54.79 0.0 OUTLIER Glycine 0 N--CA 1.479 1.567 0 O-C-N 124.513 1.133 . . . . 1.0 114.532 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.5 tpp180 -63.06 -58.98 5.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.106 0.562 . . . . 1.0 109.769 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.5 -38.75 88.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.7 t -64.16 -49.16 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 119.467 -0.893 . . . . 1.0 110.987 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.529 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -67.86 -44.43 77.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 1.0 110.413 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -42.92 -50.62 5.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.919 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.21 -39.26 93.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.18 -46.6 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.491 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.9 mpp? -62.3 -42.2 99.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -61.34 -36.41 80.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 1.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.01 -43.01 66.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.378 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -38.79 95.3 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.43 -45.46 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.679 -0.307 . . . . 1.0 110.839 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.0 -44.99 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.308 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.25 -46.98 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.191 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.03 -11.53 59.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.921 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.13 -36.93 17.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 1.0 110.129 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.9 tt -66.78 -37.58 84.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.568 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -67.06 44.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 1.0 111.099 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.517 ' O ' ' N ' ' C' ' 90' ' ' ALA . 22.7 m -89.53 -42.02 11.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 1.0 110.352 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' C' ' 90' ' ' ALA . . . -52.95 -67.65 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.411 -0.516 . . . . 1.0 111.706 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' C' ' 92' ' ' ASP . . . -48.64 -16.1 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.35 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.8 mm? -100.16 -24.28 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.495 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' C' ' 92' ' ' ASP . . . -90.01 -65.36 1.02 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.71 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.702 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' C' ' 90' ' ' ALA . 89.9 m-20 -52.38 -42.22 63.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.368 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' C' ' 94' ' ' VAL . 2.8 p90 -61.73 -43.72 98.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.408 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 58.2 t -38.78 -27.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.785 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' C' ' 93' ' ' PHE . 95.7 mtt180 -59.89 -23.4 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.688 0.28 . . . . 1.0 111.066 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -58.79 -42.89 90.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.155 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.353 179.688 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.407 ' CB ' ' NE2' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.802 0.334 . . . . 1.0 110.559 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.15 -43.91 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.62 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 4.9 p80 -69.66 -37.93 76.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.692 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.59 -34.24 77.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.98 -43.24 91.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.457 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -64.76 -38.3 90.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.037 0.446 . . . . 1.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.31 86.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.62 -37.56 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -37.95 85.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.463 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.65 70.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.098 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -64.54 -38.85 92.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.486 -0.324 . . . . 1.0 110.644 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -40.42 93.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 1.0 110.447 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.51 -32.7 74.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.651 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.98 -35.1 79.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.462 . . . . 1.0 110.29 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.13 -33.19 73.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -62.13 -45.36 93.82 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.473 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.09 -37.13 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.755 0.312 . . . . 1.0 110.935 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.1 -41.63 97.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' D' ' 23' ' ' SER . 74.0 mm-40 -66.95 -44.11 81.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 1.0 110.203 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.11 -34.03 76.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.147 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.58 -38.86 92.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.25 -43.6 95.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -61.34 -62.46 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.54 -38.11 83.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.765 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -52.12 -51.29 58.77 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.533 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -64.14 -46.26 94.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.409 -0.516 . . . . 1.0 110.171 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.43 -41.33 89.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.525 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.045 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.423 ' CD ' ' OE1' ' D' ' 66' ' ' GLU . 40.3 mm-40 -68.29 -41.85 80.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.822 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -62.69 87.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.014 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.12 7.61 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.332 -0.707 . . . . 1.0 111.332 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.92 135.19 20.51 Favored Pre-proline 0 CA--C 1.537 0.45 0 O-C-N 122.794 -0.239 . . . . 1.0 110.604 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.73 143.25 29.81 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.058 1.839 . . . . 1.0 112.228 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 18.84 75.84 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.86 143.07 56.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 1.0 110.389 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.73 -18.48 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.588 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.72 117.15 33.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 110.236 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' D' ' 40' ' ' SER . 5.1 pt -154.3 89.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.231 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.515 ' O ' ' N ' ' D' ' 44' ' ' ALA . 0.4 OUTLIER 169.57 112.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.98 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.465 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 13.5 m-85 -48.73 -53.96 31.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.76 -30.3 92.19 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.202 1.268 . . . . 1.0 112.013 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.13 -20.08 21.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.036 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' D' ' 40' ' ' SER . . . -61.16 -42.72 99.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.854 0.359 . . . . 1.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . 0.442 ' O ' ' OG ' ' D' ' 48' ' ' SER . 6.7 tt -65.4 -38.06 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.425 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.26 99.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.107 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.435 ' CE3' ' N ' ' D' ' 48' ' ' SER . 1.9 t90 -63.96 -40.15 95.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.466 -0.494 . . . . 1.0 109.975 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 78.6 p -60.17 -33.25 71.93 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.582 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.53 -44.33 99.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.312 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.461 ' OE2' ' CZ ' ' A' ' 68' ' ' ARG . 74.3 mt-10 -52.36 -31.96 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.598 ' C ' ' H ' ' D' ' 53' ' ' THR . 0.2 OUTLIER -83.39 -163.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.35 0.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.134 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.598 ' H ' ' C ' ' D' ' 51' ' ' THR . 28.8 p -121.28 -1.2 9.74 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' D' ' 53' ' ' THR . 11.8 p 56.88 15.08 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -91.33 -53.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.705 0.288 . . . . 1.0 110.457 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.03 74.45 0.23 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.56 -47.28 86.86 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.974 -0.29 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 155.65 -90.77 0.12 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' D' ' 50' ' ' GLU . 98.0 m-20 44.05 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 1.0 110.424 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' D' ' 58' ' ' GLY . 0.0 OUTLIER -124.62 162.54 23.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.736 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -162.75 138.95 5.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.528 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 157.53 57.24 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.893 1.729 . . . . 1.0 112.617 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.628 ' CG2' ' H ' ' D' ' 64' ' ' THR . 7.4 p -93.81 -121.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.495 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.628 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 39.9 m -115.0 -35.05 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.757 0.313 . . . . 1.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' D' ' 67' ' ' GLY . 51.9 tp10 -65.74 -32.09 73.44 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.232 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.5 OUTLIER -81.09 37.29 0.43 Allowed 'General case' 0 C--O 1.261 1.67 0 CA-C-O 123.349 1.547 . . . . 1.0 108.909 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 39.96 62.4 1.47 Allowed Glycine 0 C--O 1.214 -1.094 0 CA-C-N 113.663 -1.608 . . . . 1.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.537 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.5 ttt85 -24.5 -30.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.133 0.549 . . . . 1.0 111.323 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.5 mttm -53.12 -13.85 0.55 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.214 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.5 t -60.47 -48.73 87.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 C-N-CA 119.437 -0.905 . . . . 1.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.08 76.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.277 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.95 -38.85 92.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.329 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.25 -50.52 72.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.395 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.86 -42.93 89.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.368 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 34.4 ttm -58.08 -47.35 83.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.994 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -65.02 -40.05 94.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.614 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.04 81.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.5 94.64 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.3 -43.34 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.425 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' D' ' 84' ' ' LEU . 97.0 mt-10 -58.55 -50.73 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.836 0.309 . . . . 1.0 111.836 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.84 -46.11 96.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.516 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -66.24 -29.58 69.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.592 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -91.04 -20.76 21.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.575 0.226 . . . . 1.0 110.585 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 80' ' ' GLU . 8.0 tt -63.73 -42.03 97.96 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.541 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' D' ' 88' ' ' ALA . 8.7 m -60.18 -18.93 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.058 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 50.9 m -36.29 -28.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -62.97 -46.21 88.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.531 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -67.22 -26.35 66.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.178 0.514 . . . . 1.0 110.241 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 4.2 mm? -73.02 -34.73 66.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.9 -45.09 93.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.95 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -4.87 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.006 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.4 -50.26 74.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.965 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 21.7 p90 -73.96 -26.88 60.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.008 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.98 -26.28 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.219 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -57.32 -22.51 42.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.851 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -62.2 -20.76 64.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.565 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.438 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.813 0.34 . . . . 1.0 110.564 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 66.3 t0 -105.52 -29.04 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.507 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.6 p80 -81.02 -30.27 34.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.711 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.38 -45.69 83.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 1.0 110.813 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.46 -35.1 75.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.33 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.05 -40.32 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.213 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.75 92.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.391 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -63.31 -33.96 76.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.3 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.02 81.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.128 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.45 -39.45 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -62.25 -37.35 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.239 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.7 -31.07 71.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.572 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -42.31 98.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.438 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.99 -39.34 94.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.12 -40.27 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 1.0 111.328 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.17 -41.07 91.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.662 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.61 -41.61 95.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 23' ' ' SER . 96.4 mt-10 -62.73 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.3 -38.39 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.308 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.4 90.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.796 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 78.1 p -60.14 -41.19 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.31 -30.01 70.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.37 -40.73 20.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.652 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CG ' ' A' ' 30' ' ' GLU . . . -64.83 -40.44 95.19 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.78 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 7.5 p -61.47 -50.29 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.608 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.414 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 15.5 pt-20 -71.03 -43.29 68.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.545 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.99 73.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 21.7 mm-40 -67.72 -39.43 84.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.144 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -71.68 129.91 39.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.909 0.385 . . . . 1.0 110.313 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.02 -12.21 67.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.346 -0.702 . . . . 1.0 111.346 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.68 147.91 47.52 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.21 138.88 23.09 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.034 1.822 . . . . 1.0 112.306 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.39 69.22 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.59 54.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 1.0 110.396 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.48 -7.85 8.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.405 ' C ' ' CD2' ' A' ' 38' ' ' LEU . 6.9 tt -107.13 123.1 47.76 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.064 0.459 . . . . 1.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' SER . 44.3 pt -149.93 -171.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.104 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' ILE . 2.0 m 58.16 145.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.944 0.402 . . . . 1.0 110.623 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 65.0 t80 -82.7 -43.22 0.92 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.13 -0.486 . . . . 1.0 112.116 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.8 Cg_endo -60.4 -28.71 87.28 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.657 1.571 . . . . 1.0 112.829 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.7 p-10 -94.02 -28.92 15.48 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.99 -0.284 . . . . 1.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.17 83.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.271 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.82 -42.41 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.047 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CD1' ' CG2' ' B' ' 64' ' ' THR . 0.1 OUTLIER -62.88 -41.39 99.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.019 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 13.5 t90 -60.15 -39.28 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -72.87 67.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -151.99 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.007 0.432 . . . . 1.0 110.362 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.7 pm0 -48.16 -24.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.539 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -43.67 98.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.989 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.25 -28.09 67.77 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.236 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.4 p -84.32 5.63 26.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 48.05 76.61 0.11 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.899 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.98 -55.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.879 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.94 77.02 0.19 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.276 -0.73 . . . . 1.0 111.276 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.452 ' OH ' ' SD ' ' B' ' 75' ' ' MET . 75.4 m-85 -60.75 -42.77 98.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.46 9.92 1.32 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.535 ' CG ' HH22 ' B' ' 68' ' ' ARG . 20.8 m-20 -58.1 -50.08 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -147.95 163.89 35.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.46 132.85 7.15 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.446 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.3 163.19 39.59 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.075 1.85 . . . . 1.0 112.394 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.0 t -97.78 -128.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 8.6 m -115.01 -36.57 4.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.68 0.276 . . . . 1.0 110.979 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.713 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.4 tt0 -70.79 -39.41 73.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.748 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.79 27.53 0.02 OUTLIER 'General case' 0 C--O 1.265 1.899 0 CA-C-O 123.753 1.74 . . . . 1.0 109.925 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.713 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 39.16 64.35 0.96 Allowed Glycine 0 C--O 1.214 -1.117 0 CA-C-N 114.035 -1.438 . . . . 1.0 111.392 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 33.0 ttm180 -24.93 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.806 0.803 . . . . 1.0 110.969 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -50.44 -16.72 0.38 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.451 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.8 t -61.38 -48.09 90.47 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.342 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' A' ' 75' ' ' MET . . . -70.84 -42.8 69.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.007 0.432 . . . . 1.0 110.442 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.59 -43.17 46.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.474 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -62.26 -39.64 93.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.04 -43.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' A' ' 71' ' ' ALA . 3.4 mpp? -61.63 -40.2 94.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.021 -0.272 . . . . 1.0 110.503 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -61.33 -39.92 92.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.061 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.4 -45.98 62.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.487 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -51.45 53.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.486 -1.046 . . . . 1.0 110.486 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 79' ' ' ILE . 95.6 mt -67.95 -4.78 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.472 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -96.17 -49.72 5.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.427 -0.352 . . . . 1.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 82' ' ' PHE . 28.3 m -70.8 -51.0 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.06 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 45.6 m-85 -62.39 -39.18 92.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.073 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -61.15 -39.57 90.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.715 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 86' ' ' THR . 5.5 tt -63.48 -40.35 96.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.505 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -49.7 -11.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.429 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 84' ' ' LEU . 54.5 m -49.28 -42.49 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 1.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.73 -13.61 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.68 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 86' ' ' THR . . . -104.75 -15.92 15.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.683 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.1 mm? -94.84 -46.68 6.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 1.0 110.677 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.03 -22.74 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -3.67 58.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.748 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.65 -48.78 79.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.343 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.58 -19.57 45.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.765 0.317 . . . . 1.0 111.454 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.08 -42.73 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.904 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -58.06 -21.53 46.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.712 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -55.1 -42.85 73.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.546 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 97' ' ' GLU . 56.3 mp0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 1.0 110.085 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.722 0.296 . . . . 1.0 110.725 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -73.1 -35.43 66.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.714 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.26 -43.89 89.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.79 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.02 -38.89 92.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.68 -37.56 87.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.43 99.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.758 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.05 -35.73 76.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.334 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.41 -38.54 87.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.32 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.935 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.98 -34.78 78.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.562 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -62.79 -38.35 90.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.137 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.03 -33.05 74.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.36 -41.92 98.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.506 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.11 -39.11 93.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.89 -44.23 97.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.22 -40.86 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.786 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.36 -41.69 94.21 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.054 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.456 ' O ' ' OG ' ' B' ' 23' ' ' SER . 98.8 mt-10 -63.3 -48.17 79.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.118 0.485 . . . . 1.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.49 -35.85 75.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.128 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.52 86.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.35 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 91.5 p -56.58 -44.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.466 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.77 -36.2 82.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' B' ' 29' ' ' ALA . 69.1 mmtt -67.98 -44.42 76.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.833 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.31 76.76 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.463 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.82 -45.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.768 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -71.9 -42.0 67.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.85 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -43.7 -47.38 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.327 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' B' ' 38' ' ' LEU . 96.9 mt-10 -68.21 -116.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.809 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 45.67 79.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.596 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.26 17.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.413 -0.675 . . . . 1.0 111.413 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 149.7 96.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.24 121.27 6.03 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.953 1.769 . . . . 1.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 92.83 -23.06 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 49.94 175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 1.0 110.579 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.77 -85.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.552 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.529 ' N ' ' OE2' ' B' ' 30' ' ' GLU . 44.9 tp -89.93 82.3 6.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.454 ' O ' ' OG ' ' B' ' 40' ' ' SER . 15.2 tt -125.97 102.07 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.963 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.516 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 73.4 m -169.94 -124.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' B' ' 40' ' ' SER . 2.3 m-85 -174.77 -65.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.0 109.995 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.15 -36.94 97.44 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.088 1.859 . . . . 1.0 112.175 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' B' ' 43' ' ' ASP . 9.7 p-10 -92.98 0.91 57.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.617 -0.265 . . . . 1.0 111.145 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.06 93.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.003 0.43 . . . . 1.0 110.343 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -69.47 -36.61 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.546 ' O ' ' NH2' ' C' ' 68' ' ' ARG . 1.1 t90 -46.54 -68.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.647 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.467 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -57.16 -27.18 61.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.059 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.467 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -65.47 -41.77 92.97 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.701 -0.399 . . . . 1.0 111.347 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.554 ' CG1' HH12 ' C' ' 68' ' ' ARG . 55.5 t -60.95 -47.74 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.405 ' O ' ' OG1' ' B' ' 53' ' ' THR . 11.3 pt-20 -68.06 -31.59 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.571 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -60.5 -45.38 94.0 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.22 -27.57 55.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.813 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 61.1 p -85.43 1.52 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.723 0.297 . . . . 1.0 110.755 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 4.6 p 53.41 15.69 0.75 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.005 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' B' ' 56' ' ' GLY . 5.7 p -66.36 -44.69 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.02 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.483 ' N ' ' CG1' ' B' ' 55' ' ' VAL . . . 46.3 65.22 2.19 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.47 -1.052 . . . . 1.0 110.47 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -58.98 -48.47 81.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 1.0 110.743 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.69 6.82 1.96 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -58.93 -45.62 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.644 0.259 . . . . 1.0 110.419 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -145.19 173.22 12.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -155.95 130.33 4.92 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.41 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.02 156.92 63.79 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.769 1.646 . . . . 1.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.425 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 1.8 t -84.03 -141.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.171 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.412 ' CG2' ' CD1' ' A' ' 46' ' ' TRP . 3.8 m -114.36 -46.54 2.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.24 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.651 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.9 tp10 -64.5 -29.18 70.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.355 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.3 OUTLIER -70.84 32.18 0.04 OUTLIER 'General case' 0 C--O 1.261 1.663 0 CA-C-O 123.889 1.804 . . . . 1.0 110.078 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.723 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.84 62.85 1.6 Allowed Glycine 0 C--O 1.208 -1.48 0 CA-C-N 113.827 -1.533 . . . . 1.0 111.338 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.535 HH22 ' CG ' ' A' ' 59' ' ' ASP . 27.4 ttt85 -25.1 -31.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.075 0.937 . . . . 1.0 110.866 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -52.47 -14.97 0.55 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 67' ' ' GLY . 43.4 t -61.83 -46.43 96.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.364 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.05 67.18 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -57.18 -41.63 79.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.036 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.45 -44.35 94.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.08 -46.01 92.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.117 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' MET . . . . . 0.452 ' SD ' ' OH ' ' A' ' 57' ' ' TYR . 73.5 mtm -62.93 -42.72 99.89 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.432 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -63.86 -41.6 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.343 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.06 88.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -39.12 94.47 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.423 HG21 HD13 ' B' ' 79' ' ' ILE . 96.0 mt -68.94 -26.78 33.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.58 -0.365 . . . . 1.0 111.293 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.9 -51.61 25.1 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.052 0.453 . . . . 1.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 m -60.41 -47.86 90.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.17 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -67.81 -38.56 83.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.07 -36.92 85.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.536 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.454 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.6 tt -61.72 -41.52 97.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 93.4 t -49.79 -17.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.454 ' N ' ' C ' ' B' ' 84' ' ' LEU . 75.1 m -52.38 -40.87 62.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.464 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.15 -55.06 7.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.841 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -12.69 54.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.21 -27.14 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -64.85 -24.62 67.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.382 0.61 . . . . 1.0 109.858 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.536 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.1 OUTLIER -84.52 -4.72 59.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.0 109.61 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.67 -48.93 74.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.82 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 7.9 p90 -66.56 -31.81 72.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.54 -44.32 96.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.232 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 83.7 mtt85 -60.08 -28.72 68.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.147 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -56.06 -42.23 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.044 -179.826 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 1.0 110.193 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.618 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 23.3 p80 -67.11 -41.07 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.618 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.6 tt0 -62.67 -39.8 95.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.719 0.295 . . . . 1.0 110.537 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -65.1 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 1.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -64.72 -39.61 93.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.92 98.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.463 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.82 -40.82 92.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.245 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.85 -35.39 80.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.327 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.89 76.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.056 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.65 -39.59 91.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 1.0 110.877 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.49 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.742 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.73 -37.81 88.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.55 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.427 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -59.98 -31.35 69.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -61.55 -40.1 93.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.73 0.3 . . . . 1.0 111.132 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.81 -42.35 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.847 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.64 -41.7 97.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.107 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.448 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.7 mt-10 -63.31 -46.62 85.85 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.008 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 0.2 OUTLIER -70.6 -39.08 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.112 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.95 82.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.7 p -53.34 -45.77 69.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.192 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -65.08 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.215 0.531 . . . . 1.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.5 -37.9 82.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -53.51 57.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.75 0.31 . . . . 1.0 111.065 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.84 -41.45 92.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -68.14 -44.08 76.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.524 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.11 80.56 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.09 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.6 -39.4 73.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.316 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -68.38 129.09 38.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 120.943 0.401 . . . . 1.0 110.28 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.44 -0.46 65.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.334 -0.706 . . . . 1.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.37 149.9 38.31 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.43 -0.211 . . . . 1.0 110.43 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.07 139.88 22.07 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.816 1.677 . . . . 1.0 112.369 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 2.69 57.9 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.5 103.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.78 0.324 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.44 -35.46 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.393 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 15.0 tp -87.08 95.07 9.82 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.119 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 33.4 pt -138.52 49.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 1.0 110.713 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -138.66 145.3 40.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.162 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.526 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 35.9 m-85 -69.52 -50.87 17.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.3 Cg_endo -58.98 -38.54 87.43 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.727 1.618 . . . . 1.0 112.433 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.08 -11.29 59.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.221 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.86 81.71 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.788 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.456 ' O ' ' OG ' ' C' ' 48' ' ' SER . 6.3 tt -72.93 -38.89 57.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.028 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.486 ' C ' ' NH1' ' D' ' 68' ' ' ARG . 0.5 OUTLIER -63.64 -46.52 85.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.64 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' C' ' 48' ' ' SER . 3.1 t90 -61.18 -39.64 90.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 1.0 109.553 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' C' ' 45' ' ' ILE . 60.7 p -61.63 -34.53 75.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.96 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.46 -48.28 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.478 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.65 -21.29 62.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.274 -0.571 . . . . 1.0 110.58 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -75.48 -42.2 53.58 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.796 0.331 . . . . 1.0 111.367 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.41 80.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.899 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.424 ' O ' ' OG1' ' C' ' 54' ' ' THR . 54.5 p -74.85 -11.99 60.27 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' C' ' 53' ' ' THR . 1.3 p 69.88 0.85 3.21 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.636 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.21 -45.09 94.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.723 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.32 79.02 0.06 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -60.3 -46.64 89.16 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.811 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.04 23.27 0.69 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.49 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 21.8 t0 -61.65 -41.17 97.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 1.0 110.305 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -145.49 -161.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.961 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 13.4 p90 -172.17 112.37 0.38 Allowed Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.986 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -170.64 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.613 1.542 . . . . 1.0 112.126 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.658 ' CG2' ' H ' ' C' ' 64' ' ' THR . 9.9 p -139.12 -169.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.375 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.658 ' H ' ' CG2' ' C' ' 63' ' ' VAL . 11.4 m -77.25 -45.91 24.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 1.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.617 ' C ' ' H ' ' C' ' 67' ' ' GLY . 49.0 tp10 -47.49 -50.51 23.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.91 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.9 OUTLIER -72.17 35.76 0.06 Allowed 'General case' 0 C--O 1.264 1.838 0 CA-C-O 124.28 1.991 . . . . 1.0 109.859 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.85 65.88 1.46 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.76 -1.564 . . . . 1.0 111.54 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.554 HH12 ' CG1' ' B' ' 49' ' ' VAL . 8.2 ptm180 -21.33 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.775 0.798 . . . . 1.0 111.657 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.6 mmtt -43.84 -18.6 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.273 -1.331 . . . . 1.0 109.588 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' C' ' 68' ' ' ARG . 54.5 t -59.29 -44.91 93.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.453 -0.899 . . . . 1.0 110.189 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.87 63.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.966 0.412 . . . . 1.0 110.764 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.33 -35.27 79.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.955 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.93 -52.45 64.98 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.671 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.27 -43.55 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.773 0.321 . . . . 1.0 111.175 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' B' ' 55' ' ' VAL . 19.1 ttp -59.62 -43.73 93.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 56.6 tttm -63.47 -42.49 98.59 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.583 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.78 95.68 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.467 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.56 93.77 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.203 -0.522 . . . . 1.0 111.917 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.94 -43.12 97.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.676 0.274 . . . . 1.0 110.736 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.0 mt-10 -64.63 -39.4 93.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.328 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.82 -48.72 85.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.405 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -64.18 -41.9 96.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.204 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.0 82.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.859 0.361 . . . . 1.0 110.593 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.5 tt -61.66 -33.89 74.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.519 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.29 -4.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.374 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 88' ' ' ALA . 6.0 t -62.73 -39.45 94.13 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.118 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -40.09 -21.96 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.545 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -101.85 -38.35 7.87 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.215 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' C' ' 86' ' ' THR . 30.9 mt -74.03 -42.14 60.76 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.941 0.4 . . . . 1.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -55.73 -32.34 63.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.266 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.14 -4.01 45.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.095 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.06 -47.8 83.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.753 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 11.6 p90 -70.15 -29.63 66.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.08 -43.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.674 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -58.7 -23.07 58.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.427 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -40.59 -37.18 0.68 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.375 -179.458 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -158.78 -43.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.431 ' HD1' ' CB ' ' D' ' 88' ' ' ALA . 10.1 p80 -79.68 -20.15 47.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.811 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.27 -35.71 81.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 1.0 110.563 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.08 -40.93 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.53 -43.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 1.0 109.965 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.48 -38.38 89.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 68.8 tp60 -64.45 -41.0 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.407 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.4 -38.46 89.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.733 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -28.66 65.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.095 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -62.69 -40.98 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 1.0 110.952 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' D' ' 9' ' ' GLN . 58.2 mp0 -66.32 -33.73 76.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.08 -37.79 86.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.457 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 46.0 tp -62.81 -41.68 99.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.0 110.458 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.78 -34.76 76.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.144 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -61.86 -44.0 97.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.835 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -64.08 -36.13 75.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.885 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' D' ' 23' ' ' SER . 91.2 mt -60.88 -42.16 97.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.21 -47.73 72.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -66.77 -36.84 83.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.665 -0.414 . . . . 1.0 109.894 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -29.07 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.764 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 69.2 m -59.12 -45.85 89.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.997 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' D' ' 25' ' ' LYS . 13.5 ptpt -66.59 -39.12 88.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.442 ' N ' ' HG3' ' D' ' 24' ' ' LYS . 98.2 mttt -62.05 -45.34 93.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.611 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.433 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.6 -45.77 91.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.264 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -69.46 -42.49 74.82 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.575 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.81 91.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.631 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.455 ' OE1' ' CG2' ' D' ' 39' ' ' ILE . 11.8 tm-20 -67.2 -39.76 86.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.45 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -61.39 115.64 4.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.841 0.353 . . . . 1.0 110.652 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.98 -13.69 57.45 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.22 111.53 55.32 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.27 149.26 35.38 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.915 1.743 . . . . 1.0 112.688 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.69 73.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.73 164.32 16.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 1.0 110.478 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 84.56 1.66 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.433 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -173.94 79.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.233 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' D' ' 40' ' ' SER . 10.1 pt -127.48 164.65 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.015 0.436 . . . . 1.0 110.606 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 81.24 123.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.438 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 54.0 m-85 -59.57 -47.07 98.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.953 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.59 -33.61 98.26 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.572 1.515 . . . . 1.0 112.267 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.7 -29.38 16.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.049 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.02 94.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.684 0.278 . . . . 1.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 tt -63.36 -32.17 55.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.154 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -46.63 88.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.884 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' D' ' 51' ' ' THR . 0.7 OUTLIER -67.29 -40.01 86.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.466 -0.493 . . . . 1.0 110.037 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 4.3 t -56.72 -40.0 74.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.459 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.79 -48.64 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.434 ' O ' ' OG1' ' D' ' 53' ' ' THR . 80.7 mm-40 -67.54 -31.63 71.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' D' ' 47' ' ' TRP . 87.9 m -64.29 -45.17 89.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.572 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.98 65.58 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.599 -0.441 . . . . 1.0 110.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 9.3 p -88.37 6.08 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 1.0 110.324 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.453 ' O ' ' OG1' ' D' ' 54' ' ' THR . 3.4 p 42.02 67.75 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.203 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.417 ' CG2' ' HG1' ' D' ' 53' ' ' THR . 1.2 m -135.16 -40.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.432 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.43 78.51 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.506 -1.037 . . . . 1.0 110.506 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -44.65 96.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 1.0 110.629 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.63 -0.35 3.05 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.71 -0.956 . . . . 1.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 97.5 m-20 -56.8 -50.38 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -130.95 140.78 50.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' D' ' 61' ' ' TYR . 21.3 p90 -130.47 105.25 15.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.786 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.65 154.29 68.35 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.966 1.777 . . . . 1.0 112.258 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.08 -162.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.248 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.408 ' OG1' ' CD1' ' C' ' 46' ' ' TRP . 55.1 m -87.77 -20.96 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -77.55 -13.59 59.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.665 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.411 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.8 OUTLIER -103.75 28.26 6.76 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 124.293 1.997 . . . . 1.0 108.521 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.84 60.47 4.9 Favored Glycine 0 C--O 1.211 -1.285 0 CA-C-N 113.831 -1.531 . . . . 1.0 109.761 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.49 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 42.5 ttm180 -26.93 -28.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 117.351 0.576 . . . . 1.0 111.046 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 64.0 mttm -57.33 -15.14 5.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.188 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.3 t -60.73 -47.99 90.7 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 119.417 -0.913 . . . . 1.0 109.388 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . 0.545 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -65.63 -48.69 71.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.876 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -42.87 -59.33 2.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.338 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -48.93 -39.51 26.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.717 0.266 . . . . 1.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.0 t -62.23 -42.93 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.529 -0.468 . . . . 1.0 111.614 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 2.6 mpp? -59.02 -40.03 83.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.925 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.76 -39.5 88.97 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.28 96.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.044 -0.663 . . . . 1.0 110.716 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.29 -44.46 34.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.36 -44.23 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.076 -0.25 . . . . 1.0 111.397 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.94 -44.02 86.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.374 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.95 -48.55 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.464 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.93 -15.9 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.846 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -95.57 -25.96 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 1.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.92 -42.33 94.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.487 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' D' ' 87' ' ' ALA . 15.0 m -58.7 -18.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.015 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 41.2 m -36.95 -29.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.998 0.427 . . . . 1.0 110.488 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -58.94 -62.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.715 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.431 ' CB ' ' HD1' ' D' ' 4' ' ' HIS . . . -53.99 -37.38 63.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.169 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 4.2 mm? -66.03 -37.42 85.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.593 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -66.0 -66.13 0.59 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.626 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.449 ' O ' ' CG2' ' D' ' 94' ' ' VAL . 0.4 OUTLIER -49.18 -4.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.879 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' D' ' 90' ' ' ALA . 25.9 t0 -67.22 -21.21 65.76 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 1.0 111.356 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.505 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 2.3 p90 -77.41 -18.21 57.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.874 0.369 . . . . 1.0 111.194 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' D' ' 91' ' ' THR . 7.7 m -60.41 -40.05 82.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.576 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . 0.412 ' H ' HG22 ' D' ' 94' ' ' VAL . 99.8 mtt180 -49.69 -22.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.625 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -60.9 -41.97 97.11 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.889 179.71 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.801 0.334 . . . . 1.0 110.545 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.01 30.33 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 7.6 p80 -162.0 -37.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.925 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.637 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 44.1 tt0 -65.56 -42.45 91.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -64.09 -41.65 97.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.113 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.78 -34.24 75.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.36 -50.76 72.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -67.48 -33.32 74.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.439 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.68 -36.18 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.458 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.51 77.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.972 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -40.55 94.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.526 -0.306 . . . . 1.0 110.632 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -63.48 -33.57 75.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 1.0 110.493 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.21 -41.43 98.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.359 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.65 -39.47 88.24 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -49.62 -51.0 40.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.828 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -74.77 -31.27 61.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.495 -0.482 . . . . 1.0 112.069 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.51 -48.22 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.088 -0.245 . . . . 1.0 111.588 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.03 -28.88 66.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.197 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -61.2 -46.78 89.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.4 -39.51 92.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 1.0 109.675 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.9 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.201 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.41 ' OG ' ' OG ' ' A' ' 48' ' ' SER . 37.2 m -54.25 -40.69 67.99 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -62.73 -31.72 72.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.885 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.94 -39.3 34.96 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.902 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.58 88.58 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 7.6 p -61.08 -46.05 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.359 -0.536 . . . . 1.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 80.5 tt0 -67.19 -42.24 84.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.229 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.38 98.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.847 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' CG ' ' H ' ' A' ' 37' ' ' ALA . 31.5 tp10 -74.01 -42.62 60.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.592 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -70.85 126.82 30.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.234 0.54 . . . . 1.0 110.819 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.48 59.63 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.387 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 151.78 38.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 117.27 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.048 1.832 . . . . 1.0 111.751 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 94.87 20.64 27.99 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -39.52 162.49 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.65 0.262 . . . . 1.0 110.629 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.549 ' H ' ' CG ' ' A' ' 30' ' ' GLU . . . -136.37 -71.84 0.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.725 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.59 128.27 35.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.08 163.12 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.028 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER 81.33 153.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.717 0.294 . . . . 1.0 110.684 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 13.3 t80 -83.15 -50.52 0.7 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.817 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.24 -28.66 87.33 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.421 1.414 . . . . 1.0 112.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 25.1 m-20 -90.25 -28.94 18.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.87 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.67 84.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.0 110.333 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 tt -62.3 -37.97 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.287 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -47.81 81.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 2.8 t90 -66.09 -39.06 89.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.411 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 21.5 m -57.1 -39.77 75.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.858 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.33 -46.84 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.056 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 98.9 mt-10 -65.48 -44.33 87.42 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 3.0 m -62.04 -43.8 98.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.269 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.53 -52.17 23.9 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.388 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -86.12 7.6 24.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 56' ' ' GLY . 6.4 p 63.33 -133.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.574 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' OG1' ' A' ' 54' ' ' THR . 47.2 t 64.05 -40.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.547 0.529 . . . . 1.0 111.582 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 54' ' ' THR . . . 37.06 90.67 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.51 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 53.8 t80 -60.03 -45.84 91.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 1.0 110.462 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.19 7.59 1.09 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.24 -47.0 86.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 1.0 110.156 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -146.09 154.46 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.07 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 27.9 p90 -137.83 130.07 16.4 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.36 154.01 69.93 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.12 1.88 . . . . 1.0 112.518 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 64' ' ' THR . 6.2 p -75.74 -141.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.459 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.59 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 4.7 m -116.42 -39.2 3.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.678 0.275 . . . . 1.0 111.099 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.651 ' C ' ' H ' ' A' ' 67' ' ' GLY . 80.2 tt0 -77.67 -11.93 59.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.225 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -71.66 23.36 0.05 OUTLIER 'General case' 0 C--O 1.259 1.605 0 CA-C-O 123.933 1.825 . . . . 1.0 109.837 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.36 69.43 1.08 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 117.561 -1.688 . . . . 1.0 112.566 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.494 ' CB ' ' CE2' ' D' ' 46' ' ' TRP . 0.6 OUTLIER -24.39 -32.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.974 1.387 . . . . 1.0 110.665 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 67' ' ' GLY . 64.0 mttp -50.8 -33.72 24.66 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.316 -0.856 . . . . 1.0 109.888 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' GLY . 61.2 t -61.84 -49.75 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 119.4 -0.92 . . . . 1.0 110.576 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.41 -46.17 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CG1' ' D' ' 49' ' ' VAL . 77.5 tt0 -58.23 -38.84 77.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.735 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.57 -46.11 77.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.769 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.74 -42.24 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.269 -0.573 . . . . 1.0 111.498 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.3 mtt -52.94 -44.66 67.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.852 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.37 -46.34 83.8 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.04 92.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.58 -23.83 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.739 -0.271 . . . . 1.0 111.258 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -67.6 -45.72 74.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 82' ' ' PHE . 6.9 m -63.77 -43.99 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.837 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 78' ' ' GLY . 40.3 m-85 -67.39 -37.28 82.89 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.054 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.97 97.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.046 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.411 ' C ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -63.1 -36.15 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.453 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -53.56 -15.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.942 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 84' ' ' LEU . 9.8 t -48.42 -38.01 18.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.305 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -49.86 -29.51 8.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.473 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.36 29.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.788 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 86' ' ' THR . 32.6 mt -94.41 -58.2 2.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.856 0.36 . . . . 1.0 111.0 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.3 -22.98 33.81 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.454 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.465 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -98.28 -4.72 34.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.264 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.01 -47.17 87.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.233 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 3.8 p90 -58.07 -44.15 87.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.114 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 61.7 t -36.66 -26.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.484 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' PHE . 96.5 mtt180 -61.78 -36.13 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.988 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -49.04 -32.75 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.55 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 -179.848 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.683 0.277 . . . . 1.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.3 p80 -71.47 -31.95 67.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 1.0 110.567 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.29 -36.36 83.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -63.65 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 1.0 110.622 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.4 -45.17 95.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.946 -0.391 . . . . 1.0 109.946 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -40.93 85.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.61 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.12 -40.12 94.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.52 -38.07 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.513 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.21 -35.5 75.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.004 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.66 -36.09 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.38 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.78 -34.45 78.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.128 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.01 -36.92 85.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.699 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.62 -39.34 94.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.54 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.16 -38.41 86.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.978 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -62.27 -39.8 94.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 1.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.19 -41.84 91.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.649 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 90.6 mt -59.56 -41.34 89.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.608 -0.437 . . . . 1.0 109.933 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.81 -50.1 73.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.991 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.98 -33.19 75.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.008 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.6 83.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.332 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.0 t -59.85 -46.15 90.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.297 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.53 -32.59 73.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.475 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.59 -50.02 16.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.659 -0.417 . . . . 1.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.28 95.37 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.467 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 9.8 p -62.51 -46.67 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.156 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 13.0 tm-20 -70.93 -42.16 70.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.9 96.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 38' ' ' LEU . 36.3 tp10 -76.25 -41.51 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.85 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.43 111.18 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.971 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.35 -2.8 23.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.2 151.36 37.69 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 110.66 -0.126 . . . . 1.0 110.66 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' B' ' 36' ' ' ALA . 92.4 Cg_endo -74.81 146.66 33.77 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.946 1.764 . . . . 1.0 112.63 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 77.15 -24.01 2.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 37' ' ' ALA . . . 40.77 -166.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.606 0.241 . . . . 1.0 110.701 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' B' ' 36' ' ' ALA . . . 161.85 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.932 0.396 . . . . 1.0 110.117 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' B' ' 30' ' ' GLU . 15.4 tp -154.38 108.89 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 1.0 110.743 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.8 pt -131.84 167.06 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.661 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER 80.83 127.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 9.3 t80 -72.13 -44.97 11.13 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.981 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.76 -26.62 80.76 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.609 1.54 . . . . 1.0 112.738 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -94.31 -18.92 21.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.696 0.284 . . . . 1.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -66.63 -41.41 88.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.538 ' CE2' ' O ' ' C' ' 64' ' ' THR . 4.2 t-105 -61.31 -46.14 91.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.374 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.51 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 2.8 t90 -63.1 -39.37 94.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.005 0.431 . . . . 1.0 110.266 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.423 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 6.3 t -62.92 -32.77 74.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.643 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.0 t -58.85 -47.55 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.629 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.61 -30.71 69.5 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 1.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.0 m -63.33 -46.48 86.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.432 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.96 81.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.301 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' B' ' 54' ' ' THR . 76.3 p -76.81 3.47 11.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.82 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 53' ' ' THR . 58.8 p 51.24 53.77 12.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 50.4 t -125.41 -60.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.544 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.13 84.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.24 -41.16 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.302 . . . . 1.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.61 26.91 0.16 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -61.65 -47.53 84.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 1.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.539 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 94.0 mtt-85 -144.1 -169.55 3.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 52.2 m-85 -159.71 110.28 1.47 Allowed Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.433 -0.317 . . . . 1.0 110.437 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.416 1.41 . . . . 1.0 112.238 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.656 ' CG2' ' H ' ' B' ' 64' ' ' THR . 9.9 p -95.06 -165.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.656 ' H ' ' CG2' ' B' ' 63' ' ' VAL . 52.4 m -91.07 -37.69 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 1.0 110.602 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' B' ' 67' ' ' GLY . 65.5 tt0 -60.79 -31.87 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.483 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -75.33 28.04 0.1 Allowed 'General case' 0 C--O 1.262 1.727 0 CA-C-O 124.028 1.87 . . . . 1.0 109.386 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.709 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 45.58 65.48 1.93 Allowed Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.786 -1.552 . . . . 1.0 111.31 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' B' ' 67' ' ' GLY . 59.5 ttp85 -24.58 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.906 0.853 . . . . 1.0 110.572 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.2 mmtt -46.2 -22.59 0.25 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' B' ' 67' ' ' GLY . 69.6 t -61.8 -44.85 99.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 119.517 -0.873 . . . . 1.0 109.585 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.524 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -72.08 -51.0 23.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.733 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -55.29 -40.25 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.59 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.0 -45.79 89.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.942 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.98 -44.78 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.4 mpp? -63.19 -41.45 99.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.35 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -63.97 -42.13 97.35 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.445 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.12 93.85 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.511 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.22 -44.8 93.26 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.85 -43.84 99.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.881 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.34 -44.86 95.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -48.04 88.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.138 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -71.63 -21.27 61.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -93.43 -25.14 17.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.5 -40.96 98.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.09 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' ALA . 10.7 m -46.61 -24.65 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 36.9 m -37.44 -24.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.377 0.608 . . . . 1.0 110.384 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -56.01 -39.41 71.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.727 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.62 -11.18 57.63 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.718 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' B' ' 89' ' ' LEU . 5.0 mp -81.76 -4.26 55.91 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -94.9 -56.67 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.394 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -5.78 0.67 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' B' ' 93' ' ' PHE . 36.6 p-10 -61.35 -50.4 73.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.157 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 5.3 p90 -71.55 -8.26 52.85 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.829 0.347 . . . . 1.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.11 -26.09 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.417 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.53 -42.61 88.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.58 -0.282 . . . . 1.0 111.432 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.99 -38.03 0.91 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.907 0.384 . . . . 1.0 110.201 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.35 179.638 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.742 0.306 . . . . 1.0 110.736 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.646 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 5.8 p-80 -149.02 -47.99 0.14 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.705 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.646 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 31.5 tp10 -69.37 -36.42 76.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.885 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -64.25 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -61.34 -45.68 93.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.08 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.56 89.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.617 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -65.02 -37.84 88.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.26 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.166 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.54 87.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.038 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.23 -37.14 86.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 1.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.29 -36.33 83.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.851 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.5 -40.67 97.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.342 . . . . 1.0 110.571 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.45 -39.72 88.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.1 -38.87 90.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.817 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.72 -36.22 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.99 -41.66 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -60.98 -46.36 91.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.994 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -59.76 -38.9 83.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -60.78 -47.85 84.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.291 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -67.86 -36.75 80.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.443 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -78.55 -22.57 47.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.502 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -84.52 -44.7 13.34 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.251 0.344 . . . . 1.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 8.4 p -61.99 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 1.0 109.891 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 2.9 pp20? -66.22 -31.39 72.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.643 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.28 -50.95 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.577 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' C' ' 32' ' ' GLY . 80.4 mm-40 -68.37 -37.66 80.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.69 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -57.34 87.58 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.803 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 30' ' ' GLU . . . 127.82 -13.06 6.48 Favored Glycine 0 N--CA 1.466 0.679 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.8 150.95 39.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.283 -0.266 . . . . 1.0 110.283 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . 0.448 ' O ' ' CG2' ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.77 155.93 39.53 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.097 1.864 . . . . 1.0 112.096 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' C' ' 37' ' ' ALA . . . 90.6 -17.4 54.73 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' C' ' 37' ' ' ALA . . . 40.79 -96.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 1.0 110.949 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' C' ' 36' ' ' ALA . . . 80.46 -73.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.789 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.06 122.16 43.07 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tt -149.84 4.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.03 0.443 . . . . 1.0 110.22 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.549 ' HG ' ' H ' ' C' ' 43' ' ' ASP . 1.2 t -94.24 133.39 37.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.883 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 26.5 m-85 -75.04 -53.51 2.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.6 Cg_endo -59.41 -28.55 87.84 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.617 1.544 . . . . 1.0 112.246 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.549 ' H ' ' HG ' ' C' ' 40' ' ' SER . 40.3 m-20 -89.59 -18.94 25.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.089 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.86 89.77 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.472 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' C' ' 48' ' ' SER . 7.8 tt -66.74 -39.8 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.698 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -45.51 92.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.252 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.508 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.6 t90 -64.62 -39.89 94.51 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.188 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' C' ' 45' ' ' ILE . 91.1 p -59.26 -33.3 70.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.149 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . 0.419 ' N ' ' HG ' ' C' ' 48' ' ' SER . 55.9 t -60.4 -48.04 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.286 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -73.7 -23.16 59.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 70.8 m -64.12 -45.6 87.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.519 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.29 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.848 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -82.38 1.28 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 1.0 110.003 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.5 p 55.61 11.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.778 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.37 -46.18 93.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.09 59.33 3.43 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' D' ' 60' ' ' ARG . 7.9 t80 -61.0 -47.21 87.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 1.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 169.73 -97.86 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 53.9 t0 44.92 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 1.0 110.782 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' C' ' 58' ' ' GLY . 96.9 mtt-85 -124.01 153.13 41.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 43.8 p90 -143.48 133.66 12.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.02 162.18 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.857 1.705 . . . . 1.0 112.413 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.67 ' CG1' ' H ' ' C' ' 64' ' ' THR . 7.2 p -83.58 -116.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.67 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 54.8 m -116.78 -84.0 0.64 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -43.92 125.9 4.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER 57.35 -104.46 0.22 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.69 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.476 1.349 0 O-C-N 124.431 1.082 . . . . 1.0 114.901 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 54.1 ttm-85 -87.21 -46.07 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.939 0.495 . . . . 1.0 110.773 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.8 tttm -54.36 -40.19 67.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.244 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.13 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.056 -0.657 . . . . 1.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.61 -37.2 86.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -54.95 -42.4 72.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -64.93 -40.18 94.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.571 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.07 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 1.0 111.349 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.8 mtt -54.0 -44.72 71.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.887 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -63.65 -38.77 92.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 1.0 110.533 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -25.03 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.46 -39.42 5.96 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.944 -0.462 . . . . 1.0 111.944 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.423 HD13 HG21 ' C' ' 79' ' ' ILE . 93.9 mt -61.69 -43.47 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.082 -0.247 . . . . 1.0 111.004 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.9 -37.72 86.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.187 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.45 -47.54 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 121.016 -0.274 . . . . 1.0 111.271 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.0 -36.81 82.99 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.306 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -61.82 -39.61 92.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.808 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' C' ' 86' ' ' THR . 7.3 tt -65.02 -37.56 88.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.267 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -45.48 -13.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.991 -0.283 . . . . 1.0 110.7 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.58 ' O ' ' N ' ' C' ' 88' ' ' ALA . 8.9 m -60.29 -41.81 94.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.501 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -39.34 -18.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.005 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -103.36 -36.89 7.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' C' ' 86' ' ' THR . 36.2 mt -75.41 -43.17 51.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.543 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -56.58 -34.18 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.762 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.67 -5.27 52.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.801 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -56.36 -47.21 79.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.41 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.9 p90 -74.35 -40.06 62.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 84.8 t -44.87 -31.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.825 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -64.12 -22.75 67.06 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.519 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . 0.417 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 47.4 ptt85 -52.95 -42.85 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 1.0 110.497 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.512 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 1.0 110.566 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' D' ' 4' ' ' HIS . 47.7 p-10 -65.95 -33.25 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' D' ' 3' ' ' ASP . 2.0 m80 -63.99 -45.15 90.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 1.0 110.342 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.66 -39.86 91.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -60.72 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.455 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.78 -40.02 79.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 1.0 110.09 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.08 88.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' D' ' 13' ' ' GLU . 99.1 mm-40 -66.13 -37.49 85.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.566 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.29 -39.5 90.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.749 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.54 78.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.33 -39.27 86.48 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.754 0.311 . . . . 1.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' D' ' 9' ' ' GLN . 1.1 mp0 -64.12 -37.19 86.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.18 -32.51 74.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.4 -41.62 98.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.93 -35.53 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.993 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' D' ' 21' ' ' GLU . 18.0 tttp -60.59 -45.82 92.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.79 -40.99 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.905 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.66 -40.97 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.173 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -62.13 -46.87 87.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.318 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' D' ' 17' ' ' LYS . 98.3 mt-10 -68.67 -36.11 78.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.4 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.45 91.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.203 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.23 -44.43 92.33 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.757 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.66 -35.74 80.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.98 0.419 . . . . 1.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.056 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.93 86.52 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.035 -0.266 . . . . 1.0 111.044 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.24 -44.94 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.13 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.26 -41.5 73.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.856 0.36 . . . . 1.0 110.937 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.5 90.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.717 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.73 -34.45 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 1.0 110.219 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -72.42 137.52 46.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.725 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . 0.406 ' O ' ' OE1' ' D' ' 65' ' ' GLU . . . 96.1 -11.86 67.26 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.26 149.51 36.11 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.49 142.99 30.32 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.907 1.738 . . . . 1.0 112.118 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.55 33.38 81.13 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.7 141.23 38.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.918 0.39 . . . . 1.0 110.538 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' D' ' 39' ' ' ILE . . . -147.0 -32.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.513 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.88 31.91 0.43 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.019 0.437 . . . . 1.0 109.895 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' D' ' 40' ' ' SER . 4.5 tp -105.7 131.87 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.538 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.4 p 162.7 -102.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.2 m-85 171.44 -65.94 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.31 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.7 Cg_endo -59.15 -29.25 89.98 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.925 1.75 . . . . 1.0 111.526 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -86.92 -24.2 24.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.42 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.37 -45.13 95.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.774 -0.371 . . . . 1.0 110.868 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 tp -67.51 -41.72 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.572 ' CH2' ' O ' ' A' ' 63' ' ' VAL . 1.1 t90 -60.68 -40.65 92.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.122 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' D' ' 48' ' ' SER . 6.0 t90 -61.86 -39.82 93.19 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.574 ' O ' ' N ' ' D' ' 50' ' ' GLU . 3.3 p -60.59 -145.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.002 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . 0.494 ' N ' ' OG ' ' D' ' 48' ' ' SER . 28.6 t 48.99 -81.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.13 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' D' ' 48' ' ' SER . 15.7 pt-20 -48.02 -29.47 3.52 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -61.94 -43.73 98.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.12 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.6 84.85 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 41.3 p -72.97 0.03 12.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.214 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p 50.85 68.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.987 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.04 -52.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.607 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.65 77.32 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.439 ' OH ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -62.21 -44.35 96.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 1.0 110.443 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.42 14.04 0.73 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.74 -51.39 69.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.674 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' C' ' 57' ' ' TYR . 34.8 mtt-85 -146.81 140.75 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 21.5 p90 -122.22 133.92 24.57 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 121.151 -0.22 . . . . 1.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.6 159.4 52.9 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.129 1.886 . . . . 1.0 112.195 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.419 ' CG1' ' H ' ' D' ' 64' ' ' THR . 1.9 t -84.91 -142.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.088 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.419 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 46.7 m -113.46 -53.05 2.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.704 0.288 . . . . 1.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.612 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.5 tt0 -62.45 -16.43 55.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.863 0.363 . . . . 1.0 110.226 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.415 ' O ' ' CD ' ' D' ' 66' ' ' GLU . 0.6 OUTLIER -74.35 26.41 0.08 Allowed 'General case' 0 C--O 1.264 1.839 0 CA-C-O 123.808 1.766 . . . . 1.0 109.087 178.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.722 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.03 61.3 3.54 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 58.2 ttm-85 -26.0 -30.31 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.297 0.645 . . . . 1.0 110.849 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.722 ' N ' ' O ' ' D' ' 67' ' ' GLY . 28.8 mmtp -53.41 -17.37 1.87 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.272 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' D' ' 67' ' ' GLY . 55.3 t -61.79 -48.36 89.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.0 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.71 -43.16 72.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.923 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -60.11 -42.21 94.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.763 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.09 -42.3 76.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.079 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.271 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 61.1 mtt -61.0 -42.29 98.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.327 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.23 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.396 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -43.78 92.52 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -43.55 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.689 0.281 . . . . 1.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.97 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.182 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.83 -52.31 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.341 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.91 -40.08 72.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -65.06 -34.94 79.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.456 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' D' ' 86' ' ' THR . 5.2 tt -61.12 -40.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' D' ' 87' ' ' ALA . 97.0 t -50.76 -16.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.611 -0.436 . . . . 1.0 109.887 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 23.7 m -42.42 -22.49 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.81 -52.97 61.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.36 -31.05 71.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.88 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.93 -40.97 87.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.433 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.74 -43.07 94.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.032 0.444 . . . . 1.0 110.787 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -4.28 42.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.202 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -56.93 -49.27 76.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.906 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 31.5 p90 -79.5 -42.96 24.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.172 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.527 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 60.9 t -40.44 -27.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.366 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' D' ' 93' ' ' PHE . 94.8 mtt-85 -62.78 -36.46 83.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.766 0.317 . . . . 1.0 111.105 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -47.68 -32.03 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.457 . . . . 1.0 110.285 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.761 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.836 0.351 . . . . 1.0 110.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -173.02 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -77.84 -16.87 57.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.453 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.397 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -63.47 -37.93 89.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.299 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.62 -38.16 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.53 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.92 72.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.792 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -67.67 -35.35 78.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.57 -36.63 81.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.25 76.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.892 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.61 -37.21 83.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.552 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.79 -36.44 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -65.43 -34.47 78.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.422 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.49 -41.23 98.65 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.593 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.04 -38.83 90.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.146 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -40.57 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.5 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.57 -40.96 93.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.076 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.5 mt-10 -60.58 -45.11 95.15 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.086 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.72 -37.55 76.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.91 89.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -59.77 -43.02 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 14.6 tmtt? -65.09 -36.25 83.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.833 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -76.55 -37.51 56.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.635 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.08 93.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 24' ' ' LYS . 9.1 m -61.24 -43.56 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.144 -0.622 . . . . 1.0 110.24 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -75.67 -43.25 48.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.536 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.09 -45.74 90.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.491 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.25 -44.13 92.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -71.36 133.65 46.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.58 -17.49 46.29 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.55 159.94 76.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.37 116.71 4.59 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.819 1.679 . . . . 1.0 111.924 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 82.87 -23.77 5.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . 32.69 -152.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.769 0.319 . . . . 1.0 111.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.64 -53.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.363 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.0 tp -66.22 -69.02 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.574 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 pt 36.48 25.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.103 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 38' ' ' LEU . 42.0 t -132.14 129.16 39.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.882 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.46 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 26.8 t80 -80.7 -49.05 1.13 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.982 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.36 -31.08 92.3 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.107 1.205 . . . . 1.0 112.569 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -91.17 -6.05 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.604 0.24 . . . . 1.0 111.009 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.91 95.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.916 0.389 . . . . 1.0 110.331 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.21 -40.22 86.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.155 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.582 ' CZ3' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -61.96 -47.11 86.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.381 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.448 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 22.9 t90 -59.02 -39.95 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 t -76.59 66.84 2.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.698 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.24 -55.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.93 0.395 . . . . 1.0 110.201 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' A' ' 59' ' ' ASP . 15.3 pt-20 -64.4 -32.78 74.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.414 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -45.95 91.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.66 -26.87 64.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.354 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -92.9 2.79 56.6 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 p 47.0 76.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 t -129.07 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.7 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 97.14 -56.63 1.25 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' B' ' 61' ' ' TYR . 2.3 m-85 44.12 -89.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.883 0.373 . . . . 1.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . -166.78 -87.61 0.07 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 60' ' ' ARG . 2.0 p-10 39.41 -105.39 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.857 0.36 . . . . 1.0 110.626 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.704 HH21 HH22 ' B' ' 68' ' ' ARG . 0.8 OUTLIER -116.96 -175.21 2.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.65 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.32 134.23 1.09 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.44 156.78 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.949 1.766 . . . . 1.0 112.454 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.454 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.5 t -98.46 -124.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.827 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.44 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 85.3 m -115.4 -40.75 3.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.592 0.235 . . . . 1.0 111.154 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.2 tt0 -67.45 -36.28 80.89 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 1.0 110.881 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.53 28.27 0.02 OUTLIER 'General case' 0 C--O 1.26 1.623 0 CA-C-O 123.289 1.519 . . . . 1.0 110.182 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.73 65.23 1.23 Allowed Glycine 0 C--O 1.212 -1.257 0 CA-C-O 117.567 -1.685 . . . . 1.0 111.437 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.538 HH12 ' CG ' ' D' ' 59' ' ' ASP . 60.6 ttm-85 -22.62 -35.62 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.431 1.115 . . . . 1.0 111.008 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' A' ' 67' ' ' GLY . 29.7 mmtp -48.4 -18.11 0.2 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.637 -0.711 . . . . 1.0 109.565 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -61.31 -47.97 91.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.371 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 -39.25 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 1.0 110.846 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -54.65 -42.27 71.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.674 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.52 -44.98 92.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.875 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.19 -47.19 91.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.16 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.43 -42.34 98.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.39 -42.18 96.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.346 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.17 93.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.781 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.42 95.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.28 -43.42 98.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.11 -42.09 97.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.45 -50.41 76.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -70.92 -22.41 62.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.066 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -86.28 -30.24 22.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.712 0.292 . . . . 1.0 110.781 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.65 -42.87 98.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.739 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' C ' ' N ' ' A' ' 87' ' ' ALA . 4.0 m -53.81 -16.36 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.189 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.6 m -43.16 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.268 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' N ' ' C ' ' A' ' 85' ' ' VAL . . . -63.05 -50.76 69.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.05 88.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.59 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.8 mm? -65.13 -39.0 92.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -56.4 -47.46 78.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.033 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -3.7 33.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.683 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.112 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.9 p90 -78.72 -44.04 24.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.827 0.346 . . . . 1.0 111.485 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 93.1 t -41.05 -25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.383 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 93' ' ' PHE . 11.1 tpt85 -58.82 -33.6 70.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.938 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -61.04 -23.05 65.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.655 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.945 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.711 0.291 . . . . 1.0 110.988 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.8 p80 -79.01 -31.36 44.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.566 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -66.27 -37.73 86.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.931 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -63.15 -40.18 96.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.706 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -65.66 -41.98 91.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.66 92.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.49 -40.56 93.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.11 -38.84 92.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.486 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.69 78.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.996 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.32 -35.68 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.645 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.74 -38.56 91.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 1.0 110.188 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -63.2 -34.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.99 -37.91 89.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -65.57 -31.01 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.832 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.81 -47.64 82.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.378 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.63 -31.38 50.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.089 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' B' ' 48' ' ' SER . 35.6 mt -61.06 -41.84 97.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.94 -47.58 79.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 1.0 109.834 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -67.46 -34.36 77.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.826 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.12 89.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.139 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -60.76 -35.57 76.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.043 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' B' ' 26' ' ' ALA . 44.9 tptt -65.08 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.623 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -39.92 -28.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.611 0.243 . . . . 1.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 24' ' ' LYS . . . -62.55 -41.06 98.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.405 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' B' ' 24' ' ' LYS . 1.4 p -67.23 -41.5 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.09 0.472 . . . . 1.0 110.46 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 74.4 mm-40 -70.95 -40.3 72.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.594 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' B' ' 66' ' ' GLU . . . -71.96 58.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.906 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' B' ' 38' ' ' LEU . 0.0 OUTLIER 170.78 -16.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.004 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -68.11 56.38 0.07 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.442 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.8 31.28 0.55 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.734 -0.547 . . . . 1.0 111.734 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 149.56 38.04 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.72 134.38 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.902 1.735 . . . . 1.0 112.061 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.28 25.61 73.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.255 -0.738 . . . . 1.0 111.255 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.31 140.72 57.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.35 -31.34 8.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' B' ' 30' ' ' GLU . 40.1 tp -101.56 112.75 25.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.247 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' B' ' 40' ' ' SER . 5.9 pt -145.11 84.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.29 -0.414 . . . . 1.0 109.89 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 62.9 m -168.73 -117.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.081 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.4 m-85 -176.09 -64.17 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.084 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -59.03 -29.33 90.35 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.147 1.898 . . . . 1.0 112.216 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.06 -8.2 58.78 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.09 86.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.0 110.396 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -66.86 -38.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.696 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -47.51 85.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.27 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.6 t90 -63.27 -42.54 99.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 1.0 110.395 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.42 ' O ' ' CD2' ' B' ' 19' ' ' LEU . 38.4 m -57.39 -39.88 77.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.119 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.65 -48.15 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.833 0.309 . . . . 1.0 111.833 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.421 ' OE1' ' NH1' ' C' ' 68' ' ' ARG . 18.1 pt-20 -76.13 -22.73 55.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.448 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 87.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.41 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.51 55.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.286 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.513 ' C ' ' H ' ' B' ' 55' ' ' VAL . 37.9 p -83.76 4.26 29.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 1.0 110.762 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 53' ' ' THR . 19.6 p 54.28 7.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.586 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' B' ' 53' ' ' THR . 53.8 t -62.99 -47.09 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.48 68.09 0.48 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' C' ' 60' ' ' ARG . 9.9 t80 -59.8 -46.38 89.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.678 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.66 -11.06 0.96 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.504 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 84.9 m-20 -41.63 -83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.834 0.35 . . . . 1.0 110.866 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -119.83 151.8 38.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.889 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 47.8 t80 -160.8 125.79 2.17 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.11 159.23 53.88 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.533 1.489 . . . . 1.0 112.531 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.69 -166.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.887 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 67' ' ' GLY . 9.0 p -56.13 -69.45 0.15 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.522 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -47.37 -17.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' B' ' 64' ' ' THR . 67.5 mt-10 -98.0 28.14 4.14 Favored 'General case' 0 C--O 1.266 1.932 0 CA-C-O 124.303 2.002 . . . . 1.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.732 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.59 62.76 1.31 Allowed Glycine 0 C--O 1.212 -1.235 0 CA-C-N 113.147 -1.842 . . . . 1.0 111.305 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.704 HH22 HH21 ' A' ' 60' ' ' ARG . 43.0 ttm180 -24.89 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.0 0.9 . . . . 1.0 111.414 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' B' ' 67' ' ' GLY . 14.7 mptt -53.19 -14.75 0.72 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' B' ' 67' ' ' GLY . 42.4 t -61.08 -45.5 98.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 119.695 -0.802 . . . . 1.0 109.698 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.0 28.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.302 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -60.48 -40.08 89.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.31 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -61.1 -46.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.48 -44.77 86.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.337 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -61.58 -41.79 97.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.614 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.86 -40.98 99.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.233 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.68 87.99 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.68 -0.568 . . . . 1.0 111.68 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.88 -43.37 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.116 -0.233 . . . . 1.0 110.792 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.82 -41.32 91.01 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.231 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.67 -50.29 76.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.383 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -66.35 -36.81 83.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.579 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.1 -37.53 87.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.611 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' B' ' 86' ' ' THR . 7.1 tt -62.64 -40.86 98.34 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 85.4 t -49.4 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.6 m -58.2 -41.59 84.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.419 ' O ' ' CG2' ' B' ' 91' ' ' THR . . . -42.93 -19.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.581 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -103.19 -28.51 11.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.125 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' THR . 89.3 mt -69.41 -44.74 70.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.027 0.441 . . . . 1.0 111.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.565 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.1 -9.05 9.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.435 0.636 . . . . 1.0 109.817 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.9 OUTLIER -101.73 -5.13 25.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.081 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.36 -46.95 88.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.011 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 47.8 p90 -79.29 -33.81 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.7 t -50.31 -31.71 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.335 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -64.23 -21.93 66.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.305 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.439 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 23.9 ptt-85 -51.16 -42.35 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 1.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 96.3 mt-10 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.234 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.858 0.361 . . . . 1.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.636 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.8 p80 -59.25 -41.63 89.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.804 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' C' ' 95' ' ' ARG . 97.4 mt-10 -64.43 -42.42 96.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -65.21 -39.25 92.55 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.94 -39.18 87.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.155 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . 0.458 ' O ' ' OE1' ' C' ' 12' ' ' GLU . . . -64.47 -37.41 87.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.404 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' C' ' 12' ' ' GLU . 56.5 tt0 -60.0 -42.5 94.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 1.0 110.469 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.67 -28.79 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.437 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.17 -45.42 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.324 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' C' ' 8' ' ' ALA . 57.3 mp0 -67.0 -41.22 87.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 1.0 110.96 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.4 -38.18 88.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 1.0 110.43 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -64.98 -31.17 72.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.305 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' C' ' 19' ' ' LEU . 46.3 tp -62.19 -39.12 91.67 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.441 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.7 -29.81 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.215 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -77.86 -45.19 24.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.72 -46.56 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.359 0.503 . . . . 1.0 112.359 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' C' ' 15' ' ' LEU . 3.1 pp -74.95 -26.8 59.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.742 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -63.8 -53.93 43.08 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.922 0.392 . . . . 1.0 110.032 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.92 -36.34 83.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' C' ' 74' ' ' VAL . . . -66.72 -35.43 80.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.5 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.54 ' HG ' ' CB ' ' C' ' 48' ' ' SER . 38.6 m -53.1 -44.43 67.61 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.284 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.21 -44.87 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 1.0 109.58 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.3 mttp -63.22 -39.28 94.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.792 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.38 64.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.146 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.44 -44.91 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.194 0.521 . . . . 1.0 110.363 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -66.19 -35.84 81.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -61.55 -43.34 99.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.326 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -90.23 -11.17 41.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.681 -0.236 . . . . 1.0 111.249 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -58.34 96.9 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.604 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.24 5.16 46.74 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.55 151.4 68.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.91 139.73 22.31 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.977 1.785 . . . . 1.0 112.189 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.55 25.54 63.33 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.241 -0.744 . . . . 1.0 111.241 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 140.95 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 -38.52 5.37 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.417 ' O ' ' CD2' ' C' ' 38' ' ' LEU . 5.7 tt -88.74 68.48 8.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.037 0.446 . . . . 1.0 109.944 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -92.11 -5.36 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.332 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.1 m -75.48 150.98 38.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.442 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 1.1 t80 -100.83 -61.95 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.98 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.6 Cg_endo -59.0 -30.07 92.39 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.782 1.654 . . . . 1.0 112.249 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.87 -2.17 57.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.054 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.51 85.3 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.392 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 tt -66.66 -39.36 83.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.925 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -49.49 75.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.41 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' C' ' 50' ' ' GLU . 3.5 t90 -64.38 -38.79 92.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.54 ' CB ' ' HG ' ' C' ' 23' ' ' SER . 25.2 p -63.2 -36.54 83.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.34 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.39 -48.86 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 121.101 -0.24 . . . . 1.0 111.59 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' C' ' 47' ' ' TRP . 2.6 pp20? -71.08 -29.76 65.71 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.77 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.441 ' N ' ' CD ' ' C' ' 50' ' ' GLU . 69.3 m -62.36 -46.52 88.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.315 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.69 66.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.809 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' C' ' 54' ' ' THR . 81.1 p -90.64 3.31 54.52 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' C' ' 53' ' ' THR . 17.4 p 55.5 15.55 1.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.92 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.68 -45.65 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.677 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.35 61.86 1.69 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -45.12 95.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.664 0.269 . . . . 1.0 110.825 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.35 13.97 1.1 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.41 -50.58 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 1.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CE1' ' B' ' 57' ' ' TYR . 96.1 mtt-85 -145.91 167.19 23.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.572 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -143.7 123.03 7.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 158.65 54.36 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.798 1.665 . . . . 1.0 112.184 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 m -98.09 -165.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.021 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -94.03 -32.07 13.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 1.0 110.168 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.6 ' C ' ' H ' ' C' ' 67' ' ' GLY . 10.4 tm-20 -64.05 -32.98 74.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.047 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.67 28.81 0.11 Allowed 'General case' 0 C--O 1.264 1.83 0 CA-C-O 124.378 2.037 . . . . 1.0 110.008 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.33 65.78 1.77 Allowed Glycine 0 C--O 1.216 -0.976 0 CA-C-N 113.516 -1.674 . . . . 1.0 111.167 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 ttm-85 -24.92 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.148 0.974 . . . . 1.0 111.392 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' C' ' 67' ' ' GLY . 71.8 mmtt -50.08 -31.64 13.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.476 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.8 t -64.14 -49.14 82.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 119.139 -1.024 . . . . 1.0 110.6 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.25 73.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.866 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.943 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.85 -43.47 85.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.954 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' C' ' 22' ' ' ALA . 70.6 t -64.18 -43.29 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.634 -0.426 . . . . 1.0 111.165 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 39.6 mtt -55.77 -45.31 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.002 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -40.83 95.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.19 86.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 1.0 110.235 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.05 -42.65 92.13 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.78 -42.77 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.71 0.29 . . . . 1.0 110.985 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' C' ' 84' ' ' LEU . 80.9 mm-40 -58.39 -41.29 84.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.244 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -49.35 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.309 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -64.93 -35.38 80.98 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.881 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.63 -28.49 30.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.751 0.31 . . . . 1.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.8 tt -63.5 -42.94 98.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.488 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.47 2.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.527 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.559 ' H ' ' C ' ' C' ' 84' ' ' LEU . 23.9 m -62.93 -20.65 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' C' ' 91' ' ' THR . . . -56.72 -61.06 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.39 94.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.012 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.62 -43.64 96.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.464 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.19 -23.6 66.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.401 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.534 ' OG1' ' CG ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -96.44 -3.86 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.3 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -60.42 -43.35 96.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.097 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -67.46 -30.1 69.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.03 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.93 -44.26 94.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.407 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' C' ' 5' ' ' GLU . 95.2 mtt-85 -48.04 -21.75 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.224 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.2 ptt85 -50.85 -41.28 57.77 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.39 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 21.1 pt-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.021 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.706 0.289 . . . . 1.0 110.539 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -172.74 -64.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.82 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.543 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 3.2 p80 -59.2 -39.52 82.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.11 -39.09 93.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.43 -43.17 99.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.482 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.23 -38.3 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.297 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.799 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.52 -42.11 98.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.48 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.29 -39.07 93.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.26 81.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.116 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.97 -39.12 93.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.794 0.33 . . . . 1.0 110.791 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.36 -33.81 76.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.67 -34.84 79.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.09 -42.52 99.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 1.0 110.663 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -64.29 -35.88 82.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.115 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -61.74 -41.83 98.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 1.0 110.99 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.61 -39.0 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.532 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -40.76 91.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.462 ' O ' ' OG ' ' D' ' 23' ' ' SER . 98.5 mt-10 -61.8 -44.95 95.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 1.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.63 -34.84 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.997 0.427 . . . . 1.0 110.02 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.54 87.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.03 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -59.57 -45.07 92.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.876 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -64.11 -54.97 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.256 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.58 -40.79 96.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.743 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.13 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.834 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.36 -46.71 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.374 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.65 -41.94 83.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.47 97.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -69.35 -39.68 77.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.794 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -63.32 119.21 9.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.11 49.9 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.42 146.02 30.76 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.749 -0.265 . . . . 1.0 110.519 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.76 144.14 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.143 1.895 . . . . 1.0 112.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.1 71.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.46 138.6 57.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.0 110.614 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.77 -36.44 4.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.473 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -99.28 108.23 20.72 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 pt -150.94 60.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -157.81 124.44 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.504 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 34.3 m-85 -53.1 -49.87 85.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.239 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.07 -34.99 99.07 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.1 1.2 . . . . 1.0 112.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -93.4 -8.18 42.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.716 0.293 . . . . 1.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.88 -45.38 82.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 1.0 110.876 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -68.17 -39.68 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.603 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -47.82 83.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.11 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -62.15 -40.21 95.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' D' ' 48' ' ' SER . 22.7 p -69.65 61.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -149.01 -57.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.194 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -65.72 -27.08 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.168 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -47.49 85.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.201 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.93 69.6 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.298 -0.561 . . . . 1.0 109.671 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.441 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.4 p -78.75 -12.68 60.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.472 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' D' ' 53' ' ' THR . 6.1 p 60.47 10.4 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.069 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.24 -43.43 88.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.252 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.3 72.61 0.56 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.448 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.3 OUTLIER -60.24 -46.94 88.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 1.0 110.465 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.0 10.62 1.51 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.538 ' CG ' HH12 ' A' ' 68' ' ' ARG . 53.8 m-20 -58.06 -50.86 71.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -151.02 -166.11 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.7 p90 -172.07 133.44 0.78 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.831 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.48 157.74 58.11 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.999 1.8 . . . . 1.0 112.428 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' H ' ' D' ' 64' ' ' THR . 1.9 t -89.79 -143.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.924 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.44 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 94.8 m -112.09 -41.68 3.91 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.744 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.581 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.1 -19.68 65.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.9 0.381 . . . . 1.0 110.448 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.1 OUTLIER -77.86 23.67 0.25 Allowed 'General case' 0 C--O 1.266 1.973 0 CA-C-O 123.842 1.782 . . . . 1.0 108.956 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.741 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.85 61.55 3.81 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' D' ' 67' ' ' GLY . 58.0 ttm-85 -26.94 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.761 0.781 . . . . 1.0 111.214 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.9 tptm -55.85 -27.34 51.17 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.107 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.4 t -61.07 -49.42 84.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 119.649 -0.82 . . . . 1.0 109.942 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.65 -37.05 73.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.179 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.57 -43.83 89.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -61.39 -40.75 95.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.213 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.09 -43.9 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.609 -0.436 . . . . 1.0 111.196 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.9 mtt -60.26 -44.34 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -65.98 -36.77 84.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.28 88.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.586 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.62 -42.76 95.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.479 -0.648 . . . . 1.0 111.479 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.64 -43.46 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.021 -0.272 . . . . 1.0 111.092 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.18 -41.53 97.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.285 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.21 -50.25 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 1.0 111.373 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.9 -40.26 83.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.756 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -63.13 -35.16 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.371 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.73 -41.18 97.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.268 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.2 -17.82 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.695 -0.402 . . . . 1.0 109.919 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 56.7 m -47.46 -40.09 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.08 -17.29 1.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.671 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.62 20.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.563 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 3.7 mm? -92.53 -40.8 10.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.008 0.432 . . . . 1.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.535 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -57.14 -28.2 62.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.618 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.34 -4.36 55.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -49.92 75.92 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.145 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 21.3 p90 -73.47 -38.72 65.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.987 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.3 t -47.92 -27.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.161 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' D' ' 97' ' ' GLU . 94.5 mtt180 -64.73 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -54.31 -7.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . 0.521 ' H ' ' C ' ' D' ' 95' ' ' ARG . 24.1 tp10 . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.49 ' CB ' ' NE2' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.86 0.362 . . . . 1.0 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 11.6 p-10 -65.14 -36.64 84.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.682 ' CD2' HH12 ' D' ' 96' ' ' ARG . 6.4 p80 -75.14 -34.2 61.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.643 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 95' ' ' ARG . 96.2 mt-10 -63.54 -38.4 91.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.528 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.66 -39.71 94.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -50.87 -44.99 59.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.3 88.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.262 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.82 -45.2 90.64 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.89 -35.85 82.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.048 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -48.33 68.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.784 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.65 -42.64 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -64.03 -33.91 76.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.158 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.81 -34.92 78.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.389 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.773 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -55.29 -40.15 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.205 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -64.37 -31.62 72.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.787 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.38 -41.98 86.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 1.0 110.683 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.57 -40.64 92.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.784 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -55.96 -49.67 72.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.917 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.49 -37.14 82.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.994 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.24 86.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.634 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.97 -40.96 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.025 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.37 -61.45 2.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.376 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.4 -44.21 95.92 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.909 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.93 -45.76 74.87 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.37 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.55 -46.49 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.368 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.25 -41.89 72.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.019 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.15 -41.12 48.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.802 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.66 -44.87 69.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.115 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -51.81 99.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.396 . . . . 1.0 110.651 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.4 -11.89 12.57 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 111.446 -0.661 . . . . 1.0 111.446 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.49 140.26 33.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 122.705 -0.291 . . . . 1.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.27 144.18 29.09 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.015 1.81 . . . . 1.0 112.478 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.16 27.09 68.45 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.32 140.77 58.72 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.421 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.94 -30.73 4.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -87.24 122.59 31.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' SER . 41.0 pt -153.41 163.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 79.96 134.53 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.79 0.329 . . . . 1.0 110.934 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 32.4 t80 -65.79 -44.73 64.35 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.087 -0.506 . . . . 1.0 112.127 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.3 Cg_endo -60.57 -30.86 91.5 Favored 'Trans proline' 0 N--CA 1.503 2.055 0 C-N-CA 121.562 1.508 . . . . 1.0 112.737 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.29 -27.23 18.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.706 0.288 . . . . 1.0 110.785 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.02 82.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.582 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -62.84 -38.74 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.564 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.7 OUTLIER -65.96 -38.21 87.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.23 -0.441 . . . . 1.0 109.824 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -62.71 -42.34 99.6 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.247 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.6 p -58.09 -28.38 64.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.9 t -63.76 -45.69 96.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 1.0 110.419 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 77.5 mt-10 -80.26 -0.85 38.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.81 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -35.51 8.07 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 1.0 109.83 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.44 82.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.345 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -88.92 11.75 17.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 5.1 p 64.38 -135.11 0.29 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.411 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' OG1' ' A' ' 54' ' ' THR . 46.1 t 62.73 -61.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.595 0.559 . . . . 1.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 50.36 90.92 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -60.6 -44.13 96.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.726 0.298 . . . . 1.0 110.78 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.79 17.05 0.85 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.64 -51.94 67.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 1.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' ' CZ ' ' D' ' 57' ' ' TYR . 94.8 mtt-85 -145.73 139.84 26.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.949 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 62' ' ' PRO . 77.8 t80 -130.91 127.71 22.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.536 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 60.6 Cg_endo -70.33 159.92 51.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.826 1.684 . . . . 1.0 112.62 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 64' ' ' THR . 2.1 t -83.68 -138.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.428 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 51.6 m -114.72 -37.95 4.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.677 0.275 . . . . 1.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.67 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.9 tp10 -64.59 -31.21 72.33 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE2' ' C ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.79 30.54 0.04 OUTLIER 'General case' 0 C--O 1.263 1.786 0 CA-C-O 123.594 1.664 . . . . 1.0 109.952 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.77 64.35 1.25 Allowed Glycine 0 C--O 1.213 -1.196 0 CA-C-N 113.797 -1.547 . . . . 1.0 111.317 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.549 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 43.0 ttm180 -24.0 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.114 0.957 . . . . 1.0 111.108 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -48.86 -18.28 0.26 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.752 -0.658 . . . . 1.0 109.442 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.3 t -61.63 -47.83 91.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 119.494 -0.882 . . . . 1.0 110.131 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.19 64.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.631 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -58.92 -41.66 87.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.716 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.84 -42.03 96.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.051 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.93 -44.47 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.782 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.2 mtt -54.93 -43.91 73.77 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.748 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.08 -40.67 96.61 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.356 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.03 -41.64 98.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.06 81.85 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.56 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 1.0 110.717 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.37 -40.46 96.52 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.678 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.95 -50.06 78.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -68.33 -25.3 65.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.052 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.77 -23.51 21.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.667 0.27 . . . . 1.0 110.751 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -65.46 -35.44 80.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.2 m -43.17 -19.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.794 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' LEU . 24.9 m -40.92 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.963 0.411 . . . . 1.0 110.122 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.39 -46.68 89.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.436 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 -27.49 10.16 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.744 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.6 -37.56 86.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.627 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -70.9 -67.91 0.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 1.0 110.798 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -8.51 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.042 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 90' ' ' ALA . 51.0 t0 -46.99 -38.73 11.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.848 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 10.1 p90 -79.45 -28.88 41.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.388 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.88 -26.15 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.427 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 96.4 mtt180 -60.1 -31.66 70.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.517 -0.311 . . . . 1.0 111.308 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.46 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.4 ptt180 -58.15 -42.32 85.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.369 . . . . 1.0 110.617 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 97.4 mt-10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.724 0.297 . . . . 1.0 110.871 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.64 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 7.2 p-80 -80.4 -34.99 35.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.504 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.48 -39.24 85.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.27 -43.49 98.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.757 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -65.08 -36.54 84.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.1 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -65.3 -41.62 93.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.464 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.04 -40.7 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.55 92.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.928 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.443 ' OE2' ' CD1' ' B' ' 82' ' ' PHE . 80.3 mm-40 -67.92 -41.6 82.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 1.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -65.05 -37.27 87.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.59 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.416 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.02 -42.96 99.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.455 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -37.58 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.6 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.02 -41.63 96.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.0 -33.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.686 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.03 -42.1 98.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.572 -0.451 . . . . 1.0 109.922 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.48 -46.18 91.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.856 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.442 ' CG ' ' NZ ' ' B' ' 25' ' ' LYS . 83.7 tt0 -69.28 -38.65 78.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.022 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.47 -38.91 88.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.499 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -60.01 -44.29 94.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.846 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.07 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 1.0 110.258 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.442 ' NZ ' ' CG ' ' B' ' 21' ' ' GLU . 62.3 mttp -75.86 -39.51 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.364 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.97 -49.68 74.97 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.658 -0.246 . . . . 1.0 111.298 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.465 ' O ' ' OE1' ' B' ' 30' ' ' GLU . 3.8 p -63.76 -42.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.279 0.561 . . . . 1.0 110.317 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 78.8 mm-40 -70.35 -20.83 62.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.498 -0.774 . . . . 1.0 110.59 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.91 81.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.511 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' B' ' 27' ' ' VAL . 29.7 mp0 -65.21 -40.23 93.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 1.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -63.16 86.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.58 -10.45 6.79 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 141.88 23.59 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.765 0.283 . . . . 1.0 110.603 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.489 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 98.9 Cg_endo -75.39 144.93 29.57 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.229 1.953 . . . . 1.0 112.38 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.87 36.3 57.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.36 150.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 1.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.12 -45.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.253 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 33.9 tp -97.02 91.9 5.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.513 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.3 pt -105.21 2.58 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.421 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -99.86 123.54 44.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.119 0.485 . . . . 1.0 110.985 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.3 t80 -77.22 -54.86 1.44 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.312 -0.858 . . . . 1.0 110.617 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -58.12 -27.0 78.34 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.803 1.669 . . . . 1.0 112.519 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -93.66 -10.25 35.13 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.926 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.08 87.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.885 0.374 . . . . 1.0 110.352 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.45 -33.16 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.609 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.85 75.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.707 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.626 ' CB ' ' HE ' ' B' ' 60' ' ' ARG . 1.4 t90 -62.5 -42.94 99.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.474 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 11.9 p -45.13 -27.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.85 -25.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.443 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.644 ' CG ' HH21 ' C' ' 68' ' ' ARG . 1.5 tm-20 -66.24 -41.36 90.13 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.737 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.538 ' C ' ' H ' ' B' ' 53' ' ' THR . 8.4 t -82.44 -158.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.229 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.455 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 70.79 -38.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.474 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.538 ' H ' ' C ' ' B' ' 51' ' ' THR . 70.8 p -91.22 6.83 43.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' B' ' 53' ' ' THR . 44.7 p 51.61 66.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.428 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.16 -47.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.598 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.92 67.27 1.5 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.541 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 24.4 t80 -60.92 -49.14 78.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 1.0 110.908 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 160.62 -96.98 0.15 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.7 t0 52.52 -82.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.392 . . . . 1.0 110.602 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.626 ' HE ' ' CB ' ' B' ' 47' ' ' TRP . 35.4 ptt85 -127.65 -160.88 1.04 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -163.55 133.32 3.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.965 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.0 179.06 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.628 1.552 . . . . 1.0 112.12 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' B' ' 34' ' ' PRO . 0.8 OUTLIER -91.33 -154.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.242 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.553 ' O ' ' NE1' ' A' ' 46' ' ' TRP . 18.0 m -113.61 -71.83 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.673 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' B' ' 64' ' ' THR . 83.4 tt0 -35.42 -31.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.966 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.907 ' O ' ' N ' ' B' ' 68' ' ' ARG . 95.2 mt-10 -141.98 -108.25 0.14 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.66 -56.04 0.0 OUTLIER Glycine 0 N--CA 1.476 1.345 0 O-C-N 124.492 1.12 . . . . 1.0 114.032 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.907 ' N ' ' O ' ' B' ' 66' ' ' GLU . 14.7 ttm180 -65.85 -48.61 71.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -63.58 -36.31 83.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.096 -1.075 . . . . 1.0 108.096 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.79 -45.35 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.952 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.519 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -65.88 -38.14 87.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -49.0 -45.65 42.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.176 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.36 -38.25 90.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.769 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.68 -45.55 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.552 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 3.6 mpp? -63.85 -40.29 96.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.518 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.33 -40.45 96.41 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.225 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.04 87.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.84 0.352 . . . . 1.0 110.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.77 -38.98 93.48 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.485 -0.646 . . . . 1.0 111.485 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.08 -11.8 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.815 -0.226 . . . . 1.0 111.559 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.57 -53.26 3.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.08 0.467 . . . . 1.0 110.931 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.491 ' CG2' ' H ' ' B' ' 82' ' ' PHE . 17.8 m -60.69 -55.11 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.712 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.491 ' H ' ' CG2' ' B' ' 81' ' ' VAL . 42.2 m-85 -62.0 -43.79 98.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.887 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -64.67 -36.82 85.52 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.5 tt -57.62 -31.78 66.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.1 -4.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.473 ' H ' ' C ' ' B' ' 84' ' ' LEU . 72.4 m -61.16 -44.86 96.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.574 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' CG2' ' B' ' 91' ' ' THR . . . -51.37 -29.28 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.725 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.95 -12.69 35.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.739 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.79 -39.88 10.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.403 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.477 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.91 -25.78 57.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.231 0.539 . . . . 1.0 110.15 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -82.06 -6.31 59.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.395 -0.82 . . . . 1.0 109.891 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.63 -48.77 79.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.142 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.1 p90 -77.48 -40.07 44.26 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.094 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.46 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 58.8 t -44.79 -31.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.586 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.05 -22.22 66.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.057 -0.257 . . . . 1.0 111.478 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.0 ptt85 -54.42 -43.45 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 1.0 110.063 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 96.4 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.417 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.4 t0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.872 0.367 . . . . 1.0 110.064 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.585 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 24.8 p80 -67.02 -39.99 87.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.099 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.585 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 48.0 tp10 -65.9 -41.35 91.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.727 0.298 . . . . 1.0 110.577 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -64.78 -37.41 87.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -62.9 -40.92 99.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.128 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.31 98.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.37 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -65.64 -41.92 92.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.481 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.87 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.26 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.62 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.165 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -37.15 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.06 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -64.55 -34.47 78.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.778 0.323 . . . . 1.0 110.438 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -65.78 -35.9 82.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.22 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.706 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.4 -36.26 79.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.334 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.57 -40.23 90.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.775 0.322 . . . . 1.0 110.908 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.73 -35.46 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.98 -41.57 92.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.709 -0.396 . . . . 1.0 109.958 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 98.4 mt-10 -62.87 -43.34 99.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.92 -36.38 75.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.279 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.64 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.434 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 77.8 p -60.76 -43.76 97.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.824 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -60.51 -56.35 22.48 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.95 -44.24 97.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.014 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -57.1 -24.76 56.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.78 -51.77 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.191 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.83 -43.01 69.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.911 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.79 -50.57 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 3.8 mp0 -62.15 -44.92 95.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -68.01 130.32 42.61 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.94 59.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.422 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.24 151.76 41.89 Favored Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.17 123.54 7.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.726 1.617 . . . . 1.0 112.184 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 103.99 -23.12 33.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . 48.35 178.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 1.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.67 -93.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.63 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.43 111.54 22.82 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.839 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' C' ' 40' ' ' SER . 1.4 tp -144.18 101.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.068 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.537 ' O ' ' N ' ' C' ' 44' ' ' ALA . 0.3 OUTLIER 166.67 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.749 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.499 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.9 OUTLIER -49.11 -50.48 63.17 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.862 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.8 Cg_endo -58.9 -34.9 99.3 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.383 1.389 . . . . 1.0 112.453 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -98.74 -5.1 32.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.277 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -68.31 -41.55 80.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.809 0.338 . . . . 1.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -65.04 -38.9 83.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.728 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.617 ' CZ3' ' NZ ' ' D' ' 69' ' ' LYS . 0.3 OUTLIER -58.96 -46.63 87.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.557 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.541 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.9 OUTLIER -68.31 -23.6 64.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.271 -0.571 . . . . 1.0 109.508 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.4 t -75.09 -35.54 61.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.92 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.52 -44.28 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.944 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.53 -41.84 77.46 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.057 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' C' ' 52' ' ' ALA . 3.6 t -78.69 -176.28 4.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.447 ' N ' ' OG1' ' C' ' 51' ' ' THR . . . 76.3 -12.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.569 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.429 ' H ' ' C ' ' C' ' 51' ' ' THR . 68.9 p -115.66 14.21 16.41 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.548 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' C' ' 53' ' ' THR . 47.0 p 53.67 69.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.4 -73.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.22 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.81 81.15 0.06 OUTLIER Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.412 ' CB ' ' CD1' ' D' ' 61' ' ' TYR . 45.5 t80 -60.43 -47.66 85.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.821 -0.351 . . . . 1.0 110.789 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.0 30.15 0.54 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 40.6 t0 -61.69 -41.68 97.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 1.0 110.431 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -141.79 -161.32 1.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.895 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 20.5 p90 -171.61 120.29 0.47 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.2 158.32 56.75 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.699 1.599 . . . . 1.0 112.355 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.433 ' O ' ' OE2' ' C' ' 66' ' ' GLU . 1.8 t -82.06 -142.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.133 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.419 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 98.4 m -111.77 -47.44 3.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.665 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.618 ' C ' ' H ' ' C' ' 67' ' ' GLY . 46.3 tp10 -58.71 -25.17 62.63 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.2 OUTLIER -73.01 28.15 0.06 Allowed 'General case' 0 C--O 1.263 1.81 0 CA-C-O 123.52 1.628 . . . . 1.0 110.213 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 41.1 62.72 1.7 Allowed Glycine 0 C--O 1.216 -1.024 0 CA-C-N 113.773 -1.558 . . . . 1.0 110.673 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.644 HH21 ' CG ' ' B' ' 50' ' ' GLU . 46.5 ttt85 -24.21 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.796 0.798 . . . . 1.0 111.58 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.8 mttt -51.65 -16.5 0.65 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.704 -0.68 . . . . 1.0 109.373 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 67' ' ' GLY . 65.9 t -62.52 -48.08 89.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 119.324 -0.95 . . . . 1.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.06 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 1.0 110.093 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -64.79 -39.59 93.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.03 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.65 -42.44 75.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.245 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 82.5 t -66.0 -41.72 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.844 -0.343 . . . . 1.0 111.545 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.4 mtt -59.46 -44.75 92.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.939 -0.304 . . . . 1.0 111.216 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -63.37 -40.63 97.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.63 89.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.84 0.352 . . . . 1.0 110.496 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -42.39 76.15 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.222 -0.513 . . . . 1.0 111.897 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.19 -43.91 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.641 -0.329 . . . . 1.0 110.752 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.54 -43.25 85.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.303 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.76 -50.39 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.349 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -67.63 -40.76 84.59 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.22 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -68.23 -31.23 70.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.764 0.316 . . . . 1.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.1 tt -62.74 -42.23 99.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.813 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -52.64 -8.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.564 -0.455 . . . . 1.0 110.61 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.508 ' H ' ' C ' ' C' ' 84' ' ' LEU . 43.8 m -49.43 -23.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 1.0 110.247 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.58 72.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.045 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.94 85.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.454 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.38 -38.52 90.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.879 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.519 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.32 -44.26 88.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.02 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.71 44.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.233 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -56.0 -49.52 73.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.656 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -72.5 -41.12 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.08 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 93.7 t -45.71 -27.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.68 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -62.41 -22.67 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.605 -0.27 . . . . 1.0 111.414 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -55.23 -33.65 63.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.758 0.314 . . . . 1.0 110.569 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.477 179.824 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.937 0.398 . . . . 1.0 110.42 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' D' ' 6' ' ' ARG . 98.7 m-20 -64.48 -40.11 95.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.776 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -72.2 -19.93 61.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.202 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.01 -45.29 77.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 1.0 110.519 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . 0.463 ' NH2' ' OD1' ' D' ' 3' ' ' ASP . 95.4 mtm-85 -65.39 -36.72 84.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.66 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -61.02 -42.72 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.086 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.23 86.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.24 -42.29 99.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.94 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.75 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.56 77.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.905 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.8 -42.6 90.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.735 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.64 -38.91 90.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.595 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.96 -33.58 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.82 -38.54 91.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 1.0 110.075 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.59 -28.41 67.74 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -65.0 -40.15 94.51 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.824 0.345 . . . . 1.0 111.534 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.68 -31.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.15 -44.16 97.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.446 ' O ' ' OG ' ' D' ' 23' ' ' SER . 12.0 pt-20 -67.87 -35.33 78.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.001 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -66.49 -36.65 83.26 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.802 -0.359 . . . . 1.0 110.344 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.76 -40.32 96.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.091 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.0 p -58.45 -45.69 88.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.203 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.89 -63.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -58.57 -37.57 76.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -59.8 -42.31 93.16 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.705 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.16 -48.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.443 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.92 -42.58 69.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.777 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.688 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' D' ' 38' ' ' LEU . 8.8 tm-20 -69.91 -35.41 74.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.383 . . . . 1.0 111.002 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -54.07 101.84 0.05 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.912 0.387 . . . . 1.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.69 21.34 10.5 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.617 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . 0.49 ' CB ' ' OE2' ' D' ' 66' ' ' GLU . . . -105.33 145.1 30.14 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 122.918 -0.166 . . . . 1.0 110.711 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.86 139.36 24.58 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.037 1.824 . . . . 1.0 112.03 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 63.98 17.25 60.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . -46.83 176.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.932 0.396 . . . . 1.0 110.958 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.95 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.751 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' D' ' 30' ' ' GLU . 58.5 tp -123.04 108.74 13.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.821 0.343 . . . . 1.0 110.109 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' D' ' 40' ' ' SER . 14.2 pt -136.8 159.95 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' D' ' 43' ' ' ASP . 0.5 OUTLIER 81.33 139.23 0.07 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.697 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.64 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.3 OUTLIER -77.77 -38.61 1.76 Allowed Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.695 178.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.63 -32.82 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.308 1.338 . . . . 1.0 112.197 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' D' ' 40' ' ' SER . 29.6 p-10 -96.94 -6.21 36.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.578 0.228 . . . . 1.0 110.876 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.39 -40.14 67.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.948 0.404 . . . . 1.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 tt -63.91 -40.17 88.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.417 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.487 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -58.49 -45.82 87.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -63.12 -39.24 94.1 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.724 -0.472 . . . . 1.0 109.724 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -58.81 -41.57 87.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.127 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -76.6 68.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.009 0.433 . . . . 1.0 111.699 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' D' ' 53' ' ' THR . 7.5 pt-20 -173.58 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.733 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -64.68 -43.44 93.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.69 60.48 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 44.2 p -84.73 -1.82 56.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.317 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' D' ' 53' ' ' THR . 46.4 p 50.95 58.86 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' D' ' 56' ' ' GLY . 10.2 p -128.28 -46.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.587 -0.278 . . . . 1.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' D' ' 55' ' ' VAL . . . 41.26 76.58 0.09 OUTLIER Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.511 ' CZ ' ' O ' ' A' ' 60' ' ' ARG . 15.1 t80 -60.94 -46.42 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.0 110.416 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.72 36.08 0.08 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 21.6 t0 -83.86 -77.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 1.0 110.69 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -130.39 147.84 52.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.412 ' CD1' ' CB ' ' C' ' 57' ' ' TYR . 46.2 t80 -149.0 135.83 10.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.33 149.23 69.41 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.011 1.807 . . . . 1.0 112.318 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 3.3 t -80.41 -125.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.009 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 76.1 m -113.7 -36.41 4.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.839 0.352 . . . . 1.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.7 tt0 -67.4 -30.35 70.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.2 pm0 -79.36 34.53 0.26 Allowed 'General case' 0 C--O 1.265 1.891 0 CA-C-O 123.224 1.488 . . . . 1.0 108.845 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.43 61.19 1.29 Allowed Glycine 0 C--O 1.212 -1.262 0 CA-C-N 113.767 -1.561 . . . . 1.0 109.916 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 40.0 ttm180 -24.37 -31.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.533 0.784 . . . . 1.0 111.086 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.4 mttp -54.12 -13.67 0.89 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.308 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.4 t -61.32 -47.74 92.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 119.52 -0.872 . . . . 1.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.87 80.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.96 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -57.31 -39.37 75.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.232 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -66.58 -40.47 88.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 -47.52 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.539 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.64 -40.84 96.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 1.0 111.161 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -61.51 -42.54 98.96 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.744 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.96 88.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.432 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.29 -40.43 96.57 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.53 -43.61 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.712 0.291 . . . . 1.0 111.172 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.38 -35.2 79.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.01 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.28 -56.12 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.519 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -62.07 -43.22 99.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.836 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.23 -37.51 87.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.292 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.2 -42.19 99.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' D' ' 87' ' ' ALA . 89.7 t -58.11 -18.34 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 75.6 m -43.96 -20.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.467 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.22 -61.01 2.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.909 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.99 61.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.254 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 2.7 mm? -78.08 -38.04 45.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.24 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.9 -35.85 71.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.31 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -4.2 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.907 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' D' ' 89' ' ' LEU . 66.6 t0 -56.66 -44.37 81.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.836 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 12.3 p90 -74.97 -42.98 56.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.923 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 88.7 t -44.17 -26.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.358 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -57.49 -25.32 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.075 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . 0.682 HH12 ' CD2' ' A' ' 4' ' ' HIS . 7.2 ptp180 -59.2 -34.8 72.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 1.0 110.358 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.057 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.906 0.384 . . . . 1.0 110.375 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -174.25 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.544 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.0 p80 -73.47 -31.07 63.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.08 -39.46 93.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -61.38 -42.09 98.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -64.0 -39.64 94.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.144 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -38.75 92.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.213 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -64.36 -41.56 96.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -63.39 -39.31 94.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.73 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.71 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.842 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.24 -44.23 88.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 1.0 110.635 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.72 -33.87 76.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.311 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.74 -35.16 79.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.449 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.86 -42.57 99.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.392 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.24 -34.9 72.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.979 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.51 -40.76 97.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.09 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.42 -29.0 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.76 -41.97 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.46 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.06 -39.8 78.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.329 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.27 93.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.029 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.5 p -60.76 -42.28 97.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 1.0 110.177 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.59 -30.34 71.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.926 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.9 -46.59 18.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.302 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.03 88.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.7 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 m -56.71 -54.35 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.39 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -67.93 -42.19 81.4 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.839 0.352 . . . . 1.0 110.701 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.32 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.063 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -98.05 14.86 25.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.557 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt85 -80.64 99.28 8.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.0 110.351 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.45 6.42 87.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.646 -0.581 . . . . 1.0 111.646 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 149.36 95.6 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 36' ' ' ALA . 98.4 Cg_endo -75.26 141.49 25.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.926 1.751 . . . . 1.0 112.245 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.05 -6.8 8.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -77.84 155.41 31.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.839 0.352 . . . . 1.0 110.48 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.18 10.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' SER . 6.8 tt -82.96 -10.73 58.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.476 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' LEU . 4.8 pt -37.35 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.631 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.4 m 169.21 134.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.916 -0.583 . . . . 1.0 109.888 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 55.9 m-85 -82.56 -48.33 0.86 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.448 0.536 . . . . 1.0 112.448 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.0 Cg_endo -60.56 -31.68 92.59 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 121.634 1.556 . . . . 1.0 112.657 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -91.2 -6.03 54.03 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.913 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.551 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.0 -41.0 88.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.093 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.99 96.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -62.4 -40.38 96.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 p -58.83 -31.9 68.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.718 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG1' ' OE1' ' B' ' 72' ' ' GLU . 94.9 t -71.59 -44.24 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.255 0.55 . . . . 1.0 110.636 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 45.7 tp10 -52.15 -42.68 63.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.376 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.572 ' C ' ' H ' ' A' ' 53' ' ' THR . 4.6 t -80.78 -158.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.488 ' N ' ' OG1' ' A' ' 51' ' ' THR . . . 71.31 -35.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 1.0 110.141 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 51' ' ' THR . 62.0 p -81.31 5.43 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 53' ' ' THR . 10.7 p 58.17 26.7 14.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.127 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -146.95 82.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.782 0.325 . . . . 1.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 112.1 3.39 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.4 -46.05 91.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.53 27.41 0.39 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 48.7 m-20 -62.34 -42.11 99.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 1.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 38.8 mmt180 -130.87 -169.07 2.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.15 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 96.4 m-85 -159.61 91.58 1.84 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.89 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.34 157.59 60.65 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.787 1.658 . . . . 1.0 112.271 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.676 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.9 p -116.76 -165.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.987 0.423 . . . . 1.0 110.344 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.676 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 61.2 m -78.66 -42.8 27.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.608 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.3 tp10 -50.74 -47.23 59.39 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -74.49 29.78 0.08 Allowed 'General case' 0 C--O 1.26 1.638 0 CA-C-O 124.212 1.958 . . . . 1.0 109.568 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.46 66.64 1.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 113.838 -1.528 . . . . 1.0 111.863 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH1' ' OE1' ' D' ' 50' ' ' GLU . 58.2 ttm-85 -24.11 -34.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.029 0.915 . . . . 1.0 110.808 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.9 mttp -47.63 -20.53 0.27 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' GLY . 57.1 t -61.29 -48.18 90.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 119.652 -0.819 . . . . 1.0 110.453 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.46 -41.73 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.673 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -59.67 -42.52 93.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.698 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.03 -41.55 83.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.821 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.1 t -65.65 -42.79 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.572 -0.451 . . . . 1.0 111.14 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.409 ' CE ' ' OH ' ' D' ' 57' ' ' TYR . 65.2 mtt -57.36 -45.33 84.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.904 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -63.59 -41.81 98.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.02 -40.6 85.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.647 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -42.55 83.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.56 -43.92 95.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 1.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.22 -40.2 93.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.124 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.75 -49.74 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.07 -39.14 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.243 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.06 92.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.877 0.37 . . . . 1.0 110.998 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.5 tt -62.98 -41.38 99.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.302 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.3 t -47.4 -13.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 84' ' ' LEU . 76.8 m -58.07 -42.18 84.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.89 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -40.27 -33.77 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.61 19.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.684 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 86' ' ' THR . 52.2 mt -66.4 -38.77 88.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.53 -47.83 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.155 0.502 . . . . 1.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -4.14 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.449 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.41 -49.39 77.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.5 p90 -76.05 -34.41 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.439 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.1 t -43.95 -34.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.137 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -60.36 -23.04 63.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -57.48 -44.31 84.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.434 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 64.3 t0 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.765 0.317 . . . . 1.0 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -77.48 -20.56 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.372 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.39 -37.78 83.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.93 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.73 -42.72 97.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.767 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.431 . . . . 1.0 109.864 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.43 90.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.73 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.8 -43.27 96.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.146 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -63.19 -40.37 97.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.69 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.51 81.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.823 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.27 -44.27 84.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 1.0 110.647 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -64.67 -36.82 85.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.129 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -62.4 -33.44 74.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.325 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 1.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.17 -38.02 72.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.96 -38.62 89.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.76 -39.84 87.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.838 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.85 -38.72 82.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' B' ' 23' ' ' SER . 96.8 mt-10 -63.05 -43.92 97.3 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -69.32 -31.18 69.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.77 86.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.006 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -60.69 -45.77 92.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 44.3 tttm -65.47 -50.09 66.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.338 0.59 . . . . 1.0 110.073 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.09 -42.63 96.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.743 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.52 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -67.71 -50.69 56.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.106 0.253 . . . . 1.0 111.531 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.9 p -60.94 -45.91 97.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.06 0.457 . . . . 1.0 110.658 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 96.7 mt-10 -68.64 -18.81 64.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.674 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.23 70.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 56.0 mp0 -80.64 -110.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 1.0 110.113 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 41.81 50.22 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.151 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.77 25.82 0.9 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.786 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.08 150.47 39.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.71 130.18 12.35 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.975 1.784 . . . . 1.0 112.067 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.88 75.08 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.201 -0.76 . . . . 1.0 111.201 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 163.49 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.349 . . . . 1.0 110.53 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.24 -32.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.574 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.59 49.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.39 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' B' ' 40' ' ' SER . 18.7 tt -92.73 76.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.182 0.515 . . . . 1.0 110.107 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 39' ' ' ILE . 69.1 m -168.81 98.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.087 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 53.4 t80 -58.26 -50.12 89.83 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.69 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.2 Cg_endo -58.22 -33.28 97.41 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.809 1.672 . . . . 1.0 112.608 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.66 -4.2 48.04 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.237 -0.185 . . . . 1.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.88 92.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.947 0.403 . . . . 1.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 tt -67.39 -40.23 84.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.635 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.45 99.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.469 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -61.8 -42.7 99.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.549 ' C ' ' H ' ' B' ' 50' ' ' GLU . 16.2 m -56.82 -39.11 73.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.086 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.501 ' O ' ' CG1' ' B' ' 49' ' ' VAL . 58.0 t -67.18 29.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.87 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' B' ' 48' ' ' SER . 79.7 mm-40 -137.07 -21.79 1.2 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.848 -0.532 . . . . 1.0 110.493 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -36.08 14.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.02 83.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.207 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.7 p -86.18 12.96 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.849 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' B' ' 53' ' ' THR . 68.0 p 50.11 73.95 0.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.624 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -131.4 -71.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.65 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 64.76 3.25 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -46.55 89.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.779 0.323 . . . . 1.0 110.752 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.96 23.1 0.97 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.633 -0.987 . . . . 1.0 110.633 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 48.0 t0 -63.13 -41.05 99.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 1.0 110.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 35.0 mmt180 -126.57 -174.68 3.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 79.2 m-85 -159.57 83.32 2.32 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.868 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 151.97 77.94 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.545 1.497 . . . . 1.0 112.092 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 16.8 m -96.68 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.872 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' B' ' 66' ' ' GLU . 48.8 m -112.38 -55.84 2.47 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.728 0.299 . . . . 1.0 111.238 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -43.87 -16.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.86 0.362 . . . . 1.0 110.804 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' B' ' 64' ' ' THR . 0.0 OUTLIER -91.85 26.66 2.33 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 123.839 1.781 . . . . 1.0 109.477 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.89 64.35 1.09 Allowed Glycine 0 C--O 1.212 -1.26 0 CA-C-N 113.663 -1.608 . . . . 1.0 111.424 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 55.8 ttm-85 -24.87 -32.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.217 1.008 . . . . 1.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.6 mttt -48.0 -18.87 0.21 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 67' ' ' GLY . 65.0 t -64.28 -45.47 96.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 120.124 -0.631 . . . . 1.0 109.803 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.92 -40.97 78.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.997 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . 0.425 ' OE1' ' CG1' ' A' ' 49' ' ' VAL . 83.0 tt0 -65.39 -40.5 93.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.085 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.69 -59.44 5.43 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.087 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.2 -44.68 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.287 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 38.9 ttp -59.93 -47.52 85.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.64 -32.48 73.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.378 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.74 78.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.575 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -43.05 96.74 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.401 HG23 HD12 ' B' ' 79' ' ' ILE . 92.2 mt -61.74 -43.45 97.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 122.813 -0.228 . . . . 1.0 110.87 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.13 -42.1 85.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.298 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.83 -50.13 78.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.344 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.39 -37.83 80.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.789 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -64.29 -37.85 88.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.555 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.425 ' C ' ' N ' ' B' ' 86' ' ' THR . 4.4 tt -62.66 -41.58 99.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.183 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.96 -15.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 54.7 m -49.65 -40.81 40.96 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.35 -38.94 44.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.322 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.67 59.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.678 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.69 -30.33 15.61 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.203 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.521 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.75 -40.44 96.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.47 0.652 . . . . 1.0 109.93 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 -5.31 49.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.932 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.99 -50.45 68.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.917 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 20.7 p90 -67.87 -43.91 78.31 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.357 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 97.6 t -39.42 -27.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.709 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 93' ' ' PHE . 34.7 mmt180 -63.25 -36.03 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.041 -0.264 . . . . 1.0 111.295 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -43.91 -28.29 0.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 1.0 110.192 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.983 -179.487 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.786 0.327 . . . . 1.0 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 0.3 OUTLIER -171.74 -30.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.911 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 23.8 mm-40 -83.85 -22.52 31.67 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.768 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.95 -41.57 99.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.117 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.06 -44.95 83.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.62 88.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.467 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.7 -44.5 96.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.32 -33.43 75.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.203 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.48 87.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -37.81 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.786 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -65.78 -33.45 75.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.523 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.37 -44.7 92.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.796 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.23 -41.42 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -58.08 -42.25 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.567 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' C' ' 21' ' ' GLU . 56.4 mtmt -62.9 -40.8 98.68 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.147 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.48 -36.66 77.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 91.2 mt -60.81 -40.56 93.15 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.095 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.66 -50.69 72.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.146 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 12.2 mp0 -69.43 -43.0 74.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.42 93.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.475 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 20.3 m -61.76 -44.95 95.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.731 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -66.19 -36.15 82.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 1.0 109.856 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' C' ' 29' ' ' ALA . 64.3 mmtt -72.98 -41.73 64.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.597 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -52.58 -52.96 52.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.537 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 4.2 p -62.8 -44.7 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.406 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 80.8 mm-40 -65.8 -37.01 85.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -61.41 -40.48 94.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.328 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.6 mp0 -70.25 -37.85 75.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 1.0 110.69 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH2' ' OH ' ' C' ' 41' ' ' TYR . 25.5 mmt180 -56.64 100.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.721 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 116.09 -12.45 17.06 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.28 144.5 34.22 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 122.772 -0.252 . . . . 1.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.07 143.04 25.38 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.036 1.824 . . . . 1.0 112.414 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.17 28.9 67.39 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 141.03 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.311 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 -35.83 4.87 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.414 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -92.29 77.55 5.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.946 -0.39 . . . . 1.0 109.946 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.409 HD12 HG22 ' C' ' 39' ' ' ILE . 25.7 pt -110.41 -7.63 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.921 0.391 . . . . 1.0 110.466 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -81.9 134.93 35.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.46 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.531 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.2 OUTLIER -77.94 -48.57 2.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.847 178.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.5 Cg_endo -59.82 -28.73 87.91 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 121.675 1.583 . . . . 1.0 112.136 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.85 -17.28 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.383 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.66 99.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.75 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.27 -42.1 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.413 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -46.27 86.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.538 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.459 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.0 t90 -63.91 -40.95 97.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.462 -0.495 . . . . 1.0 109.819 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 64.6 p -60.14 -35.85 76.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.134 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.79 -48.95 86.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.826 -0.35 . . . . 1.0 111.56 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' C' ' 59' ' ' ASP . 15.8 pt-20 -73.46 -25.81 60.65 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.549 -0.46 . . . . 1.0 110.861 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 27.4 m -62.55 -44.28 96.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.484 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.65 -20.41 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.696 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.558 ' C ' ' H ' ' C' ' 55' ' ' VAL . 4.9 p -84.31 -2.7 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' C' ' 53' ' ' THR . 6.5 p 60.64 -3.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.726 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' C' ' 53' ' ' THR . 73.9 t -64.01 -44.84 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.795 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 70.79 -60.36 0.95 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' D' ' 47' ' ' TRP . 2.5 t80 70.6 -41.65 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 1.0 110.973 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 120.68 24.43 2.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.421 ' OD2' ' OE2' ' C' ' 50' ' ' GLU . 65.5 t0 -61.95 -48.04 82.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.984 0.421 . . . . 1.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' C' ' 61' ' ' TYR . 96.3 mtt-85 -143.54 -177.5 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 1.0 109.887 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' C' ' 60' ' ' ARG . 9.9 m-85 -155.02 106.79 2.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 120.606 -0.438 . . . . 1.0 111.01 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.16 156.42 64.99 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.725 1.616 . . . . 1.0 112.216 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.44 ' O ' ' OE2' ' C' ' 66' ' ' GLU . 1.8 t -82.47 -140.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.061 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.409 ' CA ' ' OE2' ' C' ' 66' ' ' GLU . 41.4 m -113.87 -38.93 4.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.836 0.351 . . . . 1.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.0 tt0 -63.64 -27.03 68.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.983 0.421 . . . . 1.0 110.008 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -73.17 30.21 0.07 Allowed 'General case' 0 C--O 1.263 1.796 0 CA-C-O 123.818 1.77 . . . . 1.0 110.109 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 40.53 64.03 1.27 Allowed Glycine 0 C--O 1.214 -1.126 0 CA-C-N 113.706 -1.588 . . . . 1.0 111.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' C' ' 67' ' ' GLY . 59.2 ttm-85 -24.09 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.768 0.784 . . . . 1.0 111.231 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.0 mttt -50.57 -16.51 0.38 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.764 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.5 t -61.44 -45.6 98.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.441 -0.904 . . . . 1.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.6 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.201 0.524 . . . . 1.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -69.53 -41.57 75.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.214 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -63.85 -48.44 76.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.748 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.93 -44.06 97.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.314 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 71.1 mtm -64.61 -41.09 96.44 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.991 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.52 -42.6 99.62 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.366 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.74 95.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 1.0 110.44 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.68 97.9 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.75 -0.54 . . . . 1.0 111.75 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.54 -43.3 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.277 . . . . 1.0 110.625 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.14 -40.38 86.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.6 t -62.96 -49.95 81.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.944 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -68.93 -38.87 79.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.177 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -70.56 -33.12 70.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.917 0.389 . . . . 1.0 110.857 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.7 tt -61.82 -42.36 98.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.749 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' C' ' 87' ' ' ALA . 1.5 m -49.31 -11.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.568 -0.453 . . . . 1.0 110.415 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.518 ' H ' ' C ' ' C' ' 84' ' ' LEU . 48.5 m -48.75 -19.66 0.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.935 0.398 . . . . 1.0 110.267 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.416 ' N ' ' C ' ' C' ' 85' ' ' VAL . . . -60.02 -35.25 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.17 -34.33 29.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.42 -39.85 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.727 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.527 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.59 -47.95 82.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.0 111.291 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -4.12 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.335 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -57.4 -48.34 79.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.557 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.527 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 22.9 p90 -76.08 -43.7 42.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.069 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 80.0 t -42.11 -27.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.747 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -61.78 -22.39 65.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.959 -0.296 . . . . 1.0 111.249 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -73.99 -7.68 53.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.816 0.341 . . . . 1.0 110.605 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.73 -178.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' D' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.725 0.298 . . . . 1.0 110.568 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.17 -32.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.54 ' H ' ' C ' ' D' ' 2' ' ' ALA . 28.5 p80 -82.26 -19.96 38.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.91 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.04 -40.66 78.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.805 0.336 . . . . 1.0 110.624 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -65.3 -38.04 89.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.07 -44.55 96.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.066 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.17 91.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.16 -41.33 94.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.54 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -63.79 -36.33 83.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -38.28 82.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.91 -41.16 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 1.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.81 -33.24 75.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.503 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.32 -38.52 91.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.53 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.9 tp -62.64 -39.84 95.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.551 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -57.97 -40.7 81.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.289 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -75.82 -18.03 59.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.957 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.89 -56.48 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.04 0.448 . . . . 1.0 111.169 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.36 -28.44 69.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.733 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' D' ' 23' ' ' SER . 73.6 mt-10 -64.39 -44.54 91.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.229 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -66.32 -36.68 83.54 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.888 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' D' ' 74' ' ' VAL . . . -65.32 -35.04 79.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.759 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 95.2 p -58.12 -43.89 87.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.845 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.04 -32.71 74.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -84.84 -32.3 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -60.86 -45.37 94.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.062 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 5.5 p -61.3 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.089 0.471 . . . . 1.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 10.9 tm-20 -69.26 -40.76 77.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.386 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.05 94.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.337 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -72.12 -38.52 69.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.869 0.366 . . . . 1.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -65.35 120.49 12.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.725 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.27 55.52 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.343 -0.703 . . . . 1.0 111.343 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.75 149.29 36.34 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 122.899 -0.177 . . . . 1.0 110.775 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.49 131.66 15.2 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.931 1.754 . . . . 1.0 111.965 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 7.05 88.23 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.72 143.25 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 -11.29 1.72 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.53 120.37 42.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.021 0.438 . . . . 1.0 109.982 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' D' ' 40' ' ' SER . 37.0 pt -143.47 -165.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.366 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 3.2 m 58.25 132.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.543 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -74.6 -48.76 5.07 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.0 Cg_endo -59.04 -30.73 94.11 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.438 1.426 . . . . 1.0 111.943 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.22 -25.93 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.3 90.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.766 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -63.19 -37.21 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.248 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.407 ' CD1' ' OG1' ' A' ' 64' ' ' THR . 0.4 OUTLIER -65.92 -46.6 77.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.18 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.486 ' CD1' ' OH ' ' C' ' 57' ' ' TYR . 2.3 t90 -57.47 -29.77 64.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -34.65 66.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.929 0.395 . . . . 1.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.8 -48.68 87.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.481 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 12.4 pt-20 -62.8 -38.2 89.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.554 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 20.7 m -77.64 178.57 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.509 ' H ' ' CG2' ' D' ' 51' ' ' THR . . . 78.47 -18.22 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.478 ' H ' ' C ' ' D' ' 51' ' ' THR . 59.0 p -106.52 9.32 31.58 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.451 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' D' ' 53' ' ' THR . 12.0 p 56.89 67.24 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.955 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.95 -80.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.724 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.4 96.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.409 ' OH ' ' CE ' ' A' ' 75' ' ' MET . 59.5 m-85 -61.72 -43.22 99.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.689 0.281 . . . . 1.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.51 12.78 1.54 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.81 -50.41 74.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 1.0 110.462 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -144.68 125.98 14.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -114.66 138.9 23.46 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.64 160.39 49.6 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.469 2.112 . . . . 1.0 111.875 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' D' ' 64' ' ' THR . 10.0 p -97.61 -140.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.002 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.654 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 51.8 m -114.21 -43.68 3.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.312 -0.403 . . . . 1.0 111.044 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -66.6 -19.98 65.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.58 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.69 25.84 0.11 Allowed 'General case' 0 C--O 1.262 1.723 0 CA-C-O 123.993 1.854 . . . . 1.0 109.213 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.743 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.59 62.79 3.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.0 -1.454 . . . . 1.0 109.841 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 57.0 ttm-85 -25.62 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.458 0.629 . . . . 1.0 111.03 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.743 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.22 -28.06 6.97 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.24 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' D' ' 67' ' ' GLY . 78.4 t -63.05 -48.8 86.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -74.26 -51.99 13.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.47 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -49.8 -40.31 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.096 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.29 -40.37 96.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' D' ' 22' ' ' ALA . 70.5 t -62.38 -45.19 99.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.431 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' D' ' 51' ' ' THR . 3.8 mpp? -64.25 -42.08 96.66 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.066 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -63.97 -42.03 97.38 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.53 83.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.896 0.379 . . . . 1.0 110.751 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.6 -40.15 77.83 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.34 -44.65 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.788 0.294 . . . . 1.0 111.708 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.92 -35.67 81.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.152 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 42.0 t -62.17 -48.67 87.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.552 -0.294 . . . . 1.0 111.263 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -73.78 -4.65 35.96 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.878 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -97.41 -32.37 11.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.022 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.7 tt -65.11 -40.04 93.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.442 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -53.7 -6.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.191 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.545 ' H ' ' C ' ' D' ' 84' ' ' LEU . 71.1 m -58.19 -43.54 87.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.339 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -42.78 -30.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.476 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.413 ' CB ' ' HD1' ' D' ' 4' ' ' HIS . . . -86.57 -32.92 20.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' D' ' 86' ' ' THR . 90.6 mt -67.34 -39.22 85.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.228 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.01 -48.18 82.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.182 0.515 . . . . 1.0 111.101 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -73.97 -4.98 38.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.209 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -55.14 -49.36 72.0 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.102 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 26.7 p90 -73.37 -44.13 59.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.0 t -42.47 -26.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.219 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -58.4 -32.29 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.957 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -58.77 -34.32 71.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 1.0 110.418 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 -179.641 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 4' ' ' HIS . 31.5 p-10 -172.57 -46.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.421 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 43.0 p-80 -78.92 -29.98 44.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.53 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.71 -35.93 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -63.15 -37.81 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.291 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -64.22 -41.89 96.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.063 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.87 92.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.357 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.82 -39.26 90.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.353 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.79 -41.19 97.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.617 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.43 80.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.869 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.02 -36.82 85.24 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -34.55 78.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.487 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' CD ' ' NZ ' ' A' ' 17' ' ' LYS . 39.7 tp10 -64.95 -36.35 84.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.72 -42.13 99.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 1.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.307 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.477 ' NZ ' ' CD ' ' A' ' 14' ' ' GLU . 6.8 ttpm? -62.41 -40.07 95.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.13 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.88 -35.66 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.06 -42.46 98.54 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.216 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.54 -43.29 85.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.263 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.6 -39.65 77.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.389 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.48 96.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.6 m -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.391 . . . . 1.0 110.182 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.764 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.69 -46.69 13.96 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.248 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.93 -44.58 78.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.549 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 4.7 p -59.51 -46.92 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.117 -0.633 . . . . 1.0 109.694 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 94.6 mt-10 -71.55 -33.8 69.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.653 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.29 97.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.266 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -89.89 -4.34 57.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.143 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -75.37 91.08 2.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.577 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.6 -15.36 17.25 Favored Glycine 0 N--CA 1.466 0.67 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 148.67 97.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 120.786 -0.365 . . . . 1.0 110.028 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.18 139.66 24.08 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.865 1.71 . . . . 1.0 112.333 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.62 21.92 74.92 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.64 166.35 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.902 0.382 . . . . 1.0 110.554 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 -12.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.231 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 40.2 tp -67.72 -19.07 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' LEU . 95.3 mt -33.63 89.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.273 0.559 . . . . 1.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' LEU . 8.7 t -171.66 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.561 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -179.27 -57.8 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 123.142 0.276 . . . . 1.0 111.26 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.09 -31.65 93.63 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 121.782 1.655 . . . . 1.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -82.55 -10.12 59.12 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.233 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.25 84.06 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.87 0.366 . . . . 1.0 110.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.69 -38.33 80.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.475 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.483 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.4 OUTLIER -63.96 -50.47 68.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.163 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -62.36 -42.82 99.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.751 -0.463 . . . . 1.0 109.751 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.7 m -53.64 -36.05 61.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.8 t -82.99 -4.86 8.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -107.82 37.19 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.375 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.74 -35.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.57 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.68 63.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.496 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 54' ' ' THR . 70.2 p -89.69 5.29 46.51 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 53' ' ' THR . 44.7 p 54.46 71.03 0.55 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.142 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.85 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.741 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.32 84.68 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.618 ' HH ' ' HG1' ' B' ' 51' ' ' THR . 7.4 m-85 -62.78 -41.72 99.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.768 0.318 . . . . 1.0 110.556 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.24 20.49 0.36 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.32 -35.36 80.6 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.679 ' NH2' HH22 ' B' ' 68' ' ' ARG . 2.1 tpp180 -134.77 179.07 6.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.348 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 75.1 m-85 -160.94 93.88 1.47 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.35 149.74 69.89 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.713 1.609 . . . . 1.0 112.216 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.45 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 1.5 t -85.76 -143.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.305 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 m -110.34 -38.78 5.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.697 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.2 tt0 -61.46 -20.73 63.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.059 0.457 . . . . 1.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.14 25.77 0.22 Allowed 'General case' 0 C--O 1.267 1.995 0 CA-C-O 123.915 1.817 . . . . 1.0 109.516 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.94 65.47 1.6 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.649 -1.614 . . . . 1.0 111.12 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 55.6 ttm-85 -24.45 -32.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.975 0.888 . . . . 1.0 110.999 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 99.1 mttt -47.24 -26.25 1.15 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.422 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.4 t -63.26 -46.47 95.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.764 -0.774 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.34 62.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 1.0 111.012 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.31 -41.27 96.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.835 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -55.57 -43.82 76.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.75 -44.72 89.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.486 -0.486 . . . . 1.0 111.005 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.87 -43.64 98.43 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.637 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.78 -41.06 92.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 1.0 110.299 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.67 88.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.629 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.74 92.24 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.07 -43.53 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 121.082 -0.247 . . . . 1.0 110.395 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -43.19 97.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.246 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.77 -50.02 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.796 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -68.29 -37.36 80.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -63.12 -37.68 88.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.685 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.1 tt -65.69 -37.45 86.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.24 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.3 t -46.06 -13.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.42 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 84' ' ' LEU . 16.2 m -58.79 -45.17 90.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.495 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -40.93 -21.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.758 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -106.62 -25.35 11.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.73 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 86' ' ' THR . 69.6 mt -62.79 -42.22 99.6 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.57 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -72.96 -65.24 0.82 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.36 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -47.56 -10.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.229 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 90' ' ' ALA . 46.9 t0 -63.18 -73.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.024 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.401 ' O ' ' N ' ' A' ' 95' ' ' ARG . 25.1 m-85 -86.46 -27.98 23.77 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.952 0.353 . . . . 1.0 111.952 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -40.88 -27.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.515 0.198 . . . . 1.0 111.274 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 93' ' ' PHE . 95.7 mtt-85 -61.17 -32.99 72.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -39.43 -38.68 0.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.715 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.002 0.43 . . . . 1.0 109.906 179.303 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 65.7 t0 . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.896 0.379 . . . . 1.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.456 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 16.1 p-80 -80.7 -29.63 36.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.615 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.23 -44.26 84.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.89 -36.01 75.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -67.79 -40.42 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 1.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.8 98.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.85 -32.49 73.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.24 -39.46 92.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.365 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.34 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.767 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.6 -36.85 81.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.396 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -65.73 -41.18 92.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.363 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.27 -41.86 97.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.37 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.24 -42.85 96.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.712 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -64.15 -37.93 89.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.711 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.81 -66.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.12 -31.56 61.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.837 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' B' ' 23' ' ' SER . 61.2 mt-10 -63.45 -44.66 93.86 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.52 -36.63 84.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.61 75.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.854 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 25.2 p -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.483 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.58 -56.35 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.077 -0.649 . . . . 1.0 109.856 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.1 -38.97 80.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.267 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.45 76.41 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.131 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.58 -48.56 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.263 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.88 -35.81 72.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.752 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.43 84.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.201 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' B' ' 38' ' ' LEU . 41.9 mm-40 -70.51 -42.56 71.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 1.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -53.6 94.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.899 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 115.85 11.25 10.33 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 111.15 -0.78 . . . . 1.0 111.15 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' OE2' ' B' ' 66' ' ' GLU . . . -102.03 137.41 19.48 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.614 0.207 . . . . 1.0 110.617 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.03 138.86 21.1 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.869 1.713 . . . . 1.0 112.407 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.4 3.4 39.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . -47.14 176.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 1.0 110.399 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.27 -28.92 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.537 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' B' ' 30' ' ' GLU . 23.0 tp -99.49 119.81 38.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.965 0.412 . . . . 1.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.34 64.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.036 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -169.26 128.99 1.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.372 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.54 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.2 OUTLIER -58.62 -51.45 81.73 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.669 -0.696 . . . . 1.0 111.176 178.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.3 Cg_endo -57.85 -32.24 94.48 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.701 1.601 . . . . 1.0 112.682 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' B' ' 43' ' ' ASP . 2.4 m-20 -93.22 -23.24 18.61 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.762 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.99 94.42 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.878 0.37 . . . . 1.0 110.568 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -64.27 -37.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.41 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -44.98 86.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.44 -40.33 94.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.502 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -61.47 -36.33 80.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.171 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.99 -48.07 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 1.0 111.982 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.419 ' O ' ' OG1' ' B' ' 53' ' ' THR . 15.4 pt-20 -67.88 -30.5 69.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.846 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.618 ' HG1' ' HH ' ' A' ' 57' ' ' TYR . 78.7 m -62.51 -45.08 94.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.565 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.73 -32.15 70.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.013 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' B' ' 54' ' ' THR . 45.0 p -71.82 -6.75 43.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.799 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.38 65.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.284 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -150.37 -47.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.584 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 42.85 83.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' C' ' 56' ' ' GLY . 33.1 m-85 -62.83 -41.6 99.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 167.62 -90.25 0.1 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 77.1 m-20 42.56 -88.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 1.0 110.9 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' B' ' 58' ' ' GLY . 25.6 mmt180 -115.61 -173.39 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.194 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 38.7 p90 -173.77 118.54 0.37 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.246 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.35 158.12 58.65 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.565 1.51 . . . . 1.0 112.251 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.438 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.8 t -97.22 -126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 5.9 p -114.3 -36.56 4.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.777 0.322 . . . . 1.0 111.144 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.7 tt0 -65.29 -31.48 72.65 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.553 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 1.3 pm0 -79.26 30.33 0.22 Allowed 'General case' 0 C--O 1.269 2.115 0 CA-C-O 123.969 1.842 . . . . 1.0 109.797 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 37.57 61.92 1.01 Allowed Glycine 0 C--O 1.212 -1.237 0 CA-C-N 113.092 -1.867 . . . . 1.0 111.045 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.679 HH22 ' NH2' ' A' ' 60' ' ' ARG . 40.5 ttm180 -24.96 -32.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.993 . . . . 1.0 110.947 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' B' ' 67' ' ' GLY . 68.3 mttm -49.42 -16.48 0.2 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 55.9 t -63.35 -46.1 96.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 119.788 -0.765 . . . . 1.0 109.578 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.58 72.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.241 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.12 -43.92 70.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.343 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.35 -44.22 88.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.825 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.34 -43.51 91.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.323 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 37.0 mtt -59.11 -44.86 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.721 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.19 -42.58 96.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.74 89.17 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.13 -36.81 93.71 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.89 -26.9 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.424 -0.457 . . . . 1.0 111.523 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.29 -50.6 37.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.042 0.449 . . . . 1.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 m -60.04 -48.7 86.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.355 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -66.03 -34.55 78.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.67 37.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.2 tt -69.97 -23.43 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 1.0 110.114 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 98.6 t -57.29 -3.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.644 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.551 ' H ' ' C ' ' B' ' 84' ' ' LEU . 14.6 t -49.32 -39.0 29.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.404 0.621 . . . . 1.0 109.585 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' B' ' 91' ' ' THR . . . -46.69 -35.63 6.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.423 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.23 -10.85 51.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.585 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' B' ' 92' ' ' ASP . 85.7 mt -85.29 -56.87 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.891 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.293 0.568 . . . . 1.0 109.989 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -61.11 -37.56 83.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.574 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 89' ' ' LEU . 11.1 t0 -59.56 -44.48 93.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.617 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 0.5 OUTLIER -61.25 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.756 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 96' ' ' ARG . 95.9 t -64.93 -43.83 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.738 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.533 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 46.9 mtt85 -44.79 -20.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.459 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' B' ' 94' ' ' VAL . 52.3 ptt85 -52.85 -33.13 48.16 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.247 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.438 -179.827 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.816 0.341 . . . . 1.0 110.427 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.648 ' HD1' ' N ' ' C' ' 5' ' ' GLU . 2.8 p80 -78.78 -27.7 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.054 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.648 ' N ' ' HD1' ' C' ' 4' ' ' HIS . 84.7 tt0 -70.04 -32.75 71.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.739 0.304 . . . . 1.0 110.813 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -59.36 -41.58 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.58 -39.95 89.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.187 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.38 87.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -58.06 -42.45 85.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.529 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -62.6 -34.6 77.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 1.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.95 76.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.001 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.29 -32.82 74.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.004 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.2 -41.97 94.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.705 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.44 -39.95 94.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.39 -42.36 99.36 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.649 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.61 -41.88 92.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.6 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -63.36 -38.46 91.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.793 0.33 . . . . 1.0 111.155 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.68 -42.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.754 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.239 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.427 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -64.5 -42.63 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.35 -39.0 74.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.492 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.53 85.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.996 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -58.27 -46.21 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.617 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.41 -35.71 81.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 1.0 109.964 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -70.6 -40.93 72.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.321 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -50.14 73.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.33 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.43 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.403 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -69.6 -41.83 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.89 94.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.65 -6.76 56.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.965 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -87.74 117.47 26.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.929 0.395 . . . . 1.0 110.119 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.47 -4.02 63.94 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.3 144.09 37.75 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.93 137.79 20.11 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.9 1.734 . . . . 1.0 112.346 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.75 14.9 75.6 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 149.06 47.15 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.383 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 41.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.509 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' C' ' 39' ' ' ILE . 3.7 tt -127.53 -67.15 0.84 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.191 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' C' ' 38' ' ' LEU . 19.2 pt 31.59 -123.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.557 0.536 . . . . 1.0 110.862 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t 47.82 -130.63 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.731 0.301 . . . . 1.0 110.754 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 5.9 t80 177.85 -59.37 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.454 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.33 -33.95 97.74 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.927 1.751 . . . . 1.0 112.105 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -78.01 -6.04 53.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.53 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.82 90.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tt -66.14 -33.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.425 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.08 -48.54 75.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.258 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.45 -42.61 95.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.272 -0.571 . . . . 1.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -52.81 -39.45 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.739 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' C' ' 51' ' ' THR . 71.2 t -65.47 -43.93 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.513 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.64 24.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.884 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.555 ' H ' ' C ' ' C' ' 49' ' ' VAL . 96.1 m -127.78 -43.85 1.52 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.674 -0.239 . . . . 1.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.13 66.55 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.578 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.434 ' H ' ' HG1' ' C' ' 53' ' ' THR . 16.9 p -89.9 4.4 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.834 0.349 . . . . 1.0 110.12 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' C' ' 53' ' ' THR . 44.2 p 52.19 35.76 17.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.813 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.35 -35.87 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.212 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD2' ' B' ' 57' ' ' TYR . . . 100.11 -76.3 0.45 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' C' ' 57' ' ' TYR . 44.2 p90 -61.99 117.61 6.18 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.559 ' C ' ' H ' ' C' ' 60' ' ' ARG . . . -133.77 20.02 4.14 Favored Glycine 0 N--CA 1.464 0.515 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.42 ' OD2' ' CZ ' ' C' ' 60' ' ' ARG . 11.9 t0 71.12 -29.14 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.298 . . . . 1.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' C' ' 58' ' ' GLY . 21.3 mmt180 -121.22 152.4 38.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -139.35 126.85 13.06 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.63 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.84 152.49 68.91 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.764 1.643 . . . . 1.0 111.981 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' C' ' 66' ' ' GLU . 3.4 t -92.34 -126.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.458 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 86.9 m -115.17 -38.71 3.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.909 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.693 ' C ' ' H ' ' C' ' 67' ' ' GLY . 42.7 tp10 -67.6 -38.43 83.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.647 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 0.1 OUTLIER -65.89 27.17 0.02 OUTLIER 'General case' 0 C--O 1.264 1.829 0 CA-C-O 123.176 1.465 . . . . 1.0 110.248 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.78 64.28 1.7 Allowed Glycine 0 C--O 1.216 -0.975 0 CA-C-O 118.183 -1.343 . . . . 1.0 111.192 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 56.8 ttm-85 -23.34 -32.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.05 0.925 . . . . 1.0 111.446 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.9 mttt -50.62 -16.49 0.39 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.379 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 57.0 t -60.48 -46.83 94.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.98 81.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 1.0 110.142 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -62.25 -36.72 82.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.84 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -62.55 -43.84 97.82 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.28 -45.6 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.558 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.8 -36.9 85.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.971 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -59.36 -46.26 89.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.45 87.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 1.0 110.265 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.56 73.53 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.156 -0.545 . . . . 1.0 111.809 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.15 -43.7 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.707 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -68.18 -43.02 79.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.279 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.38 -49.16 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.083 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -68.68 -28.49 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.186 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -85.44 -26.41 26.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 1.0 110.412 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.15 -42.51 96.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.625 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.8 m -62.33 -9.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.44 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' C' ' 83' ' ' ALA . 24.8 m -41.45 -20.14 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.932 0.396 . . . . 1.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -63.69 -66.46 0.54 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.542 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.57 64.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.48 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 4.2 mm? -64.98 -38.43 90.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.363 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -66.99 -69.29 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.938 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.455 ' O ' ' CG2' ' C' ' 94' ' ' VAL . 0.5 OUTLIER -40.03 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.539 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' C' ' 90' ' ' ALA . 46.4 t0 -38.83 -33.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.677 0.275 . . . . 1.0 111.364 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 7.0 p90 -64.35 -35.64 81.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.675 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 15.1 m -48.88 -36.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.755 -0.657 . . . . 1.0 111.874 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -63.86 -21.84 66.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -59.26 -43.29 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.253 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' C' ' 97' ' ' GLU . 56.3 mp0 . . . . . 0 C--N 1.332 -0.196 0 CA-C-O 120.781 0.324 . . . . 1.0 110.788 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.667 0.27 . . . . 1.0 110.595 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -174.94 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.716 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -79.56 -17.36 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.784 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.76 -36.76 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 1.0 110.452 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -62.11 -42.95 99.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.249 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.18 -44.67 96.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.107 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.18 91.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -64.95 -41.06 95.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.466 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -63.31 -37.56 87.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.57 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -39.3 92.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.33 -32.61 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.373 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.04 -38.34 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.61 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -43.41 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.522 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -56.51 -36.05 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -62.68 -36.24 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.105 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.99 -40.71 81.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 1.0 110.781 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.88 -40.81 89.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.099 -0.5 . . . . 1.0 109.98 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -55.19 -49.8 70.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.621 -0.432 . . . . 1.0 109.888 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.53 -35.06 72.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.089 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.78 85.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.138 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -60.31 -43.97 95.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 1.0 111.116 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.33 -34.32 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.654 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.03 -44.27 16.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.939 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.15 90.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.711 0.291 . . . . 1.0 110.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 2.8 p -60.43 -44.12 95.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.173 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 79.2 mm-40 -71.39 -42.9 67.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.861 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.82 99.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.423 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -65.74 -37.21 85.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.8 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -67.5 122.13 17.32 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.932 0.396 . . . . 1.0 110.553 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.65 -11.87 59.49 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.116 -0.793 . . . . 1.0 111.116 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.5 133.77 39.44 Favored Pre-proline 0 CA--C 1.538 0.515 0 O-C-N 122.798 -0.236 . . . . 1.0 110.47 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.82 142.74 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.149 1.9 . . . . 1.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.1 0.62 53.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.33 140.2 50.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.767 0.318 . . . . 1.0 110.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.93 -53.88 2.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.584 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -52.4 94.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.121 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' D' ' 39' ' ' ILE . 21.0 tt -134.11 63.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.16 0.505 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.555 ' HG ' ' H ' ' D' ' 43' ' ' ASP . 2.0 t -159.68 135.75 8.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.477 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.511 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 18.0 t80 -74.87 -49.5 4.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.72 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.8 Cg_endo -58.93 -30.71 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.321 1.347 . . . . 1.0 111.964 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.555 ' H ' ' HG ' ' D' ' 40' ' ' SER . 24.7 m-20 -87.14 -20.2 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.076 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.93 96.25 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.867 0.365 . . . . 1.0 110.692 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -66.27 -38.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.303 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -46.56 84.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.044 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -39.77 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.166 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.3 t -49.6 -20.25 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.564 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . 0.462 ' C ' ' H ' ' D' ' 51' ' ' THR . 24.9 t -97.58 -33.64 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.0 0.429 . . . . 1.0 110.258 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -78.21 16.62 0.74 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.462 ' H ' ' C ' ' D' ' 49' ' ' VAL . 6.1 t -137.38 -34.81 0.69 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.16 -24.48 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' D' ' 54' ' ' THR . 67.4 p -93.88 6.17 49.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' D' ' 53' ' ' THR . 16.3 p 56.71 11.28 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.055 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 m -63.53 -43.34 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.787 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.43 86.62 0.01 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -90.58 4.5 51.09 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.836 0.351 . . . . 1.0 110.159 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.03 17.3 65.46 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 30.1 m-20 -63.63 -46.18 86.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 1.0 110.593 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.39 167.08 21.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.019 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 9.6 p90 -153.56 102.48 2.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.591 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.76 162.38 42.3 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.885 1.723 . . . . 1.0 112.508 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.445 ' O ' ' OE2' ' D' ' 66' ' ' GLU . 1.9 t -96.13 -140.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.423 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 28.9 m -112.15 -39.71 4.39 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.668 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -59.53 -24.28 63.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.516 ' OE2' ' N ' ' D' ' 68' ' ' ARG . 0.1 OUTLIER -80.01 28.52 0.29 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 123.329 1.538 . . . . 1.0 108.944 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.15 62.19 2.15 Favored Glycine 0 C--O 1.216 -0.977 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.995 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.516 ' N ' ' OE2' ' D' ' 66' ' ' GLU . 48.2 ttm-85 -24.61 -32.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.401 0.707 . . . . 1.0 111.061 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.26 -18.23 0.57 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' D' ' 67' ' ' GLY . 62.0 t -63.01 -46.84 95.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.907 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.5 -47.31 27.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.348 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -43.77 -62.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.57 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.15 -41.68 88.9 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.72 -48.06 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.404 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' MET . . . . . 0.465 ' SD ' ' OH ' ' C' ' 57' ' ' TYR . 75.5 mtm -64.56 -41.99 95.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.697 0.284 . . . . 1.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.1 -36.16 83.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.696 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.3 -38.4 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.321 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -42.1 94.75 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.458 -0.657 . . . . 1.0 111.458 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.64 98.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.616 0.246 . . . . 1.0 111.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.36 -38.9 92.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.133 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.29 -48.29 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.05 -36.82 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.853 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -60.76 -37.75 82.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.836 -0.345 . . . . 1.0 110.266 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.8 tt -62.49 -40.34 96.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.41 -3.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.52 ' H ' ' C ' ' D' ' 84' ' ' LEU . 54.4 m -59.33 -44.53 92.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.71 -57.17 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 1.0 110.561 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.65 59.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' D' ' 86' ' ' THR . 83.8 mt -89.78 -16.95 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -80.71 -49.58 11.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -10.82 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.953 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' D' ' 90' ' ' ALA . 97.6 m-20 -61.54 -53.48 55.8 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 0.6 OUTLIER -45.44 -34.02 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.01 -27.1 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.155 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -60.56 -41.27 94.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.612 -0.267 . . . . 1.0 110.895 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -50.71 -39.36 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.338 . . . . 1.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.661 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.412 ' CB ' ' CE1' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 1.0 110.631 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.48 -43.06 99.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.723 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.631 ' HE2' HH22 ' A' ' 95' ' ' ARG . 11.2 p-80 -73.04 -32.03 64.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.626 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.27 -36.07 82.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 1.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -64.1 -39.52 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.264 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -66.84 -39.16 87.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.052 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.57 87.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.332 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.85 -45.11 94.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.114 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.21 -37.18 86.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.431 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.23 -45.8 72.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.925 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.32 -41.99 93.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 1.0 110.557 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.76 -32.59 74.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.304 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.05 -36.72 84.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.685 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.31 -42.4 99.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 1.0 110.594 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -57.93 -39.91 79.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.232 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.72 -42.65 99.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.077 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.71 -40.59 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.445 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.06 -40.76 86.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 1.0 109.952 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.64 -48.06 82.32 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.536 -0.465 . . . . 1.0 109.832 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.87 -33.37 75.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.972 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.86 90.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.488 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 27.3 m -59.53 -44.86 93.08 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -66.16 -54.92 19.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.526 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.9 mttt -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.125 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.77 90.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.198 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 23' ' ' SER . 62.3 t -64.61 -46.43 92.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.042 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.35 -23.38 46.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -52.32 -49.41 64.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.251 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 63' ' ' VAL . 2.3 mm-40 -70.19 -39.74 75.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -67.55 92.91 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.785 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.44 -15.8 6.34 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.408 -0.677 . . . . 1.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.15 148.56 36.41 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.859 0.33 . . . . 1.0 110.285 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 97.1 Cg_endo -75.78 132.89 14.86 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.975 1.783 . . . . 1.0 112.571 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 96.94 8.16 57.07 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . -35.55 154.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.761 0.315 . . . . 1.0 110.875 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.72 -50.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.471 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.5 110.36 19.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.032 0.444 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 pt -142.84 73.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.281 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' ALA . 8.5 p -162.15 98.91 1.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 56.8 t80 -51.51 -49.43 82.56 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.089 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.6 Cg_endo -59.75 -35.3 94.93 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.262 1.308 . . . . 1.0 112.509 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.0 -6.92 34.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.9 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -65.54 -43.6 89.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 1.0 110.533 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -64.64 -34.64 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.44 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -46.44 90.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.882 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.46 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 1.7 t90 -66.68 -40.48 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.498 -0.481 . . . . 1.0 109.793 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 1.2 m -54.74 -33.12 60.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.84 -46.97 95.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.024 0.44 . . . . 1.0 110.175 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' B' ' 61' ' ' TYR . 62.1 mt-10 -66.8 -33.32 75.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.387 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 96.6 m -62.2 -46.78 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.353 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.74 81.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.149 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 55' ' ' VAL . 72.0 p -74.4 -9.83 58.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 53' ' ' THR . 3.0 p 65.1 -4.86 0.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 53' ' ' THR . 69.5 t -64.7 -44.98 96.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.14 83.24 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.451 -0.66 . . . . 1.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -61.16 -41.95 97.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 1.0 110.633 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.14 9.57 2.39 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.841 -0.903 . . . . 1.0 110.841 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 38.1 t0 -56.97 -51.53 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.361 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -134.29 126.69 30.26 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -108.09 134.21 20.23 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.775 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.05 162.69 41.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.249 1.966 . . . . 1.0 112.223 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.683 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.4 p -70.16 -145.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.445 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.683 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 5.0 m -113.12 -73.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.958 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -38.87 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.349 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.882 ' O ' ' N ' ' A' ' 68' ' ' ARG . 70.9 mt-10 -77.76 -106.63 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 29' ' ' ALA . . . 18.04 -54.81 0.0 OUTLIER Glycine 0 N--CA 1.477 1.398 0 O-C-N 124.593 1.183 . . . . 1.0 114.223 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.882 ' N ' ' O ' ' A' ' 66' ' ' GLU . 10.1 tpp180 -64.05 -49.15 73.48 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.123 -0.538 . . . . 1.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 66' ' ' GLU . 68.4 mttm -64.81 -40.73 95.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.363 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.93 -45.4 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.57 83.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.99 0.424 . . . . 1.0 110.411 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -62.65 -37.66 87.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.302 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.82 -54.68 7.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.61 -46.13 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.849 -0.34 . . . . 1.0 111.09 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.2 ttp -55.97 -45.27 78.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.59 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 64.7 tttm -65.74 -33.01 74.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.368 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.62 80.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.788 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.94 99.78 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.82 -43.67 98.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.658 0.266 . . . . 1.0 110.602 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 76' ' ' LYS . 97.8 mt-10 -60.48 -35.73 76.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.202 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.98 -74.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -45.41 -38.39 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.94 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.04 86.1 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.44 -39.47 93.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.279 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -45.98 -13.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 76.8 m -51.33 -43.9 61.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -44.44 -20.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.554 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.11 -18.37 14.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.998 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 86' ' ' THR . 43.9 mt -92.51 -42.37 9.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.733 0.301 . . . . 1.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.95 -28.74 64.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.094 0.473 . . . . 1.0 110.863 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -80.81 -4.08 53.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.419 -179.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.95 -47.88 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.944 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 11.1 p90 -75.89 -20.6 57.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.306 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.16 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.11 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.631 HH22 ' HE2' ' A' ' 4' ' ' HIS . 84.6 mtt85 -59.94 -22.66 62.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.964 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttp85 -57.37 -43.92 83.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.617 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.771 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.8 t0 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.698 0.285 . . . . 1.0 110.726 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.565 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 6.5 p80 -78.74 -24.03 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.419 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.21 -39.96 86.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.42 -38.54 91.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.54 -41.28 93.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 1.0 110.021 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.13 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.81 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -65.49 -41.04 93.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.277 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -64.21 -36.2 83.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.531 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.27 78.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -70.74 -32.25 69.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 1.0 110.782 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.33 -49.36 72.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.884 0.373 . . . . 1.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -64.91 -30.2 71.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.74 -43.2 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.03 -43.02 99.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -33.86 76.79 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.511 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 49.3 t -68.3 -54.67 20.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.13 -33.89 77.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.54 -40.27 96.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.51 -40.9 96.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -63.64 -33.26 75.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.659 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.438 ' OG ' ' OG ' ' B' ' 48' ' ' SER . 2.2 m -55.54 -43.5 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.231 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.74 -55.73 31.34 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.843 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -60.89 -29.33 69.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.732 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.9 67.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 1.4 p -62.28 -44.17 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.069 0.461 . . . . 1.0 110.103 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' B' ' 30' ' ' GLU . 12.2 tm-20 -74.56 -33.35 62.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.271 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.07 45.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.92 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' B' ' 28' ' ' GLU . 0.5 OUTLIER 178.68 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.82 0.343 . . . . 1.0 110.777 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . 0.606 HH21 ' CG2' ' B' ' 39' ' ' ILE . 3.8 mmp_? -79.14 76.92 5.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.115 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.78 1.35 5.94 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.898 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.5 151.09 40.26 Favored Pre-proline 0 N--CA 1.465 0.304 0 O-C-N 122.767 -0.255 . . . . 1.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.07 144.26 29.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.974 1.783 . . . . 1.0 112.496 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.37 32.31 75.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -48.64 -60.57 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.0 110.75 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.52 4.32 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.341 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' B' ' 36' ' ' ALA . 3.1 tt -145.47 55.54 1.21 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.022 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.606 ' CG2' HH21 ' B' ' 31' ' ' ARG . 33.0 pt -92.69 51.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.908 0.385 . . . . 1.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' B' ' 43' ' ' ASP . 0.3 OUTLIER -150.72 140.19 21.48 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.178 0.513 . . . . 1.0 110.94 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.501 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.8 OUTLIER -82.0 -53.99 0.66 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.278 -0.873 . . . . 1.0 110.81 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.0 Cg_endo -57.76 -28.97 84.2 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.876 1.717 . . . . 1.0 112.701 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 40' ' ' SER . 12.1 p-10 -88.91 -4.33 58.49 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.97 92.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 1.0 110.41 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.7 tt -67.28 -37.5 79.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.517 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.511 ' NE1' ' O ' ' C' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -53.13 61.49 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -62.97 -42.69 99.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.958 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.438 ' OG ' ' OG ' ' B' ' 23' ' ' SER . 64.8 m -51.9 -38.97 58.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.711 0.291 . . . . 1.0 111.095 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.413 ' O ' ' OG1' ' B' ' 53' ' ' THR . 65.3 mm-40 -61.15 -50.4 73.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 1.0 111.588 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -59.77 -40.9 89.76 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.734 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -24.86 68.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.268 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 20.4 p -90.86 6.34 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 1.0 110.774 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 p 52.11 63.19 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.476 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.42 -53.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.12 81.79 0.06 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 1.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.38 3.77 12.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.69 -49.49 77.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 1.0 110.516 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -145.62 157.55 43.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.819 -0.438 . . . . 1.0 109.819 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 50' ' ' GLU . 64.2 t80 -172.46 132.52 0.7 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.7 -173.5 0.72 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.582 1.522 . . . . 1.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' B' ' 66' ' ' GLU . 3.6 p -134.15 165.72 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.422 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.533 ' C ' ' H ' ' B' ' 66' ' ' GLU . 14.5 m -40.76 -61.79 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.243 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.01 -14.52 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.941 0.4 . . . . 1.0 109.94 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' B' ' 63' ' ' VAL . 13.6 mm-40 -115.31 41.86 2.36 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-O 125.105 2.383 . . . . 1.0 110.392 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.46 60.04 1.48 Allowed Glycine 0 C--O 1.216 -0.978 0 CA-C-N 112.217 -2.265 . . . . 1.0 111.34 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 59' ' ' ASP . 38.5 ttm180 -28.28 -28.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.578 0.689 . . . . 1.0 110.58 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' B' ' 67' ' ' GLY . 54.4 mtpt -52.41 -12.36 0.26 Allowed 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 37.6 t -58.78 -44.95 91.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 118.902 -1.119 . . . . 1.0 109.541 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.511 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -71.1 -48.95 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 1.0 110.7 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.95 -38.25 55.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.096 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.414 ' O ' ' OE1' ' B' ' 73' ' ' GLN . 0.8 OUTLIER -58.97 -51.2 71.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.018 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 84.2 t -66.78 -43.39 89.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.506 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.2 mpp? -61.22 -41.47 96.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.662 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . 0.412 ' O ' ' OE2' ' B' ' 80' ' ' GLU . 65.9 tttm -61.49 -44.02 97.82 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.554 -0.458 . . . . 1.0 110.359 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.05 -40.27 90.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.895 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.91 96.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.79 -43.88 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 122.847 -0.208 . . . . 1.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 0.2 OUTLIER -62.57 -37.78 87.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 1.0 110.334 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.69 -68.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.184 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -55.33 -37.37 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.776 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -64.22 -37.94 89.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.5 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.99 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.117 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.2 -17.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 39.6 m -43.59 -35.3 1.67 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.253 0.549 . . . . 1.0 109.767 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.73 -61.67 2.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.034 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.9 -27.36 51.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 1.0 110.474 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.5 mm? -78.27 -32.27 49.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 1.0 110.046 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -63.03 -46.41 87.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.27 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -3.93 30.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.167 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.81 -48.77 77.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.18 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 20.9 p90 -69.5 -39.03 77.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.21 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.517 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 96.6 t -44.42 -28.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.628 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.96 -27.27 68.13 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.116 -0.234 . . . . 1.0 110.953 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.6 ptt85 -54.59 -42.6 71.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.124 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 80.4 mm-40 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.079 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . 0.509 ' OD1' ' ND1' ' C' ' 4' ' ' HIS . 35.6 p-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.698 0.285 . . . . 1.0 110.39 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.509 ' ND1' ' OD1' ' C' ' 3' ' ' ASP . 11.8 p-80 -81.6 -29.96 33.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -65.16 -44.68 87.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.789 0.328 . . . . 1.0 110.756 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -65.61 -36.83 84.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.142 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -63.78 -42.96 97.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.454 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.32 95.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.419 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.37 -40.22 93.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.533 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.435 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.58 76.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.81 -36.19 83.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 1.0 111.072 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -63.87 -41.25 97.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 1.0 110.701 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.99 -29.48 69.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.567 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 43.2 tp -62.38 -39.92 94.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.379 . . . . 1.0 110.411 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -70.73 -28.59 64.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.0 -46.55 84.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.746 0.308 . . . . 1.0 111.554 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.42 -36.56 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.87 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.17 -41.98 97.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.079 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -60.47 -45.45 93.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.59 -33.71 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.107 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.41 94.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.463 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -61.81 -46.31 90.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -63.25 -56.3 17.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.546 -0.462 . . . . 1.0 109.92 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.59 -42.61 92.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -56.09 -44.37 78.93 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.208 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.95 75.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.39 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.5 mp0 -69.54 -33.07 72.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -54.25 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.769 0.318 . . . . 1.0 110.964 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.22 -0.75 22.46 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.96 147.01 32.35 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.268 -0.271 . . . . 1.0 110.268 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.96 142.5 25.11 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.863 1.709 . . . . 1.0 112.315 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.08 66.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.35 144.45 55.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.0 110.423 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.82 -22.08 0.88 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' C' ' 39' ' ' ILE . 0.2 OUTLIER -63.6 -38.61 91.77 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.446 ' O ' ' OG ' ' C' ' 40' ' ' SER . 2.6 tp -33.53 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.276 0.56 . . . . 1.0 111.1 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' ' N ' ' C' ' 44' ' ' ALA . 11.8 m -167.94 78.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.448 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.4 OUTLIER -37.72 -56.82 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.17 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.1 Cg_endo -59.38 -54.45 2.55 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.84 1.693 . . . . 1.0 112.577 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -79.66 0.18 31.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.277 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -58.56 -42.81 88.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 1.0 110.69 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.0 tt -68.42 -40.28 82.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.564 ' NE1' ' O ' ' D' ' 64' ' ' THR . 0.5 OUTLIER -55.27 -47.55 75.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.065 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -65.09 -40.18 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.421 -0.511 . . . . 1.0 109.771 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.6 m -59.86 -41.13 90.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.986 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.07 69.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' C' ' 51' ' ' THR . 12.4 pt-20 -166.48 -42.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.977 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' C' ' 50' ' ' GLU . 0.2 OUTLIER -69.76 -36.97 76.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.146 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.2 -27.27 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.523 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' C' ' 54' ' ' THR . 43.7 p -95.25 4.57 53.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.322 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' C' ' 53' ' ' THR . 23.9 p 55.41 69.47 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.871 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -148.84 -81.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.33 96.7 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -62.2 -43.22 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 1.0 111.016 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.44 26.75 0.65 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.71 -44.52 96.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 1.0 110.545 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -141.8 161.16 38.65 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.435 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 40.2 p90 -141.76 118.86 7.41 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.764 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 157.62 59.5 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.837 1.692 . . . . 1.0 112.291 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.511 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 2.1 t -84.73 -136.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.422 ' CA ' ' OE2' ' C' ' 66' ' ' GLU . 81.8 m -114.48 -49.39 2.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.784 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' C' ' 67' ' ' GLY . 45.5 tp10 -54.38 -24.62 20.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -74.01 37.04 0.1 Allowed 'General case' 0 C--O 1.26 1.657 0 CA-C-O 123.358 1.551 . . . . 1.0 109.742 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.93 64.97 2.2 Favored Glycine 0 C--O 1.206 -1.614 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.367 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.485 ' CB ' ' NE1' ' B' ' 46' ' ' TRP . 10.8 ptp85 -21.97 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.915 0.858 . . . . 1.0 112.656 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.768 ' N ' ' O ' ' C' ' 67' ' ' GLY . 68.4 mttm -64.17 -10.14 21.22 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.291 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' C' ' 67' ' ' GLY . 43.1 t -61.89 -48.36 88.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 119.88 -0.728 . . . . 1.0 110.396 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.02 -43.56 71.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.688 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -61.59 -39.8 92.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.972 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -57.01 -43.68 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.261 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.61 -43.38 90.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.739 -0.385 . . . . 1.0 111.546 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 41.6 mtt -60.72 -43.03 98.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.03 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.774 0.321 . . . . 1.0 110.69 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.36 89.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.31 -39.73 91.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.88 -0.488 . . . . 1.0 111.88 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.91 -43.13 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 122.54 -0.388 . . . . 1.0 110.668 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -53.96 51.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.645 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -60.95 -47.97 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.163 -0.215 . . . . 1.0 111.544 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.994 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -84.83 -25.59 28.01 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.961 -0.295 . . . . 1.0 110.59 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.601 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.4 m -59.46 -19.74 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.464 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' C' ' 83' ' ' ALA . 91.6 m -41.3 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.959 0.409 . . . . 1.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -62.84 -51.1 68.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.54 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.5 84.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.235 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -71.34 -37.84 71.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.529 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.26 -34.33 68.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.152 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -3.92 41.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.287 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.08 -47.22 81.56 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.716 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 19.3 p90 -73.99 -9.37 58.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.971 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.27 -37.98 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.524 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . 0.44 HH21 ' HE2' ' C' ' 4' ' ' HIS . 95.2 mtt-85 -58.52 -28.68 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.268 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . 0.405 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.4 ptt85 -51.15 -41.53 60.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.55 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 97.3 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.183 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.83 -37.55 87.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.689 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.74 -37.94 87.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.605 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 83.2 tt0 -64.47 -35.42 80.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.746 0.307 . . . . 1.0 110.515 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.56 -40.99 96.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.436 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.03 -37.51 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 1.0 109.955 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.22 86.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.825 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.44 -40.31 96.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.62 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.71 -41.2 98.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.28 94.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.727 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.14 -45.13 74.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 1.0 110.83 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.8 80.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -63.01 -36.67 84.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.416 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -62.6 -41.46 98.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.82 0.343 . . . . 1.0 110.409 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.24 -39.29 75.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.928 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -61.91 -41.37 97.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.155 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.31 -35.01 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.711 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.98 -40.51 93.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.96 -49.32 78.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.308 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.015 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.52 94.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -46.33 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.874 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.63 -52.99 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.76 -40.43 88.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.923 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -47.52 -58.27 4.42 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.77 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -61.27 -44.99 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.212 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.36 -32.69 64.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.302 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.88 -44.92 82.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 10.8 mp0 -66.63 -36.28 82.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.317 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.88 86.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.921 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.17 -6.38 7.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.9 143.73 27.3 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 122.768 -0.254 . . . . 1.0 110.775 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.64 153.85 43.98 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.301 2.0 . . . . 1.0 112.366 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.61 34.31 85.64 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.094 -0.803 . . . . 1.0 111.094 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.54 144.11 43.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 1.0 110.603 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.72 -19.93 1.8 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.486 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -111.13 90.64 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.837 0.351 . . . . 1.0 110.099 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -133.25 103.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.08 0.467 . . . . 1.0 110.296 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 19.0 t -174.21 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 1.0 OUTLIER 173.27 -61.88 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.072 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.79 -38.55 92.42 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.725 1.616 . . . . 1.0 111.927 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.91 -4.27 58.51 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.348 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.97 -39.69 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 1.0 110.52 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.76 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.509 ' NE1' ' O ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -53.05 -45.91 68.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.598 -0.441 . . . . 1.0 109.903 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -63.89 -43.0 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.973 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 86.2 p -61.68 -36.2 80.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.922 -0.311 . . . . 1.0 110.674 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' D' ' 51' ' ' THR . 55.4 t -62.06 -48.53 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.958 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.483 ' OE1' ' CZ ' ' A' ' 68' ' ' ARG . 19.0 pt-20 -83.87 31.62 0.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.983 0.42 . . . . 1.0 109.928 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.406 ' H ' ' C ' ' D' ' 49' ' ' VAL . 21.3 m -132.58 -46.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.178 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -23.45 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 1.0 109.868 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 43.0 p -94.62 5.35 52.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.399 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 39.9 p 52.64 75.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.052 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 p -139.72 -51.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.07 82.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.38 -44.39 97.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.701 0.286 . . . . 1.0 110.85 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.3 2.68 2.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.8 m-20 -59.23 -49.82 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.375 . . . . 1.0 110.357 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -146.97 154.14 40.91 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 12.0 p90 -154.37 147.89 18.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.979 -0.288 . . . . 1.0 110.58 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.43 172.24 13.67 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.418 2.079 . . . . 1.0 112.018 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.658 ' CG1' ' H ' ' D' ' 64' ' ' THR . 3.0 p -106.24 -105.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.658 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 53.4 m -118.15 -85.22 0.65 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.979 0.419 . . . . 1.0 111.058 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -48.08 125.81 9.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' D' ' 68' ' ' ARG . 95.0 mt-10 57.94 -102.48 0.15 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.22 -57.07 0.0 OUTLIER Glycine 0 N--CA 1.474 1.179 0 O-C-N 124.487 1.117 . . . . 1.0 113.776 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.3 ttm-85 -79.84 -56.01 4.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.409 -0.395 . . . . 1.0 109.976 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -48.73 -29.19 4.2 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -80.32 -27.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.245 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -78.09 -51.7 9.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.863 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' D' ' 73' ' ' GLN . 19.7 pt-20 -50.91 -42.03 59.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.653 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' D' ' 72' ' ' GLU . 56.1 tt0 -64.5 -42.73 95.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.85 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.27 -44.91 87.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.507 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 78.5 mtm -63.74 -38.96 93.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.11 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' D' ' 80' ' ' GLU . 58.0 tttm -57.62 -40.37 79.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.582 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.48 99.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.502 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' D' ' 82' ' ' PHE . . . -67.86 -40.06 89.5 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.811 -0.516 . . . . 1.0 111.811 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.16 -43.95 98.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.612 0.244 . . . . 1.0 111.27 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' D' ' 76' ' ' LYS . 97.6 mt-10 -66.3 -35.54 80.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.756 0.312 . . . . 1.0 111.104 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.49 -46.29 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.318 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' D' ' 78' ' ' GLY . 58.4 m-85 -64.43 -31.98 73.41 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.58 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.451 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -82.93 -24.2 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.449 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' D' ' 84' ' ' LEU . 7.0 tt -64.89 -42.98 94.35 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 13.5 m -62.0 -15.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.212 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.5 ' O ' ' N ' ' D' ' 90' ' ' ALA . 47.6 m -39.26 -39.84 0.68 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.066 0.46 . . . . 1.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.74 -59.98 3.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.663 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -25.56 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.128 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 3.8 mm? -87.58 -28.45 21.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.127 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -66.35 -37.39 85.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.549 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -5.27 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.198 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -56.17 -51.38 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.276 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' D' ' 90' ' ' ALA . 24.6 p90 -75.28 -10.68 59.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.697 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.32 -32.84 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.21 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -66.38 -22.78 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 1.0 110.963 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -66.11 -19.83 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.431 . . . . 1.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.955 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.821 0.343 . . . . 1.0 110.603 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.88 -40.85 98.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.542 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -67.04 -45.04 78.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.357 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.2 -42.01 96.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.381 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -65.25 -40.29 93.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.136 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -68.95 -43.34 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.184 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.09 89.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.464 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.81 -36.59 84.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.287 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.68 80.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.799 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.8 -38.37 85.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.52 -35.88 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.0 110.319 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.33 -34.65 78.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.438 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.95 -38.54 91.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.111 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.72 -31.96 73.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -61.83 -49.63 75.5 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.241 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 m -67.12 -32.64 58.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.889 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.56 -42.03 98.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.249 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.98 -45.26 86.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 1.0 110.232 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -71.2 -39.59 71.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.546 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.84 -50.22 74.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.841 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 48' ' ' SER . 31.0 m -61.65 -44.38 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.421 . . . . 1.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.23 -33.64 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.16 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.5 -40.12 23.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.737 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.39 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.634 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.4 p -58.58 -45.98 90.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.902 -0.719 . . . . 1.0 109.68 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 97.0 mt-10 -69.86 -41.6 74.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.942 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.29 90.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.9 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 79.8 mm-40 -78.84 -37.67 39.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.905 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' NH2' ' O ' ' A' ' 40' ' ' SER . 18.7 mmt85 -67.07 116.39 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 1.0 110.823 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.85 2.99 60.93 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.09 144.06 27.87 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.05 147.07 33.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.258 1.972 . . . . 1.0 112.425 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.13 2.01 57.71 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.15 146.91 52.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.716 0.293 . . . . 1.0 110.517 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.73 -13.9 5.22 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -86.89 35.06 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.998 0.427 . . . . 1.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 39' ' ' ILE . 10.1 pt -69.74 73.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.344 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 43' ' ' ASP . 53.4 p -160.64 -126.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.782 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 11.4 t80 179.26 -56.28 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.547 -0.263 . . . . 1.0 111.317 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.17 -23.41 73.7 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.7 1.6 . . . . 1.0 112.638 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 24.1 p30 -97.22 -1.84 44.05 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.009 -0.277 . . . . 1.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.13 -20.29 48.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.836 0.35 . . . . 1.0 110.274 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 tt -68.81 -46.01 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.887 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -74.93 -31.9 61.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.867 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -54.32 -41.31 68.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 23' ' ' SER . 61.1 m -64.22 -24.36 67.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.322 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.51 -26.27 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.951 0.405 . . . . 1.0 110.839 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -78.13 3.59 14.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.408 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -127.18 -33.54 2.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.61 61.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.936 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 54' ' ' THR . 67.6 p -96.92 7.51 46.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.967 0.413 . . . . 1.0 109.904 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 53' ' ' THR . 17.0 p 59.62 10.37 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.949 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.07 -42.21 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.333 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.94 64.15 3.15 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' B' ' 50' ' ' GLU . 1.1 t80 -62.89 -21.86 66.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.328 . . . . 1.0 110.246 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.77 33.7 12.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.533 ' OD1' ' NH2' ' B' ' 68' ' ' ARG . 8.2 m-20 -62.68 -37.25 85.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 37.7 mmt180 -125.38 -161.42 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.247 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.428 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 19.9 t80 -156.51 82.41 3.4 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.66 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.66 153.35 69.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 1.0 112.478 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.669 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.9 p -108.1 -154.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.669 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 76.6 m -90.68 -43.35 10.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.618 0.247 . . . . 1.0 111.283 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.645 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.1 tt0 -52.46 -37.23 56.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.234 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.6 26.34 0.08 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.321 2.01 . . . . 1.0 109.202 178.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 44.15 65.39 1.66 Allowed Glycine 0 C--O 1.211 -1.312 0 CA-C-N 113.506 -1.679 . . . . 1.0 111.359 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 53.2 ttm-85 -24.36 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.465 1.133 . . . . 1.0 111.008 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.4 mttp -49.46 -20.99 0.81 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.929 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.4 t -61.59 -46.51 96.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.432 -0.907 . . . . 1.0 110.45 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.82 -23.15 45.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.605 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.33 -43.86 54.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.961 0.41 . . . . 1.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.1 -47.62 85.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.046 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.6 -40.14 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.713 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 49.8 ttm -62.89 -48.03 80.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.201 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.73 -38.49 89.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.317 . . . . 1.0 110.444 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.54 73.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.42 92.07 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.61 -43.08 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.808 0.337 . . . . 1.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.35 -41.95 97.89 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.357 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.61 -51.23 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.741 0.305 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -65.86 -39.09 90.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.999 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -63.4 -37.12 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.961 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.0 tt -62.68 -39.05 92.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.167 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.8 t -47.24 -10.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.745 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.9 m -50.96 -43.87 60.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.87 -19.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.722 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.23 -37.64 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.61 -40.48 84.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.412 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.96 -43.31 98.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 1.0 110.95 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -73.32 -4.27 32.23 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.019 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -61.29 -43.43 98.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.812 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.6 p90 -80.31 -24.36 40.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.856 0.36 . . . . 1.0 111.395 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 -27.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.078 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.19 -20.89 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -54.26 -32.31 55.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.692 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.0 109.799 179.516 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.698 0.285 . . . . 1.0 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -73.87 -23.24 59.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.987 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.67 -33.58 75.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.699 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.9 -38.22 90.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.704 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -64.9 -42.0 95.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 1.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.01 85.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.747 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.46 -42.08 77.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.326 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -63.24 -37.67 88.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.601 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.45 -42.15 63.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -41.09 92.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.606 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.72 -37.26 84.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.258 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.28 -34.89 78.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.433 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.25 -41.82 98.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.418 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.93 -32.96 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.643 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.27 -42.72 99.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.617 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.96 -37.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.31 -40.32 90.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.449 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.2 mm-40 -61.65 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 1.0 110.022 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.89 -38.68 76.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 1.0 109.932 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.7 85.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.675 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.544 ' HG ' ' N ' ' B' ' 24' ' ' LYS . 93.8 p -57.19 -41.3 79.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.616 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.544 ' N ' ' HG ' ' B' ' 23' ' ' SER . 63.3 tttm -70.32 -76.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.563 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' B' ' 29' ' ' ALA . 99.2 mttt -40.74 -35.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.204 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.461 ' O ' ' OE2' ' B' ' 30' ' ' GLU . . . -51.25 -60.56 2.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.717 -0.219 . . . . 1.0 111.553 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.1 p -60.93 -42.05 91.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.04 0.448 . . . . 1.0 110.103 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.483 ' CD ' ' HZ3' ' B' ' 24' ' ' LYS . 96.3 mt-10 -72.07 -13.25 61.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.0 -47.97 83.98 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.177 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 0.6 OUTLIER -81.23 -98.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 1.0 110.569 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 46.45 50.72 12.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.686 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.77 27.58 0.94 Allowed Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.359 -0.696 . . . . 1.0 111.359 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' B' ' 66' ' ' GLU . . . -93.91 153.52 40.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.68 116.72 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.912 1.741 . . . . 1.0 112.184 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 89.96 -23.59 19.82 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 44.95 -175.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 1.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.41 -66.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.345 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.53 121.33 34.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' B' ' 40' ' ' SER . 37.9 pt -143.04 -160.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.715 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.423 ' O ' ' O ' ' B' ' 39' ' ' ILE . 3.2 t 56.2 114.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.12 0.486 . . . . 1.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.49 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 2.3 t80 -63.54 -53.85 48.24 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.699 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 21.9 Cg_endo -57.72 -27.68 78.69 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.747 1.632 . . . . 1.0 112.566 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.37 -16.62 22.21 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 1.0 110.823 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.6 87.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.901 0.382 . . . . 1.0 110.318 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.43 HG23 HD11 ' B' ' 45' ' ' ILE . 7.3 tt -61.7 -37.04 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.648 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.2 OUTLIER -64.16 -43.79 94.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.477 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.77 -21.35 64.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -78.28 -32.63 49.56 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.421 . . . . 1.0 110.55 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.25 -45.41 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' B' ' 51' ' ' THR . 19.3 pt-20 -57.77 -42.38 83.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.724 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.526 ' C ' ' H ' ' B' ' 53' ' ' THR . 3.4 t -73.47 -170.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.041 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.497 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 74.19 -24.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.538 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.526 ' H ' ' C ' ' B' ' 51' ' ' THR . 31.2 p -103.45 8.18 37.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.8 p 53.55 65.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.687 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.34 -52.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.55 82.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -59.97 -43.83 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.284 . . . . 1.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.19 8.74 2.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -52.03 -67.63 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.763 0.315 . . . . 1.0 110.573 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -141.81 150.11 41.25 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 61' ' ' TYR . 7.6 p90 -141.22 128.49 11.85 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.49 148.58 73.29 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.637 1.558 . . . . 1.0 112.3 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.11 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.413 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 66' ' ' GLU . 89.4 m -113.98 -65.4 1.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.835 0.35 . . . . 1.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.544 ' C ' ' H ' ' B' ' 67' ' ' GLY . 85.0 tt0 -40.53 -21.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.589 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.564 ' OE2' ' N ' ' B' ' 66' ' ' GLU . 1.5 pm0 -80.24 30.27 0.28 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 123.741 1.734 . . . . 1.0 109.142 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.04 65.37 1.08 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.075 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.533 ' NH2' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -23.69 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.705 0.753 . . . . 1.0 110.788 -178.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 97.4 mttt -46.03 -21.21 0.12 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' B' ' 67' ' ' GLY . 77.4 t -63.07 -45.8 97.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.003 -0.679 . . . . 1.0 110.054 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.25 -50.36 19.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.842 0.353 . . . . 1.0 110.818 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -53.06 -46.64 68.63 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.312 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -57.63 -46.43 84.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.759 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.47 -47.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.342 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 74.3 mtm -65.11 -43.03 93.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.673 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -66.59 -35.04 79.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.565 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.1 74.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.389 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.3 -37.1 94.05 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' B' ' 79' ' ' ILE . 96.0 mt -70.68 -3.42 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.487 -0.42 . . . . 1.0 111.319 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.96 -54.41 3.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 1.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.444 HG22 ' H ' ' B' ' 82' ' ' PHE . 0.1 OUTLIER -61.09 -51.35 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.169 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . 0.444 ' H ' HG22 ' B' ' 81' ' ' VAL . 52.8 m-85 -65.38 -37.3 86.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.683 0.277 . . . . 1.0 110.725 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -62.59 -37.49 86.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.433 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.73 -40.3 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.191 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.34 -17.44 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.73 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 55.1 m -42.98 -37.87 2.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.1 0.476 . . . . 1.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.77 -63.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.53 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.4 32.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.27 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.1 mm? -68.94 -34.5 75.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -66.66 -66.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 110.016 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -7.9 0.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.614 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' B' ' 90' ' ' ALA . 41.7 t0 -57.01 -49.27 76.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.657 0.265 . . . . 1.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 11.9 p90 -73.39 -30.86 63.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.058 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.97 -32.86 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.674 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -57.81 -22.38 47.18 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.305 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -53.33 -25.48 15.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 1.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.933 -179.436 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' C' ' 3' ' ' ASP . 32.2 p-10 . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.874 0.369 . . . . 1.0 110.385 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -88.09 -26.64 22.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.796 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.28 -39.97 89.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.5 -38.17 90.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.385 . . . . 1.0 110.276 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -65.29 -39.9 93.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.273 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.95 94.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.602 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -62.72 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.178 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.05 -33.94 77.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.84 80.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.198 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.36 -36.79 81.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.42 -32.25 73.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.43 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.628 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.18 -42.24 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.586 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.48 -38.64 88.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.352 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -41.08 99.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 1.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.3 -38.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.794 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.16 -40.65 86.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.066 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.434 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -56.06 -47.98 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.6 -34.56 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.317 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -40.76 97.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.759 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -59.94 -40.71 89.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.551 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -64.74 -33.7 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.487 . . . . 1.0 109.772 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.9 mmtt -78.31 -41.17 34.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.937 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.09 87.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.479 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.66 -48.74 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 1.0 110.079 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.96 -36.29 77.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.122 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -89.86 65.14 6.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.032 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 3.3 mm-40 163.04 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.437 0.461 . . . . 1.0 110.706 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -108.49 67.77 0.67 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.6 0.238 . . . . 1.0 110.502 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.23 31.02 0.7 Allowed Glycine 0 N--CA 1.471 0.971 0 N-CA-C 111.928 -0.469 . . . . 1.0 111.928 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.71 161.07 24.1 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.64 116.25 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.882 1.722 . . . . 1.0 111.47 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.66 83.54 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.04 149.41 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.0 110.523 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -21.14 2.25 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.478 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.0 OUTLIER -87.88 40.0 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.746 0.307 . . . . 1.0 110.242 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.27 80.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 1.0 110.587 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.7 m -156.36 -136.57 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.443 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.414 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 11.2 t80 179.75 -57.56 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.403 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.39 -34.79 97.5 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 121.736 1.624 . . . . 1.0 112.554 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' C' ' 43' ' ' ASP . 23.3 p-10 -94.24 6.42 48.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.293 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.69 90.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.81 -32.65 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.64 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -60.05 -48.42 81.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.413 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.439 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 0.2 OUTLIER -67.31 -27.28 67.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 178.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 2.6 t -64.9 -34.74 79.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.941 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . 0.473 ' CG2' ' HZ1' ' D' ' 69' ' ' LYS . 74.0 t -61.53 -47.62 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 1.0 111.407 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.413 ' O ' ' OG1' ' C' ' 53' ' ' THR . 15.8 pt-20 -70.53 -28.82 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 1.0 111.07 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.439 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 86.5 m -61.9 -44.83 96.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 1.0 111.326 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.36 70.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 1.0 110.573 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.452 ' O ' ' OG1' ' C' ' 54' ' ' THR . 71.4 p -73.52 -7.96 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 1.0 110.216 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' C' ' 53' ' ' THR . 8.2 p 61.62 7.04 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.44 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -65.32 -40.68 89.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.538 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.32 79.83 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -61.67 -42.52 99.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 1.0 110.942 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.67 3.34 6.02 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -57.98 -64.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.837 0.351 . . . . 1.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 0.4 OUTLIER -135.09 147.72 49.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.154 179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' C' ' 61' ' ' TYR . 8.8 p90 -151.06 149.72 25.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.502 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.09 -175.75 1.34 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.198 1.932 . . . . 1.0 111.672 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.459 ' H ' ' HB2' ' C' ' 66' ' ' GLU . 1.1 t -135.64 -148.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.94 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -88.09 -43.21 11.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -73.78 -14.02 61.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.11 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 13.8 mm-40 -99.34 32.16 2.85 Favored 'General case' 0 C--O 1.261 1.674 0 CA-C-O 123.964 1.84 . . . . 1.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 36.4 62.6 0.75 Allowed Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.114 -1.857 . . . . 1.0 111.168 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' C' ' 67' ' ' GLY . 52.7 ttm-85 -24.71 -29.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.859 0.83 . . . . 1.0 111.503 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' C' ' 67' ' ' GLY . 63.3 mttp -56.8 -11.04 1.21 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.2 t -60.67 -47.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.103 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.13 72.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.911 0.386 . . . . 1.0 110.72 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -54.04 -47.97 71.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.077 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.42 -41.49 93.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.474 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.82 -44.34 96.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.837 -0.345 . . . . 1.0 111.2 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.8 mtm -61.39 -41.05 96.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.937 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -61.61 -37.98 85.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.25 84.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.34 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.2 -54.15 22.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.813 -0.708 . . . . 1.0 111.838 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 79' ' ' ILE . 95.4 mt -63.06 -42.73 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 1.0 110.661 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -59.47 -45.84 90.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.941 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.04 -49.64 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.972 -0.291 . . . . 1.0 111.205 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -67.17 -37.35 83.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.898 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.401 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -62.58 -35.33 79.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.522 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.426 ' C ' ' N ' ' C' ' 86' ' ' THR . 5.0 tt -61.96 -42.73 99.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.31 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 66.8 t -48.85 -16.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.571 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.426 ' N ' ' C ' ' C' ' 84' ' ' LEU . 63.3 m -47.74 -34.67 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.65 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.437 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -52.95 -22.04 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.96 -10.93 27.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -86.62 -59.74 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.728 0.299 . . . . 1.0 111.049 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -44.61 -49.97 9.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.91 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -45.56 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.168 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' C' ' 90' ' ' ALA . 97.8 m-20 -60.84 -47.91 84.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.431 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 0.1 OUTLIER -58.93 -44.28 91.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 59.0 t -44.62 -39.57 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.412 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.22 -22.51 52.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.176 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -55.24 -43.92 75.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.306 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.358 179.7 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.77 0.319 . . . . 1.0 110.537 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.91 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.464 ' H ' ' ND1' ' D' ' 4' ' ' HIS . 9.1 p-80 -68.49 -36.12 78.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.701 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.53 -40.72 96.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.793 0.33 . . . . 1.0 110.794 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -64.1 -42.66 96.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.544 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.26 -39.56 68.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 1.0 110.148 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.45 86.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.753 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.61 -23.26 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.719 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.13 -41.35 98.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.62 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.21 80.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.923 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -58.86 -39.09 80.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 1.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.29 -33.29 75.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.01 -35.66 81.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -62.61 -42.02 99.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 1.0 110.869 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -61.1 -41.19 96.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.996 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.08 -41.43 99.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 1.0 110.979 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.48 -43.38 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.828 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . 0.444 ' O ' ' OG ' ' D' ' 23' ' ' SER . 84.2 mt -61.28 -42.09 98.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.94 -50.99 68.65 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.58 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.8 -39.52 87.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.351 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.3 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 33.2 m -57.77 -44.92 86.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.75 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.49 -48.92 79.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 29' ' ' ALA . 5.5 mptp? -61.7 -37.86 85.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.311 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.69 59.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.324 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 m -93.74 -45.49 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.776 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.57 -40.43 96.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.709 0.29 . . . . 1.0 111.077 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 25' ' ' LYS . . . -54.41 -33.2 58.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.108 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -82.69 -113.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.05 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 44.32 75.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.634 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.46 -7.48 10.46 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.51 96.03 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.246 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.81 117.18 4.84 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.965 1.777 . . . . 1.0 112.044 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 84.57 -16.19 36.94 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . 42.26 -168.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.0 110.892 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' D' ' 61' ' ' TYR . . . 175.58 -12.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.44 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -151.8 43.67 0.73 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.897 0.38 . . . . 1.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -88.64 114.4 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' D' ' 41' ' ' TYR . 13.8 t 177.65 -122.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.549 ' N ' ' OG ' ' D' ' 40' ' ' SER . 2.2 m-85 -176.41 -66.2 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.543 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 22.8 Cg_endo -59.87 -29.92 90.62 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.011 1.807 . . . . 1.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -79.89 -5.57 55.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.961 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.64 84.8 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.37 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -73.22 -39.28 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.404 ' CH2' ' NZ ' ' A' ' 69' ' ' LYS . 2.7 t-105 -61.12 -48.22 82.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.227 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -62.41 -41.47 98.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -71.55 70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.11 0.481 . . . . 1.0 110.131 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.04 -64.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.468 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.437 ' OE2' ' OD2' ' D' ' 59' ' ' ASP . 22.6 pt-20 -66.02 -26.76 67.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.414 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.992 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 -26.57 65.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 26.1 p -88.09 3.08 50.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 1.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' D' ' 53' ' ' THR . 19.4 p 53.88 73.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.084 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' D' ' 57' ' ' TYR . 86.0 t -151.12 -50.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.694 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 73.72 -48.42 1.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' D' ' 55' ' ' VAL . 11.7 t80 67.86 -14.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.581 0.229 . . . . 1.0 110.864 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 99.63 18.71 22.42 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 84.4 m-20 -62.46 -66.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.641 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.34 161.95 27.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.668 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 3.0 p90 -140.42 105.83 6.54 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.445 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . 0.529 ' O ' ' NH2' ' D' ' 68' ' ' ARG . 71.4 Cg_endo -70.72 164.09 36.72 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.575 1.517 . . . . 1.0 112.633 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.623 ' CG2' ' H ' ' D' ' 64' ' ' THR . 11.0 p -112.08 -176.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.449 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.623 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 18.7 m -68.77 -44.06 74.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.575 ' C ' ' H ' ' D' ' 67' ' ' GLY . 58.7 tt0 -51.39 -46.93 62.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.021 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 14.3 pt-20 -79.82 36.66 0.34 Allowed 'General case' 0 C--O 1.264 1.842 0 CA-C-O 123.654 1.692 . . . . 1.0 109.0 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.39 61.75 1.2 Allowed Glycine 0 C--O 1.215 -1.038 0 CA-C-N 113.179 -1.828 . . . . 1.0 109.495 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' D' ' 62' ' ' PRO . 57.8 ttm-85 -25.52 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.298 0.646 . . . . 1.0 110.878 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.5 mmtt -56.38 -9.91 0.8 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.43 -0.805 . . . . 1.0 109.071 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 38.0 t -59.31 -47.77 89.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.391 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.43 79.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.064 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -60.59 -39.28 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.965 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.35 -41.05 96.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.437 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.74 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.02 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 74.7 mtm -63.16 -40.02 96.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.07 -45.97 91.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.465 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.82 86.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.27 92.7 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.788 -0.525 . . . . 1.0 111.788 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.09 -43.59 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.584 0.23 . . . . 1.0 111.044 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.86 -40.11 94.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.75 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.82 -49.58 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.774 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -61.77 -44.46 96.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.01 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.48 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -65.04 -35.14 80.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.053 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' D' ' 86' ' ' THR . 1.6 tm? -61.74 -53.33 57.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.338 -0.545 . . . . 1.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 75.4 t -44.74 -15.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.381 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.574 ' O ' ' N ' ' D' ' 90' ' ' ALA . 94.4 m -51.8 -42.35 62.39 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.163 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -37.98 -65.1 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.608 0.242 . . . . 1.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.84 21.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' D' ' 86' ' ' THR . 41.4 mt -92.48 -21.87 19.91 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.451 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -72.77 -36.96 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.404 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -2.85 25.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.881 -0.599 . . . . 1.0 109.896 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.03 -48.0 79.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.953 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 19.4 p90 -72.94 -8.63 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.795 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.33 -36.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -67.27 -21.64 65.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.157 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -55.28 -32.33 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 1.0 110.346 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.465 -179.685 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.604 0.24 . . . . 1.0 110.562 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t0 64.45 -65.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.524 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 2' ' ' ALA . 34.6 p80 -57.65 -41.28 81.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.773 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.432 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 81.6 tt0 -62.93 -40.05 96.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.88 0.372 . . . . 1.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.36 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -65.53 -38.07 88.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.143 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.71 97.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.233 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.77 -40.45 88.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.354 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -62.9 -38.69 91.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.449 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.961 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.24 -38.37 88.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.729 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.69 -38.03 89.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.502 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -65.37 -32.73 74.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.542 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.18 -41.8 98.67 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.552 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.21 -38.91 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.185 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -62.55 -39.84 94.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.686 -0.405 . . . . 1.0 111.404 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.44 -33.13 59.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 1.0 110.539 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.77 -40.94 96.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.9 mt-10 -58.08 -48.02 81.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 1.0 109.885 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.12 -32.65 73.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.119 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.84 96.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.654 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -60.74 -42.09 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.245 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -64.91 -50.51 66.22 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.203 0.525 . . . . 1.0 110.232 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.02 -42.74 99.49 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.256 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.12 49.44 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.564 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 2.7 p -60.99 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.192 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 70.2 mm-40 -68.28 -44.7 74.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.009 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.29 -39.32 82.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 1.0 110.203 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.438 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 52.3 mm-40 -69.51 -37.25 77.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.37 130.28 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 1.0 110.504 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.56 4.55 76.34 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.16 141.54 22.8 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 122.774 -0.251 . . . . 1.0 110.376 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.3 136.05 19.32 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.94 1.76 . . . . 1.0 112.143 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.75 30.84 70.0 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -63.05 -35.52 80.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.737 0.303 . . . . 1.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 71.77 -39.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.334 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' ALA . 6.8 tt -94.29 121.57 35.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.995 0.426 . . . . 1.0 109.886 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -155.17 60.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.494 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -155.36 138.22 15.34 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.385 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.34 -59.18 1.1 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.66 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.99 -28.83 87.93 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.807 1.671 . . . . 1.0 112.409 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -88.2 -21.26 24.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.937 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.38 81.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 ' O ' ' OG ' ' A' ' 48' ' ' SER . 5.6 tt -66.28 -37.46 79.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.301 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -46.01 87.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.415 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -64.42 -40.39 95.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 45' ' ' ILE . 84.0 p -61.53 -32.75 72.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.031 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.431 ' N ' ' HG ' ' A' ' 48' ' ' SER . 48.5 t -61.34 -49.83 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.857 0.361 . . . . 1.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH2' ' B' ' 68' ' ' ARG . 12.1 pt-20 -71.37 -25.52 62.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -63.62 -47.89 79.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.272 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.82 -36.54 77.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.465 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 44.3 p -75.11 -1.97 25.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 53' ' ' THR . 50.4 p 52.44 36.09 19.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.233 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.93 -49.91 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.042 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.19 84.73 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CZ ' ' O ' ' B' ' 60' ' ' ARG . 1.3 t80 -60.77 -46.28 91.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.534 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.36 7.1 0.59 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.5 m-20 -60.73 -47.61 85.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.803 0.335 . . . . 1.0 110.611 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' O ' ' CE1' ' D' ' 57' ' ' TYR . 26.5 mtm-85 -140.85 154.34 46.15 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.219 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.28 136.3 10.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.475 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.71 -175.15 1.28 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.794 1.662 . . . . 1.0 112.217 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.56 -131.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.342 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -113.87 -44.67 3.15 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.588 0.233 . . . . 1.0 111.194 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.64 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.7 tp10 -61.63 -40.44 94.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.254 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' OE1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -72.93 32.17 0.07 Allowed 'General case' 0 C--O 1.264 1.858 0 CA-C-O 123.703 1.716 . . . . 1.0 109.997 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.15 64.45 0.94 Allowed Glycine 0 C--O 1.212 -1.247 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.671 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' C ' ' O ' ' A' ' 67' ' ' GLY . 58.8 ttm-85 -23.59 -34.53 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.328 1.064 . . . . 1.0 111.264 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 44.9 mmtm -51.09 -15.81 0.38 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.624 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 67' ' ' GLY . 50.2 t -61.54 -47.55 92.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 119.617 -0.833 . . . . 1.0 110.225 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.23 62.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.691 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -50.66 -47.18 58.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.541 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.24 -41.55 94.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.229 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.71 -46.99 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.075 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.18 -40.85 98.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.764 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.21 -37.98 89.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.09 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.633 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.37 -41.91 83.99 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 79' ' ' ILE . 96.5 mt -61.62 -43.47 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.659 0.266 . . . . 1.0 110.444 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.49 -40.41 91.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.013 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.69 -49.1 79.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.851 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -65.76 -40.48 92.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.13 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -65.02 -36.35 84.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 86' ' ' THR . 8.0 tt -62.07 -42.04 98.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.212 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -49.11 -13.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.308 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 84' ' ' LEU . 58.0 m -51.79 -39.41 58.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.985 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -50.38 -24.94 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.03 -11.74 24.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.66 -50.01 6.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.339 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.67 -34.62 52.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 1.0 110.834 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -69.87 -12.87 61.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.401 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.91 -50.12 75.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.151 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 9.9 p90 -74.94 -23.13 58.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.314 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.48 -43.87 95.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.937 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.04 -22.57 62.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.652 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -42.68 -39.48 2.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 1.0 109.889 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t0 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.779 0.323 . . . . 1.0 110.683 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -73.41 -19.34 61.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -68.74 -36.1 77.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.511 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.72 -37.87 88.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 1.0 110.65 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.96 -40.4 80.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.579 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.5 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 1.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.08 -40.08 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.556 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.93 81.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.886 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.5 -38.76 87.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.655 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.98 -38.09 89.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.28 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.94 -31.84 73.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.05 -37.57 87.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.406 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -68.1 -36.19 79.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.11 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.46 -47.58 83.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.797 0.332 . . . . 1.0 111.547 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.48 -34.39 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.972 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt -60.54 -39.44 87.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.39 -43.83 89.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.99 -32.93 73.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.053 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.47 80.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.902 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -44.86 95.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.592 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -62.74 -51.86 65.51 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.231 -0.588 . . . . 1.0 109.917 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.4 -42.78 98.78 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.417 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.19 70.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.524 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.9 OUTLIER -64.78 -42.01 93.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.469 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 82.5 tt0 -70.26 -43.74 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.242 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.14 86.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.15 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' B' ' 38' ' ' LEU . 33.0 mm-40 -66.0 -35.12 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 1.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.76 128.67 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.624 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.09 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.44 147.94 33.82 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.819 -0.224 . . . . 1.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . 0.554 ' C ' ' H ' ' B' ' 36' ' ' ALA . 96.1 Cg_endo -75.47 142.53 26.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.18 1.92 . . . . 1.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.73 -23.29 0.4 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' B' ' 34' ' ' PRO . . . 45.3 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 1.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -178.19 -31.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.329 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.43 ' N ' ' OE1' ' B' ' 30' ' ' GLU . 14.8 tp -137.2 102.75 4.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.288 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' CB ' ' B' ' 40' ' ' SER . 4.2 pt -132.14 104.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.78 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.3 OUTLIER 164.89 143.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.545 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.413 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.5 m-85 -81.42 -61.66 0.37 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.983 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.0 Cg_endo -58.39 -27.05 80.17 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.187 1.925 . . . . 1.0 112.464 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -93.21 -22.12 19.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.056 -0.257 . . . . 1.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.51 -38.47 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.875 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.453 ' CD1' ' OG1' ' C' ' 64' ' ' THR . 3.4 t-105 -60.95 -46.95 88.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.564 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.41 ' CD2' ' C ' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -66.58 -26.05 66.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.88 -36.09 75.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.017 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.08 -47.08 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.804 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -66.87 -30.77 71.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.61 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -63.7 -46.46 85.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.452 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.62 -28.77 65.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.11 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -90.01 4.23 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 1.0 110.543 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' B' ' 54' ' ' THR . 12.9 p 46.82 66.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.971 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.96 11.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.317 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -39.01 105.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.26 -102.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.638 0.256 . . . . 1.0 110.591 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.23 11.13 3.56 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.19 -66.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 1.0 110.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 44.4 mtt-85 -145.73 157.25 43.96 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -150.98 140.41 13.75 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.3 170.84 15.1 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.021 1.814 . . . . 1.0 112.064 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.472 ' C ' ' OE1' ' B' ' 66' ' ' GLU . 2.7 t -100.83 -130.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.926 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' B' ' 66' ' ' GLU . 87.5 m -115.25 -42.02 3.23 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.424 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.688 ' C ' ' H ' ' B' ' 67' ' ' GLY . 45.4 tp10 -64.95 -37.68 88.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.755 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -67.14 28.44 0.02 OUTLIER 'General case' 0 C--O 1.265 1.885 0 CA-C-O 123.558 1.647 . . . . 1.0 110.06 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.53 63.5 1.17 Allowed Glycine 0 C--O 1.213 -1.162 0 CA-C-N 113.704 -1.589 . . . . 1.0 111.407 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.525 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.2 ttt85 -24.49 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.331 1.066 . . . . 1.0 111.018 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' B' ' 67' ' ' GLY . 32.1 mmtp -49.61 -18.09 0.4 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.456 -0.793 . . . . 1.0 108.885 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.48 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.699 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.27 -39.71 74.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.19 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -53.09 -44.17 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 109.999 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.77 -43.02 85.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.455 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.96 -44.39 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.047 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtt -60.31 -43.32 96.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.552 -0.294 . . . . 1.0 110.432 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.49 -38.94 93.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.323 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.93 87.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.01 62.2 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' B' ' 79' ' ' ILE . 93.7 mt -68.3 -3.72 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.181 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -95.0 -52.36 4.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.05 0.452 . . . . 1.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 m -60.91 -48.72 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.275 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -66.18 -38.83 89.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.956 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.04 83.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.561 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.0 tt -61.9 -40.69 96.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.107 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -47.52 -19.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.444 ' N ' ' C ' ' B' ' 84' ' ' LEU . 81.6 m -51.41 -19.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.06 -64.71 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.433 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.93 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 1.0 110.723 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.17 -6.66 30.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.101 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.447 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -87.54 -27.17 22.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -3.85 45.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.271 -0.877 . . . . 1.0 109.881 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -54.48 -47.58 72.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.011 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' B' ' 90' ' ' ALA . 21.9 p90 -75.32 -30.0 60.19 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.275 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.47 -43.88 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.542 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 ttm-85 -46.29 -21.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.971 -0.292 . . . . 1.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 42.7 ptt85 -59.97 -41.41 91.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.405 . . . . 1.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 98.0 mt-10 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.159 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.791 0.329 . . . . 1.0 110.374 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.634 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.9 p80 -57.13 -41.67 79.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.622 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -64.87 -42.84 94.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -64.73 -41.92 95.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.76 -38.26 86.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.181 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.86 98.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -64.93 -42.36 94.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.328 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.38 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.362 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.4 -34.43 72.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.223 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.77 -38.41 90.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.714 0.292 . . . . 1.0 110.889 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -63.89 -34.36 77.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 1.0 110.347 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.66 -35.39 80.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.672 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.29 -41.56 98.61 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.461 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -39.54 92.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.23 -40.77 97.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 1.0 111.283 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.22 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.662 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.37 -40.66 91.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.8 -48.75 66.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.33 -32.94 73.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.152 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.68 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.78 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -58.59 -43.54 89.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.521 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -62.35 -51.08 69.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 109.568 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.05 -41.99 97.65 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.347 -0.541 . . . . 1.0 109.987 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.66 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.084 -0.247 . . . . 1.0 111.324 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 1.2 p -65.16 -41.29 91.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.538 -0.465 . . . . 1.0 109.954 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 44.3 tp10 -66.92 -44.21 81.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.611 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.38 -38.45 87.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -71.11 -34.2 70.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.149 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -67.79 121.8 16.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.855 0.36 . . . . 1.0 110.624 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.87 61.19 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.272 -0.731 . . . . 1.0 111.272 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.48 24.76 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 110.466 -0.198 . . . . 1.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.13 144.77 27.03 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.015 1.81 . . . . 1.0 112.359 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.73 11.82 58.19 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.19 92.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.323 . . . . 1.0 110.57 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.2 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.297 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.43 118.22 26.73 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.157 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' C' ' 40' ' ' SER . 40.2 pt -145.13 164.15 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.251 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.7 OUTLIER 82.13 142.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.789 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.634 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 89.8 t80 -80.36 -38.87 1.14 Allowed Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.112 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.8 Cg_endo -60.03 -32.73 95.29 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.403 1.402 . . . . 1.0 112.378 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' C' ' 39' ' ' ILE . 9.1 p-10 -95.09 -9.91 32.27 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 121.015 -0.274 . . . . 1.0 111.1 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -38.37 81.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 1.0 110.794 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 tt -64.67 -37.26 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -47.52 86.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.604 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.453 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.8 OUTLIER -71.69 -18.19 62.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.384 178.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -81.01 48.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.009 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -147.21 -41.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.838 -0.345 . . . . 1.0 111.336 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.48 -34.55 78.17 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.853 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -44.7 83.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.181 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.53 76.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.691 0.281 . . . . 1.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 43.3 p -88.46 3.46 50.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 110.106 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.2 p 51.66 75.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.37 -66.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.282 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 81.58 -59.1 4.86 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.445 -1.062 . . . . 1.0 110.445 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 68.74 -38.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.284 . . . . 1.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 124.53 19.6 2.53 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.09 -49.0 79.37 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.37 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -147.06 -165.57 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 42.6 p90 -170.41 113.75 0.46 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.19 -171.46 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.488 1.459 . . . . 1.0 112.104 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.651 ' CG2' ' H ' ' C' ' 64' ' ' THR . 13.3 p -129.48 -176.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.651 ' H ' ' CG2' ' C' ' 63' ' ' VAL . 71.3 m -79.83 -25.23 40.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.777 0.322 . . . . 1.0 110.476 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' C' ' 67' ' ' GLY . 43.1 tp10 -66.54 -43.63 84.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.399 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -77.0 31.47 0.14 Allowed 'General case' 0 C--O 1.268 2.035 0 CA-C-O 124.212 1.958 . . . . 1.0 109.586 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.83 64.38 1.92 Allowed Glycine 0 C--O 1.217 -0.914 0 CA-C-N 113.24 -1.8 . . . . 1.0 111.266 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' C' ' 67' ' ' GLY . 42.3 ttm180 -24.79 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.9 0.85 . . . . 1.0 111.049 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' C' ' 67' ' ' GLY . 29.9 mmtp -48.75 -22.35 0.78 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.595 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' C' ' 67' ' ' GLY . 80.0 t -61.95 -48.09 90.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 118.958 -1.097 . . . . 1.0 110.564 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.45 78.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 1.0 110.793 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.76 -44.78 96.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.015 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.58 -38.45 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.221 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.31 -43.15 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.455 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.2 mtt -60.99 -42.0 97.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.84 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 64.7 tttm -61.92 -41.22 97.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 1.0 110.555 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.15 -38.88 92.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 1.0 110.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.98 91.3 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.968 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.403 HG21 HD12 ' C' ' 79' ' ' ILE . 94.1 mt -61.12 -43.1 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.682 0.277 . . . . 1.0 110.717 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.7 mt-10 -60.13 -43.59 95.55 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.202 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.45 -49.22 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.361 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.79 -38.76 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.318 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.01 85.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 1.0 110.675 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.33 -40.59 97.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.93 -20.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.435 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 5.7 t -50.78 -22.1 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 1.0 110.515 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -56.14 -25.61 46.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.202 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.29 -16.41 19.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.694 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 58.7 mt -86.2 -47.1 9.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.82 -29.19 59.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.847 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -89.58 -3.65 58.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.968 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.27 -47.28 78.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.585 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 7.9 p90 -75.19 -37.5 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.105 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 95.9 t -46.64 -27.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.575 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.688 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -42.47 -37.25 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 1.0 111.078 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.653 -179.823 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.446 ' CB ' ' NE2' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.348 . . . . 1.0 110.619 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.68 -43.96 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.907 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.601 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 5.2 p80 -69.11 -37.34 78.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.85 -36.6 84.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.47 -43.4 97.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.57 86.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.897 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . 0.441 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 59.0 tt0 -63.42 -39.93 95.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.58 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -63.91 -36.67 84.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.62 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.24 -27.56 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.282 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.52 -39.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 1.0 110.765 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' D' ' 13' ' ' GLU . 54.3 mp0 -67.06 -34.36 77.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.591 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -62.51 -37.22 85.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.651 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.72 -42.0 99.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.12 -32.5 73.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -61.91 -39.19 91.14 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.045 0.45 . . . . 1.0 110.826 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.96 -38.49 72.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.95 -45.92 91.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.645 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.17 -42.26 69.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 1.0 110.344 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.07 -40.28 82.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 1.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.27 83.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -55.54 -44.27 76.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.641 -0.254 . . . . 1.0 110.568 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -65.45 -32.87 74.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.631 -0.427 . . . . 1.0 110.169 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.3 -43.87 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.886 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -60.33 -49.63 76.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 8.7 p -60.6 -44.55 97.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 109.908 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 9.1 tm-20 -68.06 -42.51 80.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.546 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.05 91.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.628 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 3.2 mp0 -70.74 -34.18 71.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.324 . . . . 1.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -69.23 122.9 19.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 1.0 110.663 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.28 -2.06 57.62 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.574 -0.739 . . . . 1.0 111.366 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.52 35.82 Favored Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 122.847 -0.208 . . . . 1.0 110.538 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.54 143.04 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.057 1.838 . . . . 1.0 112.357 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.57 76.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.43 143.76 57.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.762 0.315 . . . . 1.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.05 -22.77 2.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 37.6 tp -70.87 -89.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.536 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' D' ' 40' ' ' SER . 95.5 mt 54.12 161.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.188 0.518 . . . . 1.0 110.671 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.477 ' N ' ' CG2' ' D' ' 39' ' ' ILE . 1.1 t 76.23 130.47 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 20.8 t80 -77.22 -43.61 2.68 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.069 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.5 Cg_endo -59.2 -29.72 91.15 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.238 1.292 . . . . 1.0 112.094 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.544 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.3 m-20 -89.96 -30.91 17.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.565 -0.289 . . . . 1.0 110.993 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.72 82.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.868 0.366 . . . . 1.0 110.774 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . 0.45 ' O ' ' OG ' ' D' ' 48' ' ' SER . 7.7 tt -63.95 -37.06 78.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.059 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.594 ' CH2' ' NZ ' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -67.41 -41.48 84.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.246 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CG ' ' D' ' 50' ' ' GLU . 13.5 t90 -60.08 -37.33 79.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 85.8 p -65.65 -33.1 75.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.29 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.72 63.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.058 0.456 . . . . 1.0 111.724 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' D' ' 53' ' ' THR . 8.3 pt-20 178.9 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.68 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.49 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 90.4 m -65.33 -42.08 93.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.23 36.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' D' ' 55' ' ' VAL . 16.8 p -83.02 0.86 42.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.235 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' D' ' 53' ' ' THR . 17.6 p 57.99 10.93 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.971 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.52 ' H ' ' HG1' ' D' ' 53' ' ' THR . 76.7 t -91.17 -54.76 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.677 0.275 . . . . 1.0 110.739 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.08 -42.1 0.61 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' D' ' 55' ' ' VAL . 0.1 OUTLIER 56.16 -74.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.763 0.316 . . . . 1.0 110.681 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . -159.15 -91.49 0.08 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' NH1' ' D' ' 60' ' ' ARG . 29.5 t70 45.41 -119.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.729 0.3 . . . . 1.0 110.345 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.544 ' NH2' ' O ' ' D' ' 43' ' ' ASP . 0.1 OUTLIER -113.78 169.24 9.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.8 p90 -137.09 136.41 20.94 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.782 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.63 154.27 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.267 1.978 . . . . 1.0 112.195 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.422 ' H ' ' HG2' ' D' ' 66' ' ' GLU . 18.1 m -93.42 -145.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.874 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -112.87 -41.04 3.85 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.694 0.283 . . . . 1.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' D' ' 67' ' ' GLY . 52.1 tp10 -66.07 -25.76 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.103 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' D' ' 30' ' ' GLU . 1.0 OUTLIER -74.39 30.44 0.08 Allowed 'General case' 0 C--O 1.263 1.79 0 CA-C-O 123.697 1.713 . . . . 1.0 108.975 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.42 61.35 3.27 Favored Glycine 0 C--O 1.21 -1.385 0 CA-C-N 114.011 -1.449 . . . . 1.0 109.537 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' D' ' 67' ' ' GLY . 55.6 ttp85 -24.48 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 O-C-N 124.328 0.664 . . . . 1.0 110.735 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.7 mttt -51.98 -18.32 1.33 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.413 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' D' ' 67' ' ' GLY . 54.0 t -62.75 -49.63 82.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.932 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . 0.541 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -70.9 -43.27 68.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.403 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -41.84 -43.93 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.234 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -70.67 -35.66 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.665 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.1 -52.07 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.056 -0.658 . . . . 1.0 111.677 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' MET . . . . . 0.541 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 0.0 OUTLIER -70.89 -40.1 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 1.0 110.71 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -43.01 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.464 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.6 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.421 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.53 98.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.582 -0.607 . . . . 1.0 111.582 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . 0.414 HD13 HG21 ' D' ' 79' ' ' ILE . 94.1 mt -62.21 -43.05 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.636 0.255 . . . . 1.0 111.072 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -42.03 97.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.072 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.41 -48.33 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.364 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -71.58 -12.79 61.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.787 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -94.65 -31.84 13.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.8 0.333 . . . . 1.0 110.185 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.1 tt -64.4 -41.51 96.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -58.42 -2.88 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.548 ' H ' ' C ' ' D' ' 84' ' ' LEU . 48.1 m -60.01 -22.26 62.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.056 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.89 83.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.249 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.78 85.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.836 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.42 -39.52 92.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.461 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -56.8 -45.37 82.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.976 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -10.06 59.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -55.82 -48.52 75.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.133 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -76.11 -30.54 58.29 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.821 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.42 -26.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.305 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp85 -57.75 -32.75 67.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.883 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' D' ' 97' ' ' GLU . 36.1 ptt85 -58.17 -39.23 78.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.411 . . . . 1.0 110.037 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' D' ' 96' ' ' ARG . 81.0 tt0 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.717 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.912 0.387 . . . . 1.0 110.704 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -106.84 -8.79 16.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.465 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -87.64 -19.74 27.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.527 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.12 -38.84 89.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.69 -38.16 90.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.233 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.1 -41.22 99.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.172 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.61 96.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 1.0 110.527 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.69 -37.16 85.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.316 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -62.46 -37.38 85.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.14 76.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.904 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.59 -38.71 92.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.597 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.2 -34.59 76.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.353 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -65.55 -34.09 77.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.392 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.92 -39.01 93.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.331 . . . . 1.0 110.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.04 -34.63 78.51 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.62 -46.77 81.16 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 m -63.62 -36.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.549 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.43 ' O ' ' OG ' ' A' ' 23' ' ' SER . 85.8 mt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.76 -45.81 77.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.104 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.94 -38.58 79.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.288 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.92 85.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.72 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 19' ' ' LEU . 21.1 m -57.62 -44.11 85.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.087 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.3 -31.71 72.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.453 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 29' ' ' ALA . 97.2 mttt -76.57 -48.44 19.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.59 79.59 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.467 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 9.0 p -61.93 -44.67 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.306 -0.558 . . . . 1.0 109.669 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 84.0 tt0 -69.85 -31.22 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.385 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -57.01 -38.09 72.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.261 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.24 -39.27 86.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -55.41 99.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.628 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.71 -2.45 23.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.06 142.42 24.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 O-C-N 122.753 -0.263 . . . . 1.0 110.653 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.07 144.19 29.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.936 1.758 . . . . 1.0 112.269 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.25 26.39 70.48 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.83 151.24 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 1.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 -53.17 0.54 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.481 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 53.93 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 40' ' ' SER . 13.7 tt -105.64 96.81 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.225 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 71.7 m -169.34 -123.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.618 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 40' ' ' SER . 4.6 m-85 -171.66 -68.54 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.197 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 41' ' ' TYR . 28.5 Cg_endo -60.15 -32.55 94.71 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.998 1.798 . . . . 1.0 112.241 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -86.29 -20.08 28.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.102 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.87 95.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 1.0 110.353 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -67.96 -39.09 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.547 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -59.43 -44.21 92.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.902 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -59.68 -39.43 84.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -65.96 -36.96 84.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.18 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.4 -48.77 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 120.734 0.302 . . . . 1.0 110.736 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.9 -31.79 70.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.515 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 m -62.38 -45.29 93.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.313 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.11 67.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.454 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -90.24 11.9 19.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 1.1 p 41.42 41.9 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.276 -0.875 . . . . 1.0 111.211 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.07 -51.74 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 88.07 -69.38 2.85 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.142 -0.551 . . . . 1.0 111.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 54.4 -83.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.932 0.396 . . . . 1.0 110.255 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . 140.48 27.84 0.21 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.27 -43.75 98.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 1.0 110.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 25.6 mmt180 -132.21 -178.72 5.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.097 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 81.7 m-85 -157.45 96.84 2.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.706 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.72 156.07 64.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.79 1.66 . . . . 1.0 112.411 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -79.69 -141.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.334 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.433 ' CA ' ' OE2' ' A' ' 66' ' ' GLU . 7.5 p -115.41 -41.76 3.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.775 0.322 . . . . 1.0 110.571 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' A' ' 67' ' ' GLY . 15.6 tm-20 -61.6 -24.94 67.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -71.89 40.74 0.07 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 123.576 1.655 . . . . 1.0 109.167 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.765 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.82 66.71 2.3 Favored Glycine 0 C--O 1.199 -2.064 0 CA-C-N 113.708 -1.587 . . . . 1.0 111.959 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' NE ' ' CD1' ' D' ' 46' ' ' TRP . 35.7 ttm105 -24.91 -27.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.726 1.263 . . . . 1.0 112.176 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.5 mttm -76.61 -6.91 53.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.944 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.748 ' N ' ' O ' ' A' ' 67' ' ' GLY . 13.9 t -58.75 -48.53 85.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.446 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.4 -41.93 69.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.567 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.93 -36.49 79.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.582 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.79 -53.51 57.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.08 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.28 -42.19 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.7 tpp -52.23 -50.58 61.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.63 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -65.17 -41.14 94.96 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.73 -46.37 70.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.839 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.74 -43.43 97.78 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -43.38 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.606 0.241 . . . . 1.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.17 -43.36 99.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.47 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.38 -49.03 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.38 -8.83 57.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.979 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.64 -39.44 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.9 tt -63.21 -42.55 99.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.573 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 m -50.77 -9.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.602 -0.439 . . . . 1.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.2 m -57.98 -38.59 76.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.969 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -48.99 -33.72 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 -11.51 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' THR . 76.4 mt -91.69 -46.65 7.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.028 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.85 -24.78 53.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 1.0 110.675 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 t -86.58 -3.56 59.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.988 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.12 -43.69 98.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.173 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 5.7 p90 -74.69 -31.59 61.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.517 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.16 -26.59 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.37 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -63.94 -21.89 66.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -60.07 -33.99 72.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 1.0 110.752 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.961 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.806 0.336 . . . . 1.0 110.745 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.479 ' CE1' HH22 ' B' ' 95' ' ' ARG . 6.0 p80 -76.13 -18.69 59.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.436 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.18 -37.26 85.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.758 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.99 -44.26 97.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.559 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -41.41 88.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.681 -0.408 . . . . 1.0 109.917 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.34 86.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.646 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -62.85 -37.46 86.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.05 76.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.01 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.53 -39.77 85.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.0 110.693 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.483 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 6.3 tm-20 -65.37 -36.87 85.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.86 -32.81 74.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.552 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.33 -40.76 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.393 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -63.24 -37.03 85.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' B' ' 13' ' ' GLU . 29.2 mtmm -62.26 -41.75 98.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.0 111.054 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.08 -40.73 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.627 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.4 -40.86 95.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.5 mt-10 -65.53 -44.01 88.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.03 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -72.03 -39.44 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.345 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.26 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.512 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.2 p -57.51 -45.41 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.77 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.81 -35.7 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.191 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.4 mttm -69.42 -45.91 68.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -54.24 -49.48 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.532 0.197 . . . . 1.0 111.532 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.83 -46.22 96.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.231 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -68.46 -35.42 77.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.687 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -59.18 -46.99 86.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.481 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 30' ' ' GLU . 4.1 mp0 -68.02 -37.61 81.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 1.0 110.396 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -55.61 97.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.743 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.12 -7.9 16.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.481 -0.648 . . . . 1.0 111.481 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.29 146.93 34.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 122.852 -0.204 . . . . 1.0 110.487 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.6 142.6 26.29 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.057 1.838 . . . . 1.0 112.503 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.77 29.81 71.15 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.98 145.39 41.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 1.0 110.188 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.525 ' O ' ' NH1' ' B' ' 60' ' ' ARG . . . -126.87 -25.79 3.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.539 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.1 119.49 38.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 110.09 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 40.4 pt -153.05 -141.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.769 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.08 -127.43 1.3 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.893 0.377 . . . . 1.0 110.653 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.436 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 2.1 m-85 -164.32 -63.19 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.084 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.5 Cg_endo -58.73 -23.36 65.9 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.199 1.932 . . . . 1.0 112.122 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -89.77 -29.66 18.53 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.828 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.27 -40.0 82.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.0 110.596 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.6 tt -65.84 -42.94 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.703 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.465 ' CZ2' ' O ' ' C' ' 65' ' ' GLU . 0.0 OUTLIER -66.19 -36.96 84.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.41 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -61.65 -40.26 94.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.633 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.8 p -58.4 -29.19 65.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.945 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.43 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.711 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' B' ' 53' ' ' THR . 23.7 mt-10 -66.8 -33.93 76.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.0 m -60.09 -44.58 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.506 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.79 -24.49 57.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.974 -0.291 . . . . 1.0 110.683 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 56.6 p -90.29 0.83 57.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.637 -0.256 . . . . 1.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.6 p 52.65 25.57 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.441 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 57' ' ' TYR . 7.4 p -83.1 -46.27 18.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 72.26 -32.93 0.66 Allowed Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' B' ' 55' ' ' VAL . 1.9 m-85 41.17 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.02 0.438 . . . . 1.0 110.563 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' B' ' 56' ' ' GLY . . . 162.86 19.72 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' B' ' 50' ' ' GLU . 92.0 m-20 -63.46 -45.68 89.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.795 0.331 . . . . 1.0 110.641 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' B' ' 37' ' ' ALA . 96.9 mtt-85 -147.38 -175.36 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.24 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.533 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 13.5 p90 -162.19 113.77 1.16 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.96 153.41 72.59 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.38 1.387 . . . . 1.0 112.56 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 2.1 t -77.82 -138.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.012 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.43 ' H ' ' CG1' ' B' ' 63' ' ' VAL . 95.2 m -114.58 -39.61 3.75 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.766 0.317 . . . . 1.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.606 ' C ' ' H ' ' B' ' 67' ' ' GLY . 80.1 tt0 -65.06 -24.19 67.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.329 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -74.95 27.03 0.09 Allowed 'General case' 0 C--O 1.263 1.769 0 CA-C-O 123.576 1.655 . . . . 1.0 109.719 179.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.12 63.47 1.3 Allowed Glycine 0 C--O 1.212 -1.246 0 CA-C-N 113.656 -1.611 . . . . 1.0 111.269 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.4 ttm180 -25.08 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 118.124 0.962 . . . . 1.0 110.943 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 67' ' ' GLY . 44.9 mmtm -48.62 -19.84 0.39 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' B' ' 67' ' ' GLY . 61.4 t -62.51 -47.26 93.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.607 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.89 -38.06 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.96 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -60.63 -40.85 93.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.18 -44.87 79.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.638 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.26 -43.98 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.346 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 55.4 mtt -55.38 -46.9 76.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.633 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -41.96 97.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.546 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.12 -24.54 64.75 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.329 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.54 -41.45 5.42 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.93 -43.85 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 122.416 -0.461 . . . . 1.0 111.318 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.69 -52.46 65.4 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.876 0.369 . . . . 1.0 111.383 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.62 -46.27 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.326 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -74.15 2.7 8.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.997 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -117.46 -30.11 5.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.771 0.319 . . . . 1.0 110.227 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.475 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.5 tt -64.03 -40.44 96.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.256 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -48.57 -15.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.873 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.475 ' N ' ' C ' ' B' ' 84' ' ' LEU . 52.7 m -49.14 -23.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.26 95.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.695 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -11.41 59.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' B' ' 92' ' ' ASP . 43.5 mt -91.0 -38.81 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -54.42 -34.86 62.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.356 0.598 . . . . 1.0 109.481 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.523 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.2 OUTLIER -79.26 -8.02 58.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.395 -0.821 . . . . 1.0 109.969 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' B' ' 89' ' ' LEU . 66.2 t0 -55.82 -51.46 67.41 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.786 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 17.4 p90 -71.84 -41.77 67.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.747 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 57.1 t -45.13 -35.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.515 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 84.5 mtt85 -63.54 -22.7 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.056 -0.257 . . . . 1.0 111.404 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -46.77 -29.03 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 1.0 110.079 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.045 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.943 0.402 . . . . 1.0 110.064 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.41 ' HE2' ' NH2' ' C' ' 95' ' ' ARG . 9.2 p-80 -81.83 -20.04 39.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.57 -43.04 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -75.49 -29.73 59.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -64.96 -42.74 94.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.214 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.26 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -66.74 -40.85 88.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.182 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -64.25 -35.25 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -43.16 87.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.193 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -40.55 96.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 1.0 110.968 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.518 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.82 -36.28 83.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.465 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.4 -41.46 98.68 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.5 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -58.92 -40.14 83.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.388 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.66 -39.37 91.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 1.0 111.032 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.22 -32.87 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.37 -41.85 97.75 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.175 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.02 -46.68 84.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.0 109.765 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.7 -40.41 72.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.433 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.75 93.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.825 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.412 ' OG ' ' OG ' ' C' ' 48' ' ' SER . 40.4 m -60.11 -45.4 93.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.655 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -66.57 -40.99 89.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.203 0.525 . . . . 1.0 110.401 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.3 mttt -66.7 -41.97 87.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.661 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.24 -51.18 69.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.361 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 7.4 p -62.37 -33.19 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.265 0.555 . . . . 1.0 110.363 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.02 -21.28 31.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.051 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -65.03 -50.83 64.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.034 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.8 pp20? -59.0 -29.36 67.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.99 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 10.8 tpt85 -62.17 118.17 7.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.794 0.33 . . . . 1.0 110.262 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.93 -9.82 63.88 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.37 148.61 34.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . 0.496 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 87.6 Cg_endo -76.21 126.76 9.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.784 1.656 . . . . 1.0 112.299 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.02 37.47 6.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 143.06 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 1.0 110.631 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -151.73 -42.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 26.47 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.013 0.435 . . . . 1.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' C' ' 37' ' ' ALA . 12.9 tt -63.27 -24.32 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.493 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 43.3 t -59.42 129.59 42.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.518 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.479 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 52.7 t80 -86.25 -50.91 0.48 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.983 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.0 Cg_endo -60.03 -33.69 95.24 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.514 1.476 . . . . 1.0 112.426 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.77 -7.27 57.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.282 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' C' ' 48' ' ' SER . . . -65.9 -38.26 88.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.777 0.322 . . . . 1.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.0 -33.72 65.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.538 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -47.37 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.432 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -61.11 -39.64 90.75 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.382 -0.527 . . . . 1.0 109.771 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.412 ' OG ' ' OG ' ' C' ' 23' ' ' SER . 6.1 m -53.18 -21.26 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.604 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.38 -43.42 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' D' ' 68' ' ' ARG . 9.8 pt-20 -90.27 57.81 3.85 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.74 0.305 . . . . 1.0 111.399 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.513 ' O ' ' SD ' ' C' ' 75' ' ' MET . 6.0 t -159.51 -42.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.223 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' C' ' 51' ' ' THR . . . -64.32 -36.99 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 1.0 110.924 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' C' ' 54' ' ' THR . 1.5 p -94.57 19.81 9.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.871 0.367 . . . . 1.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 53' ' ' THR . 27.6 p 54.6 81.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.639 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.81 -84.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.88 44.73 45.96 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.445 ' OH ' ' CD1' ' D' ' 47' ' ' TRP . 0.9 OUTLIER -59.91 -48.22 82.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 1.0 110.66 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 165.39 -100.19 0.17 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 38.5 m-20 38.41 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.883 0.373 . . . . 1.0 111.342 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' C' ' 58' ' ' GLY . 66.5 mtm-85 -123.43 157.61 33.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.57 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -141.92 146.17 39.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.34 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.88 152.32 73.7 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.126 1.884 . . . . 1.0 112.13 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 2.1 t -64.33 -139.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 1.0 109.992 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.454 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 17.1 m -114.5 -77.13 0.57 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.465 ' O ' ' CZ2' ' B' ' 46' ' ' TRP . 80.6 tt0 -37.28 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.932 -0.577 . . . . 1.0 110.736 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.3 mm-40 -73.89 -103.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.07 -56.38 0.0 OUTLIER Glycine 0 N--CA 1.476 1.338 0 O-C-N 124.378 1.049 . . . . 1.0 114.225 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 88.3 mtt180 -70.71 -45.59 64.65 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' C' ' 66' ' ' GLU . 68.1 mmtt -62.35 -41.72 98.81 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.298 -0.631 . . . . 1.0 109.298 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.77 -45.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 119.798 -0.761 . . . . 1.0 111.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.1 69.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 1.0 109.76 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -69.71 -38.58 76.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.628 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.58 -49.13 74.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.89 -32.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.826 -0.349 . . . . 1.0 111.104 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' C' ' 51' ' ' THR . 27.4 tpp -61.17 -43.6 98.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.818 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.43 -38.72 92.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.703 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.81 -46.99 77.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.633 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.98 -41.81 98.49 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.223 -0.513 . . . . 1.0 111.862 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.425 HD11 HG21 ' C' ' 79' ' ' ILE . 96.5 mt -61.56 -43.45 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.768 0.318 . . . . 1.0 110.788 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.55 -40.98 89.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.86 -50.89 75.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.365 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -67.21 -40.79 86.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.772 -0.371 . . . . 1.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.77 71.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.988 0.423 . . . . 1.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' C' ' 86' ' ' THR . 5.4 tt -62.95 -35.75 81.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.457 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' C' ' 87' ' ' ALA . 18.7 t -39.93 -23.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 1.0 110.702 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.505 ' N ' ' O ' ' C' ' 84' ' ' LEU . 1.3 p -41.9 -21.76 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.953 0.406 . . . . 1.0 109.988 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -48.1 -50.78 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.93 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.52 -33.27 7.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.759 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.31 -45.9 91.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.768 0.318 . . . . 1.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.411 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -74.2 -14.45 60.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.995 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -92.97 -2.68 55.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.32 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -59.08 -43.05 91.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.69 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 5.6 p90 -66.97 -32.0 72.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.7 -43.68 91.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.271 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . 0.41 ' NH2' ' HE2' ' C' ' 4' ' ' HIS . 84.3 mtt85 -57.97 -20.81 40.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -53.41 -43.31 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.979 -0.289 . . . . 1.0 110.364 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.998 -0.281 . . . . 1.0 110.377 179.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.758 0.313 . . . . 1.0 110.689 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -62.51 -40.32 96.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.665 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.75 -40.63 92.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.601 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.9 tt0 -64.66 -37.2 86.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.819 0.342 . . . . 1.0 110.43 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -60.86 -43.29 98.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.381 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.64 -41.78 98.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.045 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.38 93.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.642 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.9 -37.59 79.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.99 -39.79 91.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.419 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.78 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.886 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.612 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -64.07 -39.53 94.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.89 -36.01 82.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.74 -41.2 99.08 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.063 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -37.39 85.78 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.774 0.321 . . . . 1.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.21 -41.25 92.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.624 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.76 -41.5 91.18 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' D' ' 23' ' ' SER . 96.9 mt-10 -61.84 -48.47 80.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.271 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.94 -32.7 73.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.0 109.908 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.57 93.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.69 -46.39 90.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.923 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.45 -34.84 76.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 1.0 110.566 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' D' ' 29' ' ' ALA . 27.9 mmtp -73.05 -45.61 56.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.877 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.91 79.79 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.917 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 7.6 p -65.48 -42.67 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.221 0.534 . . . . 1.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.425 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 48.1 tp10 -70.63 -41.5 72.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -64.7 -45.79 85.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.047 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 39' ' ' ILE . 0.3 OUTLIER -75.5 -18.38 59.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.837 0.351 . . . . 1.0 111.305 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -67.18 108.63 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 1.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.59 -8.34 51.43 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.432 -0.667 . . . . 1.0 111.432 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.02 149.17 76.34 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.57 142.96 29.97 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.131 1.887 . . . . 1.0 112.424 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 22.07 67.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 143.56 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.328 . . . . 1.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -27.53 1.71 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.51 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -66.47 -16.38 64.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.493 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.527 ' N ' ' OE1' ' D' ' 30' ' ' GLU . 18.5 tt -37.55 105.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.973 0.416 . . . . 1.0 111.153 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 88.9 p -173.85 -133.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.192 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' D' ' 40' ' ' SER . 2.3 m-85 -177.65 -66.28 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.413 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.1 Cg_endo -58.88 -32.31 97.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.842 1.695 . . . . 1.0 111.65 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -93.92 -7.22 43.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.23 87.28 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.848 0.356 . . . . 1.0 110.493 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . 0.461 ' O ' ' OG ' ' D' ' 48' ' ' SER . 15.1 tt -69.33 -36.59 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.317 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.518 ' CD1' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -55.6 -49.06 73.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 -178.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.445 ' CD1' ' OH ' ' C' ' 57' ' ' TYR . 10.6 t90 -60.67 -40.52 92.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.167 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' D' ' 49' ' ' VAL . 54.3 p -61.42 -36.19 79.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.669 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . 0.506 ' N ' ' HG ' ' D' ' 48' ' ' SER . 50.9 t -63.53 -48.09 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.985 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.3 44.97 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -139.06 -47.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.95 67.29 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.154 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.3 p -89.41 9.87 24.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' D' ' 53' ' ' THR . 42.9 p 51.59 70.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.802 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.78 -77.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.846 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 94.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -61.82 -41.48 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 1.0 110.843 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.92 8.51 3.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.859 -0.897 . . . . 1.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.29 -47.9 83.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -140.28 148.93 42.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 25.7 p90 -136.91 137.8 24.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.514 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.54 155.37 63.5 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.376 2.051 . . . . 1.0 112.284 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.441 ' CG1' ' H ' ' D' ' 64' ' ' THR . 2.0 t -88.81 -141.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.079 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.441 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 1.7 p -113.67 -42.77 3.39 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.821 0.343 . . . . 1.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.76 -19.12 65.08 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.49 26.16 0.1 Allowed 'General case' 0 C--O 1.265 1.872 0 CA-C-O 123.7 1.714 . . . . 1.0 109.443 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 43.19 59.75 3.34 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 113.907 -1.497 . . . . 1.0 109.414 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.0 ttt85 -26.49 -28.94 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.363 0.684 . . . . 1.0 110.994 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.4 mttm -53.35 -18.68 2.7 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.044 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 53.2 t -62.46 -46.97 95.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.803 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.91 76.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.302 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.89 -46.24 82.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.76 -0.655 . . . . 1.0 111.164 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.14 -41.37 99.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.38 -46.18 96.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.241 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 25.1 mtm -63.4 -41.5 98.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.846 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.71 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.08 92.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.438 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.41 -41.89 83.8 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.523 -0.631 . . . . 1.0 111.523 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.64 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.842 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -66.82 -44.09 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.177 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.8 -49.22 81.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.436 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.58 -5.55 11.91 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.872 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.48 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -109.95 -38.2 5.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.68 -16.81 6.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.4 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.42 -1.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.723 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 19.5 m -58.31 -42.16 86.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.995 0.426 . . . . 1.0 109.91 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -48.17 -17.09 0.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.76 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -105.03 -12.95 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.775 0.322 . . . . 1.0 110.464 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.3 mt -87.67 -51.18 6.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -55.32 -28.41 53.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.136 0.493 . . . . 1.0 110.421 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.5 OUTLIER -86.9 0.53 54.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.521 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -72.04 -37.7 69.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.432 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 7.4 p90 -75.86 -42.75 48.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.608 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 17.1 m -39.97 -33.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.446 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -53.7 -22.53 9.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.741 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -55.94 -34.93 66.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.613 179.763 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.694 0.283 . . . . 1.0 110.474 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ALA . 99.5 m-20 -140.26 -50.32 0.47 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.518 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -82.46 -19.71 38.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.499 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.65 -38.89 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.01 -38.78 92.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.367 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.1 -39.84 93.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.78 96.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.271 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -68.52 -38.92 81.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.511 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.04 -38.88 92.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.396 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.69 78.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.792 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.1 -36.72 82.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 1.0 110.691 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.15 -34.56 78.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.153 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -64.77 -35.32 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.65 -41.79 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.433 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 87.6 mt-30 -60.24 -40.58 90.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.244 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -44.05 97.33 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.69 -42.06 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.441 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 48' ' ' SER . 20.1 mt -60.16 -41.93 93.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.448 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -65.17 -43.07 92.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.4 -46.53 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.381 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.02 79.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.206 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 13.4 p -53.11 -42.07 65.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.035 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' ALA . 65.4 tttm -66.4 -74.08 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -35.96 -26.5 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.147 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' LYS . . . -62.61 -42.61 99.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 2.3 m -68.11 -47.05 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.178 0.513 . . . . 1.0 110.593 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 44.1 tp10 -67.09 -34.45 77.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' OE1' ' A' ' 66' ' ' GLU . . . -54.25 -29.09 45.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -67.56 -41.11 84.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.099 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.498 HH21 ' CB ' ' A' ' 36' ' ' ALA . 5.3 mmp_? -74.13 101.97 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.225 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.03 -27.19 4.61 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 152.5 40.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 110.027 -0.361 . . . . 1.0 110.027 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.5 147.66 32.4 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.382 2.054 . . . . 1.0 112.61 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.71 36.62 7.25 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.498 ' CB ' HH21 ' A' ' 31' ' ' ARG . . . -55.08 143.88 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 1.0 110.641 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.77 -58.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.11 58.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.263 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.5 pt -85.63 -5.49 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.177 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -72.79 151.65 41.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.632 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.02 -63.17 0.1 Allowed Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.753 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.16 -29.63 89.54 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.969 1.779 . . . . 1.0 112.508 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 73.7 m-20 -81.85 -5.99 58.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.955 -0.298 . . . . 1.0 110.53 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -43.16 96.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.7 tt -67.69 -39.21 81.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.505 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -59.3 -43.8 92.6 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.513 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 14.2 t90 -63.29 -40.2 96.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 45' ' ' ILE . 58.4 p -61.64 -32.7 72.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.71 -46.53 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.239 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.63 13.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.542 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -100.21 -49.27 4.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.757 0.313 . . . . 1.0 110.56 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.22 -26.76 67.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.4 p -84.53 5.44 27.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.224 0.535 . . . . 1.0 109.628 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 54' ' ' THR . 3.4 p 42.36 60.5 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.312 -0.858 . . . . 1.0 111.29 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 56' ' ' GLY . 11.1 p -131.65 -48.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.952 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 55' ' ' VAL . . . 38.76 95.55 0.01 OUTLIER Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.649 -0.58 . . . . 1.0 111.649 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -74.49 -102.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.0 110.571 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.38 18.88 1.17 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' CZ ' ' B' ' 68' ' ' ARG . 99.8 m-20 -60.23 -47.29 86.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 33.9 mmt180 -134.63 -163.02 1.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 46.3 m-85 -161.34 100.59 1.24 Allowed Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.547 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 63' ' ' VAL . 62.1 Cg_endo -69.47 150.02 69.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.353 1.369 . . . . 1.0 112.568 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 62' ' ' PRO . 6.0 m -53.53 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.371 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.524 ' OG1' ' NH2' ' D' ' 60' ' ' ARG . 98.0 m -102.63 -71.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.535 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 84.1 tt0 -37.81 -70.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 1.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' A' ' 68' ' ' ARG . 74.2 mt-10 -83.42 -107.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -54.58 0.0 OUTLIER Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.779 1.299 . . . . 1.0 114.77 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' A' ' 66' ' ' GLU . 60.0 ttm-85 -65.74 -74.9 0.1 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.851 -0.674 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -43.55 -37.6 2.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.27 -47.32 90.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.033 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 68' ' ' ARG . . . -65.99 -36.8 84.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.644 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.22 -38.29 73.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.615 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -63.41 -43.32 97.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.594 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.91 -45.34 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.84 -42.91 98.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.95 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.62 -43.2 97.55 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.82 95.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.612 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.69 95.61 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.54 -43.27 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.988 -0.285 . . . . 1.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.43 -42.29 98.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.249 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.73 -50.88 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.009 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -68.46 -39.51 81.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.978 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.75 -36.67 85.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.222 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.461 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.7 tt -61.77 -42.54 99.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.404 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -47.75 -16.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 1.0 110.328 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.461 ' N ' ' C ' ' A' ' 84' ' ' LEU . 92.9 m -51.59 -21.35 2.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.214 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 -35.3 78.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.243 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.57 -14.59 34.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.5 -42.7 18.11 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.932 0.345 . . . . 1.0 111.932 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.72 -30.46 67.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.844 0.354 . . . . 1.0 111.216 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.4 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.17 -50.42 73.76 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.69 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 94' ' ' VAL . 15.7 p90 -72.37 -43.92 63.3 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.268 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.575 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 57.8 t -39.72 -34.37 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.662 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -63.04 -34.96 78.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 1.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 93' ' ' PHE . 40.0 ptt85 -39.46 -42.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.899 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 5.2 tp10 . . . . . 0 C--N 1.328 -0.355 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.833 0.349 . . . . 1.0 111.019 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.406 ' ND1' ' H ' ' B' ' 4' ' ' HIS . 2.3 m80 -61.67 -41.64 97.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.0 110.395 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.59 -33.36 75.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -62.0 -42.35 99.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.308 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.46 -44.22 83.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.361 . . . . 1.0 110.225 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.54 85.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.654 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.19 -38.57 90.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.671 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.72 -37.41 86.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.21 75.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.893 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.21 -36.03 76.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 1.0 110.629 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 -37.32 87.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -64.2 -33.63 76.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.664 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.43 -41.84 99.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.691 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.65 -39.92 85.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.647 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.94 -38.86 92.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.829 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.18 -41.8 94.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.754 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.37 -41.1 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.091 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.46 -44.3 96.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 1.0 109.915 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.74 -37.78 76.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.393 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.68 88.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.415 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -58.48 -45.82 87.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -65.31 -35.0 79.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.904 0.383 . . . . 1.0 110.218 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.643 ' NZ ' HE22 ' B' ' 73' ' ' GLN . 98.7 mttt -70.95 -45.22 64.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.51 77.45 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.511 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 m -58.59 -46.82 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.798 -0.761 . . . . 1.0 110.534 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.91 -42.68 80.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.784 0.326 . . . . 1.0 111.027 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.37 87.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.568 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -65.09 -47.7 76.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.737 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.51 131.45 49.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.04 69.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.38 143.03 25.79 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.32 -0.252 . . . . 1.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.45 142.6 26.71 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.151 1.901 . . . . 1.0 112.138 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.65 19.88 73.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.181 -0.767 . . . . 1.0 111.181 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.13 145.24 51.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 1.0 110.397 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.08 -34.47 0.87 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.516 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -81.75 125.5 30.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 1.0 110.588 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' SER . 35.5 pt -152.13 -166.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.408 -0.815 . . . . 1.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 39' ' ' ILE . 6.1 t 59.97 135.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 1.0 111.283 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -65.85 -48.98 61.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.369 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.45 -29.53 88.82 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.599 1.533 . . . . 1.0 112.913 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.03 -23.55 22.56 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.7 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.63 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 1.0 110.58 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.412 HD12 HG23 ' B' ' 45' ' ' ILE . 4.9 tt -65.09 -39.36 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.49 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.495 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.4 OUTLIER -59.86 -47.51 85.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.474 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -61.85 -41.91 98.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 1.0 110.267 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -64.37 -40.3 95.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.199 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.49 -47.48 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.631 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.69 -32.81 74.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -64.81 -43.55 92.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.25 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.47 -26.3 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.915 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.6 p -88.96 2.23 54.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.716 0.293 . . . . 1.0 110.712 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 53' ' ' THR . 69.6 p 51.59 66.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.708 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.88 -52.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.674 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.33 76.91 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -61.22 -42.6 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.912 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.89 20.73 0.83 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.516 ' CG ' HH22 ' C' ' 68' ' ' ARG . 32.7 m-20 -62.5 -41.71 99.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.816 0.341 . . . . 1.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 34.9 mmt180 -132.88 -175.83 3.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 58.9 m-85 -159.45 99.35 1.55 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.856 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.2 158.16 58.7 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.3 1.333 . . . . 1.0 112.606 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.11 -154.17 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.022 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -101.93 -38.26 7.88 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.626 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.9 tm-20 -61.55 -32.38 72.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 1.0 110.2 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -73.01 26.52 0.06 Allowed 'General case' 0 C--O 1.263 1.784 0 CA-C-O 124.046 1.879 . . . . 1.0 109.599 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 44.31 63.95 2.2 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-O 117.492 -1.727 . . . . 1.0 110.961 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.505 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.1 ttm180 -25.08 -31.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.297 1.049 . . . . 1.0 110.904 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.5 mttt -49.82 -17.77 0.4 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 67' ' ' GLY . 45.7 t -60.32 -47.08 93.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 119.477 -0.889 . . . . 1.0 109.488 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.54 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -68.23 -54.21 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.303 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -42.82 -34.97 1.03 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.33 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . 0.643 HE22 ' NZ ' ' B' ' 25' ' ' LYS . 59.2 tt0 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.533 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 71' ' ' ALA . 45.0 t -67.03 -52.93 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.861 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 0.0 OUTLIER -65.0 -42.59 94.36 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.612 -179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.51 -43.96 93.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.119 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.63 94.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.43 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.99 92.63 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.711 -0.556 . . . . 1.0 111.711 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.5 -43.5 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.041 -0.264 . . . . 1.0 110.77 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 84' ' ' LEU . 80.9 mm-40 -60.28 -41.47 93.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.301 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.11 -49.17 82.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.457 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -76.59 -12.16 59.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.547 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.34 -26.58 14.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.918 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 80' ' ' GLU . 4.7 tt -63.63 -41.32 98.27 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.04 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' B' ' 87' ' ' ALA . 17.3 m -47.45 -26.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.445 -0.502 . . . . 1.0 109.68 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 6.1 m -34.16 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.415 0.626 . . . . 1.0 110.211 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -53.37 -53.2 54.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.601 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -70.25 -30.18 67.17 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.333 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.29 -43.67 98.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.997 0.427 . . . . 1.0 109.886 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 -17.81 61.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.537 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -100.54 -11.56 20.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.241 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.6 m-20 -63.12 -41.92 99.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.076 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 1.4 p90 -64.94 -29.88 70.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.363 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.96 -43.4 92.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.519 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -48.71 -21.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.31 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -55.18 -32.22 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 1.0 110.119 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.125 -179.436 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 t0 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.783 0.325 . . . . 1.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.694 ' H ' ' ND1' ' C' ' 4' ' ' HIS . 3.8 p-80 -58.7 -41.77 87.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.694 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.24 -37.11 86.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.72 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.9 -39.29 93.84 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.92 -39.35 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.248 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -41.01 99.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.48 -37.19 84.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.72 -38.4 87.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.661 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.5 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.2 -36.29 83.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.971 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.85 -38.71 91.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.752 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -36.02 82.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.706 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.45 -36.09 82.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 1.0 110.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.87 -33.66 76.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.184 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -61.28 -47.84 84.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.579 -0.282 . . . . 1.0 111.56 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -65.28 -36.22 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 1.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . 0.438 ' O ' ' OG ' ' C' ' 23' ' ' SER . 36.0 mt -60.86 -41.56 96.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.74 -42.98 99.67 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.119 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -68.89 -44.75 72.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.74 78.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.456 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 72.6 m -56.75 -43.95 81.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.858 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' C' ' 27' ' ' VAL . 8.0 tmtt? -80.65 -61.86 1.84 Allowed 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -41.89 -28.75 0.17 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.159 -0.216 . . . . 1.0 110.956 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.58 78.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.571 0.224 . . . . 1.0 110.721 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' C' ' 24' ' ' LYS . 2.3 m -63.26 -43.55 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.045 0.45 . . . . 1.0 110.544 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' C' ' 27' ' ' VAL . 14.4 tm-20 -80.58 -24.22 39.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -51.01 71.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.918 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.55 78.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -53.01 90.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.564 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.12 -6.18 8.22 Favored Glycine 0 N--CA 1.47 0.911 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.14 150.73 39.14 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.255 . . . . 1.0 110.32 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.62 141.77 28.28 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.685 1.59 . . . . 1.0 111.649 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 37.35 34.27 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.64 150.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.0 110.562 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' C' ' 61' ' ' TYR . . . -132.06 -116.79 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -55.05 163.93 0.95 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.242 0.544 . . . . 1.0 110.961 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' C' ' 40' ' ' SER . 5.7 pt -152.85 -169.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.746 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.516 ' C ' ' CG ' ' C' ' 41' ' ' TYR . 37.6 m -53.02 -165.31 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.874 0.369 . . . . 1.0 110.83 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.631 ' C ' ' H ' ' C' ' 43' ' ' ASP . 0.3 OUTLIER 76.31 161.19 0.15 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.57 5.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.564 2.176 . . . . 1.0 112.131 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.631 ' H ' ' C ' ' C' ' 41' ' ' TYR . 21.2 t70 -84.2 -32.3 24.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 1.0 111.169 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 tt -63.93 -38.0 81.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.393 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.409 . . . . 1.0 110.211 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' C' ' 48' ' ' SER . 1.4 t90 -63.25 -47.72 81.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.526 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 1.9 t -50.42 -29.22 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.776 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.39 62.91 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.661 ' CG ' HH22 ' D' ' 68' ' ' ARG . 46.7 tp10 -173.28 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.658 -0.817 . . . . 1.0 110.825 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' C' ' 75' ' ' MET . 4.5 t -72.57 -38.97 67.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.38 69.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.957 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -93.67 1.82 56.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.07 0.462 . . . . 1.0 110.282 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 57.4 p 49.8 56.9 7.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.656 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' C' ' 57' ' ' TYR . 1.7 m -145.94 45.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.58 92.44 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.324 -1.11 . . . . 1.0 110.324 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.543 ' OH ' ' NE1' ' D' ' 47' ' ' TRP . 18.2 t80 -61.97 -43.21 99.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 1.0 110.41 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.17 16.24 0.75 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.98 -52.11 66.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 1.0 110.766 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -151.71 -162.28 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.493 ' O ' ' CB ' ' C' ' 37' ' ' ALA . 38.7 p90 -166.69 134.91 2.21 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.802 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 176.54 6.23 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.864 1.71 . . . . 1.0 112.362 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.25 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.416 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.495 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 1.1 m -110.08 -61.49 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.574 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -42.99 -30.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.675 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 94.1 mt-10 -144.68 -104.27 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.73 -55.28 0.0 OUTLIER Glycine 0 N--CA 1.479 1.521 0 O-C-N 124.358 1.036 . . . . 1.0 114.839 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 45.0 ttm-85 -71.12 -43.17 68.18 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.192 -0.504 . . . . 1.0 109.971 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.3 tptm -60.63 -45.16 95.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.918 -1.141 . . . . 1.0 107.918 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.53 -46.64 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.797 -0.761 . . . . 1.0 110.329 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.531 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -63.05 -39.8 95.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 1.0 110.13 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -43.73 -49.36 7.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.79 -36.35 83.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.529 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.02 -43.28 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.767 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.3 mpp? -59.36 -44.64 92.66 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.726 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -64.5 -41.18 96.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.53 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.13 65.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.786 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.29 -37.61 6.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.717 -0.553 . . . . 1.0 111.717 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.56 -43.43 98.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.07 -37.67 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.75 -47.12 94.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.321 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -73.74 -8.01 54.32 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.299 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -40.72 12.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.876 0.369 . . . . 1.0 110.285 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.07 -42.32 99.63 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.812 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.94 -15.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.432 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.475 ' O ' ' N ' ' C' ' 89' ' ' LEU . 28.1 m -60.04 -39.87 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.43 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -39.2 -50.56 1.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.59 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.26 90.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 1.0 110.084 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' C' ' 86' ' ' THR . 44.7 mt -66.68 -38.92 87.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.401 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -60.73 -37.64 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.438 . . . . 1.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -81.99 -3.6 54.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -55.64 -49.7 72.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.569 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.2 p90 -69.06 -32.62 72.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 -27.55 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.913 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.4 -22.94 67.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.611 -0.268 . . . . 1.0 111.152 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -57.59 -31.99 66.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 1.0 110.447 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.536 -179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.764 0.316 . . . . 1.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -174.03 -66.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -79.21 -18.91 52.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.58 -38.79 87.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.402 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.76 -42.13 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.507 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.78 -39.42 94.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.44 99.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.818 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.18 -39.07 92.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.06 -40.82 97.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -35.42 76.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.968 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.804 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.4 -38.07 88.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.368 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.37 -31.93 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -62.07 -39.64 93.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 1.0 110.184 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.4 -34.21 75.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -63.5 -46.78 84.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.844 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.62 -37.45 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 1.0 110.675 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.23 -41.45 96.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.345 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.9 -46.32 82.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.912 0.387 . . . . 1.0 110.318 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.53 -35.36 75.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.287 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.06 92.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 1.0 111.054 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -58.24 -43.65 87.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.123 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -63.96 -32.84 74.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.37 -45.19 60.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.683 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -49.23 78.38 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -60.87 -45.7 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.178 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.98 -43.21 79.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.95 86.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.215 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.54 -38.23 83.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.179 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -63.69 124.08 20.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.981 0.42 . . . . 1.0 110.726 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.5 68.83 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.68 139.4 21.88 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.77 144.77 31.57 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.228 1.952 . . . . 1.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.88 22.65 70.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.2 87.82 6.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.709 0.29 . . . . 1.0 110.869 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.82 91.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.405 ' C ' ' CD2' ' D' ' 38' ' ' LEU . 4.3 tt -66.6 99.14 0.56 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' D' ' 40' ' ' SER . 14.3 tt -143.45 93.34 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.4 OUTLIER 168.58 150.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.572 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.413 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 10.0 m-85 -76.87 -58.79 1.02 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.562 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.1 Cg_endo -58.93 -26.78 82.47 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.648 1.565 . . . . 1.0 111.728 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.34 -35.9 27.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 1.0 111.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.79 92.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.199 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.17 -44.21 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.896 0.379 . . . . 1.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -62.8 -42.02 99.54 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.581 -0.448 . . . . 1.0 110.175 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.543 ' NE1' ' OH ' ' C' ' 57' ' ' TYR . 36.1 t90 -62.12 -40.43 95.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.269 -0.572 . . . . 1.0 109.81 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -74.22 69.48 1.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.804 0.335 . . . . 1.0 110.455 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.3 t -155.47 -61.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 1.5 pm0 -63.06 -31.99 73.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.555 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -42.9 97.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.223 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.02 75.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 1.0 110.026 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' D' ' 54' ' ' THR . 18.1 p -80.07 9.47 5.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.16 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' D' ' 53' ' ' THR . 44.3 p 51.93 56.33 7.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.047 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -166.81 88.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.253 0.549 . . . . 1.0 111.157 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.24 109.92 3.57 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -61.32 -45.34 94.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 1.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.52 24.78 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 64.6 m-20 -61.8 -43.71 98.31 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.991 -0.284 . . . . 1.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.524 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.2 OUTLIER -144.94 -177.19 5.4 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' D' ' 60' ' ' ARG . 41.5 m-85 -156.36 128.51 4.01 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.0 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.1 -171.13 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.736 1.624 . . . . 1.0 112.064 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' D' ' 66' ' ' GLU . 1.5 t -128.96 -146.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.178 -0.465 . . . . 1.0 109.986 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.9 p -113.48 -8.7 13.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.776 -0.193 . . . . 1.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' D' ' 67' ' ' GLY . 50.8 tp10 -99.06 -26.67 14.15 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.838 -0.431 . . . . 1.0 109.838 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -80.97 30.92 0.31 Allowed 'General case' 0 C--O 1.265 1.874 0 CA-C-O 123.896 1.808 . . . . 1.0 108.879 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.01 61.71 2.24 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 113.377 -1.738 . . . . 1.0 109.493 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.661 HH22 ' CG ' ' C' ' 50' ' ' GLU . 71.3 ttt-85 -26.21 -30.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.134 0.55 . . . . 1.0 110.981 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.8 mttt -52.22 -13.61 0.35 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.292 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.0 t -59.56 -47.8 89.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.525 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.59 83.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.496 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.85 -43.14 85.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.365 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -61.92 -44.72 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.209 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.11 -46.51 93.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.476 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.66 -44.74 95.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.995 -0.282 . . . . 1.0 111.23 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -66.15 -41.54 90.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 1.0 110.785 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.16 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.707 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.65 -39.11 93.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.586 -0.606 . . . . 1.0 111.586 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.61 -43.53 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.906 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.14 -38.95 93.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.079 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.34 -54.19 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.719 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.88 -39.6 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.812 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -62.66 -35.44 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.0 110.446 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.66 -40.75 96.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.525 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' D' ' 87' ' ' ALA . 48.1 t -57.6 -22.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.831 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 86.4 m -40.32 -24.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.53 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -64.51 -42.47 95.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.669 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -72.44 -15.62 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 3.8 mm? -85.79 -41.44 15.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.033 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.87 -36.83 72.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.218 0.533 . . . . 1.0 110.244 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -15.03 62.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.9 -51.85 67.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.234 -0.587 . . . . 1.0 111.073 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 12.6 p90 -72.23 -28.51 63.21 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.057 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.97 -35.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.962 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -59.9 -22.2 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.213 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -48.66 -36.94 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.0 110.367 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.688 -179.696 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.911 0.386 . . . . 1.0 110.693 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.53 -40.36 96.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.493 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.536 ' ND1' ' H ' ' A' ' 4' ' ' HIS . 1.4 m80 -62.12 -46.23 89.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.175 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.67 -41.35 92.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 9' ' ' GLN . 8.8 tpm_? -64.1 -43.78 94.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.101 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.35 -43.76 85.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.087 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.39 92.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . 0.443 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 67.6 tp60 -64.36 -39.01 93.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.19 -41.19 96.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.91 -35.75 77.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.53 -37.8 85.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.488 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.71 -38.33 90.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.33 -32.66 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.505 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.53 -38.29 89.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.079 0.466 . . . . 1.0 110.251 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.89 -33.99 74.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.12 -45.76 87.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.844 0.313 . . . . 1.0 111.844 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -63.08 -33.14 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.51 -41.94 95.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.567 -0.453 . . . . 1.0 109.977 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.24 -47.92 82.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.626 -0.429 . . . . 1.0 109.854 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.53 -35.62 79.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.016 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.06 84.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.614 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 p -59.56 -47.88 83.81 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -67.51 -44.86 77.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.618 . . . . 1.0 110.47 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.4 mttt -63.64 -41.93 98.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.801 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.57 -51.47 68.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.642 -0.253 . . . . 1.0 111.532 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.68 -42.55 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.176 0.512 . . . . 1.0 109.855 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -70.57 -34.04 71.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -56.14 -50.69 70.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.573 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 32' ' ' GLY . 11.4 pt-20 -67.0 -36.55 82.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.019 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -55.19 87.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.352 . . . . 1.0 110.786 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 127.74 -9.09 6.83 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.498 -0.641 . . . . 1.0 111.498 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.18 143.3 26.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 122.676 -0.308 . . . . 1.0 110.175 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.29 119.04 5.13 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.03 1.82 . . . . 1.0 112.179 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 114.02 12.64 10.91 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.066 -0.813 . . . . 1.0 111.066 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -40.47 165.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.328 . . . . 1.0 110.892 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 61' ' ' TYR . . . -146.49 -86.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.064 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.428 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -72.44 57.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.41 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 tt -63.4 -18.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 1.0 110.423 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -71.86 146.5 47.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.602 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.459 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.1 t80 -83.55 -51.58 0.63 Allowed Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.767 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -59.93 -30.25 91.3 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.492 1.461 . . . . 1.0 112.484 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -88.27 -23.16 23.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.625 0.25 . . . . 1.0 111.003 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.0 -38.71 92.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 1.0 110.111 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -65.73 -38.63 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.494 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.7 92.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.415 . . . . 1.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -60.29 -38.58 84.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -56.26 -31.67 63.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -82.49 -5.42 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 1.0 110.196 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.474 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 49.5 tt0 -108.76 33.45 4.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.239 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -39.27 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.48 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -25.48 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.47 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 54' ' ' THR . 45.8 p -85.65 -2.13 57.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 53' ' ' THR . 48.5 p 53.27 73.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.118 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.27 -53.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.779 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.07 63.51 4.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.62 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 1.0 110.583 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 60' ' ' ARG . . . 161.95 -87.66 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' CG ' HH22 ' B' ' 68' ' ' ARG . 10.0 m-20 41.86 -92.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 1.0 110.486 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 mpp_? -115.23 -173.52 2.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.84 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 56.1 p90 -156.08 129.78 4.63 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.355 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.31 169.33 19.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.036 1.824 . . . . 1.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.677 ' CG2' ' H ' ' A' ' 64' ' ' THR . 6.0 p -81.27 -155.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.28 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.677 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 1.3 m -113.76 -64.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.063 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -37.5 -39.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.027 0.442 . . . . 1.0 110.549 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.85 ' O ' ' N ' ' A' ' 68' ' ' ARG . 73.7 mm-40 -135.85 -104.28 0.21 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.524 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -57.17 0.0 OUTLIER Glycine 0 N--CA 1.479 1.516 0 O-C-N 124.563 1.164 . . . . 1.0 114.449 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.85 ' N ' ' O ' ' A' ' 66' ' ' GLU . 58.4 ttm-85 -71.56 -46.94 58.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.113 0.483 . . . . 1.0 109.965 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 66' ' ' GLU . 3.5 tmtp? -60.68 -45.33 94.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.39 -43.43 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.021 -0.672 . . . . 1.0 110.029 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.3 84.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.56 -43.03 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.151 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.5 -35.47 79.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.302 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.17 -48.84 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.137 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.4 ptp -65.07 -37.5 87.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.533 -0.303 . . . . 1.0 110.572 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.45 -42.81 92.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.345 -0.388 . . . . 1.0 110.221 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.19 71.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.642 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -77.29 -38.05 30.26 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.57 -43.79 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.583 0.23 . . . . 1.0 110.624 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.83 -36.6 84.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.202 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.6 -49.71 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.919 0.39 . . . . 1.0 110.631 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.34 -31.04 71.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.252 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -83.88 -26.65 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.986 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.89 -43.76 95.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.881 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.3 m -62.08 -16.56 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.409 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' VAL . 38.0 m -36.49 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.093 0.473 . . . . 1.0 110.444 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -55.72 -57.73 10.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.476 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.96 -32.94 66.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.49 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.8 mm? -69.31 -36.35 76.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -66.76 -55.74 13.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.985 0.422 . . . . 1.0 111.276 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.97 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.4 m-20 -60.36 -48.1 83.22 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.581 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 24.6 p90 -69.49 -28.05 65.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.386 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.04 -45.7 95.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.925 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.08 -22.25 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -44.19 -23.86 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.881 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.527 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.774 0.321 . . . . 1.0 110.979 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' B' ' 5' ' ' GLU . 6.2 p80 -63.66 -29.94 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.79 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' B' ' 4' ' ' HIS . 50.2 tp10 -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.566 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -64.56 -39.22 93.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.61 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -64.09 -40.23 95.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.04 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.51 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.32 -38.36 87.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.28 -40.13 95.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.573 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.32 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.751 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.21 -35.21 79.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 1.0 110.478 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.08 -36.59 84.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.344 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.9 -37.51 87.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.54 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.52 -40.47 96.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.222 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.29 -38.77 92.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.78 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.66 -37.96 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.941 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.68 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.575 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.96 -41.19 91.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.1 mm-40 -57.85 -49.75 75.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.3 -37.01 77.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.202 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.59 -43.59 65.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.206 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -62.59 -40.18 96.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.719 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.29 -33.03 75.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 29' ' ' ALA . 4.4 mptp? -83.99 -50.75 7.72 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.909 -0.317 . . . . 1.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.45 72.79 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.081 -0.247 . . . . 1.0 111.33 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 3.8 p -62.17 -45.63 98.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.325 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.5 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -74.27 -32.02 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.033 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -58.93 -37.85 77.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.51 -37.85 77.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.359 . . . . 1.0 110.918 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -54.6 95.47 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.097 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.441 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 119.27 -7.71 12.53 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.1 22.32 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 122.836 -0.214 . . . . 1.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.58 147.5 31.92 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.03 1.82 . . . . 1.0 112.528 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.78 20.15 70.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.7 56.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 1.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -35.28 0.46 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' B' ' 39' ' ' ILE . 2.6 tt -62.85 -30.63 71.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.87 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.459 ' CG2' ' O ' ' B' ' 39' ' ' ILE . 0.2 OUTLIER -34.48 119.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.655 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.541 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 31.1 t -176.22 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.5 m-85 176.79 -65.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.001 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.1 -38.07 93.1 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.116 1.878 . . . . 1.0 112.228 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.536 ' O ' ' NH2' ' B' ' 60' ' ' ARG . 40.5 p30 -101.88 2.22 37.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.05 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.91 96.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.932 0.396 . . . . 1.0 110.17 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.407 ' O ' ' OG ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -69.66 -31.91 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.713 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.556 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.5 OUTLIER -54.74 -49.83 69.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.514 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.504 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.5 OUTLIER -64.02 -39.56 94.38 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.267 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.504 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.4 p -59.45 -35.72 74.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.203 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -48.26 89.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.538 ' CG ' HH22 ' C' ' 68' ' ' ARG . 14.5 pt-20 -68.9 -30.76 69.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.699 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -62.19 -45.64 92.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.151 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.99 68.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 1.0 111.024 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.415 ' O ' ' OG1' ' B' ' 54' ' ' THR . 47.0 p -86.81 3.8 43.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.68 0.276 . . . . 1.0 110.807 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.9 p 50.37 74.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 1.0 110.583 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -142.11 -57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.52 82.28 0.04 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -61.94 -41.83 98.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.709 0.29 . . . . 1.0 110.967 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.62 9.52 1.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -60.62 -49.18 78.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 1.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.536 ' NH2' ' O ' ' B' ' 43' ' ' ASP . 0.9 OUTLIER -145.09 145.33 31.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.112 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 47.5 p90 -133.68 126.78 19.18 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.63 156.44 63.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.735 1.623 . . . . 1.0 112.282 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.433 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 1.9 t -83.26 -138.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.033 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.401 ' H ' ' CG1' ' B' ' 63' ' ' VAL . 53.9 m -114.27 -39.88 3.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.996 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.608 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.1 tt0 -65.8 -22.9 66.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.904 0.383 . . . . 1.0 110.588 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.35 28.2 0.1 Allowed 'General case' 0 C--O 1.268 2.031 0 CA-C-O 123.513 1.625 . . . . 1.0 109.714 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.19 64.86 1.21 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-N 113.768 -1.56 . . . . 1.0 111.556 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.498 HH22 ' CG ' ' A' ' 59' ' ' ASP . 62.9 ttm-85 -23.41 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.186 0.993 . . . . 1.0 110.866 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -45.8 -21.64 0.14 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 67' ' ' GLY . 64.7 t -63.43 -44.78 99.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.473 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -77.52 -38.43 48.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.281 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.61 -41.75 91.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.79 -44.23 93.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.956 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.0 -45.58 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.245 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.5 mtm -63.02 -43.14 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.725 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -65.35 -38.21 89.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.51 90.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.693 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.21 94.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -43.48 97.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.851 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.6 -43.02 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 1.0 110.62 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.98 -47.36 90.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.283 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -74.34 0.92 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.834 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -103.47 -34.82 8.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.179 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.8 tt -64.24 -39.49 94.07 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.791 -0.363 . . . . 1.0 110.053 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.39 -13.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.304 -0.407 . . . . 1.0 109.977 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.507 ' H ' ' C ' ' B' ' 84' ' ' LEU . 55.2 m -49.33 -43.19 43.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.07 -17.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.79 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 86' ' ' THR . . . -104.13 -19.6 14.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.742 0.306 . . . . 1.0 110.744 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 2.6 mm? -95.31 -46.09 6.88 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.919 0.39 . . . . 1.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.515 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.56 -28.08 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.277 0.56 . . . . 1.0 110.051 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -79.97 -4.15 51.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.68 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.96 -49.77 76.37 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.172 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.4 p90 -70.08 -27.5 64.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.003 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.67 -44.8 99.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.315 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -64.51 -20.2 66.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttp85 -48.72 -40.26 27.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.076 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 6' ' ' ARG . 98.5 m-20 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.737 0.304 . . . . 1.0 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.487 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.1 p80 -40.88 -34.84 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.784 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.55 -37.95 86.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' C' ' 3' ' ' ASP . 83.6 mtp180 -63.79 -36.53 84.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -62.19 -40.32 95.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.17 96.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.5 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.32 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.383 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.12 -36.44 83.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.391 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.85 77.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.199 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.722 0.296 . . . . 1.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.45 -35.76 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 1.0 110.563 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -63.88 -32.84 74.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . 0.478 ' O ' ' CD2' ' C' ' 19' ' ' LEU . 46.6 tp -62.75 -40.61 97.79 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.435 ' O ' ' CG ' ' C' ' 20' ' ' GLU . 88.8 mt-30 -70.6 -25.68 63.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.924 -0.311 . . . . 1.0 111.527 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.44 -44.63 18.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.65 -47.11 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' C' ' 15' ' ' LEU . 2.8 pp -75.25 -26.27 58.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.865 0.364 . . . . 1.0 110.526 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' C' ' 16' ' ' GLN . 3.7 mm-40 -60.35 -48.33 82.19 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.666 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -65.84 -40.35 91.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.833 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -64.86 -33.63 76.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.453 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 22.3 m -56.65 -47.84 78.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.781 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.5 -39.8 92.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.561 -0.455 . . . . 1.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.7 mttt -73.55 -25.15 60.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -61.57 -45.11 95.55 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.071 -0.251 . . . . 1.0 110.684 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 42.7 t -64.82 -46.33 92.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.193 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.63 -33.65 71.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.54 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -56.68 -53.63 55.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.954 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.9 pp20? -71.2 -36.56 71.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 16.6 tpt180 -57.41 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 120.733 0.302 . . . . 1.0 110.765 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.07 -14.8 6.23 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.26 157.11 34.63 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.13 147.66 33.77 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.028 1.819 . . . . 1.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 26.37 48.92 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.14 143.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 1.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.73 -7.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.543 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -120.1 134.38 55.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.298 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 29.8 pt -153.96 -162.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.045 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.494 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 1.0 OUTLIER 59.06 126.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.09 0.471 . . . . 1.0 110.971 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 42.0 m-85 -71.56 -43.44 11.86 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.088 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.8 Cg_endo -59.34 -42.05 52.9 Favored 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 121.554 1.503 . . . . 1.0 112.959 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' C' ' 40' ' ' SER . 28.3 p-10 -84.29 -5.87 59.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.192 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' C' ' 48' ' ' SER . . . -61.73 -43.07 99.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 1.0 110.487 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.45 -35.97 76.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.563 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.416 ' NE1' ' CB ' ' D' ' 68' ' ' ARG . 0.4 OUTLIER -56.51 -36.75 69.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.533 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.415 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.5 OUTLIER -84.82 -28.76 25.88 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.491 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 1.5 m -68.77 -40.09 79.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.685 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' C' ' 50' ' ' GLU . 3.9 p -60.83 -44.85 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.585 -0.28 . . . . 1.0 111.552 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.8 pt-20 -69.76 -33.86 73.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.823 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 70.3 m -62.57 -47.86 82.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.414 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.94 67.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.752 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 59.0 p -95.07 3.28 55.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.835 0.35 . . . . 1.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' C' ' 54' ' ' THR . 17.5 p 53.79 73.66 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.63 -70.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.134 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.73 -58.3 3.44 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 70.76 -48.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.717 0.294 . . . . 1.0 110.976 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 145.24 -9.72 1.74 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 60.8 m-20 -42.93 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 1.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -124.42 154.97 39.64 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.841 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 44.2 p90 -131.24 136.15 28.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.611 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.08 155.3 68.59 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.072 1.848 . . . . 1.0 112.241 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.62 -161.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.149 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.556 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 17.1 p -111.21 -66.23 1.1 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.195 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' C' ' 64' ' ' THR . 83.1 tt0 -37.81 -44.55 0.76 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.859 0.361 . . . . 1.0 110.559 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.89 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.6 mm-40 -121.52 -98.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.32 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.619 1.199 . . . . 1.0 114.438 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.89 ' N ' ' O ' ' C' ' 66' ' ' GLU . 47.7 ttm-85 -67.02 -67.08 0.48 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.892 -0.654 . . . . 1.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' C' ' 68' ' ' ARG . 1.9 mptm? -41.42 -39.42 1.48 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.72 -49.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 119.804 -0.759 . . . . 1.0 111.212 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.38 -50.7 64.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.985 0.422 . . . . 1.0 110.534 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 68' ' ' ARG . 84.2 tt0 -44.39 -44.39 8.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.601 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.69 -41.08 97.1 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.238 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.19 -42.66 94.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.6 mtt -59.1 -42.81 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.83 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -63.25 -41.99 99.13 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.645 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.59 88.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -43.3 96.22 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.104 -0.569 . . . . 1.0 112.1 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.403 HG22 HD13 ' C' ' 79' ' ' ILE . 98.0 mt -63.25 -42.68 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.646 0.26 . . . . 1.0 110.81 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.2 -38.91 84.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.423 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.98 -49.77 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.273 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.43 -41.02 93.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.075 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -65.54 -32.52 74.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 1.0 110.652 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.9 -42.13 98.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.366 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.93 -18.17 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.221 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 90' ' ' ALA . 85.9 m -43.13 -40.46 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 1.0 110.377 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.8 -63.48 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.8 -34.58 28.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 1.0 110.317 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.0 mm? -77.28 -33.42 55.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.11 -36.09 82.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.107 0.479 . . . . 1.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -4.47 37.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.142 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.06 -51.55 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.049 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 19.4 p90 -68.97 -30.03 68.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.82 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.27 -42.22 89.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.443 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -57.28 -23.44 48.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.355 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -43.53 -33.53 1.15 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.856 0.36 . . . . 1.0 110.63 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.577 -179.777 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' D' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.652 0.263 . . . . 1.0 110.75 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' D' ' 2' ' ' ALA . 7.0 t70 80.74 -59.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' D' ' 2' ' ' ALA . 7.5 p80 -78.39 -20.4 51.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.844 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.26 -37.98 84.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.419 . . . . 1.0 110.677 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.2 -38.41 90.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.494 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.86 -40.9 95.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.404 . . . . 1.0 109.912 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.55 96.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.749 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -67.2 -39.1 86.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.531 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -62.94 -38.21 90.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.424 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.91 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.073 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.66 -37.97 88.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 1.0 110.678 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.81 -33.97 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -65.31 -35.97 82.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.628 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.27 -41.57 98.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.372 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.69 -40.62 95.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.018 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.32 -37.4 87.12 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.997 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.87 -39.55 85.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.558 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.24 -40.9 87.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 1.0 109.846 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.448 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.1 mt-10 -60.85 -51.01 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 1.0 110.037 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.85 -32.32 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 109.949 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.69 95.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.1 p -58.69 -41.31 85.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.614 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.98 -32.82 74.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -80.18 -39.3 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.333 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.5 80.07 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.886 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 7.1 p -62.65 -46.87 95.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 10.7 tm-20 -68.17 -42.75 79.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.41 ' C ' ' OE1' ' D' ' 66' ' ' GLU . . . -86.47 71.46 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.815 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 3.1 mm-40 -157.36 -58.39 0.08 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.857 0.361 . . . . 1.0 110.337 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -79.93 124.08 28.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.152 0.501 . . . . 1.0 110.56 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.81 6.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.792 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.76 39.39 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.717 -0.284 . . . . 1.0 110.613 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.12 117.75 4.99 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.592 1.528 . . . . 1.0 112.143 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.18 29.87 8.67 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.04 140.83 52.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 1.0 110.606 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.73 -69.94 0.83 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.89 129.41 40.83 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.902 -0.406 . . . . 1.0 109.902 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -150.41 30.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.542 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -134.25 137.61 44.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.517 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.539 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 22.5 t80 -76.17 -48.17 3.42 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.868 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.9 Cg_endo -58.9 -30.25 92.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.353 1.369 . . . . 1.0 112.096 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.77 -17.43 23.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.191 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.6 91.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.34 . . . . 1.0 110.885 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 10.2 tt -65.02 -40.58 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -60.42 -46.96 88.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.143 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -60.92 -33.63 73.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -66.23 -32.76 74.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.147 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.72 -48.22 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.57 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 16.1 pt-20 -69.57 -31.11 69.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.078 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -61.14 -46.55 90.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.44 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.96 72.89 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.153 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.469 ' C ' ' H ' ' D' ' 55' ' ' VAL . 63.0 p -75.58 0.94 15.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.379 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' D' ' 53' ' ' THR . 36.1 p 53.12 9.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.964 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' D' ' 53' ' ' THR . 10.0 p -64.65 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 1.0 110.604 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.72 55.54 5.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -47.14 87.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 1.0 110.326 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 160.39 -103.32 0.22 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.18 -75.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.713 0.292 . . . . 1.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' D' ' 58' ' ' GLY . 69.5 mtt-85 -141.41 179.74 6.62 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.03 144.32 0.99 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.293 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.59 164.07 36.67 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.429 2.086 . . . . 1.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.418 ' CG1' ' H ' ' D' ' 64' ' ' THR . 3.0 t -94.45 -128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.258 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.418 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 55.4 m -113.96 -55.19 2.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.745 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.2 tt0 -61.68 -18.02 57.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.151 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 37.4 mm-40 -78.83 35.6 0.25 Allowed 'General case' 0 C--O 1.269 2.108 0 CA-C-O 124.025 1.869 . . . . 1.0 108.791 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 36.74 58.68 1.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.014 -1.903 . . . . 1.0 109.477 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.539 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 48.6 ttt85 -26.47 -29.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.365 0.685 . . . . 1.0 111.245 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -56.18 -12.21 1.45 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.069 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' D' ' 67' ' ' GLY . 42.6 t -62.09 -46.36 96.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 C-N-CA 119.414 -0.915 . . . . 1.0 109.745 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.26 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.183 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.02 -42.55 80.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.081 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.42 -42.94 95.78 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.758 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.24 -47.69 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.769 -0.373 . . . . 1.0 111.204 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -63.23 -41.19 99.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.101 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 79.1 tttt -61.65 -40.69 95.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.594 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.74 94.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.837 0.351 . . . . 1.0 110.476 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.94 -40.92 93.56 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.68 -43.79 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 2.6 mp0 -65.52 -43.05 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.75 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.58 -47.23 93.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.89 -0.324 . . . . 1.0 111.116 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -75.29 -8.35 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.836 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -101.19 -30.33 11.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.747 0.308 . . . . 1.0 110.175 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.57 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.0 tt -64.31 -37.32 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.14 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -48.45 -9.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.57 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.4 m -49.38 -41.74 40.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.169 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.478 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -50.52 -19.3 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.529 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.68 -11.78 16.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.811 0.339 . . . . 1.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.0 -45.53 6.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.478 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.434 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.0 -16.27 12.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.111 0.482 . . . . 1.0 110.512 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.3 OUTLIER -96.06 0.33 51.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.2 -27.77 62.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.555 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 5.5 p90 -79.88 -43.74 21.69 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.642 ' CG2' HH11 ' D' ' 95' ' ' ARG . 21.0 m -41.11 -33.39 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.004 -0.543 . . . . 1.0 111.553 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . 0.642 HH11 ' CG2' ' D' ' 94' ' ' VAL . 11.3 mpt_? -50.9 -22.53 2.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' D' ' 97' ' ' GLU . 53.5 ptt85 -54.71 -21.69 11.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' D' ' 96' ' ' ARG . 6.1 mp0 . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.826 0.346 . . . . 1.0 110.586 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 67.3 t0 -131.78 45.75 2.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.496 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.609 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 10.5 p80 -154.87 -42.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.609 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 15.1 pt-20 -65.71 -38.94 90.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -64.86 -37.79 88.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.277 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -65.77 -38.87 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.72 88.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.176 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -64.28 -41.48 96.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.338 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.07 -36.7 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.57 78.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.47 -40.44 91.28 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.14 -35.07 79.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.274 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.37 -34.55 78.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.561 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.41 -39.82 94.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.07 -34.78 75.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.233 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -63.94 -46.28 85.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.29 -36.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 1.0 110.696 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.13 -41.64 97.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 1.0 109.973 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.2 mt-10 -63.78 -42.67 97.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -39.43 79.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.31 -39.76 81.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 78.9 p -51.42 -41.81 61.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -62.67 -47.43 83.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.057 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.33 -42.41 91.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.695 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.12 92.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.802 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.35 -47.02 91.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.456 -0.497 . . . . 1.0 110.155 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.91 -41.49 87.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.172 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.49 62.16 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.744 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -173.91 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -62.13 83.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.982 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.86 5.55 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.92 133.48 22.25 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.69 131.55 13.62 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.908 1.739 . . . . 1.0 112.778 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.14 35.91 86.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.45 129.18 54.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.887 0.375 . . . . 1.0 110.953 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.37 -166.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.215 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 tt 59.35 88.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.969 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.3 tt -136.19 160.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.93 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 1.5 p 79.31 137.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 1.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -64.92 -46.79 75.06 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.235 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.9 Cg_endo -60.32 -31.6 93.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.46 1.44 . . . . 1.0 112.664 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.431 ' H ' ' HG ' ' A' ' 40' ' ' SER . 24.8 m-20 -94.2 -31.07 14.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.672 0.272 . . . . 1.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.92 84.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.329 . . . . 1.0 110.683 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 46' ' ' TRP . 3.5 tt -63.83 -39.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.984 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CE2' ' O ' ' B' ' 64' ' ' THR . 4.8 t-105 -59.31 -46.13 89.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.4 ' CE3' ' N ' ' A' ' 48' ' ' SER . 2.4 t90 -59.93 -39.48 85.67 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.4 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 1.5 t -67.71 65.39 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.676 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.9 t -154.39 -57.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 1.0 110.23 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' CG ' HH12 ' B' ' 68' ' ' ARG . 12.3 pt-20 -66.42 -31.69 72.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -42.93 99.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.108 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 54' ' ' THR . . . -61.01 -36.79 80.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.088 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 p -80.7 16.76 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 32.14 69.25 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.597 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.42 -38.28 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.64 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.12 73.3 0.36 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.661 -0.975 . . . . 1.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 15.4 t80 -60.12 -47.18 86.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 1.0 110.507 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.6 25.76 0.44 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.032 -0.827 . . . . 1.0 111.032 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 32.6 p-10 -63.49 -41.17 98.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.317 . . . . 1.0 110.421 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.51 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 94.2 mtt-85 -151.36 -161.09 1.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.335 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 8.8 p90 -169.88 100.6 0.46 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.525 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.05 165.86 29.88 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.403 1.402 . . . . 1.0 112.399 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.703 ' CG2' ' H ' ' A' ' 64' ' ' THR . 7.8 p -100.25 -159.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 110.05 -0.352 . . . . 1.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.703 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 51.0 m -91.98 -43.9 9.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.586 0.231 . . . . 1.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.636 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' OE2' ' N ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.75 25.1 0.07 Allowed 'General case' 0 C--O 1.265 1.899 0 CA-C-O 124.116 1.913 . . . . 1.0 109.503 178.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.717 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 46.33 67.46 1.36 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.622 -1.627 . . . . 1.0 111.723 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.535 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 59.5 ttm-85 -24.15 -32.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.404 1.102 . . . . 1.0 111.158 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.717 ' N ' ' O ' ' A' ' 67' ' ' GLY . 32.3 mmtp -48.52 -31.09 5.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.55 176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' GLY . 53.9 t -62.83 -49.54 83.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.28 74.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.638 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.85 -35.61 81.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -54.96 -42.85 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.683 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.12 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.374 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 mmt -52.32 -56.76 12.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.378 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -36.87 85.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 1.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.53 -22.06 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.63 -28.45 8.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.01 -43.84 99.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 121.144 -0.222 . . . . 1.0 110.484 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.07 -36.58 84.78 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.275 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 83' ' ' ALA . 74.1 t -67.07 -72.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -51.99 -11.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.162 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . -88.54 -43.8 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.788 0.328 . . . . 1.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.3 tt -63.03 -41.73 99.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.604 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 m -51.8 -8.41 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 84' ' ' LEU . 97.6 m -61.99 -25.8 67.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.275 -0.421 . . . . 1.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.38 -24.76 57.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.308 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.43 -11.32 24.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.859 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -90.78 -45.24 8.94 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.794 0.331 . . . . 1.0 111.416 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.06 -27.01 51.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.932 0.396 . . . . 1.0 110.987 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -4.63 58.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.55 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.13 -45.02 95.33 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.927 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 7.3 p90 -76.58 -27.97 56.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.508 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.85 -40.27 82.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.296 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.82 -23.51 44.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.144 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -41.88 -40.39 2.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.797 0.332 . . . . 1.0 110.853 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.918 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.694 0.283 . . . . 1.0 110.94 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.537 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 13.4 p-80 -78.83 -31.39 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -41.62 90.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -64.34 -40.16 95.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.762 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -65.28 -44.08 89.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.954 0.407 . . . . 1.0 109.921 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.42 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.719 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.76 -40.16 87.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.332 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.02 -39.6 92.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -34.19 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.638 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' B' ' 16' ' ' GLN . 96.6 mt-10 -78.15 -37.81 45.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.59 -45.91 84.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 1.0 110.791 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.94 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.36 -39.99 92.66 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.036 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' B' ' 12' ' ' GLU . 8.4 mp0 -69.93 -28.05 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -62.96 -46.22 88.76 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.3 -31.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.118 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.43 -41.15 93.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.62 -48.14 83.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.11 -34.47 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.151 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -46.2 86.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.251 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.7 p -59.81 -46.62 88.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -61.49 -53.53 55.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.412 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.3 mttm -59.13 -43.9 92.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.008 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.419 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -59.77 -38.19 81.15 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.958 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.68 -44.43 89.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.712 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -83.5 -9.95 58.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.622 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.77 -39.0 90.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 32' ' ' GLY . 9.6 mp0 -68.93 -37.53 78.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 1.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.54 83.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.078 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 127.51 -14.1 6.49 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 111.397 -0.681 . . . . 1.0 111.397 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.81 143.8 27.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 O-C-N 122.795 -0.238 . . . . 1.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.78 157.11 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.054 1.836 . . . . 1.0 112.428 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.98 37.19 64.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.76 21.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.848 0.356 . . . . 1.0 110.566 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.49 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.582 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.451 ' O ' ' OG ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -63.37 -30.14 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.646 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' B' ' 40' ' ' SER . 18.7 tt -38.5 108.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.094 0.473 . . . . 1.0 110.757 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.3 p 163.22 102.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.97 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.543 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -56.43 -47.39 99.01 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.848 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.6 Cg_endo -57.49 -36.86 98.65 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.384 1.389 . . . . 1.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' CZ ' ' B' ' 60' ' ' ARG . 46.7 p30 -100.38 -0.76 37.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.696 0.284 . . . . 1.0 110.984 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.94 89.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.947 0.403 . . . . 1.0 110.525 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -68.82 -40.99 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.694 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -45.5 93.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.408 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.513 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 9.9 t90 -63.59 -42.68 98.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.421 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 31.3 p -65.6 -25.96 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.041 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.77 -25.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -98.37 -9.47 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.996 -0.282 . . . . 1.0 111.178 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -36.18 20.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 1.0 111.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.84 63.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.475 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 67.3 p -83.87 0.2 48.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.661 0.267 . . . . 1.0 110.712 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 26.1 p 51.12 60.3 3.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.516 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.11 -48.13 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.35 76.44 0.18 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . 0.402 ' OH ' ' OD1' ' C' ' 59' ' ' ASP . 13.2 t80 -60.04 -47.78 84.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.808 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.74 24.93 0.58 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 67.9 t0 -62.29 -49.14 76.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.352 . . . . 1.0 110.768 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.512 ' CZ ' ' OD2' ' B' ' 43' ' ' ASP . 91.7 mtt-85 -143.83 -164.44 1.88 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.139 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -150.99 118.96 3.42 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.108 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.25 153.35 71.42 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.366 1.378 . . . . 1.0 112.094 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.59 -169.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.5 ' O ' ' CE2' ' A' ' 46' ' ' TRP . 1.2 m -108.61 -62.56 1.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.993 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -40.16 -28.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 1.0 110.769 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' B' ' 68' ' ' ARG . 94.1 mt-10 -143.87 -101.32 0.12 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.256 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.02 -55.55 0.0 OUTLIER Glycine 0 N--CA 1.479 1.519 0 O-C-N 124.613 1.195 . . . . 1.0 114.223 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.905 ' N ' ' O ' ' B' ' 66' ' ' GLU . 60.4 ttm-85 -66.18 -72.48 0.16 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -42.18 -36.36 1.17 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.66 -46.03 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.809 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -70.93 -45.17 64.7 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.217 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -45.37 -48.63 13.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.064 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -61.75 -44.74 96.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -46.44 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.283 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -61.77 -38.65 88.8 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.97 85.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.325 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.42 -37.05 92.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.96 -43.85 99.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 84' ' ' LEU . 97.8 mt-10 -63.18 -38.8 92.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 1.0 110.456 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.25 -70.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.737 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.86 -14.76 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -96.41 -35.1 11.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.319 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' B' ' 80' ' ' GLU . 5.2 tt -63.53 -40.96 98.38 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.345 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.432 ' C ' ' N ' ' B' ' 87' ' ' ALA . 35.6 m -55.07 -16.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.737 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 33.4 m -44.45 -24.06 0.16 Allowed 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.159 0.504 . . . . 1.0 109.68 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.432 ' N ' ' C ' ' B' ' 85' ' ' VAL . . . -62.33 -45.23 94.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.522 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -12.7 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.673 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.6 mm? -92.49 -25.78 18.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.006 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -67.82 -40.49 83.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.617 . . . . 1.0 109.894 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -16.32 62.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.126 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -43.68 -65.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.138 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' B' ' 94' ' ' VAL . 30.6 p90 -64.16 -47.14 81.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.278 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 66.0 t -37.66 -28.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.713 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . 0.477 ' C ' ' H ' ' B' ' 97' ' ' GLU . 99.8 mtt180 -63.64 -37.57 87.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.902 -0.319 . . . . 1.0 111.4 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 93' ' ' PHE . 44.1 ptt85 -46.75 -15.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 1.0 110.303 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' B' ' 95' ' ' ARG . 43.6 tp10 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.883 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.798 0.332 . . . . 1.0 110.396 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.602 ' H ' ' ND1' ' C' ' 4' ' ' HIS . 6.8 p-80 -68.87 -38.17 79.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.839 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.26 -44.5 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.899 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -65.06 -39.07 92.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.864 0.364 . . . . 1.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -64.19 -41.01 97.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.15 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.39 -42.03 93.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.273 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -63.61 -38.68 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.521 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.49 71.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.66 -39.59 94.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.32 . . . . 1.0 111.009 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -63.41 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.292 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.49 -34.37 78.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.677 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.1 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.77 -39.64 94.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.244 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . 0.595 ' CB ' ' HZ1' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -61.52 -38.79 88.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.304 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.69 -42.67 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.683 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.9 -40.15 92.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.358 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.3 mt-10 -55.2 -54.92 37.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 1.0 110.496 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.41 -37.5 83.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.438 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.43 89.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 95.1 p -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.386 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -65.83 -33.55 76.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.189 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' C' ' 29' ' ' ALA . 53.7 mttp -70.42 -46.61 63.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.59 -50.31 70.43 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.246 0.341 . . . . 1.0 111.446 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.98 -46.77 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.457 -0.497 . . . . 1.0 109.926 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -69.32 -28.59 66.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -51.64 -49.84 61.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.762 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.469 ' CG ' ' H ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -96.78 -99.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 1.0 110.545 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.469 ' H ' ' CG ' ' C' ' 30' ' ' GLU . 30.1 mmm-85 46.71 59.46 3.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.554 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.7 4.81 7.93 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.69 61.14 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.42 120.0 5.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.884 1.723 . . . . 1.0 111.773 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.82 13.61 62.33 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 146.09 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 1.0 110.267 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.8 -30.16 2.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.485 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.19 51.47 2.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 pt -80.0 16.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.751 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.3 t -114.0 126.28 54.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.63 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.499 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 8.1 t80 -78.12 -49.95 1.85 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.923 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 27.6 Cg_endo -60.12 -29.23 88.68 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.388 1.392 . . . . 1.0 112.402 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -89.12 -3.82 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.058 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.44 96.16 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.732 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -65.55 -40.84 89.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.494 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -45.83 90.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.497 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -61.03 -41.35 96.4 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.242 -0.583 . . . . 1.0 109.482 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' C' ' 48' ' ' SER . 39.1 p -72.37 64.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -149.09 -51.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.503 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' C' ' 53' ' ' THR . 18.5 pt-20 -66.65 -32.72 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.936 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -44.05 92.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.969 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.23 -26.46 60.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.753 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 50' ' ' GLU . 62.8 p -87.31 -3.59 59.04 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.847 0.356 . . . . 1.0 110.145 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.7 p 51.7 48.75 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.082 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.73 -28.29 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.254 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.72 59.77 7.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.518 -1.033 . . . . 1.0 110.518 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -48.1 82.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 1.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.13 38.66 0.63 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' C' ' 59' ' ' ASP . 12.8 p-10 -65.27 -40.54 94.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.92 0.39 . . . . 1.0 110.601 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.464 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 30.2 mmt180 -130.4 -161.01 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.118 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.464 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 56.5 m-85 -158.59 75.54 3.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.626 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.16 156.0 66.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.058 1.839 . . . . 1.0 111.997 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.711 ' CG2' ' H ' ' C' ' 64' ' ' THR . 8.6 p -100.97 -155.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.009 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.711 ' H ' ' CG2' ' C' ' 63' ' ' VAL . 34.7 m -89.54 -46.25 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.291 . . . . 1.0 110.638 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' C' ' 67' ' ' GLY . 11.7 tm-20 -44.38 -40.18 5.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' C' ' 68' ' ' ARG . 0.1 OUTLIER -70.17 24.08 0.03 OUTLIER 'General case' 0 C--O 1.266 1.963 0 CA-C-O 123.855 1.788 . . . . 1.0 109.915 178.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.754 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 44.86 66.12 1.56 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 113.984 -1.462 . . . . 1.0 111.615 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.553 ' N ' ' OE2' ' C' ' 66' ' ' GLU . 56.1 ttm-85 -25.4 -28.31 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.17 0.985 . . . . 1.0 111.382 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.8 tppp? -52.04 -26.92 12.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.305 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.1 t -61.75 -47.19 94.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 C-N-CA 119.201 -1.0 . . . . 1.0 110.593 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -39.93 84.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.0 110.634 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.92 -38.28 88.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.721 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.2 -44.46 79.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.256 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.92 -43.76 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.229 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.1 mtt -59.54 -43.56 93.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.953 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.12 -41.34 97.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.64 90.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.834 0.35 . . . . 1.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.42 -41.53 96.39 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.761 -0.536 . . . . 1.0 111.761 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.418 HG23 HD13 ' C' ' 79' ' ' ILE . 97.2 mt -61.62 -43.01 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.599 0.238 . . . . 1.0 110.761 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.56 -43.66 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.545 -0.298 . . . . 1.0 111.143 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.38 -49.23 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.136 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.296 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 1.0 110.468 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.4 tt -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.507 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 98.6 t -49.32 -12.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 1.0 110.491 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.476 ' H ' ' C ' ' C' ' 84' ' ' LEU . 85.9 m -60.82 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.268 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.46 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -59.69 -36.31 76.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.057 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 -38.3 21.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.43 -38.65 87.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.083 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -59.23 -35.45 73.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.021 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -83.0 -4.3 58.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.07 -47.9 81.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.672 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 8.4 p90 -66.87 -39.0 87.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.525 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 95.9 t -43.84 -36.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.511 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.21 -23.12 65.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.647 0.261 . . . . 1.0 111.179 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -57.09 -42.6 81.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.368 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.882 0.373 . . . . 1.0 110.539 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.9 -42.94 99.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.9 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.447 ' H ' ' ND1' ' D' ' 4' ' ' HIS . 9.9 p-80 -73.36 -32.62 64.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.535 -0.302 . . . . 1.0 110.793 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.24 -37.42 87.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 1.0 110.551 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.26 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.47 -36.75 83.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.491 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.06 -37.72 86.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.04 79.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.021 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.24 -36.02 82.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 1.0 110.668 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.29 -38.45 91.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.665 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.36 -33.23 75.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.627 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -62.01 -42.01 98.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 1.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.01 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.965 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -62.25 -42.99 99.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.96 0.41 . . . . 1.0 111.063 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' D' ' 22' ' ' ALA . 96.9 t -63.83 -35.56 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.689 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.6 -41.81 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.679 -0.409 . . . . 1.0 109.922 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' D' ' 23' ' ' SER . 70.6 mm-40 -66.81 -50.46 62.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.543 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.29 -39.8 86.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.379 . . . . 1.0 110.422 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' D' ' 18' ' ' VAL . . . -65.07 -37.51 87.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.598 ' HG ' ' N ' ' D' ' 24' ' ' LYS . 94.5 p -57.38 -45.74 84.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.74 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.598 ' N ' ' HG ' ' D' ' 23' ' ' SER . 1.8 tmtp? -67.93 -35.33 78.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.578 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.75 -46.31 69.17 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.893 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -55.66 -51.83 65.92 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.891 -0.323 . . . . 1.0 111.204 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.62 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -64.55 -39.4 93.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.681 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 1.1 mp0 -68.31 -41.24 81.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.477 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.49 107.75 0.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.009 0.433 . . . . 1.0 110.37 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.61 -13.99 24.96 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.16 144.94 29.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.79 143.63 30.05 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.157 1.905 . . . . 1.0 112.328 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 26.58 70.54 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.41 144.23 57.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 1.0 110.649 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -16.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.554 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 30.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.952 0.406 . . . . 1.0 110.08 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' D' ' 40' ' ' SER . 42.2 pt -77.34 -158.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.445 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.1 t 80.53 -137.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.606 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' D' ' 40' ' ' SER . 5.7 m-85 -168.44 -59.88 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.55 -32.04 95.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.65 1.566 . . . . 1.0 111.95 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' D' ' 44' ' ' ALA . 18.2 p30 -87.75 -22.69 24.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.326 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' D' ' 43' ' ' ASP . . . -64.04 -41.51 97.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.349 . . . . 1.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' D' ' 48' ' ' SER . 8.5 tt -67.65 -41.83 85.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.213 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.89 80.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -62.53 -39.64 94.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.646 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 83.3 p -65.93 -29.47 69.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.773 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.92 -48.61 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.99 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.93 69.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' D' ' 52' ' ' ALA . 28.6 m -90.65 89.09 7.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 1.0 109.838 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 51' ' ' THR . . . 169.44 -23.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.37 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 4.2 p -110.64 29.98 7.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.981 0.419 . . . . 1.0 110.482 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 32.8 p 52.51 70.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -124.12 -66.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.717 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.01 53.13 31.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.429 ' OH ' ' OD1' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -59.9 -48.76 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.321 . . . . 1.0 110.518 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.7 29.72 1.03 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.02 -43.33 99.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -140.93 169.03 18.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.917 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -141.09 111.55 6.62 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.712 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.75 156.2 63.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.747 1.632 . . . . 1.0 112.491 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.444 ' O ' ' OE2' ' D' ' 66' ' ' GLU . 1.8 t -80.06 -142.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.106 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.429 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 26.5 m -113.34 -48.1 2.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.751 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.6 ' C ' ' H ' ' D' ' 67' ' ' GLY . 49.9 tp10 -58.62 -20.77 50.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.095 0.474 . . . . 1.0 109.9 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' D' ' 63' ' ' VAL . 0.6 OUTLIER -75.74 27.52 0.11 Allowed 'General case' 0 C--O 1.265 1.873 0 CA-C-O 123.543 1.64 . . . . 1.0 109.13 178.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.44 61.62 2.41 Favored Glycine 0 C--O 1.211 -1.287 0 CA-C-N 114.066 -1.425 . . . . 1.0 109.989 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 61.0 ttm-85 -25.18 -29.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.486 0.643 . . . . 1.0 111.42 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 72.5 mmtt -56.86 -14.27 3.32 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.659 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.2 t -62.31 -47.32 93.64 Favored 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.55 85.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.29 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.44 -37.77 81.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.141 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.49 -44.05 95.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.647 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.75 -46.57 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.276 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.14 -40.49 94.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.238 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.67 -43.25 99.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.794 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.06 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.537 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.37 -42.85 97.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.641 -0.583 . . . . 1.0 111.641 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.43 -43.4 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.616 0.246 . . . . 1.0 111.237 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.63 -40.96 98.2 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.39 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.09 -48.07 90.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.294 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.35 -5.09 43.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.659 -0.416 . . . . 1.0 110.952 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -97.76 -37.01 10.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.739 0.304 . . . . 1.0 110.407 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.6 tt -62.7 -41.79 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.424 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.36 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.533 ' H ' ' C ' ' D' ' 84' ' ' LEU . 57.7 m -56.88 -20.82 25.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.244 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.73 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.347 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.4 -28.65 28.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.139 0.495 . . . . 1.0 110.062 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.78 -37.76 79.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.784 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE1' ' D' ' 93' ' ' PHE . . . -58.29 -44.68 88.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.259 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -5.79 49.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.209 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.79 -49.73 76.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.895 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -75.23 -28.86 60.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.825 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.47 -44.29 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.265 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -45.13 -28.36 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.99 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -48.79 -30.9 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 1.0 110.502 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.908 -179.322 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.866 0.365 . . . . 1.0 110.494 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -172.14 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.443 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 7.6 p80 -78.12 -24.25 47.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.495 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.9 -35.84 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.42 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.99 -38.91 92.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.085 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.42 -44.1 88.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.011 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.76 -39.15 87.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.256 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -65.46 -41.21 93.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 53.8 tttp -63.93 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.42 -36.04 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.894 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.45 -32.7 72.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -65.22 -37.81 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.424 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 6.6 mp0 -60.91 -42.54 98.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -63.26 -42.39 99.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.737 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.37 -42.12 81.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.568 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -63.71 -40.02 95.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 1.0 111.381 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.4 -36.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.03 -41.16 91.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.34 -47.25 86.1 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.59 -33.2 72.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.158 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -45.7 85.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 77.7 p -60.06 -42.4 94.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -62.57 -60.51 3.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.66 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.16 -43.72 98.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.938 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 30' ' ' GLU . . . -61.15 -40.31 93.38 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.98 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 23' ' ' SER . 55.0 t -63.88 -48.36 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.454 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -72.44 -23.8 61.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.523 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.18 49.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.316 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 26' ' ' ALA . 30.2 mp0 -68.65 -35.83 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -67.54 88.19 0.22 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.893 0.377 . . . . 1.0 110.962 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.65 6.25 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.63 -0.588 . . . . 1.0 111.63 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 154.05 39.49 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.85 150.61 39.16 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.253 1.969 . . . . 1.0 112.205 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 32.53 63.06 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.23 14.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 1.0 110.611 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.75 -65.09 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.628 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 51.0 tp -66.34 78.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.077 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.404 ' O ' ' OG ' ' A' ' 40' ' ' SER . 15.8 tt -121.04 79.56 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 1.0 110.107 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 44' ' ' ALA . 18.1 m -172.02 103.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.836 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.474 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 46.5 t80 -54.87 -50.11 87.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.882 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -60.03 -34.82 94.56 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.417 1.411 . . . . 1.0 112.729 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 60.8 m-20 -92.92 -22.72 19.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.68 -0.236 . . . . 1.0 111.146 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.78 82.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 1.0 110.391 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.452 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.2 tt -60.72 -36.09 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.115 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.479 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -63.07 -46.78 85.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' OH ' ' D' ' 57' ' ' TYR . 2.1 t90 -62.54 -41.22 98.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 45' ' ' ILE . 96.9 p -60.23 -35.8 76.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.074 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.47 -49.36 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.943 0.401 . . . . 1.0 110.733 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -75.64 -23.73 56.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.519 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 95.2 m -62.49 -45.88 91.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.099 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.59 75.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.421 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 55' ' ' VAL . 76.5 p -73.92 -0.94 17.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 53' ' ' THR . 69.1 p 53.33 5.34 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 53' ' ' THR . 7.7 p -66.4 -41.98 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.04 81.08 0.02 OUTLIER Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.441 ' HH ' ' C ' ' B' ' 58' ' ' GLY . 40.7 t80 -60.27 -45.51 93.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.855 0.359 . . . . 1.0 110.593 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.83 16.89 0.96 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.61 -46.18 90.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.944 0.402 . . . . 1.0 110.382 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -141.71 149.77 40.96 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.898 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -118.56 120.89 31.4 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.621 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 154.93 67.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.84 1.693 . . . . 1.0 112.57 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -60.82 -168.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.154 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.537 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 1.5 m -110.29 -62.21 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.101 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -41.63 -31.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.062 0.458 . . . . 1.0 110.425 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.875 ' O ' ' N ' ' A' ' 68' ' ' ARG . 97.2 mt-10 -138.48 -105.83 0.18 Allowed 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.317 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.67 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.478 1.435 0 O-C-N 124.476 1.11 . . . . 1.0 114.438 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.875 ' N ' ' O ' ' A' ' 66' ' ' GLU . 33.7 ttm180 -70.78 -45.44 64.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 66' ' ' GLU . 27.8 tptp -62.39 -40.93 98.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.28 -45.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.82 81.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -49.2 -50.41 38.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.53 -40.63 95.96 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.05 -45.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.222 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.96 -39.67 95.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -60.25 -42.14 94.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.52 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.29 94.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.483 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 -41.53 93.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.55 -43.78 98.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 1.0 110.274 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 84' ' ' LEU . 97.2 mt-10 -65.28 -44.7 87.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.581 -0.447 . . . . 1.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.62 -47.72 90.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.758 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -68.33 -28.95 67.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.981 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.87 -25.46 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.281 . . . . 1.0 110.888 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 80' ' ' GLU . 4.7 tt -63.65 -42.01 98.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.568 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.4 m -49.16 -22.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.253 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 54.0 m -36.55 -24.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.216 0.531 . . . . 1.0 110.566 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -59.57 -41.74 90.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.789 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -78.55 -21.05 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 1.0 110.969 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' A' ' 89' ' ' LEU . 6.7 mp -66.32 -38.54 87.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -67.38 -62.49 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 1.0 111.588 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -46.19 -9.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.321 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' ALA . 83.3 m-20 -58.51 -50.01 75.31 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.831 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 1.9 p90 -69.79 -30.18 67.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.105 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.5 -42.29 87.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.385 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -53.07 -21.45 4.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.704 0.288 . . . . 1.0 111.057 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -54.61 -32.94 59.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.783 0.325 . . . . 1.0 110.616 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.896 -179.523 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 3' ' ' ASP . 5.5 p-10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.704 0.288 . . . . 1.0 110.951 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.609 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.2 p80 -80.57 -32.58 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 1.0 110.501 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -42.87 91.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.009 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -64.95 -39.95 94.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.635 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.84 -40.63 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.973 0.416 . . . . 1.0 110.023 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.72 94.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.659 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -66.25 -37.85 86.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.26 -40.49 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.64 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.76 78.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.912 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.31 -38.84 92.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.415 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.63 -36.4 83.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.257 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -65.68 -33.56 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.07 -42.17 99.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.14 -39.32 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.932 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -61.61 -40.14 93.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 1.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -63.02 -41.82 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' B' ' 23' ' ' SER . 93.2 mt -60.61 -40.87 93.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -48.57 80.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.72 -39.42 84.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.918 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.76 82.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.315 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 19' ' ' LEU . 29.3 m -54.77 -46.59 74.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.445 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -66.54 -41.93 87.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.352 0.596 . . . . 1.0 110.043 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.52 64.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.941 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.82 -43.94 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -63.36 -43.87 96.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.736 -0.666 . . . . 1.0 110.775 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.75 81.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.224 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -88.41 -7.69 56.21 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.751 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -83.59 107.44 16.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.377 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.49 -3.02 53.68 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.535 -0.626 . . . . 1.0 111.535 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.58 149.64 46.84 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 110.25 -0.278 . . . . 1.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.51 142.42 26.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.161 1.907 . . . . 1.0 112.369 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.7 22.7 59.92 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.131 -0.787 . . . . 1.0 111.131 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.33 144.38 54.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.706 0.289 . . . . 1.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.54 -41.9 5.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.472 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.02 74.81 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.021 0.439 . . . . 1.0 110.577 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 pt -102.26 2.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.468 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' B' ' 41' ' ' TYR . 78.6 p -75.33 -120.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.664 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.508 ' N ' ' OG ' ' B' ' 40' ' ' SER . 0.5 OUTLIER 171.5 -58.87 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.125 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -57.91 -31.77 93.45 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.869 1.713 . . . . 1.0 112.576 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.498 ' CG ' ' NH2' ' B' ' 60' ' ' ARG . 3.4 p30 -91.69 0.35 57.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.653 0.263 . . . . 1.0 110.727 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.03 89.61 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.96 0.409 . . . . 1.0 110.233 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -66.7 -42.02 88.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.949 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.571 ' CE2' ' O ' ' C' ' 64' ' ' THR . 6.2 t-105 -60.98 -46.33 91.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.263 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -61.43 -40.43 94.41 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 m -71.91 62.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.411 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.0 -50.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.153 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 56' ' ' GLY . 2.8 pp20? -66.99 -31.58 72.23 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.833 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.505 ' O ' ' SD ' ' B' ' 75' ' ' MET . 0.0 OUTLIER -59.22 -45.93 89.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.796 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -27.17 62.81 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.816 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' B' ' 54' ' ' THR . 31.9 p -89.33 4.52 48.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.641 0.258 . . . . 1.0 110.855 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 54' ' ' THR . 11.7 p 56.34 76.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.611 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -147.0 -82.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.693 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.493 ' N ' ' OE1' ' B' ' 50' ' ' GLU . . . 72.94 77.87 0.56 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -60.97 -45.03 96.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 1.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . 0.441 ' C ' ' HH ' ' A' ' 57' ' ' TYR . . . 138.55 27.62 0.28 Allowed Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.9 -48.27 77.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 1.0 110.861 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' CG ' ' B' ' 43' ' ' ASP . 2.2 mpt_? -114.79 -167.41 1.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.133 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 17.5 t80 -164.32 78.84 1.46 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.599 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.56 156.19 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.531 1.487 . . . . 1.0 111.998 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.463 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 31.8 m -103.78 -149.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 22.3 m -96.81 -38.85 9.7 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.632 -0.258 . . . . 1.0 110.842 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.0 tm-20 -56.19 -35.41 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.1 OUTLIER -74.19 26.82 0.08 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-O 123.768 1.747 . . . . 1.0 109.844 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.66 65.91 1.09 Allowed Glycine 0 C--O 1.217 -0.949 0 CA-C-N 113.62 -1.627 . . . . 1.0 111.449 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.544 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -24.82 -31.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.061 0.931 . . . . 1.0 110.897 -178.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' B' ' 67' ' ' GLY . 60.5 mttp -45.14 -23.85 0.2 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 67' ' ' GLY . 72.5 t -63.57 -47.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 C-N-CA 119.748 -0.781 . . . . 1.0 109.977 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.09 82.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.17 -39.29 92.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.016 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -47.26 -54.66 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.96 -42.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 1.0 111.34 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' B' ' 51' ' ' THR . 5.6 tpp -56.73 -47.97 78.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.493 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.42 -41.07 85.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.537 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.51 74.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.688 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.31 97.81 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.438 -0.665 . . . . 1.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.38 -25.11 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.089 -0.244 . . . . 1.0 111.37 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -72.16 -53.19 13.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 1.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 m -61.66 -47.09 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.355 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -63.63 -38.51 91.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.844 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.62 96.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.568 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' B' ' 86' ' ' THR . 7.2 tt -63.96 -41.74 97.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -51.47 -11.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 70.7 m -60.8 -38.73 86.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -38.91 -62.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.974 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.12 20.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.398 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 86' ' ' THR . 55.7 mt -98.3 -4.11 35.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -93.17 -25.16 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.622 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -4.67 58.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.586 -0.733 . . . . 1.0 110.04 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 92' ' ' ASP . 11.6 p-10 -57.43 -47.98 80.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 8.2 p90 -67.51 -30.79 70.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 1.0 111.308 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.99 -44.38 94.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.366 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -65.91 -21.9 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -58.78 -42.98 90.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.109 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.229 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 1.0 110.735 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 33.2 p80 -54.37 -42.6 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.191 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.6 tt0 -64.52 -34.29 77.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.722 0.296 . . . . 1.0 110.633 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -60.78 -45.68 93.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 1.0 109.916 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.57 -42.88 98.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.072 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.09 94.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.429 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -65.0 -42.62 94.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.01 -35.53 81.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.29 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.87 83.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.85 -36.81 85.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.36 -35.24 80.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 1.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -64.77 -36.32 83.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.538 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.42 -40.94 98.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -59.28 -38.84 81.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -39.69 93.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.804 0.335 . . . . 1.0 111.018 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.19 -33.77 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.75 -41.83 98.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.148 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -62.45 -46.23 89.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.878 -0.415 . . . . 1.0 109.878 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.51 -39.84 77.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.252 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.96 -36.4 83.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 86.6 p -60.0 -46.16 90.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.68 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' C' ' 28' ' ' GLU . 14.8 tmtt? -66.41 -37.18 84.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.508 . . . . 1.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' C' ' 29' ' ' ALA . 14.5 mptt -70.26 -40.99 74.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.481 . . . . 1.0 109.927 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.04 66.81 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.102 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 10.7 p -64.6 -43.15 96.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.07 0.462 . . . . 1.0 109.962 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . 0.526 ' OE1' ' NZ ' ' C' ' 24' ' ' LYS . 82.9 tt0 -66.58 -35.14 79.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.319 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -58.01 -26.9 62.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.84 -37.62 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -70.85 101.58 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.745 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . 0.444 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 125.96 -22.53 6.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.64 143.93 27.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 97.4 Cg_endo -75.87 138.73 21.34 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.976 1.784 . . . . 1.0 112.391 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 37.07 13.08 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.02 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 1.0 110.64 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -149.32 -39.95 0.15 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 40' ' ' SER . 0.5 OUTLIER -71.45 12.49 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.021 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.527 ' H ' ' C ' ' C' ' 37' ' ' ALA . 21.3 tt -46.5 -13.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.535 ' H ' ' C ' ' C' ' 38' ' ' LEU . 5.4 m -65.5 146.17 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.316 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.441 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 9.8 m-85 -102.36 -63.66 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 24.4 Cg_endo -59.35 -34.89 97.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.884 1.722 . . . . 1.0 112.256 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -83.54 -7.56 59.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.203 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.1 89.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.749 0.309 . . . . 1.0 110.917 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 9.9 tt -64.05 -32.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.578 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -46.43 87.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.314 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 14.0 t90 -62.05 -40.0 94.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.354 -0.538 . . . . 1.0 109.775 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -59.17 -36.74 75.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.126 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.23 -48.22 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.418 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.0 pt-20 -72.3 -26.82 62.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.459 -0.496 . . . . 1.0 110.949 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 94.4 m -63.47 -50.11 70.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.548 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.08 64.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.136 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.499 ' C ' ' H ' ' C' ' 55' ' ' VAL . 39.3 p -88.44 -0.07 56.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' C' ' 53' ' ' THR . 18.7 p 55.88 6.06 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.671 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' C' ' 53' ' ' THR . 64.2 t -64.89 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.89 58.08 6.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.395 -1.082 . . . . 1.0 110.395 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 1.7 t80 -59.99 -48.83 80.08 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 164.31 -99.74 0.17 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . 0.444 ' OD1' ' NE ' ' C' ' 60' ' ' ARG . 44.4 t0 51.58 -80.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 1.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' C' ' 58' ' ' GLY . 12.9 mmt180 -118.64 -167.99 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.47 ' CE1' ' CB ' ' C' ' 37' ' ' ALA . 26.2 p90 -160.1 129.49 3.24 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.644 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.69 161.86 44.27 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.802 1.668 . . . . 1.0 111.976 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 0.5 OUTLIER -86.45 -152.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.003 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.571 ' O ' ' CE2' ' B' ' 46' ' ' TRP . 19.6 m -112.15 -73.28 0.68 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' C' ' 64' ' ' THR . 78.9 tt0 -32.17 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.15 0.5 . . . . 1.0 111.125 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 78.1 mm-40 -138.96 -101.62 0.17 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.524 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.58 -56.07 0.0 OUTLIER Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.792 1.308 . . . . 1.0 114.415 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.9 ttm-85 -71.41 -70.19 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.282 -0.459 . . . . 1.0 110.28 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -46.1 -38.39 8.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.39 -44.77 86.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.262 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.83 82.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.055 0.455 . . . . 1.0 110.07 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -48.89 -48.89 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -65.59 -39.31 91.46 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.524 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.66 -45.68 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.39 -40.67 97.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.927 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -61.62 -38.15 86.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.708 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.34 83.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.348 . . . . 1.0 110.39 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.45 -42.2 89.59 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.08 -43.15 95.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 1.0 110.72 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.5 -42.38 95.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.01 -48.37 86.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.1 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -66.01 -39.88 90.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.069 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -71.18 -28.18 64.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.847 0.356 . . . . 1.0 110.773 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.4 tt -63.93 -38.96 92.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.711 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 1.8 m -51.97 -4.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.82 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.59 ' H ' ' C ' ' C' ' 84' ' ' LEU . 53.3 m -49.28 -38.9 28.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.936 0.398 . . . . 1.0 109.974 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -47.47 -18.31 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.461 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' C' ' 86' ' ' THR . . . -105.85 -14.07 15.33 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.725 0.297 . . . . 1.0 110.797 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' C' ' 86' ' ' THR . 86.7 mt -84.93 -51.84 6.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.587 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -56.91 -46.86 81.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.064 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.6 OUTLIER -77.63 -4.43 45.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.503 -179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -56.86 -48.59 77.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.451 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 14.6 p90 -73.42 -40.09 64.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . 0.49 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 92.6 t -43.56 -27.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.732 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -60.87 -22.82 64.66 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.905 -0.318 . . . . 1.0 111.247 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -63.09 -37.38 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 1.0 110.591 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.698 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.996 0.427 . . . . 1.0 110.622 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.42 -39.78 95.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.751 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.485 ' NE2' HH21 ' D' ' 95' ' ' ARG . 56.4 p-80 -60.02 -46.15 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.056 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.437 ' N ' ' CG ' ' D' ' 4' ' ' HIS . 81.3 tt0 -62.87 -39.43 94.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.862 0.363 . . . . 1.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -63.12 -40.71 98.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.455 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -60.19 -39.82 87.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.966 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.45 99.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.711 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -66.2 -38.67 88.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -62.62 -34.88 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.627 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.95 74.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -36.8 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.506 -0.315 . . . . 1.0 110.732 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.54 -33.21 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.416 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -40.97 97.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -53.14 -42.93 66.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.356 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -62.15 -38.98 91.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.42 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.48 -44.03 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.673 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . 0.407 ' CD1' ' C ' ' D' ' 19' ' ' LEU . 0.3 OUTLIER -61.17 -46.75 89.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.18 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.48 -27.93 69.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.33 88.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.15 -40.65 94.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.152 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -62.78 -34.01 76.36 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.374 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -85.93 -44.24 12.54 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.607 -0.269 . . . . 1.0 110.994 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.85 68.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.281 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 4.6 p -60.12 -46.87 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.829 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 44.6 tp10 -69.24 -41.24 77.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.696 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.56 -24.89 50.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.24 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' D' ' 32' ' ' GLY . 30.9 mm-40 -97.32 -39.73 9.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.0 111.203 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -59.82 79.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.159 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 128.86 21.85 1.33 Allowed Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.531 -0.628 . . . . 1.0 111.531 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.92 153.37 40.16 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 110.289 -0.263 . . . . 1.0 110.289 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . 0.553 ' C ' ' H ' ' D' ' 36' ' ' ALA . 79.2 Cg_endo -74.55 139.22 25.27 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.101 1.867 . . . . 1.0 111.904 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 69.82 -23.87 0.41 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' D' ' 34' ' ' PRO . . . 43.03 -170.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 1.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.43 -48.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -116.35 119.68 36.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.121 0.486 . . . . 1.0 110.278 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' D' ' 40' ' ' SER . 37.3 pt -141.72 169.12 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 78.99 137.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.55 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -72.81 -46.42 8.98 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.852 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.2 Cg_endo -59.11 -30.77 94.08 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.571 1.514 . . . . 1.0 112.234 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.537 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.4 m-20 -91.65 -33.96 14.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.87 76.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.845 0.355 . . . . 1.0 110.752 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 tt -64.26 -36.72 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.373 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . 0.547 ' C ' HH11 ' A' ' 68' ' ' ARG . 0.4 OUTLIER -65.02 -46.02 83.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . 0.501 ' CB ' HH21 ' D' ' 60' ' ' ARG . 2.1 t90 -62.05 -38.32 88.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 1.5 m -61.82 -37.82 85.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.822 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.71 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 120.75 0.31 . . . . 1.0 110.991 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.45 -34.16 75.48 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.005 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -61.96 -46.54 88.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.556 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.56 69.28 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.424 ' O ' ' OG1' ' D' ' 54' ' ' THR . 66.5 p -90.05 4.44 50.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.369 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' D' ' 53' ' ' THR . 27.5 p 52.82 69.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -133.41 -59.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 71.85 -59.15 1.35 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.534 ' OH ' ' CD1' ' A' ' 47' ' ' TRP . 0.5 OUTLIER 70.77 -37.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 1.0 110.538 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 117.07 11.11 9.27 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -61.42 -52.2 65.59 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.353 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.688 ' NH2' HH12 ' A' ' 68' ' ' ARG . 0.1 OUTLIER -145.78 144.27 30.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.762 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 13.2 p90 -136.95 122.54 13.09 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.56 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.18 -171.19 0.56 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.983 1.789 . . . . 1.0 111.898 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.597 ' CG2' ' H ' ' D' ' 64' ' ' THR . 8.3 p -122.26 -179.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.597 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 97.1 m -62.3 -44.97 95.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.042 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' D' ' 67' ' ' GLY . 64.2 tt0 -52.2 -31.24 30.87 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.273 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -74.27 15.76 0.3 Allowed 'General case' 0 C--O 1.255 1.387 0 CA-C-O 124.482 2.087 . . . . 1.0 107.958 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.75 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 48.44 61.33 5.15 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 49.2 ttt85 -25.3 -27.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.535 0.668 . . . . 1.0 111.254 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.1 tptm -53.66 -21.93 7.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' D' ' 67' ' ' GLY . 75.7 t -60.54 -44.43 96.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 119.979 -0.688 . . . . 1.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . 0.522 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -68.69 -48.02 64.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.982 0.42 . . . . 1.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.41 -64.29 0.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.832 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' D' ' 74' ' ' VAL . 10.3 pt20 -54.43 -43.25 71.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' D' ' 73' ' ' GLN . 86.7 t -61.56 -48.15 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.687 -0.405 . . . . 1.0 111.176 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mtp -63.71 -38.07 89.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.462 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 32.0 ttmt -58.81 -42.25 88.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.568 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.19 89.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 1.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.49 -41.11 90.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.34 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.099 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 3.2 mp0 -67.65 -40.8 84.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 1.0 110.751 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.2 -47.61 91.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.283 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.66 -9.31 58.06 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.622 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.42 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -96.34 -29.63 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.071 -0.344 . . . . 1.0 110.071 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.3 tt -63.3 -42.88 99.09 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.243 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.04 -6.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.856 0.36 . . . . 1.0 110.163 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.52 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -60.66 -20.07 59.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.293 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.66 22.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.668 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.61 -39.11 93.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.2 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.22 -40.87 96.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.038 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.532 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -64.91 -37.19 86.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.266 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.524 ' OG1' ' CG ' ' C' ' 93' ' ' PHE . 1.0 OUTLIER -78.61 -4.75 50.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.108 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.01 -52.09 66.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.212 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 10.4 p90 -63.9 -32.23 73.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.51 -42.3 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.327 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' D' ' 4' ' ' HIS . 95.7 mtt-85 -56.68 -24.29 47.88 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.113 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -8.71 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 1.0 110.146 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' D' ' 95' ' ' ARG . 72.1 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.245 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.705 0.288 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 t70 68.92 -37.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.767 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 20.7 p80 -66.64 -40.27 88.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.792 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 17.5 pt-20 -65.67 -36.32 83.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.42 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -39.63 94.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.42 -35.33 80.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.222 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.53 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.974 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.61 -37.25 86.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.293 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.41 -38.78 90.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.733 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.72 86.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.31 -38.26 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.415 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.76 -34.16 77.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.343 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.83 -33.93 76.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.33 -42.31 99.28 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.528 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.38 -40.12 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.212 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.03 -42.5 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.0 110.81 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.88 -41.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.448 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.87 -41.31 91.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.245 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' A' ' 23' ' ' SER . 80.7 mm-40 -61.47 -46.57 89.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.914 0.388 . . . . 1.0 110.0 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.68 -35.2 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.73 88.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 78.1 p -59.93 -43.71 94.76 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -66.46 -36.58 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.369 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.32 -46.51 60.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.33 -0.548 . . . . 1.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.52 76.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 7.4 p -62.49 -46.25 96.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.085 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 47.2 tp10 -66.4 -43.27 86.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.47 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.69 94.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -73.23 -34.14 65.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.799 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -66.92 121.55 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 1.0 110.601 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 8.02 63.3 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.09 140.97 25.82 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.081 1.854 . . . . 1.0 111.982 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 6.91 60.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.58 106.49 0.05 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.863 0.363 . . . . 1.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.91 -29.83 21.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD1' HH11 ' A' ' 60' ' ' ARG . 42.3 tp -101.16 78.26 1.89 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.381 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.3 pt -103.75 31.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.308 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -126.17 121.71 33.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.985 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.452 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 18.4 t80 -74.74 -52.02 3.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.632 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.6 Cg_endo -59.94 -30.66 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.343 1.362 . . . . 1.0 112.434 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.62 -3.73 54.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.576 0.227 . . . . 1.0 111.054 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.1 -40.06 92.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 45' ' ' ILE . 7.6 tt -66.69 -32.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.291 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.401 ' NE1' ' CB ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -58.84 -45.72 89.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.174 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -73.42 -24.45 60.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -70.15 -41.61 73.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.359 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' HH12 ' B' ' 68' ' ' ARG . 68.2 t -60.74 -47.93 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.83 0.348 . . . . 1.0 110.911 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.7 pt-20 -67.29 -31.19 71.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 89.3 m -61.34 -46.37 90.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.534 -0.466 . . . . 1.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.61 61.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.547 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.524 ' HG1' ' CG1' ' A' ' 55' ' ' VAL . 44.6 p -86.08 7.34 25.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p 40.13 33.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.262 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.524 ' CG1' ' HG1' ' A' ' 53' ' ' THR . 11.3 p -95.83 -45.25 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.803 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.43 ' N ' ' CG1' ' A' ' 55' ' ' VAL . . . 49.38 83.72 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -46.76 89.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.755 0.312 . . . . 1.0 110.667 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.43 3.72 2.36 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.26 -50.61 72.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.0 110.507 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.528 HH11 ' CD1' ' A' ' 38' ' ' LEU . 1.4 mtt-85 -136.15 149.86 48.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -141.87 130.6 12.12 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.503 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 -172.07 0.72 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.932 1.755 . . . . 1.0 112.215 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.644 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.8 p -130.39 -144.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.046 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.644 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 79.1 m -105.04 -41.45 5.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.669 0.271 . . . . 1.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.598 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.4 tp10 -60.82 -38.81 86.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.015 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -74.61 34.54 0.1 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 124.495 2.093 . . . . 1.0 109.943 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.71 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.19 62.52 1.51 Allowed Glycine 0 C--O 1.213 -1.214 0 CA-C-N 113.323 -1.762 . . . . 1.0 110.833 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.474 ' HE ' ' CG ' ' D' ' 50' ' ' GLU . 58.6 ttt85 -25.08 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 117.698 0.749 . . . . 1.0 110.927 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.71 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.5 mmtt -48.72 -16.38 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.005 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' GLY . 48.6 t -60.42 -45.47 96.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 119.096 -1.041 . . . . 1.0 110.08 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.27 79.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.643 0.259 . . . . 1.0 111.523 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 72' ' ' GLU . 1.5 mp0 -58.21 -43.04 87.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.052 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.33 -42.52 98.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.271 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.99 -45.15 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.117 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.427 ' SD ' ' CG1' ' D' ' 55' ' ' VAL . 76.1 mtm -62.03 -40.13 94.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.564 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -41.58 98.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.229 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.5 77.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.426 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.97 -40.49 97.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 1.0 110.696 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.35 -7.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.501 0.191 . . . . 1.0 111.385 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -96.08 -51.32 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.833 0.349 . . . . 1.0 110.872 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -50.56 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -65.03 -40.58 95.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.809 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.01 -37.23 86.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.724 0.297 . . . . 1.0 110.977 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 86' ' ' THR . 3.6 tp -62.59 -44.94 95.06 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.905 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.4 t -54.38 -3.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.414 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 84' ' ' LEU . 45.4 m -58.58 -42.1 87.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.84 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -41.44 -63.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.115 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.94 85.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.295 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.87 -43.94 97.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -66.12 -34.2 77.52 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.199 0.523 . . . . 1.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -76.19 -3.64 37.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.414 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.27 -48.94 77.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.434 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.0 p90 -65.47 -36.05 82.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 1.0 111.387 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.525 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -49.44 -28.78 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.229 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -71.52 -21.36 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.593 -0.276 . . . . 1.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' NH2' ' OE2' ' A' ' 97' ' ' GLU . 19.0 ptt-85 -50.91 -40.67 57.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.398 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.509 ' OE2' ' NH2' ' A' ' 96' ' ' ARG . 97.5 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.686 0.279 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.523 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 25.4 p-80 -73.51 -31.24 63.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.673 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.02 -39.26 90.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.87 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -64.89 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.653 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.41 -43.73 88.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.5 95.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.52 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.84 -40.11 83.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.358 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.33 -34.55 78.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.75 72.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.34 -36.52 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.46 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.7 -36.27 83.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.0 110.347 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -65.22 -33.08 75.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.403 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.17 -41.67 98.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.554 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.98 -38.92 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.767 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.89 -39.65 92.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 1.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.07 -42.76 97.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.696 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.54 -41.05 93.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.445 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.7 mm-40 -59.12 -47.89 83.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 1.0 109.887 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.13 -38.36 78.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.787 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.42 90.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 88.0 p -55.44 -43.55 75.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.234 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.58 -35.33 80.51 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.321 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -72.87 -43.41 62.59 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.196 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' B' ' 30' ' ' GLU . . . -59.27 -50.93 72.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.383 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 9.3 p -62.69 -46.47 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.55 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 45.4 tp10 -67.48 -43.97 79.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.796 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.71 82.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.329 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 26' ' ' ALA . 17.6 mm-40 -64.77 -40.27 94.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.749 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -64.43 131.49 47.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.354 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.14 1.87 81.24 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.24 146.84 33.51 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.82 -0.223 . . . . 1.0 110.438 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.56 142.46 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.322 2.015 . . . . 1.0 112.327 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.75 19.59 69.49 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.38 81.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 1.0 110.604 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.06 69.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.511 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.417 ' CD2' ' C ' ' B' ' 38' ' ' LEU . 6.3 tt -89.81 119.12 29.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.27 0.557 . . . . 1.0 110.176 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' B' ' 40' ' ' SER . 39.1 pt -143.11 168.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.326 -0.852 . . . . 1.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.1 t 78.78 129.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.0 111.012 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 22.4 t80 -72.76 -46.78 9.13 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.026 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 26.0 Cg_endo -58.61 -31.13 93.98 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.358 1.372 . . . . 1.0 112.94 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -96.61 -11.79 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.869 0.366 . . . . 1.0 110.655 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.66 91.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.274 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.03 -30.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.024 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.468 ' CZ2' ' CB ' ' C' ' 68' ' ' ARG . 7.7 t90 -59.99 -49.36 77.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.869 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.3 OUTLIER -68.29 -34.05 75.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.303 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . 0.449 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.3 p -67.69 54.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.706 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -147.22 -52.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.654 -0.248 . . . . 1.0 110.77 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.425 ' O ' ' OG1' ' B' ' 53' ' ' THR . 17.4 pt-20 -66.71 -32.8 74.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 1.0 110.613 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -45.15 82.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.145 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -26.3 60.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.028 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 51.0 p -88.21 -1.43 58.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.694 0.283 . . . . 1.0 110.795 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.6 p 51.68 64.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 m -133.66 -47.9 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.58 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.21 82.08 0.02 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.19 -42.0 98.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.707 0.289 . . . . 1.0 111.084 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.5 0.47 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.318 -0.713 . . . . 1.0 111.318 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' C' ' 61' ' ' TYR . 96.7 m-20 -48.05 -66.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 1.0 110.658 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -138.39 161.09 37.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.978 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -146.92 138.14 13.03 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.91 -172.33 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.815 1.677 . . . . 1.0 112.081 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.442 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 1.9 t -128.84 -143.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.019 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.429 ' H ' ' CG1' ' B' ' 63' ' ' VAL . 4.3 m -110.96 -42.04 4.08 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.664 0.269 . . . . 1.0 110.934 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.2 tp10 -66.2 -34.4 77.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.442 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.44 33.63 0.11 Allowed 'General case' 0 C--O 1.266 1.959 0 CA-C-O 123.961 1.838 . . . . 1.0 109.744 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.72 63.29 1.04 Allowed Glycine 0 C--O 1.214 -1.146 0 CA-C-N 113.393 -1.73 . . . . 1.0 111.175 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.489 HH12 ' CG1' ' A' ' 49' ' ' VAL . 59.6 ttp85 -23.57 -33.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.151 0.975 . . . . 1.0 110.763 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.7 mttp -48.29 -17.79 0.17 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' B' ' 67' ' ' GLY . 52.2 t -61.65 -49.29 84.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.97 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.94 64.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.5 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.28 -41.76 76.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.029 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.76 -43.02 99.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.307 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.94 -46.89 92.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.62 -43.33 99.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.637 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -65.43 -42.53 92.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.156 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.86 93.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.15 -42.41 94.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.0 -43.75 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.704 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' B' ' 84' ' ' LEU . 81.0 mm-40 -59.01 -45.58 90.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.429 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.46 -49.09 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -70.89 -22.77 62.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.582 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.2 -22.29 19.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.301 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' B' ' 80' ' ' GLU . 6.8 tt -63.98 -40.85 97.31 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.723 0.297 . . . . 1.0 110.206 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' B' ' 87' ' ' ALA . 11.1 m -50.58 -27.85 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.749 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.415 ' C ' ' O ' ' B' ' 85' ' ' VAL . 15.6 m -33.36 -31.19 0.01 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.449 0.642 . . . . 1.0 110.016 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -52.82 -57.35 10.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.651 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -65.02 -33.81 76.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.153 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.04 -44.28 94.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 1.0 109.986 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.87 -19.25 60.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.925 -0.58 . . . . 1.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' THR . . . . . 0.534 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -98.82 -11.06 22.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.485 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.9 m-20 -62.56 -40.99 98.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.417 ' CD2' ' CB ' ' C' ' 90' ' ' ALA . 1.7 p90 -71.34 -29.27 64.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' B' ' 96' ' ' ARG . 91.4 t -60.8 -43.9 96.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.773 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -40.98 -22.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.679 0.276 . . . . 1.0 111.311 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' B' ' 94' ' ' VAL . 44.7 ptt85 -62.95 -37.25 86.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.874 -179.518 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' C' ' 4' ' ' HIS . 42.3 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.873 0.368 . . . . 1.0 110.383 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 19.2 p80 -67.55 -38.94 84.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . 0.597 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.4 tt0 -63.11 -36.64 84.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.645 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.16 -40.23 95.29 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.136 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.62 -40.86 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.78 94.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.354 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.36 -32.54 74.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.366 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.23 -24.26 63.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.341 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.71 -54.2 21.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.806 0.336 . . . . 1.0 111.643 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.79 -30.51 70.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.28 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.8 -37.45 87.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.705 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.53 -36.9 85.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 1.0 110.192 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.66 -32.5 73.85 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.443 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.43 -47.47 81.81 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -64.93 -32.44 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 1.0 111.053 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.17 -40.67 90.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.893 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.417 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -60.96 -43.55 98.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.77 -33.11 73.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.124 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.39 97.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.647 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 77.4 p -61.67 -38.77 89.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.514 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -64.58 -74.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.301 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.64 -33.04 6.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.565 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.37 -52.56 61.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.471 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -39.67 83.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.29 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -67.09 -32.43 73.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.877 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.01 -39.57 69.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.198 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' C' ' 38' ' ' LEU . 4.3 mt-10 -95.13 -136.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.61 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' C' ' 39' ' ' ILE . 35.6 mmt180 58.82 57.64 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.115 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.33 11.16 2.27 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.861 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.72 147.61 35.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.87 147.15 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.275 1.983 . . . . 1.0 111.921 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.0 14.81 61.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 141.67 57.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.706 0.289 . . . . 1.0 110.475 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.22 -21.81 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.567 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.0 tt -107.66 85.37 2.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.981 0.42 . . . . 1.0 109.917 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.525 ' O ' ' NH1' ' C' ' 31' ' ' ARG . 39.6 pt -114.37 35.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -134.52 140.9 46.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.767 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.448 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 16.9 t80 -85.3 -52.06 0.5 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.95 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.76 -32.37 95.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.394 1.396 . . . . 1.0 112.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.87 -3.76 57.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.622 -0.263 . . . . 1.0 111.101 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.89 94.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 1.0 110.639 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.435 ' O ' ' OG ' ' C' ' 48' ' ' SER . 8.3 tt -66.04 -32.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -46.74 84.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.754 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' C' ' 48' ' ' SER . 0.1 OUTLIER -66.25 -29.93 70.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.457 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 50.4 p -70.07 -9.3 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.973 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . 0.444 ' C ' ' H ' ' C' ' 51' ' ' THR . 25.6 t -90.3 -48.77 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.147 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.07 32.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.483 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' THR . . . . . 0.444 ' H ' ' C ' ' C' ' 49' ' ' VAL . 10.2 t -133.89 -41.05 0.84 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.504 0.193 . . . . 1.0 111.273 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.416 ' N ' ' CG2' ' C' ' 51' ' ' THR . . . -66.16 -14.82 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.053 -0.259 . . . . 1.0 110.771 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' C' ' 54' ' ' THR . 71.0 p -98.96 8.4 45.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.937 0.399 . . . . 1.0 110.235 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.9 p 53.83 45.37 27.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.975 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.79 -44.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.739 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.29 73.26 0.27 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -44.28 96.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.599 0.237 . . . . 1.0 110.398 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.04 10.85 7.25 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.66 -49.24 78.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 1.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -147.72 162.11 39.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.846 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 t80 -163.77 136.48 4.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.39 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.75 161.4 46.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.727 1.618 . . . . 1.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' C' ' 66' ' ' GLU . 3.0 t -110.33 165.89 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.019 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 67' ' ' GLY . 21.5 m -41.17 -66.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.178 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -46.65 -17.74 0.05 Allowed 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 63' ' ' VAL . 18.0 mt-10 -101.01 27.57 5.95 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-O 124.481 2.086 . . . . 1.0 109.24 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . 0.661 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 39.27 64.11 1.02 Allowed Glycine 0 C--O 1.219 -0.819 0 CA-C-N 113.26 -1.791 . . . . 1.0 111.597 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 70' ' ' VAL . 0.3 OUTLIER -24.43 -37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.054 0.927 . . . . 1.0 110.186 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.661 ' N ' ' O ' ' C' ' 67' ' ' GLY . 99.0 mttt -43.24 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.46 -1.245 . . . . 1.0 109.758 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.7 t -60.51 -46.77 94.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 118.718 -1.193 . . . . 1.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.62 -45.67 51.55 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.769 0.319 . . . . 1.0 111.707 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.58 -42.01 99.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.106 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -58.03 -49.47 76.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.285 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.24 -43.4 84.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.391 . . . . 1.0 111.253 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 48.2 ttm -59.48 -40.07 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.728 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -60.77 -38.46 85.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.739 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.96 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.692 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.61 -39.74 97.0 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.173 -0.537 . . . . 1.0 111.834 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . 0.411 HD13 HG23 ' C' ' 79' ' ' ILE . 93.9 mt -62.64 -42.97 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.774 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.85 -40.27 96.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.68 -48.07 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.364 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -75.76 -8.08 55.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.343 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.53 -45.07 10.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.853 0.359 . . . . 1.0 110.446 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' C' ' 86' ' ' THR . 7.0 tt -63.21 -42.85 99.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.689 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.82 -11.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.667 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' THR . . . . . 0.456 ' H ' ' C ' ' C' ' 84' ' ' LEU . 25.4 m -63.76 -25.4 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.81 -28.57 61.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.376 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.51 -13.28 34.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.3 -32.69 22.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.072 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.83 -37.89 89.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.587 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.59 -6.0 37.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.033 -0.53 . . . . 1.0 109.949 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.21 -43.9 96.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -84.62 -28.15 26.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.561 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.47 -42.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -51.83 -21.9 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.223 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . 0.455 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 24.0 ptt-85 -50.6 -44.79 57.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.591 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 8.4 pt-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.553 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.357 . . . . 1.0 110.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 20.3 p80 -66.7 -40.07 88.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.1 tt0 -62.26 -38.42 89.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.495 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -61.09 -42.35 98.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.291 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.13 -41.13 97.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.47 94.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.807 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.9 -41.39 91.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.864 0.364 . . . . 1.0 110.367 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.81 -33.78 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.506 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.98 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.972 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.81 -36.3 80.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 1.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.02 -37.32 87.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -62.31 -34.83 77.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.234 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.254 -0.579 . . . . 1.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -56.41 -33.92 66.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.366 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.12 -44.69 96.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.596 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -87.37 -37.01 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.654 0.264 . . . . 1.0 111.48 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.9 -47.0 88.39 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . 0.446 ' O ' ' OG ' ' D' ' 23' ' ' SER . 70.5 mm-40 -63.53 -44.75 93.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.294 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -64.2 -29.86 70.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.09 89.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 85.7 p -61.57 -43.76 98.27 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.602 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -64.82 -34.05 77.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.48 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' D' ' 29' ' ' ALA . 44.8 mmtm -78.2 -44.83 24.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.294 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -58.22 -49.14 78.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.43 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 9.1 p -60.07 -45.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.526 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 11.0 tm-20 -68.13 -35.83 78.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.591 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -58.81 -51.96 67.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 14.0 mp0 -69.79 -32.27 70.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.589 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -50.22 103.35 0.05 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.051 0.453 . . . . 1.0 111.049 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.87 11.1 44.44 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.76 140.16 21.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 110.525 -0.176 . . . . 1.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.03 142.27 27.57 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.107 1.871 . . . . 1.0 112.299 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.0 26.42 63.23 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.65 140.91 56.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 1.0 110.791 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.81 -22.84 10.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.712 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' D' ' 30' ' ' GLU . 57.4 tp -104.7 121.1 42.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.925 0.393 . . . . 1.0 109.956 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' D' ' 40' ' ' SER . 34.2 pt -153.48 -164.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.372 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' SER . . . . . 0.452 ' O ' ' O ' ' D' ' 39' ' ' ILE . 1.3 m 58.26 141.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 1.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.412 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 7.1 m-85 -79.83 -58.42 0.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.99 -26.53 81.89 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.584 1.523 . . . . 1.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -87.98 -25.37 23.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.53 94.54 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.693 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.43 -32.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.26 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -47.89 81.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -22.96 53.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.424 ' C ' ' H ' ' D' ' 50' ' ' GLU . 6.7 t -62.21 -44.44 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.721 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.98 4.3 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 1.0 110.898 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . 0.474 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 50.6 mm-40 -103.22 -49.86 3.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.137 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' THR . . . . . 0.451 ' HG1' ' CG1' ' D' ' 74' ' ' VAL . 0.0 OUTLIER -63.67 -45.61 89.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.19 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -23.51 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 1.0 110.085 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 43.4 p -100.45 2.22 41.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.388 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 61.6 p 45.83 70.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.452 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.427 ' CG1' ' SD ' ' A' ' 75' ' ' MET . 30.0 m -117.63 -42.75 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.591 -0.277 . . . . 1.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.16 63.18 4.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -45.51 93.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.692 0.282 . . . . 1.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 -1.64 7.15 Favored Glycine 0 N--CA 1.466 0.648 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.63 -47.99 83.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.546 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -142.9 151.49 41.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.711 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 27.4 p90 -145.56 137.68 13.33 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.568 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.71 161.69 44.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.253 1.968 . . . . 1.0 112.152 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.713 ' CG2' ' H ' ' D' ' 64' ' ' THR . 8.0 p -104.76 -130.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.0 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.713 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 23.9 m -114.18 -51.33 2.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.636 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.7 tt0 -57.11 -30.51 64.43 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.603 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.1 pm0 -70.66 19.43 0.05 OUTLIER 'General case' 0 C--O 1.264 1.83 0 CA-C-O 123.651 1.691 . . . . 1.0 109.4 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.64 62.19 2.99 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' D' ' 67' ' ' GLY . 59.5 ttm-85 -26.22 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.831 0.816 . . . . 1.0 110.631 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' D' ' 67' ' ' GLY . 65.0 mttm -51.02 -24.14 3.53 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.525 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.603 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.7 t -63.17 -48.4 87.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 119.769 -0.772 . . . . 1.0 110.362 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.58 -37.07 76.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.657 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -64.05 -40.46 96.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.089 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -61.43 -47.38 86.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.672 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' HG1' ' D' ' 51' ' ' THR . 7.2 p -66.96 -36.35 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.309 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mtm -62.54 -42.7 99.7 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.092 -0.243 . . . . 1.0 111.438 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.48 -41.64 96.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.657 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.81 95.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.506 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.44 -41.73 97.89 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.22 -43.33 98.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -63.46 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.563 -0.289 . . . . 1.0 111.132 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.27 -50.37 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.261 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.48 -39.86 85.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 1.0 110.476 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.552 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' D' ' 86' ' ' THR . 4.3 tt -60.92 -40.01 91.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.274 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 97.9 t -48.49 -10.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 1.0 110.389 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' D' ' 84' ' ' LEU . 22.6 m -49.28 -39.25 30.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.093 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -49.96 -17.94 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.392 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' D' ' 92' ' ' ASP . . . -104.87 -12.2 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.737 0.303 . . . . 1.0 110.252 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.5 mt -87.54 -64.73 1.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.36 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.13 -9.49 1.46 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.275 0.559 . . . . 1.0 109.944 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' D' ' 87' ' ' ALA . 0.5 OUTLIER -99.54 -1.12 39.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.44 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' D' ' 88' ' ' ALA . 97.5 m-20 -74.57 -39.17 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.658 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 30.7 p90 -84.86 -40.39 17.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 21.2 m -43.34 -36.72 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.8 0.333 . . . . 1.0 111.401 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -57.14 -27.53 61.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.453 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -39.93 -35.98 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.676 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.39 -179.914 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.061 0 CA-C-O 120.857 0.36 . . . . 1.0 110.71 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.06 -45.56 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.544 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 4.0 p80 -67.3 -41.5 85.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.502 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.67 -46.02 87.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.705 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.05 -38.11 89.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.61 -38.22 90.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.197 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.52 94.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.233 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.03 -38.63 91.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.343 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.26 -41.68 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.82 85.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.996 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.91 -40.38 94.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.621 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.96 -38.15 87.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.447 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -65.6 -32.0 73.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.446 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.1 -44.81 95.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.826 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -60.69 -36.0 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.306 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.74 -40.77 96.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.087 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.25 -31.37 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.665 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.68 -42.12 98.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.14 -51.33 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.84 -37.46 86.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.204 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.35 83.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.69 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.94 -55.1 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.612 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.68 -23.1 39.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.965 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.45 -50.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.929 0.395 . . . . 1.0 110.396 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.33 -42.32 93.03 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.604 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -34.73 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -78.98 -114.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 45.55 78.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.88 0.372 . . . . 1.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -6.76 41.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.12 136.14 57.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.295 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.24 140.96 25.4 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.971 1.781 . . . . 1.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . 64.27 22.13 66.97 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -60.96 -48.07 83.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.789 0.328 . . . . 1.0 110.758 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 58.89 0.6 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.697 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 36' ' ' ALA . 5.1 tt -131.48 114.59 15.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.78 0.324 . . . . 1.0 110.15 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.5 pt -157.96 54.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.122 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -153.48 118.19 5.0 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.856 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.481 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 47.6 m-85 -55.37 -50.33 87.36 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.119 -0.491 . . . . 1.0 112.028 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 28.8 Cg_endo -59.72 -34.08 96.22 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.546 1.497 . . . . 1.0 112.6 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -92.52 -8.11 45.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.676 0.274 . . . . 1.0 110.82 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.14 94.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.0 110.386 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 46' ' ' TRP . 4.0 tt -69.41 -41.86 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.152 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.417 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 3.3 t-105 -55.35 -43.13 74.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -66.16 -38.46 88.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.05 -24.58 67.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.249 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.03 -49.76 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.605 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -75.35 -24.02 57.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.462 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 m -62.5 -45.76 91.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.529 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 54' ' ' THR . . . -62.13 -35.21 78.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.618 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 p -75.41 4.14 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 52' ' ' ALA . 18.7 p 41.5 73.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 1.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.05 -36.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.851 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.95 76.37 0.08 OUTLIER Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 1.0 110.745 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.52 17.67 0.2 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -63.42 -42.26 98.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 1.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mmt180 -127.98 -170.48 2.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 51.4 m-85 -162.18 88.51 1.44 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.002 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.37 156.14 65.24 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.905 1.737 . . . . 1.0 112.221 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.647 ' CG2' ' H ' ' A' ' 64' ' ' THR . 7.4 p -128.16 -171.77 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.221 0.534 . . . . 1.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.647 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 98.9 m -69.44 -43.85 72.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.8 tp10 -48.1 -49.52 31.54 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -80.79 35.55 0.37 Allowed 'General case' 0 C--O 1.258 1.511 0 CA-C-O 123.989 1.852 . . . . 1.0 109.242 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.52 66.67 0.92 Allowed Glycine 0 C--O 1.212 -1.22 0 CA-C-N 113.303 -1.771 . . . . 1.0 112.085 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' CG ' ' D' ' 59' ' ' ASP . 58.4 ttm-85 -24.24 -32.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.33 1.065 . . . . 1.0 111.15 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 67' ' ' GLY . 9.0 mtmp? -53.2 -16.48 1.25 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.81 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.2 t -63.36 -46.94 94.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 120.049 -0.661 . . . . 1.0 110.574 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -44.4 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.081 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -56.95 -43.29 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.349 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.2 -41.99 85.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.864 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.36 -45.13 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.177 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.45 -40.24 93.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.756 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -60.48 -42.63 96.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.321 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.82 82.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.492 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -39.15 93.21 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.727 -0.949 . . . . 1.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.11 -26.65 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.864 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.55 -51.83 13.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 1.0 111.2 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -61.41 -48.98 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.097 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.43 -41.65 96.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.992 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.462 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.65 -36.94 85.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.801 -0.359 . . . . 1.0 111.051 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.2 tt -63.41 -37.42 87.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.356 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.2 t -45.45 -14.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.482 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' LEU . 41.1 m -51.08 -44.25 61.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 1.0 110.058 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.83 -21.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.69 -20.62 13.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.921 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 86' ' ' THR . 41.9 mt -84.98 -43.18 14.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.772 0.32 . . . . 1.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -59.29 -38.2 79.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.036 0.446 . . . . 1.0 110.87 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -65.67 -11.78 47.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.283 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.61 -49.8 76.36 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.16 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 11.3 p90 -75.53 -22.54 57.0 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.813 0.34 . . . . 1.0 111.282 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.37 -43.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.194 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.82 -20.84 59.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -53.64 -42.66 68.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.467 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.848 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.778 0.323 . . . . 1.0 110.766 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.5 p80 -78.49 -23.57 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.45 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.72 -39.45 88.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.743 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.35 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.666 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.36 -41.17 96.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.0 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 99.3 mm-40 -65.7 -38.19 88.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -61.85 -37.48 84.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.53 71.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.881 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.81 -38.76 92.31 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.554 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' B' ' 9' ' ' GLN . 1.1 mp0 -65.71 -34.82 79.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.315 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.47 -38.54 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.37 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.78 -42.08 99.54 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.376 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.443 ' O ' ' OE2' ' B' ' 20' ' ' GLU . 76.3 mm-40 -63.86 -40.04 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -59.05 -42.1 89.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 1.0 110.612 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' B' ' 22' ' ' ALA . 88.8 t -65.43 -40.84 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.32 -40.94 87.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' B' ' 20' ' ' GLU . 0.3 OUTLIER -59.82 -48.93 79.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -31.01 69.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.992 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' B' ' 18' ' ' VAL . . . -58.81 -44.59 90.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.9 p -59.63 -43.71 93.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.412 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -65.73 -35.48 80.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.42 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.19 -47.13 37.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.794 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.7 82.57 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 9.9 p -62.18 -46.31 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.231 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 83.4 tt0 -67.09 -43.78 81.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.531 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.79 83.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.337 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -70.39 -33.95 71.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.678 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.95 123.96 21.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.53 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.01 0.64 65.83 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.75 140.45 21.09 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 122.833 -0.216 . . . . 1.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.73 149.74 34.22 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.061 1.841 . . . . 1.0 112.623 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.48 2.85 23.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.467 ' O ' ' CG2' ' B' ' 39' ' ' ILE . . . -77.43 83.01 3.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.667 0.27 . . . . 1.0 110.699 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.5 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 1.0 110.506 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' B' ' 39' ' ' ILE . 5.4 tt -58.99 -28.43 66.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.359 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' ILE . . . . . 0.468 ' O ' ' OG ' ' B' ' 40' ' ' SER . 20.4 tt -38.26 100.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.182 0.515 . . . . 1.0 110.793 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' SER . . . . . 0.531 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 59.7 m -171.42 -119.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.645 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.6 m-85 -177.57 -64.88 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.014 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 21.1 Cg_endo -58.5 -33.43 98.0 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.161 1.907 . . . . 1.0 112.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.16 -4.64 51.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.665 -0.243 . . . . 1.0 111.015 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.82 95.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.181 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.76 -37.37 73.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.361 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.612 ' NE1' ' O ' ' C' ' 64' ' ' THR . 2.8 t90 -53.95 -50.99 65.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.711 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.7 t90 -66.15 -38.32 87.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.401 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 65.2 m -55.24 -45.33 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.273 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.89 -46.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLU . . . . . 0.423 ' O ' ' OG1' ' B' ' 53' ' ' THR . 80.0 mm-40 -66.31 -31.71 72.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.6 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 98.2 m -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.157 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.7 -26.3 44.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.723 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' THR . . . . . 0.49 ' C ' ' H ' ' B' ' 55' ' ' VAL . 46.3 p -85.68 -2.25 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 1.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.5 p 57.08 5.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.097 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' B' ' 53' ' ' THR . 7.8 p -64.85 -43.8 96.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.784 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' GLY . . . . . 0.441 ' N ' ' CG1' ' B' ' 55' ' ' VAL . . . 38.55 74.64 0.11 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -59.92 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.663 0.268 . . . . 1.0 110.966 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.53 -0.75 2.26 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.06 -65.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 1.0 110.084 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.28 149.38 36.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 22.8 p90 -139.18 112.53 8.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.46 -171.05 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.49 1.46 . . . . 1.0 111.971 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' VAL . . . . . 0.655 ' CG2' ' H ' ' B' ' 64' ' ' THR . 7.2 p -133.65 -147.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.391 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' THR . . . . . 0.655 ' H ' ' CG2' ' B' ' 63' ' ' VAL . 97.9 m -101.79 -42.8 6.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.256 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' B' ' 67' ' ' GLY . 75.1 tt0 -54.79 -38.24 67.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.284 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -77.56 31.66 0.16 Allowed 'General case' 0 C--O 1.259 1.592 0 CA-C-O 123.788 1.756 . . . . 1.0 109.72 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.59 63.74 1.57 Allowed Glycine 0 C--O 1.212 -1.267 0 CA-C-N 113.659 -1.61 . . . . 1.0 111.629 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' B' ' 67' ' ' GLY . 55.0 ttm-85 -25.28 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.401 1.101 . . . . 1.0 110.579 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' B' ' 67' ' ' GLY . 67.5 mttm -48.49 -18.4 0.23 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.3 -47.82 91.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 119.847 -0.741 . . . . 1.0 109.691 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.36 -38.99 68.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.296 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -49.17 -43.33 41.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -66.64 -41.14 88.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -51.66 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.696 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 22.9 ptp -64.26 -41.01 97.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 1.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.14 -39.28 93.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.442 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.03 80.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 1.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.89 -39.88 58.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.442 -0.663 . . . . 1.0 111.442 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.21 -44.6 99.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 121.112 -0.235 . . . . 1.0 111.483 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.88 -35.29 79.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 1.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' B' ' 83' ' ' ALA . 17.9 t -62.27 -71.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -58.11 -4.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.957 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' B' ' 81' ' ' VAL . . . -97.55 -34.99 10.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.168 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -64.47 -40.79 96.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.211 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 87' ' ' ALA . 14.0 m -58.57 -16.5 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.009 -0.542 . . . . 1.0 109.621 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 52.5 m -42.43 -24.66 0.06 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.078 0.466 . . . . 1.0 109.811 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -62.75 -64.42 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.845 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.6 -24.06 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.2 mm? -87.81 -19.76 27.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.788 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.57 -50.55 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.459 0.647 . . . . 1.0 109.335 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -3.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.236 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' B' ' 90' ' ' ALA . 91.0 m-20 -58.69 -41.87 87.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.866 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 24.3 p90 -70.56 -27.53 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.906 -0.317 . . . . 1.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.79 -43.7 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.512 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.29 -21.35 59.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.932 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -55.09 -41.73 71.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.974 179.92 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' C' ' 3' ' ' ASP . 67.8 t0 . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -80.4 -17.2 52.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.776 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.44 89.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -63.06 -39.41 94.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.0 110.281 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.5 -40.69 89.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.73 92.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.593 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.09 -39.15 89.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.337 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -62.4 -36.74 83.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.291 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.71 80.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -62.82 -40.18 96.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 1.0 111.086 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -65.84 -34.25 77.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.569 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.8 -37.94 88.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.516 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.74 -44.6 96.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.585 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' C' ' 20' ' ' GLU . 85.5 mm-40 -58.48 -32.31 68.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.82 -43.24 93.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 m -87.56 -34.65 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.592 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.49 -49.14 78.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' C' ' 16' ' ' GLN . 3.4 mp0 -61.22 -43.32 99.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.64 -29.34 66.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.473 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.65 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.655 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 12.9 m -56.63 -44.8 81.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.356 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -64.59 -52.15 59.03 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.131 -0.628 . . . . 1.0 109.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.6 mmtt -59.48 -37.92 79.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.435 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.74 -57.74 5.86 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.832 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -64.33 -44.21 97.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.137 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -60.72 -32.81 72.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.15 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -60.77 -29.28 69.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.624 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.2 -44.73 92.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.66 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.03 130.23 41.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.46 -29.75 11.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.234 -0.747 . . . . 1.0 111.234 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.89 144.19 28.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 122.903 -0.174 . . . . 1.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.17 158.71 37.52 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.115 1.877 . . . . 1.0 112.442 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.77 36.9 14.55 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 141.86 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 1.0 110.569 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.4 -44.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.46 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' C' ' 39' ' ' ILE . 6.4 tt -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' C' ' 38' ' ' LEU . 2.6 tp -37.89 116.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.736 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' C' ' 41' ' ' TYR . 17.2 t -177.6 -123.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.306 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' TYR . . . . . 0.541 ' N ' ' OG ' ' C' ' 40' ' ' SER . 0.8 OUTLIER 171.97 -65.58 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.188 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' C' ' 41' ' ' TYR . 23.5 Cg_endo -58.81 -40.16 75.04 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.886 1.724 . . . . 1.0 112.171 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.455 ' CG ' ' HG ' ' C' ' 40' ' ' SER . 8.5 p30 -88.37 -0.22 56.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.31 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.77 87.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 1.0 110.615 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' C' ' 46' ' ' TRP . 20.3 tt -67.18 -41.4 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' NE ' ' D' ' 68' ' ' ARG . 0.0 OUTLIER -52.33 -49.08 64.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.737 -179.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -65.43 -38.55 90.22 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.826 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 9.0 p -62.11 -38.79 90.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.543 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.55 -47.75 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 121.181 -0.208 . . . . 1.0 111.367 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.58 -34.75 77.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.569 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -64.24 -53.7 45.07 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.55 68.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.766 0.317 . . . . 1.0 110.947 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' C' ' 54' ' ' THR . 58.9 p -90.81 3.63 53.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.274 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.4 p 52.06 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.47 -50.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.147 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.3 76.81 0.15 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 26.9 t80 -61.66 -43.21 99.28 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.63 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.14 12.19 5.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.6 -45.54 93.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' C' ' 43' ' ' ASP . 94.1 mtt-85 -138.45 147.99 43.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -115.66 128.88 25.6 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.762 -0.199 . . . . 1.0 110.563 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.55 157.16 61.78 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.029 1.82 . . . . 1.0 112.001 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -176.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' THR . . . . . 0.612 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 67.0 m -89.82 -86.25 0.2 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.643 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' C' ' 64' ' ' THR . 50.7 tp10 -28.19 -84.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.321 0.388 . . . . 1.0 111.097 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.5 mt-10 -60.95 -92.2 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.05 -56.2 0.0 OUTLIER Glycine 0 N--CA 1.478 1.457 0 O-C-N 124.376 1.047 . . . . 1.0 114.571 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 42.9 ttp85 -71.35 -47.75 54.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.289 -0.456 . . . . 1.0 110.402 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' LYS . . . . . 0.657 ' HZ3' HH12 ' C' ' 68' ' ' ARG . 4.5 mptp? -59.85 -41.46 91.46 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.64 -45.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.788 -0.765 . . . . 1.0 111.237 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.23 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.703 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' C' ' 68' ' ' ARG . 15.4 tm-20 -49.42 -40.98 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.836 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -69.25 -42.04 76.14 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.931 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -66.06 -49.48 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.722 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ptp -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.693 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.34 -40.5 96.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.522 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.72 95.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 1.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.31 -41.23 96.77 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.3 -43.06 97.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 1.0 110.852 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.28 -40.6 94.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.265 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.89 -47.02 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.35 -14.62 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.168 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.18 -34.09 19.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 1.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.16 -40.53 90.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.66 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.58 -24.58 29.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.2 t -43.12 -33.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.168 0.509 . . . . 1.0 110.456 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.1 -61.74 1.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.203 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.58 -35.02 39.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.241 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.4 mm? -75.35 -34.81 61.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.777 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -63.5 -36.18 82.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.181 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -4.47 37.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.08 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -54.77 -48.95 72.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.746 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 20.8 p90 -74.83 -9.97 59.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.1 -48.3 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.679 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -65.81 -20.35 66.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.258 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -48.84 -38.8 23.35 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.412 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.278 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.825 0.345 . . . . 1.0 110.474 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -63.75 -40.3 96.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.935 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 4' ' ' HIS . . . . . 0.62 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 2.5 p80 -58.55 -44.92 89.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.587 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.51 -39.6 92.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 1.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -65.06 -39.16 92.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.483 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.14 -37.26 86.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.931 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.76 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.846 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -63.66 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 1.0 110.306 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.98 -39.1 91.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.88 81.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.73 -41.86 87.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 1.0 110.733 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -67.14 -37.92 84.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.93 -34.83 79.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.514 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.26 -40.6 96.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.316 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -60.36 -37.05 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.43 -42.51 92.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.74 0.305 . . . . 1.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.12 -42.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.771 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LEU . . . . . 0.443 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.0 mt -61.13 -42.02 97.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -59.98 -46.15 90.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.341 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.25 -40.28 74.5 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.411 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.42 93.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.06 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 16.5 m -58.54 -45.28 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.091 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' LYS . . . . . 0.48 ' O ' ' OE1' ' D' ' 28' ' ' GLU . 60.9 tttp -60.71 -59.71 4.95 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.282 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.51 -38.86 75.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 1.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' ALA . . . . . 0.402 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -53.76 -36.14 62.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.79 -48.73 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.525 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' D' ' 28' ' ' GLU . 47.6 mp0 -73.29 -38.2 65.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -54.55 30.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.55 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 2.0 mp0 -64.91 -35.13 80.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.576 -0.283 . . . . 1.0 110.523 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.24 128.23 35.8 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.117 0.484 . . . . 1.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.08 -16.36 61.49 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.507 -0.769 . . . . 1.0 111.465 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.27 148.17 46.59 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.78 130.71 13.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.913 1.742 . . . . 1.0 112.396 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 17.88 71.36 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.73 173.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 1.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.42 -40.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.72 121.58 39.8 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 24.1 pt -152.92 54.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -149.9 119.71 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.621 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' TYR . . . . . 0.538 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 8.5 t80 -61.08 -47.99 93.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.62 -31.73 95.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.288 1.325 . . . . 1.0 112.056 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.53 -8.26 38.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.109 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.8 81.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 1.0 110.984 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -64.48 -34.45 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.082 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.06 -44.12 73.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -62.42 -41.52 98.76 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.523 -0.471 . . . . 1.0 109.803 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . 0.437 ' OG ' ' OG ' ' D' ' 23' ' ' SER . 1.2 m -72.01 57.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -145.28 -51.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.725 0.298 . . . . 1.0 110.444 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -66.46 -31.82 72.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -45.25 91.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.358 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.05 87.31 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.118 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' D' ' 53' ' ' THR . 4.0 p -86.0 8.25 21.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.075 0.464 . . . . 1.0 110.322 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 42.8 p 44.03 57.35 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' D' ' 57' ' ' TYR . 1.6 m -140.86 41.53 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.76 88.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' D' ' 55' ' ' VAL . 1.2 t80 -61.74 -44.78 96.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 1.0 110.361 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.27 27.89 0.16 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' ASP . . . . . 0.487 ' CG ' ' NH2' ' A' ' 68' ' ' ARG . 43.3 t0 -63.74 -48.91 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' ARG . . . . . 0.479 ' C ' ' CG ' ' D' ' 61' ' ' TYR . 0.8 OUTLIER -146.13 -178.7 6.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.166 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 1.6 m-85 -150.44 99.6 3.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.072 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.83 147.24 68.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.782 1.655 . . . . 1.0 112.101 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' VAL . . . . . 0.554 ' O ' ' NE1' ' C' ' 46' ' ' TRP . 2.5 t -80.74 -134.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' THR . . . . . 0.438 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 51.7 m -114.56 -54.29 2.59 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.828 0.347 . . . . 1.0 110.559 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.2 tt0 -50.88 -18.33 0.73 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' D' ' 64' ' ' THR . 0.0 OUTLIER -78.06 37.84 0.26 Allowed 'General case' 0 C--O 1.261 1.691 0 CA-C-O 123.793 1.759 . . . . 1.0 108.679 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.83 62.43 3.74 Favored Glycine 0 C--O 1.202 -1.897 0 CA-C-N 113.649 -1.614 . . . . 1.0 109.636 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' ARG . . . . . 0.574 ' NE ' ' CD1' ' C' ' 46' ' ' TRP . 19.0 ttm105 -22.5 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 117.663 0.732 . . . . 1.0 111.681 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.2 mmtt -65.83 -8.29 20.93 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.022 -0.99 . . . . 1.0 109.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' VAL . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 16.5 t -59.79 -47.49 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -76.65 -52.78 9.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.0 0.429 . . . . 1.0 110.359 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -47.9 -41.43 24.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.931 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.14 -48.92 76.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.894 -0.322 . . . . 1.0 111.784 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.82 -43.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.555 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mpp? -61.42 -43.62 98.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.624 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.03 -38.85 89.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.632 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.06 81.5 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.505 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.76 -40.55 58.11 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.37 -44.77 99.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.638 0.236 . . . . 1.0 111.638 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.07 -35.16 77.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.304 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.15 -47.47 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -72.78 -6.61 45.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.836 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ALA . . . . . 0.457 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -97.9 -32.24 11.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.198 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.5 tt -64.15 -41.47 97.17 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.338 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 m -51.31 -10.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' THR . . . . . 0.525 ' H ' ' C ' ' D' ' 84' ' ' LEU . 45.9 m -51.59 -43.07 62.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.062 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -46.02 -19.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -104.76 -17.61 14.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.45 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' D' ' 86' ' ' THR . 39.6 mt -93.27 -46.06 7.55 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -54.34 -30.08 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.705 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.1 OUTLIER -74.88 -11.76 60.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.765 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -53.22 -50.67 64.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.135 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 14.0 p90 -73.19 -11.26 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.652 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.03 -35.93 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.151 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -61.91 -42.52 99.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.137 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -53.54 -30.47 41.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 1.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.058 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.76 149.88 48.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.663 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 6' ' ' ARG . 97.7 m-20 -67.25 -14.27 62.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.525 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.665 ' H ' ' HD1' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -83.76 -35.03 24.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.895 0.379 . . . . 1.0 110.286 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.16 -44.52 88.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.808 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 3' ' ' ASP . 39.0 ptt180 -66.85 -38.51 86.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.247 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.69 -43.14 80.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.289 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.56 -36.93 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.245 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.44 -39.72 94.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.333 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -62.19 -38.82 90.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.28 74.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.972 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.09 -39.47 86.24 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.588 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.43 -33.76 76.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.47 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.78 -36.3 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.596 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.3 tp -62.02 -40.87 97.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 1.0 110.339 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -33.7 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.29 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -60.62 -43.09 97.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.055 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.07 -41.53 93.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.448 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.1 mt -59.37 -41.65 89.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.121 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.34 -49.59 77.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.631 -0.427 . . . . 1.0 109.996 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.37 -38.18 86.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.024 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.83 94.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.752 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.428 ' OG ' ' OG ' ' A' ' 48' ' ' SER . 38.7 m -53.65 -36.35 61.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' VAL . 64.9 tttm -77.57 -78.29 0.14 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.835 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' C ' ' O ' ' A' ' 24' ' ' LYS . 74.0 mmtt -36.19 -35.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.29 87.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.612 -0.435 . . . . 1.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 1.8 m -63.08 -47.8 90.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.201 -0.6 . . . . 1.0 110.564 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.9 tm-20 -70.1 -42.92 72.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.916 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 66' ' ' GLU . . . -59.48 -31.42 69.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.931 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -97.19 -33.05 11.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.605 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 27' ' ' VAL . 23.6 tpt180 -77.55 97.63 5.1 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.286 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 -14.02 7.98 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.88 42.57 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.93 142.72 28.45 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.111 1.874 . . . . 1.0 112.318 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.18 7.69 84.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.021 -0.831 . . . . 1.0 111.021 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.33 147.28 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 1.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.38 10.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' ILE . 6.7 tt -83.8 -71.08 0.52 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.358 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 40' ' ' SER . 45.0 pt 37.51 -162.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 39' ' ' ILE . 4.0 m 55.15 128.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.361 0.601 . . . . 1.0 111.055 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.423 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 23.2 m-85 -77.66 -55.68 1.23 Allowed Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.781 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.4 Cg_endo -60.28 -20.52 62.85 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.701 1.601 . . . . 1.0 112.348 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -89.0 -24.97 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.004 -0.278 . . . . 1.0 110.951 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.85 -37.84 85.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 tp -63.89 -43.51 97.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.36 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.437 ' CD1' ' CG2' ' B' ' 64' ' ' THR . 0.3 OUTLIER -60.13 -42.11 94.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.117 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 18.1 t90 -60.68 -41.95 96.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.428 ' OG ' ' OG ' ' A' ' 23' ' ' SER . 52.9 p -76.64 69.63 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.384 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -152.39 -80.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.047 0.451 . . . . 1.0 110.476 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 57' ' ' TYR . 16.7 pt-20 -60.45 -20.87 61.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.423 ' CG2' ' N ' ' A' ' 52' ' ' ALA . 15.1 t -65.18 -43.73 90.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.137 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' A' ' 54' ' ' THR . . . -56.1 -50.05 72.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.481 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.0 OUTLIER -79.82 37.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.362 0.601 . . . . 1.0 109.437 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 19.2 p 60.28 -117.95 0.8 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.388 -0.824 . . . . 1.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.537 ' N ' ' OG1' ' A' ' 54' ' ' THR . 2.5 t 69.87 -54.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.13 -1.91 88.27 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.567 ' C ' ' H ' ' A' ' 59' ' ' ASP . 3.2 m-85 -90.58 34.49 0.89 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.45 -9.78 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 57' ' ' TYR . 11.6 t0 74.29 9.36 4.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.422 . . . . 1.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -145.08 -162.13 1.44 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 13.2 p90 -167.88 98.32 0.59 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.094 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.99 150.23 77.74 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.453 1.435 . . . . 1.0 112.122 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.724 ' CG2' ' H ' ' A' ' 64' ' ' THR . 14.3 p -87.64 -136.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.724 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 29.7 m -107.19 -44.28 4.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.524 0.33 . . . . 1.0 110.907 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.726 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.0 tt0 -56.17 -41.64 75.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.807 0.337 . . . . 1.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -65.13 24.94 0.02 OUTLIER 'General case' 0 C--O 1.264 1.856 0 CA-C-O 123.625 1.679 . . . . 1.0 109.8 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.726 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 42.97 65.9 1.29 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 117.968 -1.462 . . . . 1.0 111.487 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 56.3 ttm-85 -24.33 -34.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.161 0.981 . . . . 1.0 110.833 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 67' ' ' GLY . 73.4 mmtt -48.15 -19.03 0.24 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.145 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.3 t -61.19 -47.49 93.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 119.662 -0.815 . . . . 1.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.59 -41.8 19.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.854 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -52.71 -48.29 66.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.685 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.87 -40.3 97.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.97 -46.48 96.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.177 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.11 -43.22 99.06 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.99 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.81 -41.06 94.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.61 -36.34 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.386 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.18 -39.56 94.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.07 -43.73 98.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.653 0.263 . . . . 1.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -62.51 -46.17 89.65 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.33 -49.35 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.929 0.395 . . . . 1.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -69.0 -27.88 66.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.905 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -84.54 -28.03 26.94 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.006 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.41 -45.98 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.335 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.4 m -57.41 -18.55 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.361 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.1 m -38.16 -31.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.101 0.477 . . . . 1.0 110.442 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -58.95 -51.1 71.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.338 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -61.88 -29.61 70.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.034 0.445 . . . . 1.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.462 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.8 mm? -70.86 -35.38 72.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -65.73 -50.45 64.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.088 0.47 . . . . 1.0 111.432 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.54 -4.54 0.64 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.714 -179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.445 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.0 m-20 -55.28 -66.08 0.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.305 . . . . 1.0 111.129 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.5 p90 -62.76 -39.61 94.69 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.337 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 70.9 t -43.47 -31.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.55 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.26 -22.1 66.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 1.0 111.345 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.538 HH12 ' HG1' ' B' ' 91' ' ' THR . 29.6 ptt180 -59.95 -34.28 73.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.711 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.43 -41.0 84.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.86 -33.77 74.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.595 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.94 -34.95 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.356 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -60.24 -45.06 94.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.839 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -87.45 -16.12 35.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.36 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.81 19.29 79.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.153 -0.779 . . . . 1.0 111.153 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.074 -0.965 . . . . 1.0 110.614 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.432 ' O ' ' O ' ' B' ' 2' ' ' ALA . 76.5 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.308 -0.626 . . . . 1.0 109.308 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 45.35 -172.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 4' ' ' HIS . 52.7 p-10 -133.16 -26.36 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.726 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 3' ' ' ASP . 15.8 p-80 -83.69 -26.3 29.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.531 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.31 -42.69 87.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -64.28 -42.53 96.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.567 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.2 -40.16 84.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 1.0 109.868 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.88 97.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.729 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.69 -37.95 87.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 1.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.74 -39.48 91.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.76 -36.8 79.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.788 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.68 -36.92 85.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 1.0 110.518 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.289 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -64.08 -37.22 86.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.546 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.89 -41.46 99.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.421 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.45 -38.12 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.791 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.474 ' NZ ' ' OE1' ' B' ' 21' ' ' GLU . 25.8 ttpp -61.07 -43.1 99.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.54 -41.78 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 93.6 mt -59.66 -41.35 90.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.467 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.1 mt-10 -63.06 -44.05 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.474 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 47.8 mt-10 -70.08 -33.96 72.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.023 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' B' ' 26' ' ' ALA . . . -63.6 -39.93 95.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.413 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.1 p -59.3 -43.59 92.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.07 -63.85 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.413 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -59.88 -39.61 85.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.564 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' B' ' 22' ' ' ALA . . . -51.8 -51.38 56.92 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.941 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.99 -47.18 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.141 -0.624 . . . . 1.0 110.943 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -64.37 -39.53 94.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.763 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.11 91.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.453 ' OE1' ' CB ' ' B' ' 36' ' ' ALA . 79.5 mm-40 -67.48 -42.45 82.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.789 0.328 . . . . 1.0 111.16 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -52.62 102.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 1.0 110.805 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 113.3 -9.13 24.62 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.51 138.27 23.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.834 -0.215 . . . . 1.0 110.672 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.59 141.55 25.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.91 1.74 . . . . 1.0 112.341 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.18 26.82 68.13 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -47.16 -58.3 4.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 1.0 110.794 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 70.42 -20.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.383 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' B' ' 36' ' ' ALA . 24.4 tp -110.6 119.51 39.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.1 pt -154.89 168.92 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.627 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.5 OUTLIER 80.22 135.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.0 110.989 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.626 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 4.1 t80 -72.12 -41.82 8.93 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.912 -0.585 . . . . 1.0 111.564 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.626 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.5 Cg_endo -58.22 -32.7 96.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.494 1.463 . . . . 1.0 112.794 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.527 ' CG ' HH12 ' B' ' 60' ' ' ARG . 35.4 p-10 -99.05 -7.45 26.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.54 -44.11 91.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 1.0 110.406 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -64.49 -33.58 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.683 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.404 ' NE1' ' CB ' ' C' ' 68' ' ' ARG . 0.3 OUTLIER -61.17 -46.8 89.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.515 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.404 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.1 OUTLIER -71.01 -28.36 64.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.404 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -68.49 -35.4 77.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.589 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.6 ' CG1' HH12 ' C' ' 68' ' ' ARG . 47.2 t -60.47 -48.4 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.856 0.317 . . . . 1.0 111.856 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.426 ' HB3' HH21 ' C' ' 68' ' ' ARG . 6.3 pt-20 -68.96 -28.84 66.99 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.472 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -62.28 -47.19 85.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.155 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.55 -36.74 69.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.476 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.539 ' C ' ' H ' ' B' ' 55' ' ' VAL . 82.1 p -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' B' ' 53' ' ' THR . 2.7 p 66.09 -6.7 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.302 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.579 ' C ' ' H ' ' B' ' 57' ' ' TYR . 69.5 t -65.33 -47.34 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.922 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 67.43 -34.8 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.579 ' H ' ' C ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER 61.88 -73.08 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.803 0.335 . . . . 1.0 110.604 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 57' ' ' TYR . . . 158.72 29.94 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.69 -62.41 1.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 1.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.527 HH12 ' CG ' ' B' ' 43' ' ' ASP . 81.5 mtm180 -147.43 -170.24 3.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.394 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -173.82 136.72 0.67 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.12 -171.73 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.576 1.518 . . . . 1.0 112.138 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.485 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.0 t -118.06 -135.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.155 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.437 ' CG2' ' CD1' ' A' ' 46' ' ' TRP . 26.2 m -114.39 -37.12 4.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.541 -0.299 . . . . 1.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.651 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.8 tt0 -66.49 -34.1 77.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.509 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.485 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -71.19 32.02 0.05 OUTLIER 'General case' 0 C--O 1.267 2.016 0 CA-C-O 123.709 1.718 . . . . 1.0 109.972 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.98 63.91 1.62 Allowed Glycine 0 C--O 1.214 -1.127 0 CA-C-N 113.916 -1.493 . . . . 1.0 111.14 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' B' ' 67' ' ' GLY . 58.8 ttm-85 -23.95 -33.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.384 1.092 . . . . 1.0 110.91 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 99.0 mttt -48.27 -18.48 0.22 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' B' ' 67' ' ' GLY . 53.6 t -61.93 -46.91 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 C-N-CA 119.953 -0.699 . . . . 1.0 109.754 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -48.16 38.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.457 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.45 -45.11 12.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.275 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.01 -46.93 87.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.686 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.0 -46.01 82.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.456 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.09 -44.12 97.34 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.72 -37.74 85.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.376 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.16 -41.23 96.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.674 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.2 -42.25 94.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.41 HG21 HD12 ' B' ' 79' ' ' ILE . 97.2 mt -62.53 -43.55 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.071 -0.252 . . . . 1.0 111.075 -179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.76 -40.39 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 1.0 110.797 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.07 -46.92 94.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.151 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -74.7 0.79 14.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.018 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -106.31 -37.6 6.49 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -62.98 -39.99 96.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.057 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -52.62 -8.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.005 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.7 m -61.35 -21.54 64.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.54 -23.32 49.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.49 -10.83 18.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.533 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 38.6 mt -99.14 -25.89 14.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.953 0.406 . . . . 1.0 110.293 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -13.55 60.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.891 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.538 ' HG1' HH12 ' A' ' 96' ' ' ARG . 0.1 OUTLIER -100.37 -4.46 29.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.122 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.19 -43.56 98.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.108 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 4.7 p90 -70.5 -32.64 70.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.153 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 61.7 t -61.79 -27.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.711 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.61 -22.98 64.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.441 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -59.49 -37.09 77.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 1.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH2' ' B' ' 100' ' ' ARG . 44.8 tp10 -65.82 -40.11 91.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.986 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.41 -34.78 79.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.468 ' NH2' ' OE2' ' B' ' 97' ' ' GLU . 59.8 ttp180 -60.0 -45.25 93.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 1.0 110.19 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -68.64 -36.89 79.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 84.31 22.68 53.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.437 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 97.5 m-70 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.463 ' CB ' ' NE2' ' C' ' 4' ' ' HIS . . . -82.93 171.33 13.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.837 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -59.38 -46.3 89.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.619 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 4.5 p80 -69.04 -36.55 77.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.644 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.44 -36.32 83.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -62.91 -38.3 90.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.835 0.35 . . . . 1.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.33 -42.22 98.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.021 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.0 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.63 -39.57 93.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.398 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.12 -41.33 98.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.333 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.88 88.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.52 -39.89 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 1.0 111.106 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.69 -34.67 78.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.742 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.44 -36.16 82.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.538 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.3 tp -62.17 -41.21 98.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.345 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.26 -39.15 78.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.23 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.63 -38.48 87.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.852 0.358 . . . . 1.0 110.828 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.8 mt -58.75 -40.52 84.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.672 -0.411 . . . . 1.0 109.944 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.428 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.0 mm-40 -56.94 -45.43 82.79 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.96 -37.1 78.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.033 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.62 -39.52 94.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.415 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 90.2 p -61.41 -35.78 78.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' C' ' 26' ' ' ALA . 88.2 tttt -73.79 -77.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.106 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' C' ' 29' ' ' ALA . 14.6 mptt -38.98 -25.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' C' ' 24' ' ' LYS . . . -64.88 -41.61 95.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.74 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' C' ' 28' ' ' GLU . 1.7 m -63.73 -47.63 90.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.029 0.442 . . . . 1.0 110.366 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.556 ' C ' ' H ' ' C' ' 30' ' ' GLU . 96.8 mt-10 -71.64 -36.58 70.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.428 -0.805 . . . . 1.0 110.365 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' LYS . . . -70.91 29.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.556 ' H ' ' C ' ' C' ' 28' ' ' GLU . 3.6 tp10 -153.46 -38.98 0.1 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.954 0.407 . . . . 1.0 110.283 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -65.36 86.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.065 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.4 20.42 2.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.4 151.49 39.71 Favored Pre-proline 0 N--CA 1.466 0.373 0 O-C-N 122.886 -0.185 . . . . 1.0 110.685 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.55 115.8 4.15 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.167 1.245 . . . . 1.0 111.106 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 82.5 18.08 67.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.259 -0.736 . . . . 1.0 111.259 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . -42.35 167.98 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.919 0.39 . . . . 1.0 110.472 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.95 -30.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.436 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.59 101.31 13.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.104 0.478 . . . . 1.0 110.225 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' C' ' 40' ' ' SER . 42.2 pt -128.83 161.25 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.217 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.8 OUTLIER 80.81 140.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 1.0 110.604 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.602 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 46.0 t80 -79.65 -41.96 1.51 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.188 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.602 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.5 Cg_endo -59.92 -29.9 90.51 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.489 1.459 . . . . 1.0 112.453 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' C' ' 44' ' ' ALA . 2.8 p-10 -93.56 -23.22 18.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.719 0.295 . . . . 1.0 111.198 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' C' ' 43' ' ' ASP . . . -63.55 -33.27 75.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.864 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 3.1 tp -65.38 -41.11 90.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.91 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -61.44 -42.93 99.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.811 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.535 ' NE1' ' OH ' ' B' ' 57' ' ' TYR . 3.7 t90 -59.61 -40.04 86.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' C' ' 51' ' ' THR . 15.5 m -58.27 -33.1 69.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.99 -44.89 92.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.482 ' OE1' ' NH1' ' D' ' 68' ' ' ARG . 9.0 pt-20 -87.51 73.11 9.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.693 0.282 . . . . 1.0 111.289 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' C' ' 48' ' ' SER . 0.6 OUTLIER -177.0 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.171 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.36 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.041 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 2.6 p -92.16 20.5 5.89 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p 57.5 33.5 23.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.873 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 74.2 t -132.5 87.14 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.119 0.485 . . . . 1.0 110.112 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.89 79.14 1.65 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.536 ' CZ ' ' O ' ' D' ' 60' ' ' ARG . 0.8 OUTLIER -60.08 -47.34 86.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.931 0.396 . . . . 1.0 110.523 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 147.31 -85.58 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.729 -0.949 . . . . 1.0 110.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.459 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 92.4 m-20 41.61 -89.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 1.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' C' ' 58' ' ' GLY . 84.2 mtm180 -127.8 150.85 49.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.887 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -153.41 147.51 18.81 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.74 156.94 62.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.254 1.969 . . . . 1.0 112.04 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.22 -132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.157 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.511 ' C ' ' H ' ' C' ' 66' ' ' GLU . 99.4 m -115.3 -56.96 2.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.833 0.349 . . . . 1.0 110.703 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -52.85 -10.08 0.15 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 10.7 mp0 -108.28 47.04 0.92 Allowed 'General case' 0 C--O 1.272 2.261 0 CA-C-O 124.747 2.213 . . . . 1.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 37.4 60.99 1.07 Allowed Glycine 0 C--O 1.218 -0.905 0 CA-C-N 112.432 -2.167 . . . . 1.0 111.128 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.6 HH12 ' CG1' ' B' ' 49' ' ' VAL . 60.9 ttt-85 -25.18 -32.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.738 0.769 . . . . 1.0 111.074 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.718 ' N ' ' O ' ' C' ' 67' ' ' GLY . 52.4 mtmt -55.4 -9.08 0.41 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.702 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.0 t -58.32 -45.64 89.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 118.617 -1.233 . . . . 1.0 110.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.97 38.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 1.0 111.15 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -56.89 -46.02 82.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.067 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.87 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.414 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.12 -44.02 91.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.653 -0.419 . . . . 1.0 111.395 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.14 -41.25 99.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.126 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.99 -35.49 75.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.708 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.46 74.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.357 . . . . 1.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.65 -36.63 88.18 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.07 -44.01 97.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.678 -0.307 . . . . 1.0 110.729 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.76 -43.85 87.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.814 -0.354 . . . . 1.0 111.099 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.0 -48.66 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.517 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -73.98 -14.44 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.084 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.0 -32.14 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 1.0 110.171 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.2 tt -66.45 -39.61 88.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.483 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 3.6 m -47.93 -9.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.055 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' C' ' 84' ' ' LEU . 27.1 m -57.4 -38.88 75.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.411 . . . . 1.0 110.024 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -51.3 -23.25 3.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.088 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.0 -11.54 26.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.85 -49.39 7.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.318 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.37 -13.97 4.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.975 0.417 . . . . 1.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.2 OUTLIER -101.02 -5.37 25.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.165 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.09 -47.85 84.39 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.755 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 36.9 p90 -78.35 -36.62 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.35 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 86.9 t -46.51 -34.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.763 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -62.33 -20.65 64.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.713 0.292 . . . . 1.0 111.242 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 ptt-85 -49.48 -38.96 32.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.51 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.256 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' C' ' 102' ' ' GLY . 97.2 mt-10 -67.6 -36.18 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 1.0 110.327 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.97 -26.37 65.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.563 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -59.72 -44.95 93.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.619 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -108.41 -5.86 16.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.804 0.335 . . . . 1.0 110.614 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' C' ' 98' ' ' GLU . . . 77.8 17.03 79.3 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.603 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' SER . . . . . 0.433 ' O ' ' O ' ' D' ' 2' ' ' ALA . 54.7 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' D' ' 1' ' ' SER . . . 54.05 107.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.451 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -66.8 -21.93 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.657 ' H ' ' ND1' ' D' ' 4' ' ' HIS . 1.0 OUTLIER -65.07 -41.7 94.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.267 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.45 -37.91 88.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.553 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -62.98 -42.53 99.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.354 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.51 -44.98 69.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.47 -43.85 89.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.704 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.41 -38.01 89.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.567 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -39.18 92.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.711 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.99 73.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . 0.409 ' OE2' ' CE1' ' D' ' 82' ' ' PHE . 79.7 mm-40 -65.48 -33.73 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.23 -40.98 97.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.887 0.375 . . . . 1.0 110.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.91 -30.43 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.97 -42.12 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.324 . . . . 1.0 110.486 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -62.23 -40.14 95.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.59 -41.65 92.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt -60.35 -41.77 94.33 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.181 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.9 mt-10 -62.7 -48.12 80.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -69.83 -42.23 73.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 1.0 110.49 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.06 85.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.085 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -58.98 -43.58 91.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.85 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.54 -32.37 73.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.649 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -78.5 -38.26 41.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.849 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.81 75.88 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.166 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.486 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 9.9 p -63.11 -45.15 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 1.0 110.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.486 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 83.7 tt0 -66.26 -42.85 87.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.511 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.44 97.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.279 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -64.98 -32.99 74.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.811 -0.356 . . . . 1.0 110.451 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.02 130.58 41.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.953 0.406 . . . . 1.0 110.454 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.07 -10.38 63.8 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.25 148.98 36.63 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -74.59 137.6 22.94 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.87 1.713 . . . . 1.0 112.208 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.57 74.42 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 138.52 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.979 0.419 . . . . 1.0 110.442 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.84 -30.98 4.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.311 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 tt -97.38 76.39 2.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 1.0 110.166 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -101.97 -2.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.417 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 10.6 p -76.44 148.15 37.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.46 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 0.7 OUTLIER -104.43 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.11 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.459 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.3 Cg_endo -57.98 -31.67 93.4 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.612 1.541 . . . . 1.0 111.744 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.37 -0.79 57.7 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.195 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.7 89.21 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.819 0.343 . . . . 1.0 110.39 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 tt -65.48 -38.39 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.468 178.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.44 -46.45 80.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.064 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -65.47 -38.64 90.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.17 -35.14 80.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.786 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.13 -48.79 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.834 -0.347 . . . . 1.0 110.919 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.451 ' O ' ' OG1' ' D' ' 53' ' ' THR . 13.8 pt-20 -67.78 -29.35 68.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.075 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.4 m -63.04 -44.84 94.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.54 -30.39 70.61 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.139 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.462 ' C ' ' HG1' ' D' ' 54' ' ' THR . 23.2 p -80.76 8.93 7.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.34 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.462 ' HG1' ' C ' ' D' ' 53' ' ' THR . 73.1 p 41.26 70.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.444 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.534 ' C ' ' H ' ' D' ' 57' ' ' TYR . 0.2 OUTLIER -146.78 -42.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.334 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.56 -38.8 0.6 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' D' ' 55' ' ' VAL . 1.6 t80 66.12 -68.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 1.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . 146.0 32.21 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.0 m-20 -85.44 -58.49 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.536 ' O ' ' CZ ' ' C' ' 57' ' ' TYR . 94.1 mtt-85 -141.0 -179.39 6.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -158.01 137.09 8.13 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.697 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.66 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.3 2.0 . . . . 1.0 112.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.424 ' CG1' ' H ' ' D' ' 64' ' ' THR . 2.0 t -89.4 -140.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.814 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.424 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 5.1 m -114.68 -32.54 5.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' D' ' 67' ' ' GLY . 79.9 tt0 -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.926 0.394 . . . . 1.0 110.576 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.413 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.2 OUTLIER -77.49 24.88 0.19 Allowed 'General case' 0 C--O 1.262 1.758 0 CA-C-O 123.715 1.722 . . . . 1.0 109.219 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.87 62.22 3.06 Favored Glycine 0 C--O 1.213 -1.181 0 CA-C-N 113.87 -1.514 . . . . 1.0 109.439 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.482 ' NH1' ' OE1' ' C' ' 50' ' ' GLU . 58.6 ttm-85 -25.21 -30.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.216 0.598 . . . . 1.0 110.985 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.725 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.1 mttp -51.2 -24.63 4.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.351 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' D' ' 67' ' ' GLY . 74.8 t -62.37 -49.47 83.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.039 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -39.29 72.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.476 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -61.35 -37.03 81.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.848 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.01 -41.67 99.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.411 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.43 -43.24 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.267 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 63.4 mtt -58.82 -45.92 88.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.081 -179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -65.58 -38.36 89.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 1.0 110.576 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.0 -40.26 84.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.499 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.67 -39.27 86.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.33 -43.44 97.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.414 -0.463 . . . . 1.0 111.19 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.65 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 m -60.82 -50.31 81.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.457 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . 0.409 ' CE1' ' OE2' ' D' ' 12' ' ' GLU . 24.6 m-85 -66.97 -41.38 86.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.11 78.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.313 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' D' ' 86' ' ' THR . 7.7 tt -61.79 -42.15 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 49.1 t -50.21 -15.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -54.73 -19.5 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.119 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -62.24 -62.97 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.827 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.86 75.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.139 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.06 -47.47 68.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.899 0.38 . . . . 1.0 110.732 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.457 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -61.45 -25.39 67.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 1.3 m -84.01 -3.55 58.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.319 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.62 -46.76 89.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.147 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 9.0 p90 -65.54 -32.29 73.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.615 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.51 -42.74 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.181 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -52.96 -22.12 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -50.42 -37.34 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 1.0 110.459 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.86 -44.87 82.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.876 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . 0.501 ' N ' ' OE1' ' D' ' 98' ' ' GLU . 54.1 mp0 -68.94 -39.01 79.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.917 0.389 . . . . 1.0 110.198 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.52 -37.28 84.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.226 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.46 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 64.5 ttm-85 -64.49 -40.91 96.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.598 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.65 -1.53 32.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . 0.506 ' O ' ' CD2' ' D' ' 103' ' ' HIS . 25.5 p-80 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.103 -0.951 . . . . 1.0 110.761 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.468 ' HG ' HH22 ' A' ' 6' ' ' ARG . 7.3 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . -156.43 24.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 59.54 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 2' ' ' ALA . 31.1 p80 -56.75 -40.2 75.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 1.0 110.663 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 43.7 tt0 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.315 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.468 HH22 ' HG ' ' A' ' 1' ' ' SER . 84.0 mmt-85 -64.43 -38.52 91.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.178 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.04 -40.0 90.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.68 88.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.49 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -62.21 -39.61 93.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.18 -37.67 88.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.422 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.97 79.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.59 -37.8 88.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 1.0 110.524 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -64.75 -35.97 82.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.914 0.387 . . . . 1.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.62 -33.22 75.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.29 -42.0 98.98 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.628 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.34 -37.71 86.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.153 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -61.9 -41.64 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.723 0.297 . . . . 1.0 110.98 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.53 -42.03 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.467 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.0 mt -59.49 -40.94 88.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.055 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.66 -48.59 81.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.684 -0.407 . . . . 1.0 109.935 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.039 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.99 90.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.577 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -59.67 -43.05 94.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.129 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -58.28 -64.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.56 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.97 -37.8 80.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.648 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.94 -49.41 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.861 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.74 -43.18 90.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.526 -0.469 . . . . 1.0 110.179 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -61.33 -42.62 98.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.724 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.46 -53.37 58.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -65.02 -19.58 66.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.157 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -82.53 89.41 6.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.887 -0.325 . . . . 1.0 111.249 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.58 6.12 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 116.192 -0.458 . . . . 1.0 112.012 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.94 144.55 29.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.807 0.304 . . . . 1.0 110.287 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.45 142.03 26.06 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.954 1.77 . . . . 1.0 112.231 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.47 12.14 80.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.1 138.14 57.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 1.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.77 -58.66 1.94 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.612 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.53 99.21 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.976 0.417 . . . . 1.0 110.427 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 pt -135.5 55.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.457 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 3.4 m -156.54 132.66 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.061 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 91.6 m-85 -67.19 -44.22 47.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.578 0.584 . . . . 1.0 112.578 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.5 Cg_endo -60.04 -32.44 94.85 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 121.272 1.315 . . . . 1.0 112.76 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.9 p-10 -99.8 -1.1 38.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 121.017 -0.273 . . . . 1.0 110.948 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.431 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -66.16 -43.78 85.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 1.0 110.495 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 tt -66.69 -38.73 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.653 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -56.52 -46.07 80.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE3' ' N ' ' A' ' 48' ' ' SER . 1.6 t90 -67.36 -39.01 85.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.906 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.472 ' O ' ' CG2' ' A' ' 51' ' ' THR . 1.1 m -55.74 -25.51 40.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.163 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.93 -44.81 78.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.414 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.485 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 99.5 mt-10 -79.7 69.02 5.93 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.408 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -174.65 -46.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.4 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.17 -25.4 65.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.528 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 54' ' ' THR . 33.0 p -92.44 -0.79 57.32 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 53' ' ' THR . 16.5 p 57.14 76.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.207 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.4 t -148.77 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.688 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.4 89.85 0.8 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.546 -0.622 . . . . 1.0 111.546 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -63.93 -42.87 97.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 1.0 110.948 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.76 15.61 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.67 -68.65 0.35 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.638 0.256 . . . . 1.0 110.904 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -134.14 159.49 40.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.13 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' D' ' 57' ' ' TYR . 20.3 t80 -172.34 137.8 0.91 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.46 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.13 -172.63 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.804 1.669 . . . . 1.0 112.013 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' A' ' 64' ' ' THR . 11.1 p -117.75 -121.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.613 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 36.4 m -111.31 -61.77 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.658 0.266 . . . . 1.0 111.098 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.419 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.6 tt0 -49.06 -20.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.149 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 30' ' ' GLU . 44.9 mt-10 -87.87 36.4 0.76 Allowed 'General case' 0 C--O 1.265 1.921 0 CA-C-O 124.433 2.063 . . . . 1.0 109.032 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.65 63.43 1.21 Allowed Glycine 0 C--O 1.212 -1.261 0 CA-C-N 112.937 -1.938 . . . . 1.0 111.11 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.528 HH12 ' CG ' ' D' ' 59' ' ' ASP . 62.2 ttm-85 -24.92 -33.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.025 0.913 . . . . 1.0 111.055 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 67' ' ' GLY . 70.9 mmtt -49.93 -18.27 0.5 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.48 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -62.41 -47.56 92.43 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 119.288 -0.965 . . . . 1.0 110.449 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.62 69.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.307 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.32 -37.96 88.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.823 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.1 -43.99 82.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.848 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -44.57 92.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.41 -41.58 98.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.57 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.35 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.87 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.568 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.84 -42.52 94.99 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 HD12 HG23 ' A' ' 79' ' ' ILE . 96.2 mt -62.4 -43.37 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.627 0.251 . . . . 1.0 110.429 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.71 -43.45 97.81 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.265 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.58 -49.25 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.002 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.37 -13.85 61.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.392 . . . . 1.0 111.086 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.39 -35.54 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 1.0 110.715 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.88 -42.17 97.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ALA . 11.4 m -59.42 -23.14 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.421 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.7 m -36.71 -28.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 1.0 110.624 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.35 -49.01 79.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.269 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -63.48 -32.4 73.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.284 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.476 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 4.2 mm? -66.48 -40.22 89.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.555 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.28 -45.12 84.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.842 0.353 . . . . 1.0 110.955 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.97 -3.22 34.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.258 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.42 -48.65 76.51 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.582 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.8 p90 -73.62 -37.06 65.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 1.0 111.451 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 95.3 t -48.29 -27.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.592 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -66.25 -21.44 66.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.85 -41.6 87.35 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 100' ' ' ARG . 97.2 mt-10 -79.5 -168.34 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.303 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.99 -72.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.817 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttp85 -59.34 -44.62 92.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.556 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -119.04 113.2 20.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.028 0.442 . . . . 1.0 109.857 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 0.27 23.54 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.517 ' ND1' ' OXT' ' A' ' 103' ' ' HIS . 50.1 t-80 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 43.5 -157.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.661 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 67.5 t0 -128.2 -35.59 2.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.657 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.497 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 7.3 p80 -79.3 -22.19 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.532 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.22 -37.81 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.74 -39.85 95.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.15 -40.55 90.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.935 0.398 . . . . 1.0 110.05 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.72 90.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -65.34 -41.26 94.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -63.6 -36.4 83.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.483 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.0 86.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.965 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.03 -37.25 73.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 1.0 110.613 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.3 -32.97 74.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.194 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.18 -39.52 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.389 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.9 tp -61.89 -42.79 99.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.273 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -53.95 -39.75 66.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.97 -37.77 86.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.527 -0.306 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.19 -41.83 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.36 -48.07 83.31 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.456 ' O ' ' OG ' ' B' ' 23' ' ' SER . 81.0 mm-40 -64.68 -41.96 95.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.233 0.539 . . . . 1.0 109.745 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.64 -26.69 68.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.51 87.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.248 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 97.9 p -58.86 -45.36 90.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.556 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.66 -30.75 71.49 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.45 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 29' ' ' ALA . 29.1 mmtp -79.3 -42.88 24.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.45 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.17 -47.99 77.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.441 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.484 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 8.3 p -61.75 -45.88 97.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.509 . . . . 1.0 109.971 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.484 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -71.18 -21.22 62.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -58.49 -40.47 82.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.963 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 27.3 mp0 -65.93 -36.4 83.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 1.0 110.294 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -66.79 90.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.431 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 126.72 -15.31 6.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.28 19.17 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 87.2 Cg_endo -76.42 118.42 4.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.075 1.85 . . . . 1.0 112.235 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.8 37.68 1.13 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.89 143.34 32.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.64 -51.3 0.09 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.232 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' B' ' 39' ' ' ILE . 5.0 tt -60.96 -60.29 4.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.981 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' B' ' 40' ' ' SER . 44.9 pt 31.56 -145.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 123.436 0.46 . . . . 1.0 110.729 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.464 ' O ' ' O ' ' B' ' 39' ' ' ILE . 19.3 m 57.39 144.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.331 0.586 . . . . 1.0 111.162 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.443 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 2.7 m-85 -100.58 -64.37 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.763 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 23.3 Cg_endo -58.85 -23.49 67.53 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.293 1.995 . . . . 1.0 112.432 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -90.76 -21.18 21.67 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.677 0.275 . . . . 1.0 110.697 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.69 88.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.841 0.353 . . . . 1.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -61.8 -36.49 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.216 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.504 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.6 OUTLIER -67.77 -43.16 80.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.421 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.464 ' CD1' ' OE2' ' B' ' 50' ' ' GLU . 19.5 t90 -61.6 -41.6 97.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.731 0.3 . . . . 1.0 110.669 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 m -60.94 -38.11 84.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.475 -0.49 . . . . 1.0 110.581 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.75 -44.41 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.464 ' OE2' ' CD1' ' B' ' 47' ' ' TRP . 5.0 pt-20 -55.78 -38.9 70.52 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.709 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.654 ' C ' ' H ' ' B' ' 53' ' ' THR . 6.0 t -87.34 -152.44 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.216 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 58.94 -9.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.475 0.179 . . . . 1.0 110.663 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.654 ' H ' ' C ' ' B' ' 51' ' ' THR . 67.0 p -113.06 15.32 19.6 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.648 0.261 . . . . 1.0 110.937 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.07 66.5 1.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.916 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' B' ' 56' ' ' GLY . 9.9 p -147.56 -46.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.758 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.471 ' N ' ' CG1' ' B' ' 55' ' ' VAL . . . 44.73 78.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.415 ' OH ' ' OG1' ' C' ' 51' ' ' THR . 0.2 OUTLIER -61.98 -45.23 94.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.681 0.277 . . . . 1.0 110.502 -179.425 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.65 3.63 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.644 -0.983 . . . . 1.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 99.5 m-20 -62.51 -41.43 98.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.363 . . . . 1.0 110.688 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -117.11 -173.17 2.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -139.57 99.4 7.77 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.615 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.12 160.52 48.39 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.375 1.383 . . . . 1.0 112.285 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.482 ' CG1' ' O ' ' B' ' 34' ' ' PRO . 0.9 OUTLIER -79.24 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.588 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 66' ' ' GLU . 1.8 m -115.35 -67.82 0.97 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.288 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' B' ' 32' ' ' GLY . 80.7 tt0 -34.02 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.224 0.535 . . . . 1.0 110.701 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.867 ' O ' ' N ' ' B' ' 68' ' ' ARG . 91.8 mt-10 -147.85 -107.07 0.09 Allowed 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.549 -0.75 . . . . 1.0 109.359 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.06 -56.54 0.0 OUTLIER Glycine 0 N--CA 1.478 1.49 0 O-C-N 124.635 1.209 . . . . 1.0 114.355 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.867 ' N ' ' O ' ' B' ' 66' ' ' GLU . 36.6 ttt180 -72.13 -46.09 57.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -64.16 -34.2 77.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.832 -1.173 . . . . 1.0 107.832 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.71 -44.66 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.96 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.6 76.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.234 -0.439 . . . . 1.0 109.936 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -52.39 -50.47 62.4 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.898 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.47 -48.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.516 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 78.2 mtm -61.52 -47.62 84.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.785 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' B' ' 80' ' ' GLU . 51.6 tttp -66.44 -40.51 89.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.521 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.7 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.78 94.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.55 -43.17 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.001 -0.28 . . . . 1.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -58.59 -47.39 84.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.061 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.84 -50.37 75.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.619 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -67.9 -37.21 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.689 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.03 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.32 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' B' ' 86' ' ' THR . 3.6 tt -61.59 -42.03 98.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.417 ' C ' ' N ' ' B' ' 87' ' ' ALA . 26.2 t -49.09 -21.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.406 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.5 m -48.77 -21.07 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' B' ' 91' ' ' THR . . . -58.55 -54.52 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 1.0 111.024 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.71 89.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.828 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.491 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.0 mm? -63.04 -42.75 99.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.412 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -64.35 -35.74 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.437 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.545 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -82.57 -4.36 57.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.535 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -57.93 -48.75 78.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.57 -178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 10.7 p90 -67.14 -32.44 73.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.008 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.68 -43.71 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.76 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -57.37 -21.62 37.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.487 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -58.97 -33.07 70.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.068 0.461 . . . . 1.0 109.936 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.55 -36.67 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.836 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.34 -41.07 94.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 1.0 110.595 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.17 -39.02 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.17 -44.05 97.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.45 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.29 108.88 14.71 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.97 -0.89 56.35 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.679 179.797 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.39 149.97 46.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.78 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.76 -40.3 94.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.328 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 15.2 p80 -66.83 -37.48 84.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.7 tt0 -62.69 -35.69 80.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.677 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.04 -39.7 95.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.01 -40.15 94.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.323 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.78 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.368 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.25 -36.54 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.371 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.42 -38.69 88.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.35 85.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.11 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.53 -39.49 93.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 1.0 111.011 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -63.55 -38.72 92.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.644 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.98 -32.38 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.28 -38.52 89.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 1.0 110.315 -179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.62 -33.44 74.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.202 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.55 -46.95 83.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.697 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 m -63.86 -37.6 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.81 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.15 -41.87 98.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.279 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.0 mt-10 -64.49 -43.22 94.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.35 -39.41 71.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.313 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.4 84.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.0 p -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.413 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -65.56 -39.93 92.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.236 0.541 . . . . 1.0 109.965 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.2 mttp -66.8 -43.97 82.45 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.054 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -54.39 -53.56 52.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.748 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.12 -44.81 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.66 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -68.34 -33.88 75.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.405 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' C' ' 26' ' ' ALA . 4.5 mp0 -81.79 -13.17 58.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.657 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.74 89.62 0.11 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.842 0.354 . . . . 1.0 110.425 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.08 20.05 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.3 140.47 72.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.26 141.34 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.936 1.758 . . . . 1.0 112.33 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.01 65.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.228 -0.749 . . . . 1.0 111.228 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 134.37 44.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.885 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.41 -22.73 16.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.356 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 tp -107.37 112.15 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.9 pt -139.26 -3.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.263 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -76.36 154.62 34.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.512 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -96.18 -63.17 0.12 Allowed Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.804 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -59.28 -36.12 95.52 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.99 1.794 . . . . 1.0 112.528 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.402 ' O ' ' NH1' ' C' ' 60' ' ' ARG . 90.8 m-20 -81.39 -7.11 59.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.257 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.47 87.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 1.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 16.3 tt -65.5 -38.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.591 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -54.78 -48.82 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.226 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -61.64 -41.18 97.14 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.682 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 2.2 t -68.39 60.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.645 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 73.0 t -150.66 -56.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.085 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -64.36 -30.55 71.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.584 -0.446 . . . . 1.0 110.693 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.415 ' OG1' ' OH ' ' B' ' 57' ' ' TYR . 98.9 m -62.31 -46.62 87.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.25 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.48 -26.31 66.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.66 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' C' ' 54' ' ' THR . 47.3 p -91.21 5.25 49.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.96 0.41 . . . . 1.0 110.076 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 53' ' ' THR . 43.4 p 52.4 74.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 62.1 t -139.24 -68.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.294 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.13 75.23 0.48 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -59.95 -45.98 90.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.69 0.281 . . . . 1.0 110.899 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.43 10.57 1.87 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' D' ' 61' ' ' TYR . 99.4 m-20 -60.02 -46.77 88.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 1.0 110.405 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' C' ' 43' ' ' ASP . 53.6 mtm180 -143.01 166.86 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.02 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -156.65 127.24 3.47 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.599 -0.44 . . . . 1.0 110.542 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.67 152.57 64.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.802 1.668 . . . . 1.0 112.236 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.445 ' C ' ' OE2' ' C' ' 66' ' ' GLU . 2.4 t -84.28 -134.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.24 -0.436 . . . . 1.0 109.949 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.431 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 72.3 m -114.59 -37.97 4.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.734 0.302 . . . . 1.0 110.721 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.608 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.2 tt0 -66.55 -28.2 68.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.469 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.445 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -72.17 26.05 0.05 Allowed 'General case' 0 C--O 1.264 1.82 0 CA-C-O 123.509 1.623 . . . . 1.0 110.36 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.44 64.06 1.93 Allowed Glycine 0 C--O 1.214 -1.095 0 CA-C-O 117.889 -1.506 . . . . 1.0 111.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' B' ' 59' ' ' ASP . 58.9 ttm-85 -24.41 -31.52 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.961 0.881 . . . . 1.0 111.368 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' C' ' 67' ' ' GLY . 14.5 mptt -49.5 -21.53 0.98 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.791 -0.641 . . . . 1.0 109.354 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' C' ' 67' ' ' GLY . 76.8 t -61.72 -49.52 83.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.9 -36.25 69.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.029 0.442 . . . . 1.0 110.696 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.34 -42.09 86.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.913 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.02 -41.1 97.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.086 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.31 -43.6 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.39 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 20.7 mtm -60.9 -44.08 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.125 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.57 -38.41 89.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.59 90.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.668 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.19 95.15 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.714 -0.554 . . . . 1.0 111.714 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.29 -43.14 97.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.51 -0.406 . . . . 1.0 110.982 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.97 -50.37 74.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.809 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 m -61.84 -49.45 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.918 -0.313 . . . . 1.0 111.363 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -69.34 -40.13 77.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.019 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -64.94 -36.09 83.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 1.0 110.614 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.7 tt -62.55 -41.08 98.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.53 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -46.37 -19.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.533 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' C' ' 83' ' ' ALA . 25.9 m -51.94 -40.36 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.469 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -49.35 -27.48 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.243 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.58 -16.63 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.612 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' C' ' 86' ' ' THR . 55.3 mt -87.86 -44.07 11.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.164 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.15 -23.84 50.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.936 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -85.93 -4.42 59.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.898 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.07 -45.27 93.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.698 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.421 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 7.1 p90 -76.03 -28.6 57.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.067 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.81 -42.61 89.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.468 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -55.66 -21.8 19.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.198 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 42.6 ptt85 -50.74 -41.84 56.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 1.0 110.474 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 9.4 tm-20 -62.46 -41.06 98.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.694 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -67.07 -35.7 80.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.65 -27.35 69.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.767 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -59.4 -44.41 92.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.382 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -66.01 -37.8 86.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.307 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.56 64.72 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.04 -0.981 . . . . 1.0 110.455 179.808 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' SER . . . . . 0.665 ' H1 ' HH22 ' D' ' 6' ' ' ARG . 14.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.428 ' O ' ' NH1' ' D' ' 6' ' ' ARG . . . -71.38 130.06 40.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.746 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 16.6 p-10 -77.01 -37.74 54.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.129 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.472 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.3 p80 -65.59 -34.83 79.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.01 -38.84 92.8 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.573 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . 0.665 HH22 ' H1 ' ' D' ' 1' ' ' SER . 84.2 mtt85 -64.24 -38.98 92.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.598 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -66.2 -40.15 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.175 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.85 92.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.772 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.84 -40.43 91.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 1.0 110.56 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.73 -35.66 81.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.516 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.68 79.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.966 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.16 -39.53 94.2 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.683 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.22 -36.44 83.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.65 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -63.99 -36.05 82.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.427 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -62.4 -41.38 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.643 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.86 -44.78 78.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.699 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.4 -40.09 96.28 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.204 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -49.02 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.98 -30.19 62.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.415 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -66.26 -49.92 65.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.669 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.17 -40.42 95.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' D' ' 26' ' ' ALA . . . -65.45 -34.15 77.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.823 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' D' ' 48' ' ' SER . 26.0 m -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.814 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -63.68 -39.07 93.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.46 -0.496 . . . . 1.0 110.036 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.73 -18.25 44.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.135 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -58.6 -50.23 74.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.382 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 28.9 t -65.65 -43.8 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.54 -30.76 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.32 -34.11 71.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.535 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' D' ' 32' ' ' GLY . 79.0 mm-40 -63.83 -46.87 83.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -46.21 95.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.433 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 126.93 -5.7 7.38 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.48 146.52 32.94 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.912 0.356 . . . . 1.0 110.32 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -75.64 117.34 4.73 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.113 1.875 . . . . 1.0 112.49 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' D' ' 37' ' ' ALA . . . 103.52 -22.67 35.23 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.449 ' O ' ' CB ' ' D' ' 37' ' ' ALA . . . 46.93 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.694 0.283 . . . . 1.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' D' ' 35' ' ' GLY . . . 82.44 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -73.07 53.21 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.89 0.376 . . . . 1.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' D' ' 39' ' ' ILE . 18.8 tt -105.16 111.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.065 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.546 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 17.3 t 179.45 -118.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.125 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.7 m-85 177.27 -66.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.298 -0.26 . . . . 1.0 110.298 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -59.03 -31.16 95.15 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.024 1.816 . . . . 1.0 111.666 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -84.21 -9.19 58.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -42.32 99.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.87 0.367 . . . . 1.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -67.68 -39.3 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.691 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -46.95 86.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.441 ' CD2' ' C ' ' D' ' 47' ' ' TRP . 0.3 OUTLIER -70.78 -20.76 62.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.232 -0.587 . . . . 1.0 109.604 178.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' D' ' 23' ' ' SER . 22.8 t -74.56 -40.49 61.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.106 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.89 -47.76 91.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -66.78 -37.61 84.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.118 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -62.45 -44.57 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.008 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.7 -25.42 62.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.8 p -97.77 9.81 41.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.203 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p 43.88 44.62 5.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.225 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 94.9 t -86.83 -54.57 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.843 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.57 57.15 3.37 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.616 ' CG ' ' CD1' ' A' ' 61' ' ' TYR . 5.6 t80 -61.91 -41.79 98.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 1.0 110.491 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.19 -14.63 0.22 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.528 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -40.43 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.886 0.375 . . . . 1.0 110.958 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -132.39 156.62 46.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.103 -0.498 . . . . 1.0 109.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.51 ' CD2' ' OD1' ' C' ' 59' ' ' ASP . 5.6 p90 -149.3 153.28 37.32 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.81 160.04 51.3 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.299 1.999 . . . . 1.0 111.993 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 18.2 t -90.05 -116.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.578 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 60.7 m -116.23 -77.55 0.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.815 0.341 . . . . 1.0 110.95 -179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -46.92 120.77 3.21 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.064 -0.717 . . . . 1.0 109.064 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.871 ' O ' ' N ' ' D' ' 68' ' ' ARG . 96.9 mt-10 55.09 -96.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.91 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.19 -55.68 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 O-C-N 125.086 1.491 . . . . 1.0 114.085 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.871 ' N ' ' O ' ' D' ' 66' ' ' GLU . 57.7 ttm-85 -80.04 -58.5 3.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.539 . . . . 1.0 109.87 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' D' ' 66' ' ' GLU . 99.0 mttt -43.46 -40.78 3.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.71 -46.9 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.536 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -49.84 68.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -44.18 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.863 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -67.14 -40.28 86.69 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.937 -0.305 . . . . 1.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.98 -47.65 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.509 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 18.5 ptp -62.6 -39.46 93.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.264 . . . . 1.0 111.083 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.61 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.667 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.1 -38.8 92.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.597 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.87 -41.25 95.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.568 -0.613 . . . . 1.0 111.568 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.78 -43.55 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.652 0.226 . . . . 1.0 111.394 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.38 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.072 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.48 -46.07 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.448 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.42 -8.41 50.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.801 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -102.36 -27.22 12.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.81 0.338 . . . . 1.0 110.147 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.591 ' C ' ' H ' ' D' ' 86' ' ' THR . 6.0 tt -65.03 -37.55 87.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.275 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.8 -5.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.462 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.591 ' H ' ' C ' ' D' ' 84' ' ' LEU . 65.5 m -58.82 -42.91 90.33 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.954 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -42.39 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.767 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -102.97 -32.33 9.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.174 0.511 . . . . 1.0 110.028 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' D' ' 86' ' ' THR . 58.2 mt -69.76 -39.34 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.715 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.576 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.28 -49.51 77.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.707 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -11.83 43.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.66 -49.33 78.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.786 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 17.2 p90 -76.24 -22.56 55.04 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.38 -42.64 94.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.776 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -50.41 -21.78 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.723 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -55.58 -43.57 76.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' D' ' 99' ' ' GLU . 96.6 mt-10 -81.38 179.71 7.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' D' ' 101' ' ' ARG . 95.0 mt-10 65.27 -46.3 0.36 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.75 0.656 . . . . 1.0 110.66 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' D' ' 97' ' ' GLU . 97.6 mt-10 -66.55 -43.38 85.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.928 0.394 . . . . 1.0 110.301 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -70.52 -37.99 74.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.574 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' D' ' 98' ' ' GLU . 70.3 ttp85 -107.63 114.34 28.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.165 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.73 -14.87 53.13 Favored Glycine 0 N--CA 1.465 0.608 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . 0.52 ' OXT' ' ND1' ' D' ' 103' ' ' HIS . 60.1 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.59 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.21 -103.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.476 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -162.67 -37.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.461 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.602 ' HE2' HH22 ' A' ' 95' ' ' ARG . 20.5 p-80 -81.08 -26.6 36.14 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.605 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.62 -32.49 73.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.592 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -60.38 -42.68 96.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.192 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -63.29 -45.34 91.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.072 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.59 -39.71 88.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.393 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 57.2 tt0 -64.55 -39.83 94.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.59 -36.78 85.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.96 66.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.226 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 1.0 110.722 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 57.3 mp0 -66.23 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.436 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.572 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.2 tp -62.31 -42.44 99.37 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.66 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.95 -33.06 72.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.068 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.3 ttmm -61.58 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.269 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.74 -40.94 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.52 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.28 -41.24 88.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.406 ' O ' ' OG ' ' A' ' 23' ' ' SER . 72.3 mm-40 -61.31 -47.02 87.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.624 -0.43 . . . . 1.0 109.86 179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.69 -34.2 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.008 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.793 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 92.1 p -59.41 -44.0 92.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 1.0 109.968 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.25 -40.19 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 29' ' ' ALA . 70.1 mmtt -66.83 -42.48 85.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.14 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.922 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.2 p -62.02 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.477 -0.489 . . . . 1.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 98.2 mt-10 -67.25 -39.54 86.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.429 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -62.02 -49.24 76.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.113 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 38' ' ' LEU . 5.8 tm-20 -69.67 -41.41 75.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.059 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -54.71 90.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.604 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 121.2 3.7 10.46 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.65 122.99 45.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 122.689 -0.301 . . . . 1.0 110.55 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.44 141.96 26.0 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.881 1.721 . . . . 1.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.71 15.4 81.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.15 -162.06 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 1.0 110.545 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 38' ' ' LEU . . . -171.65 -4.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.616 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.424 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 4.9 tt -99.1 89.03 4.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.034 0.445 . . . . 1.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 17.4 pt -122.76 165.66 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 81.98 135.55 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.442 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.527 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.5 t80 -75.12 -45.95 4.7 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.763 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.7 Cg_endo -60.31 -27.25 84.49 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.554 1.503 . . . . 1.0 112.501 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.73 -27.95 19.72 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.011 -0.275 . . . . 1.0 110.898 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.66 -42.07 94.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.881 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.109 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.539 ' CD1' ' OE2' ' A' ' 50' ' ' GLU . 26.6 t90 -60.09 -39.82 87.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.8 m -56.09 -36.7 68.43 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.598 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.55 71.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.843 0.354 . . . . 1.0 111.293 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE2' ' CD1' ' A' ' 47' ' ' TRP . 10.6 pt-20 -173.96 -40.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.175 0.512 . . . . 1.0 109.668 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.412 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.2 OUTLIER -68.8 -39.74 79.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.148 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.23 -24.0 51.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.481 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 50' ' ' GLU . 72.0 p -86.41 -3.16 58.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 53' ' ' THR . 69.4 p 52.49 38.84 26.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.084 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.2 m -102.76 -35.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.631 -0.259 . . . . 1.0 110.883 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.0 73.82 0.37 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.457 ' HH ' ' HE1' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -62.4 -44.08 97.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.336 . . . . 1.0 110.415 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.66 20.38 5.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.514 -1.034 . . . . 1.0 110.514 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.7 m-20 -62.8 -40.09 96.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.297 . . . . 1.0 110.411 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -132.3 164.41 26.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 109.923 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 12.5 p90 -151.66 90.83 3.89 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.675 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.69 166.53 27.19 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.736 1.624 . . . . 1.0 112.271 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 16.8 m -98.75 -124.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.231 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 p -114.33 -37.18 4.43 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -57.94 -26.04 61.74 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.61 -0.436 . . . . 1.0 109.87 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 67' ' ' GLY . 0.3 OUTLIER -87.33 29.64 0.84 Allowed 'General case' 0 C--O 1.26 1.645 0 CA-C-O 123.678 1.704 . . . . 1.0 109.199 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 38.16 65.21 0.72 Allowed Glycine 0 C--O 1.212 -1.258 0 CA-C-N 113.494 -1.685 . . . . 1.0 111.714 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.632 ' NH2' ' CE3' ' D' ' 46' ' ' TRP . 0.0 OUTLIER -22.93 -31.2 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.028 0.914 . . . . 1.0 111.507 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.2 mttt -56.79 -12.3 1.84 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.241 -0.89 . . . . 1.0 108.973 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 67' ' ' GLY . 41.3 t -60.35 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 119.507 -0.877 . . . . 1.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.91 -38.4 66.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.591 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -56.19 -39.63 72.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.577 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.38 -42.2 92.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.249 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -63.81 -46.52 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.296 -179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 63.0 mtm -63.35 -40.79 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.721 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.43 -45.0 96.14 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.439 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.85 -45.11 96.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -43.08 96.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.665 0.269 . . . . 1.0 110.418 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.62 -41.66 90.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.462 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.81 -55.31 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.699 -0.4 . . . . 1.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.07 -41.21 99.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.068 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.74 -37.4 87.46 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.008 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.2 tt -62.99 -41.23 99.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.53 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.18 -10.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.44 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' A' ' 84' ' ' LEU . 70.8 m -51.72 -44.22 63.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.354 . . . . 1.0 110.078 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.97 -20.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.827 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.15 -33.44 8.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.857 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.8 mt -69.8 -39.24 76.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.216 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.65 -49.84 75.89 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.256 0.55 . . . . 1.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -3.38 1.48 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.686 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 90' ' ' ALA . 64.4 t0 -60.25 -42.83 96.13 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.98 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.569 ' CG ' ' OG1' ' B' ' 91' ' ' THR . 31.2 p90 -85.25 -26.04 26.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.635 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -55.23 -29.51 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.239 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.602 HH22 ' HE2' ' A' ' 4' ' ' HIS . 84.2 mtt85 -65.79 -21.16 66.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 1.0 110.937 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.453 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.0 ptt-85 -50.34 -42.82 53.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.642 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.453 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 82.0 tt0 -65.18 -40.21 93.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 100' ' ' ARG . 97.7 mt-10 -83.11 -172.45 4.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.273 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 61.95 -67.31 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 98' ' ' GLU . 53.9 ttp180 -55.92 -45.46 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.274 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -78.21 -17.03 57.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.458 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' A' ' 103' ' ' HIS . . . 75.76 22.18 75.28 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 102' ' ' GLY . 76.3 m80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.516 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.413 ' OG ' ' OE1' ' B' ' 5' ' ' GLU . 16.2 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.45 -0.574 . . . . 1.0 109.45 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.44 -104.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.577 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -135.85 -54.6 0.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.795 0.331 . . . . 1.0 110.648 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.585 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 7.9 p-80 -65.31 -32.33 73.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.437 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.413 ' OE1' ' OG ' ' B' ' 1' ' ' SER . 47.3 mt-10 -65.06 -35.99 82.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.881 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.07 -39.19 93.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.26 -40.65 96.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.82 99.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.614 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.77 -37.72 82.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.44 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -61.75 -38.5 88.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.65 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.54 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.33 -40.9 97.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 1.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.01 -38.62 91.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 1.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -62.69 -32.18 73.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.57 -42.03 99.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -57.88 -39.62 78.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.774 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.65 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.73 -34.3 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.905 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.02 -40.39 93.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.91 -47.5 85.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -70.63 -32.09 69.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.054 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.13 80.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.265 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.9 t -60.18 -43.34 95.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.799 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.62 -55.55 33.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.137 0.494 . . . . 1.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.46 -44.11 97.19 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.082 -0.647 . . . . 1.0 110.639 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.47 -48.72 78.38 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.704 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.413 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.8 OUTLIER -65.61 -42.52 93.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.424 . . . . 1.0 110.375 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.413 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 95.5 mt-10 -69.67 -43.34 72.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.128 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.17 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -72.91 -22.4 60.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -77.88 122.25 25.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.955 0.407 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.15 2.79 57.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.377 -0.689 . . . . 1.0 111.377 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.7 149.46 37.13 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.533 -0.173 . . . . 1.0 110.533 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.27 143.41 28.21 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.073 1.849 . . . . 1.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.71 28.9 74.07 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.284 -0.726 . . . . 1.0 111.284 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 139.43 57.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 1.0 110.278 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.82 -40.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.999 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 tp -68.02 -21.73 65.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.28 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.433 ' O ' ' CB ' ' B' ' 40' ' ' SER . 12.5 tt -43.27 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.52 ' O ' ' N ' ' B' ' 44' ' ' ALA . 1.8 p 163.85 109.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.557 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.7 m-85 -56.72 -60.27 9.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.087 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.8 Cg_endo -57.84 -35.51 98.75 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.058 1.839 . . . . 1.0 112.771 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.73 -20.53 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.526 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' B' ' 40' ' ' SER . . . -62.36 -39.3 92.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.951 0.405 . . . . 1.0 109.988 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.1 tt -67.02 -37.82 80.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.663 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.409 ' CD1' ' NE ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -46.89 79.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.422 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.457 ' HE1' ' HH ' ' A' ' 57' ' ' TYR . 3.1 t90 -62.78 -40.45 97.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.26 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' B' ' 44' ' ' ALA . 6.7 m -50.9 -22.76 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.755 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.88 -21.04 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.809 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -93.79 16.97 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.899 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.73 -39.02 1.65 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.744 0.307 . . . . 1.0 111.14 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.35 -29.17 70.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.294 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' B' ' 54' ' ' THR . 18.7 p -90.31 9.11 30.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 1.0 110.734 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.8 p 51.32 42.04 28.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.43 ' CG2' ' N ' ' B' ' 56' ' ' GLY . 19.0 m -97.29 -44.78 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.673 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.43 ' N ' ' CG2' ' B' ' 55' ' ' VAL . . . 41.31 64.57 1.3 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.534 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.1 t80 -60.97 -47.13 87.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 1.0 110.907 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.4 10.68 1.24 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -57.51 -66.1 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.388 . . . . 1.0 110.568 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.43 HH21 ' NH2' ' C' ' 68' ' ' ARG . 52.4 mtm180 -137.04 142.42 42.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.991 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' B' ' 61' ' ' TYR . 6.1 p90 -126.31 136.24 28.31 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.297 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.52 164.67 33.42 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.889 1.726 . . . . 1.0 112.063 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.4 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 22.2 m -91.98 -140.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.223 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -114.1 -40.74 3.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.749 0.309 . . . . 1.0 111.129 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.667 ' C ' ' H ' ' B' ' 67' ' ' GLY . 79.4 tt0 -66.71 -32.72 74.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.405 ' O ' ' C ' ' B' ' 67' ' ' GLY . 0.2 OUTLIER -70.38 30.35 0.04 OUTLIER 'General case' 0 C--O 1.261 1.672 0 CA-C-O 123.715 1.721 . . . . 1.0 110.03 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.42 63.94 1.27 Allowed Glycine 0 C--O 1.21 -1.344 0 CA-C-N 113.972 -1.467 . . . . 1.0 111.585 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.5 ttm-85 -25.0 -33.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.323 1.062 . . . . 1.0 110.862 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.0 mttp -48.5 -18.59 0.25 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' B' ' 67' ' ' GLY . 59.8 t -64.09 -45.55 96.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.724 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.85 -36.2 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.69 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -57.17 -41.12 78.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.947 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -64.18 -42.8 96.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.03 -47.29 88.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.251 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.668 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.03 -38.36 90.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 1.0 110.47 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.87 92.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.535 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.32 -40.92 91.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.406 HD13 HG21 ' B' ' 79' ' ' ILE . 96.5 mt -61.93 -43.29 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.838 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.8 -42.45 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.384 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.24 -47.93 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.157 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.51 -11.23 60.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.912 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.08 -25.91 13.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.81 -41.53 97.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.94 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 87' ' ' ALA . 30.8 m -46.69 -26.66 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 32.4 m -34.53 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -50.49 -65.36 0.57 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.035 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.85 -20.54 35.4 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.48 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 -44.01 97.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.595 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.32 -60.93 2.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.766 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.569 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -50.21 -5.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.84 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.595 ' H ' ' C ' ' B' ' 90' ' ' ALA . 51.0 t0 -60.78 -40.31 92.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 93' ' ' PHE . 1.6 p90 -65.19 -33.56 76.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 1.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.77 -44.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.458 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' B' ' 97' ' ' GLU . 10.5 tpt180 -47.05 -21.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.851 -0.34 . . . . 1.0 111.207 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -46.2 -20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.377 . . . . 1.0 110.217 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' C ' ' B' ' 95' ' ' ARG . 97.0 mt-10 -60.18 -45.99 91.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.138 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.17 -40.27 78.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.815 0.34 . . . . 1.0 110.666 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -70.78 -25.72 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.727 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.418 HH12 ' NH2' ' B' ' 101' ' ' ARG . 79.2 ttt-85 -59.72 -44.35 93.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.576 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . 0.418 ' NH2' HH12 ' B' ' 100' ' ' ARG . 35.5 mmt180 -98.36 -7.85 28.09 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.413 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 10.1 86.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.546 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.27 -4.93 50.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.44 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.97 29.87 17.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.432 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 7.2 p80 -172.51 -34.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.627 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 79.8 tt0 -67.31 -41.13 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.745 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -62.28 -42.59 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.55 -39.65 91.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.104 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.98 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.477 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.08 -40.69 82.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.19 -38.16 90.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.311 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.58 78.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.044 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.17 -37.72 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 1.0 110.894 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.84 -35.5 80.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.648 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.06 -36.35 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.676 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 48.7 tp -62.07 -41.01 97.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.342 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -62.59 -40.63 97.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.54 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.14 -38.63 89.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.815 0.341 . . . . 1.0 111.116 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.38 -40.79 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -59.29 -41.35 88.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.19 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.65 -48.7 80.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.869 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.85 -32.73 71.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.13 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.29 93.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -60.27 -44.11 95.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.508 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.11 -39.14 92.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 1.0 110.12 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -72.46 -47.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.09 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.57 73.16 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.359 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.453 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 7.4 p -60.8 -44.8 98.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.961 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.453 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 42.7 tp10 -68.05 -36.98 80.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.55 86.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.3 -44.48 68.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.399 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -52.93 97.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.348 . . . . 1.0 110.701 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.63 0.15 15.63 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.176 -0.769 . . . . 1.0 111.176 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.83 140.46 21.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 1.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -76.19 143.69 25.71 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.918 1.746 . . . . 1.0 112.338 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 24.39 69.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.51 140.82 58.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.379 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.08 -34.76 4.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.422 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' C' ' 40' ' ' SER . 1.1 mt -72.2 -2.05 17.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.213 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.428 ' O ' ' OG ' ' C' ' 40' ' ' SER . 12.4 tt -46.92 90.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 1.0 110.627 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.519 ' N ' ' O ' ' C' ' 38' ' ' LEU . 70.4 m -167.04 -127.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.008 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.407 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 6.9 t80 174.39 -58.29 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.346 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.7 Cg_endo -58.86 -38.28 89.3 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.835 1.69 . . . . 1.0 112.376 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 14.6 p-10 -91.91 2.97 56.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.5 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.74 98.29 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.771 -0.371 . . . . 1.0 110.507 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 tt -68.21 -31.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.378 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.59 ' CZ2' ' O ' ' D' ' 63' ' ' VAL . 10.4 t90 -57.91 -47.17 83.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.993 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.0 OUTLIER -76.17 -22.33 55.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.404 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 6.0 t -67.5 -42.7 82.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.436 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 76.0 t -61.09 -47.9 91.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 -178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.74 -31.63 71.67 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.88 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -58.96 -44.94 91.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.2 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.98 -35.23 70.89 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.759 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.447 ' O ' ' OG1' ' C' ' 54' ' ' THR . 68.8 p -75.18 -6.81 51.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' C' ' 53' ' ' THR . 13.2 p 59.33 24.15 12.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.829 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' C' ' 56' ' ' GLY . 18.5 m -87.54 -47.5 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.611 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . 0.449 ' N ' ' CG2' ' C' ' 55' ' ' VAL . . . 38.43 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.37 -39.88 95.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.793 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.8 16.29 1.29 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.119 -0.793 . . . . 1.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.04 -41.65 99.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 1.0 110.572 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -145.44 176.3 9.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -163.67 127.7 1.87 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.593 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.27 160.02 51.0 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.918 1.745 . . . . 1.0 112.382 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.422 ' CG1' ' H ' ' C' ' 64' ' ' THR . 2.0 t -86.99 -140.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.092 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.422 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 54.0 m -114.81 -34.48 5.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' C' ' 67' ' ' GLY . 76.0 tt0 -67.17 -31.52 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -69.57 31.61 0.03 OUTLIER 'General case' 0 C--O 1.262 1.75 0 CA-C-O 123.48 1.61 . . . . 1.0 110.347 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.07 64.72 1.42 Allowed Glycine 0 C--O 1.212 -1.255 0 CA-C-N 114.103 -1.408 . . . . 1.0 111.234 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' C' ' 67' ' ' GLY . 49.6 ttm-85 -23.49 -33.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 117.848 0.824 . . . . 1.0 111.174 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.6 mptm? -49.66 -19.33 0.59 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' C' ' 67' ' ' GLY . 78.1 t -62.94 -46.64 95.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 119.23 -0.988 . . . . 1.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.34 69.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 1.0 110.628 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.75 -44.28 77.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.786 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.21 -43.09 99.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.518 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.73 -47.96 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.738 -0.385 . . . . 1.0 111.129 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 76.8 mtm -64.38 -42.64 96.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.593 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 55.2 tttm -64.68 -39.55 93.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.604 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.49 93.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 1.0 110.47 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.63 -42.1 93.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.747 -0.541 . . . . 1.0 111.747 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.401 HD12 HG22 ' C' ' 79' ' ' ILE . 96.6 mt -62.0 -44.0 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.84 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 98.0 mt-10 -63.52 -40.32 96.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.279 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 63.9 t -64.05 -49.05 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.094 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -67.85 -37.72 82.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.347 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -66.42 -36.02 81.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.0 110.644 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.7 tt -61.78 -40.05 93.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.81 -3.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.719 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.561 ' H ' ' C ' ' C' ' 84' ' ' LEU . 66.8 m -59.33 -40.93 87.87 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.685 0.279 . . . . 1.0 110.271 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.45 -25.35 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.259 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.13 -11.29 38.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.69 -61.12 1.8 Allowed 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.578 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -42.93 -52.34 5.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.819 0.343 . . . . 1.0 111.045 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.38 -13.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.002 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' C' ' 90' ' ' ALA . 96.8 m-20 -63.52 -47.52 81.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.277 . . . . 1.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 2.2 p90 -67.98 -33.3 74.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 1.0 110.847 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -43.06 94.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.773 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -58.67 -22.44 56.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.394 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . 0.446 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 37.9 ptt85 -50.39 -43.11 54.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 1.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 46.9 tp10 -59.68 -45.06 93.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.362 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.42 -42.18 88.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -68.09 -37.82 81.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.495 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -60.92 -42.99 99.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -64.78 -36.54 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.94 57.32 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.584 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.62 149.71 26.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.593 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 15.2 p-10 -77.73 -41.7 36.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.287 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.405 ' CD2' ' H ' ' D' ' 4' ' ' HIS . 6.7 p80 -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.873 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -63.75 -37.2 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.693 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.49 -41.51 97.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.666 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -65.81 -37.46 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 1.0 110.059 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.77 -39.56 93.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.499 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.21 -37.61 87.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.554 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.93 91.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.074 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.23 -38.84 92.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 1.0 110.757 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.06 -36.35 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.626 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.78 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.581 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.67 -41.57 99.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.794 -0.362 . . . . 1.0 110.418 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.05 -36.31 74.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.834 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -60.89 -41.91 96.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.715 0.293 . . . . 1.0 111.042 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.32 -37.43 79.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.89 -41.65 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.19 -47.47 84.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.016 0.436 . . . . 1.0 110.149 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.48 -34.2 77.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.895 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.11 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.715 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -60.94 -45.99 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.09 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -78.08 -35.8 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 1.0 111.064 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -72.39 -44.87 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.163 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -62.16 -49.76 74.53 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.42 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 11.4 p -61.44 -43.62 97.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 1.0 109.868 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 42.1 tp10 -69.28 -20.78 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.041 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.04 85.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.077 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 24.0 mp0 -63.97 -38.15 90.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.802 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -57.93 93.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.18 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -9.12 6.9 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.1 146.65 32.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.752 0.276 . . . . 1.0 110.353 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.72 116.47 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.766 1.644 . . . . 1.0 112.199 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.09 37.71 4.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.74 98.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.816 0.341 . . . . 1.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.63 -72.6 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.13 61.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 1.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 tt -90.38 -8.37 10.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.928 0.394 . . . . 1.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -65.69 140.13 58.44 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 0.8 OUTLIER -97.68 -61.44 0.12 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.67 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.447 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.5 Cg_endo -57.85 -32.04 93.97 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.558 1.505 . . . . 1.0 111.888 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.81 -3.27 58.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 1.0 110.574 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . 0.415 ' O ' ' OG ' ' D' ' 48' ' ' SER . 0.0 OUTLIER -66.3 -32.24 57.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.287 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.632 ' CE3' ' NH2' ' A' ' 68' ' ' ARG . 1.7 t-105 -61.18 -47.3 86.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.008 -178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.413 ' CE3' ' N ' ' D' ' 48' ' ' SER . 0.8 OUTLIER -69.86 -37.88 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 25.3 p -47.12 -34.57 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 1.0 110.323 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.2 -44.71 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.412 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.3 52.84 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.73 -0.471 . . . . 1.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.9 m -156.21 -48.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.468 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.91 -23.62 46.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.021 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.2 p -93.5 8.37 40.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.281 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.5 p 48.72 32.6 3.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.898 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 7.3 p -65.47 -39.49 85.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.101 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.31 -91.21 0.64 Allowed Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' D' ' 57' ' ' TYR . 43.7 p90 -62.91 114.66 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.263 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.57 ' C ' ' H ' ' D' ' 60' ' ' ARG . . . -126.47 28.24 4.8 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t0 63.76 -6.74 0.22 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.755 0.312 . . . . 1.0 110.789 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.57 ' H ' ' C ' ' D' ' 58' ' ' GLY . 73.4 mtt-85 -145.87 128.41 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 8.2 p90 -118.55 141.44 29.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.852 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.81 156.78 62.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.314 2.009 . . . . 1.0 112.512 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.59 ' O ' ' CZ2' ' C' ' 46' ' ' TRP . 12.3 t -77.94 -120.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.057 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 54.6 m -116.9 -72.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.961 0.41 . . . . 1.0 110.227 179.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -56.16 127.34 30.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' D' ' 68' ' ' ARG . 94.5 mt-10 58.28 -94.5 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.054 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 24.63 -57.18 0.0 OUTLIER Glycine 0 N--CA 1.48 1.57 0 O-C-N 124.483 1.114 . . . . 1.0 114.193 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.5 ttp85 -83.19 -59.48 2.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -41.08 -36.35 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.49 -46.59 80.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.949 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -66.46 -34.79 78.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.828 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.12 -48.1 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.905 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.82 -38.1 88.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.946 -0.302 . . . . 1.0 111.716 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -62.86 -46.38 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.39 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 77.2 mtm -63.77 -39.89 95.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.613 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.5 98.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.567 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.11 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.332 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.91 -42.42 94.91 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.692 -0.563 . . . . 1.0 111.692 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.423 HG22 HD13 ' D' ' 79' ' ' ILE . 95.6 mt -62.3 -43.43 98.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.621 0.248 . . . . 1.0 111.148 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.21 -38.63 91.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.899 -0.321 . . . . 1.0 111.36 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 56.1 t -62.18 -49.65 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.277 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -67.17 -40.7 86.64 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.692 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.92 -33.71 76.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.234 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.4 tt -60.95 -41.53 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.086 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.02 -14.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 1.0 110.258 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.505 ' H ' ' C ' ' D' ' 84' ' ' LEU . 39.6 m -49.6 -39.59 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.071 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.59 -26.98 14.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.63 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.92 -10.76 32.75 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.158 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.4 -59.85 2.1 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.181 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 92' ' ' ASP . . . -42.22 -53.74 3.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 1.0 111.056 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.746 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' D' ' 90' ' ' ALA . 80.1 m-20 -62.0 -45.11 95.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.313 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 0.1 OUTLIER -53.56 -37.14 62.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 1.0 110.489 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' D' ' 97' ' ' GLU . 61.4 t -61.05 -43.66 96.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.135 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -50.92 -21.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.745 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -55.47 -44.04 76.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.137 -0.32 . . . . 1.0 110.137 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' D' ' 97' ' ' GLU . 55.1 mp0 -70.16 -38.92 75.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.981 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.84 -37.04 85.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.389 . . . . 1.0 110.174 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -63.7 -31.36 72.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -55.64 -43.54 76.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -63.5 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.264 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.1 64.46 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.55 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.4 -76.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -159.94 -61.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.413 ' HD1' ' CB ' ' A' ' 88' ' ' ALA . 8.7 p80 -77.42 -23.88 50.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.836 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -67.11 -37.79 84.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.803 0.335 . . . . 1.0 110.239 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -60.76 -43.23 98.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.87 -38.89 90.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.085 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.14 99.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.331 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.09 -37.41 85.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.377 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -61.32 -41.96 97.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.283 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.2 83.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.842 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.32 -35.6 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.566 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.43 -37.16 86.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.387 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.19 -32.11 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.637 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.11 -41.73 98.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 1.0 110.504 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.22 -40.43 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.154 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -63.51 -39.85 95.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.864 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -63.11 -42.57 97.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 91.9 mt -60.24 -41.41 93.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.319 -0.4 . . . . 1.0 109.944 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.81 -45.68 92.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -69.56 -34.11 73.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.107 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.79 94.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.459 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.77 -43.35 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.21 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.92 -59.68 5.07 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.14 -45.07 96.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.154 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.69 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.483 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.43 -47.23 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.257 -0.577 . . . . 1.0 110.338 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.92 -41.57 67.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.837 -0.62 . . . . 1.0 111.35 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -35.08 65.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.804 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 5.5 mp0 -89.89 -10.18 46.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.632 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -75.24 108.52 8.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.63 61.28 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.504 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.91 142.94 26.11 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.33 143.55 28.18 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.111 1.874 . . . . 1.0 112.443 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.74 -4.44 21.87 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.91 143.25 52.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.846 0.355 . . . . 1.0 110.568 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.17 -26.76 2.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.568 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.66 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.892 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.42 ' O ' ' CB ' ' A' ' 40' ' ' SER . 14.5 tt -116.79 89.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.226 0.536 . . . . 1.0 110.439 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.471 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 0.3 OUTLIER 166.98 134.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.766 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.484 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 66.8 m-85 -69.58 -49.41 21.84 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.043 -0.526 . . . . 1.0 112.403 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.3 Cg_endo -60.19 -34.92 93.73 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.486 1.457 . . . . 1.0 113.188 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.7 p-10 -90.5 -24.28 20.7 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 121.062 -0.255 . . . . 1.0 111.08 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.529 ' N ' ' OD1' ' A' ' 43' ' ' ASP . . . -65.1 -38.29 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 1.0 110.581 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 tp -63.35 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.98 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.538 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.3 OUTLIER -62.49 -45.64 92.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.934 179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.427 ' O ' ' OG1' ' A' ' 51' ' ' THR . 3.7 t90 -57.53 -39.91 77.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -65.44 -34.78 79.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.4 -46.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.475 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.11 -8.23 56.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.062 0.458 . . . . 1.0 110.428 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 24.2 m -80.61 -45.63 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.328 . . . . 1.0 111.195 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.57 88.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.609 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -75.12 0.29 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.71 60.98 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.4 p -130.73 -44.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.682 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 36.12 89.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.731 -0.548 . . . . 1.0 111.731 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.89 -44.42 97.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.343 . . . . 1.0 110.704 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.12 15.76 0.68 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 98.4 m-20 -59.92 -50.39 73.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.337 . . . . 1.0 110.636 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 43' ' ' ASP . 0.9 OUTLIER -138.75 156.28 47.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.976 -0.557 . . . . 1.0 109.875 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -144.08 131.6 10.61 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.674 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.58 -171.62 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.827 1.685 . . . . 1.0 112.198 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.672 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.2 p -128.82 -136.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.222 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.672 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 66.4 m -112.62 -40.23 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.628 0.251 . . . . 1.0 111.341 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.636 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.3 tt0 -64.48 -36.12 83.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.461 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 1.2 pp20? -72.66 32.18 0.06 Allowed 'General case' 0 C--O 1.262 1.763 0 CA-C-O 124.537 2.113 . . . . 1.0 109.721 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.25 63.98 1.43 Allowed Glycine 0 C--O 1.212 -1.242 0 CA-C-N 113.612 -1.631 . . . . 1.0 111.098 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.471 HH21 HH22 ' D' ' 60' ' ' ARG . 56.8 ttm-85 -24.12 -34.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.95 0.875 . . . . 1.0 111.334 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.8 mtmt -50.5 -14.25 0.17 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.609 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' GLY . 43.2 t -60.95 -47.68 92.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.156 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -42.48 68.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.353 . . . . 1.0 111.161 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -52.09 -39.64 60.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.85 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -68.97 -41.33 78.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.615 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.96 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.398 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.1 ptp -63.62 -39.55 94.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.773 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -62.73 -42.63 99.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.446 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.96 86.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.361 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -36.73 93.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -26.93 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.135 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.14 -49.76 18.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.724 0.297 . . . . 1.0 111.412 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 18.4 m -62.21 -48.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.32 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -66.0 -40.79 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.707 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.09 -36.61 84.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 1.0 111.064 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.6 tt -62.16 -41.59 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.346 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.6 t -46.47 -13.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.559 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.511 ' H ' ' C ' ' A' ' 84' ' ' LEU . 94.9 m -55.31 -23.83 25.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -62.28 -29.67 70.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.111 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.413 ' CB ' ' HD1' ' A' ' 4' ' ' HIS . . . -92.52 -11.84 33.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.777 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.27 -47.63 9.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.655 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.89 -24.12 49.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.959 0.409 . . . . 1.0 111.016 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -89.17 -3.73 58.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.706 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.89 -46.48 89.2 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.384 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -81.76 -19.18 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.31 -28.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.405 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 97' ' ' GLU . 96.4 mtt180 -63.59 -28.91 70.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -42.41 -23.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.845 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 95' ' ' ARG . 44.1 tt0 -64.73 -38.24 90.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 1.0 110.04 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' GLY . 97.4 mt-10 -66.82 -39.93 87.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.343 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -68.75 -32.59 72.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.364 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -58.39 -45.6 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.705 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -107.14 -1.87 21.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.858 0.361 . . . . 1.0 110.515 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 98' ' ' GLU . . . 67.79 24.67 74.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.445 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 85.5 t60 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.422 -0.585 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.21 154.88 31.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.531 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . 0.471 ' OD1' ' NH2' ' B' ' 6' ' ' ARG . 78.8 m-20 -63.1 -40.98 99.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.436 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.572 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 2.2 m80 -60.97 -45.52 94.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.21 -48.99 75.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.592 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' B' ' 3' ' ' ASP . 88.7 mtm180 -65.42 -41.07 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 1.0 110.768 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.9 -40.24 87.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.166 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.44 96.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.521 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -65.49 -38.03 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.05 -39.07 93.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.684 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.44 67.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.903 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.85 -35.36 80.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 1.0 110.505 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.236 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.15 -37.55 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.599 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.49 -40.92 98.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 1.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.66 -39.34 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.812 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.37 -43.21 99.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.61 -40.84 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.49 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.444 ' O ' ' OG ' ' B' ' 23' ' ' SER . 32.7 mt -59.03 -42.81 91.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.46 -37.71 85.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.37 -53.11 39.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.415 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -65.93 -43.97 86.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' B' ' 48' ' ' SER . 75.2 m -56.22 -43.91 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.128 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -65.34 -32.84 74.69 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.25 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.98 -34.81 50.71 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.09 -0.244 . . . . 1.0 111.239 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.43 67.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.483 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' B' ' 28' ' ' GLU . 2.6 m -61.52 -49.08 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.406 -0.517 . . . . 1.0 110.496 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.526 ' N ' ' CG2' ' B' ' 27' ' ' VAL . 80.6 tt0 -76.35 -35.8 58.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.605 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.97 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.215 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -107.82 61.41 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.762 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -141.8 80.04 1.7 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 1.0 111.105 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.06 4.41 27.54 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.7 57.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.35 139.6 23.57 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.008 1.806 . . . . 1.0 112.244 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 19.04 74.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.05 166.02 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.753 0.311 . . . . 1.0 110.458 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.07 -11.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.642 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.447 ' C ' ' H ' ' B' ' 40' ' ' SER . 0.9 OUTLIER -87.6 33.26 0.7 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.223 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 pt -71.84 46.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.65 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.447 ' H ' ' C ' ' B' ' 38' ' ' LEU . 58.3 m -130.96 151.31 51.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.099 0.475 . . . . 1.0 111.065 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.439 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 3.0 m-85 -97.54 -64.5 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.015 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -58.52 -28.03 84.27 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 122.213 1.942 . . . . 1.0 112.525 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -87.56 -2.18 58.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 1.0 110.643 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.02 95.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 1.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.79 -39.29 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.765 179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.5 -49.49 77.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.415 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -40.78 95.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.465 ' CB ' ' OG ' ' B' ' 23' ' ' SER . 15.2 m -63.15 -39.62 95.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.53 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 25.3 t -59.5 -47.31 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.812 0.301 . . . . 1.0 111.812 -178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.482 ' CD ' HH12 ' C' ' 68' ' ' ARG . 15.0 pt-20 -65.41 -30.03 70.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -64.39 -44.75 90.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.615 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.02 -25.54 61.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.286 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.465 ' C ' ' H ' ' B' ' 55' ' ' VAL . 33.3 p -90.65 4.08 52.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.805 0.336 . . . . 1.0 110.583 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' B' ' 53' ' ' THR . 17.9 p 54.42 9.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.635 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' B' ' 53' ' ' THR . 67.6 t -63.97 -45.85 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.698 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.31 57.61 5.59 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -60.4 -49.29 78.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.371 . . . . 1.0 110.938 -178.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 158.73 -92.46 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 69.1 m-20 44.16 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.614 0.245 . . . . 1.0 110.611 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.593 ' NH2' ' NH2' ' C' ' 68' ' ' ARG . 1.1 mpp_? -114.87 161.52 18.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 16.6 p90 -141.58 105.1 5.89 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.384 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 163.21 38.62 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.525 1.483 . . . . 1.0 112.308 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.69 ' CG2' ' H ' ' B' ' 64' ' ' THR . 9.6 p -106.03 -154.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.352 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.69 ' H ' ' CG2' ' B' ' 63' ' ' VAL . 9.9 m -88.7 -53.45 4.62 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.65 0.262 . . . . 1.0 111.632 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.614 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.3 tt0 -42.09 -36.36 1.13 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.776 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.576 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -72.73 22.85 0.06 Allowed 'General case' 0 C--O 1.267 1.974 0 CA-C-O 124.283 1.992 . . . . 1.0 109.782 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.728 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 42.99 65.46 1.41 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.704 -1.609 . . . . 1.0 111.463 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.576 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -26.66 -28.55 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.067 0.934 . . . . 1.0 110.863 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.3 mttt -45.43 -26.31 0.53 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 67' ' ' GLY . 3.8 p -63.13 -43.63 98.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.627 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -79.37 -37.91 36.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.608 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -58.59 -40.19 82.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -63.71 -44.04 94.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.502 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 95.2 t -63.17 -48.23 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.891 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.1 mtm -63.03 -43.71 97.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.281 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -64.51 -40.84 96.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.161 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.04 -40.23 97.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.729 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.86 95.84 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.09 -43.75 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.781 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.14 -42.99 99.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 1.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.63 -46.91 93.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.908 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -74.98 -4.16 36.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.851 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.45 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.02 -31.69 10.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.881 0.372 . . . . 1.0 110.052 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -64.98 -39.52 93.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.025 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.02 -5.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.206 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' B' ' 84' ' ' LEU . 53.9 m -58.54 -41.43 85.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -42.23 -54.07 3.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.599 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.96 68.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 86' ' ' THR . 70.0 mt -88.2 -17.63 30.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -70.94 -37.15 72.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.441 ' HG1' ' HE ' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -66.8 -24.86 66.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.225 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -49.42 -43.79 44.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.656 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.616 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -59.74 -46.49 88.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.946 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.75 -42.32 89.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.441 ' HE ' ' HG1' ' B' ' 91' ' ' THR . 95.6 mtt-85 -49.41 -21.51 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.539 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -50.29 -39.25 44.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 1.0 110.281 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.75 -40.92 96.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' B' ' 100' ' ' ARG . 48.1 mt-10 -71.61 -169.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.31 -76.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.166 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' B' ' 98' ' ' GLU . 71.6 ttt-85 -57.14 -44.45 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.383 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -120.26 106.44 11.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.856 0.36 . . . . 1.0 110.051 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.13 -6.17 34.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 1.0 110.516 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' SER . . . . . 0.504 ' C ' ' H ' ' C' ' 3' ' ' ASP . 14.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' C' ' 4' ' ' HIS . . . 71.94 -40.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.521 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' C' ' 1' ' ' SER . 55.0 m-20 59.53 -70.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' C' ' 2' ' ' ALA . 7.1 p-80 -40.97 -31.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.22 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 20.4 pt-20 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 1.0 110.632 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' C' ' 3' ' ' ASP . 73.5 ttp85 -60.63 -43.1 97.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.299 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.08 -38.27 90.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.036 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.89 92.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.629 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.03 -40.98 95.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.52 -37.27 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.495 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.22 93.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.086 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.13 -38.7 89.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 1.0 110.847 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -65.82 -32.16 73.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -61.66 -40.64 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.538 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 55.1 tp -63.29 -39.58 94.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.87 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.53 -30.93 71.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.873 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 42.3 t -63.49 -42.35 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.4 mt -59.86 -40.32 88.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.359 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.4 mm-40 -54.59 -48.88 71.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.849 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.78 -33.46 74.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.897 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.51 82.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 91.0 p -61.78 -46.95 87.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.445 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.56 -36.33 80.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.227 0.536 . . . . 1.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.72 -46.5 53.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.504 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -64.46 -48.46 75.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.395 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.475 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 8.3 p -59.32 -44.88 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.221 -0.591 . . . . 1.0 109.685 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.475 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 82.4 tt0 -68.37 -26.96 65.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.37 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.409 ' O ' ' OE1' ' C' ' 66' ' ' GLU . . . -56.16 -51.01 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.14 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.533 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 33.3 mp0 -67.54 -36.94 81.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -72.89 92.23 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.89 -19.54 5.81 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.662 . . . . 1.0 111.444 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.51 154.03 39.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.1 150.59 37.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.264 1.976 . . . . 1.0 112.193 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.28 61.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.21 143.51 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 1.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 -39.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.539 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.502 ' O ' ' O ' ' C' ' 39' ' ' ILE . 3.5 tt -57.94 -79.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.994 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' C' ' 38' ' ' LEU . 95.4 mt 51.57 167.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.482 ' N ' ' CG2' ' C' ' 39' ' ' ILE . 1.8 t 81.65 124.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.453 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.475 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 53.4 t80 -88.28 -49.89 0.42 Allowed Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.254 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.9 Cg_endo -60.05 -28.49 87.15 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.343 1.362 . . . . 1.0 112.529 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.48 -13.2 24.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.53 0.205 . . . . 1.0 111.216 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.89 -37.46 84.44 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.532 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.32 -34.69 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.404 ' NE1' ' CB ' ' D' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -48.11 75.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.149 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.524 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 7.6 t90 -61.18 -40.2 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.414 -0.514 . . . . 1.0 109.733 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 63.5 p -67.09 45.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.842 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . 0.438 ' H ' ' C ' ' C' ' 47' ' ' TRP . 71.0 t -137.25 -50.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.535 0.207 . . . . 1.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -69.45 -27.16 65.0 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.84 -51.83 68.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.337 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.66 -25.37 53.55 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.849 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -90.94 14.21 14.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.799 0.333 . . . . 1.0 110.408 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' C' ' 54' ' ' THR . 0.1 OUTLIER 35.42 77.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.403 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -145.78 -78.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . 0.403 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 75.54 84.73 0.37 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -63.93 -40.98 97.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.622 0.248 . . . . 1.0 110.608 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.99 22.23 0.6 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 99.8 m-20 -61.83 -43.59 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 1.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 77.7 mtt-85 -144.14 -167.58 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.617 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 89.2 m-85 -157.77 123.36 2.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.72 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.86 168.39 21.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.643 1.562 . . . . 1.0 112.255 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.3 m -91.66 -167.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.088 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -101.88 -67.81 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.246 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -38.37 -31.7 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.801 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.8 mt-10 -138.62 -107.62 0.17 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.39 -54.79 0.0 OUTLIER Glycine 0 N--CA 1.479 1.567 0 O-C-N 124.513 1.133 . . . . 1.0 114.532 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.5 tpp180 -63.06 -58.98 5.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.106 0.562 . . . . 1.0 109.769 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.5 -38.75 88.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 72.7 t -64.16 -49.16 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 119.467 -0.893 . . . . 1.0 110.987 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.529 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -67.86 -44.43 77.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 1.0 110.413 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -42.92 -50.62 5.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.919 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.21 -39.26 93.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 61.4 t -63.18 -46.6 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.491 -178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.9 mpp? -62.3 -42.2 99.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -61.34 -36.41 80.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 1.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.01 -43.01 66.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.378 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -38.79 95.3 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mm -61.43 -45.46 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.679 -0.307 . . . . 1.0 110.839 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.0 -44.99 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.308 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.25 -46.98 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.191 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.03 -11.53 59.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.921 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.13 -36.93 17.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 1.0 110.129 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.9 tt -66.78 -37.58 84.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.568 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 35.1 m -67.06 44.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 1.0 111.099 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.517 ' O ' ' N ' ' C' ' 90' ' ' ALA . 22.7 m -89.53 -42.02 11.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 1.0 110.352 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' C' ' 90' ' ' ALA . . . -52.95 -67.65 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.411 -0.516 . . . . 1.0 111.706 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.452 ' O ' ' OD1' ' C' ' 92' ' ' ASP . . . -48.64 -16.1 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.35 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.489 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.8 mm? -100.16 -24.28 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.495 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.581 ' C ' ' H ' ' C' ' 92' ' ' ASP . . . -90.01 -65.36 1.02 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.71 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -45.32 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.702 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' C' ' 90' ' ' ALA . 89.9 m-20 -52.38 -42.22 63.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.368 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' C' ' 94' ' ' VAL . 2.8 p90 -61.73 -43.72 98.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.408 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 58.2 t -38.78 -27.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.785 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' C' ' 93' ' ' PHE . 95.7 mtt180 -59.89 -23.4 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.688 0.28 . . . . 1.0 111.066 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -58.79 -42.89 90.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.155 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.518 ' O ' ' NH1' ' C' ' 100' ' ' ARG . 96.9 mt-10 -67.21 -31.81 72.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.353 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -88.55 -8.22 55.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.466 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.68 -41.65 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.73 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' C' ' 97' ' ' GLU . 34.7 ptt-85 -65.79 -37.3 85.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.04 0.448 . . . . 1.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.04 -37.26 86.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.648 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.97 25.47 40.83 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.535 179.923 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' SER . . . . . 0.639 ' HG ' ' N ' ' D' ' 2' ' ' ALA . 77.3 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.639 ' N ' ' HG ' ' D' ' 1' ' ' SER . . . -79.52 167.25 21.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.559 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.15 -43.91 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.62 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 4.9 p80 -69.66 -37.93 76.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.692 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.59 -34.24 77.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.98 -43.24 91.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.457 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -64.76 -38.3 90.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.037 0.446 . . . . 1.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.31 86.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.62 -37.56 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -37.95 85.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.463 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.65 70.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.098 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -64.54 -38.85 92.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.486 -0.324 . . . . 1.0 110.644 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -40.42 93.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 1.0 110.447 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.51 -32.7 74.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.651 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.98 -35.1 79.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.462 . . . . 1.0 110.29 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.13 -33.19 73.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -62.13 -45.36 93.82 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.473 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.09 -37.13 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.755 0.312 . . . . 1.0 110.935 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.1 -41.63 97.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' D' ' 23' ' ' SER . 74.0 mm-40 -66.95 -44.11 81.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 1.0 110.203 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.11 -34.03 76.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.147 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.58 -38.86 92.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.25 -43.6 95.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -61.34 -62.46 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.54 -38.11 83.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.765 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -52.12 -51.29 58.77 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.533 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 69.6 t -64.14 -46.26 94.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.409 -0.516 . . . . 1.0 110.171 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.43 -41.33 89.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.525 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.045 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.423 ' CD ' ' OE1' ' D' ' 66' ' ' GLU . 40.3 mm-40 -68.29 -41.85 80.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.822 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -62.69 87.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.014 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.12 7.61 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.332 -0.707 . . . . 1.0 111.332 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.92 135.19 20.51 Favored Pre-proline 0 CA--C 1.537 0.45 0 O-C-N 122.794 -0.239 . . . . 1.0 110.604 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.73 143.25 29.81 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.058 1.839 . . . . 1.0 112.228 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 18.84 75.84 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.86 143.07 56.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 1.0 110.389 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.73 -18.48 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.588 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 tp -105.72 117.15 33.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 110.236 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.4 ' O ' ' CB ' ' D' ' 40' ' ' SER . 5.1 pt -154.3 89.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.231 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.515 ' O ' ' N ' ' D' ' 44' ' ' ALA . 0.4 OUTLIER 169.57 112.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.98 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.465 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 13.5 m-85 -48.73 -53.96 31.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.76 -30.3 92.19 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.202 1.268 . . . . 1.0 112.013 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.13 -20.08 21.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.036 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' D' ' 40' ' ' SER . . . -61.16 -42.72 99.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.854 0.359 . . . . 1.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . 0.442 ' O ' ' OG ' ' D' ' 48' ' ' SER . 6.7 tt -65.4 -38.06 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.425 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.26 99.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.107 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.435 ' CE3' ' N ' ' D' ' 48' ' ' SER . 1.9 t90 -63.96 -40.15 95.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.466 -0.494 . . . . 1.0 109.975 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 78.6 p -60.17 -33.25 71.93 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.582 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.53 -44.33 99.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.312 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.461 ' OE2' ' CZ ' ' A' ' 68' ' ' ARG . 74.3 mt-10 -52.36 -31.96 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.598 ' C ' ' H ' ' D' ' 53' ' ' THR . 0.2 OUTLIER -83.39 -163.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.35 0.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.134 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.598 ' H ' ' C ' ' D' ' 51' ' ' THR . 28.8 p -121.28 -1.2 9.74 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' D' ' 53' ' ' THR . 11.8 p 56.88 15.08 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -91.33 -53.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.705 0.288 . . . . 1.0 110.457 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.03 74.45 0.23 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.56 -47.28 86.86 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.974 -0.29 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 155.65 -90.77 0.12 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' D' ' 50' ' ' GLU . 98.0 m-20 44.05 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 1.0 110.424 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.489 ' N ' ' O ' ' D' ' 58' ' ' GLY . 0.0 OUTLIER -124.62 162.54 23.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.736 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -162.75 138.95 5.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.528 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 157.53 57.24 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.893 1.729 . . . . 1.0 112.617 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.628 ' CG2' ' H ' ' D' ' 64' ' ' THR . 7.4 p -93.81 -121.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.495 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.628 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 39.9 m -115.0 -35.05 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.757 0.313 . . . . 1.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.525 ' C ' ' H ' ' D' ' 67' ' ' GLY . 51.9 tp10 -65.74 -32.09 73.44 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.232 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.5 OUTLIER -81.09 37.29 0.43 Allowed 'General case' 0 C--O 1.261 1.67 0 CA-C-O 123.349 1.547 . . . . 1.0 108.909 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 39.96 62.4 1.47 Allowed Glycine 0 C--O 1.214 -1.094 0 CA-C-N 113.663 -1.608 . . . . 1.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.537 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.5 ttt85 -24.5 -30.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.133 0.549 . . . . 1.0 111.323 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.5 mttm -53.12 -13.85 0.55 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.214 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.5 t -60.47 -48.73 87.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 C-N-CA 119.437 -0.905 . . . . 1.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.08 76.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.277 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.95 -38.85 92.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.329 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.25 -50.52 72.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.395 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.86 -42.93 89.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.368 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 34.4 ttm -58.08 -47.35 83.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.994 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -65.02 -40.05 94.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.614 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.04 81.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.5 94.64 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.3 -43.34 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.425 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' D' ' 84' ' ' LEU . 97.0 mt-10 -58.55 -50.73 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.836 0.309 . . . . 1.0 111.836 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 11.4 m -60.84 -46.11 96.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.516 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -66.24 -29.58 69.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.592 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -91.04 -20.76 21.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.575 0.226 . . . . 1.0 110.585 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 80' ' ' GLU . 8.0 tt -63.73 -42.03 97.96 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.541 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' D' ' 88' ' ' ALA . 8.7 m -60.18 -18.93 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.058 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 50.9 m -36.29 -28.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -62.97 -46.21 88.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.531 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -67.22 -26.35 66.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.178 0.514 . . . . 1.0 110.241 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 4.2 mm? -73.02 -34.73 66.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.9 -45.09 93.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.95 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -4.87 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.006 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -59.4 -50.26 74.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.965 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 21.7 p90 -73.96 -26.88 60.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.008 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.98 -26.28 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.219 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -57.32 -22.51 42.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.851 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -62.2 -20.76 64.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.565 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' D' ' 99' ' ' GLU . 60.7 tt0 -120.45 164.88 15.72 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.23 -73.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.841 0.353 . . . . 1.0 110.728 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' D' ' 97' ' ' GLU . 80.2 mm-40 -56.15 -48.82 75.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.37 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -65.38 -43.05 91.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.317 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -120.23 108.79 14.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.25 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.23 29.08 9.9 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.849 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' ALA . 23.3 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 50.25 174.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 66.3 t0 -105.52 -29.04 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.507 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.6 p80 -81.02 -30.27 34.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.711 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.38 -45.69 83.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 1.0 110.813 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.46 -35.1 75.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.33 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.05 -40.32 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.213 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.75 92.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.391 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -63.31 -33.96 76.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.3 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.02 81.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.128 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.45 -39.45 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -62.25 -37.35 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.239 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.7 -31.07 71.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.572 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -42.31 98.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.438 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.99 -39.34 94.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.12 -40.27 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 1.0 111.328 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.17 -41.07 91.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.662 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.61 -41.61 95.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 23' ' ' SER . 96.4 mt-10 -62.73 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.3 -38.39 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.308 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.4 90.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.796 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 78.1 p -60.14 -41.19 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.31 -30.01 70.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.37 -40.73 20.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.652 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CG ' ' A' ' 30' ' ' GLU . . . -64.83 -40.44 95.19 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.78 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.414 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 7.5 p -61.47 -50.29 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.608 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.414 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 15.5 pt-20 -71.03 -43.29 68.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.545 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.99 73.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 21.7 mm-40 -67.72 -39.43 84.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.144 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -71.68 129.91 39.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.909 0.385 . . . . 1.0 110.313 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.02 -12.21 67.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.346 -0.702 . . . . 1.0 111.346 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.68 147.91 47.52 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -75.21 138.88 23.09 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.034 1.822 . . . . 1.0 112.306 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.39 69.22 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.59 54.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 1.0 110.396 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.48 -7.85 8.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.405 ' C ' ' CD2' ' A' ' 38' ' ' LEU . 6.9 tt -107.13 123.1 47.76 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.064 0.459 . . . . 1.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.457 ' O ' ' O ' ' A' ' 40' ' ' SER . 44.3 pt -149.93 -171.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.104 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' ILE . 2.0 m 58.16 145.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.944 0.402 . . . . 1.0 110.623 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.562 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 65.0 t80 -82.7 -43.22 0.92 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.13 -0.486 . . . . 1.0 112.116 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.8 Cg_endo -60.4 -28.71 87.28 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.657 1.571 . . . . 1.0 112.829 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.7 p-10 -94.02 -28.92 15.48 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.99 -0.284 . . . . 1.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.17 83.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.271 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.82 -42.41 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.047 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.412 ' CD1' ' CG2' ' B' ' 64' ' ' THR . 0.1 OUTLIER -62.88 -41.39 99.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.019 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 13.5 t90 -60.15 -39.28 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -72.87 67.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -151.99 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.007 0.432 . . . . 1.0 110.362 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.591 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.7 pm0 -48.16 -24.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.539 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -43.67 98.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.989 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.25 -28.09 67.77 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.236 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.4 p -84.32 5.63 26.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 48.05 76.61 0.11 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.899 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -138.98 -55.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.879 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.94 77.02 0.19 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.276 -0.73 . . . . 1.0 111.276 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.452 ' OH ' ' SD ' ' B' ' 75' ' ' MET . 75.4 m-85 -60.75 -42.77 98.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.46 9.92 1.32 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.535 ' CG ' HH22 ' B' ' 68' ' ' ARG . 20.8 m-20 -58.1 -50.08 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -147.95 163.89 35.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.46 132.85 7.15 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.446 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.3 163.19 39.59 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.075 1.85 . . . . 1.0 112.394 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.0 t -97.78 -128.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.413 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 8.6 m -115.01 -36.57 4.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.68 0.276 . . . . 1.0 110.979 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.713 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.4 tt0 -70.79 -39.41 73.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.748 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.79 27.53 0.02 OUTLIER 'General case' 0 C--O 1.265 1.899 0 CA-C-O 123.753 1.74 . . . . 1.0 109.925 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.713 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 39.16 64.35 0.96 Allowed Glycine 0 C--O 1.214 -1.117 0 CA-C-N 114.035 -1.438 . . . . 1.0 111.392 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 33.0 ttm180 -24.93 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.806 0.803 . . . . 1.0 110.969 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -50.44 -16.72 0.38 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.451 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.8 t -61.38 -48.09 90.47 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.342 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' A' ' 75' ' ' MET . . . -70.84 -42.8 69.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.007 0.432 . . . . 1.0 110.442 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.59 -43.17 46.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.474 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -62.26 -39.64 93.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.04 -43.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' A' ' 71' ' ' ALA . 3.4 mpp? -61.63 -40.2 94.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.021 -0.272 . . . . 1.0 110.503 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -61.33 -39.92 92.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.061 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -51.4 -45.98 62.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.487 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -51.45 53.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.486 -1.046 . . . . 1.0 110.486 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.415 HG21 HD11 ' A' ' 79' ' ' ILE . 95.6 mt -67.95 -4.78 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.472 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -96.17 -49.72 5.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.427 -0.352 . . . . 1.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.437 ' CG2' ' N ' ' A' ' 82' ' ' PHE . 28.3 m -70.8 -51.0 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.06 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' N ' ' CG2' ' A' ' 81' ' ' VAL . 45.6 m-85 -62.39 -39.18 92.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.073 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -61.15 -39.57 90.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.715 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' A' ' 86' ' ' THR . 5.5 tt -63.48 -40.35 96.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.505 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 59.1 t -49.7 -11.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.429 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.5 ' H ' ' C ' ' A' ' 84' ' ' LEU . 54.5 m -49.28 -42.49 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 1.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.73 -13.61 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.68 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 86' ' ' THR . . . -104.75 -15.92 15.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.683 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.1 mm? -94.84 -46.68 6.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 1.0 110.677 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.03 -22.74 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -3.67 58.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.748 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.65 -48.78 79.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.343 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.58 -19.57 45.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.765 0.317 . . . . 1.0 111.454 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.08 -42.73 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.904 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 98' ' ' GLU . 95.9 mtt-85 -58.06 -21.53 46.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.712 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -55.1 -42.85 73.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.546 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 97' ' ' GLU . 56.3 mp0 -74.74 0.33 15.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 1.0 110.085 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.519 ' C ' ' H ' ' A' ' 100' ' ' ARG . 96.9 mt-10 -129.18 168.7 15.77 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.091 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 66.73 -43.05 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.767 0.667 . . . . 1.0 110.393 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.519 ' H ' ' C ' ' A' ' 98' ' ' GLU . 70.6 ttp85 -61.71 -43.89 97.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.591 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -97.18 -1.23 45.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.572 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.2 18.55 79.25 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.033 -0.984 . . . . 1.0 110.57 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.97 165.53 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.82 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.725 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -73.1 -35.43 66.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.714 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.26 -43.89 89.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.79 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.02 -38.89 92.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.68 -37.56 87.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.43 99.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.758 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.05 -35.73 76.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.334 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.41 -38.54 87.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.32 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.935 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.98 -34.78 78.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.562 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -62.79 -38.35 90.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.137 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.03 -33.05 74.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.36 -41.92 98.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.506 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.11 -39.11 93.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.89 -44.23 97.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.22 -40.86 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.786 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.36 -41.69 94.21 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.054 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.456 ' O ' ' OG ' ' B' ' 23' ' ' SER . 98.8 mt-10 -63.3 -48.17 79.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.118 0.485 . . . . 1.0 110.056 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.49 -35.85 75.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.128 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.52 86.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.35 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 91.5 p -56.58 -44.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.466 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.77 -36.2 82.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' B' ' 29' ' ' ALA . 69.1 mmtt -67.98 -44.42 76.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.833 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.31 76.76 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.463 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.82 -45.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.768 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 46.2 tp10 -71.9 -42.0 67.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.85 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.4 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -43.7 -47.38 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.327 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' B' ' 38' ' ' LEU . 96.9 mt-10 -68.21 -116.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.809 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 45.67 79.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.596 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.26 17.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.413 -0.675 . . . . 1.0 111.413 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 149.7 96.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.24 121.27 6.03 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.953 1.769 . . . . 1.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 92.83 -23.06 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 49.94 175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 1.0 110.579 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.77 -85.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.552 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.529 ' N ' ' OE2' ' B' ' 30' ' ' GLU . 44.9 tp -89.93 82.3 6.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.454 ' O ' ' OG ' ' B' ' 40' ' ' SER . 15.2 tt -125.97 102.07 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.963 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.516 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 73.4 m -169.94 -124.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' B' ' 40' ' ' SER . 2.3 m-85 -174.77 -65.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.0 109.995 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.15 -36.94 97.44 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.088 1.859 . . . . 1.0 112.175 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' B' ' 43' ' ' ASP . 9.7 p-10 -92.98 0.91 57.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.617 -0.265 . . . . 1.0 111.145 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.06 93.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.003 0.43 . . . . 1.0 110.343 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -69.47 -36.61 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.546 ' O ' ' NH2' ' C' ' 68' ' ' ARG . 1.1 t90 -46.54 -68.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.647 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.467 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -57.16 -27.18 61.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.059 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.467 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -65.47 -41.77 92.97 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.701 -0.399 . . . . 1.0 111.347 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.554 ' CG1' HH12 ' C' ' 68' ' ' ARG . 55.5 t -60.95 -47.74 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.405 ' O ' ' OG1' ' B' ' 53' ' ' THR . 11.3 pt-20 -68.06 -31.59 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.571 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -60.5 -45.38 94.0 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.22 -27.57 55.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.813 -179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 61.1 p -85.43 1.52 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.723 0.297 . . . . 1.0 110.755 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 4.6 p 53.41 15.69 0.75 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.005 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' B' ' 56' ' ' GLY . 5.7 p -66.36 -44.69 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.02 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.483 ' N ' ' CG1' ' B' ' 55' ' ' VAL . . . 46.3 65.22 2.19 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.47 -1.052 . . . . 1.0 110.47 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -58.98 -48.47 81.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 1.0 110.743 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.69 6.82 1.96 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -58.93 -45.62 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.644 0.259 . . . . 1.0 110.419 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -145.19 173.22 12.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -155.95 130.33 4.92 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.41 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.02 156.92 63.79 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.769 1.646 . . . . 1.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.425 ' H ' ' HG2' ' B' ' 66' ' ' GLU . 1.8 t -84.03 -141.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.171 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.412 ' CG2' ' CD1' ' A' ' 46' ' ' TRP . 3.8 m -114.36 -46.54 2.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.24 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.651 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.9 tp10 -64.5 -29.18 70.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.355 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.425 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.3 OUTLIER -70.84 32.18 0.04 OUTLIER 'General case' 0 C--O 1.261 1.663 0 CA-C-O 123.889 1.804 . . . . 1.0 110.078 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.723 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.84 62.85 1.6 Allowed Glycine 0 C--O 1.208 -1.48 0 CA-C-N 113.827 -1.533 . . . . 1.0 111.338 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.535 HH22 ' CG ' ' A' ' 59' ' ' ASP . 27.4 ttt85 -25.1 -31.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.075 0.937 . . . . 1.0 110.866 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -52.47 -14.97 0.55 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 67' ' ' GLY . 43.4 t -61.83 -46.43 96.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.364 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.05 67.18 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -57.18 -41.63 79.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.036 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.45 -44.35 94.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.08 -46.01 92.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.117 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.452 ' SD ' ' OH ' ' A' ' 57' ' ' TYR . 73.5 mtm -62.93 -42.72 99.89 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.432 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -63.86 -41.6 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.343 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.06 88.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -39.12 94.47 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.423 HG21 HD13 ' B' ' 79' ' ' ILE . 96.0 mt -68.94 -26.78 33.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.58 -0.365 . . . . 1.0 111.293 -179.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.9 -51.61 25.1 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.052 0.453 . . . . 1.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 m -60.41 -47.86 90.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.17 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -67.81 -38.56 83.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.802 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.07 -36.92 85.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.536 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.454 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.6 tt -61.72 -41.52 97.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 93.4 t -49.79 -17.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.454 ' N ' ' C ' ' B' ' 84' ' ' LEU . 75.1 m -52.38 -40.87 62.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.464 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.15 -55.06 7.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.841 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -12.69 54.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 81.5 mt -98.21 -27.14 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -64.85 -24.62 67.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.382 0.61 . . . . 1.0 109.858 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.536 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.1 OUTLIER -84.52 -4.72 59.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.0 109.61 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.67 -48.93 74.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.82 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 7.9 p90 -66.56 -31.81 72.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.54 -44.32 96.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.232 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 83.7 mtt85 -60.08 -28.72 68.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.147 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -56.06 -42.23 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.55 -40.5 97.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.044 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.25 -36.11 82.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.596 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -66.13 -38.59 88.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.634 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -63.09 -43.37 98.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.507 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -112.22 112.76 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.2 -18.83 47.87 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.561 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' SER . . . . . 0.427 ' HG ' HH21 ' C' ' 6' ' ' ARG . 60.6 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.56 145.27 54.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.827 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -61.98 -40.99 97.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.618 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 23.3 p80 -67.11 -41.07 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.618 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.6 tt0 -62.67 -39.8 95.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.719 0.295 . . . . 1.0 110.537 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . 0.427 HH21 ' HG ' ' C' ' 1' ' ' SER . 34.5 mmt180 -65.1 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 1.0 110.257 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -64.72 -39.61 93.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.92 98.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.463 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.82 -40.82 92.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.245 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.85 -35.39 80.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.327 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.89 76.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.056 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.65 -39.59 91.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 1.0 110.877 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.49 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.742 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.73 -37.81 88.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 40.8 tp -61.55 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.427 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -59.98 -31.35 69.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -61.55 -40.1 93.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.73 0.3 . . . . 1.0 111.132 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.81 -42.35 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.847 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.64 -41.7 97.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.107 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.448 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.7 mt-10 -63.31 -46.62 85.85 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.008 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 0.2 OUTLIER -70.6 -39.08 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.112 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.95 82.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.7 p -53.34 -45.77 69.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.192 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -65.08 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.215 0.531 . . . . 1.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.5 -37.9 82.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -53.51 57.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.75 0.31 . . . . 1.0 111.065 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.84 -41.45 92.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -68.14 -44.08 76.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.524 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.11 80.56 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.09 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.6 -39.4 73.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.316 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -68.38 129.09 38.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 120.943 0.401 . . . . 1.0 110.28 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.44 -0.46 65.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.334 -0.706 . . . . 1.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.37 149.9 38.31 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.43 -0.211 . . . . 1.0 110.43 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.07 139.88 22.07 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.816 1.677 . . . . 1.0 112.369 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 2.69 57.9 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.5 103.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.78 0.324 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.44 -35.46 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.393 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 15.0 tp -87.08 95.07 9.82 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.119 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 33.4 pt -138.52 49.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 1.0 110.713 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -138.66 145.3 40.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.162 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.526 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 35.9 m-85 -69.52 -50.87 17.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.3 Cg_endo -58.98 -38.54 87.43 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.727 1.618 . . . . 1.0 112.433 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.08 -11.29 59.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.221 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.86 81.71 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.788 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.456 ' O ' ' OG ' ' C' ' 48' ' ' SER . 6.3 tt -72.93 -38.89 57.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.028 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.486 ' C ' ' NH1' ' D' ' 68' ' ' ARG . 0.5 OUTLIER -63.64 -46.52 85.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.64 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' C' ' 48' ' ' SER . 3.1 t90 -61.18 -39.64 90.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 1.0 109.553 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' C' ' 45' ' ' ILE . 60.7 p -61.63 -34.53 75.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.96 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.2 t -61.46 -48.28 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.478 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.65 -21.29 62.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.274 -0.571 . . . . 1.0 110.58 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -75.48 -42.2 53.58 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.796 0.331 . . . . 1.0 111.367 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.41 80.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.899 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.424 ' O ' ' OG1' ' C' ' 54' ' ' THR . 54.5 p -74.85 -11.99 60.27 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' C' ' 53' ' ' THR . 1.3 p 69.88 0.85 3.21 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.636 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 56.0 t -65.21 -45.09 94.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.723 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.32 79.02 0.06 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -60.3 -46.64 89.16 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.811 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.04 23.27 0.69 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.49 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 21.8 t0 -61.65 -41.17 97.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 1.0 110.305 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -145.49 -161.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.961 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 13.4 p90 -172.17 112.37 0.38 Allowed Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.986 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -170.64 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.613 1.542 . . . . 1.0 112.126 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.658 ' CG2' ' H ' ' C' ' 64' ' ' THR . 9.9 p -139.12 -169.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.375 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.658 ' H ' ' CG2' ' C' ' 63' ' ' VAL . 11.4 m -77.25 -45.91 24.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 1.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.617 ' C ' ' H ' ' C' ' 67' ' ' GLY . 49.0 tp10 -47.49 -50.51 23.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.91 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.427 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.9 OUTLIER -72.17 35.76 0.06 Allowed 'General case' 0 C--O 1.264 1.838 0 CA-C-O 124.28 1.991 . . . . 1.0 109.859 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.85 65.88 1.46 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.76 -1.564 . . . . 1.0 111.54 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.554 HH12 ' CG1' ' B' ' 49' ' ' VAL . 8.2 ptm180 -21.33 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.775 0.798 . . . . 1.0 111.657 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.6 mmtt -43.84 -18.6 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.273 -1.331 . . . . 1.0 109.588 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' C' ' 68' ' ' ARG . 54.5 t -59.29 -44.91 93.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.453 -0.899 . . . . 1.0 110.189 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.87 63.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.966 0.412 . . . . 1.0 110.764 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.33 -35.27 79.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.955 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.93 -52.45 64.98 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.671 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.27 -43.55 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.773 0.321 . . . . 1.0 111.175 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' B' ' 55' ' ' VAL . 19.1 ttp -59.62 -43.73 93.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 56.6 tttm -63.47 -42.49 98.59 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.583 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.14 -39.78 95.68 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.467 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.17 -44.56 93.77 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.203 -0.522 . . . . 1.0 111.917 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.94 -43.12 97.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.676 0.274 . . . . 1.0 110.736 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.0 mt-10 -64.63 -39.4 93.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.328 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.82 -48.72 85.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.405 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -64.18 -41.9 96.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.204 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.31 -36.0 82.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.859 0.361 . . . . 1.0 110.593 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.5 tt -61.66 -33.89 74.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.519 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 98.0 t -54.29 -4.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.374 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 88' ' ' ALA . 6.0 t -62.73 -39.45 94.13 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.118 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -40.09 -21.96 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.545 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -101.85 -38.35 7.87 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.215 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' C' ' 86' ' ' THR . 30.9 mt -74.03 -42.14 60.76 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.941 0.4 . . . . 1.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -55.73 -32.34 63.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.266 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.14 -4.01 45.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.095 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -59.06 -47.8 83.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.753 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 11.6 p90 -70.15 -29.63 66.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.08 -43.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.674 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' C' ' 98' ' ' GLU . 95.4 mtt180 -58.7 -23.07 58.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.427 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -40.59 -37.18 0.68 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.31 -40.58 93.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.375 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 95' ' ' ARG . 97.4 mt-10 -66.99 -42.3 85.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.94 0.4 . . . . 1.0 110.457 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.77 -47.52 71.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.44 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -65.31 -42.79 92.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.89 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -109.95 114.12 27.39 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.401 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.38 -10.62 46.75 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.499 ' ND1' ' OXT' ' C' ' 103' ' ' HIS . 59.0 t-80 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.984 -1.008 . . . . 1.0 110.588 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.0 -92.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.508 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -158.78 -43.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.431 ' HD1' ' CB ' ' D' ' 88' ' ' ALA . 10.1 p80 -79.68 -20.15 47.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.811 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.27 -35.71 81.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 1.0 110.563 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.08 -40.93 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.53 -43.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 1.0 109.965 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.48 -38.38 89.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.832 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 68.8 tp60 -64.45 -41.0 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.407 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.4 -38.46 89.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.733 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -28.66 65.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.095 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -62.69 -40.98 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 1.0 110.952 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' D' ' 9' ' ' GLN . 58.2 mp0 -66.32 -33.73 76.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.08 -37.79 86.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.457 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 46.0 tp -62.81 -41.68 99.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.0 110.458 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.78 -34.76 76.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.144 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -61.86 -44.0 97.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.835 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -64.08 -36.13 75.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.885 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . 0.437 ' O ' ' OG ' ' D' ' 23' ' ' SER . 91.2 mt -60.88 -42.16 97.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.21 -47.73 72.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -66.77 -36.84 83.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.665 -0.414 . . . . 1.0 109.894 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -29.07 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.764 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 69.2 m -59.12 -45.85 89.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.997 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.442 ' HG3' ' N ' ' D' ' 25' ' ' LYS . 13.5 ptpt -66.59 -39.12 88.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.442 ' N ' ' HG3' ' D' ' 24' ' ' LYS . 98.2 mttt -62.05 -45.34 93.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.611 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.433 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 90.1 t -65.6 -45.77 91.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.264 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -69.46 -42.49 74.82 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.575 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.81 91.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.631 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.455 ' OE1' ' CG2' ' D' ' 39' ' ' ILE . 11.8 tm-20 -67.2 -39.76 86.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.45 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -61.39 115.64 4.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.841 0.353 . . . . 1.0 110.652 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.98 -13.69 57.45 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.22 111.53 55.32 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.27 149.26 35.38 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.915 1.743 . . . . 1.0 112.688 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.69 73.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.73 164.32 16.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 1.0 110.478 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -145.98 84.56 1.66 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.433 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.5 tt -173.94 79.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.233 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' D' ' 40' ' ' SER . 10.1 pt -127.48 164.65 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.015 0.436 . . . . 1.0 110.606 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 81.24 123.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.438 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 54.0 m-85 -59.57 -47.07 98.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.953 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.59 -33.61 98.26 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.572 1.515 . . . . 1.0 112.267 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.7 -29.38 16.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.049 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.02 94.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.684 0.278 . . . . 1.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 tt -63.36 -32.17 55.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.154 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -59.72 -46.63 88.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.884 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' D' ' 51' ' ' THR . 0.7 OUTLIER -67.29 -40.01 86.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.466 -0.493 . . . . 1.0 110.037 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 4.3 t -56.72 -40.0 74.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.459 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.79 -48.64 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.434 ' O ' ' OG1' ' D' ' 53' ' ' THR . 80.7 mm-40 -67.54 -31.63 71.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.911 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' D' ' 47' ' ' TRP . 87.9 m -64.29 -45.17 89.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.572 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.93 -25.98 65.58 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.599 -0.441 . . . . 1.0 110.16 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 9.3 p -88.37 6.08 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 1.0 110.324 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.453 ' O ' ' OG1' ' D' ' 54' ' ' THR . 3.4 p 42.02 67.75 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.203 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.417 ' CG2' ' HG1' ' D' ' 53' ' ' THR . 1.2 m -135.16 -40.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.432 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.43 78.51 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.506 -1.037 . . . . 1.0 110.506 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -44.65 96.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 1.0 110.629 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.63 -0.35 3.05 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.71 -0.956 . . . . 1.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 97.5 m-20 -56.8 -50.38 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -130.95 140.78 50.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' D' ' 61' ' ' TYR . 21.3 p90 -130.47 105.25 15.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.786 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.65 154.29 68.35 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.966 1.777 . . . . 1.0 112.258 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.08 -162.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.248 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.408 ' OG1' ' CD1' ' C' ' 46' ' ' TRP . 55.1 m -87.77 -20.96 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -77.55 -13.59 59.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.665 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.411 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.8 OUTLIER -103.75 28.26 6.76 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 124.293 1.997 . . . . 1.0 108.521 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.84 60.47 4.9 Favored Glycine 0 C--O 1.211 -1.285 0 CA-C-N 113.831 -1.531 . . . . 1.0 109.761 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.49 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 42.5 ttm180 -26.93 -28.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 117.351 0.576 . . . . 1.0 111.046 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 64.0 mttm -57.33 -15.14 5.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.188 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.3 t -60.73 -47.99 90.7 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 119.417 -0.913 . . . . 1.0 109.388 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . 0.545 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -65.63 -48.69 71.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.876 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -42.87 -59.33 2.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.338 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -48.93 -39.51 26.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.717 0.266 . . . . 1.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.0 t -62.23 -42.93 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.529 -0.468 . . . . 1.0 111.614 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 2.6 mpp? -59.02 -40.03 83.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.925 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.76 -39.5 88.97 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.55 -40.28 96.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.044 -0.663 . . . . 1.0 110.716 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -73.29 -44.46 34.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.36 -44.23 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.076 -0.25 . . . . 1.0 111.397 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.94 -44.02 86.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.374 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 53.2 t -63.95 -48.55 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.464 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.93 -15.9 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.846 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -95.57 -25.96 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 1.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.92 -42.33 94.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.487 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.488 ' O ' ' N ' ' D' ' 87' ' ' ALA . 15.0 m -58.7 -18.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.015 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 41.2 m -36.95 -29.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.998 0.427 . . . . 1.0 110.488 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -58.94 -62.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.715 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.431 ' CB ' ' HD1' ' D' ' 4' ' ' HIS . . . -53.99 -37.38 63.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.169 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.474 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 4.2 mm? -66.03 -37.42 85.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.593 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -66.0 -66.13 0.59 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.626 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.449 ' O ' ' CG2' ' D' ' 94' ' ' VAL . 0.4 OUTLIER -49.18 -4.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.879 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . 0.593 ' H ' ' C ' ' D' ' 90' ' ' ALA . 25.9 t0 -67.22 -21.21 65.76 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 1.0 111.356 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.505 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 2.3 p90 -77.41 -18.21 57.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.874 0.369 . . . . 1.0 111.194 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.449 ' CG2' ' O ' ' D' ' 91' ' ' THR . 7.7 m -60.41 -40.05 82.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.576 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . 0.412 ' H ' HG22 ' D' ' 94' ' ' VAL . 99.8 mtt180 -49.69 -22.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.625 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -60.9 -41.97 97.11 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -92.06 -34.68 14.29 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' D' ' 100' ' ' ARG . 80.0 mm-40 -94.6 -176.1 3.8 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 58.94 -71.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.65 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' D' ' 98' ' ' GLU . 77.5 ttt-85 -58.11 -43.65 87.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.222 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.49 108.28 14.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.285 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' D' ' 103' ' ' HIS . . . 104.52 -4.02 43.25 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.315 -0.714 . . . . 1.0 111.315 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' D' ' 102' ' ' GLY . 26.5 p80 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.074 -0.965 . . . . 1.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.536 ' C ' ' H ' ' A' ' 3' ' ' ASP . 29.8 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.88 8.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.545 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' A' ' 1' ' ' SER . 98.2 m-20 55.01 30.33 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 7.6 p80 -162.0 -37.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.925 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.637 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 44.1 tt0 -65.56 -42.45 91.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -64.09 -41.65 97.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.113 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.78 -34.24 75.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.36 -50.76 72.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -67.48 -33.32 74.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.439 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.68 -36.18 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.458 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.51 77.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.972 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -40.55 94.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.526 -0.306 . . . . 1.0 110.632 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -63.48 -33.57 75.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 1.0 110.493 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.21 -41.43 98.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.359 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.4 tp -66.65 -39.47 88.24 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.027 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -49.62 -51.0 40.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.828 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -74.77 -31.27 61.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.495 -0.482 . . . . 1.0 112.069 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.51 -48.22 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.088 -0.245 . . . . 1.0 111.588 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.03 -28.88 66.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.197 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -61.2 -46.78 89.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.4 -39.51 92.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 1.0 109.675 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.9 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.201 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.41 ' OG ' ' OG ' ' A' ' 48' ' ' SER . 37.2 m -54.25 -40.69 67.99 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -62.73 -31.72 72.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.885 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.94 -39.3 34.96 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.902 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.58 88.58 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 7.6 p -61.08 -46.05 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.359 -0.536 . . . . 1.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 80.5 tt0 -67.19 -42.24 84.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.229 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.38 98.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.847 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' CG ' ' H ' ' A' ' 37' ' ' ALA . 31.5 tp10 -74.01 -42.62 60.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.592 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -70.85 126.82 30.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.234 0.54 . . . . 1.0 110.819 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.48 59.63 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.387 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.18 151.78 38.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.66 117.27 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.048 1.832 . . . . 1.0 111.751 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 94.87 20.64 27.99 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -39.52 162.49 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.65 0.262 . . . . 1.0 110.629 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.549 ' H ' ' CG ' ' A' ' 30' ' ' GLU . . . -136.37 -71.84 0.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.725 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.59 128.27 35.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.08 163.12 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.028 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.7 OUTLIER 81.33 153.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.717 0.294 . . . . 1.0 110.684 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 13.3 t80 -83.15 -50.52 0.7 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.817 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.24 -28.66 87.33 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.421 1.414 . . . . 1.0 112.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 25.1 m-20 -90.25 -28.94 18.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.87 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.2 -36.67 84.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.0 110.333 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 tt -62.3 -37.97 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.287 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -47.81 81.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 2.8 t90 -66.09 -39.06 89.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.411 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 21.5 m -57.1 -39.77 75.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.858 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 53.7 t -61.33 -46.84 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.056 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 98.9 mt-10 -65.48 -44.33 87.42 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 3.0 m -62.04 -43.8 98.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.269 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -48.53 -52.17 23.9 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.388 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.449 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -86.12 7.6 24.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 56' ' ' GLY . 6.4 p 63.33 -133.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.574 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' OG1' ' A' ' 54' ' ' THR . 47.2 t 64.05 -40.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.547 0.529 . . . . 1.0 111.582 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.513 ' H ' ' C ' ' A' ' 54' ' ' THR . . . 37.06 90.67 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.51 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 53.8 t80 -60.03 -45.84 91.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 1.0 110.462 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.19 7.59 1.09 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.24 -47.0 86.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 1.0 110.156 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -146.09 154.46 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.07 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 27.9 p90 -137.83 130.07 16.4 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.36 154.01 69.93 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.12 1.88 . . . . 1.0 112.518 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.59 ' CG2' ' H ' ' A' ' 64' ' ' THR . 6.2 p -75.74 -141.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.459 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.59 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 4.7 m -116.42 -39.2 3.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.678 0.275 . . . . 1.0 111.099 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.651 ' C ' ' H ' ' A' ' 67' ' ' GLY . 80.2 tt0 -77.67 -11.93 59.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.225 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -71.66 23.36 0.05 OUTLIER 'General case' 0 C--O 1.259 1.605 0 CA-C-O 123.933 1.825 . . . . 1.0 109.837 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.36 69.43 1.08 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 117.561 -1.688 . . . . 1.0 112.566 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.494 ' CB ' ' CE2' ' D' ' 46' ' ' TRP . 0.6 OUTLIER -24.39 -32.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.974 1.387 . . . . 1.0 110.665 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 67' ' ' GLY . 64.0 mttp -50.8 -33.72 24.66 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.316 -0.856 . . . . 1.0 109.888 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 67' ' ' GLY . 61.2 t -61.84 -49.75 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 119.4 -0.92 . . . . 1.0 110.576 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.41 -46.17 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CG1' ' D' ' 49' ' ' VAL . 77.5 tt0 -58.23 -38.84 77.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.735 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.57 -46.11 77.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.769 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.74 -42.24 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.269 -0.573 . . . . 1.0 111.498 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.3 mtt -52.94 -44.66 67.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.852 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.37 -46.34 83.8 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.04 92.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.58 -23.83 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.739 -0.271 . . . . 1.0 111.258 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -67.6 -45.72 74.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.402 HG22 ' N ' ' A' ' 82' ' ' PHE . 6.9 m -63.77 -43.99 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.837 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 78' ' ' GLY . 40.3 m-85 -67.39 -37.28 82.89 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.054 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.76 -40.97 97.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.046 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' C ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -63.1 -36.15 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.453 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 80.8 t -53.56 -15.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.942 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.411 ' N ' ' C ' ' A' ' 84' ' ' LEU . 9.8 t -48.42 -38.01 18.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.305 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -49.86 -29.51 8.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.473 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.36 29.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.788 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 86' ' ' THR . 32.6 mt -94.41 -58.2 2.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.856 0.36 . . . . 1.0 111.0 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.3 -22.98 33.81 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.454 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.465 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -98.28 -4.72 34.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.264 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.01 -47.17 87.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.233 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 3.8 p90 -58.07 -44.15 87.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.114 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 61.7 t -36.66 -26.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.484 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' PHE . 96.5 mtt180 -61.78 -36.13 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.988 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -49.04 -32.75 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.55 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -61.94 -41.74 98.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -68.12 -42.14 80.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.457 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -68.46 -34.08 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.269 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -59.02 -43.79 91.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.439 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.44 -37.91 88.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.57 57.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.093 -0.803 . . . . 1.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.951 -1.023 . . . . 1.0 110.603 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.46 ' CB ' ' NE2' ' B' ' 4' ' ' HIS . . . -80.63 177.19 9.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.01 -42.86 99.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.053 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.633 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.3 p80 -71.47 -31.95 67.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 1.0 110.567 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.29 -36.36 83.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -63.65 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 1.0 110.622 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.4 -45.17 95.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.946 -0.391 . . . . 1.0 109.946 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -40.93 85.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.61 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.12 -40.12 94.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.52 -38.07 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.513 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.21 -35.5 75.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.004 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.66 -36.09 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.38 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.78 -34.45 78.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.128 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.01 -36.92 85.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.699 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -63.62 -39.34 94.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.54 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.16 -38.41 86.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.978 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -62.27 -39.8 94.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 1.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.19 -41.84 91.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.649 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 90.6 mt -59.56 -41.34 89.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.608 -0.437 . . . . 1.0 109.933 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.81 -50.1 73.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.991 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.98 -33.19 75.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.008 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.6 83.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.332 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.0 t -59.85 -46.15 90.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.297 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.53 -32.59 73.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.475 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.59 -50.02 16.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.659 -0.417 . . . . 1.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.28 95.37 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.467 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 9.8 p -62.51 -46.67 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.156 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 13.0 tm-20 -70.93 -42.16 70.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.9 96.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.4 ' HG2' ' H ' ' B' ' 38' ' ' LEU . 36.3 tp10 -76.25 -41.51 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.85 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.43 111.18 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.971 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.35 -2.8 23.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.2 151.36 37.69 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 110.66 -0.126 . . . . 1.0 110.66 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' B' ' 36' ' ' ALA . 92.4 Cg_endo -74.81 146.66 33.77 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.946 1.764 . . . . 1.0 112.63 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 77.15 -24.01 2.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 37' ' ' ALA . . . 40.77 -166.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.606 0.241 . . . . 1.0 110.701 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' B' ' 36' ' ' ALA . . . 161.85 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.932 0.396 . . . . 1.0 110.117 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.4 ' H ' ' HG2' ' B' ' 30' ' ' GLU . 15.4 tp -154.38 108.89 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 1.0 110.743 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.8 pt -131.84 167.06 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.661 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER 80.83 127.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.586 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 9.3 t80 -72.13 -44.97 11.13 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.981 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.76 -26.62 80.76 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.609 1.54 . . . . 1.0 112.738 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -94.31 -18.92 21.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.696 0.284 . . . . 1.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -66.63 -41.41 88.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.562 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.538 ' CE2' ' O ' ' C' ' 64' ' ' THR . 4.2 t-105 -61.31 -46.14 91.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.374 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.51 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 2.8 t90 -63.1 -39.37 94.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.005 0.431 . . . . 1.0 110.266 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.423 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 6.3 t -62.92 -32.77 74.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.643 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 42.0 t -58.85 -47.55 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.629 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.61 -30.71 69.5 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 1.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.0 m -63.33 -46.48 86.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.432 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.96 81.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.301 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' B' ' 54' ' ' THR . 76.3 p -76.81 3.47 11.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.82 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' B' ' 53' ' ' THR . 58.8 p 51.24 53.77 12.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 50.4 t -125.41 -60.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.544 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.13 84.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.24 -41.16 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.302 . . . . 1.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.61 26.91 0.16 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -61.65 -47.53 84.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 1.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.539 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 94.0 mtt-85 -144.1 -169.55 3.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 52.2 m-85 -159.71 110.28 1.47 Allowed Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.433 -0.317 . . . . 1.0 110.437 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.416 1.41 . . . . 1.0 112.238 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.656 ' CG2' ' H ' ' B' ' 64' ' ' THR . 9.9 p -95.06 -165.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.656 ' H ' ' CG2' ' B' ' 63' ' ' VAL . 52.4 m -91.07 -37.69 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 1.0 110.602 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' B' ' 67' ' ' GLY . 65.5 tt0 -60.79 -31.87 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.483 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -75.33 28.04 0.1 Allowed 'General case' 0 C--O 1.262 1.727 0 CA-C-O 124.028 1.87 . . . . 1.0 109.386 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.709 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 45.58 65.48 1.93 Allowed Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.786 -1.552 . . . . 1.0 111.31 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.471 ' C ' ' O ' ' B' ' 67' ' ' GLY . 59.5 ttp85 -24.58 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.906 0.853 . . . . 1.0 110.572 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.2 mmtt -46.2 -22.59 0.25 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' B' ' 67' ' ' GLY . 69.6 t -61.8 -44.85 99.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 119.517 -0.873 . . . . 1.0 109.585 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.524 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -72.08 -51.0 23.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.733 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -55.29 -40.25 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.59 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.0 -45.79 89.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.942 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.98 -44.78 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.4 mpp? -63.19 -41.45 99.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.35 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -63.97 -42.13 97.35 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.445 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.54 -41.12 93.85 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.511 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.22 -44.8 93.26 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.85 -43.84 99.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.881 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.34 -44.86 95.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -48.04 88.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.138 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -71.63 -21.27 61.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.901 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.435 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -93.43 -25.14 17.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.0 110.319 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.5 -40.96 98.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.09 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' ALA . 10.7 m -46.61 -24.65 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 36.9 m -37.44 -24.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.377 0.608 . . . . 1.0 110.384 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -56.01 -39.41 71.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.727 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.62 -11.18 57.63 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.718 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' B' ' 89' ' ' LEU . 5.0 mp -81.76 -4.26 55.91 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.482 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -94.9 -56.67 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.394 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.89 -5.78 0.67 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.06 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' B' ' 93' ' ' PHE . 36.6 p-10 -61.35 -50.4 73.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.157 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 5.3 p90 -71.55 -8.26 52.85 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.829 0.347 . . . . 1.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.11 -26.09 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.417 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.53 -42.61 88.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.58 -0.282 . . . . 1.0 111.432 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.99 -38.03 0.91 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.907 0.384 . . . . 1.0 110.201 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' B' ' 99' ' ' GLU . 97.4 mt-10 -72.21 -167.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.35 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 56.87 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.91 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' B' ' 97' ' ' GLU . 1.1 pp20? -52.06 -19.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.613 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -60.59 -44.89 95.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.347 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -99.13 -2.34 37.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.66 77.26 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.426 ' ND1' ' OXT' ' B' ' 103' ' ' HIS . 59.0 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.925 -1.036 . . . . 1.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' SER . . . . . 0.519 ' C ' ' H ' ' C' ' 3' ' ' ASP . 38.8 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 75.18 -31.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.454 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.519 ' H ' ' C ' ' C' ' 1' ' ' SER . 99.0 m-20 56.61 36.83 28.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.646 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 5.8 p-80 -149.02 -47.99 0.14 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.705 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.646 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 31.5 tp10 -69.37 -36.42 76.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.885 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -64.25 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -61.34 -45.68 93.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.08 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.56 89.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.617 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -65.02 -37.84 88.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.26 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.166 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.54 87.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.038 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.23 -37.14 86.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 1.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.29 -36.33 83.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.851 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.5 -40.67 97.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.342 . . . . 1.0 110.571 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.45 -39.72 88.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.1 -38.87 90.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.817 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.72 -36.22 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.99 -41.66 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.136 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -60.98 -46.36 91.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.994 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -59.76 -38.9 83.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -60.78 -47.85 84.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.291 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -67.86 -36.75 80.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.443 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -78.55 -22.57 47.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.502 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -84.52 -44.7 13.34 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.251 0.344 . . . . 1.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.483 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 8.4 p -61.99 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 1.0 109.891 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.483 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 2.9 pp20? -66.22 -31.39 72.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.643 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.28 -50.95 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.577 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' C' ' 32' ' ' GLY . 80.4 mm-40 -68.37 -37.66 80.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.69 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -57.34 87.58 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.803 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 30' ' ' GLU . . . 127.82 -13.06 6.48 Favored Glycine 0 N--CA 1.466 0.679 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.8 150.95 39.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.283 -0.266 . . . . 1.0 110.283 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . 0.448 ' O ' ' CG2' ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.77 155.93 39.53 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.097 1.864 . . . . 1.0 112.096 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' C' ' 37' ' ' ALA . . . 90.6 -17.4 54.73 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . 0.457 ' O ' ' CB ' ' C' ' 37' ' ' ALA . . . 40.79 -96.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 1.0 110.949 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.457 ' CB ' ' O ' ' C' ' 36' ' ' ALA . . . 80.46 -73.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.789 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.06 122.16 43.07 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tt -149.84 4.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.03 0.443 . . . . 1.0 110.22 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.549 ' HG ' ' H ' ' C' ' 43' ' ' ASP . 1.2 t -94.24 133.39 37.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.883 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 26.5 m-85 -75.04 -53.51 2.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.6 Cg_endo -59.41 -28.55 87.84 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.617 1.544 . . . . 1.0 112.246 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.549 ' H ' ' HG ' ' C' ' 40' ' ' SER . 40.3 m-20 -89.59 -18.94 25.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.089 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.86 89.77 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.472 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.445 ' O ' ' OG ' ' C' ' 48' ' ' SER . 7.8 tt -66.74 -39.8 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.698 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -45.51 92.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.252 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.508 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.6 t90 -64.62 -39.89 94.51 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.188 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' C' ' 45' ' ' ILE . 91.1 p -59.26 -33.3 70.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.149 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . 0.419 ' N ' ' HG ' ' C' ' 48' ' ' SER . 55.9 t -60.4 -48.04 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.286 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -73.7 -23.16 59.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 70.8 m -64.12 -45.6 87.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.519 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.29 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.848 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 68.2 p -82.38 1.28 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 1.0 110.003 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.5 p 55.61 11.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.778 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.37 -46.18 93.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.956 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.09 59.33 3.43 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.435 ' OH ' ' O ' ' D' ' 60' ' ' ARG . 7.9 t80 -61.0 -47.21 87.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 1.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 169.73 -97.86 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 53.9 t0 44.92 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 1.0 110.782 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' C' ' 58' ' ' GLY . 96.9 mtt-85 -124.01 153.13 41.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 43.8 p90 -143.48 133.66 12.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.02 162.18 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.857 1.705 . . . . 1.0 112.413 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.67 ' CG1' ' H ' ' C' ' 64' ' ' THR . 7.2 p -83.58 -116.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.67 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 54.8 m -116.78 -84.0 0.64 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -43.92 125.9 4.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER 57.35 -104.46 0.22 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.69 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.476 1.349 0 O-C-N 124.431 1.082 . . . . 1.0 114.901 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 54.1 ttm-85 -87.21 -46.07 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.939 0.495 . . . . 1.0 110.773 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.8 tttm -54.36 -40.19 67.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.244 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.13 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.056 -0.657 . . . . 1.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.61 -37.2 86.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -54.95 -42.4 72.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -64.93 -40.18 94.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.571 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.07 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 1.0 111.349 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 59.8 mtt -54.0 -44.72 71.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.887 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -63.65 -38.77 92.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 1.0 110.533 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.1 -25.03 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.46 -39.42 5.96 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.944 -0.462 . . . . 1.0 111.944 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.423 HD13 HG21 ' C' ' 79' ' ' ILE . 93.9 mt -61.69 -43.47 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.082 -0.247 . . . . 1.0 111.004 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.9 -37.72 86.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.187 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -63.45 -47.54 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 121.016 -0.274 . . . . 1.0 111.271 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.0 -36.81 82.99 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.306 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -61.82 -39.61 92.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.808 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' C' ' 86' ' ' THR . 7.3 tt -65.02 -37.56 88.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.267 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 78.4 t -45.48 -13.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.991 -0.283 . . . . 1.0 110.7 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.58 ' O ' ' N ' ' C' ' 88' ' ' ALA . 8.9 m -60.29 -41.81 94.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.501 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -39.34 -18.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.005 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -103.36 -36.89 7.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' C' ' 86' ' ' THR . 36.2 mt -75.41 -43.17 51.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.543 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -56.58 -34.18 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.762 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.67 -5.27 52.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.801 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -56.36 -47.21 79.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.41 -179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.9 p90 -74.35 -40.06 62.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 84.8 t -44.87 -31.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.825 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -64.12 -22.75 67.06 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.519 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . 0.417 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 47.4 ptt85 -52.95 -42.85 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 1.0 110.497 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 79.9 mm-40 -65.27 -43.49 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.512 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.65 -34.35 75.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.404 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.83 -26.81 68.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.609 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -60.15 -44.5 94.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.83 -21.56 62.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.397 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.89 18.07 66.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.59 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.4 141.86 55.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.566 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' D' ' 4' ' ' HIS . 47.7 p-10 -65.95 -33.25 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' D' ' 3' ' ' ASP . 2.0 m80 -63.99 -45.15 90.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 1.0 110.342 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.66 -39.86 91.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -60.72 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.455 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.78 -40.02 79.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 1.0 110.09 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -46.08 88.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.861 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' D' ' 13' ' ' GLU . 99.1 mm-40 -66.13 -37.49 85.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.566 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.29 -39.5 90.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.749 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.54 78.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.33 -39.27 86.48 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.754 0.311 . . . . 1.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' D' ' 9' ' ' GLN . 1.1 mp0 -64.12 -37.19 86.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.18 -32.51 74.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.4 -41.62 98.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.511 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.93 -35.53 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.993 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' D' ' 21' ' ' GLU . 18.0 tttp -60.59 -45.82 92.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.79 -40.99 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.905 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.66 -40.97 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.173 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -62.13 -46.87 87.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.318 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' D' ' 17' ' ' LYS . 98.3 mt-10 -68.67 -36.11 78.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.4 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.45 91.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.203 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.23 -44.43 92.33 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.757 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.66 -35.74 80.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.98 0.419 . . . . 1.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.056 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.93 86.52 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.035 -0.266 . . . . 1.0 111.044 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.24 -44.94 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.13 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.26 -41.5 73.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.856 0.36 . . . . 1.0 110.937 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.5 90.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.717 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.73 -34.45 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 1.0 110.219 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -72.42 137.52 46.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.725 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . 0.406 ' O ' ' OE1' ' D' ' 65' ' ' GLU . . . 96.1 -11.86 67.26 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -100.26 149.51 36.11 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.49 142.99 30.32 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.907 1.738 . . . . 1.0 112.118 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.55 33.38 81.13 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.7 141.23 38.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.918 0.39 . . . . 1.0 110.538 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' D' ' 39' ' ' ILE . . . -147.0 -32.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.513 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.88 31.91 0.43 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.019 0.437 . . . . 1.0 109.895 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' D' ' 40' ' ' SER . 4.5 tp -105.7 131.87 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.538 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.4 p 162.7 -102.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.2 m-85 171.44 -65.94 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.31 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.7 Cg_endo -59.15 -29.25 89.98 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.925 1.75 . . . . 1.0 111.526 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -86.92 -24.2 24.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.42 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.37 -45.13 95.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.774 -0.371 . . . . 1.0 110.868 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 tp -67.51 -41.72 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.572 ' CH2' ' O ' ' A' ' 63' ' ' VAL . 1.1 t90 -60.68 -40.65 92.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.122 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' D' ' 48' ' ' SER . 6.0 t90 -61.86 -39.82 93.19 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.574 ' O ' ' N ' ' D' ' 50' ' ' GLU . 3.3 p -60.59 -145.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.002 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . 0.494 ' N ' ' OG ' ' D' ' 48' ' ' SER . 28.6 t 48.99 -81.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.13 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' D' ' 48' ' ' SER . 15.7 pt-20 -48.02 -29.47 3.52 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -61.94 -43.73 98.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.12 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.74 -37.6 84.85 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 41.3 p -72.97 0.03 12.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.214 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p 50.85 68.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.987 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.04 -52.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.607 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.65 77.32 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.439 ' OH ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -62.21 -44.35 96.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 1.0 110.443 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.42 14.04 0.73 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.74 -51.39 69.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.674 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.435 ' O ' ' OH ' ' C' ' 57' ' ' TYR . 34.8 mtt-85 -146.81 140.75 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 21.5 p90 -122.22 133.92 24.57 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 121.151 -0.22 . . . . 1.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.6 159.4 52.9 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.129 1.886 . . . . 1.0 112.195 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.419 ' CG1' ' H ' ' D' ' 64' ' ' THR . 1.9 t -84.91 -142.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.088 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.419 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 46.7 m -113.46 -53.05 2.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.704 0.288 . . . . 1.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.612 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.5 tt0 -62.45 -16.43 55.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.863 0.363 . . . . 1.0 110.226 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.415 ' O ' ' CD ' ' D' ' 66' ' ' GLU . 0.6 OUTLIER -74.35 26.41 0.08 Allowed 'General case' 0 C--O 1.264 1.839 0 CA-C-O 123.808 1.766 . . . . 1.0 109.087 178.36 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.722 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.03 61.3 3.54 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 58.2 ttm-85 -26.0 -30.31 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.297 0.645 . . . . 1.0 110.849 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.722 ' N ' ' O ' ' D' ' 67' ' ' GLY . 28.8 mmtp -53.41 -17.37 1.87 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.272 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' D' ' 67' ' ' GLY . 55.3 t -61.79 -48.36 89.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.0 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.71 -43.16 72.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.923 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -60.11 -42.21 94.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.763 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.09 -42.3 76.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.079 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.271 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 61.1 mtt -61.0 -42.29 98.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.327 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.23 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.02 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.396 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -43.78 92.52 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -43.55 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.689 0.281 . . . . 1.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.97 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.182 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 50.7 t -61.83 -52.31 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.341 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.91 -40.08 72.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -65.06 -34.94 79.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.456 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' D' ' 86' ' ' THR . 5.2 tt -61.12 -40.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' D' ' 87' ' ' ALA . 97.0 t -50.76 -16.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.611 -0.436 . . . . 1.0 109.887 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 23.7 m -42.42 -22.49 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.81 -52.97 61.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.36 -31.05 71.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.88 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 16.0 mt -66.93 -40.97 87.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.433 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.74 -43.07 94.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.032 0.444 . . . . 1.0 110.787 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -4.28 42.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.202 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -56.93 -49.27 76.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.906 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 31.5 p90 -79.5 -42.96 24.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.172 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.527 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 60.9 t -40.44 -27.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.366 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' D' ' 93' ' ' PHE . 94.8 mtt-85 -62.78 -36.46 83.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.766 0.317 . . . . 1.0 111.105 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -47.68 -32.03 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.457 . . . . 1.0 110.285 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' D' ' 100' ' ' ARG . 45.5 tp10 -78.07 -34.91 50.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.88 -46.32 72.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.915 0.388 . . . . 1.0 110.849 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.42 -17.33 64.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.472 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' D' ' 97' ' ' GLU . 51.6 ttp180 -58.85 -45.68 89.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.299 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -81.35 -10.87 59.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.509 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.34 72.45 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.058 -0.817 . . . . 1.0 111.058 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' D' ' 103' ' ' HIS . 64.1 t-80 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.538 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.32 -72.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.519 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -173.02 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -77.84 -16.87 57.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.453 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.397 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -63.47 -37.93 89.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.299 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.62 -38.16 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.53 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.92 72.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.792 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -67.67 -35.35 78.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.57 -36.63 81.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.25 76.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.892 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.61 -37.21 83.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.552 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.79 -36.44 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -65.43 -34.47 78.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.422 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.49 -41.23 98.65 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.593 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.04 -38.83 90.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.146 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -40.57 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.5 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.2 mt -60.57 -40.96 93.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.076 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.436 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.5 mt-10 -60.58 -45.11 95.15 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.086 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.72 -37.55 76.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.91 89.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -59.77 -43.02 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 14.6 tmtt? -65.09 -36.25 83.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.833 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -76.55 -37.51 56.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.635 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.08 93.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 24' ' ' LYS . 9.1 m -61.24 -43.56 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.144 -0.622 . . . . 1.0 110.24 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -75.67 -43.25 48.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.536 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.09 -45.74 90.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.491 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.25 -44.13 92.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -71.36 133.65 46.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.58 -17.49 46.29 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.55 159.94 76.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.37 116.71 4.59 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.819 1.679 . . . . 1.0 111.924 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 82.87 -23.77 5.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . 32.69 -152.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.769 0.319 . . . . 1.0 111.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.64 -53.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.363 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.0 tp -66.22 -69.02 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.574 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 pt 36.48 25.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.103 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 38' ' ' LEU . 42.0 t -132.14 129.16 39.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.882 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.46 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 26.8 t80 -80.7 -49.05 1.13 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.982 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.36 -31.08 92.3 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.107 1.205 . . . . 1.0 112.569 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -91.17 -6.05 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.604 0.24 . . . . 1.0 111.009 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.91 95.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.916 0.389 . . . . 1.0 110.331 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.21 -40.22 86.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.155 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.582 ' CZ3' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -61.96 -47.11 86.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.381 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 22.9 t90 -59.02 -39.95 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.1 t -76.59 66.84 2.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.698 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.3 t -156.24 -55.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.93 0.395 . . . . 1.0 110.201 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' A' ' 59' ' ' ASP . 15.3 pt-20 -64.4 -32.78 74.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.414 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.68 -45.95 91.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.034 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.66 -26.87 64.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.354 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -92.9 2.79 56.6 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 p 47.0 76.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 32.6 t -129.07 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.7 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 97.14 -56.63 1.25 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' B' ' 61' ' ' TYR . 2.3 m-85 44.12 -89.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.883 0.373 . . . . 1.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . -166.78 -87.61 0.07 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.444 ' CG ' ' H ' ' A' ' 60' ' ' ARG . 2.0 p-10 39.41 -105.39 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.857 0.36 . . . . 1.0 110.626 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.704 HH21 HH22 ' B' ' 68' ' ' ARG . 0.8 OUTLIER -116.96 -175.21 2.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.65 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.32 134.23 1.09 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.44 156.78 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.949 1.766 . . . . 1.0 112.454 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.454 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.5 t -98.46 -124.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.827 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.44 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 85.3 m -115.4 -40.75 3.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.592 0.235 . . . . 1.0 111.154 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.681 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.2 tt0 -67.45 -36.28 80.89 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 1.0 110.881 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.53 28.27 0.02 OUTLIER 'General case' 0 C--O 1.26 1.623 0 CA-C-O 123.289 1.519 . . . . 1.0 110.182 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.73 65.23 1.23 Allowed Glycine 0 C--O 1.212 -1.257 0 CA-C-O 117.567 -1.685 . . . . 1.0 111.437 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.538 HH12 ' CG ' ' D' ' 59' ' ' ASP . 60.6 ttm-85 -22.62 -35.62 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.431 1.115 . . . . 1.0 111.008 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' A' ' 67' ' ' GLY . 29.7 mmtp -48.4 -18.11 0.2 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.637 -0.711 . . . . 1.0 109.565 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -61.31 -47.97 91.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.371 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 -39.25 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 1.0 110.846 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -54.65 -42.27 71.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.674 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.52 -44.98 92.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.875 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.19 -47.19 91.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.16 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.43 -42.34 98.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.39 -42.18 96.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.346 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.17 93.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.781 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.42 95.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.28 -43.42 98.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.11 -42.09 97.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.45 -50.41 76.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -70.92 -22.41 62.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.066 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -86.28 -30.24 22.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.712 0.292 . . . . 1.0 110.781 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.65 -42.87 98.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.739 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' C ' ' N ' ' A' ' 87' ' ' ALA . 4.0 m -53.81 -16.36 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.189 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.6 m -43.16 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.268 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' N ' ' C ' ' A' ' 85' ' ' VAL . . . -63.05 -50.76 69.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.05 88.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.59 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.498 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.8 mm? -65.13 -39.0 92.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -56.4 -47.46 78.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.033 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -3.7 33.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.683 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.112 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.9 p90 -78.72 -44.04 24.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.827 0.346 . . . . 1.0 111.485 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 93.1 t -41.05 -25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.383 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 93' ' ' PHE . 11.1 tpt85 -58.82 -33.6 70.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.938 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -61.04 -23.05 65.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.655 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.69 -37.79 88.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.945 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.558 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.369 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.9 -44.23 94.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.343 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -92.78 -3.87 54.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.431 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.21 21.11 76.45 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.22 -0.752 . . . . 1.0 111.22 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.57 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.413 ' CB ' ' NE2' ' B' ' 4' ' ' HIS . . . -156.43 169.58 24.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.652 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.16 -36.98 85.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.988 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.598 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.8 p80 -79.01 -31.36 44.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.566 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -66.27 -37.73 86.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.931 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -63.15 -40.18 96.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.706 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -65.66 -41.98 91.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.66 92.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.49 -40.56 93.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.11 -38.84 92.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.486 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.69 78.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.996 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.32 -35.68 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.645 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.74 -38.56 91.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 1.0 110.188 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -63.2 -34.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.99 -37.91 89.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -65.57 -31.01 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.832 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.81 -47.64 82.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.378 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.4 m -68.63 -31.38 50.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.089 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.42 ' CD2' ' O ' ' B' ' 48' ' ' SER . 35.6 mt -61.06 -41.84 97.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.94 -47.58 79.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 1.0 109.834 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -67.46 -34.36 77.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.826 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.12 89.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.139 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -60.76 -35.57 76.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.043 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' B' ' 26' ' ' ALA . 44.9 tptt -65.08 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.623 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -39.92 -28.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.611 0.243 . . . . 1.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 24' ' ' LYS . . . -62.55 -41.06 98.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.405 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.435 ' N ' ' O ' ' B' ' 24' ' ' LYS . 1.4 p -67.23 -41.5 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.09 0.472 . . . . 1.0 110.46 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 74.4 mm-40 -70.95 -40.3 72.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.594 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' B' ' 66' ' ' GLU . . . -71.96 58.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.906 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.424 ' CD ' ' O ' ' B' ' 38' ' ' LEU . 0.0 OUTLIER 170.78 -16.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.004 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -68.11 56.38 0.07 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.442 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 130.8 31.28 0.55 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.734 -0.547 . . . . 1.0 111.734 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 149.56 38.04 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.72 134.38 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.902 1.735 . . . . 1.0 112.061 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.28 25.61 73.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.255 -0.738 . . . . 1.0 111.255 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.31 140.72 57.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.35 -31.34 8.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' B' ' 30' ' ' GLU . 40.1 tp -101.56 112.75 25.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.247 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' B' ' 40' ' ' SER . 5.9 pt -145.11 84.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.29 -0.414 . . . . 1.0 109.89 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 62.9 m -168.73 -117.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.081 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.4 m-85 -176.09 -64.17 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.084 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -59.03 -29.33 90.35 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.147 1.898 . . . . 1.0 112.216 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.06 -8.2 58.78 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.09 86.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.0 110.396 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -66.86 -38.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.696 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -47.51 85.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.27 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.448 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.6 t90 -63.27 -42.54 99.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 1.0 110.395 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.42 ' O ' ' CD2' ' B' ' 19' ' ' LEU . 38.4 m -57.39 -39.88 77.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.119 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.65 -48.15 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.833 0.309 . . . . 1.0 111.833 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.421 ' OE1' ' NH1' ' C' ' 68' ' ' ARG . 18.1 pt-20 -76.13 -22.73 55.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.448 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 87.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.41 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.2 -24.51 55.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.286 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.513 ' C ' ' H ' ' B' ' 55' ' ' VAL . 37.9 p -83.76 4.26 29.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 1.0 110.762 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 53' ' ' THR . 19.6 p 54.28 7.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.586 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' B' ' 53' ' ' THR . 53.8 t -62.99 -47.09 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.48 68.09 0.48 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' C' ' 60' ' ' ARG . 9.9 t80 -59.8 -46.38 89.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.678 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.66 -11.06 0.96 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.504 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 84.9 m-20 -41.63 -83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.834 0.35 . . . . 1.0 110.866 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -119.83 151.8 38.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.889 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 47.8 t80 -160.8 125.79 2.17 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.11 159.23 53.88 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.533 1.489 . . . . 1.0 112.531 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.69 -166.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.887 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 67' ' ' GLY . 9.0 p -56.13 -69.45 0.15 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.522 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -47.37 -17.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' B' ' 64' ' ' THR . 67.5 mt-10 -98.0 28.14 4.14 Favored 'General case' 0 C--O 1.266 1.932 0 CA-C-O 124.303 2.002 . . . . 1.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.732 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.59 62.76 1.31 Allowed Glycine 0 C--O 1.212 -1.235 0 CA-C-N 113.147 -1.842 . . . . 1.0 111.305 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.704 HH22 HH21 ' A' ' 60' ' ' ARG . 43.0 ttm180 -24.89 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.0 0.9 . . . . 1.0 111.414 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' B' ' 67' ' ' GLY . 14.7 mptt -53.19 -14.75 0.72 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' B' ' 67' ' ' GLY . 42.4 t -61.08 -45.5 98.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 119.695 -0.802 . . . . 1.0 109.698 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.0 28.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.302 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -60.48 -40.08 89.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.31 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -61.1 -46.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.48 -44.77 86.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.337 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.6 mtm -61.58 -41.79 97.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.614 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.86 -40.98 99.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.233 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.83 -41.68 87.99 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.68 -0.568 . . . . 1.0 111.68 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.88 -43.37 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.116 -0.233 . . . . 1.0 110.792 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.82 -41.32 91.01 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.231 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.67 -50.29 76.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.383 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -66.35 -36.81 83.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.579 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.1 -37.53 87.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.611 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' B' ' 86' ' ' THR . 7.1 tt -62.64 -40.86 98.34 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 85.4 t -49.4 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.6 m -58.2 -41.59 84.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.419 ' O ' ' CG2' ' B' ' 91' ' ' THR . . . -42.93 -19.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.581 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -103.19 -28.51 11.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.125 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' THR . 89.3 mt -69.41 -44.74 70.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.027 0.441 . . . . 1.0 111.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.565 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.1 -9.05 9.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.435 0.636 . . . . 1.0 109.817 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.9 OUTLIER -101.73 -5.13 25.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.081 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.36 -46.95 88.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.011 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 47.8 p90 -79.29 -33.81 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.7 t -50.31 -31.71 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.335 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -64.23 -21.93 66.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.305 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.439 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 23.9 ptt-85 -51.16 -42.35 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 1.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' B' ' 99' ' ' GLU . 96.3 mt-10 -64.72 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.234 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 57.46 -74.51 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' B' ' 97' ' ' GLU . 97.8 mt-10 -59.78 -42.97 94.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.502 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -65.4 -43.62 90.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.805 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -114.66 113.07 23.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.01 0.434 . . . . 1.0 110.006 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.01 25.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.61 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.14 121.35 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.633 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -68.84 -44.64 73.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.691 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.636 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.8 p80 -59.25 -41.63 89.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.804 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' C' ' 95' ' ' ARG . 97.4 mt-10 -64.43 -42.42 96.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -65.21 -39.25 92.55 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.94 -39.18 87.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.155 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . 0.458 ' O ' ' OE1' ' C' ' 12' ' ' GLU . . . -64.47 -37.41 87.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.404 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' C' ' 12' ' ' GLU . 56.5 tt0 -60.0 -42.5 94.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 1.0 110.469 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.67 -28.79 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.437 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.17 -45.42 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.324 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' C' ' 8' ' ' ALA . 57.3 mp0 -67.0 -41.22 87.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 1.0 110.96 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.4 -38.18 88.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 1.0 110.43 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -64.98 -31.17 72.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.305 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' C' ' 19' ' ' LEU . 46.3 tp -62.19 -39.12 91.67 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.441 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.7 -29.81 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.215 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -77.86 -45.19 24.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 28.1 m -60.72 -46.56 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.359 0.503 . . . . 1.0 112.359 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' C' ' 15' ' ' LEU . 3.1 pp -74.95 -26.8 59.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.742 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -63.8 -53.93 43.08 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.922 0.392 . . . . 1.0 110.032 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.92 -36.34 83.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' C' ' 74' ' ' VAL . . . -66.72 -35.43 80.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.5 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.54 ' HG ' ' CB ' ' C' ' 48' ' ' SER . 38.6 m -53.1 -44.43 67.61 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.284 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.21 -44.87 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 1.0 109.58 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.3 mttp -63.22 -39.28 94.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.792 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.38 64.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.146 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 3.1 p -64.44 -44.91 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.194 0.521 . . . . 1.0 110.363 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -66.19 -35.84 81.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.816 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -61.55 -43.34 99.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.326 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -90.23 -11.17 41.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.681 -0.236 . . . . 1.0 111.249 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -58.34 96.9 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.604 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.24 5.16 46.74 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.55 151.4 68.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.91 139.73 22.31 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.977 1.785 . . . . 1.0 112.189 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.55 25.54 63.33 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.241 -0.744 . . . . 1.0 111.241 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 140.95 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 -38.52 5.37 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.417 ' O ' ' CD2' ' C' ' 38' ' ' LEU . 5.7 tt -88.74 68.48 8.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.037 0.446 . . . . 1.0 109.944 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -92.11 -5.36 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.332 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.1 m -75.48 150.98 38.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.442 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 1.1 t80 -100.83 -61.95 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.98 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.442 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.6 Cg_endo -59.0 -30.07 92.39 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.782 1.654 . . . . 1.0 112.249 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.87 -2.17 57.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.054 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.51 85.3 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.392 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 tt -66.66 -39.36 83.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.925 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -49.49 75.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.41 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' C' ' 50' ' ' GLU . 3.5 t90 -64.38 -38.79 92.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.54 ' CB ' ' HG ' ' C' ' 23' ' ' SER . 25.2 p -63.2 -36.54 83.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.34 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 42.2 t -62.39 -48.86 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 121.101 -0.24 . . . . 1.0 111.59 -179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' C' ' 47' ' ' TRP . 2.6 pp20? -71.08 -29.76 65.71 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.77 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.441 ' N ' ' CD ' ' C' ' 50' ' ' GLU . 69.3 m -62.36 -46.52 88.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.315 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.1 -23.69 66.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.809 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' C' ' 54' ' ' THR . 81.1 p -90.64 3.31 54.52 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' C' ' 53' ' ' THR . 17.4 p 55.5 15.55 1.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.92 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 72.3 t -63.68 -45.65 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.677 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.35 61.86 1.69 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -45.12 95.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.664 0.269 . . . . 1.0 110.825 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.35 13.97 1.1 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.41 -50.58 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 1.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CE1' ' B' ' 57' ' ' TYR . 96.1 mtt-85 -145.91 167.19 23.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.572 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -143.7 123.03 7.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 158.65 54.36 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.798 1.665 . . . . 1.0 112.184 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 2.2 m -98.09 -165.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.021 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -94.03 -32.07 13.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 1.0 110.168 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.6 ' C ' ' H ' ' C' ' 67' ' ' GLY . 10.4 tm-20 -64.05 -32.98 74.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.047 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -75.67 28.81 0.11 Allowed 'General case' 0 C--O 1.264 1.83 0 CA-C-O 124.378 2.037 . . . . 1.0 110.008 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.33 65.78 1.77 Allowed Glycine 0 C--O 1.216 -0.976 0 CA-C-N 113.516 -1.674 . . . . 1.0 111.167 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 ttm-85 -24.92 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.148 0.974 . . . . 1.0 111.392 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' C' ' 67' ' ' GLY . 71.8 mmtt -50.08 -31.64 13.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.476 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.8 t -64.14 -49.14 82.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 119.139 -1.024 . . . . 1.0 110.6 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.25 73.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.866 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.943 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.85 -43.47 85.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.954 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' C' ' 22' ' ' ALA . 70.6 t -64.18 -43.29 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.634 -0.426 . . . . 1.0 111.165 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 39.6 mtt -55.77 -45.31 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.002 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -40.83 95.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.19 86.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 1.0 110.235 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.05 -42.65 92.13 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.78 -42.77 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.71 0.29 . . . . 1.0 110.985 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' C' ' 84' ' ' LEU . 80.9 mm-40 -58.39 -41.29 84.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.244 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -49.35 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.309 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -64.93 -35.38 80.98 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.881 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.63 -28.49 30.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.751 0.31 . . . . 1.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.559 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.8 tt -63.5 -42.94 98.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.488 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.47 2.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.527 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.559 ' H ' ' C ' ' C' ' 84' ' ' LEU . 23.9 m -62.93 -20.65 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' C' ' 91' ' ' THR . . . -56.72 -61.06 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.39 94.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.012 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.62 -43.64 96.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.464 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.19 -23.6 66.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.401 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.534 ' OG1' ' CG ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -96.44 -3.86 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.3 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -60.42 -43.35 96.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.097 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -67.46 -30.1 69.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.03 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.93 -44.26 94.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.407 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' C' ' 5' ' ' GLU . 95.2 mtt-85 -48.04 -21.75 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.224 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.2 ptt85 -50.85 -41.28 57.77 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.39 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' C' ' 99' ' ' GLU . 21.1 pt-20 -51.69 149.04 4.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.021 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' C' ' 102' ' ' GLY . 97.1 mt-10 62.74 -60.04 0.13 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.826 0.704 . . . . 1.0 110.673 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.0 mt-10 -54.95 -40.16 69.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.453 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -63.53 -44.79 93.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -82.34 -15.04 54.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' C' ' 98' ' ' GLU . . . 81.74 14.55 77.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.474 ' O ' ' CG ' ' C' ' 103' ' ' HIS . 86.1 t60 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.598 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 63.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.03 -74.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.539 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -172.74 -64.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.82 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.543 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 3.2 p80 -59.2 -39.52 82.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.11 -39.09 93.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.43 -43.17 99.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.482 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.23 -38.3 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.297 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.799 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.52 -42.11 98.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.48 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.29 -39.07 93.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.26 81.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.116 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.97 -39.12 93.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.794 0.33 . . . . 1.0 110.791 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.36 -33.81 76.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.67 -34.84 79.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.09 -42.52 99.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 1.0 110.663 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -64.29 -35.88 82.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.115 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -61.74 -41.83 98.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 1.0 110.99 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.61 -39.0 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.532 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -60.16 -40.76 91.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.462 ' O ' ' OG ' ' D' ' 23' ' ' SER . 98.5 mt-10 -61.8 -44.95 95.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 1.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.63 -34.84 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.997 0.427 . . . . 1.0 110.02 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.54 87.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.03 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -59.57 -45.07 92.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.876 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -64.11 -54.97 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.256 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.58 -40.79 96.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.743 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.13 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.834 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 72.4 t -62.36 -46.71 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.374 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.65 -41.94 83.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.47 97.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -69.35 -39.68 77.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.794 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -63.32 119.21 9.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.11 49.9 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.42 146.02 30.76 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.749 -0.265 . . . . 1.0 110.519 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -74.76 144.14 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.143 1.895 . . . . 1.0 112.377 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.1 71.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.46 138.6 57.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.0 110.614 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.77 -36.44 4.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.473 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -99.28 108.23 20.72 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 pt -150.94 60.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -157.81 124.44 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.504 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 34.3 m-85 -53.1 -49.87 85.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.239 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.07 -34.99 99.07 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.1 1.2 . . . . 1.0 112.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -93.4 -8.18 42.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.716 0.293 . . . . 1.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.88 -45.38 82.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 1.0 110.876 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -68.17 -39.68 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.603 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -47.82 83.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.11 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.4 t90 -62.15 -40.21 95.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.426 ' O ' ' OG ' ' D' ' 48' ' ' SER . 22.7 p -69.65 61.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 76.8 t -149.01 -57.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.194 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -65.72 -27.08 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.168 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.17 -47.49 85.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.201 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.45 -36.93 69.6 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.298 -0.561 . . . . 1.0 109.671 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.441 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.4 p -78.75 -12.68 60.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.472 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' D' ' 53' ' ' THR . 6.1 p 60.47 10.4 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.069 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 12.0 p -67.24 -43.43 88.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.252 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 57.3 72.61 0.56 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.448 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.3 OUTLIER -60.24 -46.94 88.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 1.0 110.465 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.0 10.62 1.51 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.538 ' CG ' HH12 ' A' ' 68' ' ' ARG . 53.8 m-20 -58.06 -50.86 71.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -151.02 -166.11 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.7 p90 -172.07 133.44 0.78 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.831 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.48 157.74 58.11 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.999 1.8 . . . . 1.0 112.428 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.44 ' CG1' ' H ' ' D' ' 64' ' ' THR . 1.9 t -89.79 -143.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.924 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.44 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 94.8 m -112.09 -41.68 3.91 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.744 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.581 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.1 -19.68 65.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.9 0.381 . . . . 1.0 110.448 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.1 OUTLIER -77.86 23.67 0.25 Allowed 'General case' 0 C--O 1.266 1.973 0 CA-C-O 123.842 1.782 . . . . 1.0 108.956 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.741 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.85 61.55 3.81 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' D' ' 67' ' ' GLY . 58.0 ttm-85 -26.94 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.761 0.781 . . . . 1.0 111.214 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.9 tptm -55.85 -27.34 51.17 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.107 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.528 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.4 t -61.07 -49.42 84.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 119.649 -0.82 . . . . 1.0 109.942 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.65 -37.05 73.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.179 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.57 -43.83 89.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -61.39 -40.75 95.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.213 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.09 -43.9 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.609 -0.436 . . . . 1.0 111.196 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 36.9 mtt -60.26 -44.34 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.902 -179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -65.98 -36.77 84.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.92 -40.28 88.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.586 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.62 -42.76 95.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.479 -0.648 . . . . 1.0 111.479 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.64 -43.46 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.021 -0.272 . . . . 1.0 111.092 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.18 -41.53 97.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.285 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 61.5 t -63.21 -50.25 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 1.0 111.373 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.9 -40.26 83.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.756 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.441 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -63.13 -35.16 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.371 179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.73 -41.18 97.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.268 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.2 -17.82 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.695 -0.402 . . . . 1.0 109.919 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 56.7 m -47.46 -40.09 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.224 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.08 -17.29 1.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.671 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.62 20.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.563 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.459 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 3.7 mm? -92.53 -40.8 10.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.008 0.432 . . . . 1.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.535 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -57.14 -28.2 62.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.618 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.34 -4.36 55.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -59.5 -49.92 75.92 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.145 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 21.3 p90 -73.47 -38.72 65.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.987 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.3 t -47.92 -27.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.161 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' D' ' 97' ' ' GLU . 94.5 mtt180 -64.73 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -54.31 -7.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' D' ' 99' ' ' GLU . 24.1 tp10 -133.53 158.16 43.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.831 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 57.36 -76.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.721 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' D' ' 97' ' ' GLU . 49.0 tp10 -57.01 -28.94 62.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -59.53 -43.03 93.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.351 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -64.89 -38.22 90.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.401 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.23 20.63 62.21 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . 0.407 ' OXT' ' CG ' ' D' ' 103' ' ' HIS . 85.2 t60 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.096 -0.955 . . . . 1.0 110.612 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.49 ' CB ' ' NE2' ' A' ' 4' ' ' HIS . . . -81.64 169.81 16.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.638 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 11.6 p-10 -65.14 -36.64 84.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.682 ' CD2' HH12 ' D' ' 96' ' ' ARG . 6.4 p80 -75.14 -34.2 61.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.643 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 95' ' ' ARG . 96.2 mt-10 -63.54 -38.4 91.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.528 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.66 -39.71 94.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -50.87 -44.99 59.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.3 88.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.262 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.82 -45.2 90.64 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.89 -35.85 82.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.048 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -48.33 68.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.784 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.65 -42.64 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -64.03 -33.91 76.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.158 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.81 -34.92 78.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.389 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.773 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -55.29 -40.15 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.205 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -64.37 -31.62 72.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.787 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.38 -41.98 86.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 1.0 110.683 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.57 -40.64 92.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.784 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -55.96 -49.67 72.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.917 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.49 -37.14 82.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.994 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.24 86.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.634 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.8 m -59.97 -40.96 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.025 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.37 -61.45 2.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.376 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.4 -44.21 95.92 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.909 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.93 -45.76 74.87 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.37 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.3 t -62.55 -46.49 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.368 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.25 -41.89 72.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.019 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.15 -41.12 48.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.802 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.66 -44.87 69.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.115 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -51.81 99.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.396 . . . . 1.0 110.651 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.4 -11.89 12.57 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 111.446 -0.661 . . . . 1.0 111.446 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.49 140.26 33.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 122.705 -0.291 . . . . 1.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.27 144.18 29.09 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.015 1.81 . . . . 1.0 112.478 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.16 27.09 68.45 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.32 140.77 58.72 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.421 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.94 -30.73 4.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -87.24 122.59 31.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' SER . 41.0 pt -153.41 163.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 79.96 134.53 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.79 0.329 . . . . 1.0 110.934 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 32.4 t80 -65.79 -44.73 64.35 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.087 -0.506 . . . . 1.0 112.127 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.3 Cg_endo -60.57 -30.86 91.5 Favored 'Trans proline' 0 N--CA 1.503 2.055 0 C-N-CA 121.562 1.508 . . . . 1.0 112.737 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.29 -27.23 18.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.706 0.288 . . . . 1.0 110.785 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.02 82.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.582 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -62.84 -38.74 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.564 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.7 OUTLIER -65.96 -38.21 87.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.23 -0.441 . . . . 1.0 109.824 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -62.71 -42.34 99.6 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.247 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.6 p -58.09 -28.38 64.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.9 t -63.76 -45.69 96.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 1.0 110.419 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 77.5 mt-10 -80.26 -0.85 38.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.81 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -35.51 8.07 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 1.0 109.83 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.44 82.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.345 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.458 ' O ' ' OG1' ' A' ' 54' ' ' THR . 0.1 OUTLIER -88.92 11.75 17.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.512 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 5.1 p 64.38 -135.11 0.29 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.411 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' OG1' ' A' ' 54' ' ' THR . 46.1 t 62.73 -61.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.595 0.559 . . . . 1.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 50.36 90.92 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -60.6 -44.13 96.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.726 0.298 . . . . 1.0 110.78 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.79 17.05 0.85 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.64 -51.94 67.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 1.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' ' CZ ' ' D' ' 57' ' ' TYR . 94.8 mtt-85 -145.73 139.84 26.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.949 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 62' ' ' PRO . 77.8 t80 -130.91 127.71 22.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.536 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 60.6 Cg_endo -70.33 159.92 51.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.826 1.684 . . . . 1.0 112.62 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 ' CG1' ' H ' ' A' ' 64' ' ' THR . 2.1 t -83.68 -138.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.428 ' H ' ' CG1' ' A' ' 63' ' ' VAL . 51.6 m -114.72 -37.95 4.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.677 0.275 . . . . 1.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.67 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.9 tp10 -64.59 -31.21 72.33 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.42 ' OE2' ' C ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -70.79 30.54 0.04 OUTLIER 'General case' 0 C--O 1.263 1.786 0 CA-C-O 123.594 1.664 . . . . 1.0 109.952 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.77 64.35 1.25 Allowed Glycine 0 C--O 1.213 -1.196 0 CA-C-N 113.797 -1.547 . . . . 1.0 111.317 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.549 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 43.0 ttm180 -24.0 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.114 0.957 . . . . 1.0 111.108 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -48.86 -18.28 0.26 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.752 -0.658 . . . . 1.0 109.442 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.3 t -61.63 -47.83 91.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 119.494 -0.882 . . . . 1.0 110.131 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.19 64.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.631 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -58.92 -41.66 87.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.716 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.84 -42.03 96.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.051 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.93 -44.47 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.782 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.2 mtt -54.93 -43.91 73.77 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.748 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.08 -40.67 96.61 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.356 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.03 -41.64 98.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.901 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.77 -44.06 81.85 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.56 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 1.0 110.717 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.37 -40.46 96.52 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.678 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 56.0 t -63.95 -50.06 78.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0 110.96 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -68.33 -25.3 65.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.052 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.77 -23.51 21.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.667 0.27 . . . . 1.0 110.751 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -65.46 -35.44 80.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.2 m -43.17 -19.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.794 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' LEU . 24.9 m -40.92 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.963 0.411 . . . . 1.0 110.122 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.39 -46.68 89.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.436 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 -27.49 10.16 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.744 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.6 tp -65.6 -37.56 86.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.627 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.574 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -70.9 -67.91 0.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 1.0 110.798 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -47.84 -8.51 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.042 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.574 ' H ' ' C ' ' A' ' 90' ' ' ALA . 51.0 t0 -46.99 -38.73 11.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.848 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 10.1 p90 -79.45 -28.88 41.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.388 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.88 -26.15 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.427 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 96.4 mtt180 -60.1 -31.66 70.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.517 -0.311 . . . . 1.0 111.308 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.46 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.4 ptt180 -58.15 -42.32 85.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.369 . . . . 1.0 110.617 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 97.4 mt-10 -72.64 151.27 42.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.473 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 97' ' ' GLU . 3.6 tm-20 77.02 -52.24 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.647 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.41 -36.87 85.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.194 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -62.01 -35.39 78.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.63 -37.23 86.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.486 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.0 12.5 61.9 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.2 m170 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.481 179.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.86 172.0 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.687 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.3 -43.82 97.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.871 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.64 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 7.2 p-80 -80.4 -34.99 35.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.504 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.48 -39.24 85.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.27 -43.49 98.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.757 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -65.08 -36.54 84.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.1 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -65.3 -41.62 93.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.464 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.04 -40.7 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.55 92.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.928 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.443 ' OE2' ' CD1' ' B' ' 82' ' ' PHE . 80.3 mm-40 -67.92 -41.6 82.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 1.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -65.05 -37.27 87.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.59 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.416 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.02 -42.96 99.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.455 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -37.58 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.6 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.02 -41.63 96.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.0 -33.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.686 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.03 -42.1 98.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.572 -0.451 . . . . 1.0 109.922 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.48 -46.18 91.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.856 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.442 ' CG ' ' NZ ' ' B' ' 25' ' ' LYS . 83.7 tt0 -69.28 -38.65 78.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.022 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.47 -38.91 88.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.499 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -60.01 -44.29 94.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.846 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.07 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 1.0 110.258 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.442 ' NZ ' ' CG ' ' B' ' 21' ' ' GLU . 62.3 mttp -75.86 -39.51 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.364 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.97 -49.68 74.97 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.658 -0.246 . . . . 1.0 111.298 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.465 ' O ' ' OE1' ' B' ' 30' ' ' GLU . 3.8 p -63.76 -42.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.279 0.561 . . . . 1.0 110.317 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 78.8 mm-40 -70.35 -20.83 62.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.498 -0.774 . . . . 1.0 110.59 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.12 -37.91 81.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.511 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' B' ' 27' ' ' VAL . 29.7 mp0 -65.21 -40.23 93.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 1.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -63.16 86.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.58 -10.45 6.79 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 141.88 23.59 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.765 0.283 . . . . 1.0 110.603 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.489 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 98.9 Cg_endo -75.39 144.93 29.57 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.229 1.953 . . . . 1.0 112.38 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.87 36.3 57.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.36 150.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 1.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.12 -45.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.253 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 33.9 tp -97.02 91.9 5.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.513 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.3 pt -105.21 2.58 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.421 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -99.86 123.54 44.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.119 0.485 . . . . 1.0 110.985 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.3 t80 -77.22 -54.86 1.44 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.312 -0.858 . . . . 1.0 110.617 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -58.12 -27.0 78.34 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.803 1.669 . . . . 1.0 112.519 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -93.66 -10.25 35.13 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.926 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.08 87.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.885 0.374 . . . . 1.0 110.352 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -63.45 -33.16 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.609 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.85 75.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.707 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.626 ' CB ' ' HE ' ' B' ' 60' ' ' ARG . 1.4 t90 -62.5 -42.94 99.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.474 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 11.9 p -45.13 -27.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.85 -25.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.443 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.644 ' CG ' HH21 ' C' ' 68' ' ' ARG . 1.5 tm-20 -66.24 -41.36 90.13 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.737 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.538 ' C ' ' H ' ' B' ' 53' ' ' THR . 8.4 t -82.44 -158.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.229 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.455 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 70.79 -38.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.474 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.538 ' H ' ' C ' ' B' ' 51' ' ' THR . 70.8 p -91.22 6.83 43.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' B' ' 53' ' ' THR . 44.7 p 51.61 66.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.428 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.16 -47.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.598 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.92 67.27 1.5 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.541 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 24.4 t80 -60.92 -49.14 78.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 1.0 110.908 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 160.62 -96.98 0.15 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.7 t0 52.52 -82.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.392 . . . . 1.0 110.602 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.626 ' HE ' ' CB ' ' B' ' 47' ' ' TRP . 35.4 ptt85 -127.65 -160.88 1.04 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -163.55 133.32 3.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.965 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.0 179.06 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.628 1.552 . . . . 1.0 112.12 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.489 ' CG1' ' O ' ' B' ' 34' ' ' PRO . 0.8 OUTLIER -91.33 -154.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.242 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.553 ' O ' ' NE1' ' A' ' 46' ' ' TRP . 18.0 m -113.61 -71.83 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.673 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' B' ' 64' ' ' THR . 83.4 tt0 -35.42 -31.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.966 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.907 ' O ' ' N ' ' B' ' 68' ' ' ARG . 95.2 mt-10 -141.98 -108.25 0.14 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.66 -56.04 0.0 OUTLIER Glycine 0 N--CA 1.476 1.345 0 O-C-N 124.492 1.12 . . . . 1.0 114.032 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.907 ' N ' ' O ' ' B' ' 66' ' ' GLU . 14.7 ttm180 -65.85 -48.61 71.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -63.58 -36.31 83.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.096 -1.075 . . . . 1.0 108.096 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.79 -45.35 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.952 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.519 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -65.88 -38.14 87.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -49.0 -45.65 42.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.176 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.36 -38.25 90.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.769 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.68 -45.55 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.552 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 3.6 mpp? -63.85 -40.29 96.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.518 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.33 -40.45 96.41 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.225 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.04 87.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.84 0.352 . . . . 1.0 110.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.77 -38.98 93.48 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.485 -0.646 . . . . 1.0 111.485 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.08 -11.8 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.815 -0.226 . . . . 1.0 111.559 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.57 -53.26 3.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.08 0.467 . . . . 1.0 110.931 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.491 ' CG2' ' H ' ' B' ' 82' ' ' PHE . 17.8 m -60.69 -55.11 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.712 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.491 ' H ' ' CG2' ' B' ' 81' ' ' VAL . 42.2 m-85 -62.0 -43.79 98.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.887 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -64.67 -36.82 85.52 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.362 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.5 tt -57.62 -31.78 66.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 46.9 t -60.1 -4.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.473 ' H ' ' C ' ' B' ' 84' ' ' LEU . 72.4 m -61.16 -44.86 96.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.574 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' CG2' ' B' ' 91' ' ' THR . . . -51.37 -29.28 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.725 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.95 -12.69 35.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.739 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.79 -39.88 10.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.403 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.477 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.91 -25.78 57.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.231 0.539 . . . . 1.0 110.15 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -82.06 -6.31 59.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.395 -0.82 . . . . 1.0 109.891 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -58.63 -48.77 79.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.142 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.1 p90 -77.48 -40.07 44.26 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.094 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.46 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 58.8 t -44.79 -31.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.586 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.05 -22.22 66.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.057 -0.257 . . . . 1.0 111.478 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.0 ptt85 -54.42 -43.45 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 1.0 110.063 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' B' ' 99' ' ' GLU . 96.4 mt-10 -64.87 177.8 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.417 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 56.99 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' B' ' 97' ' ' GLU . 83.6 tt0 -51.4 -20.32 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.505 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -60.19 -44.95 94.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.546 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.91 -11.26 51.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.307 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.15 18.12 77.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.165 -0.774 . . . . 1.0 111.165 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.475 ' CG ' ' O ' ' B' ' 103' ' ' HIS . 86.4 t60 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.05 150.09 48.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.926 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -62.38 -38.8 90.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.064 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.585 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 24.8 p80 -67.02 -39.99 87.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.099 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.585 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 48.0 tp10 -65.9 -41.35 91.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.727 0.298 . . . . 1.0 110.577 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -64.78 -37.41 87.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -62.9 -40.92 99.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.128 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.31 98.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.37 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -65.64 -41.92 92.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.481 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.87 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.26 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.62 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.165 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -37.15 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.06 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -64.55 -34.47 78.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.778 0.323 . . . . 1.0 110.438 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -65.78 -35.9 82.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.22 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.706 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.4 -36.26 79.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.334 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.57 -40.23 90.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.775 0.322 . . . . 1.0 110.908 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.73 -35.46 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.98 -41.57 92.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.709 -0.396 . . . . 1.0 109.958 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 98.4 mt-10 -62.87 -43.34 99.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.92 -36.38 75.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.279 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.64 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.434 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 77.8 p -60.76 -43.76 97.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.824 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -60.51 -56.35 22.48 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.95 -44.24 97.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.014 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -57.1 -24.76 56.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 35.0 t -80.78 -51.77 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.191 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.83 -43.01 69.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.911 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.79 -50.57 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 3.8 mp0 -62.15 -44.92 95.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -68.01 130.32 42.61 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.94 59.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.422 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.24 151.76 41.89 Favored Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -76.17 123.54 7.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.726 1.617 . . . . 1.0 112.184 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 103.99 -23.12 33.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . 48.35 178.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 1.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.67 -93.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.63 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.43 111.54 22.82 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.839 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' C' ' 40' ' ' SER . 1.4 tp -144.18 101.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.068 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.537 ' O ' ' N ' ' C' ' 44' ' ' ALA . 0.3 OUTLIER 166.67 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.749 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.499 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.9 OUTLIER -49.11 -50.48 63.17 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.862 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.8 Cg_endo -58.9 -34.9 99.3 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.383 1.389 . . . . 1.0 112.453 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -98.74 -5.1 32.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.277 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -68.31 -41.55 80.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.809 0.338 . . . . 1.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 5.9 tt -65.04 -38.9 83.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.728 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.617 ' CZ3' ' NZ ' ' D' ' 69' ' ' LYS . 0.3 OUTLIER -58.96 -46.63 87.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.557 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.541 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.9 OUTLIER -68.31 -23.6 64.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.271 -0.571 . . . . 1.0 109.508 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 3.4 t -75.09 -35.54 61.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.92 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.52 -44.28 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.944 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.53 -41.84 77.46 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.057 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' C' ' 52' ' ' ALA . 3.6 t -78.69 -176.28 4.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.447 ' N ' ' OG1' ' C' ' 51' ' ' THR . . . 76.3 -12.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.569 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.429 ' H ' ' C ' ' C' ' 51' ' ' THR . 68.9 p -115.66 14.21 16.41 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.548 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' C' ' 53' ' ' THR . 47.0 p 53.67 69.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.4 -73.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.22 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.81 81.15 0.06 OUTLIER Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.412 ' CB ' ' CD1' ' D' ' 61' ' ' TYR . 45.5 t80 -60.43 -47.66 85.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.821 -0.351 . . . . 1.0 110.789 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.0 30.15 0.54 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 40.6 t0 -61.69 -41.68 97.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 1.0 110.431 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -141.79 -161.32 1.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.895 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 20.5 p90 -171.61 120.29 0.47 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.2 158.32 56.75 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.699 1.599 . . . . 1.0 112.355 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.433 ' O ' ' OE2' ' C' ' 66' ' ' GLU . 1.8 t -82.06 -142.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.133 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.419 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 98.4 m -111.77 -47.44 3.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.665 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.618 ' C ' ' H ' ' C' ' 67' ' ' GLY . 46.3 tp10 -58.71 -25.17 62.63 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.2 OUTLIER -73.01 28.15 0.06 Allowed 'General case' 0 C--O 1.263 1.81 0 CA-C-O 123.52 1.628 . . . . 1.0 110.213 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 41.1 62.72 1.7 Allowed Glycine 0 C--O 1.216 -1.024 0 CA-C-N 113.773 -1.558 . . . . 1.0 110.673 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.644 HH21 ' CG ' ' B' ' 50' ' ' GLU . 46.5 ttt85 -24.21 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.796 0.798 . . . . 1.0 111.58 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.8 mttt -51.65 -16.5 0.65 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.704 -0.68 . . . . 1.0 109.373 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.545 ' N ' ' O ' ' C' ' 67' ' ' GLY . 65.9 t -62.52 -48.08 89.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 119.324 -0.95 . . . . 1.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.06 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 1.0 110.093 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -64.79 -39.59 93.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.03 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.65 -42.44 75.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.245 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 82.5 t -66.0 -41.72 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.844 -0.343 . . . . 1.0 111.545 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.4 mtt -59.46 -44.75 92.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.939 -0.304 . . . . 1.0 111.216 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -63.37 -40.63 97.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -41.63 89.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.84 0.352 . . . . 1.0 110.496 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -42.39 76.15 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.222 -0.513 . . . . 1.0 111.897 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.19 -43.91 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.641 -0.329 . . . . 1.0 110.752 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.54 -43.25 85.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.303 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 59.0 t -64.76 -50.39 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.349 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -67.63 -40.76 84.59 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.22 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -68.23 -31.23 70.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.764 0.316 . . . . 1.0 110.776 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.508 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.1 tt -62.74 -42.23 99.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.813 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 1.2 m -52.64 -8.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.564 -0.455 . . . . 1.0 110.61 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.508 ' H ' ' C ' ' C' ' 84' ' ' LEU . 43.8 m -49.43 -23.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 1.0 110.247 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.26 -50.58 72.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.045 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.94 85.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.454 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.38 -38.52 90.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.879 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.519 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.32 -44.26 88.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.02 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.71 44.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.233 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -56.0 -49.52 73.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.656 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -72.5 -41.12 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.08 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 93.7 t -45.71 -27.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.68 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -62.41 -22.67 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.605 -0.27 . . . . 1.0 111.414 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -55.23 -33.65 63.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.758 0.314 . . . . 1.0 110.569 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.84 -42.31 95.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.56 -39.56 70.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 1.0 110.625 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.39 -18.37 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.273 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . 0.429 ' NH1' ' CZ ' ' C' ' 101' ' ' ARG . 79.7 ttt-85 -59.34 -44.67 92.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.652 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . 0.429 ' CZ ' ' NH1' ' C' ' 100' ' ' ARG . 85.0 mtt85 -105.96 -6.57 18.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.8 0.333 . . . . 1.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.69 16.77 77.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.07 -0.812 . . . . 1.0 111.07 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.592 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.39 143.98 56.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.42 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' D' ' 6' ' ' ARG . 98.7 m-20 -64.48 -40.11 95.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.776 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 -72.2 -19.93 61.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.202 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.01 -45.29 77.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 1.0 110.519 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . 0.463 ' NH2' ' OD1' ' D' ' 3' ' ' ASP . 95.4 mtm-85 -65.39 -36.72 84.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.66 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -61.02 -42.72 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.086 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.23 86.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.24 -42.29 99.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.94 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.75 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -38.56 77.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.905 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.8 -42.6 90.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.735 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.64 -38.91 90.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.595 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.96 -33.58 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.82 -38.54 91.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 1.0 110.075 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.59 -28.41 67.74 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -65.0 -40.15 94.51 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.824 0.345 . . . . 1.0 111.534 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.68 -31.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.15 -44.16 97.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.412 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.446 ' O ' ' OG ' ' D' ' 23' ' ' SER . 12.0 pt-20 -67.87 -35.33 78.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.001 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -66.49 -36.65 83.26 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.802 -0.359 . . . . 1.0 110.344 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.76 -40.32 96.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.091 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.0 p -58.45 -45.69 88.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.203 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.89 -63.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -58.57 -37.57 76.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -59.8 -42.31 93.16 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.705 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 72.0 t -64.16 -48.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.443 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.92 -42.58 69.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.777 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.688 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.436 ' OE1' ' O ' ' D' ' 38' ' ' LEU . 8.8 tm-20 -69.91 -35.41 74.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.383 . . . . 1.0 111.002 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -54.07 101.84 0.05 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.912 0.387 . . . . 1.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.69 21.34 10.5 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.617 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . 0.49 ' CB ' ' OE2' ' D' ' 66' ' ' GLU . . . -105.33 145.1 30.14 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 122.918 -0.166 . . . . 1.0 110.711 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.86 139.36 24.58 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.037 1.824 . . . . 1.0 112.03 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 63.98 17.25 60.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . -46.83 176.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.932 0.396 . . . . 1.0 110.958 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -166.95 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.751 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' D' ' 30' ' ' GLU . 58.5 tp -123.04 108.74 13.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.821 0.343 . . . . 1.0 110.109 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.484 ' O ' ' CB ' ' D' ' 40' ' ' SER . 14.2 pt -136.8 159.95 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' D' ' 43' ' ' ASP . 0.5 OUTLIER 81.33 139.23 0.07 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.697 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.64 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.3 OUTLIER -77.77 -38.61 1.76 Allowed Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.695 178.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.64 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.63 -32.82 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.308 1.338 . . . . 1.0 112.197 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' D' ' 40' ' ' SER . 29.6 p-10 -96.94 -6.21 36.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.578 0.228 . . . . 1.0 110.876 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.39 -40.14 67.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.948 0.404 . . . . 1.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 tt -63.91 -40.17 88.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.417 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.487 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -58.49 -45.82 87.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -63.12 -39.24 94.1 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.724 -0.472 . . . . 1.0 109.724 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -58.81 -41.57 87.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.127 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 41.8 t -76.6 68.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.009 0.433 . . . . 1.0 111.699 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.45 ' O ' ' OG1' ' D' ' 53' ' ' THR . 7.5 pt-20 -173.58 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.733 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -64.68 -43.44 93.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.49 -28.69 60.48 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 44.2 p -84.73 -1.82 56.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.317 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' D' ' 53' ' ' THR . 46.4 p 50.95 58.86 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.025 179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' D' ' 56' ' ' GLY . 10.2 p -128.28 -46.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.587 -0.278 . . . . 1.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.461 ' N ' ' CG1' ' D' ' 55' ' ' VAL . . . 41.26 76.58 0.09 OUTLIER Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.511 ' CZ ' ' O ' ' A' ' 60' ' ' ARG . 15.1 t80 -60.94 -46.42 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.0 110.416 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.72 36.08 0.08 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 21.6 t0 -83.86 -77.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 1.0 110.69 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -130.39 147.84 52.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.412 ' CD1' ' CB ' ' C' ' 57' ' ' TYR . 46.2 t80 -149.0 135.83 10.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.33 149.23 69.41 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.011 1.807 . . . . 1.0 112.318 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.428 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 3.3 t -80.41 -125.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.009 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 76.1 m -113.7 -36.41 4.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.839 0.352 . . . . 1.0 110.888 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.7 tt0 -67.4 -30.35 70.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.2 pm0 -79.36 34.53 0.26 Allowed 'General case' 0 C--O 1.265 1.891 0 CA-C-O 123.224 1.488 . . . . 1.0 108.845 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.43 61.19 1.29 Allowed Glycine 0 C--O 1.212 -1.262 0 CA-C-N 113.767 -1.561 . . . . 1.0 109.916 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 40.0 ttm180 -24.37 -31.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.533 0.784 . . . . 1.0 111.086 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.4 mttp -54.12 -13.67 0.89 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.308 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.4 t -61.32 -47.74 92.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 119.52 -0.872 . . . . 1.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.87 80.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.96 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -57.31 -39.37 75.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.232 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -66.58 -40.47 88.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 -47.52 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.539 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.64 -40.84 96.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 1.0 111.161 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -61.51 -42.54 98.96 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.744 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.96 88.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.432 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.29 -40.43 96.57 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.53 -43.61 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.712 0.291 . . . . 1.0 111.172 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.38 -35.2 79.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.01 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 43.1 t -67.28 -56.12 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.519 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -62.07 -43.22 99.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.836 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.23 -37.51 87.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.292 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.2 -42.19 99.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' D' ' 87' ' ' ALA . 89.7 t -58.11 -18.34 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 75.6 m -43.96 -20.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.467 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.22 -61.01 2.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.909 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.99 61.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.254 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 2.7 mm? -78.08 -38.04 45.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.24 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.9 -35.85 71.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.31 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -4.2 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.907 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' D' ' 89' ' ' LEU . 66.6 t0 -56.66 -44.37 81.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.836 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 12.3 p90 -74.97 -42.98 56.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.923 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 88.7 t -44.17 -26.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.358 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -57.49 -25.32 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.075 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . 0.682 HH12 ' CD2' ' A' ' 4' ' ' HIS . 7.2 ptp180 -59.2 -34.8 72.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 1.0 110.358 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' D' ' 99' ' ' GLU . 97.6 mt-10 -70.97 -167.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.057 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 57.39 -73.77 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.807 0.336 . . . . 1.0 110.706 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' D' ' 97' ' ' GLU . 79.6 mm-40 -55.24 -43.85 74.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.38 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -61.36 -42.1 98.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.329 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -63.24 -36.51 83.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.443 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.66 15.32 56.92 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 33.0 m80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.957 -1.02 . . . . 1.0 110.357 179.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.27 -74.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.375 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -174.25 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.544 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.0 p80 -73.47 -31.07 63.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.08 -39.46 93.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -61.38 -42.09 98.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -64.0 -39.64 94.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.144 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -38.75 92.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.213 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -64.36 -41.56 96.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -63.39 -39.31 94.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.73 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.71 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.842 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.24 -44.23 88.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 1.0 110.635 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.72 -33.87 76.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.311 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.74 -35.16 79.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.449 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.0 tp -61.86 -42.57 99.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.392 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.24 -34.9 72.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.979 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.51 -40.76 97.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.09 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.42 -29.0 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.76 -41.97 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.46 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.06 -39.8 78.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.329 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.27 93.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.029 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.5 p -60.76 -42.28 97.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 1.0 110.177 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.59 -30.34 71.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.926 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.9 -46.59 18.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.302 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.03 88.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.7 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.8 m -56.71 -54.35 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.39 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -67.93 -42.19 81.4 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.839 0.352 . . . . 1.0 110.701 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.32 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.063 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -98.05 14.86 25.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.557 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt85 -80.64 99.28 8.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.0 110.351 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.45 6.42 87.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.646 -0.581 . . . . 1.0 111.646 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 149.36 95.6 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' C ' ' H ' ' A' ' 36' ' ' ALA . 98.4 Cg_endo -75.26 141.49 25.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.926 1.751 . . . . 1.0 112.245 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.05 -6.8 8.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.412 ' H ' ' C ' ' A' ' 34' ' ' PRO . . . -77.84 155.41 31.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.839 0.352 . . . . 1.0 110.48 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.18 10.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' SER . 6.8 tt -82.96 -10.73 58.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.476 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' LEU . 4.8 pt -37.35 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.631 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.4 m 169.21 134.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.916 -0.583 . . . . 1.0 109.888 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 55.9 m-85 -82.56 -48.33 0.86 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.448 0.536 . . . . 1.0 112.448 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.0 Cg_endo -60.56 -31.68 92.59 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 121.634 1.556 . . . . 1.0 112.657 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -91.2 -6.03 54.03 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.913 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.551 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.0 -41.0 88.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.093 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.99 96.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -62.4 -40.38 96.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.1 p -58.83 -31.9 68.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.718 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG1' ' OE1' ' B' ' 72' ' ' GLU . 94.9 t -71.59 -44.24 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.255 0.55 . . . . 1.0 110.636 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 45.7 tp10 -52.15 -42.68 63.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.376 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.572 ' C ' ' H ' ' A' ' 53' ' ' THR . 4.6 t -80.78 -158.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.488 ' N ' ' OG1' ' A' ' 51' ' ' THR . . . 71.31 -35.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 1.0 110.141 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 51' ' ' THR . 62.0 p -81.31 5.43 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 53' ' ' THR . 10.7 p 58.17 26.7 14.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.127 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -146.95 82.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.782 0.325 . . . . 1.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 112.1 3.39 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.4 -46.05 91.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.53 27.41 0.39 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 48.7 m-20 -62.34 -42.11 99.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 1.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 38.8 mmt180 -130.87 -169.07 2.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.15 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 96.4 m-85 -159.61 91.58 1.84 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.89 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.34 157.59 60.65 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.787 1.658 . . . . 1.0 112.271 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.676 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.9 p -116.76 -165.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.987 0.423 . . . . 1.0 110.344 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.676 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 61.2 m -78.66 -42.8 27.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.608 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.3 tp10 -50.74 -47.23 59.39 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.448 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -74.49 29.78 0.08 Allowed 'General case' 0 C--O 1.26 1.638 0 CA-C-O 124.212 1.958 . . . . 1.0 109.568 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.46 66.64 1.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 113.838 -1.528 . . . . 1.0 111.863 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH1' ' OE1' ' D' ' 50' ' ' GLU . 58.2 ttm-85 -24.11 -34.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.029 0.915 . . . . 1.0 110.808 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.9 mttp -47.63 -20.53 0.27 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' GLY . 57.1 t -61.29 -48.18 90.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 119.652 -0.819 . . . . 1.0 110.453 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.46 -41.73 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.673 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -59.67 -42.52 93.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.698 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.03 -41.55 83.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.821 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.1 t -65.65 -42.79 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.572 -0.451 . . . . 1.0 111.14 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.409 ' CE ' ' OH ' ' D' ' 57' ' ' TYR . 65.2 mtt -57.36 -45.33 84.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.904 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -63.59 -41.81 98.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.02 -40.6 85.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.647 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.24 -42.55 83.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.56 -43.92 95.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 1.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.22 -40.2 93.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.124 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 52.1 t -65.75 -49.74 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.914 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.07 -39.14 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.243 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.06 92.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.877 0.37 . . . . 1.0 110.998 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.495 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.5 tt -62.98 -41.38 99.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.302 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.3 t -47.4 -13.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.348 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 84' ' ' LEU . 76.8 m -58.07 -42.18 84.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.89 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -40.27 -33.77 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.561 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.61 19.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.684 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 86' ' ' THR . 52.2 mt -66.4 -38.77 88.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.53 -47.83 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.155 0.502 . . . . 1.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -4.14 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.449 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -58.41 -49.39 77.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.015 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.5 p90 -76.05 -34.41 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.439 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.1 t -43.95 -34.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.137 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -60.36 -23.04 63.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -57.48 -44.31 84.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.434 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -89.73 -68.25 0.79 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' A' ' 100' ' ' ARG . 47.7 mt-10 -75.01 162.38 28.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.491 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 71.28 -33.87 0.28 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.309 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.565 ' H ' ' C ' ' A' ' 98' ' ' GLU . 69.2 ttp85 -60.99 -44.36 97.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.471 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -94.88 -7.71 39.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.494 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.27 22.47 77.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.529 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.402 ' O ' ' O ' ' B' ' 2' ' ' ALA . 7.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 44.59 -169.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 64.3 t0 -131.03 -29.98 1.81 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -77.48 -20.56 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.372 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.39 -37.78 83.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.93 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.73 -42.72 97.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.767 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.431 . . . . 1.0 109.864 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.43 90.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.73 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.8 -43.27 96.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.146 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -63.19 -40.37 97.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.69 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.51 81.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.823 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.27 -44.27 84.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 1.0 110.647 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -64.67 -36.82 85.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.129 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -62.4 -33.44 74.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.325 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 1.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.17 -38.02 72.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.96 -38.62 89.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.76 -39.84 87.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.838 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.85 -38.72 82.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.438 ' O ' ' OG ' ' B' ' 23' ' ' SER . 96.8 mt-10 -63.05 -43.92 97.3 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -69.32 -31.18 69.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.77 86.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.006 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -60.69 -45.77 92.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 44.3 tttm -65.47 -50.09 66.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.338 0.59 . . . . 1.0 110.073 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.09 -42.63 96.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.743 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.52 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -67.71 -50.69 56.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.106 0.253 . . . . 1.0 111.531 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.9 p -60.94 -45.91 97.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.06 0.457 . . . . 1.0 110.658 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 96.7 mt-10 -68.64 -18.81 64.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.674 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.76 -51.23 70.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.048 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 56.0 mp0 -80.64 -110.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 1.0 110.113 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 41.81 50.22 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.151 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.77 25.82 0.9 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.786 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.08 150.47 39.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.71 130.18 12.35 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.975 1.784 . . . . 1.0 112.067 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.88 75.08 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.201 -0.76 . . . . 1.0 111.201 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 163.49 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.349 . . . . 1.0 110.53 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.24 -32.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.574 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.59 49.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.39 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.439 ' O ' ' OG ' ' B' ' 40' ' ' SER . 18.7 tt -92.73 76.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.182 0.515 . . . . 1.0 110.107 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 39' ' ' ILE . 69.1 m -168.81 98.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.087 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.541 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 53.4 t80 -58.26 -50.12 89.83 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.69 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.2 Cg_endo -58.22 -33.28 97.41 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.809 1.672 . . . . 1.0 112.608 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 76.5 m-20 -94.66 -4.2 48.04 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.237 -0.185 . . . . 1.0 110.958 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.88 92.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.947 0.403 . . . . 1.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 tt -67.39 -40.23 84.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.635 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.94 -42.45 99.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.469 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -61.8 -42.7 99.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.549 ' C ' ' H ' ' B' ' 50' ' ' GLU . 16.2 m -56.82 -39.11 73.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.086 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.501 ' O ' ' CG1' ' B' ' 49' ' ' VAL . 58.0 t -67.18 29.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.87 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.549 ' H ' ' C ' ' B' ' 48' ' ' SER . 79.7 mm-40 -137.07 -21.79 1.2 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.848 -0.532 . . . . 1.0 110.493 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -36.08 14.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.02 83.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.207 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.406 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.7 p -86.18 12.96 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.849 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' B' ' 53' ' ' THR . 68.0 p 50.11 73.95 0.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.624 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 29.4 t -131.4 -71.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.65 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 64.76 3.25 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -46.55 89.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.779 0.323 . . . . 1.0 110.752 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.96 23.1 0.97 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.633 -0.987 . . . . 1.0 110.633 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 48.0 t0 -63.13 -41.05 99.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 1.0 110.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 35.0 mmt180 -126.57 -174.68 3.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 79.2 m-85 -159.57 83.32 2.32 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.868 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 151.97 77.94 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.545 1.497 . . . . 1.0 112.092 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 16.8 m -96.68 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.872 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' B' ' 66' ' ' GLU . 48.8 m -112.38 -55.84 2.47 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.728 0.299 . . . . 1.0 111.238 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -43.87 -16.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.86 0.362 . . . . 1.0 110.804 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' B' ' 64' ' ' THR . 0.0 OUTLIER -91.85 26.66 2.33 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 123.839 1.781 . . . . 1.0 109.477 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.89 64.35 1.09 Allowed Glycine 0 C--O 1.212 -1.26 0 CA-C-N 113.663 -1.608 . . . . 1.0 111.424 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 55.8 ttm-85 -24.87 -32.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.217 1.008 . . . . 1.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.6 mttt -48.0 -18.87 0.21 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 67' ' ' GLY . 65.0 t -64.28 -45.47 96.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 120.124 -0.631 . . . . 1.0 109.803 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.92 -40.97 78.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.997 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . 0.425 ' OE1' ' CG1' ' A' ' 49' ' ' VAL . 83.0 tt0 -65.39 -40.5 93.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.085 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.69 -59.44 5.43 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.087 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.2 -44.68 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.287 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 38.9 ttp -59.93 -47.52 85.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.64 -32.48 73.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.378 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.74 78.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.575 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -43.05 96.74 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.401 HG23 HD12 ' B' ' 79' ' ' ILE . 92.2 mt -61.74 -43.45 97.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 122.813 -0.228 . . . . 1.0 110.87 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.13 -42.1 85.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.298 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -63.83 -50.13 78.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.344 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.39 -37.83 80.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.789 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -64.29 -37.85 88.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.555 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.425 ' C ' ' N ' ' B' ' 86' ' ' THR . 4.4 tt -62.66 -41.58 99.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.183 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 82.7 t -51.96 -15.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 54.7 m -49.65 -40.81 40.96 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.35 -38.94 44.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.322 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.67 59.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.678 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.69 -30.33 15.61 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.203 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.521 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.75 -40.44 96.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.47 0.652 . . . . 1.0 109.93 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 -5.31 49.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.932 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -54.99 -50.45 68.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.917 -178.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 20.7 p90 -67.87 -43.91 78.31 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.357 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 97.6 t -39.42 -27.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.709 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 93' ' ' PHE . 34.7 mmt180 -63.25 -36.03 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.041 -0.264 . . . . 1.0 111.295 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -43.91 -28.29 0.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 1.0 110.192 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.38 -45.78 92.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.983 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' B' ' 102' ' ' GLY . 97.0 mt-10 -70.22 -31.91 69.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.75 0.31 . . . . 1.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.17 -34.85 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.849 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.9 -44.61 96.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . 0.48 ' O ' ' CE1' ' B' ' 103' ' ' HIS . 95.8 mtt-85 -99.08 -0.9 40.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.896 0.379 . . . . 1.0 110.35 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 98' ' ' GLU . . . 78.08 3.71 85.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' B' ' 101' ' ' ARG . 40.0 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.529 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.422 ' CB ' ' CD2' ' C' ' 4' ' ' HIS . . . -155.15 12.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 56.85 53.2 8.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.966 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 0.3 OUTLIER -171.74 -30.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.911 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 23.8 mm-40 -83.85 -22.52 31.67 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.768 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.95 -41.57 99.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.117 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.06 -44.95 83.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.62 88.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.467 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.7 -44.5 96.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.32 -33.43 75.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.203 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.48 87.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -37.81 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.786 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -65.78 -33.45 75.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.523 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.37 -44.7 92.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.796 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -63.23 -41.42 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.604 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -58.08 -42.25 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.567 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' C' ' 21' ' ' GLU . 56.4 mtmt -62.9 -40.8 98.68 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.147 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.48 -36.66 77.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 91.2 mt -60.81 -40.56 93.15 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.095 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.66 -50.69 72.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.146 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 12.2 mp0 -69.43 -43.0 74.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.42 93.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.475 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 20.3 m -61.76 -44.95 95.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.731 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -66.19 -36.15 82.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 1.0 109.856 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' C' ' 29' ' ' ALA . 64.3 mmtt -72.98 -41.73 64.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.597 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -52.58 -52.96 52.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.537 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 4.2 p -62.8 -44.7 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.406 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 80.8 mm-40 -65.8 -37.01 85.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -61.41 -40.48 94.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.328 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.6 mp0 -70.25 -37.85 75.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 1.0 110.69 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH2' ' OH ' ' C' ' 41' ' ' TYR . 25.5 mmt180 -56.64 100.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.721 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 116.09 -12.45 17.06 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.28 144.5 34.22 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 122.772 -0.252 . . . . 1.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.07 143.04 25.38 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.036 1.824 . . . . 1.0 112.414 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.17 28.9 67.39 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 141.03 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.311 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 -35.83 4.87 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.414 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -92.29 77.55 5.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.946 -0.39 . . . . 1.0 109.946 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.409 HD12 HG22 ' C' ' 39' ' ' ILE . 25.7 pt -110.41 -7.63 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.921 0.391 . . . . 1.0 110.466 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -81.9 134.93 35.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.46 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.531 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.2 OUTLIER -77.94 -48.57 2.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.847 178.658 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.5 Cg_endo -59.82 -28.73 87.91 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 121.675 1.583 . . . . 1.0 112.136 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.85 -17.28 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.383 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.66 99.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.75 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tt -65.27 -42.1 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.413 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.73 -46.27 86.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.538 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.459 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.0 t90 -63.91 -40.95 97.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.462 -0.495 . . . . 1.0 109.819 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 64.6 p -60.14 -35.85 76.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.134 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.79 -48.95 86.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.826 -0.35 . . . . 1.0 111.56 -179.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' C' ' 59' ' ' ASP . 15.8 pt-20 -73.46 -25.81 60.65 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.549 -0.46 . . . . 1.0 110.861 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 27.4 m -62.55 -44.28 96.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.484 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.65 -20.41 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.696 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.558 ' C ' ' H ' ' C' ' 55' ' ' VAL . 4.9 p -84.31 -2.7 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' C' ' 53' ' ' THR . 6.5 p 60.64 -3.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.726 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' C' ' 53' ' ' THR . 73.9 t -64.01 -44.84 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.795 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . 0.48 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 70.79 -60.36 0.95 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.486 ' OH ' ' CD1' ' D' ' 47' ' ' TRP . 2.5 t80 70.6 -41.65 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 1.0 110.973 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.48 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 120.68 24.43 2.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.421 ' OD2' ' OE2' ' C' ' 50' ' ' GLU . 65.5 t0 -61.95 -48.04 82.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.984 0.421 . . . . 1.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' C' ' 61' ' ' TYR . 96.3 mtt-85 -143.54 -177.5 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 1.0 109.887 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' C' ' 60' ' ' ARG . 9.9 m-85 -155.02 106.79 2.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 120.606 -0.438 . . . . 1.0 111.01 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.16 156.42 64.99 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.725 1.616 . . . . 1.0 112.216 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.44 ' O ' ' OE2' ' C' ' 66' ' ' GLU . 1.8 t -82.47 -140.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.061 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.409 ' CA ' ' OE2' ' C' ' 66' ' ' GLU . 41.4 m -113.87 -38.93 4.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.836 0.351 . . . . 1.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.0 tt0 -63.64 -27.03 68.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.983 0.421 . . . . 1.0 110.008 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -73.17 30.21 0.07 Allowed 'General case' 0 C--O 1.263 1.796 0 CA-C-O 123.818 1.77 . . . . 1.0 110.109 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 40.53 64.03 1.27 Allowed Glycine 0 C--O 1.214 -1.126 0 CA-C-N 113.706 -1.588 . . . . 1.0 111.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' C' ' 67' ' ' GLY . 59.2 ttm-85 -24.09 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.768 0.784 . . . . 1.0 111.231 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.0 mttt -50.57 -16.51 0.38 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.764 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.5 t -61.44 -45.6 98.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.441 -0.904 . . . . 1.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.6 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.201 0.524 . . . . 1.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -69.53 -41.57 75.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.214 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -63.85 -48.44 76.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.748 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.93 -44.06 97.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.314 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 71.1 mtm -64.61 -41.09 96.44 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.991 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.52 -42.6 99.62 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.366 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.19 -39.74 95.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 1.0 110.44 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.68 97.9 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.75 -0.54 . . . . 1.0 111.75 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.54 -43.3 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.277 . . . . 1.0 110.625 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.14 -40.38 86.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 51.6 t -62.96 -49.95 81.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.944 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -68.93 -38.87 79.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.177 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -70.56 -33.12 70.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.917 0.389 . . . . 1.0 110.857 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.7 tt -61.82 -42.36 98.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.749 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.416 ' C ' ' N ' ' C' ' 87' ' ' ALA . 1.5 m -49.31 -11.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.568 -0.453 . . . . 1.0 110.415 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.518 ' H ' ' C ' ' C' ' 84' ' ' LEU . 48.5 m -48.75 -19.66 0.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.935 0.398 . . . . 1.0 110.267 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.416 ' N ' ' C ' ' C' ' 85' ' ' VAL . . . -60.02 -35.25 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.17 -34.33 29.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.42 -39.85 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.727 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.527 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.59 -47.95 82.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.0 111.291 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -4.12 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.335 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -57.4 -48.34 79.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.557 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.527 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 22.9 p90 -76.08 -43.7 42.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.069 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 80.0 t -42.11 -27.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.747 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -61.78 -22.39 65.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.959 -0.296 . . . . 1.0 111.249 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -73.99 -7.68 53.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.816 0.341 . . . . 1.0 110.605 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.76 -51.26 70.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.73 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -68.57 -35.19 77.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 1.0 110.565 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.45 -24.3 66.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.428 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -60.23 -44.39 95.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.579 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.4 -4.88 20.91 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.82 87.56 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 m170 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.508 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' D' ' 4' ' ' HIS . . . 72.15 -50.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.17 -32.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.54 ' H ' ' C ' ' D' ' 2' ' ' ALA . 28.5 p80 -82.26 -19.96 38.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.91 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.04 -40.66 78.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.805 0.336 . . . . 1.0 110.624 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -65.3 -38.04 89.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.07 -44.55 96.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.066 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.17 91.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.16 -41.33 94.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.54 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -63.79 -36.33 83.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -38.28 82.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.91 -41.16 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 1.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.81 -33.24 75.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.503 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.32 -38.52 91.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.53 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.9 tp -62.64 -39.84 95.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.551 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -57.97 -40.7 81.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.289 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -75.82 -18.03 59.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.957 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.89 -56.48 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.04 0.448 . . . . 1.0 111.169 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 pp -62.36 -28.44 69.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.733 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.46 ' O ' ' OG ' ' D' ' 23' ' ' SER . 73.6 mt-10 -64.39 -44.54 91.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.229 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -66.32 -36.68 83.54 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.888 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' D' ' 74' ' ' VAL . . . -65.32 -35.04 79.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.759 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 95.2 p -58.12 -43.89 87.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.845 -179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.04 -32.71 74.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -84.84 -32.3 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -60.86 -45.37 94.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.062 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 5.5 p -61.3 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.089 0.471 . . . . 1.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.508 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 10.9 tm-20 -69.26 -40.76 77.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.386 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.05 94.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.337 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 26.0 tp10 -72.12 -38.52 69.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.869 0.366 . . . . 1.0 110.944 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -65.35 120.49 12.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.725 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.27 55.52 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.343 -0.703 . . . . 1.0 111.343 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.75 149.29 36.34 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 122.899 -0.177 . . . . 1.0 110.775 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.49 131.66 15.2 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.931 1.754 . . . . 1.0 111.965 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 7.05 88.23 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.72 143.25 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 -11.29 1.72 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tt -110.53 120.37 42.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.021 0.438 . . . . 1.0 109.982 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' D' ' 40' ' ' SER . 37.0 pt -143.47 -165.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.366 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 3.2 m 58.25 132.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.543 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -74.6 -48.76 5.07 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.0 Cg_endo -59.04 -30.73 94.11 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.438 1.426 . . . . 1.0 111.943 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.22 -25.93 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.3 90.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.766 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -63.19 -37.21 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.248 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.407 ' CD1' ' OG1' ' A' ' 64' ' ' THR . 0.4 OUTLIER -65.92 -46.6 77.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.18 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.486 ' CD1' ' OH ' ' C' ' 57' ' ' TYR . 2.3 t90 -57.47 -29.77 64.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -34.65 66.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.929 0.395 . . . . 1.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.8 -48.68 87.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.481 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 12.4 pt-20 -62.8 -38.2 89.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.554 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 20.7 m -77.64 178.57 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.509 ' H ' ' CG2' ' D' ' 51' ' ' THR . . . 78.47 -18.22 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.478 ' H ' ' C ' ' D' ' 51' ' ' THR . 59.0 p -106.52 9.32 31.58 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.451 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' D' ' 53' ' ' THR . 12.0 p 56.89 67.24 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.955 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.95 -80.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.724 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.4 96.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.409 ' OH ' ' CE ' ' A' ' 75' ' ' MET . 59.5 m-85 -61.72 -43.22 99.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.689 0.281 . . . . 1.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.51 12.78 1.54 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.81 -50.41 74.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 1.0 110.462 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -144.68 125.98 14.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -114.66 138.9 23.46 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.64 160.39 49.6 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.469 2.112 . . . . 1.0 111.875 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.654 ' CG2' ' H ' ' D' ' 64' ' ' THR . 10.0 p -97.61 -140.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.002 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.654 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 51.8 m -114.21 -43.68 3.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.312 -0.403 . . . . 1.0 111.044 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -66.6 -19.98 65.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.58 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.412 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.69 25.84 0.11 Allowed 'General case' 0 C--O 1.262 1.723 0 CA-C-O 123.993 1.854 . . . . 1.0 109.213 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.743 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.59 62.79 3.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.0 -1.454 . . . . 1.0 109.841 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 57.0 ttm-85 -25.62 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.458 0.629 . . . . 1.0 111.03 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.743 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.22 -28.06 6.97 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.24 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' D' ' 67' ' ' GLY . 78.4 t -63.05 -48.8 86.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -74.26 -51.99 13.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.47 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -49.8 -40.31 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.096 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.29 -40.37 96.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' D' ' 22' ' ' ALA . 70.5 t -62.38 -45.19 99.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.431 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' D' ' 51' ' ' THR . 3.8 mpp? -64.25 -42.08 96.66 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.066 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -63.97 -42.03 97.38 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.8 -36.53 83.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.896 0.379 . . . . 1.0 110.751 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.6 -40.15 77.83 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.34 -44.65 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.788 0.294 . . . . 1.0 111.708 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -65.92 -35.67 81.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.152 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 42.0 t -62.17 -48.67 87.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.552 -0.294 . . . . 1.0 111.263 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -73.78 -4.65 35.96 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.878 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -97.41 -32.37 11.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.022 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.7 tt -65.11 -40.04 93.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.442 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -53.7 -6.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.191 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.545 ' H ' ' C ' ' D' ' 84' ' ' LEU . 71.1 m -58.19 -43.54 87.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.339 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.428 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -42.78 -30.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.476 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.413 ' CB ' ' HD1' ' D' ' 4' ' ' HIS . . . -86.57 -32.92 20.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.066 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' D' ' 86' ' ' THR . 90.6 mt -67.34 -39.22 85.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.228 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.01 -48.18 82.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.182 0.515 . . . . 1.0 111.101 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -73.97 -4.98 38.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.209 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 46.7 t0 -55.14 -49.36 72.0 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.102 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 26.7 p90 -73.37 -44.13 59.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.0 t -42.47 -26.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.219 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -58.4 -32.29 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.957 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -58.77 -34.32 71.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 1.0 110.418 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' D' ' 99' ' ' GLU . 67.2 tt0 -72.7 162.84 28.97 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 68.23 -41.83 0.45 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.782 0.676 . . . . 1.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' D' ' 97' ' ' GLU . 80.1 mm-40 -66.21 -36.37 82.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.398 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -60.82 -44.32 97.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.127 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -76.74 -14.76 59.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.583 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.57 8.84 85.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . 0.433 ' OXT' ' CG ' ' D' ' 103' ' ' HIS . 85.9 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.017 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -46.2 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 4' ' ' HIS . 31.5 p-10 -172.57 -46.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.421 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 43.0 p-80 -78.92 -29.98 44.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.53 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.71 -35.93 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -63.15 -37.81 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.291 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -64.22 -41.89 96.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.063 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.87 92.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.357 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.82 -39.26 90.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.353 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.79 -41.19 97.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.617 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.43 80.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.869 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.02 -36.82 85.24 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -34.55 78.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.487 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' CD ' ' NZ ' ' A' ' 17' ' ' LYS . 39.7 tp10 -64.95 -36.35 84.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.72 -42.13 99.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 1.0 110.737 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.307 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.477 ' NZ ' ' CD ' ' A' ' 14' ' ' GLU . 6.8 ttpm? -62.41 -40.07 95.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.13 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.88 -35.66 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.06 -42.46 98.54 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.216 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.54 -43.29 85.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.263 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.6 -39.65 77.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.389 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.48 96.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.6 m -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.391 . . . . 1.0 110.182 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.764 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.69 -46.69 13.96 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.248 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.93 -44.58 78.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.549 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 4.7 p -59.51 -46.92 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.117 -0.633 . . . . 1.0 109.694 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 94.6 mt-10 -71.55 -33.8 69.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.653 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.29 97.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.266 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -89.89 -4.34 57.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.143 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -75.37 91.08 2.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.577 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.6 -15.36 17.25 Favored Glycine 0 N--CA 1.466 0.67 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 148.67 97.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 120.786 -0.365 . . . . 1.0 110.028 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.18 139.66 24.08 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.865 1.71 . . . . 1.0 112.333 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.62 21.92 74.92 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.64 166.35 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.902 0.382 . . . . 1.0 110.554 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.66 -12.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.231 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 40.2 tp -67.72 -19.07 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' LEU . 95.3 mt -33.63 89.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.273 0.559 . . . . 1.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' LEU . 8.7 t -171.66 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.561 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -179.27 -57.8 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 123.142 0.276 . . . . 1.0 111.26 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -60.09 -31.65 93.63 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 121.782 1.655 . . . . 1.0 112.5 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -82.55 -10.12 59.12 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.233 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.25 84.06 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.87 0.366 . . . . 1.0 110.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.69 -38.33 80.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.475 178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.483 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.4 OUTLIER -63.96 -50.47 68.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.163 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -62.36 -42.82 99.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.751 -0.463 . . . . 1.0 109.751 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.7 m -53.64 -36.05 61.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.8 t -82.99 -4.86 8.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.0 110.459 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -107.82 37.19 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.375 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.74 -35.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.57 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.68 63.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.496 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.438 ' O ' ' OG1' ' A' ' 54' ' ' THR . 70.2 p -89.69 5.29 46.51 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 53' ' ' THR . 44.7 p 54.46 71.03 0.55 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.142 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.85 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.741 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.32 84.68 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.618 ' HH ' ' HG1' ' B' ' 51' ' ' THR . 7.4 m-85 -62.78 -41.72 99.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.768 0.318 . . . . 1.0 110.556 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.24 20.49 0.36 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.32 -35.36 80.6 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.679 ' NH2' HH22 ' B' ' 68' ' ' ARG . 2.1 tpp180 -134.77 179.07 6.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.348 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 75.1 m-85 -160.94 93.88 1.47 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.35 149.74 69.89 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.713 1.609 . . . . 1.0 112.216 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.45 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 1.5 t -85.76 -143.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.305 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.1 m -110.34 -38.78 5.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.697 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.571 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.2 tt0 -61.46 -20.73 63.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.059 0.457 . . . . 1.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.14 25.77 0.22 Allowed 'General case' 0 C--O 1.267 1.995 0 CA-C-O 123.915 1.817 . . . . 1.0 109.516 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.94 65.47 1.6 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.649 -1.614 . . . . 1.0 111.12 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 55.6 ttm-85 -24.45 -32.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.975 0.888 . . . . 1.0 110.999 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 99.1 mttt -47.24 -26.25 1.15 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.422 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.497 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.4 t -63.26 -46.47 95.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.764 -0.774 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.34 62.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 1.0 111.012 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.31 -41.27 96.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.835 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -55.57 -43.82 76.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.75 -44.72 89.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.486 -0.486 . . . . 1.0 111.005 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.3 mtt -61.87 -43.64 98.43 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.637 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.78 -41.06 92.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 1.0 110.299 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.67 88.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.629 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.28 -43.74 92.24 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.07 -43.53 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 121.082 -0.247 . . . . 1.0 110.395 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -43.19 97.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.246 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -64.77 -50.02 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.796 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -68.29 -37.36 80.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -63.12 -37.68 88.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.685 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.532 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.1 tt -65.69 -37.45 86.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.24 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.3 t -46.06 -13.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.42 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 84' ' ' LEU . 16.2 m -58.79 -45.17 90.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.495 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -40.93 -21.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.758 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -106.62 -25.35 11.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.73 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 86' ' ' THR . 69.6 mt -62.79 -42.22 99.6 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.57 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -72.96 -65.24 0.82 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.36 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -47.56 -10.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.229 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.57 ' H ' ' C ' ' A' ' 90' ' ' ALA . 46.9 t0 -63.18 -73.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.024 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' O ' ' N ' ' A' ' 95' ' ' ARG . 25.1 m-85 -86.46 -27.98 23.77 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.952 0.353 . . . . 1.0 111.952 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 56.3 t -40.88 -27.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.515 0.198 . . . . 1.0 111.274 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' GLU . 95.7 mtt-85 -61.17 -32.99 72.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -39.43 -38.68 0.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.715 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.43 -41.8 75.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.002 0.43 . . . . 1.0 109.906 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 95' ' ' ARG . 80.1 mm-40 -68.16 -35.79 78.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.27 -43.86 97.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.41 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.416 HH21 ' NH2' ' A' ' 101' ' ' ARG . 42.2 ttp-105 -65.57 -42.72 91.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.309 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.416 ' NH2' HH21 ' A' ' 100' ' ' ARG . 89.5 mtm180 -130.91 102.22 5.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.505 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.77 27.73 5.06 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.683 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.94 171.4 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.669 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 65.7 t0 -63.56 -39.02 93.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.456 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 16.1 p-80 -80.7 -29.63 36.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.615 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.23 -44.26 84.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.89 -36.01 75.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -67.79 -40.42 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 1.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.8 98.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.85 -32.49 73.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.24 -39.46 92.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.365 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.34 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.767 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.6 -36.85 81.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.396 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -65.73 -41.18 92.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.363 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 40.6 tp -61.27 -41.86 97.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.37 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.24 -42.85 96.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.712 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -64.15 -37.93 89.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.711 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.81 -66.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.12 -31.56 61.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.837 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' B' ' 23' ' ' SER . 61.2 mt-10 -63.45 -44.66 93.86 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 178.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.52 -36.63 84.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.61 75.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.854 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 25.2 p -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.483 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.58 -56.35 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.077 -0.649 . . . . 1.0 109.856 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.1 -38.97 80.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.267 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.45 76.41 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.131 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 90.2 t -63.58 -48.56 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.263 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.88 -35.81 72.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.752 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.43 84.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.201 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' B' ' 38' ' ' LEU . 41.9 mm-40 -70.51 -42.56 71.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 1.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -53.6 94.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.899 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 115.85 11.25 10.33 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 111.15 -0.78 . . . . 1.0 111.15 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' OE2' ' B' ' 66' ' ' GLU . . . -102.03 137.41 19.48 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.614 0.207 . . . . 1.0 110.617 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.03 138.86 21.1 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.869 1.713 . . . . 1.0 112.407 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.4 3.4 39.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . -47.14 176.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 1.0 110.399 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.27 -28.92 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.537 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' B' ' 30' ' ' GLU . 23.0 tp -99.49 119.81 38.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.965 0.412 . . . . 1.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.34 64.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.036 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -169.26 128.99 1.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.372 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.54 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.2 OUTLIER -58.62 -51.45 81.73 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.669 -0.696 . . . . 1.0 111.176 178.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.3 Cg_endo -57.85 -32.24 94.48 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.701 1.601 . . . . 1.0 112.682 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' B' ' 43' ' ' ASP . 2.4 m-20 -93.22 -23.24 18.61 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.762 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.99 94.42 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.878 0.37 . . . . 1.0 110.568 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -64.27 -37.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.41 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -44.98 86.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.44 -40.33 94.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.502 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -61.47 -36.33 80.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.171 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.99 -48.07 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 1.0 111.982 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.419 ' O ' ' OG1' ' B' ' 53' ' ' THR . 15.4 pt-20 -67.88 -30.5 69.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.846 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.618 ' HG1' ' HH ' ' A' ' 57' ' ' TYR . 78.7 m -62.51 -45.08 94.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.565 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.73 -32.15 70.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.013 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' B' ' 54' ' ' THR . 45.0 p -71.82 -6.75 43.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.799 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.38 65.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.284 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.7 t -150.37 -47.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.584 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 42.85 83.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' C' ' 56' ' ' GLY . 33.1 m-85 -62.83 -41.6 99.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 167.62 -90.25 0.1 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 77.1 m-20 42.56 -88.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 1.0 110.9 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' B' ' 58' ' ' GLY . 25.6 mmt180 -115.61 -173.39 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.194 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 38.7 p90 -173.77 118.54 0.37 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.246 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.35 158.12 58.65 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.565 1.51 . . . . 1.0 112.251 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.438 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.8 t -97.22 -126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 5.9 p -114.3 -36.56 4.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.777 0.322 . . . . 1.0 111.144 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.565 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.7 tt0 -65.29 -31.48 72.65 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.553 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 1.3 pm0 -79.26 30.33 0.22 Allowed 'General case' 0 C--O 1.269 2.115 0 CA-C-O 123.969 1.842 . . . . 1.0 109.797 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 37.57 61.92 1.01 Allowed Glycine 0 C--O 1.212 -1.237 0 CA-C-N 113.092 -1.867 . . . . 1.0 111.045 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.679 HH22 ' NH2' ' A' ' 60' ' ' ARG . 40.5 ttm180 -24.96 -32.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.993 . . . . 1.0 110.947 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' B' ' 67' ' ' GLY . 68.3 mttm -49.42 -16.48 0.2 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 55.9 t -63.35 -46.1 96.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 119.788 -0.765 . . . . 1.0 109.578 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.58 72.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.241 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.12 -43.92 70.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.343 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.35 -44.22 88.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.825 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.34 -43.51 91.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.323 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 37.0 mtt -59.11 -44.86 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.721 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.19 -42.58 96.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.74 89.17 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.13 -36.81 93.71 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.89 -26.9 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.424 -0.457 . . . . 1.0 111.523 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.29 -50.6 37.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.042 0.449 . . . . 1.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 5.7 m -60.04 -48.7 86.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.355 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 20.6 m-85 -66.03 -34.55 78.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.67 37.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.2 tt -69.97 -23.43 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 1.0 110.114 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 98.6 t -57.29 -3.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.644 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.551 ' H ' ' C ' ' B' ' 84' ' ' LEU . 14.6 t -49.32 -39.0 29.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.404 0.621 . . . . 1.0 109.585 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.464 ' O ' ' CG2' ' B' ' 91' ' ' THR . . . -46.69 -35.63 6.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.423 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.23 -10.85 51.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.585 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' B' ' 92' ' ' ASP . 85.7 mt -85.29 -56.87 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.891 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.293 0.568 . . . . 1.0 109.989 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -61.11 -37.56 83.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.574 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.489 ' N ' ' O ' ' B' ' 89' ' ' LEU . 11.1 t0 -59.56 -44.48 93.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.617 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 0.5 OUTLIER -61.25 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.756 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 96' ' ' ARG . 95.9 t -64.93 -43.83 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.738 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.533 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 46.9 mtt85 -44.79 -20.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.459 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' B' ' 94' ' ' VAL . 52.3 ptt85 -52.85 -33.13 48.16 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.247 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 99' ' ' GLU . 7.5 pt-20 -112.76 -169.11 1.42 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.438 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 39.87 22.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' B' ' 97' ' ' GLU . 82.0 tt0 -132.15 -48.34 0.93 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.796 0.332 . . . . 1.0 110.735 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -60.15 -36.54 77.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.43 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.508 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.45 25.17 44.09 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.339 -0.705 . . . . 1.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.555 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' SER . . . . . 0.411 ' O ' ' O ' ' C' ' 2' ' ' ALA . 42.8 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' C' ' 1' ' ' SER . . . 59.99 136.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.85 -21.29 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.427 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.648 ' HD1' ' N ' ' C' ' 5' ' ' GLU . 2.8 p80 -78.78 -27.7 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.054 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.648 ' N ' ' HD1' ' C' ' 4' ' ' HIS . 84.7 tt0 -70.04 -32.75 71.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.739 0.304 . . . . 1.0 110.813 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -59.36 -41.58 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.58 -39.95 89.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.187 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.38 87.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -58.06 -42.45 85.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.529 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -62.6 -34.6 77.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 1.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.95 76.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.001 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.29 -32.82 74.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.004 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.2 -41.97 94.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.705 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.44 -39.95 94.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.39 -42.36 99.36 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.649 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.61 -41.88 92.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.6 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -63.36 -38.46 91.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.793 0.33 . . . . 1.0 111.155 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.68 -42.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.754 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 67.1 mt -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.239 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.427 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -64.5 -42.63 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.35 -39.0 74.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.492 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.53 85.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.996 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -58.27 -46.21 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.617 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.41 -35.71 81.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 1.0 109.964 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -70.6 -40.93 72.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.321 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -50.14 73.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.33 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.43 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.403 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -69.6 -41.83 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.539 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.89 94.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.65 -6.76 56.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.965 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -87.74 117.47 26.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.929 0.395 . . . . 1.0 110.119 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.47 -4.02 63.94 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.3 144.09 37.75 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.93 137.79 20.11 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.9 1.734 . . . . 1.0 112.346 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.75 14.9 75.6 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 149.06 47.15 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.383 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 41.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.509 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' C' ' 39' ' ' ILE . 3.7 tt -127.53 -67.15 0.84 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.191 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' C' ' 38' ' ' LEU . 19.2 pt 31.59 -123.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.557 0.536 . . . . 1.0 110.862 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t 47.82 -130.63 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.731 0.301 . . . . 1.0 110.754 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . . . . . . . . . 5.9 t80 177.85 -59.37 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.454 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -59.33 -33.95 97.74 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.927 1.751 . . . . 1.0 112.105 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -78.01 -6.04 53.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.53 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.3 -44.82 90.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 1.0 111.348 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tt -66.14 -33.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.425 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -64.08 -48.54 75.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.258 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.45 -42.61 95.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.272 -0.571 . . . . 1.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -52.81 -39.45 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.739 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . 0.555 ' C ' ' H ' ' C' ' 51' ' ' THR . 71.2 t -65.47 -43.93 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.513 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.64 24.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.884 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.555 ' H ' ' C ' ' C' ' 49' ' ' VAL . 96.1 m -127.78 -43.85 1.52 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.674 -0.239 . . . . 1.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.93 -25.13 66.55 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.578 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.434 ' H ' ' HG1' ' C' ' 53' ' ' THR . 16.9 p -89.9 4.4 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.834 0.349 . . . . 1.0 110.12 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' C' ' 53' ' ' THR . 44.2 p 52.19 35.76 17.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.813 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 31.3 m -75.35 -35.87 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.212 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD2' ' B' ' 57' ' ' TYR . . . 100.11 -76.3 0.45 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' C' ' 57' ' ' TYR . 44.2 p90 -61.99 117.61 6.18 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.559 ' C ' ' H ' ' C' ' 60' ' ' ARG . . . -133.77 20.02 4.14 Favored Glycine 0 N--CA 1.464 0.515 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.42 ' OD2' ' CZ ' ' C' ' 60' ' ' ARG . 11.9 t0 71.12 -29.14 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.298 . . . . 1.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.559 ' H ' ' C ' ' C' ' 58' ' ' GLY . 21.3 mmt180 -121.22 152.4 38.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -139.35 126.85 13.06 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.63 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.84 152.49 68.91 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.764 1.643 . . . . 1.0 111.981 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' C' ' 66' ' ' GLU . 3.4 t -92.34 -126.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.458 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 86.9 m -115.17 -38.71 3.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.909 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.693 ' C ' ' H ' ' C' ' 67' ' ' GLY . 42.7 tp10 -67.6 -38.43 83.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.647 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 0.1 OUTLIER -65.89 27.17 0.02 OUTLIER 'General case' 0 C--O 1.264 1.829 0 CA-C-O 123.176 1.465 . . . . 1.0 110.248 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.78 64.28 1.7 Allowed Glycine 0 C--O 1.216 -0.975 0 CA-C-O 118.183 -1.343 . . . . 1.0 111.192 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 56.8 ttm-85 -23.34 -32.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.05 0.925 . . . . 1.0 111.446 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.9 mttt -50.62 -16.49 0.39 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.379 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 57.0 t -60.48 -46.83 94.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.98 81.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 1.0 110.142 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -62.25 -36.72 82.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.84 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -62.55 -43.84 97.82 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.28 -45.6 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.558 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.8 -36.9 85.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.971 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -59.36 -46.26 89.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.25 -38.45 87.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 1.0 110.265 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.23 -48.56 73.53 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.156 -0.545 . . . . 1.0 111.809 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.15 -43.7 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.707 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -68.18 -43.02 79.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.279 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 41.4 t -63.38 -49.16 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.083 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -68.68 -28.49 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.186 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -85.44 -26.41 26.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 1.0 110.412 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 tt -64.15 -42.51 96.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.625 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.8 m -62.33 -9.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.44 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' C' ' 83' ' ' ALA . 24.8 m -41.45 -20.14 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.932 0.396 . . . . 1.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.546 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -63.69 -66.46 0.54 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.542 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.57 64.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.48 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 4.2 mm? -64.98 -38.43 90.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.363 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -66.99 -69.29 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.938 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.455 ' O ' ' CG2' ' C' ' 94' ' ' VAL . 0.5 OUTLIER -40.03 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.539 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' C' ' 90' ' ' ALA . 46.4 t0 -38.83 -33.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.677 0.275 . . . . 1.0 111.364 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 7.0 p90 -64.35 -35.64 81.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.675 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.471 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 15.1 m -48.88 -36.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.755 -0.657 . . . . 1.0 111.874 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -63.86 -21.84 66.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -59.26 -43.29 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.253 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' C' ' 97' ' ' GLU . 56.3 mp0 -82.59 168.76 17.02 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.781 0.324 . . . . 1.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 56.86 17.76 3.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -135.9 -23.04 1.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.671 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 45.9 mtm180 -61.8 -44.6 96.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.821 0.343 . . . . 1.0 110.724 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -67.23 -36.84 82.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.65 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.38 57.06 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.548 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.76 -50.76 72.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.595 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -174.94 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.716 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -79.56 -17.36 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.784 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.76 -36.76 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 1.0 110.452 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -62.11 -42.95 99.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.249 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.18 -44.67 96.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.107 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.54 -39.18 91.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.785 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -64.95 -41.06 95.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.466 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -63.31 -37.56 87.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.57 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -39.3 92.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.33 -32.61 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.373 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.04 -38.34 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.61 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -43.41 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.522 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -56.51 -36.05 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -62.68 -36.24 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.105 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.99 -40.71 81.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 1.0 110.781 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.88 -40.81 89.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.099 -0.5 . . . . 1.0 109.98 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -55.19 -49.8 70.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.621 -0.432 . . . . 1.0 109.888 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.53 -35.06 72.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.089 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.78 85.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.138 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -60.31 -43.97 95.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 1.0 111.116 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.33 -34.32 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.654 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.03 -44.27 16.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.939 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.15 90.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.711 0.291 . . . . 1.0 110.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 2.8 p -60.43 -44.12 95.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.173 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 79.2 mm-40 -71.39 -42.9 67.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.861 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.82 99.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.423 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -65.74 -37.21 85.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.8 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -67.5 122.13 17.32 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.932 0.396 . . . . 1.0 110.553 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.65 -11.87 59.49 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.116 -0.793 . . . . 1.0 111.116 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.5 133.77 39.44 Favored Pre-proline 0 CA--C 1.538 0.515 0 O-C-N 122.798 -0.236 . . . . 1.0 110.47 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.82 142.74 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.149 1.9 . . . . 1.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.1 0.62 53.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.33 140.2 50.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.767 0.318 . . . . 1.0 110.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.93 -53.88 2.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.584 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -52.4 94.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.121 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' D' ' 39' ' ' ILE . 21.0 tt -134.11 63.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.16 0.505 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.555 ' HG ' ' H ' ' D' ' 43' ' ' ASP . 2.0 t -159.68 135.75 8.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.477 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.511 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 18.0 t80 -74.87 -49.5 4.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.72 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.8 Cg_endo -58.93 -30.71 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.321 1.347 . . . . 1.0 111.964 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.555 ' H ' ' HG ' ' D' ' 40' ' ' SER . 24.7 m-20 -87.14 -20.2 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.076 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.93 96.25 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.867 0.365 . . . . 1.0 110.692 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -66.27 -38.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.303 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -46.56 84.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.044 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -39.77 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.166 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.3 t -49.6 -20.25 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.564 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . 0.462 ' C ' ' H ' ' D' ' 51' ' ' THR . 24.9 t -97.58 -33.64 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.0 0.429 . . . . 1.0 110.258 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -78.21 16.62 0.74 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.462 ' H ' ' C ' ' D' ' 49' ' ' VAL . 6.1 t -137.38 -34.81 0.69 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.16 -24.48 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.435 ' O ' ' OG1' ' D' ' 54' ' ' THR . 67.4 p -93.88 6.17 49.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' D' ' 53' ' ' THR . 16.3 p 56.71 11.28 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.055 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 m -63.53 -43.34 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.787 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.43 86.62 0.01 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -90.58 4.5 51.09 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.836 0.351 . . . . 1.0 110.159 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.03 17.3 65.46 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 30.1 m-20 -63.63 -46.18 86.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 1.0 110.593 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.39 167.08 21.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.019 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 9.6 p90 -153.56 102.48 2.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.591 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.76 162.38 42.3 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.885 1.723 . . . . 1.0 112.508 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.445 ' O ' ' OE2' ' D' ' 66' ' ' GLU . 1.9 t -96.13 -140.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.423 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 28.9 m -112.15 -39.71 4.39 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.668 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.541 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -59.53 -24.28 63.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.516 ' OE2' ' N ' ' D' ' 68' ' ' ARG . 0.1 OUTLIER -80.01 28.52 0.29 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 123.329 1.538 . . . . 1.0 108.944 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.15 62.19 2.15 Favored Glycine 0 C--O 1.216 -0.977 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.995 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.516 ' N ' ' OE2' ' D' ' 66' ' ' GLU . 48.2 ttm-85 -24.61 -32.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.401 0.707 . . . . 1.0 111.061 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.26 -18.23 0.57 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' D' ' 67' ' ' GLY . 62.0 t -63.01 -46.84 95.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.907 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.5 -47.31 27.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.348 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -43.77 -62.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.57 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.15 -41.68 88.9 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -61.72 -48.06 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.404 -178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' MET . . . . . 0.465 ' SD ' ' OH ' ' C' ' 57' ' ' TYR . 75.5 mtm -64.56 -41.99 95.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.697 0.284 . . . . 1.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.1 -36.16 83.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.696 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.3 -38.4 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.321 -179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.07 -42.1 94.75 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.458 -0.657 . . . . 1.0 111.458 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.64 98.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.616 0.246 . . . . 1.0 111.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.36 -38.9 92.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.133 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 70.5 t -63.29 -48.29 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.091 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.05 -36.82 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.853 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.469 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -60.76 -37.75 82.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.836 -0.345 . . . . 1.0 110.266 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.8 tt -62.49 -40.34 96.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.41 -3.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.205 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.52 ' H ' ' C ' ' D' ' 84' ' ' LEU . 54.4 m -59.33 -44.53 92.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.71 -57.17 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 1.0 110.561 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.65 59.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' D' ' 86' ' ' THR . 83.8 mt -89.78 -16.95 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.494 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -80.71 -49.58 11.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -50.98 -10.82 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.953 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' D' ' 90' ' ' ALA . 97.6 m-20 -61.54 -53.48 55.8 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.469 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 0.6 OUTLIER -45.44 -34.02 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.01 -27.1 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.155 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -60.56 -41.27 94.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.612 -0.267 . . . . 1.0 110.895 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -50.71 -39.36 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.338 . . . . 1.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.48 -37.11 86.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.55 -31.77 72.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.982 0.42 . . . . 1.0 110.372 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.64 -37.87 85.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.134 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -61.54 -43.67 98.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.584 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -68.95 -24.99 64.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.439 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.07 11.41 76.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.55 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' CB ' ' CE1' ' A' ' 4' ' ' HIS . . . -58.04 176.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.631 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.48 -43.06 99.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.723 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.631 ' HE2' HH22 ' A' ' 95' ' ' ARG . 11.2 p-80 -73.04 -32.03 64.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.626 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.27 -36.07 82.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 1.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -64.1 -39.52 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.264 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -66.84 -39.16 87.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.052 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.57 87.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.332 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.85 -45.11 94.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.114 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.21 -37.18 86.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.431 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.23 -45.8 72.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.925 -179.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.32 -41.99 93.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 1.0 110.557 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.76 -32.59 74.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.304 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.05 -36.72 84.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.685 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -62.31 -42.4 99.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 1.0 110.594 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -57.93 -39.91 79.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.232 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.72 -42.65 99.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.077 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.71 -40.59 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.445 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.6 mt -59.06 -40.76 86.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 1.0 109.952 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.64 -48.06 82.32 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.536 -0.465 . . . . 1.0 109.832 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.87 -33.37 75.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.972 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.86 90.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.488 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.404 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 27.3 m -59.53 -44.86 93.08 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -66.16 -54.92 19.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.526 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.9 mttt -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.125 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.77 90.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.198 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 23' ' ' SER . 62.3 t -64.61 -46.43 92.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.042 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.35 -23.38 46.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -52.32 -49.41 64.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.251 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 63' ' ' VAL . 2.3 mm-40 -70.19 -39.74 75.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -67.55 92.91 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.785 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.44 -15.8 6.34 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.408 -0.677 . . . . 1.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.15 148.56 36.41 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.859 0.33 . . . . 1.0 110.285 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 97.1 Cg_endo -75.78 132.89 14.86 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.975 1.783 . . . . 1.0 112.571 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 96.94 8.16 57.07 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . -35.55 154.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.761 0.315 . . . . 1.0 110.875 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.72 -50.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.471 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.5 110.36 19.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.032 0.444 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 pt -142.84 73.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.281 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' ALA . 8.5 p -162.15 98.91 1.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 56.8 t80 -51.51 -49.43 82.56 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.089 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.6 Cg_endo -59.75 -35.3 94.93 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.262 1.308 . . . . 1.0 112.509 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.0 -6.92 34.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.9 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -65.54 -43.6 89.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 1.0 110.533 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -64.64 -34.64 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.44 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -46.44 90.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.882 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.46 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 1.7 t90 -66.68 -40.48 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.498 -0.481 . . . . 1.0 109.793 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 1.2 m -54.74 -33.12 60.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.84 -46.97 95.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.024 0.44 . . . . 1.0 110.175 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' B' ' 61' ' ' TYR . 62.1 mt-10 -66.8 -33.32 75.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.387 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 96.6 m -62.2 -46.78 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.353 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.59 -36.74 81.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.149 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.517 ' C ' ' H ' ' A' ' 55' ' ' VAL . 72.0 p -74.4 -9.83 58.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 53' ' ' THR . 3.0 p 65.1 -4.86 0.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.517 ' H ' ' C ' ' A' ' 53' ' ' THR . 69.5 t -64.7 -44.98 96.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.14 83.24 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.451 -0.66 . . . . 1.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 49.5 m-85 -61.16 -41.95 97.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 1.0 110.633 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.14 9.57 2.39 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.841 -0.903 . . . . 1.0 110.841 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 38.1 t0 -56.97 -51.53 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.361 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -134.29 126.69 30.26 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -108.09 134.21 20.23 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.775 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.05 162.69 41.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.249 1.966 . . . . 1.0 112.223 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.683 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.4 p -70.16 -145.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.445 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.683 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 5.0 m -113.12 -73.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.958 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -38.87 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.349 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.882 ' O ' ' N ' ' A' ' 68' ' ' ARG . 70.9 mt-10 -77.76 -106.63 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.421 ' H ' ' HB3' ' A' ' 29' ' ' ALA . . . 18.04 -54.81 0.0 OUTLIER Glycine 0 N--CA 1.477 1.398 0 O-C-N 124.593 1.183 . . . . 1.0 114.223 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.882 ' N ' ' O ' ' A' ' 66' ' ' GLU . 10.1 tpp180 -64.05 -49.15 73.48 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.123 -0.538 . . . . 1.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 66' ' ' GLU . 68.4 mttm -64.81 -40.73 95.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.363 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.93 -45.4 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.57 83.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.99 0.424 . . . . 1.0 110.411 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -62.65 -37.66 87.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.302 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.82 -54.68 7.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.61 -46.13 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.849 -0.34 . . . . 1.0 111.09 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.2 ttp -55.97 -45.27 78.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.59 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 64.7 tttm -65.74 -33.01 74.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.368 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.62 80.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.788 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.96 -41.94 99.78 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.82 -43.67 98.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.658 0.266 . . . . 1.0 110.602 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 76' ' ' LYS . 97.8 mt-10 -60.48 -35.73 76.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.202 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.98 -74.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -45.41 -38.39 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.94 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.04 86.1 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.44 -39.47 93.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.279 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.6 t -45.98 -13.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.427 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 76.8 m -51.33 -43.9 61.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -44.44 -20.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.554 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.11 -18.37 14.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.998 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 86' ' ' THR . 43.9 mt -92.51 -42.37 9.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.733 0.301 . . . . 1.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.95 -28.74 64.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.094 0.473 . . . . 1.0 110.863 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -80.81 -4.08 53.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.419 -179.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -60.95 -47.88 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.944 -179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 11.1 p90 -75.89 -20.6 57.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.306 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.16 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.11 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.631 HH22 ' HE2' ' A' ' 4' ' ' HIS . 84.6 mtt85 -59.94 -22.66 62.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.964 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttp85 -57.37 -43.92 83.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.617 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 99' ' ' GLU . 66.5 tt0 -76.38 162.16 28.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 101' ' ' ARG . 56.1 mm-40 68.49 -41.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.379 0.424 . . . . 1.0 110.73 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' A' ' 97' ' ' GLU . 84.0 tt0 -64.83 -49.96 68.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.794 0.33 . . . . 1.0 110.404 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -65.9 -39.97 91.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' A' ' 98' ' ' GLU . 30.1 mmt180 -108.84 113.46 26.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.212 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.09 -8.57 49.61 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.422 ' ND1' ' OXT' ' A' ' 103' ' ' HIS . 56.4 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.533 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . 94.2 p . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 45.93 -174.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.486 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -137.87 -34.77 0.66 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.726 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.565 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 6.5 p80 -78.74 -24.03 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.419 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.21 -39.96 86.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.42 -38.54 91.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.54 -41.28 93.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 1.0 110.021 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.32 -41.13 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.81 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -65.49 -41.04 93.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.277 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -64.21 -36.2 83.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.531 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.27 78.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -70.74 -32.25 69.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 1.0 110.782 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.33 -49.36 72.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.884 0.373 . . . . 1.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -64.91 -30.2 71.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.561 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.74 -43.2 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.03 -43.02 99.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -33.86 76.79 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.511 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 49.3 t -68.3 -54.67 20.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.13 -33.89 77.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.54 -40.27 96.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.51 -40.9 96.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -63.64 -33.26 75.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.659 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.438 ' OG ' ' OG ' ' B' ' 48' ' ' SER . 2.2 m -55.54 -43.5 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.231 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.74 -55.73 31.34 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.843 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -60.89 -29.33 69.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.732 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.9 67.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 1.4 p -62.28 -44.17 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.069 0.461 . . . . 1.0 110.103 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.466 ' C ' ' H ' ' B' ' 30' ' ' GLU . 12.2 tm-20 -74.56 -33.35 62.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.271 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.07 45.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.92 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' B' ' 28' ' ' GLU . 0.5 OUTLIER 178.68 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.82 0.343 . . . . 1.0 110.777 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.606 HH21 ' CG2' ' B' ' 39' ' ' ILE . 3.8 mmp_? -79.14 76.92 5.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.115 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.78 1.35 5.94 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.898 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.5 151.09 40.26 Favored Pre-proline 0 N--CA 1.465 0.304 0 O-C-N 122.767 -0.255 . . . . 1.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.07 144.26 29.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.974 1.783 . . . . 1.0 112.496 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.37 32.31 75.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -48.64 -60.57 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.0 110.75 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.52 4.32 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.341 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.452 ' H ' ' C ' ' B' ' 36' ' ' ALA . 3.1 tt -145.47 55.54 1.21 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.022 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.606 ' CG2' HH21 ' B' ' 31' ' ' ARG . 33.0 pt -92.69 51.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.908 0.385 . . . . 1.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' B' ' 43' ' ' ASP . 0.3 OUTLIER -150.72 140.19 21.48 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.178 0.513 . . . . 1.0 110.94 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.501 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.8 OUTLIER -82.0 -53.99 0.66 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.278 -0.873 . . . . 1.0 110.81 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.0 Cg_endo -57.76 -28.97 84.2 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.876 1.717 . . . . 1.0 112.701 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 40' ' ' SER . 12.1 p-10 -88.91 -4.33 58.49 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.97 92.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 1.0 110.41 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 20.7 tt -67.28 -37.5 79.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.517 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.511 ' NE1' ' O ' ' C' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -53.13 61.49 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -62.97 -42.69 99.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.958 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.438 ' OG ' ' OG ' ' B' ' 23' ' ' SER . 64.8 m -51.9 -38.97 58.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.711 0.291 . . . . 1.0 111.095 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.413 ' O ' ' OG1' ' B' ' 53' ' ' THR . 65.3 mm-40 -61.15 -50.4 73.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 1.0 111.588 -179.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -59.77 -40.9 89.76 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.734 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -24.86 68.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.268 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 20.4 p -90.86 6.34 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 1.0 110.774 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 p 52.11 63.19 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.476 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.42 -53.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.12 81.79 0.06 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 1.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.38 3.77 12.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.69 -49.49 77.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 1.0 110.516 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -145.62 157.55 43.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.819 -0.438 . . . . 1.0 109.819 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 50' ' ' GLU . 64.2 t80 -172.46 132.52 0.7 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.7 -173.5 0.72 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.582 1.522 . . . . 1.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' B' ' 66' ' ' GLU . 3.6 p -134.15 165.72 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.422 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.533 ' C ' ' H ' ' B' ' 66' ' ' GLU . 14.5 m -40.76 -61.79 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.243 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.01 -14.52 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.941 0.4 . . . . 1.0 109.94 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' B' ' 63' ' ' VAL . 13.6 mm-40 -115.31 41.86 2.36 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-O 125.105 2.383 . . . . 1.0 110.392 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.46 60.04 1.48 Allowed Glycine 0 C--O 1.216 -0.978 0 CA-C-N 112.217 -2.265 . . . . 1.0 111.34 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 59' ' ' ASP . 38.5 ttm180 -28.28 -28.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.578 0.689 . . . . 1.0 110.58 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' B' ' 67' ' ' GLY . 54.4 mtpt -52.41 -12.36 0.26 Allowed 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 37.6 t -58.78 -44.95 91.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 118.902 -1.119 . . . . 1.0 109.541 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.511 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -71.1 -48.95 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 1.0 110.7 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.95 -38.25 55.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.096 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.414 ' O ' ' OE1' ' B' ' 73' ' ' GLN . 0.8 OUTLIER -58.97 -51.2 71.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.018 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 84.2 t -66.78 -43.39 89.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.506 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.2 mpp? -61.22 -41.47 96.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.662 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . 0.412 ' O ' ' OE2' ' B' ' 80' ' ' GLU . 65.9 tttm -61.49 -44.02 97.82 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.554 -0.458 . . . . 1.0 110.359 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.05 -40.27 90.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.895 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.91 96.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.79 -43.88 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 122.847 -0.208 . . . . 1.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 0.2 OUTLIER -62.57 -37.78 87.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 1.0 110.334 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 24.9 t -60.69 -68.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.184 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -55.33 -37.37 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.776 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.452 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -64.22 -37.94 89.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.5 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.99 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.117 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 39.0 t -53.2 -17.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 39.6 m -43.59 -35.3 1.67 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.253 0.549 . . . . 1.0 109.767 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.73 -61.67 2.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.034 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.9 -27.36 51.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 1.0 110.474 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.5 mm? -78.27 -32.27 49.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 1.0 110.046 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -63.03 -46.41 87.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.27 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -3.93 30.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.167 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -56.81 -48.77 77.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.18 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 20.9 p90 -69.5 -39.03 77.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.21 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.517 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 96.6 t -44.42 -28.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.628 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.96 -27.27 68.13 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.116 -0.234 . . . . 1.0 110.953 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.6 ptt85 -54.59 -42.6 71.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.124 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 80.4 mm-40 -60.43 -45.93 91.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.079 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 102' ' ' GLY . 97.5 mt-10 -68.46 -40.29 81.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.783 0.325 . . . . 1.0 110.809 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -67.44 -34.11 76.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.696 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -61.04 -44.75 96.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -95.49 -9.63 31.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.938 0.399 . . . . 1.0 110.415 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 98' ' ' GLU . . . 73.9 15.8 79.56 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.421 ' ND1' ' OXT' ' B' ' 103' ' ' HIS . 56.9 t-80 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.433 ' CB ' ' CE1' ' C' ' 4' ' ' HIS . . . -81.03 177.17 9.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.738 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.509 ' OD1' ' ND1' ' C' ' 4' ' ' HIS . 35.6 p-10 -64.05 -36.42 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.39 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.509 ' ND1' ' OD1' ' C' ' 3' ' ' ASP . 11.8 p-80 -81.6 -29.96 33.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -65.16 -44.68 87.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.789 0.328 . . . . 1.0 110.756 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -65.61 -36.83 84.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.142 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -63.78 -42.96 97.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.454 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.37 -40.32 95.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.419 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.37 -40.22 93.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.533 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.435 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.58 76.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.81 -36.19 83.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 1.0 111.072 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -63.87 -41.25 97.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 1.0 110.701 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.99 -29.48 69.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.567 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 43.2 tp -62.38 -39.92 94.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.379 . . . . 1.0 110.411 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -70.73 -28.59 64.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.0 -46.55 84.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.746 0.308 . . . . 1.0 111.554 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.42 -36.56 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.87 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 90.2 mt -61.17 -41.98 97.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.079 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -60.47 -45.45 93.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.59 -33.71 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.107 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.41 94.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.463 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 91.7 p -61.81 -46.31 90.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.797 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -63.25 -56.3 17.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.546 -0.462 . . . . 1.0 109.92 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.59 -42.61 92.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -56.09 -44.37 78.93 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.208 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.95 75.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.39 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.5 mp0 -69.54 -33.07 72.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -54.25 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.769 0.318 . . . . 1.0 110.964 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.22 -0.75 22.46 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.96 147.01 32.35 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.268 -0.271 . . . . 1.0 110.268 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.96 142.5 25.11 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.863 1.709 . . . . 1.0 112.315 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.08 66.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.35 144.45 55.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.0 110.423 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.82 -22.08 0.88 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' C' ' 39' ' ' ILE . 0.2 OUTLIER -63.6 -38.61 91.77 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.446 ' O ' ' OG ' ' C' ' 40' ' ' SER . 2.6 tp -33.53 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.276 0.56 . . . . 1.0 111.1 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' ' N ' ' C' ' 44' ' ' ALA . 11.8 m -167.94 78.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.448 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.4 OUTLIER -37.72 -56.82 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.17 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.1 Cg_endo -59.38 -54.45 2.55 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.84 1.693 . . . . 1.0 112.577 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -79.66 0.18 31.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.277 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -58.56 -42.81 88.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 1.0 110.69 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 20.0 tt -68.42 -40.28 82.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.789 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.564 ' NE1' ' O ' ' D' ' 64' ' ' THR . 0.5 OUTLIER -55.27 -47.55 75.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.065 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 13.7 t90 -65.09 -40.18 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.421 -0.511 . . . . 1.0 109.771 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 36.6 m -59.86 -41.13 90.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.986 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 47.2 t -80.07 69.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' C' ' 51' ' ' THR . 12.4 pt-20 -166.48 -42.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.977 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.438 ' N ' ' CG ' ' C' ' 50' ' ' GLU . 0.2 OUTLIER -69.76 -36.97 76.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.146 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.2 -27.27 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.523 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' C' ' 54' ' ' THR . 43.7 p -95.25 4.57 53.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.322 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' C' ' 53' ' ' THR . 23.9 p 55.41 69.47 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.871 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -148.84 -81.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.33 96.7 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -62.2 -43.22 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 1.0 111.016 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.44 26.75 0.65 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.71 -44.52 96.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 1.0 110.545 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -141.8 161.16 38.65 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.435 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 40.2 p90 -141.76 118.86 7.41 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.764 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 157.62 59.5 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.837 1.692 . . . . 1.0 112.291 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.511 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 2.1 t -84.73 -136.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.422 ' CA ' ' OE2' ' C' ' 66' ' ' GLU . 81.8 m -114.48 -49.39 2.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.784 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' C' ' 67' ' ' GLY . 45.5 tp10 -54.38 -24.62 20.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -74.01 37.04 0.1 Allowed 'General case' 0 C--O 1.26 1.657 0 CA-C-O 123.358 1.551 . . . . 1.0 109.742 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.93 64.97 2.2 Favored Glycine 0 C--O 1.206 -1.614 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.367 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.485 ' CB ' ' NE1' ' B' ' 46' ' ' TRP . 10.8 ptp85 -21.97 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.915 0.858 . . . . 1.0 112.656 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.768 ' N ' ' O ' ' C' ' 67' ' ' GLY . 68.4 mttm -64.17 -10.14 21.22 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.291 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' C' ' 67' ' ' GLY . 43.1 t -61.89 -48.36 88.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 119.88 -0.728 . . . . 1.0 110.396 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.02 -43.56 71.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.688 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -61.59 -39.8 92.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.972 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -57.01 -43.68 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.261 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 97.2 t -66.61 -43.38 90.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.739 -0.385 . . . . 1.0 111.546 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 41.6 mtt -60.72 -43.03 98.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.03 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.774 0.321 . . . . 1.0 110.69 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.36 89.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.31 -39.73 91.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.88 -0.488 . . . . 1.0 111.88 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.91 -43.13 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 122.54 -0.388 . . . . 1.0 110.668 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -53.96 51.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.645 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 16.5 m -60.95 -47.97 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.163 -0.215 . . . . 1.0 111.544 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.994 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -84.83 -25.59 28.01 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.961 -0.295 . . . . 1.0 110.59 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.601 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.4 m -59.46 -19.74 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.464 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' C' ' 83' ' ' ALA . 91.6 m -41.3 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.959 0.409 . . . . 1.0 110.644 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -62.84 -51.1 68.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.54 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.5 84.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.235 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.531 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -71.34 -37.84 71.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.529 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.26 -34.33 68.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.152 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -3.92 41.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.287 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -57.08 -47.22 81.56 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.716 -178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 19.3 p90 -73.99 -9.37 58.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.971 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.27 -37.98 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.524 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.44 HH21 ' HE2' ' C' ' 4' ' ' HIS . 95.2 mtt-85 -58.52 -28.68 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.268 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . 0.405 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.4 ptt85 -51.15 -41.53 60.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.55 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.3 mt-10 -64.35 164.3 11.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.183 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 63.08 -64.13 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.557 0.535 . . . . 1.0 110.632 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' C' ' 97' ' ' GLU . 81.0 tt0 -53.93 -41.17 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.386 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -63.57 -43.28 97.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.426 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -136.2 100.8 4.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.987 0.423 . . . . 1.0 110.699 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.55 31.96 3.55 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.52 ' OXT' ' CG ' ' C' ' 103' ' ' HIS . 51.7 p-80 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.972 -1.013 . . . . 1.0 110.574 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.82 142.31 57.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.579 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.83 -37.55 87.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.689 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.74 -37.94 87.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.605 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 83.2 tt0 -64.47 -35.42 80.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.746 0.307 . . . . 1.0 110.515 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.56 -40.99 96.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.436 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.03 -37.51 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 1.0 109.955 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.22 86.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.825 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.44 -40.31 96.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.62 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.71 -41.2 98.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.28 94.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.727 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.14 -45.13 74.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 1.0 110.83 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.8 80.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -63.01 -36.67 84.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.416 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 45.3 tp -62.6 -41.46 98.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.82 0.343 . . . . 1.0 110.409 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.24 -39.29 75.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.928 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -61.91 -41.37 97.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.155 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.31 -35.01 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.711 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 36.5 mt -60.98 -40.51 93.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.96 -49.32 78.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.308 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.015 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.52 94.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -46.33 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.874 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.63 -52.99 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.76 -40.43 88.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.923 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -47.52 -58.27 4.42 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.77 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 23.5 t -61.27 -44.99 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.212 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.36 -32.69 64.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.302 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.88 -44.92 82.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.717 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 10.8 mp0 -66.63 -36.28 82.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.317 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.88 86.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.921 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.17 -6.38 7.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.9 143.73 27.3 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 122.768 -0.254 . . . . 1.0 110.775 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.64 153.85 43.98 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.301 2.0 . . . . 1.0 112.366 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.61 34.31 85.64 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.094 -0.803 . . . . 1.0 111.094 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.54 144.11 43.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 1.0 110.603 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.72 -19.93 1.8 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.486 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tt -111.13 90.64 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.837 0.351 . . . . 1.0 110.099 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -133.25 103.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.08 0.467 . . . . 1.0 110.296 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 19.0 t -174.21 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 1.0 OUTLIER 173.27 -61.88 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.072 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.79 -38.55 92.42 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.725 1.616 . . . . 1.0 111.927 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.91 -4.27 58.51 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.348 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.97 -39.69 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 1.0 110.52 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.76 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.03 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.509 ' NE1' ' O ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -53.05 -45.91 68.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.598 -0.441 . . . . 1.0 109.903 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -63.89 -43.0 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.973 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 86.2 p -61.68 -36.2 80.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.922 -0.311 . . . . 1.0 110.674 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' D' ' 51' ' ' THR . 55.4 t -62.06 -48.53 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.958 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.483 ' OE1' ' CZ ' ' A' ' 68' ' ' ARG . 19.0 pt-20 -83.87 31.62 0.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.983 0.42 . . . . 1.0 109.928 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.406 ' H ' ' C ' ' D' ' 49' ' ' VAL . 21.3 m -132.58 -46.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.178 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -23.45 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 1.0 109.868 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 43.0 p -94.62 5.35 52.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.399 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 39.9 p 52.64 75.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.052 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 p -139.72 -51.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.07 82.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.38 -44.39 97.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.701 0.286 . . . . 1.0 110.85 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.3 2.68 2.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.8 m-20 -59.23 -49.82 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.375 . . . . 1.0 110.357 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -146.97 154.14 40.91 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 12.0 p90 -154.37 147.89 18.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.979 -0.288 . . . . 1.0 110.58 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.43 172.24 13.67 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.418 2.079 . . . . 1.0 112.018 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.658 ' CG1' ' H ' ' D' ' 64' ' ' THR . 3.0 p -106.24 -105.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.658 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 53.4 m -118.15 -85.22 0.65 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.979 0.419 . . . . 1.0 111.058 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -48.08 125.81 9.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' D' ' 68' ' ' ARG . 95.0 mt-10 57.94 -102.48 0.15 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.22 -57.07 0.0 OUTLIER Glycine 0 N--CA 1.474 1.179 0 O-C-N 124.487 1.117 . . . . 1.0 113.776 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.3 ttm-85 -79.84 -56.01 4.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.409 -0.395 . . . . 1.0 109.976 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -48.73 -29.19 4.2 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -80.32 -27.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.245 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -78.09 -51.7 9.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.863 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' D' ' 73' ' ' GLN . 19.7 pt-20 -50.91 -42.03 59.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.653 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' D' ' 72' ' ' GLU . 56.1 tt0 -64.5 -42.73 95.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.85 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 97.0 t -67.27 -44.91 87.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.507 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 78.5 mtm -63.74 -38.96 93.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.11 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' D' ' 80' ' ' GLU . 58.0 tttm -57.62 -40.37 79.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.582 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.22 -41.48 99.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.502 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' D' ' 82' ' ' PHE . . . -67.86 -40.06 89.5 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.811 -0.516 . . . . 1.0 111.811 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.16 -43.95 98.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.612 0.244 . . . . 1.0 111.27 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' D' ' 76' ' ' LYS . 97.6 mt-10 -66.3 -35.54 80.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.756 0.312 . . . . 1.0 111.104 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.49 -46.29 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.318 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' D' ' 78' ' ' GLY . 58.4 m-85 -64.43 -31.98 73.41 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.58 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.451 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -82.93 -24.2 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.449 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' D' ' 84' ' ' LEU . 7.0 tt -64.89 -42.98 94.35 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 13.5 m -62.0 -15.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.212 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.5 ' O ' ' N ' ' D' ' 90' ' ' ALA . 47.6 m -39.26 -39.84 0.68 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.066 0.46 . . . . 1.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.74 -59.98 3.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.663 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -25.56 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.128 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.46 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 3.8 mm? -87.58 -28.45 21.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.127 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -66.35 -37.39 85.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.549 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -5.27 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.198 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -56.17 -51.38 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.276 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' D' ' 90' ' ' ALA . 24.6 p90 -75.28 -10.68 59.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.697 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.32 -32.84 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.21 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -66.38 -22.78 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 1.0 110.963 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -66.11 -19.83 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.431 . . . . 1.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.43 -23.41 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.955 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -98.33 -28.1 13.81 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.926 0.393 . . . . 1.0 110.208 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -68.33 -36.89 79.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.269 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -61.34 -35.9 78.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.261 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.42 -38.36 90.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.506 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.86 59.04 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.648 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.52 155.24 31.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.603 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.88 -40.85 98.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.542 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -67.04 -45.04 78.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.357 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.2 -42.01 96.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.381 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -65.25 -40.29 93.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.136 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -68.95 -43.34 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.184 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.09 89.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.464 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.81 -36.59 84.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.287 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.68 80.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.799 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.8 -38.37 85.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.52 -35.88 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.0 110.319 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.33 -34.65 78.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.438 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.95 -38.54 91.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.111 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.72 -31.96 73.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -61.83 -49.63 75.5 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.241 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.7 m -67.12 -32.64 58.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.889 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.56 -42.03 98.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.249 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.98 -45.26 86.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 1.0 110.232 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -71.2 -39.59 71.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.546 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.84 -50.22 74.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.841 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 48' ' ' SER . 31.0 m -61.65 -44.38 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.421 . . . . 1.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.23 -33.64 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.16 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.5 -40.12 23.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.737 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.52 -46.39 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.634 -179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.4 p -58.58 -45.98 90.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.902 -0.719 . . . . 1.0 109.68 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 97.0 mt-10 -69.86 -41.6 74.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.942 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.29 90.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.9 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 79.8 mm-40 -78.84 -37.67 39.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.905 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' NH2' ' O ' ' A' ' 40' ' ' SER . 18.7 mmt85 -67.07 116.39 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 1.0 110.823 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.85 2.99 60.93 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.09 144.06 27.87 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.05 147.07 33.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.258 1.972 . . . . 1.0 112.425 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.13 2.01 57.71 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.15 146.91 52.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.716 0.293 . . . . 1.0 110.517 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.73 -13.9 5.22 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -86.89 35.06 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.998 0.427 . . . . 1.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.412 HD13 HG22 ' A' ' 39' ' ' ILE . 10.1 pt -69.74 73.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.344 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 43' ' ' ASP . 53.4 p -160.64 -126.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.782 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.416 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 11.4 t80 179.26 -56.28 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.547 -0.263 . . . . 1.0 111.317 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.17 -23.41 73.7 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.7 1.6 . . . . 1.0 112.638 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 24.1 p30 -97.22 -1.84 44.05 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.009 -0.277 . . . . 1.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.13 -20.29 48.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.836 0.35 . . . . 1.0 110.274 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.4 tt -68.81 -46.01 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.887 179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -74.93 -31.9 61.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.867 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 25.3 t90 -54.32 -41.31 68.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.433 ' OG ' ' OG ' ' A' ' 23' ' ' SER . 61.1 m -64.22 -24.36 67.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.322 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.51 -26.27 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.951 0.405 . . . . 1.0 110.839 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -78.13 3.59 14.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.408 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -127.18 -33.54 2.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.2 -25.61 61.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.936 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.451 ' O ' ' OG1' ' A' ' 54' ' ' THR . 67.6 p -96.92 7.51 46.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.967 0.413 . . . . 1.0 109.904 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 53' ' ' THR . 17.0 p 59.62 10.37 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.949 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.07 -42.21 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.333 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.94 64.15 3.15 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' B' ' 50' ' ' GLU . 1.1 t80 -62.89 -21.86 66.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.328 . . . . 1.0 110.246 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.77 33.7 12.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.533 ' OD1' ' NH2' ' B' ' 68' ' ' ARG . 8.2 m-20 -62.68 -37.25 85.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 37.7 mmt180 -125.38 -161.42 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.247 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.428 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 19.9 t80 -156.51 82.41 3.4 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.66 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.66 153.35 69.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 1.0 112.478 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.669 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.9 p -108.1 -154.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.669 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 76.6 m -90.68 -43.35 10.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.618 0.247 . . . . 1.0 111.283 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.645 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.1 tt0 -52.46 -37.23 56.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.234 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.6 26.34 0.08 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.321 2.01 . . . . 1.0 109.202 178.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 44.15 65.39 1.66 Allowed Glycine 0 C--O 1.211 -1.312 0 CA-C-N 113.506 -1.679 . . . . 1.0 111.359 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 53.2 ttm-85 -24.36 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.465 1.133 . . . . 1.0 111.008 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.4 mttp -49.46 -20.99 0.81 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.929 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.4 t -61.59 -46.51 96.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.432 -0.907 . . . . 1.0 110.45 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.82 -23.15 45.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.605 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.33 -43.86 54.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.961 0.41 . . . . 1.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.1 -47.62 85.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.046 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.6 -40.14 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.713 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 49.8 ttm -62.89 -48.03 80.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.201 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.73 -38.49 89.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.317 . . . . 1.0 110.444 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.54 73.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.64 -43.42 92.07 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.61 -43.08 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.808 0.337 . . . . 1.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.35 -41.95 97.89 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.357 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.61 -51.23 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.741 0.305 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -65.86 -39.09 90.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.999 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -63.4 -37.12 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.961 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 86' ' ' THR . 7.0 tt -62.68 -39.05 92.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.167 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 65.8 t -47.24 -10.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.745 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.9 m -50.96 -43.87 60.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.87 -19.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.722 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.23 -37.64 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.61 -40.48 84.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.412 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.96 -43.31 98.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 1.0 110.95 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -73.32 -4.27 32.23 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.019 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -61.29 -43.43 98.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.812 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.6 p90 -80.31 -24.36 40.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.856 0.36 . . . . 1.0 111.395 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 -27.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.078 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.19 -20.89 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.4 mtm105 -54.26 -32.31 55.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.692 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 14.4 pt-20 -61.62 -40.83 96.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.0 109.799 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 102' ' ' GLY . 97.7 mt-10 -66.2 -41.65 89.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.644 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -66.55 -35.77 81.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.327 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -60.04 -45.07 94.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.545 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -98.21 -4.29 35.73 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.492 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 98' ' ' GLU . . . 71.36 22.05 78.58 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.066 -0.814 . . . . 1.0 111.066 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 102' ' ' GLY . 79.4 m80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.54 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.421 ' N ' ' OE1' ' B' ' 5' ' ' GLU . 22.7 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.82 155.1 40.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.632 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.53 -41.01 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.465 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -73.87 -23.24 59.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.987 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.421 ' OE1' ' N ' ' B' ' 1' ' ' SER . 44.7 tt0 -66.67 -33.58 75.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.699 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.9 -38.22 90.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.704 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -64.9 -42.0 95.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 1.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.6 -37.01 85.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.747 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.46 -42.08 77.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.326 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -63.24 -37.67 88.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.601 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.45 -42.15 63.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -41.09 92.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.606 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.72 -37.26 84.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.258 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.28 -34.89 78.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.433 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.1 tp -62.25 -41.82 98.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.418 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.93 -32.96 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.643 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.27 -42.72 99.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.617 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.96 -37.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.31 -40.32 90.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.449 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.2 mm-40 -61.65 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 1.0 110.022 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.89 -38.68 76.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 1.0 109.932 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.66 -37.7 85.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.675 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.544 ' HG ' ' N ' ' B' ' 24' ' ' LYS . 93.8 p -57.19 -41.3 79.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.616 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.544 ' N ' ' HG ' ' B' ' 23' ' ' SER . 63.3 tttm -70.32 -76.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.563 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' B' ' 29' ' ' ALA . 99.2 mttt -40.74 -35.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.204 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.461 ' O ' ' OE2' ' B' ' 30' ' ' GLU . . . -51.25 -60.56 2.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.717 -0.219 . . . . 1.0 111.553 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.1 p -60.93 -42.05 91.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.04 0.448 . . . . 1.0 110.103 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.483 ' CD ' ' HZ3' ' B' ' 24' ' ' LYS . 96.3 mt-10 -72.07 -13.25 61.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.507 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.0 -47.97 83.98 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.177 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.529 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 0.6 OUTLIER -81.23 -98.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 1.0 110.569 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 46.45 50.72 12.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.686 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.77 27.58 0.94 Allowed Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.359 -0.696 . . . . 1.0 111.359 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' B' ' 66' ' ' GLU . . . -93.91 153.52 40.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.68 116.72 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.912 1.741 . . . . 1.0 112.184 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 89.96 -23.59 19.82 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 44.95 -175.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 1.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.41 -66.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.345 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.53 121.33 34.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' B' ' 40' ' ' SER . 37.9 pt -143.04 -160.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.715 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.423 ' O ' ' O ' ' B' ' 39' ' ' ILE . 3.2 t 56.2 114.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.12 0.486 . . . . 1.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.49 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 2.3 t80 -63.54 -53.85 48.24 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.699 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 21.9 Cg_endo -57.72 -27.68 78.69 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.747 1.632 . . . . 1.0 112.566 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.37 -16.62 22.21 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 1.0 110.823 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.6 87.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.901 0.382 . . . . 1.0 110.318 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.43 HG23 HD11 ' B' ' 45' ' ' ILE . 7.3 tt -61.7 -37.04 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.648 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.2 OUTLIER -64.16 -43.79 94.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.477 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.77 -21.35 64.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -78.28 -32.63 49.56 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.421 . . . . 1.0 110.55 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.25 -45.41 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' B' ' 51' ' ' THR . 19.3 pt-20 -57.77 -42.38 83.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.724 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.526 ' C ' ' H ' ' B' ' 53' ' ' THR . 3.4 t -73.47 -170.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.041 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.497 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 74.19 -24.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.538 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.526 ' H ' ' C ' ' B' ' 51' ' ' THR . 31.2 p -103.45 8.18 37.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.8 p 53.55 65.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.687 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 4.7 p -138.34 -52.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.665 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.55 82.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -59.97 -43.83 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.284 . . . . 1.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.19 8.74 2.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -52.03 -67.63 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.763 0.315 . . . . 1.0 110.573 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -141.81 150.11 41.25 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 61' ' ' TYR . 7.6 p90 -141.22 128.49 11.85 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.49 148.58 73.29 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.637 1.558 . . . . 1.0 112.3 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.11 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.413 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 66' ' ' GLU . 89.4 m -113.98 -65.4 1.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.835 0.35 . . . . 1.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.544 ' C ' ' H ' ' B' ' 67' ' ' GLY . 85.0 tt0 -40.53 -21.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.589 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.564 ' OE2' ' N ' ' B' ' 66' ' ' GLU . 1.5 pm0 -80.24 30.27 0.28 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 123.741 1.734 . . . . 1.0 109.142 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.04 65.37 1.08 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.075 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.533 ' NH2' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -23.69 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.705 0.753 . . . . 1.0 110.788 -178.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 97.4 mttt -46.03 -21.21 0.12 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' B' ' 67' ' ' GLY . 77.4 t -63.07 -45.8 97.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.003 -0.679 . . . . 1.0 110.054 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.25 -50.36 19.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.842 0.353 . . . . 1.0 110.818 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -53.06 -46.64 68.63 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.312 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -57.63 -46.43 84.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.759 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 87.1 t -65.47 -47.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.342 -179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 74.3 mtm -65.11 -43.03 93.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.673 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -66.59 -35.04 79.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.565 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.1 74.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.389 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.3 -37.1 94.05 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' B' ' 79' ' ' ILE . 96.0 mt -70.68 -3.42 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.487 -0.42 . . . . 1.0 111.319 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.96 -54.41 3.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 1.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.444 HG22 ' H ' ' B' ' 82' ' ' PHE . 0.1 OUTLIER -61.09 -51.35 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.169 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . 0.444 ' H ' HG22 ' B' ' 81' ' ' VAL . 52.8 m-85 -65.38 -37.3 86.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.683 0.277 . . . . 1.0 110.725 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -62.59 -37.49 86.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.433 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.73 -40.3 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.191 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 47.9 t -57.34 -17.44 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.73 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 55.1 m -42.98 -37.87 2.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.1 0.476 . . . . 1.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.77 -63.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.53 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.4 32.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.27 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.1 mm? -68.94 -34.5 75.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -66.66 -66.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 110.016 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -51.89 -7.9 0.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.614 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' B' ' 90' ' ' ALA . 41.7 t0 -57.01 -49.27 76.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.657 0.265 . . . . 1.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 11.9 p90 -73.39 -30.86 63.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.058 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.97 -32.86 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.674 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.417 ' O ' ' OE1' ' B' ' 99' ' ' GLU . 79.8 mtp85 -57.81 -22.38 47.18 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.305 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -53.33 -25.48 15.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 1.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.7 -35.53 80.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.933 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.08 -43.28 98.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 1.0 110.746 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' B' ' 99' ' ' GLU . 57.6 mp0 -69.66 -34.71 74.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.721 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -60.45 -44.28 96.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.556 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -95.97 -9.25 31.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.329 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.46 15.51 80.36 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.518 -179.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' SER . . . . . 0.443 ' O ' ' O ' ' C' ' 2' ' ' ALA . 9.1 m . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' C' ' 1' ' ' SER . . . 56.25 117.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' C' ' 3' ' ' ASP . 32.2 p-10 -90.97 -4.77 56.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.385 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -88.09 -26.64 22.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.796 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.28 -39.97 89.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.5 -38.17 90.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.385 . . . . 1.0 110.276 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -65.29 -39.9 93.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.273 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -39.95 94.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.602 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -62.72 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.178 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.05 -33.94 77.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.84 80.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.198 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.36 -36.79 81.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.42 -32.25 73.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.43 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.628 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.18 -42.24 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.586 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.48 -38.64 88.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.352 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -41.08 99.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 1.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.3 -38.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.794 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.16 -40.65 86.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.066 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.434 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -56.06 -47.98 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.6 -34.56 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.317 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -40.76 97.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.759 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.434 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -59.94 -40.71 89.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.551 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -64.74 -33.7 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.487 . . . . 1.0 109.772 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.9 mmtt -78.31 -41.17 34.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.937 179.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.09 87.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.479 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.66 -48.74 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 1.0 110.079 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.96 -36.29 77.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.122 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -89.86 65.14 6.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.032 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 3.3 mm-40 163.04 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.437 0.461 . . . . 1.0 110.706 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -108.49 67.77 0.67 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.6 0.238 . . . . 1.0 110.502 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.23 31.02 0.7 Allowed Glycine 0 N--CA 1.471 0.971 0 N-CA-C 111.928 -0.469 . . . . 1.0 111.928 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.71 161.07 24.1 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.64 116.25 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.882 1.722 . . . . 1.0 111.47 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.66 83.54 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.04 149.41 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.0 110.523 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -21.14 2.25 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.478 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.0 OUTLIER -87.88 40.0 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.746 0.307 . . . . 1.0 110.242 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.27 80.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 1.0 110.587 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.7 m -156.36 -136.57 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.443 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.414 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 11.2 t80 179.75 -57.56 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.403 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.39 -34.79 97.5 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 121.736 1.624 . . . . 1.0 112.554 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.491 ' N ' ' OD1' ' C' ' 43' ' ' ASP . 23.3 p-10 -94.24 6.42 48.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.293 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.69 90.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.81 -32.65 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.64 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t-105 -60.05 -48.42 81.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.413 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.439 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 0.2 OUTLIER -67.31 -27.28 67.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 178.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 2.6 t -64.9 -34.74 79.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.941 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . 0.473 ' CG2' ' HZ1' ' D' ' 69' ' ' LYS . 74.0 t -61.53 -47.62 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 1.0 111.407 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.413 ' O ' ' OG1' ' C' ' 53' ' ' THR . 15.8 pt-20 -70.53 -28.82 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 1.0 111.07 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.439 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 86.5 m -61.9 -44.83 96.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 1.0 111.326 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.78 -35.36 70.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 1.0 110.573 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.452 ' O ' ' OG1' ' C' ' 54' ' ' THR . 71.4 p -73.52 -7.96 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 1.0 110.216 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' C' ' 53' ' ' THR . 8.2 p 61.62 7.04 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.44 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 8.1 p -65.32 -40.68 89.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.538 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.32 79.83 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -61.67 -42.52 99.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 1.0 110.942 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.67 3.34 6.02 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -57.98 -64.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.837 0.351 . . . . 1.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 0.4 OUTLIER -135.09 147.72 49.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.154 179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' C' ' 61' ' ' TYR . 8.8 p90 -151.06 149.72 25.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.502 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.09 -175.75 1.34 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.198 1.932 . . . . 1.0 111.672 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.459 ' H ' ' HB2' ' C' ' 66' ' ' GLU . 1.1 t -135.64 -148.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.94 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 6.2 p -88.09 -43.21 11.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -73.78 -14.02 61.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.11 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.562 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 13.8 mm-40 -99.34 32.16 2.85 Favored 'General case' 0 C--O 1.261 1.674 0 CA-C-O 123.964 1.84 . . . . 1.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 36.4 62.6 0.75 Allowed Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.114 -1.857 . . . . 1.0 111.168 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' C' ' 67' ' ' GLY . 52.7 ttm-85 -24.71 -29.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.859 0.83 . . . . 1.0 111.503 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' C' ' 67' ' ' GLY . 63.3 mttp -56.8 -11.04 1.21 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.2 t -60.67 -47.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.103 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.13 72.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.911 0.386 . . . . 1.0 110.72 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -54.04 -47.97 71.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.077 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.42 -41.49 93.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.474 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.82 -44.34 96.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.837 -0.345 . . . . 1.0 111.2 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.8 mtm -61.39 -41.05 96.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.937 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -61.61 -37.98 85.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.64 -38.25 84.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.34 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.2 -54.15 22.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.813 -0.708 . . . . 1.0 111.838 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.404 HD13 HG21 ' C' ' 79' ' ' ILE . 95.4 mt -63.06 -42.73 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 1.0 110.661 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -59.47 -45.84 90.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.941 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -65.04 -49.64 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.972 -0.291 . . . . 1.0 111.205 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -67.17 -37.35 83.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.898 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.401 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -62.58 -35.33 79.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.522 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.426 ' C ' ' N ' ' C' ' 86' ' ' THR . 5.0 tt -61.96 -42.73 99.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.31 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 66.8 t -48.85 -16.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.571 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.426 ' N ' ' C ' ' C' ' 84' ' ' LEU . 63.3 m -47.74 -34.67 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.65 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.437 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -52.95 -22.04 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.96 -10.93 27.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.465 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -86.62 -59.74 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.728 0.299 . . . . 1.0 111.049 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -44.61 -49.97 9.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.91 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -45.56 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.168 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' C' ' 90' ' ' ALA . 97.8 m-20 -60.84 -47.91 84.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.431 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 0.1 OUTLIER -58.93 -44.28 91.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 59.0 t -44.62 -39.57 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.412 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.22 -22.51 52.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.176 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -55.24 -43.92 75.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.306 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.5 mt-10 -80.31 -178.0 6.41 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.358 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 59.66 -69.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.555 0.535 . . . . 1.0 110.837 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.5 mt-10 -55.87 -46.01 78.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.672 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -64.08 -44.13 93.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.28 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -115.99 110.22 18.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.654 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -11.78 23.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.501 ' O ' ' CG ' ' C' ' 103' ' ' HIS . 56.8 t-80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.686 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.61 172.21 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.537 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.91 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.464 ' H ' ' ND1' ' D' ' 4' ' ' HIS . 9.1 p-80 -68.49 -36.12 78.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.701 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.53 -40.72 96.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.793 0.33 . . . . 1.0 110.794 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -64.1 -42.66 96.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.544 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.26 -39.56 68.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 1.0 110.148 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.45 86.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.753 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.61 -23.26 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.719 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.13 -41.35 98.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.62 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.69 -37.21 80.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.923 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -58.86 -39.09 80.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 1.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.29 -33.29 75.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.01 -35.66 81.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 49.7 tp -62.61 -42.02 99.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 1.0 110.869 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -61.1 -41.19 96.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.996 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.08 -41.43 99.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 1.0 110.979 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.48 -43.38 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.828 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . 0.444 ' O ' ' OG ' ' D' ' 23' ' ' SER . 84.2 mt -61.28 -42.09 98.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.94 -50.99 68.65 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.58 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.8 -39.52 87.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.351 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.3 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 33.2 m -57.77 -44.92 86.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.75 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.49 -48.92 79.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 29' ' ' ALA . 5.5 mptp? -61.7 -37.86 85.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.311 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.69 59.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.324 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 m -93.74 -45.49 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.776 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.57 -40.43 96.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.709 0.29 . . . . 1.0 111.077 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 25' ' ' LYS . . . -54.41 -33.2 58.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.108 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -82.69 -113.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.05 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 44.32 75.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.634 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.46 -7.48 10.46 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.86 147.51 96.03 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.246 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.81 117.18 4.84 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.965 1.777 . . . . 1.0 112.044 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 84.57 -16.19 36.94 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.437 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . 42.26 -168.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.0 110.892 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' D' ' 61' ' ' TYR . . . 175.58 -12.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.44 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 tt -151.8 43.67 0.73 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.897 0.38 . . . . 1.0 110.4 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -88.64 114.4 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' D' ' 41' ' ' TYR . 13.8 t 177.65 -122.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.549 ' N ' ' OG ' ' D' ' 40' ' ' SER . 2.2 m-85 -176.41 -66.2 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.543 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 22.8 Cg_endo -59.87 -29.92 90.62 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.011 1.807 . . . . 1.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -79.89 -5.57 55.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.961 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.64 84.8 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.37 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -73.22 -39.28 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.404 ' CH2' ' NZ ' ' A' ' 69' ' ' LYS . 2.7 t-105 -61.12 -48.22 82.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.227 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -62.41 -41.47 98.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -71.55 70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.11 0.481 . . . . 1.0 110.131 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.04 -64.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.468 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.437 ' OE2' ' OD2' ' D' ' 59' ' ' ASP . 22.6 pt-20 -66.02 -26.76 67.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.414 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.992 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.29 -26.57 65.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' D' ' 50' ' ' GLU . 26.1 p -88.09 3.08 50.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 1.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' D' ' 53' ' ' THR . 19.4 p 53.88 73.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.084 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.41 ' C ' ' H ' ' D' ' 57' ' ' TYR . 86.0 t -151.12 -50.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.694 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.55 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 73.72 -48.42 1.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.41 ' H ' ' C ' ' D' ' 55' ' ' VAL . 11.7 t80 67.86 -14.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.581 0.229 . . . . 1.0 110.864 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.55 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 99.63 18.71 22.42 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 84.4 m-20 -62.46 -66.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.641 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.34 161.95 27.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.668 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 3.0 p90 -140.42 105.83 6.54 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.445 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . 0.529 ' O ' ' NH2' ' D' ' 68' ' ' ARG . 71.4 Cg_endo -70.72 164.09 36.72 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.575 1.517 . . . . 1.0 112.633 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.623 ' CG2' ' H ' ' D' ' 64' ' ' THR . 11.0 p -112.08 -176.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.449 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.623 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 18.7 m -68.77 -44.06 74.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.575 ' C ' ' H ' ' D' ' 67' ' ' GLY . 58.7 tt0 -51.39 -46.93 62.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.021 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 14.3 pt-20 -79.82 36.66 0.34 Allowed 'General case' 0 C--O 1.264 1.842 0 CA-C-O 123.654 1.692 . . . . 1.0 109.0 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.39 61.75 1.2 Allowed Glycine 0 C--O 1.215 -1.038 0 CA-C-N 113.179 -1.828 . . . . 1.0 109.495 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' D' ' 62' ' ' PRO . 57.8 ttm-85 -25.52 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.298 0.646 . . . . 1.0 110.878 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.5 mmtt -56.38 -9.91 0.8 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.43 -0.805 . . . . 1.0 109.071 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 38.0 t -59.31 -47.77 89.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.391 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.43 79.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.064 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -60.59 -39.28 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.965 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.35 -41.05 96.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.437 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.74 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.02 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 74.7 mtm -63.16 -40.02 96.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.07 -45.97 91.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.465 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.35 -37.82 86.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 110.296 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.27 92.7 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.788 -0.525 . . . . 1.0 111.788 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.09 -43.59 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.584 0.23 . . . . 1.0 111.044 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.86 -40.11 94.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.75 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.82 -49.58 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.774 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -61.77 -44.46 96.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.01 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.48 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -65.04 -35.14 80.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.053 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.563 ' O ' ' N ' ' D' ' 86' ' ' THR . 1.6 tm? -61.74 -53.33 57.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.338 -0.545 . . . . 1.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 75.4 t -44.74 -15.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.381 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.574 ' O ' ' N ' ' D' ' 90' ' ' ALA . 94.4 m -51.8 -42.35 62.39 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.163 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -37.98 -65.1 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.608 0.242 . . . . 1.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.84 21.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' D' ' 86' ' ' THR . 41.4 mt -92.48 -21.87 19.91 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.451 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -72.77 -36.96 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.404 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -2.85 25.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.881 -0.599 . . . . 1.0 109.896 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.03 -48.0 79.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.953 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 19.4 p90 -72.94 -8.63 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.795 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.33 -36.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -67.27 -21.64 65.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.157 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -55.28 -32.33 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 1.0 110.346 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -61.36 147.13 45.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.465 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 48.04 23.76 0.54 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.812 0.339 . . . . 1.0 110.387 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -138.48 -35.44 0.6 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.951 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -69.38 -23.58 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.479 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.93 -36.6 84.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.464 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.39 16.05 57.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.52 179.798 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . -63.62 -38.8 92.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.562 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t0 64.45 -65.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.524 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 2' ' ' ALA . 34.6 p80 -57.65 -41.28 81.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.773 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 81.6 tt0 -62.93 -40.05 96.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.88 0.372 . . . . 1.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.36 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -65.53 -38.07 88.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.143 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.71 97.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.233 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.77 -40.45 88.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.354 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -62.9 -38.69 91.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.449 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.961 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.24 -38.37 88.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.729 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.69 -38.03 89.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.502 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -65.37 -32.73 74.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.542 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.18 -41.8 98.67 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.552 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.21 -38.91 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.185 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -62.55 -39.84 94.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.686 -0.405 . . . . 1.0 111.404 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.44 -33.13 59.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 1.0 110.539 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.77 -40.94 96.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.422 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.9 mt-10 -58.08 -48.02 81.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 1.0 109.885 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.12 -32.65 73.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.119 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.84 96.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.654 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -60.74 -42.09 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.245 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -64.91 -50.51 66.22 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.203 0.525 . . . . 1.0 110.232 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.02 -42.74 99.49 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.256 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.12 49.44 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.564 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.455 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 2.7 p -60.99 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.192 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 70.2 mm-40 -68.28 -44.7 74.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.009 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.29 -39.32 82.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 1.0 110.203 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.438 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 52.3 mm-40 -69.51 -37.25 77.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.37 130.28 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 1.0 110.504 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.56 4.55 76.34 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.16 141.54 22.8 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 122.774 -0.251 . . . . 1.0 110.376 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.3 136.05 19.32 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.94 1.76 . . . . 1.0 112.143 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.75 30.84 70.0 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -63.05 -35.52 80.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.737 0.303 . . . . 1.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 71.77 -39.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.334 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 36' ' ' ALA . 6.8 tt -94.29 121.57 35.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.995 0.426 . . . . 1.0 109.886 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.4 pt -155.17 60.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.494 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -155.36 138.22 15.34 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.385 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -76.34 -59.18 1.1 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.66 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.99 -28.83 87.93 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.807 1.671 . . . . 1.0 112.409 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -88.2 -21.26 24.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.937 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.71 -38.38 81.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 ' O ' ' OG ' ' A' ' 48' ' ' SER . 5.6 tt -66.28 -37.46 79.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.301 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -46.01 87.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.415 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -64.42 -40.39 95.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 45' ' ' ILE . 84.0 p -61.53 -32.75 72.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.031 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.431 ' N ' ' HG ' ' A' ' 48' ' ' SER . 48.5 t -61.34 -49.83 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.857 0.361 . . . . 1.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH2' ' B' ' 68' ' ' ARG . 12.1 pt-20 -71.37 -25.52 62.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -63.62 -47.89 79.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.272 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.82 -36.54 77.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.465 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 44.3 p -75.11 -1.97 25.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 53' ' ' THR . 50.4 p 52.44 36.09 19.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.233 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.93 -49.91 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.042 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.19 84.73 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CZ ' ' O ' ' B' ' 60' ' ' ARG . 1.3 t80 -60.77 -46.28 91.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.534 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.36 7.1 0.59 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.5 m-20 -60.73 -47.61 85.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.803 0.335 . . . . 1.0 110.611 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' O ' ' CE1' ' D' ' 57' ' ' TYR . 26.5 mtm-85 -140.85 154.34 46.15 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.219 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.28 136.3 10.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.475 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.71 -175.15 1.28 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.794 1.662 . . . . 1.0 112.217 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.56 -131.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.342 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.4 p -113.87 -44.67 3.15 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.588 0.233 . . . . 1.0 111.194 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.64 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.7 tp10 -61.63 -40.44 94.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.254 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' OE1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -72.93 32.17 0.07 Allowed 'General case' 0 C--O 1.264 1.858 0 CA-C-O 123.703 1.716 . . . . 1.0 109.997 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.15 64.45 0.94 Allowed Glycine 0 C--O 1.212 -1.247 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.671 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' C ' ' O ' ' A' ' 67' ' ' GLY . 58.8 ttm-85 -23.59 -34.53 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.328 1.064 . . . . 1.0 111.264 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 44.9 mmtm -51.09 -15.81 0.38 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.624 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 67' ' ' GLY . 50.2 t -61.54 -47.55 92.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 119.617 -0.833 . . . . 1.0 110.225 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.23 62.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.691 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -50.66 -47.18 58.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.541 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.24 -41.55 94.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.229 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.71 -46.99 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.075 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.18 -40.85 98.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.764 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.21 -37.98 89.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.53 -38.09 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.633 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.37 -41.91 83.99 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 79' ' ' ILE . 96.5 mt -61.62 -43.47 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.659 0.266 . . . . 1.0 110.444 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.49 -40.41 91.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.013 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.69 -49.1 79.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.851 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -65.76 -40.48 92.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.13 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -65.02 -36.35 84.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.006 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.48 ' C ' ' H ' ' A' ' 86' ' ' THR . 8.0 tt -62.07 -42.04 98.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.212 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 92.8 t -49.11 -13.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.308 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.48 ' H ' ' C ' ' A' ' 84' ' ' LEU . 58.0 m -51.79 -39.41 58.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.985 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -50.38 -24.94 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.03 -11.74 24.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.66 -50.01 6.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.339 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.67 -34.62 52.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 1.0 110.834 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -69.87 -12.87 61.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.401 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.91 -50.12 75.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.151 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 9.9 p90 -74.94 -23.13 58.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.314 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.48 -43.87 95.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.937 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' GLU . 99.7 mtt180 -60.04 -22.57 62.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.652 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -42.68 -39.48 2.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.62 -41.94 98.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 1.0 109.889 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 95' ' ' ARG . 97.3 mt-10 -70.59 -38.18 74.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.566 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.66 -30.04 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.506 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -59.28 -44.12 92.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.341 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -65.54 -37.78 87.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.503 ' O ' ' ND1' ' A' ' 103' ' ' HIS . . . 78.05 25.88 61.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 102' ' ' GLY . 78.7 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.617 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.526 ' O ' ' ND1' ' B' ' 4' ' ' HIS . . . -156.97 32.73 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.7 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t0 66.28 -65.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 2' ' ' ALA . 14.1 p-80 -73.41 -19.34 61.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.766 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -68.74 -36.1 77.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.511 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.72 -37.87 88.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 1.0 110.65 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.96 -40.4 80.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.579 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.5 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 1.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.08 -40.08 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.556 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.93 81.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.886 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.5 -38.76 87.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.655 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.98 -38.09 89.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.28 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.94 -31.84 73.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 41.5 tp -63.05 -37.57 87.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.406 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -68.1 -36.19 79.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.11 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.46 -47.58 83.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.797 0.332 . . . . 1.0 111.547 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.48 -34.39 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.972 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 35.8 mt -60.54 -39.44 87.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.39 -43.83 89.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.99 -32.93 73.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.053 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.47 80.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.902 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -44.86 95.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.592 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -62.74 -51.86 65.51 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.231 -0.588 . . . . 1.0 109.917 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.4 -42.78 98.78 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.417 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.19 70.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.524 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.9 OUTLIER -64.78 -42.01 93.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.469 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 82.5 tt0 -70.26 -43.74 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.242 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.14 86.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.15 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' B' ' 38' ' ' LEU . 33.0 mm-40 -66.0 -35.12 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 1.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.76 128.67 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.624 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.09 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.44 147.94 33.82 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.819 -0.224 . . . . 1.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . 0.554 ' C ' ' H ' ' B' ' 36' ' ' ALA . 96.1 Cg_endo -75.47 142.53 26.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.18 1.92 . . . . 1.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.73 -23.29 0.4 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.554 ' H ' ' C ' ' B' ' 34' ' ' PRO . . . 45.3 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 1.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -178.19 -31.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.329 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.43 ' N ' ' OE1' ' B' ' 30' ' ' GLU . 14.8 tp -137.2 102.75 4.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.288 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' CB ' ' B' ' 40' ' ' SER . 4.2 pt -132.14 104.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.78 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.3 OUTLIER 164.89 143.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.545 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.413 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.5 m-85 -81.42 -61.66 0.37 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.983 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.0 Cg_endo -58.39 -27.05 80.17 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.187 1.925 . . . . 1.0 112.464 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -93.21 -22.12 19.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.056 -0.257 . . . . 1.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.52 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.51 -38.47 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.875 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.453 ' CD1' ' OG1' ' C' ' 64' ' ' THR . 3.4 t-105 -60.95 -46.95 88.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.564 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.41 ' CD2' ' C ' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -66.58 -26.05 66.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.88 -36.09 75.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.017 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.08 -47.08 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.804 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -66.87 -30.77 71.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.61 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -63.7 -46.46 85.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.452 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.62 -28.77 65.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.11 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -90.01 4.23 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 1.0 110.543 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' B' ' 54' ' ' THR . 12.9 p 46.82 66.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.971 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.96 11.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.317 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -39.01 105.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.26 -102.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.638 0.256 . . . . 1.0 110.591 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.23 11.13 3.56 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.19 -66.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 1.0 110.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 44.4 mtt-85 -145.73 157.25 43.96 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -150.98 140.41 13.75 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.3 170.84 15.1 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.021 1.814 . . . . 1.0 112.064 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.472 ' C ' ' OE1' ' B' ' 66' ' ' GLU . 2.7 t -100.83 -130.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.926 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' B' ' 66' ' ' GLU . 87.5 m -115.25 -42.02 3.23 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.424 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.688 ' C ' ' H ' ' B' ' 67' ' ' GLY . 45.4 tp10 -64.95 -37.68 88.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.755 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -67.14 28.44 0.02 OUTLIER 'General case' 0 C--O 1.265 1.885 0 CA-C-O 123.558 1.647 . . . . 1.0 110.06 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.53 63.5 1.17 Allowed Glycine 0 C--O 1.213 -1.162 0 CA-C-N 113.704 -1.589 . . . . 1.0 111.407 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.525 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.2 ttt85 -24.49 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.331 1.066 . . . . 1.0 111.018 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' B' ' 67' ' ' GLY . 32.1 mmtp -49.61 -18.09 0.4 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.456 -0.793 . . . . 1.0 108.885 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.598 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.48 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.699 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.27 -39.71 74.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.19 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -53.09 -44.17 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 109.999 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.77 -43.02 85.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.455 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.96 -44.39 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.047 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtt -60.31 -43.32 96.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.552 -0.294 . . . . 1.0 110.432 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.49 -38.94 93.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.323 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.93 87.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.01 62.2 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' B' ' 79' ' ' ILE . 93.7 mt -68.3 -3.72 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.181 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -95.0 -52.36 4.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.05 0.452 . . . . 1.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 12.7 m -60.91 -48.72 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.275 -179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -66.18 -38.83 89.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.956 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.04 83.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.561 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.0 tt -61.9 -40.69 96.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.107 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 98.8 t -47.52 -19.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.444 ' N ' ' C ' ' B' ' 84' ' ' LEU . 81.6 m -51.41 -19.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.06 -64.71 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.433 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.93 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 1.0 110.723 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.17 -6.66 30.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.101 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.447 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -87.54 -27.17 22.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -3.85 45.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.271 -0.877 . . . . 1.0 109.881 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -54.48 -47.58 72.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.011 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' B' ' 90' ' ' ALA . 21.9 p90 -75.32 -30.0 60.19 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.275 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.47 -43.88 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.542 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 ttm-85 -46.29 -21.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.971 -0.292 . . . . 1.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 42.7 ptt85 -59.97 -41.41 91.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.405 . . . . 1.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 98.0 mt-10 -62.0 -39.26 91.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.159 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' B' ' 101' ' ' ARG . 80.1 mm-40 -65.99 -39.09 90.01 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.651 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' B' ' 103' ' ' HIS . 97.7 mt-10 -65.83 -47.7 74.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.681 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.56 -42.67 86.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.425 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' B' ' 98' ' ' GLU . 24.6 mmt85 -102.3 114.88 29.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 -14.07 56.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.871 -0.891 . . . . 1.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' B' ' 99' ' ' GLU . 47.7 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.093 -0.956 . . . . 1.0 110.658 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.06 92.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.855 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.7 -40.19 96.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.374 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.634 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.9 p80 -57.13 -41.67 79.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.622 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -64.87 -42.84 94.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -64.73 -41.92 95.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.76 -38.26 86.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.181 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.86 98.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -64.93 -42.36 94.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.328 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.38 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.362 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.4 -34.43 72.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.223 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.77 -38.41 90.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.714 0.292 . . . . 1.0 110.889 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -63.89 -34.36 77.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 1.0 110.347 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.66 -35.39 80.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.672 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.4 tp -62.29 -41.56 98.61 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.461 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -39.54 92.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.23 -40.77 97.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 1.0 111.283 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.22 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.662 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 84.7 mt -60.37 -40.66 91.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.415 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.8 -48.75 66.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.33 -32.94 73.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.152 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.68 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.78 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -58.59 -43.54 89.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.521 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -62.35 -51.08 69.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 109.568 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.05 -41.99 97.65 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.347 -0.541 . . . . 1.0 109.987 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.66 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.084 -0.247 . . . . 1.0 111.324 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 1.2 p -65.16 -41.29 91.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.538 -0.465 . . . . 1.0 109.954 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 44.3 tp10 -66.92 -44.21 81.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.611 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.38 -38.45 87.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 64.2 mm-40 -71.11 -34.2 70.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.149 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -67.79 121.8 16.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.855 0.36 . . . . 1.0 110.624 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.87 61.19 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.272 -0.731 . . . . 1.0 111.272 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.48 24.76 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 110.466 -0.198 . . . . 1.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.13 144.77 27.03 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.015 1.81 . . . . 1.0 112.359 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.73 11.82 58.19 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.19 92.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.323 . . . . 1.0 110.57 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.2 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.297 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.43 118.22 26.73 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.157 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' C' ' 40' ' ' SER . 40.2 pt -145.13 164.15 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.251 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.7 OUTLIER 82.13 142.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.789 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.634 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 89.8 t80 -80.36 -38.87 1.14 Allowed Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.112 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.634 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.8 Cg_endo -60.03 -32.73 95.29 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.403 1.402 . . . . 1.0 112.378 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' C' ' 39' ' ' ILE . 9.1 p-10 -95.09 -9.91 32.27 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 121.015 -0.274 . . . . 1.0 111.1 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -38.37 81.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 1.0 110.794 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 tt -64.67 -37.26 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.93 -47.52 86.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.604 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.453 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.8 OUTLIER -71.69 -18.19 62.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.384 178.894 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -81.01 48.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.009 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 92.0 t -147.21 -41.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.838 -0.345 . . . . 1.0 111.336 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.48 -34.55 78.17 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.853 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -44.7 83.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.181 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.53 76.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.691 0.281 . . . . 1.0 110.571 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 43.3 p -88.46 3.46 50.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 110.106 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.2 p 51.66 75.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.37 -66.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.282 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . 0.536 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 81.58 -59.1 4.86 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.445 -1.062 . . . . 1.0 110.445 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 68.74 -38.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.284 . . . . 1.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.536 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 124.53 19.6 2.53 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.09 -49.0 79.37 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.37 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -147.06 -165.57 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 42.6 p90 -170.41 113.75 0.46 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.19 -171.46 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.488 1.459 . . . . 1.0 112.104 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.651 ' CG2' ' H ' ' C' ' 64' ' ' THR . 13.3 p -129.48 -176.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.651 ' H ' ' CG2' ' C' ' 63' ' ' VAL . 71.3 m -79.83 -25.23 40.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.777 0.322 . . . . 1.0 110.476 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' C' ' 67' ' ' GLY . 43.1 tp10 -66.54 -43.63 84.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.399 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -77.0 31.47 0.14 Allowed 'General case' 0 C--O 1.268 2.035 0 CA-C-O 124.212 1.958 . . . . 1.0 109.586 179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.83 64.38 1.92 Allowed Glycine 0 C--O 1.217 -0.914 0 CA-C-N 113.24 -1.8 . . . . 1.0 111.266 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' C' ' 67' ' ' GLY . 42.3 ttm180 -24.79 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.9 0.85 . . . . 1.0 111.049 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' C' ' 67' ' ' GLY . 29.9 mmtp -48.75 -22.35 0.78 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.595 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' C' ' 67' ' ' GLY . 80.0 t -61.95 -48.09 90.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 118.958 -1.097 . . . . 1.0 110.564 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.45 78.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 1.0 110.793 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.76 -44.78 96.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.015 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.58 -38.45 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.221 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.31 -43.15 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.455 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 60.2 mtt -60.99 -42.0 97.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.84 -178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 64.7 tttm -61.92 -41.22 97.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 1.0 110.555 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.15 -38.88 92.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 1.0 110.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.24 -41.98 91.3 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.968 -179.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.403 HG21 HD12 ' C' ' 79' ' ' ILE . 94.1 mt -61.12 -43.1 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.682 0.277 . . . . 1.0 110.717 -179.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.7 mt-10 -60.13 -43.59 95.55 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.202 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.45 -49.22 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.361 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.79 -38.76 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.318 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.01 85.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 1.0 110.675 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.33 -40.59 97.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.93 -20.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.435 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 5.7 t -50.78 -22.1 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 1.0 110.515 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.489 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -56.14 -25.61 46.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.202 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.29 -16.41 19.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.694 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 58.7 mt -86.2 -47.1 9.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.82 -29.19 59.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.847 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -89.58 -3.65 58.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.968 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -56.27 -47.28 78.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.585 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 7.9 p90 -75.19 -37.5 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.105 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 95.9 t -46.64 -27.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.575 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' C' ' 98' ' ' GLU . 96.4 mtt180 -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.688 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -42.47 -37.25 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 1.0 111.078 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -82.06 -24.72 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.653 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' C' ' 95' ' ' ARG . 96.6 mt-10 -97.31 38.52 1.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.872 0.367 . . . . 1.0 110.5 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.35 -42.68 0.41 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.489 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 1.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -65.38 -36.71 84.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.521 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.69 15.7 51.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.083 -0.961 . . . . 1.0 110.499 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.446 ' CB ' ' NE2' ' D' ' 4' ' ' HIS . . . -83.52 170.05 14.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.619 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.68 -43.96 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.907 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.601 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 5.2 p80 -69.11 -37.34 78.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.85 -36.6 84.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.47 -43.4 97.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.57 86.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.897 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . 0.441 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 59.0 tt0 -63.42 -39.93 95.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.58 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -63.91 -36.67 84.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.62 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.24 -27.56 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.282 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.52 -39.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 1.0 110.765 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' D' ' 13' ' ' GLU . 54.3 mp0 -67.06 -34.36 77.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.591 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -62.51 -37.22 85.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.651 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 42.7 tp -62.72 -42.0 99.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.389 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.12 -32.5 73.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -61.91 -39.19 91.14 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.045 0.45 . . . . 1.0 110.826 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.96 -38.49 72.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 97.3 mt -61.95 -45.92 91.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.645 -178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.17 -42.26 69.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 1.0 110.344 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.07 -40.28 82.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 1.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.27 83.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -55.54 -44.27 76.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.641 -0.254 . . . . 1.0 110.568 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -65.45 -32.87 74.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.631 -0.427 . . . . 1.0 110.169 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.3 -43.87 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.886 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -60.33 -49.63 76.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.47 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 8.7 p -60.6 -44.55 97.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 109.908 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.47 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 9.1 tm-20 -68.06 -42.51 80.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.546 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.05 91.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.628 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 3.2 mp0 -70.74 -34.18 71.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.324 . . . . 1.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -69.23 122.9 19.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 1.0 110.663 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.28 -2.06 57.62 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.574 -0.739 . . . . 1.0 111.366 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.52 35.82 Favored Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 122.847 -0.208 . . . . 1.0 110.538 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.54 143.04 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.057 1.838 . . . . 1.0 112.357 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.57 76.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.43 143.76 57.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.762 0.315 . . . . 1.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.05 -22.77 2.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 37.6 tp -70.87 -89.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.536 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' D' ' 40' ' ' SER . 95.5 mt 54.12 161.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.188 0.518 . . . . 1.0 110.671 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.477 ' N ' ' CG2' ' D' ' 39' ' ' ILE . 1.1 t 76.23 130.47 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.596 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 20.8 t80 -77.22 -43.61 2.68 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.069 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.5 Cg_endo -59.2 -29.72 91.15 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.238 1.292 . . . . 1.0 112.094 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.544 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.3 m-20 -89.96 -30.91 17.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.565 -0.289 . . . . 1.0 110.993 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.72 82.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.868 0.366 . . . . 1.0 110.774 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . 0.45 ' O ' ' OG ' ' D' ' 48' ' ' SER . 7.7 tt -63.95 -37.06 78.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.059 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.594 ' CH2' ' NZ ' ' A' ' 69' ' ' LYS . 0.2 OUTLIER -67.41 -41.48 84.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.246 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CG ' ' D' ' 50' ' ' GLU . 13.5 t90 -60.08 -37.33 79.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 85.8 p -65.65 -33.1 75.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.29 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 62.1 t -79.72 63.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.058 0.456 . . . . 1.0 111.724 -179.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.442 ' O ' ' OG1' ' D' ' 53' ' ' THR . 8.3 pt-20 178.9 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.68 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.49 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 90.4 m -65.33 -42.08 93.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.09 -26.23 36.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' D' ' 55' ' ' VAL . 16.8 p -83.02 0.86 42.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.235 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' D' ' 53' ' ' THR . 17.6 p 57.99 10.93 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.971 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.52 ' H ' ' HG1' ' D' ' 53' ' ' THR . 76.7 t -91.17 -54.76 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.677 0.275 . . . . 1.0 110.739 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.08 -42.1 0.61 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' D' ' 55' ' ' VAL . 0.1 OUTLIER 56.16 -74.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.763 0.316 . . . . 1.0 110.681 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . -159.15 -91.49 0.08 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' NH1' ' D' ' 60' ' ' ARG . 29.5 t70 45.41 -119.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.729 0.3 . . . . 1.0 110.345 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.544 ' NH2' ' O ' ' D' ' 43' ' ' ASP . 0.1 OUTLIER -113.78 169.24 9.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.8 p90 -137.09 136.41 20.94 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.782 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.63 154.27 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.267 1.978 . . . . 1.0 112.195 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.422 ' H ' ' HG2' ' D' ' 66' ' ' GLU . 18.1 m -93.42 -145.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.874 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 5.6 m -112.87 -41.04 3.85 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.694 0.283 . . . . 1.0 110.447 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' D' ' 67' ' ' GLY . 52.1 tp10 -66.07 -25.76 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.103 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.437 ' OE1' ' OE1' ' D' ' 30' ' ' GLU . 1.0 OUTLIER -74.39 30.44 0.08 Allowed 'General case' 0 C--O 1.263 1.79 0 CA-C-O 123.697 1.713 . . . . 1.0 108.975 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.42 61.35 3.27 Favored Glycine 0 C--O 1.21 -1.385 0 CA-C-N 114.011 -1.449 . . . . 1.0 109.537 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.45 ' C ' ' O ' ' D' ' 67' ' ' GLY . 55.6 ttp85 -24.48 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 O-C-N 124.328 0.664 . . . . 1.0 110.735 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.7 mttt -51.98 -18.32 1.33 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.413 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' D' ' 67' ' ' GLY . 54.0 t -62.75 -49.63 82.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.932 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . 0.541 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -70.9 -43.27 68.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.403 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -41.84 -43.93 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.234 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -70.67 -35.66 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.665 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.1 -52.07 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.056 -0.658 . . . . 1.0 111.677 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' MET . . . . . 0.541 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 0.0 OUTLIER -70.89 -40.1 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 1.0 110.71 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -43.01 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.464 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.6 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.421 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.67 -41.53 98.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.582 -0.607 . . . . 1.0 111.582 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . 0.414 HD13 HG21 ' D' ' 79' ' ' ILE . 94.1 mt -62.21 -43.05 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.636 0.255 . . . . 1.0 111.072 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -42.03 97.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.072 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.41 -48.33 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.364 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -71.58 -12.79 61.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.787 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -94.65 -31.84 13.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.8 0.333 . . . . 1.0 110.185 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.1 tt -64.4 -41.51 96.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 35.0 m -58.42 -2.88 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.548 ' H ' ' C ' ' D' ' 84' ' ' LEU . 48.1 m -60.01 -22.26 62.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.056 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.08 -47.89 83.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.249 179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.78 85.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.836 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.42 -39.52 92.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.461 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -56.8 -45.37 82.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.976 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -10.06 59.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -55.82 -48.52 75.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.133 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -76.11 -30.54 58.29 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.821 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.42 -26.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.305 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp85 -57.75 -32.75 67.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.883 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' D' ' 97' ' ' GLU . 36.1 ptt85 -58.17 -39.23 78.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.411 . . . . 1.0 110.037 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' D' ' 96' ' ' ARG . 81.0 tt0 -63.49 -40.65 97.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.717 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.66 -42.61 86.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 1.0 110.255 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -67.76 -38.17 83.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.157 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -60.56 -47.24 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.435 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -69.9 -36.93 75.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.593 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.4 28.24 30.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 76.8 m80 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.041 -0.98 . . . . 1.0 110.622 179.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 2' ' ' ALA . 73.5 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 56.26 154.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -106.84 -8.79 16.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.465 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -87.64 -19.74 27.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.527 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.12 -38.84 89.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.69 -38.16 90.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.233 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.1 -41.22 99.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.172 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.61 96.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 1.0 110.527 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.69 -37.16 85.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.316 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -62.46 -37.38 85.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.14 76.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.904 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.59 -38.71 92.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.597 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.2 -34.59 76.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.353 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -65.55 -34.09 77.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.392 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.92 -39.01 93.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.331 . . . . 1.0 110.417 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.04 -34.63 78.51 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.62 -46.77 81.16 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.6 m -63.62 -36.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.549 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' O ' ' OG ' ' A' ' 23' ' ' SER . 85.8 mt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.76 -45.81 77.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.104 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.94 -38.58 79.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.288 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.92 85.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.72 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 19' ' ' LEU . 21.1 m -57.62 -44.11 85.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.087 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.3 -31.71 72.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.453 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 29' ' ' ALA . 97.2 mttt -76.57 -48.44 19.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.59 79.59 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.467 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 9.0 p -61.93 -44.67 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.306 -0.558 . . . . 1.0 109.669 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.462 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 84.0 tt0 -69.85 -31.22 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.385 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -57.01 -38.09 72.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.261 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.24 -39.27 86.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -55.41 99.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.628 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.71 -2.45 23.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.06 142.42 24.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 O-C-N 122.753 -0.263 . . . . 1.0 110.653 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -75.07 144.19 29.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.936 1.758 . . . . 1.0 112.269 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.25 26.39 70.48 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.83 151.24 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 1.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 -53.17 0.54 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.481 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 53.93 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.427 ' O ' ' OG ' ' A' ' 40' ' ' SER . 13.7 tt -105.64 96.81 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.225 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 71.7 m -169.34 -123.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.618 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 40' ' ' SER . 4.6 m-85 -171.66 -68.54 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.197 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 41' ' ' TYR . 28.5 Cg_endo -60.15 -32.55 94.71 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.998 1.798 . . . . 1.0 112.241 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -86.29 -20.08 28.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.102 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.87 95.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 1.0 110.353 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -67.96 -39.09 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.547 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -59.43 -44.21 92.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.902 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -59.68 -39.43 84.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -65.96 -36.96 84.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.18 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.4 -48.77 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 120.734 0.302 . . . . 1.0 110.736 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.9 -31.79 70.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.515 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 m -62.38 -45.29 93.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.313 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.46 -29.11 67.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.454 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -90.24 11.9 19.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 1.1 p 41.42 41.9 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.276 -0.875 . . . . 1.0 111.211 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.3 t -81.07 -51.74 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 88.07 -69.38 2.85 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.142 -0.551 . . . . 1.0 111.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 54.4 -83.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.932 0.396 . . . . 1.0 110.255 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . 140.48 27.84 0.21 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.27 -43.75 98.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 1.0 110.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 25.6 mmt180 -132.21 -178.72 5.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.097 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 81.7 m-85 -157.45 96.84 2.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.706 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.72 156.07 64.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.79 1.66 . . . . 1.0 112.411 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' O ' ' OE2' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -79.69 -141.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.334 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.433 ' CA ' ' OE2' ' A' ' 66' ' ' GLU . 7.5 p -115.41 -41.76 3.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.775 0.322 . . . . 1.0 110.571 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' A' ' 67' ' ' GLY . 15.6 tm-20 -61.6 -24.94 67.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -71.89 40.74 0.07 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 123.576 1.655 . . . . 1.0 109.167 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.765 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.82 66.71 2.3 Favored Glycine 0 C--O 1.199 -2.064 0 CA-C-N 113.708 -1.587 . . . . 1.0 111.959 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' NE ' ' CD1' ' D' ' 46' ' ' TRP . 35.7 ttm105 -24.91 -27.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.726 1.263 . . . . 1.0 112.176 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.5 mttm -76.61 -6.91 53.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.944 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.748 ' N ' ' O ' ' A' ' 67' ' ' GLY . 13.9 t -58.75 -48.53 85.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.446 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.4 -41.93 69.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.567 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.93 -36.49 79.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.582 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.79 -53.51 57.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.08 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.28 -42.19 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.7 tpp -52.23 -50.58 61.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.63 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -65.17 -41.14 94.96 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.73 -46.37 70.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.839 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.74 -43.43 97.78 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -43.38 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.606 0.241 . . . . 1.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.17 -43.36 99.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.47 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.38 -49.03 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.38 -8.83 57.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.979 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.64 -39.44 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.545 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.9 tt -63.21 -42.55 99.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.573 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 m -50.77 -9.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.602 -0.439 . . . . 1.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.2 m -57.98 -38.59 76.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.969 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -48.99 -33.72 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.302 179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 -11.51 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' THR . 76.4 mt -91.69 -46.65 7.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.028 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.85 -24.78 53.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 1.0 110.675 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 t -86.58 -3.56 59.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.988 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -62.12 -43.69 98.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.173 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 5.7 p90 -74.69 -31.59 61.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.517 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.16 -26.59 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.37 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -63.94 -21.89 66.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -60.07 -33.99 72.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 1.0 110.752 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.46 -40.86 88.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.44 -47.02 80.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.48 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.39 -34.04 72.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.444 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.04 -44.79 94.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -90.06 -13.77 35.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 1.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.35 26.6 72.69 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.045 -0.979 . . . . 1.0 110.619 -179.941 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.602 ' N ' ' N ' ' B' ' 6' ' ' ARG . 3.9 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.408 ' N ' ' HG ' ' B' ' 1' ' ' SER . . . -64.78 -40.38 95.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.634 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -173.14 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.745 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.479 ' CE1' HH22 ' B' ' 95' ' ' ARG . 6.0 p80 -76.13 -18.69 59.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.436 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.18 -37.26 85.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.758 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . 0.602 ' N ' ' N ' ' B' ' 1' ' ' SER . 61.0 ttt85 -60.99 -44.26 97.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.559 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -41.41 88.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.681 -0.408 . . . . 1.0 109.917 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.73 -37.34 86.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.646 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -62.85 -37.46 86.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.05 76.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.01 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.53 -39.77 85.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.0 110.693 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.483 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 6.3 tm-20 -65.37 -36.87 85.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.86 -32.81 74.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.552 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.33 -40.76 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.393 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -63.24 -37.03 85.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . 0.483 ' NZ ' ' OE1' ' B' ' 13' ' ' GLU . 29.2 mtmm -62.26 -41.75 98.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.0 111.054 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.08 -40.73 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.627 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.4 -40.86 95.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.454 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.5 mt-10 -65.53 -44.01 88.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.03 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -72.03 -39.44 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.345 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.26 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.512 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.2 p -57.51 -45.41 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.77 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.81 -35.7 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.191 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.4 mttm -69.42 -45.91 68.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -54.24 -49.48 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.532 0.197 . . . . 1.0 111.532 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.83 -46.22 96.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.231 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -68.46 -35.42 77.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.687 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -59.18 -46.99 86.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.481 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 30' ' ' GLU . 4.1 mp0 -68.02 -37.61 81.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 1.0 110.396 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -55.61 97.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.743 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.12 -7.9 16.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.481 -0.648 . . . . 1.0 111.481 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.29 146.93 34.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 122.852 -0.204 . . . . 1.0 110.487 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -75.6 142.6 26.29 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.057 1.838 . . . . 1.0 112.503 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.77 29.81 71.15 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.98 145.39 41.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 1.0 110.188 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.525 ' O ' ' NH1' ' B' ' 60' ' ' ARG . . . -126.87 -25.79 3.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.539 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -103.1 119.49 38.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 110.09 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 40.4 pt -153.05 -141.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.769 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.08 -127.43 1.3 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.893 0.377 . . . . 1.0 110.653 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.436 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 2.1 m-85 -164.32 -63.19 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.084 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.5 Cg_endo -58.73 -23.36 65.9 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.199 1.932 . . . . 1.0 112.122 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -89.77 -29.66 18.53 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.828 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.27 -40.0 82.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.0 110.596 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.6 tt -65.84 -42.94 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.703 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.465 ' CZ2' ' O ' ' C' ' 65' ' ' GLU . 0.0 OUTLIER -66.19 -36.96 84.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.41 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -61.65 -40.26 94.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.633 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.8 p -58.4 -29.19 65.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.945 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.43 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.711 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.429 ' O ' ' OG1' ' B' ' 53' ' ' THR . 23.7 mt-10 -66.8 -33.93 76.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.0 m -60.09 -44.58 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.506 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.79 -24.49 57.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.974 -0.291 . . . . 1.0 110.683 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 56.6 p -90.29 0.83 57.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.637 -0.256 . . . . 1.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.6 p 52.65 25.57 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.441 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.524 ' C ' ' H ' ' B' ' 57' ' ' TYR . 7.4 p -83.1 -46.27 18.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.538 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 72.26 -32.93 0.66 Allowed Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' B' ' 55' ' ' VAL . 1.9 m-85 41.17 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.02 0.438 . . . . 1.0 110.563 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' B' ' 56' ' ' GLY . . . 162.86 19.72 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' B' ' 50' ' ' GLU . 92.0 m-20 -63.46 -45.68 89.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.795 0.331 . . . . 1.0 110.641 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' B' ' 37' ' ' ALA . 96.9 mtt-85 -147.38 -175.36 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.24 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.533 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 13.5 p90 -162.19 113.77 1.16 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.96 153.41 72.59 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.38 1.387 . . . . 1.0 112.56 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 2.1 t -77.82 -138.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.012 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.43 ' H ' ' CG1' ' B' ' 63' ' ' VAL . 95.2 m -114.58 -39.61 3.75 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.766 0.317 . . . . 1.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.606 ' C ' ' H ' ' B' ' 67' ' ' GLY . 80.1 tt0 -65.06 -24.19 67.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.329 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -74.95 27.03 0.09 Allowed 'General case' 0 C--O 1.263 1.769 0 CA-C-O 123.576 1.655 . . . . 1.0 109.719 179.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.12 63.47 1.3 Allowed Glycine 0 C--O 1.212 -1.246 0 CA-C-N 113.656 -1.611 . . . . 1.0 111.269 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.4 ttm180 -25.08 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 118.124 0.962 . . . . 1.0 110.943 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 67' ' ' GLY . 44.9 mmtm -48.62 -19.84 0.39 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' B' ' 67' ' ' GLY . 61.4 t -62.51 -47.26 93.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.607 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.89 -38.06 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.96 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -60.63 -40.85 93.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.18 -44.87 79.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.638 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.26 -43.98 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.346 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 55.4 mtt -55.38 -46.9 76.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.633 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -41.96 97.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.546 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.12 -24.54 64.75 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.329 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.54 -41.45 5.42 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.93 -43.85 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 122.416 -0.461 . . . . 1.0 111.318 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.69 -52.46 65.4 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.876 0.369 . . . . 1.0 111.383 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 15.9 m -60.62 -46.27 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.326 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -74.15 2.7 8.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.997 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -117.46 -30.11 5.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.771 0.319 . . . . 1.0 110.227 179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.475 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.5 tt -64.03 -40.44 96.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.256 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 26.9 m -48.57 -15.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.873 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.475 ' N ' ' C ' ' B' ' 84' ' ' LEU . 52.7 m -49.14 -23.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -42.26 95.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.695 179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -11.41 59.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' B' ' 92' ' ' ASP . 43.5 mt -91.0 -38.81 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -54.42 -34.86 62.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.356 0.598 . . . . 1.0 109.481 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.523 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.2 OUTLIER -79.26 -8.02 58.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.395 -0.821 . . . . 1.0 109.969 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' B' ' 89' ' ' LEU . 66.2 t0 -55.82 -51.46 67.41 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.786 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 17.4 p90 -71.84 -41.77 67.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.747 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 57.1 t -45.13 -35.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.515 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 84.5 mtt85 -63.54 -22.7 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.056 -0.257 . . . . 1.0 111.404 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -46.77 -29.03 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 1.0 110.079 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.17 -43.95 93.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -67.85 -39.04 83.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.809 0.337 . . . . 1.0 110.797 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -66.75 -31.66 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.683 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.61 -46.87 86.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.506 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.76 -20.54 53.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.421 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.59 83.33 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.625 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.14 -106.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.483 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -135.89 -45.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.41 ' HE2' ' NH2' ' C' ' 95' ' ' ARG . 9.2 p-80 -81.83 -20.04 39.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.845 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.57 -43.04 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -75.49 -29.73 59.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -64.96 -42.74 94.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.214 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.26 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -66.74 -40.85 88.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.182 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -64.25 -35.25 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -43.16 87.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.193 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -40.55 96.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 1.0 110.968 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.518 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.82 -36.28 83.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.465 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 50.7 tp -62.4 -41.46 98.68 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.5 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -58.92 -40.14 83.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.388 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.66 -39.37 91.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 1.0 111.032 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.22 -32.87 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 92.4 mt -61.37 -41.85 97.75 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.175 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.02 -46.68 84.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.0 109.765 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.7 -40.41 72.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.433 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.75 93.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.825 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.412 ' OG ' ' OG ' ' C' ' 48' ' ' SER . 40.4 m -60.11 -45.4 93.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.655 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -66.57 -40.99 89.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.203 0.525 . . . . 1.0 110.401 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.3 mttt -66.7 -41.97 87.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.661 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.24 -51.18 69.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.361 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 7.4 p -62.37 -33.19 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.265 0.555 . . . . 1.0 110.363 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.02 -21.28 31.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.051 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -65.03 -50.83 64.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.034 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.8 pp20? -59.0 -29.36 67.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.99 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 10.8 tpt85 -62.17 118.17 7.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.794 0.33 . . . . 1.0 110.262 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.93 -9.82 63.88 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.37 148.61 34.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . 0.496 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 87.6 Cg_endo -76.21 126.76 9.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.784 1.656 . . . . 1.0 112.299 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.02 37.47 6.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 143.06 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 1.0 110.631 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.506 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -151.73 -42.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 26.47 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.013 0.435 . . . . 1.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.506 ' H ' ' C ' ' C' ' 37' ' ' ALA . 12.9 tt -63.27 -24.32 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.493 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 43.3 t -59.42 129.59 42.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.518 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.479 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 52.7 t80 -86.25 -50.91 0.48 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.983 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.0 Cg_endo -60.03 -33.69 95.24 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.514 1.476 . . . . 1.0 112.426 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.77 -7.27 57.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.282 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . 0.4 ' O ' ' OG ' ' C' ' 48' ' ' SER . . . -65.9 -38.26 88.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.777 0.322 . . . . 1.0 110.916 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -65.0 -33.72 65.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.538 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -70.18 -47.37 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.432 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -61.11 -39.64 90.75 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.382 -0.527 . . . . 1.0 109.771 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.412 ' OG ' ' OG ' ' C' ' 23' ' ' SER . 6.1 m -53.18 -21.26 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.604 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.38 -43.42 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.511 ' CD ' HH21 ' D' ' 68' ' ' ARG . 9.8 pt-20 -90.27 57.81 3.85 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.74 0.305 . . . . 1.0 111.399 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.513 ' O ' ' SD ' ' C' ' 75' ' ' MET . 6.0 t -159.51 -42.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.223 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' C' ' 51' ' ' THR . . . -64.32 -36.99 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 1.0 110.924 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' C' ' 54' ' ' THR . 1.5 p -94.57 19.81 9.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.871 0.367 . . . . 1.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 53' ' ' THR . 27.6 p 54.6 81.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.639 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.81 -84.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.88 44.73 45.96 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.445 ' OH ' ' CD1' ' D' ' 47' ' ' TRP . 0.9 OUTLIER -59.91 -48.22 82.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 1.0 110.66 -178.901 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 165.39 -100.19 0.17 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 38.5 m-20 38.41 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.883 0.373 . . . . 1.0 111.342 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' C' ' 58' ' ' GLY . 66.5 mtm-85 -123.43 157.61 33.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.57 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -141.92 146.17 39.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.34 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.88 152.32 73.7 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.126 1.884 . . . . 1.0 112.13 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 2.1 t -64.33 -139.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 1.0 109.992 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.454 ' H ' ' CG1' ' C' ' 63' ' ' VAL . 17.1 m -114.5 -77.13 0.57 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.465 ' O ' ' CZ2' ' B' ' 46' ' ' TRP . 80.6 tt0 -37.28 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.932 -0.577 . . . . 1.0 110.736 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.3 mm-40 -73.89 -103.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.07 -56.38 0.0 OUTLIER Glycine 0 N--CA 1.476 1.338 0 O-C-N 124.378 1.049 . . . . 1.0 114.225 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 88.3 mtt180 -70.71 -45.59 64.65 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' C' ' 66' ' ' GLU . 68.1 mmtt -62.35 -41.72 98.81 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.298 -0.631 . . . . 1.0 109.298 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.77 -45.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 119.798 -0.761 . . . . 1.0 111.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.1 69.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 1.0 109.76 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -69.71 -38.58 76.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.628 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.58 -49.13 74.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.89 -32.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.826 -0.349 . . . . 1.0 111.104 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' C' ' 51' ' ' THR . 27.4 tpp -61.17 -43.6 98.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.818 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.43 -38.72 92.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.703 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.81 -46.99 77.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.633 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.98 -41.81 98.49 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.223 -0.513 . . . . 1.0 111.862 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.425 HD11 HG21 ' C' ' 79' ' ' ILE . 96.5 mt -61.56 -43.45 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.768 0.318 . . . . 1.0 110.788 -179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.55 -40.98 89.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.86 -50.89 75.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.365 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -67.21 -40.79 86.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.772 -0.371 . . . . 1.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.77 71.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.988 0.423 . . . . 1.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' C' ' 86' ' ' THR . 5.4 tt -62.95 -35.75 81.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.457 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' C' ' 87' ' ' ALA . 18.7 t -39.93 -23.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 1.0 110.702 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.505 ' N ' ' O ' ' C' ' 84' ' ' LEU . 1.3 p -41.9 -21.76 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.953 0.406 . . . . 1.0 109.988 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -48.1 -50.78 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.93 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.52 -33.27 7.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.759 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.31 -45.9 91.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.768 0.318 . . . . 1.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.411 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -74.2 -14.45 60.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.995 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -92.97 -2.68 55.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.32 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -59.08 -43.05 91.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.69 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 5.6 p90 -66.97 -32.0 72.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.7 -43.68 91.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.271 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.41 ' NH2' ' HE2' ' C' ' 4' ' ' HIS . 84.3 mtt85 -57.97 -20.81 40.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -53.41 -43.31 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.979 -0.289 . . . . 1.0 110.364 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.5 mt-10 -62.88 167.64 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.998 -0.281 . . . . 1.0 110.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' C' ' 100' ' ' ARG . 96.7 mt-10 58.4 -73.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.658 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.3 mt-10 -51.59 -13.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.501 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' C' ' 98' ' ' GLU . 41.5 ttp180 -59.45 -52.22 66.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 1.0 110.505 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -70.84 -36.92 73.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.591 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . 0.423 ' O ' ' OXT' ' C' ' 103' ' ' HIS . . . 85.67 21.0 55.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.423 ' OXT' ' O ' ' C' ' 102' ' ' GLY . 96.6 m-70 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.35 147.29 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -62.51 -40.32 96.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.665 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.75 -40.63 92.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.601 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.9 tt0 -64.66 -37.2 86.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.819 0.342 . . . . 1.0 110.43 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -60.86 -43.29 98.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.381 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.64 -41.78 98.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.045 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.38 93.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.642 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.9 -37.59 79.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.99 -39.79 91.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.419 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.78 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.886 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.612 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -64.07 -39.53 94.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.89 -36.01 82.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.74 -41.2 99.08 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.063 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -37.39 85.78 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.774 0.321 . . . . 1.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.21 -41.25 92.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.624 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 88.8 mt -59.76 -41.5 91.18 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' D' ' 23' ' ' SER . 96.9 mt-10 -61.84 -48.47 80.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.271 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.94 -32.7 73.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.0 109.908 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.57 93.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.69 -46.39 90.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.923 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.45 -34.84 76.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 1.0 110.566 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' D' ' 29' ' ' ALA . 27.9 mmtp -73.05 -45.61 56.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.877 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.91 79.79 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.917 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.425 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 7.6 p -65.48 -42.67 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.221 0.534 . . . . 1.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.425 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 48.1 tp10 -70.63 -41.5 72.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -64.7 -45.79 85.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.047 -179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 39' ' ' ILE . 0.3 OUTLIER -75.5 -18.38 59.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.837 0.351 . . . . 1.0 111.305 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -67.18 108.63 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 1.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.59 -8.34 51.43 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.432 -0.667 . . . . 1.0 111.432 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.02 149.17 76.34 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.57 142.96 29.97 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.131 1.887 . . . . 1.0 112.424 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 22.07 67.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 143.56 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.328 . . . . 1.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -27.53 1.71 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.51 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -66.47 -16.38 64.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.493 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.527 ' N ' ' OE1' ' D' ' 30' ' ' GLU . 18.5 tt -37.55 105.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.973 0.416 . . . . 1.0 111.153 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 88.9 p -173.85 -133.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.192 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' D' ' 40' ' ' SER . 2.3 m-85 -177.65 -66.28 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.413 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.1 Cg_endo -58.88 -32.31 97.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.842 1.695 . . . . 1.0 111.65 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -93.92 -7.22 43.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.23 87.28 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.848 0.356 . . . . 1.0 110.493 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . 0.461 ' O ' ' OG ' ' D' ' 48' ' ' SER . 15.1 tt -69.33 -36.59 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.317 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.518 ' CD1' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -55.6 -49.06 73.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 -178.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.445 ' CD1' ' OH ' ' C' ' 57' ' ' TYR . 10.6 t90 -60.67 -40.52 92.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.167 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.506 ' HG ' ' N ' ' D' ' 49' ' ' VAL . 54.3 p -61.42 -36.19 79.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.669 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . 0.506 ' N ' ' HG ' ' D' ' 48' ' ' SER . 50.9 t -63.53 -48.09 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.985 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.3 44.97 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -139.06 -47.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.06 -25.95 67.29 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.154 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.412 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.3 p -89.41 9.87 24.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' D' ' 53' ' ' THR . 42.9 p 51.59 70.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.802 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.78 -77.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.846 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 94.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -61.82 -41.48 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 1.0 110.843 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.92 8.51 3.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.859 -0.897 . . . . 1.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.29 -47.9 83.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -140.28 148.93 42.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 25.7 p90 -136.91 137.8 24.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.514 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.54 155.37 63.5 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.376 2.051 . . . . 1.0 112.284 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.441 ' CG1' ' H ' ' D' ' 64' ' ' THR . 2.0 t -88.81 -141.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.079 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.441 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 1.7 p -113.67 -42.77 3.39 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.821 0.343 . . . . 1.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.76 -19.12 65.08 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.49 26.16 0.1 Allowed 'General case' 0 C--O 1.265 1.872 0 CA-C-O 123.7 1.714 . . . . 1.0 109.443 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 43.19 59.75 3.34 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 113.907 -1.497 . . . . 1.0 109.414 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.518 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.0 ttt85 -26.49 -28.94 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.363 0.684 . . . . 1.0 110.994 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.4 mttm -53.35 -18.68 2.7 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.044 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 53.2 t -62.46 -46.97 95.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.803 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.91 76.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.302 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.89 -46.24 82.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.76 -0.655 . . . . 1.0 111.164 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.14 -41.37 99.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.38 -46.18 96.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.241 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 25.1 mtm -63.4 -41.5 98.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.846 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.71 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.17 -41.08 92.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.438 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.41 -41.89 83.8 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.523 -0.631 . . . . 1.0 111.523 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.64 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.842 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -66.82 -44.09 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.177 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -64.8 -49.22 81.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.436 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.58 -5.55 11.91 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.872 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.48 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -109.95 -38.2 5.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 178.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.68 -16.81 6.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.4 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.42 -1.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.723 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 19.5 m -58.31 -42.16 86.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.995 0.426 . . . . 1.0 109.91 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -48.17 -17.09 0.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.76 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -105.03 -12.95 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.775 0.322 . . . . 1.0 110.464 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.3 mt -87.67 -51.18 6.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -55.32 -28.41 53.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.136 0.493 . . . . 1.0 110.421 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.485 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.5 OUTLIER -86.9 0.53 54.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.521 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -72.04 -37.7 69.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.432 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 7.4 p90 -75.86 -42.75 48.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.608 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 17.1 m -39.97 -33.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.446 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -53.7 -22.53 9.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.741 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -55.94 -34.93 66.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.579 ' C ' ' H ' ' D' ' 99' ' ' GLU . 25.9 tp10 -73.38 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.613 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 66.75 -37.57 0.3 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.493 0.496 . . . . 1.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' D' ' 97' ' ' GLU . 51.8 tp10 -67.95 -33.07 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.44 -37.03 77.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -64.94 -37.56 88.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.563 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.99 7.93 63.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.051 -0.82 . . . . 1.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 m80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.079 -0.962 . . . . 1.0 110.496 179.687 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . . . -58.83 -104.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ALA . 99.5 m-20 -140.26 -50.32 0.47 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.518 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -82.46 -19.71 38.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.499 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.65 -38.89 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.01 -38.78 92.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.367 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.1 -39.84 93.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.78 96.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.271 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -68.52 -38.92 81.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.511 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.04 -38.88 92.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.396 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.69 78.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.792 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.1 -36.72 82.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 1.0 110.691 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.15 -34.56 78.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.153 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -64.77 -35.32 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.65 -41.79 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.433 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 87.6 mt-30 -60.24 -40.58 90.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.244 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -44.05 97.33 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.69 -42.06 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.441 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 48' ' ' SER . 20.1 mt -60.16 -41.93 93.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.448 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -65.17 -43.07 92.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.4 -46.53 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.381 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.02 79.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.206 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 13.4 p -53.11 -42.07 65.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.035 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' ALA . 65.4 tttm -66.4 -74.08 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -35.96 -26.5 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.147 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' LYS . . . -62.61 -42.61 99.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 2.3 m -68.11 -47.05 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.178 0.513 . . . . 1.0 110.593 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 44.1 tp10 -67.09 -34.45 77.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' OE1' ' A' ' 66' ' ' GLU . . . -54.25 -29.09 45.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -67.56 -41.11 84.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.099 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.498 HH21 ' CB ' ' A' ' 36' ' ' ALA . 5.3 mmp_? -74.13 101.97 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.225 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.03 -27.19 4.61 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 152.5 40.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 110.027 -0.361 . . . . 1.0 110.027 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.5 147.66 32.4 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.382 2.054 . . . . 1.0 112.61 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.71 36.62 7.25 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.498 ' CB ' HH21 ' A' ' 31' ' ' ARG . . . -55.08 143.88 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 1.0 110.641 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.77 -58.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.11 58.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.263 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.5 pt -85.63 -5.49 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.177 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -72.79 151.65 41.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.632 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -98.02 -63.17 0.1 Allowed Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.753 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.16 -29.63 89.54 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.969 1.779 . . . . 1.0 112.508 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 73.7 m-20 -81.85 -5.99 58.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.955 -0.298 . . . . 1.0 110.53 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.9 -43.16 96.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.388 179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.449 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.7 tt -67.69 -39.21 81.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.505 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -59.3 -43.8 92.6 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.513 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 14.2 t90 -63.29 -40.2 96.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 45' ' ' ILE . 58.4 p -61.64 -32.7 72.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.71 -46.53 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.239 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.63 13.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.542 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -100.21 -49.27 4.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.757 0.313 . . . . 1.0 110.56 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.22 -26.76 67.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.382 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.4 p -84.53 5.44 27.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.224 0.535 . . . . 1.0 109.628 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.428 ' O ' ' OG1' ' A' ' 54' ' ' THR . 3.4 p 42.36 60.5 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.312 -0.858 . . . . 1.0 111.29 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.437 ' CG1' ' N ' ' A' ' 56' ' ' GLY . 11.1 p -131.65 -48.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.952 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.437 ' N ' ' CG1' ' A' ' 55' ' ' VAL . . . 38.76 95.55 0.01 OUTLIER Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.649 -0.58 . . . . 1.0 111.649 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -74.49 -102.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.0 110.571 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.38 18.88 1.17 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' CZ ' ' B' ' 68' ' ' ARG . 99.8 m-20 -60.23 -47.29 86.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 33.9 mmt180 -134.63 -163.02 1.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 46.3 m-85 -161.34 100.59 1.24 Allowed Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.547 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 63' ' ' VAL . 62.1 Cg_endo -69.47 150.02 69.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.353 1.369 . . . . 1.0 112.568 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 62' ' ' PRO . 6.0 m -53.53 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.371 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.524 ' OG1' ' NH2' ' D' ' 60' ' ' ARG . 98.0 m -102.63 -71.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.535 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 84.1 tt0 -37.81 -70.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 1.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' A' ' 68' ' ' ARG . 74.2 mt-10 -83.42 -107.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -54.58 0.0 OUTLIER Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.779 1.299 . . . . 1.0 114.77 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' A' ' 66' ' ' GLU . 60.0 ttm-85 -65.74 -74.9 0.1 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.851 -0.674 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -43.55 -37.6 2.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.27 -47.32 90.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.033 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 68' ' ' ARG . . . -65.99 -36.8 84.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.644 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.22 -38.29 73.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.615 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -63.41 -43.32 97.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.594 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.91 -45.34 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 65.2 mtt -60.84 -42.91 98.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.95 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.62 -43.2 97.55 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.62 -39.82 95.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.612 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.69 95.61 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.54 -43.27 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.988 -0.285 . . . . 1.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.43 -42.29 98.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.249 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.73 -50.88 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.009 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -68.46 -39.51 81.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.978 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.75 -36.67 85.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.222 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.461 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.7 tt -61.77 -42.54 99.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.404 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 99.1 t -47.75 -16.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 1.0 110.328 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.461 ' N ' ' C ' ' A' ' 84' ' ' LEU . 92.9 m -51.59 -21.35 2.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.214 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 -35.3 78.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.243 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.57 -14.59 34.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.5 -42.7 18.11 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.932 0.345 . . . . 1.0 111.932 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.72 -30.46 67.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.844 0.354 . . . . 1.0 111.216 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.4 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.17 -50.42 73.76 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.69 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 94' ' ' VAL . 15.7 p90 -72.37 -43.92 63.3 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.268 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.575 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 57.8 t -39.72 -34.37 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.662 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -63.04 -34.96 78.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 1.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 93' ' ' PHE . 40.0 ptt85 -39.46 -42.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.899 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' GLU . 5.2 tp10 -70.29 -165.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.08 -79.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.759 0.314 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 97' ' ' GLU . 97.8 mt-10 -55.21 -17.04 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -60.79 -44.91 96.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.559 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -89.54 -16.18 31.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.295 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.31 11.78 84.97 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.573 180.0 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.225 -0.658 . . . . 1.0 109.225 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.98 147.97 24.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.76 -39.52 94.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.019 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.406 ' ND1' ' H ' ' B' ' 4' ' ' HIS . 2.3 m80 -61.67 -41.64 97.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.0 110.395 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.59 -33.36 75.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -62.0 -42.35 99.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.308 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.46 -44.22 83.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.361 . . . . 1.0 110.225 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.31 -41.54 85.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.654 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.19 -38.57 90.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.671 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.72 -37.41 86.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.21 75.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.893 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.21 -36.03 76.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 1.0 110.629 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 -37.32 87.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -64.2 -33.63 76.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.664 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.43 -41.84 99.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.691 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.65 -39.92 85.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.647 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.94 -38.86 92.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.829 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.18 -41.8 94.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.754 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 94.1 mt -59.37 -41.1 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.091 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.46 -44.3 96.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 1.0 109.915 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.74 -37.78 76.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.393 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.68 88.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.415 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -58.48 -45.82 87.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -65.31 -35.0 79.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.904 0.383 . . . . 1.0 110.218 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.643 ' NZ ' HE22 ' B' ' 73' ' ' GLN . 98.7 mttt -70.95 -45.22 64.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.51 77.45 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.511 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 24.0 m -58.59 -46.82 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.798 -0.761 . . . . 1.0 110.534 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.91 -42.68 80.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.784 0.326 . . . . 1.0 111.027 179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.37 87.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.568 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -65.09 -47.7 76.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.737 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.51 131.45 49.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.04 69.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.38 143.03 25.79 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.32 -0.252 . . . . 1.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.45 142.6 26.71 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.151 1.901 . . . . 1.0 112.138 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.65 19.88 73.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.181 -0.767 . . . . 1.0 111.181 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.13 145.24 51.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 1.0 110.397 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.08 -34.47 0.87 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.516 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -81.75 125.5 30.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 1.0 110.588 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' SER . 35.5 pt -152.13 -166.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.408 -0.815 . . . . 1.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 39' ' ' ILE . 6.1 t 59.97 135.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 1.0 111.283 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -65.85 -48.98 61.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.369 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.45 -29.53 88.82 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.599 1.533 . . . . 1.0 112.913 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.03 -23.55 22.56 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.7 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.63 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 1.0 110.58 179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.412 HD12 HG23 ' B' ' 45' ' ' ILE . 4.9 tt -65.09 -39.36 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.49 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.495 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.4 OUTLIER -59.86 -47.51 85.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.474 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -61.85 -41.91 98.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 1.0 110.267 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -64.37 -40.3 95.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.199 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 44.9 t -60.49 -47.48 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.631 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.69 -32.81 74.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -64.81 -43.55 92.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.25 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.47 -26.3 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.915 -179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.6 p -88.96 2.23 54.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.716 0.293 . . . . 1.0 110.712 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 53' ' ' THR . 69.6 p 51.59 66.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.708 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 30.5 t -133.88 -52.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.674 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.33 76.91 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -61.22 -42.6 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.912 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.89 20.73 0.83 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.516 ' CG ' HH22 ' C' ' 68' ' ' ARG . 32.7 m-20 -62.5 -41.71 99.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.816 0.341 . . . . 1.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 34.9 mmt180 -132.88 -175.83 3.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 58.9 m-85 -159.45 99.35 1.55 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.856 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.2 158.16 58.7 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.3 1.333 . . . . 1.0 112.606 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -95.11 -154.17 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.022 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 26.8 m -101.93 -38.26 7.88 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.626 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.9 tm-20 -61.55 -32.38 72.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 1.0 110.2 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -73.01 26.52 0.06 Allowed 'General case' 0 C--O 1.263 1.784 0 CA-C-O 124.046 1.879 . . . . 1.0 109.599 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 44.31 63.95 2.2 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-O 117.492 -1.727 . . . . 1.0 110.961 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.505 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.1 ttm180 -25.08 -31.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.297 1.049 . . . . 1.0 110.904 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.5 mttt -49.82 -17.77 0.4 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 67' ' ' GLY . 45.7 t -60.32 -47.08 93.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 119.477 -0.889 . . . . 1.0 109.488 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.54 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -68.23 -54.21 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.303 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -42.82 -34.97 1.03 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.33 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . 0.643 HE22 ' NZ ' ' B' ' 25' ' ' LYS . 59.2 tt0 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.533 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 71' ' ' ALA . 45.0 t -67.03 -52.93 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.861 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 0.0 OUTLIER -65.0 -42.59 94.36 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.612 -179.537 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.51 -43.96 93.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.119 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.63 94.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.43 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.85 -42.99 92.63 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.711 -0.556 . . . . 1.0 111.711 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.5 -43.5 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.041 -0.264 . . . . 1.0 110.77 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 84' ' ' LEU . 80.9 mm-40 -60.28 -41.47 93.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.301 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.3 t -64.11 -49.17 82.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.457 -179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -76.59 -12.16 59.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.547 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.34 -26.58 14.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.918 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 80' ' ' GLU . 4.7 tt -63.63 -41.32 98.27 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.04 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' B' ' 87' ' ' ALA . 17.3 m -47.45 -26.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.445 -0.502 . . . . 1.0 109.68 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 6.1 m -34.16 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.415 0.626 . . . . 1.0 110.211 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -53.37 -53.2 54.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.601 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -70.25 -30.18 67.17 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.333 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.5 mp -61.29 -43.67 98.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.997 0.427 . . . . 1.0 109.886 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 -17.81 61.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.537 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -100.54 -11.56 20.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.241 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.6 m-20 -63.12 -41.92 99.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.076 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 1.4 p90 -64.94 -29.88 70.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.363 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.96 -43.4 92.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.519 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -48.71 -21.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.31 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.459 ' NH1' HH21 ' B' ' 100' ' ' ARG . 45.6 ptt85 -55.18 -32.22 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 1.0 110.119 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -61.83 -35.42 78.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.125 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 98' ' ' GLU . 2.9 pp20? -120.95 22.94 10.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.661 0.267 . . . . 1.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -132.26 -29.13 1.63 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.892 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.459 HH21 ' NH1' ' B' ' 96' ' ' ARG . 18.5 ttm105 -61.15 -46.18 91.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 1.0 110.295 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.28 -3.16 51.1 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 82.52 8.7 85.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 80.7 m80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -155.68 108.7 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -63.87 -40.91 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.473 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.694 ' H ' ' ND1' ' C' ' 4' ' ' HIS . 3.8 p-80 -58.7 -41.77 87.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.694 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.24 -37.11 86.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.72 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.9 -39.29 93.84 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.92 -39.35 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.248 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -41.01 99.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.48 -37.19 84.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.72 -38.4 87.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.661 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.5 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.2 -36.29 83.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.971 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.85 -38.71 91.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.752 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -36.02 82.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.706 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.45 -36.09 82.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 1.0 110.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.87 -33.66 76.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.184 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -61.28 -47.84 84.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.579 -0.282 . . . . 1.0 111.56 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -65.28 -36.22 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 1.0 110.653 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . 0.438 ' O ' ' OG ' ' C' ' 23' ' ' SER . 36.0 mt -60.86 -41.56 96.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.74 -42.98 99.67 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.119 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -68.89 -44.75 72.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.74 78.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.456 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 72.6 m -56.75 -43.95 81.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.858 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' C' ' 27' ' ' VAL . 8.0 tmtt? -80.65 -61.86 1.84 Allowed 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -41.89 -28.75 0.17 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.159 -0.216 . . . . 1.0 110.956 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.58 78.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.571 0.224 . . . . 1.0 110.721 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.469 ' N ' ' O ' ' C' ' 24' ' ' LYS . 2.3 m -63.26 -43.55 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.045 0.45 . . . . 1.0 110.544 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' C' ' 27' ' ' VAL . 14.4 tm-20 -80.58 -24.22 39.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -51.01 71.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.918 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.55 78.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -53.01 90.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.564 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.12 -6.18 8.22 Favored Glycine 0 N--CA 1.47 0.911 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.14 150.73 39.14 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.255 . . . . 1.0 110.32 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.62 141.77 28.28 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.685 1.59 . . . . 1.0 111.649 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 37.35 34.27 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.64 150.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.0 110.562 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' C' ' 61' ' ' TYR . . . -132.06 -116.79 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.486 ' N ' ' CD1' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -55.05 163.93 0.95 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.242 0.544 . . . . 1.0 110.961 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' C' ' 40' ' ' SER . 5.7 pt -152.85 -169.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.746 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.516 ' C ' ' CG ' ' C' ' 41' ' ' TYR . 37.6 m -53.02 -165.31 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.874 0.369 . . . . 1.0 110.83 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.631 ' C ' ' H ' ' C' ' 43' ' ' ASP . 0.3 OUTLIER 76.31 161.19 0.15 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.57 5.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.564 2.176 . . . . 1.0 112.131 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.631 ' H ' ' C ' ' C' ' 41' ' ' TYR . 21.2 t70 -84.2 -32.3 24.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -44.56 96.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 1.0 111.169 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 tt -63.93 -38.0 81.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.393 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.409 . . . . 1.0 110.211 -179.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' C' ' 48' ' ' SER . 1.4 t90 -63.25 -47.72 81.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.526 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 1.9 t -50.42 -29.22 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.776 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.39 62.91 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.661 ' CG ' HH22 ' D' ' 68' ' ' ARG . 46.7 tp10 -173.28 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.658 -0.817 . . . . 1.0 110.825 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' C' ' 75' ' ' MET . 4.5 t -72.57 -38.97 67.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.23 -28.38 69.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.957 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -93.67 1.82 56.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.07 0.462 . . . . 1.0 110.282 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 57.4 p 49.8 56.9 7.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.656 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' C' ' 57' ' ' TYR . 1.7 m -145.94 45.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.58 92.44 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.324 -1.11 . . . . 1.0 110.324 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.543 ' OH ' ' NE1' ' D' ' 47' ' ' TRP . 18.2 t80 -61.97 -43.21 99.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 1.0 110.41 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.17 16.24 0.75 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -60.98 -52.11 66.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 1.0 110.766 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -151.71 -162.28 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.493 ' O ' ' CB ' ' C' ' 37' ' ' ALA . 38.7 p90 -166.69 134.91 2.21 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.802 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 176.54 6.23 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.864 1.71 . . . . 1.0 112.362 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 16.5 m -87.25 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.416 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.495 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 1.1 m -110.08 -61.49 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.574 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -42.99 -30.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.675 -178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 94.1 mt-10 -144.68 -104.27 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.73 -55.28 0.0 OUTLIER Glycine 0 N--CA 1.479 1.521 0 O-C-N 124.358 1.036 . . . . 1.0 114.839 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 45.0 ttm-85 -71.12 -43.17 68.18 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.192 -0.504 . . . . 1.0 109.971 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.3 tptm -60.63 -45.16 95.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.918 -1.141 . . . . 1.0 107.918 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.53 -46.64 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.797 -0.761 . . . . 1.0 110.329 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.531 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -63.05 -39.8 95.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 1.0 110.13 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -43.73 -49.36 7.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.79 -36.35 83.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.529 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.02 -43.28 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.767 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.3 mpp? -59.36 -44.64 92.66 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.726 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -64.5 -41.18 96.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.53 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.98 -24.13 65.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.786 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.29 -37.61 6.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.717 -0.553 . . . . 1.0 111.717 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.56 -43.43 98.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.07 -37.67 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.1 t -62.75 -47.12 94.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.321 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -73.74 -8.01 54.32 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.299 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -40.72 12.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.876 0.369 . . . . 1.0 110.285 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.07 -42.32 99.63 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.812 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.94 -15.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.432 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.475 ' O ' ' N ' ' C' ' 89' ' ' LEU . 28.1 m -60.04 -39.87 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.43 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -39.2 -50.56 1.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.59 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.26 90.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 1.0 110.084 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' C' ' 86' ' ' THR . 44.7 mt -66.68 -38.92 87.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.401 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -60.73 -37.64 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.438 . . . . 1.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -81.99 -3.6 54.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -55.64 -49.7 72.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.569 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.2 p90 -69.06 -32.62 72.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 -27.55 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.913 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.4 -22.94 67.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.611 -0.268 . . . . 1.0 111.152 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -57.59 -31.99 66.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 1.0 110.447 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.36 -34.06 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.536 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.52 -24.78 33.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.58 -44.72 77.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.104 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.55 -36.95 85.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.357 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.16 -37.36 87.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.586 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.26 36.59 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 80.1 m80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.61 179.906 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.94 79.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -174.03 -66.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -79.21 -18.91 52.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.58 -38.79 87.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.402 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.76 -42.13 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.507 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.78 -39.42 94.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.44 99.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.818 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.18 -39.07 92.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.06 -40.82 97.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -35.42 76.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.968 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.804 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.4 -38.07 88.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.368 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.37 -31.93 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 45.7 tp -62.07 -39.64 93.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 1.0 110.184 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.4 -34.21 75.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -63.5 -46.78 84.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.844 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 m -63.62 -37.45 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 1.0 110.675 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 82.7 mt -61.23 -41.45 96.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.345 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.9 -46.32 82.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.912 0.387 . . . . 1.0 110.318 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.53 -35.36 75.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.287 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.06 92.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 1.0 111.054 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -58.24 -43.65 87.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.123 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -63.96 -32.84 74.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.37 -45.19 60.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.683 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -49.23 78.38 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 10.9 p -60.87 -45.7 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.178 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -67.98 -43.21 79.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.704 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.95 86.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.215 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -67.54 -38.23 83.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.179 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -63.69 124.08 20.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.981 0.42 . . . . 1.0 110.726 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.5 68.83 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.68 139.4 21.88 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -74.77 144.77 31.57 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.228 1.952 . . . . 1.0 112.53 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.88 22.65 70.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -91.2 87.82 6.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.709 0.29 . . . . 1.0 110.869 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.14 -38.82 91.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.916 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.405 ' C ' ' CD2' ' D' ' 38' ' ' LEU . 4.3 tt -66.6 99.14 0.56 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.405 ' O ' ' CB ' ' D' ' 40' ' ' SER . 14.3 tt -143.45 93.34 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.4 OUTLIER 168.58 150.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.572 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.413 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 10.0 m-85 -76.87 -58.79 1.02 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.562 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.413 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.1 Cg_endo -58.93 -26.78 82.47 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.648 1.565 . . . . 1.0 111.728 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.34 -35.9 27.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 1.0 111.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.79 92.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.199 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.17 -44.21 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.896 0.379 . . . . 1.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -62.8 -42.02 99.54 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.581 -0.448 . . . . 1.0 110.175 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.543 ' NE1' ' OH ' ' C' ' 57' ' ' TYR . 36.1 t90 -62.12 -40.43 95.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.269 -0.572 . . . . 1.0 109.81 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 1.4 m -74.22 69.48 1.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.804 0.335 . . . . 1.0 110.455 179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 53.3 t -155.47 -61.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 1.0 110.178 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 1.5 pm0 -63.06 -31.99 73.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.555 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.62 -42.9 97.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.223 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.96 -35.02 75.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 1.0 110.026 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' D' ' 54' ' ' THR . 18.1 p -80.07 9.47 5.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.16 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' D' ' 53' ' ' THR . 44.3 p 51.93 56.33 7.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.047 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 5.9 p -166.81 88.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.253 0.549 . . . . 1.0 111.157 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.24 109.92 3.57 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -61.32 -45.34 94.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 1.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.52 24.78 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 64.6 m-20 -61.8 -43.71 98.31 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.991 -0.284 . . . . 1.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.524 ' NH2' ' OG1' ' A' ' 64' ' ' THR . 0.2 OUTLIER -144.94 -177.19 5.4 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' D' ' 60' ' ' ARG . 41.5 m-85 -156.36 128.51 4.01 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.0 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.1 -171.13 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.736 1.624 . . . . 1.0 112.064 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' D' ' 66' ' ' GLU . 1.5 t -128.96 -146.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.178 -0.465 . . . . 1.0 109.986 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' THR . . . . . . . . . . . . . 2.9 p -113.48 -8.7 13.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.776 -0.193 . . . . 1.0 110.847 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' D' ' 67' ' ' GLY . 50.8 tp10 -99.06 -26.67 14.15 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.838 -0.431 . . . . 1.0 109.838 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.464 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -80.97 30.92 0.31 Allowed 'General case' 0 C--O 1.265 1.874 0 CA-C-O 123.896 1.808 . . . . 1.0 108.879 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.01 61.71 2.24 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 113.377 -1.738 . . . . 1.0 109.493 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.661 HH22 ' CG ' ' C' ' 50' ' ' GLU . 71.3 ttt-85 -26.21 -30.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.134 0.55 . . . . 1.0 110.981 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.8 mttt -52.22 -13.61 0.35 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.292 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.0 t -59.56 -47.8 89.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.525 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.59 83.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.496 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.85 -43.14 85.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.365 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -61.92 -44.72 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.209 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 98.1 t -64.11 -46.51 93.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.476 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.66 -44.74 95.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.995 -0.282 . . . . 1.0 111.23 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -66.15 -41.54 90.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 1.0 110.785 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.16 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.707 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.65 -39.11 93.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.586 -0.606 . . . . 1.0 111.586 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.61 -43.53 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.906 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.14 -38.95 93.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.079 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.34 -54.19 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.719 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.88 -39.6 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.812 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -62.66 -35.44 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.0 110.446 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.66 -40.75 96.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.525 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' D' ' 87' ' ' ALA . 48.1 t -57.6 -22.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.831 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 86.4 m -40.32 -24.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.53 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -64.51 -42.47 95.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.669 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -72.44 -15.62 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 3.8 mm? -85.79 -41.44 15.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.033 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.87 -36.83 72.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.218 0.533 . . . . 1.0 110.244 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -15.03 62.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.9 -51.85 67.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.234 -0.587 . . . . 1.0 111.073 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 12.6 p90 -72.23 -28.51 63.21 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.057 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.97 -35.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.962 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -59.9 -22.2 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.213 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -48.66 -36.94 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.0 110.367 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.75 -29.28 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.688 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.1 -22.49 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.381 . . . . 1.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.16 -44.19 80.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.698 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -66.19 -33.32 75.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.285 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -62.47 -36.79 83.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 22.01 52.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.339 179.925 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.32 145.02 55.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.693 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.53 -40.36 96.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.493 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.536 ' ND1' ' H ' ' A' ' 4' ' ' HIS . 1.4 m80 -62.12 -46.23 89.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.175 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.67 -41.35 92.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 9' ' ' GLN . 8.8 tpm_? -64.1 -43.78 94.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.101 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.35 -43.76 85.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.087 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.39 92.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.443 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 67.6 tp60 -64.36 -39.01 93.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.19 -41.19 96.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.91 -35.75 77.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.53 -37.8 85.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.488 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.71 -38.33 90.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.33 -32.66 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.505 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.6 tp -62.53 -38.29 89.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.079 0.466 . . . . 1.0 110.251 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.89 -33.99 74.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.12 -45.76 87.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.844 0.313 . . . . 1.0 111.844 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -63.08 -33.14 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 77.3 mt -60.51 -41.94 95.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.567 -0.453 . . . . 1.0 109.977 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.24 -47.92 82.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.626 -0.429 . . . . 1.0 109.854 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.53 -35.62 79.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.016 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.06 84.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.614 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 p -59.56 -47.88 83.81 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -67.51 -44.86 77.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.618 . . . . 1.0 110.47 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.4 mttt -63.64 -41.93 98.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.801 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.57 -51.47 68.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.642 -0.253 . . . . 1.0 111.532 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.4 p -64.68 -42.55 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.176 0.512 . . . . 1.0 109.855 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -70.57 -34.04 71.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.516 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -56.14 -50.69 70.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.573 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 32' ' ' GLY . 11.4 pt-20 -67.0 -36.55 82.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.019 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -55.19 87.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.352 . . . . 1.0 110.786 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 127.74 -9.09 6.83 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.498 -0.641 . . . . 1.0 111.498 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.18 143.3 26.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 122.676 -0.308 . . . . 1.0 110.175 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.29 119.04 5.13 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.03 1.82 . . . . 1.0 112.179 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 114.02 12.64 10.91 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.066 -0.813 . . . . 1.0 111.066 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -40.47 165.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.328 . . . . 1.0 110.892 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 61' ' ' TYR . . . -146.49 -86.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.064 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.428 ' O ' ' OE2' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -72.44 57.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.41 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 tt -63.4 -18.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 1.0 110.423 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.9 m -71.86 146.5 47.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.602 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.459 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.1 t80 -83.55 -51.58 0.63 Allowed Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.767 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -59.93 -30.25 91.3 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.492 1.461 . . . . 1.0 112.484 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -88.27 -23.16 23.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.625 0.25 . . . . 1.0 111.003 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.0 -38.71 92.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 1.0 110.111 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -65.73 -38.63 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.494 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.7 92.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.415 . . . . 1.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -60.29 -38.58 84.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -56.26 -31.67 63.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.9 t -82.49 -5.42 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 1.0 110.196 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 49.5 tt0 -108.76 33.45 4.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.239 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -39.27 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.48 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.59 -25.48 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.47 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 54' ' ' THR . 45.8 p -85.65 -2.13 57.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 53' ' ' THR . 48.5 p 53.27 73.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.118 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.27 -53.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.779 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.07 63.51 4.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.62 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 1.0 110.583 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 60' ' ' ARG . . . 161.95 -87.66 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' CG ' HH22 ' B' ' 68' ' ' ARG . 10.0 m-20 41.86 -92.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 1.0 110.486 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 mpp_? -115.23 -173.52 2.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.84 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 56.1 p90 -156.08 129.78 4.63 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.355 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.31 169.33 19.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.036 1.824 . . . . 1.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.677 ' CG2' ' H ' ' A' ' 64' ' ' THR . 6.0 p -81.27 -155.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.28 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.677 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 1.3 m -113.76 -64.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.063 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -37.5 -39.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.027 0.442 . . . . 1.0 110.549 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.85 ' O ' ' N ' ' A' ' 68' ' ' ARG . 73.7 mm-40 -135.85 -104.28 0.21 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.524 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -57.17 0.0 OUTLIER Glycine 0 N--CA 1.479 1.516 0 O-C-N 124.563 1.164 . . . . 1.0 114.449 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.85 ' N ' ' O ' ' A' ' 66' ' ' GLU . 58.4 ttm-85 -71.56 -46.94 58.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.113 0.483 . . . . 1.0 109.965 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 66' ' ' GLU . 3.5 tmtp? -60.68 -45.33 94.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.39 -43.43 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.021 -0.672 . . . . 1.0 110.029 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.3 84.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.56 -43.03 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.151 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.5 -35.47 79.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.302 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.17 -48.84 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.137 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.4 ptp -65.07 -37.5 87.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.533 -0.303 . . . . 1.0 110.572 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.45 -42.81 92.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.345 -0.388 . . . . 1.0 110.221 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.19 71.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.642 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -77.29 -38.05 30.26 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.57 -43.79 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.583 0.23 . . . . 1.0 110.624 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.83 -36.6 84.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.202 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.3 t -63.6 -49.71 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.919 0.39 . . . . 1.0 110.631 179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.34 -31.04 71.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.252 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -83.88 -26.65 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.986 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.89 -43.76 95.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.881 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.3 m -62.08 -16.56 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.409 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' VAL . 38.0 m -36.49 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.093 0.473 . . . . 1.0 110.444 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -55.72 -57.73 10.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.476 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.96 -32.94 66.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.49 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 3.8 mm? -69.31 -36.35 76.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -66.76 -55.74 13.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.985 0.422 . . . . 1.0 111.276 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.97 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.561 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.4 m-20 -60.36 -48.1 83.22 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.581 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 24.6 p90 -69.49 -28.05 65.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.386 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.04 -45.7 95.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.925 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 98' ' ' GLU . 99.7 mtt180 -68.08 -22.25 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.706 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -44.19 -23.86 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.881 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.12 -38.54 90.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ARG . 98.3 mt-10 -66.57 -36.05 81.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.592 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.23 -36.06 82.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.464 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -60.15 -46.97 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -71.05 -25.12 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 9.64 72.48 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.094 -0.955 . . . . 1.0 110.539 179.918 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.381 -0.599 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.52 139.91 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.667 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.3 -40.47 93.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.979 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' B' ' 5' ' ' GLU . 6.2 p80 -63.66 -29.94 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.79 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' B' ' 4' ' ' HIS . 50.2 tp10 -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.566 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -64.56 -39.22 93.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.61 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -64.09 -40.23 95.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.04 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.51 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.32 -38.36 87.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.28 -40.13 95.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.573 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.32 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.751 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.21 -35.21 79.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 1.0 110.478 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.08 -36.59 84.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.344 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.9 -37.51 87.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.54 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.52 -40.47 96.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.222 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.29 -38.77 92.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.78 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.66 -37.96 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.941 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.68 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.575 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 95.9 mt -59.96 -41.19 91.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.439 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.1 mm-40 -57.85 -49.75 75.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.3 -37.01 77.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.202 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.59 -43.59 65.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.206 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -62.59 -40.18 96.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.719 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.29 -33.03 75.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 29' ' ' ALA . 4.4 mptp? -83.99 -50.75 7.72 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.909 -0.317 . . . . 1.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.45 72.79 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.081 -0.247 . . . . 1.0 111.33 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 3.8 p -62.17 -45.63 98.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.325 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.5 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -74.27 -32.02 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.033 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.407 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -58.93 -37.85 77.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.51 -37.85 77.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.359 . . . . 1.0 110.918 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -54.6 95.47 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.097 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.441 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 119.27 -7.71 12.53 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.1 22.32 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 122.836 -0.214 . . . . 1.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.58 147.5 31.92 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.03 1.82 . . . . 1.0 112.528 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.78 20.15 70.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.7 56.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 1.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -35.28 0.46 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' B' ' 39' ' ' ILE . 2.6 tt -62.85 -30.63 71.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.87 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.459 ' CG2' ' O ' ' B' ' 39' ' ' ILE . 0.2 OUTLIER -34.48 119.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.655 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.541 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 31.1 t -176.22 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.5 m-85 176.79 -65.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.001 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.1 -38.07 93.1 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.116 1.878 . . . . 1.0 112.228 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.536 ' O ' ' NH2' ' B' ' 60' ' ' ARG . 40.5 p30 -101.88 2.22 37.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.05 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.91 96.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.932 0.396 . . . . 1.0 110.17 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.407 ' O ' ' OG ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -69.66 -31.91 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.713 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.556 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.5 OUTLIER -54.74 -49.83 69.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.514 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.504 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.5 OUTLIER -64.02 -39.56 94.38 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.267 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.504 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.4 p -59.45 -35.72 74.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.203 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -48.26 89.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.538 ' CG ' HH22 ' C' ' 68' ' ' ARG . 14.5 pt-20 -68.9 -30.76 69.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.699 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -62.19 -45.64 92.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.151 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.69 -27.99 68.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 1.0 111.024 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.415 ' O ' ' OG1' ' B' ' 54' ' ' THR . 47.0 p -86.81 3.8 43.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.68 0.276 . . . . 1.0 110.807 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.415 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.9 p 50.37 74.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 1.0 110.583 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -142.11 -57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.54 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.52 82.28 0.04 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -61.94 -41.83 98.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.709 0.29 . . . . 1.0 110.967 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.62 9.52 1.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -60.62 -49.18 78.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 1.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.536 ' NH2' ' O ' ' B' ' 43' ' ' ASP . 0.9 OUTLIER -145.09 145.33 31.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.112 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 47.5 p90 -133.68 126.78 19.18 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.63 156.44 63.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.735 1.623 . . . . 1.0 112.282 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.433 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 1.9 t -83.26 -138.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.033 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.401 ' H ' ' CG1' ' B' ' 63' ' ' VAL . 53.9 m -114.27 -39.88 3.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.996 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.608 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.1 tt0 -65.8 -22.9 66.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.904 0.383 . . . . 1.0 110.588 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.35 28.2 0.1 Allowed 'General case' 0 C--O 1.268 2.031 0 CA-C-O 123.513 1.625 . . . . 1.0 109.714 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.19 64.86 1.21 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-N 113.768 -1.56 . . . . 1.0 111.556 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.498 HH22 ' CG ' ' A' ' 59' ' ' ASP . 62.9 ttm-85 -23.41 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.186 0.993 . . . . 1.0 110.866 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -45.8 -21.64 0.14 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 67' ' ' GLY . 64.7 t -63.43 -44.78 99.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.473 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -77.52 -38.43 48.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.281 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.61 -41.75 91.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.79 -44.23 93.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.956 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.0 -45.58 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.245 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.5 mtm -63.02 -43.14 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.725 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -65.35 -38.21 89.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.79 -43.51 90.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.693 -179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.1 -42.21 94.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -43.48 97.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.851 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.6 -43.02 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 1.0 110.62 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.3 t -63.98 -47.36 90.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.283 -179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -74.34 0.92 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.834 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -103.47 -34.82 8.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.179 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.8 tt -64.24 -39.49 94.07 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.791 -0.363 . . . . 1.0 110.053 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.39 -13.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.304 -0.407 . . . . 1.0 109.977 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.507 ' H ' ' C ' ' B' ' 84' ' ' LEU . 55.2 m -49.33 -43.19 43.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -46.07 -17.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.79 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' B' ' 86' ' ' THR . . . -104.13 -19.6 14.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.742 0.306 . . . . 1.0 110.744 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 2.6 mm? -95.31 -46.09 6.88 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.919 0.39 . . . . 1.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.515 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.56 -28.08 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.277 0.56 . . . . 1.0 110.051 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -79.97 -4.15 51.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.68 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -59.96 -49.77 76.37 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.172 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.4 p90 -70.08 -27.5 64.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.003 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.67 -44.8 99.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.315 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -64.51 -20.2 66.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttp85 -48.72 -40.26 27.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.474 ' C ' HH21 ' B' ' 101' ' ' ARG . 80.8 mm-40 -64.6 -41.76 96.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.076 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.05 -35.79 78.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.34 -30.88 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -59.36 -44.2 92.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.78 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . 0.474 HH21 ' C ' ' B' ' 97' ' ' GLU . 0.4 OUTLIER -78.34 -16.15 57.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.168 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 82.89 11.94 80.61 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 51.8 p-80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.927 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' SER . . . . . 0.495 ' N ' ' OE1' ' C' ' 5' ' ' GLU . 63.3 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.501 ' O ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.36 80.08 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.496 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 6' ' ' ARG . 98.5 m-20 41.58 -91.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.501 ' CD2' ' O ' ' C' ' 2' ' ' ALA . 2.1 p80 -40.88 -34.84 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.784 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' C' ' 1' ' ' SER . 96.9 mt-10 -66.55 -37.95 86.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.903 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' C' ' 3' ' ' ASP . 83.6 mtp180 -63.79 -36.53 84.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -62.19 -40.32 95.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.43 -41.17 96.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.5 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.32 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.383 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.12 -36.44 83.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.391 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.85 77.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.199 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.722 0.296 . . . . 1.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.45 -35.76 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 1.0 110.563 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -63.88 -32.84 74.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . 0.478 ' O ' ' CD2' ' C' ' 19' ' ' LEU . 46.6 tp -62.75 -40.61 97.79 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.435 ' O ' ' CG ' ' C' ' 20' ' ' GLU . 88.8 mt-30 -70.6 -25.68 63.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.924 -0.311 . . . . 1.0 111.527 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.44 -44.63 18.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 25.9 m -61.65 -47.11 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -177.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' C' ' 15' ' ' LEU . 2.8 pp -75.25 -26.27 58.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.865 0.364 . . . . 1.0 110.526 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' C' ' 16' ' ' GLN . 3.7 mm-40 -60.35 -48.33 82.19 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.666 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -65.84 -40.35 91.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.833 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -64.86 -33.63 76.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.453 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 22.3 m -56.65 -47.84 78.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.781 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.5 -39.8 92.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.561 -0.455 . . . . 1.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.7 mttt -73.55 -25.15 60.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -61.57 -45.11 95.55 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.071 -0.251 . . . . 1.0 110.684 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 42.7 t -64.82 -46.33 92.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.193 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.63 -33.65 71.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.54 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -56.68 -53.63 55.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.954 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.9 pp20? -71.2 -36.56 71.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 16.6 tpt180 -57.41 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 120.733 0.302 . . . . 1.0 110.765 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.07 -14.8 6.23 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.26 157.11 34.63 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.13 147.66 33.77 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.028 1.819 . . . . 1.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 26.37 48.92 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.14 143.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 1.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.73 -7.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.543 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -120.1 134.38 55.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.298 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 29.8 pt -153.96 -162.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.045 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.494 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 1.0 OUTLIER 59.06 126.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.09 0.471 . . . . 1.0 110.971 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.588 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 42.0 m-85 -71.56 -43.44 11.86 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.088 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.8 Cg_endo -59.34 -42.05 52.9 Favored 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 121.554 1.503 . . . . 1.0 112.959 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' C' ' 40' ' ' SER . 28.3 p-10 -84.29 -5.87 59.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.192 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . 0.435 ' O ' ' OG ' ' C' ' 48' ' ' SER . . . -61.73 -43.07 99.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 1.0 110.487 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -65.45 -35.97 76.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.563 179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.416 ' NE1' ' CB ' ' D' ' 68' ' ' ARG . 0.4 OUTLIER -56.51 -36.75 69.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.533 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.415 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.5 OUTLIER -84.82 -28.76 25.88 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.491 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 1.5 m -68.77 -40.09 79.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.685 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' C' ' 50' ' ' GLU . 3.9 p -60.83 -44.85 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.585 -0.28 . . . . 1.0 111.552 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.539 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.8 pt-20 -69.76 -33.86 73.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.823 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 70.3 m -62.57 -47.86 82.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.414 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.94 67.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.752 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 59.0 p -95.07 3.28 55.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.835 0.35 . . . . 1.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' C' ' 54' ' ' THR . 17.5 p 53.79 73.66 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.63 -70.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.134 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.73 -58.3 3.44 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 70.76 -48.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.717 0.294 . . . . 1.0 110.976 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 145.24 -9.72 1.74 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 60.8 m-20 -42.93 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 1.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 81.1 mtm-85 -124.42 154.97 39.64 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.841 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 44.2 p90 -131.24 136.15 28.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.611 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.08 155.3 68.59 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.072 1.848 . . . . 1.0 112.241 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.62 -161.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.149 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.556 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 17.1 p -111.21 -66.23 1.1 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.195 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' C' ' 64' ' ' THR . 83.1 tt0 -37.81 -44.55 0.76 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.859 0.361 . . . . 1.0 110.559 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.89 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.6 mm-40 -121.52 -98.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.32 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.619 1.199 . . . . 1.0 114.438 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.89 ' N ' ' O ' ' C' ' 66' ' ' GLU . 47.7 ttm-85 -67.02 -67.08 0.48 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.892 -0.654 . . . . 1.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' C' ' 68' ' ' ARG . 1.9 mptm? -41.42 -39.42 1.48 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.72 -49.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 119.804 -0.759 . . . . 1.0 111.212 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.38 -50.7 64.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.985 0.422 . . . . 1.0 110.534 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 68' ' ' ARG . 84.2 tt0 -44.39 -44.39 8.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.601 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.69 -41.08 97.1 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.238 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.19 -42.66 94.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.6 mtt -59.1 -42.81 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.83 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -63.25 -41.99 99.13 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.645 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.59 88.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -43.3 96.22 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.104 -0.569 . . . . 1.0 112.1 -179.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.403 HG22 HD13 ' C' ' 79' ' ' ILE . 98.0 mt -63.25 -42.68 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.646 0.26 . . . . 1.0 110.81 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.2 -38.91 84.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.423 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.98 -49.77 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.273 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.43 -41.02 93.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.075 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.414 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -65.54 -32.52 74.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 1.0 110.652 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.9 -42.13 98.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.366 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 24.6 t -58.93 -18.17 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.221 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 90' ' ' ALA . 85.9 m -43.13 -40.46 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 1.0 110.377 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.8 -63.48 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.8 -34.58 28.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 1.0 110.317 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.0 mm? -77.28 -33.42 55.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.11 -36.09 82.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.107 0.479 . . . . 1.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -4.47 37.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.142 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -56.06 -51.55 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.049 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 19.4 p90 -68.97 -30.03 68.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.82 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.27 -42.22 89.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.443 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' C' ' 98' ' ' GLU . 97.0 mtt180 -57.28 -23.44 48.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.355 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -43.53 -33.53 1.15 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.856 0.36 . . . . 1.0 110.63 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.97 -38.25 88.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' C' ' 95' ' ' ARG . 71.4 mm-40 -65.86 -40.82 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.279 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.47 -39.32 85.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.354 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -64.82 -43.69 92.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.685 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -135.88 100.5 4.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.608 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.88 34.89 3.36 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.515 ' OXT' ' CG ' ' C' ' 103' ' ' HIS . 53.7 p-80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.972 -1.013 . . . . 1.0 110.512 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' SER . . . . . 0.496 ' C ' ' H ' ' D' ' 3' ' ' ASP . 58.0 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.6 29.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.75 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' D' ' 1' ' ' SER . 7.0 t70 80.74 -59.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.477 ' CD2' ' O ' ' D' ' 2' ' ' ALA . 7.5 p80 -78.39 -20.4 51.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.844 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.26 -37.98 84.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.419 . . . . 1.0 110.677 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.2 -38.41 90.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.494 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.86 -40.9 95.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.404 . . . . 1.0 109.912 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.55 96.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.749 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -67.2 -39.1 86.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.531 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -62.94 -38.21 90.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.424 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.91 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.073 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.66 -37.97 88.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 1.0 110.678 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.81 -33.97 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -65.31 -35.97 82.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.628 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.27 -41.57 98.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.372 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.69 -40.62 95.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.018 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.32 -37.4 87.12 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.997 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.87 -39.55 85.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.558 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 92.5 mt -59.24 -40.9 87.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 1.0 109.846 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.448 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.1 mt-10 -60.85 -51.01 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 1.0 110.037 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.85 -32.32 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 109.949 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.69 95.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.1 p -58.69 -41.31 85.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.614 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.98 -32.82 74.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -80.18 -39.3 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.333 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.5 80.07 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.886 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.491 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 7.1 p -62.65 -46.87 95.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.491 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 10.7 tm-20 -68.17 -42.75 79.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.41 ' C ' ' OE1' ' D' ' 66' ' ' GLU . . . -86.47 71.46 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.815 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 3.1 mm-40 -157.36 -58.39 0.08 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.857 0.361 . . . . 1.0 110.337 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -79.93 124.08 28.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.152 0.501 . . . . 1.0 110.56 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.81 6.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.792 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.76 39.39 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.717 -0.284 . . . . 1.0 110.613 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.12 117.75 4.99 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.592 1.528 . . . . 1.0 112.143 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.18 29.87 8.67 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.04 140.83 52.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 1.0 110.606 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.73 -69.94 0.83 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.89 129.41 40.83 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.902 -0.406 . . . . 1.0 109.902 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -150.41 30.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.542 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 1.6 p -134.25 137.61 44.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.517 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.539 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 22.5 t80 -76.17 -48.17 3.42 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.868 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.9 Cg_endo -58.9 -30.25 92.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.353 1.369 . . . . 1.0 112.096 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.77 -17.43 23.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.191 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.84 -38.6 91.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.34 . . . . 1.0 110.885 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 10.2 tt -65.02 -40.58 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 3.7 t-105 -60.42 -46.96 88.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.143 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -60.92 -33.63 73.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -66.23 -32.76 74.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.147 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.72 -48.22 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.57 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 16.1 pt-20 -69.57 -31.11 69.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.078 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -61.14 -46.55 90.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.44 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.27 -34.96 72.89 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.153 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.469 ' C ' ' H ' ' D' ' 55' ' ' VAL . 63.0 p -75.58 0.94 15.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.379 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' D' ' 53' ' ' THR . 36.1 p 53.12 9.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.964 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.469 ' H ' ' C ' ' D' ' 53' ' ' THR . 10.0 p -64.65 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 1.0 110.604 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.72 55.54 5.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -47.14 87.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 1.0 110.326 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 160.39 -103.32 0.22 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.18 -75.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.713 0.292 . . . . 1.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' D' ' 58' ' ' GLY . 69.5 mtt-85 -141.41 179.74 6.62 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.03 144.32 0.99 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.293 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.59 164.07 36.67 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.429 2.086 . . . . 1.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.418 ' CG1' ' H ' ' D' ' 64' ' ' THR . 3.0 t -94.45 -128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.258 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.418 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 55.4 m -113.96 -55.19 2.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.745 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.588 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.2 tt0 -61.68 -18.02 57.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.151 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 37.4 mm-40 -78.83 35.6 0.25 Allowed 'General case' 0 C--O 1.269 2.108 0 CA-C-O 124.025 1.869 . . . . 1.0 108.791 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 36.74 58.68 1.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.014 -1.903 . . . . 1.0 109.477 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.539 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 48.6 ttt85 -26.47 -29.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.365 0.685 . . . . 1.0 111.245 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -56.18 -12.21 1.45 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.069 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' D' ' 67' ' ' GLY . 42.6 t -62.09 -46.36 96.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 C-N-CA 119.414 -0.915 . . . . 1.0 109.745 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.26 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.183 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.02 -42.55 80.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.081 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.42 -42.94 95.78 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.758 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.24 -47.69 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.769 -0.373 . . . . 1.0 111.204 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -63.23 -41.19 99.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.101 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 79.1 tttt -61.65 -40.69 95.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.594 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.74 94.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.837 0.351 . . . . 1.0 110.476 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.94 -40.92 93.56 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.68 -43.79 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 2.6 mp0 -65.52 -43.05 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.75 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.58 -47.23 93.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.89 -0.324 . . . . 1.0 111.116 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -75.29 -8.35 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.836 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -101.19 -30.33 11.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.747 0.308 . . . . 1.0 110.175 179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.57 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.0 tt -64.31 -37.32 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.14 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -48.45 -9.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.57 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.4 m -49.38 -41.74 40.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.169 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.478 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -50.52 -19.3 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.529 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.68 -11.78 16.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.811 0.339 . . . . 1.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.0 -45.53 6.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.478 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.434 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.0 -16.27 12.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.111 0.482 . . . . 1.0 110.512 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.478 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.3 OUTLIER -96.06 0.33 51.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -72.2 -27.77 62.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.555 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 5.5 p90 -79.88 -43.74 21.69 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.642 ' CG2' HH11 ' D' ' 95' ' ' ARG . 21.0 m -41.11 -33.39 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.004 -0.543 . . . . 1.0 111.553 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . 0.642 HH11 ' CG2' ' D' ' 94' ' ' VAL . 11.3 mpt_? -50.9 -22.53 2.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' D' ' 97' ' ' GLU . 53.5 ptt85 -54.71 -21.69 11.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' D' ' 96' ' ' ARG . 6.1 mp0 -73.42 -58.09 3.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.0 -36.65 78.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.962 0.411 . . . . 1.0 110.484 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.44 -19.8 65.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.452 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -60.25 -44.58 95.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.265 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -94.96 -5.68 44.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.42 89.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 60.7 m170 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.435 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ALA . 8.1 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 45.17 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 67.3 t0 -131.78 45.75 2.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.496 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.609 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 10.5 p80 -154.87 -42.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 15.1 pt-20 -65.71 -38.94 90.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -64.86 -37.79 88.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.277 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -65.77 -38.87 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.72 88.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.176 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -64.28 -41.48 96.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.338 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.07 -36.7 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.57 78.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.47 -40.44 91.28 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.14 -35.07 79.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.274 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.37 -34.55 78.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.561 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 43.8 tp -62.41 -39.82 94.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.303 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.07 -34.78 75.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.233 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -63.94 -46.28 85.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.29 -36.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 1.0 110.696 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.13 -41.64 97.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 1.0 109.973 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.2 mt-10 -63.78 -42.67 97.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -39.43 79.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.31 -39.76 81.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 78.9 p -51.42 -41.81 61.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -62.67 -47.43 83.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.057 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.33 -42.41 91.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.695 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.12 92.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.802 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.1 t -64.35 -47.02 91.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.456 -0.497 . . . . 1.0 110.155 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.91 -41.49 87.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.172 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.49 62.16 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.744 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -173.91 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -62.13 83.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.982 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.86 5.55 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.92 133.48 22.25 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.69 131.55 13.62 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.908 1.739 . . . . 1.0 112.778 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.14 35.91 86.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.45 129.18 54.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.887 0.375 . . . . 1.0 110.953 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.37 -166.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.215 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.1 tt 59.35 88.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.969 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.3 tt -136.19 160.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.93 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 1.5 p 79.31 137.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 1.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -64.92 -46.79 75.06 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.235 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.9 Cg_endo -60.32 -31.6 93.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.46 1.44 . . . . 1.0 112.664 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.431 ' H ' ' HG ' ' A' ' 40' ' ' SER . 24.8 m-20 -94.2 -31.07 14.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.672 0.272 . . . . 1.0 110.704 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.92 84.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.329 . . . . 1.0 110.683 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.409 ' CG2' ' N ' ' A' ' 46' ' ' TRP . 3.5 tt -63.83 -39.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.984 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CE2' ' O ' ' B' ' 64' ' ' THR . 4.8 t-105 -59.31 -46.13 89.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.4 ' CE3' ' N ' ' A' ' 48' ' ' SER . 2.4 t90 -59.93 -39.48 85.67 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.4 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 1.5 t -67.71 65.39 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.676 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.9 t -154.39 -57.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 1.0 110.23 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' CG ' HH12 ' B' ' 68' ' ' ARG . 12.3 pt-20 -66.42 -31.69 72.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -42.93 99.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.108 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 54' ' ' THR . . . -61.01 -36.79 80.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.088 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 p -80.7 16.76 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.45 ' H ' ' C ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 32.14 69.25 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.597 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.42 -38.28 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.64 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.12 73.3 0.36 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.661 -0.975 . . . . 1.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 15.4 t80 -60.12 -47.18 86.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 1.0 110.507 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.6 25.76 0.44 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.032 -0.827 . . . . 1.0 111.032 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 32.6 p-10 -63.49 -41.17 98.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.317 . . . . 1.0 110.421 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.51 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 94.2 mtt-85 -151.36 -161.09 1.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.335 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 8.8 p90 -169.88 100.6 0.46 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.525 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.05 165.86 29.88 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.403 1.402 . . . . 1.0 112.399 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.703 ' CG2' ' H ' ' A' ' 64' ' ' THR . 7.8 p -100.25 -159.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 110.05 -0.352 . . . . 1.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.703 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 51.0 m -91.98 -43.9 9.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.586 0.231 . . . . 1.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.636 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' OE2' ' N ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.75 25.1 0.07 Allowed 'General case' 0 C--O 1.265 1.899 0 CA-C-O 124.116 1.913 . . . . 1.0 109.503 178.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.717 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 46.33 67.46 1.36 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.622 -1.627 . . . . 1.0 111.723 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.535 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 59.5 ttm-85 -24.15 -32.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.404 1.102 . . . . 1.0 111.158 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.717 ' N ' ' O ' ' A' ' 67' ' ' GLY . 32.3 mmtp -48.52 -31.09 5.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.55 176.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' A' ' 67' ' ' GLY . 53.9 t -62.83 -49.54 83.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.28 74.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.638 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.85 -35.61 81.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -54.96 -42.85 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.683 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.12 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.374 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 mmt -52.32 -56.76 12.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.378 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -36.87 85.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 1.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.53 -22.06 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.63 -28.45 8.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 36.8 mm -63.01 -43.84 99.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 121.144 -0.222 . . . . 1.0 110.484 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.07 -36.58 84.78 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.275 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 83' ' ' ALA . 74.1 t -67.07 -72.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.145 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -51.99 -11.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.162 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' H ' ' C ' ' A' ' 81' ' ' VAL . . . -88.54 -43.8 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.788 0.328 . . . . 1.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.547 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.3 tt -63.03 -41.73 99.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.604 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 m -51.8 -8.41 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 84' ' ' LEU . 97.6 m -61.99 -25.8 67.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.275 -0.421 . . . . 1.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.38 -24.76 57.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.308 179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.43 -11.32 24.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.859 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -90.78 -45.24 8.94 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.794 0.331 . . . . 1.0 111.416 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.06 -27.01 51.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.932 0.396 . . . . 1.0 110.987 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -4.63 58.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.55 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -62.13 -45.02 95.33 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.927 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 7.3 p90 -76.58 -27.97 56.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.508 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.85 -40.27 82.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.296 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.82 -23.51 44.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.144 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -41.88 -40.39 2.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.797 0.332 . . . . 1.0 110.853 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -62.97 -45.68 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.918 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.46 -41.45 80.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.653 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.6 -41.6 83.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.65 -44.24 97.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.598 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.97 -37.34 85.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.532 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 21.88 42.58 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.56 179.88 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.97 174.05 12.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.785 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.58 -41.91 98.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.94 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.537 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 13.4 p-80 -78.83 -31.39 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -41.62 90.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -64.34 -40.16 95.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.762 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -65.28 -44.08 89.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.954 0.407 . . . . 1.0 109.921 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.42 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.719 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.76 -40.16 87.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.332 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.02 -39.6 92.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.66 -34.19 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.638 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' B' ' 16' ' ' GLN . 96.6 mt-10 -78.15 -37.81 45.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.59 -45.91 84.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 1.0 110.791 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.94 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.36 -39.99 92.66 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.036 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' B' ' 12' ' ' GLU . 8.4 mp0 -69.93 -28.05 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -62.96 -46.22 88.76 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 14.8 m -66.3 -31.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.118 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 84.9 mt -60.43 -41.15 93.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.62 -48.14 83.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.11 -34.47 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.151 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -46.2 86.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.251 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 66.7 p -59.81 -46.62 88.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.928 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -61.49 -53.53 55.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.412 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.3 mttm -59.13 -43.9 92.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.008 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.419 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -59.77 -38.19 81.15 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.958 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.68 -44.43 89.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.712 179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -83.5 -9.95 58.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.622 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.77 -39.0 90.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 32' ' ' GLY . 9.6 mp0 -68.93 -37.53 78.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 1.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.54 83.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.078 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 127.51 -14.1 6.49 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 111.397 -0.681 . . . . 1.0 111.397 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.81 143.8 27.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 O-C-N 122.795 -0.238 . . . . 1.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.78 157.11 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.054 1.836 . . . . 1.0 112.428 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.98 37.19 64.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.76 21.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.848 0.356 . . . . 1.0 110.566 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.49 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.582 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.451 ' O ' ' OG ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -63.37 -30.14 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.646 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' B' ' 40' ' ' SER . 18.7 tt -38.5 108.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.094 0.473 . . . . 1.0 110.757 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.3 p 163.22 102.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.97 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.543 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -56.43 -47.39 99.01 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.848 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.6 Cg_endo -57.49 -36.86 98.65 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.384 1.389 . . . . 1.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' CZ ' ' B' ' 60' ' ' ARG . 46.7 p30 -100.38 -0.76 37.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.696 0.284 . . . . 1.0 110.984 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.94 89.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.947 0.403 . . . . 1.0 110.525 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -68.82 -40.99 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.694 179.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -61.54 -45.5 93.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.408 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.513 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 9.9 t90 -63.59 -42.68 98.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.421 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 31.3 p -65.6 -25.96 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.041 -179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 20.4 t -71.77 -25.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -98.37 -9.47 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.996 -0.282 . . . . 1.0 111.178 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -36.18 20.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 1.0 111.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.1 -22.84 63.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.475 -179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 67.3 p -83.87 0.2 48.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.661 0.267 . . . . 1.0 110.712 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 26.1 p 51.12 60.3 3.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.516 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 48.1 t -133.11 -48.13 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.519 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.35 76.44 0.18 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . 0.402 ' OH ' ' OD1' ' C' ' 59' ' ' ASP . 13.2 t80 -60.04 -47.78 84.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.808 -179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.74 24.93 0.58 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 67.9 t0 -62.29 -49.14 76.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.352 . . . . 1.0 110.768 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.512 ' CZ ' ' OD2' ' B' ' 43' ' ' ASP . 91.7 mtt-85 -143.83 -164.44 1.88 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.139 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -150.99 118.96 3.42 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.108 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.25 153.35 71.42 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.366 1.378 . . . . 1.0 112.094 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.59 -169.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.5 ' O ' ' CE2' ' A' ' 46' ' ' TRP . 1.2 m -108.61 -62.56 1.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.993 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -40.16 -28.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 1.0 110.769 -178.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' B' ' 68' ' ' ARG . 94.1 mt-10 -143.87 -101.32 0.12 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.256 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.02 -55.55 0.0 OUTLIER Glycine 0 N--CA 1.479 1.519 0 O-C-N 124.613 1.195 . . . . 1.0 114.223 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.905 ' N ' ' O ' ' B' ' 66' ' ' GLU . 60.4 ttm-85 -66.18 -72.48 0.16 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -42.18 -36.36 1.17 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.66 -46.03 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.809 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -70.93 -45.17 64.7 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.217 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -45.37 -48.63 13.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.064 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -61.75 -44.74 96.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -46.44 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.283 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -61.77 -38.65 88.8 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.97 85.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.325 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.42 -37.05 92.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.96 -43.85 99.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 84' ' ' LEU . 97.8 mt-10 -63.18 -38.8 92.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 1.0 110.456 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 25.1 t -62.25 -70.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.737 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.86 -14.76 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -96.41 -35.1 11.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.319 179.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' B' ' 80' ' ' GLU . 5.2 tt -63.53 -40.96 98.38 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.345 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.432 ' C ' ' N ' ' B' ' 87' ' ' ALA . 35.6 m -55.07 -16.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.737 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 33.4 m -44.45 -24.06 0.16 Allowed 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.159 0.504 . . . . 1.0 109.68 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.432 ' N ' ' C ' ' B' ' 85' ' ' VAL . . . -62.33 -45.23 94.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.522 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -12.7 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.673 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.6 mm? -92.49 -25.78 18.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.006 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -67.82 -40.49 83.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.617 . . . . 1.0 109.894 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -16.32 62.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.126 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -43.68 -65.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.138 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' B' ' 94' ' ' VAL . 30.6 p90 -64.16 -47.14 81.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.278 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 66.0 t -37.66 -28.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.713 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . 0.477 ' C ' ' H ' ' B' ' 97' ' ' GLU . 99.8 mtt180 -63.64 -37.57 87.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.902 -0.319 . . . . 1.0 111.4 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 93' ' ' PHE . 44.1 ptt85 -46.75 -15.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 1.0 110.303 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 100' ' ' ARG . 43.6 tp10 -63.31 -41.82 98.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.883 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.3 -40.58 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 1.0 110.775 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' B' ' 99' ' ' GLU . 59.0 mp0 -69.44 -36.46 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.899 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 97' ' ' GLU . 55.0 ttp180 -60.62 -45.22 94.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -79.76 -14.83 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.529 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 77.43 21.48 72.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 33.7 p80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.62 170.52 22.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.701 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.45 -50.7 70.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.396 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.602 ' H ' ' ND1' ' C' ' 4' ' ' HIS . 6.8 p-80 -68.87 -38.17 79.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.839 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.26 -44.5 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.899 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -65.06 -39.07 92.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.864 0.364 . . . . 1.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -64.19 -41.01 97.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.15 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.39 -42.03 93.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.273 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -63.61 -38.68 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.521 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.49 71.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.66 -39.59 94.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.32 . . . . 1.0 111.009 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -63.41 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.292 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.49 -34.37 78.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.677 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.1 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.77 -39.64 94.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.244 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . 0.595 ' CB ' ' HZ1' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -61.52 -38.79 88.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.304 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.69 -42.67 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.683 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -60.9 -40.15 92.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.358 -179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.3 mt-10 -55.2 -54.92 37.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 1.0 110.496 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.41 -37.5 83.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.438 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.43 89.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 95.1 p -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.386 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -65.83 -33.55 76.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.189 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' C' ' 29' ' ' ALA . 53.7 mttp -70.42 -46.61 63.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.59 -50.31 70.43 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.246 0.341 . . . . 1.0 111.446 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 5.0 p -60.98 -46.77 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.457 -0.497 . . . . 1.0 109.926 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -69.32 -28.59 66.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.468 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -51.64 -49.84 61.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.762 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.469 ' CG ' ' H ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -96.78 -99.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 1.0 110.545 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.469 ' H ' ' CG ' ' C' ' 30' ' ' GLU . 30.1 mmm-85 46.71 59.46 3.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.554 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.7 4.81 7.93 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.69 61.14 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.42 120.0 5.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.884 1.723 . . . . 1.0 111.773 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.82 13.61 62.33 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 146.09 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 1.0 110.267 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.8 -30.16 2.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.485 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.19 51.47 2.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 pt -80.0 16.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.751 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.3 t -114.0 126.28 54.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.63 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.499 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 8.1 t80 -78.12 -49.95 1.85 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.923 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 27.6 Cg_endo -60.12 -29.23 88.68 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.388 1.392 . . . . 1.0 112.402 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -89.12 -3.82 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.058 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.44 96.16 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.732 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -65.55 -40.84 89.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.494 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.07 -45.83 90.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.497 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -61.03 -41.35 96.4 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.242 -0.583 . . . . 1.0 109.482 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' C' ' 48' ' ' SER . 39.1 p -72.37 64.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -149.09 -51.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.503 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.43 ' O ' ' OG1' ' C' ' 53' ' ' THR . 18.5 pt-20 -66.65 -32.72 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.936 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -44.05 92.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.969 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.23 -26.46 60.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.753 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 50' ' ' GLU . 62.8 p -87.31 -3.59 59.04 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.847 0.356 . . . . 1.0 110.145 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.7 p 51.7 48.75 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.082 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.73 -28.29 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.254 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.72 59.77 7.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.518 -1.033 . . . . 1.0 110.518 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -48.1 82.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 1.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.13 38.66 0.63 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' C' ' 59' ' ' ASP . 12.8 p-10 -65.27 -40.54 94.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.92 0.39 . . . . 1.0 110.601 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.464 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 30.2 mmt180 -130.4 -161.01 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.118 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.464 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 56.5 m-85 -158.59 75.54 3.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.626 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.16 156.0 66.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.058 1.839 . . . . 1.0 111.997 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.711 ' CG2' ' H ' ' C' ' 64' ' ' THR . 8.6 p -100.97 -155.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.009 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.711 ' H ' ' CG2' ' C' ' 63' ' ' VAL . 34.7 m -89.54 -46.25 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.291 . . . . 1.0 110.638 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' C' ' 67' ' ' GLY . 11.7 tm-20 -44.38 -40.18 5.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' C' ' 68' ' ' ARG . 0.1 OUTLIER -70.17 24.08 0.03 OUTLIER 'General case' 0 C--O 1.266 1.963 0 CA-C-O 123.855 1.788 . . . . 1.0 109.915 178.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.754 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 44.86 66.12 1.56 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 113.984 -1.462 . . . . 1.0 111.615 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.553 ' N ' ' OE2' ' C' ' 66' ' ' GLU . 56.1 ttm-85 -25.4 -28.31 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.17 0.985 . . . . 1.0 111.382 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.8 tppp? -52.04 -26.92 12.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.305 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.1 t -61.75 -47.19 94.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 C-N-CA 119.201 -1.0 . . . . 1.0 110.593 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -39.93 84.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.0 110.634 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.92 -38.28 88.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.721 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.2 -44.46 79.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.256 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.92 -43.76 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.229 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.1 mtt -59.54 -43.56 93.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.953 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.12 -41.34 97.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.64 90.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.834 0.35 . . . . 1.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.42 -41.53 96.39 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.761 -0.536 . . . . 1.0 111.761 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.418 HG23 HD13 ' C' ' 79' ' ' ILE . 97.2 mt -61.62 -43.01 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.599 0.238 . . . . 1.0 110.761 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.56 -43.66 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.545 -0.298 . . . . 1.0 111.143 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.38 -49.23 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.136 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.296 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 1.0 110.468 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.4 tt -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.507 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 98.6 t -49.32 -12.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 1.0 110.491 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.476 ' H ' ' C ' ' C' ' 84' ' ' LEU . 85.9 m -60.82 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.268 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.46 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -59.69 -36.31 76.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.057 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 -38.3 21.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.43 -38.65 87.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.083 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -59.23 -35.45 73.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.021 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -83.0 -4.3 58.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -58.07 -47.9 81.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.672 -179.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 8.4 p90 -66.87 -39.0 87.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.525 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 95.9 t -43.84 -36.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.511 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.21 -23.12 65.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.647 0.261 . . . . 1.0 111.179 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -57.09 -42.6 81.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.66 -39.29 93.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.06 -39.61 86.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.851 0.358 . . . . 1.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.78 -35.43 80.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.449 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.22 -44.75 94.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.678 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.67 -37.38 84.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' C' ' 103' ' ' HIS . . . 83.85 22.58 55.18 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' C' ' 102' ' ' GLY . 81.0 m80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.641 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.57 174.5 11.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.539 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.9 -42.94 99.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.9 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.447 ' H ' ' ND1' ' D' ' 4' ' ' HIS . 9.9 p-80 -73.36 -32.62 64.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.535 -0.302 . . . . 1.0 110.793 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.24 -37.42 87.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 1.0 110.551 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.26 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.47 -36.75 83.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.491 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.06 -37.72 86.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.04 79.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.021 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.24 -36.02 82.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 1.0 110.668 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.29 -38.45 91.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.665 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.36 -33.23 75.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.627 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 40.9 tp -62.01 -42.01 98.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 1.0 110.441 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.01 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.965 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -62.25 -42.99 99.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.96 0.41 . . . . 1.0 111.063 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' D' ' 22' ' ' ALA . 96.9 t -63.83 -35.56 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.689 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 96.9 mt -61.6 -41.81 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.679 -0.409 . . . . 1.0 109.922 -179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' D' ' 23' ' ' SER . 70.6 mm-40 -66.81 -50.46 62.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.543 179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.29 -39.8 86.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.379 . . . . 1.0 110.422 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' D' ' 18' ' ' VAL . . . -65.07 -37.51 87.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.598 ' HG ' ' N ' ' D' ' 24' ' ' LYS . 94.5 p -57.38 -45.74 84.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.74 -178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.598 ' N ' ' HG ' ' D' ' 23' ' ' SER . 1.8 tmtp? -67.93 -35.33 78.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.578 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.75 -46.31 69.17 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.893 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -55.66 -51.83 65.92 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.891 -0.323 . . . . 1.0 111.204 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 7.5 p -62.62 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.264 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -64.55 -39.4 93.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.681 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 1.1 mp0 -68.31 -41.24 81.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.477 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.49 107.75 0.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.009 0.433 . . . . 1.0 110.37 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.61 -13.99 24.96 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.16 144.94 29.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -74.79 143.63 30.05 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.157 1.905 . . . . 1.0 112.328 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 26.58 70.54 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.41 144.23 57.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 1.0 110.649 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -16.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.554 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 30.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.952 0.406 . . . . 1.0 110.08 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' D' ' 40' ' ' SER . 42.2 pt -77.34 -158.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.445 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.1 t 80.53 -137.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.606 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' D' ' 40' ' ' SER . 5.7 m-85 -168.44 -59.88 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.55 -32.04 95.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.65 1.566 . . . . 1.0 111.95 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' D' ' 44' ' ' ALA . 18.2 p30 -87.75 -22.69 24.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.326 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' D' ' 43' ' ' ASP . . . -64.04 -41.51 97.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.349 . . . . 1.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . 0.437 ' O ' ' OG ' ' D' ' 48' ' ' SER . 8.5 tt -67.65 -41.83 85.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.213 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.88 -36.89 80.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.114 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -62.53 -39.64 94.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.646 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' D' ' 45' ' ' ILE . 83.3 p -65.93 -29.47 69.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.773 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.92 -48.61 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.99 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.93 69.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.408 ' O ' ' CB ' ' D' ' 52' ' ' ALA . 28.6 m -90.65 89.09 7.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 1.0 109.838 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 51' ' ' THR . . . 169.44 -23.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.37 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 4.2 p -110.64 29.98 7.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.981 0.419 . . . . 1.0 110.482 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 32.8 p 52.51 70.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -124.12 -66.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.717 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.01 53.13 31.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.429 ' OH ' ' OD1' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -59.9 -48.76 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.321 . . . . 1.0 110.518 -179.06 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.7 29.72 1.03 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.02 -43.33 99.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -140.93 169.03 18.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.917 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -141.09 111.55 6.62 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.712 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.75 156.2 63.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.747 1.632 . . . . 1.0 112.491 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.444 ' O ' ' OE2' ' D' ' 66' ' ' GLU . 1.8 t -80.06 -142.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.106 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.429 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 26.5 m -113.34 -48.1 2.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.751 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.6 ' C ' ' H ' ' D' ' 67' ' ' GLY . 49.9 tp10 -58.62 -20.77 50.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.095 0.474 . . . . 1.0 109.9 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' D' ' 63' ' ' VAL . 0.6 OUTLIER -75.74 27.52 0.11 Allowed 'General case' 0 C--O 1.265 1.873 0 CA-C-O 123.543 1.64 . . . . 1.0 109.13 178.336 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.44 61.62 2.41 Favored Glycine 0 C--O 1.211 -1.287 0 CA-C-N 114.066 -1.425 . . . . 1.0 109.989 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 61.0 ttm-85 -25.18 -29.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.486 0.643 . . . . 1.0 111.42 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 72.5 mmtt -56.86 -14.27 3.32 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.659 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.2 t -62.31 -47.32 93.64 Favored 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.55 85.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.29 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.44 -37.77 81.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.141 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.49 -44.05 95.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.647 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.75 -46.57 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.276 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.14 -40.49 94.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.238 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.67 -43.25 99.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.794 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.63 -39.06 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.537 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.37 -42.85 97.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.641 -0.583 . . . . 1.0 111.641 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.43 -43.4 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.616 0.246 . . . . 1.0 111.237 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.63 -40.96 98.2 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.39 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 64.2 t -62.09 -48.07 90.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.294 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.35 -5.09 43.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.659 -0.416 . . . . 1.0 110.952 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.433 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -97.76 -37.01 10.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.739 0.304 . . . . 1.0 110.407 179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.533 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.6 tt -62.7 -41.79 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.424 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.36 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.533 ' H ' ' C ' ' D' ' 84' ' ' LEU . 57.7 m -56.88 -20.82 25.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.244 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.23 -36.73 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.347 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.4 -28.65 28.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.139 0.495 . . . . 1.0 110.062 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.78 -37.76 79.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.784 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE1' ' D' ' 93' ' ' PHE . . . -58.29 -44.68 88.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.259 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -5.79 49.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.209 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -58.79 -49.73 76.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.895 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -75.23 -28.86 60.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.825 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.47 -44.29 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.265 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . 0.449 ' O ' ' OE1' ' D' ' 99' ' ' GLU . 17.5 tpp180 -45.13 -28.36 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.99 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -48.79 -30.9 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 1.0 110.502 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.536 ' OE2' ' NH2' ' D' ' 100' ' ' ARG . 80.3 mm-40 -58.54 -23.39 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.908 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -82.53 -41.06 20.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.882 0.372 . . . . 1.0 110.624 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' D' ' 99' ' ' GLU . 51.4 mp0 -67.19 -41.75 85.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.621 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . 0.536 ' NH2' ' OE2' ' D' ' 97' ' ' GLU . 15.0 ttm180 -60.84 -46.72 89.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.161 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.35 -36.03 78.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.357 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.54 47.91 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 43.5 t60 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.67 179.791 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.67 -73.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -172.14 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.443 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 7.6 p80 -78.12 -24.25 47.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.495 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.9 -35.84 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.42 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.99 -38.91 92.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.085 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.42 -44.1 88.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.011 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.76 -39.15 87.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.256 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -65.46 -41.21 93.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 53.8 tttp -63.93 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.42 -36.04 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.894 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.45 -32.7 72.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -65.22 -37.81 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.424 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 6.6 mp0 -60.91 -42.54 98.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.5 tp -63.26 -42.39 99.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.737 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.37 -42.12 81.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.568 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -63.71 -40.02 95.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 1.0 111.381 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.4 -36.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.03 -41.16 91.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.34 -47.25 86.1 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.59 -33.2 72.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.158 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -45.7 85.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 77.7 p -60.06 -42.4 94.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -62.57 -60.51 3.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.66 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.16 -43.72 98.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.938 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 30' ' ' GLU . . . -61.15 -40.31 93.38 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.98 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.452 ' CG2' ' O ' ' A' ' 23' ' ' SER . 55.0 t -63.88 -48.36 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.454 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -72.44 -23.8 61.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.523 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.82 -49.18 49.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.316 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' OE1' ' O ' ' A' ' 26' ' ' ALA . 30.2 mp0 -68.65 -35.83 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -67.54 88.19 0.22 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.893 0.377 . . . . 1.0 110.962 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.65 6.25 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.63 -0.588 . . . . 1.0 111.63 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 154.05 39.49 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.85 150.61 39.16 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.253 1.969 . . . . 1.0 112.205 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 32.53 63.06 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.23 14.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 1.0 110.611 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.75 -65.09 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.628 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 51.0 tp -66.34 78.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.077 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.404 ' O ' ' OG ' ' A' ' 40' ' ' SER . 15.8 tt -121.04 79.56 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 1.0 110.107 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 44' ' ' ALA . 18.1 m -172.02 103.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.836 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.474 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 46.5 t80 -54.87 -50.11 87.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.882 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -60.03 -34.82 94.56 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.417 1.411 . . . . 1.0 112.729 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 60.8 m-20 -92.92 -22.72 19.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.68 -0.236 . . . . 1.0 111.146 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.78 82.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 1.0 110.391 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.452 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.2 tt -60.72 -36.09 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.115 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.479 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -63.07 -46.78 85.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.534 ' CD1' ' OH ' ' D' ' 57' ' ' TYR . 2.1 t90 -62.54 -41.22 98.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 45' ' ' ILE . 96.9 p -60.23 -35.8 76.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.074 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 43.6 t -60.47 -49.36 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.943 0.401 . . . . 1.0 110.733 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -75.64 -23.73 56.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.697 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.519 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 95.2 m -62.49 -45.88 91.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.099 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.59 75.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.421 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.526 ' C ' ' H ' ' A' ' 55' ' ' VAL . 76.5 p -73.92 -0.94 17.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 53' ' ' THR . 69.1 p 53.33 5.34 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.928 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.526 ' H ' ' C ' ' A' ' 53' ' ' THR . 7.7 p -66.4 -41.98 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.04 81.08 0.02 OUTLIER Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.441 ' HH ' ' C ' ' B' ' 58' ' ' GLY . 40.7 t80 -60.27 -45.51 93.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.855 0.359 . . . . 1.0 110.593 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.83 16.89 0.96 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.61 -46.18 90.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.944 0.402 . . . . 1.0 110.382 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -141.71 149.77 40.96 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.898 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -118.56 120.89 31.4 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.621 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 154.93 67.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.84 1.693 . . . . 1.0 112.57 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -60.82 -168.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.154 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.537 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 1.5 m -110.29 -62.21 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.101 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -41.63 -31.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.062 0.458 . . . . 1.0 110.425 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.875 ' O ' ' N ' ' A' ' 68' ' ' ARG . 97.2 mt-10 -138.48 -105.83 0.18 Allowed 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.317 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.67 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.478 1.435 0 O-C-N 124.476 1.11 . . . . 1.0 114.438 177.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.875 ' N ' ' O ' ' A' ' 66' ' ' GLU . 33.7 ttm180 -70.78 -45.44 64.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.411 ' N ' ' O ' ' A' ' 66' ' ' GLU . 27.8 tptp -62.39 -40.93 98.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.28 -45.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.82 81.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -49.2 -50.41 38.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.53 -40.63 95.96 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.05 -45.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.222 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.96 -39.67 95.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -60.25 -42.14 94.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.52 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -40.29 94.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.483 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 -41.53 93.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.55 -43.78 98.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 1.0 110.274 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 84' ' ' LEU . 97.2 mt-10 -65.28 -44.7 87.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.581 -0.447 . . . . 1.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.4 t -63.62 -47.72 90.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.758 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -68.33 -28.95 67.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.981 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.87 -25.46 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.281 . . . . 1.0 110.888 -179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 80' ' ' GLU . 4.7 tt -63.65 -42.01 98.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.568 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.4 m -49.16 -22.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.253 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 54.0 m -36.55 -24.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.216 0.531 . . . . 1.0 110.566 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -59.57 -41.74 90.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.789 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -78.55 -21.05 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 1.0 110.969 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' A' ' 89' ' ' LEU . 6.7 mp -66.32 -38.54 87.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -67.38 -62.49 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 1.0 111.588 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -46.19 -9.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.321 -179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' ALA . 83.3 m-20 -58.51 -50.01 75.31 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.831 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 1.9 p90 -69.79 -30.18 67.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.105 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 89.6 t -59.5 -42.29 87.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.385 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -53.07 -21.45 4.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.704 0.288 . . . . 1.0 111.057 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -54.61 -32.94 59.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.783 0.325 . . . . 1.0 110.616 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.41 -41.78 81.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.896 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.42 -34.59 76.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.449 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.7 -30.12 71.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.491 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -58.56 -45.09 89.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.73 -37.85 85.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 1.0 110.449 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.67 9.75 60.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.066 -0.969 . . . . 1.0 110.561 179.795 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.416 ' CB ' ' NE2' ' B' ' 4' ' ' HIS . . . -82.02 172.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.669 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 3' ' ' ASP . 5.5 p-10 -63.8 -36.22 83.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.951 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.609 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.2 p80 -80.57 -32.58 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 1.0 110.501 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -42.87 91.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.009 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -64.95 -39.95 94.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.635 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.84 -40.63 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.973 0.416 . . . . 1.0 110.023 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.72 94.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.659 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -66.25 -37.85 86.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.26 -40.49 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.64 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.76 78.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.912 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.31 -38.84 92.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.415 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.63 -36.4 83.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.257 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -65.68 -33.56 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.07 -42.17 99.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.14 -39.32 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.932 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -61.61 -40.14 93.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 1.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -63.02 -41.82 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . 0.414 ' O ' ' OG ' ' B' ' 23' ' ' SER . 93.2 mt -60.61 -40.87 93.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -48.57 80.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.72 -39.42 84.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.918 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.76 82.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.315 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.414 ' OG ' ' O ' ' B' ' 19' ' ' LEU . 29.3 m -54.77 -46.59 74.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.445 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -66.54 -41.93 87.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.352 0.596 . . . . 1.0 110.043 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.52 64.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.941 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 11.6 p -69.82 -43.94 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.74 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -63.36 -43.87 96.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.736 -0.666 . . . . 1.0 110.775 -179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.75 81.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.224 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -88.41 -7.69 56.21 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.751 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -83.59 107.44 16.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.377 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.49 -3.02 53.68 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.535 -0.626 . . . . 1.0 111.535 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.58 149.64 46.84 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 110.25 -0.278 . . . . 1.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.51 142.42 26.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.161 1.907 . . . . 1.0 112.369 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.7 22.7 59.92 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.131 -0.787 . . . . 1.0 111.131 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.33 144.38 54.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.706 0.289 . . . . 1.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.54 -41.9 5.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.472 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.02 74.81 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.021 0.439 . . . . 1.0 110.577 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 pt -102.26 2.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.468 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' B' ' 41' ' ' TYR . 78.6 p -75.33 -120.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.664 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.508 ' N ' ' OG ' ' B' ' 40' ' ' SER . 0.5 OUTLIER 171.5 -58.87 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.125 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -57.91 -31.77 93.45 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.869 1.713 . . . . 1.0 112.576 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.498 ' CG ' ' NH2' ' B' ' 60' ' ' ARG . 3.4 p30 -91.69 0.35 57.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.653 0.263 . . . . 1.0 110.727 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.03 89.61 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.96 0.409 . . . . 1.0 110.233 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.0 tt -66.7 -42.02 88.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.949 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.571 ' CE2' ' O ' ' C' ' 64' ' ' THR . 6.2 t-105 -60.98 -46.33 91.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.263 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -61.43 -40.43 94.41 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 23.7 m -71.91 62.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.411 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.0 -50.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.153 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 56' ' ' GLY . 2.8 pp20? -66.99 -31.58 72.23 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.833 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.505 ' O ' ' SD ' ' B' ' 75' ' ' MET . 0.0 OUTLIER -59.22 -45.93 89.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.796 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.76 -27.17 62.81 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.816 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.422 ' O ' ' OG1' ' B' ' 54' ' ' THR . 31.9 p -89.33 4.52 48.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.641 0.258 . . . . 1.0 110.855 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 54' ' ' THR . 11.7 p 56.34 76.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.611 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -147.0 -82.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.693 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.493 ' N ' ' OE1' ' B' ' 50' ' ' GLU . . . 72.94 77.87 0.56 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -60.97 -45.03 96.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 1.0 111.057 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . 0.441 ' C ' ' HH ' ' A' ' 57' ' ' TYR . . . 138.55 27.62 0.28 Allowed Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -63.9 -48.27 77.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 1.0 110.861 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' CG ' ' B' ' 43' ' ' ASP . 2.2 mpt_? -114.79 -167.41 1.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.133 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 17.5 t80 -164.32 78.84 1.46 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.599 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.56 156.19 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.531 1.487 . . . . 1.0 111.998 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.463 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 31.8 m -103.78 -149.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' THR . . . . . . . . . . . . . 22.3 m -96.81 -38.85 9.7 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.632 -0.258 . . . . 1.0 110.842 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.0 tm-20 -56.19 -35.41 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.1 OUTLIER -74.19 26.82 0.08 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-O 123.768 1.747 . . . . 1.0 109.844 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.66 65.91 1.09 Allowed Glycine 0 C--O 1.217 -0.949 0 CA-C-N 113.62 -1.627 . . . . 1.0 111.449 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.544 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -24.82 -31.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.061 0.931 . . . . 1.0 110.897 -178.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' B' ' 67' ' ' GLY . 60.5 mttp -45.14 -23.85 0.2 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 67' ' ' GLY . 72.5 t -63.57 -47.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 C-N-CA 119.748 -0.781 . . . . 1.0 109.977 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.09 82.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.17 -39.29 92.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.016 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -47.26 -54.66 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 85.8 t -65.96 -42.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 1.0 111.34 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' B' ' 51' ' ' THR . 5.6 tpp -56.73 -47.97 78.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.493 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.42 -41.07 85.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.537 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.51 74.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.688 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.31 97.81 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.438 -0.665 . . . . 1.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.38 -25.11 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.089 -0.244 . . . . 1.0 111.37 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -72.16 -53.19 13.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 1.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 6.9 m -61.66 -47.09 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.355 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -63.63 -38.51 91.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.844 -179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.62 96.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.568 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.507 ' C ' ' H ' ' B' ' 86' ' ' THR . 7.2 tt -63.96 -41.74 97.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 63.5 t -51.47 -11.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 70.7 m -60.8 -38.73 86.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -38.91 -62.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.974 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.12 20.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.398 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 86' ' ' THR . 55.7 mt -98.3 -4.11 35.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -93.17 -25.16 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.622 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.05 -4.67 58.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.586 -0.733 . . . . 1.0 110.04 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 92' ' ' ASP . 11.6 p-10 -57.43 -47.98 80.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 8.2 p90 -67.51 -30.79 70.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 1.0 111.308 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.99 -44.38 94.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.366 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -65.91 -21.9 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.656 ' NH1' HH21 ' B' ' 100' ' ' ARG . 68.8 ttp85 -58.78 -42.98 90.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.109 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.83 -57.26 6.67 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.229 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' B' ' 101' ' ' ARG . 14.6 pt-20 -67.04 -33.38 75.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 1.0 110.723 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -61.49 -44.69 96.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.487 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.656 HH21 ' NH1' ' B' ' 96' ' ' ARG . 16.4 ttm105 -70.15 -43.19 71.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.578 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 98' ' ' GLU . 89.4 mtt180 -107.21 117.39 33.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.319 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.6 -21.81 13.92 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.533 179.806 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' SER . . . . . 0.53 ' O ' ' N ' ' C' ' 3' ' ' ASP . 9.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' C' ' 4' ' ' HIS . . . 43.09 17.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.863 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' C' ' 1' ' ' SER . 97.1 m-20 56.76 -73.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.735 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' C' ' 2' ' ' ALA . 33.2 p80 -54.37 -42.6 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.191 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.6 tt0 -64.52 -34.29 77.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.722 0.296 . . . . 1.0 110.633 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -60.78 -45.68 93.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 1.0 109.916 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.57 -42.88 98.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.072 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.09 94.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.429 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -65.0 -42.62 94.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.01 -35.53 81.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.29 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.87 83.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.85 -36.81 85.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.36 -35.24 80.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 1.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -64.77 -36.32 83.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.538 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 42.9 tp -62.42 -40.94 98.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.539 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -59.28 -38.84 81.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -39.69 93.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.804 0.335 . . . . 1.0 111.018 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.19 -33.77 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 92.3 mt -61.75 -41.83 98.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.148 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.424 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -62.45 -46.23 89.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.878 -0.415 . . . . 1.0 109.878 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.51 -39.84 77.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.252 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.96 -36.4 83.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 86.6 p -60.0 -46.16 90.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.68 -179.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' C' ' 28' ' ' GLU . 14.8 tmtt? -66.41 -37.18 84.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.508 . . . . 1.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' C' ' 29' ' ' ALA . 14.5 mptt -70.26 -40.99 74.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.481 . . . . 1.0 109.927 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.04 66.81 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.102 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 10.7 p -64.6 -43.15 96.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.07 0.462 . . . . 1.0 109.962 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . 0.526 ' OE1' ' NZ ' ' C' ' 24' ' ' LYS . 82.9 tt0 -66.58 -35.14 79.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.319 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -58.01 -26.9 62.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.84 -37.62 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -70.85 101.58 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.745 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . 0.444 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 125.96 -22.53 6.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.64 143.93 27.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 97.4 Cg_endo -75.87 138.73 21.34 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.976 1.784 . . . . 1.0 112.391 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 37.07 13.08 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.02 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 1.0 110.64 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -149.32 -39.95 0.15 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 40' ' ' SER . 0.5 OUTLIER -71.45 12.49 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.021 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.527 ' H ' ' C ' ' C' ' 37' ' ' ALA . 21.3 tt -46.5 -13.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.535 ' H ' ' C ' ' C' ' 38' ' ' LEU . 5.4 m -65.5 146.17 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.316 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.441 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 9.8 m-85 -102.36 -63.66 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.441 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 24.4 Cg_endo -59.35 -34.89 97.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.884 1.722 . . . . 1.0 112.256 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -83.54 -7.56 59.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.203 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.1 89.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.749 0.309 . . . . 1.0 110.917 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 9.9 tt -64.05 -32.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.578 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -46.43 87.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.314 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 14.0 t90 -62.05 -40.0 94.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.354 -0.538 . . . . 1.0 109.775 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -59.17 -36.74 75.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.126 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.23 -48.22 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.418 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.0 pt-20 -72.3 -26.82 62.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.459 -0.496 . . . . 1.0 110.949 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 94.4 m -63.47 -50.11 70.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.548 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.47 -26.08 64.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.136 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.499 ' C ' ' H ' ' C' ' 55' ' ' VAL . 39.3 p -88.44 -0.07 56.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' C' ' 53' ' ' THR . 18.7 p 55.88 6.06 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.671 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.499 ' H ' ' C ' ' C' ' 53' ' ' THR . 64.2 t -64.89 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.89 58.08 6.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.395 -1.082 . . . . 1.0 110.395 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 1.7 t80 -59.99 -48.83 80.08 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 164.31 -99.74 0.17 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . 0.444 ' OD1' ' NE ' ' C' ' 60' ' ' ARG . 44.4 t0 51.58 -80.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 1.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' C' ' 58' ' ' GLY . 12.9 mmt180 -118.64 -167.99 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.47 ' CE1' ' CB ' ' C' ' 37' ' ' ALA . 26.2 p90 -160.1 129.49 3.24 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.644 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.69 161.86 44.27 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.802 1.668 . . . . 1.0 111.976 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 0.5 OUTLIER -86.45 -152.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.003 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.571 ' O ' ' CE2' ' B' ' 46' ' ' TRP . 19.6 m -112.15 -73.28 0.68 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' C' ' 64' ' ' THR . 78.9 tt0 -32.17 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.15 0.5 . . . . 1.0 111.125 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 78.1 mm-40 -138.96 -101.62 0.17 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.524 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.58 -56.07 0.0 OUTLIER Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.792 1.308 . . . . 1.0 114.415 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.9 ttm-85 -71.41 -70.19 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.282 -0.459 . . . . 1.0 110.28 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -46.1 -38.39 8.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.39 -44.77 86.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.262 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.83 82.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.055 0.455 . . . . 1.0 110.07 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -48.89 -48.89 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -65.59 -39.31 91.46 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.524 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.66 -45.68 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.39 -40.67 97.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.927 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -61.62 -38.15 86.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.708 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.34 83.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.348 . . . . 1.0 110.39 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.45 -42.2 89.59 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.08 -43.15 95.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 1.0 110.72 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.5 -42.38 95.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.01 -48.37 86.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.1 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -66.01 -39.88 90.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.069 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -71.18 -28.18 64.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.847 0.356 . . . . 1.0 110.773 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.59 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.4 tt -63.93 -38.96 92.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.711 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 1.8 m -51.97 -4.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.82 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.59 ' H ' ' C ' ' C' ' 84' ' ' LEU . 53.3 m -49.28 -38.9 28.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.936 0.398 . . . . 1.0 109.974 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -47.47 -18.31 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.461 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' C' ' 86' ' ' THR . . . -105.85 -14.07 15.33 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.725 0.297 . . . . 1.0 110.797 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' C' ' 86' ' ' THR . 86.7 mt -84.93 -51.84 6.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.587 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -56.91 -46.86 81.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.064 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.6 OUTLIER -77.63 -4.43 45.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.503 -179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -56.86 -48.59 77.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.451 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 14.6 p90 -73.42 -40.09 64.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . 0.49 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 92.6 t -43.56 -27.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.732 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -60.87 -22.82 64.66 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.905 -0.318 . . . . 1.0 111.247 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -63.09 -37.38 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 1.0 110.591 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.19 -33.09 75.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.698 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' C' ' 100' ' ' ARG . 98.5 mt-10 -106.64 -176.36 3.05 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 66.4 -56.14 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.532 0.52 . . . . 1.0 110.613 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . 0.577 ' NH2' ' CZ ' ' C' ' 101' ' ' ARG . 70.9 ttp85 -59.38 -43.67 92.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . 0.577 ' CZ ' ' NH2' ' C' ' 100' ' ' ARG . 1.8 mpt_? -64.42 -36.95 85.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.209 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.5 23.46 33.8 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.447 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.319 -0.623 . . . . 1.0 109.319 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . 44.07 88.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 1.0 110.622 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.42 -39.78 95.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.751 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.485 ' NE2' HH21 ' D' ' 95' ' ' ARG . 56.4 p-80 -60.02 -46.15 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.056 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.437 ' N ' ' CG ' ' D' ' 4' ' ' HIS . 81.3 tt0 -62.87 -39.43 94.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.862 0.363 . . . . 1.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -63.12 -40.71 98.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.455 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -60.19 -39.82 87.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.966 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.45 99.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.711 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -66.2 -38.67 88.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -62.62 -34.88 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.627 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.95 74.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -36.8 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.506 -0.315 . . . . 1.0 110.732 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.54 -33.21 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.416 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -40.97 97.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -53.14 -42.93 66.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.356 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -62.15 -38.98 91.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.42 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.48 -44.03 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.673 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . 0.407 ' CD1' ' C ' ' D' ' 19' ' ' LEU . 0.3 OUTLIER -61.17 -46.75 89.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.18 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.48 -27.93 69.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.13 -46.33 88.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.913 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.15 -40.65 94.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.152 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -62.78 -34.01 76.36 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.374 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -85.93 -44.24 12.54 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.607 -0.269 . . . . 1.0 110.994 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.85 68.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.281 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.505 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 4.6 p -60.12 -46.87 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.829 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.505 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 44.6 tp10 -69.24 -41.24 77.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.696 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.56 -24.89 50.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.24 179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.471 ' O ' ' N ' ' D' ' 32' ' ' GLY . 30.9 mm-40 -97.32 -39.73 9.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.0 111.203 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -59.82 79.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.159 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 128.86 21.85 1.33 Allowed Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.531 -0.628 . . . . 1.0 111.531 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.92 153.37 40.16 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 110.289 -0.263 . . . . 1.0 110.289 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . 0.553 ' C ' ' H ' ' D' ' 36' ' ' ALA . 79.2 Cg_endo -74.55 139.22 25.27 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.101 1.867 . . . . 1.0 111.904 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 69.82 -23.87 0.41 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . 0.553 ' H ' ' C ' ' D' ' 34' ' ' PRO . . . 43.03 -170.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 1.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . 175.43 -48.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 50.9 tp -116.35 119.68 36.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.121 0.486 . . . . 1.0 110.278 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' D' ' 40' ' ' SER . 37.3 pt -141.72 169.12 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 78.99 137.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.55 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -72.81 -46.42 8.98 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.852 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.2 Cg_endo -59.11 -30.77 94.08 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.571 1.514 . . . . 1.0 112.234 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.537 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.4 m-20 -91.65 -33.96 14.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.87 76.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.845 0.355 . . . . 1.0 110.752 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 9.6 tt -64.26 -36.72 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.373 179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . 0.547 ' C ' HH11 ' A' ' 68' ' ' ARG . 0.4 OUTLIER -65.02 -46.02 83.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . 0.501 ' CB ' HH21 ' D' ' 60' ' ' ARG . 2.1 t90 -62.05 -38.32 88.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 1.5 m -61.82 -37.82 85.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.822 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 48.2 t -59.71 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 120.75 0.31 . . . . 1.0 110.991 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -68.45 -34.16 75.48 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.005 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -61.96 -46.54 88.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.556 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.56 69.28 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.424 ' O ' ' OG1' ' D' ' 54' ' ' THR . 66.5 p -90.05 4.44 50.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.369 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' D' ' 53' ' ' THR . 27.5 p 52.82 69.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -133.41 -59.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . 0.549 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 71.85 -59.15 1.35 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.534 ' OH ' ' CD1' ' A' ' 47' ' ' TRP . 0.5 OUTLIER 70.77 -37.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 1.0 110.538 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 117.07 11.11 9.27 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -61.42 -52.2 65.59 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.353 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.688 ' NH2' HH12 ' A' ' 68' ' ' ARG . 0.1 OUTLIER -145.78 144.27 30.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.762 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 13.2 p90 -136.95 122.54 13.09 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.56 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.18 -171.19 0.56 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.983 1.789 . . . . 1.0 111.898 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.597 ' CG2' ' H ' ' D' ' 64' ' ' THR . 8.3 p -122.26 -179.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.597 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 97.1 m -62.3 -44.97 95.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.042 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' D' ' 67' ' ' GLY . 64.2 tt0 -52.2 -31.24 30.87 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.273 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -74.27 15.76 0.3 Allowed 'General case' 0 C--O 1.255 1.387 0 CA-C-O 124.482 2.087 . . . . 1.0 107.958 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.75 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 48.44 61.33 5.15 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 49.2 ttt85 -25.3 -27.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.535 0.668 . . . . 1.0 111.254 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.1 tptm -53.66 -21.93 7.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' D' ' 67' ' ' GLY . 75.7 t -60.54 -44.43 96.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 119.979 -0.688 . . . . 1.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . 0.522 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -68.69 -48.02 64.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.982 0.42 . . . . 1.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.41 -64.29 0.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.832 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' D' ' 74' ' ' VAL . 10.3 pt20 -54.43 -43.25 71.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.428 ' N ' ' CG ' ' D' ' 73' ' ' GLN . 86.7 t -61.56 -48.15 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.687 -0.405 . . . . 1.0 111.176 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mtp -63.71 -38.07 89.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.462 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 32.0 ttmt -58.81 -42.25 88.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.568 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.31 -40.19 89.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 1.0 110.373 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.49 -41.11 90.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.34 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.099 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . 0.492 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 3.2 mp0 -67.65 -40.8 84.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 1.0 110.751 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 47.2 t -63.2 -47.61 91.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.283 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.66 -9.31 58.06 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.622 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.42 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -96.34 -29.63 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.071 -0.344 . . . . 1.0 110.071 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.3 tt -63.3 -42.88 99.09 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.243 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.04 -6.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.856 0.36 . . . . 1.0 110.163 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.52 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -60.66 -20.07 59.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.293 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.66 22.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.668 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.61 -39.11 93.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.2 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.22 -40.87 96.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.038 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.532 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -64.91 -37.19 86.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.266 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.524 ' OG1' ' CG ' ' C' ' 93' ' ' PHE . 1.0 OUTLIER -78.61 -4.75 50.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.108 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.01 -52.09 66.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.212 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 10.4 p90 -63.9 -32.23 73.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.51 -42.3 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.327 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . 0.485 HH21 ' NE2' ' D' ' 4' ' ' HIS . 95.7 mtt-85 -56.68 -24.29 47.88 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.113 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -58.88 -8.71 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 1.0 110.146 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' D' ' 95' ' ' ARG . 72.1 mm-40 -85.7 -1.44 57.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.245 -178.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.56 -23.61 2.07 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.814 0.34 . . . . 1.0 110.385 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.51 -41.41 93.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -61.39 -48.83 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.461 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -69.67 -36.59 76.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.465 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.64 24.66 27.53 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.641 179.893 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 4' ' ' HIS . . . -164.31 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 t70 68.92 -37.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.767 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 20.7 p80 -66.64 -40.27 88.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.792 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 17.5 pt-20 -65.67 -36.32 83.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.42 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -39.63 94.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.42 -35.33 80.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.222 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.53 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.974 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.61 -37.25 86.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.293 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.41 -38.78 90.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.733 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.72 86.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.31 -38.26 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.415 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.76 -34.16 77.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.343 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.83 -33.93 76.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.33 -42.31 99.28 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.528 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.38 -40.12 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.212 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.03 -42.5 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.0 110.81 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.88 -41.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.448 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 93.5 mt -59.87 -41.31 91.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.245 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.443 ' O ' ' OG ' ' A' ' 23' ' ' SER . 80.7 mm-40 -61.47 -46.57 89.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.914 0.388 . . . . 1.0 110.0 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.68 -35.2 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.73 88.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 78.1 p -59.93 -43.71 94.76 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.83 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -66.46 -36.58 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.369 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.32 -46.51 60.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.33 -0.548 . . . . 1.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.52 76.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 7.4 p -62.49 -46.25 96.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.085 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.473 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 47.2 tp10 -66.4 -43.27 86.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.47 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.69 94.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -73.23 -34.14 65.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.799 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -66.92 121.55 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 1.0 110.601 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 8.02 63.3 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.09 140.97 25.82 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.081 1.854 . . . . 1.0 111.982 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 6.91 60.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.58 106.49 0.05 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.863 0.363 . . . . 1.0 111.067 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.91 -29.83 21.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.528 ' CD1' HH11 ' A' ' 60' ' ' ARG . 42.3 tp -101.16 78.26 1.89 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.381 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.3 pt -103.75 31.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.308 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -126.17 121.71 33.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.985 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.452 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 18.4 t80 -74.74 -52.02 3.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.632 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.6 Cg_endo -59.94 -30.66 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.343 1.362 . . . . 1.0 112.434 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.62 -3.73 54.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.576 0.227 . . . . 1.0 111.054 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.1 -40.06 92.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.412 HD13 HG23 ' A' ' 45' ' ' ILE . 7.6 tt -66.69 -32.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.291 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.401 ' NE1' ' CB ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -58.84 -45.72 89.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.174 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -73.42 -24.45 60.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -70.15 -41.61 73.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.359 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 ' CG1' HH12 ' B' ' 68' ' ' ARG . 68.2 t -60.74 -47.93 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.83 0.348 . . . . 1.0 110.911 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.453 ' O ' ' OG1' ' A' ' 53' ' ' THR . 16.7 pt-20 -67.29 -31.19 71.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.267 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 89.3 m -61.34 -46.37 90.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.534 -0.466 . . . . 1.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.31 -26.61 61.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.547 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.524 ' HG1' ' CG1' ' A' ' 55' ' ' VAL . 44.6 p -86.08 7.34 25.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p 40.13 33.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.262 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.524 ' CG1' ' HG1' ' A' ' 53' ' ' THR . 11.3 p -95.83 -45.25 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.803 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.43 ' N ' ' CG1' ' A' ' 55' ' ' VAL . . . 49.38 83.72 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -46.76 89.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.755 0.312 . . . . 1.0 110.667 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.43 3.72 2.36 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.26 -50.61 72.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.0 110.507 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.528 HH11 ' CD1' ' A' ' 38' ' ' LEU . 1.4 mtt-85 -136.15 149.86 48.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -141.87 130.6 12.12 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.503 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 -172.07 0.72 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.932 1.755 . . . . 1.0 112.215 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.644 ' CG2' ' H ' ' A' ' 64' ' ' THR . 8.8 p -130.39 -144.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.046 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.644 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 79.1 m -105.04 -41.45 5.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.669 0.271 . . . . 1.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.598 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.4 tp10 -60.82 -38.81 86.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.015 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.421 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -74.61 34.54 0.1 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 124.495 2.093 . . . . 1.0 109.943 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.71 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.19 62.52 1.51 Allowed Glycine 0 C--O 1.213 -1.214 0 CA-C-N 113.323 -1.762 . . . . 1.0 110.833 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.474 ' HE ' ' CG ' ' D' ' 50' ' ' GLU . 58.6 ttt85 -25.08 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 117.698 0.749 . . . . 1.0 110.927 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.71 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.5 mmtt -48.72 -16.38 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.005 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' GLY . 48.6 t -60.42 -45.47 96.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 119.096 -1.041 . . . . 1.0 110.08 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.27 79.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.643 0.259 . . . . 1.0 111.523 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' N ' ' OE1' ' A' ' 72' ' ' GLU . 1.5 mp0 -58.21 -43.04 87.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.052 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.33 -42.52 98.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.271 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.99 -45.15 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.117 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.427 ' SD ' ' CG1' ' D' ' 55' ' ' VAL . 76.1 mtm -62.03 -40.13 94.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.564 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -41.58 98.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.229 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.5 77.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.426 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.97 -40.49 97.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 1.0 110.696 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 90.5 mt -71.35 -7.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.501 0.191 . . . . 1.0 111.385 -179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -96.08 -51.32 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.833 0.349 . . . . 1.0 110.872 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 m -61.61 -50.56 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.067 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -65.03 -40.58 95.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.809 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.443 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.01 -37.23 86.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.724 0.297 . . . . 1.0 110.977 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.601 ' C ' ' H ' ' A' ' 86' ' ' THR . 3.6 tp -62.59 -44.94 95.06 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.905 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 83.4 t -54.38 -3.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.414 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.601 ' H ' ' C ' ' A' ' 84' ' ' LEU . 45.4 m -58.58 -42.1 87.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.84 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.476 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -41.44 -63.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.115 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.94 85.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.295 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.87 -43.94 97.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -66.12 -34.2 77.52 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.199 0.523 . . . . 1.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -76.19 -3.64 37.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.414 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.27 -48.94 77.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.434 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.0 p90 -65.47 -36.05 82.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 1.0 111.387 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.525 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -49.44 -28.78 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.229 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -71.52 -21.36 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.593 -0.276 . . . . 1.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' NH2' ' OE2' ' A' ' 97' ' ' GLU . 19.0 ptt-85 -50.91 -40.67 57.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.398 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' A' ' 99' ' ' GLU . 97.5 mt-10 -75.65 168.85 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.096 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 57.84 0.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.615 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 97' ' ' GLU . 80.5 tt0 -101.5 -31.72 10.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.212 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.62 -45.41 94.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.16 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -79.9 -17.37 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.455 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.83 14.53 80.78 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.904 -1.046 . . . . 1.0 110.625 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.558 ' HG ' ' H ' ' B' ' 2' ' ' ALA . 47.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.558 ' H ' ' HG ' ' B' ' 1' ' ' SER . . . -173.08 -109.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.487 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -132.98 -45.32 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.53 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.523 ' H ' ' ND1' ' B' ' 4' ' ' HIS . 25.4 p-80 -73.51 -31.24 63.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.673 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.02 -39.26 90.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.87 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -64.89 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.653 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.41 -43.73 88.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.5 95.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.52 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.84 -40.11 83.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.358 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.33 -34.55 78.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.75 72.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.34 -36.52 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.46 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.7 -36.27 83.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.0 110.347 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -65.22 -33.08 75.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.403 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.17 -41.67 98.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.554 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.98 -38.92 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.767 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.89 -39.65 92.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 1.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.07 -42.76 97.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.696 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 97.0 mt -60.54 -41.05 93.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.445 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.7 mm-40 -59.12 -47.89 83.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 1.0 109.887 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.13 -38.36 78.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.787 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.42 90.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 88.0 p -55.44 -43.55 75.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.234 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.58 -35.33 80.51 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.321 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -72.87 -43.41 62.59 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.196 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' B' ' 30' ' ' GLU . . . -59.27 -50.93 72.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.383 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 9.3 p -62.69 -46.47 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.55 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.479 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 45.4 tp10 -67.48 -43.97 79.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.796 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.71 82.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.329 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 26' ' ' ALA . 17.6 mm-40 -64.77 -40.27 94.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.749 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -64.43 131.49 47.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.354 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.14 1.87 81.24 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.24 146.84 33.51 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.82 -0.223 . . . . 1.0 110.438 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.56 142.46 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.322 2.015 . . . . 1.0 112.327 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.75 19.59 69.49 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.38 81.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 1.0 110.604 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.06 69.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.511 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.417 ' CD2' ' C ' ' B' ' 38' ' ' LEU . 6.3 tt -89.81 119.12 29.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.27 0.557 . . . . 1.0 110.176 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.457 ' O ' ' CB ' ' B' ' 40' ' ' SER . 39.1 pt -143.11 168.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.326 -0.852 . . . . 1.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.1 t 78.78 129.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.0 111.012 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 22.4 t80 -72.76 -46.78 9.13 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.026 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 26.0 Cg_endo -58.61 -31.13 93.98 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.358 1.372 . . . . 1.0 112.94 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -96.61 -11.79 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.869 0.366 . . . . 1.0 110.655 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.66 91.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.274 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.03 -30.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.024 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.468 ' CZ2' ' CB ' ' C' ' 68' ' ' ARG . 7.7 t90 -59.99 -49.36 77.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.869 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.3 OUTLIER -68.29 -34.05 75.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.303 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . 0.449 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.3 p -67.69 54.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.706 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -147.22 -52.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.654 -0.248 . . . . 1.0 110.77 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.425 ' O ' ' OG1' ' B' ' 53' ' ' THR . 17.4 pt-20 -66.71 -32.8 74.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 1.0 110.613 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -45.15 82.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.145 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -26.3 60.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.028 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 50' ' ' GLU . 51.0 p -88.21 -1.43 58.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.694 0.283 . . . . 1.0 110.795 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.6 p 51.68 64.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 21.6 m -133.66 -47.9 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.58 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.21 82.08 0.02 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.19 -42.0 98.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.707 0.289 . . . . 1.0 111.084 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.5 0.47 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.318 -0.713 . . . . 1.0 111.318 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' C' ' 61' ' ' TYR . 96.7 m-20 -48.05 -66.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 1.0 110.658 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -138.39 161.09 37.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.978 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -146.92 138.14 13.03 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.91 -172.33 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.815 1.677 . . . . 1.0 112.081 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.442 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 1.9 t -128.84 -143.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.019 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.429 ' H ' ' CG1' ' B' ' 63' ' ' VAL . 4.3 m -110.96 -42.04 4.08 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.664 0.269 . . . . 1.0 110.934 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.2 tp10 -66.2 -34.4 77.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.442 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.44 33.63 0.11 Allowed 'General case' 0 C--O 1.266 1.959 0 CA-C-O 123.961 1.838 . . . . 1.0 109.744 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.72 63.29 1.04 Allowed Glycine 0 C--O 1.214 -1.146 0 CA-C-N 113.393 -1.73 . . . . 1.0 111.175 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.489 HH12 ' CG1' ' A' ' 49' ' ' VAL . 59.6 ttp85 -23.57 -33.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.151 0.975 . . . . 1.0 110.763 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.7 mttp -48.29 -17.79 0.17 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' B' ' 67' ' ' GLY . 52.2 t -61.65 -49.29 84.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.97 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.94 64.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.5 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.28 -41.76 76.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.029 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.76 -43.02 99.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.307 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.94 -46.89 92.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 74.4 mtm -62.62 -43.33 99.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.637 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -65.43 -42.53 92.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.156 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.86 93.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.15 -42.41 94.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.0 -43.75 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.704 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' B' ' 84' ' ' LEU . 81.0 mm-40 -59.01 -45.58 90.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.429 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.46 -49.09 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -70.89 -22.77 62.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.582 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.2 -22.29 19.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.301 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' B' ' 80' ' ' GLU . 6.8 tt -63.98 -40.85 97.31 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.723 0.297 . . . . 1.0 110.206 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' B' ' 87' ' ' ALA . 11.1 m -50.58 -27.85 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.749 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.415 ' C ' ' O ' ' B' ' 85' ' ' VAL . 15.6 m -33.36 -31.19 0.01 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.449 0.642 . . . . 1.0 110.016 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -52.82 -57.35 10.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.651 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -65.02 -33.81 76.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.153 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 9.0 mp -60.04 -44.28 94.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 1.0 109.986 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.87 -19.25 60.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.925 -0.58 . . . . 1.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' THR . . . . . 0.534 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -98.82 -11.06 22.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.485 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.9 m-20 -62.56 -40.99 98.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.417 ' CD2' ' CB ' ' C' ' 90' ' ' ALA . 1.7 p90 -71.34 -29.27 64.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' B' ' 96' ' ' ARG . 91.4 t -60.8 -43.9 96.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.773 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -40.98 -22.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.679 0.276 . . . . 1.0 111.311 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' B' ' 94' ' ' VAL . 44.7 ptt85 -62.95 -37.25 86.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.11 -35.74 75.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.874 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.19 -36.32 83.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 1.0 110.453 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.49 -30.51 71.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -59.49 -44.31 93.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.622 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -77.21 -18.9 57.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.481 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.02 14.69 76.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.567 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.46 151.1 29.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.718 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' C' ' 4' ' ' HIS . 42.3 p-10 -65.4 -36.03 82.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.383 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 19.2 p80 -67.55 -38.94 84.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . 0.597 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.4 tt0 -63.11 -36.64 84.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.645 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.16 -40.23 95.29 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.136 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.62 -40.86 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.78 94.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.354 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.36 -32.54 74.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.366 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.23 -24.26 63.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.341 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.71 -54.2 21.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.806 0.336 . . . . 1.0 111.643 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.79 -30.51 70.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.28 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.8 -37.45 87.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.705 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.53 -36.9 85.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 1.0 110.192 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.66 -32.5 73.85 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.443 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.43 -47.47 81.81 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -64.93 -32.44 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 1.0 111.053 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 41.3 mt -60.17 -40.67 90.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.893 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.417 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -60.96 -43.55 98.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.77 -33.11 73.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.124 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.89 -41.39 97.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.647 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 77.4 p -61.67 -38.77 89.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.514 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -64.58 -74.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.301 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.64 -33.04 6.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.565 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.37 -52.56 61.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.471 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -67.17 -39.67 83.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.29 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -67.09 -32.43 73.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.877 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.01 -39.57 69.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.198 -179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' C' ' 38' ' ' LEU . 4.3 mt-10 -95.13 -136.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.61 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' C' ' 39' ' ' ILE . 35.6 mmt180 58.82 57.64 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.115 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.33 11.16 2.27 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.861 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.72 147.61 35.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.87 147.15 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.275 1.983 . . . . 1.0 111.921 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.0 14.81 61.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 141.67 57.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.706 0.289 . . . . 1.0 110.475 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.22 -21.81 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.567 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.0 tt -107.66 85.37 2.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.981 0.42 . . . . 1.0 109.917 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.525 ' O ' ' NH1' ' C' ' 31' ' ' ARG . 39.6 pt -114.37 35.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -134.52 140.9 46.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.767 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.448 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 16.9 t80 -85.3 -52.06 0.5 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.95 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.76 -32.37 95.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.394 1.396 . . . . 1.0 112.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.87 -3.76 57.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.622 -0.263 . . . . 1.0 111.101 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.89 94.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 1.0 110.639 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.435 ' O ' ' OG ' ' C' ' 48' ' ' SER . 8.3 tt -66.04 -32.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -46.74 84.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.754 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' C' ' 48' ' ' SER . 0.1 OUTLIER -66.25 -29.93 70.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.457 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 50.4 p -70.07 -9.3 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.973 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . 0.444 ' C ' ' H ' ' C' ' 51' ' ' THR . 25.6 t -90.3 -48.77 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.147 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.07 32.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.483 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' THR . . . . . 0.444 ' H ' ' C ' ' C' ' 49' ' ' VAL . 10.2 t -133.89 -41.05 0.84 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.504 0.193 . . . . 1.0 111.273 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.416 ' N ' ' CG2' ' C' ' 51' ' ' THR . . . -66.16 -14.82 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.053 -0.259 . . . . 1.0 110.771 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.445 ' O ' ' OG1' ' C' ' 54' ' ' THR . 71.0 p -98.96 8.4 45.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.937 0.399 . . . . 1.0 110.235 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.9 p 53.83 45.37 27.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.975 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -103.79 -44.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.739 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.29 73.26 0.27 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -44.28 96.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.599 0.237 . . . . 1.0 110.398 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.04 10.85 7.25 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.66 -49.24 78.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 1.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -147.72 162.11 39.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.846 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 t80 -163.77 136.48 4.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.39 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.75 161.4 46.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.727 1.618 . . . . 1.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' C' ' 66' ' ' GLU . 3.0 t -110.33 165.89 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.019 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 67' ' ' GLY . 21.5 m -41.17 -66.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.178 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -46.65 -17.74 0.05 Allowed 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 63' ' ' VAL . 18.0 mt-10 -101.01 27.57 5.95 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-O 124.481 2.086 . . . . 1.0 109.24 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . 0.661 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 39.27 64.11 1.02 Allowed Glycine 0 C--O 1.219 -0.819 0 CA-C-N 113.26 -1.791 . . . . 1.0 111.597 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 70' ' ' VAL . 0.3 OUTLIER -24.43 -37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.054 0.927 . . . . 1.0 110.186 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.661 ' N ' ' O ' ' C' ' 67' ' ' GLY . 99.0 mttt -43.24 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.46 -1.245 . . . . 1.0 109.758 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.7 t -60.51 -46.77 94.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 118.718 -1.193 . . . . 1.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.62 -45.67 51.55 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.769 0.319 . . . . 1.0 111.707 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.58 -42.01 99.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.106 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -58.03 -49.47 76.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.285 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.24 -43.4 84.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.391 . . . . 1.0 111.253 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 48.2 ttm -59.48 -40.07 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.728 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -60.77 -38.46 85.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.739 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.96 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.692 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.61 -39.74 97.0 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.173 -0.537 . . . . 1.0 111.834 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . 0.411 HD13 HG23 ' C' ' 79' ' ' ILE . 93.9 mt -62.64 -42.97 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.774 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.85 -40.27 96.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 53.3 t -63.68 -48.07 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.364 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -75.76 -8.08 55.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.343 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.53 -45.07 10.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.853 0.359 . . . . 1.0 110.446 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.456 ' C ' ' H ' ' C' ' 86' ' ' THR . 7.0 tt -63.21 -42.85 99.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.689 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.82 -11.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.667 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' THR . . . . . 0.456 ' H ' ' C ' ' C' ' 84' ' ' LEU . 25.4 m -63.76 -25.4 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.81 -28.57 61.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.376 179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.51 -13.28 34.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.3 -32.69 22.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.072 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.83 -37.89 89.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.587 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.59 -6.0 37.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.033 -0.53 . . . . 1.0 109.949 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -63.21 -43.9 96.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.06 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -84.62 -28.15 26.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.561 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.47 -42.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -51.83 -21.9 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.223 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . 0.455 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 24.0 ptt-85 -50.6 -44.79 57.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.591 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' C' ' 99' ' ' GLU . 8.4 pt-20 -86.7 162.56 17.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.553 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 72.83 -38.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.556 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' C' ' 97' ' ' GLU . 81.8 tt0 -65.85 -50.74 63.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.132 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . 0.43 HH22 ' NH2' ' C' ' 101' ' ' ARG . 73.5 ttp85 -66.59 -43.41 84.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.054 0.454 . . . . 1.0 110.46 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . 0.43 ' NH2' HH22 ' C' ' 100' ' ' ARG . 29.9 mmt180 -66.68 -36.79 83.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.505 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.64 18.81 29.12 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 66.8 t60 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.933 -1.032 . . . . 1.0 110.721 179.782 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.88 145.05 55.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.444 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 20.3 p80 -66.7 -40.07 88.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.1 tt0 -62.26 -38.42 89.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.495 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -61.09 -42.35 98.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.291 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.13 -41.13 97.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.47 94.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.807 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.9 -41.39 91.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.864 0.364 . . . . 1.0 110.367 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.81 -33.78 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.506 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.98 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.972 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.81 -36.3 80.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 1.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.02 -37.32 87.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -62.31 -34.83 77.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.234 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 43.3 tp -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.254 -0.579 . . . . 1.0 110.306 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -56.41 -33.92 66.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.366 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.12 -44.69 96.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.596 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -87.37 -37.01 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.654 0.264 . . . . 1.0 111.48 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 tp -60.9 -47.0 88.39 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . 0.446 ' O ' ' OG ' ' D' ' 23' ' ' SER . 70.5 mm-40 -63.53 -44.75 93.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.294 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -64.2 -29.86 70.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.43 -39.09 89.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.625 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 85.7 p -61.57 -43.76 98.27 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.602 -179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -64.82 -34.05 77.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.48 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' D' ' 29' ' ' ALA . 44.8 mmtm -78.2 -44.83 24.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.294 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -58.22 -49.14 78.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.43 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . 0.476 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 9.1 p -60.07 -45.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.526 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.476 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 11.0 tm-20 -68.13 -35.83 78.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.591 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -58.81 -51.96 67.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 14.0 mp0 -69.79 -32.27 70.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.589 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -50.22 103.35 0.05 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.051 0.453 . . . . 1.0 111.049 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.87 11.1 44.44 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.76 140.16 21.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 110.525 -0.176 . . . . 1.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.03 142.27 27.57 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.107 1.871 . . . . 1.0 112.299 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.0 26.42 63.23 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.65 140.91 56.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 1.0 110.791 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.81 -22.84 10.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.712 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' D' ' 30' ' ' GLU . 57.4 tp -104.7 121.1 42.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.925 0.393 . . . . 1.0 109.956 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' D' ' 40' ' ' SER . 34.2 pt -153.48 -164.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.372 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' SER . . . . . 0.452 ' O ' ' O ' ' D' ' 39' ' ' ILE . 1.3 m 58.26 141.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 1.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.412 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 7.1 m-85 -79.83 -58.42 0.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.99 -26.53 81.89 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.584 1.523 . . . . 1.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -87.98 -25.37 23.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.69 -39.53 94.54 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.693 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.43 -32.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.26 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -47.89 81.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -76.76 -22.96 53.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.424 ' C ' ' H ' ' D' ' 50' ' ' GLU . 6.7 t -62.21 -44.44 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.721 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.98 4.3 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 1.0 110.898 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . 0.474 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 50.6 mm-40 -103.22 -49.86 3.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.137 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' THR . . . . . 0.451 ' HG1' ' CG1' ' D' ' 74' ' ' VAL . 0.0 OUTLIER -63.67 -45.61 89.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.19 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -23.51 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 1.0 110.085 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 43.4 p -100.45 2.22 41.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.388 179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 61.6 p 45.83 70.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.452 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.427 ' CG1' ' SD ' ' A' ' 75' ' ' MET . 30.0 m -117.63 -42.75 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.591 -0.277 . . . . 1.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.16 63.18 4.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -45.51 93.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.692 0.282 . . . . 1.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 -1.64 7.15 Favored Glycine 0 N--CA 1.466 0.648 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.63 -47.99 83.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.546 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -142.9 151.49 41.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.711 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 27.4 p90 -145.56 137.68 13.33 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.568 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.71 161.69 44.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.253 1.968 . . . . 1.0 112.152 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.713 ' CG2' ' H ' ' D' ' 64' ' ' THR . 8.0 p -104.76 -130.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.0 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.713 ' H ' ' CG2' ' D' ' 63' ' ' VAL . 23.9 m -114.18 -51.33 2.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.636 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.7 tt0 -57.11 -30.51 64.43 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.603 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.66 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.1 pm0 -70.66 19.43 0.05 OUTLIER 'General case' 0 C--O 1.264 1.83 0 CA-C-O 123.651 1.691 . . . . 1.0 109.4 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.64 62.19 2.99 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' D' ' 67' ' ' GLY . 59.5 ttm-85 -26.22 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.831 0.816 . . . . 1.0 110.631 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' D' ' 67' ' ' GLY . 65.0 mttm -51.02 -24.14 3.53 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.525 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.603 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.7 t -63.17 -48.4 87.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 119.769 -0.772 . . . . 1.0 110.362 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.58 -37.07 76.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.657 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -64.05 -40.46 96.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.089 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -61.43 -47.38 86.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.672 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . 0.451 ' CG1' ' HG1' ' D' ' 51' ' ' THR . 7.2 p -66.96 -36.35 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.309 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 17.9 mtm -62.54 -42.7 99.7 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.092 -0.243 . . . . 1.0 111.438 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.48 -41.64 96.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.657 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.4 -40.81 95.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.506 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.44 -41.73 97.89 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.22 -43.33 98.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -63.46 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.563 -0.289 . . . . 1.0 111.132 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.27 -50.37 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.261 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.48 -39.86 85.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 1.0 110.476 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.552 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' D' ' 86' ' ' THR . 4.3 tt -60.92 -40.01 91.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.274 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 97.9 t -48.49 -10.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 1.0 110.389 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' D' ' 84' ' ' LEU . 22.6 m -49.28 -39.25 30.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.093 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -49.96 -17.94 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.392 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' D' ' 92' ' ' ASP . . . -104.87 -12.2 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.737 0.303 . . . . 1.0 110.252 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.5 mt -87.54 -64.73 1.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.36 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.13 -9.49 1.46 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.275 0.559 . . . . 1.0 109.944 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' D' ' 87' ' ' ALA . 0.5 OUTLIER -99.54 -1.12 39.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.44 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' D' ' 88' ' ' ALA . 97.5 m-20 -74.57 -39.17 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.658 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 30.7 p90 -84.86 -40.39 17.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 21.2 m -43.34 -36.72 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.8 0.333 . . . . 1.0 111.401 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' D' ' 98' ' ' GLU . 95.2 mtt-85 -57.14 -27.53 61.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -39.93 -35.98 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.676 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.514 ' OE2' ' NH2' ' D' ' 101' ' ' ARG . 48.7 tp10 -66.83 -39.19 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.39 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' D' ' 95' ' ' ARG . 79.7 mm-40 -96.53 -178.79 4.39 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 67.11 -46.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.855 0.722 . . . . 1.0 110.096 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . 0.498 ' H ' ' C ' ' D' ' 98' ' ' GLU . 9.0 tmm_? -63.82 -42.84 97.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.39 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . 0.514 ' NH2' ' OE2' ' D' ' 97' ' ' GLU . 99.6 mtt180 -64.19 -37.4 87.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.481 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.91 4.73 41.92 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.051 -0.976 . . . . 1.0 110.515 179.734 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.46 167.12 21.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.71 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.06 -45.56 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.544 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 4.0 p80 -67.3 -41.5 85.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.502 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.67 -46.02 87.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.705 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.05 -38.11 89.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.61 -38.22 90.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.197 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.52 94.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.233 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.03 -38.63 91.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.343 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.26 -41.68 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.82 85.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.996 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.91 -40.38 94.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.621 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.96 -38.15 87.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.447 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -65.6 -32.0 73.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.446 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.1 -44.81 95.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.826 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -60.69 -36.0 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.306 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.74 -40.77 96.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.087 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.25 -31.37 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.665 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.68 -42.12 98.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.14 -51.33 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.84 -37.46 86.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.204 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.35 83.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -59.48 -39.69 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.94 -55.1 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.612 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.68 -23.1 39.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.965 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 83.2 t -92.45 -50.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.929 0.395 . . . . 1.0 110.396 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.33 -42.32 93.03 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.604 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -34.73 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -78.98 -114.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 45.55 78.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.88 0.372 . . . . 1.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -6.76 41.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.12 136.14 57.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.295 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.24 140.96 25.4 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.971 1.781 . . . . 1.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . 64.27 22.13 66.97 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -60.96 -48.07 83.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.789 0.328 . . . . 1.0 110.758 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 58.89 0.6 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.697 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 36' ' ' ALA . 5.1 tt -131.48 114.59 15.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.78 0.324 . . . . 1.0 110.15 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.5 pt -157.96 54.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.122 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -153.48 118.19 5.0 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.856 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.481 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 47.6 m-85 -55.37 -50.33 87.36 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.119 -0.491 . . . . 1.0 112.028 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 28.8 Cg_endo -59.72 -34.08 96.22 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.546 1.497 . . . . 1.0 112.6 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -92.52 -8.11 45.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.676 0.274 . . . . 1.0 110.82 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.64 -45.14 94.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.0 110.386 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.417 ' CG2' ' N ' ' A' ' 46' ' ' TRP . 4.0 tt -69.41 -41.86 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.152 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.417 ' N ' ' CG2' ' A' ' 45' ' ' ILE . 3.3 t-105 -55.35 -43.13 74.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -66.16 -38.46 88.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.05 -24.58 67.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.249 -179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.03 -49.76 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.605 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -75.35 -24.02 57.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.462 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 m -62.5 -45.76 91.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.529 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' C ' ' H ' ' A' ' 54' ' ' THR . . . -62.13 -35.21 78.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.618 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 p -75.41 4.14 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 52' ' ' ALA . 18.7 p 41.5 73.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 1.0 111.17 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.9 p -139.05 -36.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.851 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.95 76.37 0.08 OUTLIER Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 1.0 110.745 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.52 17.67 0.2 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -63.42 -42.26 98.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 1.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mmt180 -127.98 -170.48 2.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 51.4 m-85 -162.18 88.51 1.44 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.002 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.37 156.14 65.24 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.905 1.737 . . . . 1.0 112.221 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.647 ' CG2' ' H ' ' A' ' 64' ' ' THR . 7.4 p -128.16 -171.77 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.221 0.534 . . . . 1.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.647 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 98.9 m -69.44 -43.85 72.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.8 tp10 -48.1 -49.52 31.54 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.532 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -80.79 35.55 0.37 Allowed 'General case' 0 C--O 1.258 1.511 0 CA-C-O 123.989 1.852 . . . . 1.0 109.242 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.52 66.67 0.92 Allowed Glycine 0 C--O 1.212 -1.22 0 CA-C-N 113.303 -1.771 . . . . 1.0 112.085 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' CG ' ' D' ' 59' ' ' ASP . 58.4 ttm-85 -24.24 -32.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.33 1.065 . . . . 1.0 111.15 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 67' ' ' GLY . 9.0 mtmp? -53.2 -16.48 1.25 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.81 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.2 t -63.36 -46.94 94.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 120.049 -0.661 . . . . 1.0 110.574 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -44.4 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.081 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -56.95 -43.29 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.349 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.2 -41.99 85.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.864 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.36 -45.13 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.177 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.45 -40.24 93.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.756 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -60.48 -42.63 96.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.321 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.82 82.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.492 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -39.15 93.21 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.727 -0.949 . . . . 1.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.11 -26.65 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.864 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.55 -51.83 13.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 1.0 111.2 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.6 m -61.41 -48.98 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.097 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -64.43 -41.65 96.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.992 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.462 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.65 -36.94 85.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.801 -0.359 . . . . 1.0 111.051 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.2 tt -63.41 -37.42 87.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.356 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 90.2 t -45.45 -14.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.482 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' LEU . 41.1 m -51.08 -44.25 61.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 1.0 110.058 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.83 -21.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.69 -20.62 13.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.921 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 86' ' ' THR . 41.9 mt -84.98 -43.18 14.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.772 0.32 . . . . 1.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -59.29 -38.2 79.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.036 0.446 . . . . 1.0 110.87 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -65.67 -11.78 47.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.283 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.61 -49.8 76.36 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.16 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 11.3 p90 -75.53 -22.54 57.0 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.813 0.34 . . . . 1.0 111.282 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.37 -43.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.194 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.82 -20.84 59.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -53.64 -42.66 68.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.467 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -61.17 -41.0 95.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.73 -37.46 79.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.669 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.82 -35.11 79.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.327 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -60.42 -43.68 96.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.325 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.6 -36.03 82.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.305 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.07 8.06 56.98 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.531 179.883 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' SER . . . . . 0.411 ' O ' ' OG ' ' B' ' 1' ' ' SER . 15.3 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 41.6 -161.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.744 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -125.22 -25.26 3.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.766 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' HIS . . . . . 0.485 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.5 p80 -78.49 -23.57 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.45 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.72 -39.45 88.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.743 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.35 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.666 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.36 -41.17 96.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.0 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 99.3 mm-40 -65.7 -38.19 88.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -61.85 -37.48 84.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.53 71.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.881 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.81 -38.76 92.31 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.554 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' B' ' 9' ' ' GLN . 1.1 mp0 -65.71 -34.82 79.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.315 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.47 -38.54 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.37 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 53.2 tp -62.78 -42.08 99.54 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.376 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.443 ' O ' ' OE2' ' B' ' 20' ' ' GLU . 76.3 mm-40 -63.86 -40.04 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -59.05 -42.1 89.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 1.0 110.612 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.443 ' O ' ' N ' ' B' ' 22' ' ' ALA . 88.8 t -65.43 -40.84 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.673 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 82.5 mt -59.32 -40.94 87.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' B' ' 20' ' ' GLU . 0.3 OUTLIER -59.82 -48.93 79.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -31.01 69.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.992 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' B' ' 18' ' ' VAL . . . -58.81 -44.59 90.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.496 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.9 p -59.63 -43.71 93.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.412 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -65.73 -35.48 80.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.42 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.19 -47.13 37.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.794 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.7 82.57 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' VAL . . . . . 0.487 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 9.9 p -62.18 -46.31 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.231 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.487 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 83.4 tt0 -67.09 -43.78 81.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.531 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.79 83.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.337 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -70.39 -33.95 71.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.678 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.95 123.96 21.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.53 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.01 0.64 65.83 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.75 140.45 21.09 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 122.833 -0.216 . . . . 1.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.73 149.74 34.22 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.061 1.841 . . . . 1.0 112.623 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.48 2.85 23.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.467 ' O ' ' CG2' ' B' ' 39' ' ' ILE . . . -77.43 83.01 3.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.667 0.27 . . . . 1.0 110.699 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.5 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 1.0 110.506 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' B' ' 39' ' ' ILE . 5.4 tt -58.99 -28.43 66.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.359 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' ILE . . . . . 0.468 ' O ' ' OG ' ' B' ' 40' ' ' SER . 20.4 tt -38.26 100.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.182 0.515 . . . . 1.0 110.793 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' SER . . . . . 0.531 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 59.7 m -171.42 -119.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.645 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.6 m-85 -177.57 -64.88 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.014 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 21.1 Cg_endo -58.5 -33.43 98.0 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.161 1.907 . . . . 1.0 112.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.16 -4.64 51.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.665 -0.243 . . . . 1.0 111.015 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.82 95.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.181 179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.76 -37.37 73.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.361 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.612 ' NE1' ' O ' ' C' ' 64' ' ' THR . 2.8 t90 -53.95 -50.99 65.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.711 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.7 t90 -66.15 -38.32 87.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.401 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 65.2 m -55.24 -45.33 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.273 -178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.89 -46.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLU . . . . . 0.423 ' O ' ' OG1' ' B' ' 53' ' ' THR . 80.0 mm-40 -66.31 -31.71 72.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.6 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 98.2 m -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.157 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.7 -26.3 44.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.723 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' THR . . . . . 0.49 ' C ' ' H ' ' B' ' 55' ' ' VAL . 46.3 p -85.68 -2.25 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 1.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.5 p 57.08 5.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.097 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' B' ' 53' ' ' THR . 7.8 p -64.85 -43.8 96.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.784 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' GLY . . . . . 0.441 ' N ' ' CG1' ' B' ' 55' ' ' VAL . . . 38.55 74.64 0.11 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -59.92 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.663 0.268 . . . . 1.0 110.966 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.53 -0.75 2.26 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.06 -65.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 1.0 110.084 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.28 149.38 36.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 22.8 p90 -139.18 112.53 8.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.46 -171.05 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.49 1.46 . . . . 1.0 111.971 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . 0.655 ' CG2' ' H ' ' B' ' 64' ' ' THR . 7.2 p -133.65 -147.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.391 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' THR . . . . . 0.655 ' H ' ' CG2' ' B' ' 63' ' ' VAL . 97.9 m -101.79 -42.8 6.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.256 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' B' ' 67' ' ' GLY . 75.1 tt0 -54.79 -38.24 67.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.284 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.43 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -77.56 31.66 0.16 Allowed 'General case' 0 C--O 1.259 1.592 0 CA-C-O 123.788 1.756 . . . . 1.0 109.72 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.59 63.74 1.57 Allowed Glycine 0 C--O 1.212 -1.267 0 CA-C-N 113.659 -1.61 . . . . 1.0 111.629 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' B' ' 67' ' ' GLY . 55.0 ttm-85 -25.28 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.401 1.101 . . . . 1.0 110.579 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' B' ' 67' ' ' GLY . 67.5 mttm -48.49 -18.4 0.23 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.3 -47.82 91.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 119.847 -0.741 . . . . 1.0 109.691 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.36 -38.99 68.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.296 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -49.17 -43.33 41.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -66.64 -41.14 88.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -51.66 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.696 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 22.9 ptp -64.26 -41.01 97.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 1.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.14 -39.28 93.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.442 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.87 -36.03 80.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 1.0 110.526 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.89 -39.88 58.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.442 -0.663 . . . . 1.0 111.442 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.21 -44.6 99.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 121.112 -0.235 . . . . 1.0 111.483 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.88 -35.29 79.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 1.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' VAL . . . . . 0.49 ' C ' ' H ' ' B' ' 83' ' ' ALA . 17.9 t -62.27 -71.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -58.11 -4.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.957 -178.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ALA . . . . . 0.49 ' H ' ' C ' ' B' ' 81' ' ' VAL . . . -97.55 -34.99 10.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.168 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -64.47 -40.79 96.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.211 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 87' ' ' ALA . 14.0 m -58.57 -16.5 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.009 -0.542 . . . . 1.0 109.621 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 52.5 m -42.43 -24.66 0.06 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.078 0.466 . . . . 1.0 109.811 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.461 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -62.75 -64.42 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.845 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.6 -24.06 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.2 mm? -87.81 -19.76 27.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.788 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ALA . . . . . 0.585 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.57 -50.55 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.459 0.647 . . . . 1.0 109.335 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -54.23 -3.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.236 179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' ASP . . . . . 0.585 ' H ' ' C ' ' B' ' 90' ' ' ALA . 91.0 m-20 -58.69 -41.87 87.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.866 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 24.3 p90 -70.56 -27.53 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.906 -0.317 . . . . 1.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.79 -43.7 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.512 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.29 -21.35 59.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.932 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -55.09 -41.73 71.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.77 -40.95 96.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.974 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.33 -36.82 83.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.84 0.352 . . . . 1.0 110.785 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.95 -26.5 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -60.17 -43.41 95.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.319 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -64.5 -37.29 87.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.63 13.4 65.17 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.615 179.785 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.365 -0.605 . . . . 1.0 109.365 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 39.3 -106.56 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.814 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' C' ' 3' ' ' ASP . 67.8 t0 -173.74 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.924 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -80.4 -17.2 52.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.776 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.44 89.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -63.06 -39.41 94.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.0 110.281 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.5 -40.69 89.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.73 92.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.593 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.09 -39.15 89.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.337 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -62.4 -36.74 83.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.291 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.71 80.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -62.82 -40.18 96.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 1.0 111.086 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -65.84 -34.25 77.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.569 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.8 -37.94 88.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.516 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 49.0 tp -61.74 -44.6 96.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.585 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' C' ' 20' ' ' GLU . 85.5 mm-40 -58.48 -32.31 68.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.82 -43.24 93.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 m -87.56 -34.65 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.592 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.49 -49.14 78.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' C' ' 16' ' ' GLN . 3.4 mp0 -61.22 -43.32 99.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.64 -29.34 66.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.473 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.17 -37.65 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.655 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 12.9 m -56.63 -44.8 81.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.356 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -64.59 -52.15 59.03 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.131 -0.628 . . . . 1.0 109.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.6 mmtt -59.48 -37.92 79.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.435 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.74 -57.74 5.86 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.832 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -64.33 -44.21 97.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.137 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -60.72 -32.81 72.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.15 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -60.77 -29.28 69.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.624 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.2 -44.73 92.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.66 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.03 130.23 41.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.46 -29.75 11.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.234 -0.747 . . . . 1.0 111.234 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.89 144.19 28.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 122.903 -0.174 . . . . 1.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.17 158.71 37.52 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.115 1.877 . . . . 1.0 112.442 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.77 36.9 14.55 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 141.86 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 1.0 110.569 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.4 -44.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.46 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' C' ' 39' ' ' ILE . 6.4 tt -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' C' ' 38' ' ' LEU . 2.6 tp -37.89 116.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.736 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' C' ' 41' ' ' TYR . 17.2 t -177.6 -123.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.306 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' TYR . . . . . 0.541 ' N ' ' OG ' ' C' ' 40' ' ' SER . 0.8 OUTLIER 171.97 -65.58 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.188 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' C' ' 41' ' ' TYR . 23.5 Cg_endo -58.81 -40.16 75.04 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.886 1.724 . . . . 1.0 112.171 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.455 ' CG ' ' HG ' ' C' ' 40' ' ' SER . 8.5 p30 -88.37 -0.22 56.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.31 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.77 87.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 1.0 110.615 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' C' ' 46' ' ' TRP . 20.3 tt -67.18 -41.4 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' NE ' ' D' ' 68' ' ' ARG . 0.0 OUTLIER -52.33 -49.08 64.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.737 -179.58 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -65.43 -38.55 90.22 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.826 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 9.0 p -62.11 -38.79 90.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.543 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 42.9 t -59.55 -47.75 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 121.181 -0.208 . . . . 1.0 111.367 -178.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.58 -34.75 77.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.569 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -64.24 -53.7 45.07 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.55 68.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.766 0.317 . . . . 1.0 110.947 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.418 ' O ' ' OG1' ' C' ' 54' ' ' THR . 58.9 p -90.81 3.63 53.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.274 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.4 p 52.06 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.47 -50.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.147 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.3 76.81 0.15 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 26.9 t80 -61.66 -43.21 99.28 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.63 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.14 12.19 5.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.6 -45.54 93.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' C' ' 43' ' ' ASP . 94.1 mtt-85 -138.45 147.99 43.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -115.66 128.88 25.6 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.762 -0.199 . . . . 1.0 110.563 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.55 157.16 61.78 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.029 1.82 . . . . 1.0 112.001 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.2 -176.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.276 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' THR . . . . . 0.612 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 67.0 m -89.82 -86.25 0.2 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.643 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' C' ' 64' ' ' THR . 50.7 tp10 -28.19 -84.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.321 0.388 . . . . 1.0 111.097 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.5 mt-10 -60.95 -92.2 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.05 -56.2 0.0 OUTLIER Glycine 0 N--CA 1.478 1.457 0 O-C-N 124.376 1.047 . . . . 1.0 114.571 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 42.9 ttp85 -71.35 -47.75 54.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.289 -0.456 . . . . 1.0 110.402 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' LYS . . . . . 0.657 ' HZ3' HH12 ' C' ' 68' ' ' ARG . 4.5 mptp? -59.85 -41.46 91.46 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.7 t -76.64 -45.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.788 -0.765 . . . . 1.0 111.237 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.23 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.703 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' C' ' 68' ' ' ARG . 15.4 tm-20 -49.42 -40.98 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.836 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -69.25 -42.04 76.14 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.931 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.0 t -66.06 -49.48 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.722 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ptp -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.693 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.34 -40.5 96.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.522 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.72 95.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 1.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.31 -41.23 96.77 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.3 -43.06 97.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 1.0 110.852 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.28 -40.6 94.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.265 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.89 -47.02 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.35 -14.62 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.168 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.18 -34.09 19.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 1.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.16 -40.53 90.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.66 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.58 -24.58 29.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 1.2 t -43.12 -33.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.168 0.509 . . . . 1.0 110.456 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.1 -61.74 1.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.203 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.58 -35.02 39.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.241 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' LEU . . . . . 0.539 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.4 mm? -75.35 -34.81 61.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.777 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -63.5 -36.18 82.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.181 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -4.47 37.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.08 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -54.77 -48.95 72.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.746 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 20.8 p90 -74.83 -9.97 59.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.1 -48.3 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.679 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -65.81 -20.35 66.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.258 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -48.84 -38.8 23.35 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.412 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' C' ' 99' ' ' GLU . 17.3 pt-20 -43.55 152.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.278 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 60.42 -68.82 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.492 0.495 . . . . 1.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' C' ' 97' ' ' GLU . 79.4 mm-40 -52.11 -21.73 3.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.446 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -61.7 -43.45 98.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.34 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.75 -36.55 84.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.529 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.43 11.58 62.34 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.539 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' SER . . . . . 0.423 ' O ' ' O ' ' D' ' 2' ' ' ALA . 40.8 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' D' ' 1' ' ' SER . . . 45.3 95.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.474 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -63.75 -40.3 96.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.935 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' HIS . . . . . 0.62 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 2.5 p80 -58.55 -44.92 89.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.587 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.51 -39.6 92.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 1.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -65.06 -39.16 92.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.483 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.14 -37.26 86.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.931 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.76 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.846 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -63.66 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 1.0 110.306 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.98 -39.1 91.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.88 81.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.73 -41.86 87.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 1.0 110.733 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -67.14 -37.92 84.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.93 -34.83 79.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.514 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.26 -40.6 96.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.316 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -60.36 -37.05 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.43 -42.51 92.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.74 0.305 . . . . 1.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.12 -42.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.771 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LEU . . . . . 0.443 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.0 mt -61.13 -42.02 97.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -59.98 -46.15 90.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.341 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.25 -40.28 74.5 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.411 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.42 93.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.06 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 16.5 m -58.54 -45.28 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.091 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' LYS . . . . . 0.48 ' O ' ' OE1' ' D' ' 28' ' ' GLU . 60.9 tttp -60.71 -59.71 4.95 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.282 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.51 -38.86 75.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 1.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' ALA . . . . . 0.402 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -53.76 -36.14 62.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.79 -48.73 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.525 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' D' ' 28' ' ' GLU . 47.6 mp0 -73.29 -38.2 65.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -54.55 30.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.55 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 2.0 mp0 -64.91 -35.13 80.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.576 -0.283 . . . . 1.0 110.523 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.24 128.23 35.8 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.117 0.484 . . . . 1.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.08 -16.36 61.49 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.507 -0.769 . . . . 1.0 111.465 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.27 148.17 46.59 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -74.78 130.71 13.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.913 1.742 . . . . 1.0 112.396 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 17.88 71.36 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.73 173.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 1.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.42 -40.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.72 121.58 39.8 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 24.1 pt -152.92 54.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -149.9 119.71 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.621 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' TYR . . . . . 0.538 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 8.5 t80 -61.08 -47.99 93.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.62 -31.73 95.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.288 1.325 . . . . 1.0 112.056 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.53 -8.26 38.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.109 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.8 81.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 1.0 110.984 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -64.48 -34.45 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.082 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -69.06 -44.12 73.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.168 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -62.42 -41.52 98.76 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.523 -0.471 . . . . 1.0 109.803 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.437 ' OG ' ' OG ' ' D' ' 23' ' ' SER . 1.2 m -72.01 57.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -145.28 -51.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.725 0.298 . . . . 1.0 110.444 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -66.46 -31.82 72.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -45.25 91.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.358 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.76 -39.05 87.31 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.118 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' D' ' 53' ' ' THR . 4.0 p -86.0 8.25 21.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.075 0.464 . . . . 1.0 110.322 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 42.8 p 44.03 57.35 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' D' ' 57' ' ' TYR . 1.6 m -140.86 41.53 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.76 88.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' D' ' 55' ' ' VAL . 1.2 t80 -61.74 -44.78 96.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 1.0 110.361 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.27 27.89 0.16 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' ASP . . . . . 0.487 ' CG ' ' NH2' ' A' ' 68' ' ' ARG . 43.3 t0 -63.74 -48.91 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' ARG . . . . . 0.479 ' C ' ' CG ' ' D' ' 61' ' ' TYR . 0.8 OUTLIER -146.13 -178.7 6.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.166 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 1.6 m-85 -150.44 99.6 3.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.072 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.83 147.24 68.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.782 1.655 . . . . 1.0 112.101 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . 0.554 ' O ' ' NE1' ' C' ' 46' ' ' TRP . 2.5 t -80.74 -134.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' THR . . . . . 0.438 ' H ' ' CG1' ' D' ' 63' ' ' VAL . 51.7 m -114.56 -54.29 2.59 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.828 0.347 . . . . 1.0 110.559 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' GLU . . . . . 0.573 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.2 tt0 -50.88 -18.33 0.73 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' D' ' 64' ' ' THR . 0.0 OUTLIER -78.06 37.84 0.26 Allowed 'General case' 0 C--O 1.261 1.691 0 CA-C-O 123.793 1.759 . . . . 1.0 108.679 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.83 62.43 3.74 Favored Glycine 0 C--O 1.202 -1.897 0 CA-C-N 113.649 -1.614 . . . . 1.0 109.636 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' ARG . . . . . 0.574 ' NE ' ' CD1' ' C' ' 46' ' ' TRP . 19.0 ttm105 -22.5 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 117.663 0.732 . . . . 1.0 111.681 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.2 mmtt -65.83 -8.29 20.93 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.022 -0.99 . . . . 1.0 109.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' VAL . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 16.5 t -59.79 -47.49 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -76.65 -52.78 9.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.0 0.429 . . . . 1.0 110.359 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -47.9 -41.43 24.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.931 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.14 -48.92 76.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.894 -0.322 . . . . 1.0 111.784 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.82 -43.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.555 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mpp? -61.42 -43.62 98.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.624 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.03 -38.85 89.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.632 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.15 -37.06 81.5 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.505 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.76 -40.55 58.11 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.37 -44.77 99.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.638 0.236 . . . . 1.0 111.638 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.07 -35.16 77.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.304 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.15 -47.47 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.166 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -72.78 -6.61 45.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.836 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ALA . . . . . 0.457 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -97.9 -32.24 11.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.198 179.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' LEU . . . . . 0.525 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.5 tt -64.15 -41.47 97.17 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.338 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 m -51.31 -10.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' THR . . . . . 0.525 ' H ' ' C ' ' D' ' 84' ' ' LEU . 45.9 m -51.59 -43.07 62.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.062 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -46.02 -19.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -104.76 -17.61 14.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.45 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' D' ' 86' ' ' THR . 39.6 mt -93.27 -46.06 7.55 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -54.34 -30.08 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.705 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.1 OUTLIER -74.88 -11.76 60.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.765 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -53.22 -50.67 64.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.135 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 14.0 p90 -73.19 -11.26 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.652 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.03 -35.93 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.151 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -61.91 -42.52 99.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.137 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -53.54 -30.47 41.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 1.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' D' ' 99' ' ' GLU . 30.8 tp10 -76.02 158.76 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.058 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' D' ' 100' ' ' ARG . 97.2 mt-10 58.38 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' D' ' 97' ' ' GLU . 47.2 tp10 -40.86 -25.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.302 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' D' ' 98' ' ' GLU . 2.1 ptm180 -60.14 -44.15 95.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.075 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' D' ' 98' ' ' GLU . 85.1 mtp180 -68.8 -21.75 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.635 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.46 12.03 67.9 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.073 -0.965 . . . . 1.0 110.728 179.831 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.894 0.378 . . . . 1.0 110.663 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 6' ' ' ARG . 97.7 m-20 -67.25 -14.27 62.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.525 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.552 ' ND1' ' N ' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -83.76 -35.03 24.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.895 0.379 . . . . 1.0 110.286 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.16 -44.52 88.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.808 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 3' ' ' ASP . 39.0 ptt180 -66.85 -38.51 86.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.247 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.69 -43.14 80.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.289 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -67.56 -36.93 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.245 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.44 -39.72 94.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.333 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -62.19 -38.82 90.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.28 74.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.972 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.09 -39.47 86.24 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.588 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.43 -33.76 76.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.47 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.78 -36.3 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.596 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 52' ' ' ALA . 47.3 tp -62.02 -40.87 97.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 1.0 110.339 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -33.7 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.29 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -60.62 -43.09 97.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.055 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.07 -41.53 93.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.448 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.1 mt -59.37 -41.65 89.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.121 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.34 -49.59 77.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.631 -0.427 . . . . 1.0 109.996 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.37 -38.18 86.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.024 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.83 94.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.752 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 27' ' ' VAL . 38.7 m -53.65 -36.35 61.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' VAL . 64.9 tttm -77.57 -78.29 0.14 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.835 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 74.0 mmtt -36.19 -35.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.29 87.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.612 -0.435 . . . . 1.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 1.8 m -63.08 -47.8 90.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.201 -0.6 . . . . 1.0 110.564 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.9 tm-20 -70.1 -42.92 72.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.916 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 66' ' ' GLU . . . -59.48 -31.42 69.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.931 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -97.19 -33.05 11.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.605 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 27' ' ' VAL . 23.6 tpt180 -77.55 97.63 5.1 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.286 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 -14.02 7.98 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.88 42.57 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.93 142.72 28.45 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.111 1.874 . . . . 1.0 112.318 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.18 7.69 84.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.021 -0.831 . . . . 1.0 111.021 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.33 147.28 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 1.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.38 10.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' ILE . 6.7 tt -83.8 -71.08 0.52 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.358 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 40' ' ' SER . 45.0 pt 37.51 -162.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 39' ' ' ILE . 4.0 m 55.15 128.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.361 0.601 . . . . 1.0 111.055 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 23.2 m-85 -77.66 -55.68 1.23 Allowed Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.781 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.4 Cg_endo -60.28 -20.52 62.85 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.701 1.601 . . . . 1.0 112.348 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -89.0 -24.97 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.004 -0.278 . . . . 1.0 110.951 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.85 -37.84 85.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 45' ' ' ILE . 2.5 tp -63.89 -43.51 97.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.36 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.953 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -60.13 -42.11 94.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.117 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 18.1 t90 -60.68 -41.95 96.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.409 ' C ' HD22 ' A' ' 19' ' ' LEU . 52.9 p -76.64 69.63 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.384 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -152.39 -80.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.047 0.451 . . . . 1.0 110.476 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 57' ' ' TYR . 16.7 pt-20 -60.45 -20.87 61.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 52' ' ' ALA . 15.1 t -65.18 -43.73 90.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.137 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -56.1 -50.05 72.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -79.82 37.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.362 0.601 . . . . 1.0 109.437 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 19.2 p 60.28 -117.95 0.8 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.388 -0.824 . . . . 1.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 53' ' ' THR . 2.5 t 69.87 -54.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.13 -1.91 88.27 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' ASP . 3.2 m-85 -90.58 34.49 0.89 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.45 -9.78 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 57' ' ' TYR . 11.6 t0 74.29 9.36 4.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.422 . . . . 1.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -145.08 -162.13 1.44 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 13.2 p90 -167.88 98.32 0.59 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.094 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.99 150.23 77.74 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.453 1.435 . . . . 1.0 112.122 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.99 HG22 ' H ' ' A' ' 64' ' ' THR . 14.3 p -87.64 -136.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.99 ' H ' HG22 ' A' ' 63' ' ' VAL . 29.7 m -107.19 -44.28 4.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.524 0.33 . . . . 1.0 110.907 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.0 tt0 -56.17 -41.64 75.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.807 0.337 . . . . 1.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -65.13 24.94 0.02 OUTLIER 'General case' 0 C--O 1.264 1.856 0 CA-C-O 123.625 1.679 . . . . 1.0 109.8 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 42.97 65.9 1.29 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 117.968 -1.462 . . . . 1.0 111.487 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 56.3 ttm-85 -24.33 -34.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.161 0.981 . . . . 1.0 110.833 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 67' ' ' GLY . 73.4 mmtt -48.15 -19.03 0.24 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.145 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.3 t -61.19 -47.49 93.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 119.662 -0.815 . . . . 1.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.59 -41.8 19.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.854 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -52.71 -48.29 66.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.685 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.87 -40.3 97.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 70' ' ' VAL . 95.0 t -62.97 -46.48 96.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.177 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.11 -43.22 99.06 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.99 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.81 -41.06 94.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.61 -36.34 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.386 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.18 -39.56 94.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.07 -43.73 98.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.653 0.263 . . . . 1.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -62.51 -46.17 89.65 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.33 -49.35 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.929 0.395 . . . . 1.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -69.0 -27.88 66.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.905 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -84.54 -28.03 26.94 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.006 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.41 -45.98 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.335 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HB1' ' A' ' 8' ' ' ALA . 4.4 m -57.41 -18.55 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.361 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.1 m -38.16 -31.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.101 0.477 . . . . 1.0 110.442 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -58.95 -51.1 71.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.338 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -61.88 -29.61 70.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.034 0.445 . . . . 1.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.471 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -70.86 -35.38 72.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -65.73 -50.45 64.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.088 0.47 . . . . 1.0 111.432 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -59.54 -4.54 0.64 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.0 m-20 -55.28 -66.08 0.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.305 . . . . 1.0 111.129 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.5 p90 -62.76 -39.61 94.69 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.337 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 70.9 t -43.47 -31.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.55 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.26 -22.1 66.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 1.0 111.345 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.541 ' NH2' HG11 ' B' ' 94' ' ' VAL . 29.6 ptt180 -59.95 -34.28 73.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.711 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.961 -179.749 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 4' ' ' HIS . 52.7 p-10 . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.768 0.318 . . . . 1.0 110.726 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 3' ' ' ASP . 15.8 p-80 -83.69 -26.3 29.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.531 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.31 -42.69 87.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -64.28 -42.53 96.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.567 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.2 -40.16 84.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 1.0 109.868 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.88 97.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.729 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.69 -37.95 87.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 1.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.74 -39.48 91.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.76 -36.8 79.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.788 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.68 -36.92 85.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 1.0 110.518 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.289 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -64.08 -37.22 86.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.546 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' B' ' 52' ' ' ALA . 50.4 tp -62.89 -41.46 99.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.421 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.45 -38.12 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.791 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' B' ' 21' ' ' GLU . 25.8 ttpp -61.07 -43.1 99.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.54 -41.78 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.6 mt -59.66 -41.35 90.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.1 mt-10 -63.06 -44.05 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 47.8 mt-10 -70.08 -33.96 72.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.023 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -63.6 -39.93 95.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.413 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.1 p -59.3 -43.59 92.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.07 -63.85 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.413 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -59.88 -39.61 85.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.564 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.8 -51.38 56.92 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.941 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.99 -47.18 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.141 -0.624 . . . . 1.0 110.943 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -64.37 -39.53 94.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.763 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.11 91.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 79.5 mm-40 -67.48 -42.45 82.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.789 0.328 . . . . 1.0 111.16 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -52.62 102.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 1.0 110.805 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 113.3 -9.13 24.62 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.51 138.27 23.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.834 -0.215 . . . . 1.0 110.672 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.59 141.55 25.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.91 1.74 . . . . 1.0 112.341 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.18 26.82 68.13 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -47.16 -58.3 4.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 1.0 110.794 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' B' ' 36' ' ' ALA . . . 70.42 -20.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.383 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' B' ' 36' ' ' ALA . 24.4 tp -110.6 119.51 39.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.1 pt -154.89 168.92 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.627 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.5 OUTLIER 80.22 135.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.0 110.989 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.668 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 4.1 t80 -72.12 -41.82 8.93 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.912 -0.585 . . . . 1.0 111.564 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.5 Cg_endo -58.22 -32.7 96.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.494 1.463 . . . . 1.0 112.794 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.546 ' CG ' HH12 ' B' ' 60' ' ' ARG . 35.4 p-10 -99.05 -7.45 26.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.54 -44.11 91.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 1.0 110.406 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -64.49 -33.58 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.683 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.3 OUTLIER -61.17 -46.8 89.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.515 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.404 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.1 OUTLIER -71.01 -28.36 64.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.42 ' O ' HD22 ' B' ' 19' ' ' LEU . 3.1 t -68.49 -35.4 77.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.589 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.662 HG11 HH12 ' C' ' 68' ' ' ARG . 47.2 t -60.47 -48.4 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.856 0.317 . . . . 1.0 111.856 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.433 ' HB3' HH21 ' C' ' 68' ' ' ARG . 6.3 pt-20 -68.96 -28.84 66.99 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.472 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -62.28 -47.19 85.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.155 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.721 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.55 -36.74 69.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.502 ' C ' ' H ' ' B' ' 55' ' ' VAL . 82.1 p -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.43 HG23 ' C ' ' B' ' 53' ' ' THR . 2.7 p 66.09 -6.7 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.302 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' B' ' 57' ' ' TYR . 69.5 t -65.33 -47.34 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.922 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 67.43 -34.8 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER 61.88 -73.08 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.803 0.335 . . . . 1.0 110.604 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 57' ' ' TYR . . . 158.72 29.94 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.69 -62.41 1.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 1.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.546 HH12 ' CG ' ' B' ' 43' ' ' ASP . 81.5 mtm180 -147.43 -170.24 3.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.394 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -173.82 136.72 0.67 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.12 -171.73 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.576 1.518 . . . . 1.0 112.138 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.552 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.0 t -118.06 -135.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.155 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.953 HG23 ' CD1' ' A' ' 46' ' ' TRP . 26.2 m -114.39 -37.12 4.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.541 -0.299 . . . . 1.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.612 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.8 tt0 -66.49 -34.1 77.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.509 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -71.19 32.02 0.05 OUTLIER 'General case' 0 C--O 1.267 2.016 0 CA-C-O 123.709 1.718 . . . . 1.0 109.972 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.98 63.91 1.62 Allowed Glycine 0 C--O 1.214 -1.127 0 CA-C-N 113.916 -1.493 . . . . 1.0 111.14 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' B' ' 67' ' ' GLY . 58.8 ttm-85 -23.95 -33.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.384 1.092 . . . . 1.0 110.91 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 99.0 mttt -48.27 -18.48 0.22 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' B' ' 67' ' ' GLY . 53.6 t -61.93 -46.91 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 C-N-CA 119.953 -0.699 . . . . 1.0 109.754 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -48.16 38.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.457 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.45 -45.11 12.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.275 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.01 -46.93 87.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.686 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.0 -46.01 82.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.456 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.09 -44.12 97.34 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.72 -37.74 85.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.376 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.495 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.16 -41.23 96.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.674 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.2 -42.25 94.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.53 -43.55 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.071 -0.252 . . . . 1.0 111.075 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.76 -40.39 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 1.0 110.797 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.8 t -63.07 -46.92 94.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.151 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -74.7 0.79 14.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.018 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -106.31 -37.6 6.49 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -62.98 -39.99 96.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.057 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -52.62 -8.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.005 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.494 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.7 m -61.35 -21.54 64.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.54 -23.32 49.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.49 -10.83 18.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.533 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 38.6 mt -99.14 -25.89 14.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.953 0.406 . . . . 1.0 110.293 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -13.55 60.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.891 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.37 -4.46 29.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.122 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 89.2 m-20 -61.19 -43.56 98.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 4.7 p90 -70.5 -32.64 70.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.153 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.541 HG11 ' NH2' ' A' ' 96' ' ' ARG . 61.7 t -61.79 -27.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.711 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.61 -22.98 64.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.441 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -59.49 -37.09 77.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 1.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.986 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.9 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.866 0.365 . . . . 1.0 110.457 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -69.04 -36.55 77.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.644 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.44 -36.32 83.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -62.91 -38.3 90.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.835 0.35 . . . . 1.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.33 -42.22 98.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.021 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.0 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.63 -39.57 93.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.398 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.12 -41.33 98.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.333 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.88 88.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.52 -39.89 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 1.0 111.106 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.69 -34.67 78.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.742 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.44 -36.16 82.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.538 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.416 HD13 ' HA2' ' C' ' 78' ' ' GLY . 51.3 tp -62.17 -41.21 98.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.345 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.26 -39.15 78.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.23 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.63 -38.48 87.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.852 0.358 . . . . 1.0 110.828 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.8 mt -58.75 -40.52 84.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.672 -0.411 . . . . 1.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.4 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.0 mm-40 -56.94 -45.43 82.79 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.96 -37.1 78.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.033 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -63.62 -39.52 94.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.415 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 90.2 p -61.41 -35.78 78.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' C' ' 26' ' ' ALA . 88.2 tttt -73.79 -77.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.106 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' C' ' 29' ' ' ALA . 14.6 mptt -38.98 -25.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' C' ' 24' ' ' LYS . . . -64.88 -41.61 95.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.74 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' C' ' 28' ' ' GLU . 1.7 m -63.73 -47.63 90.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.029 0.442 . . . . 1.0 110.366 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' C' ' 30' ' ' GLU . 96.8 mt-10 -71.64 -36.58 70.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.428 -0.805 . . . . 1.0 110.365 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' LYS . . . -70.91 29.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' C' ' 28' ' ' GLU . 3.6 tp10 -153.46 -38.98 0.1 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.954 0.407 . . . . 1.0 110.283 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -65.36 86.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.065 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.4 20.42 2.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.489 ' HB2' ' CD ' ' C' ' 66' ' ' GLU . . . -105.4 151.49 39.71 Favored Pre-proline 0 N--CA 1.466 0.373 0 O-C-N 122.886 -0.185 . . . . 1.0 110.685 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.55 115.8 4.15 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.167 1.245 . . . . 1.0 111.106 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 35' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 82.5 18.08 67.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.259 -0.736 . . . . 1.0 111.259 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.48 ' HB1' ' HG3' ' C' ' 30' ' ' GLU . . . -42.35 167.98 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.919 0.39 . . . . 1.0 110.472 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.95 -30.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.436 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.59 101.31 13.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.104 0.478 . . . . 1.0 110.225 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' C' ' 40' ' ' SER . 42.2 pt -128.83 161.25 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.217 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.8 OUTLIER 80.81 140.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 1.0 110.604 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.641 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 46.0 t80 -79.65 -41.96 1.51 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.188 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.5 Cg_endo -59.92 -29.9 90.51 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.489 1.459 . . . . 1.0 112.453 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' C' ' 44' ' ' ALA . 2.8 p-10 -93.56 -23.22 18.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.719 0.295 . . . . 1.0 111.198 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' C' ' 43' ' ' ASP . . . -63.55 -33.27 75.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.864 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.403 ' H ' HG22 ' C' ' 45' ' ' ILE . 3.1 tp -65.38 -41.11 90.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.686 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.5 OUTLIER -61.44 -42.93 99.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.811 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.535 ' NE1' ' OH ' ' B' ' 57' ' ' TYR . 3.7 t90 -59.61 -40.04 86.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' C' ' 51' ' ' THR . 15.5 m -58.27 -33.1 69.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.99 -44.89 92.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.482 ' OE1' ' NH1' ' D' ' 68' ' ' ARG . 9.0 pt-20 -87.51 73.11 9.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.693 0.282 . . . . 1.0 111.289 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' C' ' 48' ' ' SER . 0.6 OUTLIER -177.0 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.171 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.455 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -71.36 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.041 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.405 ' C ' HG23 ' C' ' 54' ' ' THR . 2.6 p -92.16 20.5 5.89 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.405 HG23 ' C ' ' C' ' 53' ' ' THR . 1.2 p 57.5 33.5 23.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.873 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.429 HG11 ' SD ' ' D' ' 75' ' ' MET . 74.2 t -132.5 87.14 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.119 0.485 . . . . 1.0 110.112 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.89 79.14 1.65 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.536 ' CZ ' ' O ' ' D' ' 60' ' ' ARG . 0.8 OUTLIER -60.08 -47.34 86.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.931 0.396 . . . . 1.0 110.523 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 147.31 -85.58 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.729 -0.949 . . . . 1.0 110.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.459 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 92.4 m-20 41.61 -89.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 1.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' C' ' 58' ' ' GLY . 84.2 mtm180 -127.8 150.85 49.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.887 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -153.41 147.51 18.81 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.74 156.94 62.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.254 1.969 . . . . 1.0 112.04 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.1 t -89.22 -132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.476 ' C ' ' H ' ' C' ' 66' ' ' GLU . 99.4 m -115.3 -56.96 2.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.833 0.349 . . . . 1.0 110.703 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -52.85 -10.08 0.15 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 10.7 mp0 -108.28 47.04 0.92 Allowed 'General case' 0 C--O 1.272 2.261 0 CA-C-O 124.747 2.213 . . . . 1.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 37.4 60.99 1.07 Allowed Glycine 0 C--O 1.218 -0.905 0 CA-C-N 112.432 -2.167 . . . . 1.0 111.128 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.662 HH12 HG11 ' B' ' 49' ' ' VAL . 60.9 ttt-85 -25.18 -32.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.738 0.769 . . . . 1.0 111.074 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.718 ' N ' ' O ' ' C' ' 67' ' ' GLY . 52.4 mtmt -55.4 -9.08 0.41 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.702 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.0 t -58.32 -45.64 89.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 118.617 -1.233 . . . . 1.0 110.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.97 38.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 1.0 111.15 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -56.89 -46.02 82.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.067 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.87 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.414 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.12 -44.02 91.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.653 -0.419 . . . . 1.0 111.395 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.14 -41.25 99.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.126 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.99 -35.49 75.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.708 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.46 74.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.357 . . . . 1.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.65 -36.63 88.18 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.07 -44.01 97.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.678 -0.307 . . . . 1.0 110.729 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.76 -43.85 87.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.814 -0.354 . . . . 1.0 111.099 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.0 -48.66 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.517 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.456 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.4 m-85 -73.98 -14.44 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.084 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.0 -32.14 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 1.0 110.171 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.2 tt -66.45 -39.61 88.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.483 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.456 HG22 ' O ' ' C' ' 82' ' ' PHE . 3.6 m -47.93 -9.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.055 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.516 ' H ' ' C ' ' C' ' 84' ' ' LEU . 27.1 m -57.4 -38.88 75.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.411 . . . . 1.0 110.024 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -51.3 -23.25 3.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.088 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.0 -11.54 26.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.85 -49.39 7.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.318 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.37 -13.97 4.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.975 0.417 . . . . 1.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.2 OUTLIER -101.02 -5.37 25.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.165 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 91.3 m-20 -61.09 -47.85 84.39 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 36.9 p90 -78.35 -36.62 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.35 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 86.9 t -46.51 -34.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.763 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -62.33 -20.65 64.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.713 0.292 . . . . 1.0 111.242 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' C' ' 96' ' ' ARG . 25.1 ptt-85 -49.48 -38.96 32.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.51 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.256 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.902 0.382 . . . . 1.0 110.451 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -66.8 -21.93 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -41.7 94.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.267 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.45 -37.91 88.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.553 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -62.98 -42.53 99.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.354 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.51 -44.98 69.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 8' ' ' ALA . . . . . 0.432 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -65.47 -43.85 89.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.41 -38.01 89.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.567 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -39.18 92.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.711 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.99 73.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLU . . . . . 0.409 ' OE2' ' CE1' ' D' ' 82' ' ' PHE . 79.7 mm-40 -65.48 -33.73 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.23 -40.98 97.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.887 0.375 . . . . 1.0 110.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.91 -30.43 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.431 HD11 ' HB1' ' D' ' 52' ' ' ALA . 51.8 tp -61.97 -42.12 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.324 . . . . 1.0 110.486 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -62.23 -40.14 95.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.59 -41.65 92.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -60.35 -41.77 94.33 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.181 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.9 mt-10 -62.7 -48.12 80.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -69.83 -42.23 73.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 1.0 110.49 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.06 85.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.085 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -58.98 -43.58 91.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.85 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.54 -32.37 73.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.649 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -78.5 -38.26 41.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.849 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.81 75.88 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.166 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.537 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.9 p -63.11 -45.15 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 1.0 110.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.537 ' N ' HG13 ' D' ' 27' ' ' VAL . 83.7 tt0 -66.26 -42.85 87.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.511 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.44 97.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.279 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -64.98 -32.99 74.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.811 -0.356 . . . . 1.0 110.451 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.02 130.58 41.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.953 0.406 . . . . 1.0 110.454 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.07 -10.38 63.8 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.25 148.98 36.63 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.453 ' O ' HG11 ' D' ' 63' ' ' VAL . 80.9 Cg_endo -74.59 137.6 22.94 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.87 1.713 . . . . 1.0 112.208 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.57 74.42 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 138.52 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.979 0.419 . . . . 1.0 110.442 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.84 -30.98 4.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.311 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.414 ' C ' HD23 ' D' ' 38' ' ' LEU . 4.3 tt -97.38 76.39 2.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 1.0 110.166 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -101.97 -2.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.417 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 10.6 p -76.44 148.15 37.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.552 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.7 OUTLIER -104.43 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.11 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.3 Cg_endo -57.98 -31.67 93.4 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.612 1.541 . . . . 1.0 111.744 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.37 -0.79 57.7 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.195 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.7 89.21 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.819 0.343 . . . . 1.0 110.39 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.428 ' O ' HG23 ' D' ' 49' ' ' VAL . 5.1 tt -65.48 -38.39 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.468 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.44 -46.45 80.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.064 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -65.47 -38.64 90.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.17 -35.14 80.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.786 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 45' ' ' ILE . 40.9 t -60.13 -48.79 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.834 -0.347 . . . . 1.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.78 -29.35 68.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.075 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.4 m -63.04 -44.84 94.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.54 -30.39 70.61 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 23.2 p -80.76 8.93 7.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.34 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 73.1 p 41.26 70.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.444 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' D' ' 57' ' ' TYR . 0.2 OUTLIER -146.78 -42.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.334 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.56 -38.8 0.6 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' D' ' 55' ' ' VAL . 1.6 t80 66.12 -68.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 1.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . 146.0 32.21 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.0 m-20 -85.44 -58.49 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.536 ' O ' ' CZ ' ' C' ' 57' ' ' TYR . 94.1 mtt-85 -141.0 -179.39 6.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -158.01 137.09 8.13 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.697 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.66 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.3 2.0 . . . . 1.0 112.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.528 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -89.4 -140.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.814 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.686 HG23 ' CD1' ' C' ' 46' ' ' TRP . 5.1 m -114.68 -32.54 5.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' D' ' 67' ' ' GLY . 79.9 tt0 -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.926 0.394 . . . . 1.0 110.576 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.2 OUTLIER -77.49 24.88 0.19 Allowed 'General case' 0 C--O 1.262 1.758 0 CA-C-O 123.715 1.722 . . . . 1.0 109.219 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.87 62.22 3.06 Favored Glycine 0 C--O 1.213 -1.181 0 CA-C-N 113.87 -1.514 . . . . 1.0 109.439 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.482 ' NH1' ' OE1' ' C' ' 50' ' ' GLU . 58.6 ttm-85 -25.21 -30.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.216 0.598 . . . . 1.0 110.985 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.725 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.1 mttp -51.2 -24.63 4.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.351 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' D' ' 67' ' ' GLY . 74.8 t -62.37 -49.47 83.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.039 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -39.29 72.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.476 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -61.35 -37.03 81.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.848 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.01 -41.67 99.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.411 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.43 -43.24 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.267 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.429 ' SD ' HG11 ' C' ' 55' ' ' VAL . 63.4 mtt -58.82 -45.92 88.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.081 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -65.58 -38.36 89.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 1.0 110.576 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.405 ' O ' HG22 ' D' ' 81' ' ' VAL . . . -59.0 -40.26 84.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.499 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.67 -39.27 86.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.33 -43.44 97.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.414 -0.463 . . . . 1.0 111.19 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.65 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.501 HG23 ' N ' ' D' ' 82' ' ' PHE . 16.0 m -60.82 -50.31 81.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.457 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' PHE . . . . . 0.501 ' N ' HG23 ' D' ' 81' ' ' VAL . 24.6 m-85 -66.97 -41.38 86.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.11 78.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.313 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' D' ' 86' ' ' THR . 7.7 tt -61.79 -42.15 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.432 HG22 ' HB1' ' D' ' 8' ' ' ALA . 49.1 t -50.21 -15.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -54.73 -19.5 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.119 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -62.24 -62.97 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.827 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.86 75.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.139 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.06 -47.47 68.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.899 0.38 . . . . 1.0 110.732 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.457 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -61.45 -25.39 67.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 1.3 m -84.01 -3.55 58.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.319 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 87.1 m-20 -60.62 -46.76 89.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 9.0 p90 -65.54 -32.29 73.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.615 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.51 -42.74 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.181 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -52.96 -22.12 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -50.42 -37.34 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 1.0 110.459 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.876 -179.317 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 120.544 0.211 . . . . 1.0 110.568 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 59.54 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 2' ' ' ALA . 31.1 p80 -56.75 -40.2 75.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 1.0 110.663 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.441 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 43.7 tt0 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.315 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -64.43 -38.52 91.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.178 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.04 -40.0 90.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.68 88.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.49 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -62.21 -39.61 93.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.18 -37.67 88.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.422 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.97 79.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.59 -37.8 88.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 1.0 110.524 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -64.75 -35.97 82.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.914 0.387 . . . . 1.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.62 -33.22 75.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' HA2' ' A' ' 78' ' ' GLY . 49.6 tp -62.29 -42.0 98.98 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.628 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.34 -37.71 86.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.153 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -61.9 -41.64 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.723 0.297 . . . . 1.0 110.98 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.53 -42.03 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.467 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.0 mt -59.49 -40.94 88.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.055 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.66 -48.59 81.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.684 -0.407 . . . . 1.0 109.935 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.039 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.99 90.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.577 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -59.67 -43.05 94.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.129 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -58.28 -64.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.56 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.97 -37.8 80.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.648 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.94 -49.41 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.861 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.74 -43.18 90.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.526 -0.469 . . . . 1.0 110.179 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -61.33 -42.62 98.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.724 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -56.46 -53.37 58.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -65.02 -19.58 66.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.157 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -82.53 89.41 6.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.887 -0.325 . . . . 1.0 111.249 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.58 6.12 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 116.192 -0.458 . . . . 1.0 112.012 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.94 144.55 29.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.807 0.304 . . . . 1.0 110.287 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.45 142.03 26.06 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.954 1.77 . . . . 1.0 112.231 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.47 12.14 80.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.1 138.14 57.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 1.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.77 -58.66 1.94 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.612 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.53 99.21 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.976 0.417 . . . . 1.0 110.427 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 pt -135.5 55.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.457 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 3.4 m -156.54 132.66 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.061 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.576 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 91.6 m-85 -67.19 -44.22 47.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.578 0.584 . . . . 1.0 112.578 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.5 Cg_endo -60.04 -32.44 94.85 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 121.272 1.315 . . . . 1.0 112.76 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.9 p-10 -99.8 -1.1 38.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 121.017 -0.273 . . . . 1.0 110.948 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.429 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -66.16 -43.78 85.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 1.0 110.495 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.412 ' H ' HG22 ' A' ' 45' ' ' ILE . 5.1 tt -66.69 -38.73 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.653 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -56.52 -46.07 80.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE3' ' N ' ' A' ' 48' ' ' SER . 1.6 t90 -67.36 -39.01 85.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.906 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.492 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 m -55.74 -25.51 40.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.163 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.93 -44.81 78.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.414 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 99.5 mt-10 -79.7 69.02 5.93 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.408 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -174.65 -46.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.4 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.17 -25.4 65.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 54' ' ' THR . 33.0 p -92.44 -0.79 57.32 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 53' ' ' THR . 16.5 p 57.14 76.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.207 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' B' ' 75' ' ' MET . 89.4 t -148.77 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.688 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.4 89.85 0.8 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.546 -0.622 . . . . 1.0 111.546 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -63.93 -42.87 97.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 1.0 110.948 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.76 15.61 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.67 -68.65 0.35 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.638 0.256 . . . . 1.0 110.904 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -134.14 159.49 40.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.13 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' D' ' 57' ' ' TYR . 20.3 t80 -172.34 137.8 0.91 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.46 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.13 -172.63 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.804 1.669 . . . . 1.0 112.013 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 64' ' ' THR . 11.1 p -117.75 -121.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.746 ' N ' HG13 ' A' ' 63' ' ' VAL . 36.4 m -111.31 -61.77 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.658 0.266 . . . . 1.0 111.098 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -49.06 -20.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.149 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.627 ' CD ' HG12 ' A' ' 63' ' ' VAL . 44.9 mt-10 -87.87 36.4 0.76 Allowed 'General case' 0 C--O 1.265 1.921 0 CA-C-O 124.433 2.063 . . . . 1.0 109.032 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.65 63.43 1.21 Allowed Glycine 0 C--O 1.212 -1.261 0 CA-C-N 112.937 -1.938 . . . . 1.0 111.11 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' D' ' 59' ' ' ASP . 62.2 ttm-85 -24.92 -33.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.025 0.913 . . . . 1.0 111.055 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 67' ' ' GLY . 70.9 mmtt -49.93 -18.27 0.5 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.48 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -62.41 -47.56 92.43 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 119.288 -0.965 . . . . 1.0 110.449 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.62 69.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.307 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.32 -37.96 88.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.823 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.1 -43.99 82.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.848 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -44.57 92.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.41 -41.58 98.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.57 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.35 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.87 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.568 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -65.84 -42.52 94.99 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.4 -43.37 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.627 0.251 . . . . 1.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.71 -43.45 97.81 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.265 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.58 -49.25 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.002 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.37 -13.85 61.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.392 . . . . 1.0 111.086 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.39 -35.54 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 1.0 110.715 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.88 -42.17 97.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ALA . 11.4 m -59.42 -23.14 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.421 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.7 m -36.71 -28.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 1.0 110.624 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.35 -49.01 79.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.269 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -63.48 -32.4 73.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.284 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.2 mm? -66.48 -40.22 89.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.555 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.28 -45.12 84.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.842 0.353 . . . . 1.0 110.955 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.97 -3.22 34.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.258 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.42 -48.65 76.51 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.582 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.8 p90 -73.62 -37.06 65.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 1.0 111.451 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 95.3 t -48.29 -27.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.592 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -66.25 -21.44 66.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 67.5 t0 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.69 0.281 . . . . 1.0 110.657 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -79.3 -22.19 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.22 -37.81 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.74 -39.85 95.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.15 -40.55 90.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.935 0.398 . . . . 1.0 110.05 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -63.05 -45.72 90.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -65.34 -41.26 94.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -63.6 -36.4 83.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.483 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.0 86.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.965 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.03 -37.25 73.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 1.0 110.613 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.3 -32.97 74.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.194 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.18 -39.52 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.389 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.9 tp -61.89 -42.79 99.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.273 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -53.95 -39.75 66.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.97 -37.77 86.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.527 -0.306 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.19 -41.83 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 1.5 tp -60.36 -48.07 83.31 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' B' ' 23' ' ' SER . 81.0 mm-40 -64.68 -41.96 95.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.233 0.539 . . . . 1.0 109.745 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.64 -26.69 68.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' LEU . . . -64.67 -37.51 87.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.248 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 97.9 p -58.86 -45.36 90.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.556 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.66 -30.75 71.49 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.45 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 29' ' ' ALA . 29.1 mmtp -79.3 -42.88 24.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.45 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.17 -47.99 77.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.441 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 28' ' ' GLU . 8.3 p -61.75 -45.88 97.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.509 . . . . 1.0 109.971 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.564 ' N ' HG13 ' B' ' 27' ' ' VAL . 79.9 tt0 -71.18 -21.22 62.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -58.49 -40.47 82.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.963 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 27.3 mp0 -65.93 -36.4 83.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 1.0 110.294 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -66.79 90.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.431 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 126.72 -15.31 6.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.28 19.17 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 87.2 Cg_endo -76.42 118.42 4.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.075 1.85 . . . . 1.0 112.235 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.8 37.68 1.13 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.89 143.34 32.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.64 -51.3 0.09 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.232 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.581 ' C ' HD23 ' B' ' 38' ' ' LEU . 5.0 tt -60.96 -60.29 4.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.981 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' B' ' 40' ' ' SER . 44.9 pt 31.56 -145.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 123.436 0.46 . . . . 1.0 110.729 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.464 ' O ' ' O ' ' B' ' 39' ' ' ILE . 19.3 m 57.39 144.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.331 0.586 . . . . 1.0 111.162 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.54 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 2.7 m-85 -100.58 -64.37 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.763 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 23.3 Cg_endo -58.85 -23.49 67.53 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.293 1.995 . . . . 1.0 112.432 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -90.76 -21.18 21.67 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.677 0.275 . . . . 1.0 110.697 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.69 88.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.841 0.353 . . . . 1.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.409 ' H ' HG22 ' B' ' 45' ' ' ILE . 5.9 tt -61.8 -36.49 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.216 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.504 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.6 OUTLIER -67.77 -43.16 80.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.421 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.464 ' CD1' ' OE2' ' B' ' 50' ' ' GLU . 19.5 t90 -61.6 -41.6 97.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.731 0.3 . . . . 1.0 110.669 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 m -60.94 -38.11 84.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.475 -0.49 . . . . 1.0 110.581 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.75 -44.41 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.464 ' OE2' ' CD1' ' B' ' 47' ' ' TRP . 5.0 pt-20 -55.78 -38.9 70.52 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.709 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.63 ' C ' ' H ' ' B' ' 53' ' ' THR . 6.0 t -87.34 -152.44 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.216 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 58.94 -9.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.475 0.179 . . . . 1.0 110.663 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.63 ' H ' ' C ' ' B' ' 51' ' ' THR . 67.0 p -113.06 15.32 19.6 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.648 0.261 . . . . 1.0 110.937 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.07 66.5 1.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.916 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.529 HG13 ' N ' ' B' ' 56' ' ' GLY . 9.9 p -147.56 -46.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.758 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 44.73 78.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -45.23 94.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.681 0.277 . . . . 1.0 110.502 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.65 3.63 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.644 -0.983 . . . . 1.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 99.5 m-20 -62.51 -41.43 98.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.363 . . . . 1.0 110.688 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -117.11 -173.17 2.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -139.57 99.4 7.77 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.615 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.12 160.52 48.39 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.375 1.383 . . . . 1.0 112.285 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.537 HG12 ' H ' ' B' ' 64' ' ' THR . 0.9 OUTLIER -79.24 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.588 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 66' ' ' GLU . 1.8 m -115.35 -67.82 0.97 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.288 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.438 ' N ' HG22 ' B' ' 64' ' ' THR . 80.7 tt0 -34.02 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.224 0.535 . . . . 1.0 110.701 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.867 ' O ' ' N ' ' B' ' 68' ' ' ARG . 91.8 mt-10 -147.85 -107.07 0.09 Allowed 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.549 -0.75 . . . . 1.0 109.359 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 23.06 -56.54 0.0 OUTLIER Glycine 0 N--CA 1.478 1.49 0 O-C-N 124.635 1.209 . . . . 1.0 114.355 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.867 ' N ' ' O ' ' B' ' 66' ' ' GLU . 36.6 ttt180 -72.13 -46.09 57.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' B' ' 66' ' ' GLU . 84.5 tttt -64.16 -34.2 77.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.832 -1.173 . . . . 1.0 107.832 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.71 -44.66 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.96 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.6 76.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.234 -0.439 . . . . 1.0 109.936 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -52.39 -50.47 62.4 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.898 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.47 -48.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.516 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 55' ' ' VAL . 78.2 mtm -61.52 -47.62 84.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.785 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' B' ' 80' ' ' GLU . 51.6 tttp -66.44 -40.51 89.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.521 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.7 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.78 94.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.55 -43.17 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.001 -0.28 . . . . 1.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -58.59 -47.39 84.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.061 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.84 -50.37 75.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.619 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -67.9 -37.21 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.689 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.03 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.32 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' B' ' 86' ' ' THR . 3.6 tt -61.59 -42.03 98.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.477 HG13 ' HB1' ' B' ' 8' ' ' ALA . 26.2 t -49.09 -21.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.406 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.5 m -48.77 -21.07 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' B' ' 91' ' ' THR . . . -58.55 -54.52 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 1.0 111.024 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.71 89.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.828 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.519 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.0 mm? -63.04 -42.75 99.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.412 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -64.35 -35.74 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.437 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -82.57 -4.36 57.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.535 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.567 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 36.6 t0 -57.93 -48.75 78.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.57 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 10.7 p90 -67.14 -32.44 73.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.008 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.68 -43.71 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.76 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -57.37 -21.62 37.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.487 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -58.97 -33.07 70.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.068 0.461 . . . . 1.0 109.936 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.836 -178.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.883 0.373 . . . . 1.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 15.2 p80 -66.83 -37.48 84.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.7 tt0 -62.69 -35.69 80.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.677 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.04 -39.7 95.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.01 -40.15 94.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.323 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.78 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.368 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.25 -36.54 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.371 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.42 -38.69 88.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.35 85.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.11 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.53 -39.49 93.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 1.0 111.011 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -63.55 -38.72 92.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.644 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.98 -32.38 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.546 HD11 ' HB1' ' C' ' 52' ' ' ALA . 45.5 tp -62.28 -38.52 89.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 1.0 110.315 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.62 -33.44 74.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.202 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.55 -46.95 83.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.697 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 18' ' ' VAL . 10.8 m -63.86 -37.6 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.81 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.9 mt -62.15 -41.87 98.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.0 mt-10 -64.49 -43.22 94.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.35 -39.41 71.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.313 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.4 84.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.0 p -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.413 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -65.56 -39.93 92.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.236 0.541 . . . . 1.0 109.965 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.2 mttp -66.8 -43.97 82.45 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.054 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -54.39 -53.56 52.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.748 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.433 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.3 p -58.12 -44.81 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.66 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.433 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.7 tt0 -68.34 -33.88 75.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.405 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' C' ' 26' ' ' ALA . 4.5 mp0 -81.79 -13.17 58.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.657 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.74 89.62 0.11 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.842 0.354 . . . . 1.0 110.425 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.08 20.05 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.3 140.47 72.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.438 ' O ' HG11 ' C' ' 63' ' ' VAL . 94.2 Cg_endo -76.26 141.34 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.936 1.758 . . . . 1.0 112.33 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.01 65.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.228 -0.749 . . . . 1.0 111.228 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 134.37 44.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.885 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.41 -22.73 16.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.356 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 tp -107.37 112.15 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.9 pt -139.26 -3.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.263 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -76.36 154.62 34.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.512 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 11.3 m-85 -96.18 -63.17 0.12 Allowed Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.3 Cg_endo -59.28 -36.12 95.52 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.99 1.794 . . . . 1.0 112.528 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.402 ' O ' ' NH1' ' C' ' 60' ' ' ARG . 90.8 m-20 -81.39 -7.11 59.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.257 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.47 87.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 1.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.448 HG23 ' N ' ' C' ' 46' ' ' TRP . 16.3 tt -65.5 -38.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.448 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.6 OUTLIER -54.78 -48.82 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.226 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.403 ' O ' ' N ' ' C' ' 49' ' ' VAL . 3.5 t90 -61.64 -41.18 97.14 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.682 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.454 ' O ' HD22 ' C' ' 19' ' ' LEU . 2.2 t -68.39 60.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.645 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' C' ' 47' ' ' TRP . 73.0 t -150.66 -56.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.085 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.405 ' HB3' HH12 ' D' ' 68' ' ' ARG . 9.1 pt-20 -64.36 -30.55 71.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.584 -0.446 . . . . 1.0 110.693 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 98.9 m -62.31 -46.62 87.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.25 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.713 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.48 -26.31 66.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.66 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' C' ' 54' ' ' THR . 47.3 p -91.21 5.25 49.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.96 0.41 . . . . 1.0 110.076 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 53' ' ' THR . 43.4 p 52.4 74.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.416 HG11 ' CE1' ' C' ' 57' ' ' TYR . 62.1 t -139.24 -68.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.294 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.13 75.23 0.48 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.416 ' CE1' HG11 ' C' ' 55' ' ' VAL . 37.4 m-85 -59.95 -45.98 90.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.69 0.281 . . . . 1.0 110.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.43 10.57 1.87 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' D' ' 61' ' ' TYR . 99.4 m-20 -60.02 -46.77 88.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 1.0 110.405 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' C' ' 43' ' ' ASP . 53.6 mtm180 -143.01 166.86 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.02 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -156.65 127.24 3.47 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.599 -0.44 . . . . 1.0 110.542 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.67 152.57 64.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.802 1.668 . . . . 1.0 112.236 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' C' ' 64' ' ' THR . 2.4 t -84.28 -134.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.24 -0.436 . . . . 1.0 109.949 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' C' ' 63' ' ' VAL . 72.3 m -114.59 -37.97 4.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.734 0.302 . . . . 1.0 110.721 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.2 tt0 -66.55 -28.2 68.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.469 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.445 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -72.17 26.05 0.05 Allowed 'General case' 0 C--O 1.264 1.82 0 CA-C-O 123.509 1.623 . . . . 1.0 110.36 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.44 64.06 1.93 Allowed Glycine 0 C--O 1.214 -1.095 0 CA-C-O 117.889 -1.506 . . . . 1.0 111.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' B' ' 59' ' ' ASP . 58.9 ttm-85 -24.41 -31.52 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.961 0.881 . . . . 1.0 111.368 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' C' ' 67' ' ' GLY . 14.5 mptt -49.5 -21.53 0.98 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.791 -0.641 . . . . 1.0 109.354 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 76.8 t -61.72 -49.52 83.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.9 -36.25 69.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.029 0.442 . . . . 1.0 110.696 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.34 -42.09 86.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.913 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.02 -41.1 97.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.086 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.31 -43.6 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.39 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 20.7 mtm -60.9 -44.08 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.125 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.57 -38.41 89.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.59 90.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.668 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.19 95.15 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.714 -0.554 . . . . 1.0 111.714 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.29 -43.14 97.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.51 -0.406 . . . . 1.0 110.982 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.97 -50.37 74.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.809 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' N ' ' C' ' 82' ' ' PHE . 12.0 m -61.84 -49.45 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.918 -0.313 . . . . 1.0 111.363 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.464 ' N ' HG23 ' C' ' 81' ' ' VAL . 32.5 m-85 -69.34 -40.13 77.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.019 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.519 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -64.94 -36.09 83.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 1.0 110.614 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.7 tt -62.55 -41.08 98.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.53 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -46.37 -19.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.533 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.9 m -51.94 -40.36 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -49.35 -27.48 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.243 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.58 -16.63 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.612 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' C' ' 86' ' ' THR . 55.3 mt -87.86 -44.07 11.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.164 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.15 -23.84 50.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.936 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -85.93 -4.42 59.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.898 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 94.3 m-20 -60.07 -45.27 93.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.698 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HB1' ' D' ' 90' ' ' ALA . 7.1 p90 -76.03 -28.6 57.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.067 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.81 -42.61 89.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.468 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -55.66 -21.8 19.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.198 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 42.6 ptt85 -50.74 -41.84 56.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 1.0 110.474 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 9.4 tm-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.694 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.651 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.866 0.365 . . . . 1.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 3' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 16.6 p-10 -77.01 -37.74 54.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.129 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.651 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 14.1 p-80 -65.59 -34.83 79.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.01 -38.84 92.8 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.573 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 6' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' D' ' 2' ' ' ALA . 84.2 mtt85 -64.24 -38.98 92.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.598 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -66.2 -40.15 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.175 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.85 92.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.772 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.84 -40.43 91.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 1.0 110.56 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.73 -35.66 81.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.516 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.68 79.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.966 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.16 -39.53 94.2 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.683 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.22 -36.44 83.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.65 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -63.99 -36.05 82.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.427 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -62.4 -41.38 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.643 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.86 -44.78 78.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.699 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.4 -40.09 96.28 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.204 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -49.02 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.98 -30.19 62.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.415 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -66.26 -49.92 65.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.669 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.17 -40.42 95.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' D' ' 26' ' ' ALA . . . -65.45 -34.15 77.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.823 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' D' ' 48' ' ' SER . 26.0 m -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.814 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -63.68 -39.07 93.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.46 -0.496 . . . . 1.0 110.036 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.73 -18.25 44.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.135 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -58.6 -50.23 74.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.382 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' D' ' 44' ' ' ALA . 28.9 t -65.65 -43.8 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.54 -30.76 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.32 -34.11 71.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.535 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' D' ' 32' ' ' GLY . 79.0 mm-40 -63.83 -46.87 83.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -46.21 95.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.433 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 126.93 -5.7 7.38 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -105.48 146.52 32.94 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.912 0.356 . . . . 1.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.627 ' O ' HG11 ' D' ' 63' ' ' VAL . 81.2 Cg_endo -75.64 117.34 4.73 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.113 1.875 . . . . 1.0 112.49 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 35' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' D' ' 37' ' ' ALA . . . 103.52 -22.67 35.23 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' D' ' 37' ' ' ALA . . . 46.93 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.694 0.283 . . . . 1.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 37' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' D' ' 36' ' ' ALA . . . 82.44 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -73.07 53.21 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.89 0.376 . . . . 1.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.8 tt -105.16 111.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.065 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.546 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 17.3 t 179.45 -118.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.125 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.7 m-85 177.27 -66.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.298 -0.26 . . . . 1.0 110.298 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -59.03 -31.16 95.15 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.024 1.816 . . . . 1.0 111.666 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -84.21 -9.19 58.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 44' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.24 -42.32 99.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.87 0.367 . . . . 1.0 110.516 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -67.68 -39.3 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.691 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -46.95 86.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.441 ' CD2' ' C ' ' D' ' 47' ' ' TRP . 0.3 OUTLIER -70.78 -20.76 62.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.232 -0.587 . . . . 1.0 109.604 178.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' D' ' 23' ' ' SER . 22.8 t -74.56 -40.49 61.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.106 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.89 -47.76 91.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -66.78 -37.61 84.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.118 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -62.45 -44.57 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.008 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.7 -25.42 62.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.413 ' OG1' HG23 ' D' ' 55' ' ' VAL . 21.8 p -97.77 9.81 41.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.203 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p 43.88 44.62 5.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.225 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' D' ' 53' ' ' THR . 94.9 t -86.83 -54.57 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.843 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.57 57.15 3.37 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.616 ' CG ' ' CD1' ' A' ' 61' ' ' TYR . 5.6 t80 -61.91 -41.79 98.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 1.0 110.491 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.19 -14.63 0.22 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.548 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -40.43 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.886 0.375 . . . . 1.0 110.958 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -132.39 156.62 46.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.103 -0.498 . . . . 1.0 109.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.51 ' CD2' ' OD1' ' C' ' 59' ' ' ASP . 5.6 p90 -149.3 153.28 37.32 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.81 160.04 51.3 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.299 1.999 . . . . 1.0 111.993 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.627 HG11 ' O ' ' D' ' 34' ' ' PRO . 18.2 t -90.05 -116.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.578 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.499 ' N ' HG12 ' D' ' 63' ' ' VAL . 60.7 m -116.23 -77.55 0.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.815 0.341 . . . . 1.0 110.95 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' D' ' 33' ' ' ALA . 52.5 tp10 -46.92 120.77 3.21 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.064 -0.717 . . . . 1.0 109.064 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.871 ' O ' ' N ' ' D' ' 68' ' ' ARG . 96.9 mt-10 55.09 -96.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.91 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.19 -55.68 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 O-C-N 125.086 1.491 . . . . 1.0 114.085 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.871 ' N ' ' O ' ' D' ' 66' ' ' GLU . 57.7 ttm-85 -80.04 -58.5 3.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.539 . . . . 1.0 109.87 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' D' ' 66' ' ' GLU . 99.0 mttt -43.46 -40.78 3.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.71 -46.9 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.536 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -49.84 68.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -44.18 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.863 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -67.14 -40.28 86.69 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.937 -0.305 . . . . 1.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.98 -47.65 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.509 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 18.5 ptp -62.6 -39.46 93.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.264 . . . . 1.0 111.083 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.61 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.667 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.468 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.1 -38.8 92.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.597 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.87 -41.25 95.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.568 -0.613 . . . . 1.0 111.568 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.78 -43.55 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.652 0.226 . . . . 1.0 111.394 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.38 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.072 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 77' ' ' ALA . 66.9 t -63.48 -46.07 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.448 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.42 -8.41 50.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.801 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.36 -27.22 12.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.81 0.338 . . . . 1.0 110.147 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' D' ' 86' ' ' THR . 6.0 tt -65.03 -37.55 87.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.275 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.8 -5.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.462 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' D' ' 84' ' ' LEU . 65.5 m -58.82 -42.91 90.33 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.954 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' C' ' 92' ' ' ASP . . . -42.39 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.767 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -102.97 -32.33 9.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.174 0.511 . . . . 1.0 110.028 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' D' ' 86' ' ' THR . 58.2 mt -69.76 -39.34 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.715 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.576 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.28 -49.51 77.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.707 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -11.83 43.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.66 -49.33 78.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.786 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 17.2 p90 -76.24 -22.56 55.04 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.38 -42.64 94.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.776 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -50.41 -21.78 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.723 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -55.58 -43.57 76.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.252 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.323 . . . . 1.0 110.476 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -162.67 -37.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.461 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -81.08 -26.6 36.14 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.605 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.62 -32.49 73.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.592 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -60.38 -42.68 96.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.192 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -63.29 -45.34 91.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.072 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -66.59 -39.71 88.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.393 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 57.2 tt0 -64.55 -39.83 94.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.59 -36.78 85.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.96 66.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.226 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 1.0 110.722 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 57.3 mp0 -66.23 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.436 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.572 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.2 tp -62.31 -42.44 99.37 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.66 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.95 -33.06 72.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.068 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 17' ' ' LYS . 5.3 ttmm -61.58 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.269 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.74 -40.94 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.52 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -59.28 -41.24 88.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.31 -47.02 87.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.624 -0.43 . . . . 1.0 109.86 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.69 -34.2 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.008 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.793 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.1 p -59.41 -44.0 92.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 1.0 109.968 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.25 -40.19 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 29' ' ' ALA . 70.1 mmtt -66.83 -42.48 85.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.14 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.922 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.2 p -62.02 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.477 -0.489 . . . . 1.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 98.2 mt-10 -67.25 -39.54 86.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.429 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -62.02 -49.24 76.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.113 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 38' ' ' LEU . 5.8 tm-20 -69.67 -41.41 75.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.059 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -54.71 90.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.604 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 121.2 3.7 10.46 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.65 122.99 45.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 122.689 -0.301 . . . . 1.0 110.55 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.44 141.96 26.0 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.881 1.721 . . . . 1.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.71 15.4 81.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.15 -162.06 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 1.0 110.545 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -171.65 -4.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.616 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 38' ' ' LEU . 4.9 tt -99.1 89.03 4.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.034 0.445 . . . . 1.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 17.4 pt -122.76 165.66 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 81.98 135.55 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.442 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.5 t80 -75.12 -45.95 4.7 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.763 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.7 Cg_endo -60.31 -27.25 84.49 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.554 1.503 . . . . 1.0 112.501 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.73 -27.95 19.72 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.011 -0.275 . . . . 1.0 110.898 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.66 -42.07 94.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.881 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.687 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.2 OUTLIER -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.109 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.539 ' CD1' ' OE2' ' A' ' 50' ' ' GLU . 26.6 t90 -60.09 -39.82 87.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.471 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.8 m -56.09 -36.7 68.43 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.55 71.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.843 0.354 . . . . 1.0 111.293 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE2' ' CD1' ' A' ' 47' ' ' TRP . 10.6 pt-20 -173.96 -40.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.175 0.512 . . . . 1.0 109.668 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.47 HG23 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -68.8 -39.74 79.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.148 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.23 -24.0 51.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.481 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 50' ' ' GLU . 72.0 p -86.41 -3.16 58.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.4 p 52.49 38.84 26.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.084 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 ' OG1' ' A' ' 53' ' ' THR . 25.2 m -102.76 -35.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.631 -0.259 . . . . 1.0 110.883 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.0 73.82 0.37 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -44.08 97.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.336 . . . . 1.0 110.415 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.66 20.38 5.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.514 -1.034 . . . . 1.0 110.514 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.7 m-20 -62.8 -40.09 96.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.297 . . . . 1.0 110.411 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -132.3 164.41 26.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 109.923 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 12.5 p90 -151.66 90.83 3.89 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.675 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.69 166.53 27.19 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.736 1.624 . . . . 1.0 112.271 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.487 HG22 ' OE2' ' A' ' 66' ' ' GLU . 16.8 m -98.75 -124.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.585 HG22 ' CD1' ' D' ' 46' ' ' TRP . 66.5 p -114.33 -37.18 4.43 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -57.94 -26.04 61.74 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.61 -0.436 . . . . 1.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.487 ' OE2' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -87.33 29.64 0.84 Allowed 'General case' 0 C--O 1.26 1.645 0 CA-C-O 123.678 1.704 . . . . 1.0 109.199 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 38.16 65.21 0.72 Allowed Glycine 0 C--O 1.212 -1.258 0 CA-C-N 113.494 -1.685 . . . . 1.0 111.714 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.632 ' NH2' ' CE3' ' D' ' 46' ' ' TRP . 0.0 OUTLIER -22.93 -31.2 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.028 0.914 . . . . 1.0 111.507 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.2 mttt -56.79 -12.3 1.84 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.241 -0.89 . . . . 1.0 108.973 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 67' ' ' GLY . 41.3 t -60.35 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 119.507 -0.877 . . . . 1.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.91 -38.4 66.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.591 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -56.19 -39.63 72.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.577 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.38 -42.2 92.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.249 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.47 HG11 HG23 ' A' ' 51' ' ' THR . 58.1 t -63.81 -46.52 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.296 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 63.0 mtm -63.35 -40.79 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.721 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.43 -45.0 96.14 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.439 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.85 -45.11 96.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -43.08 96.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.665 0.269 . . . . 1.0 110.418 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.62 -41.66 90.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.462 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.81 -55.31 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.699 -0.4 . . . . 1.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.07 -41.21 99.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.068 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.4 87.46 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.008 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.2 tt -62.99 -41.23 99.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.53 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 85' ' ' VAL . 71.6 t -49.18 -10.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.44 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' ALA . 70.8 m -51.72 -44.22 63.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.354 . . . . 1.0 110.078 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.97 -20.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.827 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.15 -33.44 8.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.857 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.8 mt -69.8 -39.24 76.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.216 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.65 -49.84 75.89 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.256 0.55 . . . . 1.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -3.38 1.48 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.686 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.25 -42.83 96.13 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.98 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.567 ' CG ' ' OG1' ' B' ' 91' ' ' THR . 31.2 p90 -85.25 -26.04 26.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.635 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -55.23 -29.51 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.239 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -65.79 -21.16 66.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 1.0 110.937 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.453 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.0 ptt-85 -50.34 -42.82 53.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.642 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.453 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 82.0 tt0 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.795 0.331 . . . . 1.0 110.648 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -65.31 -32.33 73.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.437 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.06 -35.99 82.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.07 -39.19 93.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.26 -40.65 96.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.82 99.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.614 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.77 -37.72 82.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.44 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -61.75 -38.5 88.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.65 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.54 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.33 -40.9 97.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 1.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.01 -38.62 91.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 1.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -62.69 -32.18 73.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.57 -42.03 99.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -57.88 -39.62 78.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.774 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.65 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.73 -34.3 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.905 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.3 mt -61.02 -40.39 93.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.91 -47.5 85.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -70.63 -32.09 69.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.054 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.13 80.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.265 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.9 t -60.18 -43.34 95.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.799 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.62 -55.55 33.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.137 0.494 . . . . 1.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.46 -44.11 97.19 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.082 -0.647 . . . . 1.0 110.639 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.47 -48.72 78.38 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.704 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 40' ' ' SER . 0.8 OUTLIER -65.61 -42.52 93.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.424 . . . . 1.0 110.375 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.413 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 95.5 mt-10 -69.67 -43.34 72.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.128 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.17 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -72.91 -22.4 60.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -77.88 122.25 25.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.955 0.407 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.15 2.79 57.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.377 -0.689 . . . . 1.0 111.377 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.7 149.46 37.13 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.533 -0.173 . . . . 1.0 110.533 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.27 143.41 28.21 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.073 1.849 . . . . 1.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.71 28.9 74.07 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.284 -0.726 . . . . 1.0 111.284 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 139.43 57.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 1.0 110.278 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.82 -40.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.999 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 tp -68.02 -21.73 65.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.28 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.515 HG23 ' O ' ' B' ' 39' ' ' ILE . 12.5 tt -43.27 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 1.8 p 163.85 109.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.557 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.449 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.7 m-85 -56.72 -60.27 9.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.087 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.8 Cg_endo -57.84 -35.51 98.75 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.058 1.839 . . . . 1.0 112.771 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.73 -20.53 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.526 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.36 -39.3 92.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.951 0.405 . . . . 1.0 109.988 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.405 ' H ' HG22 ' B' ' 45' ' ' ILE . 8.1 tt -67.02 -37.82 80.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.409 ' CD1' ' NE ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -46.89 79.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.422 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -62.78 -40.45 97.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.26 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' B' ' 44' ' ' ALA . 6.7 m -50.9 -22.76 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.755 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.88 -21.04 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.809 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' B' ' 55' ' ' VAL . 80.9 mm-40 -93.79 16.97 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.899 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.73 -39.02 1.65 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.744 0.307 . . . . 1.0 111.14 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.35 -29.17 70.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.294 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.54 ' OG1' HG13 ' B' ' 55' ' ' VAL . 18.7 p -90.31 9.11 30.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 1.0 110.734 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.8 p 51.32 42.04 28.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.597 HG11 ' SD ' ' C' ' 75' ' ' MET . 19.0 m -97.29 -44.78 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.673 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.566 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.31 64.57 1.3 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -60.97 -47.13 87.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 1.0 110.907 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.4 10.68 1.24 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -57.51 -66.1 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.388 . . . . 1.0 110.568 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.442 HH21 ' NH2' ' C' ' 68' ' ' ARG . 52.4 mtm180 -137.04 142.42 42.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.991 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' B' ' 61' ' ' TYR . 6.1 p90 -126.31 136.24 28.31 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.297 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.52 164.67 33.42 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.889 1.726 . . . . 1.0 112.063 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 66' ' ' GLU . 22.2 m -91.98 -140.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.223 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.687 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.4 m -114.1 -40.74 3.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.749 0.309 . . . . 1.0 111.129 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.642 ' C ' ' H ' ' B' ' 67' ' ' GLY . 79.4 tt0 -66.71 -32.72 74.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.44 ' H ' HG23 ' B' ' 63' ' ' VAL . 0.2 OUTLIER -70.38 30.35 0.04 OUTLIER 'General case' 0 C--O 1.261 1.672 0 CA-C-O 123.715 1.721 . . . . 1.0 110.03 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.42 63.94 1.27 Allowed Glycine 0 C--O 1.21 -1.344 0 CA-C-N 113.972 -1.467 . . . . 1.0 111.585 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.5 ttm-85 -25.0 -33.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.323 1.062 . . . . 1.0 110.862 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.0 mttp -48.5 -18.59 0.25 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' B' ' 67' ' ' GLY . 59.8 t -64.09 -45.55 96.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.724 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.85 -36.2 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.69 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -57.17 -41.12 78.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.947 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -64.18 -42.8 96.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.03 -47.29 88.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.251 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.668 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.03 -38.36 90.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 1.0 110.47 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.87 92.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.535 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.32 -40.92 91.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.93 -43.29 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.838 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.8 -42.45 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.384 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.24 -47.93 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.157 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.51 -11.23 60.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.912 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.08 -25.91 13.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.81 -41.53 97.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.94 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 87' ' ' ALA . 30.8 m -46.69 -26.66 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' B' ' 85' ' ' VAL . 32.4 m -34.53 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -50.49 -65.36 0.57 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.035 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.85 -20.54 35.4 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.48 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 -44.01 97.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.32 -60.93 2.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.766 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.567 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -50.21 -5.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.84 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' B' ' 90' ' ' ALA . 51.0 t0 -60.78 -40.31 92.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 93' ' ' PHE . 1.6 p90 -65.19 -33.56 76.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 1.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.77 -44.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.458 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' B' ' 97' ' ' GLU . 10.5 tpt180 -47.05 -21.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.851 -0.34 . . . . 1.0 111.207 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -46.2 -20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.377 . . . . 1.0 110.217 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' C ' ' B' ' 95' ' ' ARG . 97.0 mt-10 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.138 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.743 0.306 . . . . 1.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 7.2 p80 -172.51 -34.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.627 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 79.8 tt0 -67.31 -41.13 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.745 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -62.28 -42.59 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.55 -39.65 91.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.104 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.98 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.477 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.08 -40.69 82.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.19 -38.16 90.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.311 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.58 78.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.044 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.17 -37.72 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 1.0 110.894 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.84 -35.5 80.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.648 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.06 -36.35 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.676 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.7 tp -62.07 -41.01 97.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.342 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -62.59 -40.63 97.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.54 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.14 -38.63 89.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.815 0.341 . . . . 1.0 111.116 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.38 -40.79 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -59.29 -41.35 88.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.19 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.65 -48.7 80.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.869 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.85 -32.73 71.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.13 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.29 93.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -60.27 -44.11 95.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.508 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.11 -39.14 92.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 1.0 110.12 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -72.46 -47.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.09 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.57 73.16 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.359 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.517 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -60.8 -44.8 98.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.961 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.517 ' N ' HG13 ' C' ' 27' ' ' VAL . 42.7 tp10 -68.05 -36.98 80.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.55 86.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.3 -44.48 68.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.399 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -52.93 97.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.348 . . . . 1.0 110.701 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.63 0.15 15.63 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.176 -0.769 . . . . 1.0 111.176 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.83 140.46 21.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 1.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.2 Cg_endo -76.19 143.69 25.71 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.918 1.746 . . . . 1.0 112.338 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 24.39 69.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.51 140.82 58.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.379 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.08 -34.76 4.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.422 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' C' ' 40' ' ' SER . 1.1 mt -72.2 -2.05 17.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.213 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.545 HG23 ' O ' ' C' ' 39' ' ' ILE . 12.4 tt -46.92 90.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 1.0 110.627 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.519 ' N ' ' O ' ' C' ' 38' ' ' LEU . 70.4 m -167.04 -127.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.008 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.424 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 6.9 t80 174.39 -58.29 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.346 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.7 Cg_endo -58.86 -38.28 89.3 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.835 1.69 . . . . 1.0 112.376 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 14.6 p-10 -91.91 2.97 56.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.5 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.74 98.29 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.771 -0.371 . . . . 1.0 110.507 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.401 HG21 HD13 ' C' ' 45' ' ' ILE . 6.6 tt -68.21 -31.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.59 ' CZ2' ' O ' ' D' ' 63' ' ' VAL . 10.4 t90 -57.91 -47.17 83.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.993 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.468 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.0 OUTLIER -76.17 -22.33 55.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.0 t -67.5 -42.7 82.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.436 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.522 HG11 ' NH1' ' D' ' 68' ' ' ARG . 76.0 t -61.09 -47.9 91.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.74 -31.63 71.67 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.88 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -58.96 -44.94 91.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.2 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.98 -35.23 70.89 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.759 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.524 ' OG1' HG22 ' C' ' 55' ' ' VAL . 68.8 p -75.18 -6.81 51.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 59.33 24.15 12.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.589 HG23 ' N ' ' C' ' 56' ' ' GLY . 18.5 m -87.54 -47.5 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.611 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.589 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 38.43 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.37 -39.88 95.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.793 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.8 16.29 1.29 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.119 -0.793 . . . . 1.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.04 -41.65 99.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 1.0 110.572 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -145.44 176.3 9.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -163.67 127.7 1.87 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.593 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.27 160.02 51.0 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.918 1.745 . . . . 1.0 112.382 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 2.0 t -86.99 -140.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.092 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 54.0 m -114.81 -34.48 5.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' C' ' 67' ' ' GLY . 76.0 tt0 -67.17 -31.52 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -69.57 31.61 0.03 OUTLIER 'General case' 0 C--O 1.262 1.75 0 CA-C-O 123.48 1.61 . . . . 1.0 110.347 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.07 64.72 1.42 Allowed Glycine 0 C--O 1.212 -1.255 0 CA-C-N 114.103 -1.408 . . . . 1.0 111.234 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' C' ' 67' ' ' GLY . 49.6 ttm-85 -23.49 -33.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 117.848 0.824 . . . . 1.0 111.174 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.6 mptm? -49.66 -19.33 0.59 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' C' ' 67' ' ' GLY . 78.1 t -62.94 -46.64 95.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 119.23 -0.988 . . . . 1.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.34 69.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 1.0 110.628 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.75 -44.28 77.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.786 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.21 -43.09 99.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.518 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.73 -47.96 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.738 -0.385 . . . . 1.0 111.129 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.597 ' SD ' HG11 ' B' ' 55' ' ' VAL . 76.8 mtm -64.38 -42.64 96.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.593 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 55.2 tttm -64.68 -39.55 93.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.604 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.421 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.79 -42.49 93.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 1.0 110.47 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -66.63 -42.1 93.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.747 -0.541 . . . . 1.0 111.747 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -44.0 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.84 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 98.0 mt-10 -63.52 -40.32 96.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.279 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 77' ' ' ALA . 63.9 t -64.05 -49.05 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.094 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -67.85 -37.72 82.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.347 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.42 -36.02 81.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.0 110.644 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.7 tt -61.78 -40.05 93.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.517 ' O ' HG12 ' C' ' 85' ' ' VAL . 61.3 t -54.81 -3.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.719 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.505 ' H ' ' C ' ' C' ' 84' ' ' LEU . 66.8 m -59.33 -40.93 87.87 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.685 0.279 . . . . 1.0 110.271 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -52.45 -25.35 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.259 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.13 -11.29 38.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.69 -61.12 1.8 Allowed 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.578 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -42.93 -52.34 5.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.819 0.343 . . . . 1.0 111.045 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.38 -13.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.002 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' C' ' 90' ' ' ALA . 96.8 m-20 -63.52 -47.52 81.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.277 . . . . 1.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 2.2 p90 -67.98 -33.3 74.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 1.0 110.847 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -43.06 94.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.773 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -58.67 -22.44 56.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.394 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' ARG . . . . . 0.446 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 37.9 ptt85 -50.39 -43.11 54.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 1.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 97' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 46.9 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.362 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.878 0.37 . . . . 1.0 110.593 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 3' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 15.2 p-10 -77.73 -41.7 36.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.287 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.496 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.7 p80 -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.873 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -63.75 -37.2 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.693 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.49 -41.51 97.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.666 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -65.81 -37.46 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 1.0 110.059 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.77 -39.56 93.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.499 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.21 -37.61 87.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.554 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.93 91.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.074 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.23 -38.84 92.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 1.0 110.757 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.06 -36.35 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.626 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.78 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.581 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.5 tp -62.67 -41.57 99.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.794 -0.362 . . . . 1.0 110.418 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.05 -36.31 74.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.834 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -60.89 -41.91 96.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.715 0.293 . . . . 1.0 111.042 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.32 -37.43 79.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.0 mt -59.89 -41.65 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.19 -47.47 84.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.016 0.436 . . . . 1.0 110.149 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.48 -34.2 77.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.895 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.11 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.715 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -60.94 -45.99 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.09 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -78.08 -35.8 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 1.0 111.064 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -72.39 -44.87 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.163 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' D' ' 29' ' ' ALA . . . -62.16 -49.76 74.53 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.53 HG13 ' N ' ' D' ' 28' ' ' GLU . 11.4 p -61.44 -43.62 97.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 1.0 109.868 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.53 ' N ' HG13 ' D' ' 27' ' ' VAL . 42.1 tp10 -69.28 -20.78 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.041 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -60.33 -39.04 85.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.077 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 24.0 mp0 -63.97 -38.15 90.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.802 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -57.93 93.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.18 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -9.12 6.9 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.1 146.65 32.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.752 0.276 . . . . 1.0 110.353 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.473 ' O ' HG11 ' D' ' 63' ' ' VAL . 71.7 Cg_endo -75.72 116.47 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.766 1.644 . . . . 1.0 112.199 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.09 37.71 4.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.74 98.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.816 0.341 . . . . 1.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.63 -72.6 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.13 61.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 1.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 tt -90.38 -8.37 10.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.928 0.394 . . . . 1.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -65.69 140.13 58.44 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.543 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.8 OUTLIER -97.68 -61.44 0.12 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.67 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.5 Cg_endo -57.85 -32.04 93.97 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.558 1.505 . . . . 1.0 111.888 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.81 -3.27 58.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 1.0 110.574 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.434 HG22 ' H ' ' D' ' 45' ' ' ILE . 0.0 OUTLIER -66.3 -32.24 57.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.287 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.632 ' CE3' ' NH2' ' A' ' 68' ' ' ARG . 1.7 t-105 -61.18 -47.3 86.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.008 -178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.413 ' CE3' ' N ' ' D' ' 48' ' ' SER . 0.8 OUTLIER -69.86 -37.88 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.413 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 25.3 p -47.12 -34.57 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 1.0 110.323 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.2 -44.71 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.412 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.3 52.84 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.73 -0.471 . . . . 1.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.9 m -156.21 -48.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.468 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.597 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.91 -23.62 46.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.021 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.2 p -93.5 8.37 40.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.281 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.5 p 48.72 32.6 3.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.898 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.427 HG13 ' N ' ' D' ' 56' ' ' GLY . 7.3 p -65.47 -39.49 85.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.101 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.427 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 109.31 -91.21 0.64 Allowed Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' D' ' 57' ' ' TYR . 43.7 p90 -62.91 114.66 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.263 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' D' ' 60' ' ' ARG . . . -126.47 28.24 4.8 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t0 63.76 -6.74 0.22 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.755 0.312 . . . . 1.0 110.789 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' D' ' 58' ' ' GLY . 73.4 mtt-85 -145.87 128.41 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 8.2 p90 -118.55 141.44 29.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.852 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.81 156.78 62.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.314 2.009 . . . . 1.0 112.512 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.59 ' O ' ' CZ2' ' C' ' 46' ' ' TRP . 12.3 t -77.94 -120.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.057 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.487 ' N ' HG12 ' D' ' 63' ' ' VAL . 54.6 m -116.9 -72.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.961 0.41 . . . . 1.0 110.227 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -56.16 127.34 30.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' D' ' 68' ' ' ARG . 94.5 mt-10 58.28 -94.5 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.054 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 24.63 -57.18 0.0 OUTLIER Glycine 0 N--CA 1.48 1.57 0 O-C-N 124.483 1.114 . . . . 1.0 114.193 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.5 ttp85 -83.19 -59.48 2.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -41.08 -36.35 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.49 -46.59 80.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.949 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -66.46 -34.79 78.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.828 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.12 -48.1 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.905 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.82 -38.1 88.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.946 -0.302 . . . . 1.0 111.716 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -62.86 -46.38 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.39 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.41 ' SD ' HG11 ' C' ' 55' ' ' VAL . 77.2 mtm -63.77 -39.89 95.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.613 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.5 98.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.567 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.497 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.99 -39.11 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.91 -42.42 94.91 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.692 -0.563 . . . . 1.0 111.692 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.3 -43.43 98.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.621 0.248 . . . . 1.0 111.148 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.21 -38.63 91.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.899 -0.321 . . . . 1.0 111.36 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.497 HG23 ' O ' ' D' ' 77' ' ' ALA . 56.1 t -62.18 -49.65 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.277 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -67.17 -40.7 86.64 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.692 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.71 76.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.681 HD23 ' C ' ' D' ' 84' ' ' LEU . 7.4 tt -60.95 -41.53 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.086 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.423 ' O ' HG12 ' D' ' 85' ' ' VAL . 98.1 t -47.02 -14.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 1.0 110.258 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.489 ' N ' ' C ' ' D' ' 84' ' ' LEU . 39.6 m -49.6 -39.59 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.071 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.59 -26.98 14.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.63 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.92 -10.76 32.75 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.158 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.4 -59.85 2.1 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.181 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 92' ' ' ASP . . . -42.22 -53.74 3.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 1.0 111.056 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.746 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' D' ' 90' ' ' ALA . 80.1 m-20 -62.0 -45.11 95.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.313 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 0.1 OUTLIER -53.56 -37.14 62.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 1.0 110.489 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' D' ' 97' ' ' GLU . 61.4 t -61.05 -43.66 96.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.135 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -50.92 -21.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.745 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -55.47 -44.04 76.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.137 -0.32 . . . . 1.0 110.137 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 97' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' D' ' 97' ' ' GLU . 55.1 mp0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.857 0.361 . . . . 1.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -159.94 -61.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.416 ' CD2' ' H ' ' A' ' 4' ' ' HIS . 8.7 p80 -77.42 -23.88 50.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.836 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -67.11 -37.79 84.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.803 0.335 . . . . 1.0 110.239 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -60.76 -43.23 98.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.87 -38.89 90.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.085 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.14 99.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.331 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.09 -37.41 85.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.377 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -61.32 -41.96 97.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.283 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.2 83.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.842 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.32 -35.6 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.566 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.43 -37.16 86.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.387 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.19 -32.11 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.637 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.11 -41.73 98.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 1.0 110.504 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.22 -40.43 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.154 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -63.51 -39.85 95.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.864 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -63.11 -42.57 97.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 52' ' ' ALA . 91.9 mt -60.24 -41.41 93.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.319 -0.4 . . . . 1.0 109.944 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.81 -45.68 92.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -69.56 -34.11 73.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.107 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.79 94.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.459 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.1 p -61.77 -43.35 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.21 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.92 -59.68 5.07 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.14 -45.07 96.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.154 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.69 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.483 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 23' ' ' SER . 78.1 t -63.43 -47.23 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.257 -0.577 . . . . 1.0 110.338 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.92 -41.57 67.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.837 -0.62 . . . . 1.0 111.35 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -35.08 65.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.804 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 5.5 mp0 -89.89 -10.18 46.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.632 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -75.24 108.52 8.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.63 61.28 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.504 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.91 142.94 26.11 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.33 143.55 28.18 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.111 1.874 . . . . 1.0 112.443 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.74 -4.44 21.87 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.91 143.25 52.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.846 0.355 . . . . 1.0 110.568 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.17 -26.76 2.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.568 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.66 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.892 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 39' ' ' ILE . 14.5 tt -116.79 89.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.226 0.536 . . . . 1.0 110.439 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER 166.98 134.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.766 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 66.8 m-85 -69.58 -49.41 21.84 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.043 -0.526 . . . . 1.0 112.403 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.3 Cg_endo -60.19 -34.92 93.73 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.486 1.457 . . . . 1.0 113.188 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.7 p-10 -90.5 -24.28 20.7 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 121.062 -0.255 . . . . 1.0 111.08 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -65.1 -38.29 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 1.0 110.581 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' ILE . 2.8 tp -63.35 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.98 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CE2' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -62.49 -45.64 92.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.934 179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -57.53 -39.91 77.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -65.44 -34.78 79.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.4 -46.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.475 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.11 -8.23 56.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.062 0.458 . . . . 1.0 110.428 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -80.61 -45.63 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.328 . . . . 1.0 111.195 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -64.39 -37.57 88.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.609 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -75.12 0.29 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.71 60.98 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 56' ' ' GLY . 8.4 p -130.73 -44.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.682 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 36.12 89.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.731 -0.548 . . . . 1.0 111.731 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.89 -44.42 97.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.343 . . . . 1.0 110.704 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.12 15.76 0.68 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 98.4 m-20 -59.92 -50.39 73.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.337 . . . . 1.0 110.636 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 43' ' ' ASP . 0.9 OUTLIER -138.75 156.28 47.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.976 -0.557 . . . . 1.0 109.875 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -144.08 131.6 10.61 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.674 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.58 -171.62 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.827 1.685 . . . . 1.0 112.198 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 64' ' ' THR . 8.2 p -128.82 -136.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.222 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.855 ' H ' HG22 ' A' ' 63' ' ' VAL . 66.4 m -112.62 -40.23 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.628 0.251 . . . . 1.0 111.341 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.3 tt0 -64.48 -36.12 83.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.461 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 1.2 pp20? -72.66 32.18 0.06 Allowed 'General case' 0 C--O 1.262 1.763 0 CA-C-O 124.537 2.113 . . . . 1.0 109.721 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.25 63.98 1.43 Allowed Glycine 0 C--O 1.212 -1.242 0 CA-C-N 113.612 -1.631 . . . . 1.0 111.098 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.497 HH21 HH22 ' D' ' 60' ' ' ARG . 56.8 ttm-85 -24.12 -34.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.95 0.875 . . . . 1.0 111.334 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.8 mtmt -50.5 -14.25 0.17 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.609 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' GLY . 43.2 t -60.95 -47.68 92.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.156 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -42.48 68.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.353 . . . . 1.0 111.161 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -52.09 -39.64 60.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.85 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -68.97 -41.33 78.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.615 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.96 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.398 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.1 ptp -63.62 -39.55 94.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.773 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -62.73 -42.63 99.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.446 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.96 86.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.361 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -36.73 93.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -26.93 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.135 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.14 -49.76 18.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.724 0.297 . . . . 1.0 111.412 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 82' ' ' PHE . 18.4 m -62.21 -48.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.32 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' N ' HG23 ' A' ' 81' ' ' VAL . 13.1 m-85 -66.0 -40.79 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.707 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.61 84.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 1.0 111.064 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.6 tt -62.16 -41.59 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.346 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 85' ' ' VAL . 81.6 t -46.47 -13.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.559 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' LEU . 94.9 m -55.31 -23.83 25.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -62.28 -29.67 70.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.111 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.52 -11.84 33.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.777 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.27 -47.63 9.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.655 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.89 -24.12 49.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.959 0.409 . . . . 1.0 111.016 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -89.17 -3.73 58.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.706 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 91.5 m-20 -59.89 -46.48 89.2 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.384 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -81.76 -19.18 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.31 -28.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.405 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 97' ' ' GLU . 96.4 mtt180 -63.59 -28.91 70.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -42.41 -23.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.845 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 95' ' ' ARG . 44.1 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 1.0 110.04 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ASP . . . . . 0.471 ' OD1' ' NH2' ' B' ' 6' ' ' ARG . 78.8 m-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.637 0.256 . . . . 1.0 110.436 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -60.97 -45.52 94.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.21 -48.99 75.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.592 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' B' ' 3' ' ' ASP . 88.7 mtm180 -65.42 -41.07 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 1.0 110.768 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.9 -40.24 87.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.166 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.44 96.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.521 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -65.49 -38.03 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.05 -39.07 93.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.684 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.44 67.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.903 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.85 -35.36 80.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 1.0 110.505 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.236 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.15 -37.55 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.599 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.49 -40.92 98.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 1.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.66 -39.34 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.812 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.37 -43.21 99.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.61 -40.84 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.49 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' B' ' 52' ' ' ALA . 32.7 mt -59.03 -42.81 91.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.46 -37.71 85.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.37 -53.11 39.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.415 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -65.93 -43.97 86.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' B' ' 48' ' ' SER . 75.2 m -56.22 -43.91 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.128 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.582 ' O ' HG22 ' B' ' 27' ' ' VAL . 14.9 tmtt? -65.34 -32.84 74.69 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.25 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.98 -34.81 50.71 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.09 -0.244 . . . . 1.0 111.239 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.43 67.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.483 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 24' ' ' LYS . 2.6 m -61.52 -49.08 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.406 -0.517 . . . . 1.0 110.496 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.527 ' N ' HG23 ' B' ' 27' ' ' VAL . 80.6 tt0 -76.35 -35.8 58.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.605 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' B' ' 66' ' ' GLU . . . -59.12 -38.97 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.215 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 40.2 mm-40 -107.82 61.41 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -141.8 80.04 1.7 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 1.0 111.105 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.06 4.41 27.54 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.7 57.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.35 139.6 23.57 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.008 1.806 . . . . 1.0 112.244 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 19.04 74.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' B' ' 30' ' ' GLU . . . -84.05 166.02 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.753 0.311 . . . . 1.0 110.458 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' B' ' 38' ' ' LEU . . . -161.07 -11.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.642 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' B' ' 47' ' ' TRP . 0.9 OUTLIER -87.6 33.26 0.7 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.223 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 pt -71.84 46.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.65 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.3 m -130.96 151.31 51.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.099 0.475 . . . . 1.0 111.065 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.525 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 3.0 m-85 -97.54 -64.5 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.015 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -58.52 -28.03 84.27 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 122.213 1.942 . . . . 1.0 112.525 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -87.56 -2.18 58.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 1.0 110.643 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.02 95.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 1.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.498 ' O ' HG23 ' B' ' 49' ' ' VAL . 6.7 tt -67.79 -39.29 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.765 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.2 OUTLIER -59.5 -49.49 77.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.415 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.479 ' CG ' HD11 ' B' ' 38' ' ' LEU . 5.3 t90 -65.06 -40.78 95.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.465 ' CB ' ' OG ' ' B' ' 23' ' ' SER . 15.2 m -63.15 -39.62 95.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.53 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 45' ' ' ILE . 25.3 t -59.5 -47.31 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.812 0.301 . . . . 1.0 111.812 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 68' ' ' ARG . 15.0 pt-20 -65.41 -30.03 70.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -64.39 -44.75 90.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.615 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.531 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.02 -25.54 61.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.286 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.51 ' OG1' HG23 ' B' ' 55' ' ' VAL . 33.3 p -90.65 4.08 52.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.805 0.336 . . . . 1.0 110.583 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 17.9 p 54.42 9.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.635 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.51 HG23 ' OG1' ' B' ' 53' ' ' THR . 67.6 t -63.97 -45.85 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.698 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.31 57.61 5.59 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -60.4 -49.29 78.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.371 . . . . 1.0 110.938 -178.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 158.73 -92.46 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 69.1 m-20 44.16 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.614 0.245 . . . . 1.0 110.611 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.593 ' NH2' ' NH2' ' C' ' 68' ' ' ARG . 1.1 mpp_? -114.87 161.52 18.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.494 ' O ' ' CD2' ' B' ' 61' ' ' TYR . 16.6 p90 -141.58 105.1 5.89 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.384 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 163.21 38.62 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.525 1.483 . . . . 1.0 112.308 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 1.052 HG22 ' H ' ' B' ' 64' ' ' THR . 9.6 p -106.03 -154.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.352 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' THR . . . . . 1.052 ' H ' HG22 ' B' ' 63' ' ' VAL . 9.9 m -88.7 -53.45 4.62 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.65 0.262 . . . . 1.0 111.632 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.3 tt0 -42.09 -36.36 1.13 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.776 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.576 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -72.73 22.85 0.06 Allowed 'General case' 0 C--O 1.267 1.974 0 CA-C-O 124.283 1.992 . . . . 1.0 109.782 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.728 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 42.99 65.46 1.41 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.704 -1.609 . . . . 1.0 111.463 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.576 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -26.66 -28.55 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.067 0.934 . . . . 1.0 110.863 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.3 mttt -45.43 -26.31 0.53 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 67' ' ' GLY . 3.8 p -63.13 -43.63 98.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.627 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -79.37 -37.91 36.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.608 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -58.59 -40.19 82.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -63.71 -44.04 94.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.502 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 95.2 t -63.17 -48.23 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.891 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.1 mtm -63.03 -43.71 97.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.281 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -64.51 -40.84 96.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.161 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -63.04 -40.23 97.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.729 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.86 95.84 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.09 -43.75 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.781 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.14 -42.99 99.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 1.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 77' ' ' ALA . 71.8 t -63.63 -46.91 93.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.908 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -74.98 -4.16 36.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.851 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.02 -31.69 10.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.881 0.372 . . . . 1.0 110.052 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -64.98 -39.52 93.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.025 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.02 -5.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.206 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' B' ' 90' ' ' ALA . 53.9 m -58.54 -41.43 85.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -42.23 -54.07 3.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.599 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.96 68.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 86' ' ' THR . 70.0 mt -88.2 -17.63 30.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -70.94 -37.15 72.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.422 HG23 ' H ' ' B' ' 91' ' ' THR . 0.0 OUTLIER -66.8 -24.86 66.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.225 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -49.42 -43.79 44.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.656 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -59.74 -46.49 88.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.946 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.75 -42.32 89.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -49.41 -21.51 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.539 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -50.29 -39.25 44.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 1.0 110.281 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 -179.615 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 3' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' C' ' 6' ' ' ARG . 55.0 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.827 0.346 . . . . 1.0 111.074 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -40.97 -31.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.22 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 1.0 110.632 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 6' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' C' ' 3' ' ' ASP . 73.5 ttp85 -60.63 -43.1 97.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.299 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.08 -38.27 90.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.036 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.89 92.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.629 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.03 -40.98 95.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.52 -37.27 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.495 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.22 93.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.086 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.13 -38.7 89.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 1.0 110.847 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -65.82 -32.16 73.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLU . . . . . 0.472 ' O ' HG23 ' C' ' 18' ' ' VAL . 46.8 tp10 -61.66 -40.64 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.538 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' C' ' 52' ' ' ALA . 55.1 tp -63.29 -39.58 94.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.53 -30.93 71.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.873 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 18' ' ' VAL . . . . . 0.472 HG23 ' O ' ' C' ' 14' ' ' GLU . 42.3 t -63.49 -42.35 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.216 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.4 mt -59.86 -40.32 88.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.359 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.59 -48.88 71.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.849 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.78 -33.46 74.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.897 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.51 82.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -61.78 -46.95 87.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.445 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.56 -36.33 80.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.227 0.536 . . . . 1.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.72 -46.5 53.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.504 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -64.46 -48.46 75.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.395 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.529 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.3 p -59.32 -44.88 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.221 -0.591 . . . . 1.0 109.685 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.529 ' N ' HG13 ' C' ' 27' ' ' VAL . 82.4 tt0 -68.37 -26.96 65.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.37 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' C' ' 67' ' ' GLY . . . -56.16 -51.01 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.14 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 33.3 mp0 -67.54 -36.94 81.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -72.89 92.23 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.89 -19.54 5.81 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.662 . . . . 1.0 111.444 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.51 154.03 39.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.1 150.59 37.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.264 1.976 . . . . 1.0 112.193 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.28 61.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.21 143.51 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 1.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 -39.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.539 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.524 ' C ' HD23 ' C' ' 38' ' ' LEU . 3.5 tt -57.94 -79.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.994 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.617 HG22 ' N ' ' C' ' 40' ' ' SER . 95.4 mt 51.57 167.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.617 ' N ' HG22 ' C' ' 39' ' ' ILE . 1.8 t 81.65 124.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.453 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.503 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 53.4 t80 -88.28 -49.89 0.42 Allowed Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.254 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.9 Cg_endo -60.05 -28.49 87.15 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.343 1.362 . . . . 1.0 112.529 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.48 -13.2 24.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.53 0.205 . . . . 1.0 111.216 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' C' ' 40' ' ' SER . . . -66.89 -37.46 84.44 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.32 -34.69 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.2 OUTLIER -64.95 -48.11 75.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.149 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.524 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 7.6 t90 -61.18 -40.2 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.414 -0.514 . . . . 1.0 109.733 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.498 ' O ' HD22 ' C' ' 19' ' ' LEU . 63.5 p -67.09 45.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.842 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' C' ' 47' ' ' TRP . 71.0 t -137.25 -50.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.535 0.207 . . . . 1.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -69.45 -27.16 65.0 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.445 HG22 ' H ' ' C' ' 51' ' ' THR . 0.1 OUTLIER -59.84 -51.83 68.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.337 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -56.66 -25.37 53.55 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.849 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -90.94 14.21 14.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.799 0.333 . . . . 1.0 110.408 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' C' ' 54' ' ' THR . 0.1 OUTLIER 35.42 77.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.402 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -145.78 -78.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.402 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 75.54 84.73 0.37 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -63.93 -40.98 97.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.622 0.248 . . . . 1.0 110.608 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.99 22.23 0.6 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 99.8 m-20 -61.83 -43.59 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 1.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 77.7 mtt-85 -144.14 -167.58 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.617 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 89.2 m-85 -157.77 123.36 2.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.72 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.86 168.39 21.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.643 1.562 . . . . 1.0 112.255 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 63' ' ' VAL . 2.3 m -91.66 -167.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.088 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.434 ' HA ' ' HE1' ' B' ' 46' ' ' TRP . 2.4 m -101.88 -67.81 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.246 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -38.37 -31.7 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.801 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.8 mt-10 -138.62 -107.62 0.17 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' C' ' 29' ' ' ALA . . . 20.39 -54.79 0.0 OUTLIER Glycine 0 N--CA 1.479 1.567 0 O-C-N 124.513 1.133 . . . . 1.0 114.532 177.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.5 tpp180 -63.06 -58.98 5.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.106 0.562 . . . . 1.0 109.769 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.5 -38.75 88.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.416 ' O ' HG23 ' C' ' 74' ' ' VAL . 72.7 t -64.16 -49.16 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 119.467 -0.893 . . . . 1.0 110.987 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.529 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -67.86 -44.43 77.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 1.0 110.413 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -42.92 -50.62 5.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.919 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.21 -39.26 93.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.416 HG23 ' O ' ' C' ' 70' ' ' VAL . 61.4 t -63.18 -46.6 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.491 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.9 mpp? -62.3 -42.2 99.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -61.34 -36.41 80.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 1.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.01 -43.01 66.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.378 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -38.79 95.3 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' C' ' 83' ' ' ALA . 38.2 mm -61.43 -45.46 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.679 -0.307 . . . . 1.0 110.839 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.0 -44.99 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.308 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.25 -46.98 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.191 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.03 -11.53 59.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.921 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.13 -36.93 17.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 1.0 110.129 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' C' ' 86' ' ' THR . 4.9 tt -66.78 -37.58 84.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.568 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.544 ' O ' HD23 ' C' ' 89' ' ' LEU . 35.1 m -67.06 44.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 1.0 111.099 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.517 ' O ' ' N ' ' C' ' 90' ' ' ALA . 22.7 m -89.53 -42.02 11.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 1.0 110.352 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.533 ' O ' HG23 ' C' ' 91' ' ' THR . . . -52.95 -67.65 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.411 -0.516 . . . . 1.0 111.706 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.479 ' C ' HD22 ' C' ' 89' ' ' LEU . . . -48.64 -16.1 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.35 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.544 HD23 ' O ' ' C' ' 85' ' ' VAL . 3.8 mm? -100.16 -24.28 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.495 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -90.01 -65.36 1.02 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.71 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 87' ' ' ALA . 0.7 OUTLIER -45.32 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.702 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' C' ' 90' ' ' ALA . 89.9 m-20 -52.38 -42.22 63.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.368 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' C' ' 94' ' ' VAL . 2.8 p90 -61.73 -43.72 98.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.408 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 58.2 t -38.78 -27.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.785 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' C' ' 93' ' ' PHE . 95.7 mtt180 -59.89 -23.4 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.688 0.28 . . . . 1.0 111.066 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -58.79 -42.89 90.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.155 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.353 179.688 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.635 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.802 0.334 . . . . 1.0 110.559 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.15 -43.91 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.635 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 10.4 p-80 -69.66 -37.93 76.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.692 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.59 -34.24 77.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.98 -43.24 91.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.457 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -64.76 -38.3 90.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.037 0.446 . . . . 1.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.31 86.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.62 -37.56 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -37.95 85.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.463 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.65 70.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.098 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -64.54 -38.85 92.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.486 -0.324 . . . . 1.0 110.644 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -40.42 93.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 1.0 110.447 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.51 -32.7 74.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.651 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.531 HD11 ' HB1' ' D' ' 52' ' ' ALA . 43.4 tp -62.98 -35.1 79.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.462 . . . . 1.0 110.29 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.13 -33.19 73.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -62.13 -45.36 93.82 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.473 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.09 -37.13 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.755 0.312 . . . . 1.0 110.935 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.1 -41.63 97.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' D' ' 23' ' ' SER . 74.0 mm-40 -66.95 -44.11 81.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 1.0 110.203 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.11 -34.03 76.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.147 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' D' ' 26' ' ' ALA . . . -63.58 -38.86 92.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.25 -43.6 95.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -61.34 -62.46 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.54 -38.11 83.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.765 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' D' ' 22' ' ' ALA . . . -52.12 -51.29 58.77 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.533 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 69.6 t -64.14 -46.26 94.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.409 -0.516 . . . . 1.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.43 -41.33 89.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.525 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' D' ' 66' ' ' GLU . . . -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.045 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 40.3 mm-40 -68.29 -41.85 80.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.822 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -62.69 87.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.014 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.12 7.61 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.332 -0.707 . . . . 1.0 111.332 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.92 135.19 20.51 Favored Pre-proline 0 CA--C 1.537 0.45 0 O-C-N 122.794 -0.239 . . . . 1.0 110.604 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.73 143.25 29.81 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.058 1.839 . . . . 1.0 112.228 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 18.84 75.84 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -61.86 143.07 56.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 1.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.73 -18.48 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.588 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.42 ' O ' HG23 ' D' ' 39' ' ' ILE . 39.2 tp -105.72 117.15 33.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 110.236 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.42 HG23 ' O ' ' D' ' 38' ' ' LEU . 5.1 pt -154.3 89.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.231 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.515 ' O ' ' N ' ' D' ' 44' ' ' ALA . 0.4 OUTLIER 169.57 112.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.98 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.493 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 13.5 m-85 -48.73 -53.96 31.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.76 -30.3 92.19 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.202 1.268 . . . . 1.0 112.013 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.13 -20.08 21.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.036 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 44' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' D' ' 40' ' ' SER . . . -61.16 -42.72 99.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.854 0.359 . . . . 1.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -65.4 -38.06 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.425 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.26 99.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.107 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.435 ' CE3' ' N ' ' D' ' 48' ' ' SER . 1.9 t90 -63.96 -40.15 95.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.466 -0.494 . . . . 1.0 109.975 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.435 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 78.6 p -60.17 -33.25 71.93 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.582 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.53 -44.33 99.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.312 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.461 ' OE2' ' CZ ' ' A' ' 68' ' ' ARG . 74.3 mt-10 -52.36 -31.96 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.575 ' C ' ' H ' ' D' ' 53' ' ' THR . 0.2 OUTLIER -83.39 -163.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . 56.35 0.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.134 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.575 ' H ' ' C ' ' D' ' 51' ' ' THR . 28.8 p -121.28 -1.2 9.74 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' D' ' 53' ' ' THR . 11.8 p 56.88 15.08 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -91.33 -53.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.705 0.288 . . . . 1.0 110.457 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.03 74.45 0.23 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.56 -47.28 86.86 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.974 -0.29 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 155.65 -90.77 0.12 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' D' ' 50' ' ' GLU . 98.0 m-20 44.05 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 1.0 110.424 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.497 HH22 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -124.62 162.54 23.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.736 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -162.75 138.95 5.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.528 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 157.53 57.24 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.893 1.729 . . . . 1.0 112.617 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.792 HG22 ' H ' ' D' ' 64' ' ' THR . 7.4 p -93.81 -121.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.495 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.792 ' H ' HG22 ' D' ' 63' ' ' VAL . 39.9 m -115.0 -35.05 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.757 0.313 . . . . 1.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 67' ' ' GLY . 51.9 tp10 -65.74 -32.09 73.44 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.232 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.519 ' CB ' ' HB1' ' D' ' 29' ' ' ALA . 0.5 OUTLIER -81.09 37.29 0.43 Allowed 'General case' 0 C--O 1.261 1.67 0 CA-C-O 123.349 1.547 . . . . 1.0 108.909 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 39.96 62.4 1.47 Allowed Glycine 0 C--O 1.214 -1.094 0 CA-C-N 113.663 -1.608 . . . . 1.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.537 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.5 ttt85 -24.5 -30.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.133 0.549 . . . . 1.0 111.323 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.5 mttm -53.12 -13.85 0.55 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.214 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.5 t -60.47 -48.73 87.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 C-N-CA 119.437 -0.905 . . . . 1.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.08 76.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.277 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.95 -38.85 92.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.329 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.25 -50.52 72.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.395 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.86 -42.93 89.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.368 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 34.4 ttm -58.08 -47.35 83.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.994 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -65.02 -40.05 94.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.614 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.04 81.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.5 94.64 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.3 -43.34 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.425 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' D' ' 84' ' ' LEU . 97.0 mt-10 -58.55 -50.73 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.836 0.309 . . . . 1.0 111.836 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.422 HG23 ' N ' ' D' ' 82' ' ' PHE . 11.4 m -60.84 -46.11 96.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.516 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' PHE . . . . . 0.422 ' N ' HG23 ' D' ' 81' ' ' VAL . 11.6 m-85 -66.24 -29.58 69.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.592 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -91.04 -20.76 21.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.575 0.226 . . . . 1.0 110.585 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 80' ' ' GLU . 8.0 tt -63.73 -42.03 97.96 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.541 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' D' ' 88' ' ' ALA . 8.7 m -60.18 -18.93 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.058 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.405 ' C ' ' O ' ' D' ' 85' ' ' VAL . 50.9 m -36.29 -28.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -62.97 -46.21 88.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.531 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -67.22 -26.35 66.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.178 0.514 . . . . 1.0 110.241 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.513 HD22 ' N ' ' D' ' 89' ' ' LEU . 4.2 mm? -73.02 -34.73 66.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.9 -45.09 93.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.95 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -4.87 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.006 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 40.7 t0 -59.4 -50.26 74.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.965 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 21.7 p90 -73.96 -26.88 60.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.008 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.98 -26.28 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.219 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -57.32 -22.51 42.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.851 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -62.2 -20.76 64.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.565 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.438 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' CE1' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.813 0.34 . . . . 1.0 110.564 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 66.3 t0 -105.52 -29.04 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.46 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 18.2 p-80 -81.02 -30.27 34.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.711 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.38 -45.69 83.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 1.0 110.813 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.46 -35.1 75.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.33 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.05 -40.32 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.213 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.75 92.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.391 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -63.31 -33.96 76.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.3 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.02 81.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.128 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.45 -39.45 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -62.25 -37.35 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.239 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.7 -31.07 71.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.572 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -42.31 98.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.438 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.99 -39.34 94.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.12 -40.27 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 1.0 111.328 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.17 -41.07 91.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.662 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.4 mt -60.61 -41.61 95.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.73 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.3 -38.39 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.308 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.4 90.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.796 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -60.14 -41.19 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.151 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.31 -30.01 70.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.37 -40.73 20.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.652 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CG ' ' A' ' 30' ' ' GLU . . . -64.83 -40.44 95.19 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.78 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.6 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.5 p -61.47 -50.29 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.608 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.6 ' N ' HG13 ' A' ' 27' ' ' VAL . 15.5 pt-20 -71.03 -43.29 68.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.545 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.99 73.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 21.7 mm-40 -67.72 -39.43 84.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.144 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -71.68 129.91 39.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.909 0.385 . . . . 1.0 110.313 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.02 -12.21 67.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.346 -0.702 . . . . 1.0 111.346 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.68 147.91 47.52 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' O ' HG11 ' A' ' 63' ' ' VAL . 97.8 Cg_endo -75.21 138.88 23.09 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.034 1.822 . . . . 1.0 112.306 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.39 69.22 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.59 54.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 1.0 110.396 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.48 -7.85 8.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.9 tt -107.13 123.1 47.76 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.064 0.459 . . . . 1.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 38' ' ' LEU . 44.3 pt -149.93 -171.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.104 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' ILE . 2.0 m 58.16 145.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.944 0.402 . . . . 1.0 110.623 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 65.0 t80 -82.7 -43.22 0.92 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.13 -0.486 . . . . 1.0 112.116 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.8 Cg_endo -60.4 -28.71 87.28 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.657 1.571 . . . . 1.0 112.829 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.7 p-10 -94.02 -28.92 15.48 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.99 -0.284 . . . . 1.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.17 83.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.271 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.82 -42.41 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.047 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.872 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.1 OUTLIER -62.88 -41.39 99.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.019 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 13.5 t90 -60.15 -39.28 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -72.87 67.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -151.99 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.007 0.432 . . . . 1.0 110.362 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.7 pm0 -48.16 -24.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.539 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -62.31 -43.67 98.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.989 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -28.09 67.77 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.236 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.4 p -84.32 5.63 26.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 48.05 76.61 0.11 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.899 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG22 ' O ' ' B' ' 54' ' ' THR . 94.5 t -138.98 -55.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.879 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.94 77.02 0.19 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.276 -0.73 . . . . 1.0 111.276 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -60.75 -42.77 98.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.46 9.92 1.32 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CG ' HH22 ' B' ' 68' ' ' ARG . 20.8 m-20 -58.1 -50.08 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -147.95 163.89 35.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.46 132.85 7.15 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.446 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.3 163.19 39.59 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.075 1.85 . . . . 1.0 112.394 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.0 t -97.78 -128.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.431 ' H ' HG12 ' A' ' 63' ' ' VAL . 8.6 m -115.01 -36.57 4.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.68 0.276 . . . . 1.0 110.979 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.692 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.4 tt0 -70.79 -39.41 73.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.748 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.79 27.53 0.02 OUTLIER 'General case' 0 C--O 1.265 1.899 0 CA-C-O 123.753 1.74 . . . . 1.0 109.925 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.16 64.35 0.96 Allowed Glycine 0 C--O 1.214 -1.117 0 CA-C-N 114.035 -1.438 . . . . 1.0 111.392 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 33.0 ttm180 -24.93 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.806 0.803 . . . . 1.0 110.969 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -50.44 -16.72 0.38 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.451 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.8 t -61.38 -48.09 90.47 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.342 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' A' ' 75' ' ' MET . . . -70.84 -42.8 69.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.007 0.432 . . . . 1.0 110.442 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.59 -43.17 46.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.474 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -62.26 -39.64 93.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.04 -43.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' A' ' 71' ' ' ALA . 3.4 mpp? -61.63 -40.2 94.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.021 -0.272 . . . . 1.0 110.503 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -61.33 -39.92 92.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.061 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 81' ' ' VAL . . . -51.4 -45.98 62.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.487 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -51.45 53.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.486 -1.046 . . . . 1.0 110.486 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 79' ' ' ILE . 95.6 mt -67.95 -4.78 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.472 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -96.17 -49.72 5.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.427 -0.352 . . . . 1.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 82' ' ' PHE . 28.3 m -70.8 -51.0 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.06 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.625 ' N ' HG23 ' A' ' 81' ' ' VAL . 45.6 m-85 -62.39 -39.18 92.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.073 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.691 ' O ' HD12 ' D' ' 89' ' ' LEU . . . -61.15 -39.57 90.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.715 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.5 tt -63.48 -40.35 96.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.505 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 85' ' ' VAL . 59.1 t -49.7 -11.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.429 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.481 ' N ' ' C ' ' A' ' 84' ' ' LEU . 54.5 m -49.28 -42.49 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 1.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.73 -13.61 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.68 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 86' ' ' THR . . . -104.75 -15.92 15.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.683 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.547 HD13 ' OD2' ' A' ' 92' ' ' ASP . 3.1 mm? -94.84 -46.68 6.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 1.0 110.677 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.03 -22.74 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -3.67 58.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.748 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD2' HD13 ' A' ' 89' ' ' LEU . 86.2 m-20 -61.65 -48.78 79.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.343 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.58 -19.57 45.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.765 0.317 . . . . 1.0 111.454 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.08 -42.73 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.904 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -58.06 -21.53 46.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.712 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -55.1 -42.85 73.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.546 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 97' ' ' GLU . 56.3 mp0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 1.0 110.085 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.722 0.296 . . . . 1.0 110.725 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -73.1 -35.43 66.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.714 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.26 -43.89 89.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.79 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.02 -38.89 92.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.68 -37.56 87.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.43 99.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.758 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.05 -35.73 76.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.334 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.41 -38.54 87.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.32 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.935 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.98 -34.78 78.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.562 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -62.79 -38.35 90.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.137 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.03 -33.05 74.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' B' ' 52' ' ' ALA . 47.8 tp -62.36 -41.92 98.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.506 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.11 -39.11 93.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.89 -44.23 97.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.22 -40.86 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.786 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.3 mt -60.36 -41.69 94.21 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.054 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.3 -48.17 79.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.118 0.485 . . . . 1.0 110.056 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.49 -35.85 75.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.128 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.52 86.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.35 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.5 p -56.58 -44.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.466 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.77 -36.2 82.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -67.98 -44.42 76.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.31 76.76 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.463 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.46 HG23 ' N ' ' B' ' 28' ' ' GLU . 16.9 m -62.82 -45.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.768 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.46 ' N ' HG23 ' B' ' 27' ' ' VAL . 46.2 tp10 -71.9 -42.0 67.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -43.7 -47.38 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.327 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' B' ' 38' ' ' LEU . 96.9 mt-10 -68.21 -116.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.809 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 45.67 79.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.596 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.26 17.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.413 -0.675 . . . . 1.0 111.413 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 149.7 96.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.24 121.27 6.03 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.953 1.769 . . . . 1.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 92.83 -23.06 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 49.94 175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 1.0 110.579 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.77 -85.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.552 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.529 ' N ' ' OE2' ' B' ' 30' ' ' GLU . 44.9 tp -89.93 82.3 6.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.594 HG23 ' O ' ' B' ' 39' ' ' ILE . 15.2 tt -125.97 102.07 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.963 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.516 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 73.4 m -169.94 -124.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' B' ' 40' ' ' SER . 2.3 m-85 -174.77 -65.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.0 109.995 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.15 -36.94 97.44 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.088 1.859 . . . . 1.0 112.175 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -92.98 0.91 57.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.617 -0.265 . . . . 1.0 111.145 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.06 93.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.003 0.43 . . . . 1.0 110.343 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -69.47 -36.61 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.546 ' O ' ' NH2' ' C' ' 68' ' ' ARG . 1.1 t90 -46.54 -68.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.647 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.467 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -57.16 -27.18 61.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.059 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.467 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -65.47 -41.77 92.97 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.701 -0.399 . . . . 1.0 111.347 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.572 ' CG1' HH12 ' C' ' 68' ' ' ARG . 55.5 t -60.95 -47.74 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.06 -31.59 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -60.5 -45.38 94.0 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.735 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.22 -27.57 55.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.813 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -85.43 1.52 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.723 0.297 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.6 p 53.41 15.69 0.75 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.005 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' N ' ' B' ' 56' ' ' GLY . 5.7 p -66.36 -44.69 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.02 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.496 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 46.3 65.22 2.19 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.47 -1.052 . . . . 1.0 110.47 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -58.98 -48.47 81.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 1.0 110.743 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.69 6.82 1.96 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -58.93 -45.62 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.644 0.259 . . . . 1.0 110.419 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -145.19 173.22 12.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -155.95 130.33 4.92 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.41 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.02 156.92 63.79 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.769 1.646 . . . . 1.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.51 HG12 ' H ' ' B' ' 64' ' ' THR . 1.8 t -84.03 -141.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.171 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.872 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.8 m -114.36 -46.54 2.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.24 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.9 tp10 -64.5 -29.18 70.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.355 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.3 OUTLIER -70.84 32.18 0.04 OUTLIER 'General case' 0 C--O 1.261 1.663 0 CA-C-O 123.889 1.804 . . . . 1.0 110.078 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.723 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.84 62.85 1.6 Allowed Glycine 0 C--O 1.208 -1.48 0 CA-C-N 113.827 -1.533 . . . . 1.0 111.338 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 50' ' ' GLU . 27.4 ttt85 -25.1 -31.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.075 0.937 . . . . 1.0 110.866 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -52.47 -14.97 0.55 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 67' ' ' GLY . 43.4 t -61.83 -46.43 96.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.364 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.05 67.18 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -57.18 -41.63 79.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.036 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.45 -44.35 94.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.08 -46.01 92.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.117 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 73.5 mtm -62.93 -42.72 99.89 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.432 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -63.86 -41.6 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.343 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.06 88.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -39.12 94.47 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.94 -26.78 33.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.58 -0.365 . . . . 1.0 111.293 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.9 -51.61 25.1 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.052 0.453 . . . . 1.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.446 HG23 ' N ' ' B' ' 82' ' ' PHE . 7.6 m -60.41 -47.86 90.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.17 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.446 ' N ' HG23 ' B' ' 81' ' ' VAL . 20.7 m-85 -67.81 -38.56 83.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.802 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.92 85.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.536 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.454 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.6 tt -61.72 -41.52 97.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 93.4 t -49.79 -17.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.457 ' O ' ' N ' ' B' ' 90' ' ' ALA . 75.1 m -52.38 -40.87 62.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.464 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.15 -55.06 7.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.841 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -12.69 54.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' C' ' 86' ' ' THR . 81.5 mt -98.21 -27.14 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -64.85 -24.62 67.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.382 0.61 . . . . 1.0 109.858 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.536 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.1 OUTLIER -84.52 -4.72 59.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.0 109.61 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.67 -48.93 74.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.82 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 7.9 p90 -66.56 -31.81 72.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.54 -44.32 96.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.232 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 83.7 mtt85 -60.08 -28.72 68.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.147 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -56.06 -42.23 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.044 -179.826 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 1.0 110.193 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.618 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 23.3 p80 -67.11 -41.07 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.618 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.6 tt0 -62.67 -39.8 95.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.719 0.295 . . . . 1.0 110.537 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -65.1 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 1.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -64.72 -39.61 93.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.92 98.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.463 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.82 -40.82 92.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.245 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.85 -35.39 80.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.327 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.89 76.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.056 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.65 -39.59 91.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 1.0 110.877 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.49 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.742 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.73 -37.81 88.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' C' ' 78' ' ' GLY . 40.8 tp -61.55 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.427 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -59.98 -31.35 69.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -61.55 -40.1 93.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.73 0.3 . . . . 1.0 111.132 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.81 -42.35 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.847 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.64 -41.7 97.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.107 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.421 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.7 mt-10 -63.31 -46.62 85.85 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.008 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 0.2 OUTLIER -70.6 -39.08 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.112 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.95 82.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.7 p -53.34 -45.77 69.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.192 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -65.08 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.215 0.531 . . . . 1.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.5 -37.9 82.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -53.51 57.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.75 0.31 . . . . 1.0 111.065 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.84 -41.45 92.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -68.14 -44.08 76.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.524 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.11 80.56 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.09 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.6 -39.4 73.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.316 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -68.38 129.09 38.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 120.943 0.401 . . . . 1.0 110.28 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.44 -0.46 65.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.334 -0.706 . . . . 1.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.37 149.9 38.31 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.43 -0.211 . . . . 1.0 110.43 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.07 139.88 22.07 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.816 1.677 . . . . 1.0 112.369 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 2.69 57.9 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.5 103.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.78 0.324 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.44 -35.46 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.393 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 15.0 tp -87.08 95.07 9.82 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.119 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 33.4 pt -138.52 49.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 1.0 110.713 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -138.66 145.3 40.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.162 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 35.9 m-85 -69.52 -50.87 17.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.3 Cg_endo -58.98 -38.54 87.43 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.727 1.618 . . . . 1.0 112.433 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.08 -11.29 59.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.221 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.86 81.71 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.788 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.405 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.3 tt -72.93 -38.89 57.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.028 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.486 ' C ' ' NH1' ' D' ' 68' ' ' ARG . 0.5 OUTLIER -63.64 -46.52 85.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.64 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' C' ' 48' ' ' SER . 3.1 t90 -61.18 -39.64 90.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 1.0 109.553 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.417 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 60.7 p -61.63 -34.53 75.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.96 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 45' ' ' ILE . 50.2 t -61.46 -48.28 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.478 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.65 -21.29 62.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.274 -0.571 . . . . 1.0 110.58 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -75.48 -42.2 53.58 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.796 0.331 . . . . 1.0 111.367 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.41 80.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.899 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.592 ' C ' HG23 ' C' ' 54' ' ' THR . 54.5 p -74.85 -11.99 60.27 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.592 HG23 ' C ' ' C' ' 53' ' ' THR . 1.3 p 69.88 0.85 3.21 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.636 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' C' ' 57' ' ' TYR . 56.0 t -65.21 -45.09 94.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.723 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.32 79.02 0.06 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.424 ' CZ ' HG11 ' C' ' 55' ' ' VAL . 52.6 m-85 -60.3 -46.64 89.16 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.811 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.04 23.27 0.69 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.49 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 21.8 t0 -61.65 -41.17 97.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 1.0 110.305 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -145.49 -161.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.961 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 13.4 p90 -172.17 112.37 0.38 Allowed Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.986 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -170.64 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.613 1.542 . . . . 1.0 112.126 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.987 HG22 ' H ' ' C' ' 64' ' ' THR . 9.9 p -139.12 -169.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.375 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.987 ' H ' HG22 ' C' ' 63' ' ' VAL . 11.4 m -77.25 -45.91 24.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 1.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' C' ' 67' ' ' GLY . 49.0 tp10 -47.49 -50.51 23.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.91 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.9 OUTLIER -72.17 35.76 0.06 Allowed 'General case' 0 C--O 1.264 1.838 0 CA-C-O 124.28 1.991 . . . . 1.0 109.859 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.85 65.88 1.46 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.76 -1.564 . . . . 1.0 111.54 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.572 HH12 ' CG1' ' B' ' 49' ' ' VAL . 8.2 ptm180 -21.33 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.775 0.798 . . . . 1.0 111.657 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.6 mmtt -43.84 -18.6 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.273 -1.331 . . . . 1.0 109.588 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' C' ' 68' ' ' ARG . 54.5 t -59.29 -44.91 93.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.453 -0.899 . . . . 1.0 110.189 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.87 63.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.966 0.412 . . . . 1.0 110.764 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.33 -35.27 79.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.955 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.93 -52.45 64.98 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.671 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.27 -43.55 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.773 0.321 . . . . 1.0 111.175 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.553 ' HG3' HG22 ' C' ' 54' ' ' THR . 19.1 ttp -59.62 -43.73 93.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 56.6 tttm -63.47 -42.49 98.59 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.583 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.482 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.14 -39.78 95.68 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.17 -44.56 93.77 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.203 -0.522 . . . . 1.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.94 -43.12 97.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.676 0.274 . . . . 1.0 110.736 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.0 mt-10 -64.63 -39.4 93.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.328 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' C' ' 77' ' ' ALA . 53.7 t -63.82 -48.72 85.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.405 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -64.18 -41.9 96.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.204 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.483 ' O ' HG22 ' C' ' 86' ' ' THR . . . -65.31 -36.0 82.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.859 0.361 . . . . 1.0 110.593 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.5 tt -61.66 -33.89 74.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.519 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.539 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.0 t -54.29 -4.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.374 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 88' ' ' ALA . 6.0 t -62.73 -39.45 94.13 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.118 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -40.09 -21.96 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.545 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -101.85 -38.35 7.87 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.215 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' C' ' 86' ' ' THR . 30.9 mt -74.03 -42.14 60.76 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.941 0.4 . . . . 1.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -55.73 -32.34 63.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.266 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.14 -4.01 45.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.095 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 87.5 m-20 -59.06 -47.8 83.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 11.6 p90 -70.15 -29.63 66.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.08 -43.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.674 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -58.7 -23.07 58.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.427 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -40.59 -37.18 0.68 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.375 -179.458 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -158.78 -43.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -79.68 -20.15 47.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.811 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.27 -35.71 81.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 1.0 110.563 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.08 -40.93 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.53 -43.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 1.0 109.965 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 8' ' ' ALA . . . . . 0.492 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.48 -38.38 89.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.832 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 9' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 68.8 tp60 -64.45 -41.0 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.407 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.4 -38.46 89.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.733 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -28.66 65.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.095 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -62.69 -40.98 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 1.0 110.952 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' D' ' 9' ' ' GLN . 58.2 mp0 -66.32 -33.73 76.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.08 -37.79 86.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.457 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.0 tp -62.81 -41.68 99.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.78 -34.76 76.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.144 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -61.86 -44.0 97.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.835 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -64.08 -36.13 75.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.885 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' D' ' 52' ' ' ALA . 91.2 mt -60.88 -42.16 97.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.21 -47.73 72.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -66.77 -36.84 83.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.665 -0.414 . . . . 1.0 109.894 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -29.07 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.764 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' D' ' 27' ' ' VAL . 69.2 m -59.12 -45.85 89.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.997 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' D' ' 25' ' ' LYS . 13.5 ptpt -66.59 -39.12 88.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.46 ' N ' ' HG3' ' D' ' 24' ' ' LYS . 98.2 mttt -62.05 -45.34 93.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.611 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.433 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 23' ' ' SER . 90.1 t -65.6 -45.77 91.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.264 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -69.46 -42.49 74.82 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.575 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.81 91.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.631 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.455 ' OE1' ' CG2' ' D' ' 39' ' ' ILE . 11.8 tm-20 -67.2 -39.76 86.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.45 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -61.39 115.64 4.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.841 0.353 . . . . 1.0 110.652 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.98 -13.69 57.45 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.22 111.53 55.32 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.27 149.26 35.38 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.915 1.743 . . . . 1.0 112.688 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.69 73.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.73 164.32 16.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 1.0 110.478 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' ALA . . . . . 0.451 ' HB3' ' CE1' ' D' ' 61' ' ' TYR . . . -145.98 84.56 1.66 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.433 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.448 HD23 ' C ' ' D' ' 38' ' ' LEU . 3.5 tt -173.94 79.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.233 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' D' ' 40' ' ' SER . 10.1 pt -127.48 164.65 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.015 0.436 . . . . 1.0 110.606 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 81.24 123.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.438 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 54.0 m-85 -59.57 -47.07 98.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.953 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.59 -33.61 98.26 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.572 1.515 . . . . 1.0 112.267 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.7 -29.38 16.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.049 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.02 94.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.684 0.278 . . . . 1.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.488 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.5 tt -63.36 -32.17 55.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.154 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.488 ' HE3' HG23 ' D' ' 45' ' ' ILE . 0.3 OUTLIER -59.72 -46.63 88.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.884 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' D' ' 51' ' ' THR . 0.7 OUTLIER -67.29 -40.01 86.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.466 -0.493 . . . . 1.0 110.037 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 4.3 t -56.72 -40.0 74.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.459 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.79 -48.64 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.54 -31.63 71.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.911 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' D' ' 47' ' ' TRP . 87.9 m -64.29 -45.17 89.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.572 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.93 -25.98 65.58 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.599 -0.441 . . . . 1.0 110.16 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.3 p -88.37 6.08 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 1.0 110.324 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.02 67.75 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.203 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.16 -40.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.432 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.43 78.51 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.506 -1.037 . . . . 1.0 110.506 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -44.65 96.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 1.0 110.629 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.63 -0.35 3.05 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.71 -0.956 . . . . 1.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 97.5 m-20 -56.8 -50.38 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -130.95 140.78 50.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' D' ' 61' ' ' TYR . 21.3 p90 -130.47 105.25 15.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.786 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.65 154.29 68.35 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.966 1.777 . . . . 1.0 112.258 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.08 -162.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.248 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 55.1 m -87.77 -20.96 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -77.55 -13.59 59.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.665 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.411 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.8 OUTLIER -103.75 28.26 6.76 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 124.293 1.997 . . . . 1.0 108.521 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.84 60.47 4.9 Favored Glycine 0 C--O 1.211 -1.285 0 CA-C-N 113.831 -1.531 . . . . 1.0 109.761 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.49 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 42.5 ttm180 -26.93 -28.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 117.351 0.576 . . . . 1.0 111.046 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 64.0 mttm -57.33 -15.14 5.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.188 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.3 t -60.73 -47.99 90.7 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 119.417 -0.913 . . . . 1.0 109.388 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' ALA . . . . . 0.545 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -65.63 -48.69 71.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.876 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -42.87 -59.33 2.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.338 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -48.93 -39.51 26.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.717 0.266 . . . . 1.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.0 t -62.23 -42.93 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.529 -0.468 . . . . 1.0 111.614 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 2.6 mpp? -59.02 -40.03 83.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.925 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.76 -39.5 88.97 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.472 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.55 -40.28 96.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.044 -0.663 . . . . 1.0 110.716 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -73.29 -44.46 34.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.36 -44.23 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.076 -0.25 . . . . 1.0 111.397 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.94 -44.02 86.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.374 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.472 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.2 t -63.95 -48.55 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.464 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.93 -15.9 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.846 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -95.57 -25.96 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 1.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.92 -42.33 94.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.487 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.492 HG12 ' HB1' ' D' ' 8' ' ' ALA . 15.0 m -58.7 -18.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.015 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 41.2 m -36.95 -29.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.998 0.427 . . . . 1.0 110.488 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.555 ' O ' HG22 ' D' ' 91' ' ' THR . . . -58.94 -62.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.715 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.38 63.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.169 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 83' ' ' ALA . 4.2 mm? -66.03 -37.42 85.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -66.0 -66.13 0.59 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.626 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.802 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.4 OUTLIER -49.18 -4.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.879 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' D' ' 90' ' ' ALA . 25.9 t0 -67.22 -21.21 65.76 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 1.0 111.356 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.505 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 2.3 p90 -77.41 -18.21 57.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.874 0.369 . . . . 1.0 111.194 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.802 HG22 ' O ' ' D' ' 91' ' ' THR . 7.7 m -60.41 -40.05 82.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.576 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ARG . . . . . 0.432 ' N ' HG23 ' D' ' 94' ' ' VAL . 99.8 mtt180 -49.69 -22.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.625 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -60.9 -41.97 97.11 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.889 179.71 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.801 0.334 . . . . 1.0 110.545 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.01 30.33 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 7.6 p80 -162.0 -37.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.925 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.637 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 44.1 tt0 -65.56 -42.45 91.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -64.09 -41.65 97.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.113 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.78 -34.24 75.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.36 -50.76 72.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.48 -33.32 74.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.439 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.68 -36.18 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.458 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.51 77.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.972 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -40.55 94.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.526 -0.306 . . . . 1.0 110.632 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -63.48 -33.57 75.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 1.0 110.493 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' VAL . 80.8 tt0 -62.21 -41.43 98.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.359 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 78' ' ' GLY . 54.4 tp -66.65 -39.47 88.24 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -49.62 -51.0 40.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.828 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -74.77 -31.27 61.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.495 -0.482 . . . . 1.0 112.069 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 14' ' ' GLU . 53.8 t -63.51 -48.22 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.088 -0.245 . . . . 1.0 111.588 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.03 -28.88 66.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.197 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -61.2 -46.78 89.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.4 -39.51 92.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 1.0 109.675 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.9 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.201 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.51 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 37.2 m -54.25 -40.69 67.99 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -62.73 -31.72 72.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.885 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.94 -39.3 34.96 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.902 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.58 88.58 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.6 p -61.08 -46.05 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.359 -0.536 . . . . 1.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 27' ' ' VAL . 80.5 tt0 -67.19 -42.24 84.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.229 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.38 98.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.847 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 37' ' ' ALA . 31.5 tp10 -74.01 -42.62 60.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.592 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -70.85 126.82 30.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.234 0.54 . . . . 1.0 110.819 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.48 59.63 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.387 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -103.18 151.78 38.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.599 ' O ' HG21 ' A' ' 63' ' ' VAL . 72.6 Cg_endo -75.66 117.27 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.048 1.832 . . . . 1.0 111.751 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 94.87 20.64 27.99 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -39.52 162.49 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.65 0.262 . . . . 1.0 110.629 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.572 ' H ' ' CG ' ' A' ' 30' ' ' GLU . . . -136.37 -71.84 0.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.725 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.59 128.27 35.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.08 163.12 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.028 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.7 OUTLIER 81.33 153.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.717 0.294 . . . . 1.0 110.684 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 13.3 t80 -83.15 -50.52 0.7 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.817 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.24 -28.66 87.33 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.421 1.414 . . . . 1.0 112.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 25.1 m-20 -90.25 -28.94 18.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.87 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -64.2 -36.67 84.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 tt -62.3 -37.97 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.287 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -47.81 81.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.446 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -66.09 -39.06 89.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.51 ' HG ' ' CB ' ' A' ' 23' ' ' SER . 21.5 m -57.1 -39.77 75.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.858 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG21 ' NH2' ' B' ' 68' ' ' ARG . 53.7 t -61.33 -46.84 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 98.9 mt-10 -65.48 -44.33 87.42 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 54' ' ' THR . 3.0 m -62.04 -43.8 98.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.269 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -48.53 -52.17 23.9 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.388 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.12 7.6 24.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.4 p 63.33 -133.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.574 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' OG1' ' A' ' 54' ' ' THR . 47.2 t 64.05 -40.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.547 0.529 . . . . 1.0 111.582 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 37.06 90.67 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 53.8 t80 -60.03 -45.84 91.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 1.0 110.462 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.19 7.59 1.09 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.24 -47.0 86.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 1.0 110.156 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -146.09 154.46 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.07 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 27.9 p90 -137.83 130.07 16.4 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.36 154.01 69.93 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.12 1.88 . . . . 1.0 112.518 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.794 HG22 ' H ' ' A' ' 64' ' ' THR . 6.2 p -75.74 -141.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.459 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.794 ' H ' HG22 ' A' ' 63' ' ' VAL . 4.7 m -116.42 -39.2 3.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.678 0.275 . . . . 1.0 111.099 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 80.2 tt0 -77.67 -11.93 59.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.225 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 63' ' ' VAL . 2.1 pp20? -71.66 23.36 0.05 OUTLIER 'General case' 0 C--O 1.259 1.605 0 CA-C-O 123.933 1.825 . . . . 1.0 109.837 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.36 69.43 1.08 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 117.561 -1.688 . . . . 1.0 112.566 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HE ' ' HA ' ' D' ' 46' ' ' TRP . 0.6 OUTLIER -24.39 -32.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.974 1.387 . . . . 1.0 110.665 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 67' ' ' GLY . 64.0 mttp -50.8 -33.72 24.66 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.316 -0.856 . . . . 1.0 109.888 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' GLY . 61.2 t -61.84 -49.75 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 119.4 -0.92 . . . . 1.0 110.576 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.41 -46.17 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CG1' ' D' ' 49' ' ' VAL . 77.5 tt0 -58.23 -38.84 77.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.735 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.57 -46.11 77.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.769 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.74 -42.24 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.269 -0.573 . . . . 1.0 111.498 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.3 mtt -52.94 -44.66 67.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.852 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.37 -46.34 83.8 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.04 92.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 15' ' ' LEU . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.58 -23.83 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.739 -0.271 . . . . 1.0 111.258 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -67.6 -45.72 74.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 81' ' ' VAL . 6.9 m -63.77 -43.99 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.837 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 78' ' ' GLY . 40.3 m-85 -67.39 -37.28 82.89 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.054 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 86' ' ' THR . . . -63.76 -40.97 97.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.046 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.411 ' C ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -63.1 -36.15 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.453 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 85' ' ' VAL . 80.8 t -53.56 -15.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.942 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.627 HG21 ' HB3' ' D' ' 89' ' ' LEU . 9.8 t -48.42 -38.01 18.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.305 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -49.86 -29.51 8.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.473 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.36 29.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.788 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.41 -58.2 2.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.856 0.36 . . . . 1.0 111.0 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.3 -22.98 33.81 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.454 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.465 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -98.28 -4.72 34.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.264 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.01 -47.17 87.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.233 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 3.8 p90 -58.07 -44.15 87.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.114 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 61.7 t -36.66 -26.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.484 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' PHE . 96.5 mtt180 -61.78 -36.13 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.988 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -49.04 -32.75 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.55 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 -179.848 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.683 0.277 . . . . 1.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -71.47 -31.95 67.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 1.0 110.567 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.29 -36.36 83.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -63.65 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 1.0 110.622 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.4 -45.17 95.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.946 -0.391 . . . . 1.0 109.946 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -40.93 85.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.61 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.12 -40.12 94.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.52 -38.07 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.513 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.21 -35.5 75.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.004 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.66 -36.09 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.38 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.78 -34.45 78.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.128 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.01 -36.92 85.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.699 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.3 tp -63.62 -39.34 94.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.54 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.16 -38.41 86.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.978 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -62.27 -39.8 94.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 1.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.19 -41.84 91.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.649 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' B' ' 52' ' ' ALA . 90.6 mt -59.56 -41.34 89.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.608 -0.437 . . . . 1.0 109.933 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.81 -50.1 73.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.991 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.98 -33.19 75.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.008 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.6 83.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.332 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.0 t -59.85 -46.15 90.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.297 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.53 -32.59 73.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.475 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.59 -50.02 16.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.659 -0.417 . . . . 1.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.28 95.37 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.467 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.8 p -62.51 -46.67 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.156 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.541 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.0 tm-20 -70.93 -42.16 70.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.9 96.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.492 ' HG2' ' H ' ' B' ' 38' ' ' LEU . 36.3 tp10 -76.25 -41.51 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.85 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.43 111.18 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.971 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.35 -2.8 23.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.2 151.36 37.69 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 110.66 -0.126 . . . . 1.0 110.66 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' B' ' 36' ' ' ALA . 92.4 Cg_endo -74.81 146.66 33.77 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.946 1.764 . . . . 1.0 112.63 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 77.15 -24.01 2.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.646 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . 40.77 -166.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.606 0.241 . . . . 1.0 110.701 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 161.85 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.932 0.396 . . . . 1.0 110.117 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.492 ' H ' ' HG2' ' B' ' 30' ' ' GLU . 15.4 tp -154.38 108.89 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 1.0 110.743 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.8 pt -131.84 167.06 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.661 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER 80.83 127.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.624 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 9.3 t80 -72.13 -44.97 11.13 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.981 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.76 -26.62 80.76 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.609 1.54 . . . . 1.0 112.738 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -94.31 -18.92 21.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.696 0.284 . . . . 1.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.458 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.63 -41.41 88.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.562 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.538 ' CE2' ' O ' ' C' ' 64' ' ' THR . 4.2 t-105 -61.31 -46.14 91.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.374 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 2.8 t90 -63.1 -39.37 94.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.005 0.431 . . . . 1.0 110.266 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.423 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 6.3 t -62.92 -32.77 74.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.643 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 45' ' ' ILE . 42.0 t -58.85 -47.55 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.629 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.61 -30.71 69.5 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 1.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.0 m -63.33 -46.48 86.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.432 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.48 -35.96 81.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.301 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 55' ' ' VAL . 76.3 p -76.81 3.47 11.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.82 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' B' ' 53' ' ' THR . 58.8 p 51.24 53.77 12.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.426 HG21 ' SD ' ' C' ' 75' ' ' MET . 50.4 t -125.41 -60.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.544 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.13 84.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.24 -41.16 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.302 . . . . 1.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.61 26.91 0.16 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -61.65 -47.53 84.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 1.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.539 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 94.0 mtt-85 -144.1 -169.55 3.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 52.2 m-85 -159.71 110.28 1.47 Allowed Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.433 -0.317 . . . . 1.0 110.437 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.416 1.41 . . . . 1.0 112.238 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.965 HG22 ' H ' ' B' ' 64' ' ' THR . 9.9 p -95.06 -165.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.965 ' H ' HG22 ' B' ' 63' ' ' VAL . 52.4 m -91.07 -37.69 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 1.0 110.602 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 65.5 tt0 -60.79 -31.87 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.483 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -75.33 28.04 0.1 Allowed 'General case' 0 C--O 1.262 1.727 0 CA-C-O 124.028 1.87 . . . . 1.0 109.386 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.709 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 45.58 65.48 1.93 Allowed Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.786 -1.552 . . . . 1.0 111.31 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH2' HG21 ' A' ' 49' ' ' VAL . 59.5 ttp85 -24.58 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.906 0.853 . . . . 1.0 110.572 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.2 mmtt -46.2 -22.59 0.25 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 69.6 t -61.8 -44.85 99.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 119.517 -0.873 . . . . 1.0 109.585 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.524 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -72.08 -51.0 23.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.733 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -55.29 -40.25 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.59 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.0 -45.79 89.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.942 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.98 -44.78 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.4 mpp? -63.19 -41.45 99.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.35 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -63.97 -42.13 97.35 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.445 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.412 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -60.54 -41.12 93.85 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.511 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -65.22 -44.8 93.26 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.85 -43.84 99.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.881 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.34 -44.86 95.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.412 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.0 t -63.75 -48.04 88.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.138 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.441 ' O ' HG22 ' B' ' 85' ' ' VAL . 27.5 m-85 -71.63 -21.27 61.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.901 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.43 -25.14 17.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.0 110.319 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.5 -40.96 98.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.09 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' ALA . 10.7 m -46.61 -24.65 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.678 ' HA ' HD22 ' B' ' 89' ' ' LEU . 36.9 m -37.44 -24.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.377 0.608 . . . . 1.0 110.384 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -56.01 -39.41 71.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.727 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.62 -11.18 57.63 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.718 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' B' ' 86' ' ' THR . 5.0 mp -81.76 -4.26 55.91 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.468 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -94.9 -56.67 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.394 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.448 ' H ' HG22 ' B' ' 91' ' ' THR . 0.1 OUTLIER -58.89 -5.78 0.67 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.06 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' B' ' 93' ' ' PHE . 36.6 p-10 -61.35 -50.4 73.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.157 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 5.3 p90 -71.55 -8.26 52.85 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.829 0.347 . . . . 1.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.11 -26.09 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.417 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.53 -42.61 88.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.58 -0.282 . . . . 1.0 111.432 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.99 -38.03 0.91 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.907 0.384 . . . . 1.0 110.201 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.35 179.638 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.742 0.306 . . . . 1.0 110.736 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.646 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 5.8 p-80 -149.02 -47.99 0.14 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.705 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.646 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 31.5 tp10 -69.37 -36.42 76.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.885 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -64.25 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -61.34 -45.68 93.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.08 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.56 89.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.617 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -65.02 -37.84 88.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.26 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.166 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.54 87.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.038 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.23 -37.14 86.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 1.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.29 -36.33 83.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.851 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.3 tp -62.5 -40.67 97.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.342 . . . . 1.0 110.571 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.45 -39.72 88.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.1 -38.87 90.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.817 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.72 -36.22 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.9 mt -59.99 -41.66 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.136 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -60.98 -46.36 91.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.994 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -59.76 -38.9 83.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -60.78 -47.85 84.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.291 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -67.86 -36.75 80.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.443 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -78.55 -22.57 47.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.502 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -84.52 -44.7 13.34 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.251 0.344 . . . . 1.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.557 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.4 p -61.99 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 1.0 109.891 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.557 ' N ' HG13 ' C' ' 27' ' ' VAL . 2.9 pp20? -66.22 -31.39 72.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.643 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' C' ' 26' ' ' ALA . . . -49.28 -50.95 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.577 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' C' ' 32' ' ' GLY . 80.4 mm-40 -68.37 -37.66 80.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.69 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -57.34 87.58 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.803 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 32' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 30' ' ' GLU . . . 127.82 -13.06 6.48 Favored Glycine 0 N--CA 1.466 0.679 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.8 150.95 39.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.283 -0.266 . . . . 1.0 110.283 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.777 ' O ' HG21 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.77 155.93 39.53 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.097 1.864 . . . . 1.0 112.096 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' C' ' 37' ' ' ALA . . . 90.6 -17.4 54.73 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' C' ' 37' ' ' ALA . . . 40.79 -96.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 1.0 110.949 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' C' ' 36' ' ' ALA . . . 80.46 -73.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.789 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.06 122.16 43.07 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tt -149.84 4.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.03 0.443 . . . . 1.0 110.22 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -94.24 133.39 37.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.883 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.495 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 26.5 m-85 -75.04 -53.51 2.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.6 Cg_endo -59.41 -28.55 87.84 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.617 1.544 . . . . 1.0 112.246 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.59 -18.94 25.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.089 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.86 89.77 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.472 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.74 -39.8 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.698 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -45.51 92.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.252 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.508 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.6 t90 -64.62 -39.89 94.51 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.188 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.43 ' O ' HD22 ' C' ' 19' ' ' LEU . 91.1 p -59.26 -33.3 70.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.149 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.4 -48.04 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -73.7 -23.16 59.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 70.8 m -64.12 -45.6 87.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.519 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.02 -34.29 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.848 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.415 ' OG1' HG23 ' C' ' 55' ' ' VAL . 68.2 p -82.38 1.28 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 1.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.5 p 55.61 11.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.778 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' D' ' 75' ' ' MET . 79.6 t -64.37 -46.18 93.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.956 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.09 59.33 3.43 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 7.9 t80 -61.0 -47.21 87.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 1.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 169.73 -97.86 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 53.9 t0 44.92 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 1.0 110.782 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' C' ' 58' ' ' GLY . 96.9 mtt-85 -124.01 153.13 41.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' C' ' 61' ' ' TYR . 43.8 p90 -143.48 133.66 12.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.02 162.18 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.857 1.705 . . . . 1.0 112.413 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.805 HG13 ' H ' ' C' ' 64' ' ' THR . 7.2 p -83.58 -116.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.805 ' H ' HG13 ' C' ' 63' ' ' VAL . 54.8 m -116.78 -84.0 0.64 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -43.92 125.9 4.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER 57.35 -104.46 0.22 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.69 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.476 1.349 0 O-C-N 124.431 1.082 . . . . 1.0 114.901 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 54.1 ttm-85 -87.21 -46.07 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.939 0.495 . . . . 1.0 110.773 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.8 tttm -54.36 -40.19 67.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.244 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.13 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.056 -0.657 . . . . 1.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.61 -37.2 86.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -54.95 -42.4 72.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -64.93 -40.18 94.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.571 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.07 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 1.0 111.349 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.426 ' SD ' HG21 ' B' ' 55' ' ' VAL . 59.8 mtt -54.0 -44.72 71.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.887 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -63.65 -38.77 92.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 1.0 110.533 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.51 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -62.1 -25.03 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.586 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -90.46 -39.42 5.96 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.944 -0.462 . . . . 1.0 111.944 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.69 -43.47 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.082 -0.247 . . . . 1.0 111.004 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.9 -37.72 86.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.187 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.51 HG23 ' O ' ' C' ' 77' ' ' ALA . 62.1 t -63.45 -47.54 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 121.016 -0.274 . . . . 1.0 111.271 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.0 -36.81 82.99 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.306 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' B' ' 89' ' ' LEU . . . -61.82 -39.61 92.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.808 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' C' ' 86' ' ' THR . 7.3 tt -65.02 -37.56 88.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.267 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.43 HG12 ' O ' ' C' ' 85' ' ' VAL . 78.4 t -45.48 -13.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.991 -0.283 . . . . 1.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.58 ' O ' ' N ' ' C' ' 88' ' ' ALA . 8.9 m -60.29 -41.81 94.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.501 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -39.34 -18.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.005 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -103.36 -36.89 7.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' C' ' 86' ' ' THR . 36.2 mt -75.41 -43.17 51.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' C' ' 86' ' ' THR . . . -56.58 -34.18 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.762 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.67 -5.27 52.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.801 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.488 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 61.9 t0 -56.36 -47.21 79.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.41 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.9 p90 -74.35 -40.06 62.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 84.8 t -44.87 -31.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.825 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -64.12 -22.75 67.06 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.519 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' ARG . . . . . 0.417 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 47.4 ptt85 -52.95 -42.85 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 1.0 110.497 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 97' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.512 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.416 ' HB1' ' HD1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 3' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' D' ' 4' ' ' HIS . 47.7 p-10 -65.95 -33.25 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' D' ' 3' ' ' ASP . 2.0 m80 -63.99 -45.15 90.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 1.0 110.342 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.66 -39.86 91.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -60.72 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.455 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.78 -40.02 79.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 1.0 110.09 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 8' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -63.15 -46.08 88.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 9' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' D' ' 13' ' ' GLU . 99.1 mm-40 -66.13 -37.49 85.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.566 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.29 -39.5 90.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.749 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.54 78.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.33 -39.27 86.48 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.754 0.311 . . . . 1.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' D' ' 9' ' ' GLN . 1.1 mp0 -64.12 -37.19 86.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.18 -32.51 74.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.4 tp -62.4 -41.62 98.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.511 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.93 -35.53 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.993 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 17' ' ' LYS . . . . . 0.52 ' NZ ' ' OE2' ' D' ' 21' ' ' GLU . 18.0 tttp -60.59 -45.82 92.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.79 -40.99 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.905 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.4 mt -59.66 -40.97 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.173 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -62.13 -46.87 87.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.318 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' D' ' 17' ' ' LYS . 98.3 mt-10 -68.67 -36.11 78.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.4 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.45 91.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.203 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.23 -44.43 92.33 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.757 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.66 -35.74 80.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.98 0.419 . . . . 1.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.056 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.93 86.52 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.035 -0.266 . . . . 1.0 111.044 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.24 -44.94 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.13 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.26 -41.5 73.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.856 0.36 . . . . 1.0 110.937 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.5 90.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.717 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.73 -34.45 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 1.0 110.219 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' ARG . . . . . 0.422 ' HG2' HD13 ' D' ' 39' ' ' ILE . 29.0 mmt180 -72.42 137.52 46.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' GLY . . . . . 0.406 ' O ' ' OE1' ' D' ' 65' ' ' GLU . . . 96.1 -11.86 67.26 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -100.26 149.51 36.11 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.455 ' O ' HG11 ' D' ' 63' ' ' VAL . 88.6 Cg_endo -74.49 142.99 30.32 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.907 1.738 . . . . 1.0 112.118 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.55 33.38 81.13 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.7 141.23 38.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.918 0.39 . . . . 1.0 110.538 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -32.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.513 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.88 31.91 0.43 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.019 0.437 . . . . 1.0 109.895 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' D' ' 40' ' ' SER . 4.5 tp -105.7 131.87 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.538 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.4 p 162.7 -102.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.2 m-85 171.44 -65.94 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.31 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.7 Cg_endo -59.15 -29.25 89.98 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.925 1.75 . . . . 1.0 111.526 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -86.92 -24.2 24.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.42 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.37 -45.13 95.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.774 -0.371 . . . . 1.0 110.868 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 46' ' ' TRP . 3.3 tp -67.51 -41.72 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.572 ' CH2' ' O ' ' A' ' 63' ' ' VAL . 1.1 t90 -60.68 -40.65 92.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.122 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' D' ' 48' ' ' SER . 6.0 t90 -61.86 -39.82 93.19 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.574 ' O ' ' N ' ' D' ' 50' ' ' GLU . 3.3 p -60.59 -145.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.002 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.593 ' H ' HD22 ' D' ' 19' ' ' LEU . 28.6 t 48.99 -81.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.13 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' D' ' 48' ' ' SER . 15.7 pt-20 -48.02 -29.47 3.52 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -61.94 -43.73 98.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.12 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.74 -37.6 84.85 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 41.3 p -72.97 0.03 12.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p 50.85 68.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.987 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.04 -52.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.607 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.65 77.32 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -44.35 96.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 1.0 110.443 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.42 14.04 0.73 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.74 -51.39 69.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.674 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.433 ' O ' ' CE1' ' C' ' 57' ' ' TYR . 34.8 mtt-85 -146.81 140.75 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 21.5 p90 -122.22 133.92 24.57 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 121.151 -0.22 . . . . 1.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.6 159.4 52.9 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.129 1.886 . . . . 1.0 112.195 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.543 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -84.91 -142.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.088 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.543 ' H ' HG12 ' D' ' 63' ' ' VAL . 46.7 m -113.46 -53.05 2.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.704 0.288 . . . . 1.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.5 tt0 -62.45 -16.43 55.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.863 0.363 . . . . 1.0 110.226 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.6 OUTLIER -74.35 26.41 0.08 Allowed 'General case' 0 C--O 1.264 1.839 0 CA-C-O 123.808 1.766 . . . . 1.0 109.087 178.36 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.722 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.03 61.3 3.54 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 58.2 ttm-85 -26.0 -30.31 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.297 0.645 . . . . 1.0 110.849 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.722 ' N ' ' O ' ' D' ' 67' ' ' GLY . 28.8 mmtp -53.41 -17.37 1.87 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.272 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' D' ' 67' ' ' GLY . 55.3 t -61.79 -48.36 89.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.0 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.71 -43.16 72.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.923 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -60.11 -42.21 94.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.763 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.09 -42.3 76.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.079 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.271 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.538 ' SD ' HG21 ' C' ' 55' ' ' VAL . 61.1 mtt -61.0 -42.29 98.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.327 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.23 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.479 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.02 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.396 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.14 -43.78 92.52 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -43.55 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.689 0.281 . . . . 1.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.97 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.182 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.479 HG23 ' O ' ' D' ' 77' ' ' ALA . 50.7 t -61.83 -52.31 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.341 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.91 -40.08 72.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.06 -34.94 79.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.456 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' D' ' 86' ' ' THR . 5.2 tt -61.12 -40.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' D' ' 87' ' ' ALA . 97.0 t -50.76 -16.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.611 -0.436 . . . . 1.0 109.887 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' D' ' 84' ' ' LEU . 23.7 m -42.42 -22.49 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.81 -52.97 61.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.36 -31.05 71.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.88 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.627 ' HB3' HG21 ' A' ' 86' ' ' THR . 16.0 mt -66.93 -40.97 87.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.433 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.74 -43.07 94.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.032 0.444 . . . . 1.0 110.787 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -4.28 42.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.202 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -56.93 -49.27 76.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.906 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 31.5 p90 -79.5 -42.96 24.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.172 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.527 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 60.9 t -40.44 -27.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.366 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' D' ' 93' ' ' PHE . 94.8 mtt-85 -62.78 -36.46 83.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.766 0.317 . . . . 1.0 111.105 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -47.68 -32.03 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.457 . . . . 1.0 110.285 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.761 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.836 0.351 . . . . 1.0 110.519 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -173.02 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -77.84 -16.87 57.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.453 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.397 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -63.47 -37.93 89.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.299 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.62 -38.16 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.53 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.92 72.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.792 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -67.67 -35.35 78.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.57 -36.63 81.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.25 76.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.892 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.61 -37.21 83.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.552 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.79 -36.44 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -65.43 -34.47 78.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.422 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.49 -41.23 98.65 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.593 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.04 -38.83 90.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.146 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -40.57 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.5 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.2 mt -60.57 -40.96 93.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.076 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.5 mt-10 -60.58 -45.11 95.15 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.086 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.72 -37.55 76.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.91 89.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -59.77 -43.02 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 14.6 tmtt? -65.09 -36.25 83.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.833 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -76.55 -37.51 56.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.635 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.08 93.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 24' ' ' LYS . 9.1 m -61.24 -43.56 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.144 -0.622 . . . . 1.0 110.24 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -75.67 -43.25 48.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.536 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.09 -45.74 90.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.491 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.25 -44.13 92.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -71.36 133.65 46.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.58 -17.49 46.29 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.55 159.94 76.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.37 116.71 4.59 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.819 1.679 . . . . 1.0 111.924 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 82.87 -23.77 5.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . 32.69 -152.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.769 0.319 . . . . 1.0 111.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.64 -53.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.363 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.0 tp -66.22 -69.02 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.574 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 pt 36.48 25.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.103 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 38' ' ' LEU . 42.0 t -132.14 129.16 39.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.882 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 26.8 t80 -80.7 -49.05 1.13 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.982 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.36 -31.08 92.3 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.107 1.205 . . . . 1.0 112.569 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -91.17 -6.05 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.604 0.24 . . . . 1.0 111.009 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.91 95.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.916 0.389 . . . . 1.0 110.331 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 45' ' ' ILE . 7.6 tt -66.21 -40.22 86.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.155 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.59 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.96 -47.11 86.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.381 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.448 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 22.9 t90 -59.02 -39.95 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.46 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 t -76.59 66.84 2.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.698 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 48' ' ' SER . 58.3 t -156.24 -55.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.93 0.395 . . . . 1.0 110.201 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' A' ' 59' ' ' ASP . 15.3 pt-20 -64.4 -32.78 74.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.414 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -61.68 -45.95 91.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.034 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.66 -26.87 64.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.354 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -92.9 2.79 56.6 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 p 47.0 76.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 57' ' ' TYR . 32.6 t -129.07 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.7 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 97.14 -56.63 1.25 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' B' ' 61' ' ' TYR . 2.3 m-85 44.12 -89.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.883 0.373 . . . . 1.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . -166.78 -87.61 0.07 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' A' ' 50' ' ' GLU . 2.0 p-10 39.41 -105.39 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.857 0.36 . . . . 1.0 110.626 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.728 HH21 HH22 ' B' ' 68' ' ' ARG . 0.8 OUTLIER -116.96 -175.21 2.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.65 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.32 134.23 1.09 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.44 156.78 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.949 1.766 . . . . 1.0 112.454 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.454 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.5 t -98.46 -124.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.827 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.44 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 85.3 m -115.4 -40.75 3.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.592 0.235 . . . . 1.0 111.154 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.2 tt0 -67.45 -36.28 80.89 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 1.0 110.881 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.53 28.27 0.02 OUTLIER 'General case' 0 C--O 1.26 1.623 0 CA-C-O 123.289 1.519 . . . . 1.0 110.182 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.73 65.23 1.23 Allowed Glycine 0 C--O 1.212 -1.257 0 CA-C-O 117.567 -1.685 . . . . 1.0 111.437 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' D' ' 59' ' ' ASP . 60.6 ttm-85 -22.62 -35.62 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.431 1.115 . . . . 1.0 111.008 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' A' ' 67' ' ' GLY . 29.7 mmtp -48.4 -18.11 0.2 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.637 -0.711 . . . . 1.0 109.565 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -61.31 -47.97 91.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.371 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 -39.25 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 1.0 110.846 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -54.65 -42.27 71.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.674 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.52 -44.98 92.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.875 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.19 -47.19 91.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.16 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.43 -42.34 98.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.39 -42.18 96.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.346 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.17 93.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.781 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.42 95.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.28 -43.42 98.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.11 -42.09 97.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.45 -50.41 76.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -70.92 -22.41 62.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.066 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 -30.24 22.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.712 0.292 . . . . 1.0 110.781 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.65 -42.87 98.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.739 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' C ' ' N ' ' A' ' 87' ' ' ALA . 4.0 m -53.81 -16.36 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.189 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -43.16 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.268 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' N ' ' C ' ' A' ' 85' ' ' VAL . . . -63.05 -50.76 69.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.05 88.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.59 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.8 mm? -65.13 -39.0 92.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -56.4 -47.46 78.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.033 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -3.7 33.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.683 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.497 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 50.2 t0 -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.112 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.9 p90 -78.72 -44.04 24.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.827 0.346 . . . . 1.0 111.485 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 93.1 t -41.05 -25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.383 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 93' ' ' PHE . 11.1 tpt85 -58.82 -33.6 70.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.938 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -61.04 -23.05 65.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.655 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.945 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.711 0.291 . . . . 1.0 110.988 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -79.01 -31.36 44.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.566 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -66.27 -37.73 86.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.931 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -63.15 -40.18 96.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.706 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -65.66 -41.98 91.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.66 92.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.49 -40.56 93.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.11 -38.84 92.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.486 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.69 78.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.996 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.32 -35.68 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.645 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.74 -38.56 91.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 1.0 110.188 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -63.2 -34.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.7 tp -62.99 -37.91 89.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.276 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -65.57 -31.01 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.832 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.81 -47.64 82.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.378 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 18' ' ' VAL . 15.4 m -68.63 -31.38 50.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.089 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.6 mt -61.06 -41.84 97.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.94 -47.58 79.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 1.0 109.834 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -67.46 -34.36 77.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.826 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.12 89.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.139 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -60.76 -35.57 76.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.043 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' B' ' 27' ' ' VAL . 44.9 tptt -65.08 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.623 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -39.92 -28.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.611 0.243 . . . . 1.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 24' ' ' LYS . . . -62.55 -41.06 98.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.405 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' B' ' 24' ' ' LYS . 1.4 p -67.23 -41.5 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.09 0.472 . . . . 1.0 110.46 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 74.4 mm-40 -70.95 -40.3 72.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.594 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' B' ' 66' ' ' GLU . . . -71.96 58.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.906 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' B' ' 32' ' ' GLY . 0.0 OUTLIER 170.78 -16.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.004 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -68.11 56.38 0.07 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.442 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 130.8 31.28 0.55 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.734 -0.547 . . . . 1.0 111.734 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 149.56 38.04 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.72 134.38 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.902 1.735 . . . . 1.0 112.061 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.28 25.61 73.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.255 -0.738 . . . . 1.0 111.255 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.31 140.72 57.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.35 -31.34 8.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' B' ' 30' ' ' GLU . 40.1 tp -101.56 112.75 25.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.247 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.421 ' O ' ' OG ' ' B' ' 40' ' ' SER . 5.9 pt -145.11 84.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.29 -0.414 . . . . 1.0 109.89 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 62.9 m -168.73 -117.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.081 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.4 m-85 -176.09 -64.17 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.084 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -59.03 -29.33 90.35 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.147 1.898 . . . . 1.0 112.216 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.06 -8.2 58.78 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.09 86.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.0 110.396 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.423 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.5 tt -66.86 -38.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.696 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -47.51 85.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.27 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.422 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.6 t90 -63.27 -42.54 99.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 1.0 110.395 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.425 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.4 m -57.39 -39.88 77.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.119 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.65 -48.15 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.833 0.309 . . . . 1.0 111.833 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.421 ' OE1' ' NH1' ' C' ' 68' ' ' ARG . 18.1 pt-20 -76.13 -22.73 55.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.422 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 87.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.41 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.2 -24.51 55.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.286 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.517 HG21 ' OE2' ' C' ' 72' ' ' GLU . 37.9 p -83.76 4.26 29.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 1.0 110.762 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p 54.28 7.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' B' ' 53' ' ' THR . 53.8 t -62.99 -47.09 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.48 68.09 0.48 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' C' ' 60' ' ' ARG . 9.9 t80 -59.8 -46.38 89.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.678 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.66 -11.06 0.96 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.504 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 84.9 m-20 -41.63 -83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.834 0.35 . . . . 1.0 110.866 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -119.83 151.8 38.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.889 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 47.8 t80 -160.8 125.79 2.17 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.11 159.23 53.88 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.533 1.489 . . . . 1.0 112.531 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.69 -166.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.887 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.59 HG22 ' CD1' ' A' ' 46' ' ' TRP . 9.0 p -56.13 -69.45 0.15 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.522 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -47.37 -17.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 64' ' ' THR . 67.5 mt-10 -98.0 28.14 4.14 Favored 'General case' 0 C--O 1.266 1.932 0 CA-C-O 124.303 2.002 . . . . 1.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.732 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.59 62.76 1.31 Allowed Glycine 0 C--O 1.212 -1.235 0 CA-C-N 113.147 -1.842 . . . . 1.0 111.305 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.728 HH22 HH21 ' A' ' 60' ' ' ARG . 43.0 ttm180 -24.89 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.0 0.9 . . . . 1.0 111.414 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' B' ' 67' ' ' GLY . 14.7 mptt -53.19 -14.75 0.72 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' B' ' 67' ' ' GLY . 42.4 t -61.08 -45.5 98.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 119.695 -0.802 . . . . 1.0 109.698 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.0 28.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.302 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -60.48 -40.08 89.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.31 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -61.1 -46.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.48 -44.77 86.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.337 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 75.6 mtm -61.58 -41.79 97.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.614 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.86 -40.98 99.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.233 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -67.83 -41.68 87.99 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.68 -0.568 . . . . 1.0 111.68 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.88 -43.37 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.116 -0.233 . . . . 1.0 110.792 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.82 -41.32 91.01 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.231 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.67 -50.29 76.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.383 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -66.35 -36.81 83.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.579 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.1 -37.53 87.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.611 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.486 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.1 tt -62.64 -40.86 98.34 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.451 ' O ' HG12 ' B' ' 85' ' ' VAL . 85.4 t -49.4 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.513 ' O ' ' N ' ' B' ' 89' ' ' LEU . 73.6 m -58.2 -41.59 84.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -42.93 -19.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.581 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -103.19 -28.51 11.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.125 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' THR . 89.3 mt -69.41 -44.74 70.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.027 0.441 . . . . 1.0 111.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.565 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.1 -9.05 9.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.435 0.636 . . . . 1.0 109.817 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.9 OUTLIER -101.73 -5.13 25.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.081 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.445 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 96.0 m-20 -61.36 -46.95 88.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.011 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 47.8 p90 -79.29 -33.81 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.7 t -50.31 -31.71 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.335 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -64.23 -21.93 66.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.305 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.439 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 23.9 ptt-85 -51.16 -42.35 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 1.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 96.3 mt-10 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.234 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.858 0.361 . . . . 1.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.447 ' CD2' ' HG3' ' C' ' 5' ' ' GLU . 4.5 p-80 -59.25 -41.63 89.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.804 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' C' ' 95' ' ' ARG . 97.4 mt-10 -64.43 -42.42 96.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -65.21 -39.25 92.55 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.94 -39.18 87.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.155 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' C' ' 11' ' ' ALA . . . -64.47 -37.41 87.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.404 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' C' ' 12' ' ' GLU . 56.5 tt0 -60.0 -42.5 94.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 1.0 110.469 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.67 -28.79 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.437 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' C' ' 8' ' ' ALA . . . -54.17 -45.42 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.324 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' C' ' 8' ' ' ALA . 57.3 mp0 -67.0 -41.22 87.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 1.0 110.96 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.4 -38.18 88.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 1.0 110.43 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -64.98 -31.17 72.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.305 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.99 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.3 tp -62.19 -39.12 91.67 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.441 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.7 -29.81 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.215 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -77.86 -45.19 24.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' VAL . . . . . 0.484 HG23 ' N ' ' C' ' 19' ' ' LEU . 28.1 m -60.72 -46.56 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.359 0.503 . . . . 1.0 112.359 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.484 ' N ' HG23 ' C' ' 18' ' ' VAL . 3.1 pp -74.95 -26.8 59.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.742 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -63.8 -53.93 43.08 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.922 0.392 . . . . 1.0 110.032 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.92 -36.34 83.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' C' ' 74' ' ' VAL . . . -66.72 -35.43 80.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.5 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 38.6 m -53.1 -44.43 67.61 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.284 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.21 -44.87 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 1.0 109.58 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -63.22 -39.28 94.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.792 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.38 64.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.146 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.406 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.1 p -64.44 -44.91 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.194 0.521 . . . . 1.0 110.363 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.406 ' N ' HG13 ' C' ' 27' ' ' VAL . 41.0 tp10 -66.19 -35.84 81.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.816 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.34 99.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.326 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -90.23 -11.17 41.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.681 -0.236 . . . . 1.0 111.249 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -58.34 96.9 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.604 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.24 5.16 46.74 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.55 151.4 68.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.91 139.73 22.31 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.977 1.785 . . . . 1.0 112.189 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.55 25.54 63.33 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.241 -0.744 . . . . 1.0 111.241 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 140.95 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 -38.52 5.37 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.541 HD23 ' O ' ' C' ' 38' ' ' LEU . 5.7 tt -88.74 68.48 8.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.037 0.446 . . . . 1.0 109.944 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -92.11 -5.36 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.332 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.1 m -75.48 150.98 38.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.53 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 1.1 t80 -100.83 -61.95 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.98 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.6 Cg_endo -59.0 -30.07 92.39 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.782 1.654 . . . . 1.0 112.249 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.87 -2.17 57.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.054 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.51 85.3 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.392 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.43 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.6 tt -66.66 -39.36 83.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.925 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -49.49 75.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.41 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' C' ' 50' ' ' GLU . 3.5 t90 -64.38 -38.79 92.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 25.2 p -63.2 -36.54 83.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.34 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.2 t -62.39 -48.86 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 121.101 -0.24 . . . . 1.0 111.59 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' C' ' 47' ' ' TRP . 2.6 pp20? -71.08 -29.76 65.71 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.77 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.441 ' N ' ' CD ' ' C' ' 50' ' ' GLU . 69.3 m -62.36 -46.52 88.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.315 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.99 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -62.1 -23.69 66.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.809 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.604 ' OG1' HG23 ' C' ' 55' ' ' VAL . 81.1 p -90.64 3.31 54.52 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.4 p 55.5 15.55 1.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.92 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.605 HG21 ' SD ' ' D' ' 75' ' ' MET . 72.3 t -63.68 -45.65 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.677 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.35 61.86 1.69 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -45.12 95.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.664 0.269 . . . . 1.0 110.825 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.35 13.97 1.1 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.41 -50.58 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 1.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CE1' ' B' ' 57' ' ' TYR . 96.1 mtt-85 -145.91 167.19 23.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.572 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -143.7 123.03 7.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 158.65 54.36 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.798 1.665 . . . . 1.0 112.184 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.2 m -98.09 -165.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.021 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -94.03 -32.07 13.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 1.0 110.168 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' C' ' 67' ' ' GLY . 10.4 tm-20 -64.05 -32.98 74.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.047 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -75.67 28.81 0.11 Allowed 'General case' 0 C--O 1.264 1.83 0 CA-C-O 124.378 2.037 . . . . 1.0 110.008 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.33 65.78 1.77 Allowed Glycine 0 C--O 1.216 -0.976 0 CA-C-N 113.516 -1.674 . . . . 1.0 111.167 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 ttm-85 -24.92 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.148 0.974 . . . . 1.0 111.392 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' C' ' 67' ' ' GLY . 71.8 mmtt -50.08 -31.64 13.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.476 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.8 t -64.14 -49.14 82.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 119.139 -1.024 . . . . 1.0 110.6 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.25 73.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.866 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' GLU . . . . . 0.517 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.0 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.943 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.85 -43.47 85.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.954 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' C' ' 22' ' ' ALA . 70.6 t -64.18 -43.29 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.634 -0.426 . . . . 1.0 111.165 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 39.6 mtt -55.77 -45.31 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.002 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -40.83 95.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.19 86.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 1.0 110.235 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.05 -42.65 92.13 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.78 -42.77 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.71 0.29 . . . . 1.0 110.985 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' C' ' 84' ' ' LEU . 80.9 mm-40 -58.39 -41.29 84.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.244 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -49.35 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.309 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -64.93 -35.38 80.98 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.881 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.63 -28.49 30.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.751 0.31 . . . . 1.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.8 tt -63.5 -42.94 98.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.488 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.47 2.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.527 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' C' ' 84' ' ' LEU . 23.9 m -62.93 -20.65 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' C' ' 91' ' ' THR . . . -56.72 -61.06 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.39 94.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.012 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.62 -43.64 96.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.464 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.19 -23.6 66.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.401 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.529 ' OG1' ' CG ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -96.44 -3.86 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.3 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 47.2 t0 -60.42 -43.35 96.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.097 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -67.46 -30.1 69.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.03 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.93 -44.26 94.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.407 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' C' ' 5' ' ' GLU . 95.2 mtt-85 -48.04 -21.75 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.224 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 96' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.2 ptt85 -50.85 -41.28 57.77 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.39 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 21.1 pt-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.021 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.706 0.289 . . . . 1.0 110.539 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -172.74 -64.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.82 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.456 ' CD2' ' HG3' ' D' ' 5' ' ' GLU . 5.6 p-80 -59.2 -39.52 82.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.456 ' HG3' ' CD2' ' D' ' 4' ' ' HIS . 96.7 mt-10 -63.11 -39.09 93.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.43 -43.17 99.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.482 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.23 -38.3 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.297 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.799 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.52 -42.11 98.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.48 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.29 -39.07 93.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.26 81.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.116 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.97 -39.12 93.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.794 0.33 . . . . 1.0 110.791 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.36 -33.81 76.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.67 -34.84 79.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.9 tp -62.09 -42.52 99.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 1.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -64.29 -35.88 82.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.115 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -61.74 -41.83 98.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 1.0 110.99 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.61 -39.0 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.532 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.8 mt -60.16 -40.76 91.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' D' ' 23' ' ' SER . 98.5 mt-10 -61.8 -44.95 95.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 1.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.63 -34.84 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.997 0.427 . . . . 1.0 110.02 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.54 87.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.03 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -59.57 -45.07 92.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.876 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -64.11 -54.97 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.256 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.58 -40.79 96.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.743 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.13 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.834 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 72.4 t -62.36 -46.71 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.65 -41.94 83.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.47 97.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -69.35 -39.68 77.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.794 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -63.32 119.21 9.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.11 49.9 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.42 146.02 30.76 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.749 -0.265 . . . . 1.0 110.519 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' D' ' 63' ' ' VAL . 94.0 Cg_endo -74.76 144.14 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.143 1.895 . . . . 1.0 112.377 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.1 71.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.46 138.6 57.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.0 110.614 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.77 -36.44 4.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.473 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -99.28 108.23 20.72 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 pt -150.94 60.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -157.81 124.44 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.535 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 34.3 m-85 -53.1 -49.87 85.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.239 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.07 -34.99 99.07 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.1 1.2 . . . . 1.0 112.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -93.4 -8.18 42.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.716 0.293 . . . . 1.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 44' ' ' ALA . . . . . 0.416 ' HB2' ' CG2' ' D' ' 27' ' ' VAL . . . -65.88 -45.38 82.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 1.0 110.876 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -68.17 -39.68 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.603 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -47.82 83.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.11 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.415 ' O ' ' N ' ' D' ' 49' ' ' VAL . 6.4 t90 -62.15 -40.21 95.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' D' ' 19' ' ' LEU . 22.7 p -69.65 61.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' D' ' 47' ' ' TRP . 76.8 t -149.01 -57.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.194 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -65.72 -27.08 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.168 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.445 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -61.17 -47.49 85.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.201 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.45 -36.93 69.6 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.298 -0.561 . . . . 1.0 109.671 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.457 ' OG1' HG12 ' D' ' 55' ' ' VAL . 49.4 p -78.75 -12.68 60.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.472 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 6.1 p 60.47 10.4 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.069 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.517 HG13 ' N ' ' D' ' 56' ' ' GLY . 12.0 p -67.24 -43.43 88.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.517 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 57.3 72.61 0.56 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.448 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.3 OUTLIER -60.24 -46.94 88.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 1.0 110.465 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.0 10.62 1.51 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 68' ' ' ARG . 53.8 m-20 -58.06 -50.86 71.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -151.02 -166.11 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.7 p90 -172.07 133.44 0.78 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.831 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.48 157.74 58.11 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.999 1.8 . . . . 1.0 112.428 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.566 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -89.79 -143.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.924 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.566 ' H ' HG12 ' D' ' 63' ' ' VAL . 94.8 m -112.09 -41.68 3.91 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.744 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.1 -19.68 65.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.9 0.381 . . . . 1.0 110.448 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.1 OUTLIER -77.86 23.67 0.25 Allowed 'General case' 0 C--O 1.266 1.973 0 CA-C-O 123.842 1.782 . . . . 1.0 108.956 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.741 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.85 61.55 3.81 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' D' ' 67' ' ' GLY . 58.0 ttm-85 -26.94 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.761 0.781 . . . . 1.0 111.214 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.9 tptm -55.85 -27.34 51.17 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.107 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.4 t -61.07 -49.42 84.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 119.649 -0.82 . . . . 1.0 109.942 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.65 -37.05 73.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.179 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.57 -43.83 89.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -61.39 -40.75 95.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.213 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.09 -43.9 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.609 -0.436 . . . . 1.0 111.196 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.605 ' SD ' HG21 ' C' ' 55' ' ' VAL . 36.9 mtt -60.26 -44.34 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.902 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -65.98 -36.77 84.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.43 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -59.92 -40.28 88.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.586 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.62 -42.76 95.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.479 -0.648 . . . . 1.0 111.479 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.64 -43.46 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.021 -0.272 . . . . 1.0 111.092 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.18 -41.53 97.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.285 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 77' ' ' ALA . 61.5 t -63.21 -50.25 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 1.0 111.373 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.9 -40.26 83.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.756 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.16 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.371 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.73 -41.18 97.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.268 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.2 -17.82 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.695 -0.402 . . . . 1.0 109.919 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 56.7 m -47.46 -40.09 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.224 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -53.08 -17.29 1.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.671 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.62 20.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.563 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.51 HD13 ' OD2' ' D' ' 92' ' ' ASP . 3.7 mm? -92.53 -40.8 10.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.008 0.432 . . . . 1.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.535 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -57.14 -28.2 62.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.618 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.34 -4.36 55.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.51 ' OD2' HD13 ' D' ' 89' ' ' LEU . 89.2 m-20 -59.5 -49.92 75.92 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.145 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 21.3 p90 -73.47 -38.72 65.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.987 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.3 t -47.92 -27.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.161 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' D' ' 97' ' ' GLU . 94.5 mtt180 -64.73 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -54.31 -7.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' D' ' 95' ' ' ARG . 24.1 tp10 . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.69 ' CB ' ' CE1' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.86 0.362 . . . . 1.0 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 11.6 p-10 -65.14 -36.64 84.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.69 ' CE1' ' CB ' ' A' ' 2' ' ' ALA . 15.4 p-80 -75.14 -34.2 61.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.643 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 95' ' ' ARG . 96.2 mt-10 -63.54 -38.4 91.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.528 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.66 -39.71 94.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -50.87 -44.99 59.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.3 88.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.262 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.82 -45.2 90.64 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.89 -35.85 82.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.048 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -48.33 68.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.784 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.65 -42.64 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -64.03 -33.91 76.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.158 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.81 -34.92 78.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.389 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' A' ' 78' ' ' GLY . 44.8 tp -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.773 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -55.29 -40.15 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.205 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -64.37 -31.62 72.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.787 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.38 -41.98 86.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 1.0 110.683 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.2 mp -60.57 -40.64 92.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.784 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -55.96 -49.67 72.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.917 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.49 -37.14 82.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.994 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.24 86.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.634 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' VAL . 15.8 m -59.97 -40.96 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.37 -61.45 2.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.376 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.4 -44.21 95.92 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.909 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.93 -45.76 74.87 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.37 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' SER . 92.3 t -62.55 -46.49 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.25 -41.89 72.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.019 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.15 -41.12 48.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.802 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.66 -44.87 69.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.115 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -51.81 99.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.396 . . . . 1.0 110.651 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.4 -11.89 12.57 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 111.446 -0.661 . . . . 1.0 111.446 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.49 140.26 33.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 122.705 -0.291 . . . . 1.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' O ' HG11 ' A' ' 63' ' ' VAL . 94.5 Cg_endo -75.27 144.18 29.09 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.015 1.81 . . . . 1.0 112.478 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.16 27.09 68.45 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.32 140.77 58.72 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.421 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.94 -30.73 4.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -87.24 122.59 31.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' SER . 41.0 pt -153.41 163.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 79.96 134.53 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.79 0.329 . . . . 1.0 110.934 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 32.4 t80 -65.79 -44.73 64.35 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.087 -0.506 . . . . 1.0 112.127 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.3 Cg_endo -60.57 -30.86 91.5 Favored 'Trans proline' 0 N--CA 1.503 2.055 0 C-N-CA 121.562 1.508 . . . . 1.0 112.737 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.29 -27.23 18.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.706 0.288 . . . . 1.0 110.785 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.02 82.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.582 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.423 HG23 ' HE3' ' A' ' 46' ' ' TRP . 7.9 tt -62.84 -38.74 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.564 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.7 OUTLIER -65.96 -38.21 87.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.23 -0.441 . . . . 1.0 109.824 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -62.71 -42.34 99.6 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.247 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.6 p -58.09 -28.38 64.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.9 t -63.76 -45.69 96.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 1.0 110.419 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 77.5 mt-10 -80.26 -0.85 38.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.81 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -35.51 8.07 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 1.0 109.83 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.44 82.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.345 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.92 11.75 17.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' GLY . 5.1 p 64.38 -135.11 0.29 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.411 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' OG1' ' A' ' 54' ' ' THR . 46.1 t 62.73 -61.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.595 0.559 . . . . 1.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 50.36 90.92 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -60.6 -44.13 96.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.726 0.298 . . . . 1.0 110.78 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.79 17.05 0.85 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.64 -51.94 67.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 1.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' ' CZ ' ' D' ' 57' ' ' TYR . 94.8 mtt-85 -145.73 139.84 26.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.949 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 62' ' ' PRO . 77.8 t80 -130.91 127.71 22.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.536 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 60.6 Cg_endo -70.33 159.92 51.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.826 1.684 . . . . 1.0 112.62 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' THR . 2.1 t -83.68 -138.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.501 ' H ' HG12 ' A' ' 63' ' ' VAL . 51.6 m -114.72 -37.95 4.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.677 0.275 . . . . 1.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.634 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.9 tp10 -64.59 -31.21 72.33 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -70.79 30.54 0.04 OUTLIER 'General case' 0 C--O 1.263 1.786 0 CA-C-O 123.594 1.664 . . . . 1.0 109.952 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.77 64.35 1.25 Allowed Glycine 0 C--O 1.213 -1.196 0 CA-C-N 113.797 -1.547 . . . . 1.0 111.317 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.549 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 43.0 ttm180 -24.0 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.114 0.957 . . . . 1.0 111.108 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -48.86 -18.28 0.26 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.752 -0.658 . . . . 1.0 109.442 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.3 t -61.63 -47.83 91.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 119.494 -0.882 . . . . 1.0 110.131 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.19 64.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.631 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -58.92 -41.66 87.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.716 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.84 -42.03 96.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.051 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.93 -44.47 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.782 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.2 mtt -54.93 -43.91 73.77 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.748 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.08 -40.67 96.61 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.356 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.03 -41.64 98.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -67.77 -44.06 81.85 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.56 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 1.0 110.717 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.37 -40.46 96.52 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.678 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 77' ' ' ALA . 56.0 t -63.95 -50.06 78.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0 110.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' B' ' 79' ' ' ILE . 46.9 m-85 -68.33 -25.3 65.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.052 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.77 -23.51 21.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.667 0.27 . . . . 1.0 110.751 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -65.46 -35.44 80.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.2 m -43.17 -19.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.794 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' LEU . 24.9 m -40.92 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.963 0.411 . . . . 1.0 110.122 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.39 -46.68 89.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.436 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 -27.49 10.16 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.744 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' B' ' 86' ' ' THR . 44.6 tp -65.6 -37.56 86.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.627 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -70.9 -67.91 0.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 1.0 110.798 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -47.84 -8.51 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.042 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 90' ' ' ALA . 51.0 t0 -46.99 -38.73 11.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.848 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 10.1 p90 -79.45 -28.88 41.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.388 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.88 -26.15 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.427 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 96.4 mtt180 -60.1 -31.66 70.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.517 -0.311 . . . . 1.0 111.308 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' NH2' HG11 ' B' ' 94' ' ' VAL . 24.4 ptt180 -58.15 -42.32 85.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.369 . . . . 1.0 110.617 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 97.4 mt-10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.724 0.297 . . . . 1.0 110.871 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -80.4 -34.99 35.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.48 -39.24 85.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.27 -43.49 98.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.757 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -65.08 -36.54 84.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.1 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -65.3 -41.62 93.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.464 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.04 -40.7 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.55 92.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.928 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.443 ' OE2' ' CD1' ' B' ' 82' ' ' PHE . 80.3 mm-40 -67.92 -41.6 82.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 1.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -65.05 -37.27 87.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.59 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.416 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.02 -42.96 99.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.455 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -37.58 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.6 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.02 -41.63 96.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.0 -33.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.686 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.665 HD22 ' O ' ' B' ' 48' ' ' SER . 95.3 mt -62.03 -42.1 98.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.572 -0.451 . . . . 1.0 109.922 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.48 -46.18 91.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.856 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.442 ' CG ' ' NZ ' ' B' ' 25' ' ' LYS . 83.7 tt0 -69.28 -38.65 78.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.022 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.47 -38.91 88.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.499 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -60.01 -44.29 94.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.846 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.07 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 1.0 110.258 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.442 ' NZ ' ' CG ' ' B' ' 21' ' ' GLU . 62.3 mttp -75.86 -39.51 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.364 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.97 -49.68 74.97 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.658 -0.246 . . . . 1.0 111.298 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.465 ' O ' ' OE1' ' B' ' 30' ' ' GLU . 3.8 p -63.76 -42.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.279 0.561 . . . . 1.0 110.317 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 78.8 mm-40 -70.35 -20.83 62.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.498 -0.774 . . . . 1.0 110.59 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -60.12 -37.91 81.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' B' ' 27' ' ' VAL . 29.7 mp0 -65.21 -40.23 93.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 1.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -63.16 86.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.58 -10.45 6.79 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 141.88 23.59 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.765 0.283 . . . . 1.0 110.603 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.489 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 98.9 Cg_endo -75.39 144.93 29.57 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.229 1.953 . . . . 1.0 112.38 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.87 36.3 57.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.36 150.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 1.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.12 -45.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.253 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' B' ' 60' ' ' ARG . 33.9 tp -97.02 91.9 5.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.513 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.3 pt -105.21 2.58 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.421 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -99.86 123.54 44.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.119 0.485 . . . . 1.0 110.985 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.523 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.3 t80 -77.22 -54.86 1.44 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.312 -0.858 . . . . 1.0 110.617 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -58.12 -27.0 78.34 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.803 1.669 . . . . 1.0 112.519 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -93.66 -10.25 35.13 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.926 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.08 87.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.885 0.374 . . . . 1.0 110.352 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.408 ' H ' HG22 ' B' ' 45' ' ' ILE . 6.7 tt -63.45 -33.16 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.609 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.85 75.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.707 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.666 ' CB ' ' HE ' ' B' ' 60' ' ' ARG . 1.4 t90 -62.5 -42.94 99.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.474 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.665 ' O ' HD22 ' B' ' 19' ' ' LEU . 11.9 p -45.13 -27.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.85 -25.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.443 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.66 ' CG ' HH21 ' C' ' 68' ' ' ARG . 1.5 tm-20 -66.24 -41.36 90.13 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.737 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.503 ' C ' ' H ' ' B' ' 53' ' ' THR . 8.4 t -82.44 -158.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.229 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 70.79 -38.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.474 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.541 HG21 ' OE2' ' C' ' 72' ' ' GLU . 70.8 p -91.22 6.83 43.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 44.7 p 51.61 66.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.428 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.16 -47.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.598 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.92 67.27 1.5 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.541 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 24.4 t80 -60.92 -49.14 78.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 1.0 110.908 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 160.62 -96.98 0.15 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.7 t0 52.52 -82.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.392 . . . . 1.0 110.602 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.675 ' CZ ' HD22 ' B' ' 38' ' ' LEU . 35.4 ptt85 -127.65 -160.88 1.04 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -163.55 133.32 3.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.965 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.0 179.06 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.628 1.552 . . . . 1.0 112.12 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.545 HG12 ' H ' ' B' ' 64' ' ' THR . 0.8 OUTLIER -91.33 -154.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.242 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.553 ' O ' ' NE1' ' A' ' 46' ' ' TRP . 18.0 m -113.61 -71.83 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.673 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' B' ' 64' ' ' THR . 83.4 tt0 -35.42 -31.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.966 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.907 ' O ' ' N ' ' B' ' 68' ' ' ARG . 95.2 mt-10 -141.98 -108.25 0.14 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.466 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 21.66 -56.04 0.0 OUTLIER Glycine 0 N--CA 1.476 1.345 0 O-C-N 124.492 1.12 . . . . 1.0 114.032 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.907 ' N ' ' O ' ' B' ' 66' ' ' GLU . 14.7 ttm180 -65.85 -48.61 71.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -63.58 -36.31 83.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.096 -1.075 . . . . 1.0 108.096 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.79 -45.35 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.952 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.519 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -65.88 -38.14 87.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -49.0 -45.65 42.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.176 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.36 -38.25 90.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.769 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.68 -45.55 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.552 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 3.6 mpp? -63.85 -40.29 96.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.518 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.33 -40.45 96.41 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.225 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.04 87.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.84 0.352 . . . . 1.0 110.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.77 -38.98 93.48 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.485 -0.646 . . . . 1.0 111.485 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.476 HG22 ' O ' ' B' ' 79' ' ' ILE . 95.8 mt -69.08 -11.8 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.815 -0.226 . . . . 1.0 111.559 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.57 -53.26 3.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.08 0.467 . . . . 1.0 110.931 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.687 HG23 ' H ' ' B' ' 82' ' ' PHE . 17.8 m -60.69 -55.11 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.712 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.687 ' H ' HG23 ' B' ' 81' ' ' VAL . 42.2 m-85 -62.0 -43.79 98.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.887 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.52 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.362 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.5 tt -57.62 -31.78 66.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.485 ' O ' HG12 ' B' ' 85' ' ' VAL . 46.9 t -60.1 -4.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.43 ' H ' ' C ' ' B' ' 84' ' ' LEU . 72.4 m -61.16 -44.86 96.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.574 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -51.37 -29.28 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.725 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.95 -12.69 35.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.739 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.79 -39.88 10.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.403 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.477 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.91 -25.78 57.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.231 0.539 . . . . 1.0 110.15 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -82.06 -6.31 59.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.395 -0.82 . . . . 1.0 109.891 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 96.8 m-20 -58.63 -48.77 79.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.142 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.1 p90 -77.48 -40.07 44.26 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.094 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.526 HG11 ' NH2' ' A' ' 96' ' ' ARG . 58.8 t -44.79 -31.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.586 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.05 -22.22 66.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.057 -0.257 . . . . 1.0 111.478 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.0 ptt85 -54.42 -43.45 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 1.0 110.063 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 96.4 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.417 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.4 t0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.872 0.367 . . . . 1.0 110.064 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.585 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 24.8 p80 -67.02 -39.99 87.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.099 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.585 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 48.0 tp10 -65.9 -41.35 91.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.727 0.298 . . . . 1.0 110.577 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -64.78 -37.41 87.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -62.9 -40.92 99.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.128 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.31 98.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.37 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -65.64 -41.92 92.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.481 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.87 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.26 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.62 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.165 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -37.15 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.06 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -64.55 -34.47 78.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.778 0.323 . . . . 1.0 110.438 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -65.78 -35.9 82.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.22 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.706 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.4 -36.26 79.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.334 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.57 -40.23 90.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.775 0.322 . . . . 1.0 110.908 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.73 -35.46 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.522 HD22 ' O ' ' C' ' 48' ' ' SER . 94.0 mt -59.98 -41.57 92.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.709 -0.396 . . . . 1.0 109.958 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 98.4 mt-10 -62.87 -43.34 99.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.92 -36.38 75.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.279 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.64 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.434 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.47 ' O ' HG23 ' C' ' 27' ' ' VAL . 77.8 p -60.76 -43.76 97.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.824 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -60.51 -56.35 22.48 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.95 -44.24 97.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.014 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -57.1 -24.76 56.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.47 HG23 ' O ' ' C' ' 23' ' ' SER . 35.0 t -80.78 -51.77 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.191 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.83 -43.01 69.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.911 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.79 -50.57 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 3.8 mp0 -62.15 -44.92 95.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -68.01 130.32 42.61 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.94 59.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.422 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.24 151.76 41.89 Favored Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.469 ' O ' HG11 ' C' ' 63' ' ' VAL . 89.2 Cg_endo -76.17 123.54 7.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.726 1.617 . . . . 1.0 112.184 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 103.99 -23.12 33.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . 48.35 178.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 1.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.67 -93.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.63 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.43 111.54 22.82 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.839 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' C' ' 40' ' ' SER . 1.4 tp -144.18 101.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.068 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.537 ' O ' ' N ' ' C' ' 44' ' ' ALA . 0.3 OUTLIER 166.67 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.749 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.9 OUTLIER -49.11 -50.48 63.17 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.862 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.8 Cg_endo -58.9 -34.9 99.3 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.383 1.389 . . . . 1.0 112.453 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -98.74 -5.1 32.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.277 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -68.31 -41.55 80.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.809 0.338 . . . . 1.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' C' ' 45' ' ' ILE . 5.9 tt -65.04 -38.9 83.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.617 ' CZ3' ' NZ ' ' D' ' 69' ' ' LYS . 0.3 OUTLIER -58.96 -46.63 87.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.557 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.541 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.9 OUTLIER -68.31 -23.6 64.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.271 -0.571 . . . . 1.0 109.508 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.522 ' O ' HD22 ' C' ' 19' ' ' LEU . 3.4 t -75.09 -35.54 61.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.92 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.52 -44.28 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.944 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.53 -41.84 77.46 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.057 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' C' ' 52' ' ' ALA . 3.6 t -78.69 -176.28 4.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' C' ' 51' ' ' THR . . . 76.3 -12.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.569 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.453 HG21 ' OE2' ' D' ' 72' ' ' GLU . 68.9 p -115.66 14.21 16.41 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.548 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' C' ' 53' ' ' THR . 47.0 p 53.67 69.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.4 -73.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.22 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.81 81.15 0.06 OUTLIER Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.412 ' CB ' ' CD1' ' D' ' 61' ' ' TYR . 45.5 t80 -60.43 -47.66 85.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.821 -0.351 . . . . 1.0 110.789 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.0 30.15 0.54 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 40.6 t0 -61.69 -41.68 97.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 1.0 110.431 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -141.79 -161.32 1.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.895 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 20.5 p90 -171.61 120.29 0.47 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.2 158.32 56.75 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.699 1.599 . . . . 1.0 112.355 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.541 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.06 -142.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.133 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.541 ' H ' HG12 ' C' ' 63' ' ' VAL . 98.4 m -111.77 -47.44 3.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.665 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' C' ' 67' ' ' GLY . 46.3 tp10 -58.71 -25.17 62.63 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.2 OUTLIER -73.01 28.15 0.06 Allowed 'General case' 0 C--O 1.263 1.81 0 CA-C-O 123.52 1.628 . . . . 1.0 110.213 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 41.1 62.72 1.7 Allowed Glycine 0 C--O 1.216 -1.024 0 CA-C-N 113.773 -1.558 . . . . 1.0 110.673 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.66 HH21 ' CG ' ' B' ' 50' ' ' GLU . 46.5 ttt85 -24.21 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.796 0.798 . . . . 1.0 111.58 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.8 mttt -51.65 -16.5 0.65 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.704 -0.68 . . . . 1.0 109.373 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' C' ' 67' ' ' GLY . 65.9 t -62.52 -48.08 89.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 119.324 -0.95 . . . . 1.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.06 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 1.0 110.093 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.8 tp10 -64.79 -39.59 93.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.03 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.65 -42.44 75.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.245 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' C' ' 52' ' ' ALA . 82.5 t -66.0 -41.72 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.844 -0.343 . . . . 1.0 111.545 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.4 mtt -59.46 -44.75 92.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.939 -0.304 . . . . 1.0 111.216 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -63.37 -40.63 97.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.424 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.34 -41.63 89.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.84 0.352 . . . . 1.0 110.496 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -42.39 76.15 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.222 -0.513 . . . . 1.0 111.897 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.19 -43.91 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.641 -0.329 . . . . 1.0 110.752 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.54 -43.25 85.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.303 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 77' ' ' ALA . 59.0 t -64.76 -50.39 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.511 ' O ' HG22 ' C' ' 85' ' ' VAL . 38.0 m-85 -67.63 -40.76 84.59 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.22 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.23 70.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.764 0.316 . . . . 1.0 110.776 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.1 tt -62.74 -42.23 99.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.813 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.511 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.2 m -52.64 -8.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.564 -0.455 . . . . 1.0 110.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.466 ' H ' ' C ' ' C' ' 84' ' ' LEU . 43.8 m -49.43 -23.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 1.0 110.247 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -57.26 -50.58 72.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.045 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.94 85.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.454 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.38 -38.52 90.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.879 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.519 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.32 -44.26 88.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.02 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.71 44.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.233 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.415 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 56.1 t0 -56.0 -49.52 73.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.656 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -72.5 -41.12 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.08 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 93.7 t -45.71 -27.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.68 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -62.41 -22.67 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.605 -0.27 . . . . 1.0 111.414 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -55.23 -33.65 63.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.758 0.314 . . . . 1.0 110.569 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.477 179.824 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.937 0.398 . . . . 1.0 110.42 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' D' ' 6' ' ' ARG . 98.7 m-20 -64.48 -40.11 95.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.776 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -72.2 -19.93 61.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.202 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.01 -45.29 77.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 1.0 110.519 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 6' ' ' ARG . . . . . 0.463 ' NH2' ' OD1' ' D' ' 3' ' ' ASP . 95.4 mtm-85 -65.39 -36.72 84.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.66 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -61.02 -42.72 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.086 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.23 86.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.24 -42.29 99.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.94 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.75 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.486 ' HB1' HG13 ' D' ' 81' ' ' VAL . . . -58.25 -38.56 77.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.905 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.8 -42.6 90.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.735 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.64 -38.91 90.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.595 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.96 -33.58 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.4 tp -62.82 -38.54 91.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 1.0 110.075 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.59 -28.41 67.74 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -65.0 -40.15 94.51 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.824 0.345 . . . . 1.0 111.534 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.68 -31.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.429 HD22 ' O ' ' D' ' 48' ' ' SER . 29.4 mt -61.15 -44.16 97.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.412 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' D' ' 23' ' ' SER . 12.0 pt-20 -67.87 -35.33 78.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.001 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -66.49 -36.65 83.26 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.802 -0.359 . . . . 1.0 110.344 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.76 -40.32 96.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.091 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.662 ' O ' HG23 ' D' ' 27' ' ' VAL . 78.0 p -58.45 -45.69 88.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.203 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.89 -63.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -58.57 -37.57 76.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -59.8 -42.31 93.16 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.705 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 23' ' ' SER . 72.0 t -64.16 -48.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.443 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.92 -42.58 69.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.777 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.688 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.529 ' OE1' HG22 ' D' ' 39' ' ' ILE . 8.8 tm-20 -69.91 -35.41 74.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.383 . . . . 1.0 111.002 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -54.07 101.84 0.05 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.912 0.387 . . . . 1.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.69 21.34 10.5 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.617 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.49 ' CB ' ' OE2' ' D' ' 66' ' ' GLU . . . -105.33 145.1 30.14 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 122.918 -0.166 . . . . 1.0 110.711 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.86 139.36 24.58 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.037 1.824 . . . . 1.0 112.03 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 63.98 17.25 60.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . -46.83 176.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.932 0.396 . . . . 1.0 110.958 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' D' ' 38' ' ' LEU . . . -166.95 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.751 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' D' ' 30' ' ' GLU . 58.5 tp -123.04 108.74 13.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.821 0.343 . . . . 1.0 110.109 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.529 HG22 ' OE1' ' D' ' 30' ' ' GLU . 14.2 pt -136.8 159.95 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' D' ' 43' ' ' ASP . 0.5 OUTLIER 81.33 139.23 0.07 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.697 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.3 OUTLIER -77.77 -38.61 1.76 Allowed Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.695 178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.63 -32.82 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.308 1.338 . . . . 1.0 112.197 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' D' ' 40' ' ' SER . 29.6 p-10 -96.94 -6.21 36.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.578 0.228 . . . . 1.0 110.876 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.39 -40.14 67.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.948 0.404 . . . . 1.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 tt -63.91 -40.17 88.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.417 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.487 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -58.49 -45.82 87.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -63.12 -39.24 94.1 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.724 -0.472 . . . . 1.0 109.724 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.429 ' O ' HD22 ' D' ' 19' ' ' LEU . 4.8 t -58.81 -41.57 87.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.127 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.408 ' O ' HG12 ' D' ' 49' ' ' VAL . 41.8 t -76.6 68.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.009 0.433 . . . . 1.0 111.699 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -173.58 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.733 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -64.68 -43.44 93.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . -56.49 -28.69 60.48 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -84.73 -1.82 56.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.317 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p 50.95 58.86 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.025 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.584 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.2 p -128.28 -46.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.587 -0.278 . . . . 1.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.584 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 41.26 76.58 0.09 OUTLIER Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.511 ' CZ ' ' O ' ' A' ' 60' ' ' ARG . 15.1 t80 -60.94 -46.42 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.0 110.416 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.72 36.08 0.08 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 21.6 t0 -83.86 -77.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 1.0 110.69 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -130.39 147.84 52.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.412 ' CD1' ' CB ' ' C' ' 57' ' ' TYR . 46.2 t80 -149.0 135.83 10.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.33 149.23 69.41 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.011 1.807 . . . . 1.0 112.318 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.441 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 3.3 t -80.41 -125.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.009 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.415 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 76.1 m -113.7 -36.41 4.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.839 0.352 . . . . 1.0 110.888 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.7 tt0 -67.4 -30.35 70.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.2 pm0 -79.36 34.53 0.26 Allowed 'General case' 0 C--O 1.265 1.891 0 CA-C-O 123.224 1.488 . . . . 1.0 108.845 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.43 61.19 1.29 Allowed Glycine 0 C--O 1.212 -1.262 0 CA-C-N 113.767 -1.561 . . . . 1.0 109.916 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 40.0 ttm180 -24.37 -31.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.533 0.784 . . . . 1.0 111.086 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.4 mttp -54.12 -13.67 0.89 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.308 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.4 t -61.32 -47.74 92.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 119.52 -0.872 . . . . 1.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.87 80.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.96 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' C' ' 53' ' ' THR . 35.8 tp10 -57.31 -39.37 75.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.232 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -66.58 -40.47 88.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 -47.52 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.539 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.64 -40.84 96.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 1.0 111.161 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -61.51 -42.54 98.96 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.744 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.96 88.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.432 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.29 -40.43 96.57 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.53 -43.61 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.712 0.291 . . . . 1.0 111.172 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.38 -35.2 79.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.01 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.486 HG13 ' HB1' ' D' ' 11' ' ' ALA . 43.1 t -67.28 -56.12 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.519 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -62.07 -43.22 99.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.836 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.23 -37.51 87.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.292 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.2 -42.19 99.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' D' ' 87' ' ' ALA . 89.7 t -58.11 -18.34 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 75.6 m -43.96 -20.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.467 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.22 -61.01 2.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.909 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.99 61.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.254 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 2.7 mm? -78.08 -38.04 45.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.24 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.9 -35.85 71.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.31 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -4.2 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.907 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' D' ' 89' ' ' LEU . 66.6 t0 -56.66 -44.37 81.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.836 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 12.3 p90 -74.97 -42.98 56.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.923 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 88.7 t -44.17 -26.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.358 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -57.49 -25.32 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.075 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' ARG . . . . . 0.577 HH12 ' CG ' ' A' ' 4' ' ' HIS . 7.2 ptp180 -59.2 -34.8 72.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 1.0 110.358 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.057 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.906 0.384 . . . . 1.0 110.375 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -174.25 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 15.3 p-80 -73.47 -31.07 63.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.08 -39.46 93.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -61.38 -42.09 98.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -64.0 -39.64 94.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.144 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -38.75 92.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.213 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -64.36 -41.56 96.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -63.39 -39.31 94.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.73 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HB1' HG13 ' A' ' 81' ' ' VAL . . . -59.23 -39.71 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.842 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.24 -44.23 88.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 1.0 110.635 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.72 -33.87 76.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.311 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.74 -35.16 79.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.449 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.0 tp -61.86 -42.57 99.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.392 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.24 -34.9 72.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.979 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.51 -40.76 97.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.09 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.42 -29.0 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 48' ' ' SER . 96.4 mt -62.76 -41.97 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.46 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.06 -39.8 78.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.329 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.27 93.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.029 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.5 p -60.76 -42.28 97.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 1.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.59 -30.34 71.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.926 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.9 -46.59 18.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.302 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.03 88.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.7 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 28' ' ' GLU . 11.8 m -56.71 -54.35 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.39 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' H ' HG23 ' A' ' 27' ' ' VAL . 88.2 mt-10 -67.93 -42.19 81.4 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.839 0.352 . . . . 1.0 110.701 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.32 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.063 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -98.05 14.86 25.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.557 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt85 -80.64 99.28 8.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.0 110.351 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.45 6.42 87.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.646 -0.581 . . . . 1.0 111.646 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 149.36 95.6 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.26 141.49 25.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.926 1.751 . . . . 1.0 112.245 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.05 -6.8 8.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.84 155.41 31.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.839 0.352 . . . . 1.0 110.48 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.18 10.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' SER . 6.8 tt -82.96 -10.73 58.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.476 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' LEU . 4.8 pt -37.35 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.631 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.4 m 169.21 134.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.916 -0.583 . . . . 1.0 109.888 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 55.9 m-85 -82.56 -48.33 0.86 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.448 0.536 . . . . 1.0 112.448 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.0 Cg_endo -60.56 -31.68 92.59 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 121.634 1.556 . . . . 1.0 112.657 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -91.2 -6.03 54.03 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.913 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.551 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.0 -41.0 88.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.093 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.99 96.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -62.4 -40.38 96.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.53 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.1 p -58.83 -31.9 68.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.718 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG1' ' OE1' ' B' ' 72' ' ' GLU . 94.9 t -71.59 -44.24 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.255 0.55 . . . . 1.0 110.636 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 45.7 tp10 -52.15 -42.68 63.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.376 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' THR . 4.6 t -80.78 -158.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' THR . . . 71.31 -35.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 1.0 110.141 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' THR . 62.0 p -81.31 5.43 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 p 58.17 26.7 14.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.127 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -146.95 82.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.782 0.325 . . . . 1.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 112.1 3.39 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.4 -46.05 91.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.53 27.41 0.39 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 48.7 m-20 -62.34 -42.11 99.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 1.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 38.8 mmt180 -130.87 -169.07 2.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.15 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 96.4 m-85 -159.61 91.58 1.84 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.89 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.34 157.59 60.65 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.787 1.658 . . . . 1.0 112.271 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.026 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -116.76 -165.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.987 0.423 . . . . 1.0 110.344 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 63' ' ' VAL . 61.2 m -78.66 -42.8 27.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.3 tp10 -50.74 -47.23 59.39 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -74.49 29.78 0.08 Allowed 'General case' 0 C--O 1.26 1.638 0 CA-C-O 124.212 1.958 . . . . 1.0 109.568 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.46 66.64 1.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 113.838 -1.528 . . . . 1.0 111.863 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH1' ' OE1' ' D' ' 50' ' ' GLU . 58.2 ttm-85 -24.11 -34.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.029 0.915 . . . . 1.0 110.808 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.9 mttp -47.63 -20.53 0.27 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' GLY . 57.1 t -61.29 -48.18 90.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 119.652 -0.819 . . . . 1.0 110.453 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.46 -41.73 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.673 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -59.67 -42.52 93.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.698 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.03 -41.55 83.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.821 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.1 t -65.65 -42.79 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.572 -0.451 . . . . 1.0 111.14 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.409 ' CE ' ' OH ' ' D' ' 57' ' ' TYR . 65.2 mtt -57.36 -45.33 84.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.904 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -63.59 -41.81 98.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.02 -40.6 85.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.647 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -68.24 -42.55 83.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.56 -43.92 95.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 1.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.22 -40.2 93.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.124 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.404 HG13 ' HB1' ' A' ' 11' ' ' ALA . 52.1 t -65.75 -49.74 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.07 -39.14 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.243 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.06 92.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.877 0.37 . . . . 1.0 110.998 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' C ' ' N ' ' A' ' 86' ' ' THR . 7.5 tt -62.98 -41.38 99.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.302 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 85' ' ' VAL . 81.3 t -47.4 -13.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.348 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 84' ' ' LEU . 76.8 m -58.07 -42.18 84.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.89 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -40.27 -33.77 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.561 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -86.46 -35.61 19.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 86' ' ' THR . 52.2 mt -66.4 -38.77 88.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.53 -47.83 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.155 0.502 . . . . 1.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -4.14 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.449 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.64 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 39.6 t0 -58.41 -49.39 77.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.015 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.5 p90 -76.05 -34.41 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.439 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.1 t -43.95 -34.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.137 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -60.36 -23.04 63.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -57.48 -44.31 84.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.434 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 64.3 t0 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.765 0.317 . . . . 1.0 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.8 p80 -77.48 -20.56 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.372 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.39 -37.78 83.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.93 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.73 -42.72 97.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.767 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.431 . . . . 1.0 109.864 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.43 90.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.73 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.8 -43.27 96.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.146 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -63.19 -40.37 97.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.69 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -59.69 -38.51 81.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.823 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.27 -44.27 84.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 1.0 110.647 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -64.67 -36.82 85.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.129 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -62.4 -33.44 74.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.325 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 1.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.17 -38.02 72.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.96 -38.62 89.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.76 -39.84 87.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.838 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.85 -38.72 82.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' B' ' 23' ' ' SER . 96.8 mt-10 -63.05 -43.92 97.3 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -69.32 -31.18 69.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.77 86.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.006 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -60.69 -45.77 92.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 44.3 tttm -65.47 -50.09 66.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.338 0.59 . . . . 1.0 110.073 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.09 -42.63 96.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.743 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.52 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -67.71 -50.69 56.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.106 0.253 . . . . 1.0 111.531 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.9 p -60.94 -45.91 97.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.06 0.457 . . . . 1.0 110.658 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 96.7 mt-10 -68.64 -18.81 64.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.674 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.66 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -59.76 -51.23 70.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.048 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 56.0 mp0 -80.64 -110.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 1.0 110.113 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 41.81 50.22 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.151 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.77 25.82 0.9 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.786 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.08 150.47 39.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.71 130.18 12.35 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.975 1.784 . . . . 1.0 112.067 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.88 75.08 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.201 -0.76 . . . . 1.0 111.201 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 163.49 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.349 . . . . 1.0 110.53 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.24 -32.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.574 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.59 49.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.39 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.635 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -92.73 76.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.182 0.515 . . . . 1.0 110.107 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' B' ' 39' ' ' ILE . 69.1 m -168.81 98.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.087 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 53.4 t80 -58.26 -50.12 89.83 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.69 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.2 Cg_endo -58.22 -33.28 97.41 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.809 1.672 . . . . 1.0 112.608 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.406 ' HB3' HH21 ' B' ' 60' ' ' ARG . 76.5 m-20 -94.66 -4.2 48.04 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.237 -0.185 . . . . 1.0 110.958 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.88 92.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.947 0.403 . . . . 1.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.41 HG22 ' H ' ' B' ' 45' ' ' ILE . 7.7 tt -67.39 -40.23 84.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.426 ' CD1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -62.94 -42.45 99.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.469 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -61.8 -42.7 99.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.513 ' C ' ' H ' ' B' ' 50' ' ' GLU . 16.2 m -56.82 -39.11 73.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.086 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.764 HG12 ' O ' ' B' ' 49' ' ' VAL . 58.0 t -67.18 29.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.87 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' B' ' 48' ' ' SER . 79.7 mm-40 -137.07 -21.79 1.2 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.848 -0.532 . . . . 1.0 110.493 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -36.08 14.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.02 83.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.207 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.7 p -86.18 12.96 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.849 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' B' ' 53' ' ' THR . 68.0 p 50.11 73.95 0.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.624 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' C' ' 75' ' ' MET . 29.4 t -131.4 -71.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.65 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 64.76 3.25 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -46.55 89.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.779 0.323 . . . . 1.0 110.752 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.96 23.1 0.97 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.633 -0.987 . . . . 1.0 110.633 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 48.0 t0 -63.13 -41.05 99.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 1.0 110.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 35.0 mmt180 -126.57 -174.68 3.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 79.2 m-85 -159.57 83.32 2.32 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.868 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 151.97 77.94 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.545 1.497 . . . . 1.0 112.092 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 16.8 m -96.68 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.872 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' B' ' 66' ' ' GLU . 48.8 m -112.38 -55.84 2.47 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.728 0.299 . . . . 1.0 111.238 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -43.87 -16.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.86 0.362 . . . . 1.0 110.804 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.66 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -91.85 26.66 2.33 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 123.839 1.781 . . . . 1.0 109.477 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.89 64.35 1.09 Allowed Glycine 0 C--O 1.212 -1.26 0 CA-C-N 113.663 -1.608 . . . . 1.0 111.424 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 55.8 ttm-85 -24.87 -32.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.217 1.008 . . . . 1.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.6 mttt -48.0 -18.87 0.21 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 67' ' ' GLY . 65.0 t -64.28 -45.47 96.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 120.124 -0.631 . . . . 1.0 109.803 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.92 -40.97 78.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.997 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLU . . . . . 0.425 ' OE1' ' CG1' ' A' ' 49' ' ' VAL . 83.0 tt0 -65.39 -40.5 93.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.085 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.69 -59.44 5.43 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.087 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.2 -44.68 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.287 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 38.9 ttp -59.93 -47.52 85.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.64 -32.48 73.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.378 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.74 78.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.575 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -43.05 96.74 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.74 -43.45 97.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 122.813 -0.228 . . . . 1.0 110.87 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.13 -42.1 85.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.298 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.405 HG13 ' HB1' ' B' ' 11' ' ' ALA . 53.7 t -63.83 -50.13 78.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.344 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.39 -37.83 80.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.789 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.29 -37.85 88.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.555 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.425 ' C ' ' N ' ' B' ' 86' ' ' THR . 4.4 tt -62.66 -41.58 99.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.183 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 85' ' ' VAL . 82.7 t -51.96 -15.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.425 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.7 m -49.65 -40.81 40.96 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -50.35 -38.94 44.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.67 59.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.678 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.69 -30.33 15.61 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.203 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.521 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.75 -40.44 96.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.47 0.652 . . . . 1.0 109.93 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 -5.31 49.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.932 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 51.4 t0 -54.99 -50.45 68.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.917 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 20.7 p90 -67.87 -43.91 78.31 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.357 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 97.6 t -39.42 -27.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.709 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 93' ' ' PHE . 34.7 mmt180 -63.25 -36.03 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.041 -0.264 . . . . 1.0 111.295 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -43.91 -28.29 0.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 1.0 110.192 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.983 -179.487 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.786 0.327 . . . . 1.0 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.564 ' CE1' ' HG2' ' C' ' 5' ' ' GLU . 1.9 p-80 -171.74 -30.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.911 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' C' ' 4' ' ' HIS . 23.8 mm-40 -83.85 -22.52 31.67 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.768 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.95 -41.57 99.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.117 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.06 -44.95 83.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.62 88.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.467 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.7 -44.5 96.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.32 -33.43 75.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.203 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.48 87.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -37.81 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.786 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -65.78 -33.45 75.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.523 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.37 -44.7 92.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.796 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' C' ' 52' ' ' ALA . 42.6 tp -63.23 -41.42 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.604 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -58.08 -42.25 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.567 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' C' ' 21' ' ' GLU . 56.4 mtmt -62.9 -40.8 98.68 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.147 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.48 -36.66 77.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.2 mt -60.81 -40.56 93.15 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.095 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.66 -50.69 72.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.146 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 12.2 mp0 -69.43 -43.0 74.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.42 93.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.475 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 20.3 m -61.76 -44.95 95.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.731 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -66.19 -36.15 82.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 1.0 109.856 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -72.98 -41.73 64.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.597 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -52.58 -52.96 52.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.537 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 4.2 p -62.8 -44.7 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.406 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 80.8 mm-40 -65.8 -37.01 85.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.48 94.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.328 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.6 mp0 -70.25 -37.85 75.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 1.0 110.69 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH2' ' OH ' ' C' ' 41' ' ' TYR . 25.5 mmt180 -56.64 100.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.721 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 116.09 -12.45 17.06 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.28 144.5 34.22 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 122.772 -0.252 . . . . 1.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.454 ' O ' HG11 ' C' ' 63' ' ' VAL . 92.6 Cg_endo -76.07 143.04 25.38 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.036 1.824 . . . . 1.0 112.414 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.17 28.9 67.39 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 141.03 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.311 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 -35.83 4.87 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.414 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.498 HD23 ' O ' ' C' ' 38' ' ' LEU . 6.5 tt -92.29 77.55 5.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.946 -0.39 . . . . 1.0 109.946 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 pt -110.41 -7.63 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.921 0.391 . . . . 1.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -81.9 134.93 35.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.46 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.2 OUTLIER -77.94 -48.57 2.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.847 178.658 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.5 Cg_endo -59.82 -28.73 87.91 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 121.675 1.583 . . . . 1.0 112.136 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.85 -17.28 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.383 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.66 99.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.75 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.425 ' O ' HG23 ' C' ' 49' ' ' VAL . 8.3 tt -65.27 -42.1 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.413 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.429 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.73 -46.27 86.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.538 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.459 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.0 t90 -63.91 -40.95 97.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.462 -0.495 . . . . 1.0 109.819 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 64.6 p -60.14 -35.85 76.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.134 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.3 t -61.79 -48.95 86.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.826 -0.35 . . . . 1.0 111.56 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' C' ' 59' ' ' ASP . 15.8 pt-20 -73.46 -25.81 60.65 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.549 -0.46 . . . . 1.0 110.861 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 27.4 m -62.55 -44.28 96.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.484 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -55.65 -20.41 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.696 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.542 ' C ' ' H ' ' C' ' 55' ' ' VAL . 4.9 p -84.31 -2.7 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.5 p 60.64 -3.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.726 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' C' ' 53' ' ' THR . 73.9 t -64.01 -44.84 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.795 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 70.79 -60.36 0.95 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.556 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 2.5 t80 70.6 -41.65 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 1.0 110.973 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 120.68 24.43 2.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.421 ' OD2' ' OE2' ' C' ' 50' ' ' GLU . 65.5 t0 -61.95 -48.04 82.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.984 0.421 . . . . 1.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' C' ' 61' ' ' TYR . 96.3 mtt-85 -143.54 -177.5 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 1.0 109.887 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' C' ' 60' ' ' ARG . 9.9 m-85 -155.02 106.79 2.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 120.606 -0.438 . . . . 1.0 111.01 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.16 156.42 64.99 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.725 1.616 . . . . 1.0 112.216 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.484 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.47 -140.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.061 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.484 ' H ' HG12 ' C' ' 63' ' ' VAL . 41.4 m -113.87 -38.93 4.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.836 0.351 . . . . 1.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.595 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.0 tt0 -63.64 -27.03 68.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.983 0.421 . . . . 1.0 110.008 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -73.17 30.21 0.07 Allowed 'General case' 0 C--O 1.263 1.796 0 CA-C-O 123.818 1.77 . . . . 1.0 110.109 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 40.53 64.03 1.27 Allowed Glycine 0 C--O 1.214 -1.126 0 CA-C-N 113.706 -1.588 . . . . 1.0 111.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' C' ' 67' ' ' GLY . 59.2 ttm-85 -24.09 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.768 0.784 . . . . 1.0 111.231 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.0 mttt -50.57 -16.51 0.38 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.764 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.5 t -61.44 -45.6 98.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.441 -0.904 . . . . 1.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.6 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.201 0.524 . . . . 1.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -69.53 -41.57 75.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.214 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -63.85 -48.44 76.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.748 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.496 HG13 ' N ' ' C' ' 75' ' ' MET . 7.9 p -63.93 -44.06 97.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.314 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.496 ' N ' HG13 ' C' ' 74' ' ' VAL . 71.1 mtm -64.61 -41.09 96.44 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.52 -42.6 99.62 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.366 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.463 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.19 -39.74 95.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 1.0 110.44 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.68 97.9 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.75 -0.54 . . . . 1.0 111.75 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.54 -43.3 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.277 . . . . 1.0 110.625 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.14 -40.38 86.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 77' ' ' ALA . 51.6 t -62.96 -49.95 81.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.944 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.545 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.2 m-85 -68.93 -38.87 79.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.177 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.56 -33.12 70.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.917 0.389 . . . . 1.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.7 tt -61.82 -42.36 98.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.749 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.545 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.5 m -49.31 -11.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.568 -0.453 . . . . 1.0 110.415 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.482 ' H ' ' C ' ' C' ' 84' ' ' LEU . 48.5 m -48.75 -19.66 0.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.935 0.398 . . . . 1.0 110.267 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -60.02 -35.25 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.17 -34.33 29.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.42 -39.85 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.727 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.527 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.59 -47.95 82.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.0 111.291 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -4.12 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.335 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 43.1 t0 -57.4 -48.34 79.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.557 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.527 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 22.9 p90 -76.08 -43.7 42.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.069 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 80.0 t -42.11 -27.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.747 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -61.78 -22.39 65.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.959 -0.296 . . . . 1.0 111.249 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -73.99 -7.68 53.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.816 0.341 . . . . 1.0 110.605 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.73 -178.97 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' D' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.725 0.298 . . . . 1.0 110.568 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.17 -32.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' D' ' 2' ' ' ALA . 28.5 p80 -82.26 -19.96 38.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.91 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.04 -40.66 78.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.805 0.336 . . . . 1.0 110.624 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -65.3 -38.04 89.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.07 -44.55 96.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.066 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.17 91.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.16 -41.33 94.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.54 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -63.79 -36.33 83.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -38.28 82.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.91 -41.16 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 1.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.81 -33.24 75.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.503 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLU . . . . . 0.434 ' O ' HG23 ' D' ' 18' ' ' VAL . 81.6 tt0 -63.32 -38.52 91.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.53 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.449 HD13 ' HA2' ' D' ' 78' ' ' GLY . 41.9 tp -62.64 -39.84 95.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.551 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -57.97 -40.7 81.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.289 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -75.82 -18.03 59.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.957 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 14' ' ' GLU . 37.9 t -76.89 -56.48 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.04 0.448 . . . . 1.0 111.169 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' D' ' 19' ' ' LEU . 1.9 pp -62.36 -28.44 69.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.733 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.39 -44.54 91.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.229 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -66.32 -36.68 83.54 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.888 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' D' ' 74' ' ' VAL . . . -65.32 -35.04 79.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.759 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -58.12 -43.89 87.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.845 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.04 -32.71 74.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -84.84 -32.3 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -60.86 -45.37 94.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.062 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.525 HG13 ' N ' ' D' ' 28' ' ' GLU . 5.5 p -61.3 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.089 0.471 . . . . 1.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.525 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.9 tm-20 -69.26 -40.76 77.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.386 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.05 94.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.337 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' D' ' 38' ' ' LEU . 26.0 tp10 -72.12 -38.52 69.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.869 0.366 . . . . 1.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -65.35 120.49 12.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.725 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.27 55.52 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.343 -0.703 . . . . 1.0 111.343 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.595 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -101.75 149.29 36.34 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 122.899 -0.177 . . . . 1.0 110.775 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.49 131.66 15.2 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.931 1.754 . . . . 1.0 111.965 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 7.05 88.23 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.72 143.25 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 -11.29 1.72 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.497 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.7 tt -110.53 120.37 42.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.021 0.438 . . . . 1.0 109.982 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' D' ' 40' ' ' SER . 37.0 pt -143.47 -165.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.366 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 3.2 m 58.25 132.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -74.6 -48.76 5.07 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.0 Cg_endo -59.04 -30.73 94.11 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.438 1.426 . . . . 1.0 111.943 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.22 -25.93 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.3 90.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.766 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' D' ' 45' ' ' ILE . 6.2 tt -63.19 -37.21 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.248 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -65.92 -46.6 77.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.18 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.556 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 2.3 t90 -57.47 -29.77 64.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -34.65 66.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.929 0.395 . . . . 1.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.8 -48.68 87.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.481 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 12.4 pt-20 -62.8 -38.2 89.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.73 HG22 ' H ' ' D' ' 52' ' ' ALA . 20.7 m -77.64 178.57 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.73 ' H ' HG22 ' D' ' 51' ' ' THR . . . 78.47 -18.22 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.446 ' H ' ' C ' ' D' ' 51' ' ' THR . 59.0 p -106.52 9.32 31.58 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.451 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' D' ' 53' ' ' THR . 12.0 p 56.89 67.24 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.955 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.95 -80.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.724 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.4 96.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.409 ' OH ' ' CE ' ' A' ' 75' ' ' MET . 59.5 m-85 -61.72 -43.22 99.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.689 0.281 . . . . 1.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.51 12.78 1.54 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.81 -50.41 74.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 1.0 110.462 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -144.68 125.98 14.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -114.66 138.9 23.46 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.64 160.39 49.6 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.469 2.112 . . . . 1.0 111.875 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.88 HG22 ' H ' ' D' ' 64' ' ' THR . 10.0 p -97.61 -140.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.002 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.88 ' H ' HG22 ' D' ' 63' ' ' VAL . 51.8 m -114.21 -43.68 3.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.312 -0.403 . . . . 1.0 111.044 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.581 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -66.6 -19.98 65.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.58 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.3 OUTLIER -75.69 25.84 0.11 Allowed 'General case' 0 C--O 1.262 1.723 0 CA-C-O 123.993 1.854 . . . . 1.0 109.213 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.743 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.59 62.79 3.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.0 -1.454 . . . . 1.0 109.841 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 57.0 ttm-85 -25.62 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.458 0.629 . . . . 1.0 111.03 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.743 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.22 -28.06 6.97 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.24 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' D' ' 67' ' ' GLY . 78.4 t -63.05 -48.8 86.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -74.26 -51.99 13.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.47 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -49.8 -40.31 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.096 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.29 -40.37 96.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' D' ' 52' ' ' ALA . 70.5 t -62.38 -45.19 99.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.431 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' D' ' 51' ' ' THR . 3.8 mpp? -64.25 -42.08 96.66 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.066 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -63.97 -42.03 97.38 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.505 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.8 -36.53 83.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.896 0.379 . . . . 1.0 110.751 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -69.6 -40.15 77.83 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.34 -44.65 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.788 0.294 . . . . 1.0 111.708 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' D' ' 80' ' ' GLU . 9.4 pt-20 -65.92 -35.67 81.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.152 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 77' ' ' ALA . 42.0 t -62.17 -48.67 87.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.552 -0.294 . . . . 1.0 111.263 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -73.78 -4.65 35.96 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.878 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.41 -32.37 11.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.7 tt -65.11 -40.04 93.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.442 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -53.7 -6.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.191 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.502 ' O ' ' N ' ' D' ' 89' ' ' LEU . 71.1 m -58.19 -43.54 87.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.339 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.489 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -42.78 -30.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.476 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.57 -32.92 20.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.066 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' D' ' 86' ' ' THR . 90.6 mt -67.34 -39.22 85.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.228 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.01 -48.18 82.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.182 0.515 . . . . 1.0 111.101 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -73.97 -4.98 38.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.209 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 46.7 t0 -55.14 -49.36 72.0 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.102 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 26.7 p90 -73.37 -44.13 59.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.0 t -42.47 -26.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.219 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -58.4 -32.29 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.957 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -58.77 -34.32 71.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 1.0 110.418 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 -179.641 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 4' ' ' HIS . 31.5 p-10 -172.57 -46.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.442 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 43.0 p-80 -78.92 -29.98 44.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.53 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.71 -35.93 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -63.15 -37.81 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.291 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -64.22 -41.89 96.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.063 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.87 92.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.357 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.82 -39.26 90.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.353 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.79 -41.19 97.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.617 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.43 80.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.869 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.02 -36.82 85.24 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -34.55 78.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.487 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.567 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 39.7 tp10 -64.95 -36.35 84.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.451 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.5 tp -62.72 -42.13 99.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 1.0 110.737 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.307 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HZ1' ' CD ' ' A' ' 14' ' ' GLU . 6.8 ttpm? -62.41 -40.07 95.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.13 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.88 -35.66 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.5 mt -61.06 -42.46 98.54 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.216 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.54 -43.29 85.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.263 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.6 -39.65 77.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.389 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.48 96.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.6 m -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.391 . . . . 1.0 110.182 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.764 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.69 -46.69 13.96 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.248 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.93 -44.58 78.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.549 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 4.7 p -59.51 -46.92 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.117 -0.633 . . . . 1.0 109.694 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 94.6 mt-10 -71.55 -33.8 69.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.653 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.29 97.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.266 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -89.89 -4.34 57.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.143 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -75.37 91.08 2.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.577 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.6 -15.36 17.25 Favored Glycine 0 N--CA 1.466 0.67 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 148.67 97.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 120.786 -0.365 . . . . 1.0 110.028 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 63' ' ' VAL . 93.0 Cg_endo -75.18 139.66 24.08 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.865 1.71 . . . . 1.0 112.333 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.62 21.92 74.92 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.64 166.35 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.902 0.382 . . . . 1.0 110.554 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 38' ' ' LEU . . . -151.66 -12.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.231 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 40.2 tp -67.72 -19.07 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' LEU . 95.3 mt -33.63 89.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.273 0.559 . . . . 1.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' LEU . 8.7 t -171.66 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.561 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 22.0 t80 -179.27 -57.8 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 123.142 0.276 . . . . 1.0 111.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 45' ' ' ILE . 30.3 Cg_endo -60.09 -31.65 93.63 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 121.782 1.655 . . . . 1.0 112.5 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -82.55 -10.12 59.12 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.233 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.25 84.06 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.87 0.366 . . . . 1.0 110.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 49' ' ' VAL . 6.7 tt -67.69 -38.33 80.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.475 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.4 OUTLIER -63.96 -50.47 68.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.163 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -62.36 -42.82 99.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.751 -0.463 . . . . 1.0 109.751 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.7 m -53.64 -36.05 61.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 49' ' ' VAL . 57.8 t -82.99 -4.86 8.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.0 110.459 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -107.82 37.19 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.375 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.422 HG23 HG11 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -148.74 -35.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.57 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.31 -24.68 63.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.496 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 54' ' ' THR . 70.2 p -89.69 5.29 46.51 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 53' ' ' THR . 44.7 p 54.46 71.03 0.55 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.142 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.85 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.741 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.32 84.68 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.78 -41.72 99.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.768 0.318 . . . . 1.0 110.556 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.24 20.49 0.36 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.32 -35.36 80.6 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.697 ' NH2' HH22 ' B' ' 68' ' ' ARG . 2.1 tpp180 -134.77 179.07 6.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.348 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 75.1 m-85 -160.94 93.88 1.47 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.35 149.74 69.89 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.713 1.609 . . . . 1.0 112.216 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 34' ' ' PRO . 1.5 t -85.76 -143.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.305 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' A' ' 63' ' ' VAL . 52.1 m -110.34 -38.78 5.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.697 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.2 tt0 -61.46 -20.73 63.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.059 0.457 . . . . 1.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.14 25.77 0.22 Allowed 'General case' 0 C--O 1.267 1.995 0 CA-C-O 123.915 1.817 . . . . 1.0 109.516 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.94 65.47 1.6 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.649 -1.614 . . . . 1.0 111.12 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 55.6 ttm-85 -24.45 -32.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.975 0.888 . . . . 1.0 110.999 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 99.1 mttt -47.24 -26.25 1.15 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.422 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.4 t -63.26 -46.47 95.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.764 -0.774 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.34 62.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 1.0 111.012 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.31 -41.27 96.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.835 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -55.57 -43.82 76.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 HG23 ' A' ' 51' ' ' THR . 95.0 t -66.75 -44.72 89.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.486 -0.486 . . . . 1.0 111.005 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.508 ' SD ' HG11 ' D' ' 55' ' ' VAL . 64.3 mtt -61.87 -43.64 98.43 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.637 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.78 -41.06 92.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 1.0 110.299 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -59.76 -40.67 88.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.451 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.28 -43.74 92.24 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.07 -43.53 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 121.082 -0.247 . . . . 1.0 110.395 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -43.19 97.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.246 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' ALA . 55.6 t -64.77 -50.02 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.796 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -68.29 -37.36 80.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.68 88.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.685 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.1 tt -65.69 -37.45 86.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.24 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 t -46.06 -13.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.42 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 16.2 m -58.79 -45.17 90.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.495 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -40.93 -21.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.758 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -106.62 -25.35 11.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.73 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 86' ' ' THR . 69.6 mt -62.79 -42.22 99.6 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -72.96 -65.24 0.82 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.36 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -47.56 -10.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.229 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' ALA . 46.9 t0 -63.18 -73.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.024 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' B' ' 87' ' ' ALA . 25.1 m-85 -86.46 -27.98 23.77 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.952 0.353 . . . . 1.0 111.952 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 90' ' ' ALA . 56.3 t -40.88 -27.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.515 0.198 . . . . 1.0 111.274 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 93' ' ' PHE . 95.7 mtt-85 -61.17 -32.99 72.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -39.43 -38.68 0.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.715 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.002 0.43 . . . . 1.0 109.906 179.303 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 65.7 t0 . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.896 0.379 . . . . 1.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -80.7 -29.63 36.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.23 -44.26 84.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.89 -36.01 75.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -67.79 -40.42 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 1.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.8 98.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.85 -32.49 73.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.24 -39.46 92.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.365 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.34 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.767 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.6 -36.85 81.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.396 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -65.73 -41.18 92.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.363 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' B' ' 52' ' ' ALA . 40.6 tp -61.27 -41.86 97.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.37 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.24 -42.85 96.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.712 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -64.15 -37.93 89.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.711 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.81 -66.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.12 -31.56 61.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.837 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -63.45 -44.66 93.86 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.52 -36.63 84.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.61 75.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.854 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.466 ' O ' HG23 ' B' ' 27' ' ' VAL . 25.2 p -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.483 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.58 -56.35 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.077 -0.649 . . . . 1.0 109.856 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.1 -38.97 80.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.267 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.45 76.41 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.131 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 23' ' ' SER . 90.2 t -63.58 -48.56 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.263 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.88 -35.81 72.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.752 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.43 84.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.201 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' B' ' 38' ' ' LEU . 41.9 mm-40 -70.51 -42.56 71.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 1.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -53.6 94.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.899 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 115.85 11.25 10.33 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 111.15 -0.78 . . . . 1.0 111.15 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' OE2' ' B' ' 66' ' ' GLU . . . -102.03 137.41 19.48 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.614 0.207 . . . . 1.0 110.617 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.03 138.86 21.1 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.869 1.713 . . . . 1.0 112.407 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.4 3.4 39.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . -47.14 176.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 1.0 110.399 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.27 -28.92 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.537 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' B' ' 30' ' ' GLU . 23.0 tp -99.49 119.81 38.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.965 0.412 . . . . 1.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.34 64.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.036 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -169.26 128.99 1.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.372 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.2 OUTLIER -58.62 -51.45 81.73 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.669 -0.696 . . . . 1.0 111.176 178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.3 Cg_endo -57.85 -32.24 94.48 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.701 1.601 . . . . 1.0 112.682 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' B' ' 43' ' ' ASP . 2.4 m-20 -93.22 -23.24 18.61 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.762 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.99 94.42 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.878 0.37 . . . . 1.0 110.568 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -64.27 -37.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.41 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -44.98 86.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.44 -40.33 94.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.502 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -61.47 -36.33 80.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.171 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.99 -48.07 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 1.0 111.982 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.88 -30.5 69.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.846 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -62.51 -45.08 94.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.565 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' B' ' 15' ' ' LEU . . . -59.73 -32.15 70.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.013 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' B' ' 54' ' ' THR . 45.0 p -71.82 -6.75 43.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.799 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.38 65.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.284 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.584 HG11 ' CE1' ' B' ' 57' ' ' TYR . 92.7 t -150.37 -47.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 42.85 83.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.584 ' CE1' HG11 ' B' ' 55' ' ' VAL . 33.1 m-85 -62.83 -41.6 99.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 167.62 -90.25 0.1 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 77.1 m-20 42.56 -88.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 1.0 110.9 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' B' ' 58' ' ' GLY . 25.6 mmt180 -115.61 -173.39 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.194 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 38.7 p90 -173.77 118.54 0.37 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.246 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.35 158.12 58.65 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.565 1.51 . . . . 1.0 112.251 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.468 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.8 t -97.22 -126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.543 HG22 ' CD1' ' A' ' 46' ' ' TRP . 5.9 p -114.3 -36.56 4.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.777 0.322 . . . . 1.0 111.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.7 tt0 -65.29 -31.48 72.65 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.553 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 1.3 pm0 -79.26 30.33 0.22 Allowed 'General case' 0 C--O 1.269 2.115 0 CA-C-O 123.969 1.842 . . . . 1.0 109.797 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 37.57 61.92 1.01 Allowed Glycine 0 C--O 1.212 -1.237 0 CA-C-N 113.092 -1.867 . . . . 1.0 111.045 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.697 HH22 ' NH2' ' A' ' 60' ' ' ARG . 40.5 ttm180 -24.96 -32.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.993 . . . . 1.0 110.947 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' B' ' 67' ' ' GLY . 68.3 mttm -49.42 -16.48 0.2 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 67' ' ' GLY . 55.9 t -63.35 -46.1 96.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 119.788 -0.765 . . . . 1.0 109.578 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.58 72.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.241 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.12 -43.92 70.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.343 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.35 -44.22 88.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.825 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.34 -43.51 91.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.323 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 37.0 mtt -59.11 -44.86 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.721 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.19 -42.58 96.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.74 89.17 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.13 -36.81 93.71 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.89 -26.9 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.424 -0.457 . . . . 1.0 111.523 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.29 -50.6 37.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.042 0.449 . . . . 1.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' H ' ' B' ' 82' ' ' PHE . 5.7 m -60.04 -48.7 86.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.355 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.442 ' H ' HG23 ' B' ' 81' ' ' VAL . 20.6 m-85 -66.03 -34.55 78.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.67 37.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.2 tt -69.97 -23.43 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 1.0 110.114 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.534 ' O ' HG12 ' B' ' 85' ' ' VAL . 98.6 t -57.29 -3.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.644 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.521 ' H ' ' C ' ' B' ' 84' ' ' LEU . 14.6 t -49.32 -39.0 29.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.404 0.621 . . . . 1.0 109.585 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -46.69 -35.63 6.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.423 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.23 -10.85 51.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.585 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' B' ' 92' ' ' ASP . 85.7 mt -85.29 -56.87 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.891 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 94' ' ' VAL . . . -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.293 0.568 . . . . 1.0 109.989 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -61.11 -37.56 83.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.574 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 11.1 t0 -59.56 -44.48 93.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.617 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 0.5 OUTLIER -61.25 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.756 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 96' ' ' ARG . 95.9 t -64.93 -43.83 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.738 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.533 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 46.9 mtt85 -44.79 -20.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.459 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' B' ' 94' ' ' VAL . 52.3 ptt85 -52.85 -33.13 48.16 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.247 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.438 -179.827 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.816 0.341 . . . . 1.0 110.427 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 2.8 p80 -78.78 -27.7 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.054 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.645 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 84.7 tt0 -70.04 -32.75 71.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.739 0.304 . . . . 1.0 110.813 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -59.36 -41.58 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.58 -39.95 89.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.187 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.38 87.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -58.06 -42.45 85.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.529 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -62.6 -34.6 77.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 1.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' C' ' 84' ' ' LEU . . . -58.5 -37.95 76.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.001 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.29 -32.82 74.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.004 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.2 -41.97 94.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.705 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.44 -39.95 94.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' C' ' 52' ' ' ALA . 50.0 tp -62.39 -42.36 99.36 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.649 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.61 -41.88 92.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.6 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -63.36 -38.46 91.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.793 0.33 . . . . 1.0 111.155 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.68 -42.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.754 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' C' ' 52' ' ' ALA . 67.1 mt -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.239 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -64.5 -42.63 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.35 -39.0 74.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.492 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.53 85.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.996 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -58.27 -46.21 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.617 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.41 -35.71 81.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 1.0 109.964 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -70.6 -40.93 72.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.321 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -50.14 73.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.33 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 18.9 m -61.43 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.403 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' HG23 ' C' ' 27' ' ' VAL . 40.3 tp10 -69.6 -41.83 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.539 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.89 94.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.65 -6.76 56.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.965 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -87.74 117.47 26.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.929 0.395 . . . . 1.0 110.119 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.47 -4.02 63.94 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.3 144.09 37.75 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.93 137.79 20.11 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.9 1.734 . . . . 1.0 112.346 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.75 14.9 75.6 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 149.06 47.15 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.383 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 41.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.509 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.493 HD23 ' C ' ' C' ' 38' ' ' LEU . 3.7 tt -127.53 -67.15 0.84 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.191 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' C' ' 38' ' ' LEU . 19.2 pt 31.59 -123.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.557 0.536 . . . . 1.0 110.862 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t 47.82 -130.63 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.731 0.301 . . . . 1.0 110.754 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.466 ' HA ' HG11 ' C' ' 27' ' ' VAL . 5.9 t80 177.85 -59.37 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.1 Cg_endo -59.33 -33.95 97.74 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.927 1.751 . . . . 1.0 112.105 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -78.01 -6.04 53.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.53 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.49 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -64.3 -44.82 90.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 1.0 111.348 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.474 HG23 ' HE3' ' C' ' 46' ' ' TRP . 10.1 tt -66.14 -33.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.474 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.3 OUTLIER -64.08 -48.54 75.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.258 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.45 -42.61 95.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.272 -0.571 . . . . 1.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -52.81 -39.45 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.739 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' C' ' 51' ' ' THR . 71.2 t -65.47 -43.93 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.513 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.64 24.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.884 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.522 ' H ' ' C ' ' C' ' 49' ' ' VAL . 96.1 m -127.78 -43.85 1.52 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.674 -0.239 . . . . 1.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.93 -25.13 66.55 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.578 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.513 ' OG1' HG13 ' C' ' 55' ' ' VAL . 16.9 p -89.9 4.4 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.834 0.349 . . . . 1.0 110.12 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 44.2 p 52.19 35.76 17.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.813 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.594 HG11 ' SD ' ' D' ' 75' ' ' MET . 31.3 m -75.35 -35.87 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.212 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD2' ' B' ' 57' ' ' TYR . . . 100.11 -76.3 0.45 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' C' ' 57' ' ' TYR . 44.2 p90 -61.99 117.61 6.18 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' C' ' 60' ' ' ARG . . . -133.77 20.02 4.14 Favored Glycine 0 N--CA 1.464 0.515 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.42 ' OD2' ' CZ ' ' C' ' 60' ' ' ARG . 11.9 t0 71.12 -29.14 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.298 . . . . 1.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' C' ' 58' ' ' GLY . 21.3 mmt180 -121.22 152.4 38.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -139.35 126.85 13.06 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.63 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.84 152.49 68.91 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.764 1.643 . . . . 1.0 111.981 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.492 HG11 ' O ' ' C' ' 34' ' ' PRO . 3.4 t -92.34 -126.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.458 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 86.9 m -115.17 -38.71 3.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.909 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.669 ' C ' ' H ' ' C' ' 67' ' ' GLY . 42.7 tp10 -67.6 -38.43 83.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.647 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 0.1 OUTLIER -65.89 27.17 0.02 OUTLIER 'General case' 0 C--O 1.264 1.829 0 CA-C-O 123.176 1.465 . . . . 1.0 110.248 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.78 64.28 1.7 Allowed Glycine 0 C--O 1.216 -0.975 0 CA-C-O 118.183 -1.343 . . . . 1.0 111.192 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 56.8 ttm-85 -23.34 -32.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.05 0.925 . . . . 1.0 111.446 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.9 mttt -50.62 -16.49 0.39 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.379 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 57.0 t -60.48 -46.83 94.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.98 81.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 1.0 110.142 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -62.25 -36.72 82.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.84 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -62.55 -43.84 97.82 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.28 -45.6 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.558 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.8 -36.9 85.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.971 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -59.36 -46.26 89.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.494 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -66.25 -38.45 87.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 1.0 110.265 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.23 -48.56 73.53 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.156 -0.545 . . . . 1.0 111.809 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.15 -43.7 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.707 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -68.18 -43.02 79.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.279 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.494 HG23 ' O ' ' C' ' 77' ' ' ALA . 41.4 t -63.38 -49.16 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.083 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -68.68 -28.49 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.186 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.44 -26.41 26.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 1.0 110.412 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' C' ' 11' ' ' ALA . 4.7 tt -64.15 -42.51 96.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.625 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.8 m -62.33 -9.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.44 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 24.8 m -41.45 -20.14 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.932 0.396 . . . . 1.0 110.555 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -63.69 -66.46 0.54 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.542 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.57 64.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.48 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.638 HD12 ' O ' ' D' ' 83' ' ' ALA . 4.2 mm? -64.98 -38.43 90.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.363 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -66.99 -69.29 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.938 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.872 ' O ' HG22 ' C' ' 94' ' ' VAL . 0.5 OUTLIER -40.03 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.539 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' C' ' 90' ' ' ALA . 46.4 t0 -38.83 -33.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.677 0.275 . . . . 1.0 111.364 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 7.0 p90 -64.35 -35.64 81.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.675 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.872 HG22 ' O ' ' C' ' 91' ' ' THR . 15.1 m -48.88 -36.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.755 -0.657 . . . . 1.0 111.874 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -63.86 -21.84 66.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -59.26 -43.29 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.253 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' C' ' 97' ' ' GLU . 56.3 mp0 . . . . . 0 C--N 1.332 -0.196 0 CA-C-O 120.781 0.324 . . . . 1.0 110.788 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.667 0.27 . . . . 1.0 110.595 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -174.94 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.716 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -79.56 -17.36 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.784 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.76 -36.76 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 1.0 110.452 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -62.11 -42.95 99.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.249 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.18 -44.67 96.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.107 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 8' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' D' ' 85' ' ' VAL . . . -65.54 -39.18 91.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.785 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -64.95 -41.06 95.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.466 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -63.31 -37.56 87.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.57 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -39.3 92.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.33 -32.61 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.373 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.04 -38.34 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.61 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.6 tp -61.86 -43.41 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.522 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -56.51 -36.05 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -62.68 -36.24 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.105 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.99 -40.71 81.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 1.0 110.781 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.88 -40.81 89.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.099 -0.5 . . . . 1.0 109.98 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -55.19 -49.8 70.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.621 -0.432 . . . . 1.0 109.888 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.53 -35.06 72.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.089 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.78 85.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.138 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -60.31 -43.97 95.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 1.0 111.116 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.33 -34.32 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.654 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.03 -44.27 16.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.939 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.15 90.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.711 0.291 . . . . 1.0 110.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 2.8 p -60.43 -44.12 95.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.173 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 79.2 mm-40 -71.39 -42.9 67.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.861 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.82 99.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.423 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -65.74 -37.21 85.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.8 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -67.5 122.13 17.32 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.932 0.396 . . . . 1.0 110.553 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.65 -11.87 59.49 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.116 -0.793 . . . . 1.0 111.116 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.5 133.77 39.44 Favored Pre-proline 0 CA--C 1.538 0.515 0 O-C-N 122.798 -0.236 . . . . 1.0 110.47 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.82 142.74 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.149 1.9 . . . . 1.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.1 0.62 53.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.33 140.2 50.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.767 0.318 . . . . 1.0 110.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.93 -53.88 2.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.584 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -52.4 94.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.121 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.713 HG23 ' O ' ' D' ' 39' ' ' ILE . 21.0 tt -134.11 63.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.16 0.505 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -159.68 135.75 8.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.477 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 18.0 t80 -74.87 -49.5 4.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.72 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.8 Cg_endo -58.93 -30.71 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.321 1.347 . . . . 1.0 111.964 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -87.14 -20.2 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.076 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.93 96.25 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.867 0.365 . . . . 1.0 110.692 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.413 ' H ' HG22 ' D' ' 45' ' ' ILE . 7.3 tt -66.27 -38.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.303 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.402 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -63.86 -46.56 84.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.044 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -39.77 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.166 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.3 t -49.6 -20.25 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.564 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' D' ' 51' ' ' THR . 24.9 t -97.58 -33.64 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.0 0.429 . . . . 1.0 110.258 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -78.21 16.62 0.74 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.43 ' H ' ' C ' ' D' ' 49' ' ' VAL . 6.1 t -137.38 -34.81 0.69 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.16 -24.48 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.523 ' OG1' HG13 ' D' ' 55' ' ' VAL . 67.4 p -93.88 6.17 49.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.3 p 56.71 11.28 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.055 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.523 HG13 ' OG1' ' D' ' 53' ' ' THR . 25.8 m -63.53 -43.34 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.787 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.465 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 41.43 86.62 0.01 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -90.58 4.5 51.09 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.836 0.351 . . . . 1.0 110.159 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.03 17.3 65.46 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 30.1 m-20 -63.63 -46.18 86.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 1.0 110.593 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.39 167.08 21.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.019 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 9.6 p90 -153.56 102.48 2.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.591 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.76 162.38 42.3 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.885 1.723 . . . . 1.0 112.508 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.502 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -96.13 -140.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.502 ' H ' HG12 ' D' ' 63' ' ' VAL . 28.9 m -112.15 -39.71 4.39 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.668 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -59.53 -24.28 63.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.516 ' OE2' ' N ' ' D' ' 68' ' ' ARG . 0.1 OUTLIER -80.01 28.52 0.29 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 123.329 1.538 . . . . 1.0 108.944 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.15 62.19 2.15 Favored Glycine 0 C--O 1.216 -0.977 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.995 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.516 ' N ' ' OE2' ' D' ' 66' ' ' GLU . 48.2 ttm-85 -24.61 -32.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.401 0.707 . . . . 1.0 111.061 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.26 -18.23 0.57 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.615 ' O ' HG23 ' D' ' 74' ' ' VAL . 62.0 t -63.01 -46.84 95.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.907 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.5 -47.31 27.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.348 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -43.77 -62.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.57 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.15 -41.68 88.9 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.615 HG23 ' O ' ' D' ' 70' ' ' VAL . 89.9 t -61.72 -48.06 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.404 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.594 ' SD ' HG11 ' C' ' 55' ' ' VAL . 75.5 mtm -64.56 -41.99 95.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.697 0.284 . . . . 1.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.1 -36.16 83.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.696 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.466 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -58.3 -38.4 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.321 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.07 -42.1 94.75 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.458 -0.657 . . . . 1.0 111.458 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.64 98.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.616 0.246 . . . . 1.0 111.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.36 -38.9 92.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.133 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 77' ' ' ALA . 70.5 t -63.29 -48.29 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.091 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.05 -36.82 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.853 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.638 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -60.76 -37.75 82.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.836 -0.345 . . . . 1.0 110.266 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.8 tt -62.49 -40.34 96.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.557 ' O ' HG12 ' D' ' 85' ' ' VAL . 99.8 t -58.41 -3.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.205 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 89' ' ' LEU . 54.4 m -59.33 -44.53 92.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.649 ' O ' HG22 ' D' ' 91' ' ' THR . . . -41.71 -57.17 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 1.0 110.561 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.65 59.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' D' ' 86' ' ' THR . 83.8 mt -89.78 -16.95 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -80.71 -49.58 11.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.649 HG22 ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -50.98 -10.82 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.953 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.482 ' N ' ' C ' ' D' ' 90' ' ' ALA . 97.6 m-20 -61.54 -53.48 55.8 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -45.44 -34.02 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.01 -27.1 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.155 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -60.56 -41.27 94.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.612 -0.267 . . . . 1.0 110.895 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -50.71 -39.36 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.338 . . . . 1.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.661 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 1.0 110.631 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.48 -43.06 99.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.723 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 11.2 p-80 -73.04 -32.03 64.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.626 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.27 -36.07 82.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 1.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -64.1 -39.52 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.264 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -66.84 -39.16 87.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.052 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.57 87.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.332 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.85 -45.11 94.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.114 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.21 -37.18 86.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.431 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 84' ' ' LEU . . . -54.23 -45.8 72.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.925 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.32 -41.99 93.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 1.0 110.557 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.76 -32.59 74.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.304 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.05 -36.72 84.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.685 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.2 tp -62.31 -42.4 99.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 1.0 110.594 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -57.93 -39.91 79.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.232 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.72 -42.65 99.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.077 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.71 -40.59 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.445 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 52' ' ' ALA . 89.6 mt -59.06 -40.76 86.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 1.0 109.952 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.64 -48.06 82.32 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.536 -0.465 . . . . 1.0 109.832 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.87 -33.37 75.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.972 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.86 90.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.488 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.783 ' O ' HG23 ' A' ' 27' ' ' VAL . 27.3 m -59.53 -44.86 93.08 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -66.16 -54.92 19.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.526 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.9 mttt -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.125 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.77 90.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.198 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 23' ' ' SER . 62.3 t -64.61 -46.43 92.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.042 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.35 -23.38 46.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -52.32 -49.41 64.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.251 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 63' ' ' VAL . 2.3 mm-40 -70.19 -39.74 75.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -67.55 92.91 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.785 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.44 -15.8 6.34 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.408 -0.677 . . . . 1.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.496 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -105.15 148.56 36.41 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.859 0.33 . . . . 1.0 110.285 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 97.1 Cg_endo -75.78 132.89 14.86 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.975 1.783 . . . . 1.0 112.571 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 96.94 8.16 57.07 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . -35.55 154.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.761 0.315 . . . . 1.0 110.875 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.72 -50.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.471 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.5 110.36 19.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.032 0.444 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 pt -142.84 73.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.281 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' ALA . 8.5 p -162.15 98.91 1.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 56.8 t80 -51.51 -49.43 82.56 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.089 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.6 Cg_endo -59.75 -35.3 94.93 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.262 1.308 . . . . 1.0 112.509 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.0 -6.92 34.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.9 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -65.54 -43.6 89.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 1.0 110.533 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -64.64 -34.64 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.44 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.43 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.34 -46.44 90.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.882 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.46 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 1.7 t90 -66.68 -40.48 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.498 -0.481 . . . . 1.0 109.793 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 1.2 m -54.74 -33.12 60.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.84 -46.97 95.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.024 0.44 . . . . 1.0 110.175 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' B' ' 61' ' ' TYR . 62.1 mt-10 -66.8 -33.32 75.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.387 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 96.6 m -62.2 -46.78 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.353 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.59 -36.74 81.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.149 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 55' ' ' VAL . 72.0 p -74.4 -9.83 58.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 53' ' ' THR . 3.0 p 65.1 -4.86 0.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 57' ' ' TYR . 69.5 t -64.7 -44.98 96.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.14 83.24 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.451 -0.66 . . . . 1.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.535 ' CE1' HG11 ' A' ' 55' ' ' VAL . 49.5 m-85 -61.16 -41.95 97.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 1.0 110.633 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.14 9.57 2.39 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.841 -0.903 . . . . 1.0 110.841 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 38.1 t0 -56.97 -51.53 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.361 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -134.29 126.69 30.26 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -108.09 134.21 20.23 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.775 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.05 162.69 41.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.249 1.966 . . . . 1.0 112.223 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 64' ' ' THR . 8.4 p -70.16 -145.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.445 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.939 ' H ' HG22 ' A' ' 63' ' ' VAL . 5.0 m -113.12 -73.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.958 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 64' ' ' THR . 79.9 tt0 -38.87 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.349 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.882 ' O ' ' N ' ' A' ' 68' ' ' ARG . 70.9 mt-10 -77.76 -106.63 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.553 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 18.04 -54.81 0.0 OUTLIER Glycine 0 N--CA 1.477 1.398 0 O-C-N 124.593 1.183 . . . . 1.0 114.223 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.882 ' N ' ' O ' ' A' ' 66' ' ' GLU . 10.1 tpp180 -64.05 -49.15 73.48 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.123 -0.538 . . . . 1.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 66' ' ' GLU . 68.4 mttm -64.81 -40.73 95.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.363 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.93 -45.4 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.57 83.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.99 0.424 . . . . 1.0 110.411 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -62.65 -37.66 87.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.302 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.82 -54.68 7.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.61 -46.13 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.849 -0.34 . . . . 1.0 111.09 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.2 ttp -55.97 -45.27 78.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.59 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 64.7 tttm -65.74 -33.01 74.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.368 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.62 80.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.788 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.96 -41.94 99.78 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.82 -43.67 98.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.658 0.266 . . . . 1.0 110.602 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 76' ' ' LYS . 97.8 mt-10 -60.48 -35.73 76.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.202 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.98 -74.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -45.41 -38.39 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.94 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.04 86.1 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.44 -39.47 93.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.279 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 85' ' ' VAL . 99.6 t -45.98 -13.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.427 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 76.8 m -51.33 -43.9 61.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -44.44 -20.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.554 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.11 -18.37 14.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.998 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 86' ' ' THR . 43.9 mt -92.51 -42.37 9.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.733 0.301 . . . . 1.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.95 -28.74 64.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.094 0.473 . . . . 1.0 110.863 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -80.81 -4.08 53.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.419 -179.386 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.2 m-20 -60.95 -47.88 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.944 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 11.1 p90 -75.89 -20.6 57.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.306 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.16 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.11 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -59.94 -22.66 62.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.964 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttp85 -57.37 -43.92 83.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.617 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.771 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.8 t0 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.698 0.285 . . . . 1.0 110.726 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 17.6 p-80 -78.74 -24.03 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.419 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.21 -39.96 86.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.42 -38.54 91.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.54 -41.28 93.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 1.0 110.021 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.32 -41.13 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -65.49 -41.04 93.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.277 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -64.21 -36.2 83.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.531 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.27 78.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -70.74 -32.25 69.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 1.0 110.782 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.33 -49.36 72.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.884 0.373 . . . . 1.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.449 ' O ' HG23 ' B' ' 18' ' ' VAL . 13.3 pt-20 -64.91 -30.2 71.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.561 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.74 -43.2 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.03 -43.02 99.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -33.86 76.79 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.511 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 14' ' ' GLU . 49.3 t -68.3 -54.67 20.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.13 -33.89 77.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.54 -40.27 96.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.51 -40.9 96.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -63.64 -33.26 75.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.659 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' B' ' 48' ' ' SER . 2.2 m -55.54 -43.5 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.231 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.487 ' O ' HG12 ' B' ' 27' ' ' VAL . 24.9 tptp -58.74 -55.73 31.34 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.843 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -60.89 -29.33 69.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.732 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.9 67.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 24' ' ' LYS . 1.4 p -62.28 -44.17 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.069 0.461 . . . . 1.0 110.103 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.463 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 12.2 tm-20 -74.56 -33.35 62.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.271 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.07 45.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.92 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.51 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 0.5 OUTLIER 178.68 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.82 0.343 . . . . 1.0 110.777 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ARG . . . . . 0.626 HH21 ' CG2' ' B' ' 39' ' ' ILE . 3.8 mmp_? -79.14 76.92 5.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.115 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.78 1.35 5.94 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.898 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.5 151.09 40.26 Favored Pre-proline 0 N--CA 1.465 0.304 0 O-C-N 122.767 -0.255 . . . . 1.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.07 144.26 29.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.974 1.783 . . . . 1.0 112.496 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.37 32.31 75.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -48.64 -60.57 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.0 110.75 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.52 4.32 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.341 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.426 HD23 ' O ' ' B' ' 38' ' ' LEU . 3.1 tt -145.47 55.54 1.21 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.022 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.626 ' CG2' HH21 ' B' ' 31' ' ' ARG . 33.0 pt -92.69 51.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.908 0.385 . . . . 1.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' B' ' 43' ' ' ASP . 0.3 OUTLIER -150.72 140.19 21.48 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.178 0.513 . . . . 1.0 110.94 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.8 OUTLIER -82.0 -53.99 0.66 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.278 -0.873 . . . . 1.0 110.81 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.0 Cg_endo -57.76 -28.97 84.2 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.876 1.717 . . . . 1.0 112.701 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 40' ' ' SER . 12.1 p-10 -88.91 -4.33 58.49 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.97 92.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 1.0 110.41 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 46' ' ' TRP . 20.7 tt -67.28 -37.5 79.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.517 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.511 ' NE1' ' O ' ' C' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -53.13 61.49 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -62.97 -42.69 99.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.958 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' B' ' 23' ' ' SER . 64.8 m -51.9 -38.97 58.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.711 0.291 . . . . 1.0 111.095 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.15 -50.4 73.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 1.0 111.588 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -59.77 -40.9 89.76 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.734 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -24.86 68.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.268 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 20.4 p -90.86 6.34 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 1.0 110.774 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 p 52.11 63.19 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.476 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.42 -53.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.12 81.79 0.06 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 1.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.38 3.77 12.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.69 -49.49 77.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 1.0 110.516 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -145.62 157.55 43.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.819 -0.438 . . . . 1.0 109.819 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 50' ' ' GLU . 64.2 t80 -172.46 132.52 0.7 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.7 -173.5 0.72 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.582 1.522 . . . . 1.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.592 HG22 ' N ' ' B' ' 64' ' ' THR . 3.6 p -134.15 165.72 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.422 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.592 ' N ' HG22 ' B' ' 63' ' ' VAL . 14.5 m -40.76 -61.79 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.243 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.01 -14.52 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.941 0.4 . . . . 1.0 109.94 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' B' ' 64' ' ' THR . 13.6 mm-40 -115.31 41.86 2.36 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-O 125.105 2.383 . . . . 1.0 110.392 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.46 60.04 1.48 Allowed Glycine 0 C--O 1.216 -0.978 0 CA-C-N 112.217 -2.265 . . . . 1.0 111.34 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 59' ' ' ASP . 38.5 ttm180 -28.28 -28.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.578 0.689 . . . . 1.0 110.58 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' B' ' 67' ' ' GLY . 54.4 mtpt -52.41 -12.36 0.26 Allowed 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 37.6 t -58.78 -44.95 91.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 118.902 -1.119 . . . . 1.0 109.541 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.511 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -71.1 -48.95 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 1.0 110.7 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.95 -38.25 55.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.096 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' GLN . . . . . 0.414 ' O ' ' OE1' ' B' ' 73' ' ' GLN . 0.8 OUTLIER -58.97 -51.2 71.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.018 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 84.2 t -66.78 -43.39 89.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.506 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.2 mpp? -61.22 -41.47 96.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.662 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' LYS . . . . . 0.412 ' O ' ' OE2' ' B' ' 80' ' ' GLU . 65.9 tttm -61.49 -44.02 97.82 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.554 -0.458 . . . . 1.0 110.359 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -66.05 -40.27 90.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.91 96.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.79 -43.88 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 122.847 -0.208 . . . . 1.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 0.2 OUTLIER -62.57 -37.78 87.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 1.0 110.334 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 77' ' ' ALA . 24.9 t -60.69 -68.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.184 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -55.33 -37.37 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.776 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.94 89.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.5 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.99 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.117 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' B' ' 8' ' ' ALA . 39.0 t -53.2 -17.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 39.6 m -43.59 -35.3 1.67 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.253 0.549 . . . . 1.0 109.767 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -51.73 -61.67 2.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -55.9 -27.36 51.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 1.0 110.474 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.615 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.5 mm? -78.27 -32.27 49.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 1.0 110.046 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -63.03 -46.41 87.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.27 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.445 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.5 OUTLIER -73.57 -3.93 30.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.167 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.516 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 50.2 t0 -56.81 -48.77 77.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.18 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 20.9 p90 -69.5 -39.03 77.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.21 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.517 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 96.6 t -44.42 -28.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.628 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.96 -27.27 68.13 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.116 -0.234 . . . . 1.0 110.953 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.6 ptt85 -54.59 -42.6 71.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.124 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 80.4 mm-40 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.079 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 3' ' ' ASP . . . . . 0.509 ' OD1' ' ND1' ' C' ' 4' ' ' HIS . 35.6 p-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.698 0.285 . . . . 1.0 110.39 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.509 ' ND1' ' OD1' ' C' ' 3' ' ' ASP . 11.8 p-80 -81.6 -29.96 33.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -65.16 -44.68 87.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.789 0.328 . . . . 1.0 110.756 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -65.61 -36.83 84.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.142 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -63.78 -42.96 97.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.454 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 8' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' C' ' 85' ' ' VAL . . . -64.37 -40.32 95.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.419 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.37 -40.22 93.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.533 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.435 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.58 76.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.81 -36.19 83.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 1.0 111.072 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -63.87 -41.25 97.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 1.0 110.701 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.99 -29.48 69.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.567 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.575 HD11 ' HB1' ' C' ' 52' ' ' ALA . 43.2 tp -62.38 -39.92 94.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.379 . . . . 1.0 110.411 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -70.73 -28.59 64.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.0 -46.55 84.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.746 0.308 . . . . 1.0 111.554 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 18' ' ' VAL . . . . . 0.43 HG22 ' H ' ' C' ' 18' ' ' VAL . 8.6 m -64.42 -36.56 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.87 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -61.17 -41.98 97.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -60.47 -45.45 93.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.59 -33.71 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.107 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.41 94.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.463 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.507 ' O ' HG23 ' C' ' 27' ' ' VAL . 91.7 p -61.81 -46.31 90.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -63.25 -56.3 17.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.546 -0.462 . . . . 1.0 109.92 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.59 -42.61 92.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -56.09 -44.37 78.93 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.507 HG23 ' O ' ' C' ' 23' ' ' SER . 76.8 t -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.208 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.95 75.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.39 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.5 mp0 -69.54 -33.07 72.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -54.25 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.769 0.318 . . . . 1.0 110.964 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.22 -0.75 22.46 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.96 147.01 32.35 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.268 -0.271 . . . . 1.0 110.268 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.488 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.1 Cg_endo -75.96 142.5 25.11 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.863 1.709 . . . . 1.0 112.315 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.08 66.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.35 144.45 55.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.0 110.423 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.82 -22.08 0.88 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.603 HD13 ' O ' ' C' ' 38' ' ' LEU . 0.2 OUTLIER -63.6 -38.61 91.77 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.481 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -33.53 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.276 0.56 . . . . 1.0 111.1 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' ' N ' ' C' ' 44' ' ' ALA . 11.8 m -167.94 78.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.4 OUTLIER -37.72 -56.82 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.17 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.1 Cg_endo -59.38 -54.45 2.55 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.84 1.693 . . . . 1.0 112.577 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -79.66 0.18 31.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.277 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -58.56 -42.81 88.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 1.0 110.69 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.452 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.0 tt -68.42 -40.28 82.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.564 ' NE1' ' O ' ' D' ' 64' ' ' THR . 0.5 OUTLIER -55.27 -47.55 75.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.065 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.511 ' CG ' HD21 ' C' ' 38' ' ' LEU . 13.7 t90 -65.09 -40.18 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.421 -0.511 . . . . 1.0 109.771 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.474 ' O ' HD22 ' C' ' 19' ' ' LEU . 36.6 m -59.86 -41.13 90.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.429 ' O ' HG12 ' C' ' 49' ' ' VAL . 47.2 t -80.07 69.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' C' ' 51' ' ' THR . 12.4 pt-20 -166.48 -42.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.977 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.607 HG23 HG11 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -69.76 -36.97 76.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.146 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -57.2 -27.27 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.523 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' C' ' 54' ' ' THR . 43.7 p -95.25 4.57 53.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.322 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' C' ' 53' ' ' THR . 23.9 p 55.41 69.47 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.871 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -148.84 -81.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.33 96.7 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -62.2 -43.22 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 1.0 111.016 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.44 26.75 0.65 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.71 -44.52 96.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 1.0 110.545 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -141.8 161.16 38.65 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.435 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 40.2 p90 -141.76 118.86 7.41 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.764 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 157.62 59.5 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.837 1.692 . . . . 1.0 112.291 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.511 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 2.1 t -84.73 -136.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' C' ' 63' ' ' VAL . 81.8 m -114.48 -49.39 2.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.784 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' C' ' 67' ' ' GLY . 45.5 tp10 -54.38 -24.62 20.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -74.01 37.04 0.1 Allowed 'General case' 0 C--O 1.26 1.657 0 CA-C-O 123.358 1.551 . . . . 1.0 109.742 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.93 64.97 2.2 Favored Glycine 0 C--O 1.206 -1.614 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.367 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.485 ' CB ' ' NE1' ' B' ' 46' ' ' TRP . 10.8 ptp85 -21.97 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.915 0.858 . . . . 1.0 112.656 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.768 ' N ' ' O ' ' C' ' 67' ' ' GLY . 68.4 mttm -64.17 -10.14 21.22 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.291 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' C' ' 67' ' ' GLY . 43.1 t -61.89 -48.36 88.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 119.88 -0.728 . . . . 1.0 110.396 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.02 -43.56 71.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.688 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -61.59 -39.8 92.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.972 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -57.01 -43.68 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.261 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.607 HG11 HG23 ' C' ' 51' ' ' THR . 97.2 t -66.61 -43.38 90.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.739 -0.385 . . . . 1.0 111.546 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 41.6 mtt -60.72 -43.03 98.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.03 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.774 0.321 . . . . 1.0 110.69 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.36 89.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.31 -39.73 91.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.88 -0.488 . . . . 1.0 111.88 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.91 -43.13 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 122.54 -0.388 . . . . 1.0 110.668 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -53.96 51.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.645 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.495 HG23 ' N ' ' C' ' 82' ' ' PHE . 16.5 m -60.95 -47.97 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.163 -0.215 . . . . 1.0 111.544 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.495 ' N ' HG23 ' C' ' 81' ' ' VAL . 16.1 m-85 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.994 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -84.83 -25.59 28.01 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.961 -0.295 . . . . 1.0 110.59 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.601 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.4 m -59.46 -19.74 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.464 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -41.3 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.959 0.409 . . . . 1.0 110.644 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.516 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -62.84 -51.1 68.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.54 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.5 84.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.235 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.542 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -71.34 -37.84 71.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.529 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.26 -34.33 68.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.152 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -3.92 41.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.287 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 90.1 m-20 -57.08 -47.22 81.56 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.716 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 19.3 p90 -73.99 -9.37 58.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.971 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.27 -37.98 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.524 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.52 -28.68 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.268 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 96' ' ' ARG . . . . . 0.405 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.4 ptt85 -51.15 -41.53 60.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.55 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 97.3 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.183 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.83 -37.55 87.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.689 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.74 -37.94 87.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.605 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 83.2 tt0 -64.47 -35.42 80.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.746 0.307 . . . . 1.0 110.515 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.56 -40.99 96.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.436 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.03 -37.51 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 1.0 109.955 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 8' ' ' ALA . . . . . 0.404 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -63.49 -37.22 86.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.825 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.44 -40.31 96.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.62 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.71 -41.2 98.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.28 94.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.727 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.14 -45.13 74.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 1.0 110.83 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.8 80.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -63.01 -36.67 84.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.416 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.3 tp -62.6 -41.46 98.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.82 0.343 . . . . 1.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.24 -39.29 75.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.928 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -61.91 -41.37 97.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.155 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.31 -35.01 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.711 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 52' ' ' ALA . 36.5 mt -60.98 -40.51 93.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.96 -49.32 78.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.308 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.015 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.52 94.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' D' ' 44' ' ' ALA . 1.2 m -59.93 -46.33 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.874 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.63 -52.99 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.76 -40.43 88.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.923 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -47.52 -58.27 4.42 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.77 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' D' ' 44' ' ' ALA . 23.5 t -61.27 -44.99 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.212 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.36 -32.69 64.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.302 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -56.88 -44.92 82.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.717 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 10.8 mp0 -66.63 -36.28 82.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.317 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.88 86.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.921 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.17 -6.38 7.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.9 143.73 27.3 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 122.768 -0.254 . . . . 1.0 110.775 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.708 ' O ' HG21 ' D' ' 63' ' ' VAL . 98.3 Cg_endo -74.64 153.85 43.98 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.301 2.0 . . . . 1.0 112.366 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.61 34.31 85.64 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.094 -0.803 . . . . 1.0 111.094 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.54 144.11 43.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 1.0 110.603 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.72 -19.93 1.8 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.486 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.488 HD23 ' C ' ' D' ' 38' ' ' LEU . 2.3 tt -111.13 90.64 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.837 0.351 . . . . 1.0 110.099 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -133.25 103.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.08 0.467 . . . . 1.0 110.296 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 19.0 t -174.21 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 1.0 OUTLIER 173.27 -61.88 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.072 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.79 -38.55 92.42 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.725 1.616 . . . . 1.0 111.927 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.91 -4.27 58.51 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.348 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' ALA . . . . . 0.449 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.97 -39.69 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 1.0 110.52 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.416 ' H ' HG22 ' D' ' 45' ' ' ILE . 1.1 tt -65.76 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.03 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.509 ' NE1' ' O ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -53.05 -45.91 68.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.598 -0.441 . . . . 1.0 109.903 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -63.89 -43.0 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.973 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 86.2 p -61.68 -36.2 80.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.922 -0.311 . . . . 1.0 110.674 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.06 -48.53 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.958 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.483 ' OE1' ' CZ ' ' A' ' 68' ' ' ARG . 19.0 pt-20 -83.87 31.62 0.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.983 0.42 . . . . 1.0 109.928 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 21.3 m -132.58 -46.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.178 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -57.02 -23.45 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 1.0 109.868 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' D' ' 54' ' ' THR . 43.0 p -94.62 5.35 52.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.399 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' D' ' 53' ' ' THR . 39.9 p 52.64 75.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.052 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.577 HG13 ' N ' ' D' ' 56' ' ' GLY . 6.6 p -139.72 -51.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.577 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 50.07 82.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.38 -44.39 97.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.701 0.286 . . . . 1.0 110.85 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.3 2.68 2.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.8 m-20 -59.23 -49.82 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.375 . . . . 1.0 110.357 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -146.97 154.14 40.91 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 12.0 p90 -154.37 147.89 18.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.979 -0.288 . . . . 1.0 110.58 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.43 172.24 13.67 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.418 2.079 . . . . 1.0 112.018 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.84 HG13 ' H ' ' D' ' 64' ' ' THR . 3.0 p -106.24 -105.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.84 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.4 m -118.15 -85.22 0.65 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.979 0.419 . . . . 1.0 111.058 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.402 ' N ' HG22 ' D' ' 64' ' ' THR . 51.9 tp10 -48.08 125.81 9.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' D' ' 68' ' ' ARG . 95.0 mt-10 57.94 -102.48 0.15 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.22 -57.07 0.0 OUTLIER Glycine 0 N--CA 1.474 1.179 0 O-C-N 124.487 1.117 . . . . 1.0 113.776 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.3 ttm-85 -79.84 -56.01 4.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.409 -0.395 . . . . 1.0 109.976 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -48.73 -29.19 4.2 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.458 ' O ' HG23 ' D' ' 74' ' ' VAL . 60.2 t -80.32 -27.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.245 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -78.09 -51.7 9.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.863 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 72' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' D' ' 73' ' ' GLN . 19.7 pt-20 -50.91 -42.03 59.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.653 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 73' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' D' ' 72' ' ' GLU . 56.1 tt0 -64.5 -42.73 95.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.85 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 70' ' ' VAL . 97.0 t -67.27 -44.91 87.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 78.5 mtm -63.74 -38.96 93.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.11 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' D' ' 80' ' ' GLU . 58.0 tttm -57.62 -40.37 79.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.582 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.562 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.22 -41.48 99.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.502 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' D' ' 82' ' ' PHE . . . -67.86 -40.06 89.5 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.811 -0.516 . . . . 1.0 111.811 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.16 -43.95 98.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.612 0.244 . . . . 1.0 111.27 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' D' ' 76' ' ' LYS . 97.6 mt-10 -66.3 -35.54 80.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.756 0.312 . . . . 1.0 111.104 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.562 HG23 ' O ' ' D' ' 77' ' ' ALA . 55.1 t -62.49 -46.29 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.318 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' D' ' 78' ' ' GLY . 58.4 m-85 -64.43 -31.98 73.41 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.58 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -82.93 -24.2 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.449 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.698 HD23 ' C ' ' D' ' 84' ' ' LEU . 7.0 tt -64.89 -42.98 94.35 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.404 HG12 ' HB1' ' D' ' 8' ' ' ALA . 13.5 m -62.0 -15.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.212 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.5 ' O ' ' N ' ' D' ' 90' ' ' ALA . 47.6 m -39.26 -39.84 0.68 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.066 0.46 . . . . 1.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' C' ' 92' ' ' ASP . . . -51.74 -59.98 3.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.663 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -25.56 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.128 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.484 ' N ' HD22 ' D' ' 89' ' ' LEU . 3.8 mm? -87.58 -28.45 21.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.127 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -66.35 -37.39 85.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.549 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -5.27 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.198 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -56.17 -51.38 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.276 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' D' ' 90' ' ' ALA . 24.6 p90 -75.28 -10.68 59.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.697 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.32 -32.84 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.21 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -66.38 -22.78 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 1.0 110.963 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -66.11 -19.83 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.431 . . . . 1.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.955 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.821 0.343 . . . . 1.0 110.603 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.88 -40.85 98.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.542 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -67.04 -45.04 78.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.357 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.2 -42.01 96.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.381 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -65.25 -40.29 93.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.136 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -68.95 -43.34 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.184 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.09 89.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.464 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.81 -36.59 84.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.287 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.68 80.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.799 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.8 -38.37 85.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.52 -35.88 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.0 110.319 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.33 -34.65 78.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.438 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA2' ' A' ' 78' ' ' GLY . 47.2 tp -62.95 -38.54 91.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.111 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.72 -31.96 73.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -61.83 -49.63 75.5 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.241 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 18' ' ' VAL . 15.7 m -67.12 -32.64 58.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 52' ' ' ALA . 33.9 mt -61.56 -42.03 98.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.249 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.98 -45.26 86.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 1.0 110.232 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -71.2 -39.59 71.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.546 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.84 -50.22 74.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.841 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.502 ' HG ' ' CB ' ' A' ' 48' ' ' SER . 31.0 m -61.65 -44.38 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.421 . . . . 1.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.23 -33.64 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.16 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.5 -40.12 23.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.737 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.52 -46.39 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.634 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 28' ' ' GLU . 5.4 p -58.58 -45.98 90.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.902 -0.719 . . . . 1.0 109.68 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 27' ' ' VAL . 97.0 mt-10 -69.86 -41.6 74.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.942 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.29 90.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.9 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 79.8 mm-40 -78.84 -37.67 39.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.905 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' NH2' ' O ' ' A' ' 40' ' ' SER . 18.7 mmt85 -67.07 116.39 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 1.0 110.823 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.85 2.99 60.93 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.09 144.06 27.87 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.05 147.07 33.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.258 1.972 . . . . 1.0 112.425 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.13 2.01 57.71 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.15 146.91 52.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.716 0.293 . . . . 1.0 110.517 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.73 -13.9 5.22 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -86.89 35.06 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.998 0.427 . . . . 1.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.74 73.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.344 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 43' ' ' ASP . 53.4 p -160.64 -126.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.782 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 11.4 t80 179.26 -56.28 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.547 -0.263 . . . . 1.0 111.317 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.17 -23.41 73.7 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.7 1.6 . . . . 1.0 112.638 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 24.1 p30 -97.22 -1.84 44.05 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.009 -0.277 . . . . 1.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.13 -20.29 48.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.836 0.35 . . . . 1.0 110.274 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 46' ' ' TRP . 12.4 tt -68.81 -46.01 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.521 ' N ' HG23 ' A' ' 45' ' ' ILE . 29.0 m95 -74.93 -31.9 61.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.867 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.418 ' CZ3' ' HB2' ' A' ' 26' ' ' ALA . 25.3 t90 -54.32 -41.31 68.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.502 ' CB ' ' HG ' ' A' ' 23' ' ' SER . 61.1 m -64.22 -24.36 67.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.322 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.51 -26.27 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.951 0.405 . . . . 1.0 110.839 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -78.13 3.59 14.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.408 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -127.18 -33.54 2.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.2 -25.61 61.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.936 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.585 ' OG1' HG13 ' A' ' 55' ' ' VAL . 67.6 p -96.92 7.51 46.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.967 0.413 . . . . 1.0 109.904 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 p 59.62 10.37 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.949 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG13 ' OG1' ' A' ' 53' ' ' THR . 29.1 m -66.07 -42.21 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.333 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 55' ' ' VAL . . . 47.94 64.15 3.15 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' B' ' 50' ' ' GLU . 1.1 t80 -62.89 -21.86 66.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.328 . . . . 1.0 110.246 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.77 33.7 12.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.533 ' OD1' ' NH2' ' B' ' 68' ' ' ARG . 8.2 m-20 -62.68 -37.25 85.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 37.7 mmt180 -125.38 -161.42 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.247 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.428 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 19.9 t80 -156.51 82.41 3.4 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.66 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.66 153.35 69.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 1.0 112.478 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.008 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -108.1 -154.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 1.008 ' H ' HG22 ' A' ' 63' ' ' VAL . 76.6 m -90.68 -43.35 10.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.618 0.247 . . . . 1.0 111.283 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.1 tt0 -52.46 -37.23 56.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.234 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.6 26.34 0.08 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.321 2.01 . . . . 1.0 109.202 178.493 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 44.15 65.39 1.66 Allowed Glycine 0 C--O 1.211 -1.312 0 CA-C-N 113.506 -1.679 . . . . 1.0 111.359 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 53.2 ttm-85 -24.36 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.465 1.133 . . . . 1.0 111.008 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.4 mttp -49.46 -20.99 0.81 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.929 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.4 t -61.59 -46.51 96.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.432 -0.907 . . . . 1.0 110.45 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.82 -23.15 45.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.605 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.33 -43.86 54.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.961 0.41 . . . . 1.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.1 -47.62 85.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.046 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 75' ' ' MET . 10.6 p -66.6 -40.14 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.713 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.454 ' N ' HG13 ' A' ' 74' ' ' VAL . 49.8 ttm -62.89 -48.03 80.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.201 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.73 -38.49 89.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.317 . . . . 1.0 110.444 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.54 73.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.64 -43.42 92.07 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.61 -43.08 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.808 0.337 . . . . 1.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.35 -41.95 97.89 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.357 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.61 -51.23 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.741 0.305 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -65.86 -39.09 90.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.999 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.12 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.961 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.68 -39.05 92.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.167 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 85' ' ' VAL . 65.8 t -47.24 -10.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.745 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 84' ' ' LEU . 71.9 m -50.96 -43.87 60.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.87 -19.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.722 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.23 -37.64 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.61 -40.48 84.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.412 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.96 -43.31 98.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 1.0 110.95 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -73.32 -4.27 32.23 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.019 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -61.29 -43.43 98.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.812 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.6 p90 -80.31 -24.36 40.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.856 0.36 . . . . 1.0 111.395 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 -27.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.078 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.19 -20.89 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 93' ' ' PHE . 35.4 mtm105 -54.26 -32.31 55.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.692 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.0 109.799 179.516 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.698 0.285 . . . . 1.0 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -73.87 -23.24 59.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.987 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.67 -33.58 75.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.699 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.9 -38.22 90.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.704 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -64.9 -42.0 95.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 1.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.6 -37.01 85.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.46 -42.08 77.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.326 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -63.24 -37.67 88.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.601 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.45 -42.15 63.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -41.09 92.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.606 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.72 -37.26 84.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.258 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.28 -34.89 78.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.433 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 HG21 ' B' ' 81' ' ' VAL . 46.1 tp -62.25 -41.82 98.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.93 -32.96 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.643 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.27 -42.72 99.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.617 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.96 -37.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.528 HD22 ' O ' ' B' ' 48' ' ' SER . 98.3 mt -60.31 -40.32 90.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 1.0 110.022 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.89 -38.68 76.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 1.0 109.932 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -66.66 -37.7 85.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 93.8 p -57.19 -41.3 79.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.616 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 63.3 tttm -70.32 -76.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.563 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' B' ' 29' ' ' ALA . 99.2 mttt -40.74 -35.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.204 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.25 -60.56 2.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.717 -0.219 . . . . 1.0 111.553 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.1 p -60.93 -42.05 91.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.04 0.448 . . . . 1.0 110.103 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' B' ' 24' ' ' LYS . 96.3 mt-10 -72.07 -13.25 61.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.533 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -61.0 -47.97 83.98 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.177 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 0.6 OUTLIER -81.23 -98.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 1.0 110.569 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 46.45 50.72 12.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.686 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.77 27.58 0.94 Allowed Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.359 -0.696 . . . . 1.0 111.359 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' B' ' 66' ' ' GLU . . . -93.91 153.52 40.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.68 116.72 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.912 1.741 . . . . 1.0 112.184 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 89.96 -23.59 19.82 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 44.95 -175.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 1.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 175.41 -66.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.53 121.33 34.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' B' ' 40' ' ' SER . 37.9 pt -143.04 -160.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.715 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.423 ' O ' ' O ' ' B' ' 39' ' ' ILE . 3.2 t 56.2 114.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.12 0.486 . . . . 1.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 2.3 t80 -63.54 -53.85 48.24 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.699 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 21.9 Cg_endo -57.72 -27.68 78.69 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.747 1.632 . . . . 1.0 112.566 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.37 -16.62 22.21 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 1.0 110.823 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.6 87.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.901 0.382 . . . . 1.0 110.318 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -61.7 -37.04 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.648 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.2 OUTLIER -64.16 -43.79 94.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.477 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.77 -21.35 64.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.528 ' O ' HD22 ' B' ' 19' ' ' LEU . 1.3 t -78.28 -32.63 49.56 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.421 . . . . 1.0 110.55 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.25 -45.41 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' B' ' 51' ' ' THR . 19.3 pt-20 -57.77 -42.38 83.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.724 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 3.4 t -73.47 -170.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.041 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 74.19 -24.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.538 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.503 ' H ' ' C ' ' B' ' 51' ' ' THR . 31.2 p -103.45 8.18 37.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.8 p 53.55 65.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.687 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.568 HG13 ' N ' ' B' ' 56' ' ' GLY . 4.7 p -138.34 -52.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.665 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.568 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 41.55 82.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -59.97 -43.83 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.284 . . . . 1.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.19 8.74 2.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -52.03 -67.63 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.763 0.315 . . . . 1.0 110.573 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -141.81 150.11 41.25 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 61' ' ' TYR . 7.6 p90 -141.22 128.49 11.85 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.49 148.58 73.29 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.637 1.558 . . . . 1.0 112.3 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.11 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.413 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 66' ' ' GLU . 89.4 m -113.98 -65.4 1.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.835 0.35 . . . . 1.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' B' ' 67' ' ' GLY . 85.0 tt0 -40.53 -21.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.589 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.564 ' OE2' ' N ' ' B' ' 66' ' ' GLU . 1.5 pm0 -80.24 30.27 0.28 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 123.741 1.734 . . . . 1.0 109.142 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.04 65.37 1.08 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.075 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.533 ' NH2' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -23.69 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.705 0.753 . . . . 1.0 110.788 -178.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 97.4 mttt -46.03 -21.21 0.12 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' B' ' 67' ' ' GLY . 77.4 t -63.07 -45.8 97.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.003 -0.679 . . . . 1.0 110.054 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.25 -50.36 19.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.842 0.353 . . . . 1.0 110.818 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -53.06 -46.64 68.63 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.312 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -57.63 -46.43 84.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.759 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 70' ' ' VAL . 87.1 t -65.47 -47.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.527 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.3 mtm -65.11 -43.03 93.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.673 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -66.59 -35.04 79.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.565 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.1 74.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.389 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.3 -37.1 94.05 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.577 HG22 ' O ' ' B' ' 79' ' ' ILE . 96.0 mt -70.68 -3.42 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.487 -0.42 . . . . 1.0 111.319 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.96 -54.41 3.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 1.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.431 HG21 HD13 ' B' ' 15' ' ' LEU . 0.1 OUTLIER -61.09 -51.35 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.169 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -65.38 -37.3 86.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.683 0.277 . . . . 1.0 110.725 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -62.59 -37.49 86.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.433 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.73 -40.3 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.191 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.524 HG13 ' HB1' ' B' ' 8' ' ' ALA . 47.9 t -57.34 -17.44 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 55.1 m -42.98 -37.87 2.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.1 0.476 . . . . 1.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.619 ' O ' HG22 ' B' ' 91' ' ' THR . . . -49.77 -63.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.4 32.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.27 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.505 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.1 mm? -68.94 -34.5 75.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -66.66 -66.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 110.016 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.2 OUTLIER -51.89 -7.9 0.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.614 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' B' ' 90' ' ' ALA . 41.7 t0 -57.01 -49.27 76.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.657 0.265 . . . . 1.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 11.9 p90 -73.39 -30.86 63.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.058 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.97 -32.86 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.674 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -57.81 -22.38 47.18 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.305 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -53.33 -25.48 15.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 1.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.933 -179.436 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 3' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' C' ' 3' ' ' ASP . 32.2 p-10 . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.874 0.369 . . . . 1.0 110.385 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -88.09 -26.64 22.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.796 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.28 -39.97 89.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.5 -38.17 90.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.385 . . . . 1.0 110.276 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -65.29 -39.9 93.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.273 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 8' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.59 -39.95 94.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.602 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -62.72 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.178 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.05 -33.94 77.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.84 80.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.198 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.36 -36.79 81.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.42 -32.25 73.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.43 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.628 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.18 -42.24 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.586 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.48 -38.64 88.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.352 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -41.08 99.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 1.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.3 -38.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.794 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' C' ' 52' ' ' ALA . 97.1 mt -59.16 -40.65 86.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.066 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -56.06 -47.98 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.6 -34.56 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.317 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -40.76 97.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.759 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -59.94 -40.71 89.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.551 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -64.74 -33.7 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.487 . . . . 1.0 109.772 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.31 -41.17 34.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.09 87.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.479 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.572 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -59.66 -48.74 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 1.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.572 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.6 tt0 -68.96 -36.29 77.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.122 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.86 65.14 6.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.032 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 3.3 mm-40 163.04 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.437 0.461 . . . . 1.0 110.706 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 30' ' ' GLU . 14.5 tpt180 -108.49 67.77 0.67 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.6 0.238 . . . . 1.0 110.502 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.23 31.02 0.7 Allowed Glycine 0 N--CA 1.471 0.971 0 N-CA-C 111.928 -0.469 . . . . 1.0 111.928 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.742 ' HB2' ' OE2' ' C' ' 66' ' ' GLU . . . -103.71 161.07 24.1 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' C' ' 33' ' ' ALA . 72.2 Cg_endo -76.64 116.25 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.882 1.722 . . . . 1.0 111.47 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.66 83.54 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -56.04 149.41 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -21.14 2.25 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.478 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.0 OUTLIER -87.88 40.0 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.746 0.307 . . . . 1.0 110.242 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.27 80.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 1.0 110.587 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.7 m -156.36 -136.57 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.443 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.432 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 11.2 t80 179.75 -57.56 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.403 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.39 -34.79 97.5 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 121.736 1.624 . . . . 1.0 112.554 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' C' ' 43' ' ' ASP . 23.3 p-10 -94.24 6.42 48.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.293 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.69 90.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.81 -32.65 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.64 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.685 ' CZ2' HG23 ' D' ' 64' ' ' THR . 1.2 t-105 -60.05 -48.42 81.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.413 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.466 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.2 OUTLIER -67.31 -27.28 67.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 178.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 2.6 t -64.9 -34.74 79.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.941 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.53 -47.62 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 1.0 111.407 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.53 -28.82 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 1.0 111.07 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 86.5 m -61.9 -44.83 96.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 1.0 111.326 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.78 -35.36 70.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 1.0 110.573 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 71.4 p -73.52 -7.96 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 1.0 110.216 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.2 p 61.62 7.04 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' C' ' 57' ' ' TYR . 8.1 p -65.32 -40.68 89.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.538 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.458 ' N ' HG13 ' C' ' 55' ' ' VAL . . . 46.32 79.83 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.519 ' CE2' HG11 ' C' ' 55' ' ' VAL . 79.1 m-85 -61.67 -42.52 99.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 1.0 110.942 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.67 3.34 6.02 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -57.98 -64.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.837 0.351 . . . . 1.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 0.4 OUTLIER -135.09 147.72 49.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.154 179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' C' ' 61' ' ' TYR . 8.8 p90 -151.06 149.72 25.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.502 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.09 -175.75 1.34 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.198 1.932 . . . . 1.0 111.672 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.51 ' H ' ' HB2' ' C' ' 66' ' ' GLU . 1.1 t -135.64 -148.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.94 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.48 ' H ' HG12 ' C' ' 63' ' ' VAL . 6.2 p -88.09 -43.21 11.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -73.78 -14.02 61.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.11 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.742 ' OE2' ' HB2' ' C' ' 33' ' ' ALA . 13.8 mm-40 -99.34 32.16 2.85 Favored 'General case' 0 C--O 1.261 1.674 0 CA-C-O 123.964 1.84 . . . . 1.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 36.4 62.6 0.75 Allowed Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.114 -1.857 . . . . 1.0 111.168 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' C' ' 67' ' ' GLY . 52.7 ttm-85 -24.71 -29.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.859 0.83 . . . . 1.0 111.503 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' C' ' 67' ' ' GLY . 63.3 mttp -56.8 -11.04 1.21 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.2 t -60.67 -47.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.103 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.13 72.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.911 0.386 . . . . 1.0 110.72 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -54.04 -47.97 71.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.077 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.42 -41.49 93.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.474 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.82 -44.34 96.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.837 -0.345 . . . . 1.0 111.2 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.8 mtm -61.39 -41.05 96.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.937 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -61.61 -37.98 85.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.464 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.64 -38.25 84.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.34 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.2 -54.15 22.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.813 -0.708 . . . . 1.0 111.838 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.06 -42.73 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 1.0 110.661 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -59.47 -45.84 90.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.941 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 77' ' ' ALA . 54.6 t -65.04 -49.64 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.972 -0.291 . . . . 1.0 111.205 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -67.17 -37.35 83.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.898 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ALA . . . . . 0.505 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -62.58 -35.33 79.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.522 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.426 ' C ' ' N ' ' C' ' 86' ' ' THR . 5.0 tt -61.96 -42.73 99.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.31 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' C' ' 8' ' ' ALA . 66.8 t -48.85 -16.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.571 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.426 ' N ' ' C ' ' C' ' 84' ' ' LEU . 63.3 m -47.74 -34.67 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.65 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.437 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -52.95 -22.04 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.96 -10.93 27.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.568 HD12 ' O ' ' D' ' 83' ' ' ALA . 3.5 mm? -86.62 -59.74 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.728 0.299 . . . . 1.0 111.049 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -44.61 -49.97 9.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.91 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -45.56 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.168 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' C' ' 90' ' ' ALA . 97.8 m-20 -60.84 -47.91 84.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.431 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 0.1 OUTLIER -58.93 -44.28 91.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 59.0 t -44.62 -39.57 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.412 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.22 -22.51 52.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.176 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -55.24 -43.92 75.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.306 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.358 179.7 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.77 0.319 . . . . 1.0 110.537 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.91 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -68.49 -36.12 78.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.701 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.53 -40.72 96.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.793 0.33 . . . . 1.0 110.794 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -64.1 -42.66 96.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.544 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.26 -39.56 68.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 1.0 110.148 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.45 86.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.753 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.61 -23.26 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.719 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.13 -41.35 98.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.62 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' D' ' 84' ' ' LEU . . . -60.69 -37.21 80.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.923 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -58.86 -39.09 80.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 1.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.29 -33.29 75.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.01 -35.66 81.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' D' ' 52' ' ' ALA . 49.7 tp -62.61 -42.02 99.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 1.0 110.869 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -61.1 -41.19 96.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.996 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.08 -41.43 99.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 1.0 110.979 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.48 -43.38 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.828 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 52' ' ' ALA . 84.2 mt -61.28 -42.09 98.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.94 -50.99 68.65 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.58 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.8 -39.52 87.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.351 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.3 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 33.2 m -57.77 -44.92 86.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.75 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.49 -48.92 79.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 29' ' ' ALA . 5.5 mptp? -61.7 -37.86 85.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.311 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.69 59.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.324 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 m -93.74 -45.49 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.776 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.57 -40.43 96.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.709 0.29 . . . . 1.0 111.077 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 25' ' ' LYS . . . -54.41 -33.2 58.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.108 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -82.69 -113.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.05 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 44.32 75.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.634 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.46 -7.48 10.46 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -63.86 147.51 96.03 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.81 117.18 4.84 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.965 1.777 . . . . 1.0 112.044 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 84.57 -16.19 36.94 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' D' ' 37' ' ' ALA . . . 42.26 -168.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.0 110.892 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' D' ' 61' ' ' TYR . . . 175.58 -12.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.44 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.439 HD11 ' CG ' ' D' ' 47' ' ' TRP . 1.5 tt -151.8 43.67 0.73 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.897 0.38 . . . . 1.0 110.4 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -88.64 114.4 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' D' ' 41' ' ' TYR . 13.8 t 177.65 -122.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.549 ' N ' ' OG ' ' D' ' 40' ' ' SER . 2.2 m-85 -176.41 -66.2 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.543 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 22.8 Cg_endo -59.87 -29.92 90.62 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.011 1.807 . . . . 1.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -79.89 -5.57 55.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.961 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.64 84.8 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.37 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 46' ' ' TRP . 6.2 tt -73.22 -39.28 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.462 ' CE2' HG23 ' A' ' 64' ' ' THR . 2.7 t-105 -61.12 -48.22 82.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.227 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.439 ' CG ' HD11 ' D' ' 38' ' ' LEU . 18.9 t90 -62.41 -41.47 98.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -71.55 70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.11 0.481 . . . . 1.0 110.131 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.04 -64.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.468 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.437 ' OE2' ' OD2' ' D' ' 59' ' ' ASP . 22.6 pt-20 -66.02 -26.76 67.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.414 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.408 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.992 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.29 -26.57 65.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' D' ' 54' ' ' THR . 26.1 p -88.09 3.08 50.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 1.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' D' ' 53' ' ' THR . 19.4 p 53.88 73.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.084 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.0 t -151.12 -50.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.694 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 73.72 -48.42 1.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 11.7 t80 67.86 -14.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.581 0.229 . . . . 1.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 99.63 18.71 22.42 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 84.4 m-20 -62.46 -66.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.641 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.34 161.95 27.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.668 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 3.0 p90 -140.42 105.83 6.54 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.445 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 62' ' ' PRO . . . . . 0.529 ' O ' ' NH2' ' D' ' 68' ' ' ARG . 71.4 Cg_endo -70.72 164.09 36.72 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.575 1.517 . . . . 1.0 112.633 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' D' ' 64' ' ' THR . 11.0 p -112.08 -176.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.449 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' D' ' 63' ' ' VAL . 18.7 m -68.77 -44.06 74.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' D' ' 67' ' ' GLY . 58.7 tt0 -51.39 -46.93 62.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.021 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 14.3 pt-20 -79.82 36.66 0.34 Allowed 'General case' 0 C--O 1.264 1.842 0 CA-C-O 123.654 1.692 . . . . 1.0 109.0 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.39 61.75 1.2 Allowed Glycine 0 C--O 1.215 -1.038 0 CA-C-N 113.179 -1.828 . . . . 1.0 109.495 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' D' ' 62' ' ' PRO . 57.8 ttm-85 -25.52 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.298 0.646 . . . . 1.0 110.878 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.5 mmtt -56.38 -9.91 0.8 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.43 -0.805 . . . . 1.0 109.071 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 38.0 t -59.31 -47.77 89.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.391 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.43 79.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.064 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -60.59 -39.28 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.965 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.35 -41.05 96.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.437 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.74 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.02 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 74.7 mtm -63.16 -40.02 96.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.07 -45.97 91.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.465 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.513 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -66.35 -37.82 86.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 110.296 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.27 92.7 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.788 -0.525 . . . . 1.0 111.788 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.09 -43.59 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.584 0.23 . . . . 1.0 111.044 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.86 -40.11 94.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.75 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 77' ' ' ALA . 54.8 t -64.82 -49.58 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.774 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -61.77 -44.46 96.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.01 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.568 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -65.04 -35.14 80.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.053 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.709 ' C ' HD13 ' D' ' 84' ' ' LEU . 1.6 tm? -61.74 -53.33 57.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.338 -0.545 . . . . 1.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.541 ' N ' HD13 ' D' ' 84' ' ' LEU . 75.4 t -44.74 -15.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.574 ' O ' ' N ' ' D' ' 90' ' ' ALA . 94.4 m -51.8 -42.35 62.39 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.163 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -37.98 -65.1 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.608 0.242 . . . . 1.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.84 21.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' D' ' 86' ' ' THR . 41.4 mt -92.48 -21.87 19.91 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.451 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -72.77 -36.96 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.404 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -2.85 25.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.881 -0.599 . . . . 1.0 109.896 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.03 -48.0 79.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.953 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 19.4 p90 -72.94 -8.63 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.795 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.33 -36.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -67.27 -21.64 65.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.157 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -55.28 -32.33 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 1.0 110.346 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.465 -179.685 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.604 0.24 . . . . 1.0 110.562 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t0 64.45 -65.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.524 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 2' ' ' ALA . 34.6 p80 -57.65 -41.28 81.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.773 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.432 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 81.6 tt0 -62.93 -40.05 96.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.88 0.372 . . . . 1.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.36 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -65.53 -38.07 88.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.143 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.71 97.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.233 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.77 -40.45 88.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.354 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -62.9 -38.69 91.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.449 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.961 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.24 -38.37 88.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.729 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.69 -38.03 89.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.502 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -65.37 -32.73 74.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.542 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.18 -41.8 98.67 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.552 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.21 -38.91 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.185 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -62.55 -39.84 94.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.686 -0.405 . . . . 1.0 111.404 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.44 -33.13 59.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 1.0 110.539 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.9 mt -61.77 -40.94 96.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.08 -48.02 81.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 1.0 109.885 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.12 -32.65 73.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.119 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.84 96.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.654 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -60.74 -42.09 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -64.91 -50.51 66.22 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.203 0.525 . . . . 1.0 110.232 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.02 -42.74 99.49 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.256 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.12 49.44 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.564 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -60.99 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.192 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 70.2 mm-40 -68.28 -44.7 74.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.009 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.29 -39.32 82.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 1.0 110.203 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.438 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 52.3 mm-40 -69.51 -37.25 77.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.37 130.28 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 1.0 110.504 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.56 4.55 76.34 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.16 141.54 22.8 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 122.774 -0.251 . . . . 1.0 110.376 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.3 136.05 19.32 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.94 1.76 . . . . 1.0 112.143 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.75 30.84 70.0 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -63.05 -35.52 80.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.737 0.303 . . . . 1.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . 71.77 -39.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.334 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.8 tt -94.29 121.57 35.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.995 0.426 . . . . 1.0 109.886 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 38' ' ' LEU . 20.4 pt -155.17 60.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 m -155.36 138.22 15.34 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.385 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 27' ' ' VAL . 21.9 m-85 -76.34 -59.18 1.1 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.66 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.99 -28.83 87.93 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.807 1.671 . . . . 1.0 112.409 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -88.2 -21.26 24.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.937 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.38 81.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.6 tt -66.28 -37.46 79.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.301 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -46.01 87.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.478 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -64.42 -40.39 95.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.4 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 84.0 p -61.53 -32.75 72.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.031 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 45' ' ' ILE . 48.5 t -61.34 -49.83 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.857 0.361 . . . . 1.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH2' ' B' ' 68' ' ' ARG . 12.1 pt-20 -71.37 -25.52 62.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -63.62 -47.89 79.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.272 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.82 -36.54 77.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.465 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.3 p -75.11 -1.97 25.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.4 p 52.44 36.09 19.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.233 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.93 -49.91 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.042 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.19 84.73 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CZ ' ' O ' ' B' ' 60' ' ' ARG . 1.3 t80 -60.77 -46.28 91.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.534 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.36 7.1 0.59 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.5 m-20 -60.73 -47.61 85.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.803 0.335 . . . . 1.0 110.611 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' O ' ' CE1' ' D' ' 57' ' ' TYR . 26.5 mtm-85 -140.85 154.34 46.15 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.219 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.28 136.3 10.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.475 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.71 -175.15 1.28 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.794 1.662 . . . . 1.0 112.217 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 29.2 m -132.56 -131.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.342 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.669 HG22 ' CD1' ' D' ' 46' ' ' TRP . 7.4 p -113.87 -44.67 3.15 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.588 0.233 . . . . 1.0 111.194 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.7 tp10 -61.63 -40.44 94.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.254 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' OE1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -72.93 32.17 0.07 Allowed 'General case' 0 C--O 1.264 1.858 0 CA-C-O 123.703 1.716 . . . . 1.0 109.997 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.15 64.45 0.94 Allowed Glycine 0 C--O 1.212 -1.247 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.671 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' C ' ' O ' ' A' ' 67' ' ' GLY . 58.8 ttm-85 -23.59 -34.53 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.328 1.064 . . . . 1.0 111.264 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 44.9 mmtm -51.09 -15.81 0.38 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.624 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 67' ' ' GLY . 50.2 t -61.54 -47.55 92.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 119.617 -0.833 . . . . 1.0 110.225 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.23 62.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.691 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -50.66 -47.18 58.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.541 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.24 -41.55 94.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.229 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.71 -46.99 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.075 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.18 -40.85 98.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.764 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.21 -37.98 89.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.53 -38.09 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.37 -41.91 83.99 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 -43.47 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.659 0.266 . . . . 1.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.49 -40.41 91.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.013 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 75.5 t -65.69 -49.1 79.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.851 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -65.76 -40.48 92.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.13 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.35 84.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.006 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 86' ' ' THR . 8.0 tt -62.07 -42.04 98.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.212 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 85' ' ' VAL . 92.8 t -49.11 -13.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.308 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.47 ' N ' ' C ' ' A' ' 84' ' ' LEU . 58.0 m -51.79 -39.41 58.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.985 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -50.38 -24.94 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.03 -11.74 24.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.66 -50.01 6.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.339 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.67 -34.62 52.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 1.0 110.834 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -69.87 -12.87 61.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.401 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.91 -50.12 75.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.151 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 9.9 p90 -74.94 -23.13 58.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.314 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.48 -43.87 95.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.937 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.04 -22.57 62.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.652 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -42.68 -39.48 2.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 1.0 109.889 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t0 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.779 0.323 . . . . 1.0 110.683 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -73.41 -19.34 61.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -68.74 -36.1 77.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.511 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.72 -37.87 88.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 1.0 110.65 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.96 -40.4 80.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.579 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.5 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 1.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.08 -40.08 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.556 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.93 81.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.886 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.5 -38.76 87.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.655 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.98 -38.09 89.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.28 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.94 -31.84 73.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' B' ' 52' ' ' ALA . 41.5 tp -63.05 -37.57 87.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.406 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -68.1 -36.19 79.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.11 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.46 -47.58 83.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.797 0.332 . . . . 1.0 111.547 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.48 -34.39 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.972 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.8 mt -60.54 -39.44 87.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.39 -43.83 89.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.99 -32.93 73.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.053 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.47 80.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.902 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -44.86 95.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.592 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -62.74 -51.86 65.51 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.231 -0.588 . . . . 1.0 109.917 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.4 -42.78 98.78 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.417 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.19 70.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.524 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.9 OUTLIER -64.78 -42.01 93.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.469 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 82.5 tt0 -70.26 -43.74 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.242 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.14 86.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.15 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' B' ' 38' ' ' LEU . 33.0 mm-40 -66.0 -35.12 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 1.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.76 128.67 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.624 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.09 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.44 147.94 33.82 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.819 -0.224 . . . . 1.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' B' ' 36' ' ' ALA . 96.1 Cg_endo -75.47 142.53 26.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.18 1.92 . . . . 1.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.73 -23.29 0.4 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' B' ' 34' ' ' PRO . . . 45.3 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 1.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -178.19 -31.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.329 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.43 ' N ' ' OE1' ' B' ' 30' ' ' GLU . 14.8 tp -137.2 102.75 4.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.288 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' CB ' ' B' ' 40' ' ' SER . 4.2 pt -132.14 104.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.78 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 0.3 OUTLIER 164.89 143.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.545 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.5 m-85 -81.42 -61.66 0.37 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.983 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.0 Cg_endo -58.39 -27.05 80.17 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.187 1.925 . . . . 1.0 112.464 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -93.21 -22.12 19.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.056 -0.257 . . . . 1.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.52 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.51 -38.47 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.875 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' C' ' 68' ' ' ARG . 3.4 t-105 -60.95 -46.95 88.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.564 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.41 ' CD2' ' C ' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -66.58 -26.05 66.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.88 -36.09 75.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.017 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.08 -47.08 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.804 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -66.87 -30.77 71.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.61 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -63.7 -46.46 85.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.452 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.62 -28.77 65.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.11 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -90.01 4.23 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 1.0 110.543 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 p 46.82 66.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.971 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.409 HG21 ' SD ' ' C' ' 75' ' ' MET . 0.8 OUTLIER -148.96 11.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.317 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -39.01 105.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.26 -102.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.638 0.256 . . . . 1.0 110.591 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.23 11.13 3.56 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.19 -66.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 1.0 110.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 44.4 mtt-85 -145.73 157.25 43.96 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -150.98 140.41 13.75 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.3 170.84 15.1 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.021 1.814 . . . . 1.0 112.064 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.472 ' C ' ' OE1' ' B' ' 66' ' ' GLU . 2.7 t -100.83 -130.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.926 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' B' ' 66' ' ' GLU . 87.5 m -115.25 -42.02 3.23 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.424 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.694 ' C ' ' H ' ' B' ' 67' ' ' GLY . 45.4 tp10 -64.95 -37.68 88.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.755 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -67.14 28.44 0.02 OUTLIER 'General case' 0 C--O 1.265 1.885 0 CA-C-O 123.558 1.647 . . . . 1.0 110.06 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.53 63.5 1.17 Allowed Glycine 0 C--O 1.213 -1.162 0 CA-C-N 113.704 -1.589 . . . . 1.0 111.407 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.525 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.2 ttt85 -24.49 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.331 1.066 . . . . 1.0 111.018 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' B' ' 67' ' ' GLY . 32.1 mmtp -49.61 -18.09 0.4 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.456 -0.793 . . . . 1.0 108.885 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.48 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.699 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.27 -39.71 74.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.19 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -53.09 -44.17 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 109.999 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.77 -43.02 85.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.455 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.96 -44.39 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.047 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtt -60.31 -43.32 96.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.552 -0.294 . . . . 1.0 110.432 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.49 -38.94 93.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.323 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.93 87.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.01 62.2 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 79' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 79' ' ' ILE . 93.7 mt -68.3 -3.72 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.181 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -95.0 -52.36 4.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.05 0.452 . . . . 1.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 82' ' ' PHE . 12.7 m -60.91 -48.72 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.275 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.484 ' N ' HG23 ' B' ' 81' ' ' VAL . 44.4 m-85 -66.18 -38.83 89.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.956 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.04 83.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.561 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.0 tt -61.9 -40.69 96.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.107 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 89' ' ' LEU . 98.8 t -47.52 -19.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' B' ' 90' ' ' ALA . 81.6 m -51.41 -19.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.06 -64.71 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.433 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.93 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 1.0 110.723 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.549 HD23 HG12 ' B' ' 85' ' ' VAL . 3.6 mm? -98.17 -6.66 30.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.101 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 86' ' ' THR . . . -87.54 -27.17 22.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -3.85 45.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.271 -0.877 . . . . 1.0 109.881 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.543 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 35.9 t0 -54.48 -47.58 72.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.011 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' B' ' 90' ' ' ALA . 21.9 p90 -75.32 -30.0 60.19 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.275 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.47 -43.88 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.542 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 ttm-85 -46.29 -21.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.971 -0.292 . . . . 1.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 42.7 ptt85 -59.97 -41.41 91.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.405 . . . . 1.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 98.0 mt-10 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.159 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.791 0.329 . . . . 1.0 110.374 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.475 ' CD2' ' HG2' ' C' ' 5' ' ' GLU . 5.0 p-80 -57.13 -41.67 79.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.622 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.475 ' HG2' ' CD2' ' C' ' 4' ' ' HIS . 67.3 mm-40 -64.87 -42.84 94.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.912 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -64.73 -41.92 95.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.76 -38.26 86.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.181 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.86 98.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -64.93 -42.36 94.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.328 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.38 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.362 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.4 -34.43 72.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.223 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.77 -38.41 90.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.714 0.292 . . . . 1.0 110.889 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -63.89 -34.36 77.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 1.0 110.347 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.66 -35.39 80.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.672 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' C' ' 78' ' ' GLY . 45.4 tp -62.29 -41.56 98.61 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.461 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -39.54 92.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.23 -40.77 97.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 1.0 111.283 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.22 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.662 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' C' ' 52' ' ' ALA . 84.7 mt -60.37 -40.66 91.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.415 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.8 -48.75 66.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.33 -32.94 73.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.152 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.68 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.78 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -58.59 -43.54 89.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.521 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -62.35 -51.08 69.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 109.568 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.05 -41.99 97.65 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.347 -0.541 . . . . 1.0 109.987 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.66 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.084 -0.247 . . . . 1.0 111.324 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 1.2 p -65.16 -41.29 91.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.538 -0.465 . . . . 1.0 109.954 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 44.3 tp10 -66.92 -44.21 81.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.611 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.38 -38.45 87.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.418 ' OE1' ' HB1' ' C' ' 36' ' ' ALA . 64.2 mm-40 -71.11 -34.2 70.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.149 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -67.79 121.8 16.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.855 0.36 . . . . 1.0 110.624 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.87 61.19 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.272 -0.731 . . . . 1.0 111.272 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.48 24.76 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 110.466 -0.198 . . . . 1.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.13 144.77 27.03 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.015 1.81 . . . . 1.0 112.359 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.73 11.82 58.19 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' OE1' ' C' ' 30' ' ' GLU . . . -60.19 92.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.323 . . . . 1.0 110.57 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.2 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.297 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.43 118.22 26.73 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.157 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' C' ' 40' ' ' SER . 40.2 pt -145.13 164.15 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.251 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.7 OUTLIER 82.13 142.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.789 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 89.8 t80 -80.36 -38.87 1.14 Allowed Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.112 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.8 Cg_endo -60.03 -32.73 95.29 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.403 1.402 . . . . 1.0 112.378 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' C' ' 39' ' ' ILE . 9.1 p-10 -95.09 -9.91 32.27 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 121.015 -0.274 . . . . 1.0 111.1 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -38.37 81.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 1.0 110.794 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 tt -64.67 -37.26 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.1 OUTLIER -60.93 -47.52 86.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.604 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.453 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.8 OUTLIER -71.69 -18.19 62.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.384 178.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.645 ' O ' HD22 ' C' ' 19' ' ' LEU . 7.5 t -81.01 48.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.009 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.544 HG11 HH12 ' D' ' 68' ' ' ARG . 92.0 t -147.21 -41.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.838 -0.345 . . . . 1.0 111.336 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.48 -34.55 78.17 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.853 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -44.7 83.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.181 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.795 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.46 -35.53 76.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.691 0.281 . . . . 1.0 110.571 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 43.3 p -88.46 3.46 50.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 110.106 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.2 p 51.66 75.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.37 -66.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.282 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 81.58 -59.1 4.86 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.445 -1.062 . . . . 1.0 110.445 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 68.74 -38.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.284 . . . . 1.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 124.53 19.6 2.53 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.09 -49.0 79.37 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.37 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -147.06 -165.57 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 42.6 p90 -170.41 113.75 0.46 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.19 -171.46 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.488 1.459 . . . . 1.0 112.104 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' C' ' 64' ' ' THR . 13.3 p -129.48 -176.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' C' ' 63' ' ' VAL . 71.3 m -79.83 -25.23 40.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.777 0.322 . . . . 1.0 110.476 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' C' ' 67' ' ' GLY . 43.1 tp10 -66.54 -43.63 84.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.399 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -77.0 31.47 0.14 Allowed 'General case' 0 C--O 1.268 2.035 0 CA-C-O 124.212 1.958 . . . . 1.0 109.586 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.83 64.38 1.92 Allowed Glycine 0 C--O 1.217 -0.914 0 CA-C-N 113.24 -1.8 . . . . 1.0 111.266 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' C' ' 67' ' ' GLY . 42.3 ttm180 -24.79 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.9 0.85 . . . . 1.0 111.049 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' C' ' 67' ' ' GLY . 29.9 mmtp -48.75 -22.35 0.78 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.595 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' C' ' 67' ' ' GLY . 80.0 t -61.95 -48.09 90.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 118.958 -1.097 . . . . 1.0 110.564 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.45 78.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 1.0 110.793 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.76 -44.78 96.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.015 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.58 -38.45 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.221 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.31 -43.15 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.455 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.409 ' SD ' HG21 ' B' ' 55' ' ' VAL . 60.2 mtt -60.99 -42.0 97.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.84 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 64.7 tttm -61.92 -41.22 97.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 1.0 110.555 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.15 -38.88 92.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 1.0 110.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.24 -41.98 91.3 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.968 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -61.12 -43.1 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.682 0.277 . . . . 1.0 110.717 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.7 mt-10 -60.13 -43.59 95.55 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.202 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.45 -49.22 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.361 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.79 -38.76 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.318 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.01 85.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 1.0 110.675 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.33 -40.59 97.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.93 -20.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.435 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 5.7 t -50.78 -22.1 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 1.0 110.515 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.543 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -56.14 -25.61 46.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.202 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -98.29 -16.41 19.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.694 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 58.7 mt -86.2 -47.1 9.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.82 -29.19 59.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.847 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -89.58 -3.65 58.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.968 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 53.3 t0 -56.27 -47.28 78.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.585 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 7.9 p90 -75.19 -37.5 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.105 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 95.9 t -46.64 -27.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.575 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.688 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -42.47 -37.25 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 1.0 111.078 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.653 -179.823 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.645 ' CB ' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.348 . . . . 1.0 110.619 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.68 -43.96 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.907 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.645 ' CE1' ' CB ' ' D' ' 2' ' ' ALA . 11.2 p-80 -69.11 -37.34 78.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.85 -36.6 84.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.47 -43.4 97.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 8' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.88 -37.57 86.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.897 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 9' ' ' GLN . . . . . 0.441 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 59.0 tt0 -63.42 -39.93 95.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.58 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -63.91 -36.67 84.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.62 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.24 -27.56 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.282 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.52 -39.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 1.0 110.765 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' D' ' 13' ' ' GLU . 54.3 mp0 -67.06 -34.36 77.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.591 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -62.51 -37.22 85.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.651 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.7 tp -62.72 -42.0 99.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.389 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.12 -32.5 73.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -61.91 -39.19 91.14 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.045 0.45 . . . . 1.0 110.826 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.96 -38.49 72.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.637 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.3 mt -61.95 -45.92 91.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.645 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.17 -42.26 69.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 1.0 110.344 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.07 -40.28 82.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 1.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.27 83.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -55.54 -44.27 76.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.641 -0.254 . . . . 1.0 110.568 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -65.45 -32.87 74.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.631 -0.427 . . . . 1.0 110.169 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.3 -43.87 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.886 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -60.33 -49.63 76.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.533 HG13 ' N ' ' D' ' 28' ' ' GLU . 8.7 p -60.6 -44.55 97.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 109.908 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.533 ' N ' HG13 ' D' ' 27' ' ' VAL . 9.1 tm-20 -68.06 -42.51 80.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.546 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.05 91.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.628 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 3.2 mp0 -70.74 -34.18 71.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.324 . . . . 1.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -69.23 122.9 19.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 1.0 110.663 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.28 -2.06 57.62 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.574 -0.739 . . . . 1.0 111.366 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.52 35.82 Favored Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 122.847 -0.208 . . . . 1.0 110.538 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.54 143.04 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.057 1.838 . . . . 1.0 112.357 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.57 76.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.43 143.76 57.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.762 0.315 . . . . 1.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.05 -22.77 2.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 37.6 tp -70.87 -89.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.536 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.546 HG22 ' N ' ' D' ' 40' ' ' SER . 95.5 mt 54.12 161.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.188 0.518 . . . . 1.0 110.671 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.546 ' N ' HG22 ' D' ' 39' ' ' ILE . 1.1 t 76.23 130.47 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 20.8 t80 -77.22 -43.61 2.68 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.069 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.5 Cg_endo -59.2 -29.72 91.15 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.238 1.292 . . . . 1.0 112.094 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.544 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.3 m-20 -89.96 -30.91 17.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.565 -0.289 . . . . 1.0 110.993 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.72 82.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.868 0.366 . . . . 1.0 110.774 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.407 ' O ' HG23 ' D' ' 49' ' ' VAL . 7.7 tt -63.95 -37.06 78.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.059 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.669 ' CD1' HG22 ' A' ' 64' ' ' THR . 0.2 OUTLIER -67.41 -41.48 84.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.246 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CG ' ' D' ' 50' ' ' GLU . 13.5 t90 -60.08 -37.33 79.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' D' ' 19' ' ' LEU . 85.8 p -65.65 -33.1 75.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.29 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.564 ' O ' HG12 ' D' ' 49' ' ' VAL . 62.1 t -79.72 63.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.058 0.456 . . . . 1.0 111.724 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' D' ' 47' ' ' TRP . 8.3 pt-20 178.9 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.68 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.49 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 90.4 m -65.33 -42.08 93.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.637 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -55.09 -26.23 36.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 16.8 p -83.02 0.86 42.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.235 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.6 p 57.99 10.93 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.971 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' D' ' 57' ' ' TYR . 76.7 t -91.17 -54.76 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.677 0.275 . . . . 1.0 110.739 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.08 -42.1 0.61 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' D' ' 55' ' ' VAL . 0.1 OUTLIER 56.16 -74.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.763 0.316 . . . . 1.0 110.681 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . -159.15 -91.49 0.08 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' NH1' ' D' ' 60' ' ' ARG . 29.5 t70 45.41 -119.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.729 0.3 . . . . 1.0 110.345 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.544 ' NH2' ' O ' ' D' ' 43' ' ' ASP . 0.1 OUTLIER -113.78 169.24 9.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.8 p90 -137.09 136.41 20.94 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.782 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.63 154.27 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.267 1.978 . . . . 1.0 112.195 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.519 HG23 ' H ' ' D' ' 66' ' ' GLU . 18.1 m -93.42 -145.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.874 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.439 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 5.6 m -112.87 -41.04 3.85 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.694 0.283 . . . . 1.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' D' ' 67' ' ' GLY . 52.1 tp10 -66.07 -25.76 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.103 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.519 ' H ' HG23 ' D' ' 63' ' ' VAL . 1.0 OUTLIER -74.39 30.44 0.08 Allowed 'General case' 0 C--O 1.263 1.79 0 CA-C-O 123.697 1.713 . . . . 1.0 108.975 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.42 61.35 3.27 Favored Glycine 0 C--O 1.21 -1.385 0 CA-C-N 114.011 -1.449 . . . . 1.0 109.537 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.544 HH12 HG11 ' C' ' 49' ' ' VAL . 55.6 ttp85 -24.48 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 O-C-N 124.328 0.664 . . . . 1.0 110.735 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.7 mttt -51.98 -18.32 1.33 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.413 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' D' ' 67' ' ' GLY . 54.0 t -62.75 -49.63 82.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.932 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' ALA . . . . . 0.541 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -70.9 -43.27 68.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.403 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -41.84 -43.93 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.234 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -70.67 -35.66 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.665 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.1 -52.07 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.056 -0.658 . . . . 1.0 111.677 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.541 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 0.0 OUTLIER -70.89 -40.1 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 1.0 110.71 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -43.01 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.464 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.6 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.421 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -63.67 -41.53 98.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.582 -0.607 . . . . 1.0 111.582 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.21 -43.05 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.636 0.255 . . . . 1.0 111.072 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -42.03 97.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.072 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.41 -48.33 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.364 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -71.58 -12.79 61.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.787 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -94.65 -31.84 13.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.8 0.333 . . . . 1.0 110.185 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.1 tt -64.4 -41.51 96.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.459 HG12 ' HB1' ' D' ' 8' ' ' ALA . 35.0 m -58.42 -2.88 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.5 ' H ' ' C ' ' D' ' 84' ' ' LEU . 48.1 m -60.01 -22.26 62.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.056 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -59.08 -47.89 83.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.249 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.78 85.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.836 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.42 -39.52 92.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.461 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -56.8 -45.37 82.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.976 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -10.06 59.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.641 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.9 t0 -55.82 -48.52 75.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.133 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -76.11 -30.54 58.29 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.821 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.42 -26.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.305 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp85 -57.75 -32.75 67.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.883 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' D' ' 97' ' ' GLU . 36.1 ptt85 -58.17 -39.23 78.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.411 . . . . 1.0 110.037 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 97' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' D' ' 96' ' ' ARG . 81.0 tt0 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.717 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.468 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.912 0.387 . . . . 1.0 110.704 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -106.84 -8.79 16.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.465 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.468 ' NE2' ' HB1' ' A' ' 2' ' ' ALA . 13.4 p80 -87.64 -19.74 27.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.12 -38.84 89.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.69 -38.16 90.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.233 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.1 -41.22 99.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.172 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.61 96.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 1.0 110.527 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.69 -37.16 85.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.316 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -62.46 -37.38 85.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.14 76.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.904 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.59 -38.71 92.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.597 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.2 -34.59 76.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.353 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -65.55 -34.09 77.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.392 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 52' ' ' ALA . 48.3 tp -62.92 -39.01 93.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.331 . . . . 1.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.04 -34.63 78.51 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.62 -46.77 81.16 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.6 m -63.62 -36.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.549 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.8 mt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.76 -45.81 77.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.104 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.94 -38.58 79.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.288 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.92 85.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.72 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -57.62 -44.11 85.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.087 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.3 -31.71 72.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.453 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 29' ' ' ALA . 97.2 mttt -76.57 -48.44 19.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.59 79.59 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.467 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.0 p -61.93 -44.67 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.306 -0.558 . . . . 1.0 109.669 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 27' ' ' VAL . 84.0 tt0 -69.85 -31.22 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.385 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -57.01 -38.09 72.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.261 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.24 -39.27 86.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -55.41 99.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.628 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.71 -2.45 23.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.06 142.42 24.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 O-C-N 122.753 -0.263 . . . . 1.0 110.653 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.503 ' O ' HG11 ' A' ' 63' ' ' VAL . 98.5 Cg_endo -75.07 144.19 29.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.936 1.758 . . . . 1.0 112.269 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.25 26.39 70.48 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.83 151.24 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 1.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 -53.17 0.54 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.481 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 53.93 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 39' ' ' ILE . 13.7 tt -105.64 96.81 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.225 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 71.7 m -169.34 -123.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.618 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 40' ' ' SER . 4.6 m-85 -171.66 -68.54 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.197 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 41' ' ' TYR . 28.5 Cg_endo -60.15 -32.55 94.71 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.998 1.798 . . . . 1.0 112.241 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -86.29 -20.08 28.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.102 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.87 95.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 1.0 110.353 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -67.96 -39.09 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.545 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -59.43 -44.21 92.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.902 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -59.68 -39.43 84.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -65.96 -36.96 84.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.18 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.4 -48.77 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 120.734 0.302 . . . . 1.0 110.736 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.9 -31.79 70.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.515 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 m -62.38 -45.29 93.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.313 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.46 -29.11 67.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.454 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 55' ' ' VAL . 13.9 p -90.24 11.9 19.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 1.1 p 41.42 41.9 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.276 -0.875 . . . . 1.0 111.211 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 ' SD ' ' B' ' 75' ' ' MET . 45.3 t -81.07 -51.74 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.972 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 88.07 -69.38 2.85 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.142 -0.551 . . . . 1.0 111.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.404 ' CD2' HG11 ' A' ' 55' ' ' VAL . 1.3 m-85 54.4 -83.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.932 0.396 . . . . 1.0 110.255 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . 140.48 27.84 0.21 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.27 -43.75 98.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 1.0 110.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 25.6 mmt180 -132.21 -178.72 5.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.097 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 81.7 m-85 -157.45 96.84 2.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.706 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.72 156.07 64.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.79 1.66 . . . . 1.0 112.411 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -79.69 -141.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.334 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.433 ' CA ' ' OE2' ' A' ' 66' ' ' GLU . 7.5 p -115.41 -41.76 3.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.775 0.322 . . . . 1.0 110.571 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' GLY . 15.6 tm-20 -61.6 -24.94 67.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -71.89 40.74 0.07 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 123.576 1.655 . . . . 1.0 109.167 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.765 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.82 66.71 2.3 Favored Glycine 0 C--O 1.199 -2.064 0 CA-C-N 113.708 -1.587 . . . . 1.0 111.959 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' NE ' ' CD1' ' D' ' 46' ' ' TRP . 35.7 ttm105 -24.91 -27.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.726 1.263 . . . . 1.0 112.176 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.5 mttm -76.61 -6.91 53.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.944 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.748 ' N ' ' O ' ' A' ' 67' ' ' GLY . 13.9 t -58.75 -48.53 85.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.446 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.4 -41.93 69.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.567 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.93 -36.49 79.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.582 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.79 -53.51 57.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.08 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.28 -42.19 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.7 tpp -52.23 -50.58 61.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.63 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -65.17 -41.14 94.96 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.73 -46.37 70.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.839 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -63.74 -43.43 97.78 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -43.38 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.606 0.241 . . . . 1.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.17 -43.36 99.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.47 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.38 -49.03 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.38 -8.83 57.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.979 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.64 -39.44 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.9 tt -63.21 -42.55 99.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.573 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 m -50.77 -9.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.602 -0.439 . . . . 1.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.2 m -57.98 -38.59 76.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.969 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -48.99 -33.72 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.302 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 -11.51 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' THR . 76.4 mt -91.69 -46.65 7.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.028 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.85 -24.78 53.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 1.0 110.675 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 t -86.58 -3.56 59.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.988 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.1 m-20 -62.12 -43.69 98.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.173 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 5.7 p90 -74.69 -31.59 61.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.517 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.16 -26.59 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.37 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -63.94 -21.89 66.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -60.07 -33.99 72.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 1.0 110.752 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.961 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.806 0.336 . . . . 1.0 110.745 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.49 ' CE1' HH22 ' B' ' 95' ' ' ARG . 6.0 p80 -76.13 -18.69 59.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.436 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.18 -37.26 85.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.758 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.99 -44.26 97.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.559 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -41.41 88.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.681 -0.408 . . . . 1.0 109.917 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -65.73 -37.34 86.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.646 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -62.85 -37.46 86.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.05 76.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.01 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.53 -39.77 85.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.0 110.693 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.434 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 6.3 tm-20 -65.37 -36.87 85.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.86 -32.81 74.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.552 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.33 -40.76 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.393 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -63.24 -37.03 85.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' LYS . . . . . 0.434 ' NZ ' ' OE1' ' B' ' 13' ' ' GLU . 29.2 mtmm -62.26 -41.75 98.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.0 111.054 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.08 -40.73 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.627 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' B' ' 52' ' ' ALA . 96.0 mt -61.4 -40.86 95.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.5 mt-10 -65.53 -44.01 88.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.03 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -72.03 -39.44 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.345 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.26 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.512 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.2 p -57.51 -45.41 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.77 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.81 -35.7 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.191 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.4 mttm -69.42 -45.91 68.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -54.24 -49.48 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.532 0.197 . . . . 1.0 111.532 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.432 HG13 ' N ' ' B' ' 28' ' ' GLU . 3.0 p -60.83 -46.22 96.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.432 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.7 tm-20 -68.46 -35.42 77.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.687 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -59.18 -46.99 86.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.481 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 30' ' ' GLU . 4.1 mp0 -68.02 -37.61 81.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 1.0 110.396 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -55.61 97.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.743 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.12 -7.9 16.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.481 -0.648 . . . . 1.0 111.481 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.29 146.93 34.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 122.852 -0.204 . . . . 1.0 110.487 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.522 ' O ' HG11 ' B' ' 63' ' ' VAL . 96.9 Cg_endo -75.6 142.6 26.29 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.057 1.838 . . . . 1.0 112.503 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.77 29.81 71.15 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.98 145.39 41.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 1.0 110.188 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.525 ' O ' ' NH1' ' B' ' 60' ' ' ARG . . . -126.87 -25.79 3.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.539 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.56 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.5 tt -103.1 119.49 38.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 110.09 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.465 ' N ' HD23 ' B' ' 38' ' ' LEU . 40.4 pt -153.05 -141.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.769 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.08 -127.43 1.3 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.893 0.377 . . . . 1.0 110.653 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.436 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 2.1 m-85 -164.32 -63.19 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.084 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.5 Cg_endo -58.73 -23.36 65.9 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.199 1.932 . . . . 1.0 112.122 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -89.77 -29.66 18.53 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.828 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.444 ' CB ' HD21 ' B' ' 38' ' ' LEU . . . -68.27 -40.0 82.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.0 110.596 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.6 tt -65.84 -42.94 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.703 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.481 ' N ' HG23 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -66.19 -36.96 84.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.41 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -61.65 -40.26 94.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.633 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.453 ' O ' HD22 ' B' ' 19' ' ' LEU . 10.8 p -58.4 -29.19 65.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.945 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.43 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.711 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' B' ' 59' ' ' ASP . 23.7 mt-10 -66.8 -33.93 76.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.0 m -60.09 -44.58 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.506 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.79 -24.49 57.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.974 -0.291 . . . . 1.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 56.6 p -90.29 0.83 57.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.637 -0.256 . . . . 1.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.6 p 52.65 25.57 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.441 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.571 HG13 ' N ' ' B' ' 56' ' ' GLY . 7.4 p -83.1 -46.27 18.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 72.26 -32.93 0.66 Allowed Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' B' ' 55' ' ' VAL . 1.9 m-85 41.17 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.02 0.438 . . . . 1.0 110.563 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' B' ' 56' ' ' GLY . . . 162.86 19.72 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' B' ' 50' ' ' GLU . 92.0 m-20 -63.46 -45.68 89.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.795 0.331 . . . . 1.0 110.641 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' B' ' 37' ' ' ALA . 96.9 mtt-85 -147.38 -175.36 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.24 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.533 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 13.5 p90 -162.19 113.77 1.16 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.96 153.41 72.59 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.38 1.387 . . . . 1.0 112.56 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.522 HG11 ' O ' ' B' ' 34' ' ' PRO . 2.1 t -77.82 -138.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.012 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 63' ' ' VAL . 95.2 m -114.58 -39.61 3.75 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.766 0.317 . . . . 1.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' B' ' 67' ' ' GLY . 80.1 tt0 -65.06 -24.19 67.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.329 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -74.95 27.03 0.09 Allowed 'General case' 0 C--O 1.263 1.769 0 CA-C-O 123.576 1.655 . . . . 1.0 109.719 179.065 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.12 63.47 1.3 Allowed Glycine 0 C--O 1.212 -1.246 0 CA-C-N 113.656 -1.611 . . . . 1.0 111.269 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.4 ttm180 -25.08 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 118.124 0.962 . . . . 1.0 110.943 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 67' ' ' GLY . 44.9 mmtm -48.62 -19.84 0.39 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' B' ' 67' ' ' GLY . 61.4 t -62.51 -47.26 93.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.607 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.89 -38.06 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.96 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -60.63 -40.85 93.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.18 -44.87 79.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.638 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.26 -43.98 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.346 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 55' ' ' VAL . 55.4 mtt -55.38 -46.9 76.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.633 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -41.96 97.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.546 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.41 ' O ' HG22 ' B' ' 81' ' ' VAL . . . -60.12 -24.54 64.75 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.54 -41.45 5.42 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.93 -43.85 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 122.416 -0.461 . . . . 1.0 111.318 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.69 -52.46 65.4 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.876 0.369 . . . . 1.0 111.383 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 82' ' ' PHE . 15.9 m -60.62 -46.27 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.479 ' N ' HG23 ' B' ' 81' ' ' VAL . 18.3 m-85 -74.15 2.7 8.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.997 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.46 -30.11 5.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.771 0.319 . . . . 1.0 110.227 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.475 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.5 tt -64.03 -40.44 96.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.256 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.468 HG12 ' HB1' ' B' ' 8' ' ' ALA . 26.9 m -48.57 -15.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.873 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.475 ' N ' ' C ' ' B' ' 84' ' ' LEU . 52.7 m -49.14 -23.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -64.64 -42.26 95.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.695 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -11.41 59.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' B' ' 92' ' ' ASP . 43.5 mt -91.0 -38.81 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -54.42 -34.86 62.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.356 0.598 . . . . 1.0 109.481 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.523 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.2 OUTLIER -79.26 -8.02 58.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.395 -0.821 . . . . 1.0 109.969 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' B' ' 89' ' ' LEU . 66.2 t0 -55.82 -51.46 67.41 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.786 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 17.4 p90 -71.84 -41.77 67.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.747 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 57.1 t -45.13 -35.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.515 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 84.5 mtt85 -63.54 -22.7 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.056 -0.257 . . . . 1.0 111.404 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' B' ' 96' ' ' ARG . 23.7 ptt-85 -46.77 -29.03 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 1.0 110.079 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.045 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.943 0.402 . . . . 1.0 110.064 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -81.83 -20.04 39.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.57 -43.04 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -75.49 -29.73 59.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -64.96 -42.74 94.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.214 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.26 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -66.74 -40.85 88.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.182 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -64.25 -35.25 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -43.16 87.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.193 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -40.55 96.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 1.0 110.968 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.518 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.82 -36.28 83.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.465 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.414 HD13 ' HA2' ' C' ' 78' ' ' GLY . 50.7 tp -62.4 -41.46 98.68 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.5 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -58.92 -40.14 83.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.388 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.66 -39.37 91.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 1.0 111.032 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.22 -32.87 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.4 mt -61.37 -41.85 97.75 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.02 -46.68 84.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.0 109.765 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.7 -40.41 72.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.433 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.75 93.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.825 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.526 ' HG ' ' CB ' ' C' ' 48' ' ' SER . 40.4 m -60.11 -45.4 93.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.655 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -66.57 -40.99 89.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.203 0.525 . . . . 1.0 110.401 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.3 mttt -66.7 -41.97 87.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.661 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.24 -51.18 69.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.361 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 7.4 p -62.37 -33.19 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.265 0.555 . . . . 1.0 110.363 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.02 -21.28 31.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.051 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -65.03 -50.83 64.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.034 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.8 pp20? -59.0 -29.36 67.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.99 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 10.8 tpt85 -62.17 118.17 7.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.794 0.33 . . . . 1.0 110.262 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.93 -9.82 63.88 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.37 148.61 34.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.496 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 87.6 Cg_endo -76.21 126.76 9.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.784 1.656 . . . . 1.0 112.299 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.02 37.47 6.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 143.06 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 1.0 110.631 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -151.73 -42.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 26.47 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.013 0.435 . . . . 1.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' C' ' 37' ' ' ALA . 12.9 tt -63.27 -24.32 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.493 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 43.3 t -59.42 129.59 42.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.518 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.507 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 52.7 t80 -86.25 -50.91 0.48 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.983 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.0 Cg_endo -60.03 -33.69 95.24 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.514 1.476 . . . . 1.0 112.426 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.77 -7.27 57.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.282 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.26 88.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.777 0.322 . . . . 1.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.459 HG23 ' HE3' ' C' ' 46' ' ' TRP . 12.0 tt -65.0 -33.72 65.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.538 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.663 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -70.18 -47.37 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.432 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -61.11 -39.64 90.75 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.382 -0.527 . . . . 1.0 109.771 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.534 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.1 m -53.18 -21.26 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.604 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.38 -43.42 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.519 ' CD ' HH21 ' D' ' 68' ' ' ARG . 9.8 pt-20 -90.27 57.81 3.85 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.74 0.305 . . . . 1.0 111.399 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.513 ' O ' ' SD ' ' C' ' 75' ' ' MET . 6.0 t -159.51 -42.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.223 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -64.32 -36.99 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 1.0 110.924 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' C' ' 54' ' ' THR . 1.5 p -94.57 19.81 9.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.871 0.367 . . . . 1.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 53' ' ' THR . 27.6 p 54.6 81.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.639 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.81 -84.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.88 44.73 45.96 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -48.22 82.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 1.0 110.66 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 165.39 -100.19 0.17 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 38.5 m-20 38.41 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.883 0.373 . . . . 1.0 111.342 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' C' ' 58' ' ' GLY . 66.5 mtm-85 -123.43 157.61 33.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.57 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -141.92 146.17 39.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.34 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.88 152.32 73.7 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.126 1.884 . . . . 1.0 112.13 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.549 HG12 ' H ' ' C' ' 64' ' ' THR . 2.1 t -64.33 -139.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 1.0 109.992 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.549 ' H ' HG12 ' C' ' 63' ' ' VAL . 17.1 m -114.5 -77.13 0.57 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.465 ' O ' ' CZ2' ' B' ' 46' ' ' TRP . 80.6 tt0 -37.28 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.932 -0.577 . . . . 1.0 110.736 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.3 mm-40 -73.89 -103.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.07 -56.38 0.0 OUTLIER Glycine 0 N--CA 1.476 1.338 0 O-C-N 124.378 1.049 . . . . 1.0 114.225 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 88.3 mtt180 -70.71 -45.59 64.65 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' C' ' 66' ' ' GLU . 68.1 mmtt -62.35 -41.72 98.81 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.298 -0.631 . . . . 1.0 109.298 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.77 -45.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 119.798 -0.761 . . . . 1.0 111.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.1 69.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 1.0 109.76 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -69.71 -38.58 76.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.628 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.58 -49.13 74.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.89 -32.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.826 -0.349 . . . . 1.0 111.104 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' C' ' 51' ' ' THR . 27.4 tpp -61.17 -43.6 98.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.818 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.43 -38.72 92.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.703 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.459 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -55.81 -46.99 77.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.633 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -63.98 -41.81 98.49 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.223 -0.513 . . . . 1.0 111.862 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.56 -43.45 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.768 0.318 . . . . 1.0 110.788 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.55 -40.98 89.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 77' ' ' ALA . 69.5 t -63.86 -50.89 75.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.365 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -67.21 -40.79 86.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.772 -0.371 . . . . 1.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.77 71.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.988 0.423 . . . . 1.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' C' ' 86' ' ' THR . 5.4 tt -62.95 -35.75 81.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.457 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' C' ' 87' ' ' ALA . 18.7 t -39.93 -23.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 1.0 110.702 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 1.3 p -41.9 -21.76 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.953 0.406 . . . . 1.0 109.988 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -48.1 -50.78 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.93 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.52 -33.27 7.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.759 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.31 -45.9 91.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.768 0.318 . . . . 1.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' C' ' 86' ' ' THR . . . -74.2 -14.45 60.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.995 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -92.97 -2.68 55.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.32 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -59.08 -43.05 91.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.69 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 5.6 p90 -66.97 -32.0 72.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.7 -43.68 91.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.271 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -57.97 -20.81 40.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -53.41 -43.31 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.979 -0.289 . . . . 1.0 110.364 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.998 -0.281 . . . . 1.0 110.377 179.655 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.758 0.313 . . . . 1.0 110.689 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -62.51 -40.32 96.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.665 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.75 -40.63 92.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.601 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.9 tt0 -64.66 -37.2 86.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.819 0.342 . . . . 1.0 110.43 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -60.86 -43.29 98.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.381 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.64 -41.78 98.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.045 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.38 93.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.642 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.9 -37.59 79.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.99 -39.79 91.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.419 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.78 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.886 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.612 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -64.07 -39.53 94.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.89 -36.01 82.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.74 -41.2 99.08 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.063 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -37.39 85.78 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.774 0.321 . . . . 1.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.21 -41.25 92.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.624 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' D' ' 52' ' ' ALA . 88.8 mt -59.76 -41.5 91.18 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 20' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' D' ' 23' ' ' SER . 96.9 mt-10 -61.84 -48.47 80.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.271 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.94 -32.7 73.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.0 109.908 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.57 93.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.69 -46.39 90.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.923 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.45 -34.84 76.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 1.0 110.566 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -73.05 -45.61 56.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.877 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.91 79.79 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.917 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.49 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.6 p -65.48 -42.67 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.221 0.534 . . . . 1.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.49 ' N ' HG13 ' D' ' 27' ' ' VAL . 48.1 tp10 -70.63 -41.5 72.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.7 -45.79 85.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 39' ' ' ILE . 0.3 OUTLIER -75.5 -18.38 59.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.837 0.351 . . . . 1.0 111.305 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -67.18 108.63 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 1.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.59 -8.34 51.43 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.432 -0.667 . . . . 1.0 111.432 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.02 149.17 76.34 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.54 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.6 Cg_endo -74.57 142.96 29.97 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.131 1.887 . . . . 1.0 112.424 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 22.07 67.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 143.56 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.328 . . . . 1.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -27.53 1.71 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.51 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -66.47 -16.38 64.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.493 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.638 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.5 tt -37.55 105.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.973 0.416 . . . . 1.0 111.153 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 88.9 p -173.85 -133.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.192 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' D' ' 40' ' ' SER . 2.3 m-85 -177.65 -66.28 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.413 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.1 Cg_endo -58.88 -32.31 97.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.842 1.695 . . . . 1.0 111.65 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -93.92 -7.22 43.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.23 87.28 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.848 0.356 . . . . 1.0 110.493 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -69.33 -36.59 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.317 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.518 ' CD1' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -55.6 -49.06 73.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 -178.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.67 -40.52 92.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.167 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.401 ' O ' HD22 ' D' ' 19' ' ' LEU . 54.3 p -61.42 -36.19 79.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.669 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -63.53 -48.09 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.985 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.3 44.97 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -139.06 -47.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.06 -25.95 67.29 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.3 p -89.41 9.87 24.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 53' ' ' THR . 42.9 p 51.59 70.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.802 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.78 -77.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.846 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 94.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -61.82 -41.48 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 1.0 110.843 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.92 8.51 3.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.859 -0.897 . . . . 1.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.29 -47.9 83.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -140.28 148.93 42.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 25.7 p90 -136.91 137.8 24.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.514 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.54 155.37 63.5 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.376 2.051 . . . . 1.0 112.284 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -88.81 -141.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.079 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.663 HG22 ' CD1' ' C' ' 46' ' ' TRP . 1.7 p -113.67 -42.77 3.39 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.821 0.343 . . . . 1.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.76 -19.12 65.08 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.49 26.16 0.1 Allowed 'General case' 0 C--O 1.265 1.872 0 CA-C-O 123.7 1.714 . . . . 1.0 109.443 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 43.19 59.75 3.34 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 113.907 -1.497 . . . . 1.0 109.414 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.519 HH21 ' CD ' ' C' ' 50' ' ' GLU . 51.0 ttt85 -26.49 -28.94 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.363 0.684 . . . . 1.0 110.994 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.4 mttm -53.35 -18.68 2.7 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.044 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 53.2 t -62.46 -46.97 95.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.803 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.91 76.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.302 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.89 -46.24 82.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.76 -0.655 . . . . 1.0 111.164 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.14 -41.37 99.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.38 -46.18 96.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.241 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 25.1 mtm -63.4 -41.5 98.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.846 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.71 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.438 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.17 -41.08 92.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.438 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.41 -41.89 83.8 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.523 -0.631 . . . . 1.0 111.523 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.64 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.842 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -66.82 -44.09 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.177 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 77' ' ' ALA . 74.3 t -64.8 -49.22 81.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.436 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.58 -5.55 11.91 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.872 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.95 -38.2 5.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.68 -16.81 6.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.4 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.42 -1.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.723 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 89' ' ' LEU . 19.5 m -58.31 -42.16 86.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.995 0.426 . . . . 1.0 109.91 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -48.17 -17.09 0.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.76 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -105.03 -12.95 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.775 0.322 . . . . 1.0 110.464 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.3 mt -87.67 -51.18 6.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -55.32 -28.41 53.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.136 0.493 . . . . 1.0 110.421 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.803 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.5 OUTLIER -86.9 0.53 54.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.521 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 44.4 t0 -72.04 -37.7 69.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.432 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 7.4 p90 -75.86 -42.75 48.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.803 HG22 ' O ' ' D' ' 91' ' ' THR . 17.1 m -39.97 -33.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.446 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -53.7 -22.53 9.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.741 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -55.94 -34.93 66.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.613 179.763 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.694 0.283 . . . . 1.0 110.474 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ALA . 99.5 m-20 -140.26 -50.32 0.47 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.518 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -82.46 -19.71 38.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.499 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.65 -38.89 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.01 -38.78 92.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.367 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.1 -39.84 93.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.78 96.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.271 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -68.52 -38.92 81.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.511 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.04 -38.88 92.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.396 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.69 78.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.792 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.1 -36.72 82.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 1.0 110.691 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.15 -34.56 78.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.153 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -64.77 -35.32 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.65 -41.79 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.433 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 87.6 mt-30 -60.24 -40.58 90.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.244 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -44.05 97.33 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.69 -42.06 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.441 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 52' ' ' ALA . 20.1 mt -60.16 -41.93 93.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.448 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -65.17 -43.07 92.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.4 -46.53 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.381 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.02 79.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.206 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 13.4 p -53.11 -42.07 65.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.035 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' ALA . 65.4 tttm -66.4 -74.08 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -35.96 -26.5 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.147 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' LYS . . . -62.61 -42.61 99.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 2.3 m -68.11 -47.05 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.178 0.513 . . . . 1.0 110.593 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 44.1 tp10 -67.09 -34.45 77.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' OE1' ' A' ' 66' ' ' GLU . . . -54.25 -29.09 45.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -67.56 -41.11 84.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.099 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.51 HH21 ' CB ' ' A' ' 36' ' ' ALA . 5.3 mmp_? -74.13 101.97 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.225 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.03 -27.19 4.61 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 152.5 40.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 110.027 -0.361 . . . . 1.0 110.027 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.5 147.66 32.4 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.382 2.054 . . . . 1.0 112.61 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.71 36.62 7.25 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.51 ' CB ' HH21 ' A' ' 31' ' ' ARG . . . -55.08 143.88 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 1.0 110.641 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.77 -58.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.11 58.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.263 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.5 pt -85.63 -5.49 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.177 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -72.79 151.65 41.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.632 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' A' ' 42' ' ' PRO . 20.1 m-85 -98.02 -63.17 0.1 Allowed Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.753 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.16 -29.63 89.54 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.969 1.779 . . . . 1.0 112.508 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 73.7 m-20 -81.85 -5.99 58.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.955 -0.298 . . . . 1.0 110.53 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . . . -63.9 -43.16 96.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.388 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.69 -39.21 81.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.505 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -59.3 -43.8 92.6 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.506 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 14.2 t90 -63.29 -40.2 96.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 58.4 p -61.64 -32.7 72.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.71 -46.53 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.239 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.63 13.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.542 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -100.21 -49.27 4.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.757 0.313 . . . . 1.0 110.56 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.22 -26.76 67.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.382 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.4 p -84.53 5.44 27.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.224 0.535 . . . . 1.0 109.628 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.36 60.5 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.312 -0.858 . . . . 1.0 111.29 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.1 p -131.65 -48.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.952 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.76 95.55 0.01 OUTLIER Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.649 -0.58 . . . . 1.0 111.649 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -74.49 -102.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.0 110.571 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.38 18.88 1.17 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' CZ ' ' B' ' 68' ' ' ARG . 99.8 m-20 -60.23 -47.29 86.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 33.9 mmt180 -134.63 -163.02 1.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 46.3 m-85 -161.34 100.59 1.24 Allowed Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.547 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 63' ' ' VAL . 62.1 Cg_endo -69.47 150.02 69.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.353 1.369 . . . . 1.0 112.568 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 62' ' ' PRO . 6.0 m -53.53 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.371 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.543 ' CG2' HH22 ' D' ' 60' ' ' ARG . 98.0 m -102.63 -71.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.535 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 84.1 tt0 -37.81 -70.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 1.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' A' ' 68' ' ' ARG . 74.2 mt-10 -83.42 -107.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -54.58 0.0 OUTLIER Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.779 1.299 . . . . 1.0 114.77 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' A' ' 66' ' ' GLU . 60.0 ttm-85 -65.74 -74.9 0.1 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.851 -0.674 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -43.55 -37.6 2.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.27 -47.32 90.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.033 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 68' ' ' ARG . . . -65.99 -36.8 84.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.644 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.22 -38.29 73.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.615 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -63.41 -43.32 97.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.594 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.91 -45.34 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.622 ' SD ' HG11 ' D' ' 55' ' ' VAL . 65.2 mtt -60.84 -42.91 98.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.95 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.62 -43.2 97.55 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.62 -39.82 95.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.612 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.69 95.61 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.54 -43.27 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.988 -0.285 . . . . 1.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.43 -42.29 98.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.249 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 59.9 t -64.73 -50.88 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -68.46 -39.51 81.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.978 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.67 85.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.222 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.461 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.7 tt -61.77 -42.54 99.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.404 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 85' ' ' VAL . 99.1 t -47.75 -16.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 1.0 110.328 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.461 ' N ' ' C ' ' A' ' 84' ' ' LEU . 92.9 m -51.59 -21.35 2.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.214 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 -35.3 78.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.243 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.57 -14.59 34.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.5 -42.7 18.11 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.932 0.345 . . . . 1.0 111.932 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.72 -30.46 67.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.844 0.354 . . . . 1.0 111.216 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.4 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.17 -50.42 73.76 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.69 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 94' ' ' VAL . 15.7 p90 -72.37 -43.92 63.3 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.268 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.575 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 57.8 t -39.72 -34.37 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.662 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -63.04 -34.96 78.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 1.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' PHE . 40.0 ptt85 -39.46 -42.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.899 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 5.2 tp10 . . . . . 0 C--N 1.328 -0.355 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.833 0.349 . . . . 1.0 111.019 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.67 -41.64 97.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.0 110.395 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.59 -33.36 75.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -62.0 -42.35 99.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.308 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.46 -44.22 83.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.361 . . . . 1.0 110.225 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -67.31 -41.54 85.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.654 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.19 -38.57 90.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.671 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.72 -37.41 86.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.21 75.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.893 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.21 -36.03 76.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 1.0 110.629 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 -37.32 87.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -64.2 -33.63 76.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.664 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.6 tp -62.43 -41.84 99.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.691 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.65 -39.92 85.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.647 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.94 -38.86 92.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.829 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.18 -41.8 94.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.754 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 94.1 mt -59.37 -41.1 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.46 -44.3 96.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 1.0 109.915 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.74 -37.78 76.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.393 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.68 88.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.415 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -58.48 -45.82 87.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -65.31 -35.0 79.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.904 0.383 . . . . 1.0 110.218 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.95 -45.22 64.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.51 77.45 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.511 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.488 HG23 ' N ' ' B' ' 28' ' ' GLU . 24.0 m -58.59 -46.82 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.798 -0.761 . . . . 1.0 110.534 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.488 ' N ' HG23 ' B' ' 27' ' ' VAL . 89.5 mt-10 -67.91 -42.68 80.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.784 0.326 . . . . 1.0 111.027 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.37 87.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.568 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -65.09 -47.7 76.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.737 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.51 131.45 49.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.04 69.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.38 143.03 25.79 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.32 -0.252 . . . . 1.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' B' ' 63' ' ' VAL . 93.5 Cg_endo -75.45 142.6 26.71 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.151 1.901 . . . . 1.0 112.138 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.65 19.88 73.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.181 -0.767 . . . . 1.0 111.181 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.13 145.24 51.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 1.0 110.397 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.08 -34.47 0.87 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.516 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -81.75 125.5 30.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 1.0 110.588 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' SER . 35.5 pt -152.13 -166.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.408 -0.815 . . . . 1.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 39' ' ' ILE . 6.1 t 59.97 135.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 1.0 111.283 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.567 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -65.85 -48.98 61.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.369 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.45 -29.53 88.82 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.599 1.533 . . . . 1.0 112.913 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.03 -23.55 22.56 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.7 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' B' ' 27' ' ' VAL . . . -63.54 -41.63 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 1.0 110.58 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 49' ' ' VAL . 4.9 tt -65.09 -39.36 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.49 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.495 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.4 OUTLIER -59.86 -47.51 85.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.474 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -61.85 -41.91 98.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 1.0 110.267 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -64.37 -40.3 95.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.199 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 45' ' ' ILE . 44.9 t -60.49 -47.48 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.631 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.69 -32.81 74.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -64.81 -43.55 92.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.25 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -54.47 -26.3 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.915 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.6 p -88.96 2.23 54.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.716 0.293 . . . . 1.0 110.712 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' B' ' 53' ' ' THR . 69.6 p 51.59 66.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.708 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' B' ' 57' ' ' TYR . 30.5 t -133.88 -52.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.674 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.33 76.91 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.489 ' CZ ' HG11 ' B' ' 55' ' ' VAL . 81.3 m-85 -61.22 -42.6 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.912 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.89 20.73 0.83 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.527 ' CG ' HH22 ' C' ' 68' ' ' ARG . 32.7 m-20 -62.5 -41.71 99.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.816 0.341 . . . . 1.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 34.9 mmt180 -132.88 -175.83 3.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 58.9 m-85 -159.45 99.35 1.55 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.856 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.2 158.16 58.7 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.3 1.333 . . . . 1.0 112.606 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.556 HG11 ' O ' ' B' ' 34' ' ' PRO . 0.8 OUTLIER -95.11 -154.17 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.022 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.523 ' H ' HG12 ' B' ' 63' ' ' VAL . 26.8 m -101.93 -38.26 7.88 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.9 tm-20 -61.55 -32.38 72.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 1.0 110.2 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -73.01 26.52 0.06 Allowed 'General case' 0 C--O 1.263 1.784 0 CA-C-O 124.046 1.879 . . . . 1.0 109.599 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 44.31 63.95 2.2 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-O 117.492 -1.727 . . . . 1.0 110.961 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.505 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.1 ttm180 -25.08 -31.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.297 1.049 . . . . 1.0 110.904 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.5 mttt -49.82 -17.77 0.4 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 67' ' ' GLY . 45.7 t -60.32 -47.08 93.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 119.477 -0.889 . . . . 1.0 109.488 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.54 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -68.23 -54.21 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.303 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -42.82 -34.97 1.03 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.33 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.533 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 71' ' ' ALA . 45.0 t -67.03 -52.93 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.861 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 0.0 OUTLIER -65.0 -42.59 94.36 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.612 -179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.51 -43.96 93.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.119 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.428 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -64.16 -39.63 94.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.43 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.85 -42.99 92.63 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.711 -0.556 . . . . 1.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.5 -43.5 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.041 -0.264 . . . . 1.0 110.77 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 84' ' ' LEU . 80.9 mm-40 -60.28 -41.47 93.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.301 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 77' ' ' ALA . 65.3 t -64.11 -49.17 82.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.457 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -76.59 -12.16 59.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.547 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.34 -26.58 14.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.918 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 80' ' ' GLU . 4.7 tt -63.63 -41.32 98.27 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.04 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' B' ' 87' ' ' ALA . 17.3 m -47.45 -26.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.445 -0.502 . . . . 1.0 109.68 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 6.1 m -34.16 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.415 0.626 . . . . 1.0 110.211 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -53.37 -53.2 54.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.601 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -70.25 -30.18 67.17 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.333 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.445 ' N ' HD12 ' B' ' 89' ' ' LEU . 9.5 mp -61.29 -43.67 98.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.997 0.427 . . . . 1.0 109.886 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 -17.81 61.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.513 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -100.54 -11.56 20.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.241 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.6 m-20 -63.12 -41.92 99.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.076 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 1.4 p90 -64.94 -29.88 70.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.363 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.96 -43.4 92.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.519 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -48.71 -21.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.31 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -55.18 -32.22 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 1.0 110.119 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.125 -179.436 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 t0 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.783 0.325 . . . . 1.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -58.7 -41.77 87.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.24 -37.11 86.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.72 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.9 -39.29 93.84 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.92 -39.35 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.248 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -41.01 99.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.48 -37.19 84.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.72 -38.4 87.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.661 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.5 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.2 -36.29 83.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.971 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.85 -38.71 91.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.752 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -36.02 82.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.706 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.45 -36.09 82.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 1.0 110.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.87 -33.66 76.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.184 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -61.28 -47.84 84.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.579 -0.282 . . . . 1.0 111.56 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 18' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 18' ' ' VAL . 12.5 m -65.28 -36.22 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 1.0 110.653 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' C' ' 52' ' ' ALA . 36.0 mt -60.86 -41.56 96.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.74 -42.98 99.67 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.119 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -68.89 -44.75 72.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.74 78.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.468 ' O ' ' HB1' ' C' ' 44' ' ' ALA . 72.6 m -56.75 -43.95 81.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.858 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.471 ' O ' HG22 ' C' ' 27' ' ' VAL . 8.0 tmtt? -80.65 -61.86 1.84 Allowed 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -41.89 -28.75 0.17 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.159 -0.216 . . . . 1.0 110.956 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.58 78.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.571 0.224 . . . . 1.0 110.721 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 24' ' ' LYS . 2.3 m -63.26 -43.55 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.045 0.45 . . . . 1.0 110.544 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' C' ' 27' ' ' VAL . 14.4 tm-20 -80.58 -24.22 39.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -51.01 71.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.918 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.55 78.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -53.01 90.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.564 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.12 -6.18 8.22 Favored Glycine 0 N--CA 1.47 0.911 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.14 150.73 39.14 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.255 . . . . 1.0 110.32 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.62 141.77 28.28 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.685 1.59 . . . . 1.0 111.649 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 37.35 34.27 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.64 150.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.0 110.562 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' C' ' 61' ' ' TYR . . . -132.06 -116.79 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.71 HD22 ' C ' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -55.05 163.93 0.95 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.242 0.544 . . . . 1.0 110.961 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' C' ' 40' ' ' SER . 5.7 pt -152.85 -169.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.746 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.516 ' C ' ' CG ' ' C' ' 41' ' ' TYR . 37.6 m -53.02 -165.31 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.874 0.369 . . . . 1.0 110.83 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.597 ' C ' ' H ' ' C' ' 43' ' ' ASP . 0.3 OUTLIER 76.31 161.19 0.15 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.57 5.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.564 2.176 . . . . 1.0 112.131 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' C' ' 41' ' ' TYR . 21.2 t70 -84.2 -32.3 24.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' C' ' 23' ' ' SER . . . -60.9 -44.56 96.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 1.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.53 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.4 tt -63.93 -38.0 81.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.393 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.409 . . . . 1.0 110.211 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' C' ' 48' ' ' SER . 1.4 t90 -63.25 -47.72 81.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.608 ' O ' HD22 ' C' ' 19' ' ' LEU . 1.9 t -50.42 -29.22 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.776 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' C' ' 49' ' ' VAL . 57.4 t -90.39 62.91 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.684 ' CG ' HH22 ' D' ' 68' ' ' ARG . 46.7 tp10 -173.28 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.658 -0.817 . . . . 1.0 110.825 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' C' ' 75' ' ' MET . 4.5 t -72.57 -38.97 67.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.695 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -61.23 -28.38 69.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.957 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -93.67 1.82 56.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.07 0.462 . . . . 1.0 110.282 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 57.4 p 49.8 56.9 7.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.656 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' C' ' 57' ' ' TYR . 1.7 m -145.94 45.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.422 ' H ' HG13 ' B' ' 55' ' ' VAL . . . -45.58 92.44 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.324 -1.11 . . . . 1.0 110.324 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.579 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 18.2 t80 -61.97 -43.21 99.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 1.0 110.41 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.17 16.24 0.75 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.418 ' HB2' ' HE ' ' D' ' 68' ' ' ARG . 68.0 t0 -60.98 -52.11 66.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 1.0 110.766 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -151.71 -162.28 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.493 ' O ' ' CB ' ' C' ' 37' ' ' ALA . 38.7 p90 -166.69 134.91 2.21 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.802 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 176.54 6.23 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.864 1.71 . . . . 1.0 112.362 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 63' ' ' VAL . 16.5 m -87.25 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.416 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.495 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 1.1 m -110.08 -61.49 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.574 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.455 ' N ' HG22 ' C' ' 64' ' ' THR . 81.4 tt0 -42.99 -30.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.675 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 94.1 mt-10 -144.68 -104.27 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.73 -55.28 0.0 OUTLIER Glycine 0 N--CA 1.479 1.521 0 O-C-N 124.358 1.036 . . . . 1.0 114.839 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 45.0 ttm-85 -71.12 -43.17 68.18 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.192 -0.504 . . . . 1.0 109.971 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.3 tptm -60.63 -45.16 95.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.918 -1.141 . . . . 1.0 107.918 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.53 -46.64 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.797 -0.761 . . . . 1.0 110.329 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.531 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -63.05 -39.8 95.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 1.0 110.13 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -43.73 -49.36 7.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.79 -36.35 83.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.529 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.02 -43.28 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.767 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.3 mpp? -59.36 -44.64 92.66 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.726 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -64.5 -41.18 96.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.53 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 77' ' ' ALA . . . . . 0.534 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.98 -24.13 65.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.786 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.29 -37.61 6.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.717 -0.553 . . . . 1.0 111.717 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.56 -43.43 98.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.07 -37.67 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.534 HG23 ' O ' ' C' ' 77' ' ' ALA . 55.1 t -62.75 -47.12 94.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.321 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -73.74 -8.01 54.32 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.299 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -40.72 12.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.876 0.369 . . . . 1.0 110.285 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.07 -42.32 99.63 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.812 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.94 -15.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.432 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.475 ' O ' ' N ' ' C' ' 89' ' ' LEU . 28.1 m -60.04 -39.87 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.43 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -39.2 -50.56 1.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.59 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.26 90.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 1.0 110.084 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' C' ' 86' ' ' THR . 44.7 mt -66.68 -38.92 87.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.401 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -60.73 -37.64 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.438 . . . . 1.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -81.99 -3.6 54.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -55.64 -49.7 72.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.569 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.2 p90 -69.06 -32.62 72.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 -27.55 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.913 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.4 -22.94 67.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.611 -0.268 . . . . 1.0 111.152 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -57.59 -31.99 66.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 1.0 110.447 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.536 -179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.764 0.316 . . . . 1.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -174.03 -66.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -79.21 -18.91 52.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.58 -38.79 87.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.402 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.76 -42.13 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.507 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.78 -39.42 94.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.44 99.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.818 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.18 -39.07 92.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.06 -40.82 97.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -35.42 76.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.968 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.804 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.4 -38.07 88.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.368 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.37 -31.93 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.516 HD11 ' HB1' ' D' ' 52' ' ' ALA . 45.7 tp -62.07 -39.64 93.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 1.0 110.184 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.4 -34.21 75.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -63.5 -46.78 84.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.844 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.402 ' H ' HG22 ' D' ' 18' ' ' VAL . 12.2 m -63.62 -37.45 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 1.0 110.675 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' D' ' 52' ' ' ALA . 82.7 mt -61.23 -41.45 96.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.345 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.9 -46.32 82.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.912 0.387 . . . . 1.0 110.318 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.53 -35.36 75.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.287 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.06 92.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 1.0 111.054 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -58.24 -43.65 87.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.123 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -63.96 -32.84 74.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.37 -45.19 60.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.683 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -49.23 78.38 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.54 HG13 ' N ' ' D' ' 28' ' ' GLU . 10.9 p -60.87 -45.7 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.54 ' N ' HG13 ' D' ' 27' ' ' VAL . 80.3 tt0 -67.98 -43.21 79.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.704 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.95 86.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.215 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.444 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 37.7 mm-40 -67.54 -38.23 83.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.179 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 31' ' ' ARG . . . . . 0.504 HH11 HD11 ' D' ' 39' ' ' ILE . 16.3 tpp180 -63.69 124.08 20.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.981 0.42 . . . . 1.0 110.726 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.5 68.83 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.68 139.4 21.88 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.539 ' O ' HG11 ' D' ' 63' ' ' VAL . 95.7 Cg_endo -74.77 144.77 31.57 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.228 1.952 . . . . 1.0 112.53 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.88 22.65 70.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -91.2 87.82 6.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.709 0.29 . . . . 1.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 37' ' ' ALA . . . . . 0.433 ' O ' HG22 ' D' ' 39' ' ' ILE . . . -65.14 -38.82 91.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.916 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.561 HD23 ' C ' ' D' ' 38' ' ' LEU . 4.3 tt -66.6 99.14 0.56 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.587 HG23 ' O ' ' D' ' 39' ' ' ILE . 14.3 tt -143.45 93.34 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.4 OUTLIER 168.58 150.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.572 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 10.0 m-85 -76.87 -58.79 1.02 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.562 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.1 Cg_endo -58.93 -26.78 82.47 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.648 1.565 . . . . 1.0 111.728 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.34 -35.9 27.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 1.0 111.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.79 92.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.199 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.17 -44.21 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.896 0.379 . . . . 1.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -62.8 -42.02 99.54 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.581 -0.448 . . . . 1.0 110.175 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.579 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 36.1 t90 -62.12 -40.43 95.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.269 -0.572 . . . . 1.0 109.81 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.454 ' O ' HG23 ' D' ' 49' ' ' VAL . 1.4 m -74.22 69.48 1.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.804 0.335 . . . . 1.0 110.455 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.454 HG23 ' O ' ' D' ' 48' ' ' SER . 53.3 t -155.47 -61.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 1.0 110.178 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 1.5 pm0 -63.06 -31.99 73.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.555 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.468 HG23 HG11 ' D' ' 74' ' ' VAL . 0.0 OUTLIER -60.62 -42.9 97.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.223 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.779 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.96 -35.02 75.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 1.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' D' ' 54' ' ' THR . 18.1 p -80.07 9.47 5.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.16 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' D' ' 53' ' ' THR . 44.3 p 51.93 56.33 7.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.047 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.622 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.9 p -166.81 88.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.253 0.549 . . . . 1.0 111.157 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.24 109.92 3.57 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.506 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -61.32 -45.34 94.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 1.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.52 24.78 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 64.6 m-20 -61.8 -43.71 98.31 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.991 -0.284 . . . . 1.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.543 HH22 ' CG2' ' A' ' 64' ' ' THR . 0.2 OUTLIER -144.94 -177.19 5.4 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' D' ' 60' ' ' ARG . 41.5 m-85 -156.36 128.51 4.01 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.0 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.1 -171.13 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.736 1.624 . . . . 1.0 112.064 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 1.5 t -128.96 -146.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.178 -0.465 . . . . 1.0 109.986 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.615 HG22 ' CD1' ' C' ' 46' ' ' TRP . 2.9 p -113.48 -8.7 13.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.776 -0.193 . . . . 1.0 110.847 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' D' ' 67' ' ' GLY . 50.8 tp10 -99.06 -26.67 14.15 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.838 -0.431 . . . . 1.0 109.838 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.0 OUTLIER -80.97 30.92 0.31 Allowed 'General case' 0 C--O 1.265 1.874 0 CA-C-O 123.896 1.808 . . . . 1.0 108.879 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.01 61.71 2.24 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 113.377 -1.738 . . . . 1.0 109.493 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.684 HH22 ' CG ' ' C' ' 50' ' ' GLU . 71.3 ttt-85 -26.21 -30.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.134 0.55 . . . . 1.0 110.981 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.8 mttt -52.22 -13.61 0.35 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.292 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.0 t -59.56 -47.8 89.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.525 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.59 83.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.496 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.85 -43.14 85.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.365 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -61.92 -44.72 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.209 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.468 HG11 HG23 ' D' ' 51' ' ' THR . 98.1 t -64.11 -46.51 93.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.476 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.66 -44.74 95.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.995 -0.282 . . . . 1.0 111.23 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -66.15 -41.54 90.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 1.0 110.785 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.16 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.707 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.65 -39.11 93.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.586 -0.606 . . . . 1.0 111.586 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.61 -43.53 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.906 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.14 -38.95 93.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.079 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.34 -54.19 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.719 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.88 -39.6 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.812 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.44 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.0 110.446 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.66 -40.75 96.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.525 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' D' ' 87' ' ' ALA . 48.1 t -57.6 -22.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.831 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 86.4 m -40.32 -24.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.53 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -64.51 -42.47 95.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.669 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -72.44 -15.62 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.493 ' N ' HD22 ' D' ' 89' ' ' LEU . 3.8 mm? -85.79 -41.44 15.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.033 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.87 -36.83 72.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.218 0.533 . . . . 1.0 110.244 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -15.03 62.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.9 -51.85 67.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.234 -0.587 . . . . 1.0 111.073 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 12.6 p90 -72.23 -28.51 63.21 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.057 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.97 -35.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.962 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -59.9 -22.2 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.213 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -48.66 -36.94 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.0 110.367 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.688 -179.696 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.911 0.386 . . . . 1.0 110.693 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.53 -40.36 96.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.493 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.12 -46.23 89.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.175 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.67 -41.35 92.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 9' ' ' GLN . 8.8 tpm_? -64.1 -43.78 94.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.101 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.35 -43.76 85.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.087 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.39 92.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLN . . . . . 0.443 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 67.6 tp60 -64.36 -39.01 93.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.19 -41.19 96.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.91 -35.75 77.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.53 -37.8 85.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.488 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.71 -38.33 90.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.33 -32.66 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.505 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' HB1' ' A' ' 52' ' ' ALA . 49.6 tp -62.53 -38.29 89.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.079 0.466 . . . . 1.0 110.251 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.89 -33.99 74.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.12 -45.76 87.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.844 0.313 . . . . 1.0 111.844 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -63.08 -33.14 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 52' ' ' ALA . 77.3 mt -60.51 -41.94 95.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.567 -0.453 . . . . 1.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.24 -47.92 82.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.626 -0.429 . . . . 1.0 109.854 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.53 -35.62 79.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.016 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.06 84.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.614 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 p -59.56 -47.88 83.81 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -67.51 -44.86 77.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.618 . . . . 1.0 110.47 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.4 mttt -63.64 -41.93 98.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.801 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.57 -51.47 68.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.642 -0.253 . . . . 1.0 111.532 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.4 p -64.68 -42.55 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.176 0.512 . . . . 1.0 109.855 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' N ' HG13 ' A' ' 27' ' ' VAL . 44.8 tp10 -70.57 -34.04 71.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.516 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -56.14 -50.69 70.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.573 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 32' ' ' GLY . 11.4 pt-20 -67.0 -36.55 82.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.019 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -55.19 87.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.352 . . . . 1.0 110.786 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 127.74 -9.09 6.83 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.498 -0.641 . . . . 1.0 111.498 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.18 143.3 26.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 122.676 -0.308 . . . . 1.0 110.175 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.29 119.04 5.13 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.03 1.82 . . . . 1.0 112.179 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 114.02 12.64 10.91 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.066 -0.813 . . . . 1.0 111.066 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -40.47 165.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.328 . . . . 1.0 110.892 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 61' ' ' TYR . . . -146.49 -86.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.064 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -72.44 57.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.41 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 tt -63.4 -18.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 1.0 110.423 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 9.9 m -71.86 146.5 47.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.1 t80 -83.55 -51.58 0.63 Allowed Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.767 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -59.93 -30.25 91.3 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.492 1.461 . . . . 1.0 112.484 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -88.27 -23.16 23.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.625 0.25 . . . . 1.0 111.003 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -63.0 -38.71 92.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 1.0 110.111 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -65.73 -38.63 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.494 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.7 92.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.415 . . . . 1.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -60.29 -38.58 84.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.0 m -56.26 -31.67 63.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 49' ' ' VAL . 46.9 t -82.49 -5.42 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 1.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.474 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 49.5 tt0 -108.76 33.45 4.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.239 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -39.27 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.48 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.59 -25.48 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.47 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 54' ' ' THR . 45.8 p -85.65 -2.13 57.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 53' ' ' THR . 48.5 p 53.27 73.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.118 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.27 -53.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.779 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.07 63.51 4.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.62 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 1.0 110.583 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 60' ' ' ARG . . . 161.95 -87.66 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.514 ' CG ' HH22 ' B' ' 68' ' ' ARG . 10.0 m-20 41.86 -92.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 1.0 110.486 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 mpp_? -115.23 -173.52 2.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.84 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 56.1 p90 -156.08 129.78 4.63 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.355 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.31 169.33 19.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.036 1.824 . . . . 1.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.985 HG22 ' H ' ' A' ' 64' ' ' THR . 6.0 p -81.27 -155.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.28 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 63' ' ' VAL . 1.3 m -113.76 -64.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.063 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' THR . 80.6 tt0 -37.5 -39.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.027 0.442 . . . . 1.0 110.549 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.85 ' O ' ' N ' ' A' ' 68' ' ' ARG . 73.7 mm-40 -135.85 -104.28 0.21 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.524 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -57.17 0.0 OUTLIER Glycine 0 N--CA 1.479 1.516 0 O-C-N 124.563 1.164 . . . . 1.0 114.449 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.85 ' N ' ' O ' ' A' ' 66' ' ' GLU . 58.4 ttm-85 -71.56 -46.94 58.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.113 0.483 . . . . 1.0 109.965 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 66' ' ' GLU . 3.5 tmtp? -60.68 -45.33 94.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.39 -43.43 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.021 -0.672 . . . . 1.0 110.029 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.3 84.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.56 -43.03 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.151 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.5 -35.47 79.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.302 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.17 -48.84 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.137 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.4 ptp -65.07 -37.5 87.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.533 -0.303 . . . . 1.0 110.572 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.45 -42.81 92.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.345 -0.388 . . . . 1.0 110.221 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.69 -31.19 71.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.642 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -77.29 -38.05 30.26 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.57 -43.79 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.583 0.23 . . . . 1.0 110.624 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.83 -36.6 84.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.202 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' ALA . 39.3 t -63.6 -49.71 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.919 0.39 . . . . 1.0 110.631 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.34 -31.04 71.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.252 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.88 -26.65 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.986 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.89 -43.76 95.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.881 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.3 m -62.08 -16.56 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.409 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' VAL . 38.0 m -36.49 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.093 0.473 . . . . 1.0 110.444 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' O ' HG22 ' A' ' 91' ' ' THR . . . -55.72 -57.73 10.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.476 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.96 -32.94 66.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.49 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.495 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -69.31 -36.35 76.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -66.76 -55.74 13.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.985 0.422 . . . . 1.0 111.276 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -51.45 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.97 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.4 m-20 -60.36 -48.1 83.22 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.581 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 24.6 p90 -69.49 -28.05 65.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.386 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.04 -45.7 95.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.925 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.08 -22.25 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -44.19 -23.86 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.881 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.527 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.774 0.321 . . . . 1.0 110.979 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' B' ' 5' ' ' GLU . 6.2 p80 -63.66 -29.94 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.79 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' B' ' 4' ' ' HIS . 50.2 tp10 -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.566 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -64.56 -39.22 93.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.61 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -64.09 -40.23 95.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.04 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.51 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.32 -38.36 87.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.28 -40.13 95.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.573 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.32 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.751 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.21 -35.21 79.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 1.0 110.478 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.08 -36.59 84.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.344 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.9 -37.51 87.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.54 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 ' HA2' ' B' ' 78' ' ' GLY . 48.4 tp -62.52 -40.47 96.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.29 -38.77 92.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.78 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.66 -37.96 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.941 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.68 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.575 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' B' ' 52' ' ' ALA . 95.9 mt -59.96 -41.19 91.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.1 mm-40 -57.85 -49.75 75.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.3 -37.01 77.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.202 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.59 -43.59 65.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.206 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -62.59 -40.18 96.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.719 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.29 -33.03 75.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 29' ' ' ALA . 4.4 mptp? -83.99 -50.75 7.72 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.909 -0.317 . . . . 1.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.45 72.79 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.081 -0.247 . . . . 1.0 111.33 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 3.8 p -62.17 -45.63 98.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.325 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.5 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -74.27 -32.02 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.033 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -58.93 -37.85 77.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.51 -37.85 77.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.359 . . . . 1.0 110.918 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -54.6 95.47 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.097 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.441 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 119.27 -7.71 12.53 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.1 22.32 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 122.836 -0.214 . . . . 1.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.58 147.5 31.92 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.03 1.82 . . . . 1.0 112.528 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.78 20.15 70.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.7 56.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 1.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -35.28 0.46 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.77 HD23 ' O ' ' B' ' 38' ' ' LEU . 2.6 tt -62.85 -30.63 71.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.87 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.6 HD13 ' N ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -34.48 119.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.655 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.6 ' N ' HD13 ' B' ' 39' ' ' ILE . 31.1 t -176.22 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.5 m-85 176.79 -65.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.001 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.1 -38.07 93.1 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.116 1.878 . . . . 1.0 112.228 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.536 ' O ' ' NH2' ' B' ' 60' ' ' ARG . 40.5 p30 -101.88 2.22 37.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.05 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.91 96.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.932 0.396 . . . . 1.0 110.17 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -31.91 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.713 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.556 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.5 OUTLIER -54.74 -49.83 69.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.514 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.504 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.5 OUTLIER -64.02 -39.56 94.38 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.267 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.504 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.4 p -59.45 -35.72 74.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.203 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -48.26 89.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.557 ' CG ' HH22 ' C' ' 68' ' ' ARG . 14.5 pt-20 -68.9 -30.76 69.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.699 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -62.19 -45.64 92.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.151 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.648 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -60.69 -27.99 68.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 1.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 47.0 p -86.81 3.8 43.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.68 0.276 . . . . 1.0 110.807 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 50.37 74.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 1.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.501 HG11 ' CE1' ' B' ' 57' ' ' TYR . 57.6 t -142.11 -57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.54 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.52 82.28 0.04 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.501 ' CE1' HG11 ' B' ' 55' ' ' VAL . 57.7 m-85 -61.94 -41.83 98.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.709 0.29 . . . . 1.0 110.967 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.62 9.52 1.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -60.62 -49.18 78.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 1.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.536 ' NH2' ' O ' ' B' ' 43' ' ' ASP . 0.9 OUTLIER -145.09 145.33 31.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.112 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 47.5 p90 -133.68 126.78 19.18 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.63 156.44 63.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.735 1.623 . . . . 1.0 112.282 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.455 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -83.26 -138.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.033 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.455 ' H ' HG12 ' B' ' 63' ' ' VAL . 53.9 m -114.27 -39.88 3.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.996 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.1 tt0 -65.8 -22.9 66.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.904 0.383 . . . . 1.0 110.588 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -75.35 28.2 0.1 Allowed 'General case' 0 C--O 1.268 2.031 0 CA-C-O 123.513 1.625 . . . . 1.0 109.714 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.19 64.86 1.21 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-N 113.768 -1.56 . . . . 1.0 111.556 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.514 HH22 ' CG ' ' A' ' 59' ' ' ASP . 62.9 ttm-85 -23.41 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.186 0.993 . . . . 1.0 110.866 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -45.8 -21.64 0.14 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 67' ' ' GLY . 64.7 t -63.43 -44.78 99.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.473 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -77.52 -38.43 48.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.281 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.61 -41.75 91.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.79 -44.23 93.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.956 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.0 -45.58 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.245 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.5 mtm -63.02 -43.14 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.725 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -65.35 -38.21 89.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.42 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -58.79 -43.51 90.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.693 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.1 -42.21 94.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -43.48 97.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.851 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.6 -43.02 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 1.0 110.62 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 77' ' ' ALA . 66.3 t -63.98 -47.36 90.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.283 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -74.34 0.92 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.834 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -103.47 -34.82 8.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.179 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.8 tt -64.24 -39.49 94.07 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.791 -0.363 . . . . 1.0 110.053 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.39 -13.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.304 -0.407 . . . . 1.0 109.977 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.48 ' O ' ' N ' ' B' ' 89' ' ' LEU . 55.2 m -49.33 -43.19 43.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.07 -17.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.79 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' B' ' 86' ' ' THR . . . -104.13 -19.6 14.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.742 0.306 . . . . 1.0 110.744 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 2.6 mm? -95.31 -46.09 6.88 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.919 0.39 . . . . 1.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.515 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.56 -28.08 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.277 0.56 . . . . 1.0 110.051 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -79.97 -4.15 51.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.68 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 88.5 m-20 -59.96 -49.77 76.37 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.172 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.4 p90 -70.08 -27.5 64.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.003 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.67 -44.8 99.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.315 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -64.51 -20.2 66.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttp85 -48.72 -40.26 27.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.076 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 3' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 6' ' ' ARG . 98.5 m-20 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.737 0.304 . . . . 1.0 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -40.88 -34.84 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.784 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.55 -37.95 86.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 6' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' C' ' 3' ' ' ASP . 83.6 mtp180 -63.79 -36.53 84.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -62.19 -40.32 95.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.43 -41.17 96.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.5 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.32 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.383 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.12 -36.44 83.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.391 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.85 77.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.199 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.722 0.296 . . . . 1.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.45 -35.76 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 1.0 110.563 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -63.88 -32.84 74.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.6 tp -62.75 -40.61 97.79 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.435 ' O ' ' CG ' ' C' ' 20' ' ' GLU . 88.8 mt-30 -70.6 -25.68 63.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.924 -0.311 . . . . 1.0 111.527 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.44 -44.63 18.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 18' ' ' VAL . . . . . 0.483 HG23 ' N ' ' C' ' 19' ' ' LEU . 25.9 m -61.65 -47.11 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 18' ' ' VAL . 2.8 pp -75.25 -26.27 58.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.865 0.364 . . . . 1.0 110.526 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' C' ' 16' ' ' GLN . 3.7 mm-40 -60.35 -48.33 82.19 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.666 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -65.84 -40.35 91.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.833 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -64.86 -33.63 76.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.453 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 23' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 22.3 m -56.65 -47.84 78.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.781 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.5 -39.8 92.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.561 -0.455 . . . . 1.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.7 mttt -73.55 -25.15 60.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -61.57 -45.11 95.55 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.071 -0.251 . . . . 1.0 110.684 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 42.7 t -64.82 -46.33 92.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.193 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.63 -33.65 71.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.54 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -56.68 -53.63 55.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.954 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.9 pp20? -71.2 -36.56 71.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 16.6 tpt180 -57.41 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 120.733 0.302 . . . . 1.0 110.765 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.07 -14.8 6.23 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.26 157.11 34.63 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.13 147.66 33.77 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.028 1.819 . . . . 1.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 26.37 48.92 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.14 143.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 1.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.73 -7.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.543 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -120.1 134.38 55.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.298 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 29.8 pt -153.96 -162.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.045 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.494 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 1.0 OUTLIER 59.06 126.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.09 0.471 . . . . 1.0 110.971 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 42.0 m-85 -71.56 -43.44 11.86 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.088 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.8 Cg_endo -59.34 -42.05 52.9 Favored 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 121.554 1.503 . . . . 1.0 112.959 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' C' ' 40' ' ' SER . 28.3 p-10 -84.29 -5.87 59.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.192 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.07 99.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 1.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.479 HG23 ' HE3' ' C' ' 46' ' ' TRP . 8.4 tt -65.45 -35.97 76.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.563 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.479 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.4 OUTLIER -56.51 -36.75 69.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.533 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.419 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.5 OUTLIER -84.82 -28.76 25.88 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.75 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.491 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 1.5 m -68.77 -40.09 79.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.685 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' C' ' 50' ' ' GLU . 3.9 p -60.83 -44.85 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.585 -0.28 . . . . 1.0 111.552 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' D' ' 68' ' ' ARG . 15.8 pt-20 -69.76 -33.86 73.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.823 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 70.3 m -62.57 -47.86 82.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.414 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -63.0 -23.94 67.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.752 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 59.0 p -95.07 3.28 55.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.835 0.35 . . . . 1.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' C' ' 54' ' ' THR . 17.5 p 53.79 73.66 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.63 -70.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.134 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.73 -58.3 3.44 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 70.76 -48.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.717 0.294 . . . . 1.0 110.976 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 145.24 -9.72 1.74 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 60.8 m-20 -42.93 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 1.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 81.1 mtm-85 -124.42 154.97 39.64 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.841 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 44.2 p90 -131.24 136.15 28.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.611 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.08 155.3 68.59 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.072 1.848 . . . . 1.0 112.241 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.62 -161.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.149 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.556 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 17.1 p -111.21 -66.23 1.1 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.195 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' C' ' 64' ' ' THR . 83.1 tt0 -37.81 -44.55 0.76 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.859 0.361 . . . . 1.0 110.559 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.89 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.6 mm-40 -121.52 -98.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.32 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.619 1.199 . . . . 1.0 114.438 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.89 ' N ' ' O ' ' C' ' 66' ' ' GLU . 47.7 ttm-85 -67.02 -67.08 0.48 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.892 -0.654 . . . . 1.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' C' ' 68' ' ' ARG . 1.9 mptm? -41.42 -39.42 1.48 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.72 -49.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 119.804 -0.759 . . . . 1.0 111.212 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.38 -50.7 64.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.985 0.422 . . . . 1.0 110.534 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 68' ' ' ARG . 84.2 tt0 -44.39 -44.39 8.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.601 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.69 -41.08 97.1 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.238 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.19 -42.66 94.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.6 mtt -59.1 -42.81 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.83 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -63.25 -41.99 99.13 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.645 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.59 88.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.9 -43.3 96.22 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.104 -0.569 . . . . 1.0 112.1 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.25 -42.68 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.646 0.26 . . . . 1.0 110.81 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.2 -38.91 84.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.423 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.98 -49.77 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.273 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.43 -41.02 93.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.075 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.54 -32.52 74.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 1.0 110.652 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.9 -42.13 98.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.366 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' C' ' 8' ' ' ALA . 24.6 t -58.93 -18.17 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.221 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 90' ' ' ALA . 85.9 m -43.13 -40.46 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 1.0 110.377 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' B' ' 92' ' ' ASP . . . -47.8 -63.48 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.8 -34.58 28.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 1.0 110.317 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.0 mm? -77.28 -33.42 55.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.11 -36.09 82.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.107 0.479 . . . . 1.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -4.47 37.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.142 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 86.9 m-20 -56.06 -51.55 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.049 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 19.4 p90 -68.97 -30.03 68.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.82 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.27 -42.22 89.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.443 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -57.28 -23.44 48.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.355 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -43.53 -33.53 1.15 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.856 0.36 . . . . 1.0 110.63 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.577 -179.777 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' D' ' 3' ' ' ASP . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.652 0.263 . . . . 1.0 110.75 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 3' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' D' ' 2' ' ' ALA . 7.0 t70 80.74 -59.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -78.39 -20.4 51.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.844 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.26 -37.98 84.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.419 . . . . 1.0 110.677 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.2 -38.41 90.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.494 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.86 -40.9 95.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.404 . . . . 1.0 109.912 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.55 96.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.749 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -67.2 -39.1 86.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.531 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -62.94 -38.21 90.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.424 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.91 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.073 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.66 -37.97 88.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 1.0 110.678 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.81 -33.97 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -65.31 -35.97 82.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.628 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.27 -41.57 98.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.372 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.69 -40.62 95.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.018 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.32 -37.4 87.12 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.997 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.87 -39.55 85.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.558 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -59.24 -40.9 87.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 1.0 109.846 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.1 mt-10 -60.85 -51.01 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 1.0 110.037 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.85 -32.32 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 109.949 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.69 95.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.1 p -58.69 -41.31 85.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.614 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.98 -32.82 74.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 44.5 mmtm -80.18 -39.3 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.333 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.5 80.07 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.886 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.578 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.1 p -62.65 -46.87 95.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.578 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.7 tm-20 -68.17 -42.75 79.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' D' ' 25' ' ' LYS . . . -86.47 71.46 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.815 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 3.1 mm-40 -157.36 -58.39 0.08 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.857 0.361 . . . . 1.0 110.337 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -79.93 124.08 28.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.152 0.501 . . . . 1.0 110.56 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.81 6.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.792 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -104.76 151.76 39.39 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.717 -0.284 . . . . 1.0 110.613 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.471 ' O ' HG11 ' D' ' 63' ' ' VAL . 72.9 Cg_endo -75.12 117.75 4.99 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.592 1.528 . . . . 1.0 112.143 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.18 29.87 8.67 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.04 140.83 52.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 1.0 110.606 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.73 -69.94 0.83 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.89 129.41 40.83 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.902 -0.406 . . . . 1.0 109.902 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -150.41 30.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.542 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 44' ' ' ALA . 1.6 p -134.25 137.61 44.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.517 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 22.5 t80 -76.17 -48.17 3.42 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.868 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.9 Cg_endo -58.9 -30.25 92.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.353 1.369 . . . . 1.0 112.096 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.77 -17.43 23.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.191 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 44' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -62.84 -38.6 91.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.34 . . . . 1.0 110.885 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.474 HG23 ' N ' ' D' ' 46' ' ' TRP . 10.2 tt -65.02 -40.58 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.502 ' CD1' HG23 ' A' ' 64' ' ' THR . 3.7 t-105 -60.42 -46.96 88.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.143 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -60.92 -33.63 73.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -66.23 -32.76 74.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.147 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.72 -48.22 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.57 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 16.1 pt-20 -69.57 -31.11 69.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.078 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -61.14 -46.55 90.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.44 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.27 -34.96 72.89 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.419 ' C ' ' H ' ' D' ' 55' ' ' VAL . 63.0 p -75.58 0.94 15.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.379 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 36.1 p 53.12 9.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.964 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.437 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.0 p -64.65 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 1.0 110.604 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.437 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 43.72 55.54 5.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -47.14 87.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 1.0 110.326 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 160.39 -103.32 0.22 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.18 -75.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.713 0.292 . . . . 1.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' D' ' 58' ' ' GLY . 69.5 mtt-85 -141.41 179.74 6.62 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.03 144.32 0.99 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.293 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.59 164.07 36.67 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.429 2.086 . . . . 1.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.471 HG11 ' O ' ' D' ' 34' ' ' PRO . 3.0 t -94.45 -128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.258 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.453 ' H ' HG12 ' D' ' 63' ' ' VAL . 55.4 m -113.96 -55.19 2.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.745 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.2 tt0 -61.68 -18.02 57.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.151 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 37.4 mm-40 -78.83 35.6 0.25 Allowed 'General case' 0 C--O 1.269 2.108 0 CA-C-O 124.025 1.869 . . . . 1.0 108.791 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 36.74 58.68 1.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.014 -1.903 . . . . 1.0 109.477 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' C' ' 50' ' ' GLU . 48.6 ttt85 -26.47 -29.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.365 0.685 . . . . 1.0 111.245 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -56.18 -12.21 1.45 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.069 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' D' ' 67' ' ' GLY . 42.6 t -62.09 -46.36 96.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 C-N-CA 119.414 -0.915 . . . . 1.0 109.745 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.26 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.183 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.02 -42.55 80.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.081 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.42 -42.94 95.78 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.758 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.24 -47.69 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.769 -0.373 . . . . 1.0 111.204 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -63.23 -41.19 99.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.101 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 76' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 79.1 tttt -61.65 -40.69 95.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.594 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.74 94.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.837 0.351 . . . . 1.0 110.476 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.94 -40.92 93.56 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.68 -43.79 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 2.6 mp0 -65.52 -43.05 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.75 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.58 -47.23 93.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.89 -0.324 . . . . 1.0 111.116 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -75.29 -8.35 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.836 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -30.33 11.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.747 0.308 . . . . 1.0 110.175 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.0 tt -64.31 -37.32 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.14 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -48.45 -9.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.523 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.4 m -49.38 -41.74 40.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.169 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.478 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -50.52 -19.3 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.529 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.68 -11.78 16.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.811 0.339 . . . . 1.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.0 -45.53 6.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.478 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.434 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.0 -16.27 12.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.111 0.482 . . . . 1.0 110.512 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.809 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.3 OUTLIER -96.06 0.33 51.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 86.7 m-20 -72.2 -27.77 62.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.555 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 5.5 p90 -79.88 -43.74 21.69 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.809 HG22 ' O ' ' D' ' 91' ' ' THR . 21.0 m -41.11 -33.39 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.004 -0.543 . . . . 1.0 111.553 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ARG . . . . . 0.662 HH11 ' CG2' ' D' ' 94' ' ' VAL . 11.3 mpt_? -50.9 -22.53 2.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 96' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' D' ' 97' ' ' GLU . 53.5 ptt85 -54.71 -21.69 11.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 97' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' D' ' 96' ' ' ARG . 6.1 mp0 . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.826 0.346 . . . . 1.0 110.586 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 67.3 t0 -131.78 45.75 2.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.496 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.609 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 10.5 p80 -154.87 -42.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.609 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 15.1 pt-20 -65.71 -38.94 90.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -64.86 -37.79 88.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.277 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -65.77 -38.87 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.72 88.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.176 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -64.28 -41.48 96.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.338 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.07 -36.7 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.57 78.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.47 -40.44 91.28 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.14 -35.07 79.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.274 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.37 -34.55 78.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.561 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 52' ' ' ALA . 43.8 tp -62.41 -39.82 94.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.07 -34.78 75.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.233 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -63.94 -46.28 85.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.29 -36.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 1.0 110.696 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 52' ' ' ALA . 79.9 mt -61.13 -41.64 97.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 1.0 109.973 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.2 mt-10 -63.78 -42.67 97.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -39.43 79.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.31 -39.76 81.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.9 p -51.42 -41.81 61.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -62.67 -47.43 83.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.057 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.33 -42.41 91.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.695 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.12 92.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.802 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 41' ' ' TYR . 99.1 t -64.35 -47.02 91.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.456 -0.497 . . . . 1.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.91 -41.49 87.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.172 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -73.49 62.16 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.744 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -173.91 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -62.13 83.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.982 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.86 5.55 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.92 133.48 22.25 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.69 131.55 13.62 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.908 1.739 . . . . 1.0 112.778 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.14 35.91 86.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.45 129.18 54.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.887 0.375 . . . . 1.0 110.953 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.37 -166.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.215 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 47' ' ' TRP . 4.1 tt 59.35 88.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.969 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.3 tt -136.19 160.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.93 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 1.5 p 79.31 137.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 1.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -64.92 -46.79 75.06 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.235 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.9 Cg_endo -60.32 -31.6 93.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.46 1.44 . . . . 1.0 112.664 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -94.2 -31.07 14.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.672 0.272 . . . . 1.0 110.704 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.92 84.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.329 . . . . 1.0 110.683 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 46' ' ' TRP . 3.5 tt -63.83 -39.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.984 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CE2' ' O ' ' B' ' 64' ' ' THR . 4.8 t-105 -59.31 -46.13 89.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.586 ' CD2' HD11 ' A' ' 38' ' ' LEU . 2.4 t90 -59.93 -39.48 85.67 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.5 t -67.71 65.39 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.676 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 47' ' ' TRP . 75.9 t -154.39 -57.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 1.0 110.23 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' CG ' HH12 ' B' ' 68' ' ' ARG . 12.3 pt-20 -66.42 -31.69 72.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -61.83 -42.93 99.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.108 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.01 -36.79 80.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.088 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 p -80.7 16.76 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 32.14 69.25 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.597 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.42 -38.28 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.64 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.12 73.3 0.36 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.661 -0.975 . . . . 1.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 15.4 t80 -60.12 -47.18 86.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 1.0 110.507 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.6 25.76 0.44 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.032 -0.827 . . . . 1.0 111.032 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 32.6 p-10 -63.49 -41.17 98.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.317 . . . . 1.0 110.421 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.514 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 94.2 mtt-85 -151.36 -161.09 1.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.335 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 8.8 p90 -169.88 100.6 0.46 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.525 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.05 165.86 29.88 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.403 1.402 . . . . 1.0 112.399 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 64' ' ' THR . 7.8 p -100.25 -159.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 110.05 -0.352 . . . . 1.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.994 ' H ' HG22 ' A' ' 63' ' ' VAL . 51.0 m -91.98 -43.9 9.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.586 0.231 . . . . 1.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' OE2' ' N ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.75 25.1 0.07 Allowed 'General case' 0 C--O 1.265 1.899 0 CA-C-O 124.116 1.913 . . . . 1.0 109.503 178.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.717 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 46.33 67.46 1.36 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.622 -1.627 . . . . 1.0 111.723 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.535 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 59.5 ttm-85 -24.15 -32.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.404 1.102 . . . . 1.0 111.158 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.717 ' N ' ' O ' ' A' ' 67' ' ' GLY . 32.3 mmtp -48.52 -31.09 5.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.55 176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 67' ' ' GLY . 53.9 t -62.83 -49.54 83.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.28 74.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.638 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.85 -35.61 81.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -54.96 -42.85 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.683 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG11 HG23 ' A' ' 51' ' ' THR . 73.5 t -65.12 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.374 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 mmt -52.32 -56.76 12.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.378 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -36.87 85.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 1.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.53 -22.06 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.63 -28.45 8.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 36.8 mm -63.01 -43.84 99.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 121.144 -0.222 . . . . 1.0 110.484 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.07 -36.58 84.78 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.275 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.07 -72.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.145 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -51.99 -11.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.162 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -88.54 -43.8 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.788 0.328 . . . . 1.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.3 tt -63.03 -41.73 99.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.604 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 m -51.8 -8.41 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 84' ' ' LEU . 97.6 m -61.99 -25.8 67.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.275 -0.421 . . . . 1.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -57.38 -24.76 57.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.43 -11.32 24.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.859 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -90.78 -45.24 8.94 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.794 0.331 . . . . 1.0 111.416 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.06 -27.01 51.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.932 0.396 . . . . 1.0 110.987 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -4.63 58.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.55 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 87.8 m-20 -62.13 -45.02 95.33 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 7.3 p90 -76.58 -27.97 56.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.508 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.85 -40.27 82.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.296 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.82 -23.51 44.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.144 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -41.88 -40.39 2.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.797 0.332 . . . . 1.0 110.853 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.918 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.694 0.283 . . . . 1.0 110.94 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -78.83 -31.39 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.636 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -41.62 90.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -64.34 -40.16 95.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.762 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -65.28 -44.08 89.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.954 0.407 . . . . 1.0 109.921 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.42 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.719 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.76 -40.16 87.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.332 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.02 -39.6 92.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -57.66 -34.19 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.638 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' B' ' 16' ' ' GLN . 96.6 mt-10 -78.15 -37.81 45.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.59 -45.91 84.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 1.0 110.791 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.94 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.36 -39.99 92.66 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.036 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' B' ' 12' ' ' GLU . 8.4 mp0 -69.93 -28.05 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -62.96 -46.22 88.76 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.43 ' H ' HG22 ' B' ' 18' ' ' VAL . 14.8 m -66.3 -31.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.118 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.9 mt -60.43 -41.15 93.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.62 -48.14 83.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.11 -34.47 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.151 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -46.2 86.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.251 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 23' ' ' SER . . . . . 0.555 ' O ' HG23 ' B' ' 27' ' ' VAL . 66.7 p -59.81 -46.62 88.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.928 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -61.49 -53.53 55.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.412 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.3 mttm -59.13 -43.9 92.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.008 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.419 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -59.77 -38.19 81.15 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.958 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 23' ' ' SER . 69.1 t -66.68 -44.43 89.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.712 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -83.5 -9.95 58.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.622 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.77 -39.0 90.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 32' ' ' GLY . 9.6 mp0 -68.93 -37.53 78.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 1.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.54 83.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.078 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 127.51 -14.1 6.49 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 111.397 -0.681 . . . . 1.0 111.397 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.81 143.8 27.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 O-C-N 122.795 -0.238 . . . . 1.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.78 157.11 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.054 1.836 . . . . 1.0 112.428 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.98 37.19 64.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.76 21.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.848 0.356 . . . . 1.0 110.566 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.49 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.582 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.566 ' O ' HD13 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -63.37 -30.14 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.646 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.615 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -38.5 108.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.094 0.473 . . . . 1.0 110.757 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.3 p 163.22 102.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.97 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -56.43 -47.39 99.01 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.848 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.6 Cg_endo -57.49 -36.86 98.65 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.384 1.389 . . . . 1.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' CZ ' ' B' ' 60' ' ' ARG . 46.7 p30 -100.38 -0.76 37.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.696 0.284 . . . . 1.0 110.984 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.94 89.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.947 0.403 . . . . 1.0 110.525 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 49' ' ' VAL . 7.3 tt -68.82 -40.99 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.694 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.438 ' NE1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -61.54 -45.5 93.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.408 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.513 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 9.9 t90 -63.59 -42.68 98.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.421 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' B' ' 19' ' ' LEU . 31.3 p -65.6 -25.96 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.041 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 45' ' ' ILE . 20.4 t -71.77 -25.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -98.37 -9.47 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.996 -0.282 . . . . 1.0 111.178 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -36.18 20.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 1.0 111.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -69.1 -22.84 63.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.475 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 67.3 p -83.87 0.2 48.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.661 0.267 . . . . 1.0 110.712 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 26.1 p 51.12 60.3 3.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.516 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' THR . 48.1 t -133.11 -48.13 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.519 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.35 76.44 0.18 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -60.04 -47.78 84.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.808 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.74 24.93 0.58 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 67.9 t0 -62.29 -49.14 76.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.352 . . . . 1.0 110.768 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.512 ' CZ ' ' OD2' ' B' ' 43' ' ' ASP . 91.7 mtt-85 -143.83 -164.44 1.88 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.139 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -150.99 118.96 3.42 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.108 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.25 153.35 71.42 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.366 1.378 . . . . 1.0 112.094 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.59 -169.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.5 ' O ' ' CE2' ' A' ' 46' ' ' TRP . 1.2 m -108.61 -62.56 1.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.993 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 64' ' ' THR . 79.9 tt0 -40.16 -28.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 1.0 110.769 -178.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' B' ' 68' ' ' ARG . 94.1 mt-10 -143.87 -101.32 0.12 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.256 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.02 -55.55 0.0 OUTLIER Glycine 0 N--CA 1.479 1.519 0 O-C-N 124.613 1.195 . . . . 1.0 114.223 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.905 ' N ' ' O ' ' B' ' 66' ' ' GLU . 60.4 ttm-85 -66.18 -72.48 0.16 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -42.18 -36.36 1.17 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.66 -46.03 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.809 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -70.93 -45.17 64.7 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.217 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -45.37 -48.63 13.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.064 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -61.75 -44.74 96.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -46.44 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.283 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -61.77 -38.65 88.8 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.97 85.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.325 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.42 -37.05 92.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.96 -43.85 99.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 84' ' ' LEU . 97.8 mt-10 -63.18 -38.8 92.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 1.0 110.456 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' B' ' 11' ' ' ALA . 25.1 t -62.25 -70.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.86 -14.76 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.41 -35.1 11.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.319 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' B' ' 80' ' ' GLU . 5.2 tt -63.53 -40.96 98.38 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.345 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.432 ' C ' ' N ' ' B' ' 87' ' ' ALA . 35.6 m -55.07 -16.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.737 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.4 m -44.45 -24.06 0.16 Allowed 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.159 0.504 . . . . 1.0 109.68 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.33 -45.23 94.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.522 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -12.7 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.673 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.6 mm? -92.49 -25.78 18.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.006 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -67.82 -40.49 83.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.617 . . . . 1.0 109.894 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -16.32 62.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.126 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -43.68 -65.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.138 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' B' ' 94' ' ' VAL . 30.6 p90 -64.16 -47.14 81.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.278 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 66.0 t -37.66 -28.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.713 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ARG . . . . . 0.475 ' C ' ' N ' ' B' ' 97' ' ' GLU . 99.8 mtt180 -63.64 -37.57 87.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.902 -0.319 . . . . 1.0 111.4 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 93' ' ' PHE . 44.1 ptt85 -46.75 -15.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 1.0 110.303 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' B' ' 95' ' ' ARG . 43.6 tp10 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.883 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.798 0.332 . . . . 1.0 110.396 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -68.87 -38.17 79.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.839 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.26 -44.5 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.899 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -65.06 -39.07 92.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.864 0.364 . . . . 1.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -64.19 -41.01 97.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.15 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.39 -42.03 93.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.273 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -63.61 -38.68 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.521 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.49 71.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.66 -39.59 94.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.32 . . . . 1.0 111.009 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -63.41 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.292 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.49 -34.37 78.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.677 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.1 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.77 -39.64 94.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.244 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -61.52 -38.79 88.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.304 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.69 -42.67 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.683 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' C' ' 52' ' ' ALA . 96.0 mt -60.9 -40.15 92.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.358 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.2 -54.92 37.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 1.0 110.496 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.41 -37.5 83.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.438 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.43 89.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.386 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -65.83 -33.55 76.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.189 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' C' ' 29' ' ' ALA . 53.7 mttp -70.42 -46.61 63.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' C' ' 29' ' ' ALA . . . -55.59 -50.31 70.43 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.246 0.341 . . . . 1.0 111.446 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.494 HG13 ' N ' ' C' ' 28' ' ' GLU . 5.0 p -60.98 -46.77 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.457 -0.497 . . . . 1.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.494 ' N ' HG13 ' C' ' 27' ' ' VAL . 40.7 tp10 -69.32 -28.59 66.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -51.64 -49.84 61.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.762 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -96.78 -99.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 1.0 110.545 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' C' ' 30' ' ' GLU . 30.1 mmm-85 46.71 59.46 3.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.554 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.7 4.81 7.93 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.69 61.14 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.42 120.0 5.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.884 1.723 . . . . 1.0 111.773 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.82 13.61 62.33 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 146.09 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 1.0 110.267 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.8 -30.16 2.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.485 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.19 51.47 2.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 pt -80.0 16.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.751 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.3 t -114.0 126.28 54.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.63 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 8.1 t80 -78.12 -49.95 1.85 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.923 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 27.6 Cg_endo -60.12 -29.23 88.68 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.388 1.392 . . . . 1.0 112.402 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -89.12 -3.82 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.058 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.44 96.16 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.732 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -65.55 -40.84 89.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.494 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.433 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.07 -45.83 90.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.497 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -61.03 -41.35 96.4 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.242 -0.583 . . . . 1.0 109.482 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.422 ' O ' HD22 ' C' ' 19' ' ' LEU . 39.1 p -72.37 64.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -149.09 -51.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.503 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -66.65 -32.72 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.936 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.4 ' H ' HG22 ' C' ' 51' ' ' THR . 0.0 OUTLIER -59.17 -44.05 92.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.969 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.23 -26.46 60.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.753 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -87.31 -3.59 59.04 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.847 0.356 . . . . 1.0 110.145 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.7 p 51.7 48.75 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.082 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.73 -28.29 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.254 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.72 59.77 7.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.518 -1.033 . . . . 1.0 110.518 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -48.1 82.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 1.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.13 38.66 0.63 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' C' ' 59' ' ' ASP . 12.8 p-10 -65.27 -40.54 94.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.92 0.39 . . . . 1.0 110.601 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.464 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 30.2 mmt180 -130.4 -161.01 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.118 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.464 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 56.5 m-85 -158.59 75.54 3.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.626 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.16 156.0 66.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.058 1.839 . . . . 1.0 111.997 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 1.061 HG22 ' H ' ' C' ' 64' ' ' THR . 8.6 p -100.97 -155.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.009 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 64' ' ' THR . . . . . 1.061 ' H ' HG22 ' C' ' 63' ' ' VAL . 34.7 m -89.54 -46.25 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.291 . . . . 1.0 110.638 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' C' ' 67' ' ' GLY . 11.7 tm-20 -44.38 -40.18 5.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' C' ' 68' ' ' ARG . 0.1 OUTLIER -70.17 24.08 0.03 OUTLIER 'General case' 0 C--O 1.266 1.963 0 CA-C-O 123.855 1.788 . . . . 1.0 109.915 178.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.754 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 44.86 66.12 1.56 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 113.984 -1.462 . . . . 1.0 111.615 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.553 ' N ' ' OE2' ' C' ' 66' ' ' GLU . 56.1 ttm-85 -25.4 -28.31 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.17 0.985 . . . . 1.0 111.382 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.8 tppp? -52.04 -26.92 12.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.305 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.1 t -61.75 -47.19 94.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 C-N-CA 119.201 -1.0 . . . . 1.0 110.593 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -39.93 84.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.0 110.634 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.92 -38.28 88.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.721 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.2 -44.46 79.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.256 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.92 -43.76 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.229 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.1 mtt -59.54 -43.56 93.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.953 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.12 -41.34 97.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.64 90.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.834 0.35 . . . . 1.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.42 -41.53 96.39 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.761 -0.536 . . . . 1.0 111.761 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.62 -43.01 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.599 0.238 . . . . 1.0 110.761 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.56 -43.66 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.545 -0.298 . . . . 1.0 111.143 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.38 -49.23 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.136 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.296 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 1.0 110.468 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.4 tt -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.507 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.449 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.6 t -49.32 -12.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 1.0 110.491 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' C' ' 84' ' ' LEU . 85.9 m -60.82 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.268 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.46 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -59.69 -36.31 76.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.057 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 -38.3 21.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.43 -38.65 87.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.083 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -59.23 -35.45 73.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.021 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -83.0 -4.3 58.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.522 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 42.4 t0 -58.07 -47.9 81.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.672 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 8.4 p90 -66.87 -39.0 87.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.525 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 95.9 t -43.84 -36.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.511 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.21 -23.12 65.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.647 0.261 . . . . 1.0 111.179 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -57.09 -42.6 81.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.368 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.882 0.373 . . . . 1.0 110.539 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.9 -42.94 99.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.9 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.9 p-80 -73.36 -32.62 64.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.535 -0.302 . . . . 1.0 110.793 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.24 -37.42 87.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 1.0 110.551 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.26 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.47 -36.75 83.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.491 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.06 -37.72 86.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.04 79.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.021 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.24 -36.02 82.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 1.0 110.668 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.29 -38.45 91.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.665 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.36 -33.23 75.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.627 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' D' ' 52' ' ' ALA . 40.9 tp -62.01 -42.01 98.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 1.0 110.441 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.01 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.965 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -62.25 -42.99 99.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.96 0.41 . . . . 1.0 111.063 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' D' ' 22' ' ' ALA . 96.9 t -63.83 -35.56 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.689 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.9 mt -61.6 -41.81 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.679 -0.409 . . . . 1.0 109.922 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.81 -50.46 62.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.543 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.29 -39.8 86.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.379 . . . . 1.0 110.422 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' D' ' 18' ' ' VAL . . . -65.07 -37.51 87.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -57.38 -45.74 84.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.74 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -67.93 -35.33 78.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.578 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.75 -46.31 69.17 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.893 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -55.66 -51.83 65.92 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.891 -0.323 . . . . 1.0 111.204 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.506 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.5 p -62.62 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.264 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.506 ' N ' HG13 ' D' ' 27' ' ' VAL . 82.6 tt0 -64.55 -39.4 93.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.681 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 1.1 mp0 -68.31 -41.24 81.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.477 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.49 107.75 0.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.009 0.433 . . . . 1.0 110.37 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.61 -13.99 24.96 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.16 144.94 29.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.532 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.4 Cg_endo -74.79 143.63 30.05 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.157 1.905 . . . . 1.0 112.328 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 26.58 70.54 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.41 144.23 57.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 1.0 110.649 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -16.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.554 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 30.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.952 0.406 . . . . 1.0 110.08 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' D' ' 40' ' ' SER . 42.2 pt -77.34 -158.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.445 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.1 t 80.53 -137.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.606 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' D' ' 40' ' ' SER . 5.7 m-85 -168.44 -59.88 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 19.6 Cg_endo -58.55 -32.04 95.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.65 1.566 . . . . 1.0 111.95 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' D' ' 44' ' ' ALA . 18.2 p30 -87.75 -22.69 24.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.326 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' D' ' 43' ' ' ASP . . . -64.04 -41.51 97.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.349 . . . . 1.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.65 -41.83 85.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.213 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.477 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.1 OUTLIER -60.88 -36.89 80.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.114 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -62.53 -39.64 94.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.646 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.426 ' O ' HD22 ' D' ' 19' ' ' LEU . 83.3 p -65.93 -29.47 69.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.773 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.92 -48.61 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.99 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.93 69.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' D' ' 52' ' ' ALA . 28.6 m -90.65 89.09 7.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 1.0 109.838 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' D' ' 51' ' ' THR . . . 169.44 -23.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.37 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 4.2 p -110.64 29.98 7.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.981 0.419 . . . . 1.0 110.482 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 32.8 p 52.51 70.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -124.12 -66.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.717 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.01 53.13 31.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -48.76 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.321 . . . . 1.0 110.518 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.7 29.72 1.03 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.02 -43.33 99.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -140.93 169.03 18.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.917 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -141.09 111.55 6.62 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.712 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.75 156.2 63.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.747 1.632 . . . . 1.0 112.491 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.532 HG11 ' O ' ' D' ' 34' ' ' PRO . 1.8 t -80.06 -142.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.106 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.532 ' H ' HG12 ' D' ' 63' ' ' VAL . 26.5 m -113.34 -48.1 2.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.751 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' D' ' 67' ' ' GLY . 49.9 tp10 -58.62 -20.77 50.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.095 0.474 . . . . 1.0 109.9 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' D' ' 63' ' ' VAL . 0.6 OUTLIER -75.74 27.52 0.11 Allowed 'General case' 0 C--O 1.265 1.873 0 CA-C-O 123.543 1.64 . . . . 1.0 109.13 178.336 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.44 61.62 2.41 Favored Glycine 0 C--O 1.211 -1.287 0 CA-C-N 114.066 -1.425 . . . . 1.0 109.989 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 61.0 ttm-85 -25.18 -29.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.486 0.643 . . . . 1.0 111.42 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 72.5 mmtt -56.86 -14.27 3.32 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.659 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.2 t -62.31 -47.32 93.64 Favored 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.55 85.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.29 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.44 -37.77 81.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.141 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.49 -44.05 95.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.647 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.416 ' H ' HG23 ' D' ' 74' ' ' VAL . 3.5 t -64.75 -46.57 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.276 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.14 -40.49 94.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.238 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.67 -43.25 99.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.794 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.449 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.63 -39.06 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.537 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.37 -42.85 97.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.641 -0.583 . . . . 1.0 111.641 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.43 -43.4 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.616 0.246 . . . . 1.0 111.237 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.63 -40.96 98.2 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.39 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 77' ' ' ALA . 64.2 t -62.09 -48.07 90.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.294 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.35 -5.09 43.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.659 -0.416 . . . . 1.0 110.952 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.76 -37.01 10.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.739 0.304 . . . . 1.0 110.407 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.6 tt -62.7 -41.79 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.424 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.36 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' LEU . 57.7 m -56.88 -20.82 25.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.244 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.23 -36.73 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.347 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.4 -28.65 28.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.139 0.495 . . . . 1.0 110.062 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.78 -37.76 79.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.784 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE1' ' D' ' 93' ' ' PHE . . . -58.29 -44.68 88.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.259 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -5.79 49.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.209 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.1 t0 -58.79 -49.73 76.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.895 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -75.23 -28.86 60.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.825 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.47 -44.29 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.265 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -45.13 -28.36 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.99 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -48.79 -30.9 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 1.0 110.502 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.908 -179.322 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.866 0.365 . . . . 1.0 110.494 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -172.14 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.507 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 7.6 p80 -78.12 -24.25 47.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.495 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.9 -35.84 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.42 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.99 -38.91 92.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.085 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.42 -44.1 88.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.011 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.407 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -66.76 -39.15 87.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -65.46 -41.21 93.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 53.8 tttp -63.93 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.42 -36.04 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.894 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.45 -32.7 72.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -65.22 -37.81 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.424 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 6.6 mp0 -60.91 -42.54 98.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 52' ' ' ALA . 48.5 tp -63.26 -42.39 99.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.737 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.37 -42.12 81.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.568 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -63.71 -40.02 95.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 1.0 111.381 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.4 -36.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.2 mt -60.03 -41.16 91.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.34 -47.25 86.1 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.59 -33.2 72.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.158 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -45.7 85.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . 77.7 p -60.06 -42.4 94.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -62.57 -60.51 3.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.66 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.16 -43.72 98.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.938 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 30' ' ' GLU . . . -61.15 -40.31 93.38 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.98 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' SER . 55.0 t -63.88 -48.36 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.454 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -72.44 -23.8 61.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.523 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.504 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -49.82 -49.18 49.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.316 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 30.2 mp0 -68.65 -35.83 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -67.54 88.19 0.22 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.893 0.377 . . . . 1.0 110.962 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.65 6.25 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.63 -0.588 . . . . 1.0 111.63 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 154.05 39.49 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.85 150.61 39.16 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.253 1.969 . . . . 1.0 112.205 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 32.53 63.06 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.23 14.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 1.0 110.611 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.75 -65.09 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.628 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 51.0 tp -66.34 78.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.077 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 39' ' ' ILE . 15.8 tt -121.04 79.56 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 1.0 110.107 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 44' ' ' ALA . 18.1 m -172.02 103.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.836 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 46.5 t80 -54.87 -50.11 87.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.882 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -60.03 -34.82 94.56 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.417 1.411 . . . . 1.0 112.729 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 60.8 m-20 -92.92 -22.72 19.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.68 -0.236 . . . . 1.0 111.146 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.78 82.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 1.0 110.391 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.424 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.2 tt -60.72 -36.09 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.115 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.479 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -63.07 -46.78 85.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 2.1 t90 -62.54 -41.22 98.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.43 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 96.9 p -60.23 -35.8 76.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.074 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 45' ' ' ILE . 43.6 t -60.47 -49.36 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.943 0.401 . . . . 1.0 110.733 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 19.3 pt-20 -75.64 -23.73 56.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.51 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 95.2 m -62.49 -45.88 91.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.099 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.06 -36.59 75.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 55' ' ' VAL . 76.5 p -73.92 -0.94 17.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.1 p 53.33 5.34 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 53' ' ' THR . 7.7 p -66.4 -41.98 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.04 81.08 0.02 OUTLIER Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.41 ' OH ' ' O ' ' B' ' 60' ' ' ARG . 40.7 t80 -60.27 -45.51 93.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.855 0.359 . . . . 1.0 110.593 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.83 16.89 0.96 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.61 -46.18 90.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.944 0.402 . . . . 1.0 110.382 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -141.71 149.77 40.96 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.898 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -118.56 120.89 31.4 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.621 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 154.93 67.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.84 1.693 . . . . 1.0 112.57 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 63' ' ' VAL . 4.5 m -60.82 -168.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.154 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.537 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 1.5 m -110.29 -62.21 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.101 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -41.63 -31.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.062 0.458 . . . . 1.0 110.425 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.875 ' O ' ' N ' ' A' ' 68' ' ' ARG . 97.2 mt-10 -138.48 -105.83 0.18 Allowed 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.317 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 20.67 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.478 1.435 0 O-C-N 124.476 1.11 . . . . 1.0 114.438 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.875 ' N ' ' O ' ' A' ' 66' ' ' GLU . 33.7 ttm180 -70.78 -45.44 64.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' GLU . 27.8 tptp -62.39 -40.93 98.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.28 -45.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.82 81.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -49.2 -50.41 38.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.53 -40.63 95.96 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.05 -45.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.222 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.96 -39.67 95.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -60.25 -42.14 94.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.52 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.6 -40.29 94.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.483 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 -41.53 93.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.55 -43.78 98.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 1.0 110.274 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 84' ' ' LEU . 97.2 mt-10 -65.28 -44.7 87.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.581 -0.447 . . . . 1.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 77' ' ' ALA . 53.4 t -63.62 -47.72 90.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -68.33 -28.95 67.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.981 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -25.46 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.281 . . . . 1.0 110.888 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 80' ' ' GLU . 4.7 tt -63.65 -42.01 98.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.568 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.4 m -49.16 -22.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.253 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.671 ' HA ' HD22 ' A' ' 89' ' ' LEU . 54.0 m -36.55 -24.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.216 0.531 . . . . 1.0 110.566 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -59.57 -41.74 90.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.789 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -78.55 -21.05 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 1.0 110.969 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 86' ' ' THR . 6.7 mp -66.32 -38.54 87.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -67.38 -62.49 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 1.0 111.588 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -46.19 -9.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.321 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' ALA . 83.3 m-20 -58.51 -50.01 75.31 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.831 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 1.9 p90 -69.79 -30.18 67.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.105 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG11 ' NH2' ' D' ' 96' ' ' ARG . 89.6 t -59.5 -42.29 87.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.385 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -53.07 -21.45 4.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.704 0.288 . . . . 1.0 111.057 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -54.61 -32.94 59.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.783 0.325 . . . . 1.0 110.616 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.896 -179.523 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 3' ' ' ASP . 5.5 p-10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.704 0.288 . . . . 1.0 110.951 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -80.57 -32.58 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 1.0 110.501 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -42.87 91.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.009 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -64.95 -39.95 94.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.635 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.84 -40.63 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.973 0.416 . . . . 1.0 110.023 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.72 94.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.659 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -66.25 -37.85 86.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.26 -40.49 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.64 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.76 78.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.912 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.31 -38.84 92.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.415 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.63 -36.4 83.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.257 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -65.68 -33.56 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.07 -42.17 99.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.14 -39.32 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.932 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -61.61 -40.14 93.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 1.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -63.02 -41.82 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.2 mt -60.61 -40.87 93.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -48.57 80.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.72 -39.42 84.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.918 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.76 82.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.315 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -54.77 -46.59 74.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -66.54 -41.93 87.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.352 0.596 . . . . 1.0 110.043 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.52 64.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.941 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.484 HG13 ' N ' ' B' ' 28' ' ' GLU . 11.6 p -69.82 -43.94 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.74 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.484 ' N ' HG13 ' B' ' 27' ' ' VAL . 41.6 tp10 -63.36 -43.87 96.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.736 -0.666 . . . . 1.0 110.775 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.75 81.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.224 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -88.41 -7.69 56.21 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.751 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -83.59 107.44 16.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.377 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.49 -3.02 53.68 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.535 -0.626 . . . . 1.0 111.535 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.58 149.64 46.84 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 110.25 -0.278 . . . . 1.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.51 142.42 26.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.161 1.907 . . . . 1.0 112.369 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.7 22.7 59.92 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.131 -0.787 . . . . 1.0 111.131 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.33 144.38 54.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.706 0.289 . . . . 1.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.54 -41.9 5.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.472 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.499 HD11 ' OD1' ' B' ' 43' ' ' ASP . 40.6 tp -92.02 74.81 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.021 0.439 . . . . 1.0 110.577 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 pt -102.26 2.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.468 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' B' ' 43' ' ' ASP . 78.6 p -75.33 -120.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.664 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.508 ' N ' ' OG ' ' B' ' 40' ' ' SER . 0.5 OUTLIER 171.5 -58.87 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.125 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -57.91 -31.77 93.45 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.869 1.713 . . . . 1.0 112.576 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' B' ' 40' ' ' SER . 3.4 p30 -91.69 0.35 57.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.653 0.263 . . . . 1.0 110.727 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.03 89.61 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.96 0.409 . . . . 1.0 110.233 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.7 -42.02 88.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.949 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.657 ' CD1' HG23 ' C' ' 64' ' ' THR . 6.2 t-105 -60.98 -46.33 91.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.263 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -61.43 -40.43 94.41 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' B' ' 19' ' ' LEU . 23.7 m -71.91 62.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.411 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.0 -50.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.153 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 56' ' ' GLY . 2.8 pp20? -66.99 -31.58 72.23 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.833 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.505 ' O ' ' SD ' ' B' ' 75' ' ' MET . 0.0 OUTLIER -59.22 -45.93 89.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.796 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.76 -27.17 62.81 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 31.9 p -89.33 4.52 48.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.641 0.258 . . . . 1.0 110.855 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 54' ' ' THR . 11.7 p 56.34 76.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.611 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' B' ' 57' ' ' TYR . 59.0 t -147.0 -82.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.693 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.493 ' N ' ' OE1' ' B' ' 50' ' ' GLU . . . 72.94 77.87 0.56 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.532 ' CE1' HG11 ' B' ' 55' ' ' VAL . 78.7 m-85 -60.97 -45.03 96.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 1.0 111.057 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.55 27.62 0.28 Allowed Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' HH22 ' C' ' 68' ' ' ARG . 67.2 t0 -63.9 -48.27 77.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 1.0 110.861 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' CG ' ' B' ' 43' ' ' ASP . 2.2 mpt_? -114.79 -167.41 1.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.133 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 17.5 t80 -164.32 78.84 1.46 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.599 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.56 156.19 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.531 1.487 . . . . 1.0 111.998 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.463 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 31.8 m -103.78 -149.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 46' ' ' TRP . 22.3 m -96.81 -38.85 9.7 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.632 -0.258 . . . . 1.0 110.842 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.0 tm-20 -56.19 -35.41 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.1 OUTLIER -74.19 26.82 0.08 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-O 123.768 1.747 . . . . 1.0 109.844 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.66 65.91 1.09 Allowed Glycine 0 C--O 1.217 -0.949 0 CA-C-N 113.62 -1.627 . . . . 1.0 111.449 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.544 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -24.82 -31.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.061 0.931 . . . . 1.0 110.897 -178.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' B' ' 67' ' ' GLY . 60.5 mttp -45.14 -23.85 0.2 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 67' ' ' GLY . 72.5 t -63.57 -47.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 C-N-CA 119.748 -0.781 . . . . 1.0 109.977 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.09 82.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.17 -39.29 92.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.016 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -47.26 -54.66 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.436 HG11 HG23 ' B' ' 51' ' ' THR . 85.8 t -65.96 -42.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 1.0 111.34 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' B' ' 51' ' ' THR . 5.6 tpp -56.73 -47.97 78.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.493 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.42 -41.07 85.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.537 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.51 74.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.688 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.31 97.81 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.438 -0.665 . . . . 1.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.38 -25.11 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.089 -0.244 . . . . 1.0 111.37 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -72.16 -53.19 13.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 1.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 82' ' ' PHE . 6.9 m -61.66 -47.09 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.355 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.429 ' N ' HG23 ' B' ' 81' ' ' VAL . 14.6 m-85 -63.63 -38.51 91.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.844 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.62 96.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.568 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.463 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.2 tt -63.96 -41.74 97.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 85' ' ' VAL . 63.5 t -51.47 -11.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 70.7 m -60.8 -38.73 86.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -38.91 -62.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.974 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.12 20.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.398 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 86' ' ' THR . 55.7 mt -98.3 -4.11 35.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -93.17 -25.16 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.622 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -84.05 -4.67 58.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.586 -0.733 . . . . 1.0 110.04 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 92' ' ' ASP . 11.6 p-10 -57.43 -47.98 80.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 8.2 p90 -67.51 -30.79 70.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 1.0 111.308 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.99 -44.38 94.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.366 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -65.91 -21.9 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -58.78 -42.98 90.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.109 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.229 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 1.0 110.735 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 33.2 p80 -54.37 -42.6 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.191 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.6 tt0 -64.52 -34.29 77.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.722 0.296 . . . . 1.0 110.633 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -60.78 -45.68 93.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 1.0 109.916 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.57 -42.88 98.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.072 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.09 94.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.429 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -65.0 -42.62 94.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.01 -35.53 81.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.29 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.87 83.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.85 -36.81 85.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.36 -35.24 80.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 1.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -64.77 -36.32 83.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.538 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.42 HD13 ' HA2' ' C' ' 78' ' ' GLY . 42.9 tp -62.42 -40.94 98.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.539 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -59.28 -38.84 81.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -39.69 93.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.804 0.335 . . . . 1.0 111.018 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.19 -33.77 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.3 mt -61.75 -41.83 98.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.45 -46.23 89.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.878 -0.415 . . . . 1.0 109.878 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.51 -39.84 77.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.252 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.96 -36.4 83.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 86.6 p -60.0 -46.16 90.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.68 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 24' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' C' ' 28' ' ' GLU . 14.8 tmtt? -66.41 -37.18 84.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.508 . . . . 1.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' C' ' 29' ' ' ALA . 14.5 mptt -70.26 -40.99 74.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.481 . . . . 1.0 109.927 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.04 66.81 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.102 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' C' ' 28' ' ' GLU . 10.7 p -64.6 -43.15 96.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.07 0.462 . . . . 1.0 109.962 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 28' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' C' ' 24' ' ' LYS . 82.9 tt0 -66.58 -35.14 79.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.319 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -58.01 -26.9 62.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.84 -37.62 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -70.85 101.58 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.745 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 32' ' ' GLY . . . . . 0.444 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 125.96 -22.53 6.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.64 143.93 27.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 97.4 Cg_endo -75.87 138.73 21.34 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.976 1.784 . . . . 1.0 112.391 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 37.07 13.08 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.02 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 1.0 110.64 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -149.32 -39.95 0.15 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 40' ' ' SER . 0.5 OUTLIER -71.45 12.49 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.021 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' C' ' 37' ' ' ALA . 21.3 tt -46.5 -13.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.516 ' N ' ' O ' ' C' ' 38' ' ' LEU . 5.4 m -65.5 146.17 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.316 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.539 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 9.8 m-85 -102.36 -63.66 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.547 ' O ' HG22 ' C' ' 45' ' ' ILE . 24.4 Cg_endo -59.35 -34.89 97.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.884 1.722 . . . . 1.0 112.256 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -83.54 -7.56 59.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.203 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.1 89.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.749 0.309 . . . . 1.0 110.917 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.547 HG22 ' O ' ' C' ' 42' ' ' PRO . 9.9 tt -64.05 -32.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.578 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.493 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.2 OUTLIER -62.81 -46.43 87.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.314 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 14.0 t90 -62.05 -40.0 94.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.354 -0.538 . . . . 1.0 109.775 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -59.17 -36.74 75.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.126 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.23 -48.22 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.418 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.0 pt-20 -72.3 -26.82 62.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.459 -0.496 . . . . 1.0 110.949 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 94.4 m -63.47 -50.11 70.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.548 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -59.47 -26.08 64.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.136 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.457 ' C ' ' H ' ' C' ' 55' ' ' VAL . 39.3 p -88.44 -0.07 56.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 55.88 6.06 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.671 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' C' ' 53' ' ' THR . 64.2 t -64.89 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.89 58.08 6.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.395 -1.082 . . . . 1.0 110.395 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 1.7 t80 -59.99 -48.83 80.08 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 164.31 -99.74 0.17 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 59' ' ' ASP . . . . . 0.444 ' OD1' ' NE ' ' C' ' 60' ' ' ARG . 44.4 t0 51.58 -80.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 1.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' C' ' 58' ' ' GLY . 12.9 mmt180 -118.64 -167.99 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.47 ' CE1' ' CB ' ' C' ' 37' ' ' ALA . 26.2 p90 -160.1 129.49 3.24 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.644 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.69 161.86 44.27 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.802 1.668 . . . . 1.0 111.976 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 0.5 OUTLIER -86.45 -152.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.003 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.657 HG23 ' CD1' ' B' ' 46' ' ' TRP . 19.6 m -112.15 -73.28 0.68 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' C' ' 64' ' ' THR . 78.9 tt0 -32.17 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.15 0.5 . . . . 1.0 111.125 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 78.1 mm-40 -138.96 -101.62 0.17 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.524 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.58 -56.07 0.0 OUTLIER Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.792 1.308 . . . . 1.0 114.415 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.9 ttm-85 -71.41 -70.19 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.282 -0.459 . . . . 1.0 110.28 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -46.1 -38.39 8.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.39 -44.77 86.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.262 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.83 82.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.055 0.455 . . . . 1.0 110.07 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -48.89 -48.89 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -65.59 -39.31 91.46 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.524 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.66 -45.68 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.39 -40.67 97.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.927 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -61.62 -38.15 86.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.708 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.34 83.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.348 . . . . 1.0 110.39 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.45 -42.2 89.59 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.08 -43.15 95.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 1.0 110.72 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.5 -42.38 95.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.01 -48.37 86.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.1 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' PHE . . . . . 0.538 ' O ' HG22 ' C' ' 85' ' ' VAL . 36.6 m-85 -66.01 -39.88 90.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.069 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.18 -28.18 64.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.847 0.356 . . . . 1.0 110.773 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.4 tt -63.93 -38.96 92.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.711 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 85' ' ' VAL . . . . . 0.538 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.8 m -51.97 -4.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.561 ' H ' ' C ' ' C' ' 84' ' ' LEU . 53.3 m -49.28 -38.9 28.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.936 0.398 . . . . 1.0 109.974 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -47.47 -18.31 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.461 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 88' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' C' ' 86' ' ' THR . . . -105.85 -14.07 15.33 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.725 0.297 . . . . 1.0 110.797 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' C' ' 86' ' ' THR . 86.7 mt -84.93 -51.84 6.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.587 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -56.91 -46.86 81.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.064 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.6 OUTLIER -77.63 -4.43 45.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.503 -179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -56.86 -48.59 77.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.451 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 14.6 p90 -73.42 -40.09 64.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 94' ' ' VAL . . . . . 0.49 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 92.6 t -43.56 -27.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.732 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -60.87 -22.82 64.66 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.905 -0.318 . . . . 1.0 111.247 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -63.09 -37.38 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 1.0 110.591 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.698 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 2' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.996 0.427 . . . . 1.0 110.622 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.42 -39.78 95.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.751 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.472 ' CE1' HH21 ' D' ' 95' ' ' ARG . 56.4 p-80 -60.02 -46.15 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.056 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.437 ' N ' ' CG ' ' D' ' 4' ' ' HIS . 81.3 tt0 -62.87 -39.43 94.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.862 0.363 . . . . 1.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -63.12 -40.71 98.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.455 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -60.19 -39.82 87.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.966 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.45 99.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.711 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -66.2 -38.67 88.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -62.62 -34.88 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.627 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.95 74.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -36.8 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.506 -0.315 . . . . 1.0 110.732 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.54 -33.21 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.416 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -40.97 97.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -53.14 -42.93 66.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.356 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -62.15 -38.98 91.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.42 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.48 -44.03 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.673 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.785 HD12 ' O ' ' D' ' 19' ' ' LEU . 0.3 OUTLIER -61.17 -46.75 89.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.18 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.48 -27.93 69.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -59.13 -46.33 88.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.15 -40.65 94.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.152 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -62.78 -34.01 76.36 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.374 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -85.93 -44.24 12.54 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.607 -0.269 . . . . 1.0 110.994 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.85 68.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.281 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.515 HG13 ' N ' ' D' ' 28' ' ' GLU . 4.6 p -60.12 -46.87 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.829 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.515 ' N ' HG13 ' D' ' 27' ' ' VAL . 44.6 tp10 -69.24 -41.24 77.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.696 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -56.56 -24.89 50.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.24 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' D' ' 32' ' ' GLY . 30.9 mm-40 -97.32 -39.73 9.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.0 111.203 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -59.82 79.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.159 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 32' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 128.86 21.85 1.33 Allowed Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.531 -0.628 . . . . 1.0 111.531 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 33' ' ' ALA . . . . . 0.549 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -105.92 153.37 40.16 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 110.289 -0.263 . . . . 1.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' D' ' 36' ' ' ALA . 79.2 Cg_endo -74.55 139.22 25.27 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.101 1.867 . . . . 1.0 111.904 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 35' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 69.82 -23.87 0.41 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 36' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' D' ' 34' ' ' PRO . . . 43.03 -170.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 1.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 37' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' D' ' 36' ' ' ALA . . . 175.43 -48.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.192 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.621 HD13 ' HE ' ' D' ' 60' ' ' ARG . 50.9 tp -116.35 119.68 36.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.121 0.486 . . . . 1.0 110.278 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' D' ' 40' ' ' SER . 37.3 pt -141.72 169.12 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 78.99 137.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.55 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -72.81 -46.42 8.98 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.852 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.2 Cg_endo -59.11 -30.77 94.08 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.571 1.514 . . . . 1.0 112.234 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.537 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.4 m-20 -91.65 -33.96 14.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.87 76.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.845 0.355 . . . . 1.0 110.752 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ILE . . . . . 0.404 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.6 tt -64.26 -36.72 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.373 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.563 ' C ' HH11 ' A' ' 68' ' ' ARG . 0.4 OUTLIER -65.02 -46.02 83.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.515 ' CB ' HH21 ' D' ' 60' ' ' ARG . 2.1 t90 -62.05 -38.32 88.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 1.5 m -61.82 -37.82 85.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.822 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 49' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 45' ' ' ILE . 48.2 t -59.71 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 120.75 0.31 . . . . 1.0 110.991 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' D' ' 50' ' ' GLU . 17.4 pt-20 -68.45 -34.16 75.48 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.005 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -61.96 -46.54 88.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.556 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.56 69.28 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' D' ' 54' ' ' THR . 66.5 p -90.05 4.44 50.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.369 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 53' ' ' THR . 27.5 p 52.82 69.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -133.41 -59.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 71.85 -59.15 1.35 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 47' ' ' TRP . 0.5 OUTLIER 70.77 -37.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 1.0 110.538 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 58' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 117.07 11.11 9.27 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -61.42 -52.2 65.59 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.353 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.703 ' NH2' HH12 ' A' ' 68' ' ' ARG . 0.1 OUTLIER -145.78 144.27 30.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.762 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 13.2 p90 -136.95 122.54 13.09 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.56 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.18 -171.19 0.56 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.983 1.789 . . . . 1.0 111.898 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.863 HG22 ' H ' ' D' ' 64' ' ' THR . 8.3 p -122.26 -179.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.863 ' H ' HG22 ' D' ' 63' ' ' VAL . 97.1 m -62.3 -44.97 95.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.042 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' D' ' 67' ' ' GLY . 64.2 tt0 -52.2 -31.24 30.87 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.273 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -74.27 15.76 0.3 Allowed 'General case' 0 C--O 1.255 1.387 0 CA-C-O 124.482 2.087 . . . . 1.0 107.958 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.75 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 48.44 61.33 5.15 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 49.2 ttt85 -25.3 -27.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.535 0.668 . . . . 1.0 111.254 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.1 tptm -53.66 -21.93 7.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.587 ' O ' HG23 ' D' ' 74' ' ' VAL . 75.7 t -60.54 -44.43 96.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 119.979 -0.688 . . . . 1.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 71' ' ' ALA . . . . . 0.522 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -68.69 -48.02 64.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.982 0.42 . . . . 1.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.41 -64.29 0.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.832 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' D' ' 74' ' ' VAL . 10.3 pt20 -54.43 -43.25 71.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' VAL . . . . . 0.587 HG23 ' O ' ' D' ' 70' ' ' VAL . 86.7 t -61.56 -48.15 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.687 -0.405 . . . . 1.0 111.176 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mtp -63.71 -38.07 89.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.462 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 32.0 ttmt -58.81 -42.25 88.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.568 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.31 -40.19 89.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 1.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.49 -41.11 90.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.34 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.099 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' D' ' 80' ' ' GLU . 3.2 mp0 -67.65 -40.8 84.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 1.0 110.751 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 77' ' ' ALA . 47.2 t -63.2 -47.61 91.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.283 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.66 -9.31 58.06 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.622 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 -29.63 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.071 -0.344 . . . . 1.0 110.071 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.694 ' C ' HD23 ' D' ' 84' ' ' LEU . 7.3 tt -63.3 -42.88 99.09 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.243 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.04 -6.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.856 0.36 . . . . 1.0 110.163 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.506 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -60.66 -20.07 59.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.293 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.66 22.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.668 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.61 -39.11 93.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.2 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.22 -40.87 96.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.038 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.532 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -64.91 -37.19 86.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.266 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.523 ' OG1' ' CG ' ' C' ' 93' ' ' PHE . 1.0 OUTLIER -78.61 -4.75 50.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.108 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.01 -52.09 66.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.212 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 10.4 p90 -63.9 -32.23 73.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.51 -42.3 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.327 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ARG . . . . . 0.472 HH21 ' CE1' ' D' ' 4' ' ' HIS . 95.7 mtt-85 -56.68 -24.29 47.88 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.113 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 96' ' ' ARG . . . . . 0.501 ' NH2' HG11 ' A' ' 94' ' ' VAL . 15.0 ptt180 -58.88 -8.71 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 1.0 110.146 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.245 -178.869 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.705 0.288 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 t70 68.92 -37.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.767 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 20.7 p80 -66.64 -40.27 88.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.792 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 17.5 pt-20 -65.67 -36.32 83.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.42 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -39.63 94.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.42 -35.33 80.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.222 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -60.92 -40.53 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.974 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.61 -37.25 86.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.293 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.41 -38.78 90.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.733 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.72 86.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.31 -38.26 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.415 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.76 -34.16 77.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.343 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.83 -33.93 76.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.33 -42.31 99.28 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.528 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.38 -40.12 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.212 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.03 -42.5 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.0 110.81 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.88 -41.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.448 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.5 mt -59.87 -41.31 91.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.47 -46.57 89.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.914 0.388 . . . . 1.0 110.0 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.68 -35.2 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.73 88.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.93 -43.71 94.76 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.83 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -66.46 -36.58 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.369 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.32 -46.51 60.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.33 -0.548 . . . . 1.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.52 76.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -62.49 -46.25 96.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.085 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 27' ' ' VAL . 47.2 tp10 -66.4 -43.27 86.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.47 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.69 94.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 17.1 tp10 -73.23 -34.14 65.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.799 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -66.92 121.55 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 1.0 110.601 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 8.02 63.3 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.09 140.97 25.82 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.081 1.854 . . . . 1.0 111.982 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 6.91 60.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.58 106.49 0.05 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.863 0.363 . . . . 1.0 111.067 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.91 -29.83 21.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' CD1' HH11 ' A' ' 60' ' ' ARG . 42.3 tp -101.16 78.26 1.89 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.381 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.3 pt -103.75 31.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.308 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -126.17 121.71 33.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.985 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.477 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 18.4 t80 -74.74 -52.02 3.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.632 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.6 Cg_endo -59.94 -30.66 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.343 1.362 . . . . 1.0 112.434 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.62 -3.73 54.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.576 0.227 . . . . 1.0 111.054 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.1 -40.06 92.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.69 -32.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.291 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.432 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -58.84 -45.72 89.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.174 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -73.42 -24.45 60.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -70.15 -41.61 73.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.359 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG21 HH22 ' B' ' 68' ' ' ARG . 68.2 t -60.74 -47.93 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.83 0.348 . . . . 1.0 110.911 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.29 -31.19 71.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.267 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 89.3 m -61.34 -46.37 90.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.534 -0.466 . . . . 1.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.31 -26.61 61.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.525 ' OG1' HG12 ' A' ' 55' ' ' VAL . 44.6 p -86.08 7.34 25.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p 40.13 33.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.262 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.3 p -95.83 -45.25 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.803 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 49.38 83.72 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -46.76 89.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.755 0.312 . . . . 1.0 110.667 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.43 3.72 2.36 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.26 -50.61 72.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.0 110.507 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.541 HH11 ' CD1' ' A' ' 38' ' ' LEU . 1.4 mtt-85 -136.15 149.86 48.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -141.87 130.6 12.12 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.503 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 -172.07 0.72 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.932 1.755 . . . . 1.0 112.215 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 64' ' ' THR . 8.8 p -130.39 -144.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.046 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.879 ' H ' HG22 ' A' ' 63' ' ' VAL . 79.1 m -105.04 -41.45 5.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.669 0.271 . . . . 1.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.4 tp10 -60.82 -38.81 86.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.015 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -74.61 34.54 0.1 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 124.495 2.093 . . . . 1.0 109.943 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.71 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.19 62.52 1.51 Allowed Glycine 0 C--O 1.213 -1.214 0 CA-C-N 113.323 -1.762 . . . . 1.0 110.833 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' D' ' 50' ' ' GLU . 58.6 ttt85 -25.08 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 117.698 0.749 . . . . 1.0 110.927 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.71 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.5 mmtt -48.72 -16.38 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.005 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' GLY . 48.6 t -60.42 -45.47 96.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 119.096 -1.041 . . . . 1.0 110.08 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.27 79.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.643 0.259 . . . . 1.0 111.523 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 72' ' ' GLU . 1.5 mp0 -58.21 -43.04 87.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.052 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.33 -42.52 98.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.271 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.99 -45.15 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.117 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.555 ' SD ' HG11 ' D' ' 55' ' ' VAL . 76.1 mtm -62.03 -40.13 94.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.564 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -41.58 98.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.229 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.5 77.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.426 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.97 -40.49 97.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 1.0 110.696 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 79' ' ' ILE . 90.5 mt -71.35 -7.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.501 0.191 . . . . 1.0 111.385 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -96.08 -51.32 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.833 0.349 . . . . 1.0 110.872 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.9 m -61.61 -50.56 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.067 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 81' ' ' VAL . 38.2 m-85 -65.03 -40.58 95.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.809 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.23 86.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.724 0.297 . . . . 1.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 86' ' ' THR . 3.6 tp -62.59 -44.94 95.06 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.905 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 83.4 t -54.38 -3.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.414 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 84' ' ' LEU . 45.4 m -58.58 -42.1 87.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.84 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -41.44 -63.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.115 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.94 85.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.295 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.87 -43.94 97.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -66.12 -34.2 77.52 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.199 0.523 . . . . 1.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -76.19 -3.64 37.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.414 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.27 -48.94 77.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.434 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.0 p90 -65.47 -36.05 82.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 1.0 111.387 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.525 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -49.44 -28.78 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.229 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -71.52 -21.36 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.593 -0.276 . . . . 1.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' NH2' ' OE2' ' A' ' 97' ' ' GLU . 19.0 ptt-85 -50.91 -40.67 57.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.398 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.509 ' OE2' ' NH2' ' A' ' 96' ' ' ARG . 97.5 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.686 0.279 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -73.51 -31.24 63.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.673 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.02 -39.26 90.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.87 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -64.89 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.653 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.41 -43.73 88.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.5 95.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.52 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.84 -40.11 83.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.358 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.33 -34.55 78.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.75 72.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.34 -36.52 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.46 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.7 -36.27 83.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.0 110.347 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -65.22 -33.08 75.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.403 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.17 -41.67 98.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.554 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.98 -38.92 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.767 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.89 -39.65 92.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 1.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.07 -42.76 97.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.696 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.0 mt -60.54 -41.05 93.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.12 -47.89 83.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 1.0 109.887 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.13 -38.36 78.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.787 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.42 90.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 88.0 p -55.44 -43.55 75.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.234 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.58 -35.33 80.51 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.321 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -72.87 -43.41 62.59 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.196 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' B' ' 30' ' ' GLU . . . -59.27 -50.93 72.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.383 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.55 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.3 p -62.69 -46.47 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.55 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.55 ' N ' HG13 ' B' ' 27' ' ' VAL . 45.4 tp10 -67.48 -43.97 79.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.796 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.71 82.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.329 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 26' ' ' ALA . 17.6 mm-40 -64.77 -40.27 94.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.749 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -64.43 131.49 47.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.354 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.14 1.87 81.24 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.24 146.84 33.51 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.82 -0.223 . . . . 1.0 110.438 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' PRO . . . . . 0.533 ' O ' HG11 ' B' ' 63' ' ' VAL . 95.1 Cg_endo -75.56 142.46 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.322 2.015 . . . . 1.0 112.327 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.75 19.59 69.49 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.38 81.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 1.0 110.604 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.06 69.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.511 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.629 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.3 tt -89.81 119.12 29.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.27 0.557 . . . . 1.0 110.176 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.561 ' N ' HD23 ' B' ' 38' ' ' LEU . 39.1 pt -143.11 168.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.326 -0.852 . . . . 1.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.1 t 78.78 129.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.0 111.012 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.587 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 22.4 t80 -72.76 -46.78 9.13 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.026 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 26.0 Cg_endo -58.61 -31.13 93.98 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.358 1.372 . . . . 1.0 112.94 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -96.61 -11.79 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.869 0.366 . . . . 1.0 110.655 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.66 91.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.274 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.03 -30.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.024 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.468 ' CZ2' ' CB ' ' C' ' 68' ' ' ARG . 7.7 t90 -59.99 -49.36 77.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.869 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.3 OUTLIER -68.29 -34.05 75.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.303 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.459 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.3 p -67.69 54.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.706 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -147.22 -52.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.654 -0.248 . . . . 1.0 110.77 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.71 -32.8 74.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 1.0 110.613 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 51' ' ' THR . 0.0 OUTLIER -56.92 -45.15 82.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.145 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.1 -26.3 60.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.028 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.447 ' OG1' HG22 ' B' ' 55' ' ' VAL . 51.0 p -88.21 -1.43 58.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.694 0.283 . . . . 1.0 110.795 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.6 p 51.68 64.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.529 HG23 ' N ' ' B' ' 56' ' ' GLY . 21.6 m -133.66 -47.9 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.21 82.08 0.02 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.19 -42.0 98.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.707 0.289 . . . . 1.0 111.084 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.5 0.47 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.318 -0.713 . . . . 1.0 111.318 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' C' ' 61' ' ' TYR . 96.7 m-20 -48.05 -66.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 1.0 110.658 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -138.39 161.09 37.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.978 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -146.92 138.14 13.03 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.91 -172.33 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.815 1.677 . . . . 1.0 112.081 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.558 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -128.84 -143.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.019 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.558 ' H ' HG12 ' B' ' 63' ' ' VAL . 4.3 m -110.96 -42.04 4.08 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.664 0.269 . . . . 1.0 110.934 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.2 tp10 -66.2 -34.4 77.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.502 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.44 33.63 0.11 Allowed 'General case' 0 C--O 1.266 1.959 0 CA-C-O 123.961 1.838 . . . . 1.0 109.744 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.72 63.29 1.04 Allowed Glycine 0 C--O 1.214 -1.146 0 CA-C-N 113.393 -1.73 . . . . 1.0 111.175 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.605 HH22 HG21 ' A' ' 49' ' ' VAL . 59.6 ttp85 -23.57 -33.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.151 0.975 . . . . 1.0 110.763 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.7 mttp -48.29 -17.79 0.17 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' B' ' 67' ' ' GLY . 52.2 t -61.65 -49.29 84.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.97 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.94 64.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.5 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.28 -41.76 76.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.029 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.76 -43.02 99.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.307 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.94 -46.89 92.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 55' ' ' VAL . 74.4 mtm -62.62 -43.33 99.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.637 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -65.43 -42.53 92.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.156 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.86 93.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.15 -42.41 94.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.0 -43.75 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.704 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' B' ' 84' ' ' LEU . 81.0 mm-40 -59.01 -45.58 90.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.429 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.46 -49.09 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.413 ' O ' HG22 ' B' ' 85' ' ' VAL . 32.9 m-85 -70.89 -22.77 62.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.582 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.2 -22.29 19.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.301 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' B' ' 80' ' ' GLU . 6.8 tt -63.98 -40.85 97.31 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.723 0.297 . . . . 1.0 110.206 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' B' ' 87' ' ' ALA . 11.1 m -50.58 -27.85 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.749 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.415 ' C ' ' O ' ' B' ' 85' ' ' VAL . 15.6 m -33.36 -31.19 0.01 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.449 0.642 . . . . 1.0 110.016 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -52.82 -57.35 10.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.651 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -65.02 -33.81 76.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.153 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.418 HD12 ' N ' ' B' ' 89' ' ' LEU . 9.0 mp -60.04 -44.28 94.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 1.0 109.986 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.87 -19.25 60.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.925 -0.58 . . . . 1.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.527 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -98.82 -11.06 22.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.485 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.9 m-20 -62.56 -40.99 98.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.417 ' CD2' ' CB ' ' C' ' 90' ' ' ALA . 1.7 p90 -71.34 -29.27 64.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' B' ' 96' ' ' ARG . 91.4 t -60.8 -43.9 96.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.773 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -40.98 -22.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.679 0.276 . . . . 1.0 111.311 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' B' ' 94' ' ' VAL . 44.7 ptt85 -62.95 -37.25 86.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.874 -179.518 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 3' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' C' ' 4' ' ' HIS . 42.3 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.873 0.368 . . . . 1.0 110.383 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 4' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 19.2 p80 -67.55 -38.94 84.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 5' ' ' GLU . . . . . 0.597 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.4 tt0 -63.11 -36.64 84.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.645 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.16 -40.23 95.29 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.136 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.62 -40.86 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.78 94.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.354 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.36 -32.54 74.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.366 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 11' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' C' ' 81' ' ' VAL . . . -69.23 -24.26 63.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.71 -54.2 21.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.806 0.336 . . . . 1.0 111.643 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.79 -30.51 70.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.28 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.8 -37.45 87.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.705 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.53 -36.9 85.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 1.0 110.192 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.66 -32.5 73.85 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.443 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.43 -47.47 81.81 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -64.93 -32.44 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 1.0 111.053 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' C' ' 52' ' ' ALA . 41.3 mt -60.17 -40.67 90.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.893 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.96 -43.55 98.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.77 -33.11 73.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.124 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -61.89 -41.39 97.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.647 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -61.67 -38.77 89.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.514 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -64.58 -74.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.301 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.64 -33.04 6.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.565 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 22' ' ' ALA . . . -54.37 -52.56 61.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.471 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 27' ' ' VAL . . . . . 0.439 HG22 ' HE ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -67.17 -39.67 83.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.29 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -67.09 -32.43 73.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.877 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' C' ' 66' ' ' GLU . . . -55.01 -39.57 69.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.198 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' C' ' 38' ' ' LEU . 4.3 mt-10 -95.13 -136.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.61 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' C' ' 39' ' ' ILE . 35.6 mmt180 58.82 57.64 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.115 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.33 11.16 2.27 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.861 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' ALA . . . . . 0.51 ' HB3' ' OE2' ' C' ' 66' ' ' GLU . . . -106.72 147.61 35.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.87 147.15 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.275 1.983 . . . . 1.0 111.921 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.0 14.81 61.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 141.67 57.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.706 0.289 . . . . 1.0 110.475 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.22 -21.81 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.567 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.0 tt -107.66 85.37 2.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.981 0.42 . . . . 1.0 109.917 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.525 ' O ' ' NH1' ' C' ' 31' ' ' ARG . 39.6 pt -114.37 35.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -134.52 140.9 46.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.767 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 16.9 t80 -85.3 -52.06 0.5 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.95 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.76 -32.37 95.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.394 1.396 . . . . 1.0 112.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.87 -3.76 57.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.622 -0.263 . . . . 1.0 111.101 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.89 94.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 1.0 110.639 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.04 -32.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -46.74 84.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.754 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 47' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' C' ' 48' ' ' SER . 0.1 OUTLIER -66.25 -29.93 70.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.52 ' O ' HD22 ' C' ' 19' ' ' LEU . 50.4 p -70.07 -9.3 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.973 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' C' ' 51' ' ' THR . 25.6 t -90.3 -48.77 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.147 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.07 32.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.483 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' THR . . . . . 0.478 HG23 ' N ' ' C' ' 52' ' ' ALA . 10.2 t -133.89 -41.05 0.84 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.504 0.193 . . . . 1.0 111.273 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -66.16 -14.82 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.053 -0.259 . . . . 1.0 110.771 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.479 ' OG1' HG13 ' C' ' 55' ' ' VAL . 71.0 p -98.96 8.4 45.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.937 0.399 . . . . 1.0 110.235 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.9 p 53.83 45.37 27.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.975 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.51 HG23 ' N ' ' C' ' 56' ' ' GLY . 27.7 m -103.79 -44.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.739 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 56' ' ' GLY . . . . . 0.51 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 44.29 73.26 0.27 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -44.28 96.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.599 0.237 . . . . 1.0 110.398 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.04 10.85 7.25 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.66 -49.24 78.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 1.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -147.72 162.11 39.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.846 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 61' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 t80 -163.77 136.48 4.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.39 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.75 161.4 46.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.727 1.618 . . . . 1.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' C' ' 66' ' ' GLU . 3.0 t -110.33 165.89 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.019 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' C' ' 67' ' ' GLY . 21.5 m -41.17 -66.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.178 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -46.65 -17.74 0.05 Allowed 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 63' ' ' VAL . 18.0 mt-10 -101.01 27.57 5.95 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-O 124.481 2.086 . . . . 1.0 109.24 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 67' ' ' GLY . . . . . 0.661 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 39.27 64.11 1.02 Allowed Glycine 0 C--O 1.219 -0.819 0 CA-C-N 113.26 -1.791 . . . . 1.0 111.597 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 70' ' ' VAL . 0.3 OUTLIER -24.43 -37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.054 0.927 . . . . 1.0 110.186 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.661 ' N ' ' O ' ' C' ' 67' ' ' GLY . 99.0 mttt -43.24 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.46 -1.245 . . . . 1.0 109.758 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.7 t -60.51 -46.77 94.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 118.718 -1.193 . . . . 1.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.62 -45.67 51.55 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.769 0.319 . . . . 1.0 111.707 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.58 -42.01 99.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.106 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -58.03 -49.47 76.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.285 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.24 -43.4 84.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.391 . . . . 1.0 111.253 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 48.2 ttm -59.48 -40.07 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.728 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -60.77 -38.46 85.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.739 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.96 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.692 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.61 -39.74 97.0 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.173 -0.537 . . . . 1.0 111.834 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.64 -42.97 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.774 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.85 -40.27 96.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' VAL . . . . . 0.419 HG13 ' HB1' ' C' ' 11' ' ' ALA . 53.3 t -63.68 -48.07 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.364 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -75.76 -8.08 55.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.343 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.53 -45.07 10.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.853 0.359 . . . . 1.0 110.446 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.427 ' C ' ' N ' ' C' ' 86' ' ' THR . 7.0 tt -63.21 -42.85 99.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.689 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.82 -11.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.667 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.427 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.4 m -63.76 -25.4 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -56.81 -28.57 61.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.376 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.51 -13.28 34.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.3 -32.69 22.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.072 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.83 -37.89 89.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.587 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.59 -6.0 37.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.033 -0.53 . . . . 1.0 109.949 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.454 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 40.8 t0 -63.21 -43.9 96.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -84.62 -28.15 26.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.561 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.47 -42.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -51.83 -21.9 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.223 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' ARG . . . . . 0.455 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 24.0 ptt-85 -50.6 -44.79 57.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.591 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 97' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 8.4 pt-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.553 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.357 . . . . 1.0 110.444 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 20.3 p80 -66.7 -40.07 88.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.1 tt0 -62.26 -38.42 89.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.495 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -61.09 -42.35 98.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.291 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.13 -41.13 97.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.47 94.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.807 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.9 -41.39 91.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.864 0.364 . . . . 1.0 110.367 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.81 -33.78 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.506 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.98 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.972 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.81 -36.3 80.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 1.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.02 -37.32 87.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -62.31 -34.83 77.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.234 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 15' ' ' LEU . . . . . 0.545 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.3 tp -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.254 -0.579 . . . . 1.0 110.306 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -56.41 -33.92 66.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.366 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.12 -44.69 96.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.596 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' D' ' 18' ' ' VAL . 4.9 m -87.37 -37.01 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.654 0.264 . . . . 1.0 111.48 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.438 HD12 ' O ' ' D' ' 19' ' ' LEU . 1.5 tp -60.9 -47.0 88.39 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -63.53 -44.75 93.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.294 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -64.2 -29.86 70.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -61.43 -39.09 89.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.625 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 85.7 p -61.57 -43.76 98.27 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.602 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -64.82 -34.05 77.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.48 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' D' ' 29' ' ' ALA . 44.8 mmtm -78.2 -44.83 24.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.294 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -58.22 -49.14 78.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.43 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 27' ' ' VAL . . . . . 0.548 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.1 p -60.07 -45.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.526 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.548 ' N ' HG13 ' D' ' 27' ' ' VAL . 11.0 tm-20 -68.13 -35.83 78.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.591 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 29' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -58.81 -51.96 67.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 14.0 mp0 -69.79 -32.27 70.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.589 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -50.22 103.35 0.05 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.051 0.453 . . . . 1.0 111.049 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.87 11.1 44.44 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.76 140.16 21.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 110.525 -0.176 . . . . 1.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.03 142.27 27.57 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.107 1.871 . . . . 1.0 112.299 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.0 26.42 63.23 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.65 140.91 56.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 1.0 110.791 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.81 -22.84 10.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.712 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' D' ' 30' ' ' GLU . 57.4 tp -104.7 121.1 42.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.925 0.393 . . . . 1.0 109.956 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' D' ' 40' ' ' SER . 34.2 pt -153.48 -164.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.372 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 40' ' ' SER . . . . . 0.452 ' O ' ' O ' ' D' ' 39' ' ' ILE . 1.3 m 58.26 141.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 1.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 7.1 m-85 -79.83 -58.42 0.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.99 -26.53 81.89 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.584 1.523 . . . . 1.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -87.98 -25.37 23.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 44' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -63.69 -39.53 94.54 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.693 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.43 -32.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.26 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -47.89 81.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 47' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' D' ' 51' ' ' THR . 0.2 OUTLIER -76.76 -22.96 53.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.21 -44.44 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.721 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.98 4.3 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 1.0 110.898 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 50.6 mm-40 -103.22 -49.86 3.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.137 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 51' ' ' THR . . . . . 0.46 ' H ' HG22 ' D' ' 51' ' ' THR . 0.0 OUTLIER -63.67 -45.61 89.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.19 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -23.51 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 1.0 110.085 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 53' ' ' THR . . . . . 0.462 ' OG1' HG13 ' D' ' 55' ' ' VAL . 43.4 p -100.45 2.22 41.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.388 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 61.6 p 45.83 70.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.452 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.555 HG11 ' SD ' ' A' ' 75' ' ' MET . 30.0 m -117.63 -42.75 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.591 -0.277 . . . . 1.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 56' ' ' GLY . . . . . 0.533 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 51.16 63.18 4.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -45.51 93.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.692 0.282 . . . . 1.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 -1.64 7.15 Favored Glycine 0 N--CA 1.466 0.648 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.63 -47.99 83.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.546 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -142.9 151.49 41.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.711 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 27.4 p90 -145.56 137.68 13.33 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.568 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.71 161.69 44.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.253 1.968 . . . . 1.0 112.152 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.947 HG22 ' H ' ' D' ' 64' ' ' THR . 8.0 p -104.76 -130.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.0 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.947 ' H ' HG22 ' D' ' 63' ' ' VAL . 23.9 m -114.18 -51.33 2.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.603 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.7 tt0 -57.11 -30.51 64.43 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.603 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.66 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 1.1 pm0 -70.66 19.43 0.05 OUTLIER 'General case' 0 C--O 1.264 1.83 0 CA-C-O 123.651 1.691 . . . . 1.0 109.4 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.64 62.19 2.99 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' D' ' 67' ' ' GLY . 59.5 ttm-85 -26.22 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.831 0.816 . . . . 1.0 110.631 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' D' ' 67' ' ' GLY . 65.0 mttm -51.02 -24.14 3.53 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.525 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.603 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.7 t -63.17 -48.4 87.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 119.769 -0.772 . . . . 1.0 110.362 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.58 -37.07 76.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.657 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -64.05 -40.46 96.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.089 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -61.43 -47.38 86.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.672 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.96 -36.35 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.309 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.47 ' SD ' HG11 ' C' ' 55' ' ' VAL . 17.9 mtm -62.54 -42.7 99.7 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.092 -0.243 . . . . 1.0 111.438 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.48 -41.64 96.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.657 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.4 -40.81 95.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.506 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 78' ' ' GLY . . . . . 0.545 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -64.44 -41.73 97.89 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.22 -43.33 98.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -63.46 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.563 -0.289 . . . . 1.0 111.132 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.5 t -62.27 -50.37 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.261 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.48 -39.86 85.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 1.0 110.476 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.552 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' D' ' 86' ' ' THR . 4.3 tt -60.92 -40.01 91.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.274 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 85' ' ' VAL . . . . . 0.481 HG12 ' O ' ' D' ' 85' ' ' VAL . 97.9 t -48.49 -10.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 1.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.519 ' N ' ' O ' ' D' ' 84' ' ' LEU . 22.6 m -49.28 -39.25 30.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.093 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -49.96 -17.94 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.392 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' D' ' 92' ' ' ASP . . . -104.87 -12.2 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.737 0.303 . . . . 1.0 110.252 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.5 mt -87.54 -64.73 1.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.36 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.13 -9.49 1.46 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.275 0.559 . . . . 1.0 109.944 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.482 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 0.5 OUTLIER -99.54 -1.12 39.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.44 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 92' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m-20 -74.57 -39.17 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.658 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 30.7 p90 -84.86 -40.39 17.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 94' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 21.2 m -43.34 -36.72 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.8 0.333 . . . . 1.0 111.401 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ARG . . . . . 0.464 ' N ' HG23 ' D' ' 94' ' ' VAL . 95.2 mtt-85 -57.14 -27.53 61.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -39.93 -35.98 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.676 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.39 -179.914 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.523 -0.061 0 CA-C-O 120.857 0.36 . . . . 1.0 110.71 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.06 -45.56 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.628 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 4.0 p80 -67.3 -41.5 85.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.502 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.67 -46.02 87.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.705 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.05 -38.11 89.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.61 -38.22 90.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.197 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.52 94.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.233 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.03 -38.63 91.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.343 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.26 -41.68 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.82 85.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.996 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.91 -40.38 94.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.621 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.96 -38.15 87.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.447 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -65.6 -32.0 73.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.446 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.1 -44.81 95.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.826 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -60.69 -36.0 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.306 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.74 -40.77 96.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.087 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.25 -31.37 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.665 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -61.68 -42.12 98.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.14 -51.33 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.84 -37.46 86.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.204 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.35 83.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -59.48 -39.69 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.94 -55.1 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.612 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.68 -23.1 39.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.965 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 23' ' ' SER . 83.2 t -92.45 -50.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.929 0.395 . . . . 1.0 110.396 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.33 -42.32 93.03 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.604 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -34.73 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -78.98 -114.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 45.55 78.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.88 0.372 . . . . 1.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -6.76 41.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.12 136.14 57.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.295 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.24 140.96 25.4 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.971 1.781 . . . . 1.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . 64.27 22.13 66.97 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -60.96 -48.07 83.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.789 0.328 . . . . 1.0 110.758 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 58.89 0.6 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.697 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 38' ' ' LEU . 5.1 tt -131.48 114.59 15.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.78 0.324 . . . . 1.0 110.15 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 23.5 pt -157.96 54.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.122 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -153.48 118.19 5.0 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.856 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 47.6 m-85 -55.37 -50.33 87.36 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.119 -0.491 . . . . 1.0 112.028 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 28.8 Cg_endo -59.72 -34.08 96.22 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.546 1.497 . . . . 1.0 112.6 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB3' HH21 ' A' ' 60' ' ' ARG . 61.5 m-20 -92.52 -8.11 45.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.676 0.274 . . . . 1.0 110.82 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . . . -62.64 -45.14 94.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.0 110.386 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 46' ' ' TRP . 4.0 tt -69.41 -41.86 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.152 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.517 ' N ' HG23 ' A' ' 45' ' ' ILE . 3.3 t-105 -55.35 -43.13 74.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -66.16 -38.46 88.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 19' ' ' LEU . 3.5 t -65.05 -24.58 67.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.249 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.03 -49.76 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.605 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -75.35 -24.02 57.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.462 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 m -62.5 -45.76 91.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.529 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -62.13 -35.21 78.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.618 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 p -75.41 4.14 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 41.5 73.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 1.0 111.17 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 3.9 p -139.05 -36.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.851 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.95 76.37 0.08 OUTLIER Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CZ ' HG21 ' A' ' 55' ' ' VAL . 57.9 m-85 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 1.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.52 17.67 0.2 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -63.42 -42.26 98.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 1.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mmt180 -127.98 -170.48 2.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 51.4 m-85 -162.18 88.51 1.44 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.002 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.37 156.14 65.24 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.905 1.737 . . . . 1.0 112.221 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.995 HG22 ' H ' ' A' ' 64' ' ' THR . 7.4 p -128.16 -171.77 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.221 0.534 . . . . 1.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.995 ' H ' HG22 ' A' ' 63' ' ' VAL . 98.9 m -69.44 -43.85 72.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.8 tp10 -48.1 -49.52 31.54 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -80.79 35.55 0.37 Allowed 'General case' 0 C--O 1.258 1.511 0 CA-C-O 123.989 1.852 . . . . 1.0 109.242 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.52 66.67 0.92 Allowed Glycine 0 C--O 1.212 -1.22 0 CA-C-N 113.303 -1.771 . . . . 1.0 112.085 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' CG ' ' D' ' 59' ' ' ASP . 58.4 ttm-85 -24.24 -32.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.33 1.065 . . . . 1.0 111.15 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 67' ' ' GLY . 9.0 mtmp? -53.2 -16.48 1.25 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.81 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.2 t -63.36 -46.94 94.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 120.049 -0.661 . . . . 1.0 110.574 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -44.4 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.081 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -56.95 -43.29 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.349 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.2 -41.99 85.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.864 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.36 -45.13 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.177 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.45 -40.24 93.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.756 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -60.48 -42.63 96.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.321 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.82 82.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.492 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -39.15 93.21 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.727 -0.949 . . . . 1.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.11 -26.65 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.864 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.55 -51.83 13.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 1.0 111.2 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.6 m -61.41 -48.98 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.097 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.526 ' N ' HG23 ' A' ' 81' ' ' VAL . 16.2 m-85 -64.43 -41.65 96.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.992 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.65 -36.94 85.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.801 -0.359 . . . . 1.0 111.051 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.2 tt -63.41 -37.42 87.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.356 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 85' ' ' VAL . 90.2 t -45.45 -14.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.482 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' LEU . 41.1 m -51.08 -44.25 61.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 1.0 110.058 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.83 -21.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.69 -20.62 13.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.921 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 86' ' ' THR . 41.9 mt -84.98 -43.18 14.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.772 0.32 . . . . 1.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -59.29 -38.2 79.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.036 0.446 . . . . 1.0 110.87 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -65.67 -11.78 47.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.283 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 67.1 m-20 -59.61 -49.8 76.36 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.16 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 11.3 p90 -75.53 -22.54 57.0 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.813 0.34 . . . . 1.0 111.282 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.37 -43.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.194 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.82 -20.84 59.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -53.64 -42.66 68.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.467 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.848 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.778 0.323 . . . . 1.0 110.766 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -78.49 -23.57 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.45 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.72 -39.45 88.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.743 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.35 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.666 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.36 -41.17 96.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.0 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 99.3 mm-40 -65.7 -38.19 88.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -61.85 -37.48 84.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.53 71.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.881 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.81 -38.76 92.31 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.554 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' B' ' 9' ' ' GLN . 1.1 mp0 -65.71 -34.82 79.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.315 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.47 -38.54 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.37 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.405 HD11 ' HB1' ' B' ' 52' ' ' ALA . 53.2 tp -62.78 -42.08 99.54 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.443 ' O ' ' OE2' ' B' ' 20' ' ' GLU . 76.3 mm-40 -63.86 -40.04 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -59.05 -42.1 89.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 1.0 110.612 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.43 -40.84 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.673 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 52' ' ' ALA . 82.5 mt -59.32 -40.94 87.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' B' ' 20' ' ' GLU . 0.3 OUTLIER -59.82 -48.93 79.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -31.01 69.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.992 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.59 90.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.496 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.9 p -59.63 -43.71 93.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.412 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -65.73 -35.48 80.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.42 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.19 -47.13 37.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.794 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.7 82.57 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' VAL . . . . . 0.546 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.9 p -62.18 -46.31 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.231 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.546 ' N ' HG13 ' B' ' 27' ' ' VAL . 83.4 tt0 -67.09 -43.78 81.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.531 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.79 83.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.337 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -70.39 -33.95 71.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.678 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.95 123.96 21.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.53 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.01 0.64 65.83 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.75 140.45 21.09 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 122.833 -0.216 . . . . 1.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.73 149.74 34.22 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.061 1.841 . . . . 1.0 112.623 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.48 2.85 23.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.68 ' O ' HG22 ' B' ' 39' ' ' ILE . . . -77.43 83.01 3.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.667 0.27 . . . . 1.0 110.699 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.5 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 1.0 110.506 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.821 HD23 ' O ' ' B' ' 38' ' ' LEU . 5.4 tt -58.99 -28.43 66.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.359 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' ILE . . . . . 0.694 HG23 ' O ' ' B' ' 39' ' ' ILE . 20.4 tt -38.26 100.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.182 0.515 . . . . 1.0 110.793 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.531 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 59.7 m -171.42 -119.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.645 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.6 m-85 -177.57 -64.88 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.014 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 21.1 Cg_endo -58.5 -33.43 98.0 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.161 1.907 . . . . 1.0 112.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.16 -4.64 51.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.665 -0.243 . . . . 1.0 111.015 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 38' ' ' LEU . . . -65.03 -40.82 95.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.181 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.76 -37.37 73.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.361 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.612 ' NE1' ' O ' ' C' ' 64' ' ' THR . 2.8 t90 -53.95 -50.99 65.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.711 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.7 t90 -66.15 -38.32 87.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.401 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . 0.443 ' O ' HD22 ' B' ' 19' ' ' LEU . 65.2 m -55.24 -45.33 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.273 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.89 -46.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.31 -31.71 72.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 98.2 m -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.157 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -55.7 -26.3 44.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.723 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' THR . . . . . 0.539 ' OG1' HG12 ' B' ' 55' ' ' VAL . 46.3 p -85.68 -2.25 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 1.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.5 p 57.08 5.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.097 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' B' ' 53' ' ' THR . 7.8 p -64.85 -43.8 96.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.784 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' GLY . . . . . 0.523 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 38.55 74.64 0.11 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' B' ' 55' ' ' VAL . 47.0 m-85 -59.92 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.663 0.268 . . . . 1.0 110.966 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.53 -0.75 2.26 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.06 -65.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 1.0 110.084 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.28 149.38 36.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 61' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 22.8 p90 -139.18 112.53 8.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.46 -171.05 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.49 1.46 . . . . 1.0 111.971 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' VAL . . . . . 0.898 HG22 ' H ' ' B' ' 64' ' ' THR . 7.2 p -133.65 -147.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.391 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' THR . . . . . 0.898 ' H ' HG22 ' B' ' 63' ' ' VAL . 97.9 m -101.79 -42.8 6.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.256 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' B' ' 67' ' ' GLY . 75.1 tt0 -54.79 -38.24 67.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.284 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -77.56 31.66 0.16 Allowed 'General case' 0 C--O 1.259 1.592 0 CA-C-O 123.788 1.756 . . . . 1.0 109.72 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.59 63.74 1.57 Allowed Glycine 0 C--O 1.212 -1.267 0 CA-C-N 113.659 -1.61 . . . . 1.0 111.629 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' B' ' 67' ' ' GLY . 55.0 ttm-85 -25.28 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.401 1.101 . . . . 1.0 110.579 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' B' ' 67' ' ' GLY . 67.5 mttm -48.49 -18.4 0.23 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.3 -47.82 91.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 119.847 -0.741 . . . . 1.0 109.691 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.36 -38.99 68.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.296 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -49.17 -43.33 41.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -66.64 -41.14 88.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -51.66 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.696 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 22.9 ptp -64.26 -41.01 97.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 1.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.14 -39.28 93.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.442 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' ALA . . . . . 0.543 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.87 -36.03 80.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 1.0 110.526 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.89 -39.88 58.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.442 -0.663 . . . . 1.0 111.442 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.21 -44.6 99.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 121.112 -0.235 . . . . 1.0 111.483 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.88 -35.29 79.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 1.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 77' ' ' ALA . 17.9 t -62.27 -71.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' PHE . . . . . 0.433 ' N ' HG12 ' B' ' 81' ' ' VAL . 69.8 m-85 -58.11 -4.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.957 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' B' ' 81' ' ' VAL . . . -97.55 -34.99 10.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.168 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -64.47 -40.79 96.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.211 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 87' ' ' ALA . 14.0 m -58.57 -16.5 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.009 -0.542 . . . . 1.0 109.621 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 52.5 m -42.43 -24.66 0.06 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.078 0.466 . . . . 1.0 109.811 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.75 -64.42 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.845 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.6 -24.06 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.2 mm? -87.81 -19.76 27.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.788 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.57 -50.55 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.459 0.647 . . . . 1.0 109.335 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' H ' ' B' ' 91' ' ' THR . 0.4 OUTLIER -54.23 -3.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.236 179.112 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 92' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' B' ' 90' ' ' ALA . 91.0 m-20 -58.69 -41.87 87.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.866 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 24.3 p90 -70.56 -27.53 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.906 -0.317 . . . . 1.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.79 -43.7 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.512 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.29 -21.35 59.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.932 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -55.09 -41.73 71.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.974 179.92 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' C' ' 3' ' ' ASP . 67.8 t0 . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -80.4 -17.2 52.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.776 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.44 89.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -63.06 -39.41 94.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.0 110.281 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.5 -40.69 89.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.73 92.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.593 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.09 -39.15 89.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.337 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -62.4 -36.74 83.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.291 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.71 80.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -62.82 -40.18 96.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 1.0 111.086 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -65.84 -34.25 77.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.569 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.8 -37.94 88.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.516 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 15' ' ' LEU . . . . . 0.438 HD13 ' HA2' ' C' ' 78' ' ' GLY . 49.0 tp -61.74 -44.6 96.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.585 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 16' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' C' ' 20' ' ' GLU . 85.5 mm-40 -58.48 -32.31 68.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.82 -43.24 93.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 m -87.56 -34.65 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.592 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LEU . . . . . 0.699 HD12 ' O ' ' C' ' 19' ' ' LEU . 0.9 OUTLIER -60.49 -49.14 78.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 20' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' C' ' 16' ' ' GLN . 3.4 mp0 -61.22 -43.32 99.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.64 -29.34 66.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.473 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' C' ' 19' ' ' LEU . . . -65.17 -37.65 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 12.9 m -56.63 -44.8 81.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.356 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -64.59 -52.15 59.03 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.131 -0.628 . . . . 1.0 109.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.6 mmtt -59.48 -37.92 79.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.435 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.74 -57.74 5.86 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.832 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -64.33 -44.21 97.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.137 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -60.72 -32.81 72.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.15 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 29' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -60.77 -29.28 69.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.624 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.2 -44.73 92.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.66 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.03 130.23 41.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.46 -29.75 11.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.234 -0.747 . . . . 1.0 111.234 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.89 144.19 28.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 122.903 -0.174 . . . . 1.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.17 158.71 37.52 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.115 1.877 . . . . 1.0 112.442 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.77 36.9 14.55 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 141.86 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 1.0 110.569 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.4 -44.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.46 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.413 ' O ' HD23 ' C' ' 38' ' ' LEU . 6.4 tt -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.411 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -37.89 116.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.736 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 40' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' C' ' 41' ' ' TYR . 17.2 t -177.6 -123.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.306 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 41' ' ' TYR . . . . . 0.541 ' N ' ' OG ' ' C' ' 40' ' ' SER . 0.8 OUTLIER 171.97 -65.58 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.188 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 42' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' C' ' 41' ' ' TYR . 23.5 Cg_endo -58.81 -40.16 75.04 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.886 1.724 . . . . 1.0 112.171 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.455 ' CB ' ' NH2' ' C' ' 60' ' ' ARG . 8.5 p30 -88.37 -0.22 56.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.31 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.77 87.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 1.0 110.615 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.472 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.3 tt -67.18 -41.4 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' NE ' ' D' ' 68' ' ' ARG . 0.0 OUTLIER -52.33 -49.08 64.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.737 -179.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -65.43 -38.55 90.22 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.826 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 9.0 p -62.11 -38.79 90.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.543 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' VAL . . . . . 0.474 ' O ' HG23 ' C' ' 53' ' ' THR . 42.9 t -59.55 -47.75 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 121.181 -0.208 . . . . 1.0 111.367 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.58 -34.75 77.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.569 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -64.24 -53.7 45.07 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.55 68.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.766 0.317 . . . . 1.0 110.947 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 53' ' ' THR . . . . . 0.474 HG23 ' O ' ' C' ' 49' ' ' VAL . 58.9 p -90.81 3.63 53.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.274 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.4 p 52.06 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.47 -50.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.147 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.3 76.81 0.15 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 26.9 t80 -61.66 -43.21 99.28 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.63 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.14 12.19 5.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.6 -45.54 93.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' C' ' 43' ' ' ASP . 94.1 mtt-85 -138.45 147.99 43.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -115.66 128.88 25.6 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.762 -0.199 . . . . 1.0 110.563 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.55 157.16 61.78 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.029 1.82 . . . . 1.0 112.001 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' VAL . . . . . 0.457 ' H ' HG22 ' C' ' 63' ' ' VAL . 0.0 OUTLIER -56.2 -176.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.276 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 64' ' ' THR . . . . . 0.612 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 67.0 m -89.82 -86.25 0.2 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.643 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' C' ' 64' ' ' THR . 50.7 tp10 -28.19 -84.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.321 0.388 . . . . 1.0 111.097 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.5 mt-10 -60.95 -92.2 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.05 -56.2 0.0 OUTLIER Glycine 0 N--CA 1.478 1.457 0 O-C-N 124.376 1.047 . . . . 1.0 114.571 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 42.9 ttp85 -71.35 -47.75 54.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.289 -0.456 . . . . 1.0 110.402 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 69' ' ' LYS . . . . . 0.556 ' NZ ' HH12 ' C' ' 68' ' ' ARG . 4.5 mptp? -59.85 -41.46 91.46 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 70' ' ' VAL . . . . . 0.618 ' O ' HG23 ' C' ' 74' ' ' VAL . 58.7 t -76.64 -45.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.788 -0.765 . . . . 1.0 111.237 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.23 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.703 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' C' ' 68' ' ' ARG . 15.4 tm-20 -49.42 -40.98 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.836 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -69.25 -42.04 76.14 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.931 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.618 HG23 ' O ' ' C' ' 70' ' ' VAL . 74.0 t -66.06 -49.48 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.722 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ptp -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.693 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.34 -40.5 96.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.522 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.72 95.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 1.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.31 -41.23 96.77 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.3 -43.06 97.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 1.0 110.852 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.28 -40.6 94.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.265 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.89 -47.02 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.35 -14.62 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.168 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.18 -34.09 19.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 1.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.16 -40.53 90.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.66 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.58 -24.58 29.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' THR . . . . . 0.43 ' O ' ' N ' ' C' ' 90' ' ' ALA . 1.2 t -43.12 -33.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.168 0.509 . . . . 1.0 110.456 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -49.1 -61.74 1.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.203 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.58 -35.02 39.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.241 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' LEU . . . . . 0.562 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.4 mm? -75.35 -34.81 61.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.777 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -63.5 -36.18 82.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.181 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -4.47 37.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.08 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 92' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 88.9 m-20 -54.77 -48.95 72.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.746 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 93' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 20.8 p90 -74.83 -9.97 59.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.1 -48.3 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.679 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -65.81 -20.35 66.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.258 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -48.84 -38.8 23.35 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.412 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.278 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.825 0.345 . . . . 1.0 110.474 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -63.75 -40.3 96.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.935 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 4' ' ' HIS . . . . . 0.501 ' CD2' ' HG3' ' D' ' 5' ' ' GLU . 3.8 p-80 -58.55 -44.92 89.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.587 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 5' ' ' GLU . . . . . 0.501 ' HG3' ' CD2' ' D' ' 4' ' ' HIS . 97.8 mt-10 -65.51 -39.6 92.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 1.0 110.581 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -65.06 -39.16 92.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.483 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.14 -37.26 86.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.931 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.76 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.846 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -63.66 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 1.0 110.306 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.98 -39.1 91.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.88 81.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.73 -41.86 87.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 1.0 110.733 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -67.14 -37.92 84.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.93 -34.83 79.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.514 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.26 -40.6 96.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.316 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -60.36 -37.05 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.43 -42.51 92.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.74 0.305 . . . . 1.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.12 -42.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.771 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.0 mt -61.13 -42.02 97.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -59.98 -46.15 90.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.341 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.25 -40.28 74.5 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.411 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.42 93.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.06 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' SER . . . . . 0.437 ' OG ' ' OG ' ' D' ' 48' ' ' SER . 16.5 m -58.54 -45.28 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.091 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' LYS . . . . . 0.48 ' O ' ' OE1' ' D' ' 28' ' ' GLU . 60.9 tttp -60.71 -59.71 4.95 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.282 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.51 -38.86 75.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 1.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 26' ' ' ALA . . . . . 0.402 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -53.76 -36.14 62.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.79 -48.73 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.525 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 28' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' D' ' 28' ' ' GLU . 47.6 mp0 -73.29 -38.2 65.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -54.55 30.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.55 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 30' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 2.0 mp0 -64.91 -35.13 80.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.576 -0.283 . . . . 1.0 110.523 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.24 128.23 35.8 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.117 0.484 . . . . 1.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.08 -16.36 61.49 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.507 -0.769 . . . . 1.0 111.465 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.27 148.17 46.59 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' PRO . . . . . 0.576 ' O ' HG11 ' D' ' 63' ' ' VAL . 76.7 Cg_endo -74.78 130.71 13.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.913 1.742 . . . . 1.0 112.396 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 17.88 71.36 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.73 173.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 1.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.42 -40.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' LEU . . . . . 0.465 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.1 tt -97.72 121.58 39.8 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' ILE . . . . . 0.451 ' N ' HD23 ' D' ' 38' ' ' LEU . 24.1 pt -152.92 54.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -149.9 119.71 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.621 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 8.5 t80 -61.08 -47.99 93.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.62 -31.73 95.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.288 1.325 . . . . 1.0 112.056 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.53 -8.26 38.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.109 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.8 81.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 1.0 110.984 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -64.48 -34.45 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.082 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -69.06 -44.12 73.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.168 179.49 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -62.42 -41.52 98.76 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.523 -0.471 . . . . 1.0 109.803 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . 0.44 ' O ' HD22 ' D' ' 19' ' ' LEU . 1.2 m -72.01 57.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -145.28 -51.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.725 0.298 . . . . 1.0 110.444 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -66.46 -31.82 72.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -45.25 91.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.358 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.76 -39.05 87.31 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.118 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 8.25 21.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.075 0.464 . . . . 1.0 110.322 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 42.8 p 44.03 57.35 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' D' ' 57' ' ' TYR . 1.6 m -140.86 41.53 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.76 88.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' D' ' 55' ' ' VAL . 1.2 t80 -61.74 -44.78 96.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 1.0 110.361 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.27 27.89 0.16 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' ASP . . . . . 0.487 ' CG ' ' NH2' ' A' ' 68' ' ' ARG . 43.3 t0 -63.74 -48.91 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' ARG . . . . . 0.479 ' C ' ' CG ' ' D' ' 61' ' ' TYR . 0.8 OUTLIER -146.13 -178.7 6.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.166 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 1.6 m-85 -150.44 99.6 3.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.072 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.83 147.24 68.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.782 1.655 . . . . 1.0 112.101 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' VAL . . . . . 0.576 HG11 ' O ' ' D' ' 34' ' ' PRO . 2.5 t -80.74 -134.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' THR . . . . . 0.54 HG23 ' NH2' ' D' ' 68' ' ' ARG . 51.7 m -114.56 -54.29 2.59 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.828 0.347 . . . . 1.0 110.559 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 65' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.2 tt0 -50.88 -18.33 0.73 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 66' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' D' ' 64' ' ' THR . 0.0 OUTLIER -78.06 37.84 0.26 Allowed 'General case' 0 C--O 1.261 1.691 0 CA-C-O 123.793 1.759 . . . . 1.0 108.679 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 67' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.83 62.43 3.74 Favored Glycine 0 C--O 1.202 -1.897 0 CA-C-N 113.649 -1.614 . . . . 1.0 109.636 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 68' ' ' ARG . . . . . 0.574 ' NE ' ' CD1' ' C' ' 46' ' ' TRP . 19.0 ttm105 -22.5 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 117.663 0.732 . . . . 1.0 111.681 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.2 mmtt -65.83 -8.29 20.93 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.022 -0.99 . . . . 1.0 109.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 70' ' ' VAL . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 16.5 t -59.79 -47.49 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -76.65 -52.78 9.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.0 0.429 . . . . 1.0 110.359 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -47.9 -41.43 24.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.931 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.14 -48.92 76.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.894 -0.322 . . . . 1.0 111.784 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.82 -43.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.555 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mpp? -61.42 -43.62 98.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.624 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.03 -38.85 89.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.632 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 77' ' ' ALA . . . . . 0.566 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.15 -37.06 81.5 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.505 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.76 -40.55 58.11 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.37 -44.77 99.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.638 0.236 . . . . 1.0 111.638 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.07 -35.16 77.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.304 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 81' ' ' VAL . . . . . 0.566 HG23 ' O ' ' D' ' 77' ' ' ALA . 34.5 t -62.15 -47.47 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.166 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -72.78 -6.61 45.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.836 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.9 -32.24 11.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.198 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.5 tt -64.15 -41.47 97.17 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.338 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 m -51.31 -10.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 86' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 89' ' ' LEU . 45.9 m -51.59 -43.07 62.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.062 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -46.02 -19.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 88' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -104.76 -17.61 14.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.45 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 89' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' D' ' 86' ' ' THR . 39.6 mt -93.27 -46.06 7.55 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -54.34 -30.08 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.705 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 91' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.1 OUTLIER -74.88 -11.76 60.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.765 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -53.22 -50.67 64.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.135 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 14.0 p90 -73.19 -11.26 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.652 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.03 -35.93 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.151 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -61.91 -42.52 99.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.137 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -53.54 -30.47 41.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 1.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.058 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.76 149.88 48.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.663 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 6' ' ' ARG . 97.7 m-20 -67.25 -14.27 62.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.525 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.552 ' ND1' ' N ' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -83.76 -35.03 24.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.895 0.379 . . . . 1.0 110.286 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.16 -44.52 88.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.808 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 3' ' ' ASP . 39.0 ptt180 -66.85 -38.51 86.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.247 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.69 -43.14 80.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.289 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -67.56 -36.93 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.245 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.44 -39.72 94.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.333 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -62.19 -38.82 90.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.28 74.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.972 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.09 -39.47 86.24 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.588 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.43 -33.76 76.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.47 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.78 -36.3 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.596 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 52' ' ' ALA . 47.3 tp -62.02 -40.87 97.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 1.0 110.339 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -33.7 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.29 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -60.62 -43.09 97.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.055 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.07 -41.53 93.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.448 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.1 mt -59.37 -41.65 89.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.121 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.34 -49.59 77.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.631 -0.427 . . . . 1.0 109.996 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.37 -38.18 86.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.024 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.83 94.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.752 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 27' ' ' VAL . 38.7 m -53.65 -36.35 61.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' VAL . 64.9 tttm -77.57 -78.29 0.14 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.835 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 74.0 mmtt -36.19 -35.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.29 87.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.612 -0.435 . . . . 1.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 1.8 m -63.08 -47.8 90.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.201 -0.6 . . . . 1.0 110.564 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.9 tm-20 -70.1 -42.92 72.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.916 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 66' ' ' GLU . . . -59.48 -31.42 69.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.931 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -97.19 -33.05 11.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.605 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 27' ' ' VAL . 23.6 tpt180 -77.55 97.63 5.1 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.286 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 -14.02 7.98 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.88 42.57 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.93 142.72 28.45 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.111 1.874 . . . . 1.0 112.318 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.18 7.69 84.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.021 -0.831 . . . . 1.0 111.021 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.33 147.28 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 1.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.38 10.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' ILE . 6.7 tt -83.8 -71.08 0.52 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.358 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 40' ' ' SER . 45.0 pt 37.51 -162.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 39' ' ' ILE . 4.0 m 55.15 128.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.361 0.601 . . . . 1.0 111.055 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 23.2 m-85 -77.66 -55.68 1.23 Allowed Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.781 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.4 Cg_endo -60.28 -20.52 62.85 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.701 1.601 . . . . 1.0 112.348 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -89.0 -24.97 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.004 -0.278 . . . . 1.0 110.951 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.85 -37.84 85.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 45' ' ' ILE . 2.5 tp -63.89 -43.51 97.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.36 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.953 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -60.13 -42.11 94.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.117 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 18.1 t90 -60.68 -41.95 96.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.409 ' C ' HD22 ' A' ' 19' ' ' LEU . 52.9 p -76.64 69.63 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.384 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -152.39 -80.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.047 0.451 . . . . 1.0 110.476 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 57' ' ' TYR . 16.7 pt-20 -60.45 -20.87 61.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 52' ' ' ALA . 15.1 t -65.18 -43.73 90.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.137 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -56.1 -50.05 72.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -79.82 37.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.362 0.601 . . . . 1.0 109.437 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 19.2 p 60.28 -117.95 0.8 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.388 -0.824 . . . . 1.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 53' ' ' THR . 2.5 t 69.87 -54.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.13 -1.91 88.27 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' ASP . 3.2 m-85 -90.58 34.49 0.89 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.45 -9.78 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 57' ' ' TYR . 11.6 t0 74.29 9.36 4.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.422 . . . . 1.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -145.08 -162.13 1.44 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 13.2 p90 -167.88 98.32 0.59 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.094 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.99 150.23 77.74 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.453 1.435 . . . . 1.0 112.122 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.99 HG22 ' H ' ' A' ' 64' ' ' THR . 14.3 p -87.64 -136.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.99 ' H ' HG22 ' A' ' 63' ' ' VAL . 29.7 m -107.19 -44.28 4.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.524 0.33 . . . . 1.0 110.907 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.0 tt0 -56.17 -41.64 75.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.807 0.337 . . . . 1.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -65.13 24.94 0.02 OUTLIER 'General case' 0 C--O 1.264 1.856 0 CA-C-O 123.625 1.679 . . . . 1.0 109.8 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 42.97 65.9 1.29 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 117.968 -1.462 . . . . 1.0 111.487 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 56.3 ttm-85 -24.33 -34.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.161 0.981 . . . . 1.0 110.833 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 67' ' ' GLY . 73.4 mmtt -48.15 -19.03 0.24 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.145 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.3 t -61.19 -47.49 93.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 119.662 -0.815 . . . . 1.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.59 -41.8 19.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.854 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -52.71 -48.29 66.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.685 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.87 -40.3 97.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 70' ' ' VAL . 95.0 t -62.97 -46.48 96.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.177 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.11 -43.22 99.06 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.99 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.81 -41.06 94.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.61 -36.34 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.386 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.18 -39.56 94.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.07 -43.73 98.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.653 0.263 . . . . 1.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -62.51 -46.17 89.65 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.33 -49.35 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.929 0.395 . . . . 1.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -69.0 -27.88 66.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.905 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -84.54 -28.03 26.94 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.006 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.41 -45.98 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.335 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HB1' ' A' ' 8' ' ' ALA . 4.4 m -57.41 -18.55 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.361 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.1 m -38.16 -31.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.101 0.477 . . . . 1.0 110.442 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -58.95 -51.1 71.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.338 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -61.88 -29.61 70.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.034 0.445 . . . . 1.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.471 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -70.86 -35.38 72.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -65.73 -50.45 64.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.088 0.47 . . . . 1.0 111.432 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -59.54 -4.54 0.64 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.0 m-20 -55.28 -66.08 0.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.305 . . . . 1.0 111.129 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.5 p90 -62.76 -39.61 94.69 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.337 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 70.9 t -43.47 -31.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.55 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.26 -22.1 66.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 1.0 111.345 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.541 ' NH2' HG11 ' B' ' 94' ' ' VAL . 29.6 ptt180 -59.95 -34.28 73.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.711 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.43 -41.0 84.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.86 -33.77 74.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.595 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.94 -34.95 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.356 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -60.24 -45.06 94.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.839 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -87.45 -16.12 35.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.36 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.81 19.29 79.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.153 -0.779 . . . . 1.0 111.153 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.074 -0.965 . . . . 1.0 110.614 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.432 ' O ' ' O ' ' B' ' 2' ' ' ALA . 76.5 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.308 -0.626 . . . . 1.0 109.308 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 45.35 -172.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 4' ' ' HIS . 52.7 p-10 -133.16 -26.36 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.726 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 3' ' ' ASP . 15.8 p-80 -83.69 -26.3 29.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.531 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.31 -42.69 87.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -64.28 -42.53 96.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.567 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.2 -40.16 84.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 1.0 109.868 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.88 97.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.729 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.69 -37.95 87.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 1.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.74 -39.48 91.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.76 -36.8 79.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.788 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.68 -36.92 85.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 1.0 110.518 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.289 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -64.08 -37.22 86.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.546 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' B' ' 52' ' ' ALA . 50.4 tp -62.89 -41.46 99.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.421 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.45 -38.12 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.791 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' B' ' 21' ' ' GLU . 25.8 ttpp -61.07 -43.1 99.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.54 -41.78 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.6 mt -59.66 -41.35 90.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.1 mt-10 -63.06 -44.05 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 47.8 mt-10 -70.08 -33.96 72.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.023 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -63.6 -39.93 95.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.413 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.1 p -59.3 -43.59 92.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.07 -63.85 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.413 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -59.88 -39.61 85.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.564 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.8 -51.38 56.92 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.941 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.99 -47.18 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.141 -0.624 . . . . 1.0 110.943 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -64.37 -39.53 94.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.763 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.11 91.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 79.5 mm-40 -67.48 -42.45 82.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.789 0.328 . . . . 1.0 111.16 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -52.62 102.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 1.0 110.805 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 113.3 -9.13 24.62 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.51 138.27 23.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.834 -0.215 . . . . 1.0 110.672 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.59 141.55 25.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.91 1.74 . . . . 1.0 112.341 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.18 26.82 68.13 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -47.16 -58.3 4.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 1.0 110.794 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' B' ' 36' ' ' ALA . . . 70.42 -20.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.383 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' B' ' 36' ' ' ALA . 24.4 tp -110.6 119.51 39.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.1 pt -154.89 168.92 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.627 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.5 OUTLIER 80.22 135.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.0 110.989 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.668 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 4.1 t80 -72.12 -41.82 8.93 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.912 -0.585 . . . . 1.0 111.564 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.5 Cg_endo -58.22 -32.7 96.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.494 1.463 . . . . 1.0 112.794 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.546 ' CG ' HH12 ' B' ' 60' ' ' ARG . 35.4 p-10 -99.05 -7.45 26.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.54 -44.11 91.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 1.0 110.406 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -64.49 -33.58 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.683 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.3 OUTLIER -61.17 -46.8 89.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.515 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.404 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.1 OUTLIER -71.01 -28.36 64.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.42 ' O ' HD22 ' B' ' 19' ' ' LEU . 3.1 t -68.49 -35.4 77.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.589 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.662 HG11 HH12 ' C' ' 68' ' ' ARG . 47.2 t -60.47 -48.4 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.856 0.317 . . . . 1.0 111.856 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.433 ' HB3' HH21 ' C' ' 68' ' ' ARG . 6.3 pt-20 -68.96 -28.84 66.99 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.472 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -62.28 -47.19 85.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.155 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.721 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.55 -36.74 69.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.502 ' C ' ' H ' ' B' ' 55' ' ' VAL . 82.1 p -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.43 HG23 ' C ' ' B' ' 53' ' ' THR . 2.7 p 66.09 -6.7 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.302 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' B' ' 57' ' ' TYR . 69.5 t -65.33 -47.34 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.922 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 67.43 -34.8 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER 61.88 -73.08 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.803 0.335 . . . . 1.0 110.604 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 57' ' ' TYR . . . 158.72 29.94 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.69 -62.41 1.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 1.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.546 HH12 ' CG ' ' B' ' 43' ' ' ASP . 81.5 mtm180 -147.43 -170.24 3.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.394 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -173.82 136.72 0.67 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.12 -171.73 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.576 1.518 . . . . 1.0 112.138 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.552 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.0 t -118.06 -135.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.155 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.953 HG23 ' CD1' ' A' ' 46' ' ' TRP . 26.2 m -114.39 -37.12 4.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.541 -0.299 . . . . 1.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.612 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.8 tt0 -66.49 -34.1 77.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.509 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -71.19 32.02 0.05 OUTLIER 'General case' 0 C--O 1.267 2.016 0 CA-C-O 123.709 1.718 . . . . 1.0 109.972 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.98 63.91 1.62 Allowed Glycine 0 C--O 1.214 -1.127 0 CA-C-N 113.916 -1.493 . . . . 1.0 111.14 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' B' ' 67' ' ' GLY . 58.8 ttm-85 -23.95 -33.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.384 1.092 . . . . 1.0 110.91 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 99.0 mttt -48.27 -18.48 0.22 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' B' ' 67' ' ' GLY . 53.6 t -61.93 -46.91 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 C-N-CA 119.953 -0.699 . . . . 1.0 109.754 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -48.16 38.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.457 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.45 -45.11 12.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.275 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.01 -46.93 87.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.686 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.0 -46.01 82.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.456 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.09 -44.12 97.34 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.72 -37.74 85.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.376 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.495 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.16 -41.23 96.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.674 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.2 -42.25 94.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.53 -43.55 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.071 -0.252 . . . . 1.0 111.075 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.76 -40.39 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 1.0 110.797 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.8 t -63.07 -46.92 94.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.151 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -74.7 0.79 14.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.018 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -106.31 -37.6 6.49 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -62.98 -39.99 96.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.057 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -52.62 -8.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.005 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.494 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.7 m -61.35 -21.54 64.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.54 -23.32 49.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.49 -10.83 18.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.533 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 38.6 mt -99.14 -25.89 14.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.953 0.406 . . . . 1.0 110.293 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -13.55 60.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.891 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.37 -4.46 29.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.122 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 89.2 m-20 -61.19 -43.56 98.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 4.7 p90 -70.5 -32.64 70.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.153 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.541 HG11 ' NH2' ' A' ' 96' ' ' ARG . 61.7 t -61.79 -27.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.711 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.61 -22.98 64.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.441 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -59.49 -37.09 77.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 1.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH2' ' B' ' 100' ' ' ARG . 44.8 tp10 -65.82 -40.11 91.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.986 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.41 -34.78 79.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.468 ' NH2' ' OE2' ' B' ' 97' ' ' GLU . 59.8 ttp180 -60.0 -45.25 93.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 1.0 110.19 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -68.64 -36.89 79.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 84.31 22.68 53.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.437 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 97.5 m-70 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.663 ' CB ' ' CE1' ' C' ' 4' ' ' HIS . . . -82.93 171.33 13.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.837 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -59.38 -46.3 89.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.663 ' CE1' ' CB ' ' C' ' 2' ' ' ALA . 8.7 p-80 -69.04 -36.55 77.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.644 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.44 -36.32 83.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -62.91 -38.3 90.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.835 0.35 . . . . 1.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.33 -42.22 98.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.021 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.0 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.63 -39.57 93.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.398 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.12 -41.33 98.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.333 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.88 88.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.52 -39.89 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 1.0 111.106 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.69 -34.67 78.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.742 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.44 -36.16 82.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.538 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.416 HD13 ' HA2' ' C' ' 78' ' ' GLY . 51.3 tp -62.17 -41.21 98.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.345 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -58.26 -39.15 78.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.23 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.63 -38.48 87.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.852 0.358 . . . . 1.0 110.828 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.8 mt -58.75 -40.52 84.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.672 -0.411 . . . . 1.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.4 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.0 mm-40 -56.94 -45.43 82.79 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.96 -37.1 78.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.033 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -63.62 -39.52 94.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.415 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 90.2 p -61.41 -35.78 78.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' C' ' 26' ' ' ALA . 88.2 tttt -73.79 -77.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.106 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' C' ' 29' ' ' ALA . 14.6 mptt -38.98 -25.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' C' ' 24' ' ' LYS . . . -64.88 -41.61 95.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.74 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' C' ' 28' ' ' GLU . 1.7 m -63.73 -47.63 90.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.029 0.442 . . . . 1.0 110.366 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' C' ' 30' ' ' GLU . 96.8 mt-10 -71.64 -36.58 70.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.428 -0.805 . . . . 1.0 110.365 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' LYS . . . -70.91 29.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' C' ' 28' ' ' GLU . 3.6 tp10 -153.46 -38.98 0.1 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.954 0.407 . . . . 1.0 110.283 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -65.36 86.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.065 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.4 20.42 2.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.489 ' HB2' ' CD ' ' C' ' 66' ' ' GLU . . . -105.4 151.49 39.71 Favored Pre-proline 0 N--CA 1.466 0.373 0 O-C-N 122.886 -0.185 . . . . 1.0 110.685 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.55 115.8 4.15 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.167 1.245 . . . . 1.0 111.106 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 82.5 18.08 67.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.259 -0.736 . . . . 1.0 111.259 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.48 ' HB1' ' HG3' ' C' ' 30' ' ' GLU . . . -42.35 167.98 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.919 0.39 . . . . 1.0 110.472 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.95 -30.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.436 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.59 101.31 13.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.104 0.478 . . . . 1.0 110.225 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' C' ' 40' ' ' SER . 42.2 pt -128.83 161.25 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.217 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.8 OUTLIER 80.81 140.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 1.0 110.604 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.641 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 46.0 t80 -79.65 -41.96 1.51 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.188 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.5 Cg_endo -59.92 -29.9 90.51 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.489 1.459 . . . . 1.0 112.453 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' C' ' 44' ' ' ALA . 2.8 p-10 -93.56 -23.22 18.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.719 0.295 . . . . 1.0 111.198 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' C' ' 43' ' ' ASP . . . -63.55 -33.27 75.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.864 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.403 ' H ' HG22 ' C' ' 45' ' ' ILE . 3.1 tp -65.38 -41.11 90.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.686 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.5 OUTLIER -61.44 -42.93 99.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.811 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.535 ' NE1' ' OH ' ' B' ' 57' ' ' TYR . 3.7 t90 -59.61 -40.04 86.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' C' ' 51' ' ' THR . 15.5 m -58.27 -33.1 69.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.99 -44.89 92.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.482 ' OE1' ' NH1' ' D' ' 68' ' ' ARG . 9.0 pt-20 -87.51 73.11 9.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.693 0.282 . . . . 1.0 111.289 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' C' ' 48' ' ' SER . 0.6 OUTLIER -177.0 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.171 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.455 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -71.36 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.041 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.405 ' C ' HG23 ' C' ' 54' ' ' THR . 2.6 p -92.16 20.5 5.89 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.405 HG23 ' C ' ' C' ' 53' ' ' THR . 1.2 p 57.5 33.5 23.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.873 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.429 HG11 ' SD ' ' D' ' 75' ' ' MET . 74.2 t -132.5 87.14 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.119 0.485 . . . . 1.0 110.112 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.89 79.14 1.65 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.536 ' CZ ' ' O ' ' D' ' 60' ' ' ARG . 0.8 OUTLIER -60.08 -47.34 86.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.931 0.396 . . . . 1.0 110.523 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 147.31 -85.58 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.729 -0.949 . . . . 1.0 110.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.459 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 92.4 m-20 41.61 -89.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 1.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' C' ' 58' ' ' GLY . 84.2 mtm180 -127.8 150.85 49.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.887 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -153.41 147.51 18.81 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.74 156.94 62.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.254 1.969 . . . . 1.0 112.04 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.1 t -89.22 -132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.476 ' C ' ' H ' ' C' ' 66' ' ' GLU . 99.4 m -115.3 -56.96 2.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.833 0.349 . . . . 1.0 110.703 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -52.85 -10.08 0.15 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 10.7 mp0 -108.28 47.04 0.92 Allowed 'General case' 0 C--O 1.272 2.261 0 CA-C-O 124.747 2.213 . . . . 1.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 37.4 60.99 1.07 Allowed Glycine 0 C--O 1.218 -0.905 0 CA-C-N 112.432 -2.167 . . . . 1.0 111.128 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.662 HH12 HG11 ' B' ' 49' ' ' VAL . 60.9 ttt-85 -25.18 -32.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.738 0.769 . . . . 1.0 111.074 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.718 ' N ' ' O ' ' C' ' 67' ' ' GLY . 52.4 mtmt -55.4 -9.08 0.41 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.702 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.0 t -58.32 -45.64 89.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 118.617 -1.233 . . . . 1.0 110.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.97 38.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 1.0 111.15 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -56.89 -46.02 82.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.067 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.87 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.414 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.12 -44.02 91.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.653 -0.419 . . . . 1.0 111.395 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.14 -41.25 99.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.126 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.99 -35.49 75.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.708 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.46 74.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.357 . . . . 1.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.65 -36.63 88.18 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.07 -44.01 97.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.678 -0.307 . . . . 1.0 110.729 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.76 -43.85 87.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.814 -0.354 . . . . 1.0 111.099 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.0 -48.66 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.517 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.456 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.4 m-85 -73.98 -14.44 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.084 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.0 -32.14 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 1.0 110.171 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.2 tt -66.45 -39.61 88.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.483 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.456 HG22 ' O ' ' C' ' 82' ' ' PHE . 3.6 m -47.93 -9.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.055 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.516 ' H ' ' C ' ' C' ' 84' ' ' LEU . 27.1 m -57.4 -38.88 75.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.411 . . . . 1.0 110.024 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -51.3 -23.25 3.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.088 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.0 -11.54 26.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.85 -49.39 7.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.318 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.37 -13.97 4.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.975 0.417 . . . . 1.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.2 OUTLIER -101.02 -5.37 25.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.165 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 91.3 m-20 -61.09 -47.85 84.39 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 36.9 p90 -78.35 -36.62 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.35 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 86.9 t -46.51 -34.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.763 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -62.33 -20.65 64.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.713 0.292 . . . . 1.0 111.242 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' C' ' 96' ' ' ARG . 25.1 ptt-85 -49.48 -38.96 32.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.51 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.256 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' C' ' 102' ' ' GLY . 97.2 mt-10 -67.6 -36.18 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 1.0 110.327 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.97 -26.37 65.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.563 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -59.72 -44.95 93.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.619 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -108.41 -5.86 16.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.804 0.335 . . . . 1.0 110.614 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 102' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' C' ' 98' ' ' GLU . . . 77.8 17.03 79.3 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.603 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' SER . . . . . 0.433 ' O ' ' O ' ' D' ' 2' ' ' ALA . 54.7 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' D' ' 1' ' ' SER . . . 54.05 107.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.451 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -66.8 -21.93 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -41.7 94.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.267 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.45 -37.91 88.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.553 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -62.98 -42.53 99.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.354 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.51 -44.98 69.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' ALA . . . . . 0.432 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -65.47 -43.85 89.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.41 -38.01 89.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.567 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -39.18 92.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.711 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.99 73.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLU . . . . . 0.409 ' OE2' ' CE1' ' D' ' 82' ' ' PHE . 79.7 mm-40 -65.48 -33.73 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.23 -40.98 97.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.887 0.375 . . . . 1.0 110.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.91 -30.43 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.431 HD11 ' HB1' ' D' ' 52' ' ' ALA . 51.8 tp -61.97 -42.12 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.324 . . . . 1.0 110.486 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -62.23 -40.14 95.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.59 -41.65 92.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -60.35 -41.77 94.33 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.181 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.9 mt-10 -62.7 -48.12 80.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -69.83 -42.23 73.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 1.0 110.49 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.06 85.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.085 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -58.98 -43.58 91.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.85 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.54 -32.37 73.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.649 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -78.5 -38.26 41.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.849 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.81 75.88 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.166 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.537 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.9 p -63.11 -45.15 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 1.0 110.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.537 ' N ' HG13 ' D' ' 27' ' ' VAL . 83.7 tt0 -66.26 -42.85 87.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.511 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.44 97.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.279 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -64.98 -32.99 74.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.811 -0.356 . . . . 1.0 110.451 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.02 130.58 41.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.953 0.406 . . . . 1.0 110.454 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.07 -10.38 63.8 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.25 148.98 36.63 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.453 ' O ' HG11 ' D' ' 63' ' ' VAL . 80.9 Cg_endo -74.59 137.6 22.94 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.87 1.713 . . . . 1.0 112.208 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.57 74.42 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 138.52 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.979 0.419 . . . . 1.0 110.442 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.84 -30.98 4.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.311 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.414 ' C ' HD23 ' D' ' 38' ' ' LEU . 4.3 tt -97.38 76.39 2.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 1.0 110.166 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -101.97 -2.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.417 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 10.6 p -76.44 148.15 37.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.552 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.7 OUTLIER -104.43 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.11 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.3 Cg_endo -57.98 -31.67 93.4 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.612 1.541 . . . . 1.0 111.744 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.37 -0.79 57.7 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.195 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.7 89.21 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.819 0.343 . . . . 1.0 110.39 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.428 ' O ' HG23 ' D' ' 49' ' ' VAL . 5.1 tt -65.48 -38.39 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.468 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.44 -46.45 80.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.064 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -65.47 -38.64 90.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.17 -35.14 80.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.786 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 45' ' ' ILE . 40.9 t -60.13 -48.79 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.834 -0.347 . . . . 1.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.78 -29.35 68.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.075 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.4 m -63.04 -44.84 94.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.54 -30.39 70.61 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 23.2 p -80.76 8.93 7.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.34 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 73.1 p 41.26 70.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.444 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' D' ' 57' ' ' TYR . 0.2 OUTLIER -146.78 -42.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.334 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.56 -38.8 0.6 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' D' ' 55' ' ' VAL . 1.6 t80 66.12 -68.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 1.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . 146.0 32.21 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.0 m-20 -85.44 -58.49 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.536 ' O ' ' CZ ' ' C' ' 57' ' ' TYR . 94.1 mtt-85 -141.0 -179.39 6.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -158.01 137.09 8.13 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.697 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.66 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.3 2.0 . . . . 1.0 112.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.528 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -89.4 -140.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.814 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.686 HG23 ' CD1' ' C' ' 46' ' ' TRP . 5.1 m -114.68 -32.54 5.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' D' ' 67' ' ' GLY . 79.9 tt0 -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.926 0.394 . . . . 1.0 110.576 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.2 OUTLIER -77.49 24.88 0.19 Allowed 'General case' 0 C--O 1.262 1.758 0 CA-C-O 123.715 1.722 . . . . 1.0 109.219 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.87 62.22 3.06 Favored Glycine 0 C--O 1.213 -1.181 0 CA-C-N 113.87 -1.514 . . . . 1.0 109.439 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.482 ' NH1' ' OE1' ' C' ' 50' ' ' GLU . 58.6 ttm-85 -25.21 -30.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.216 0.598 . . . . 1.0 110.985 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.725 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.1 mttp -51.2 -24.63 4.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.351 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' D' ' 67' ' ' GLY . 74.8 t -62.37 -49.47 83.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.039 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -39.29 72.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.476 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -61.35 -37.03 81.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.848 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.01 -41.67 99.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.411 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.43 -43.24 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.267 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.429 ' SD ' HG11 ' C' ' 55' ' ' VAL . 63.4 mtt -58.82 -45.92 88.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.081 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -65.58 -38.36 89.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 1.0 110.576 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.405 ' O ' HG22 ' D' ' 81' ' ' VAL . . . -59.0 -40.26 84.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.499 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.67 -39.27 86.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.33 -43.44 97.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.414 -0.463 . . . . 1.0 111.19 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.65 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.501 HG23 ' N ' ' D' ' 82' ' ' PHE . 16.0 m -60.82 -50.31 81.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.457 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' PHE . . . . . 0.501 ' N ' HG23 ' D' ' 81' ' ' VAL . 24.6 m-85 -66.97 -41.38 86.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.11 78.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.313 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' D' ' 86' ' ' THR . 7.7 tt -61.79 -42.15 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.432 HG22 ' HB1' ' D' ' 8' ' ' ALA . 49.1 t -50.21 -15.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -54.73 -19.5 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.119 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -62.24 -62.97 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.827 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.86 75.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.139 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.06 -47.47 68.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.899 0.38 . . . . 1.0 110.732 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.457 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -61.45 -25.39 67.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 1.3 m -84.01 -3.55 58.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.319 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 87.1 m-20 -60.62 -46.76 89.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 9.0 p90 -65.54 -32.29 73.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.615 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.51 -42.74 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.181 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -52.96 -22.12 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -50.42 -37.34 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 1.0 110.459 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.86 -44.87 82.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.876 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' D' ' 98' ' ' GLU . 54.1 mp0 -68.94 -39.01 79.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.917 0.389 . . . . 1.0 110.198 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.52 -37.28 84.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.226 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.46 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 64.5 ttm-85 -64.49 -40.91 96.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.598 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.65 -1.53 32.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 26.5 p80 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.103 -0.951 . . . . 1.0 110.761 179.775 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.442 ' OG ' ' NH2' ' A' ' 6' ' ' ARG . 7.3 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . -156.43 24.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 59.54 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 2' ' ' ALA . 31.1 p80 -56.75 -40.2 75.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 1.0 110.663 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 43.7 tt0 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.315 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' NH2' ' OG ' ' A' ' 1' ' ' SER . 84.0 mmt-85 -64.43 -38.52 91.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.178 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.04 -40.0 90.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.68 88.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.49 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -62.21 -39.61 93.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.18 -37.67 88.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.422 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.97 79.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.59 -37.8 88.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 1.0 110.524 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -64.75 -35.97 82.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.914 0.387 . . . . 1.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.62 -33.22 75.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' HA2' ' A' ' 78' ' ' GLY . 49.6 tp -62.29 -42.0 98.98 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.628 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.34 -37.71 86.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.153 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -61.9 -41.64 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.723 0.297 . . . . 1.0 110.98 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.53 -42.03 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.467 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.0 mt -59.49 -40.94 88.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.055 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.66 -48.59 81.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.684 -0.407 . . . . 1.0 109.935 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.039 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.99 90.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.577 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -59.67 -43.05 94.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.129 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -58.28 -64.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.56 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.97 -37.8 80.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.648 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.94 -49.41 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.861 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.74 -43.18 90.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.526 -0.469 . . . . 1.0 110.179 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -61.33 -42.62 98.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.724 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -56.46 -53.37 58.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -65.02 -19.58 66.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.157 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -82.53 89.41 6.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.887 -0.325 . . . . 1.0 111.249 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.58 6.12 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 116.192 -0.458 . . . . 1.0 112.012 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.94 144.55 29.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.807 0.304 . . . . 1.0 110.287 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.45 142.03 26.06 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.954 1.77 . . . . 1.0 112.231 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.47 12.14 80.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.1 138.14 57.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 1.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.77 -58.66 1.94 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.612 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.53 99.21 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.976 0.417 . . . . 1.0 110.427 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 pt -135.5 55.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.457 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 3.4 m -156.54 132.66 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.061 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.576 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 91.6 m-85 -67.19 -44.22 47.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.578 0.584 . . . . 1.0 112.578 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.5 Cg_endo -60.04 -32.44 94.85 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 121.272 1.315 . . . . 1.0 112.76 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.9 p-10 -99.8 -1.1 38.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 121.017 -0.273 . . . . 1.0 110.948 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.429 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -66.16 -43.78 85.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 1.0 110.495 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.412 ' H ' HG22 ' A' ' 45' ' ' ILE . 5.1 tt -66.69 -38.73 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.653 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -56.52 -46.07 80.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE3' ' N ' ' A' ' 48' ' ' SER . 1.6 t90 -67.36 -39.01 85.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.906 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.492 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 m -55.74 -25.51 40.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.163 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.93 -44.81 78.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.414 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 99.5 mt-10 -79.7 69.02 5.93 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.408 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -174.65 -46.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.4 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.17 -25.4 65.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 54' ' ' THR . 33.0 p -92.44 -0.79 57.32 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 53' ' ' THR . 16.5 p 57.14 76.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.207 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' B' ' 75' ' ' MET . 89.4 t -148.77 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.688 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.4 89.85 0.8 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.546 -0.622 . . . . 1.0 111.546 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -63.93 -42.87 97.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 1.0 110.948 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.76 15.61 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.67 -68.65 0.35 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.638 0.256 . . . . 1.0 110.904 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -134.14 159.49 40.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.13 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' D' ' 57' ' ' TYR . 20.3 t80 -172.34 137.8 0.91 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.46 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.13 -172.63 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.804 1.669 . . . . 1.0 112.013 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 64' ' ' THR . 11.1 p -117.75 -121.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.746 ' N ' HG13 ' A' ' 63' ' ' VAL . 36.4 m -111.31 -61.77 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.658 0.266 . . . . 1.0 111.098 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -49.06 -20.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.149 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.627 ' CD ' HG12 ' A' ' 63' ' ' VAL . 44.9 mt-10 -87.87 36.4 0.76 Allowed 'General case' 0 C--O 1.265 1.921 0 CA-C-O 124.433 2.063 . . . . 1.0 109.032 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.65 63.43 1.21 Allowed Glycine 0 C--O 1.212 -1.261 0 CA-C-N 112.937 -1.938 . . . . 1.0 111.11 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' D' ' 59' ' ' ASP . 62.2 ttm-85 -24.92 -33.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.025 0.913 . . . . 1.0 111.055 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 67' ' ' GLY . 70.9 mmtt -49.93 -18.27 0.5 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.48 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -62.41 -47.56 92.43 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 119.288 -0.965 . . . . 1.0 110.449 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.62 69.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.307 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.32 -37.96 88.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.823 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.1 -43.99 82.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.848 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -44.57 92.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.41 -41.58 98.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.57 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.35 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.87 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.568 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -65.84 -42.52 94.99 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.4 -43.37 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.627 0.251 . . . . 1.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.71 -43.45 97.81 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.265 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.58 -49.25 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.002 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.37 -13.85 61.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.392 . . . . 1.0 111.086 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.39 -35.54 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 1.0 110.715 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.88 -42.17 97.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ALA . 11.4 m -59.42 -23.14 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.421 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.7 m -36.71 -28.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 1.0 110.624 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.35 -49.01 79.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.269 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -63.48 -32.4 73.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.284 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.2 mm? -66.48 -40.22 89.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.555 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.28 -45.12 84.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.842 0.353 . . . . 1.0 110.955 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.97 -3.22 34.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.258 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.42 -48.65 76.51 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.582 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.8 p90 -73.62 -37.06 65.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 1.0 111.451 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 95.3 t -48.29 -27.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.592 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -66.25 -21.44 66.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.85 -41.6 87.35 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 100' ' ' ARG . 97.2 mt-10 -79.5 -168.34 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.303 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.99 -72.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.817 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttp85 -59.34 -44.62 92.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.556 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -119.04 113.2 20.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.028 0.442 . . . . 1.0 109.857 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 0.27 23.54 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.517 ' ND1' ' OXT' ' A' ' 103' ' ' HIS . 50.1 t-80 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 43.5 -157.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.661 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 67.5 t0 -128.2 -35.59 2.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.657 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 15.4 p-80 -79.3 -22.19 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.532 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.22 -37.81 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.74 -39.85 95.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.15 -40.55 90.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.935 0.398 . . . . 1.0 110.05 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -63.05 -45.72 90.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -65.34 -41.26 94.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -63.6 -36.4 83.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.483 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.0 86.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.965 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.03 -37.25 73.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 1.0 110.613 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.3 -32.97 74.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.194 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.18 -39.52 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.389 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.9 tp -61.89 -42.79 99.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.273 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -53.95 -39.75 66.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.97 -37.77 86.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.527 -0.306 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.19 -41.83 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 1.5 tp -60.36 -48.07 83.31 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' B' ' 23' ' ' SER . 81.0 mm-40 -64.68 -41.96 95.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.233 0.539 . . . . 1.0 109.745 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.64 -26.69 68.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' LEU . . . -64.67 -37.51 87.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.248 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 97.9 p -58.86 -45.36 90.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.556 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.66 -30.75 71.49 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.45 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 29' ' ' ALA . 29.1 mmtp -79.3 -42.88 24.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.45 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.17 -47.99 77.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.441 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 28' ' ' GLU . 8.3 p -61.75 -45.88 97.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.509 . . . . 1.0 109.971 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.564 ' N ' HG13 ' B' ' 27' ' ' VAL . 79.9 tt0 -71.18 -21.22 62.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -58.49 -40.47 82.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.963 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 27.3 mp0 -65.93 -36.4 83.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 1.0 110.294 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -66.79 90.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.431 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 126.72 -15.31 6.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.28 19.17 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 87.2 Cg_endo -76.42 118.42 4.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.075 1.85 . . . . 1.0 112.235 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.8 37.68 1.13 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.89 143.34 32.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.64 -51.3 0.09 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.232 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.581 ' C ' HD23 ' B' ' 38' ' ' LEU . 5.0 tt -60.96 -60.29 4.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.981 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' B' ' 40' ' ' SER . 44.9 pt 31.56 -145.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 123.436 0.46 . . . . 1.0 110.729 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.464 ' O ' ' O ' ' B' ' 39' ' ' ILE . 19.3 m 57.39 144.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.331 0.586 . . . . 1.0 111.162 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.54 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 2.7 m-85 -100.58 -64.37 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.763 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 23.3 Cg_endo -58.85 -23.49 67.53 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.293 1.995 . . . . 1.0 112.432 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -90.76 -21.18 21.67 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.677 0.275 . . . . 1.0 110.697 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.69 88.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.841 0.353 . . . . 1.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.409 ' H ' HG22 ' B' ' 45' ' ' ILE . 5.9 tt -61.8 -36.49 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.216 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.504 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.6 OUTLIER -67.77 -43.16 80.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.421 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.464 ' CD1' ' OE2' ' B' ' 50' ' ' GLU . 19.5 t90 -61.6 -41.6 97.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.731 0.3 . . . . 1.0 110.669 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 m -60.94 -38.11 84.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.475 -0.49 . . . . 1.0 110.581 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.75 -44.41 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.464 ' OE2' ' CD1' ' B' ' 47' ' ' TRP . 5.0 pt-20 -55.78 -38.9 70.52 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.709 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.63 ' C ' ' H ' ' B' ' 53' ' ' THR . 6.0 t -87.34 -152.44 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.216 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 58.94 -9.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.475 0.179 . . . . 1.0 110.663 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.63 ' H ' ' C ' ' B' ' 51' ' ' THR . 67.0 p -113.06 15.32 19.6 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.648 0.261 . . . . 1.0 110.937 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.07 66.5 1.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.916 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.529 HG13 ' N ' ' B' ' 56' ' ' GLY . 9.9 p -147.56 -46.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.758 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 44.73 78.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -45.23 94.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.681 0.277 . . . . 1.0 110.502 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.65 3.63 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.644 -0.983 . . . . 1.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 99.5 m-20 -62.51 -41.43 98.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.363 . . . . 1.0 110.688 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -117.11 -173.17 2.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -139.57 99.4 7.77 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.615 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.12 160.52 48.39 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.375 1.383 . . . . 1.0 112.285 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.537 HG12 ' H ' ' B' ' 64' ' ' THR . 0.9 OUTLIER -79.24 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.588 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 66' ' ' GLU . 1.8 m -115.35 -67.82 0.97 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.288 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.438 ' N ' HG22 ' B' ' 64' ' ' THR . 80.7 tt0 -34.02 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.224 0.535 . . . . 1.0 110.701 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.867 ' O ' ' N ' ' B' ' 68' ' ' ARG . 91.8 mt-10 -147.85 -107.07 0.09 Allowed 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.549 -0.75 . . . . 1.0 109.359 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 23.06 -56.54 0.0 OUTLIER Glycine 0 N--CA 1.478 1.49 0 O-C-N 124.635 1.209 . . . . 1.0 114.355 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.867 ' N ' ' O ' ' B' ' 66' ' ' GLU . 36.6 ttt180 -72.13 -46.09 57.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' B' ' 66' ' ' GLU . 84.5 tttt -64.16 -34.2 77.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.832 -1.173 . . . . 1.0 107.832 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.71 -44.66 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.96 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.6 76.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.234 -0.439 . . . . 1.0 109.936 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -52.39 -50.47 62.4 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.898 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.47 -48.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.516 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 55' ' ' VAL . 78.2 mtm -61.52 -47.62 84.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.785 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' B' ' 80' ' ' GLU . 51.6 tttp -66.44 -40.51 89.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.521 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.7 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.78 94.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.55 -43.17 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.001 -0.28 . . . . 1.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -58.59 -47.39 84.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.061 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.84 -50.37 75.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.619 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -67.9 -37.21 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.689 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.03 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.32 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' B' ' 86' ' ' THR . 3.6 tt -61.59 -42.03 98.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.477 HG13 ' HB1' ' B' ' 8' ' ' ALA . 26.2 t -49.09 -21.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.406 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.5 m -48.77 -21.07 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' B' ' 91' ' ' THR . . . -58.55 -54.52 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 1.0 111.024 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.71 89.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.828 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.519 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.0 mm? -63.04 -42.75 99.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.412 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -64.35 -35.74 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.437 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -82.57 -4.36 57.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.535 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.567 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 36.6 t0 -57.93 -48.75 78.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.57 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 10.7 p90 -67.14 -32.44 73.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.008 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.68 -43.71 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.76 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -57.37 -21.62 37.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.487 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -58.97 -33.07 70.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.068 0.461 . . . . 1.0 109.936 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.55 -36.67 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.836 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.34 -41.07 94.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 1.0 110.595 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.17 -39.02 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.17 -44.05 97.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.45 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.29 108.88 14.71 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.97 -0.89 56.35 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.679 179.797 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.39 149.97 46.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.78 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.76 -40.3 94.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.328 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 15.2 p80 -66.83 -37.48 84.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.7 tt0 -62.69 -35.69 80.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.677 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.04 -39.7 95.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.01 -40.15 94.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.323 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.78 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.368 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.25 -36.54 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.371 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.42 -38.69 88.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.35 85.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.11 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.53 -39.49 93.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 1.0 111.011 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -63.55 -38.72 92.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.644 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.98 -32.38 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.546 HD11 ' HB1' ' C' ' 52' ' ' ALA . 45.5 tp -62.28 -38.52 89.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 1.0 110.315 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.62 -33.44 74.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.202 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.55 -46.95 83.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.697 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 18' ' ' VAL . 10.8 m -63.86 -37.6 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.81 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.9 mt -62.15 -41.87 98.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.0 mt-10 -64.49 -43.22 94.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.35 -39.41 71.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.313 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.4 84.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.0 p -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.413 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -65.56 -39.93 92.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.236 0.541 . . . . 1.0 109.965 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.2 mttp -66.8 -43.97 82.45 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.054 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -54.39 -53.56 52.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.748 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.433 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.3 p -58.12 -44.81 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.66 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.433 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.7 tt0 -68.34 -33.88 75.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.405 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' C' ' 26' ' ' ALA . 4.5 mp0 -81.79 -13.17 58.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.657 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.74 89.62 0.11 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.842 0.354 . . . . 1.0 110.425 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.08 20.05 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.3 140.47 72.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.438 ' O ' HG11 ' C' ' 63' ' ' VAL . 94.2 Cg_endo -76.26 141.34 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.936 1.758 . . . . 1.0 112.33 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.01 65.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.228 -0.749 . . . . 1.0 111.228 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 134.37 44.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.885 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.41 -22.73 16.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.356 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 tp -107.37 112.15 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.9 pt -139.26 -3.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.263 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -76.36 154.62 34.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.512 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 11.3 m-85 -96.18 -63.17 0.12 Allowed Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.3 Cg_endo -59.28 -36.12 95.52 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.99 1.794 . . . . 1.0 112.528 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.402 ' O ' ' NH1' ' C' ' 60' ' ' ARG . 90.8 m-20 -81.39 -7.11 59.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.257 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.47 87.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 1.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.448 HG23 ' N ' ' C' ' 46' ' ' TRP . 16.3 tt -65.5 -38.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.448 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.6 OUTLIER -54.78 -48.82 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.226 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.403 ' O ' ' N ' ' C' ' 49' ' ' VAL . 3.5 t90 -61.64 -41.18 97.14 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.682 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.454 ' O ' HD22 ' C' ' 19' ' ' LEU . 2.2 t -68.39 60.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.645 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' C' ' 47' ' ' TRP . 73.0 t -150.66 -56.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.085 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.405 ' HB3' HH12 ' D' ' 68' ' ' ARG . 9.1 pt-20 -64.36 -30.55 71.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.584 -0.446 . . . . 1.0 110.693 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 98.9 m -62.31 -46.62 87.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.25 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.713 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.48 -26.31 66.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.66 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' C' ' 54' ' ' THR . 47.3 p -91.21 5.25 49.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.96 0.41 . . . . 1.0 110.076 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 53' ' ' THR . 43.4 p 52.4 74.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.416 HG11 ' CE1' ' C' ' 57' ' ' TYR . 62.1 t -139.24 -68.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.294 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.13 75.23 0.48 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.416 ' CE1' HG11 ' C' ' 55' ' ' VAL . 37.4 m-85 -59.95 -45.98 90.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.69 0.281 . . . . 1.0 110.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.43 10.57 1.87 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' D' ' 61' ' ' TYR . 99.4 m-20 -60.02 -46.77 88.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 1.0 110.405 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' C' ' 43' ' ' ASP . 53.6 mtm180 -143.01 166.86 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.02 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -156.65 127.24 3.47 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.599 -0.44 . . . . 1.0 110.542 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.67 152.57 64.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.802 1.668 . . . . 1.0 112.236 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' C' ' 64' ' ' THR . 2.4 t -84.28 -134.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.24 -0.436 . . . . 1.0 109.949 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' C' ' 63' ' ' VAL . 72.3 m -114.59 -37.97 4.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.734 0.302 . . . . 1.0 110.721 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.2 tt0 -66.55 -28.2 68.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.469 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.445 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -72.17 26.05 0.05 Allowed 'General case' 0 C--O 1.264 1.82 0 CA-C-O 123.509 1.623 . . . . 1.0 110.36 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.44 64.06 1.93 Allowed Glycine 0 C--O 1.214 -1.095 0 CA-C-O 117.889 -1.506 . . . . 1.0 111.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' B' ' 59' ' ' ASP . 58.9 ttm-85 -24.41 -31.52 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.961 0.881 . . . . 1.0 111.368 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' C' ' 67' ' ' GLY . 14.5 mptt -49.5 -21.53 0.98 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.791 -0.641 . . . . 1.0 109.354 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 76.8 t -61.72 -49.52 83.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.9 -36.25 69.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.029 0.442 . . . . 1.0 110.696 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.34 -42.09 86.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.913 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.02 -41.1 97.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.086 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.31 -43.6 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.39 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 20.7 mtm -60.9 -44.08 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.125 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.57 -38.41 89.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.59 90.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.668 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.19 95.15 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.714 -0.554 . . . . 1.0 111.714 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.29 -43.14 97.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.51 -0.406 . . . . 1.0 110.982 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.97 -50.37 74.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.809 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' N ' ' C' ' 82' ' ' PHE . 12.0 m -61.84 -49.45 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.918 -0.313 . . . . 1.0 111.363 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.464 ' N ' HG23 ' C' ' 81' ' ' VAL . 32.5 m-85 -69.34 -40.13 77.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.019 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.519 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -64.94 -36.09 83.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 1.0 110.614 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.7 tt -62.55 -41.08 98.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.53 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -46.37 -19.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.533 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.9 m -51.94 -40.36 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -49.35 -27.48 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.243 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.58 -16.63 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.612 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' C' ' 86' ' ' THR . 55.3 mt -87.86 -44.07 11.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.164 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.15 -23.84 50.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.936 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -85.93 -4.42 59.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.898 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 94.3 m-20 -60.07 -45.27 93.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.698 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HB1' ' D' ' 90' ' ' ALA . 7.1 p90 -76.03 -28.6 57.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.067 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.81 -42.61 89.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.468 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -55.66 -21.8 19.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.198 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 42.6 ptt85 -50.74 -41.84 56.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 1.0 110.474 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 9.4 tm-20 -62.46 -41.06 98.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.694 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -67.07 -35.7 80.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.65 -27.35 69.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.767 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -59.4 -44.41 92.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.382 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -66.01 -37.8 86.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.307 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.56 64.72 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.04 -0.981 . . . . 1.0 110.455 179.808 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' SER . . . . . 0.625 ' N ' HH22 ' D' ' 6' ' ' ARG . 14.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.651 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -71.38 130.06 40.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.746 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 3' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 16.6 p-10 -77.01 -37.74 54.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.129 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.651 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 14.1 p-80 -65.59 -34.83 79.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.01 -38.84 92.8 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.573 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ARG . . . . . 0.625 HH22 ' N ' ' D' ' 1' ' ' SER . 84.2 mtt85 -64.24 -38.98 92.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.598 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -66.2 -40.15 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.175 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.85 92.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.772 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.84 -40.43 91.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 1.0 110.56 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.73 -35.66 81.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.516 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.68 79.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.966 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.16 -39.53 94.2 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.683 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.22 -36.44 83.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.65 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -63.99 -36.05 82.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.427 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -62.4 -41.38 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.643 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.86 -44.78 78.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.699 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.4 -40.09 96.28 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.204 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -49.02 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.98 -30.19 62.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.415 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -66.26 -49.92 65.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.669 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.17 -40.42 95.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' D' ' 26' ' ' ALA . . . -65.45 -34.15 77.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.823 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' D' ' 48' ' ' SER . 26.0 m -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.814 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -63.68 -39.07 93.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.46 -0.496 . . . . 1.0 110.036 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.73 -18.25 44.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.135 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -58.6 -50.23 74.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.382 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' D' ' 44' ' ' ALA . 28.9 t -65.65 -43.8 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.54 -30.76 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.32 -34.11 71.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.535 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' D' ' 32' ' ' GLY . 79.0 mm-40 -63.83 -46.87 83.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -46.21 95.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.433 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 126.93 -5.7 7.38 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -105.48 146.52 32.94 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.912 0.356 . . . . 1.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.627 ' O ' HG11 ' D' ' 63' ' ' VAL . 81.2 Cg_endo -75.64 117.34 4.73 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.113 1.875 . . . . 1.0 112.49 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 35' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' D' ' 37' ' ' ALA . . . 103.52 -22.67 35.23 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' D' ' 37' ' ' ALA . . . 46.93 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.694 0.283 . . . . 1.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 37' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' D' ' 36' ' ' ALA . . . 82.44 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -73.07 53.21 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.89 0.376 . . . . 1.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.8 tt -105.16 111.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.065 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.546 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 17.3 t 179.45 -118.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.125 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.7 m-85 177.27 -66.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.298 -0.26 . . . . 1.0 110.298 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -59.03 -31.16 95.15 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.024 1.816 . . . . 1.0 111.666 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -84.21 -9.19 58.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 44' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.24 -42.32 99.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.87 0.367 . . . . 1.0 110.516 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -67.68 -39.3 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.691 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -46.95 86.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.441 ' CD2' ' C ' ' D' ' 47' ' ' TRP . 0.3 OUTLIER -70.78 -20.76 62.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.232 -0.587 . . . . 1.0 109.604 178.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' D' ' 23' ' ' SER . 22.8 t -74.56 -40.49 61.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.106 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.89 -47.76 91.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -66.78 -37.61 84.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.118 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -62.45 -44.57 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.008 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.7 -25.42 62.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.413 ' OG1' HG23 ' D' ' 55' ' ' VAL . 21.8 p -97.77 9.81 41.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.203 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p 43.88 44.62 5.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.225 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' D' ' 53' ' ' THR . 94.9 t -86.83 -54.57 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.843 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.57 57.15 3.37 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.616 ' CG ' ' CD1' ' A' ' 61' ' ' TYR . 5.6 t80 -61.91 -41.79 98.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 1.0 110.491 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.19 -14.63 0.22 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.548 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -40.43 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.886 0.375 . . . . 1.0 110.958 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -132.39 156.62 46.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.103 -0.498 . . . . 1.0 109.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.51 ' CD2' ' OD1' ' C' ' 59' ' ' ASP . 5.6 p90 -149.3 153.28 37.32 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.81 160.04 51.3 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.299 1.999 . . . . 1.0 111.993 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.627 HG11 ' O ' ' D' ' 34' ' ' PRO . 18.2 t -90.05 -116.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.578 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.499 ' N ' HG12 ' D' ' 63' ' ' VAL . 60.7 m -116.23 -77.55 0.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.815 0.341 . . . . 1.0 110.95 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' D' ' 33' ' ' ALA . 52.5 tp10 -46.92 120.77 3.21 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.064 -0.717 . . . . 1.0 109.064 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.871 ' O ' ' N ' ' D' ' 68' ' ' ARG . 96.9 mt-10 55.09 -96.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.91 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.19 -55.68 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 O-C-N 125.086 1.491 . . . . 1.0 114.085 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.871 ' N ' ' O ' ' D' ' 66' ' ' GLU . 57.7 ttm-85 -80.04 -58.5 3.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.539 . . . . 1.0 109.87 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' D' ' 66' ' ' GLU . 99.0 mttt -43.46 -40.78 3.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.71 -46.9 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.536 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -49.84 68.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -44.18 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.863 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -67.14 -40.28 86.69 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.937 -0.305 . . . . 1.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.98 -47.65 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.509 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 18.5 ptp -62.6 -39.46 93.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.264 . . . . 1.0 111.083 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.61 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.667 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.468 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.1 -38.8 92.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.597 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.87 -41.25 95.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.568 -0.613 . . . . 1.0 111.568 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.78 -43.55 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.652 0.226 . . . . 1.0 111.394 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.38 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.072 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 77' ' ' ALA . 66.9 t -63.48 -46.07 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.448 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.42 -8.41 50.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.801 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.36 -27.22 12.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.81 0.338 . . . . 1.0 110.147 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' D' ' 86' ' ' THR . 6.0 tt -65.03 -37.55 87.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.275 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.8 -5.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.462 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' D' ' 84' ' ' LEU . 65.5 m -58.82 -42.91 90.33 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.954 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' C' ' 92' ' ' ASP . . . -42.39 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.767 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -102.97 -32.33 9.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.174 0.511 . . . . 1.0 110.028 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' D' ' 86' ' ' THR . 58.2 mt -69.76 -39.34 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.715 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.576 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.28 -49.51 77.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.707 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -11.83 43.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.66 -49.33 78.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.786 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 17.2 p90 -76.24 -22.56 55.04 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.38 -42.64 94.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.776 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -50.41 -21.78 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.723 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -55.58 -43.57 76.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' D' ' 99' ' ' GLU . 96.6 mt-10 -81.38 179.71 7.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 98' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' D' ' 101' ' ' ARG . 95.0 mt-10 65.27 -46.3 0.36 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.75 0.656 . . . . 1.0 110.66 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' D' ' 97' ' ' GLU . 97.6 mt-10 -66.55 -43.38 85.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.928 0.394 . . . . 1.0 110.301 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -70.52 -37.99 74.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.574 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 101' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' D' ' 98' ' ' GLU . 70.3 ttp85 -107.63 114.34 28.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.165 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.73 -14.87 53.13 Favored Glycine 0 N--CA 1.465 0.608 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 103' ' ' HIS . . . . . 0.52 ' OXT' ' ND1' ' D' ' 103' ' ' HIS . 60.1 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.59 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.21 -103.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.476 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -162.67 -37.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.461 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -81.08 -26.6 36.14 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.605 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.62 -32.49 73.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.592 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -60.38 -42.68 96.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.192 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -63.29 -45.34 91.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.072 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -66.59 -39.71 88.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.393 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 57.2 tt0 -64.55 -39.83 94.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.59 -36.78 85.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.96 66.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.226 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 1.0 110.722 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 57.3 mp0 -66.23 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.436 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.572 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.2 tp -62.31 -42.44 99.37 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.66 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.95 -33.06 72.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.068 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 17' ' ' LYS . 5.3 ttmm -61.58 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.269 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.74 -40.94 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.52 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -59.28 -41.24 88.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.31 -47.02 87.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.624 -0.43 . . . . 1.0 109.86 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.69 -34.2 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.008 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.793 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.1 p -59.41 -44.0 92.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 1.0 109.968 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.25 -40.19 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 29' ' ' ALA . 70.1 mmtt -66.83 -42.48 85.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.14 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.922 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.2 p -62.02 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.477 -0.489 . . . . 1.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 98.2 mt-10 -67.25 -39.54 86.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.429 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -62.02 -49.24 76.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.113 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 38' ' ' LEU . 5.8 tm-20 -69.67 -41.41 75.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.059 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -54.71 90.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.604 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 121.2 3.7 10.46 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.65 122.99 45.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 122.689 -0.301 . . . . 1.0 110.55 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.44 141.96 26.0 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.881 1.721 . . . . 1.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.71 15.4 81.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.15 -162.06 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 1.0 110.545 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -171.65 -4.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.616 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 38' ' ' LEU . 4.9 tt -99.1 89.03 4.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.034 0.445 . . . . 1.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 17.4 pt -122.76 165.66 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 81.98 135.55 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.442 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.5 t80 -75.12 -45.95 4.7 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.763 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.7 Cg_endo -60.31 -27.25 84.49 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.554 1.503 . . . . 1.0 112.501 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.73 -27.95 19.72 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.011 -0.275 . . . . 1.0 110.898 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.66 -42.07 94.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.881 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.687 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.2 OUTLIER -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.109 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.539 ' CD1' ' OE2' ' A' ' 50' ' ' GLU . 26.6 t90 -60.09 -39.82 87.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.471 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.8 m -56.09 -36.7 68.43 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.55 71.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.843 0.354 . . . . 1.0 111.293 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE2' ' CD1' ' A' ' 47' ' ' TRP . 10.6 pt-20 -173.96 -40.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.175 0.512 . . . . 1.0 109.668 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.47 HG23 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -68.8 -39.74 79.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.148 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.23 -24.0 51.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.481 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 50' ' ' GLU . 72.0 p -86.41 -3.16 58.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.4 p 52.49 38.84 26.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.084 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 ' OG1' ' A' ' 53' ' ' THR . 25.2 m -102.76 -35.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.631 -0.259 . . . . 1.0 110.883 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.0 73.82 0.37 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -44.08 97.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.336 . . . . 1.0 110.415 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.66 20.38 5.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.514 -1.034 . . . . 1.0 110.514 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.7 m-20 -62.8 -40.09 96.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.297 . . . . 1.0 110.411 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -132.3 164.41 26.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 109.923 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 12.5 p90 -151.66 90.83 3.89 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.675 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.69 166.53 27.19 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.736 1.624 . . . . 1.0 112.271 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.487 HG22 ' OE2' ' A' ' 66' ' ' GLU . 16.8 m -98.75 -124.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.585 HG22 ' CD1' ' D' ' 46' ' ' TRP . 66.5 p -114.33 -37.18 4.43 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -57.94 -26.04 61.74 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.61 -0.436 . . . . 1.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.487 ' OE2' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -87.33 29.64 0.84 Allowed 'General case' 0 C--O 1.26 1.645 0 CA-C-O 123.678 1.704 . . . . 1.0 109.199 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 38.16 65.21 0.72 Allowed Glycine 0 C--O 1.212 -1.258 0 CA-C-N 113.494 -1.685 . . . . 1.0 111.714 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.632 ' NH2' ' CE3' ' D' ' 46' ' ' TRP . 0.0 OUTLIER -22.93 -31.2 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.028 0.914 . . . . 1.0 111.507 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.2 mttt -56.79 -12.3 1.84 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.241 -0.89 . . . . 1.0 108.973 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 67' ' ' GLY . 41.3 t -60.35 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 119.507 -0.877 . . . . 1.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.91 -38.4 66.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.591 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -56.19 -39.63 72.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.577 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.38 -42.2 92.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.249 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG11 HG23 ' A' ' 51' ' ' THR . 58.1 t -63.81 -46.52 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.296 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 63.0 mtm -63.35 -40.79 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.721 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.43 -45.0 96.14 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.439 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.85 -45.11 96.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -43.08 96.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.665 0.269 . . . . 1.0 110.418 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.62 -41.66 90.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.462 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.81 -55.31 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.699 -0.4 . . . . 1.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.07 -41.21 99.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.068 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.4 87.46 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.008 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.2 tt -62.99 -41.23 99.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.53 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 85' ' ' VAL . 71.6 t -49.18 -10.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.44 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' ALA . 70.8 m -51.72 -44.22 63.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.354 . . . . 1.0 110.078 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.97 -20.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.827 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.15 -33.44 8.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.857 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.8 mt -69.8 -39.24 76.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.216 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.65 -49.84 75.89 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.256 0.55 . . . . 1.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -3.38 1.48 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.686 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.25 -42.83 96.13 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.98 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.567 ' CG ' ' OG1' ' B' ' 91' ' ' THR . 31.2 p90 -85.25 -26.04 26.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.635 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -55.23 -29.51 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.239 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -65.79 -21.16 66.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 1.0 110.937 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.453 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.0 ptt-85 -50.34 -42.82 53.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.642 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.453 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 82.0 tt0 -65.18 -40.21 93.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 100' ' ' ARG . 97.7 mt-10 -83.11 -172.45 4.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.273 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 61.95 -67.31 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 98' ' ' GLU . 53.9 ttp180 -55.92 -45.46 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.274 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -78.21 -17.03 57.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.458 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' A' ' 103' ' ' HIS . . . 75.76 22.18 75.28 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 102' ' ' GLY . 76.3 m80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.516 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.413 ' OG ' ' OE1' ' B' ' 5' ' ' GLU . 16.2 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.45 -0.574 . . . . 1.0 109.45 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.44 -104.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.577 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -135.85 -54.6 0.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.795 0.331 . . . . 1.0 110.648 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -65.31 -32.33 73.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.437 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.413 ' OE1' ' OG ' ' B' ' 1' ' ' SER . 47.3 mt-10 -65.06 -35.99 82.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.881 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.07 -39.19 93.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.26 -40.65 96.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.82 99.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.614 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.77 -37.72 82.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.44 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -61.75 -38.5 88.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.65 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.54 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.33 -40.9 97.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 1.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.01 -38.62 91.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 1.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -62.69 -32.18 73.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.57 -42.03 99.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -57.88 -39.62 78.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.774 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.65 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.73 -34.3 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.905 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.3 mt -61.02 -40.39 93.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.91 -47.5 85.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -70.63 -32.09 69.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.054 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.13 80.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.265 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.9 t -60.18 -43.34 95.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.799 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.62 -55.55 33.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.137 0.494 . . . . 1.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.46 -44.11 97.19 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.082 -0.647 . . . . 1.0 110.639 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.47 -48.72 78.38 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.704 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 40' ' ' SER . 0.8 OUTLIER -65.61 -42.52 93.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.424 . . . . 1.0 110.375 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.413 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 95.5 mt-10 -69.67 -43.34 72.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.128 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.17 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -72.91 -22.4 60.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -77.88 122.25 25.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.955 0.407 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.15 2.79 57.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.377 -0.689 . . . . 1.0 111.377 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.7 149.46 37.13 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.533 -0.173 . . . . 1.0 110.533 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.27 143.41 28.21 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.073 1.849 . . . . 1.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.71 28.9 74.07 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.284 -0.726 . . . . 1.0 111.284 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 139.43 57.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 1.0 110.278 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.82 -40.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.999 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 tp -68.02 -21.73 65.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.28 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.515 HG23 ' O ' ' B' ' 39' ' ' ILE . 12.5 tt -43.27 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 1.8 p 163.85 109.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.557 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.449 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.7 m-85 -56.72 -60.27 9.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.087 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.8 Cg_endo -57.84 -35.51 98.75 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.058 1.839 . . . . 1.0 112.771 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.73 -20.53 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.526 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.36 -39.3 92.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.951 0.405 . . . . 1.0 109.988 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.405 ' H ' HG22 ' B' ' 45' ' ' ILE . 8.1 tt -67.02 -37.82 80.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.409 ' CD1' ' NE ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -46.89 79.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.422 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -62.78 -40.45 97.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.26 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' B' ' 44' ' ' ALA . 6.7 m -50.9 -22.76 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.755 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.88 -21.04 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.809 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' B' ' 55' ' ' VAL . 80.9 mm-40 -93.79 16.97 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.899 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.73 -39.02 1.65 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.744 0.307 . . . . 1.0 111.14 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.35 -29.17 70.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.294 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.54 ' OG1' HG13 ' B' ' 55' ' ' VAL . 18.7 p -90.31 9.11 30.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 1.0 110.734 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.8 p 51.32 42.04 28.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.597 HG11 ' SD ' ' C' ' 75' ' ' MET . 19.0 m -97.29 -44.78 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.673 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.566 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.31 64.57 1.3 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -60.97 -47.13 87.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 1.0 110.907 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.4 10.68 1.24 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -57.51 -66.1 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.388 . . . . 1.0 110.568 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.442 HH21 ' NH2' ' C' ' 68' ' ' ARG . 52.4 mtm180 -137.04 142.42 42.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.991 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' B' ' 61' ' ' TYR . 6.1 p90 -126.31 136.24 28.31 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.297 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.52 164.67 33.42 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.889 1.726 . . . . 1.0 112.063 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 66' ' ' GLU . 22.2 m -91.98 -140.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.223 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.687 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.4 m -114.1 -40.74 3.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.749 0.309 . . . . 1.0 111.129 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.642 ' C ' ' H ' ' B' ' 67' ' ' GLY . 79.4 tt0 -66.71 -32.72 74.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.44 ' H ' HG23 ' B' ' 63' ' ' VAL . 0.2 OUTLIER -70.38 30.35 0.04 OUTLIER 'General case' 0 C--O 1.261 1.672 0 CA-C-O 123.715 1.721 . . . . 1.0 110.03 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.42 63.94 1.27 Allowed Glycine 0 C--O 1.21 -1.344 0 CA-C-N 113.972 -1.467 . . . . 1.0 111.585 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.5 ttm-85 -25.0 -33.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.323 1.062 . . . . 1.0 110.862 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.0 mttp -48.5 -18.59 0.25 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' B' ' 67' ' ' GLY . 59.8 t -64.09 -45.55 96.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.724 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.85 -36.2 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.69 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -57.17 -41.12 78.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.947 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -64.18 -42.8 96.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.03 -47.29 88.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.251 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.668 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.03 -38.36 90.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 1.0 110.47 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.87 92.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.535 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.32 -40.92 91.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.93 -43.29 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.838 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.8 -42.45 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.384 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.24 -47.93 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.157 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.51 -11.23 60.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.912 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.08 -25.91 13.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.81 -41.53 97.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.94 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 87' ' ' ALA . 30.8 m -46.69 -26.66 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' B' ' 85' ' ' VAL . 32.4 m -34.53 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -50.49 -65.36 0.57 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.035 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.85 -20.54 35.4 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.48 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 -44.01 97.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.32 -60.93 2.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.766 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.567 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -50.21 -5.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.84 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' B' ' 90' ' ' ALA . 51.0 t0 -60.78 -40.31 92.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 93' ' ' PHE . 1.6 p90 -65.19 -33.56 76.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 1.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.77 -44.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.458 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' B' ' 97' ' ' GLU . 10.5 tpt180 -47.05 -21.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.851 -0.34 . . . . 1.0 111.207 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -46.2 -20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.377 . . . . 1.0 110.217 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' C ' ' B' ' 95' ' ' ARG . 97.0 mt-10 -60.18 -45.99 91.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.138 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.17 -40.27 78.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.815 0.34 . . . . 1.0 110.666 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -70.78 -25.72 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.727 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.435 HH12 ' NH2' ' B' ' 101' ' ' ARG . 79.2 ttt-85 -59.72 -44.35 93.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.576 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ARG . . . . . 0.435 ' NH2' HH12 ' B' ' 100' ' ' ARG . 35.5 mmt180 -98.36 -7.85 28.09 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.413 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 10.1 86.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.546 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.485 ' HB1' ' NE2' ' C' ' 4' ' ' HIS . . . -78.27 -4.93 50.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.97 29.87 17.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.432 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 7.2 p80 -172.51 -34.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.627 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 79.8 tt0 -67.31 -41.13 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.745 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -62.28 -42.59 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.55 -39.65 91.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.104 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.98 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.477 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.08 -40.69 82.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.19 -38.16 90.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.311 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.58 78.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.044 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.17 -37.72 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 1.0 110.894 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.84 -35.5 80.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.648 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.06 -36.35 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.676 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.7 tp -62.07 -41.01 97.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.342 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -62.59 -40.63 97.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.54 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.14 -38.63 89.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.815 0.341 . . . . 1.0 111.116 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.38 -40.79 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -59.29 -41.35 88.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.19 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.65 -48.7 80.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.869 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.85 -32.73 71.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.13 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.29 93.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -60.27 -44.11 95.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.508 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.11 -39.14 92.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 1.0 110.12 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -72.46 -47.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.09 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.57 73.16 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.359 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.517 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -60.8 -44.8 98.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.961 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.517 ' N ' HG13 ' C' ' 27' ' ' VAL . 42.7 tp10 -68.05 -36.98 80.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.55 86.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.3 -44.48 68.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.399 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -52.93 97.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.348 . . . . 1.0 110.701 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.63 0.15 15.63 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.176 -0.769 . . . . 1.0 111.176 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.83 140.46 21.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 1.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.2 Cg_endo -76.19 143.69 25.71 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.918 1.746 . . . . 1.0 112.338 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 24.39 69.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.51 140.82 58.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.379 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.08 -34.76 4.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.422 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' C' ' 40' ' ' SER . 1.1 mt -72.2 -2.05 17.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.213 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.545 HG23 ' O ' ' C' ' 39' ' ' ILE . 12.4 tt -46.92 90.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 1.0 110.627 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.519 ' N ' ' O ' ' C' ' 38' ' ' LEU . 70.4 m -167.04 -127.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.008 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.424 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 6.9 t80 174.39 -58.29 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.346 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.7 Cg_endo -58.86 -38.28 89.3 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.835 1.69 . . . . 1.0 112.376 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 14.6 p-10 -91.91 2.97 56.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.5 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.74 98.29 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.771 -0.371 . . . . 1.0 110.507 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.401 HG21 HD13 ' C' ' 45' ' ' ILE . 6.6 tt -68.21 -31.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.59 ' CZ2' ' O ' ' D' ' 63' ' ' VAL . 10.4 t90 -57.91 -47.17 83.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.993 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.468 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.0 OUTLIER -76.17 -22.33 55.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.0 t -67.5 -42.7 82.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.436 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.522 HG11 ' NH1' ' D' ' 68' ' ' ARG . 76.0 t -61.09 -47.9 91.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.74 -31.63 71.67 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.88 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -58.96 -44.94 91.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.2 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.98 -35.23 70.89 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.759 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.524 ' OG1' HG22 ' C' ' 55' ' ' VAL . 68.8 p -75.18 -6.81 51.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 59.33 24.15 12.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.589 HG23 ' N ' ' C' ' 56' ' ' GLY . 18.5 m -87.54 -47.5 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.611 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.589 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 38.43 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.37 -39.88 95.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.793 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.8 16.29 1.29 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.119 -0.793 . . . . 1.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.04 -41.65 99.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 1.0 110.572 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -145.44 176.3 9.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -163.67 127.7 1.87 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.593 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.27 160.02 51.0 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.918 1.745 . . . . 1.0 112.382 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 2.0 t -86.99 -140.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.092 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 54.0 m -114.81 -34.48 5.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' C' ' 67' ' ' GLY . 76.0 tt0 -67.17 -31.52 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -69.57 31.61 0.03 OUTLIER 'General case' 0 C--O 1.262 1.75 0 CA-C-O 123.48 1.61 . . . . 1.0 110.347 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.07 64.72 1.42 Allowed Glycine 0 C--O 1.212 -1.255 0 CA-C-N 114.103 -1.408 . . . . 1.0 111.234 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' C' ' 67' ' ' GLY . 49.6 ttm-85 -23.49 -33.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 117.848 0.824 . . . . 1.0 111.174 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.6 mptm? -49.66 -19.33 0.59 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' C' ' 67' ' ' GLY . 78.1 t -62.94 -46.64 95.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 119.23 -0.988 . . . . 1.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.34 69.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 1.0 110.628 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.75 -44.28 77.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.786 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.21 -43.09 99.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.518 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.73 -47.96 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.738 -0.385 . . . . 1.0 111.129 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.597 ' SD ' HG11 ' B' ' 55' ' ' VAL . 76.8 mtm -64.38 -42.64 96.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.593 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 55.2 tttm -64.68 -39.55 93.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.604 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.421 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.79 -42.49 93.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 1.0 110.47 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -66.63 -42.1 93.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.747 -0.541 . . . . 1.0 111.747 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -44.0 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.84 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 98.0 mt-10 -63.52 -40.32 96.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.279 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 77' ' ' ALA . 63.9 t -64.05 -49.05 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.094 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -67.85 -37.72 82.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.347 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.42 -36.02 81.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.0 110.644 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.7 tt -61.78 -40.05 93.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.517 ' O ' HG12 ' C' ' 85' ' ' VAL . 61.3 t -54.81 -3.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.719 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.505 ' H ' ' C ' ' C' ' 84' ' ' LEU . 66.8 m -59.33 -40.93 87.87 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.685 0.279 . . . . 1.0 110.271 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -52.45 -25.35 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.259 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.13 -11.29 38.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.69 -61.12 1.8 Allowed 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.578 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -42.93 -52.34 5.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.819 0.343 . . . . 1.0 111.045 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.38 -13.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.002 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' C' ' 90' ' ' ALA . 96.8 m-20 -63.52 -47.52 81.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.277 . . . . 1.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 2.2 p90 -67.98 -33.3 74.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 1.0 110.847 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -43.06 94.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.773 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -58.67 -22.44 56.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.394 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' ARG . . . . . 0.446 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 37.9 ptt85 -50.39 -43.11 54.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 1.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 46.9 tp10 -59.68 -45.06 93.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.362 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.42 -42.18 88.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -68.09 -37.82 81.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.495 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -60.92 -42.99 99.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -64.78 -36.54 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.94 57.32 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.584 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . -154.62 149.71 26.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.593 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 3' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 15.2 p-10 -77.73 -41.7 36.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.287 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.496 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.7 p80 -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.873 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -63.75 -37.2 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.693 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.49 -41.51 97.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.666 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -65.81 -37.46 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 1.0 110.059 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.77 -39.56 93.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.499 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.21 -37.61 87.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.554 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.93 91.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.074 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.23 -38.84 92.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 1.0 110.757 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.06 -36.35 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.626 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.78 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.581 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.5 tp -62.67 -41.57 99.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.794 -0.362 . . . . 1.0 110.418 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.05 -36.31 74.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.834 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -60.89 -41.91 96.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.715 0.293 . . . . 1.0 111.042 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.32 -37.43 79.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.0 mt -59.89 -41.65 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.19 -47.47 84.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.016 0.436 . . . . 1.0 110.149 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.48 -34.2 77.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.895 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.11 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.715 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -60.94 -45.99 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.09 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -78.08 -35.8 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 1.0 111.064 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -72.39 -44.87 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.163 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' D' ' 29' ' ' ALA . . . -62.16 -49.76 74.53 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.53 HG13 ' N ' ' D' ' 28' ' ' GLU . 11.4 p -61.44 -43.62 97.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 1.0 109.868 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.53 ' N ' HG13 ' D' ' 27' ' ' VAL . 42.1 tp10 -69.28 -20.78 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.041 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -60.33 -39.04 85.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.077 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 24.0 mp0 -63.97 -38.15 90.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.802 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -57.93 93.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.18 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -9.12 6.9 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.1 146.65 32.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.752 0.276 . . . . 1.0 110.353 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.473 ' O ' HG11 ' D' ' 63' ' ' VAL . 71.7 Cg_endo -75.72 116.47 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.766 1.644 . . . . 1.0 112.199 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.09 37.71 4.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.74 98.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.816 0.341 . . . . 1.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.63 -72.6 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.13 61.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 1.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 tt -90.38 -8.37 10.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.928 0.394 . . . . 1.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -65.69 140.13 58.44 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.543 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.8 OUTLIER -97.68 -61.44 0.12 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.67 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.5 Cg_endo -57.85 -32.04 93.97 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.558 1.505 . . . . 1.0 111.888 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.81 -3.27 58.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 1.0 110.574 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.434 HG22 ' H ' ' D' ' 45' ' ' ILE . 0.0 OUTLIER -66.3 -32.24 57.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.287 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.632 ' CE3' ' NH2' ' A' ' 68' ' ' ARG . 1.7 t-105 -61.18 -47.3 86.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.008 -178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.413 ' CE3' ' N ' ' D' ' 48' ' ' SER . 0.8 OUTLIER -69.86 -37.88 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.413 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 25.3 p -47.12 -34.57 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 1.0 110.323 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.2 -44.71 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.412 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.3 52.84 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.73 -0.471 . . . . 1.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.9 m -156.21 -48.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.468 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.597 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.91 -23.62 46.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.021 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.2 p -93.5 8.37 40.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.281 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.5 p 48.72 32.6 3.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.898 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.427 HG13 ' N ' ' D' ' 56' ' ' GLY . 7.3 p -65.47 -39.49 85.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.101 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.427 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 109.31 -91.21 0.64 Allowed Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' D' ' 57' ' ' TYR . 43.7 p90 -62.91 114.66 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.263 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' D' ' 60' ' ' ARG . . . -126.47 28.24 4.8 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t0 63.76 -6.74 0.22 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.755 0.312 . . . . 1.0 110.789 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' D' ' 58' ' ' GLY . 73.4 mtt-85 -145.87 128.41 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 8.2 p90 -118.55 141.44 29.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.852 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.81 156.78 62.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.314 2.009 . . . . 1.0 112.512 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.59 ' O ' ' CZ2' ' C' ' 46' ' ' TRP . 12.3 t -77.94 -120.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.057 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.487 ' N ' HG12 ' D' ' 63' ' ' VAL . 54.6 m -116.9 -72.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.961 0.41 . . . . 1.0 110.227 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -56.16 127.34 30.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' D' ' 68' ' ' ARG . 94.5 mt-10 58.28 -94.5 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.054 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 24.63 -57.18 0.0 OUTLIER Glycine 0 N--CA 1.48 1.57 0 O-C-N 124.483 1.114 . . . . 1.0 114.193 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.5 ttp85 -83.19 -59.48 2.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -41.08 -36.35 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.49 -46.59 80.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.949 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -66.46 -34.79 78.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.828 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.12 -48.1 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.905 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.82 -38.1 88.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.946 -0.302 . . . . 1.0 111.716 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -62.86 -46.38 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.39 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.41 ' SD ' HG11 ' C' ' 55' ' ' VAL . 77.2 mtm -63.77 -39.89 95.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.613 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.5 98.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.567 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.497 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.99 -39.11 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.91 -42.42 94.91 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.692 -0.563 . . . . 1.0 111.692 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.3 -43.43 98.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.621 0.248 . . . . 1.0 111.148 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.21 -38.63 91.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.899 -0.321 . . . . 1.0 111.36 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.497 HG23 ' O ' ' D' ' 77' ' ' ALA . 56.1 t -62.18 -49.65 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.277 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -67.17 -40.7 86.64 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.692 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.71 76.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.681 HD23 ' C ' ' D' ' 84' ' ' LEU . 7.4 tt -60.95 -41.53 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.086 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.423 ' O ' HG12 ' D' ' 85' ' ' VAL . 98.1 t -47.02 -14.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 1.0 110.258 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.489 ' N ' ' C ' ' D' ' 84' ' ' LEU . 39.6 m -49.6 -39.59 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.071 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.59 -26.98 14.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.63 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.92 -10.76 32.75 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.158 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.4 -59.85 2.1 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.181 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 92' ' ' ASP . . . -42.22 -53.74 3.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 1.0 111.056 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.746 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' D' ' 90' ' ' ALA . 80.1 m-20 -62.0 -45.11 95.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.313 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 0.1 OUTLIER -53.56 -37.14 62.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 1.0 110.489 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' D' ' 97' ' ' GLU . 61.4 t -61.05 -43.66 96.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.135 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -50.92 -21.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.745 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -55.47 -44.04 76.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.137 -0.32 . . . . 1.0 110.137 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' D' ' 97' ' ' GLU . 55.1 mp0 -70.16 -38.92 75.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.981 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.84 -37.04 85.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.389 . . . . 1.0 110.174 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -63.7 -31.36 72.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -55.64 -43.54 76.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -63.5 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.264 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.1 64.46 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.55 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.4 -76.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -159.94 -61.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' CD2' ' H ' ' A' ' 4' ' ' HIS . 8.7 p80 -77.42 -23.88 50.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.836 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -67.11 -37.79 84.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.803 0.335 . . . . 1.0 110.239 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -60.76 -43.23 98.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.87 -38.89 90.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.085 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.14 99.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.331 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.09 -37.41 85.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.377 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -61.32 -41.96 97.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.283 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.2 83.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.842 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.32 -35.6 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.566 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.43 -37.16 86.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.387 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.19 -32.11 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.637 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.11 -41.73 98.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 1.0 110.504 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.22 -40.43 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.154 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -63.51 -39.85 95.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.864 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -63.11 -42.57 97.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 52' ' ' ALA . 91.9 mt -60.24 -41.41 93.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.319 -0.4 . . . . 1.0 109.944 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.81 -45.68 92.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -69.56 -34.11 73.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.107 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.79 94.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.459 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.1 p -61.77 -43.35 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.21 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.92 -59.68 5.07 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.14 -45.07 96.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.154 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.69 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.483 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 23' ' ' SER . 78.1 t -63.43 -47.23 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.257 -0.577 . . . . 1.0 110.338 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.92 -41.57 67.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.837 -0.62 . . . . 1.0 111.35 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -35.08 65.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.804 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 5.5 mp0 -89.89 -10.18 46.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.632 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -75.24 108.52 8.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.63 61.28 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.504 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.91 142.94 26.11 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.33 143.55 28.18 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.111 1.874 . . . . 1.0 112.443 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.74 -4.44 21.87 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.91 143.25 52.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.846 0.355 . . . . 1.0 110.568 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.17 -26.76 2.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.568 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.66 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.892 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 39' ' ' ILE . 14.5 tt -116.79 89.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.226 0.536 . . . . 1.0 110.439 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER 166.98 134.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.766 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 66.8 m-85 -69.58 -49.41 21.84 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.043 -0.526 . . . . 1.0 112.403 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.3 Cg_endo -60.19 -34.92 93.73 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.486 1.457 . . . . 1.0 113.188 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.7 p-10 -90.5 -24.28 20.7 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 121.062 -0.255 . . . . 1.0 111.08 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -65.1 -38.29 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 1.0 110.581 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' ILE . 2.8 tp -63.35 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.98 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CE2' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -62.49 -45.64 92.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.934 179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -57.53 -39.91 77.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -65.44 -34.78 79.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.4 -46.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.475 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.11 -8.23 56.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.062 0.458 . . . . 1.0 110.428 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -80.61 -45.63 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.328 . . . . 1.0 111.195 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -64.39 -37.57 88.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.609 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -75.12 0.29 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.71 60.98 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 56' ' ' GLY . 8.4 p -130.73 -44.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.682 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 36.12 89.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.731 -0.548 . . . . 1.0 111.731 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.89 -44.42 97.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.343 . . . . 1.0 110.704 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.12 15.76 0.68 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 98.4 m-20 -59.92 -50.39 73.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.337 . . . . 1.0 110.636 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 43' ' ' ASP . 0.9 OUTLIER -138.75 156.28 47.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.976 -0.557 . . . . 1.0 109.875 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -144.08 131.6 10.61 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.674 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.58 -171.62 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.827 1.685 . . . . 1.0 112.198 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 64' ' ' THR . 8.2 p -128.82 -136.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.222 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.855 ' H ' HG22 ' A' ' 63' ' ' VAL . 66.4 m -112.62 -40.23 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.628 0.251 . . . . 1.0 111.341 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.3 tt0 -64.48 -36.12 83.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.461 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 1.2 pp20? -72.66 32.18 0.06 Allowed 'General case' 0 C--O 1.262 1.763 0 CA-C-O 124.537 2.113 . . . . 1.0 109.721 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.25 63.98 1.43 Allowed Glycine 0 C--O 1.212 -1.242 0 CA-C-N 113.612 -1.631 . . . . 1.0 111.098 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.497 HH21 HH22 ' D' ' 60' ' ' ARG . 56.8 ttm-85 -24.12 -34.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.95 0.875 . . . . 1.0 111.334 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.8 mtmt -50.5 -14.25 0.17 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.609 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' GLY . 43.2 t -60.95 -47.68 92.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.156 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -42.48 68.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.353 . . . . 1.0 111.161 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -52.09 -39.64 60.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.85 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -68.97 -41.33 78.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.615 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.96 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.398 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.1 ptp -63.62 -39.55 94.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.773 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -62.73 -42.63 99.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.446 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.96 86.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.361 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -36.73 93.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -26.93 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.135 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.14 -49.76 18.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.724 0.297 . . . . 1.0 111.412 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 82' ' ' PHE . 18.4 m -62.21 -48.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.32 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' N ' HG23 ' A' ' 81' ' ' VAL . 13.1 m-85 -66.0 -40.79 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.707 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.61 84.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 1.0 111.064 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.6 tt -62.16 -41.59 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.346 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 85' ' ' VAL . 81.6 t -46.47 -13.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.559 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' LEU . 94.9 m -55.31 -23.83 25.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -62.28 -29.67 70.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.111 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.52 -11.84 33.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.777 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.27 -47.63 9.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.655 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.89 -24.12 49.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.959 0.409 . . . . 1.0 111.016 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -89.17 -3.73 58.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.706 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 91.5 m-20 -59.89 -46.48 89.2 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.384 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -81.76 -19.18 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.31 -28.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.405 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 97' ' ' GLU . 96.4 mtt180 -63.59 -28.91 70.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -42.41 -23.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.845 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 95' ' ' ARG . 44.1 tt0 -64.73 -38.24 90.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 1.0 110.04 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' GLY . 97.4 mt-10 -66.82 -39.93 87.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.343 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -68.75 -32.59 72.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.364 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -58.39 -45.6 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.705 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -107.14 -1.87 21.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.858 0.361 . . . . 1.0 110.515 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 98' ' ' GLU . . . 67.79 24.67 74.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.445 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 85.5 t60 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.422 -0.585 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.21 154.88 31.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.531 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.471 ' OD1' ' NH2' ' B' ' 6' ' ' ARG . 78.8 m-20 -63.1 -40.98 99.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.436 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -60.97 -45.52 94.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.21 -48.99 75.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.592 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' B' ' 3' ' ' ASP . 88.7 mtm180 -65.42 -41.07 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 1.0 110.768 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.9 -40.24 87.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.166 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.44 96.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.521 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -65.49 -38.03 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.05 -39.07 93.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.684 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.44 67.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.903 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.85 -35.36 80.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 1.0 110.505 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.236 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.15 -37.55 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.599 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.49 -40.92 98.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 1.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.66 -39.34 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.812 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.37 -43.21 99.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.61 -40.84 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.49 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' B' ' 52' ' ' ALA . 32.7 mt -59.03 -42.81 91.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.46 -37.71 85.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.37 -53.11 39.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.415 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -65.93 -43.97 86.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' B' ' 48' ' ' SER . 75.2 m -56.22 -43.91 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.128 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.582 ' O ' HG22 ' B' ' 27' ' ' VAL . 14.9 tmtt? -65.34 -32.84 74.69 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.25 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.98 -34.81 50.71 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.09 -0.244 . . . . 1.0 111.239 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.43 67.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.483 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 24' ' ' LYS . 2.6 m -61.52 -49.08 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.406 -0.517 . . . . 1.0 110.496 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.527 ' N ' HG23 ' B' ' 27' ' ' VAL . 80.6 tt0 -76.35 -35.8 58.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.605 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' B' ' 66' ' ' GLU . . . -59.12 -38.97 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.215 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 40.2 mm-40 -107.82 61.41 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -141.8 80.04 1.7 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 1.0 111.105 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.06 4.41 27.54 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.7 57.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.35 139.6 23.57 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.008 1.806 . . . . 1.0 112.244 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 19.04 74.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' B' ' 30' ' ' GLU . . . -84.05 166.02 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.753 0.311 . . . . 1.0 110.458 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' B' ' 38' ' ' LEU . . . -161.07 -11.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.642 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' B' ' 47' ' ' TRP . 0.9 OUTLIER -87.6 33.26 0.7 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.223 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 pt -71.84 46.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.65 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.3 m -130.96 151.31 51.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.099 0.475 . . . . 1.0 111.065 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.525 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 3.0 m-85 -97.54 -64.5 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.015 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -58.52 -28.03 84.27 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 122.213 1.942 . . . . 1.0 112.525 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -87.56 -2.18 58.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 1.0 110.643 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.02 95.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 1.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.498 ' O ' HG23 ' B' ' 49' ' ' VAL . 6.7 tt -67.79 -39.29 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.765 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.2 OUTLIER -59.5 -49.49 77.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.415 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.479 ' CG ' HD11 ' B' ' 38' ' ' LEU . 5.3 t90 -65.06 -40.78 95.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.465 ' CB ' ' OG ' ' B' ' 23' ' ' SER . 15.2 m -63.15 -39.62 95.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.53 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 45' ' ' ILE . 25.3 t -59.5 -47.31 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.812 0.301 . . . . 1.0 111.812 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 68' ' ' ARG . 15.0 pt-20 -65.41 -30.03 70.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -64.39 -44.75 90.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.615 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.531 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.02 -25.54 61.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.286 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.51 ' OG1' HG23 ' B' ' 55' ' ' VAL . 33.3 p -90.65 4.08 52.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.805 0.336 . . . . 1.0 110.583 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 17.9 p 54.42 9.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.635 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.51 HG23 ' OG1' ' B' ' 53' ' ' THR . 67.6 t -63.97 -45.85 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.698 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.31 57.61 5.59 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -60.4 -49.29 78.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.371 . . . . 1.0 110.938 -178.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 158.73 -92.46 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 69.1 m-20 44.16 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.614 0.245 . . . . 1.0 110.611 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.593 ' NH2' ' NH2' ' C' ' 68' ' ' ARG . 1.1 mpp_? -114.87 161.52 18.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.494 ' O ' ' CD2' ' B' ' 61' ' ' TYR . 16.6 p90 -141.58 105.1 5.89 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.384 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 163.21 38.62 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.525 1.483 . . . . 1.0 112.308 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 1.052 HG22 ' H ' ' B' ' 64' ' ' THR . 9.6 p -106.03 -154.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.352 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' THR . . . . . 1.052 ' H ' HG22 ' B' ' 63' ' ' VAL . 9.9 m -88.7 -53.45 4.62 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.65 0.262 . . . . 1.0 111.632 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.3 tt0 -42.09 -36.36 1.13 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.776 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.576 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -72.73 22.85 0.06 Allowed 'General case' 0 C--O 1.267 1.974 0 CA-C-O 124.283 1.992 . . . . 1.0 109.782 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.728 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 42.99 65.46 1.41 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.704 -1.609 . . . . 1.0 111.463 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.576 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -26.66 -28.55 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.067 0.934 . . . . 1.0 110.863 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.3 mttt -45.43 -26.31 0.53 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 67' ' ' GLY . 3.8 p -63.13 -43.63 98.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.627 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -79.37 -37.91 36.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.608 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -58.59 -40.19 82.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -63.71 -44.04 94.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.502 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 95.2 t -63.17 -48.23 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.891 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.1 mtm -63.03 -43.71 97.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.281 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -64.51 -40.84 96.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.161 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -63.04 -40.23 97.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.729 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.86 95.84 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.09 -43.75 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.781 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.14 -42.99 99.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 1.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 77' ' ' ALA . 71.8 t -63.63 -46.91 93.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.908 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -74.98 -4.16 36.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.851 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.02 -31.69 10.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.881 0.372 . . . . 1.0 110.052 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -64.98 -39.52 93.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.025 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.02 -5.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.206 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' B' ' 90' ' ' ALA . 53.9 m -58.54 -41.43 85.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -42.23 -54.07 3.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.599 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.96 68.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 86' ' ' THR . 70.0 mt -88.2 -17.63 30.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -70.94 -37.15 72.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.422 HG23 ' H ' ' B' ' 91' ' ' THR . 0.0 OUTLIER -66.8 -24.86 66.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.225 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -49.42 -43.79 44.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.656 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -59.74 -46.49 88.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.946 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.75 -42.32 89.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -49.41 -21.51 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.539 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -50.29 -39.25 44.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 1.0 110.281 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.75 -40.92 96.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' B' ' 100' ' ' ARG . 48.1 mt-10 -71.61 -169.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.31 -76.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.166 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' B' ' 98' ' ' GLU . 71.6 ttt-85 -57.14 -44.45 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.383 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -120.26 106.44 11.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.856 0.36 . . . . 1.0 110.051 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.13 -6.17 34.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 1.0 110.516 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' C' ' 2' ' ' ALA . 14.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' C' ' 4' ' ' HIS . . . 71.94 -40.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.521 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' C' ' 6' ' ' ARG . 55.0 m-20 59.53 -70.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' C' ' 2' ' ' ALA . 7.1 p-80 -40.97 -31.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.22 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 20.4 pt-20 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 1.0 110.632 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' C' ' 3' ' ' ASP . 73.5 ttp85 -60.63 -43.1 97.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.299 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.08 -38.27 90.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.036 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.89 92.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.629 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.03 -40.98 95.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.52 -37.27 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.495 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.22 93.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.086 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.13 -38.7 89.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 1.0 110.847 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -65.82 -32.16 73.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLU . . . . . 0.472 ' O ' HG23 ' C' ' 18' ' ' VAL . 46.8 tp10 -61.66 -40.64 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.538 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' C' ' 52' ' ' ALA . 55.1 tp -63.29 -39.58 94.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.53 -30.93 71.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.873 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 18' ' ' VAL . . . . . 0.472 HG23 ' O ' ' C' ' 14' ' ' GLU . 42.3 t -63.49 -42.35 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.216 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.4 mt -59.86 -40.32 88.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.359 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.59 -48.88 71.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.849 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.78 -33.46 74.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.897 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.51 82.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -61.78 -46.95 87.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.445 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.56 -36.33 80.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.227 0.536 . . . . 1.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.72 -46.5 53.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.504 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -64.46 -48.46 75.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.395 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.529 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.3 p -59.32 -44.88 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.221 -0.591 . . . . 1.0 109.685 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.529 ' N ' HG13 ' C' ' 27' ' ' VAL . 82.4 tt0 -68.37 -26.96 65.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.37 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' C' ' 67' ' ' GLY . . . -56.16 -51.01 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.14 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 33.3 mp0 -67.54 -36.94 81.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -72.89 92.23 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.89 -19.54 5.81 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.662 . . . . 1.0 111.444 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.51 154.03 39.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.1 150.59 37.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.264 1.976 . . . . 1.0 112.193 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.28 61.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.21 143.51 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 1.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 -39.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.539 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.524 ' C ' HD23 ' C' ' 38' ' ' LEU . 3.5 tt -57.94 -79.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.994 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.617 HG22 ' N ' ' C' ' 40' ' ' SER . 95.4 mt 51.57 167.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.617 ' N ' HG22 ' C' ' 39' ' ' ILE . 1.8 t 81.65 124.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.453 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.503 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 53.4 t80 -88.28 -49.89 0.42 Allowed Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.254 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.9 Cg_endo -60.05 -28.49 87.15 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.343 1.362 . . . . 1.0 112.529 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.48 -13.2 24.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.53 0.205 . . . . 1.0 111.216 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' C' ' 40' ' ' SER . . . -66.89 -37.46 84.44 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.32 -34.69 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.2 OUTLIER -64.95 -48.11 75.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.149 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.524 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 7.6 t90 -61.18 -40.2 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.414 -0.514 . . . . 1.0 109.733 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.498 ' O ' HD22 ' C' ' 19' ' ' LEU . 63.5 p -67.09 45.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.842 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' C' ' 47' ' ' TRP . 71.0 t -137.25 -50.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.535 0.207 . . . . 1.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -69.45 -27.16 65.0 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.445 HG22 ' H ' ' C' ' 51' ' ' THR . 0.1 OUTLIER -59.84 -51.83 68.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.337 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -56.66 -25.37 53.55 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.849 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -90.94 14.21 14.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.799 0.333 . . . . 1.0 110.408 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' C' ' 54' ' ' THR . 0.1 OUTLIER 35.42 77.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.402 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -145.78 -78.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.402 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 75.54 84.73 0.37 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -63.93 -40.98 97.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.622 0.248 . . . . 1.0 110.608 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.99 22.23 0.6 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 99.8 m-20 -61.83 -43.59 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 1.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 77.7 mtt-85 -144.14 -167.58 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.617 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 89.2 m-85 -157.77 123.36 2.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.72 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.86 168.39 21.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.643 1.562 . . . . 1.0 112.255 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 63' ' ' VAL . 2.3 m -91.66 -167.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.088 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.434 ' HA ' ' HE1' ' B' ' 46' ' ' TRP . 2.4 m -101.88 -67.81 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.246 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -38.37 -31.7 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.801 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.8 mt-10 -138.62 -107.62 0.17 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' C' ' 29' ' ' ALA . . . 20.39 -54.79 0.0 OUTLIER Glycine 0 N--CA 1.479 1.567 0 O-C-N 124.513 1.133 . . . . 1.0 114.532 177.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.5 tpp180 -63.06 -58.98 5.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.106 0.562 . . . . 1.0 109.769 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.5 -38.75 88.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.416 ' O ' HG23 ' C' ' 74' ' ' VAL . 72.7 t -64.16 -49.16 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 119.467 -0.893 . . . . 1.0 110.987 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.529 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -67.86 -44.43 77.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 1.0 110.413 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -42.92 -50.62 5.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.919 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.21 -39.26 93.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.416 HG23 ' O ' ' C' ' 70' ' ' VAL . 61.4 t -63.18 -46.6 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.491 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.9 mpp? -62.3 -42.2 99.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -61.34 -36.41 80.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 1.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.01 -43.01 66.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.378 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -38.79 95.3 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' C' ' 83' ' ' ALA . 38.2 mm -61.43 -45.46 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.679 -0.307 . . . . 1.0 110.839 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.0 -44.99 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.308 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.25 -46.98 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.191 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.03 -11.53 59.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.921 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.13 -36.93 17.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 1.0 110.129 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' C' ' 86' ' ' THR . 4.9 tt -66.78 -37.58 84.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.568 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.544 ' O ' HD23 ' C' ' 89' ' ' LEU . 35.1 m -67.06 44.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 1.0 111.099 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.517 ' O ' ' N ' ' C' ' 90' ' ' ALA . 22.7 m -89.53 -42.02 11.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 1.0 110.352 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.533 ' O ' HG23 ' C' ' 91' ' ' THR . . . -52.95 -67.65 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.411 -0.516 . . . . 1.0 111.706 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.479 ' C ' HD22 ' C' ' 89' ' ' LEU . . . -48.64 -16.1 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.35 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.544 HD23 ' O ' ' C' ' 85' ' ' VAL . 3.8 mm? -100.16 -24.28 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.495 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -90.01 -65.36 1.02 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.71 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 87' ' ' ALA . 0.7 OUTLIER -45.32 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.702 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' C' ' 90' ' ' ALA . 89.9 m-20 -52.38 -42.22 63.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.368 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' C' ' 94' ' ' VAL . 2.8 p90 -61.73 -43.72 98.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.408 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 58.2 t -38.78 -27.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.785 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' C' ' 93' ' ' PHE . 95.7 mtt180 -59.89 -23.4 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.688 0.28 . . . . 1.0 111.066 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -58.79 -42.89 90.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.155 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.518 ' O ' ' NH1' ' C' ' 100' ' ' ARG . 96.9 mt-10 -67.21 -31.81 72.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.353 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -88.55 -8.22 55.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.466 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.68 -41.65 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.73 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' C' ' 97' ' ' GLU . 34.7 ptt-85 -65.79 -37.3 85.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.04 0.448 . . . . 1.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.04 -37.26 86.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.648 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.97 25.47 40.83 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.535 179.923 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.635 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -79.52 167.25 21.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.559 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.15 -43.91 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.635 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 10.4 p-80 -69.66 -37.93 76.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.692 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.59 -34.24 77.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.98 -43.24 91.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.457 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -64.76 -38.3 90.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.037 0.446 . . . . 1.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.31 86.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.62 -37.56 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -37.95 85.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.463 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.65 70.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.098 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -64.54 -38.85 92.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.486 -0.324 . . . . 1.0 110.644 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -40.42 93.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 1.0 110.447 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.51 -32.7 74.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.651 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.531 HD11 ' HB1' ' D' ' 52' ' ' ALA . 43.4 tp -62.98 -35.1 79.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.462 . . . . 1.0 110.29 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.13 -33.19 73.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -62.13 -45.36 93.82 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.473 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.09 -37.13 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.755 0.312 . . . . 1.0 110.935 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.1 -41.63 97.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' D' ' 23' ' ' SER . 74.0 mm-40 -66.95 -44.11 81.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 1.0 110.203 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.11 -34.03 76.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.147 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' D' ' 26' ' ' ALA . . . -63.58 -38.86 92.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.25 -43.6 95.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -61.34 -62.46 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.54 -38.11 83.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.765 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' D' ' 22' ' ' ALA . . . -52.12 -51.29 58.77 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.533 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 69.6 t -64.14 -46.26 94.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.409 -0.516 . . . . 1.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.43 -41.33 89.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.525 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' D' ' 66' ' ' GLU . . . -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.045 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 40.3 mm-40 -68.29 -41.85 80.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.822 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -62.69 87.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.014 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.12 7.61 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.332 -0.707 . . . . 1.0 111.332 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.92 135.19 20.51 Favored Pre-proline 0 CA--C 1.537 0.45 0 O-C-N 122.794 -0.239 . . . . 1.0 110.604 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.73 143.25 29.81 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.058 1.839 . . . . 1.0 112.228 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 18.84 75.84 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -61.86 143.07 56.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 1.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.73 -18.48 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.588 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.42 ' O ' HG23 ' D' ' 39' ' ' ILE . 39.2 tp -105.72 117.15 33.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 110.236 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.42 HG23 ' O ' ' D' ' 38' ' ' LEU . 5.1 pt -154.3 89.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.231 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.515 ' O ' ' N ' ' D' ' 44' ' ' ALA . 0.4 OUTLIER 169.57 112.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.98 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.493 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 13.5 m-85 -48.73 -53.96 31.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.76 -30.3 92.19 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.202 1.268 . . . . 1.0 112.013 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.13 -20.08 21.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.036 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 44' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' D' ' 40' ' ' SER . . . -61.16 -42.72 99.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.854 0.359 . . . . 1.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -65.4 -38.06 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.425 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.26 99.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.107 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.435 ' CE3' ' N ' ' D' ' 48' ' ' SER . 1.9 t90 -63.96 -40.15 95.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.466 -0.494 . . . . 1.0 109.975 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.435 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 78.6 p -60.17 -33.25 71.93 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.582 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.53 -44.33 99.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.312 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.461 ' OE2' ' CZ ' ' A' ' 68' ' ' ARG . 74.3 mt-10 -52.36 -31.96 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.575 ' C ' ' H ' ' D' ' 53' ' ' THR . 0.2 OUTLIER -83.39 -163.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . 56.35 0.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.134 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.575 ' H ' ' C ' ' D' ' 51' ' ' THR . 28.8 p -121.28 -1.2 9.74 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' D' ' 53' ' ' THR . 11.8 p 56.88 15.08 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -91.33 -53.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.705 0.288 . . . . 1.0 110.457 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.03 74.45 0.23 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.56 -47.28 86.86 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.974 -0.29 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 155.65 -90.77 0.12 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' D' ' 50' ' ' GLU . 98.0 m-20 44.05 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 1.0 110.424 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.497 HH22 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -124.62 162.54 23.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.736 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -162.75 138.95 5.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.528 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 157.53 57.24 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.893 1.729 . . . . 1.0 112.617 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.792 HG22 ' H ' ' D' ' 64' ' ' THR . 7.4 p -93.81 -121.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.495 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.792 ' H ' HG22 ' D' ' 63' ' ' VAL . 39.9 m -115.0 -35.05 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.757 0.313 . . . . 1.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 67' ' ' GLY . 51.9 tp10 -65.74 -32.09 73.44 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.232 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.519 ' CB ' ' HB1' ' D' ' 29' ' ' ALA . 0.5 OUTLIER -81.09 37.29 0.43 Allowed 'General case' 0 C--O 1.261 1.67 0 CA-C-O 123.349 1.547 . . . . 1.0 108.909 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 39.96 62.4 1.47 Allowed Glycine 0 C--O 1.214 -1.094 0 CA-C-N 113.663 -1.608 . . . . 1.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.537 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.5 ttt85 -24.5 -30.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.133 0.549 . . . . 1.0 111.323 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.5 mttm -53.12 -13.85 0.55 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.214 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.5 t -60.47 -48.73 87.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 C-N-CA 119.437 -0.905 . . . . 1.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.08 76.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.277 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.95 -38.85 92.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.329 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.25 -50.52 72.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.395 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.86 -42.93 89.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.368 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 34.4 ttm -58.08 -47.35 83.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.994 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -65.02 -40.05 94.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.614 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.04 81.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.5 94.64 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.3 -43.34 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.425 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' D' ' 84' ' ' LEU . 97.0 mt-10 -58.55 -50.73 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.836 0.309 . . . . 1.0 111.836 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.422 HG23 ' N ' ' D' ' 82' ' ' PHE . 11.4 m -60.84 -46.11 96.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.516 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' PHE . . . . . 0.422 ' N ' HG23 ' D' ' 81' ' ' VAL . 11.6 m-85 -66.24 -29.58 69.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.592 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -91.04 -20.76 21.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.575 0.226 . . . . 1.0 110.585 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 80' ' ' GLU . 8.0 tt -63.73 -42.03 97.96 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.541 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' D' ' 88' ' ' ALA . 8.7 m -60.18 -18.93 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.058 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.405 ' C ' ' O ' ' D' ' 85' ' ' VAL . 50.9 m -36.29 -28.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -62.97 -46.21 88.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.531 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -67.22 -26.35 66.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.178 0.514 . . . . 1.0 110.241 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.513 HD22 ' N ' ' D' ' 89' ' ' LEU . 4.2 mm? -73.02 -34.73 66.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.9 -45.09 93.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.95 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -4.87 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.006 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 40.7 t0 -59.4 -50.26 74.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.965 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 21.7 p90 -73.96 -26.88 60.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.008 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.98 -26.28 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.219 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -57.32 -22.51 42.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.851 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -62.2 -20.76 64.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.565 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' D' ' 99' ' ' GLU . 60.7 tt0 -120.45 164.88 15.72 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.23 -73.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.841 0.353 . . . . 1.0 110.728 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' D' ' 97' ' ' GLU . 80.2 mm-40 -56.15 -48.82 75.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.37 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -65.38 -43.05 91.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.317 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -120.23 108.79 14.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.25 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.23 29.08 9.9 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.849 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' ALA . 23.3 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' CE1' ' A' ' 4' ' ' HIS . . . 50.25 174.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 66.3 t0 -105.52 -29.04 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.46 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 18.2 p-80 -81.02 -30.27 34.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.711 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.38 -45.69 83.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 1.0 110.813 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.46 -35.1 75.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.33 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.05 -40.32 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.213 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.75 92.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.391 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -63.31 -33.96 76.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.3 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.02 81.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.128 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.45 -39.45 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -62.25 -37.35 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.239 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.7 -31.07 71.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.572 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -42.31 98.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.438 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.99 -39.34 94.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.12 -40.27 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 1.0 111.328 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.17 -41.07 91.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.662 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.4 mt -60.61 -41.61 95.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.73 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.3 -38.39 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.308 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.4 90.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.796 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -60.14 -41.19 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.151 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.31 -30.01 70.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.37 -40.73 20.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.652 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CG ' ' A' ' 30' ' ' GLU . . . -64.83 -40.44 95.19 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.78 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.5 p -61.47 -50.29 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.608 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.6 ' N ' HG13 ' A' ' 27' ' ' VAL . 15.5 pt-20 -71.03 -43.29 68.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.545 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.99 73.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 21.7 mm-40 -67.72 -39.43 84.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.144 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -71.68 129.91 39.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.909 0.385 . . . . 1.0 110.313 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.02 -12.21 67.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.346 -0.702 . . . . 1.0 111.346 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.68 147.91 47.52 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' O ' HG11 ' A' ' 63' ' ' VAL . 97.8 Cg_endo -75.21 138.88 23.09 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.034 1.822 . . . . 1.0 112.306 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.39 69.22 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.59 54.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 1.0 110.396 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.48 -7.85 8.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.9 tt -107.13 123.1 47.76 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.064 0.459 . . . . 1.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 38' ' ' LEU . 44.3 pt -149.93 -171.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.104 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' ILE . 2.0 m 58.16 145.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.944 0.402 . . . . 1.0 110.623 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 65.0 t80 -82.7 -43.22 0.92 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.13 -0.486 . . . . 1.0 112.116 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.8 Cg_endo -60.4 -28.71 87.28 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.657 1.571 . . . . 1.0 112.829 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.7 p-10 -94.02 -28.92 15.48 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.99 -0.284 . . . . 1.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.17 83.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.271 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.82 -42.41 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.047 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.872 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.1 OUTLIER -62.88 -41.39 99.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.019 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 13.5 t90 -60.15 -39.28 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -72.87 67.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -151.99 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.007 0.432 . . . . 1.0 110.362 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.7 pm0 -48.16 -24.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.539 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -62.31 -43.67 98.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.989 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -28.09 67.77 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.236 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.4 p -84.32 5.63 26.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 48.05 76.61 0.11 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.899 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG22 ' O ' ' B' ' 54' ' ' THR . 94.5 t -138.98 -55.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.879 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.94 77.02 0.19 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.276 -0.73 . . . . 1.0 111.276 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -60.75 -42.77 98.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.46 9.92 1.32 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CG ' HH22 ' B' ' 68' ' ' ARG . 20.8 m-20 -58.1 -50.08 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -147.95 163.89 35.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.46 132.85 7.15 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.446 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.3 163.19 39.59 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.075 1.85 . . . . 1.0 112.394 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.0 t -97.78 -128.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.431 ' H ' HG12 ' A' ' 63' ' ' VAL . 8.6 m -115.01 -36.57 4.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.68 0.276 . . . . 1.0 110.979 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.692 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.4 tt0 -70.79 -39.41 73.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.748 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.79 27.53 0.02 OUTLIER 'General case' 0 C--O 1.265 1.899 0 CA-C-O 123.753 1.74 . . . . 1.0 109.925 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.16 64.35 0.96 Allowed Glycine 0 C--O 1.214 -1.117 0 CA-C-N 114.035 -1.438 . . . . 1.0 111.392 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 33.0 ttm180 -24.93 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.806 0.803 . . . . 1.0 110.969 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -50.44 -16.72 0.38 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.451 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.8 t -61.38 -48.09 90.47 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.342 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' A' ' 75' ' ' MET . . . -70.84 -42.8 69.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.007 0.432 . . . . 1.0 110.442 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.59 -43.17 46.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.474 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -62.26 -39.64 93.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.04 -43.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' A' ' 71' ' ' ALA . 3.4 mpp? -61.63 -40.2 94.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.021 -0.272 . . . . 1.0 110.503 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -61.33 -39.92 92.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.061 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 81' ' ' VAL . . . -51.4 -45.98 62.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.487 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -51.45 53.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.486 -1.046 . . . . 1.0 110.486 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 79' ' ' ILE . 95.6 mt -67.95 -4.78 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.472 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -96.17 -49.72 5.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.427 -0.352 . . . . 1.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 82' ' ' PHE . 28.3 m -70.8 -51.0 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.06 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.625 ' N ' HG23 ' A' ' 81' ' ' VAL . 45.6 m-85 -62.39 -39.18 92.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.073 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.691 ' O ' HD12 ' D' ' 89' ' ' LEU . . . -61.15 -39.57 90.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.715 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.5 tt -63.48 -40.35 96.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.505 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 85' ' ' VAL . 59.1 t -49.7 -11.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.429 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.481 ' N ' ' C ' ' A' ' 84' ' ' LEU . 54.5 m -49.28 -42.49 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 1.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.73 -13.61 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.68 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 86' ' ' THR . . . -104.75 -15.92 15.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.683 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.547 HD13 ' OD2' ' A' ' 92' ' ' ASP . 3.1 mm? -94.84 -46.68 6.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 1.0 110.677 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.03 -22.74 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -3.67 58.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.748 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD2' HD13 ' A' ' 89' ' ' LEU . 86.2 m-20 -61.65 -48.78 79.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.343 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.58 -19.57 45.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.765 0.317 . . . . 1.0 111.454 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.08 -42.73 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.904 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 98' ' ' GLU . 95.9 mtt-85 -58.06 -21.53 46.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.712 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -55.1 -42.85 73.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.546 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 97' ' ' GLU . 56.3 mp0 -74.74 0.33 15.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 1.0 110.085 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 100' ' ' ARG . 96.9 mt-10 -129.18 168.7 15.77 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.091 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 66.73 -43.05 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.767 0.667 . . . . 1.0 110.393 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 98' ' ' GLU . 70.6 ttp85 -61.71 -43.89 97.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.591 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -97.18 -1.23 45.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.572 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.2 18.55 79.25 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.033 -0.984 . . . . 1.0 110.57 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.97 165.53 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.82 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.725 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -73.1 -35.43 66.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.714 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.26 -43.89 89.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.79 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.02 -38.89 92.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.68 -37.56 87.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.43 99.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.758 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.05 -35.73 76.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.334 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.41 -38.54 87.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.32 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.935 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.98 -34.78 78.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.562 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -62.79 -38.35 90.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.137 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.03 -33.05 74.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' B' ' 52' ' ' ALA . 47.8 tp -62.36 -41.92 98.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.506 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.11 -39.11 93.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.89 -44.23 97.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.22 -40.86 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.786 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.3 mt -60.36 -41.69 94.21 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.054 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.3 -48.17 79.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.118 0.485 . . . . 1.0 110.056 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.49 -35.85 75.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.128 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.52 86.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.35 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.5 p -56.58 -44.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.466 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.77 -36.2 82.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -67.98 -44.42 76.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.31 76.76 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.463 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.46 HG23 ' N ' ' B' ' 28' ' ' GLU . 16.9 m -62.82 -45.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.768 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.46 ' N ' HG23 ' B' ' 27' ' ' VAL . 46.2 tp10 -71.9 -42.0 67.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -43.7 -47.38 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.327 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' B' ' 38' ' ' LEU . 96.9 mt-10 -68.21 -116.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.809 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 45.67 79.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.596 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.26 17.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.413 -0.675 . . . . 1.0 111.413 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 149.7 96.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.24 121.27 6.03 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.953 1.769 . . . . 1.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 92.83 -23.06 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 49.94 175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 1.0 110.579 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.77 -85.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.552 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.529 ' N ' ' OE2' ' B' ' 30' ' ' GLU . 44.9 tp -89.93 82.3 6.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.594 HG23 ' O ' ' B' ' 39' ' ' ILE . 15.2 tt -125.97 102.07 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.963 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.516 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 73.4 m -169.94 -124.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' B' ' 40' ' ' SER . 2.3 m-85 -174.77 -65.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.0 109.995 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.15 -36.94 97.44 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.088 1.859 . . . . 1.0 112.175 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -92.98 0.91 57.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.617 -0.265 . . . . 1.0 111.145 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.06 93.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.003 0.43 . . . . 1.0 110.343 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -69.47 -36.61 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.546 ' O ' ' NH2' ' C' ' 68' ' ' ARG . 1.1 t90 -46.54 -68.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.647 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.467 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -57.16 -27.18 61.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.059 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.467 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -65.47 -41.77 92.97 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.701 -0.399 . . . . 1.0 111.347 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.572 ' CG1' HH12 ' C' ' 68' ' ' ARG . 55.5 t -60.95 -47.74 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.06 -31.59 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -60.5 -45.38 94.0 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.735 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.22 -27.57 55.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.813 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -85.43 1.52 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.723 0.297 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.6 p 53.41 15.69 0.75 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.005 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' N ' ' B' ' 56' ' ' GLY . 5.7 p -66.36 -44.69 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.02 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.496 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 46.3 65.22 2.19 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.47 -1.052 . . . . 1.0 110.47 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -58.98 -48.47 81.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 1.0 110.743 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.69 6.82 1.96 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -58.93 -45.62 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.644 0.259 . . . . 1.0 110.419 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -145.19 173.22 12.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -155.95 130.33 4.92 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.41 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.02 156.92 63.79 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.769 1.646 . . . . 1.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.51 HG12 ' H ' ' B' ' 64' ' ' THR . 1.8 t -84.03 -141.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.171 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.872 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.8 m -114.36 -46.54 2.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.24 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.9 tp10 -64.5 -29.18 70.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.355 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.3 OUTLIER -70.84 32.18 0.04 OUTLIER 'General case' 0 C--O 1.261 1.663 0 CA-C-O 123.889 1.804 . . . . 1.0 110.078 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.723 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.84 62.85 1.6 Allowed Glycine 0 C--O 1.208 -1.48 0 CA-C-N 113.827 -1.533 . . . . 1.0 111.338 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 50' ' ' GLU . 27.4 ttt85 -25.1 -31.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.075 0.937 . . . . 1.0 110.866 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -52.47 -14.97 0.55 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 67' ' ' GLY . 43.4 t -61.83 -46.43 96.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.364 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.05 67.18 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -57.18 -41.63 79.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.036 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.45 -44.35 94.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.08 -46.01 92.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.117 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 73.5 mtm -62.93 -42.72 99.89 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.432 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -63.86 -41.6 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.343 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.06 88.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -39.12 94.47 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.94 -26.78 33.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.58 -0.365 . . . . 1.0 111.293 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.9 -51.61 25.1 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.052 0.453 . . . . 1.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.446 HG23 ' N ' ' B' ' 82' ' ' PHE . 7.6 m -60.41 -47.86 90.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.17 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.446 ' N ' HG23 ' B' ' 81' ' ' VAL . 20.7 m-85 -67.81 -38.56 83.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.802 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.92 85.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.536 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.454 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.6 tt -61.72 -41.52 97.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 93.4 t -49.79 -17.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.457 ' O ' ' N ' ' B' ' 90' ' ' ALA . 75.1 m -52.38 -40.87 62.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.464 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.15 -55.06 7.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.841 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -12.69 54.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' C' ' 86' ' ' THR . 81.5 mt -98.21 -27.14 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -64.85 -24.62 67.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.382 0.61 . . . . 1.0 109.858 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.536 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.1 OUTLIER -84.52 -4.72 59.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.0 109.61 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.67 -48.93 74.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.82 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 7.9 p90 -66.56 -31.81 72.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.54 -44.32 96.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.232 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 83.7 mtt85 -60.08 -28.72 68.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.147 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -56.06 -42.23 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.55 -40.5 97.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.044 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.25 -36.11 82.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.596 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -66.13 -38.59 88.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.634 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -63.09 -43.37 98.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.507 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -112.22 112.76 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.2 -18.83 47.87 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.561 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -68.56 145.27 54.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.827 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -61.98 -40.99 97.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.618 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 23.3 p80 -67.11 -41.07 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.618 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.6 tt0 -62.67 -39.8 95.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.719 0.295 . . . . 1.0 110.537 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -65.1 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 1.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -64.72 -39.61 93.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.92 98.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.463 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.82 -40.82 92.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.245 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.85 -35.39 80.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.327 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.89 76.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.056 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.65 -39.59 91.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 1.0 110.877 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.49 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.742 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.73 -37.81 88.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' C' ' 78' ' ' GLY . 40.8 tp -61.55 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.427 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -59.98 -31.35 69.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -61.55 -40.1 93.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.73 0.3 . . . . 1.0 111.132 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.81 -42.35 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.847 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.64 -41.7 97.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.107 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.421 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.7 mt-10 -63.31 -46.62 85.85 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.008 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 0.2 OUTLIER -70.6 -39.08 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.112 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.95 82.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.7 p -53.34 -45.77 69.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.192 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -65.08 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.215 0.531 . . . . 1.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.5 -37.9 82.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -53.51 57.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.75 0.31 . . . . 1.0 111.065 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.84 -41.45 92.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -68.14 -44.08 76.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.524 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.11 80.56 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.09 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.6 -39.4 73.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.316 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -68.38 129.09 38.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 120.943 0.401 . . . . 1.0 110.28 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.44 -0.46 65.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.334 -0.706 . . . . 1.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.37 149.9 38.31 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.43 -0.211 . . . . 1.0 110.43 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.07 139.88 22.07 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.816 1.677 . . . . 1.0 112.369 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 2.69 57.9 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.5 103.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.78 0.324 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.44 -35.46 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.393 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 15.0 tp -87.08 95.07 9.82 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.119 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 33.4 pt -138.52 49.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 1.0 110.713 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -138.66 145.3 40.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.162 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 35.9 m-85 -69.52 -50.87 17.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.3 Cg_endo -58.98 -38.54 87.43 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.727 1.618 . . . . 1.0 112.433 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.08 -11.29 59.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.221 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.86 81.71 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.788 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.405 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.3 tt -72.93 -38.89 57.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.028 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.486 ' C ' ' NH1' ' D' ' 68' ' ' ARG . 0.5 OUTLIER -63.64 -46.52 85.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.64 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' C' ' 48' ' ' SER . 3.1 t90 -61.18 -39.64 90.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 1.0 109.553 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.417 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 60.7 p -61.63 -34.53 75.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.96 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 45' ' ' ILE . 50.2 t -61.46 -48.28 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.478 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.65 -21.29 62.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.274 -0.571 . . . . 1.0 110.58 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -75.48 -42.2 53.58 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.796 0.331 . . . . 1.0 111.367 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.41 80.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.899 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.592 ' C ' HG23 ' C' ' 54' ' ' THR . 54.5 p -74.85 -11.99 60.27 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.592 HG23 ' C ' ' C' ' 53' ' ' THR . 1.3 p 69.88 0.85 3.21 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.636 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' C' ' 57' ' ' TYR . 56.0 t -65.21 -45.09 94.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.723 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.32 79.02 0.06 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.424 ' CZ ' HG11 ' C' ' 55' ' ' VAL . 52.6 m-85 -60.3 -46.64 89.16 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.811 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.04 23.27 0.69 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.49 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 21.8 t0 -61.65 -41.17 97.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 1.0 110.305 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -145.49 -161.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.961 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 13.4 p90 -172.17 112.37 0.38 Allowed Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.986 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -170.64 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.613 1.542 . . . . 1.0 112.126 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.987 HG22 ' H ' ' C' ' 64' ' ' THR . 9.9 p -139.12 -169.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.375 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.987 ' H ' HG22 ' C' ' 63' ' ' VAL . 11.4 m -77.25 -45.91 24.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 1.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' C' ' 67' ' ' GLY . 49.0 tp10 -47.49 -50.51 23.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.91 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.9 OUTLIER -72.17 35.76 0.06 Allowed 'General case' 0 C--O 1.264 1.838 0 CA-C-O 124.28 1.991 . . . . 1.0 109.859 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.85 65.88 1.46 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.76 -1.564 . . . . 1.0 111.54 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.572 HH12 ' CG1' ' B' ' 49' ' ' VAL . 8.2 ptm180 -21.33 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.775 0.798 . . . . 1.0 111.657 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.6 mmtt -43.84 -18.6 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.273 -1.331 . . . . 1.0 109.588 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' C' ' 68' ' ' ARG . 54.5 t -59.29 -44.91 93.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.453 -0.899 . . . . 1.0 110.189 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.87 63.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.966 0.412 . . . . 1.0 110.764 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.33 -35.27 79.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.955 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.93 -52.45 64.98 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.671 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.27 -43.55 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.773 0.321 . . . . 1.0 111.175 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.553 ' HG3' HG22 ' C' ' 54' ' ' THR . 19.1 ttp -59.62 -43.73 93.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 56.6 tttm -63.47 -42.49 98.59 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.583 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.482 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.14 -39.78 95.68 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.17 -44.56 93.77 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.203 -0.522 . . . . 1.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.94 -43.12 97.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.676 0.274 . . . . 1.0 110.736 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.0 mt-10 -64.63 -39.4 93.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.328 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' C' ' 77' ' ' ALA . 53.7 t -63.82 -48.72 85.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.405 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -64.18 -41.9 96.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.204 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.483 ' O ' HG22 ' C' ' 86' ' ' THR . . . -65.31 -36.0 82.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.859 0.361 . . . . 1.0 110.593 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.5 tt -61.66 -33.89 74.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.519 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.539 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.0 t -54.29 -4.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.374 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 88' ' ' ALA . 6.0 t -62.73 -39.45 94.13 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.118 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -40.09 -21.96 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.545 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -101.85 -38.35 7.87 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.215 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' C' ' 86' ' ' THR . 30.9 mt -74.03 -42.14 60.76 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.941 0.4 . . . . 1.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -55.73 -32.34 63.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.266 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.14 -4.01 45.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.095 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 87.5 m-20 -59.06 -47.8 83.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 11.6 p90 -70.15 -29.63 66.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.08 -43.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.674 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' C' ' 98' ' ' GLU . 95.4 mtt180 -58.7 -23.07 58.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.427 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -40.59 -37.18 0.68 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.31 -40.58 93.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.375 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 95' ' ' ARG . 97.4 mt-10 -66.99 -42.3 85.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.94 0.4 . . . . 1.0 110.457 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.77 -47.52 71.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.44 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -65.31 -42.79 92.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.89 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -109.95 114.12 27.39 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.401 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.38 -10.62 46.75 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.499 ' ND1' ' OXT' ' C' ' 103' ' ' HIS . 59.0 t-80 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.984 -1.008 . . . . 1.0 110.588 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.0 -92.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.508 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -158.78 -43.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -79.68 -20.15 47.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.811 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.27 -35.71 81.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 1.0 110.563 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.08 -40.93 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.53 -43.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 1.0 109.965 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' ALA . . . . . 0.492 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.48 -38.38 89.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.832 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 68.8 tp60 -64.45 -41.0 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.407 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.4 -38.46 89.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.733 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -28.66 65.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.095 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -62.69 -40.98 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 1.0 110.952 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' D' ' 9' ' ' GLN . 58.2 mp0 -66.32 -33.73 76.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.08 -37.79 86.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.457 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.0 tp -62.81 -41.68 99.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.78 -34.76 76.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.144 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -61.86 -44.0 97.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.835 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -64.08 -36.13 75.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.885 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' D' ' 52' ' ' ALA . 91.2 mt -60.88 -42.16 97.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.21 -47.73 72.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -66.77 -36.84 83.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.665 -0.414 . . . . 1.0 109.894 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -29.07 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.764 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' D' ' 27' ' ' VAL . 69.2 m -59.12 -45.85 89.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.997 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' D' ' 25' ' ' LYS . 13.5 ptpt -66.59 -39.12 88.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.46 ' N ' ' HG3' ' D' ' 24' ' ' LYS . 98.2 mttt -62.05 -45.34 93.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.611 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.433 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 23' ' ' SER . 90.1 t -65.6 -45.77 91.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.264 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -69.46 -42.49 74.82 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.575 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.81 91.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.631 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.455 ' OE1' ' CG2' ' D' ' 39' ' ' ILE . 11.8 tm-20 -67.2 -39.76 86.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.45 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -61.39 115.64 4.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.841 0.353 . . . . 1.0 110.652 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.98 -13.69 57.45 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.22 111.53 55.32 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.27 149.26 35.38 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.915 1.743 . . . . 1.0 112.688 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.69 73.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.73 164.32 16.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 1.0 110.478 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' ALA . . . . . 0.451 ' HB3' ' CE1' ' D' ' 61' ' ' TYR . . . -145.98 84.56 1.66 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.433 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.448 HD23 ' C ' ' D' ' 38' ' ' LEU . 3.5 tt -173.94 79.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.233 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' D' ' 40' ' ' SER . 10.1 pt -127.48 164.65 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.015 0.436 . . . . 1.0 110.606 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 81.24 123.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.438 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 54.0 m-85 -59.57 -47.07 98.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.953 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.59 -33.61 98.26 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.572 1.515 . . . . 1.0 112.267 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.7 -29.38 16.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.049 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.02 94.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.684 0.278 . . . . 1.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.488 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.5 tt -63.36 -32.17 55.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.154 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.488 ' HE3' HG23 ' D' ' 45' ' ' ILE . 0.3 OUTLIER -59.72 -46.63 88.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.884 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' D' ' 51' ' ' THR . 0.7 OUTLIER -67.29 -40.01 86.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.466 -0.493 . . . . 1.0 110.037 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 4.3 t -56.72 -40.0 74.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.459 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.79 -48.64 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.54 -31.63 71.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.911 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' D' ' 47' ' ' TRP . 87.9 m -64.29 -45.17 89.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.572 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.93 -25.98 65.58 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.599 -0.441 . . . . 1.0 110.16 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.3 p -88.37 6.08 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 1.0 110.324 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.02 67.75 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.203 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.16 -40.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.432 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.43 78.51 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.506 -1.037 . . . . 1.0 110.506 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -44.65 96.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 1.0 110.629 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.63 -0.35 3.05 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.71 -0.956 . . . . 1.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 97.5 m-20 -56.8 -50.38 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -130.95 140.78 50.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' D' ' 61' ' ' TYR . 21.3 p90 -130.47 105.25 15.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.786 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.65 154.29 68.35 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.966 1.777 . . . . 1.0 112.258 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.08 -162.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.248 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 55.1 m -87.77 -20.96 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -77.55 -13.59 59.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.665 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.411 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.8 OUTLIER -103.75 28.26 6.76 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 124.293 1.997 . . . . 1.0 108.521 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.84 60.47 4.9 Favored Glycine 0 C--O 1.211 -1.285 0 CA-C-N 113.831 -1.531 . . . . 1.0 109.761 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.49 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 42.5 ttm180 -26.93 -28.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 117.351 0.576 . . . . 1.0 111.046 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 64.0 mttm -57.33 -15.14 5.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.188 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.3 t -60.73 -47.99 90.7 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 119.417 -0.913 . . . . 1.0 109.388 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' ALA . . . . . 0.545 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -65.63 -48.69 71.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.876 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -42.87 -59.33 2.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.338 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -48.93 -39.51 26.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.717 0.266 . . . . 1.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.0 t -62.23 -42.93 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.529 -0.468 . . . . 1.0 111.614 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 2.6 mpp? -59.02 -40.03 83.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.925 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.76 -39.5 88.97 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.472 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.55 -40.28 96.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.044 -0.663 . . . . 1.0 110.716 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -73.29 -44.46 34.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.36 -44.23 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.076 -0.25 . . . . 1.0 111.397 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.94 -44.02 86.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.374 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.472 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.2 t -63.95 -48.55 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.464 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.93 -15.9 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.846 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -95.57 -25.96 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 1.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.92 -42.33 94.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.487 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.492 HG12 ' HB1' ' D' ' 8' ' ' ALA . 15.0 m -58.7 -18.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.015 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 41.2 m -36.95 -29.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.998 0.427 . . . . 1.0 110.488 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.555 ' O ' HG22 ' D' ' 91' ' ' THR . . . -58.94 -62.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.715 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.38 63.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.169 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 83' ' ' ALA . 4.2 mm? -66.03 -37.42 85.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -66.0 -66.13 0.59 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.626 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.802 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.4 OUTLIER -49.18 -4.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.879 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' D' ' 90' ' ' ALA . 25.9 t0 -67.22 -21.21 65.76 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 1.0 111.356 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.505 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 2.3 p90 -77.41 -18.21 57.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.874 0.369 . . . . 1.0 111.194 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.802 HG22 ' O ' ' D' ' 91' ' ' THR . 7.7 m -60.41 -40.05 82.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.576 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.432 ' N ' HG23 ' D' ' 94' ' ' VAL . 99.8 mtt180 -49.69 -22.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.625 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -60.9 -41.97 97.11 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -92.06 -34.68 14.29 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' D' ' 100' ' ' ARG . 80.0 mm-40 -94.6 -176.1 3.8 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 58.94 -71.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.65 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' D' ' 98' ' ' GLU . 77.5 ttt-85 -58.11 -43.65 87.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.222 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.49 108.28 14.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.285 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' D' ' 103' ' ' HIS . . . 104.52 -4.02 43.25 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.315 -0.714 . . . . 1.0 111.315 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 103' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' D' ' 102' ' ' GLY . 26.5 p80 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.074 -0.965 . . . . 1.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 3' ' ' ASP . 29.8 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 4' ' ' HIS . . . 51.88 8.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.545 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 1' ' ' SER . 98.2 m-20 55.01 30.33 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 7.6 p80 -162.0 -37.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.925 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.637 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 44.1 tt0 -65.56 -42.45 91.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -64.09 -41.65 97.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.113 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.78 -34.24 75.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.36 -50.76 72.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -67.48 -33.32 74.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.439 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.68 -36.18 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.458 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.51 77.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.972 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -40.55 94.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.526 -0.306 . . . . 1.0 110.632 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -63.48 -33.57 75.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 1.0 110.493 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' VAL . 80.8 tt0 -62.21 -41.43 98.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.359 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 78' ' ' GLY . 54.4 tp -66.65 -39.47 88.24 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -49.62 -51.0 40.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.828 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -74.77 -31.27 61.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.495 -0.482 . . . . 1.0 112.069 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 14' ' ' GLU . 53.8 t -63.51 -48.22 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.088 -0.245 . . . . 1.0 111.588 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.03 -28.88 66.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.197 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -61.2 -46.78 89.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.4 -39.51 92.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 1.0 109.675 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.9 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.201 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.51 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 37.2 m -54.25 -40.69 67.99 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -62.73 -31.72 72.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.885 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.94 -39.3 34.96 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.902 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.58 88.58 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.6 p -61.08 -46.05 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.359 -0.536 . . . . 1.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 27' ' ' VAL . 80.5 tt0 -67.19 -42.24 84.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.229 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.38 98.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.847 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 37' ' ' ALA . 31.5 tp10 -74.01 -42.62 60.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.592 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -70.85 126.82 30.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.234 0.54 . . . . 1.0 110.819 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.48 59.63 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.387 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -103.18 151.78 38.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.599 ' O ' HG21 ' A' ' 63' ' ' VAL . 72.6 Cg_endo -75.66 117.27 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.048 1.832 . . . . 1.0 111.751 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 94.87 20.64 27.99 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -39.52 162.49 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.65 0.262 . . . . 1.0 110.629 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' H ' ' CG ' ' A' ' 30' ' ' GLU . . . -136.37 -71.84 0.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.725 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.59 128.27 35.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.08 163.12 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.028 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.7 OUTLIER 81.33 153.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.717 0.294 . . . . 1.0 110.684 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 13.3 t80 -83.15 -50.52 0.7 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.817 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.24 -28.66 87.33 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.421 1.414 . . . . 1.0 112.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 25.1 m-20 -90.25 -28.94 18.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.87 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -64.2 -36.67 84.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 tt -62.3 -37.97 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.287 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -47.81 81.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.446 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -66.09 -39.06 89.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.51 ' HG ' ' CB ' ' A' ' 23' ' ' SER . 21.5 m -57.1 -39.77 75.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.858 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG21 ' NH2' ' B' ' 68' ' ' ARG . 53.7 t -61.33 -46.84 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 98.9 mt-10 -65.48 -44.33 87.42 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 54' ' ' THR . 3.0 m -62.04 -43.8 98.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.269 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -48.53 -52.17 23.9 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.388 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.12 7.6 24.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.4 p 63.33 -133.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.574 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' OG1' ' A' ' 54' ' ' THR . 47.2 t 64.05 -40.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.547 0.529 . . . . 1.0 111.582 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 37.06 90.67 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 53.8 t80 -60.03 -45.84 91.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 1.0 110.462 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.19 7.59 1.09 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.24 -47.0 86.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 1.0 110.156 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -146.09 154.46 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.07 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 27.9 p90 -137.83 130.07 16.4 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.36 154.01 69.93 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.12 1.88 . . . . 1.0 112.518 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.794 HG22 ' H ' ' A' ' 64' ' ' THR . 6.2 p -75.74 -141.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.459 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.794 ' H ' HG22 ' A' ' 63' ' ' VAL . 4.7 m -116.42 -39.2 3.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.678 0.275 . . . . 1.0 111.099 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 80.2 tt0 -77.67 -11.93 59.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.225 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 63' ' ' VAL . 2.1 pp20? -71.66 23.36 0.05 OUTLIER 'General case' 0 C--O 1.259 1.605 0 CA-C-O 123.933 1.825 . . . . 1.0 109.837 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.36 69.43 1.08 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 117.561 -1.688 . . . . 1.0 112.566 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HE ' ' HA ' ' D' ' 46' ' ' TRP . 0.6 OUTLIER -24.39 -32.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.974 1.387 . . . . 1.0 110.665 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 67' ' ' GLY . 64.0 mttp -50.8 -33.72 24.66 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.316 -0.856 . . . . 1.0 109.888 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' GLY . 61.2 t -61.84 -49.75 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 119.4 -0.92 . . . . 1.0 110.576 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.41 -46.17 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CG1' ' D' ' 49' ' ' VAL . 77.5 tt0 -58.23 -38.84 77.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.735 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.57 -46.11 77.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.769 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.74 -42.24 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.269 -0.573 . . . . 1.0 111.498 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.3 mtt -52.94 -44.66 67.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.852 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.37 -46.34 83.8 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.04 92.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 15' ' ' LEU . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.58 -23.83 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.739 -0.271 . . . . 1.0 111.258 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -67.6 -45.72 74.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 81' ' ' VAL . 6.9 m -63.77 -43.99 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.837 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 78' ' ' GLY . 40.3 m-85 -67.39 -37.28 82.89 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.054 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 86' ' ' THR . . . -63.76 -40.97 97.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.046 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' C ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -63.1 -36.15 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.453 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 85' ' ' VAL . 80.8 t -53.56 -15.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.942 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.627 HG21 ' HB3' ' D' ' 89' ' ' LEU . 9.8 t -48.42 -38.01 18.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.305 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -49.86 -29.51 8.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.473 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.36 29.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.788 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.41 -58.2 2.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.856 0.36 . . . . 1.0 111.0 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.3 -22.98 33.81 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.454 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.465 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -98.28 -4.72 34.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.264 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.01 -47.17 87.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.233 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 3.8 p90 -58.07 -44.15 87.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.114 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 61.7 t -36.66 -26.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.484 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' PHE . 96.5 mtt180 -61.78 -36.13 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.988 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -49.04 -32.75 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.55 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -61.94 -41.74 98.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -68.12 -42.14 80.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.457 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -68.46 -34.08 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.269 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -59.02 -43.79 91.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.439 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.44 -37.91 88.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.57 57.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.093 -0.803 . . . . 1.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.951 -1.023 . . . . 1.0 110.603 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.66 ' CB ' ' CE1' ' B' ' 4' ' ' HIS . . . -80.63 177.19 9.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.01 -42.86 99.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.053 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.66 ' CE1' ' CB ' ' B' ' 2' ' ' ALA . 10.4 p-80 -71.47 -31.95 67.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 1.0 110.567 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.29 -36.36 83.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -63.65 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 1.0 110.622 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.4 -45.17 95.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.946 -0.391 . . . . 1.0 109.946 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -40.93 85.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.61 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.12 -40.12 94.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.52 -38.07 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.513 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.21 -35.5 75.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.004 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.66 -36.09 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.38 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.78 -34.45 78.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.128 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.01 -36.92 85.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.699 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.3 tp -63.62 -39.34 94.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.54 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.16 -38.41 86.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.978 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -62.27 -39.8 94.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 1.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.19 -41.84 91.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.649 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' B' ' 52' ' ' ALA . 90.6 mt -59.56 -41.34 89.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.608 -0.437 . . . . 1.0 109.933 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.81 -50.1 73.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.991 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.98 -33.19 75.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.008 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.6 83.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.332 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.0 t -59.85 -46.15 90.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.297 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.53 -32.59 73.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.475 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.59 -50.02 16.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.659 -0.417 . . . . 1.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.28 95.37 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.467 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.8 p -62.51 -46.67 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.156 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.541 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.0 tm-20 -70.93 -42.16 70.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.9 96.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.492 ' HG2' ' H ' ' B' ' 38' ' ' LEU . 36.3 tp10 -76.25 -41.51 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.85 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.43 111.18 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.971 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.35 -2.8 23.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.2 151.36 37.69 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 110.66 -0.126 . . . . 1.0 110.66 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' B' ' 36' ' ' ALA . 92.4 Cg_endo -74.81 146.66 33.77 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.946 1.764 . . . . 1.0 112.63 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 77.15 -24.01 2.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.646 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . 40.77 -166.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.606 0.241 . . . . 1.0 110.701 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 161.85 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.932 0.396 . . . . 1.0 110.117 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.492 ' H ' ' HG2' ' B' ' 30' ' ' GLU . 15.4 tp -154.38 108.89 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 1.0 110.743 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.8 pt -131.84 167.06 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.661 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER 80.83 127.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.624 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 9.3 t80 -72.13 -44.97 11.13 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.981 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.76 -26.62 80.76 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.609 1.54 . . . . 1.0 112.738 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -94.31 -18.92 21.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.696 0.284 . . . . 1.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.458 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.63 -41.41 88.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.562 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.538 ' CE2' ' O ' ' C' ' 64' ' ' THR . 4.2 t-105 -61.31 -46.14 91.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.374 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 2.8 t90 -63.1 -39.37 94.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.005 0.431 . . . . 1.0 110.266 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.423 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 6.3 t -62.92 -32.77 74.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.643 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 45' ' ' ILE . 42.0 t -58.85 -47.55 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.629 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.61 -30.71 69.5 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 1.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.0 m -63.33 -46.48 86.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.432 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.48 -35.96 81.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.301 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 55' ' ' VAL . 76.3 p -76.81 3.47 11.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.82 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' B' ' 53' ' ' THR . 58.8 p 51.24 53.77 12.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.426 HG21 ' SD ' ' C' ' 75' ' ' MET . 50.4 t -125.41 -60.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.544 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.13 84.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.24 -41.16 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.302 . . . . 1.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.61 26.91 0.16 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -61.65 -47.53 84.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 1.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.539 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 94.0 mtt-85 -144.1 -169.55 3.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 52.2 m-85 -159.71 110.28 1.47 Allowed Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.433 -0.317 . . . . 1.0 110.437 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.416 1.41 . . . . 1.0 112.238 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.965 HG22 ' H ' ' B' ' 64' ' ' THR . 9.9 p -95.06 -165.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.965 ' H ' HG22 ' B' ' 63' ' ' VAL . 52.4 m -91.07 -37.69 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 1.0 110.602 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 65.5 tt0 -60.79 -31.87 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.483 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -75.33 28.04 0.1 Allowed 'General case' 0 C--O 1.262 1.727 0 CA-C-O 124.028 1.87 . . . . 1.0 109.386 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.709 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 45.58 65.48 1.93 Allowed Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.786 -1.552 . . . . 1.0 111.31 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH2' HG21 ' A' ' 49' ' ' VAL . 59.5 ttp85 -24.58 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.906 0.853 . . . . 1.0 110.572 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.2 mmtt -46.2 -22.59 0.25 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 69.6 t -61.8 -44.85 99.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 119.517 -0.873 . . . . 1.0 109.585 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.524 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -72.08 -51.0 23.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.733 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -55.29 -40.25 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.59 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.0 -45.79 89.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.942 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.98 -44.78 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.4 mpp? -63.19 -41.45 99.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.35 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -63.97 -42.13 97.35 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.445 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.412 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -60.54 -41.12 93.85 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.511 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -65.22 -44.8 93.26 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.85 -43.84 99.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.881 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.34 -44.86 95.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.412 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.0 t -63.75 -48.04 88.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.138 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.441 ' O ' HG22 ' B' ' 85' ' ' VAL . 27.5 m-85 -71.63 -21.27 61.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.901 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.43 -25.14 17.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.0 110.319 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.5 -40.96 98.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.09 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' ALA . 10.7 m -46.61 -24.65 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.678 ' HA ' HD22 ' B' ' 89' ' ' LEU . 36.9 m -37.44 -24.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.377 0.608 . . . . 1.0 110.384 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -56.01 -39.41 71.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.727 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.62 -11.18 57.63 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.718 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' B' ' 86' ' ' THR . 5.0 mp -81.76 -4.26 55.91 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.468 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -94.9 -56.67 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.394 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.448 ' H ' HG22 ' B' ' 91' ' ' THR . 0.1 OUTLIER -58.89 -5.78 0.67 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.06 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' B' ' 93' ' ' PHE . 36.6 p-10 -61.35 -50.4 73.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.157 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 5.3 p90 -71.55 -8.26 52.85 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.829 0.347 . . . . 1.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.11 -26.09 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.417 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.53 -42.61 88.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.58 -0.282 . . . . 1.0 111.432 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.99 -38.03 0.91 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.907 0.384 . . . . 1.0 110.201 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' B' ' 99' ' ' GLU . 97.4 mt-10 -72.21 -167.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.35 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 56.87 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.91 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' B' ' 97' ' ' GLU . 1.1 pp20? -52.06 -19.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.613 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -60.59 -44.89 95.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.347 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -99.13 -2.34 37.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.66 77.26 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.426 ' OXT' ' ND1' ' B' ' 103' ' ' HIS . 59.0 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.925 -1.036 . . . . 1.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' C' ' 2' ' ' ALA . 38.8 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.702 ' HB1' ' ND1' ' C' ' 4' ' ' HIS . . . 75.18 -31.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.454 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' C' ' 1' ' ' SER . 99.0 m-20 56.61 36.83 28.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.702 ' ND1' ' HB1' ' C' ' 2' ' ' ALA . 5.8 p-80 -149.02 -47.99 0.14 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.705 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.646 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 31.5 tp10 -69.37 -36.42 76.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.885 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -64.25 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -61.34 -45.68 93.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.08 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.56 89.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.617 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -65.02 -37.84 88.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.26 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.166 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.54 87.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.038 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.23 -37.14 86.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 1.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.29 -36.33 83.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.851 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.3 tp -62.5 -40.67 97.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.342 . . . . 1.0 110.571 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -60.45 -39.72 88.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.1 -38.87 90.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.817 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.72 -36.22 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.9 mt -59.99 -41.66 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.136 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -60.98 -46.36 91.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.994 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -59.76 -38.9 83.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -60.78 -47.85 84.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.291 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -67.86 -36.75 80.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.443 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -78.55 -22.57 47.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.502 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -84.52 -44.7 13.34 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.251 0.344 . . . . 1.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.557 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.4 p -61.99 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 1.0 109.891 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.557 ' N ' HG13 ' C' ' 27' ' ' VAL . 2.9 pp20? -66.22 -31.39 72.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.643 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' C' ' 26' ' ' ALA . . . -49.28 -50.95 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.577 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' C' ' 32' ' ' GLY . 80.4 mm-40 -68.37 -37.66 80.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.69 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -57.34 87.58 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.803 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 30' ' ' GLU . . . 127.82 -13.06 6.48 Favored Glycine 0 N--CA 1.466 0.679 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.8 150.95 39.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.283 -0.266 . . . . 1.0 110.283 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.777 ' O ' HG21 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.77 155.93 39.53 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.097 1.864 . . . . 1.0 112.096 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' C' ' 37' ' ' ALA . . . 90.6 -17.4 54.73 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' C' ' 37' ' ' ALA . . . 40.79 -96.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 1.0 110.949 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' C' ' 36' ' ' ALA . . . 80.46 -73.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.789 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.06 122.16 43.07 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tt -149.84 4.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.03 0.443 . . . . 1.0 110.22 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -94.24 133.39 37.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.883 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.495 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 26.5 m-85 -75.04 -53.51 2.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.6 Cg_endo -59.41 -28.55 87.84 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.617 1.544 . . . . 1.0 112.246 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.59 -18.94 25.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.089 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.86 89.77 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.472 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.74 -39.8 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.698 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -45.51 92.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.252 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.508 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.6 t90 -64.62 -39.89 94.51 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.188 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.43 ' O ' HD22 ' C' ' 19' ' ' LEU . 91.1 p -59.26 -33.3 70.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.149 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.4 -48.04 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -73.7 -23.16 59.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 70.8 m -64.12 -45.6 87.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.519 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.02 -34.29 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.848 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.415 ' OG1' HG23 ' C' ' 55' ' ' VAL . 68.2 p -82.38 1.28 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 1.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.5 p 55.61 11.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.778 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' D' ' 75' ' ' MET . 79.6 t -64.37 -46.18 93.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.956 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.09 59.33 3.43 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 7.9 t80 -61.0 -47.21 87.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 1.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 169.73 -97.86 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 53.9 t0 44.92 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 1.0 110.782 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' C' ' 58' ' ' GLY . 96.9 mtt-85 -124.01 153.13 41.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' C' ' 61' ' ' TYR . 43.8 p90 -143.48 133.66 12.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.02 162.18 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.857 1.705 . . . . 1.0 112.413 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.805 HG13 ' H ' ' C' ' 64' ' ' THR . 7.2 p -83.58 -116.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.805 ' H ' HG13 ' C' ' 63' ' ' VAL . 54.8 m -116.78 -84.0 0.64 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -43.92 125.9 4.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER 57.35 -104.46 0.22 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.69 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.476 1.349 0 O-C-N 124.431 1.082 . . . . 1.0 114.901 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 54.1 ttm-85 -87.21 -46.07 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.939 0.495 . . . . 1.0 110.773 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.8 tttm -54.36 -40.19 67.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.244 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.13 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.056 -0.657 . . . . 1.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.61 -37.2 86.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -54.95 -42.4 72.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -64.93 -40.18 94.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.571 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.07 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 1.0 111.349 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.426 ' SD ' HG21 ' B' ' 55' ' ' VAL . 59.8 mtt -54.0 -44.72 71.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.887 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -63.65 -38.77 92.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 1.0 110.533 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.51 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -62.1 -25.03 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.586 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -90.46 -39.42 5.96 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.944 -0.462 . . . . 1.0 111.944 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.69 -43.47 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.082 -0.247 . . . . 1.0 111.004 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.9 -37.72 86.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.187 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.51 HG23 ' O ' ' C' ' 77' ' ' ALA . 62.1 t -63.45 -47.54 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 121.016 -0.274 . . . . 1.0 111.271 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.0 -36.81 82.99 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.306 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' B' ' 89' ' ' LEU . . . -61.82 -39.61 92.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.808 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' C' ' 86' ' ' THR . 7.3 tt -65.02 -37.56 88.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.267 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.43 HG12 ' O ' ' C' ' 85' ' ' VAL . 78.4 t -45.48 -13.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.991 -0.283 . . . . 1.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.58 ' O ' ' N ' ' C' ' 88' ' ' ALA . 8.9 m -60.29 -41.81 94.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.501 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -39.34 -18.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.005 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -103.36 -36.89 7.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' C' ' 86' ' ' THR . 36.2 mt -75.41 -43.17 51.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' C' ' 86' ' ' THR . . . -56.58 -34.18 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.762 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.67 -5.27 52.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.801 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.488 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 61.9 t0 -56.36 -47.21 79.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.41 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.9 p90 -74.35 -40.06 62.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 84.8 t -44.87 -31.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.825 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -64.12 -22.75 67.06 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.519 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' ARG . . . . . 0.417 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 47.4 ptt85 -52.95 -42.85 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 1.0 110.497 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 79.9 mm-40 -65.27 -43.49 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.512 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.65 -34.35 75.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.404 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.83 -26.81 68.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.609 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -60.15 -44.5 94.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.83 -21.56 62.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.397 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.89 18.07 66.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.59 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.416 ' HB1' ' HD1' ' D' ' 4' ' ' HIS . . . -68.4 141.86 55.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 3' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' D' ' 4' ' ' HIS . 47.7 p-10 -65.95 -33.25 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' D' ' 3' ' ' ASP . 2.0 m80 -63.99 -45.15 90.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 1.0 110.342 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.66 -39.86 91.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -60.72 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.455 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.78 -40.02 79.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 1.0 110.09 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -63.15 -46.08 88.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' D' ' 13' ' ' GLU . 99.1 mm-40 -66.13 -37.49 85.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.566 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.29 -39.5 90.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.749 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.54 78.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.33 -39.27 86.48 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.754 0.311 . . . . 1.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' D' ' 9' ' ' GLN . 1.1 mp0 -64.12 -37.19 86.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.18 -32.51 74.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.4 tp -62.4 -41.62 98.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.511 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.93 -35.53 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.993 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 17' ' ' LYS . . . . . 0.52 ' NZ ' ' OE2' ' D' ' 21' ' ' GLU . 18.0 tttp -60.59 -45.82 92.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.79 -40.99 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.905 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.4 mt -59.66 -40.97 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.173 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -62.13 -46.87 87.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.318 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' D' ' 17' ' ' LYS . 98.3 mt-10 -68.67 -36.11 78.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.4 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.45 91.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.203 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.23 -44.43 92.33 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.757 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.66 -35.74 80.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.98 0.419 . . . . 1.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.056 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.93 86.52 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.035 -0.266 . . . . 1.0 111.044 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.24 -44.94 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.13 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.26 -41.5 73.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.856 0.36 . . . . 1.0 110.937 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.5 90.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.717 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.73 -34.45 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 1.0 110.219 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' ARG . . . . . 0.422 ' HG2' HD13 ' D' ' 39' ' ' ILE . 29.0 mmt180 -72.42 137.52 46.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' GLY . . . . . 0.406 ' O ' ' OE1' ' D' ' 65' ' ' GLU . . . 96.1 -11.86 67.26 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -100.26 149.51 36.11 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.455 ' O ' HG11 ' D' ' 63' ' ' VAL . 88.6 Cg_endo -74.49 142.99 30.32 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.907 1.738 . . . . 1.0 112.118 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.55 33.38 81.13 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.7 141.23 38.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.918 0.39 . . . . 1.0 110.538 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -32.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.513 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.88 31.91 0.43 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.019 0.437 . . . . 1.0 109.895 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' D' ' 40' ' ' SER . 4.5 tp -105.7 131.87 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.538 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.4 p 162.7 -102.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.2 m-85 171.44 -65.94 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.31 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.7 Cg_endo -59.15 -29.25 89.98 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.925 1.75 . . . . 1.0 111.526 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -86.92 -24.2 24.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.42 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.37 -45.13 95.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.774 -0.371 . . . . 1.0 110.868 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 46' ' ' TRP . 3.3 tp -67.51 -41.72 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.572 ' CH2' ' O ' ' A' ' 63' ' ' VAL . 1.1 t90 -60.68 -40.65 92.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.122 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' D' ' 48' ' ' SER . 6.0 t90 -61.86 -39.82 93.19 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.574 ' O ' ' N ' ' D' ' 50' ' ' GLU . 3.3 p -60.59 -145.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.002 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.593 ' H ' HD22 ' D' ' 19' ' ' LEU . 28.6 t 48.99 -81.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.13 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' D' ' 48' ' ' SER . 15.7 pt-20 -48.02 -29.47 3.52 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -61.94 -43.73 98.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.12 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.74 -37.6 84.85 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 41.3 p -72.97 0.03 12.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p 50.85 68.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.987 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.04 -52.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.607 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.65 77.32 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -44.35 96.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 1.0 110.443 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.42 14.04 0.73 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.74 -51.39 69.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.674 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.433 ' O ' ' CE1' ' C' ' 57' ' ' TYR . 34.8 mtt-85 -146.81 140.75 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 21.5 p90 -122.22 133.92 24.57 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 121.151 -0.22 . . . . 1.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.6 159.4 52.9 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.129 1.886 . . . . 1.0 112.195 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.543 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -84.91 -142.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.088 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.543 ' H ' HG12 ' D' ' 63' ' ' VAL . 46.7 m -113.46 -53.05 2.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.704 0.288 . . . . 1.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.5 tt0 -62.45 -16.43 55.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.863 0.363 . . . . 1.0 110.226 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.6 OUTLIER -74.35 26.41 0.08 Allowed 'General case' 0 C--O 1.264 1.839 0 CA-C-O 123.808 1.766 . . . . 1.0 109.087 178.36 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.722 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.03 61.3 3.54 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 58.2 ttm-85 -26.0 -30.31 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.297 0.645 . . . . 1.0 110.849 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.722 ' N ' ' O ' ' D' ' 67' ' ' GLY . 28.8 mmtp -53.41 -17.37 1.87 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.272 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' D' ' 67' ' ' GLY . 55.3 t -61.79 -48.36 89.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.0 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.71 -43.16 72.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.923 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -60.11 -42.21 94.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.763 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.09 -42.3 76.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.079 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.271 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.538 ' SD ' HG21 ' C' ' 55' ' ' VAL . 61.1 mtt -61.0 -42.29 98.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.327 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.23 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.479 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.02 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.396 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.14 -43.78 92.52 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -43.55 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.689 0.281 . . . . 1.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.97 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.182 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.479 HG23 ' O ' ' D' ' 77' ' ' ALA . 50.7 t -61.83 -52.31 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.341 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.91 -40.08 72.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.06 -34.94 79.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.456 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' D' ' 86' ' ' THR . 5.2 tt -61.12 -40.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' D' ' 87' ' ' ALA . 97.0 t -50.76 -16.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.611 -0.436 . . . . 1.0 109.887 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' D' ' 84' ' ' LEU . 23.7 m -42.42 -22.49 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.81 -52.97 61.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.36 -31.05 71.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.88 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.627 ' HB3' HG21 ' A' ' 86' ' ' THR . 16.0 mt -66.93 -40.97 87.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.433 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.74 -43.07 94.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.032 0.444 . . . . 1.0 110.787 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -4.28 42.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.202 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -56.93 -49.27 76.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.906 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 31.5 p90 -79.5 -42.96 24.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.172 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.527 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 60.9 t -40.44 -27.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.366 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' D' ' 93' ' ' PHE . 94.8 mtt-85 -62.78 -36.46 83.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.766 0.317 . . . . 1.0 111.105 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -47.68 -32.03 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.457 . . . . 1.0 110.285 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' D' ' 100' ' ' ARG . 45.5 tp10 -78.07 -34.91 50.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.88 -46.32 72.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.915 0.388 . . . . 1.0 110.849 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.42 -17.33 64.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.472 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' D' ' 97' ' ' GLU . 51.6 ttp180 -58.85 -45.68 89.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.299 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -81.35 -10.87 59.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.509 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.34 72.45 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.058 -0.817 . . . . 1.0 111.058 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 103' ' ' HIS . . . . . 0.444 ' O ' ' ND1' ' D' ' 103' ' ' HIS . 64.1 t-80 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.538 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.32 -72.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.519 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -173.02 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -77.84 -16.87 57.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.453 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.397 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -63.47 -37.93 89.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.299 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.62 -38.16 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.53 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.92 72.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.792 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -67.67 -35.35 78.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.57 -36.63 81.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.25 76.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.892 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.61 -37.21 83.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.552 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.79 -36.44 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -65.43 -34.47 78.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.422 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.49 -41.23 98.65 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.593 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.04 -38.83 90.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.146 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -40.57 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.5 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.2 mt -60.57 -40.96 93.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.076 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.5 mt-10 -60.58 -45.11 95.15 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.086 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.72 -37.55 76.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.91 89.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -59.77 -43.02 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 14.6 tmtt? -65.09 -36.25 83.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.833 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -76.55 -37.51 56.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.635 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.08 93.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 24' ' ' LYS . 9.1 m -61.24 -43.56 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.144 -0.622 . . . . 1.0 110.24 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -75.67 -43.25 48.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.536 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.09 -45.74 90.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.491 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.25 -44.13 92.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -71.36 133.65 46.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.58 -17.49 46.29 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.55 159.94 76.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.37 116.71 4.59 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.819 1.679 . . . . 1.0 111.924 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 82.87 -23.77 5.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . 32.69 -152.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.769 0.319 . . . . 1.0 111.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.64 -53.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.363 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.0 tp -66.22 -69.02 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.574 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 pt 36.48 25.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.103 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 38' ' ' LEU . 42.0 t -132.14 129.16 39.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.882 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 26.8 t80 -80.7 -49.05 1.13 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.982 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.36 -31.08 92.3 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.107 1.205 . . . . 1.0 112.569 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -91.17 -6.05 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.604 0.24 . . . . 1.0 111.009 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.91 95.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.916 0.389 . . . . 1.0 110.331 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 45' ' ' ILE . 7.6 tt -66.21 -40.22 86.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.155 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.59 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.96 -47.11 86.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.381 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 22.9 t90 -59.02 -39.95 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.46 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 t -76.59 66.84 2.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.698 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 48' ' ' SER . 58.3 t -156.24 -55.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.93 0.395 . . . . 1.0 110.201 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' A' ' 59' ' ' ASP . 15.3 pt-20 -64.4 -32.78 74.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.414 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -61.68 -45.95 91.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.034 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.66 -26.87 64.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.354 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -92.9 2.79 56.6 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 p 47.0 76.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 57' ' ' TYR . 32.6 t -129.07 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.7 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 97.14 -56.63 1.25 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' B' ' 61' ' ' TYR . 2.3 m-85 44.12 -89.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.883 0.373 . . . . 1.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . -166.78 -87.61 0.07 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' A' ' 50' ' ' GLU . 2.0 p-10 39.41 -105.39 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.857 0.36 . . . . 1.0 110.626 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.728 HH21 HH22 ' B' ' 68' ' ' ARG . 0.8 OUTLIER -116.96 -175.21 2.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.65 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.32 134.23 1.09 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.44 156.78 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.949 1.766 . . . . 1.0 112.454 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.454 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.5 t -98.46 -124.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.827 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.44 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 85.3 m -115.4 -40.75 3.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.592 0.235 . . . . 1.0 111.154 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.2 tt0 -67.45 -36.28 80.89 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 1.0 110.881 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.53 28.27 0.02 OUTLIER 'General case' 0 C--O 1.26 1.623 0 CA-C-O 123.289 1.519 . . . . 1.0 110.182 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.73 65.23 1.23 Allowed Glycine 0 C--O 1.212 -1.257 0 CA-C-O 117.567 -1.685 . . . . 1.0 111.437 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' D' ' 59' ' ' ASP . 60.6 ttm-85 -22.62 -35.62 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.431 1.115 . . . . 1.0 111.008 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' A' ' 67' ' ' GLY . 29.7 mmtp -48.4 -18.11 0.2 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.637 -0.711 . . . . 1.0 109.565 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -61.31 -47.97 91.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.371 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 -39.25 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 1.0 110.846 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -54.65 -42.27 71.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.674 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.52 -44.98 92.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.875 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.19 -47.19 91.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.16 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.43 -42.34 98.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.39 -42.18 96.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.346 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.17 93.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.781 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.42 95.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.28 -43.42 98.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.11 -42.09 97.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.45 -50.41 76.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -70.92 -22.41 62.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.066 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 -30.24 22.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.712 0.292 . . . . 1.0 110.781 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.65 -42.87 98.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.739 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' C ' ' N ' ' A' ' 87' ' ' ALA . 4.0 m -53.81 -16.36 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.189 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -43.16 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.268 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' N ' ' C ' ' A' ' 85' ' ' VAL . . . -63.05 -50.76 69.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.05 88.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.59 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.8 mm? -65.13 -39.0 92.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -56.4 -47.46 78.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.033 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -3.7 33.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.683 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.497 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 50.2 t0 -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.112 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.9 p90 -78.72 -44.04 24.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.827 0.346 . . . . 1.0 111.485 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 93.1 t -41.05 -25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.383 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 93' ' ' PHE . 11.1 tpt85 -58.82 -33.6 70.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.938 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -61.04 -23.05 65.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.655 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.69 -37.79 88.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.945 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.558 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.369 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.9 -44.23 94.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.343 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -92.78 -3.87 54.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.431 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.21 21.11 76.45 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.22 -0.752 . . . . 1.0 111.22 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.57 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.61 ' CB ' ' CE1' ' B' ' 4' ' ' HIS . . . -156.43 169.58 24.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.652 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.16 -36.98 85.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.988 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.61 ' CE1' ' CB ' ' B' ' 2' ' ' ALA . 12.7 p-80 -79.01 -31.36 44.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.566 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -66.27 -37.73 86.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.931 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -63.15 -40.18 96.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.706 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -65.66 -41.98 91.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.66 92.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.49 -40.56 93.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.11 -38.84 92.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.486 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.69 78.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.996 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.32 -35.68 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.645 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.74 -38.56 91.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 1.0 110.188 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -63.2 -34.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.7 tp -62.99 -37.91 89.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.276 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -65.57 -31.01 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.832 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.81 -47.64 82.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.378 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 18' ' ' VAL . 15.4 m -68.63 -31.38 50.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.089 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.6 mt -61.06 -41.84 97.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.94 -47.58 79.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 1.0 109.834 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -67.46 -34.36 77.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.826 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.12 89.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.139 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -60.76 -35.57 76.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.043 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' B' ' 27' ' ' VAL . 44.9 tptt -65.08 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.623 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -39.92 -28.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.611 0.243 . . . . 1.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 24' ' ' LYS . . . -62.55 -41.06 98.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.405 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' B' ' 24' ' ' LYS . 1.4 p -67.23 -41.5 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.09 0.472 . . . . 1.0 110.46 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 74.4 mm-40 -70.95 -40.3 72.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.594 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' B' ' 66' ' ' GLU . . . -71.96 58.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.906 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' B' ' 32' ' ' GLY . 0.0 OUTLIER 170.78 -16.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.004 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -68.11 56.38 0.07 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.442 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 130.8 31.28 0.55 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.734 -0.547 . . . . 1.0 111.734 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 149.56 38.04 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.72 134.38 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.902 1.735 . . . . 1.0 112.061 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.28 25.61 73.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.255 -0.738 . . . . 1.0 111.255 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.31 140.72 57.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.35 -31.34 8.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' B' ' 30' ' ' GLU . 40.1 tp -101.56 112.75 25.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.247 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.421 ' O ' ' OG ' ' B' ' 40' ' ' SER . 5.9 pt -145.11 84.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.29 -0.414 . . . . 1.0 109.89 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 62.9 m -168.73 -117.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.081 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.4 m-85 -176.09 -64.17 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.084 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -59.03 -29.33 90.35 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.147 1.898 . . . . 1.0 112.216 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.06 -8.2 58.78 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.09 86.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.0 110.396 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.423 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.5 tt -66.86 -38.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.696 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -47.51 85.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.27 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.422 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.6 t90 -63.27 -42.54 99.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 1.0 110.395 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.425 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.4 m -57.39 -39.88 77.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.119 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.65 -48.15 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.833 0.309 . . . . 1.0 111.833 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.421 ' OE1' ' NH1' ' C' ' 68' ' ' ARG . 18.1 pt-20 -76.13 -22.73 55.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.422 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 87.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.41 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.2 -24.51 55.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.286 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.517 HG21 ' OE2' ' C' ' 72' ' ' GLU . 37.9 p -83.76 4.26 29.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 1.0 110.762 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p 54.28 7.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' B' ' 53' ' ' THR . 53.8 t -62.99 -47.09 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.48 68.09 0.48 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' C' ' 60' ' ' ARG . 9.9 t80 -59.8 -46.38 89.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.678 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.66 -11.06 0.96 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.504 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 84.9 m-20 -41.63 -83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.834 0.35 . . . . 1.0 110.866 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -119.83 151.8 38.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.889 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 47.8 t80 -160.8 125.79 2.17 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.11 159.23 53.88 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.533 1.489 . . . . 1.0 112.531 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.69 -166.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.887 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.59 HG22 ' CD1' ' A' ' 46' ' ' TRP . 9.0 p -56.13 -69.45 0.15 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.522 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -47.37 -17.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 64' ' ' THR . 67.5 mt-10 -98.0 28.14 4.14 Favored 'General case' 0 C--O 1.266 1.932 0 CA-C-O 124.303 2.002 . . . . 1.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.732 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.59 62.76 1.31 Allowed Glycine 0 C--O 1.212 -1.235 0 CA-C-N 113.147 -1.842 . . . . 1.0 111.305 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.728 HH22 HH21 ' A' ' 60' ' ' ARG . 43.0 ttm180 -24.89 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.0 0.9 . . . . 1.0 111.414 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' B' ' 67' ' ' GLY . 14.7 mptt -53.19 -14.75 0.72 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' B' ' 67' ' ' GLY . 42.4 t -61.08 -45.5 98.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 119.695 -0.802 . . . . 1.0 109.698 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.0 28.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.302 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -60.48 -40.08 89.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.31 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -61.1 -46.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.48 -44.77 86.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.337 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 75.6 mtm -61.58 -41.79 97.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.614 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.86 -40.98 99.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.233 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -67.83 -41.68 87.99 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.68 -0.568 . . . . 1.0 111.68 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.88 -43.37 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.116 -0.233 . . . . 1.0 110.792 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.82 -41.32 91.01 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.231 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.67 -50.29 76.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.383 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -66.35 -36.81 83.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.579 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.1 -37.53 87.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.611 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.486 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.1 tt -62.64 -40.86 98.34 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.451 ' O ' HG12 ' B' ' 85' ' ' VAL . 85.4 t -49.4 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.513 ' O ' ' N ' ' B' ' 89' ' ' LEU . 73.6 m -58.2 -41.59 84.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -42.93 -19.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.581 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -103.19 -28.51 11.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.125 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' THR . 89.3 mt -69.41 -44.74 70.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.027 0.441 . . . . 1.0 111.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.565 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.1 -9.05 9.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.435 0.636 . . . . 1.0 109.817 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.9 OUTLIER -101.73 -5.13 25.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.081 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.445 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 96.0 m-20 -61.36 -46.95 88.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.011 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 47.8 p90 -79.29 -33.81 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.7 t -50.31 -31.71 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.335 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -64.23 -21.93 66.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.305 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.439 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 23.9 ptt-85 -51.16 -42.35 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 1.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' B' ' 99' ' ' GLU . 96.3 mt-10 -64.72 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.234 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 57.46 -74.51 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' B' ' 97' ' ' GLU . 97.8 mt-10 -59.78 -42.97 94.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.502 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -65.4 -43.62 90.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.805 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -114.66 113.07 23.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.01 0.434 . . . . 1.0 110.006 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.01 25.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.61 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.522 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -157.14 121.35 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -68.84 -44.64 73.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.691 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.522 ' CE1' ' HB1' ' C' ' 2' ' ' ALA . 4.5 p-80 -59.25 -41.63 89.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.804 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' C' ' 95' ' ' ARG . 97.4 mt-10 -64.43 -42.42 96.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -65.21 -39.25 92.55 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.94 -39.18 87.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.155 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' C' ' 11' ' ' ALA . . . -64.47 -37.41 87.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.404 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' C' ' 12' ' ' GLU . 56.5 tt0 -60.0 -42.5 94.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 1.0 110.469 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.67 -28.79 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.437 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' C' ' 8' ' ' ALA . . . -54.17 -45.42 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.324 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' C' ' 8' ' ' ALA . 57.3 mp0 -67.0 -41.22 87.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 1.0 110.96 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.4 -38.18 88.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 1.0 110.43 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -64.98 -31.17 72.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.305 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.99 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.3 tp -62.19 -39.12 91.67 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.441 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.7 -29.81 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.215 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -77.86 -45.19 24.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' VAL . . . . . 0.484 HG23 ' N ' ' C' ' 19' ' ' LEU . 28.1 m -60.72 -46.56 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.359 0.503 . . . . 1.0 112.359 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.484 ' N ' HG23 ' C' ' 18' ' ' VAL . 3.1 pp -74.95 -26.8 59.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.742 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -63.8 -53.93 43.08 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.922 0.392 . . . . 1.0 110.032 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.92 -36.34 83.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' C' ' 74' ' ' VAL . . . -66.72 -35.43 80.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.5 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 38.6 m -53.1 -44.43 67.61 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.284 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.21 -44.87 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 1.0 109.58 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -63.22 -39.28 94.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.792 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.38 64.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.146 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.406 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.1 p -64.44 -44.91 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.194 0.521 . . . . 1.0 110.363 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.406 ' N ' HG13 ' C' ' 27' ' ' VAL . 41.0 tp10 -66.19 -35.84 81.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.816 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.34 99.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.326 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -90.23 -11.17 41.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.681 -0.236 . . . . 1.0 111.249 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -58.34 96.9 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.604 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.24 5.16 46.74 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.55 151.4 68.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.91 139.73 22.31 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.977 1.785 . . . . 1.0 112.189 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.55 25.54 63.33 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.241 -0.744 . . . . 1.0 111.241 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 140.95 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 -38.52 5.37 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.541 HD23 ' O ' ' C' ' 38' ' ' LEU . 5.7 tt -88.74 68.48 8.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.037 0.446 . . . . 1.0 109.944 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -92.11 -5.36 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.332 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.1 m -75.48 150.98 38.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.53 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 1.1 t80 -100.83 -61.95 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.98 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.6 Cg_endo -59.0 -30.07 92.39 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.782 1.654 . . . . 1.0 112.249 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.87 -2.17 57.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.054 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.51 85.3 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.392 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.43 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.6 tt -66.66 -39.36 83.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.925 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -49.49 75.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.41 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' C' ' 50' ' ' GLU . 3.5 t90 -64.38 -38.79 92.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 25.2 p -63.2 -36.54 83.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.34 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.2 t -62.39 -48.86 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 121.101 -0.24 . . . . 1.0 111.59 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' C' ' 47' ' ' TRP . 2.6 pp20? -71.08 -29.76 65.71 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.77 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.441 ' N ' ' CD ' ' C' ' 50' ' ' GLU . 69.3 m -62.36 -46.52 88.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.315 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.99 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -62.1 -23.69 66.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.809 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.604 ' OG1' HG23 ' C' ' 55' ' ' VAL . 81.1 p -90.64 3.31 54.52 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.4 p 55.5 15.55 1.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.92 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.605 HG21 ' SD ' ' D' ' 75' ' ' MET . 72.3 t -63.68 -45.65 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.677 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.35 61.86 1.69 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -45.12 95.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.664 0.269 . . . . 1.0 110.825 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.35 13.97 1.1 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.41 -50.58 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 1.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CE1' ' B' ' 57' ' ' TYR . 96.1 mtt-85 -145.91 167.19 23.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.572 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -143.7 123.03 7.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 158.65 54.36 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.798 1.665 . . . . 1.0 112.184 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.2 m -98.09 -165.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.021 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -94.03 -32.07 13.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 1.0 110.168 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' C' ' 67' ' ' GLY . 10.4 tm-20 -64.05 -32.98 74.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.047 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -75.67 28.81 0.11 Allowed 'General case' 0 C--O 1.264 1.83 0 CA-C-O 124.378 2.037 . . . . 1.0 110.008 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.33 65.78 1.77 Allowed Glycine 0 C--O 1.216 -0.976 0 CA-C-N 113.516 -1.674 . . . . 1.0 111.167 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 ttm-85 -24.92 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.148 0.974 . . . . 1.0 111.392 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' C' ' 67' ' ' GLY . 71.8 mmtt -50.08 -31.64 13.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.476 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.8 t -64.14 -49.14 82.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 119.139 -1.024 . . . . 1.0 110.6 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.25 73.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.866 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' GLU . . . . . 0.517 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.0 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.943 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.85 -43.47 85.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.954 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' C' ' 22' ' ' ALA . 70.6 t -64.18 -43.29 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.634 -0.426 . . . . 1.0 111.165 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 39.6 mtt -55.77 -45.31 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.002 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -40.83 95.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.19 86.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 1.0 110.235 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.05 -42.65 92.13 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.78 -42.77 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.71 0.29 . . . . 1.0 110.985 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' C' ' 84' ' ' LEU . 80.9 mm-40 -58.39 -41.29 84.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.244 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -49.35 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.309 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -64.93 -35.38 80.98 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.881 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.63 -28.49 30.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.751 0.31 . . . . 1.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.8 tt -63.5 -42.94 98.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.488 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.47 2.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.527 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' C' ' 84' ' ' LEU . 23.9 m -62.93 -20.65 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' C' ' 91' ' ' THR . . . -56.72 -61.06 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.39 94.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.012 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.62 -43.64 96.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.464 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.19 -23.6 66.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.401 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.529 ' OG1' ' CG ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -96.44 -3.86 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.3 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 47.2 t0 -60.42 -43.35 96.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.097 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -67.46 -30.1 69.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.03 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.93 -44.26 94.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.407 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' C' ' 5' ' ' GLU . 95.2 mtt-85 -48.04 -21.75 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.224 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 96' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.2 ptt85 -50.85 -41.28 57.77 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.39 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' C' ' 99' ' ' GLU . 21.1 pt-20 -51.69 149.04 4.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.021 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' C' ' 102' ' ' GLY . 97.1 mt-10 62.74 -60.04 0.13 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.826 0.704 . . . . 1.0 110.673 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.0 mt-10 -54.95 -40.16 69.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.453 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -63.53 -44.79 93.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -82.34 -15.04 54.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' C' ' 98' ' ' GLU . . . 81.74 14.55 77.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.474 ' O ' ' CG ' ' C' ' 103' ' ' HIS . 49.6 t-80 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.598 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 63.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.03 -74.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.539 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -172.74 -64.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.82 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.456 ' CD2' ' HG3' ' D' ' 5' ' ' GLU . 5.6 p-80 -59.2 -39.52 82.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.456 ' HG3' ' CD2' ' D' ' 4' ' ' HIS . 96.7 mt-10 -63.11 -39.09 93.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.43 -43.17 99.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.482 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.23 -38.3 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.297 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.799 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.52 -42.11 98.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.48 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.29 -39.07 93.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.26 81.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.116 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.97 -39.12 93.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.794 0.33 . . . . 1.0 110.791 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.36 -33.81 76.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.67 -34.84 79.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.9 tp -62.09 -42.52 99.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 1.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -64.29 -35.88 82.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.115 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -61.74 -41.83 98.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 1.0 110.99 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.61 -39.0 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.532 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.8 mt -60.16 -40.76 91.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' D' ' 23' ' ' SER . 98.5 mt-10 -61.8 -44.95 95.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 1.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.63 -34.84 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.997 0.427 . . . . 1.0 110.02 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.54 87.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.03 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -59.57 -45.07 92.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.876 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -64.11 -54.97 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.256 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.58 -40.79 96.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.743 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.13 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.834 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 72.4 t -62.36 -46.71 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.65 -41.94 83.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.47 97.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -69.35 -39.68 77.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.794 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -63.32 119.21 9.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.11 49.9 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.42 146.02 30.76 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.749 -0.265 . . . . 1.0 110.519 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' D' ' 63' ' ' VAL . 94.0 Cg_endo -74.76 144.14 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.143 1.895 . . . . 1.0 112.377 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.1 71.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.46 138.6 57.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.0 110.614 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.77 -36.44 4.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.473 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -99.28 108.23 20.72 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 pt -150.94 60.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -157.81 124.44 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.535 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 34.3 m-85 -53.1 -49.87 85.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.239 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.07 -34.99 99.07 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.1 1.2 . . . . 1.0 112.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -93.4 -8.18 42.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.716 0.293 . . . . 1.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 44' ' ' ALA . . . . . 0.416 ' HB2' ' CG2' ' D' ' 27' ' ' VAL . . . -65.88 -45.38 82.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 1.0 110.876 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -68.17 -39.68 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.603 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -47.82 83.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.11 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.415 ' O ' ' N ' ' D' ' 49' ' ' VAL . 6.4 t90 -62.15 -40.21 95.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' D' ' 19' ' ' LEU . 22.7 p -69.65 61.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' D' ' 47' ' ' TRP . 76.8 t -149.01 -57.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.194 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -65.72 -27.08 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.168 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.445 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -61.17 -47.49 85.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.201 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.45 -36.93 69.6 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.298 -0.561 . . . . 1.0 109.671 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.457 ' OG1' HG12 ' D' ' 55' ' ' VAL . 49.4 p -78.75 -12.68 60.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.472 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 6.1 p 60.47 10.4 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.069 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.517 HG13 ' N ' ' D' ' 56' ' ' GLY . 12.0 p -67.24 -43.43 88.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.517 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 57.3 72.61 0.56 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.448 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.3 OUTLIER -60.24 -46.94 88.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 1.0 110.465 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.0 10.62 1.51 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 68' ' ' ARG . 53.8 m-20 -58.06 -50.86 71.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -151.02 -166.11 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.7 p90 -172.07 133.44 0.78 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.831 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.48 157.74 58.11 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.999 1.8 . . . . 1.0 112.428 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.566 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -89.79 -143.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.924 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.566 ' H ' HG12 ' D' ' 63' ' ' VAL . 94.8 m -112.09 -41.68 3.91 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.744 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.1 -19.68 65.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.9 0.381 . . . . 1.0 110.448 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.1 OUTLIER -77.86 23.67 0.25 Allowed 'General case' 0 C--O 1.266 1.973 0 CA-C-O 123.842 1.782 . . . . 1.0 108.956 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.741 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.85 61.55 3.81 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' D' ' 67' ' ' GLY . 58.0 ttm-85 -26.94 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.761 0.781 . . . . 1.0 111.214 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.9 tptm -55.85 -27.34 51.17 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.107 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.4 t -61.07 -49.42 84.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 119.649 -0.82 . . . . 1.0 109.942 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.65 -37.05 73.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.179 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.57 -43.83 89.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -61.39 -40.75 95.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.213 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.09 -43.9 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.609 -0.436 . . . . 1.0 111.196 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.605 ' SD ' HG21 ' C' ' 55' ' ' VAL . 36.9 mtt -60.26 -44.34 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.902 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -65.98 -36.77 84.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.43 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -59.92 -40.28 88.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.586 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.62 -42.76 95.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.479 -0.648 . . . . 1.0 111.479 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.64 -43.46 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.021 -0.272 . . . . 1.0 111.092 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.18 -41.53 97.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.285 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 77' ' ' ALA . 61.5 t -63.21 -50.25 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 1.0 111.373 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.9 -40.26 83.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.756 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.16 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.371 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.73 -41.18 97.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.268 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.2 -17.82 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.695 -0.402 . . . . 1.0 109.919 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 56.7 m -47.46 -40.09 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.224 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -53.08 -17.29 1.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.671 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.62 20.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.563 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.51 HD13 ' OD2' ' D' ' 92' ' ' ASP . 3.7 mm? -92.53 -40.8 10.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.008 0.432 . . . . 1.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.535 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -57.14 -28.2 62.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.618 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.34 -4.36 55.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.51 ' OD2' HD13 ' D' ' 89' ' ' LEU . 89.2 m-20 -59.5 -49.92 75.92 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.145 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 21.3 p90 -73.47 -38.72 65.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.987 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.3 t -47.92 -27.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.161 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' D' ' 97' ' ' GLU . 94.5 mtt180 -64.73 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -54.31 -7.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' D' ' 99' ' ' GLU . 24.1 tp10 -133.53 158.16 43.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.831 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 57.36 -76.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.721 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' D' ' 97' ' ' GLU . 49.0 tp10 -57.01 -28.94 62.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.427 ' NH2' ' HE ' ' D' ' 101' ' ' ARG . 73.2 ttp85 -59.53 -43.03 93.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.351 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 101' ' ' ARG . . . . . 0.427 ' HE ' ' NH2' ' D' ' 100' ' ' ARG . 3.2 mpt_? -64.89 -38.22 90.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.401 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.23 20.63 62.21 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' HIS . . . . . 0.407 ' OXT' ' CG ' ' D' ' 103' ' ' HIS . 51.2 t-80 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.096 -0.955 . . . . 1.0 110.612 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.69 ' CB ' ' CE1' ' A' ' 4' ' ' HIS . . . -81.64 169.81 16.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.638 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 11.6 p-10 -65.14 -36.64 84.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.69 ' CE1' ' CB ' ' A' ' 2' ' ' ALA . 15.4 p-80 -75.14 -34.2 61.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.643 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 95' ' ' ARG . 96.2 mt-10 -63.54 -38.4 91.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.528 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.66 -39.71 94.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -50.87 -44.99 59.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.3 88.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.262 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.82 -45.2 90.64 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.89 -35.85 82.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.048 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -48.33 68.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.784 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.65 -42.64 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -64.03 -33.91 76.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.158 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.81 -34.92 78.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.389 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' A' ' 78' ' ' GLY . 44.8 tp -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.773 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -55.29 -40.15 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.205 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -64.37 -31.62 72.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.787 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.38 -41.98 86.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 1.0 110.683 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.2 mp -60.57 -40.64 92.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.784 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -55.96 -49.67 72.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.917 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.49 -37.14 82.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.994 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.24 86.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.634 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' VAL . 15.8 m -59.97 -40.96 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.37 -61.45 2.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.376 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.4 -44.21 95.92 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.909 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.93 -45.76 74.87 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.37 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' SER . 92.3 t -62.55 -46.49 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.25 -41.89 72.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.019 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.15 -41.12 48.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.802 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.66 -44.87 69.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.115 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -51.81 99.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.396 . . . . 1.0 110.651 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.4 -11.89 12.57 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 111.446 -0.661 . . . . 1.0 111.446 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.49 140.26 33.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 122.705 -0.291 . . . . 1.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' O ' HG11 ' A' ' 63' ' ' VAL . 94.5 Cg_endo -75.27 144.18 29.09 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.015 1.81 . . . . 1.0 112.478 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.16 27.09 68.45 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.32 140.77 58.72 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.421 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.94 -30.73 4.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -87.24 122.59 31.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' SER . 41.0 pt -153.41 163.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 79.96 134.53 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.79 0.329 . . . . 1.0 110.934 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 32.4 t80 -65.79 -44.73 64.35 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.087 -0.506 . . . . 1.0 112.127 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.3 Cg_endo -60.57 -30.86 91.5 Favored 'Trans proline' 0 N--CA 1.503 2.055 0 C-N-CA 121.562 1.508 . . . . 1.0 112.737 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.29 -27.23 18.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.706 0.288 . . . . 1.0 110.785 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.02 82.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.582 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.423 HG23 ' HE3' ' A' ' 46' ' ' TRP . 7.9 tt -62.84 -38.74 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.564 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.7 OUTLIER -65.96 -38.21 87.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.23 -0.441 . . . . 1.0 109.824 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -62.71 -42.34 99.6 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.247 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.6 p -58.09 -28.38 64.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.9 t -63.76 -45.69 96.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 1.0 110.419 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 77.5 mt-10 -80.26 -0.85 38.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.81 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -35.51 8.07 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 1.0 109.83 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.44 82.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.345 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.92 11.75 17.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' GLY . 5.1 p 64.38 -135.11 0.29 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.411 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' OG1' ' A' ' 54' ' ' THR . 46.1 t 62.73 -61.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.595 0.559 . . . . 1.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 50.36 90.92 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -60.6 -44.13 96.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.726 0.298 . . . . 1.0 110.78 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.79 17.05 0.85 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.64 -51.94 67.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 1.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' ' CZ ' ' D' ' 57' ' ' TYR . 94.8 mtt-85 -145.73 139.84 26.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.949 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 62' ' ' PRO . 77.8 t80 -130.91 127.71 22.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.536 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 60.6 Cg_endo -70.33 159.92 51.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.826 1.684 . . . . 1.0 112.62 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' THR . 2.1 t -83.68 -138.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.501 ' H ' HG12 ' A' ' 63' ' ' VAL . 51.6 m -114.72 -37.95 4.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.677 0.275 . . . . 1.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.634 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.9 tp10 -64.59 -31.21 72.33 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -70.79 30.54 0.04 OUTLIER 'General case' 0 C--O 1.263 1.786 0 CA-C-O 123.594 1.664 . . . . 1.0 109.952 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.77 64.35 1.25 Allowed Glycine 0 C--O 1.213 -1.196 0 CA-C-N 113.797 -1.547 . . . . 1.0 111.317 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.549 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 43.0 ttm180 -24.0 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.114 0.957 . . . . 1.0 111.108 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -48.86 -18.28 0.26 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.752 -0.658 . . . . 1.0 109.442 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.3 t -61.63 -47.83 91.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 119.494 -0.882 . . . . 1.0 110.131 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.19 64.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.631 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -58.92 -41.66 87.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.716 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.84 -42.03 96.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.051 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.93 -44.47 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.782 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.2 mtt -54.93 -43.91 73.77 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.748 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.08 -40.67 96.61 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.356 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.03 -41.64 98.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -67.77 -44.06 81.85 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.56 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 1.0 110.717 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.37 -40.46 96.52 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.678 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 77' ' ' ALA . 56.0 t -63.95 -50.06 78.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0 110.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' B' ' 79' ' ' ILE . 46.9 m-85 -68.33 -25.3 65.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.052 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.77 -23.51 21.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.667 0.27 . . . . 1.0 110.751 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -65.46 -35.44 80.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.2 m -43.17 -19.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.794 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' LEU . 24.9 m -40.92 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.963 0.411 . . . . 1.0 110.122 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.39 -46.68 89.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.436 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 -27.49 10.16 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.744 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' B' ' 86' ' ' THR . 44.6 tp -65.6 -37.56 86.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.627 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -70.9 -67.91 0.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 1.0 110.798 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -47.84 -8.51 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.042 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 90' ' ' ALA . 51.0 t0 -46.99 -38.73 11.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.848 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 10.1 p90 -79.45 -28.88 41.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.388 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.88 -26.15 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.427 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 96.4 mtt180 -60.1 -31.66 70.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.517 -0.311 . . . . 1.0 111.308 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' NH2' HG11 ' B' ' 94' ' ' VAL . 24.4 ptt180 -58.15 -42.32 85.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.369 . . . . 1.0 110.617 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 97.4 mt-10 -72.64 151.27 42.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.473 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 97' ' ' GLU . 3.6 tm-20 77.02 -52.24 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.647 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.41 -36.87 85.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.194 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -62.01 -35.39 78.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.63 -37.23 86.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.486 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.0 12.5 61.9 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.2 m170 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.481 179.888 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . -77.86 172.0 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.3 -43.82 97.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.871 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.403 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 7.2 p-80 -80.4 -34.99 35.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.504 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.48 -39.24 85.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.27 -43.49 98.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.757 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -65.08 -36.54 84.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.1 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -65.3 -41.62 93.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.464 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.04 -40.7 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.55 92.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.928 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.443 ' OE2' ' CD1' ' B' ' 82' ' ' PHE . 80.3 mm-40 -67.92 -41.6 82.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 1.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -65.05 -37.27 87.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.59 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.416 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.02 -42.96 99.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.455 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -37.58 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.6 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.02 -41.63 96.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.0 -33.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.686 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.665 HD22 ' O ' ' B' ' 48' ' ' SER . 95.3 mt -62.03 -42.1 98.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.572 -0.451 . . . . 1.0 109.922 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.48 -46.18 91.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.856 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.442 ' CG ' ' NZ ' ' B' ' 25' ' ' LYS . 83.7 tt0 -69.28 -38.65 78.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.022 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.47 -38.91 88.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.499 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -60.01 -44.29 94.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.846 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.07 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 1.0 110.258 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.442 ' NZ ' ' CG ' ' B' ' 21' ' ' GLU . 62.3 mttp -75.86 -39.51 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.364 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.97 -49.68 74.97 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.658 -0.246 . . . . 1.0 111.298 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.465 ' O ' ' OE1' ' B' ' 30' ' ' GLU . 3.8 p -63.76 -42.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.279 0.561 . . . . 1.0 110.317 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 78.8 mm-40 -70.35 -20.83 62.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.498 -0.774 . . . . 1.0 110.59 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -60.12 -37.91 81.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' B' ' 27' ' ' VAL . 29.7 mp0 -65.21 -40.23 93.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 1.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -63.16 86.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.58 -10.45 6.79 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 141.88 23.59 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.765 0.283 . . . . 1.0 110.603 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.489 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 98.9 Cg_endo -75.39 144.93 29.57 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.229 1.953 . . . . 1.0 112.38 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.87 36.3 57.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.36 150.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 1.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.12 -45.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.253 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' B' ' 60' ' ' ARG . 33.9 tp -97.02 91.9 5.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.513 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.3 pt -105.21 2.58 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.421 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -99.86 123.54 44.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.119 0.485 . . . . 1.0 110.985 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.523 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.3 t80 -77.22 -54.86 1.44 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.312 -0.858 . . . . 1.0 110.617 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -58.12 -27.0 78.34 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.803 1.669 . . . . 1.0 112.519 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -93.66 -10.25 35.13 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.926 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.08 87.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.885 0.374 . . . . 1.0 110.352 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.408 ' H ' HG22 ' B' ' 45' ' ' ILE . 6.7 tt -63.45 -33.16 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.609 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.85 75.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.707 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.666 ' CB ' ' HE ' ' B' ' 60' ' ' ARG . 1.4 t90 -62.5 -42.94 99.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.474 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.665 ' O ' HD22 ' B' ' 19' ' ' LEU . 11.9 p -45.13 -27.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.85 -25.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.443 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.66 ' CG ' HH21 ' C' ' 68' ' ' ARG . 1.5 tm-20 -66.24 -41.36 90.13 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.737 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.503 ' C ' ' H ' ' B' ' 53' ' ' THR . 8.4 t -82.44 -158.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.229 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 70.79 -38.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.474 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.541 HG21 ' OE2' ' C' ' 72' ' ' GLU . 70.8 p -91.22 6.83 43.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 44.7 p 51.61 66.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.428 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.16 -47.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.598 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.92 67.27 1.5 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.541 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 24.4 t80 -60.92 -49.14 78.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 1.0 110.908 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 160.62 -96.98 0.15 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.7 t0 52.52 -82.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.392 . . . . 1.0 110.602 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.675 ' CZ ' HD22 ' B' ' 38' ' ' LEU . 35.4 ptt85 -127.65 -160.88 1.04 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -163.55 133.32 3.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.965 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.0 179.06 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.628 1.552 . . . . 1.0 112.12 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.545 HG12 ' H ' ' B' ' 64' ' ' THR . 0.8 OUTLIER -91.33 -154.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.242 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.553 ' O ' ' NE1' ' A' ' 46' ' ' TRP . 18.0 m -113.61 -71.83 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.673 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' B' ' 64' ' ' THR . 83.4 tt0 -35.42 -31.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.966 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.907 ' O ' ' N ' ' B' ' 68' ' ' ARG . 95.2 mt-10 -141.98 -108.25 0.14 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.466 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 21.66 -56.04 0.0 OUTLIER Glycine 0 N--CA 1.476 1.345 0 O-C-N 124.492 1.12 . . . . 1.0 114.032 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.907 ' N ' ' O ' ' B' ' 66' ' ' GLU . 14.7 ttm180 -65.85 -48.61 71.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -63.58 -36.31 83.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.096 -1.075 . . . . 1.0 108.096 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.79 -45.35 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.952 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.519 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -65.88 -38.14 87.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -49.0 -45.65 42.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.176 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.36 -38.25 90.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.769 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.68 -45.55 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.552 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 3.6 mpp? -63.85 -40.29 96.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.518 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.33 -40.45 96.41 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.225 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.04 87.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.84 0.352 . . . . 1.0 110.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.77 -38.98 93.48 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.485 -0.646 . . . . 1.0 111.485 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.476 HG22 ' O ' ' B' ' 79' ' ' ILE . 95.8 mt -69.08 -11.8 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.815 -0.226 . . . . 1.0 111.559 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.57 -53.26 3.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.08 0.467 . . . . 1.0 110.931 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.687 HG23 ' H ' ' B' ' 82' ' ' PHE . 17.8 m -60.69 -55.11 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.712 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.687 ' H ' HG23 ' B' ' 81' ' ' VAL . 42.2 m-85 -62.0 -43.79 98.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.887 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.52 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.362 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.5 tt -57.62 -31.78 66.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.485 ' O ' HG12 ' B' ' 85' ' ' VAL . 46.9 t -60.1 -4.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.43 ' H ' ' C ' ' B' ' 84' ' ' LEU . 72.4 m -61.16 -44.86 96.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.574 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -51.37 -29.28 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.725 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.95 -12.69 35.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.739 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.79 -39.88 10.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.403 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.477 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.91 -25.78 57.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.231 0.539 . . . . 1.0 110.15 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -82.06 -6.31 59.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.395 -0.82 . . . . 1.0 109.891 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 96.8 m-20 -58.63 -48.77 79.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.142 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.1 p90 -77.48 -40.07 44.26 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.094 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.526 HG11 ' NH2' ' A' ' 96' ' ' ARG . 58.8 t -44.79 -31.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.586 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.05 -22.22 66.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.057 -0.257 . . . . 1.0 111.478 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.0 ptt85 -54.42 -43.45 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 1.0 110.063 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' B' ' 99' ' ' GLU . 96.4 mt-10 -64.87 177.8 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.417 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 56.99 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' B' ' 97' ' ' GLU . 83.6 tt0 -51.4 -20.32 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.505 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -60.19 -44.95 94.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.546 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.91 -11.26 51.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.307 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.15 18.12 77.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.165 -0.774 . . . . 1.0 111.165 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.475 ' CG ' ' O ' ' B' ' 103' ' ' HIS . 86.4 t60 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.491 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -69.05 150.09 48.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.926 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -62.38 -38.8 90.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.064 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.585 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 24.8 p80 -67.02 -39.99 87.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.099 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.585 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 48.0 tp10 -65.9 -41.35 91.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.727 0.298 . . . . 1.0 110.577 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -64.78 -37.41 87.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -62.9 -40.92 99.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.128 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.31 98.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.37 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -65.64 -41.92 92.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.481 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.87 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.26 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.62 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.165 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -37.15 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.06 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -64.55 -34.47 78.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.778 0.323 . . . . 1.0 110.438 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -65.78 -35.9 82.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.22 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.706 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.4 -36.26 79.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.334 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.57 -40.23 90.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.775 0.322 . . . . 1.0 110.908 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.73 -35.46 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.522 HD22 ' O ' ' C' ' 48' ' ' SER . 94.0 mt -59.98 -41.57 92.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.709 -0.396 . . . . 1.0 109.958 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 98.4 mt-10 -62.87 -43.34 99.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.92 -36.38 75.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.279 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.64 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.434 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.47 ' O ' HG23 ' C' ' 27' ' ' VAL . 77.8 p -60.76 -43.76 97.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.824 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -60.51 -56.35 22.48 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.95 -44.24 97.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.014 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -57.1 -24.76 56.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.47 HG23 ' O ' ' C' ' 23' ' ' SER . 35.0 t -80.78 -51.77 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.191 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.83 -43.01 69.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.911 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.79 -50.57 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 3.8 mp0 -62.15 -44.92 95.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -68.01 130.32 42.61 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.94 59.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.422 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.24 151.76 41.89 Favored Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.469 ' O ' HG11 ' C' ' 63' ' ' VAL . 89.2 Cg_endo -76.17 123.54 7.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.726 1.617 . . . . 1.0 112.184 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 103.99 -23.12 33.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . 48.35 178.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 1.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.67 -93.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.63 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.43 111.54 22.82 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.839 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' C' ' 40' ' ' SER . 1.4 tp -144.18 101.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.068 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.537 ' O ' ' N ' ' C' ' 44' ' ' ALA . 0.3 OUTLIER 166.67 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.749 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.9 OUTLIER -49.11 -50.48 63.17 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.862 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.8 Cg_endo -58.9 -34.9 99.3 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.383 1.389 . . . . 1.0 112.453 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -98.74 -5.1 32.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.277 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -68.31 -41.55 80.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.809 0.338 . . . . 1.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' C' ' 45' ' ' ILE . 5.9 tt -65.04 -38.9 83.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.617 ' CZ3' ' NZ ' ' D' ' 69' ' ' LYS . 0.3 OUTLIER -58.96 -46.63 87.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.557 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.541 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.9 OUTLIER -68.31 -23.6 64.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.271 -0.571 . . . . 1.0 109.508 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.522 ' O ' HD22 ' C' ' 19' ' ' LEU . 3.4 t -75.09 -35.54 61.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.92 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.52 -44.28 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.944 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.53 -41.84 77.46 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.057 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' C' ' 52' ' ' ALA . 3.6 t -78.69 -176.28 4.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' C' ' 51' ' ' THR . . . 76.3 -12.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.569 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.453 HG21 ' OE2' ' D' ' 72' ' ' GLU . 68.9 p -115.66 14.21 16.41 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.548 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' C' ' 53' ' ' THR . 47.0 p 53.67 69.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.4 -73.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.22 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.81 81.15 0.06 OUTLIER Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.412 ' CB ' ' CD1' ' D' ' 61' ' ' TYR . 45.5 t80 -60.43 -47.66 85.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.821 -0.351 . . . . 1.0 110.789 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.0 30.15 0.54 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 40.6 t0 -61.69 -41.68 97.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 1.0 110.431 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -141.79 -161.32 1.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.895 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 20.5 p90 -171.61 120.29 0.47 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.2 158.32 56.75 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.699 1.599 . . . . 1.0 112.355 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.541 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.06 -142.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.133 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.541 ' H ' HG12 ' C' ' 63' ' ' VAL . 98.4 m -111.77 -47.44 3.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.665 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' C' ' 67' ' ' GLY . 46.3 tp10 -58.71 -25.17 62.63 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.2 OUTLIER -73.01 28.15 0.06 Allowed 'General case' 0 C--O 1.263 1.81 0 CA-C-O 123.52 1.628 . . . . 1.0 110.213 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 41.1 62.72 1.7 Allowed Glycine 0 C--O 1.216 -1.024 0 CA-C-N 113.773 -1.558 . . . . 1.0 110.673 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.66 HH21 ' CG ' ' B' ' 50' ' ' GLU . 46.5 ttt85 -24.21 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.796 0.798 . . . . 1.0 111.58 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.8 mttt -51.65 -16.5 0.65 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.704 -0.68 . . . . 1.0 109.373 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' C' ' 67' ' ' GLY . 65.9 t -62.52 -48.08 89.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 119.324 -0.95 . . . . 1.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.06 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 1.0 110.093 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.8 tp10 -64.79 -39.59 93.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.03 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.65 -42.44 75.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.245 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' C' ' 52' ' ' ALA . 82.5 t -66.0 -41.72 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.844 -0.343 . . . . 1.0 111.545 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.4 mtt -59.46 -44.75 92.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.939 -0.304 . . . . 1.0 111.216 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -63.37 -40.63 97.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.424 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.34 -41.63 89.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.84 0.352 . . . . 1.0 110.496 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -42.39 76.15 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.222 -0.513 . . . . 1.0 111.897 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.19 -43.91 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.641 -0.329 . . . . 1.0 110.752 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.54 -43.25 85.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.303 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 77' ' ' ALA . 59.0 t -64.76 -50.39 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.511 ' O ' HG22 ' C' ' 85' ' ' VAL . 38.0 m-85 -67.63 -40.76 84.59 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.22 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.23 70.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.764 0.316 . . . . 1.0 110.776 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.1 tt -62.74 -42.23 99.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.813 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.511 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.2 m -52.64 -8.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.564 -0.455 . . . . 1.0 110.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.466 ' H ' ' C ' ' C' ' 84' ' ' LEU . 43.8 m -49.43 -23.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 1.0 110.247 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -57.26 -50.58 72.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.045 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.94 85.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.454 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.38 -38.52 90.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.879 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.519 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.32 -44.26 88.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.02 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.71 44.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.233 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.415 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 56.1 t0 -56.0 -49.52 73.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.656 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -72.5 -41.12 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.08 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 93.7 t -45.71 -27.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.68 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -62.41 -22.67 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.605 -0.27 . . . . 1.0 111.414 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -55.23 -33.65 63.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.758 0.314 . . . . 1.0 110.569 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.84 -42.31 95.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.56 -39.56 70.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 1.0 110.625 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.39 -18.37 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.273 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.429 ' NH1' ' CZ ' ' C' ' 101' ' ' ARG . 79.7 ttt-85 -59.34 -44.67 92.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.652 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' ARG . . . . . 0.429 ' CZ ' ' NH1' ' C' ' 100' ' ' ARG . 85.0 mtt85 -105.96 -6.57 18.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.8 0.333 . . . . 1.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.69 16.77 77.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.07 -0.812 . . . . 1.0 111.07 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.592 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -67.39 143.98 56.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.42 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' D' ' 6' ' ' ARG . 98.7 m-20 -64.48 -40.11 95.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.776 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -72.2 -19.93 61.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.202 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.01 -45.29 77.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 1.0 110.519 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ARG . . . . . 0.463 ' NH2' ' OD1' ' D' ' 3' ' ' ASP . 95.4 mtm-85 -65.39 -36.72 84.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.66 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -61.02 -42.72 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.086 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.23 86.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.24 -42.29 99.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.94 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.75 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.486 ' HB1' HG13 ' D' ' 81' ' ' VAL . . . -58.25 -38.56 77.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.905 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.8 -42.6 90.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.735 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.64 -38.91 90.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.595 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.96 -33.58 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.4 tp -62.82 -38.54 91.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 1.0 110.075 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.59 -28.41 67.74 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -65.0 -40.15 94.51 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.824 0.345 . . . . 1.0 111.534 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.68 -31.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.429 HD22 ' O ' ' D' ' 48' ' ' SER . 29.4 mt -61.15 -44.16 97.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.412 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' D' ' 23' ' ' SER . 12.0 pt-20 -67.87 -35.33 78.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.001 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -66.49 -36.65 83.26 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.802 -0.359 . . . . 1.0 110.344 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.76 -40.32 96.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.091 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.662 ' O ' HG23 ' D' ' 27' ' ' VAL . 78.0 p -58.45 -45.69 88.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.203 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.89 -63.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -58.57 -37.57 76.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -59.8 -42.31 93.16 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.705 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 23' ' ' SER . 72.0 t -64.16 -48.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.443 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.92 -42.58 69.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.777 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.688 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.529 ' OE1' HG22 ' D' ' 39' ' ' ILE . 8.8 tm-20 -69.91 -35.41 74.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.383 . . . . 1.0 111.002 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -54.07 101.84 0.05 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.912 0.387 . . . . 1.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.69 21.34 10.5 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.617 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.49 ' CB ' ' OE2' ' D' ' 66' ' ' GLU . . . -105.33 145.1 30.14 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 122.918 -0.166 . . . . 1.0 110.711 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.86 139.36 24.58 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.037 1.824 . . . . 1.0 112.03 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 63.98 17.25 60.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . -46.83 176.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.932 0.396 . . . . 1.0 110.958 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' D' ' 38' ' ' LEU . . . -166.95 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.751 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' D' ' 30' ' ' GLU . 58.5 tp -123.04 108.74 13.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.821 0.343 . . . . 1.0 110.109 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.529 HG22 ' OE1' ' D' ' 30' ' ' GLU . 14.2 pt -136.8 159.95 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' D' ' 43' ' ' ASP . 0.5 OUTLIER 81.33 139.23 0.07 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.697 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.3 OUTLIER -77.77 -38.61 1.76 Allowed Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.695 178.055 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.63 -32.82 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.308 1.338 . . . . 1.0 112.197 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' D' ' 40' ' ' SER . 29.6 p-10 -96.94 -6.21 36.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.578 0.228 . . . . 1.0 110.876 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.39 -40.14 67.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.948 0.404 . . . . 1.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 tt -63.91 -40.17 88.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.417 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.487 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -58.49 -45.82 87.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -63.12 -39.24 94.1 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.724 -0.472 . . . . 1.0 109.724 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.429 ' O ' HD22 ' D' ' 19' ' ' LEU . 4.8 t -58.81 -41.57 87.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.127 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.408 ' O ' HG12 ' D' ' 49' ' ' VAL . 41.8 t -76.6 68.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.009 0.433 . . . . 1.0 111.699 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -173.58 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.733 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -64.68 -43.44 93.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . -56.49 -28.69 60.48 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -84.73 -1.82 56.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.317 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p 50.95 58.86 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.025 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.584 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.2 p -128.28 -46.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.587 -0.278 . . . . 1.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.584 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 41.26 76.58 0.09 OUTLIER Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.511 ' CZ ' ' O ' ' A' ' 60' ' ' ARG . 15.1 t80 -60.94 -46.42 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.0 110.416 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.72 36.08 0.08 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 21.6 t0 -83.86 -77.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 1.0 110.69 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -130.39 147.84 52.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.412 ' CD1' ' CB ' ' C' ' 57' ' ' TYR . 46.2 t80 -149.0 135.83 10.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.33 149.23 69.41 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.011 1.807 . . . . 1.0 112.318 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.441 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 3.3 t -80.41 -125.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.009 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.415 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 76.1 m -113.7 -36.41 4.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.839 0.352 . . . . 1.0 110.888 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.7 tt0 -67.4 -30.35 70.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.2 pm0 -79.36 34.53 0.26 Allowed 'General case' 0 C--O 1.265 1.891 0 CA-C-O 123.224 1.488 . . . . 1.0 108.845 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.43 61.19 1.29 Allowed Glycine 0 C--O 1.212 -1.262 0 CA-C-N 113.767 -1.561 . . . . 1.0 109.916 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 40.0 ttm180 -24.37 -31.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.533 0.784 . . . . 1.0 111.086 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.4 mttp -54.12 -13.67 0.89 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.308 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.4 t -61.32 -47.74 92.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 119.52 -0.872 . . . . 1.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.87 80.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.96 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' C' ' 53' ' ' THR . 35.8 tp10 -57.31 -39.37 75.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.232 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -66.58 -40.47 88.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 -47.52 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.539 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.64 -40.84 96.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 1.0 111.161 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -61.51 -42.54 98.96 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.744 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.96 88.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.432 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.29 -40.43 96.57 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.53 -43.61 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.712 0.291 . . . . 1.0 111.172 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.38 -35.2 79.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.01 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.486 HG13 ' HB1' ' D' ' 11' ' ' ALA . 43.1 t -67.28 -56.12 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.519 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -62.07 -43.22 99.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.836 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.23 -37.51 87.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.292 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.2 -42.19 99.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' D' ' 87' ' ' ALA . 89.7 t -58.11 -18.34 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 75.6 m -43.96 -20.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.467 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.22 -61.01 2.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.909 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.99 61.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.254 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 2.7 mm? -78.08 -38.04 45.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.24 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.9 -35.85 71.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.31 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -4.2 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.907 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' D' ' 89' ' ' LEU . 66.6 t0 -56.66 -44.37 81.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.836 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 12.3 p90 -74.97 -42.98 56.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.923 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 88.7 t -44.17 -26.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.358 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -57.49 -25.32 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.075 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 96' ' ' ARG . . . . . 0.577 HH12 ' CG ' ' A' ' 4' ' ' HIS . 7.2 ptp180 -59.2 -34.8 72.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 1.0 110.358 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' D' ' 99' ' ' GLU . 97.6 mt-10 -70.97 -167.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.057 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 57.39 -73.77 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.807 0.336 . . . . 1.0 110.706 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' D' ' 97' ' ' GLU . 79.6 mm-40 -55.24 -43.85 74.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.38 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -61.36 -42.1 98.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.329 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -63.24 -36.51 83.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.443 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.66 15.32 56.92 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 33.0 m80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.957 -1.02 . . . . 1.0 110.357 179.7 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.27 -74.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.375 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -174.25 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 88' ' ' ALA . 15.3 p-80 -73.47 -31.07 63.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.08 -39.46 93.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -61.38 -42.09 98.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -64.0 -39.64 94.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.144 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -38.75 92.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.213 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -64.36 -41.56 96.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -63.39 -39.31 94.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.73 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HB1' HG13 ' A' ' 81' ' ' VAL . . . -59.23 -39.71 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.842 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.24 -44.23 88.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 1.0 110.635 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.72 -33.87 76.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.311 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.74 -35.16 79.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.449 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.0 tp -61.86 -42.57 99.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.392 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.24 -34.9 72.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.979 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.51 -40.76 97.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.09 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.42 -29.0 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 48' ' ' SER . 96.4 mt -62.76 -41.97 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.46 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.06 -39.8 78.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.329 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.27 93.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.029 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.5 p -60.76 -42.28 97.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 1.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.59 -30.34 71.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.926 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.9 -46.59 18.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.302 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.03 88.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.7 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 28' ' ' GLU . 11.8 m -56.71 -54.35 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.39 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' H ' HG23 ' A' ' 27' ' ' VAL . 88.2 mt-10 -67.93 -42.19 81.4 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.839 0.352 . . . . 1.0 110.701 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.32 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.063 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -98.05 14.86 25.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.557 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt85 -80.64 99.28 8.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.0 110.351 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.45 6.42 87.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.646 -0.581 . . . . 1.0 111.646 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 149.36 95.6 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.26 141.49 25.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.926 1.751 . . . . 1.0 112.245 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.05 -6.8 8.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.84 155.41 31.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.839 0.352 . . . . 1.0 110.48 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.18 10.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' SER . 6.8 tt -82.96 -10.73 58.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.476 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' LEU . 4.8 pt -37.35 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.631 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.4 m 169.21 134.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.916 -0.583 . . . . 1.0 109.888 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 55.9 m-85 -82.56 -48.33 0.86 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.448 0.536 . . . . 1.0 112.448 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.0 Cg_endo -60.56 -31.68 92.59 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 121.634 1.556 . . . . 1.0 112.657 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -91.2 -6.03 54.03 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.913 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.551 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.0 -41.0 88.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.093 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.99 96.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -62.4 -40.38 96.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.53 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.1 p -58.83 -31.9 68.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.718 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG1' ' OE1' ' B' ' 72' ' ' GLU . 94.9 t -71.59 -44.24 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.255 0.55 . . . . 1.0 110.636 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 45.7 tp10 -52.15 -42.68 63.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.376 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' THR . 4.6 t -80.78 -158.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' THR . . . 71.31 -35.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 1.0 110.141 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' THR . 62.0 p -81.31 5.43 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 p 58.17 26.7 14.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.127 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -146.95 82.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.782 0.325 . . . . 1.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 112.1 3.39 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.4 -46.05 91.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.53 27.41 0.39 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 48.7 m-20 -62.34 -42.11 99.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 1.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 38.8 mmt180 -130.87 -169.07 2.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.15 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 96.4 m-85 -159.61 91.58 1.84 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.89 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.34 157.59 60.65 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.787 1.658 . . . . 1.0 112.271 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.026 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -116.76 -165.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.987 0.423 . . . . 1.0 110.344 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 63' ' ' VAL . 61.2 m -78.66 -42.8 27.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.3 tp10 -50.74 -47.23 59.39 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -74.49 29.78 0.08 Allowed 'General case' 0 C--O 1.26 1.638 0 CA-C-O 124.212 1.958 . . . . 1.0 109.568 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.46 66.64 1.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 113.838 -1.528 . . . . 1.0 111.863 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH1' ' OE1' ' D' ' 50' ' ' GLU . 58.2 ttm-85 -24.11 -34.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.029 0.915 . . . . 1.0 110.808 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.9 mttp -47.63 -20.53 0.27 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' GLY . 57.1 t -61.29 -48.18 90.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 119.652 -0.819 . . . . 1.0 110.453 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.46 -41.73 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.673 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -59.67 -42.52 93.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.698 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.03 -41.55 83.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.821 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.1 t -65.65 -42.79 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.572 -0.451 . . . . 1.0 111.14 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.409 ' CE ' ' OH ' ' D' ' 57' ' ' TYR . 65.2 mtt -57.36 -45.33 84.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.904 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -63.59 -41.81 98.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.02 -40.6 85.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.647 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -68.24 -42.55 83.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.56 -43.92 95.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 1.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.22 -40.2 93.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.124 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.404 HG13 ' HB1' ' A' ' 11' ' ' ALA . 52.1 t -65.75 -49.74 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.07 -39.14 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.243 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.06 92.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.877 0.37 . . . . 1.0 110.998 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' C ' ' N ' ' A' ' 86' ' ' THR . 7.5 tt -62.98 -41.38 99.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.302 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 85' ' ' VAL . 81.3 t -47.4 -13.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.348 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 84' ' ' LEU . 76.8 m -58.07 -42.18 84.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.89 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -40.27 -33.77 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.561 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.403 ' HA ' ' CD2' ' A' ' 4' ' ' HIS . . . -86.46 -35.61 19.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.684 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 86' ' ' THR . 52.2 mt -66.4 -38.77 88.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.53 -47.83 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.155 0.502 . . . . 1.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -4.14 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.449 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.64 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 39.6 t0 -58.41 -49.39 77.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.015 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.5 p90 -76.05 -34.41 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.439 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.1 t -43.95 -34.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.137 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -60.36 -23.04 63.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -57.48 -44.31 84.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.434 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -89.73 -68.25 0.79 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 100' ' ' ARG . 47.7 mt-10 -75.01 162.38 28.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.491 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 71.28 -33.87 0.28 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.309 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 98' ' ' GLU . 69.2 ttp85 -60.99 -44.36 97.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.471 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -94.88 -7.71 39.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.494 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.27 22.47 77.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.529 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.402 ' O ' ' O ' ' B' ' 2' ' ' ALA . 7.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 44.59 -169.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 64.3 t0 -131.03 -29.98 1.81 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.8 p80 -77.48 -20.56 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.372 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.39 -37.78 83.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.93 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.73 -42.72 97.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.767 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.431 . . . . 1.0 109.864 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.43 90.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.73 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.8 -43.27 96.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.146 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -63.19 -40.37 97.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.69 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -59.69 -38.51 81.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.823 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.27 -44.27 84.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 1.0 110.647 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -64.67 -36.82 85.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.129 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -62.4 -33.44 74.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.325 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 1.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.17 -38.02 72.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.96 -38.62 89.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.76 -39.84 87.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.838 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.85 -38.72 82.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' B' ' 23' ' ' SER . 96.8 mt-10 -63.05 -43.92 97.3 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -69.32 -31.18 69.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.77 86.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.006 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -60.69 -45.77 92.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 44.3 tttm -65.47 -50.09 66.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.338 0.59 . . . . 1.0 110.073 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.09 -42.63 96.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.743 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.52 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -67.71 -50.69 56.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.106 0.253 . . . . 1.0 111.531 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.9 p -60.94 -45.91 97.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.06 0.457 . . . . 1.0 110.658 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 96.7 mt-10 -68.64 -18.81 64.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.674 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.66 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -59.76 -51.23 70.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.048 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 56.0 mp0 -80.64 -110.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 1.0 110.113 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 41.81 50.22 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.151 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.77 25.82 0.9 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.786 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.08 150.47 39.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.71 130.18 12.35 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.975 1.784 . . . . 1.0 112.067 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.88 75.08 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.201 -0.76 . . . . 1.0 111.201 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 163.49 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.349 . . . . 1.0 110.53 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.24 -32.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.574 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.59 49.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.39 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.635 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -92.73 76.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.182 0.515 . . . . 1.0 110.107 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' B' ' 39' ' ' ILE . 69.1 m -168.81 98.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.087 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 53.4 t80 -58.26 -50.12 89.83 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.69 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.2 Cg_endo -58.22 -33.28 97.41 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.809 1.672 . . . . 1.0 112.608 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.406 ' HB3' HH21 ' B' ' 60' ' ' ARG . 76.5 m-20 -94.66 -4.2 48.04 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.237 -0.185 . . . . 1.0 110.958 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.88 92.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.947 0.403 . . . . 1.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.41 HG22 ' H ' ' B' ' 45' ' ' ILE . 7.7 tt -67.39 -40.23 84.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.426 ' CD1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -62.94 -42.45 99.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.469 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -61.8 -42.7 99.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.513 ' C ' ' H ' ' B' ' 50' ' ' GLU . 16.2 m -56.82 -39.11 73.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.086 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.764 HG12 ' O ' ' B' ' 49' ' ' VAL . 58.0 t -67.18 29.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.87 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' B' ' 48' ' ' SER . 79.7 mm-40 -137.07 -21.79 1.2 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.848 -0.532 . . . . 1.0 110.493 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -36.08 14.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.02 83.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.207 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.7 p -86.18 12.96 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.849 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' B' ' 53' ' ' THR . 68.0 p 50.11 73.95 0.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.624 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' C' ' 75' ' ' MET . 29.4 t -131.4 -71.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.65 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 64.76 3.25 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -46.55 89.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.779 0.323 . . . . 1.0 110.752 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.96 23.1 0.97 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.633 -0.987 . . . . 1.0 110.633 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 48.0 t0 -63.13 -41.05 99.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 1.0 110.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 35.0 mmt180 -126.57 -174.68 3.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 79.2 m-85 -159.57 83.32 2.32 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.868 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 151.97 77.94 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.545 1.497 . . . . 1.0 112.092 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 16.8 m -96.68 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.872 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' B' ' 66' ' ' GLU . 48.8 m -112.38 -55.84 2.47 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.728 0.299 . . . . 1.0 111.238 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -43.87 -16.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.86 0.362 . . . . 1.0 110.804 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.66 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -91.85 26.66 2.33 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 123.839 1.781 . . . . 1.0 109.477 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.89 64.35 1.09 Allowed Glycine 0 C--O 1.212 -1.26 0 CA-C-N 113.663 -1.608 . . . . 1.0 111.424 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 55.8 ttm-85 -24.87 -32.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.217 1.008 . . . . 1.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.6 mttt -48.0 -18.87 0.21 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 67' ' ' GLY . 65.0 t -64.28 -45.47 96.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 120.124 -0.631 . . . . 1.0 109.803 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.92 -40.97 78.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.997 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLU . . . . . 0.425 ' OE1' ' CG1' ' A' ' 49' ' ' VAL . 83.0 tt0 -65.39 -40.5 93.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.085 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.69 -59.44 5.43 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.087 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.2 -44.68 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.287 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 38.9 ttp -59.93 -47.52 85.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.64 -32.48 73.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.378 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.74 78.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.575 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -43.05 96.74 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.74 -43.45 97.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 122.813 -0.228 . . . . 1.0 110.87 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.13 -42.1 85.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.298 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.405 HG13 ' HB1' ' B' ' 11' ' ' ALA . 53.7 t -63.83 -50.13 78.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.344 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.39 -37.83 80.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.789 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.29 -37.85 88.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.555 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.425 ' C ' ' N ' ' B' ' 86' ' ' THR . 4.4 tt -62.66 -41.58 99.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.183 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 85' ' ' VAL . 82.7 t -51.96 -15.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.425 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.7 m -49.65 -40.81 40.96 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -50.35 -38.94 44.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.67 59.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.678 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.69 -30.33 15.61 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.203 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.521 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.75 -40.44 96.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.47 0.652 . . . . 1.0 109.93 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 -5.31 49.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.932 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 51.4 t0 -54.99 -50.45 68.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.917 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 20.7 p90 -67.87 -43.91 78.31 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.357 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 97.6 t -39.42 -27.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.709 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 93' ' ' PHE . 34.7 mmt180 -63.25 -36.03 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.041 -0.264 . . . . 1.0 111.295 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -43.91 -28.29 0.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 1.0 110.192 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.38 -45.78 92.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.983 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' B' ' 102' ' ' GLY . 97.0 mt-10 -70.22 -31.91 69.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.75 0.31 . . . . 1.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.17 -34.85 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.849 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.9 -44.61 96.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ARG . . . . . 0.48 ' O ' ' CE1' ' B' ' 103' ' ' HIS . 95.8 mtt-85 -99.08 -0.9 40.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.896 0.379 . . . . 1.0 110.35 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 98' ' ' GLU . . . 78.08 3.71 85.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' B' ' 101' ' ' ARG . 40.0 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.529 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.868 ' HB3' ' CE1' ' C' ' 4' ' ' HIS . . . -155.15 12.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 56.85 53.2 8.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.966 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.868 ' CE1' ' HB3' ' C' ' 2' ' ' ALA . 1.9 p-80 -171.74 -30.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.911 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.564 ' HG2' ' CE1' ' C' ' 4' ' ' HIS . 23.8 mm-40 -83.85 -22.52 31.67 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.768 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.95 -41.57 99.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.117 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.06 -44.95 83.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.62 88.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.467 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.7 -44.5 96.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.32 -33.43 75.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.203 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.48 87.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -37.81 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.786 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -65.78 -33.45 75.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.523 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.37 -44.7 92.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.796 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' C' ' 52' ' ' ALA . 42.6 tp -63.23 -41.42 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.604 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -58.08 -42.25 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.567 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' C' ' 21' ' ' GLU . 56.4 mtmt -62.9 -40.8 98.68 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.147 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.48 -36.66 77.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.2 mt -60.81 -40.56 93.15 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.095 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.66 -50.69 72.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.146 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 12.2 mp0 -69.43 -43.0 74.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.42 93.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.475 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 20.3 m -61.76 -44.95 95.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.731 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -66.19 -36.15 82.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 1.0 109.856 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -72.98 -41.73 64.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.597 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -52.58 -52.96 52.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.537 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 4.2 p -62.8 -44.7 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.406 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 80.8 mm-40 -65.8 -37.01 85.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.48 94.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.328 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.6 mp0 -70.25 -37.85 75.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 1.0 110.69 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH2' ' OH ' ' C' ' 41' ' ' TYR . 25.5 mmt180 -56.64 100.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.721 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 116.09 -12.45 17.06 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.28 144.5 34.22 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 122.772 -0.252 . . . . 1.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.454 ' O ' HG11 ' C' ' 63' ' ' VAL . 92.6 Cg_endo -76.07 143.04 25.38 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.036 1.824 . . . . 1.0 112.414 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.17 28.9 67.39 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 141.03 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.311 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 -35.83 4.87 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.414 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.498 HD23 ' O ' ' C' ' 38' ' ' LEU . 6.5 tt -92.29 77.55 5.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.946 -0.39 . . . . 1.0 109.946 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 pt -110.41 -7.63 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.921 0.391 . . . . 1.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -81.9 134.93 35.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.46 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.2 OUTLIER -77.94 -48.57 2.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.847 178.658 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.5 Cg_endo -59.82 -28.73 87.91 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 121.675 1.583 . . . . 1.0 112.136 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.85 -17.28 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.383 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.66 99.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.75 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.425 ' O ' HG23 ' C' ' 49' ' ' VAL . 8.3 tt -65.27 -42.1 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.413 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.429 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.73 -46.27 86.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.538 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.459 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.0 t90 -63.91 -40.95 97.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.462 -0.495 . . . . 1.0 109.819 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 64.6 p -60.14 -35.85 76.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.134 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.3 t -61.79 -48.95 86.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.826 -0.35 . . . . 1.0 111.56 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' C' ' 59' ' ' ASP . 15.8 pt-20 -73.46 -25.81 60.65 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.549 -0.46 . . . . 1.0 110.861 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 27.4 m -62.55 -44.28 96.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.484 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -55.65 -20.41 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.696 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.542 ' C ' ' H ' ' C' ' 55' ' ' VAL . 4.9 p -84.31 -2.7 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.5 p 60.64 -3.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.726 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' C' ' 53' ' ' THR . 73.9 t -64.01 -44.84 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.795 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 70.79 -60.36 0.95 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.556 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 2.5 t80 70.6 -41.65 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 1.0 110.973 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 120.68 24.43 2.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.421 ' OD2' ' OE2' ' C' ' 50' ' ' GLU . 65.5 t0 -61.95 -48.04 82.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.984 0.421 . . . . 1.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' C' ' 61' ' ' TYR . 96.3 mtt-85 -143.54 -177.5 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 1.0 109.887 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' C' ' 60' ' ' ARG . 9.9 m-85 -155.02 106.79 2.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 120.606 -0.438 . . . . 1.0 111.01 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.16 156.42 64.99 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.725 1.616 . . . . 1.0 112.216 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.484 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.47 -140.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.061 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.484 ' H ' HG12 ' C' ' 63' ' ' VAL . 41.4 m -113.87 -38.93 4.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.836 0.351 . . . . 1.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.595 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.0 tt0 -63.64 -27.03 68.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.983 0.421 . . . . 1.0 110.008 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -73.17 30.21 0.07 Allowed 'General case' 0 C--O 1.263 1.796 0 CA-C-O 123.818 1.77 . . . . 1.0 110.109 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 40.53 64.03 1.27 Allowed Glycine 0 C--O 1.214 -1.126 0 CA-C-N 113.706 -1.588 . . . . 1.0 111.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' C' ' 67' ' ' GLY . 59.2 ttm-85 -24.09 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.768 0.784 . . . . 1.0 111.231 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.0 mttt -50.57 -16.51 0.38 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.764 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.5 t -61.44 -45.6 98.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.441 -0.904 . . . . 1.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.6 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.201 0.524 . . . . 1.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -69.53 -41.57 75.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.214 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -63.85 -48.44 76.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.748 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.496 HG13 ' N ' ' C' ' 75' ' ' MET . 7.9 p -63.93 -44.06 97.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.314 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.496 ' N ' HG13 ' C' ' 74' ' ' VAL . 71.1 mtm -64.61 -41.09 96.44 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.52 -42.6 99.62 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.366 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.463 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.19 -39.74 95.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 1.0 110.44 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.68 97.9 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.75 -0.54 . . . . 1.0 111.75 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.54 -43.3 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.277 . . . . 1.0 110.625 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.14 -40.38 86.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 77' ' ' ALA . 51.6 t -62.96 -49.95 81.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.944 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.545 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.2 m-85 -68.93 -38.87 79.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.177 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.56 -33.12 70.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.917 0.389 . . . . 1.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.7 tt -61.82 -42.36 98.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.749 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.545 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.5 m -49.31 -11.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.568 -0.453 . . . . 1.0 110.415 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.482 ' H ' ' C ' ' C' ' 84' ' ' LEU . 48.5 m -48.75 -19.66 0.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.935 0.398 . . . . 1.0 110.267 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -60.02 -35.25 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.17 -34.33 29.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.42 -39.85 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.727 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.527 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.59 -47.95 82.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.0 111.291 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -4.12 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.335 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 43.1 t0 -57.4 -48.34 79.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.557 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.527 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 22.9 p90 -76.08 -43.7 42.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.069 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 80.0 t -42.11 -27.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.747 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -61.78 -22.39 65.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.959 -0.296 . . . . 1.0 111.249 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -73.99 -7.68 53.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.816 0.341 . . . . 1.0 110.605 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.76 -51.26 70.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.73 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -68.57 -35.19 77.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 1.0 110.565 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.45 -24.3 66.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.428 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -60.23 -44.39 95.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.579 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.4 -4.88 20.91 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.82 87.56 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 m170 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.508 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' D' ' 2' ' ' ALA . 75.7 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' D' ' 1' ' ' SER . . . 72.15 -50.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.17 -32.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' D' ' 2' ' ' ALA . 28.5 p80 -82.26 -19.96 38.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.91 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.04 -40.66 78.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.805 0.336 . . . . 1.0 110.624 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -65.3 -38.04 89.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.07 -44.55 96.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.066 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.17 91.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.16 -41.33 94.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.54 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -63.79 -36.33 83.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -38.28 82.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.91 -41.16 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 1.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.81 -33.24 75.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.503 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLU . . . . . 0.434 ' O ' HG23 ' D' ' 18' ' ' VAL . 81.6 tt0 -63.32 -38.52 91.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.53 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.449 HD13 ' HA2' ' D' ' 78' ' ' GLY . 41.9 tp -62.64 -39.84 95.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.551 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -57.97 -40.7 81.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.289 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -75.82 -18.03 59.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.957 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 14' ' ' GLU . 37.9 t -76.89 -56.48 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.04 0.448 . . . . 1.0 111.169 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' D' ' 19' ' ' LEU . 1.9 pp -62.36 -28.44 69.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.733 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.39 -44.54 91.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.229 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -66.32 -36.68 83.54 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.888 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' D' ' 74' ' ' VAL . . . -65.32 -35.04 79.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.759 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -58.12 -43.89 87.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.845 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.04 -32.71 74.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -84.84 -32.3 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -60.86 -45.37 94.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.062 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.525 HG13 ' N ' ' D' ' 28' ' ' GLU . 5.5 p -61.3 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.089 0.471 . . . . 1.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.525 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.9 tm-20 -69.26 -40.76 77.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.386 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.05 94.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.337 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' D' ' 38' ' ' LEU . 26.0 tp10 -72.12 -38.52 69.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.869 0.366 . . . . 1.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -65.35 120.49 12.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.725 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.27 55.52 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.343 -0.703 . . . . 1.0 111.343 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.595 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -101.75 149.29 36.34 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 122.899 -0.177 . . . . 1.0 110.775 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.49 131.66 15.2 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.931 1.754 . . . . 1.0 111.965 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 7.05 88.23 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.72 143.25 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 -11.29 1.72 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.497 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.7 tt -110.53 120.37 42.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.021 0.438 . . . . 1.0 109.982 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' D' ' 40' ' ' SER . 37.0 pt -143.47 -165.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.366 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 3.2 m 58.25 132.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -74.6 -48.76 5.07 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.0 Cg_endo -59.04 -30.73 94.11 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.438 1.426 . . . . 1.0 111.943 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.22 -25.93 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.3 90.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.766 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' D' ' 45' ' ' ILE . 6.2 tt -63.19 -37.21 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.248 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -65.92 -46.6 77.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.18 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.556 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 2.3 t90 -57.47 -29.77 64.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -34.65 66.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.929 0.395 . . . . 1.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.8 -48.68 87.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.481 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 12.4 pt-20 -62.8 -38.2 89.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.73 HG22 ' H ' ' D' ' 52' ' ' ALA . 20.7 m -77.64 178.57 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.73 ' H ' HG22 ' D' ' 51' ' ' THR . . . 78.47 -18.22 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.446 ' H ' ' C ' ' D' ' 51' ' ' THR . 59.0 p -106.52 9.32 31.58 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.451 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' D' ' 53' ' ' THR . 12.0 p 56.89 67.24 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.955 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.95 -80.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.724 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.4 96.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.409 ' OH ' ' CE ' ' A' ' 75' ' ' MET . 59.5 m-85 -61.72 -43.22 99.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.689 0.281 . . . . 1.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.51 12.78 1.54 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.81 -50.41 74.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 1.0 110.462 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -144.68 125.98 14.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -114.66 138.9 23.46 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.64 160.39 49.6 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.469 2.112 . . . . 1.0 111.875 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.88 HG22 ' H ' ' D' ' 64' ' ' THR . 10.0 p -97.61 -140.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.002 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.88 ' H ' HG22 ' D' ' 63' ' ' VAL . 51.8 m -114.21 -43.68 3.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.312 -0.403 . . . . 1.0 111.044 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.581 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -66.6 -19.98 65.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.58 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.3 OUTLIER -75.69 25.84 0.11 Allowed 'General case' 0 C--O 1.262 1.723 0 CA-C-O 123.993 1.854 . . . . 1.0 109.213 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.743 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.59 62.79 3.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.0 -1.454 . . . . 1.0 109.841 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 57.0 ttm-85 -25.62 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.458 0.629 . . . . 1.0 111.03 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.743 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.22 -28.06 6.97 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.24 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' D' ' 67' ' ' GLY . 78.4 t -63.05 -48.8 86.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -74.26 -51.99 13.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.47 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -49.8 -40.31 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.096 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.29 -40.37 96.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' D' ' 52' ' ' ALA . 70.5 t -62.38 -45.19 99.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.431 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' D' ' 51' ' ' THR . 3.8 mpp? -64.25 -42.08 96.66 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.066 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -63.97 -42.03 97.38 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.505 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.8 -36.53 83.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.896 0.379 . . . . 1.0 110.751 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -69.6 -40.15 77.83 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.34 -44.65 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.788 0.294 . . . . 1.0 111.708 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' D' ' 80' ' ' GLU . 9.4 pt-20 -65.92 -35.67 81.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.152 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 77' ' ' ALA . 42.0 t -62.17 -48.67 87.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.552 -0.294 . . . . 1.0 111.263 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -73.78 -4.65 35.96 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.878 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.41 -32.37 11.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.7 tt -65.11 -40.04 93.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.442 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -53.7 -6.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.191 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.502 ' O ' ' N ' ' D' ' 89' ' ' LEU . 71.1 m -58.19 -43.54 87.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.339 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.489 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -42.78 -30.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.476 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.57 -32.92 20.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.066 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' D' ' 86' ' ' THR . 90.6 mt -67.34 -39.22 85.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.228 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.01 -48.18 82.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.182 0.515 . . . . 1.0 111.101 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -73.97 -4.98 38.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.209 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 46.7 t0 -55.14 -49.36 72.0 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.102 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 26.7 p90 -73.37 -44.13 59.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.0 t -42.47 -26.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.219 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -58.4 -32.29 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.957 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -58.77 -34.32 71.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 1.0 110.418 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' D' ' 99' ' ' GLU . 67.2 tt0 -72.7 162.84 28.97 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 68.23 -41.83 0.45 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.782 0.676 . . . . 1.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' D' ' 97' ' ' GLU . 80.1 mm-40 -66.21 -36.37 82.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.398 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -60.82 -44.32 97.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.127 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -76.74 -14.76 59.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.583 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.57 8.84 85.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' HIS . . . . . 0.433 ' OXT' ' CG ' ' D' ' 103' ' ' HIS . 85.9 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.017 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -46.2 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 4' ' ' HIS . 31.5 p-10 -172.57 -46.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.442 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 43.0 p-80 -78.92 -29.98 44.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.53 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.71 -35.93 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -63.15 -37.81 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.291 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -64.22 -41.89 96.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.063 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.87 92.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.357 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.82 -39.26 90.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.353 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.79 -41.19 97.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.617 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.43 80.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.869 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.02 -36.82 85.24 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -34.55 78.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.487 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.567 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 39.7 tp10 -64.95 -36.35 84.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.451 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.5 tp -62.72 -42.13 99.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 1.0 110.737 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.307 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HZ1' ' CD ' ' A' ' 14' ' ' GLU . 6.8 ttpm? -62.41 -40.07 95.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.13 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.88 -35.66 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.5 mt -61.06 -42.46 98.54 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.216 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.54 -43.29 85.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.263 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.6 -39.65 77.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.389 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.48 96.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.6 m -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.391 . . . . 1.0 110.182 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.764 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.69 -46.69 13.96 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.248 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.93 -44.58 78.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.549 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 4.7 p -59.51 -46.92 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.117 -0.633 . . . . 1.0 109.694 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 94.6 mt-10 -71.55 -33.8 69.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.653 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.29 97.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.266 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -89.89 -4.34 57.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.143 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -75.37 91.08 2.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.577 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.6 -15.36 17.25 Favored Glycine 0 N--CA 1.466 0.67 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 148.67 97.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 120.786 -0.365 . . . . 1.0 110.028 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 63' ' ' VAL . 93.0 Cg_endo -75.18 139.66 24.08 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.865 1.71 . . . . 1.0 112.333 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.62 21.92 74.92 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.64 166.35 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.902 0.382 . . . . 1.0 110.554 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 38' ' ' LEU . . . -151.66 -12.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.231 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 40.2 tp -67.72 -19.07 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' LEU . 95.3 mt -33.63 89.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.273 0.559 . . . . 1.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' LEU . 8.7 t -171.66 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.561 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 22.0 t80 -179.27 -57.8 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 123.142 0.276 . . . . 1.0 111.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 45' ' ' ILE . 30.3 Cg_endo -60.09 -31.65 93.63 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 121.782 1.655 . . . . 1.0 112.5 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -82.55 -10.12 59.12 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.233 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.25 84.06 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.87 0.366 . . . . 1.0 110.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 49' ' ' VAL . 6.7 tt -67.69 -38.33 80.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.475 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.4 OUTLIER -63.96 -50.47 68.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.163 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -62.36 -42.82 99.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.751 -0.463 . . . . 1.0 109.751 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.7 m -53.64 -36.05 61.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 49' ' ' VAL . 57.8 t -82.99 -4.86 8.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.0 110.459 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -107.82 37.19 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.375 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.422 HG23 HG11 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -148.74 -35.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.57 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.31 -24.68 63.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.496 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 54' ' ' THR . 70.2 p -89.69 5.29 46.51 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 53' ' ' THR . 44.7 p 54.46 71.03 0.55 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.142 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.85 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.741 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.32 84.68 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.78 -41.72 99.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.768 0.318 . . . . 1.0 110.556 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.24 20.49 0.36 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.32 -35.36 80.6 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.697 ' NH2' HH22 ' B' ' 68' ' ' ARG . 2.1 tpp180 -134.77 179.07 6.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.348 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 75.1 m-85 -160.94 93.88 1.47 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.35 149.74 69.89 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.713 1.609 . . . . 1.0 112.216 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 34' ' ' PRO . 1.5 t -85.76 -143.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.305 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' A' ' 63' ' ' VAL . 52.1 m -110.34 -38.78 5.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.697 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.2 tt0 -61.46 -20.73 63.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.059 0.457 . . . . 1.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.14 25.77 0.22 Allowed 'General case' 0 C--O 1.267 1.995 0 CA-C-O 123.915 1.817 . . . . 1.0 109.516 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.94 65.47 1.6 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.649 -1.614 . . . . 1.0 111.12 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 55.6 ttm-85 -24.45 -32.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.975 0.888 . . . . 1.0 110.999 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 99.1 mttt -47.24 -26.25 1.15 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.422 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.4 t -63.26 -46.47 95.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.764 -0.774 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.34 62.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 1.0 111.012 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.31 -41.27 96.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.835 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -55.57 -43.82 76.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 HG23 ' A' ' 51' ' ' THR . 95.0 t -66.75 -44.72 89.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.486 -0.486 . . . . 1.0 111.005 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.508 ' SD ' HG11 ' D' ' 55' ' ' VAL . 64.3 mtt -61.87 -43.64 98.43 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.637 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.78 -41.06 92.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 1.0 110.299 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -59.76 -40.67 88.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.451 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.28 -43.74 92.24 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.07 -43.53 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 121.082 -0.247 . . . . 1.0 110.395 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -43.19 97.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.246 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' ALA . 55.6 t -64.77 -50.02 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.796 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -68.29 -37.36 80.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.68 88.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.685 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.1 tt -65.69 -37.45 86.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.24 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 t -46.06 -13.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.42 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 16.2 m -58.79 -45.17 90.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.495 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -40.93 -21.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.758 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -106.62 -25.35 11.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.73 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 86' ' ' THR . 69.6 mt -62.79 -42.22 99.6 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -72.96 -65.24 0.82 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.36 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -47.56 -10.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.229 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' ALA . 46.9 t0 -63.18 -73.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.024 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' B' ' 87' ' ' ALA . 25.1 m-85 -86.46 -27.98 23.77 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.952 0.353 . . . . 1.0 111.952 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 90' ' ' ALA . 56.3 t -40.88 -27.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.515 0.198 . . . . 1.0 111.274 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' GLU . 95.7 mtt-85 -61.17 -32.99 72.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -39.43 -38.68 0.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.715 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.43 -41.8 75.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.002 0.43 . . . . 1.0 109.906 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 95' ' ' ARG . 80.1 mm-40 -68.16 -35.79 78.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.27 -43.86 97.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.41 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.427 HH21 ' NH2' ' A' ' 101' ' ' ARG . 42.2 ttp-105 -65.57 -42.72 91.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.309 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' NH2' HH21 ' A' ' 100' ' ' ARG . 89.5 mtm180 -130.91 102.22 5.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.505 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.77 27.73 5.06 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.683 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . -160.94 171.4 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.669 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 65.7 t0 -63.56 -39.02 93.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.515 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 16.1 p-80 -80.7 -29.63 36.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.615 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.23 -44.26 84.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.89 -36.01 75.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -67.79 -40.42 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 1.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.8 98.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.85 -32.49 73.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.24 -39.46 92.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.365 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.34 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.767 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.6 -36.85 81.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.396 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -65.73 -41.18 92.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.363 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' B' ' 52' ' ' ALA . 40.6 tp -61.27 -41.86 97.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.37 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.24 -42.85 96.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.712 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -64.15 -37.93 89.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.711 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.81 -66.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.12 -31.56 61.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.837 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -63.45 -44.66 93.86 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.52 -36.63 84.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.61 75.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.854 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.466 ' O ' HG23 ' B' ' 27' ' ' VAL . 25.2 p -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.483 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.58 -56.35 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.077 -0.649 . . . . 1.0 109.856 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.1 -38.97 80.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.267 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.45 76.41 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.131 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 23' ' ' SER . 90.2 t -63.58 -48.56 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.263 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.88 -35.81 72.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.752 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.43 84.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.201 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' B' ' 38' ' ' LEU . 41.9 mm-40 -70.51 -42.56 71.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 1.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -53.6 94.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.899 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 115.85 11.25 10.33 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 111.15 -0.78 . . . . 1.0 111.15 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' OE2' ' B' ' 66' ' ' GLU . . . -102.03 137.41 19.48 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.614 0.207 . . . . 1.0 110.617 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.03 138.86 21.1 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.869 1.713 . . . . 1.0 112.407 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.4 3.4 39.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . -47.14 176.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 1.0 110.399 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.27 -28.92 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.537 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' B' ' 30' ' ' GLU . 23.0 tp -99.49 119.81 38.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.965 0.412 . . . . 1.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.34 64.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.036 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -169.26 128.99 1.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.372 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.2 OUTLIER -58.62 -51.45 81.73 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.669 -0.696 . . . . 1.0 111.176 178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.3 Cg_endo -57.85 -32.24 94.48 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.701 1.601 . . . . 1.0 112.682 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' B' ' 43' ' ' ASP . 2.4 m-20 -93.22 -23.24 18.61 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.762 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.99 94.42 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.878 0.37 . . . . 1.0 110.568 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -64.27 -37.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.41 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -44.98 86.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.44 -40.33 94.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.502 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -61.47 -36.33 80.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.171 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.99 -48.07 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 1.0 111.982 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.88 -30.5 69.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.846 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -62.51 -45.08 94.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.565 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' B' ' 15' ' ' LEU . . . -59.73 -32.15 70.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.013 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' B' ' 54' ' ' THR . 45.0 p -71.82 -6.75 43.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.799 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.38 65.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.284 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.584 HG11 ' CE1' ' B' ' 57' ' ' TYR . 92.7 t -150.37 -47.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 42.85 83.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.584 ' CE1' HG11 ' B' ' 55' ' ' VAL . 33.1 m-85 -62.83 -41.6 99.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 167.62 -90.25 0.1 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 77.1 m-20 42.56 -88.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 1.0 110.9 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' B' ' 58' ' ' GLY . 25.6 mmt180 -115.61 -173.39 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.194 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 38.7 p90 -173.77 118.54 0.37 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.246 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.35 158.12 58.65 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.565 1.51 . . . . 1.0 112.251 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.468 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.8 t -97.22 -126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.543 HG22 ' CD1' ' A' ' 46' ' ' TRP . 5.9 p -114.3 -36.56 4.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.777 0.322 . . . . 1.0 111.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.7 tt0 -65.29 -31.48 72.65 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.553 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 1.3 pm0 -79.26 30.33 0.22 Allowed 'General case' 0 C--O 1.269 2.115 0 CA-C-O 123.969 1.842 . . . . 1.0 109.797 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 37.57 61.92 1.01 Allowed Glycine 0 C--O 1.212 -1.237 0 CA-C-N 113.092 -1.867 . . . . 1.0 111.045 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.697 HH22 ' NH2' ' A' ' 60' ' ' ARG . 40.5 ttm180 -24.96 -32.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.993 . . . . 1.0 110.947 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' B' ' 67' ' ' GLY . 68.3 mttm -49.42 -16.48 0.2 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 67' ' ' GLY . 55.9 t -63.35 -46.1 96.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 119.788 -0.765 . . . . 1.0 109.578 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.58 72.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.241 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.12 -43.92 70.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.343 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.35 -44.22 88.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.825 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.34 -43.51 91.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.323 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 37.0 mtt -59.11 -44.86 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.721 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.19 -42.58 96.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.74 89.17 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.13 -36.81 93.71 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.89 -26.9 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.424 -0.457 . . . . 1.0 111.523 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.29 -50.6 37.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.042 0.449 . . . . 1.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' H ' ' B' ' 82' ' ' PHE . 5.7 m -60.04 -48.7 86.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.355 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.442 ' H ' HG23 ' B' ' 81' ' ' VAL . 20.6 m-85 -66.03 -34.55 78.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.67 37.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.2 tt -69.97 -23.43 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 1.0 110.114 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.534 ' O ' HG12 ' B' ' 85' ' ' VAL . 98.6 t -57.29 -3.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.644 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.521 ' H ' ' C ' ' B' ' 84' ' ' LEU . 14.6 t -49.32 -39.0 29.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.404 0.621 . . . . 1.0 109.585 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -46.69 -35.63 6.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.423 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.23 -10.85 51.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.585 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' B' ' 92' ' ' ASP . 85.7 mt -85.29 -56.87 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.891 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 94' ' ' VAL . . . -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.293 0.568 . . . . 1.0 109.989 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -61.11 -37.56 83.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.574 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 11.1 t0 -59.56 -44.48 93.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.617 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 0.5 OUTLIER -61.25 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.756 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 96' ' ' ARG . 95.9 t -64.93 -43.83 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.738 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.533 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 46.9 mtt85 -44.79 -20.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.459 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' B' ' 94' ' ' VAL . 52.3 ptt85 -52.85 -33.13 48.16 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.247 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 99' ' ' GLU . 7.5 pt-20 -112.76 -169.11 1.42 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.438 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 39.87 22.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' B' ' 97' ' ' GLU . 82.0 tt0 -132.15 -48.34 0.93 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.796 0.332 . . . . 1.0 110.735 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -60.15 -36.54 77.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.43 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.508 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.45 25.17 44.09 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.339 -0.705 . . . . 1.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.555 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' SER . . . . . 0.411 ' O ' ' O ' ' C' ' 2' ' ' ALA . 42.8 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' C' ' 1' ' ' SER . . . 59.99 136.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.85 -21.29 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.427 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 2.8 p80 -78.78 -27.7 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.054 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.645 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 84.7 tt0 -70.04 -32.75 71.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.739 0.304 . . . . 1.0 110.813 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -59.36 -41.58 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.58 -39.95 89.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.187 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.38 87.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -58.06 -42.45 85.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.529 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -62.6 -34.6 77.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 1.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' C' ' 84' ' ' LEU . . . -58.5 -37.95 76.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.001 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.29 -32.82 74.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.004 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.2 -41.97 94.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.705 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.44 -39.95 94.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' C' ' 52' ' ' ALA . 50.0 tp -62.39 -42.36 99.36 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.649 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.61 -41.88 92.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.6 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -63.36 -38.46 91.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.793 0.33 . . . . 1.0 111.155 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.68 -42.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.754 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' C' ' 52' ' ' ALA . 67.1 mt -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.239 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -64.5 -42.63 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.35 -39.0 74.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.492 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.53 85.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.996 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -58.27 -46.21 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.617 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.41 -35.71 81.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 1.0 109.964 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -70.6 -40.93 72.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.321 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -50.14 73.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.33 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 18.9 m -61.43 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.403 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' HG23 ' C' ' 27' ' ' VAL . 40.3 tp10 -69.6 -41.83 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.539 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.89 94.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.65 -6.76 56.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.965 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -87.74 117.47 26.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.929 0.395 . . . . 1.0 110.119 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.47 -4.02 63.94 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.3 144.09 37.75 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.93 137.79 20.11 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.9 1.734 . . . . 1.0 112.346 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.75 14.9 75.6 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 149.06 47.15 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.383 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 41.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.509 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.493 HD23 ' C ' ' C' ' 38' ' ' LEU . 3.7 tt -127.53 -67.15 0.84 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.191 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' C' ' 38' ' ' LEU . 19.2 pt 31.59 -123.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.557 0.536 . . . . 1.0 110.862 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t 47.82 -130.63 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.731 0.301 . . . . 1.0 110.754 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.466 ' HA ' HG11 ' C' ' 27' ' ' VAL . 5.9 t80 177.85 -59.37 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.1 Cg_endo -59.33 -33.95 97.74 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.927 1.751 . . . . 1.0 112.105 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -78.01 -6.04 53.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.53 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.49 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -64.3 -44.82 90.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 1.0 111.348 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.474 HG23 ' HE3' ' C' ' 46' ' ' TRP . 10.1 tt -66.14 -33.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.474 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.3 OUTLIER -64.08 -48.54 75.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.258 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.45 -42.61 95.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.272 -0.571 . . . . 1.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -52.81 -39.45 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.739 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' C' ' 51' ' ' THR . 71.2 t -65.47 -43.93 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.513 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.64 24.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.884 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.522 ' H ' ' C ' ' C' ' 49' ' ' VAL . 96.1 m -127.78 -43.85 1.52 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.674 -0.239 . . . . 1.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.93 -25.13 66.55 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.578 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.513 ' OG1' HG13 ' C' ' 55' ' ' VAL . 16.9 p -89.9 4.4 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.834 0.349 . . . . 1.0 110.12 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 44.2 p 52.19 35.76 17.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.813 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.594 HG11 ' SD ' ' D' ' 75' ' ' MET . 31.3 m -75.35 -35.87 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.212 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD2' ' B' ' 57' ' ' TYR . . . 100.11 -76.3 0.45 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' C' ' 57' ' ' TYR . 44.2 p90 -61.99 117.61 6.18 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' C' ' 60' ' ' ARG . . . -133.77 20.02 4.14 Favored Glycine 0 N--CA 1.464 0.515 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.42 ' OD2' ' CZ ' ' C' ' 60' ' ' ARG . 11.9 t0 71.12 -29.14 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.298 . . . . 1.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' C' ' 58' ' ' GLY . 21.3 mmt180 -121.22 152.4 38.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -139.35 126.85 13.06 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.63 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.84 152.49 68.91 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.764 1.643 . . . . 1.0 111.981 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.492 HG11 ' O ' ' C' ' 34' ' ' PRO . 3.4 t -92.34 -126.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.458 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 86.9 m -115.17 -38.71 3.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.909 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.669 ' C ' ' H ' ' C' ' 67' ' ' GLY . 42.7 tp10 -67.6 -38.43 83.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.647 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 0.1 OUTLIER -65.89 27.17 0.02 OUTLIER 'General case' 0 C--O 1.264 1.829 0 CA-C-O 123.176 1.465 . . . . 1.0 110.248 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.78 64.28 1.7 Allowed Glycine 0 C--O 1.216 -0.975 0 CA-C-O 118.183 -1.343 . . . . 1.0 111.192 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 56.8 ttm-85 -23.34 -32.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.05 0.925 . . . . 1.0 111.446 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.9 mttt -50.62 -16.49 0.39 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.379 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 57.0 t -60.48 -46.83 94.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.98 81.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 1.0 110.142 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -62.25 -36.72 82.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.84 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -62.55 -43.84 97.82 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.28 -45.6 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.558 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.8 -36.9 85.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.971 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -59.36 -46.26 89.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.494 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -66.25 -38.45 87.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 1.0 110.265 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.23 -48.56 73.53 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.156 -0.545 . . . . 1.0 111.809 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.15 -43.7 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.707 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -68.18 -43.02 79.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.279 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.494 HG23 ' O ' ' C' ' 77' ' ' ALA . 41.4 t -63.38 -49.16 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.083 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -68.68 -28.49 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.186 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.44 -26.41 26.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 1.0 110.412 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' C' ' 11' ' ' ALA . 4.7 tt -64.15 -42.51 96.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.625 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.8 m -62.33 -9.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.44 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 24.8 m -41.45 -20.14 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.932 0.396 . . . . 1.0 110.555 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -63.69 -66.46 0.54 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.542 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.57 64.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.48 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.638 HD12 ' O ' ' D' ' 83' ' ' ALA . 4.2 mm? -64.98 -38.43 90.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.363 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -66.99 -69.29 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.938 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.872 ' O ' HG22 ' C' ' 94' ' ' VAL . 0.5 OUTLIER -40.03 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.539 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' C' ' 90' ' ' ALA . 46.4 t0 -38.83 -33.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.677 0.275 . . . . 1.0 111.364 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 7.0 p90 -64.35 -35.64 81.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.675 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.872 HG22 ' O ' ' C' ' 91' ' ' THR . 15.1 m -48.88 -36.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.755 -0.657 . . . . 1.0 111.874 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -63.86 -21.84 66.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -59.26 -43.29 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.253 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' C' ' 97' ' ' GLU . 56.3 mp0 -82.59 168.76 17.02 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.781 0.324 . . . . 1.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 56.86 17.76 3.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -135.9 -23.04 1.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.671 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' C' ' 100' ' ' ARG . 45.9 mtm180 -61.8 -44.6 96.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.821 0.343 . . . . 1.0 110.724 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -67.23 -36.84 82.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.65 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.38 57.06 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.548 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.76 -50.76 72.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.595 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -174.94 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.716 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -79.56 -17.36 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.784 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.76 -36.76 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 1.0 110.452 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -62.11 -42.95 99.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.249 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.18 -44.67 96.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.107 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' D' ' 85' ' ' VAL . . . -65.54 -39.18 91.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.785 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -64.95 -41.06 95.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.466 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -63.31 -37.56 87.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.57 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -39.3 92.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.33 -32.61 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.373 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.04 -38.34 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.61 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.6 tp -61.86 -43.41 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.522 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -56.51 -36.05 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -62.68 -36.24 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.105 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.99 -40.71 81.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 1.0 110.781 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.88 -40.81 89.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.099 -0.5 . . . . 1.0 109.98 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -55.19 -49.8 70.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.621 -0.432 . . . . 1.0 109.888 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.53 -35.06 72.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.089 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.78 85.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.138 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -60.31 -43.97 95.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 1.0 111.116 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.33 -34.32 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.654 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.03 -44.27 16.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.939 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.15 90.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.711 0.291 . . . . 1.0 110.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 2.8 p -60.43 -44.12 95.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.173 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 79.2 mm-40 -71.39 -42.9 67.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.861 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.82 99.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.423 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -65.74 -37.21 85.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.8 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -67.5 122.13 17.32 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.932 0.396 . . . . 1.0 110.553 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.65 -11.87 59.49 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.116 -0.793 . . . . 1.0 111.116 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.5 133.77 39.44 Favored Pre-proline 0 CA--C 1.538 0.515 0 O-C-N 122.798 -0.236 . . . . 1.0 110.47 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.82 142.74 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.149 1.9 . . . . 1.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.1 0.62 53.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.33 140.2 50.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.767 0.318 . . . . 1.0 110.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.93 -53.88 2.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.584 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -52.4 94.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.121 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.713 HG23 ' O ' ' D' ' 39' ' ' ILE . 21.0 tt -134.11 63.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.16 0.505 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -159.68 135.75 8.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.477 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 18.0 t80 -74.87 -49.5 4.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.72 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.8 Cg_endo -58.93 -30.71 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.321 1.347 . . . . 1.0 111.964 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -87.14 -20.2 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.076 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.93 96.25 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.867 0.365 . . . . 1.0 110.692 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.413 ' H ' HG22 ' D' ' 45' ' ' ILE . 7.3 tt -66.27 -38.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.303 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.402 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -63.86 -46.56 84.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.044 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -39.77 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.166 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.3 t -49.6 -20.25 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.564 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' D' ' 51' ' ' THR . 24.9 t -97.58 -33.64 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.0 0.429 . . . . 1.0 110.258 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -78.21 16.62 0.74 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.43 ' H ' ' C ' ' D' ' 49' ' ' VAL . 6.1 t -137.38 -34.81 0.69 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.16 -24.48 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.523 ' OG1' HG13 ' D' ' 55' ' ' VAL . 67.4 p -93.88 6.17 49.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.3 p 56.71 11.28 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.055 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.523 HG13 ' OG1' ' D' ' 53' ' ' THR . 25.8 m -63.53 -43.34 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.787 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.465 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 41.43 86.62 0.01 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -90.58 4.5 51.09 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.836 0.351 . . . . 1.0 110.159 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.03 17.3 65.46 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 30.1 m-20 -63.63 -46.18 86.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 1.0 110.593 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.39 167.08 21.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.019 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 9.6 p90 -153.56 102.48 2.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.591 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.76 162.38 42.3 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.885 1.723 . . . . 1.0 112.508 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.502 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -96.13 -140.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.502 ' H ' HG12 ' D' ' 63' ' ' VAL . 28.9 m -112.15 -39.71 4.39 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.668 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -59.53 -24.28 63.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.516 ' OE2' ' N ' ' D' ' 68' ' ' ARG . 0.1 OUTLIER -80.01 28.52 0.29 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 123.329 1.538 . . . . 1.0 108.944 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.15 62.19 2.15 Favored Glycine 0 C--O 1.216 -0.977 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.995 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.516 ' N ' ' OE2' ' D' ' 66' ' ' GLU . 48.2 ttm-85 -24.61 -32.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.401 0.707 . . . . 1.0 111.061 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.26 -18.23 0.57 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.615 ' O ' HG23 ' D' ' 74' ' ' VAL . 62.0 t -63.01 -46.84 95.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.907 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.5 -47.31 27.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.348 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -43.77 -62.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.57 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.15 -41.68 88.9 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.615 HG23 ' O ' ' D' ' 70' ' ' VAL . 89.9 t -61.72 -48.06 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.404 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.594 ' SD ' HG11 ' C' ' 55' ' ' VAL . 75.5 mtm -64.56 -41.99 95.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.697 0.284 . . . . 1.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.1 -36.16 83.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.696 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.466 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -58.3 -38.4 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.321 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.07 -42.1 94.75 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.458 -0.657 . . . . 1.0 111.458 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.64 98.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.616 0.246 . . . . 1.0 111.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.36 -38.9 92.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.133 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 77' ' ' ALA . 70.5 t -63.29 -48.29 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.091 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.05 -36.82 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.853 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.638 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -60.76 -37.75 82.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.836 -0.345 . . . . 1.0 110.266 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.8 tt -62.49 -40.34 96.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.557 ' O ' HG12 ' D' ' 85' ' ' VAL . 99.8 t -58.41 -3.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.205 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 89' ' ' LEU . 54.4 m -59.33 -44.53 92.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.649 ' O ' HG22 ' D' ' 91' ' ' THR . . . -41.71 -57.17 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 1.0 110.561 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.65 59.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' D' ' 86' ' ' THR . 83.8 mt -89.78 -16.95 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -80.71 -49.58 11.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.649 HG22 ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -50.98 -10.82 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.953 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.482 ' N ' ' C ' ' D' ' 90' ' ' ALA . 97.6 m-20 -61.54 -53.48 55.8 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -45.44 -34.02 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.01 -27.1 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.155 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -60.56 -41.27 94.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.612 -0.267 . . . . 1.0 110.895 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -50.71 -39.36 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.338 . . . . 1.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.48 -37.11 86.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.55 -31.77 72.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.982 0.42 . . . . 1.0 110.372 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.64 -37.87 85.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.134 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -61.54 -43.67 98.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.584 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -68.95 -24.99 64.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.439 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.07 11.41 76.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.55 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 4' ' ' HIS . . . -58.04 176.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.631 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.48 -43.06 99.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.723 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 11.2 p-80 -73.04 -32.03 64.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.626 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.27 -36.07 82.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 1.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -64.1 -39.52 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.264 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -66.84 -39.16 87.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.052 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.57 87.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.332 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.85 -45.11 94.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.114 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.21 -37.18 86.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.431 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 84' ' ' LEU . . . -54.23 -45.8 72.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.925 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.32 -41.99 93.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 1.0 110.557 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.76 -32.59 74.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.304 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.05 -36.72 84.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.685 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.2 tp -62.31 -42.4 99.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 1.0 110.594 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -57.93 -39.91 79.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.232 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.72 -42.65 99.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.077 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.71 -40.59 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.445 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 52' ' ' ALA . 89.6 mt -59.06 -40.76 86.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 1.0 109.952 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.64 -48.06 82.32 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.536 -0.465 . . . . 1.0 109.832 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.87 -33.37 75.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.972 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.86 90.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.488 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.783 ' O ' HG23 ' A' ' 27' ' ' VAL . 27.3 m -59.53 -44.86 93.08 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -66.16 -54.92 19.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.526 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.9 mttt -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.125 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.77 90.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.198 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 23' ' ' SER . 62.3 t -64.61 -46.43 92.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.042 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.35 -23.38 46.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -52.32 -49.41 64.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.251 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 63' ' ' VAL . 2.3 mm-40 -70.19 -39.74 75.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -67.55 92.91 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.785 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.44 -15.8 6.34 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.408 -0.677 . . . . 1.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.496 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -105.15 148.56 36.41 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.859 0.33 . . . . 1.0 110.285 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 97.1 Cg_endo -75.78 132.89 14.86 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.975 1.783 . . . . 1.0 112.571 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 96.94 8.16 57.07 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . -35.55 154.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.761 0.315 . . . . 1.0 110.875 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.72 -50.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.471 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.5 110.36 19.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.032 0.444 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 pt -142.84 73.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.281 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' ALA . 8.5 p -162.15 98.91 1.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 56.8 t80 -51.51 -49.43 82.56 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.089 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.6 Cg_endo -59.75 -35.3 94.93 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.262 1.308 . . . . 1.0 112.509 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.0 -6.92 34.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.9 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -65.54 -43.6 89.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 1.0 110.533 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -64.64 -34.64 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.44 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.43 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.34 -46.44 90.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.882 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.46 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 1.7 t90 -66.68 -40.48 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.498 -0.481 . . . . 1.0 109.793 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 1.2 m -54.74 -33.12 60.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.84 -46.97 95.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.024 0.44 . . . . 1.0 110.175 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' B' ' 61' ' ' TYR . 62.1 mt-10 -66.8 -33.32 75.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.387 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 96.6 m -62.2 -46.78 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.353 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.59 -36.74 81.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.149 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 55' ' ' VAL . 72.0 p -74.4 -9.83 58.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 53' ' ' THR . 3.0 p 65.1 -4.86 0.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 57' ' ' TYR . 69.5 t -64.7 -44.98 96.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.14 83.24 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.451 -0.66 . . . . 1.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.535 ' CE1' HG11 ' A' ' 55' ' ' VAL . 49.5 m-85 -61.16 -41.95 97.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 1.0 110.633 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.14 9.57 2.39 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.841 -0.903 . . . . 1.0 110.841 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 38.1 t0 -56.97 -51.53 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.361 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -134.29 126.69 30.26 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -108.09 134.21 20.23 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.775 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.05 162.69 41.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.249 1.966 . . . . 1.0 112.223 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 64' ' ' THR . 8.4 p -70.16 -145.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.445 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.939 ' H ' HG22 ' A' ' 63' ' ' VAL . 5.0 m -113.12 -73.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.958 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 64' ' ' THR . 79.9 tt0 -38.87 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.349 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.882 ' O ' ' N ' ' A' ' 68' ' ' ARG . 70.9 mt-10 -77.76 -106.63 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.553 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 18.04 -54.81 0.0 OUTLIER Glycine 0 N--CA 1.477 1.398 0 O-C-N 124.593 1.183 . . . . 1.0 114.223 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.882 ' N ' ' O ' ' A' ' 66' ' ' GLU . 10.1 tpp180 -64.05 -49.15 73.48 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.123 -0.538 . . . . 1.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 66' ' ' GLU . 68.4 mttm -64.81 -40.73 95.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.363 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.93 -45.4 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.57 83.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.99 0.424 . . . . 1.0 110.411 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -62.65 -37.66 87.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.302 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.82 -54.68 7.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.61 -46.13 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.849 -0.34 . . . . 1.0 111.09 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.2 ttp -55.97 -45.27 78.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.59 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 64.7 tttm -65.74 -33.01 74.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.368 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.62 80.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.788 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.96 -41.94 99.78 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.82 -43.67 98.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.658 0.266 . . . . 1.0 110.602 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 76' ' ' LYS . 97.8 mt-10 -60.48 -35.73 76.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.202 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.98 -74.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -45.41 -38.39 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.94 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.04 86.1 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.44 -39.47 93.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.279 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 85' ' ' VAL . 99.6 t -45.98 -13.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.427 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 76.8 m -51.33 -43.9 61.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -44.44 -20.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.554 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.11 -18.37 14.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.998 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 86' ' ' THR . 43.9 mt -92.51 -42.37 9.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.733 0.301 . . . . 1.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.95 -28.74 64.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.094 0.473 . . . . 1.0 110.863 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -80.81 -4.08 53.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.419 -179.386 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.2 m-20 -60.95 -47.88 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.944 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 11.1 p90 -75.89 -20.6 57.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.306 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.16 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.11 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -59.94 -22.66 62.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.964 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttp85 -57.37 -43.92 83.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.617 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 99' ' ' GLU . 66.5 tt0 -76.38 162.16 28.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 101' ' ' ARG . 56.1 mm-40 68.49 -41.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.379 0.424 . . . . 1.0 110.73 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 97' ' ' GLU . 84.0 tt0 -64.83 -49.96 68.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.794 0.33 . . . . 1.0 110.404 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -65.9 -39.97 91.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' A' ' 98' ' ' GLU . 30.1 mmt180 -108.84 113.46 26.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.212 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.09 -8.57 49.61 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.422 ' OXT' ' ND1' ' A' ' 103' ' ' HIS . 56.4 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.533 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . 94.2 p . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 45.93 -174.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.486 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -137.87 -34.77 0.66 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.726 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.401 ' CD2' ' HA ' ' B' ' 88' ' ' ALA . 17.6 p-80 -78.74 -24.03 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.419 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.21 -39.96 86.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.42 -38.54 91.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.54 -41.28 93.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 1.0 110.021 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.32 -41.13 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -65.49 -41.04 93.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.277 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -64.21 -36.2 83.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.531 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.27 78.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -70.74 -32.25 69.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 1.0 110.782 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.33 -49.36 72.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.884 0.373 . . . . 1.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.449 ' O ' HG23 ' B' ' 18' ' ' VAL . 13.3 pt-20 -64.91 -30.2 71.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.561 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.74 -43.2 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.03 -43.02 99.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -33.86 76.79 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.511 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 14' ' ' GLU . 49.3 t -68.3 -54.67 20.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.13 -33.89 77.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.54 -40.27 96.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.51 -40.9 96.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -63.64 -33.26 75.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.659 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' B' ' 48' ' ' SER . 2.2 m -55.54 -43.5 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.231 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.487 ' O ' HG12 ' B' ' 27' ' ' VAL . 24.9 tptp -58.74 -55.73 31.34 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.843 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -60.89 -29.33 69.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.732 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.9 67.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 24' ' ' LYS . 1.4 p -62.28 -44.17 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.069 0.461 . . . . 1.0 110.103 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.463 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 12.2 tm-20 -74.56 -33.35 62.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.271 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.07 45.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.92 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.51 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 0.5 OUTLIER 178.68 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.82 0.343 . . . . 1.0 110.777 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.626 HH21 ' CG2' ' B' ' 39' ' ' ILE . 3.8 mmp_? -79.14 76.92 5.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.115 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.78 1.35 5.94 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.898 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.5 151.09 40.26 Favored Pre-proline 0 N--CA 1.465 0.304 0 O-C-N 122.767 -0.255 . . . . 1.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.07 144.26 29.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.974 1.783 . . . . 1.0 112.496 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.37 32.31 75.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -48.64 -60.57 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.0 110.75 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.52 4.32 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.341 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.426 HD23 ' O ' ' B' ' 38' ' ' LEU . 3.1 tt -145.47 55.54 1.21 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.022 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.626 ' CG2' HH21 ' B' ' 31' ' ' ARG . 33.0 pt -92.69 51.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.908 0.385 . . . . 1.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' B' ' 43' ' ' ASP . 0.3 OUTLIER -150.72 140.19 21.48 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.178 0.513 . . . . 1.0 110.94 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.8 OUTLIER -82.0 -53.99 0.66 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.278 -0.873 . . . . 1.0 110.81 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.0 Cg_endo -57.76 -28.97 84.2 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.876 1.717 . . . . 1.0 112.701 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 40' ' ' SER . 12.1 p-10 -88.91 -4.33 58.49 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.97 92.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 1.0 110.41 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 46' ' ' TRP . 20.7 tt -67.28 -37.5 79.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.517 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.511 ' NE1' ' O ' ' C' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -53.13 61.49 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -62.97 -42.69 99.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.958 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' B' ' 23' ' ' SER . 64.8 m -51.9 -38.97 58.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.711 0.291 . . . . 1.0 111.095 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.15 -50.4 73.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 1.0 111.588 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -59.77 -40.9 89.76 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.734 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -24.86 68.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.268 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 20.4 p -90.86 6.34 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 1.0 110.774 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 p 52.11 63.19 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.476 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.42 -53.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.12 81.79 0.06 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 1.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.38 3.77 12.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.69 -49.49 77.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 1.0 110.516 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -145.62 157.55 43.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.819 -0.438 . . . . 1.0 109.819 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 50' ' ' GLU . 64.2 t80 -172.46 132.52 0.7 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.7 -173.5 0.72 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.582 1.522 . . . . 1.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.592 HG22 ' N ' ' B' ' 64' ' ' THR . 3.6 p -134.15 165.72 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.422 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.592 ' N ' HG22 ' B' ' 63' ' ' VAL . 14.5 m -40.76 -61.79 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.243 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.01 -14.52 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.941 0.4 . . . . 1.0 109.94 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' B' ' 64' ' ' THR . 13.6 mm-40 -115.31 41.86 2.36 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-O 125.105 2.383 . . . . 1.0 110.392 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.46 60.04 1.48 Allowed Glycine 0 C--O 1.216 -0.978 0 CA-C-N 112.217 -2.265 . . . . 1.0 111.34 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 59' ' ' ASP . 38.5 ttm180 -28.28 -28.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.578 0.689 . . . . 1.0 110.58 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' B' ' 67' ' ' GLY . 54.4 mtpt -52.41 -12.36 0.26 Allowed 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 37.6 t -58.78 -44.95 91.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 118.902 -1.119 . . . . 1.0 109.541 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.511 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -71.1 -48.95 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 1.0 110.7 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.95 -38.25 55.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.096 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLN . . . . . 0.414 ' O ' ' OE1' ' B' ' 73' ' ' GLN . 0.8 OUTLIER -58.97 -51.2 71.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.018 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 84.2 t -66.78 -43.39 89.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.506 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.2 mpp? -61.22 -41.47 96.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.662 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' LYS . . . . . 0.412 ' O ' ' OE2' ' B' ' 80' ' ' GLU . 65.9 tttm -61.49 -44.02 97.82 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.554 -0.458 . . . . 1.0 110.359 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -66.05 -40.27 90.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.91 96.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.79 -43.88 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 122.847 -0.208 . . . . 1.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 80' ' ' GLU . 0.2 OUTLIER -62.57 -37.78 87.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 1.0 110.334 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 77' ' ' ALA . 24.9 t -60.69 -68.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.184 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -55.33 -37.37 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.776 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.94 89.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.5 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.99 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.117 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' B' ' 8' ' ' ALA . 39.0 t -53.2 -17.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 39.6 m -43.59 -35.3 1.67 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.253 0.549 . . . . 1.0 109.767 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -51.73 -61.67 2.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' B' ' 4' ' ' HIS . . . -55.9 -27.36 51.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 1.0 110.474 -179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.615 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.5 mm? -78.27 -32.27 49.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 1.0 110.046 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -63.03 -46.41 87.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.27 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.445 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.5 OUTLIER -73.57 -3.93 30.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.167 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.516 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 50.2 t0 -56.81 -48.77 77.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.18 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 20.9 p90 -69.5 -39.03 77.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.21 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.517 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 96.6 t -44.42 -28.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.628 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.96 -27.27 68.13 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.116 -0.234 . . . . 1.0 110.953 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.6 ptt85 -54.59 -42.6 71.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.124 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 80.4 mm-40 -60.43 -45.93 91.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.079 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 102' ' ' GLY . 97.5 mt-10 -68.46 -40.29 81.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.783 0.325 . . . . 1.0 110.809 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -67.44 -34.11 76.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.696 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -61.04 -44.75 96.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -95.49 -9.63 31.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.938 0.399 . . . . 1.0 110.415 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 98' ' ' GLU . . . 73.9 15.8 79.56 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.421 ' OXT' ' ND1' ' B' ' 103' ' ' HIS . 56.9 t-80 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -81.03 177.17 9.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.738 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.509 ' OD1' ' ND1' ' C' ' 4' ' ' HIS . 35.6 p-10 -64.05 -36.42 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.39 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.509 ' ND1' ' OD1' ' C' ' 3' ' ' ASP . 11.8 p-80 -81.6 -29.96 33.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -65.16 -44.68 87.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.789 0.328 . . . . 1.0 110.756 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -65.61 -36.83 84.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.142 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -63.78 -42.96 97.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.454 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' C' ' 85' ' ' VAL . . . -64.37 -40.32 95.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.419 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.37 -40.22 93.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.533 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.435 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.58 76.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.81 -36.19 83.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 1.0 111.072 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -63.87 -41.25 97.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 1.0 110.701 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.99 -29.48 69.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.567 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.575 HD11 ' HB1' ' C' ' 52' ' ' ALA . 43.2 tp -62.38 -39.92 94.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.379 . . . . 1.0 110.411 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -70.73 -28.59 64.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.0 -46.55 84.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.746 0.308 . . . . 1.0 111.554 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 18' ' ' VAL . . . . . 0.43 HG22 ' H ' ' C' ' 18' ' ' VAL . 8.6 m -64.42 -36.56 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.87 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -61.17 -41.98 97.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -60.47 -45.45 93.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.59 -33.71 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.107 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.41 94.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.463 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.507 ' O ' HG23 ' C' ' 27' ' ' VAL . 91.7 p -61.81 -46.31 90.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -63.25 -56.3 17.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.546 -0.462 . . . . 1.0 109.92 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.59 -42.61 92.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -56.09 -44.37 78.93 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.507 HG23 ' O ' ' C' ' 23' ' ' SER . 76.8 t -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.208 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.95 75.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.39 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 5.5 mp0 -69.54 -33.07 72.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -54.25 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.769 0.318 . . . . 1.0 110.964 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.22 -0.75 22.46 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.96 147.01 32.35 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.268 -0.271 . . . . 1.0 110.268 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.488 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.1 Cg_endo -75.96 142.5 25.11 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.863 1.709 . . . . 1.0 112.315 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.08 66.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.35 144.45 55.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.0 110.423 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.82 -22.08 0.88 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.603 HD13 ' O ' ' C' ' 38' ' ' LEU . 0.2 OUTLIER -63.6 -38.61 91.77 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.481 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -33.53 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.276 0.56 . . . . 1.0 111.1 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' ' N ' ' C' ' 44' ' ' ALA . 11.8 m -167.94 78.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.4 OUTLIER -37.72 -56.82 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.17 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.1 Cg_endo -59.38 -54.45 2.55 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.84 1.693 . . . . 1.0 112.577 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -79.66 0.18 31.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.277 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -58.56 -42.81 88.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 1.0 110.69 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.452 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.0 tt -68.42 -40.28 82.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.564 ' NE1' ' O ' ' D' ' 64' ' ' THR . 0.5 OUTLIER -55.27 -47.55 75.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.065 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.511 ' CG ' HD21 ' C' ' 38' ' ' LEU . 13.7 t90 -65.09 -40.18 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.421 -0.511 . . . . 1.0 109.771 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.474 ' O ' HD22 ' C' ' 19' ' ' LEU . 36.6 m -59.86 -41.13 90.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.429 HG12 ' O ' ' C' ' 49' ' ' VAL . 47.2 t -80.07 69.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' C' ' 51' ' ' THR . 12.4 pt-20 -166.48 -42.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.977 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.607 HG23 HG11 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -69.76 -36.97 76.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.146 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -57.2 -27.27 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.523 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' C' ' 54' ' ' THR . 43.7 p -95.25 4.57 53.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.322 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' C' ' 53' ' ' THR . 23.9 p 55.41 69.47 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.871 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -148.84 -81.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.33 96.7 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -62.2 -43.22 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 1.0 111.016 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.44 26.75 0.65 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.71 -44.52 96.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 1.0 110.545 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -141.8 161.16 38.65 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.435 ' CD2' ' O ' ' C' ' 61' ' ' TYR . 40.2 p90 -141.76 118.86 7.41 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.764 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 157.62 59.5 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.837 1.692 . . . . 1.0 112.291 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.511 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 2.1 t -84.73 -136.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' C' ' 63' ' ' VAL . 81.8 m -114.48 -49.39 2.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.784 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' C' ' 67' ' ' GLY . 45.5 tp10 -54.38 -24.62 20.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -74.01 37.04 0.1 Allowed 'General case' 0 C--O 1.26 1.657 0 CA-C-O 123.358 1.551 . . . . 1.0 109.742 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.93 64.97 2.2 Favored Glycine 0 C--O 1.206 -1.614 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.367 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.485 ' CB ' ' NE1' ' B' ' 46' ' ' TRP . 10.8 ptp85 -21.97 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.915 0.858 . . . . 1.0 112.656 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.768 ' N ' ' O ' ' C' ' 67' ' ' GLY . 68.4 mttm -64.17 -10.14 21.22 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.291 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' C' ' 67' ' ' GLY . 43.1 t -61.89 -48.36 88.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 119.88 -0.728 . . . . 1.0 110.396 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.02 -43.56 71.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.688 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -61.59 -39.8 92.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.972 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -57.01 -43.68 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.261 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.607 HG11 HG23 ' C' ' 51' ' ' THR . 97.2 t -66.61 -43.38 90.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.739 -0.385 . . . . 1.0 111.546 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 41.6 mtt -60.72 -43.03 98.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.03 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.774 0.321 . . . . 1.0 110.69 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.36 89.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.31 -39.73 91.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.88 -0.488 . . . . 1.0 111.88 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.91 -43.13 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 122.54 -0.388 . . . . 1.0 110.668 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -53.96 51.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.645 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.495 HG23 ' N ' ' C' ' 82' ' ' PHE . 16.5 m -60.95 -47.97 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.163 -0.215 . . . . 1.0 111.544 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.495 ' N ' HG23 ' C' ' 81' ' ' VAL . 16.1 m-85 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.994 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -84.83 -25.59 28.01 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.961 -0.295 . . . . 1.0 110.59 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.601 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.4 m -59.46 -19.74 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.464 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -41.3 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.959 0.409 . . . . 1.0 110.644 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.516 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -62.84 -51.1 68.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.54 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.5 84.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.235 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.542 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -71.34 -37.84 71.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.529 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.26 -34.33 68.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.152 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -3.92 41.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.287 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 90.1 m-20 -57.08 -47.22 81.56 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.716 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 19.3 p90 -73.99 -9.37 58.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.971 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.27 -37.98 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.524 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.52 -28.68 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.268 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 96' ' ' ARG . . . . . 0.405 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.4 ptt85 -51.15 -41.53 60.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.55 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.3 mt-10 -64.35 164.3 11.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.183 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 63.08 -64.13 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.557 0.535 . . . . 1.0 110.632 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 97' ' ' GLU . 81.0 tt0 -53.93 -41.17 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.386 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -63.57 -43.28 97.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.426 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -136.2 100.8 4.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.987 0.423 . . . . 1.0 110.699 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.55 31.96 3.55 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.52 ' OXT' ' CG ' ' C' ' 103' ' ' HIS . 51.7 p-80 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.972 -1.013 . . . . 1.0 110.574 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.82 142.31 57.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.579 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.83 -37.55 87.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.689 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.74 -37.94 87.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.605 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 83.2 tt0 -64.47 -35.42 80.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.746 0.307 . . . . 1.0 110.515 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.56 -40.99 96.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.436 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.03 -37.51 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 1.0 109.955 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' ALA . . . . . 0.404 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -63.49 -37.22 86.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.825 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.44 -40.31 96.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.62 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.71 -41.2 98.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.28 94.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.727 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.14 -45.13 74.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 1.0 110.83 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.8 80.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -63.01 -36.67 84.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.416 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.3 tp -62.6 -41.46 98.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.82 0.343 . . . . 1.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.24 -39.29 75.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.928 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -61.91 -41.37 97.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.155 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.31 -35.01 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.711 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 52' ' ' ALA . 36.5 mt -60.98 -40.51 93.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.96 -49.32 78.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.308 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.015 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.52 94.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' D' ' 44' ' ' ALA . 1.2 m -59.93 -46.33 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.874 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.63 -52.99 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.76 -40.43 88.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.923 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -47.52 -58.27 4.42 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.77 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' D' ' 44' ' ' ALA . 23.5 t -61.27 -44.99 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.212 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.36 -32.69 64.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.302 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -56.88 -44.92 82.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.717 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 10.8 mp0 -66.63 -36.28 82.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.317 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.88 86.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.921 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.17 -6.38 7.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.9 143.73 27.3 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 122.768 -0.254 . . . . 1.0 110.775 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.708 ' O ' HG21 ' D' ' 63' ' ' VAL . 98.3 Cg_endo -74.64 153.85 43.98 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.301 2.0 . . . . 1.0 112.366 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.61 34.31 85.64 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.094 -0.803 . . . . 1.0 111.094 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.54 144.11 43.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 1.0 110.603 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.72 -19.93 1.8 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.486 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.488 ' C ' HD23 ' D' ' 38' ' ' LEU . 2.3 tt -111.13 90.64 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.837 0.351 . . . . 1.0 110.099 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -133.25 103.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.08 0.467 . . . . 1.0 110.296 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 19.0 t -174.21 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 1.0 OUTLIER 173.27 -61.88 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.072 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.79 -38.55 92.42 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.725 1.616 . . . . 1.0 111.927 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.91 -4.27 58.51 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.348 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' ALA . . . . . 0.449 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.97 -39.69 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 1.0 110.52 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.416 ' H ' HG22 ' D' ' 45' ' ' ILE . 1.1 tt -65.76 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.03 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.509 ' NE1' ' O ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -53.05 -45.91 68.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.598 -0.441 . . . . 1.0 109.903 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -63.89 -43.0 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.973 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 86.2 p -61.68 -36.2 80.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.922 -0.311 . . . . 1.0 110.674 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.06 -48.53 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.958 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.483 ' OE1' ' CZ ' ' A' ' 68' ' ' ARG . 19.0 pt-20 -83.87 31.62 0.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.983 0.42 . . . . 1.0 109.928 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 21.3 m -132.58 -46.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.178 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -57.02 -23.45 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 1.0 109.868 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' D' ' 54' ' ' THR . 43.0 p -94.62 5.35 52.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.399 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' D' ' 53' ' ' THR . 39.9 p 52.64 75.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.052 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.577 HG13 ' N ' ' D' ' 56' ' ' GLY . 6.6 p -139.72 -51.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.577 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 50.07 82.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.38 -44.39 97.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.701 0.286 . . . . 1.0 110.85 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.3 2.68 2.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.8 m-20 -59.23 -49.82 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.375 . . . . 1.0 110.357 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -146.97 154.14 40.91 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 12.0 p90 -154.37 147.89 18.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.979 -0.288 . . . . 1.0 110.58 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.43 172.24 13.67 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.418 2.079 . . . . 1.0 112.018 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.84 HG13 ' H ' ' D' ' 64' ' ' THR . 3.0 p -106.24 -105.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.84 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.4 m -118.15 -85.22 0.65 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.979 0.419 . . . . 1.0 111.058 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.402 ' N ' HG22 ' D' ' 64' ' ' THR . 51.9 tp10 -48.08 125.81 9.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' D' ' 68' ' ' ARG . 95.0 mt-10 57.94 -102.48 0.15 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.22 -57.07 0.0 OUTLIER Glycine 0 N--CA 1.474 1.179 0 O-C-N 124.487 1.117 . . . . 1.0 113.776 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.3 ttm-85 -79.84 -56.01 4.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.409 -0.395 . . . . 1.0 109.976 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -48.73 -29.19 4.2 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.458 ' O ' HG23 ' D' ' 74' ' ' VAL . 60.2 t -80.32 -27.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.245 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -78.09 -51.7 9.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.863 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 72' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' D' ' 73' ' ' GLN . 19.7 pt-20 -50.91 -42.03 59.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.653 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 73' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' D' ' 72' ' ' GLU . 56.1 tt0 -64.5 -42.73 95.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.85 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 70' ' ' VAL . 97.0 t -67.27 -44.91 87.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 78.5 mtm -63.74 -38.96 93.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.11 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' D' ' 80' ' ' GLU . 58.0 tttm -57.62 -40.37 79.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.582 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.562 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.22 -41.48 99.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.502 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' D' ' 82' ' ' PHE . . . -67.86 -40.06 89.5 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.811 -0.516 . . . . 1.0 111.811 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.16 -43.95 98.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.612 0.244 . . . . 1.0 111.27 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' D' ' 76' ' ' LYS . 97.6 mt-10 -66.3 -35.54 80.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.756 0.312 . . . . 1.0 111.104 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.562 HG23 ' O ' ' D' ' 77' ' ' ALA . 55.1 t -62.49 -46.29 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.318 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' D' ' 78' ' ' GLY . 58.4 m-85 -64.43 -31.98 73.41 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.58 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -82.93 -24.2 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.449 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.698 ' C ' HD23 ' D' ' 84' ' ' LEU . 7.0 tt -64.89 -42.98 94.35 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.404 HG12 ' HB1' ' D' ' 8' ' ' ALA . 13.5 m -62.0 -15.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.212 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.5 ' O ' ' N ' ' D' ' 90' ' ' ALA . 47.6 m -39.26 -39.84 0.68 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.066 0.46 . . . . 1.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' C' ' 92' ' ' ASP . . . -51.74 -59.98 3.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.663 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -25.56 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.128 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.484 HD22 ' N ' ' D' ' 89' ' ' LEU . 3.8 mm? -87.58 -28.45 21.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.127 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -66.35 -37.39 85.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.549 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -5.27 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.198 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -56.17 -51.38 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.276 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' D' ' 90' ' ' ALA . 24.6 p90 -75.28 -10.68 59.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.697 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.32 -32.84 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.21 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -66.38 -22.78 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 1.0 110.963 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -66.11 -19.83 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.431 . . . . 1.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.43 -23.41 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.955 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -98.33 -28.1 13.81 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.926 0.393 . . . . 1.0 110.208 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -68.33 -36.89 79.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.269 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -61.34 -35.9 78.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.261 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.42 -38.36 90.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.506 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.86 59.04 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.648 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.52 155.24 31.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.603 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.88 -40.85 98.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.542 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -67.04 -45.04 78.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.357 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.2 -42.01 96.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.381 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -65.25 -40.29 93.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.136 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -68.95 -43.34 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.184 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.09 89.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.464 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.81 -36.59 84.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.287 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.68 80.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.799 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.8 -38.37 85.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.52 -35.88 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.0 110.319 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.33 -34.65 78.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.438 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA2' ' A' ' 78' ' ' GLY . 47.2 tp -62.95 -38.54 91.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.111 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.72 -31.96 73.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -61.83 -49.63 75.5 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.241 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 18' ' ' VAL . 15.7 m -67.12 -32.64 58.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 52' ' ' ALA . 33.9 mt -61.56 -42.03 98.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.249 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.98 -45.26 86.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 1.0 110.232 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -71.2 -39.59 71.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.546 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.84 -50.22 74.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.841 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.502 ' HG ' ' CB ' ' A' ' 48' ' ' SER . 31.0 m -61.65 -44.38 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.421 . . . . 1.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.23 -33.64 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.16 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.5 -40.12 23.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.737 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.52 -46.39 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.634 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 28' ' ' GLU . 5.4 p -58.58 -45.98 90.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.902 -0.719 . . . . 1.0 109.68 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 27' ' ' VAL . 97.0 mt-10 -69.86 -41.6 74.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.942 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.29 90.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.9 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 79.8 mm-40 -78.84 -37.67 39.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.905 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' NH2' ' O ' ' A' ' 40' ' ' SER . 18.7 mmt85 -67.07 116.39 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 1.0 110.823 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.85 2.99 60.93 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.09 144.06 27.87 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.05 147.07 33.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.258 1.972 . . . . 1.0 112.425 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.13 2.01 57.71 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.15 146.91 52.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.716 0.293 . . . . 1.0 110.517 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.73 -13.9 5.22 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -86.89 35.06 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.998 0.427 . . . . 1.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.74 73.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.344 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 43' ' ' ASP . 53.4 p -160.64 -126.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.782 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 11.4 t80 179.26 -56.28 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.547 -0.263 . . . . 1.0 111.317 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.17 -23.41 73.7 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.7 1.6 . . . . 1.0 112.638 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 24.1 p30 -97.22 -1.84 44.05 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.009 -0.277 . . . . 1.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.13 -20.29 48.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.836 0.35 . . . . 1.0 110.274 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 46' ' ' TRP . 12.4 tt -68.81 -46.01 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.521 ' N ' HG23 ' A' ' 45' ' ' ILE . 29.0 m95 -74.93 -31.9 61.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.867 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.418 ' CZ3' ' HB2' ' A' ' 26' ' ' ALA . 25.3 t90 -54.32 -41.31 68.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.502 ' CB ' ' HG ' ' A' ' 23' ' ' SER . 61.1 m -64.22 -24.36 67.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.322 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.51 -26.27 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.951 0.405 . . . . 1.0 110.839 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -78.13 3.59 14.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.408 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -127.18 -33.54 2.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.2 -25.61 61.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.936 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.585 ' OG1' HG13 ' A' ' 55' ' ' VAL . 67.6 p -96.92 7.51 46.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.967 0.413 . . . . 1.0 109.904 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 p 59.62 10.37 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.949 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG13 ' OG1' ' A' ' 53' ' ' THR . 29.1 m -66.07 -42.21 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.333 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 55' ' ' VAL . . . 47.94 64.15 3.15 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' B' ' 50' ' ' GLU . 1.1 t80 -62.89 -21.86 66.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.328 . . . . 1.0 110.246 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.77 33.7 12.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.533 ' OD1' ' NH2' ' B' ' 68' ' ' ARG . 8.2 m-20 -62.68 -37.25 85.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 37.7 mmt180 -125.38 -161.42 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.247 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.428 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 19.9 t80 -156.51 82.41 3.4 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.66 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.66 153.35 69.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 1.0 112.478 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.008 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -108.1 -154.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 1.008 ' H ' HG22 ' A' ' 63' ' ' VAL . 76.6 m -90.68 -43.35 10.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.618 0.247 . . . . 1.0 111.283 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.1 tt0 -52.46 -37.23 56.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.234 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.6 26.34 0.08 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.321 2.01 . . . . 1.0 109.202 178.493 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 44.15 65.39 1.66 Allowed Glycine 0 C--O 1.211 -1.312 0 CA-C-N 113.506 -1.679 . . . . 1.0 111.359 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 53.2 ttm-85 -24.36 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.465 1.133 . . . . 1.0 111.008 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.4 mttp -49.46 -20.99 0.81 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.929 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.4 t -61.59 -46.51 96.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.432 -0.907 . . . . 1.0 110.45 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.82 -23.15 45.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.605 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.33 -43.86 54.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.961 0.41 . . . . 1.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.1 -47.62 85.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.046 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 75' ' ' MET . 10.6 p -66.6 -40.14 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.713 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.454 ' N ' HG13 ' A' ' 74' ' ' VAL . 49.8 ttm -62.89 -48.03 80.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.201 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.73 -38.49 89.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.317 . . . . 1.0 110.444 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.54 73.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.64 -43.42 92.07 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.61 -43.08 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.808 0.337 . . . . 1.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.35 -41.95 97.89 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.357 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.61 -51.23 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.741 0.305 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -65.86 -39.09 90.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.999 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.12 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.961 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.68 -39.05 92.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.167 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 85' ' ' VAL . 65.8 t -47.24 -10.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.745 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 84' ' ' LEU . 71.9 m -50.96 -43.87 60.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.87 -19.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.722 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.23 -37.64 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.61 -40.48 84.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.412 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.96 -43.31 98.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 1.0 110.95 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -73.32 -4.27 32.23 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.019 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -61.29 -43.43 98.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.812 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.6 p90 -80.31 -24.36 40.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.856 0.36 . . . . 1.0 111.395 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 -27.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.078 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.19 -20.89 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 93' ' ' PHE . 35.4 mtm105 -54.26 -32.31 55.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.692 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 14.4 pt-20 -61.62 -40.83 96.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.0 109.799 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 102' ' ' GLY . 97.7 mt-10 -66.2 -41.65 89.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.644 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -66.55 -35.77 81.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.327 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -60.04 -45.07 94.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.545 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -98.21 -4.29 35.73 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.492 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 98' ' ' GLU . . . 71.36 22.05 78.58 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.066 -0.814 . . . . 1.0 111.066 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 102' ' ' GLY . 79.4 m80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.54 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.82 155.1 40.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.632 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.53 -41.01 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.465 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -73.87 -23.24 59.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.987 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.67 -33.58 75.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.699 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.9 -38.22 90.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.704 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -64.9 -42.0 95.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 1.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.6 -37.01 85.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.46 -42.08 77.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.326 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -63.24 -37.67 88.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.601 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.45 -42.15 63.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -41.09 92.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.606 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.72 -37.26 84.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.258 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.28 -34.89 78.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.433 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 HG21 ' B' ' 81' ' ' VAL . 46.1 tp -62.25 -41.82 98.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.93 -32.96 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.643 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.27 -42.72 99.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.617 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.96 -37.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.528 HD22 ' O ' ' B' ' 48' ' ' SER . 98.3 mt -60.31 -40.32 90.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 1.0 110.022 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.89 -38.68 76.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 1.0 109.932 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -66.66 -37.7 85.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 93.8 p -57.19 -41.3 79.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.616 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 63.3 tttm -70.32 -76.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.563 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' B' ' 29' ' ' ALA . 99.2 mttt -40.74 -35.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.204 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.25 -60.56 2.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.717 -0.219 . . . . 1.0 111.553 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.1 p -60.93 -42.05 91.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.04 0.448 . . . . 1.0 110.103 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' B' ' 24' ' ' LYS . 96.3 mt-10 -72.07 -13.25 61.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.533 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -61.0 -47.97 83.98 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.177 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 0.6 OUTLIER -81.23 -98.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 1.0 110.569 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 46.45 50.72 12.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.686 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.77 27.58 0.94 Allowed Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.359 -0.696 . . . . 1.0 111.359 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' B' ' 66' ' ' GLU . . . -93.91 153.52 40.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.68 116.72 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.912 1.741 . . . . 1.0 112.184 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 89.96 -23.59 19.82 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 44.95 -175.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 1.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 175.41 -66.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.53 121.33 34.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' B' ' 40' ' ' SER . 37.9 pt -143.04 -160.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.715 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.423 ' O ' ' O ' ' B' ' 39' ' ' ILE . 3.2 t 56.2 114.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.12 0.486 . . . . 1.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 2.3 t80 -63.54 -53.85 48.24 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.699 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 21.9 Cg_endo -57.72 -27.68 78.69 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.747 1.632 . . . . 1.0 112.566 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.37 -16.62 22.21 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 1.0 110.823 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.6 87.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.901 0.382 . . . . 1.0 110.318 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -61.7 -37.04 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.648 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.2 OUTLIER -64.16 -43.79 94.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.477 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.77 -21.35 64.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.528 ' O ' HD22 ' B' ' 19' ' ' LEU . 1.3 t -78.28 -32.63 49.56 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.421 . . . . 1.0 110.55 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.25 -45.41 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' B' ' 51' ' ' THR . 19.3 pt-20 -57.77 -42.38 83.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.724 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 3.4 t -73.47 -170.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.041 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 74.19 -24.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.538 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.503 ' H ' ' C ' ' B' ' 51' ' ' THR . 31.2 p -103.45 8.18 37.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.8 p 53.55 65.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.687 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.568 HG13 ' N ' ' B' ' 56' ' ' GLY . 4.7 p -138.34 -52.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.665 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.568 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 41.55 82.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -59.97 -43.83 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.284 . . . . 1.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.19 8.74 2.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -52.03 -67.63 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.763 0.315 . . . . 1.0 110.573 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -141.81 150.11 41.25 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 61' ' ' TYR . 7.6 p90 -141.22 128.49 11.85 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.49 148.58 73.29 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.637 1.558 . . . . 1.0 112.3 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.11 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.413 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 66' ' ' GLU . 89.4 m -113.98 -65.4 1.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.835 0.35 . . . . 1.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' B' ' 67' ' ' GLY . 85.0 tt0 -40.53 -21.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.589 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.564 ' OE2' ' N ' ' B' ' 66' ' ' GLU . 1.5 pm0 -80.24 30.27 0.28 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 123.741 1.734 . . . . 1.0 109.142 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.04 65.37 1.08 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.075 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.533 ' NH2' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -23.69 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.705 0.753 . . . . 1.0 110.788 -178.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 97.4 mttt -46.03 -21.21 0.12 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' B' ' 67' ' ' GLY . 77.4 t -63.07 -45.8 97.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.003 -0.679 . . . . 1.0 110.054 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.25 -50.36 19.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.842 0.353 . . . . 1.0 110.818 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -53.06 -46.64 68.63 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.312 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -57.63 -46.43 84.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.759 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 70' ' ' VAL . 87.1 t -65.47 -47.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.527 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.3 mtm -65.11 -43.03 93.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.673 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -66.59 -35.04 79.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.565 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.1 74.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.389 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.3 -37.1 94.05 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.577 HG22 ' O ' ' B' ' 79' ' ' ILE . 96.0 mt -70.68 -3.42 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.487 -0.42 . . . . 1.0 111.319 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.96 -54.41 3.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 1.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.431 HG21 HD13 ' B' ' 15' ' ' LEU . 0.1 OUTLIER -61.09 -51.35 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.169 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -65.38 -37.3 86.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.683 0.277 . . . . 1.0 110.725 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -62.59 -37.49 86.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.433 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.73 -40.3 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.191 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.524 HG13 ' HB1' ' B' ' 8' ' ' ALA . 47.9 t -57.34 -17.44 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 55.1 m -42.98 -37.87 2.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.1 0.476 . . . . 1.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.619 ' O ' HG22 ' B' ' 91' ' ' THR . . . -49.77 -63.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.4 32.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.27 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.505 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.1 mm? -68.94 -34.5 75.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -66.66 -66.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 110.016 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.2 OUTLIER -51.89 -7.9 0.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.614 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' B' ' 90' ' ' ALA . 41.7 t0 -57.01 -49.27 76.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.657 0.265 . . . . 1.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 11.9 p90 -73.39 -30.86 63.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.058 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.97 -32.86 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.674 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.417 ' O ' ' OE1' ' B' ' 99' ' ' GLU . 79.8 mtp85 -57.81 -22.38 47.18 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.305 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -53.33 -25.48 15.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 1.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.7 -35.53 80.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.933 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.08 -43.28 98.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 1.0 110.746 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' B' ' 95' ' ' ARG . 57.6 mp0 -69.66 -34.71 74.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.721 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -60.45 -44.28 96.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.556 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -95.97 -9.25 31.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.329 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.46 15.51 80.36 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.518 -179.923 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' SER . . . . . 0.443 ' O ' ' O ' ' C' ' 2' ' ' ALA . 9.1 m . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.625 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . 56.25 117.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' C' ' 3' ' ' ASP . 32.2 p-10 -90.97 -4.77 56.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.385 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.625 ' CE1' ' HB1' ' C' ' 2' ' ' ALA . 10.0 p-80 -88.09 -26.64 22.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.796 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.28 -39.97 89.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.5 -38.17 90.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.385 . . . . 1.0 110.276 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -65.29 -39.9 93.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.273 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.59 -39.95 94.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.602 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -62.72 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.178 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.05 -33.94 77.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.84 80.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.198 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.36 -36.79 81.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.42 -32.25 73.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.43 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.628 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.18 -42.24 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.586 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.48 -38.64 88.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.352 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -41.08 99.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 1.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.3 -38.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.794 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' C' ' 52' ' ' ALA . 97.1 mt -59.16 -40.65 86.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.066 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -56.06 -47.98 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.6 -34.56 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.317 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -40.76 97.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.759 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -59.94 -40.71 89.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.551 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -64.74 -33.7 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.487 . . . . 1.0 109.772 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.31 -41.17 34.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.09 87.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.479 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.572 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -59.66 -48.74 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 1.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.572 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.6 tt0 -68.96 -36.29 77.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.122 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.86 65.14 6.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.032 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 3.3 mm-40 163.04 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.437 0.461 . . . . 1.0 110.706 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 30' ' ' GLU . 14.5 tpt180 -108.49 67.77 0.67 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.6 0.238 . . . . 1.0 110.502 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.23 31.02 0.7 Allowed Glycine 0 N--CA 1.471 0.971 0 N-CA-C 111.928 -0.469 . . . . 1.0 111.928 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.742 ' HB2' ' OE2' ' C' ' 66' ' ' GLU . . . -103.71 161.07 24.1 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' C' ' 33' ' ' ALA . 72.2 Cg_endo -76.64 116.25 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.882 1.722 . . . . 1.0 111.47 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.66 83.54 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -56.04 149.41 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -21.14 2.25 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.478 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.0 OUTLIER -87.88 40.0 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.746 0.307 . . . . 1.0 110.242 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.27 80.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 1.0 110.587 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.7 m -156.36 -136.57 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.443 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.432 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 11.2 t80 179.75 -57.56 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.403 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.39 -34.79 97.5 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 121.736 1.624 . . . . 1.0 112.554 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 23.3 p-10 -94.24 6.42 48.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.293 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.69 90.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.81 -32.65 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.64 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.685 ' CZ2' HG23 ' D' ' 64' ' ' THR . 1.2 t-105 -60.05 -48.42 81.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.413 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.466 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.2 OUTLIER -67.31 -27.28 67.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 178.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 2.6 t -64.9 -34.74 79.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.941 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.53 -47.62 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 1.0 111.407 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.53 -28.82 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 1.0 111.07 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 86.5 m -61.9 -44.83 96.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 1.0 111.326 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.78 -35.36 70.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 1.0 110.573 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 71.4 p -73.52 -7.96 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 1.0 110.216 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.2 p 61.62 7.04 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' C' ' 57' ' ' TYR . 8.1 p -65.32 -40.68 89.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.538 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.458 ' N ' HG13 ' C' ' 55' ' ' VAL . . . 46.32 79.83 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.519 ' CE2' HG11 ' C' ' 55' ' ' VAL . 79.1 m-85 -61.67 -42.52 99.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 1.0 110.942 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.67 3.34 6.02 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -57.98 -64.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.837 0.351 . . . . 1.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 0.4 OUTLIER -135.09 147.72 49.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.154 179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' C' ' 61' ' ' TYR . 8.8 p90 -151.06 149.72 25.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.502 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.09 -175.75 1.34 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.198 1.932 . . . . 1.0 111.672 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.51 ' H ' ' HB2' ' C' ' 66' ' ' GLU . 1.1 t -135.64 -148.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.94 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.48 ' H ' HG12 ' C' ' 63' ' ' VAL . 6.2 p -88.09 -43.21 11.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -73.78 -14.02 61.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.11 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.742 ' OE2' ' HB2' ' C' ' 33' ' ' ALA . 13.8 mm-40 -99.34 32.16 2.85 Favored 'General case' 0 C--O 1.261 1.674 0 CA-C-O 123.964 1.84 . . . . 1.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 36.4 62.6 0.75 Allowed Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.114 -1.857 . . . . 1.0 111.168 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' C' ' 67' ' ' GLY . 52.7 ttm-85 -24.71 -29.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.859 0.83 . . . . 1.0 111.503 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' C' ' 67' ' ' GLY . 63.3 mttp -56.8 -11.04 1.21 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.2 t -60.67 -47.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.103 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.13 72.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.911 0.386 . . . . 1.0 110.72 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -54.04 -47.97 71.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.077 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.42 -41.49 93.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.474 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.82 -44.34 96.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.837 -0.345 . . . . 1.0 111.2 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.8 mtm -61.39 -41.05 96.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.937 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -61.61 -37.98 85.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.464 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.64 -38.25 84.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.34 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.2 -54.15 22.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.813 -0.708 . . . . 1.0 111.838 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.06 -42.73 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 1.0 110.661 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -59.47 -45.84 90.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.941 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 77' ' ' ALA . 54.6 t -65.04 -49.64 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.972 -0.291 . . . . 1.0 111.205 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -67.17 -37.35 83.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.898 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ALA . . . . . 0.505 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -62.58 -35.33 79.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.522 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.426 ' C ' ' N ' ' C' ' 86' ' ' THR . 5.0 tt -61.96 -42.73 99.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.31 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' C' ' 8' ' ' ALA . 66.8 t -48.85 -16.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.571 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.426 ' N ' ' C ' ' C' ' 84' ' ' LEU . 63.3 m -47.74 -34.67 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.65 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.437 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -52.95 -22.04 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.96 -10.93 27.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.568 HD12 ' O ' ' D' ' 83' ' ' ALA . 3.5 mm? -86.62 -59.74 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.728 0.299 . . . . 1.0 111.049 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -44.61 -49.97 9.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.91 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -45.56 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.168 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' C' ' 90' ' ' ALA . 97.8 m-20 -60.84 -47.91 84.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.431 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 0.1 OUTLIER -58.93 -44.28 91.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 59.0 t -44.62 -39.57 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.412 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.22 -22.51 52.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.176 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -55.24 -43.92 75.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.306 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.5 mt-10 -80.31 -178.0 6.41 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.358 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 59.66 -69.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.555 0.535 . . . . 1.0 110.837 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.5 mt-10 -55.87 -46.01 78.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.672 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -64.08 -44.13 93.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.28 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -115.99 110.22 18.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.654 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -11.78 23.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.501 ' O ' ' CG ' ' C' ' 103' ' ' HIS . 56.8 t-80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.686 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -81.61 172.21 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.537 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.91 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -68.49 -36.12 78.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.701 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.53 -40.72 96.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.793 0.33 . . . . 1.0 110.794 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -64.1 -42.66 96.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.544 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.26 -39.56 68.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 1.0 110.148 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.45 86.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.753 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.61 -23.26 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.719 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.13 -41.35 98.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.62 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 11' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' D' ' 84' ' ' LEU . . . -60.69 -37.21 80.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.923 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -58.86 -39.09 80.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 1.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.29 -33.29 75.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.01 -35.66 81.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' D' ' 52' ' ' ALA . 49.7 tp -62.61 -42.02 99.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 1.0 110.869 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -61.1 -41.19 96.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.996 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.08 -41.43 99.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 1.0 110.979 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.48 -43.38 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.828 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 52' ' ' ALA . 84.2 mt -61.28 -42.09 98.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.94 -50.99 68.65 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.58 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.8 -39.52 87.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.351 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.3 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 33.2 m -57.77 -44.92 86.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.75 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.49 -48.92 79.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 29' ' ' ALA . 5.5 mptp? -61.7 -37.86 85.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.311 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.69 59.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.324 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 m -93.74 -45.49 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.776 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.57 -40.43 96.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.709 0.29 . . . . 1.0 111.077 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 25' ' ' LYS . . . -54.41 -33.2 58.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.108 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -82.69 -113.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.05 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 44.32 75.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.634 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.46 -7.48 10.46 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -63.86 147.51 96.03 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.81 117.18 4.84 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.965 1.777 . . . . 1.0 112.044 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 84.57 -16.19 36.94 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' D' ' 37' ' ' ALA . . . 42.26 -168.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.0 110.892 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' D' ' 61' ' ' TYR . . . 175.58 -12.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.44 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.439 HD11 ' CG ' ' D' ' 47' ' ' TRP . 1.5 tt -151.8 43.67 0.73 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.897 0.38 . . . . 1.0 110.4 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -88.64 114.4 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' D' ' 41' ' ' TYR . 13.8 t 177.65 -122.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.549 ' N ' ' OG ' ' D' ' 40' ' ' SER . 2.2 m-85 -176.41 -66.2 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.543 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 22.8 Cg_endo -59.87 -29.92 90.62 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.011 1.807 . . . . 1.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -79.89 -5.57 55.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.961 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.64 84.8 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.37 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 46' ' ' TRP . 6.2 tt -73.22 -39.28 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.462 ' CE2' HG23 ' A' ' 64' ' ' THR . 2.7 t-105 -61.12 -48.22 82.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.227 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.439 ' CG ' HD11 ' D' ' 38' ' ' LEU . 18.9 t90 -62.41 -41.47 98.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -71.55 70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.11 0.481 . . . . 1.0 110.131 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.04 -64.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.468 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.437 ' OE2' ' OD2' ' D' ' 59' ' ' ASP . 22.6 pt-20 -66.02 -26.76 67.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.414 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.408 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.992 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.29 -26.57 65.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' D' ' 54' ' ' THR . 26.1 p -88.09 3.08 50.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 1.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' D' ' 53' ' ' THR . 19.4 p 53.88 73.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.084 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.0 t -151.12 -50.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.694 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 73.72 -48.42 1.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 11.7 t80 67.86 -14.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.581 0.229 . . . . 1.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 99.63 18.71 22.42 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 84.4 m-20 -62.46 -66.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.641 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.34 161.95 27.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.668 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 3.0 p90 -140.42 105.83 6.54 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.445 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' PRO . . . . . 0.529 ' O ' ' NH2' ' D' ' 68' ' ' ARG . 71.4 Cg_endo -70.72 164.09 36.72 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.575 1.517 . . . . 1.0 112.633 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' D' ' 64' ' ' THR . 11.0 p -112.08 -176.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.449 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' D' ' 63' ' ' VAL . 18.7 m -68.77 -44.06 74.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' D' ' 67' ' ' GLY . 58.7 tt0 -51.39 -46.93 62.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.021 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 14.3 pt-20 -79.82 36.66 0.34 Allowed 'General case' 0 C--O 1.264 1.842 0 CA-C-O 123.654 1.692 . . . . 1.0 109.0 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.39 61.75 1.2 Allowed Glycine 0 C--O 1.215 -1.038 0 CA-C-N 113.179 -1.828 . . . . 1.0 109.495 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' D' ' 62' ' ' PRO . 57.8 ttm-85 -25.52 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.298 0.646 . . . . 1.0 110.878 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.5 mmtt -56.38 -9.91 0.8 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.43 -0.805 . . . . 1.0 109.071 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 38.0 t -59.31 -47.77 89.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.391 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.43 79.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.064 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -60.59 -39.28 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.965 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.35 -41.05 96.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.437 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.74 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.02 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 74.7 mtm -63.16 -40.02 96.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.07 -45.97 91.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.465 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.513 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -66.35 -37.82 86.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 110.296 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.27 92.7 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.788 -0.525 . . . . 1.0 111.788 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.09 -43.59 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.584 0.23 . . . . 1.0 111.044 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.86 -40.11 94.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.75 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 77' ' ' ALA . 54.8 t -64.82 -49.58 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.774 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -61.77 -44.46 96.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.01 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.568 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -65.04 -35.14 80.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.053 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.709 ' C ' HD13 ' D' ' 84' ' ' LEU . 1.6 tm? -61.74 -53.33 57.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.338 -0.545 . . . . 1.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.541 ' N ' HD13 ' D' ' 84' ' ' LEU . 75.4 t -44.74 -15.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.574 ' O ' ' N ' ' D' ' 90' ' ' ALA . 94.4 m -51.8 -42.35 62.39 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.163 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -37.98 -65.1 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.608 0.242 . . . . 1.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.84 21.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' D' ' 86' ' ' THR . 41.4 mt -92.48 -21.87 19.91 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.451 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -72.77 -36.96 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.404 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -2.85 25.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.881 -0.599 . . . . 1.0 109.896 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.03 -48.0 79.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.953 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 19.4 p90 -72.94 -8.63 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.795 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.33 -36.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -67.27 -21.64 65.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.157 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -55.28 -32.33 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 1.0 110.346 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -61.36 147.13 45.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.465 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 48.04 23.76 0.54 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.812 0.339 . . . . 1.0 110.387 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -138.48 -35.44 0.6 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.951 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -69.38 -23.58 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.479 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.93 -36.6 84.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.464 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.39 16.05 57.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.52 179.798 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . -63.62 -38.8 92.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.562 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t0 64.45 -65.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.524 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 2' ' ' ALA . 34.6 p80 -57.65 -41.28 81.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.773 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 81.6 tt0 -62.93 -40.05 96.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.88 0.372 . . . . 1.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.36 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -65.53 -38.07 88.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.143 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.71 97.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.233 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.77 -40.45 88.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.354 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -62.9 -38.69 91.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.449 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.961 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.24 -38.37 88.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.729 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.69 -38.03 89.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.502 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -65.37 -32.73 74.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.542 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.18 -41.8 98.67 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.552 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.21 -38.91 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.185 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -62.55 -39.84 94.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.686 -0.405 . . . . 1.0 111.404 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.44 -33.13 59.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 1.0 110.539 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.9 mt -61.77 -40.94 96.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.08 -48.02 81.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 1.0 109.885 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.12 -32.65 73.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.119 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.84 96.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.654 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -60.74 -42.09 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -64.91 -50.51 66.22 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.203 0.525 . . . . 1.0 110.232 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.02 -42.74 99.49 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.256 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.12 49.44 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.564 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -60.99 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.192 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 70.2 mm-40 -68.28 -44.7 74.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.009 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.29 -39.32 82.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 1.0 110.203 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.438 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 52.3 mm-40 -69.51 -37.25 77.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.37 130.28 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 1.0 110.504 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.56 4.55 76.34 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.16 141.54 22.8 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 122.774 -0.251 . . . . 1.0 110.376 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.3 136.05 19.32 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.94 1.76 . . . . 1.0 112.143 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.75 30.84 70.0 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -63.05 -35.52 80.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.737 0.303 . . . . 1.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . 71.77 -39.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.334 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.8 tt -94.29 121.57 35.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.995 0.426 . . . . 1.0 109.886 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 38' ' ' LEU . 20.4 pt -155.17 60.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 m -155.36 138.22 15.34 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.385 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 27' ' ' VAL . 21.9 m-85 -76.34 -59.18 1.1 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.66 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.99 -28.83 87.93 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.807 1.671 . . . . 1.0 112.409 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -88.2 -21.26 24.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.937 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.38 81.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.6 tt -66.28 -37.46 79.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.301 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -46.01 87.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.478 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -64.42 -40.39 95.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.4 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 84.0 p -61.53 -32.75 72.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.031 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 45' ' ' ILE . 48.5 t -61.34 -49.83 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.857 0.361 . . . . 1.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH2' ' B' ' 68' ' ' ARG . 12.1 pt-20 -71.37 -25.52 62.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -63.62 -47.89 79.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.272 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.82 -36.54 77.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.465 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.3 p -75.11 -1.97 25.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.4 p 52.44 36.09 19.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.233 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.93 -49.91 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.042 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.19 84.73 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CZ ' ' O ' ' B' ' 60' ' ' ARG . 1.3 t80 -60.77 -46.28 91.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.534 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.36 7.1 0.59 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.5 m-20 -60.73 -47.61 85.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.803 0.335 . . . . 1.0 110.611 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' O ' ' CE1' ' D' ' 57' ' ' TYR . 26.5 mtm-85 -140.85 154.34 46.15 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.219 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.28 136.3 10.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.475 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.71 -175.15 1.28 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.794 1.662 . . . . 1.0 112.217 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 29.2 m -132.56 -131.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.342 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.669 HG22 ' CD1' ' D' ' 46' ' ' TRP . 7.4 p -113.87 -44.67 3.15 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.588 0.233 . . . . 1.0 111.194 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.7 tp10 -61.63 -40.44 94.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.254 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' OE1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -72.93 32.17 0.07 Allowed 'General case' 0 C--O 1.264 1.858 0 CA-C-O 123.703 1.716 . . . . 1.0 109.997 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.15 64.45 0.94 Allowed Glycine 0 C--O 1.212 -1.247 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.671 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' C ' ' O ' ' A' ' 67' ' ' GLY . 58.8 ttm-85 -23.59 -34.53 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.328 1.064 . . . . 1.0 111.264 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 44.9 mmtm -51.09 -15.81 0.38 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.624 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 67' ' ' GLY . 50.2 t -61.54 -47.55 92.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 119.617 -0.833 . . . . 1.0 110.225 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.23 62.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.691 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -50.66 -47.18 58.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.541 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.24 -41.55 94.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.229 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.71 -46.99 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.075 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.18 -40.85 98.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.764 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.21 -37.98 89.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.53 -38.09 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.37 -41.91 83.99 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 -43.47 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.659 0.266 . . . . 1.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.49 -40.41 91.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.013 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 75.5 t -65.69 -49.1 79.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.851 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -65.76 -40.48 92.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.13 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.35 84.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.006 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 86' ' ' THR . 8.0 tt -62.07 -42.04 98.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.212 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 85' ' ' VAL . 92.8 t -49.11 -13.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.308 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.47 ' N ' ' C ' ' A' ' 84' ' ' LEU . 58.0 m -51.79 -39.41 58.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.985 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -50.38 -24.94 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.03 -11.74 24.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.66 -50.01 6.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.339 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.67 -34.62 52.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 1.0 110.834 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -69.87 -12.87 61.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.401 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.91 -50.12 75.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.151 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 9.9 p90 -74.94 -23.13 58.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.314 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.48 -43.87 95.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.937 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' GLU . 99.7 mtt180 -60.04 -22.57 62.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.652 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -42.68 -39.48 2.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.62 -41.94 98.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 1.0 109.889 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 95' ' ' ARG . 97.3 mt-10 -70.59 -38.18 74.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.566 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.66 -30.04 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.506 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -59.28 -44.12 92.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.341 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -65.54 -37.78 87.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.503 ' O ' ' ND1' ' A' ' 103' ' ' HIS . . . 78.05 25.88 61.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 102' ' ' GLY . 78.7 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.617 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.526 ' O ' ' ND1' ' B' ' 4' ' ' HIS . . . -156.97 32.73 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.7 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t0 66.28 -65.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 2' ' ' ALA . 14.1 p-80 -73.41 -19.34 61.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.766 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -68.74 -36.1 77.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.511 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.72 -37.87 88.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 1.0 110.65 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.96 -40.4 80.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.579 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.5 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 1.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.08 -40.08 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.556 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.93 81.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.886 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.5 -38.76 87.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.655 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.98 -38.09 89.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.28 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.94 -31.84 73.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' B' ' 52' ' ' ALA . 41.5 tp -63.05 -37.57 87.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.406 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -68.1 -36.19 79.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.11 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.46 -47.58 83.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.797 0.332 . . . . 1.0 111.547 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.48 -34.39 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.972 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.8 mt -60.54 -39.44 87.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.39 -43.83 89.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.99 -32.93 73.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.053 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.47 80.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.902 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -44.86 95.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.592 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -62.74 -51.86 65.51 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.231 -0.588 . . . . 1.0 109.917 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.4 -42.78 98.78 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.417 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.19 70.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.524 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.9 OUTLIER -64.78 -42.01 93.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.469 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 82.5 tt0 -70.26 -43.74 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.242 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.14 86.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.15 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' B' ' 38' ' ' LEU . 33.0 mm-40 -66.0 -35.12 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 1.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.76 128.67 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.624 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.09 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.44 147.94 33.82 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.819 -0.224 . . . . 1.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' B' ' 36' ' ' ALA . 96.1 Cg_endo -75.47 142.53 26.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.18 1.92 . . . . 1.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.73 -23.29 0.4 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' B' ' 34' ' ' PRO . . . 45.3 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 1.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -178.19 -31.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.329 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.43 ' N ' ' OE1' ' B' ' 30' ' ' GLU . 14.8 tp -137.2 102.75 4.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.288 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' CB ' ' B' ' 40' ' ' SER . 4.2 pt -132.14 104.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.78 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 0.3 OUTLIER 164.89 143.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.545 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.5 m-85 -81.42 -61.66 0.37 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.983 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.0 Cg_endo -58.39 -27.05 80.17 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.187 1.925 . . . . 1.0 112.464 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -93.21 -22.12 19.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.056 -0.257 . . . . 1.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.52 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.51 -38.47 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.875 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' C' ' 68' ' ' ARG . 3.4 t-105 -60.95 -46.95 88.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.564 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.41 ' CD2' ' C ' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -66.58 -26.05 66.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.88 -36.09 75.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.017 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.08 -47.08 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.804 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -66.87 -30.77 71.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.61 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -63.7 -46.46 85.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.452 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.62 -28.77 65.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.11 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -90.01 4.23 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 1.0 110.543 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 p 46.82 66.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.971 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.409 HG21 ' SD ' ' C' ' 75' ' ' MET . 0.8 OUTLIER -148.96 11.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.317 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -39.01 105.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.26 -102.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.638 0.256 . . . . 1.0 110.591 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.23 11.13 3.56 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.19 -66.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 1.0 110.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 44.4 mtt-85 -145.73 157.25 43.96 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -150.98 140.41 13.75 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.3 170.84 15.1 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.021 1.814 . . . . 1.0 112.064 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.472 ' C ' ' OE1' ' B' ' 66' ' ' GLU . 2.7 t -100.83 -130.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.926 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' B' ' 66' ' ' GLU . 87.5 m -115.25 -42.02 3.23 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.424 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.694 ' C ' ' H ' ' B' ' 67' ' ' GLY . 45.4 tp10 -64.95 -37.68 88.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.755 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -67.14 28.44 0.02 OUTLIER 'General case' 0 C--O 1.265 1.885 0 CA-C-O 123.558 1.647 . . . . 1.0 110.06 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.53 63.5 1.17 Allowed Glycine 0 C--O 1.213 -1.162 0 CA-C-N 113.704 -1.589 . . . . 1.0 111.407 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.525 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.2 ttt85 -24.49 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.331 1.066 . . . . 1.0 111.018 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' B' ' 67' ' ' GLY . 32.1 mmtp -49.61 -18.09 0.4 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.456 -0.793 . . . . 1.0 108.885 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.48 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.699 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.27 -39.71 74.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.19 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -53.09 -44.17 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 109.999 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.77 -43.02 85.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.455 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.96 -44.39 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.047 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtt -60.31 -43.32 96.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.552 -0.294 . . . . 1.0 110.432 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.49 -38.94 93.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.323 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.93 87.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.01 62.2 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 79' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 79' ' ' ILE . 93.7 mt -68.3 -3.72 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.181 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -95.0 -52.36 4.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.05 0.452 . . . . 1.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 82' ' ' PHE . 12.7 m -60.91 -48.72 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.275 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.484 ' N ' HG23 ' B' ' 81' ' ' VAL . 44.4 m-85 -66.18 -38.83 89.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.956 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.04 83.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.561 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.0 tt -61.9 -40.69 96.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.107 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 89' ' ' LEU . 98.8 t -47.52 -19.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' B' ' 90' ' ' ALA . 81.6 m -51.41 -19.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.06 -64.71 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.433 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.93 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 1.0 110.723 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.549 HD23 HG12 ' B' ' 85' ' ' VAL . 3.6 mm? -98.17 -6.66 30.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.101 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 86' ' ' THR . . . -87.54 -27.17 22.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -3.85 45.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.271 -0.877 . . . . 1.0 109.881 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.543 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 35.9 t0 -54.48 -47.58 72.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.011 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' B' ' 90' ' ' ALA . 21.9 p90 -75.32 -30.0 60.19 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.275 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.47 -43.88 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.542 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 ttm-85 -46.29 -21.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.971 -0.292 . . . . 1.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 42.7 ptt85 -59.97 -41.41 91.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.405 . . . . 1.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 98.0 mt-10 -62.0 -39.26 91.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.159 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' B' ' 101' ' ' ARG . 80.1 mm-40 -65.99 -39.09 90.01 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.651 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' B' ' 103' ' ' HIS . 97.7 mt-10 -65.83 -47.7 74.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.681 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.56 -42.67 86.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.425 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' B' ' 98' ' ' GLU . 24.6 mmt85 -102.3 114.88 29.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 -14.07 56.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.871 -0.891 . . . . 1.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' B' ' 99' ' ' GLU . 47.7 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.093 -0.956 . . . . 1.0 110.658 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.06 92.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.855 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.7 -40.19 96.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.374 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.475 ' CD2' ' HG2' ' C' ' 5' ' ' GLU . 5.0 p-80 -57.13 -41.67 79.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.622 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.475 ' HG2' ' CD2' ' C' ' 4' ' ' HIS . 67.3 mm-40 -64.87 -42.84 94.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.912 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -64.73 -41.92 95.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.76 -38.26 86.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.181 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.86 98.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -64.93 -42.36 94.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.328 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.38 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.362 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.4 -34.43 72.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.223 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.77 -38.41 90.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.714 0.292 . . . . 1.0 110.889 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -63.89 -34.36 77.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 1.0 110.347 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.66 -35.39 80.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.672 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' C' ' 78' ' ' GLY . 45.4 tp -62.29 -41.56 98.61 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.461 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -39.54 92.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.23 -40.77 97.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 1.0 111.283 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.22 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.662 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' C' ' 52' ' ' ALA . 84.7 mt -60.37 -40.66 91.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.415 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.8 -48.75 66.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.33 -32.94 73.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.152 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.68 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.78 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -58.59 -43.54 89.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.521 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -62.35 -51.08 69.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 109.568 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.05 -41.99 97.65 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.347 -0.541 . . . . 1.0 109.987 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.66 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.084 -0.247 . . . . 1.0 111.324 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 1.2 p -65.16 -41.29 91.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.538 -0.465 . . . . 1.0 109.954 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 44.3 tp10 -66.92 -44.21 81.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.611 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.38 -38.45 87.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.418 ' OE1' ' HB1' ' C' ' 36' ' ' ALA . 64.2 mm-40 -71.11 -34.2 70.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.149 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -67.79 121.8 16.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.855 0.36 . . . . 1.0 110.624 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.87 61.19 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.272 -0.731 . . . . 1.0 111.272 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.48 24.76 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 110.466 -0.198 . . . . 1.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.13 144.77 27.03 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.015 1.81 . . . . 1.0 112.359 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.73 11.82 58.19 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' OE1' ' C' ' 30' ' ' GLU . . . -60.19 92.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.323 . . . . 1.0 110.57 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.2 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.297 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.43 118.22 26.73 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.157 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' C' ' 40' ' ' SER . 40.2 pt -145.13 164.15 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.251 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.7 OUTLIER 82.13 142.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.789 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 89.8 t80 -80.36 -38.87 1.14 Allowed Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.112 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.8 Cg_endo -60.03 -32.73 95.29 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.403 1.402 . . . . 1.0 112.378 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' C' ' 39' ' ' ILE . 9.1 p-10 -95.09 -9.91 32.27 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 121.015 -0.274 . . . . 1.0 111.1 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -38.37 81.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 1.0 110.794 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 tt -64.67 -37.26 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.1 OUTLIER -60.93 -47.52 86.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.604 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.453 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.8 OUTLIER -71.69 -18.19 62.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.384 178.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.645 ' O ' HD22 ' C' ' 19' ' ' LEU . 7.5 t -81.01 48.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.009 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.544 HG11 HH12 ' D' ' 68' ' ' ARG . 92.0 t -147.21 -41.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.838 -0.345 . . . . 1.0 111.336 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.48 -34.55 78.17 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.853 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -44.7 83.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.181 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.795 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.46 -35.53 76.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.691 0.281 . . . . 1.0 110.571 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 43.3 p -88.46 3.46 50.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 110.106 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.2 p 51.66 75.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.37 -66.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.282 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 81.58 -59.1 4.86 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.445 -1.062 . . . . 1.0 110.445 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 68.74 -38.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.284 . . . . 1.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 124.53 19.6 2.53 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.09 -49.0 79.37 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.37 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -147.06 -165.57 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 42.6 p90 -170.41 113.75 0.46 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.19 -171.46 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.488 1.459 . . . . 1.0 112.104 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' C' ' 64' ' ' THR . 13.3 p -129.48 -176.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' C' ' 63' ' ' VAL . 71.3 m -79.83 -25.23 40.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.777 0.322 . . . . 1.0 110.476 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' C' ' 67' ' ' GLY . 43.1 tp10 -66.54 -43.63 84.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.399 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -77.0 31.47 0.14 Allowed 'General case' 0 C--O 1.268 2.035 0 CA-C-O 124.212 1.958 . . . . 1.0 109.586 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.83 64.38 1.92 Allowed Glycine 0 C--O 1.217 -0.914 0 CA-C-N 113.24 -1.8 . . . . 1.0 111.266 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' C' ' 67' ' ' GLY . 42.3 ttm180 -24.79 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.9 0.85 . . . . 1.0 111.049 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' C' ' 67' ' ' GLY . 29.9 mmtp -48.75 -22.35 0.78 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.595 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' C' ' 67' ' ' GLY . 80.0 t -61.95 -48.09 90.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 118.958 -1.097 . . . . 1.0 110.564 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.45 78.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 1.0 110.793 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.76 -44.78 96.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.015 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.58 -38.45 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.221 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.31 -43.15 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.455 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.409 ' SD ' HG21 ' B' ' 55' ' ' VAL . 60.2 mtt -60.99 -42.0 97.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.84 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 64.7 tttm -61.92 -41.22 97.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 1.0 110.555 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.15 -38.88 92.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 1.0 110.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.24 -41.98 91.3 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.968 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -61.12 -43.1 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.682 0.277 . . . . 1.0 110.717 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.7 mt-10 -60.13 -43.59 95.55 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.202 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.45 -49.22 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.361 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.79 -38.76 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.318 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.01 85.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 1.0 110.675 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.33 -40.59 97.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.93 -20.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.435 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 5.7 t -50.78 -22.1 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 1.0 110.515 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.543 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -56.14 -25.61 46.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.202 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' C' ' 4' ' ' HIS . . . -98.29 -16.41 19.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.694 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 58.7 mt -86.2 -47.1 9.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.82 -29.19 59.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.847 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -89.58 -3.65 58.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.968 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 53.3 t0 -56.27 -47.28 78.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.585 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 7.9 p90 -75.19 -37.5 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.105 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 95.9 t -46.64 -27.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.575 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' C' ' 98' ' ' GLU . 96.4 mtt180 -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.688 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -42.47 -37.25 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 1.0 111.078 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -82.06 -24.72 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.653 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' C' ' 95' ' ' ARG . 96.6 mt-10 -97.31 38.52 1.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.872 0.367 . . . . 1.0 110.5 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.35 -42.68 0.41 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.489 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 1.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -65.38 -36.71 84.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.521 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.69 15.7 51.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.083 -0.961 . . . . 1.0 110.499 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.645 ' CB ' ' CE1' ' D' ' 4' ' ' HIS . . . -83.52 170.05 14.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.619 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.68 -43.96 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.907 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.645 ' CE1' ' CB ' ' D' ' 2' ' ' ALA . 11.2 p-80 -69.11 -37.34 78.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.85 -36.6 84.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.47 -43.4 97.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.88 -37.57 86.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.897 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 9' ' ' GLN . . . . . 0.441 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 59.0 tt0 -63.42 -39.93 95.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.58 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -63.91 -36.67 84.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.62 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.24 -27.56 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.282 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.52 -39.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 1.0 110.765 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' D' ' 13' ' ' GLU . 54.3 mp0 -67.06 -34.36 77.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.591 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -62.51 -37.22 85.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.651 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.7 tp -62.72 -42.0 99.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.389 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.12 -32.5 73.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -61.91 -39.19 91.14 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.045 0.45 . . . . 1.0 110.826 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.96 -38.49 72.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.637 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.3 mt -61.95 -45.92 91.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.645 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.17 -42.26 69.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 1.0 110.344 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.07 -40.28 82.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 1.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.27 83.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -55.54 -44.27 76.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.641 -0.254 . . . . 1.0 110.568 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -65.45 -32.87 74.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.631 -0.427 . . . . 1.0 110.169 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.3 -43.87 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.886 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -60.33 -49.63 76.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.533 HG13 ' N ' ' D' ' 28' ' ' GLU . 8.7 p -60.6 -44.55 97.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 109.908 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.533 ' N ' HG13 ' D' ' 27' ' ' VAL . 9.1 tm-20 -68.06 -42.51 80.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.546 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.05 91.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.628 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 3.2 mp0 -70.74 -34.18 71.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.324 . . . . 1.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -69.23 122.9 19.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 1.0 110.663 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.28 -2.06 57.62 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.574 -0.739 . . . . 1.0 111.366 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.52 35.82 Favored Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 122.847 -0.208 . . . . 1.0 110.538 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.54 143.04 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.057 1.838 . . . . 1.0 112.357 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.57 76.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.43 143.76 57.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.762 0.315 . . . . 1.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.05 -22.77 2.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 37.6 tp -70.87 -89.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.536 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.546 HG22 ' N ' ' D' ' 40' ' ' SER . 95.5 mt 54.12 161.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.188 0.518 . . . . 1.0 110.671 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.546 ' N ' HG22 ' D' ' 39' ' ' ILE . 1.1 t 76.23 130.47 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 20.8 t80 -77.22 -43.61 2.68 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.069 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.5 Cg_endo -59.2 -29.72 91.15 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.238 1.292 . . . . 1.0 112.094 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.544 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.3 m-20 -89.96 -30.91 17.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.565 -0.289 . . . . 1.0 110.993 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.72 82.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.868 0.366 . . . . 1.0 110.774 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.407 ' O ' HG23 ' D' ' 49' ' ' VAL . 7.7 tt -63.95 -37.06 78.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.059 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.669 ' CD1' HG22 ' A' ' 64' ' ' THR . 0.2 OUTLIER -67.41 -41.48 84.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.246 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CG ' ' D' ' 50' ' ' GLU . 13.5 t90 -60.08 -37.33 79.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' D' ' 19' ' ' LEU . 85.8 p -65.65 -33.1 75.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.29 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.564 ' O ' HG12 ' D' ' 49' ' ' VAL . 62.1 t -79.72 63.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.058 0.456 . . . . 1.0 111.724 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' D' ' 47' ' ' TRP . 8.3 pt-20 178.9 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.68 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.49 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 90.4 m -65.33 -42.08 93.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.637 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -55.09 -26.23 36.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 16.8 p -83.02 0.86 42.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.235 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.6 p 57.99 10.93 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.971 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' D' ' 57' ' ' TYR . 76.7 t -91.17 -54.76 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.677 0.275 . . . . 1.0 110.739 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.08 -42.1 0.61 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' D' ' 55' ' ' VAL . 0.1 OUTLIER 56.16 -74.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.763 0.316 . . . . 1.0 110.681 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . -159.15 -91.49 0.08 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' NH1' ' D' ' 60' ' ' ARG . 29.5 t70 45.41 -119.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.729 0.3 . . . . 1.0 110.345 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.544 ' NH2' ' O ' ' D' ' 43' ' ' ASP . 0.1 OUTLIER -113.78 169.24 9.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.8 p90 -137.09 136.41 20.94 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.782 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.63 154.27 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.267 1.978 . . . . 1.0 112.195 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.519 HG23 ' H ' ' D' ' 66' ' ' GLU . 18.1 m -93.42 -145.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.874 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.439 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 5.6 m -112.87 -41.04 3.85 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.694 0.283 . . . . 1.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' D' ' 67' ' ' GLY . 52.1 tp10 -66.07 -25.76 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.103 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.519 ' H ' HG23 ' D' ' 63' ' ' VAL . 1.0 OUTLIER -74.39 30.44 0.08 Allowed 'General case' 0 C--O 1.263 1.79 0 CA-C-O 123.697 1.713 . . . . 1.0 108.975 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.42 61.35 3.27 Favored Glycine 0 C--O 1.21 -1.385 0 CA-C-N 114.011 -1.449 . . . . 1.0 109.537 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.544 HH12 HG11 ' C' ' 49' ' ' VAL . 55.6 ttp85 -24.48 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 O-C-N 124.328 0.664 . . . . 1.0 110.735 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.7 mttt -51.98 -18.32 1.33 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.413 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' D' ' 67' ' ' GLY . 54.0 t -62.75 -49.63 82.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.932 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' ALA . . . . . 0.541 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -70.9 -43.27 68.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.403 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -41.84 -43.93 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.234 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -70.67 -35.66 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.665 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.1 -52.07 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.056 -0.658 . . . . 1.0 111.677 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.541 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 0.0 OUTLIER -70.89 -40.1 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 1.0 110.71 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -43.01 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.464 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.6 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.421 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -63.67 -41.53 98.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.582 -0.607 . . . . 1.0 111.582 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.21 -43.05 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.636 0.255 . . . . 1.0 111.072 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -42.03 97.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.072 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.41 -48.33 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.364 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -71.58 -12.79 61.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.787 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -94.65 -31.84 13.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.8 0.333 . . . . 1.0 110.185 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.1 tt -64.4 -41.51 96.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.459 HG12 ' HB1' ' D' ' 8' ' ' ALA . 35.0 m -58.42 -2.88 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.5 ' H ' ' C ' ' D' ' 84' ' ' LEU . 48.1 m -60.01 -22.26 62.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.056 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -59.08 -47.89 83.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.249 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.78 85.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.836 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.42 -39.52 92.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.461 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -56.8 -45.37 82.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.976 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -10.06 59.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.641 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.9 t0 -55.82 -48.52 75.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.133 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -76.11 -30.54 58.29 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.821 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.42 -26.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.305 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp85 -57.75 -32.75 67.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.883 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 96' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' D' ' 97' ' ' GLU . 36.1 ptt85 -58.17 -39.23 78.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.411 . . . . 1.0 110.037 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' D' ' 96' ' ' ARG . 81.0 tt0 -63.49 -40.65 97.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.717 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.66 -42.61 86.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 1.0 110.255 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -67.76 -38.17 83.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.157 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -60.56 -47.24 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.435 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -69.9 -36.93 75.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.593 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.4 28.24 30.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 76.8 m80 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.041 -0.98 . . . . 1.0 110.622 179.915 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 2' ' ' ALA . 73.5 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.468 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . 56.26 154.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -106.84 -8.79 16.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.465 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.468 ' NE2' ' HB1' ' A' ' 2' ' ' ALA . 13.4 p80 -87.64 -19.74 27.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.12 -38.84 89.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.69 -38.16 90.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.233 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.1 -41.22 99.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.172 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.61 96.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 1.0 110.527 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.69 -37.16 85.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.316 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -62.46 -37.38 85.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.14 76.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.904 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.59 -38.71 92.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.597 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.2 -34.59 76.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.353 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -65.55 -34.09 77.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.392 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 52' ' ' ALA . 48.3 tp -62.92 -39.01 93.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.331 . . . . 1.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.04 -34.63 78.51 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.62 -46.77 81.16 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.6 m -63.62 -36.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.549 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.8 mt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.76 -45.81 77.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.104 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.94 -38.58 79.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.288 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.92 85.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.72 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -57.62 -44.11 85.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.087 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.3 -31.71 72.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.453 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 29' ' ' ALA . 97.2 mttt -76.57 -48.44 19.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.59 79.59 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.467 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.0 p -61.93 -44.67 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.306 -0.558 . . . . 1.0 109.669 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 27' ' ' VAL . 84.0 tt0 -69.85 -31.22 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.385 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -57.01 -38.09 72.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.261 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.24 -39.27 86.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -55.41 99.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.628 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.71 -2.45 23.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.06 142.42 24.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 O-C-N 122.753 -0.263 . . . . 1.0 110.653 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.503 ' O ' HG11 ' A' ' 63' ' ' VAL . 98.5 Cg_endo -75.07 144.19 29.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.936 1.758 . . . . 1.0 112.269 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.25 26.39 70.48 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.83 151.24 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 1.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 -53.17 0.54 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.481 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 53.93 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 39' ' ' ILE . 13.7 tt -105.64 96.81 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.225 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 71.7 m -169.34 -123.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.618 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 40' ' ' SER . 4.6 m-85 -171.66 -68.54 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.197 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 41' ' ' TYR . 28.5 Cg_endo -60.15 -32.55 94.71 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.998 1.798 . . . . 1.0 112.241 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -86.29 -20.08 28.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.102 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.87 95.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 1.0 110.353 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -67.96 -39.09 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.545 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -59.43 -44.21 92.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.902 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -59.68 -39.43 84.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -65.96 -36.96 84.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.18 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.4 -48.77 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 120.734 0.302 . . . . 1.0 110.736 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.9 -31.79 70.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.515 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 m -62.38 -45.29 93.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.313 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.46 -29.11 67.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.454 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 55' ' ' VAL . 13.9 p -90.24 11.9 19.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 1.1 p 41.42 41.9 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.276 -0.875 . . . . 1.0 111.211 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 ' SD ' ' B' ' 75' ' ' MET . 45.3 t -81.07 -51.74 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.972 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 88.07 -69.38 2.85 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.142 -0.551 . . . . 1.0 111.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.404 ' CD2' HG11 ' A' ' 55' ' ' VAL . 1.3 m-85 54.4 -83.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.932 0.396 . . . . 1.0 110.255 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . 140.48 27.84 0.21 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.27 -43.75 98.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 1.0 110.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 25.6 mmt180 -132.21 -178.72 5.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.097 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 81.7 m-85 -157.45 96.84 2.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.706 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.72 156.07 64.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.79 1.66 . . . . 1.0 112.411 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -79.69 -141.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.334 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.433 ' CA ' ' OE2' ' A' ' 66' ' ' GLU . 7.5 p -115.41 -41.76 3.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.775 0.322 . . . . 1.0 110.571 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' GLY . 15.6 tm-20 -61.6 -24.94 67.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -71.89 40.74 0.07 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 123.576 1.655 . . . . 1.0 109.167 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.765 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.82 66.71 2.3 Favored Glycine 0 C--O 1.199 -2.064 0 CA-C-N 113.708 -1.587 . . . . 1.0 111.959 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' NE ' ' CD1' ' D' ' 46' ' ' TRP . 35.7 ttm105 -24.91 -27.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.726 1.263 . . . . 1.0 112.176 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.5 mttm -76.61 -6.91 53.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.944 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.748 ' N ' ' O ' ' A' ' 67' ' ' GLY . 13.9 t -58.75 -48.53 85.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.446 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.4 -41.93 69.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.567 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.93 -36.49 79.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.582 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.79 -53.51 57.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.08 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.28 -42.19 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.7 tpp -52.23 -50.58 61.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.63 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -65.17 -41.14 94.96 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.73 -46.37 70.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.839 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -63.74 -43.43 97.78 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -43.38 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.606 0.241 . . . . 1.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.17 -43.36 99.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.47 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.38 -49.03 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.38 -8.83 57.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.979 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.64 -39.44 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.9 tt -63.21 -42.55 99.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.573 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 m -50.77 -9.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.602 -0.439 . . . . 1.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.2 m -57.98 -38.59 76.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.969 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -48.99 -33.72 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.302 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 -11.51 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' THR . 76.4 mt -91.69 -46.65 7.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.028 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.85 -24.78 53.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 1.0 110.675 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 t -86.58 -3.56 59.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.988 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.1 m-20 -62.12 -43.69 98.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.173 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 5.7 p90 -74.69 -31.59 61.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.517 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.16 -26.59 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.37 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -63.94 -21.89 66.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -60.07 -33.99 72.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 1.0 110.752 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.46 -40.86 88.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.44 -47.02 80.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.48 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.39 -34.04 72.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.444 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.04 -44.79 94.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -90.06 -13.77 35.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 1.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.35 26.6 72.69 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.045 -0.979 . . . . 1.0 110.619 -179.941 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.602 ' N ' ' N ' ' B' ' 6' ' ' ARG . 3.9 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.38 95.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.634 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -173.14 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.745 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.49 ' CE1' HH22 ' B' ' 95' ' ' ARG . 6.0 p80 -76.13 -18.69 59.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.436 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.18 -37.26 85.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.758 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ARG . . . . . 0.602 ' N ' ' N ' ' B' ' 1' ' ' SER . 61.0 ttt85 -60.99 -44.26 97.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.559 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -41.41 88.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.681 -0.408 . . . . 1.0 109.917 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -65.73 -37.34 86.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.646 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -62.85 -37.46 86.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.05 76.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.01 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.53 -39.77 85.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.0 110.693 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.434 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 6.3 tm-20 -65.37 -36.87 85.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.86 -32.81 74.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.552 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.33 -40.76 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.393 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -63.24 -37.03 85.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' LYS . . . . . 0.434 ' NZ ' ' OE1' ' B' ' 13' ' ' GLU . 29.2 mtmm -62.26 -41.75 98.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.0 111.054 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.08 -40.73 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.627 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' B' ' 52' ' ' ALA . 96.0 mt -61.4 -40.86 95.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.5 mt-10 -65.53 -44.01 88.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.03 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -72.03 -39.44 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.345 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.26 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.512 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.2 p -57.51 -45.41 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.77 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.81 -35.7 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.191 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.4 mttm -69.42 -45.91 68.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -54.24 -49.48 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.532 0.197 . . . . 1.0 111.532 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.432 HG13 ' N ' ' B' ' 28' ' ' GLU . 3.0 p -60.83 -46.22 96.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.432 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.7 tm-20 -68.46 -35.42 77.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.687 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -59.18 -46.99 86.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.481 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 30' ' ' GLU . 4.1 mp0 -68.02 -37.61 81.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 1.0 110.396 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -55.61 97.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.743 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.12 -7.9 16.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.481 -0.648 . . . . 1.0 111.481 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.29 146.93 34.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 122.852 -0.204 . . . . 1.0 110.487 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.522 ' O ' HG11 ' B' ' 63' ' ' VAL . 96.9 Cg_endo -75.6 142.6 26.29 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.057 1.838 . . . . 1.0 112.503 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.77 29.81 71.15 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.98 145.39 41.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 1.0 110.188 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.525 ' O ' ' NH1' ' B' ' 60' ' ' ARG . . . -126.87 -25.79 3.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.539 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.56 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.5 tt -103.1 119.49 38.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 110.09 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.465 ' N ' HD23 ' B' ' 38' ' ' LEU . 40.4 pt -153.05 -141.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.769 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.08 -127.43 1.3 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.893 0.377 . . . . 1.0 110.653 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.436 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 2.1 m-85 -164.32 -63.19 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.084 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.5 Cg_endo -58.73 -23.36 65.9 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.199 1.932 . . . . 1.0 112.122 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -89.77 -29.66 18.53 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.828 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.444 ' CB ' HD21 ' B' ' 38' ' ' LEU . . . -68.27 -40.0 82.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.0 110.596 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.6 tt -65.84 -42.94 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.703 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.481 ' N ' HG23 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -66.19 -36.96 84.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.41 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -61.65 -40.26 94.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.633 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.453 ' O ' HD22 ' B' ' 19' ' ' LEU . 10.8 p -58.4 -29.19 65.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.945 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.43 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.711 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' B' ' 59' ' ' ASP . 23.7 mt-10 -66.8 -33.93 76.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.0 m -60.09 -44.58 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.506 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.79 -24.49 57.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.974 -0.291 . . . . 1.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 56.6 p -90.29 0.83 57.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.637 -0.256 . . . . 1.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.6 p 52.65 25.57 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.441 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.571 HG13 ' N ' ' B' ' 56' ' ' GLY . 7.4 p -83.1 -46.27 18.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 72.26 -32.93 0.66 Allowed Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' B' ' 55' ' ' VAL . 1.9 m-85 41.17 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.02 0.438 . . . . 1.0 110.563 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' B' ' 56' ' ' GLY . . . 162.86 19.72 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' B' ' 50' ' ' GLU . 92.0 m-20 -63.46 -45.68 89.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.795 0.331 . . . . 1.0 110.641 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' B' ' 37' ' ' ALA . 96.9 mtt-85 -147.38 -175.36 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.24 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.533 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 13.5 p90 -162.19 113.77 1.16 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.96 153.41 72.59 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.38 1.387 . . . . 1.0 112.56 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.522 HG11 ' O ' ' B' ' 34' ' ' PRO . 2.1 t -77.82 -138.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.012 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 63' ' ' VAL . 95.2 m -114.58 -39.61 3.75 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.766 0.317 . . . . 1.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' B' ' 67' ' ' GLY . 80.1 tt0 -65.06 -24.19 67.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.329 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -74.95 27.03 0.09 Allowed 'General case' 0 C--O 1.263 1.769 0 CA-C-O 123.576 1.655 . . . . 1.0 109.719 179.065 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.12 63.47 1.3 Allowed Glycine 0 C--O 1.212 -1.246 0 CA-C-N 113.656 -1.611 . . . . 1.0 111.269 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.4 ttm180 -25.08 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 118.124 0.962 . . . . 1.0 110.943 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 67' ' ' GLY . 44.9 mmtm -48.62 -19.84 0.39 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' B' ' 67' ' ' GLY . 61.4 t -62.51 -47.26 93.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.607 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.89 -38.06 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.96 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -60.63 -40.85 93.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.18 -44.87 79.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.638 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.26 -43.98 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.346 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 55' ' ' VAL . 55.4 mtt -55.38 -46.9 76.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.633 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -41.96 97.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.546 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.41 ' O ' HG22 ' B' ' 81' ' ' VAL . . . -60.12 -24.54 64.75 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.54 -41.45 5.42 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.93 -43.85 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 122.416 -0.461 . . . . 1.0 111.318 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.69 -52.46 65.4 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.876 0.369 . . . . 1.0 111.383 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 82' ' ' PHE . 15.9 m -60.62 -46.27 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.479 ' N ' HG23 ' B' ' 81' ' ' VAL . 18.3 m-85 -74.15 2.7 8.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.997 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.46 -30.11 5.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.771 0.319 . . . . 1.0 110.227 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.475 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.5 tt -64.03 -40.44 96.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.256 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.468 HG12 ' HB1' ' B' ' 8' ' ' ALA . 26.9 m -48.57 -15.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.873 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.475 ' N ' ' C ' ' B' ' 84' ' ' LEU . 52.7 m -49.14 -23.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -64.64 -42.26 95.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.695 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -11.41 59.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' B' ' 92' ' ' ASP . 43.5 mt -91.0 -38.81 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -54.42 -34.86 62.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.356 0.598 . . . . 1.0 109.481 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.523 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.2 OUTLIER -79.26 -8.02 58.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.395 -0.821 . . . . 1.0 109.969 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' B' ' 89' ' ' LEU . 66.2 t0 -55.82 -51.46 67.41 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.786 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 17.4 p90 -71.84 -41.77 67.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.747 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 57.1 t -45.13 -35.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.515 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 84.5 mtt85 -63.54 -22.7 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.056 -0.257 . . . . 1.0 111.404 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' B' ' 96' ' ' ARG . 23.7 ptt-85 -46.77 -29.03 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 1.0 110.079 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.17 -43.95 93.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -67.85 -39.04 83.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.809 0.337 . . . . 1.0 110.797 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -66.75 -31.66 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.683 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.61 -46.87 86.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.506 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.76 -20.54 53.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.421 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.59 83.33 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.625 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.14 -106.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.483 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -135.89 -45.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -81.83 -20.04 39.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.57 -43.04 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -75.49 -29.73 59.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -64.96 -42.74 94.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.214 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.26 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -66.74 -40.85 88.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.182 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -64.25 -35.25 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -43.16 87.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.193 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -40.55 96.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 1.0 110.968 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.518 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.82 -36.28 83.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.465 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.414 HD13 ' HA2' ' C' ' 78' ' ' GLY . 50.7 tp -62.4 -41.46 98.68 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.5 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -58.92 -40.14 83.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.388 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.66 -39.37 91.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 1.0 111.032 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.22 -32.87 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.4 mt -61.37 -41.85 97.75 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.02 -46.68 84.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.0 109.765 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.7 -40.41 72.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.433 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.75 93.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.825 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.526 ' HG ' ' CB ' ' C' ' 48' ' ' SER . 40.4 m -60.11 -45.4 93.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.655 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -66.57 -40.99 89.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.203 0.525 . . . . 1.0 110.401 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.3 mttt -66.7 -41.97 87.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.661 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.24 -51.18 69.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.361 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 7.4 p -62.37 -33.19 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.265 0.555 . . . . 1.0 110.363 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.02 -21.28 31.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.051 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -65.03 -50.83 64.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.034 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.8 pp20? -59.0 -29.36 67.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.99 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 10.8 tpt85 -62.17 118.17 7.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.794 0.33 . . . . 1.0 110.262 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.93 -9.82 63.88 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.37 148.61 34.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.496 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 87.6 Cg_endo -76.21 126.76 9.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.784 1.656 . . . . 1.0 112.299 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.02 37.47 6.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 143.06 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 1.0 110.631 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -151.73 -42.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 26.47 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.013 0.435 . . . . 1.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' C' ' 37' ' ' ALA . 12.9 tt -63.27 -24.32 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.493 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 43.3 t -59.42 129.59 42.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.518 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.507 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 52.7 t80 -86.25 -50.91 0.48 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.983 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.0 Cg_endo -60.03 -33.69 95.24 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.514 1.476 . . . . 1.0 112.426 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.77 -7.27 57.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.282 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.26 88.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.777 0.322 . . . . 1.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.459 HG23 ' HE3' ' C' ' 46' ' ' TRP . 12.0 tt -65.0 -33.72 65.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.538 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.663 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -70.18 -47.37 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.432 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -61.11 -39.64 90.75 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.382 -0.527 . . . . 1.0 109.771 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.534 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.1 m -53.18 -21.26 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.604 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.38 -43.42 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.519 ' CD ' HH21 ' D' ' 68' ' ' ARG . 9.8 pt-20 -90.27 57.81 3.85 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.74 0.305 . . . . 1.0 111.399 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.513 ' O ' ' SD ' ' C' ' 75' ' ' MET . 6.0 t -159.51 -42.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.223 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -64.32 -36.99 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 1.0 110.924 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' C' ' 54' ' ' THR . 1.5 p -94.57 19.81 9.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.871 0.367 . . . . 1.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 53' ' ' THR . 27.6 p 54.6 81.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.639 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.81 -84.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.88 44.73 45.96 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -48.22 82.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 1.0 110.66 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 165.39 -100.19 0.17 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 38.5 m-20 38.41 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.883 0.373 . . . . 1.0 111.342 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' C' ' 58' ' ' GLY . 66.5 mtm-85 -123.43 157.61 33.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.57 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -141.92 146.17 39.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.34 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.88 152.32 73.7 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.126 1.884 . . . . 1.0 112.13 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.549 HG12 ' H ' ' C' ' 64' ' ' THR . 2.1 t -64.33 -139.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 1.0 109.992 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.549 ' H ' HG12 ' C' ' 63' ' ' VAL . 17.1 m -114.5 -77.13 0.57 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.465 ' O ' ' CZ2' ' B' ' 46' ' ' TRP . 80.6 tt0 -37.28 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.932 -0.577 . . . . 1.0 110.736 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.3 mm-40 -73.89 -103.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.07 -56.38 0.0 OUTLIER Glycine 0 N--CA 1.476 1.338 0 O-C-N 124.378 1.049 . . . . 1.0 114.225 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 88.3 mtt180 -70.71 -45.59 64.65 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' C' ' 66' ' ' GLU . 68.1 mmtt -62.35 -41.72 98.81 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.298 -0.631 . . . . 1.0 109.298 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.77 -45.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 119.798 -0.761 . . . . 1.0 111.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.1 69.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 1.0 109.76 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -69.71 -38.58 76.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.628 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.58 -49.13 74.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.89 -32.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.826 -0.349 . . . . 1.0 111.104 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' C' ' 51' ' ' THR . 27.4 tpp -61.17 -43.6 98.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.818 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.43 -38.72 92.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.703 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.459 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -55.81 -46.99 77.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.633 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -63.98 -41.81 98.49 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.223 -0.513 . . . . 1.0 111.862 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.56 -43.45 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.768 0.318 . . . . 1.0 110.788 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.55 -40.98 89.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 77' ' ' ALA . 69.5 t -63.86 -50.89 75.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.365 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -67.21 -40.79 86.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.772 -0.371 . . . . 1.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.77 71.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.988 0.423 . . . . 1.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' C' ' 86' ' ' THR . 5.4 tt -62.95 -35.75 81.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.457 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' C' ' 87' ' ' ALA . 18.7 t -39.93 -23.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 1.0 110.702 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 1.3 p -41.9 -21.76 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.953 0.406 . . . . 1.0 109.988 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -48.1 -50.78 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.93 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.52 -33.27 7.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.759 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.31 -45.9 91.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.768 0.318 . . . . 1.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' C' ' 86' ' ' THR . . . -74.2 -14.45 60.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.995 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -92.97 -2.68 55.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.32 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -59.08 -43.05 91.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.69 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 5.6 p90 -66.97 -32.0 72.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.7 -43.68 91.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.271 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -57.97 -20.81 40.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -53.41 -43.31 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.979 -0.289 . . . . 1.0 110.364 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.5 mt-10 -62.88 167.64 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.998 -0.281 . . . . 1.0 110.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.41 ' C ' ' N ' ' C' ' 100' ' ' ARG . 96.7 mt-10 58.4 -73.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.658 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.3 mt-10 -51.59 -13.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.501 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.41 ' N ' ' C ' ' C' ' 98' ' ' GLU . 41.5 ttp180 -59.45 -52.22 66.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 1.0 110.505 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -70.84 -36.92 73.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.591 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' GLY . . . . . 0.423 ' O ' ' OXT' ' C' ' 103' ' ' HIS . . . 85.67 21.0 55.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.423 ' OXT' ' O ' ' C' ' 102' ' ' GLY . 96.6 m-70 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.35 147.29 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -62.51 -40.32 96.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.665 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.75 -40.63 92.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.601 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.9 tt0 -64.66 -37.2 86.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.819 0.342 . . . . 1.0 110.43 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -60.86 -43.29 98.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.381 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.64 -41.78 98.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.045 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.38 93.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.642 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.9 -37.59 79.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.99 -39.79 91.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.419 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.78 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.886 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.612 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -64.07 -39.53 94.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.89 -36.01 82.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.74 -41.2 99.08 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.063 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -37.39 85.78 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.774 0.321 . . . . 1.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.21 -41.25 92.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.624 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' D' ' 52' ' ' ALA . 88.8 mt -59.76 -41.5 91.18 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 20' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' D' ' 23' ' ' SER . 96.9 mt-10 -61.84 -48.47 80.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.271 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.94 -32.7 73.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.0 109.908 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.57 93.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.69 -46.39 90.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.923 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.45 -34.84 76.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 1.0 110.566 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -73.05 -45.61 56.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.877 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.91 79.79 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.917 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.49 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.6 p -65.48 -42.67 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.221 0.534 . . . . 1.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.49 ' N ' HG13 ' D' ' 27' ' ' VAL . 48.1 tp10 -70.63 -41.5 72.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.7 -45.79 85.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 39' ' ' ILE . 0.3 OUTLIER -75.5 -18.38 59.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.837 0.351 . . . . 1.0 111.305 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -67.18 108.63 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 1.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.59 -8.34 51.43 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.432 -0.667 . . . . 1.0 111.432 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.02 149.17 76.34 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.54 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.6 Cg_endo -74.57 142.96 29.97 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.131 1.887 . . . . 1.0 112.424 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 22.07 67.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 143.56 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.328 . . . . 1.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -27.53 1.71 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.51 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -66.47 -16.38 64.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.493 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.638 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.5 tt -37.55 105.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.973 0.416 . . . . 1.0 111.153 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 88.9 p -173.85 -133.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.192 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' D' ' 40' ' ' SER . 2.3 m-85 -177.65 -66.28 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.413 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.1 Cg_endo -58.88 -32.31 97.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.842 1.695 . . . . 1.0 111.65 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -93.92 -7.22 43.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.23 87.28 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.848 0.356 . . . . 1.0 110.493 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -69.33 -36.59 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.317 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.518 ' CD1' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -55.6 -49.06 73.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 -178.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.67 -40.52 92.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.167 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.401 ' O ' HD22 ' D' ' 19' ' ' LEU . 54.3 p -61.42 -36.19 79.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.669 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -63.53 -48.09 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.985 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.3 44.97 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -139.06 -47.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.06 -25.95 67.29 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.3 p -89.41 9.87 24.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 53' ' ' THR . 42.9 p 51.59 70.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.802 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.78 -77.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.846 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 94.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -61.82 -41.48 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 1.0 110.843 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.92 8.51 3.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.859 -0.897 . . . . 1.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.29 -47.9 83.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -140.28 148.93 42.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 25.7 p90 -136.91 137.8 24.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.514 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.54 155.37 63.5 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.376 2.051 . . . . 1.0 112.284 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -88.81 -141.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.079 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.663 HG22 ' CD1' ' C' ' 46' ' ' TRP . 1.7 p -113.67 -42.77 3.39 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.821 0.343 . . . . 1.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.76 -19.12 65.08 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.49 26.16 0.1 Allowed 'General case' 0 C--O 1.265 1.872 0 CA-C-O 123.7 1.714 . . . . 1.0 109.443 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 43.19 59.75 3.34 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 113.907 -1.497 . . . . 1.0 109.414 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.519 HH21 ' CD ' ' C' ' 50' ' ' GLU . 51.0 ttt85 -26.49 -28.94 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.363 0.684 . . . . 1.0 110.994 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.4 mttm -53.35 -18.68 2.7 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.044 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 53.2 t -62.46 -46.97 95.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.803 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.91 76.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.302 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.89 -46.24 82.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.76 -0.655 . . . . 1.0 111.164 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.14 -41.37 99.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.38 -46.18 96.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.241 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 25.1 mtm -63.4 -41.5 98.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.846 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.71 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.438 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.17 -41.08 92.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.438 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.41 -41.89 83.8 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.523 -0.631 . . . . 1.0 111.523 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.64 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.842 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -66.82 -44.09 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.177 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 77' ' ' ALA . 74.3 t -64.8 -49.22 81.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.436 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.58 -5.55 11.91 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.872 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.95 -38.2 5.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.68 -16.81 6.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.4 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.42 -1.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.723 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 89' ' ' LEU . 19.5 m -58.31 -42.16 86.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.995 0.426 . . . . 1.0 109.91 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -48.17 -17.09 0.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.76 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -105.03 -12.95 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.775 0.322 . . . . 1.0 110.464 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.3 mt -87.67 -51.18 6.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -55.32 -28.41 53.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.136 0.493 . . . . 1.0 110.421 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.803 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.5 OUTLIER -86.9 0.53 54.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.521 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 44.4 t0 -72.04 -37.7 69.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.432 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 7.4 p90 -75.86 -42.75 48.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.803 HG22 ' O ' ' D' ' 91' ' ' THR . 17.1 m -39.97 -33.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.446 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -53.7 -22.53 9.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.741 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -55.94 -34.93 66.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' D' ' 99' ' ' GLU . 25.9 tp10 -73.38 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.613 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 66.75 -37.57 0.3 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.493 0.496 . . . . 1.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' D' ' 97' ' ' GLU . 51.8 tp10 -67.95 -33.07 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.44 -37.03 77.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -64.94 -37.56 88.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.563 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.99 7.93 63.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.051 -0.82 . . . . 1.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 m80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.079 -0.962 . . . . 1.0 110.496 179.687 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . . . -58.83 -104.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ALA . 99.5 m-20 -140.26 -50.32 0.47 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.518 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -82.46 -19.71 38.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.499 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.65 -38.89 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.01 -38.78 92.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.367 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.1 -39.84 93.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.78 96.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.271 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -68.52 -38.92 81.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.511 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.04 -38.88 92.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.396 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.69 78.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.792 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.1 -36.72 82.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 1.0 110.691 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.15 -34.56 78.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.153 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -64.77 -35.32 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.65 -41.79 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.433 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 87.6 mt-30 -60.24 -40.58 90.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.244 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -44.05 97.33 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.69 -42.06 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.441 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 52' ' ' ALA . 20.1 mt -60.16 -41.93 93.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.448 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -65.17 -43.07 92.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.4 -46.53 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.381 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.02 79.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.206 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 13.4 p -53.11 -42.07 65.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.035 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' ALA . 65.4 tttm -66.4 -74.08 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -35.96 -26.5 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.147 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' LYS . . . -62.61 -42.61 99.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 2.3 m -68.11 -47.05 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.178 0.513 . . . . 1.0 110.593 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 44.1 tp10 -67.09 -34.45 77.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' OE1' ' A' ' 66' ' ' GLU . . . -54.25 -29.09 45.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -67.56 -41.11 84.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.099 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.51 HH21 ' CB ' ' A' ' 36' ' ' ALA . 5.3 mmp_? -74.13 101.97 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.225 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.03 -27.19 4.61 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 152.5 40.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 110.027 -0.361 . . . . 1.0 110.027 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.5 147.66 32.4 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.382 2.054 . . . . 1.0 112.61 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.71 36.62 7.25 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' CB ' HH21 ' A' ' 31' ' ' ARG . . . -55.08 143.88 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 1.0 110.641 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.77 -58.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.11 58.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.263 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.5 pt -85.63 -5.49 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.177 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -72.79 151.65 41.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.632 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' A' ' 42' ' ' PRO . 20.1 m-85 -98.02 -63.17 0.1 Allowed Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.753 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.16 -29.63 89.54 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.969 1.779 . . . . 1.0 112.508 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 73.7 m-20 -81.85 -5.99 58.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.955 -0.298 . . . . 1.0 110.53 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . . . -63.9 -43.16 96.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.388 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.69 -39.21 81.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.505 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -59.3 -43.8 92.6 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.506 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 14.2 t90 -63.29 -40.2 96.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 58.4 p -61.64 -32.7 72.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.71 -46.53 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.239 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.63 13.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.542 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -100.21 -49.27 4.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.757 0.313 . . . . 1.0 110.56 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.22 -26.76 67.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.382 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.4 p -84.53 5.44 27.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.224 0.535 . . . . 1.0 109.628 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.36 60.5 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.312 -0.858 . . . . 1.0 111.29 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.1 p -131.65 -48.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.952 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.76 95.55 0.01 OUTLIER Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.649 -0.58 . . . . 1.0 111.649 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -74.49 -102.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.0 110.571 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.38 18.88 1.17 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' CZ ' ' B' ' 68' ' ' ARG . 99.8 m-20 -60.23 -47.29 86.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 33.9 mmt180 -134.63 -163.02 1.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 46.3 m-85 -161.34 100.59 1.24 Allowed Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.547 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 63' ' ' VAL . 62.1 Cg_endo -69.47 150.02 69.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.353 1.369 . . . . 1.0 112.568 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 62' ' ' PRO . 6.0 m -53.53 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.371 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.543 ' CG2' HH22 ' D' ' 60' ' ' ARG . 98.0 m -102.63 -71.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.535 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 84.1 tt0 -37.81 -70.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 1.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' A' ' 68' ' ' ARG . 74.2 mt-10 -83.42 -107.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -54.58 0.0 OUTLIER Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.779 1.299 . . . . 1.0 114.77 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' A' ' 66' ' ' GLU . 60.0 ttm-85 -65.74 -74.9 0.1 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.851 -0.674 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -43.55 -37.6 2.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.27 -47.32 90.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.033 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 68' ' ' ARG . . . -65.99 -36.8 84.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.644 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.22 -38.29 73.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.615 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -63.41 -43.32 97.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.594 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.91 -45.34 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.622 ' SD ' HG11 ' D' ' 55' ' ' VAL . 65.2 mtt -60.84 -42.91 98.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.95 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.62 -43.2 97.55 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.62 -39.82 95.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.612 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.69 95.61 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.54 -43.27 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.988 -0.285 . . . . 1.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.43 -42.29 98.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.249 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 59.9 t -64.73 -50.88 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -68.46 -39.51 81.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.978 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.67 85.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.222 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.461 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.7 tt -61.77 -42.54 99.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.404 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 85' ' ' VAL . 99.1 t -47.75 -16.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 1.0 110.328 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.461 ' N ' ' C ' ' A' ' 84' ' ' LEU . 92.9 m -51.59 -21.35 2.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.214 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 -35.3 78.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.243 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.57 -14.59 34.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.5 -42.7 18.11 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.932 0.345 . . . . 1.0 111.932 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.72 -30.46 67.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.844 0.354 . . . . 1.0 111.216 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.4 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.17 -50.42 73.76 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.69 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 94' ' ' VAL . 15.7 p90 -72.37 -43.92 63.3 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.268 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.575 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 57.8 t -39.72 -34.37 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.662 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -63.04 -34.96 78.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 1.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' PHE . 40.0 ptt85 -39.46 -42.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.899 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' GLU . 5.2 tp10 -70.29 -165.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.08 -79.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.759 0.314 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 97' ' ' GLU . 97.8 mt-10 -55.21 -17.04 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -60.79 -44.91 96.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.559 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -89.54 -16.18 31.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.295 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.31 11.78 84.97 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.573 180.0 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.225 -0.658 . . . . 1.0 109.225 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.98 147.97 24.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.76 -39.52 94.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.019 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.67 -41.64 97.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.0 110.395 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.59 -33.36 75.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -62.0 -42.35 99.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.308 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.46 -44.22 83.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.361 . . . . 1.0 110.225 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -67.31 -41.54 85.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.654 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.19 -38.57 90.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.671 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.72 -37.41 86.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.21 75.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.893 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.21 -36.03 76.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 1.0 110.629 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 -37.32 87.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -64.2 -33.63 76.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.664 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.6 tp -62.43 -41.84 99.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.691 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.65 -39.92 85.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.647 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.94 -38.86 92.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.829 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.18 -41.8 94.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.754 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 94.1 mt -59.37 -41.1 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.46 -44.3 96.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 1.0 109.915 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.74 -37.78 76.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.393 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.68 88.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.415 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -58.48 -45.82 87.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -65.31 -35.0 79.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.904 0.383 . . . . 1.0 110.218 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -70.95 -45.22 64.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.899 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.51 77.45 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.511 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.488 HG23 ' N ' ' B' ' 28' ' ' GLU . 24.0 m -58.59 -46.82 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.798 -0.761 . . . . 1.0 110.534 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.488 ' N ' HG23 ' B' ' 27' ' ' VAL . 89.5 mt-10 -67.91 -42.68 80.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.784 0.326 . . . . 1.0 111.027 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.37 87.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.568 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -65.09 -47.7 76.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.737 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.51 131.45 49.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.04 69.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.38 143.03 25.79 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.32 -0.252 . . . . 1.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' B' ' 63' ' ' VAL . 93.5 Cg_endo -75.45 142.6 26.71 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.151 1.901 . . . . 1.0 112.138 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.65 19.88 73.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.181 -0.767 . . . . 1.0 111.181 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.13 145.24 51.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 1.0 110.397 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.08 -34.47 0.87 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.516 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -81.75 125.5 30.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 1.0 110.588 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' SER . 35.5 pt -152.13 -166.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.408 -0.815 . . . . 1.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 39' ' ' ILE . 6.1 t 59.97 135.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 1.0 111.283 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.567 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -65.85 -48.98 61.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.369 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.45 -29.53 88.82 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.599 1.533 . . . . 1.0 112.913 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.03 -23.55 22.56 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.7 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' B' ' 27' ' ' VAL . . . -63.54 -41.63 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 1.0 110.58 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 49' ' ' VAL . 4.9 tt -65.09 -39.36 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.49 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.495 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.4 OUTLIER -59.86 -47.51 85.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.474 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -61.85 -41.91 98.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 1.0 110.267 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -64.37 -40.3 95.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.199 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 45' ' ' ILE . 44.9 t -60.49 -47.48 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.631 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.69 -32.81 74.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -64.81 -43.55 92.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.25 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -54.47 -26.3 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.915 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.6 p -88.96 2.23 54.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.716 0.293 . . . . 1.0 110.712 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' B' ' 53' ' ' THR . 69.6 p 51.59 66.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.708 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' B' ' 57' ' ' TYR . 30.5 t -133.88 -52.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.674 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.33 76.91 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.489 ' CZ ' HG11 ' B' ' 55' ' ' VAL . 81.3 m-85 -61.22 -42.6 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.912 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.89 20.73 0.83 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.527 ' CG ' HH22 ' C' ' 68' ' ' ARG . 32.7 m-20 -62.5 -41.71 99.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.816 0.341 . . . . 1.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 34.9 mmt180 -132.88 -175.83 3.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 58.9 m-85 -159.45 99.35 1.55 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.856 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.2 158.16 58.7 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.3 1.333 . . . . 1.0 112.606 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.556 HG11 ' O ' ' B' ' 34' ' ' PRO . 0.8 OUTLIER -95.11 -154.17 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.022 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.523 ' H ' HG12 ' B' ' 63' ' ' VAL . 26.8 m -101.93 -38.26 7.88 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.9 tm-20 -61.55 -32.38 72.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 1.0 110.2 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -73.01 26.52 0.06 Allowed 'General case' 0 C--O 1.263 1.784 0 CA-C-O 124.046 1.879 . . . . 1.0 109.599 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 44.31 63.95 2.2 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-O 117.492 -1.727 . . . . 1.0 110.961 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.505 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.1 ttm180 -25.08 -31.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.297 1.049 . . . . 1.0 110.904 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.5 mttt -49.82 -17.77 0.4 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 67' ' ' GLY . 45.7 t -60.32 -47.08 93.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 119.477 -0.889 . . . . 1.0 109.488 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.54 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -68.23 -54.21 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.303 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -42.82 -34.97 1.03 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.33 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.533 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 71' ' ' ALA . 45.0 t -67.03 -52.93 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.861 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 0.0 OUTLIER -65.0 -42.59 94.36 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.612 -179.537 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.51 -43.96 93.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.119 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.428 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -64.16 -39.63 94.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.43 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.85 -42.99 92.63 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.711 -0.556 . . . . 1.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.5 -43.5 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.041 -0.264 . . . . 1.0 110.77 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 84' ' ' LEU . 80.9 mm-40 -60.28 -41.47 93.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.301 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 77' ' ' ALA . 65.3 t -64.11 -49.17 82.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.457 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -76.59 -12.16 59.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.547 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.34 -26.58 14.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.918 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 80' ' ' GLU . 4.7 tt -63.63 -41.32 98.27 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.04 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' B' ' 87' ' ' ALA . 17.3 m -47.45 -26.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.445 -0.502 . . . . 1.0 109.68 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 6.1 m -34.16 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.415 0.626 . . . . 1.0 110.211 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -53.37 -53.2 54.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.601 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -70.25 -30.18 67.17 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.333 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.445 ' N ' HD12 ' B' ' 89' ' ' LEU . 9.5 mp -61.29 -43.67 98.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.997 0.427 . . . . 1.0 109.886 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 -17.81 61.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.513 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -100.54 -11.56 20.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.241 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.6 m-20 -63.12 -41.92 99.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.076 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 1.4 p90 -64.94 -29.88 70.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.363 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.96 -43.4 92.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.519 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -48.71 -21.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.31 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.48 HH11 HH21 ' B' ' 100' ' ' ARG . 45.6 ptt85 -55.18 -32.22 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 1.0 110.119 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -61.83 -35.42 78.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.125 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 98' ' ' GLU . 2.9 pp20? -120.95 22.94 10.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.661 0.267 . . . . 1.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -132.26 -29.13 1.63 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.892 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.48 HH21 HH11 ' B' ' 96' ' ' ARG . 18.5 ttm105 -61.15 -46.18 91.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 1.0 110.295 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.28 -3.16 51.1 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 82.52 8.7 85.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 80.7 m80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.545 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -155.68 108.7 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -63.87 -40.91 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.473 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.545 ' CE1' ' HB1' ' C' ' 2' ' ' ALA . 3.8 p-80 -58.7 -41.77 87.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.694 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.24 -37.11 86.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.72 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.9 -39.29 93.84 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.92 -39.35 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.248 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -41.01 99.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.48 -37.19 84.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.72 -38.4 87.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.661 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.5 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.2 -36.29 83.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.971 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.85 -38.71 91.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.752 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -36.02 82.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.706 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.45 -36.09 82.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 1.0 110.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -66.87 -33.66 76.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.184 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -61.28 -47.84 84.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.579 -0.282 . . . . 1.0 111.56 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 18' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 18' ' ' VAL . 12.5 m -65.28 -36.22 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 1.0 110.653 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' C' ' 52' ' ' ALA . 36.0 mt -60.86 -41.56 96.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.74 -42.98 99.67 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.119 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -68.89 -44.75 72.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.74 78.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.468 ' O ' ' HB1' ' C' ' 44' ' ' ALA . 72.6 m -56.75 -43.95 81.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.858 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.471 ' O ' HG22 ' C' ' 27' ' ' VAL . 8.0 tmtt? -80.65 -61.86 1.84 Allowed 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -41.89 -28.75 0.17 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.159 -0.216 . . . . 1.0 110.956 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.58 78.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.571 0.224 . . . . 1.0 110.721 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 24' ' ' LYS . 2.3 m -63.26 -43.55 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.045 0.45 . . . . 1.0 110.544 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' C' ' 27' ' ' VAL . 14.4 tm-20 -80.58 -24.22 39.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -51.01 71.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.918 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.55 78.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -53.01 90.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.564 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.12 -6.18 8.22 Favored Glycine 0 N--CA 1.47 0.911 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.14 150.73 39.14 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.255 . . . . 1.0 110.32 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.62 141.77 28.28 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.685 1.59 . . . . 1.0 111.649 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 37.35 34.27 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.64 150.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.0 110.562 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' C' ' 61' ' ' TYR . . . -132.06 -116.79 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.71 HD22 ' C ' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -55.05 163.93 0.95 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.242 0.544 . . . . 1.0 110.961 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' C' ' 40' ' ' SER . 5.7 pt -152.85 -169.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.746 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.516 ' C ' ' CG ' ' C' ' 41' ' ' TYR . 37.6 m -53.02 -165.31 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.874 0.369 . . . . 1.0 110.83 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.597 ' C ' ' H ' ' C' ' 43' ' ' ASP . 0.3 OUTLIER 76.31 161.19 0.15 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.57 5.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.564 2.176 . . . . 1.0 112.131 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' C' ' 41' ' ' TYR . 21.2 t70 -84.2 -32.3 24.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' C' ' 23' ' ' SER . . . -60.9 -44.56 96.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 1.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.53 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.4 tt -63.93 -38.0 81.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.393 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.409 . . . . 1.0 110.211 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' C' ' 48' ' ' SER . 1.4 t90 -63.25 -47.72 81.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.608 ' O ' HD22 ' C' ' 19' ' ' LEU . 1.9 t -50.42 -29.22 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.776 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' C' ' 49' ' ' VAL . 57.4 t -90.39 62.91 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.684 ' CG ' HH22 ' D' ' 68' ' ' ARG . 46.7 tp10 -173.28 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.658 -0.817 . . . . 1.0 110.825 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' C' ' 75' ' ' MET . 4.5 t -72.57 -38.97 67.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.695 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -61.23 -28.38 69.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.957 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -93.67 1.82 56.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.07 0.462 . . . . 1.0 110.282 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 57.4 p 49.8 56.9 7.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.656 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' C' ' 57' ' ' TYR . 1.7 m -145.94 45.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.422 ' H ' HG13 ' B' ' 55' ' ' VAL . . . -45.58 92.44 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.324 -1.11 . . . . 1.0 110.324 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.579 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 18.2 t80 -61.97 -43.21 99.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 1.0 110.41 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.17 16.24 0.75 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.418 ' HB2' ' HE ' ' D' ' 68' ' ' ARG . 68.0 t0 -60.98 -52.11 66.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 1.0 110.766 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -151.71 -162.28 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.493 ' O ' ' CB ' ' C' ' 37' ' ' ALA . 38.7 p90 -166.69 134.91 2.21 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.802 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 176.54 6.23 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.864 1.71 . . . . 1.0 112.362 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 63' ' ' VAL . 16.5 m -87.25 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.416 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.495 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 1.1 m -110.08 -61.49 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.574 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.455 ' N ' HG22 ' C' ' 64' ' ' THR . 81.4 tt0 -42.99 -30.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.675 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 94.1 mt-10 -144.68 -104.27 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.73 -55.28 0.0 OUTLIER Glycine 0 N--CA 1.479 1.521 0 O-C-N 124.358 1.036 . . . . 1.0 114.839 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 45.0 ttm-85 -71.12 -43.17 68.18 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.192 -0.504 . . . . 1.0 109.971 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.3 tptm -60.63 -45.16 95.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.918 -1.141 . . . . 1.0 107.918 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.53 -46.64 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.797 -0.761 . . . . 1.0 110.329 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.531 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -63.05 -39.8 95.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 1.0 110.13 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -43.73 -49.36 7.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.79 -36.35 83.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.529 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.02 -43.28 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.767 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.3 mpp? -59.36 -44.64 92.66 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.726 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -64.5 -41.18 96.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.53 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 77' ' ' ALA . . . . . 0.534 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.98 -24.13 65.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.786 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.29 -37.61 6.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.717 -0.553 . . . . 1.0 111.717 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.56 -43.43 98.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.07 -37.67 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.534 HG23 ' O ' ' C' ' 77' ' ' ALA . 55.1 t -62.75 -47.12 94.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.321 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -73.74 -8.01 54.32 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.299 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -40.72 12.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.876 0.369 . . . . 1.0 110.285 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.07 -42.32 99.63 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.812 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.94 -15.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.432 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.475 ' O ' ' N ' ' C' ' 89' ' ' LEU . 28.1 m -60.04 -39.87 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.43 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -39.2 -50.56 1.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.59 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.26 90.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 1.0 110.084 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' C' ' 86' ' ' THR . 44.7 mt -66.68 -38.92 87.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.401 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -60.73 -37.64 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.438 . . . . 1.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -81.99 -3.6 54.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -55.64 -49.7 72.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.569 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.2 p90 -69.06 -32.62 72.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 -27.55 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.913 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.4 -22.94 67.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.611 -0.268 . . . . 1.0 111.152 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -57.59 -31.99 66.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 1.0 110.447 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.36 -34.06 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.536 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.52 -24.78 33.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.58 -44.72 77.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.104 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.55 -36.95 85.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.357 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.16 -37.36 87.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.586 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.26 36.59 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 80.1 m80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.61 179.906 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.94 79.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -174.03 -66.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -79.21 -18.91 52.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.58 -38.79 87.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.402 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.76 -42.13 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.507 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.78 -39.42 94.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.44 99.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.818 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.18 -39.07 92.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.06 -40.82 97.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -35.42 76.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.968 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.804 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.4 -38.07 88.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.368 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.37 -31.93 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.516 HD11 ' HB1' ' D' ' 52' ' ' ALA . 45.7 tp -62.07 -39.64 93.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 1.0 110.184 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.4 -34.21 75.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -63.5 -46.78 84.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.844 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.402 ' H ' HG22 ' D' ' 18' ' ' VAL . 12.2 m -63.62 -37.45 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 1.0 110.675 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' D' ' 52' ' ' ALA . 82.7 mt -61.23 -41.45 96.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.345 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.9 -46.32 82.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.912 0.387 . . . . 1.0 110.318 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.53 -35.36 75.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.287 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.06 92.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 1.0 111.054 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -58.24 -43.65 87.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.123 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -63.96 -32.84 74.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.37 -45.19 60.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.683 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -49.23 78.38 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.54 HG13 ' N ' ' D' ' 28' ' ' GLU . 10.9 p -60.87 -45.7 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.54 ' N ' HG13 ' D' ' 27' ' ' VAL . 80.3 tt0 -67.98 -43.21 79.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.704 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.95 86.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.215 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.444 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 37.7 mm-40 -67.54 -38.23 83.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.179 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 31' ' ' ARG . . . . . 0.504 HH11 HD11 ' D' ' 39' ' ' ILE . 16.3 tpp180 -63.69 124.08 20.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.981 0.42 . . . . 1.0 110.726 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.5 68.83 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.68 139.4 21.88 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.539 ' O ' HG11 ' D' ' 63' ' ' VAL . 95.7 Cg_endo -74.77 144.77 31.57 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.228 1.952 . . . . 1.0 112.53 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.88 22.65 70.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -91.2 87.82 6.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.709 0.29 . . . . 1.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 37' ' ' ALA . . . . . 0.433 ' O ' HG22 ' D' ' 39' ' ' ILE . . . -65.14 -38.82 91.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.916 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.561 HD23 ' C ' ' D' ' 38' ' ' LEU . 4.3 tt -66.6 99.14 0.56 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.587 HG23 ' O ' ' D' ' 39' ' ' ILE . 14.3 tt -143.45 93.34 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.4 OUTLIER 168.58 150.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.572 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 10.0 m-85 -76.87 -58.79 1.02 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.562 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.1 Cg_endo -58.93 -26.78 82.47 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.648 1.565 . . . . 1.0 111.728 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.34 -35.9 27.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 1.0 111.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.79 92.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.199 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.17 -44.21 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.896 0.379 . . . . 1.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -62.8 -42.02 99.54 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.581 -0.448 . . . . 1.0 110.175 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.579 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 36.1 t90 -62.12 -40.43 95.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.269 -0.572 . . . . 1.0 109.81 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.454 ' O ' HG23 ' D' ' 49' ' ' VAL . 1.4 m -74.22 69.48 1.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.804 0.335 . . . . 1.0 110.455 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.454 HG23 ' O ' ' D' ' 48' ' ' SER . 53.3 t -155.47 -61.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 1.0 110.178 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 1.5 pm0 -63.06 -31.99 73.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.555 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.468 HG23 HG11 ' D' ' 74' ' ' VAL . 0.0 OUTLIER -60.62 -42.9 97.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.223 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.779 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.96 -35.02 75.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 1.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' D' ' 54' ' ' THR . 18.1 p -80.07 9.47 5.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.16 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' D' ' 53' ' ' THR . 44.3 p 51.93 56.33 7.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.047 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.622 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.9 p -166.81 88.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.253 0.549 . . . . 1.0 111.157 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.24 109.92 3.57 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.506 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -61.32 -45.34 94.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 1.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.52 24.78 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 64.6 m-20 -61.8 -43.71 98.31 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.991 -0.284 . . . . 1.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.543 HH22 ' CG2' ' A' ' 64' ' ' THR . 0.2 OUTLIER -144.94 -177.19 5.4 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' D' ' 60' ' ' ARG . 41.5 m-85 -156.36 128.51 4.01 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.0 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.1 -171.13 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.736 1.624 . . . . 1.0 112.064 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 1.5 t -128.96 -146.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.178 -0.465 . . . . 1.0 109.986 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.615 HG22 ' CD1' ' C' ' 46' ' ' TRP . 2.9 p -113.48 -8.7 13.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.776 -0.193 . . . . 1.0 110.847 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' D' ' 67' ' ' GLY . 50.8 tp10 -99.06 -26.67 14.15 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.838 -0.431 . . . . 1.0 109.838 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.0 OUTLIER -80.97 30.92 0.31 Allowed 'General case' 0 C--O 1.265 1.874 0 CA-C-O 123.896 1.808 . . . . 1.0 108.879 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.01 61.71 2.24 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 113.377 -1.738 . . . . 1.0 109.493 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.684 HH22 ' CG ' ' C' ' 50' ' ' GLU . 71.3 ttt-85 -26.21 -30.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.134 0.55 . . . . 1.0 110.981 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.8 mttt -52.22 -13.61 0.35 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.292 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.0 t -59.56 -47.8 89.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.525 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.59 83.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.496 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.85 -43.14 85.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.365 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -61.92 -44.72 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.209 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.468 HG11 HG23 ' D' ' 51' ' ' THR . 98.1 t -64.11 -46.51 93.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.476 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.66 -44.74 95.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.995 -0.282 . . . . 1.0 111.23 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -66.15 -41.54 90.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 1.0 110.785 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.16 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.707 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.65 -39.11 93.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.586 -0.606 . . . . 1.0 111.586 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.61 -43.53 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.906 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.14 -38.95 93.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.079 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.34 -54.19 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.719 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.88 -39.6 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.812 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.44 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.0 110.446 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.66 -40.75 96.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.525 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' D' ' 87' ' ' ALA . 48.1 t -57.6 -22.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.831 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 86.4 m -40.32 -24.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.53 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -64.51 -42.47 95.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.669 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -72.44 -15.62 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.493 ' N ' HD22 ' D' ' 89' ' ' LEU . 3.8 mm? -85.79 -41.44 15.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.033 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.87 -36.83 72.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.218 0.533 . . . . 1.0 110.244 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -15.03 62.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.9 -51.85 67.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.234 -0.587 . . . . 1.0 111.073 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 12.6 p90 -72.23 -28.51 63.21 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.057 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.97 -35.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.962 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -59.9 -22.2 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.213 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -48.66 -36.94 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.0 110.367 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.75 -29.28 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.688 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.1 -22.49 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.381 . . . . 1.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.16 -44.19 80.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.698 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -66.19 -33.32 75.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.285 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -62.47 -36.79 83.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 22.01 52.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.339 179.925 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.32 145.02 55.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.693 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.53 -40.36 96.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.493 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.12 -46.23 89.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.175 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.67 -41.35 92.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 9' ' ' GLN . 8.8 tpm_? -64.1 -43.78 94.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.101 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.35 -43.76 85.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.087 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.39 92.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.443 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 67.6 tp60 -64.36 -39.01 93.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.19 -41.19 96.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.91 -35.75 77.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.53 -37.8 85.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.488 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.71 -38.33 90.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.33 -32.66 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.505 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' HB1' ' A' ' 52' ' ' ALA . 49.6 tp -62.53 -38.29 89.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.079 0.466 . . . . 1.0 110.251 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.89 -33.99 74.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.12 -45.76 87.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.844 0.313 . . . . 1.0 111.844 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -63.08 -33.14 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 52' ' ' ALA . 77.3 mt -60.51 -41.94 95.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.567 -0.453 . . . . 1.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.24 -47.92 82.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.626 -0.429 . . . . 1.0 109.854 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.53 -35.62 79.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.016 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.06 84.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.614 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 p -59.56 -47.88 83.81 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -67.51 -44.86 77.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.618 . . . . 1.0 110.47 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.4 mttt -63.64 -41.93 98.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.801 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.57 -51.47 68.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.642 -0.253 . . . . 1.0 111.532 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.4 p -64.68 -42.55 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.176 0.512 . . . . 1.0 109.855 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' N ' HG13 ' A' ' 27' ' ' VAL . 44.8 tp10 -70.57 -34.04 71.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.516 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -56.14 -50.69 70.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.573 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 32' ' ' GLY . 11.4 pt-20 -67.0 -36.55 82.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.019 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -55.19 87.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.352 . . . . 1.0 110.786 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 127.74 -9.09 6.83 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.498 -0.641 . . . . 1.0 111.498 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.18 143.3 26.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 122.676 -0.308 . . . . 1.0 110.175 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.29 119.04 5.13 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.03 1.82 . . . . 1.0 112.179 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 114.02 12.64 10.91 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.066 -0.813 . . . . 1.0 111.066 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -40.47 165.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.328 . . . . 1.0 110.892 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 61' ' ' TYR . . . -146.49 -86.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.064 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -72.44 57.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.41 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 tt -63.4 -18.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 1.0 110.423 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 9.9 m -71.86 146.5 47.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.1 t80 -83.55 -51.58 0.63 Allowed Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.767 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -59.93 -30.25 91.3 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.492 1.461 . . . . 1.0 112.484 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -88.27 -23.16 23.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.625 0.25 . . . . 1.0 111.003 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -63.0 -38.71 92.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 1.0 110.111 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -65.73 -38.63 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.494 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.7 92.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.415 . . . . 1.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -60.29 -38.58 84.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.0 m -56.26 -31.67 63.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 49' ' ' VAL . 46.9 t -82.49 -5.42 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 1.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 49.5 tt0 -108.76 33.45 4.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.239 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -39.27 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.48 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.59 -25.48 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.47 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 54' ' ' THR . 45.8 p -85.65 -2.13 57.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 53' ' ' THR . 48.5 p 53.27 73.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.118 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.27 -53.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.779 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.07 63.51 4.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.62 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 1.0 110.583 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 60' ' ' ARG . . . 161.95 -87.66 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.514 ' CG ' HH22 ' B' ' 68' ' ' ARG . 10.0 m-20 41.86 -92.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 1.0 110.486 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 mpp_? -115.23 -173.52 2.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.84 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 56.1 p90 -156.08 129.78 4.63 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.355 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.31 169.33 19.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.036 1.824 . . . . 1.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.985 HG22 ' H ' ' A' ' 64' ' ' THR . 6.0 p -81.27 -155.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.28 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 63' ' ' VAL . 1.3 m -113.76 -64.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.063 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' THR . 80.6 tt0 -37.5 -39.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.027 0.442 . . . . 1.0 110.549 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.85 ' O ' ' N ' ' A' ' 68' ' ' ARG . 73.7 mm-40 -135.85 -104.28 0.21 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.524 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -57.17 0.0 OUTLIER Glycine 0 N--CA 1.479 1.516 0 O-C-N 124.563 1.164 . . . . 1.0 114.449 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.85 ' N ' ' O ' ' A' ' 66' ' ' GLU . 58.4 ttm-85 -71.56 -46.94 58.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.113 0.483 . . . . 1.0 109.965 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 66' ' ' GLU . 3.5 tmtp? -60.68 -45.33 94.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.39 -43.43 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.021 -0.672 . . . . 1.0 110.029 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.3 84.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.56 -43.03 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.151 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.5 -35.47 79.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.302 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.17 -48.84 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.137 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.4 ptp -65.07 -37.5 87.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.533 -0.303 . . . . 1.0 110.572 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.45 -42.81 92.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.345 -0.388 . . . . 1.0 110.221 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.69 -31.19 71.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.642 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -77.29 -38.05 30.26 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.57 -43.79 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.583 0.23 . . . . 1.0 110.624 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.83 -36.6 84.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.202 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' ALA . 39.3 t -63.6 -49.71 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.919 0.39 . . . . 1.0 110.631 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.34 -31.04 71.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.252 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.88 -26.65 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.986 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.89 -43.76 95.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.881 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.3 m -62.08 -16.56 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.409 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' VAL . 38.0 m -36.49 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.093 0.473 . . . . 1.0 110.444 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' O ' HG22 ' A' ' 91' ' ' THR . . . -55.72 -57.73 10.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.476 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.96 -32.94 66.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.49 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.495 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -69.31 -36.35 76.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -66.76 -55.74 13.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.985 0.422 . . . . 1.0 111.276 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -51.45 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.97 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.4 m-20 -60.36 -48.1 83.22 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.581 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 24.6 p90 -69.49 -28.05 65.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.386 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.04 -45.7 95.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.925 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 98' ' ' GLU . 99.7 mtt180 -68.08 -22.25 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.706 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -44.19 -23.86 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.881 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.12 -38.54 90.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ARG . 98.3 mt-10 -66.57 -36.05 81.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.592 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.23 -36.06 82.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.464 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -60.15 -46.97 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -71.05 -25.12 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 9.64 72.48 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.094 -0.955 . . . . 1.0 110.539 179.918 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.381 -0.599 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.52 139.91 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.667 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.3 -40.47 93.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.979 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' B' ' 5' ' ' GLU . 6.2 p80 -63.66 -29.94 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.79 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' B' ' 4' ' ' HIS . 50.2 tp10 -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.566 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -64.56 -39.22 93.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.61 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -64.09 -40.23 95.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.04 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.51 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.32 -38.36 87.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.28 -40.13 95.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.573 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.32 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.751 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.21 -35.21 79.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 1.0 110.478 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.08 -36.59 84.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.344 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.9 -37.51 87.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.54 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 ' HA2' ' B' ' 78' ' ' GLY . 48.4 tp -62.52 -40.47 96.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.29 -38.77 92.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.78 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.66 -37.96 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.941 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.68 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.575 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' B' ' 52' ' ' ALA . 95.9 mt -59.96 -41.19 91.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.1 mm-40 -57.85 -49.75 75.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.3 -37.01 77.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.202 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.59 -43.59 65.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.206 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -62.59 -40.18 96.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.719 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.29 -33.03 75.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 29' ' ' ALA . 4.4 mptp? -83.99 -50.75 7.72 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.909 -0.317 . . . . 1.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.45 72.79 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.081 -0.247 . . . . 1.0 111.33 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 3.8 p -62.17 -45.63 98.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.325 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.5 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -74.27 -32.02 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.033 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -58.93 -37.85 77.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.51 -37.85 77.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.359 . . . . 1.0 110.918 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -54.6 95.47 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.097 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.441 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 119.27 -7.71 12.53 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.1 22.32 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 122.836 -0.214 . . . . 1.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.58 147.5 31.92 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.03 1.82 . . . . 1.0 112.528 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.78 20.15 70.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.7 56.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 1.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -35.28 0.46 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.77 HD23 ' O ' ' B' ' 38' ' ' LEU . 2.6 tt -62.85 -30.63 71.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.87 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.6 HD13 ' N ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -34.48 119.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.655 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.6 ' N ' HD13 ' B' ' 39' ' ' ILE . 31.1 t -176.22 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.5 m-85 176.79 -65.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.001 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.1 -38.07 93.1 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.116 1.878 . . . . 1.0 112.228 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.536 ' O ' ' NH2' ' B' ' 60' ' ' ARG . 40.5 p30 -101.88 2.22 37.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.05 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.91 96.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.932 0.396 . . . . 1.0 110.17 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -31.91 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.713 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.556 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.5 OUTLIER -54.74 -49.83 69.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.514 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.504 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.5 OUTLIER -64.02 -39.56 94.38 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.267 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.504 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.4 p -59.45 -35.72 74.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.203 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -48.26 89.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.557 ' CG ' HH22 ' C' ' 68' ' ' ARG . 14.5 pt-20 -68.9 -30.76 69.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.699 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -62.19 -45.64 92.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.151 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.648 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -60.69 -27.99 68.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 1.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 47.0 p -86.81 3.8 43.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.68 0.276 . . . . 1.0 110.807 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 50.37 74.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 1.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.501 HG11 ' CE1' ' B' ' 57' ' ' TYR . 57.6 t -142.11 -57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.54 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.52 82.28 0.04 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.501 ' CE1' HG11 ' B' ' 55' ' ' VAL . 57.7 m-85 -61.94 -41.83 98.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.709 0.29 . . . . 1.0 110.967 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.62 9.52 1.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -60.62 -49.18 78.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 1.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.536 ' NH2' ' O ' ' B' ' 43' ' ' ASP . 0.9 OUTLIER -145.09 145.33 31.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.112 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 47.5 p90 -133.68 126.78 19.18 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.63 156.44 63.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.735 1.623 . . . . 1.0 112.282 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.455 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -83.26 -138.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.033 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.455 ' H ' HG12 ' B' ' 63' ' ' VAL . 53.9 m -114.27 -39.88 3.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.996 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.1 tt0 -65.8 -22.9 66.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.904 0.383 . . . . 1.0 110.588 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -75.35 28.2 0.1 Allowed 'General case' 0 C--O 1.268 2.031 0 CA-C-O 123.513 1.625 . . . . 1.0 109.714 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.19 64.86 1.21 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-N 113.768 -1.56 . . . . 1.0 111.556 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.514 HH22 ' CG ' ' A' ' 59' ' ' ASP . 62.9 ttm-85 -23.41 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.186 0.993 . . . . 1.0 110.866 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -45.8 -21.64 0.14 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 67' ' ' GLY . 64.7 t -63.43 -44.78 99.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.473 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -77.52 -38.43 48.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.281 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.61 -41.75 91.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.79 -44.23 93.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.956 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.0 -45.58 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.245 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.5 mtm -63.02 -43.14 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.725 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -65.35 -38.21 89.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.42 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -58.79 -43.51 90.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.693 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.1 -42.21 94.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -43.48 97.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.851 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.6 -43.02 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 1.0 110.62 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 77' ' ' ALA . 66.3 t -63.98 -47.36 90.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.283 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -74.34 0.92 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.834 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -103.47 -34.82 8.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.179 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.8 tt -64.24 -39.49 94.07 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.791 -0.363 . . . . 1.0 110.053 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.39 -13.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.304 -0.407 . . . . 1.0 109.977 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.48 ' O ' ' N ' ' B' ' 89' ' ' LEU . 55.2 m -49.33 -43.19 43.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.07 -17.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.79 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' B' ' 86' ' ' THR . . . -104.13 -19.6 14.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.742 0.306 . . . . 1.0 110.744 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 2.6 mm? -95.31 -46.09 6.88 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.919 0.39 . . . . 1.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.515 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.56 -28.08 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.277 0.56 . . . . 1.0 110.051 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -79.97 -4.15 51.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.68 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 88.5 m-20 -59.96 -49.77 76.37 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.172 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.4 p90 -70.08 -27.5 64.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.003 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.67 -44.8 99.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.315 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -64.51 -20.2 66.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttp85 -48.72 -40.26 27.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.493 ' C ' HH21 ' B' ' 101' ' ' ARG . 80.8 mm-40 -64.6 -41.76 96.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.076 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.05 -35.79 78.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.34 -30.88 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -59.36 -44.2 92.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.78 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ARG . . . . . 0.493 HH21 ' C ' ' B' ' 97' ' ' GLU . 0.4 OUTLIER -78.34 -16.15 57.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.168 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 82.89 11.94 80.61 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 51.8 p-80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.927 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 1' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' C' ' 5' ' ' GLU . 63.3 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.49 ' O ' ' N ' ' C' ' 4' ' ' HIS . . . -75.36 80.08 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.496 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 6' ' ' ARG . 98.5 m-20 41.58 -91.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.49 ' N ' ' O ' ' C' ' 2' ' ' ALA . 2.5 p-80 -40.88 -34.84 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.784 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' C' ' 1' ' ' SER . 96.9 mt-10 -66.55 -37.95 86.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.903 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' C' ' 3' ' ' ASP . 83.6 mtp180 -63.79 -36.53 84.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -62.19 -40.32 95.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.43 -41.17 96.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.5 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.32 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.383 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.12 -36.44 83.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.391 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.85 77.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.199 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.722 0.296 . . . . 1.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.45 -35.76 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 1.0 110.563 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -63.88 -32.84 74.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.6 tp -62.75 -40.61 97.79 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.435 ' O ' ' CG ' ' C' ' 20' ' ' GLU . 88.8 mt-30 -70.6 -25.68 63.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.924 -0.311 . . . . 1.0 111.527 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.44 -44.63 18.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 18' ' ' VAL . . . . . 0.483 HG23 ' N ' ' C' ' 19' ' ' LEU . 25.9 m -61.65 -47.11 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 18' ' ' VAL . 2.8 pp -75.25 -26.27 58.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.865 0.364 . . . . 1.0 110.526 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' C' ' 16' ' ' GLN . 3.7 mm-40 -60.35 -48.33 82.19 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.666 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -65.84 -40.35 91.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.833 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -64.86 -33.63 76.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.453 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 23' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 22.3 m -56.65 -47.84 78.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.781 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.5 -39.8 92.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.561 -0.455 . . . . 1.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.7 mttt -73.55 -25.15 60.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -61.57 -45.11 95.55 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.071 -0.251 . . . . 1.0 110.684 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 42.7 t -64.82 -46.33 92.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.193 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.63 -33.65 71.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.54 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -56.68 -53.63 55.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.954 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.9 pp20? -71.2 -36.56 71.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 16.6 tpt180 -57.41 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 120.733 0.302 . . . . 1.0 110.765 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.07 -14.8 6.23 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.26 157.11 34.63 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.13 147.66 33.77 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.028 1.819 . . . . 1.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 26.37 48.92 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.14 143.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 1.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.73 -7.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.543 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -120.1 134.38 55.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.298 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 29.8 pt -153.96 -162.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.045 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.494 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 1.0 OUTLIER 59.06 126.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.09 0.471 . . . . 1.0 110.971 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 42.0 m-85 -71.56 -43.44 11.86 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.088 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.8 Cg_endo -59.34 -42.05 52.9 Favored 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 121.554 1.503 . . . . 1.0 112.959 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' C' ' 40' ' ' SER . 28.3 p-10 -84.29 -5.87 59.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.192 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.07 99.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 1.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.479 HG23 ' HE3' ' C' ' 46' ' ' TRP . 8.4 tt -65.45 -35.97 76.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.563 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.479 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.4 OUTLIER -56.51 -36.75 69.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.533 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.419 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.5 OUTLIER -84.82 -28.76 25.88 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.75 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.491 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 1.5 m -68.77 -40.09 79.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.685 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' C' ' 50' ' ' GLU . 3.9 p -60.83 -44.85 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.585 -0.28 . . . . 1.0 111.552 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' D' ' 68' ' ' ARG . 15.8 pt-20 -69.76 -33.86 73.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.823 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 70.3 m -62.57 -47.86 82.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.414 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -63.0 -23.94 67.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.752 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 59.0 p -95.07 3.28 55.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.835 0.35 . . . . 1.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' C' ' 54' ' ' THR . 17.5 p 53.79 73.66 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.63 -70.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.134 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.73 -58.3 3.44 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 70.76 -48.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.717 0.294 . . . . 1.0 110.976 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 145.24 -9.72 1.74 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 60.8 m-20 -42.93 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 1.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 81.1 mtm-85 -124.42 154.97 39.64 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.841 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 44.2 p90 -131.24 136.15 28.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.611 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.08 155.3 68.59 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.072 1.848 . . . . 1.0 112.241 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.62 -161.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.149 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.556 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 17.1 p -111.21 -66.23 1.1 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.195 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' C' ' 64' ' ' THR . 83.1 tt0 -37.81 -44.55 0.76 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.859 0.361 . . . . 1.0 110.559 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.89 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.6 mm-40 -121.52 -98.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.32 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.619 1.199 . . . . 1.0 114.438 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.89 ' N ' ' O ' ' C' ' 66' ' ' GLU . 47.7 ttm-85 -67.02 -67.08 0.48 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.892 -0.654 . . . . 1.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' C' ' 68' ' ' ARG . 1.9 mptm? -41.42 -39.42 1.48 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.72 -49.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 119.804 -0.759 . . . . 1.0 111.212 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.38 -50.7 64.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.985 0.422 . . . . 1.0 110.534 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 68' ' ' ARG . 84.2 tt0 -44.39 -44.39 8.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.601 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.69 -41.08 97.1 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.238 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.19 -42.66 94.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.6 mtt -59.1 -42.81 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.83 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -63.25 -41.99 99.13 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.645 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.59 88.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.9 -43.3 96.22 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.104 -0.569 . . . . 1.0 112.1 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.25 -42.68 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.646 0.26 . . . . 1.0 110.81 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.2 -38.91 84.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.423 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.98 -49.77 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.273 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.43 -41.02 93.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.075 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.54 -32.52 74.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 1.0 110.652 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.9 -42.13 98.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.366 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' C' ' 8' ' ' ALA . 24.6 t -58.93 -18.17 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.221 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 90' ' ' ALA . 85.9 m -43.13 -40.46 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 1.0 110.377 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' B' ' 92' ' ' ASP . . . -47.8 -63.48 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.8 -34.58 28.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 1.0 110.317 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.0 mm? -77.28 -33.42 55.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.11 -36.09 82.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.107 0.479 . . . . 1.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -4.47 37.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.142 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 86.9 m-20 -56.06 -51.55 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.049 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 19.4 p90 -68.97 -30.03 68.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.82 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.27 -42.22 89.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.443 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' C' ' 98' ' ' GLU . 97.0 mtt180 -57.28 -23.44 48.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.355 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -43.53 -33.53 1.15 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.856 0.36 . . . . 1.0 110.63 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.97 -38.25 88.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' C' ' 95' ' ' ARG . 71.4 mm-40 -65.86 -40.82 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.279 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.47 -39.32 85.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.354 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -64.82 -43.69 92.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.685 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -135.88 100.5 4.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.608 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.88 34.89 3.36 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.515 ' OXT' ' CG ' ' C' ' 103' ' ' HIS . 53.7 p-80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.972 -1.013 . . . . 1.0 110.512 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 1' ' ' SER . . . . . 0.458 ' C ' ' H ' ' D' ' 3' ' ' ASP . 58.0 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.45 ' O ' ' CB ' ' D' ' 3' ' ' ASP . . . -76.6 29.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.75 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 3' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' D' ' 1' ' ' SER . 7.0 t70 80.74 -59.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -78.39 -20.4 51.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.844 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.26 -37.98 84.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.419 . . . . 1.0 110.677 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.2 -38.41 90.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.494 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.86 -40.9 95.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.404 . . . . 1.0 109.912 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.55 96.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.749 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -67.2 -39.1 86.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.531 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -62.94 -38.21 90.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.424 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.91 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.073 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.66 -37.97 88.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 1.0 110.678 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.81 -33.97 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -65.31 -35.97 82.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.628 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.27 -41.57 98.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.372 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.69 -40.62 95.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.018 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.32 -37.4 87.12 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.997 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.87 -39.55 85.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.558 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -59.24 -40.9 87.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 1.0 109.846 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.1 mt-10 -60.85 -51.01 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 1.0 110.037 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.85 -32.32 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 109.949 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.69 95.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.1 p -58.69 -41.31 85.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.614 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.98 -32.82 74.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 44.5 mmtm -80.18 -39.3 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.333 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.5 80.07 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.886 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.578 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.1 p -62.65 -46.87 95.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.578 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.7 tm-20 -68.17 -42.75 79.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' D' ' 25' ' ' LYS . . . -86.47 71.46 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.815 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 3.1 mm-40 -157.36 -58.39 0.08 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.857 0.361 . . . . 1.0 110.337 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -79.93 124.08 28.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.152 0.501 . . . . 1.0 110.56 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.81 6.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.792 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -104.76 151.76 39.39 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.717 -0.284 . . . . 1.0 110.613 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.471 ' O ' HG11 ' D' ' 63' ' ' VAL . 72.9 Cg_endo -75.12 117.75 4.99 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.592 1.528 . . . . 1.0 112.143 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.18 29.87 8.67 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.04 140.83 52.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 1.0 110.606 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.73 -69.94 0.83 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.89 129.41 40.83 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.902 -0.406 . . . . 1.0 109.902 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -150.41 30.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.542 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 44' ' ' ALA . 1.6 p -134.25 137.61 44.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.517 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 22.5 t80 -76.17 -48.17 3.42 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.868 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.9 Cg_endo -58.9 -30.25 92.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.353 1.369 . . . . 1.0 112.096 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.77 -17.43 23.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.191 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 44' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -62.84 -38.6 91.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.34 . . . . 1.0 110.885 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.474 HG23 ' N ' ' D' ' 46' ' ' TRP . 10.2 tt -65.02 -40.58 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.502 ' CD1' HG23 ' A' ' 64' ' ' THR . 3.7 t-105 -60.42 -46.96 88.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.143 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -60.92 -33.63 73.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -66.23 -32.76 74.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.147 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.72 -48.22 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.57 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 16.1 pt-20 -69.57 -31.11 69.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.078 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -61.14 -46.55 90.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.44 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.27 -34.96 72.89 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.419 ' C ' ' H ' ' D' ' 55' ' ' VAL . 63.0 p -75.58 0.94 15.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.379 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 36.1 p 53.12 9.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.964 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.437 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.0 p -64.65 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 1.0 110.604 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.437 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 43.72 55.54 5.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -47.14 87.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 1.0 110.326 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 160.39 -103.32 0.22 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.18 -75.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.713 0.292 . . . . 1.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' D' ' 58' ' ' GLY . 69.5 mtt-85 -141.41 179.74 6.62 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.03 144.32 0.99 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.293 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.59 164.07 36.67 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.429 2.086 . . . . 1.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.471 HG11 ' O ' ' D' ' 34' ' ' PRO . 3.0 t -94.45 -128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.258 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.453 ' H ' HG12 ' D' ' 63' ' ' VAL . 55.4 m -113.96 -55.19 2.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.745 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.2 tt0 -61.68 -18.02 57.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.151 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 37.4 mm-40 -78.83 35.6 0.25 Allowed 'General case' 0 C--O 1.269 2.108 0 CA-C-O 124.025 1.869 . . . . 1.0 108.791 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 36.74 58.68 1.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.014 -1.903 . . . . 1.0 109.477 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' C' ' 50' ' ' GLU . 48.6 ttt85 -26.47 -29.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.365 0.685 . . . . 1.0 111.245 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -56.18 -12.21 1.45 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.069 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' D' ' 67' ' ' GLY . 42.6 t -62.09 -46.36 96.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 C-N-CA 119.414 -0.915 . . . . 1.0 109.745 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.26 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.183 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.02 -42.55 80.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.081 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.42 -42.94 95.78 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.758 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.24 -47.69 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.769 -0.373 . . . . 1.0 111.204 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -63.23 -41.19 99.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.101 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 76' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 79.1 tttt -61.65 -40.69 95.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.594 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.74 94.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.837 0.351 . . . . 1.0 110.476 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.94 -40.92 93.56 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.68 -43.79 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 2.6 mp0 -65.52 -43.05 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.75 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.58 -47.23 93.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.89 -0.324 . . . . 1.0 111.116 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -75.29 -8.35 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.836 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -30.33 11.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.747 0.308 . . . . 1.0 110.175 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.0 tt -64.31 -37.32 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.14 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -48.45 -9.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.523 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.4 m -49.38 -41.74 40.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.169 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.478 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -50.52 -19.3 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.529 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.68 -11.78 16.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.811 0.339 . . . . 1.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.0 -45.53 6.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.478 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.434 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.0 -16.27 12.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.111 0.482 . . . . 1.0 110.512 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.809 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.3 OUTLIER -96.06 0.33 51.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 86.7 m-20 -72.2 -27.77 62.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.555 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 5.5 p90 -79.88 -43.74 21.69 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.809 HG22 ' O ' ' D' ' 91' ' ' THR . 21.0 m -41.11 -33.39 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.004 -0.543 . . . . 1.0 111.553 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.662 HH11 ' CG2' ' D' ' 94' ' ' VAL . 11.3 mpt_? -50.9 -22.53 2.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 96' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' D' ' 97' ' ' GLU . 53.5 ptt85 -54.71 -21.69 11.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' D' ' 96' ' ' ARG . 6.1 mp0 -73.42 -58.09 3.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.0 -36.65 78.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.962 0.411 . . . . 1.0 110.484 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.44 -19.8 65.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.452 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -60.25 -44.58 95.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.265 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -94.96 -5.68 44.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.42 89.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 60.7 m170 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.435 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ALA . 8.1 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 45.17 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 67.3 t0 -131.78 45.75 2.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.496 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.609 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 10.5 p80 -154.87 -42.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 15.1 pt-20 -65.71 -38.94 90.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -64.86 -37.79 88.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.277 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -65.77 -38.87 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.72 88.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.176 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -64.28 -41.48 96.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.338 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.07 -36.7 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.57 78.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.47 -40.44 91.28 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.14 -35.07 79.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.274 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.37 -34.55 78.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.561 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 52' ' ' ALA . 43.8 tp -62.41 -39.82 94.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.07 -34.78 75.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.233 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -63.94 -46.28 85.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.29 -36.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 1.0 110.696 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 52' ' ' ALA . 79.9 mt -61.13 -41.64 97.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 1.0 109.973 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.2 mt-10 -63.78 -42.67 97.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -39.43 79.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.31 -39.76 81.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.9 p -51.42 -41.81 61.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -62.67 -47.43 83.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.057 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.33 -42.41 91.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.695 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.12 92.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.802 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 41' ' ' TYR . 99.1 t -64.35 -47.02 91.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.456 -0.497 . . . . 1.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.91 -41.49 87.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.172 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -73.49 62.16 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.744 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -173.91 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -62.13 83.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.982 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.86 5.55 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.92 133.48 22.25 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.69 131.55 13.62 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.908 1.739 . . . . 1.0 112.778 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.14 35.91 86.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.45 129.18 54.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.887 0.375 . . . . 1.0 110.953 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.37 -166.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.215 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 47' ' ' TRP . 4.1 tt 59.35 88.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.969 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.3 tt -136.19 160.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.93 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 1.5 p 79.31 137.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 1.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -64.92 -46.79 75.06 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.235 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.9 Cg_endo -60.32 -31.6 93.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.46 1.44 . . . . 1.0 112.664 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -94.2 -31.07 14.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.672 0.272 . . . . 1.0 110.704 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.92 84.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.329 . . . . 1.0 110.683 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 46' ' ' TRP . 3.5 tt -63.83 -39.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.984 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CE2' ' O ' ' B' ' 64' ' ' THR . 4.8 t-105 -59.31 -46.13 89.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' CD2' HD11 ' A' ' 38' ' ' LEU . 2.4 t90 -59.93 -39.48 85.67 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.5 t -67.71 65.39 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.676 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 47' ' ' TRP . 75.9 t -154.39 -57.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 1.0 110.23 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' CG ' HH12 ' B' ' 68' ' ' ARG . 12.3 pt-20 -66.42 -31.69 72.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -61.83 -42.93 99.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.108 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.01 -36.79 80.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.088 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 p -80.7 16.76 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 32.14 69.25 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.597 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.42 -38.28 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.64 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.12 73.3 0.36 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.661 -0.975 . . . . 1.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 15.4 t80 -60.12 -47.18 86.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 1.0 110.507 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.6 25.76 0.44 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.032 -0.827 . . . . 1.0 111.032 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 32.6 p-10 -63.49 -41.17 98.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.317 . . . . 1.0 110.421 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.514 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 94.2 mtt-85 -151.36 -161.09 1.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.335 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 8.8 p90 -169.88 100.6 0.46 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.525 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.05 165.86 29.88 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.403 1.402 . . . . 1.0 112.399 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 64' ' ' THR . 7.8 p -100.25 -159.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 110.05 -0.352 . . . . 1.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.994 ' H ' HG22 ' A' ' 63' ' ' VAL . 51.0 m -91.98 -43.9 9.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.586 0.231 . . . . 1.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' OE2' ' N ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.75 25.1 0.07 Allowed 'General case' 0 C--O 1.265 1.899 0 CA-C-O 124.116 1.913 . . . . 1.0 109.503 178.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.717 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 46.33 67.46 1.36 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.622 -1.627 . . . . 1.0 111.723 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.535 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 59.5 ttm-85 -24.15 -32.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.404 1.102 . . . . 1.0 111.158 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.717 ' N ' ' O ' ' A' ' 67' ' ' GLY . 32.3 mmtp -48.52 -31.09 5.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.55 176.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 67' ' ' GLY . 53.9 t -62.83 -49.54 83.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.28 74.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.638 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.85 -35.61 81.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -54.96 -42.85 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.683 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG11 HG23 ' A' ' 51' ' ' THR . 73.5 t -65.12 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.374 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 mmt -52.32 -56.76 12.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.378 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -36.87 85.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 1.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.53 -22.06 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.63 -28.45 8.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 36.8 mm -63.01 -43.84 99.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 121.144 -0.222 . . . . 1.0 110.484 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.07 -36.58 84.78 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.275 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.07 -72.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.145 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -51.99 -11.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.162 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -88.54 -43.8 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.788 0.328 . . . . 1.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.3 tt -63.03 -41.73 99.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.604 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 m -51.8 -8.41 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 84' ' ' LEU . 97.6 m -61.99 -25.8 67.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.275 -0.421 . . . . 1.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -57.38 -24.76 57.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.43 -11.32 24.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.859 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -90.78 -45.24 8.94 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.794 0.331 . . . . 1.0 111.416 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.06 -27.01 51.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.932 0.396 . . . . 1.0 110.987 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -4.63 58.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.55 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 87.8 m-20 -62.13 -45.02 95.33 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 7.3 p90 -76.58 -27.97 56.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.508 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.85 -40.27 82.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.296 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.82 -23.51 44.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.144 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -41.88 -40.39 2.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.797 0.332 . . . . 1.0 110.853 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -62.97 -45.68 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.918 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.46 -41.45 80.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.653 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.6 -41.6 83.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.65 -44.24 97.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.598 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.97 -37.34 85.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.532 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 21.88 42.58 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.56 179.88 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.45 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . -80.97 174.05 12.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.785 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.58 -41.91 98.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.94 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.45 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 13.4 p-80 -78.83 -31.39 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -41.62 90.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -64.34 -40.16 95.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.762 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -65.28 -44.08 89.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.954 0.407 . . . . 1.0 109.921 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.42 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.719 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.76 -40.16 87.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.332 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.02 -39.6 92.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -57.66 -34.19 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.638 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' B' ' 16' ' ' GLN . 96.6 mt-10 -78.15 -37.81 45.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.59 -45.91 84.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 1.0 110.791 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.94 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.36 -39.99 92.66 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.036 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' B' ' 12' ' ' GLU . 8.4 mp0 -69.93 -28.05 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -62.96 -46.22 88.76 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.43 ' H ' HG22 ' B' ' 18' ' ' VAL . 14.8 m -66.3 -31.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.118 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.9 mt -60.43 -41.15 93.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.62 -48.14 83.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.11 -34.47 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.151 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -46.2 86.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.251 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.555 ' O ' HG23 ' B' ' 27' ' ' VAL . 66.7 p -59.81 -46.62 88.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.928 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -61.49 -53.53 55.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.412 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.3 mttm -59.13 -43.9 92.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.008 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.419 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -59.77 -38.19 81.15 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.958 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 23' ' ' SER . 69.1 t -66.68 -44.43 89.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.712 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -83.5 -9.95 58.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.622 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.77 -39.0 90.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 32' ' ' GLY . 9.6 mp0 -68.93 -37.53 78.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 1.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.54 83.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.078 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 127.51 -14.1 6.49 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 111.397 -0.681 . . . . 1.0 111.397 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.81 143.8 27.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 O-C-N 122.795 -0.238 . . . . 1.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.78 157.11 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.054 1.836 . . . . 1.0 112.428 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.98 37.19 64.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.76 21.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.848 0.356 . . . . 1.0 110.566 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.49 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.582 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.566 ' O ' HD13 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -63.37 -30.14 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.646 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.615 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -38.5 108.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.094 0.473 . . . . 1.0 110.757 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.3 p 163.22 102.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.97 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -56.43 -47.39 99.01 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.848 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.6 Cg_endo -57.49 -36.86 98.65 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.384 1.389 . . . . 1.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' CZ ' ' B' ' 60' ' ' ARG . 46.7 p30 -100.38 -0.76 37.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.696 0.284 . . . . 1.0 110.984 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.94 89.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.947 0.403 . . . . 1.0 110.525 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 49' ' ' VAL . 7.3 tt -68.82 -40.99 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.694 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.438 ' NE1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -61.54 -45.5 93.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.408 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.513 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 9.9 t90 -63.59 -42.68 98.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.421 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' B' ' 19' ' ' LEU . 31.3 p -65.6 -25.96 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.041 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 45' ' ' ILE . 20.4 t -71.77 -25.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -98.37 -9.47 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.996 -0.282 . . . . 1.0 111.178 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -36.18 20.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 1.0 111.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -69.1 -22.84 63.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.475 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 67.3 p -83.87 0.2 48.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.661 0.267 . . . . 1.0 110.712 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 26.1 p 51.12 60.3 3.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.516 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' THR . 48.1 t -133.11 -48.13 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.519 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.35 76.44 0.18 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -60.04 -47.78 84.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.808 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.74 24.93 0.58 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 67.9 t0 -62.29 -49.14 76.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.352 . . . . 1.0 110.768 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.512 ' CZ ' ' OD2' ' B' ' 43' ' ' ASP . 91.7 mtt-85 -143.83 -164.44 1.88 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.139 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -150.99 118.96 3.42 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.108 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.25 153.35 71.42 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.366 1.378 . . . . 1.0 112.094 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.59 -169.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.5 ' O ' ' CE2' ' A' ' 46' ' ' TRP . 1.2 m -108.61 -62.56 1.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.993 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 64' ' ' THR . 79.9 tt0 -40.16 -28.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 1.0 110.769 -178.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' B' ' 68' ' ' ARG . 94.1 mt-10 -143.87 -101.32 0.12 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.256 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.02 -55.55 0.0 OUTLIER Glycine 0 N--CA 1.479 1.519 0 O-C-N 124.613 1.195 . . . . 1.0 114.223 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.905 ' N ' ' O ' ' B' ' 66' ' ' GLU . 60.4 ttm-85 -66.18 -72.48 0.16 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -42.18 -36.36 1.17 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.66 -46.03 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.809 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -70.93 -45.17 64.7 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.217 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -45.37 -48.63 13.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.064 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -61.75 -44.74 96.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -46.44 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.283 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -61.77 -38.65 88.8 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.97 85.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.325 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.42 -37.05 92.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.96 -43.85 99.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 84' ' ' LEU . 97.8 mt-10 -63.18 -38.8 92.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 1.0 110.456 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' B' ' 11' ' ' ALA . 25.1 t -62.25 -70.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.86 -14.76 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.41 -35.1 11.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.319 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' B' ' 80' ' ' GLU . 5.2 tt -63.53 -40.96 98.38 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.345 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.432 ' C ' ' N ' ' B' ' 87' ' ' ALA . 35.6 m -55.07 -16.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.737 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.4 m -44.45 -24.06 0.16 Allowed 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.159 0.504 . . . . 1.0 109.68 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.33 -45.23 94.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.522 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -12.7 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.673 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.6 mm? -92.49 -25.78 18.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.006 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -67.82 -40.49 83.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.617 . . . . 1.0 109.894 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -16.32 62.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.126 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -43.68 -65.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.138 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' B' ' 94' ' ' VAL . 30.6 p90 -64.16 -47.14 81.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.278 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 66.0 t -37.66 -28.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.713 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ARG . . . . . 0.475 ' C ' ' N ' ' B' ' 97' ' ' GLU . 99.8 mtt180 -63.64 -37.57 87.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.902 -0.319 . . . . 1.0 111.4 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 93' ' ' PHE . 44.1 ptt85 -46.75 -15.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 1.0 110.303 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 100' ' ' ARG . 43.6 tp10 -63.31 -41.82 98.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.883 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.3 -40.58 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 1.0 110.775 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' B' ' 99' ' ' GLU . 59.0 mp0 -69.44 -36.46 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.899 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 97' ' ' GLU . 55.0 ttp180 -60.62 -45.22 94.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -79.76 -14.83 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.529 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 77.43 21.48 72.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 103' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 33.7 p80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -157.62 170.52 22.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.701 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.45 -50.7 70.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.396 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.485 ' CE1' ' HB1' ' C' ' 2' ' ' ALA . 6.8 p-80 -68.87 -38.17 79.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.839 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' C' ' 2' ' ' ALA . 96.4 mt-10 -64.26 -44.5 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -65.06 -39.07 92.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.864 0.364 . . . . 1.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -64.19 -41.01 97.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.15 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.39 -42.03 93.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.273 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -63.61 -38.68 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.521 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.49 71.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.66 -39.59 94.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.32 . . . . 1.0 111.009 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -63.41 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.292 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.49 -34.37 78.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.677 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.1 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.77 -39.64 94.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.244 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -61.52 -38.79 88.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.304 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.69 -42.67 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.683 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' C' ' 52' ' ' ALA . 96.0 mt -60.9 -40.15 92.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.358 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.2 -54.92 37.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 1.0 110.496 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.41 -37.5 83.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.438 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.43 89.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.386 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -65.83 -33.55 76.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.189 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' C' ' 29' ' ' ALA . 53.7 mttp -70.42 -46.61 63.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' C' ' 29' ' ' ALA . . . -55.59 -50.31 70.43 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.246 0.341 . . . . 1.0 111.446 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.494 HG13 ' N ' ' C' ' 28' ' ' GLU . 5.0 p -60.98 -46.77 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.457 -0.497 . . . . 1.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.494 ' N ' HG13 ' C' ' 27' ' ' VAL . 40.7 tp10 -69.32 -28.59 66.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -51.64 -49.84 61.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.762 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -96.78 -99.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 1.0 110.545 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' C' ' 30' ' ' GLU . 30.1 mmm-85 46.71 59.46 3.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.554 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.7 4.81 7.93 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.69 61.14 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.42 120.0 5.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.884 1.723 . . . . 1.0 111.773 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.82 13.61 62.33 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 146.09 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 1.0 110.267 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.8 -30.16 2.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.485 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.19 51.47 2.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 pt -80.0 16.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.751 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.3 t -114.0 126.28 54.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.63 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 8.1 t80 -78.12 -49.95 1.85 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.923 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 27.6 Cg_endo -60.12 -29.23 88.68 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.388 1.392 . . . . 1.0 112.402 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -89.12 -3.82 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.058 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.44 96.16 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.732 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -65.55 -40.84 89.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.494 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.433 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.07 -45.83 90.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.497 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -61.03 -41.35 96.4 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.242 -0.583 . . . . 1.0 109.482 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.422 ' O ' HD22 ' C' ' 19' ' ' LEU . 39.1 p -72.37 64.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -149.09 -51.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.503 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -66.65 -32.72 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.936 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.4 ' H ' HG22 ' C' ' 51' ' ' THR . 0.0 OUTLIER -59.17 -44.05 92.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.969 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.23 -26.46 60.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.753 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -87.31 -3.59 59.04 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.847 0.356 . . . . 1.0 110.145 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.7 p 51.7 48.75 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.082 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.73 -28.29 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.254 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.72 59.77 7.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.518 -1.033 . . . . 1.0 110.518 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -48.1 82.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 1.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.13 38.66 0.63 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' C' ' 59' ' ' ASP . 12.8 p-10 -65.27 -40.54 94.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.92 0.39 . . . . 1.0 110.601 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.464 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 30.2 mmt180 -130.4 -161.01 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.118 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.464 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 56.5 m-85 -158.59 75.54 3.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.626 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.16 156.0 66.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.058 1.839 . . . . 1.0 111.997 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 1.061 HG22 ' H ' ' C' ' 64' ' ' THR . 8.6 p -100.97 -155.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.009 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 64' ' ' THR . . . . . 1.061 ' H ' HG22 ' C' ' 63' ' ' VAL . 34.7 m -89.54 -46.25 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.291 . . . . 1.0 110.638 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' C' ' 67' ' ' GLY . 11.7 tm-20 -44.38 -40.18 5.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' C' ' 68' ' ' ARG . 0.1 OUTLIER -70.17 24.08 0.03 OUTLIER 'General case' 0 C--O 1.266 1.963 0 CA-C-O 123.855 1.788 . . . . 1.0 109.915 178.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.754 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 44.86 66.12 1.56 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 113.984 -1.462 . . . . 1.0 111.615 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.553 ' N ' ' OE2' ' C' ' 66' ' ' GLU . 56.1 ttm-85 -25.4 -28.31 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.17 0.985 . . . . 1.0 111.382 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.8 tppp? -52.04 -26.92 12.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.305 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.1 t -61.75 -47.19 94.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 C-N-CA 119.201 -1.0 . . . . 1.0 110.593 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -39.93 84.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.0 110.634 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.92 -38.28 88.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.721 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.2 -44.46 79.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.256 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.92 -43.76 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.229 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.1 mtt -59.54 -43.56 93.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.953 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.12 -41.34 97.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.64 90.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.834 0.35 . . . . 1.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.42 -41.53 96.39 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.761 -0.536 . . . . 1.0 111.761 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.62 -43.01 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.599 0.238 . . . . 1.0 110.761 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.56 -43.66 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.545 -0.298 . . . . 1.0 111.143 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.38 -49.23 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.136 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.296 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 1.0 110.468 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.4 tt -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.507 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.449 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.6 t -49.32 -12.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 1.0 110.491 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' C' ' 84' ' ' LEU . 85.9 m -60.82 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.268 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.46 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -59.69 -36.31 76.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.057 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 -38.3 21.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.43 -38.65 87.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.083 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -59.23 -35.45 73.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.021 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -83.0 -4.3 58.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.522 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 42.4 t0 -58.07 -47.9 81.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.672 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 8.4 p90 -66.87 -39.0 87.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.525 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 95.9 t -43.84 -36.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.511 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.21 -23.12 65.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.647 0.261 . . . . 1.0 111.179 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -57.09 -42.6 81.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.66 -39.29 93.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.06 -39.61 86.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.851 0.358 . . . . 1.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.78 -35.43 80.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.449 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.22 -44.75 94.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.678 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.67 -37.38 84.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' C' ' 103' ' ' HIS . . . 83.85 22.58 55.18 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 103' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' C' ' 102' ' ' GLY . 81.0 m80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.641 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -79.57 174.5 11.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.539 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.9 -42.94 99.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.9 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.9 p-80 -73.36 -32.62 64.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.535 -0.302 . . . . 1.0 110.793 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.24 -37.42 87.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 1.0 110.551 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.26 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.47 -36.75 83.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.491 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.06 -37.72 86.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.04 79.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.021 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.24 -36.02 82.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 1.0 110.668 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.29 -38.45 91.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.665 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.36 -33.23 75.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.627 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' D' ' 52' ' ' ALA . 40.9 tp -62.01 -42.01 98.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 1.0 110.441 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.01 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.965 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -62.25 -42.99 99.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.96 0.41 . . . . 1.0 111.063 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' D' ' 22' ' ' ALA . 96.9 t -63.83 -35.56 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.689 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.9 mt -61.6 -41.81 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.679 -0.409 . . . . 1.0 109.922 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.81 -50.46 62.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.543 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.29 -39.8 86.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.379 . . . . 1.0 110.422 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' D' ' 18' ' ' VAL . . . -65.07 -37.51 87.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -57.38 -45.74 84.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.74 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -67.93 -35.33 78.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.578 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.75 -46.31 69.17 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.893 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -55.66 -51.83 65.92 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.891 -0.323 . . . . 1.0 111.204 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.506 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.5 p -62.62 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.264 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.506 ' N ' HG13 ' D' ' 27' ' ' VAL . 82.6 tt0 -64.55 -39.4 93.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.681 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 1.1 mp0 -68.31 -41.24 81.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.477 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.49 107.75 0.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.009 0.433 . . . . 1.0 110.37 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.61 -13.99 24.96 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.16 144.94 29.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.532 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.4 Cg_endo -74.79 143.63 30.05 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.157 1.905 . . . . 1.0 112.328 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 26.58 70.54 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.41 144.23 57.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 1.0 110.649 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -16.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.554 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 30.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.952 0.406 . . . . 1.0 110.08 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' D' ' 40' ' ' SER . 42.2 pt -77.34 -158.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.445 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.1 t 80.53 -137.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.606 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' D' ' 40' ' ' SER . 5.7 m-85 -168.44 -59.88 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 19.6 Cg_endo -58.55 -32.04 95.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.65 1.566 . . . . 1.0 111.95 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' D' ' 44' ' ' ALA . 18.2 p30 -87.75 -22.69 24.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.326 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' D' ' 43' ' ' ASP . . . -64.04 -41.51 97.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.349 . . . . 1.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.65 -41.83 85.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.213 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.477 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.1 OUTLIER -60.88 -36.89 80.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.114 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -62.53 -39.64 94.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.646 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.426 ' O ' HD22 ' D' ' 19' ' ' LEU . 83.3 p -65.93 -29.47 69.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.773 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.92 -48.61 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.99 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.93 69.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' D' ' 52' ' ' ALA . 28.6 m -90.65 89.09 7.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 1.0 109.838 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' D' ' 51' ' ' THR . . . 169.44 -23.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.37 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 4.2 p -110.64 29.98 7.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.981 0.419 . . . . 1.0 110.482 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 32.8 p 52.51 70.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -124.12 -66.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.717 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.01 53.13 31.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -48.76 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.321 . . . . 1.0 110.518 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.7 29.72 1.03 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.02 -43.33 99.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -140.93 169.03 18.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.917 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -141.09 111.55 6.62 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.712 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.75 156.2 63.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.747 1.632 . . . . 1.0 112.491 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.532 HG11 ' O ' ' D' ' 34' ' ' PRO . 1.8 t -80.06 -142.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.106 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.532 ' H ' HG12 ' D' ' 63' ' ' VAL . 26.5 m -113.34 -48.1 2.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.751 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' D' ' 67' ' ' GLY . 49.9 tp10 -58.62 -20.77 50.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.095 0.474 . . . . 1.0 109.9 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' D' ' 63' ' ' VAL . 0.6 OUTLIER -75.74 27.52 0.11 Allowed 'General case' 0 C--O 1.265 1.873 0 CA-C-O 123.543 1.64 . . . . 1.0 109.13 178.336 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.44 61.62 2.41 Favored Glycine 0 C--O 1.211 -1.287 0 CA-C-N 114.066 -1.425 . . . . 1.0 109.989 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 61.0 ttm-85 -25.18 -29.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.486 0.643 . . . . 1.0 111.42 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 72.5 mmtt -56.86 -14.27 3.32 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.659 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.2 t -62.31 -47.32 93.64 Favored 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.55 85.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.29 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.44 -37.77 81.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.141 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.49 -44.05 95.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.647 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.416 ' H ' HG23 ' D' ' 74' ' ' VAL . 3.5 t -64.75 -46.57 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.276 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.14 -40.49 94.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.238 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.67 -43.25 99.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.794 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.449 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.63 -39.06 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.537 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.37 -42.85 97.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.641 -0.583 . . . . 1.0 111.641 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.43 -43.4 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.616 0.246 . . . . 1.0 111.237 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.63 -40.96 98.2 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.39 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 77' ' ' ALA . 64.2 t -62.09 -48.07 90.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.294 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.35 -5.09 43.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.659 -0.416 . . . . 1.0 110.952 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.76 -37.01 10.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.739 0.304 . . . . 1.0 110.407 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.6 tt -62.7 -41.79 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.424 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.36 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' LEU . 57.7 m -56.88 -20.82 25.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.244 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.23 -36.73 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.347 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.4 -28.65 28.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.139 0.495 . . . . 1.0 110.062 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.78 -37.76 79.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.784 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE1' ' D' ' 93' ' ' PHE . . . -58.29 -44.68 88.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.259 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -5.79 49.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.209 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.1 t0 -58.79 -49.73 76.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.895 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -75.23 -28.86 60.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.825 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.47 -44.29 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.265 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.449 ' O ' ' OE1' ' D' ' 99' ' ' GLU . 17.5 tpp180 -45.13 -28.36 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.99 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -48.79 -30.9 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 1.0 110.502 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.536 ' OE2' ' NH2' ' D' ' 100' ' ' ARG . 80.3 mm-40 -58.54 -23.39 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.908 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -82.53 -41.06 20.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.882 0.372 . . . . 1.0 110.624 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' D' ' 99' ' ' GLU . 51.4 mp0 -67.19 -41.75 85.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.621 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.536 ' NH2' ' OE2' ' D' ' 97' ' ' GLU . 15.0 ttm180 -60.84 -46.72 89.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.161 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.35 -36.03 78.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.357 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.54 47.91 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.67 179.791 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.67 -73.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -172.14 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.507 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 7.6 p80 -78.12 -24.25 47.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.495 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.9 -35.84 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.42 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.99 -38.91 92.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.085 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.42 -44.1 88.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.011 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.407 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -66.76 -39.15 87.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -65.46 -41.21 93.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 53.8 tttp -63.93 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.42 -36.04 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.894 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.45 -32.7 72.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -65.22 -37.81 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.424 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 6.6 mp0 -60.91 -42.54 98.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 52' ' ' ALA . 48.5 tp -63.26 -42.39 99.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.737 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -57.37 -42.12 81.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.568 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -63.71 -40.02 95.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 1.0 111.381 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.4 -36.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.2 mt -60.03 -41.16 91.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.34 -47.25 86.1 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.59 -33.2 72.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.158 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -45.7 85.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . 77.7 p -60.06 -42.4 94.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -62.57 -60.51 3.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.66 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.16 -43.72 98.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.938 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 30' ' ' GLU . . . -61.15 -40.31 93.38 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.98 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' SER . 55.0 t -63.88 -48.36 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.454 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -72.44 -23.8 61.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.523 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.504 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -49.82 -49.18 49.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.316 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 30.2 mp0 -68.65 -35.83 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -67.54 88.19 0.22 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.893 0.377 . . . . 1.0 110.962 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.65 6.25 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.63 -0.588 . . . . 1.0 111.63 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 154.05 39.49 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.85 150.61 39.16 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.253 1.969 . . . . 1.0 112.205 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 32.53 63.06 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.23 14.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 1.0 110.611 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.75 -65.09 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.628 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 51.0 tp -66.34 78.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.077 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 39' ' ' ILE . 15.8 tt -121.04 79.56 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 1.0 110.107 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 44' ' ' ALA . 18.1 m -172.02 103.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.836 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 46.5 t80 -54.87 -50.11 87.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.882 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -60.03 -34.82 94.56 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.417 1.411 . . . . 1.0 112.729 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 60.8 m-20 -92.92 -22.72 19.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.68 -0.236 . . . . 1.0 111.146 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.78 82.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 1.0 110.391 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.424 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.2 tt -60.72 -36.09 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.115 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.479 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -63.07 -46.78 85.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 2.1 t90 -62.54 -41.22 98.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.43 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 96.9 p -60.23 -35.8 76.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.074 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 45' ' ' ILE . 43.6 t -60.47 -49.36 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.943 0.401 . . . . 1.0 110.733 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 19.3 pt-20 -75.64 -23.73 56.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.51 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 95.2 m -62.49 -45.88 91.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.099 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.06 -36.59 75.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 55' ' ' VAL . 76.5 p -73.92 -0.94 17.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.1 p 53.33 5.34 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 53' ' ' THR . 7.7 p -66.4 -41.98 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.04 81.08 0.02 OUTLIER Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.41 ' OH ' ' O ' ' B' ' 60' ' ' ARG . 40.7 t80 -60.27 -45.51 93.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.855 0.359 . . . . 1.0 110.593 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.83 16.89 0.96 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.61 -46.18 90.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.944 0.402 . . . . 1.0 110.382 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -141.71 149.77 40.96 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.898 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -118.56 120.89 31.4 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.621 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 154.93 67.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.84 1.693 . . . . 1.0 112.57 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 63' ' ' VAL . 4.5 m -60.82 -168.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.154 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.537 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 1.5 m -110.29 -62.21 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.101 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -41.63 -31.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.062 0.458 . . . . 1.0 110.425 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.875 ' O ' ' N ' ' A' ' 68' ' ' ARG . 97.2 mt-10 -138.48 -105.83 0.18 Allowed 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.317 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 20.67 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.478 1.435 0 O-C-N 124.476 1.11 . . . . 1.0 114.438 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.875 ' N ' ' O ' ' A' ' 66' ' ' GLU . 33.7 ttm180 -70.78 -45.44 64.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' GLU . 27.8 tptp -62.39 -40.93 98.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.28 -45.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.82 81.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -49.2 -50.41 38.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.53 -40.63 95.96 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.05 -45.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.222 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.96 -39.67 95.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -60.25 -42.14 94.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.52 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.6 -40.29 94.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.483 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 -41.53 93.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.55 -43.78 98.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 1.0 110.274 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 84' ' ' LEU . 97.2 mt-10 -65.28 -44.7 87.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.581 -0.447 . . . . 1.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 77' ' ' ALA . 53.4 t -63.62 -47.72 90.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -68.33 -28.95 67.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.981 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -25.46 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.281 . . . . 1.0 110.888 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 80' ' ' GLU . 4.7 tt -63.65 -42.01 98.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.568 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.4 m -49.16 -22.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.253 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.671 ' HA ' HD22 ' A' ' 89' ' ' LEU . 54.0 m -36.55 -24.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.216 0.531 . . . . 1.0 110.566 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -59.57 -41.74 90.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.789 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -78.55 -21.05 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 1.0 110.969 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 86' ' ' THR . 6.7 mp -66.32 -38.54 87.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -67.38 -62.49 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 1.0 111.588 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -46.19 -9.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.321 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' ALA . 83.3 m-20 -58.51 -50.01 75.31 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.831 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 1.9 p90 -69.79 -30.18 67.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.105 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG11 ' NH2' ' D' ' 96' ' ' ARG . 89.6 t -59.5 -42.29 87.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.385 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -53.07 -21.45 4.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.704 0.288 . . . . 1.0 111.057 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -54.61 -32.94 59.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.783 0.325 . . . . 1.0 110.616 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.41 -41.78 81.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.896 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.42 -34.59 76.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.449 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.7 -30.12 71.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.491 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -58.56 -45.09 89.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.73 -37.85 85.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 1.0 110.449 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.67 9.75 60.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.066 -0.969 . . . . 1.0 110.561 179.795 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.416 ' CB ' ' NE2' ' B' ' 4' ' ' HIS . . . -82.02 172.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.669 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.8 -36.22 83.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.668 ' H ' ' CD2' ' B' ' 4' ' ' HIS . 5.2 p80 -80.57 -32.58 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 1.0 110.501 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -42.87 91.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.009 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -64.95 -39.95 94.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.635 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.84 -40.63 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.973 0.416 . . . . 1.0 110.023 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.72 94.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.659 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -66.25 -37.85 86.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.26 -40.49 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.64 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.76 78.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.912 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.31 -38.84 92.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.415 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.63 -36.4 83.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.257 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -65.68 -33.56 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.07 -42.17 99.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.14 -39.32 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.932 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -61.61 -40.14 93.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 1.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -63.02 -41.82 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.2 mt -60.61 -40.87 93.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -48.57 80.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.72 -39.42 84.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.918 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.76 82.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.315 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -54.77 -46.59 74.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -66.54 -41.93 87.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.352 0.596 . . . . 1.0 110.043 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.52 64.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.941 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.484 HG13 ' N ' ' B' ' 28' ' ' GLU . 11.6 p -69.82 -43.94 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.74 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.484 ' N ' HG13 ' B' ' 27' ' ' VAL . 41.6 tp10 -63.36 -43.87 96.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.736 -0.666 . . . . 1.0 110.775 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.75 81.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.224 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -88.41 -7.69 56.21 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.751 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -83.59 107.44 16.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.377 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.49 -3.02 53.68 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.535 -0.626 . . . . 1.0 111.535 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.58 149.64 46.84 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 110.25 -0.278 . . . . 1.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.51 142.42 26.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.161 1.907 . . . . 1.0 112.369 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.7 22.7 59.92 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.131 -0.787 . . . . 1.0 111.131 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.33 144.38 54.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.706 0.289 . . . . 1.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.54 -41.9 5.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.472 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.499 HD11 ' OD1' ' B' ' 43' ' ' ASP . 40.6 tp -92.02 74.81 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.021 0.439 . . . . 1.0 110.577 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 pt -102.26 2.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.468 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' B' ' 43' ' ' ASP . 78.6 p -75.33 -120.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.664 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.508 ' N ' ' OG ' ' B' ' 40' ' ' SER . 0.5 OUTLIER 171.5 -58.87 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.125 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -57.91 -31.77 93.45 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.869 1.713 . . . . 1.0 112.576 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' B' ' 40' ' ' SER . 3.4 p30 -91.69 0.35 57.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.653 0.263 . . . . 1.0 110.727 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.03 89.61 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.96 0.409 . . . . 1.0 110.233 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.7 -42.02 88.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.949 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.657 ' CD1' HG23 ' C' ' 64' ' ' THR . 6.2 t-105 -60.98 -46.33 91.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.263 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -61.43 -40.43 94.41 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' B' ' 19' ' ' LEU . 23.7 m -71.91 62.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.411 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.0 -50.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.153 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 56' ' ' GLY . 2.8 pp20? -66.99 -31.58 72.23 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.833 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.505 ' O ' ' SD ' ' B' ' 75' ' ' MET . 0.0 OUTLIER -59.22 -45.93 89.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.796 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.76 -27.17 62.81 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 31.9 p -89.33 4.52 48.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.641 0.258 . . . . 1.0 110.855 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 54' ' ' THR . 11.7 p 56.34 76.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.611 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' B' ' 57' ' ' TYR . 59.0 t -147.0 -82.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.693 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.493 ' N ' ' OE1' ' B' ' 50' ' ' GLU . . . 72.94 77.87 0.56 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.532 ' CE1' HG11 ' B' ' 55' ' ' VAL . 78.7 m-85 -60.97 -45.03 96.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 1.0 111.057 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.55 27.62 0.28 Allowed Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' HH22 ' C' ' 68' ' ' ARG . 67.2 t0 -63.9 -48.27 77.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 1.0 110.861 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' CG ' ' B' ' 43' ' ' ASP . 2.2 mpt_? -114.79 -167.41 1.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.133 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 17.5 t80 -164.32 78.84 1.46 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.599 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.56 156.19 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.531 1.487 . . . . 1.0 111.998 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.463 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 31.8 m -103.78 -149.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 46' ' ' TRP . 22.3 m -96.81 -38.85 9.7 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.632 -0.258 . . . . 1.0 110.842 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.0 tm-20 -56.19 -35.41 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.1 OUTLIER -74.19 26.82 0.08 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-O 123.768 1.747 . . . . 1.0 109.844 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.66 65.91 1.09 Allowed Glycine 0 C--O 1.217 -0.949 0 CA-C-N 113.62 -1.627 . . . . 1.0 111.449 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.544 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -24.82 -31.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.061 0.931 . . . . 1.0 110.897 -178.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' B' ' 67' ' ' GLY . 60.5 mttp -45.14 -23.85 0.2 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 67' ' ' GLY . 72.5 t -63.57 -47.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 C-N-CA 119.748 -0.781 . . . . 1.0 109.977 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.09 82.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.17 -39.29 92.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.016 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -47.26 -54.66 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.436 HG11 HG23 ' B' ' 51' ' ' THR . 85.8 t -65.96 -42.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 1.0 111.34 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' B' ' 51' ' ' THR . 5.6 tpp -56.73 -47.97 78.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.493 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.42 -41.07 85.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.537 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.51 74.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.688 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.31 97.81 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.438 -0.665 . . . . 1.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.38 -25.11 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.089 -0.244 . . . . 1.0 111.37 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -72.16 -53.19 13.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 1.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 82' ' ' PHE . 6.9 m -61.66 -47.09 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.355 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.429 ' N ' HG23 ' B' ' 81' ' ' VAL . 14.6 m-85 -63.63 -38.51 91.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.844 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.62 96.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.568 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.463 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.2 tt -63.96 -41.74 97.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 85' ' ' VAL . 63.5 t -51.47 -11.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 70.7 m -60.8 -38.73 86.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -38.91 -62.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.974 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.12 20.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.398 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 86' ' ' THR . 55.7 mt -98.3 -4.11 35.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -93.17 -25.16 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.622 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -84.05 -4.67 58.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.586 -0.733 . . . . 1.0 110.04 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 92' ' ' ASP . 11.6 p-10 -57.43 -47.98 80.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 8.2 p90 -67.51 -30.79 70.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 1.0 111.308 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.99 -44.38 94.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.366 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -65.91 -21.9 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.674 ' NH1' HH21 ' B' ' 100' ' ' ARG . 68.8 ttp85 -58.78 -42.98 90.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.109 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.83 -57.26 6.67 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.229 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' B' ' 101' ' ' ARG . 14.6 pt-20 -67.04 -33.38 75.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 1.0 110.723 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -61.49 -44.69 96.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.487 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.674 HH21 ' NH1' ' B' ' 96' ' ' ARG . 16.4 ttm105 -70.15 -43.19 71.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.578 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 98' ' ' GLU . 89.4 mtt180 -107.21 117.39 33.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.319 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.6 -21.81 13.92 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.533 179.806 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' SER . . . . . 0.53 ' O ' ' N ' ' C' ' 3' ' ' ASP . 9.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' C' ' 4' ' ' HIS . . . 43.09 17.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.863 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' C' ' 1' ' ' SER . 97.1 m-20 56.76 -73.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.735 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' C' ' 2' ' ' ALA . 33.2 p80 -54.37 -42.6 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.191 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.6 tt0 -64.52 -34.29 77.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.722 0.296 . . . . 1.0 110.633 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -60.78 -45.68 93.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 1.0 109.916 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.57 -42.88 98.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.072 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.09 94.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.429 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -65.0 -42.62 94.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.01 -35.53 81.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.29 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.87 83.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.85 -36.81 85.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.36 -35.24 80.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 1.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -64.77 -36.32 83.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.538 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.42 HD13 ' HA2' ' C' ' 78' ' ' GLY . 42.9 tp -62.42 -40.94 98.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.539 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -59.28 -38.84 81.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -39.69 93.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.804 0.335 . . . . 1.0 111.018 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.19 -33.77 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.3 mt -61.75 -41.83 98.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.45 -46.23 89.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.878 -0.415 . . . . 1.0 109.878 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.51 -39.84 77.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.252 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.96 -36.4 83.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 86.6 p -60.0 -46.16 90.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.68 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 24' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' C' ' 28' ' ' GLU . 14.8 tmtt? -66.41 -37.18 84.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.508 . . . . 1.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' C' ' 29' ' ' ALA . 14.5 mptt -70.26 -40.99 74.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.481 . . . . 1.0 109.927 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.04 66.81 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.102 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' C' ' 28' ' ' GLU . 10.7 p -64.6 -43.15 96.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.07 0.462 . . . . 1.0 109.962 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 28' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' C' ' 24' ' ' LYS . 82.9 tt0 -66.58 -35.14 79.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.319 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -58.01 -26.9 62.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.84 -37.62 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -70.85 101.58 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.745 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 32' ' ' GLY . . . . . 0.444 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 125.96 -22.53 6.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.64 143.93 27.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 97.4 Cg_endo -75.87 138.73 21.34 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.976 1.784 . . . . 1.0 112.391 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 37.07 13.08 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.02 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 1.0 110.64 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -149.32 -39.95 0.15 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 40' ' ' SER . 0.5 OUTLIER -71.45 12.49 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.021 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' C' ' 37' ' ' ALA . 21.3 tt -46.5 -13.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.516 ' N ' ' O ' ' C' ' 38' ' ' LEU . 5.4 m -65.5 146.17 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.316 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.539 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 9.8 m-85 -102.36 -63.66 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.547 ' O ' HG22 ' C' ' 45' ' ' ILE . 24.4 Cg_endo -59.35 -34.89 97.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.884 1.722 . . . . 1.0 112.256 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -83.54 -7.56 59.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.203 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.1 89.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.749 0.309 . . . . 1.0 110.917 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.547 HG22 ' O ' ' C' ' 42' ' ' PRO . 9.9 tt -64.05 -32.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.578 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.493 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.2 OUTLIER -62.81 -46.43 87.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.314 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 14.0 t90 -62.05 -40.0 94.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.354 -0.538 . . . . 1.0 109.775 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -59.17 -36.74 75.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.126 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.23 -48.22 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.418 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.0 pt-20 -72.3 -26.82 62.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.459 -0.496 . . . . 1.0 110.949 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 94.4 m -63.47 -50.11 70.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.548 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -59.47 -26.08 64.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.136 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.457 ' C ' ' H ' ' C' ' 55' ' ' VAL . 39.3 p -88.44 -0.07 56.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 55.88 6.06 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.671 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' C' ' 53' ' ' THR . 64.2 t -64.89 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.89 58.08 6.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.395 -1.082 . . . . 1.0 110.395 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 1.7 t80 -59.99 -48.83 80.08 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 164.31 -99.74 0.17 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 59' ' ' ASP . . . . . 0.444 ' OD1' ' NE ' ' C' ' 60' ' ' ARG . 44.4 t0 51.58 -80.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 1.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' C' ' 58' ' ' GLY . 12.9 mmt180 -118.64 -167.99 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.47 ' CE1' ' CB ' ' C' ' 37' ' ' ALA . 26.2 p90 -160.1 129.49 3.24 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.644 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.69 161.86 44.27 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.802 1.668 . . . . 1.0 111.976 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 0.5 OUTLIER -86.45 -152.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.003 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.657 HG23 ' CD1' ' B' ' 46' ' ' TRP . 19.6 m -112.15 -73.28 0.68 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' C' ' 64' ' ' THR . 78.9 tt0 -32.17 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.15 0.5 . . . . 1.0 111.125 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 78.1 mm-40 -138.96 -101.62 0.17 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.524 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.58 -56.07 0.0 OUTLIER Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.792 1.308 . . . . 1.0 114.415 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.9 ttm-85 -71.41 -70.19 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.282 -0.459 . . . . 1.0 110.28 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -46.1 -38.39 8.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.39 -44.77 86.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.262 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.83 82.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.055 0.455 . . . . 1.0 110.07 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -48.89 -48.89 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -65.59 -39.31 91.46 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.524 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.66 -45.68 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.39 -40.67 97.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.927 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -61.62 -38.15 86.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.708 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.34 83.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.348 . . . . 1.0 110.39 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.45 -42.2 89.59 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.08 -43.15 95.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 1.0 110.72 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.5 -42.38 95.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.01 -48.37 86.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.1 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' PHE . . . . . 0.538 ' O ' HG22 ' C' ' 85' ' ' VAL . 36.6 m-85 -66.01 -39.88 90.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.069 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.18 -28.18 64.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.847 0.356 . . . . 1.0 110.773 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.4 tt -63.93 -38.96 92.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.711 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 85' ' ' VAL . . . . . 0.538 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.8 m -51.97 -4.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.561 ' H ' ' C ' ' C' ' 84' ' ' LEU . 53.3 m -49.28 -38.9 28.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.936 0.398 . . . . 1.0 109.974 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -47.47 -18.31 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.461 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 88' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' C' ' 86' ' ' THR . . . -105.85 -14.07 15.33 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.725 0.297 . . . . 1.0 110.797 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' C' ' 86' ' ' THR . 86.7 mt -84.93 -51.84 6.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.587 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -56.91 -46.86 81.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.064 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.6 OUTLIER -77.63 -4.43 45.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.503 -179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -56.86 -48.59 77.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.451 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 14.6 p90 -73.42 -40.09 64.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 94' ' ' VAL . . . . . 0.49 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 92.6 t -43.56 -27.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.732 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -60.87 -22.82 64.66 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.905 -0.318 . . . . 1.0 111.247 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -63.09 -37.38 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 1.0 110.591 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.19 -33.09 75.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.698 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' C' ' 100' ' ' ARG . 98.5 mt-10 -106.64 -176.36 3.05 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 66.4 -56.14 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.532 0.52 . . . . 1.0 110.613 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.586 HH22 ' NH2' ' C' ' 101' ' ' ARG . 70.9 ttp85 -59.38 -43.67 92.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 101' ' ' ARG . . . . . 0.586 ' NH2' HH22 ' C' ' 100' ' ' ARG . 1.8 mpt_? -64.42 -36.95 85.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.209 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.5 23.46 33.8 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.447 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.319 -0.623 . . . . 1.0 109.319 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . 44.07 88.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 1.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.42 -39.78 95.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.751 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.472 ' CE1' HH21 ' D' ' 95' ' ' ARG . 56.4 p-80 -60.02 -46.15 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.056 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.437 ' N ' ' CG ' ' D' ' 4' ' ' HIS . 81.3 tt0 -62.87 -39.43 94.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.862 0.363 . . . . 1.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -63.12 -40.71 98.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.455 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -60.19 -39.82 87.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.966 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.45 99.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.711 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -66.2 -38.67 88.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -62.62 -34.88 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.627 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.95 74.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -36.8 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.506 -0.315 . . . . 1.0 110.732 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.54 -33.21 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.416 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -40.97 97.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -53.14 -42.93 66.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.356 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -62.15 -38.98 91.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.42 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.48 -44.03 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.673 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.785 HD12 ' O ' ' D' ' 19' ' ' LEU . 0.3 OUTLIER -61.17 -46.75 89.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.18 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.48 -27.93 69.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -59.13 -46.33 88.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.15 -40.65 94.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.152 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -62.78 -34.01 76.36 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.374 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -85.93 -44.24 12.54 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.607 -0.269 . . . . 1.0 110.994 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.85 68.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.281 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.515 HG13 ' N ' ' D' ' 28' ' ' GLU . 4.6 p -60.12 -46.87 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.829 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.515 ' N ' HG13 ' D' ' 27' ' ' VAL . 44.6 tp10 -69.24 -41.24 77.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.696 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -56.56 -24.89 50.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.24 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' D' ' 32' ' ' GLY . 30.9 mm-40 -97.32 -39.73 9.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.0 111.203 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -59.82 79.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.159 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 32' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 128.86 21.85 1.33 Allowed Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.531 -0.628 . . . . 1.0 111.531 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 33' ' ' ALA . . . . . 0.549 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -105.92 153.37 40.16 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 110.289 -0.263 . . . . 1.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' D' ' 36' ' ' ALA . 79.2 Cg_endo -74.55 139.22 25.27 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.101 1.867 . . . . 1.0 111.904 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 35' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 69.82 -23.87 0.41 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 36' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' D' ' 34' ' ' PRO . . . 43.03 -170.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 1.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 37' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' D' ' 36' ' ' ALA . . . 175.43 -48.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.192 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.621 HD13 ' HE ' ' D' ' 60' ' ' ARG . 50.9 tp -116.35 119.68 36.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.121 0.486 . . . . 1.0 110.278 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' D' ' 40' ' ' SER . 37.3 pt -141.72 169.12 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 78.99 137.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.55 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -72.81 -46.42 8.98 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.852 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.2 Cg_endo -59.11 -30.77 94.08 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.571 1.514 . . . . 1.0 112.234 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.537 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.4 m-20 -91.65 -33.96 14.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.87 76.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.845 0.355 . . . . 1.0 110.752 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ILE . . . . . 0.404 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.6 tt -64.26 -36.72 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.373 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.563 ' C ' HH11 ' A' ' 68' ' ' ARG . 0.4 OUTLIER -65.02 -46.02 83.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.515 ' CB ' HH21 ' D' ' 60' ' ' ARG . 2.1 t90 -62.05 -38.32 88.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 1.5 m -61.82 -37.82 85.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.822 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 49' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 45' ' ' ILE . 48.2 t -59.71 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 120.75 0.31 . . . . 1.0 110.991 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' D' ' 50' ' ' GLU . 17.4 pt-20 -68.45 -34.16 75.48 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.005 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -61.96 -46.54 88.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.556 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.56 69.28 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' D' ' 54' ' ' THR . 66.5 p -90.05 4.44 50.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.369 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 53' ' ' THR . 27.5 p 52.82 69.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -133.41 -59.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 71.85 -59.15 1.35 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 47' ' ' TRP . 0.5 OUTLIER 70.77 -37.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 1.0 110.538 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 58' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 117.07 11.11 9.27 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -61.42 -52.2 65.59 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.353 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.703 ' NH2' HH12 ' A' ' 68' ' ' ARG . 0.1 OUTLIER -145.78 144.27 30.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.762 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 13.2 p90 -136.95 122.54 13.09 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.56 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.18 -171.19 0.56 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.983 1.789 . . . . 1.0 111.898 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.863 HG22 ' H ' ' D' ' 64' ' ' THR . 8.3 p -122.26 -179.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.863 ' H ' HG22 ' D' ' 63' ' ' VAL . 97.1 m -62.3 -44.97 95.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.042 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' D' ' 67' ' ' GLY . 64.2 tt0 -52.2 -31.24 30.87 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.273 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -74.27 15.76 0.3 Allowed 'General case' 0 C--O 1.255 1.387 0 CA-C-O 124.482 2.087 . . . . 1.0 107.958 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.75 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 48.44 61.33 5.15 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 49.2 ttt85 -25.3 -27.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.535 0.668 . . . . 1.0 111.254 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.1 tptm -53.66 -21.93 7.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.587 ' O ' HG23 ' D' ' 74' ' ' VAL . 75.7 t -60.54 -44.43 96.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 119.979 -0.688 . . . . 1.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 71' ' ' ALA . . . . . 0.522 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -68.69 -48.02 64.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.982 0.42 . . . . 1.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.41 -64.29 0.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.832 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' D' ' 74' ' ' VAL . 10.3 pt20 -54.43 -43.25 71.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' VAL . . . . . 0.587 HG23 ' O ' ' D' ' 70' ' ' VAL . 86.7 t -61.56 -48.15 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.687 -0.405 . . . . 1.0 111.176 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mtp -63.71 -38.07 89.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.462 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 32.0 ttmt -58.81 -42.25 88.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.568 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.31 -40.19 89.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 1.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.49 -41.11 90.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.34 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.099 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' D' ' 80' ' ' GLU . 3.2 mp0 -67.65 -40.8 84.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 1.0 110.751 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 77' ' ' ALA . 47.2 t -63.2 -47.61 91.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.283 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.66 -9.31 58.06 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.622 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 -29.63 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.071 -0.344 . . . . 1.0 110.071 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.694 ' C ' HD23 ' D' ' 84' ' ' LEU . 7.3 tt -63.3 -42.88 99.09 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.243 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.04 -6.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.856 0.36 . . . . 1.0 110.163 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.506 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -60.66 -20.07 59.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.293 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.66 22.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.668 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.61 -39.11 93.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.2 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.22 -40.87 96.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.038 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.532 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -64.91 -37.19 86.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.266 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.523 ' OG1' ' CG ' ' C' ' 93' ' ' PHE . 1.0 OUTLIER -78.61 -4.75 50.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.108 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.01 -52.09 66.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.212 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 10.4 p90 -63.9 -32.23 73.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.51 -42.3 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.327 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.472 HH21 ' CE1' ' D' ' 4' ' ' HIS . 95.7 mtt-85 -56.68 -24.29 47.88 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.113 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 96' ' ' ARG . . . . . 0.501 ' NH2' HG11 ' A' ' 94' ' ' VAL . 15.0 ptt180 -58.88 -8.71 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 1.0 110.146 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.7 -1.44 57.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.245 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.56 -23.61 2.07 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.814 0.34 . . . . 1.0 110.385 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.51 -41.41 93.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -61.39 -48.83 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.461 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -69.67 -36.59 76.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.465 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.64 24.66 27.53 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.641 179.893 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 4' ' ' HIS . . . -164.31 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 t70 68.92 -37.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.767 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 20.7 p80 -66.64 -40.27 88.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.792 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 17.5 pt-20 -65.67 -36.32 83.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.42 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -39.63 94.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.42 -35.33 80.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.222 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -60.92 -40.53 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.974 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.61 -37.25 86.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.293 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.41 -38.78 90.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.733 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.72 86.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.31 -38.26 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.415 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.76 -34.16 77.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.343 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.83 -33.93 76.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.33 -42.31 99.28 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.528 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.38 -40.12 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.212 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.03 -42.5 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.0 110.81 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.88 -41.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.448 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.5 mt -59.87 -41.31 91.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.47 -46.57 89.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.914 0.388 . . . . 1.0 110.0 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.68 -35.2 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.73 88.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.93 -43.71 94.76 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.83 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -66.46 -36.58 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.369 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.32 -46.51 60.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.33 -0.548 . . . . 1.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.52 76.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -62.49 -46.25 96.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.085 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 27' ' ' VAL . 47.2 tp10 -66.4 -43.27 86.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.47 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.69 94.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 17.1 tp10 -73.23 -34.14 65.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.799 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -66.92 121.55 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 1.0 110.601 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 8.02 63.3 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.09 140.97 25.82 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.081 1.854 . . . . 1.0 111.982 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 6.91 60.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.58 106.49 0.05 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.863 0.363 . . . . 1.0 111.067 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.91 -29.83 21.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' CD1' HH11 ' A' ' 60' ' ' ARG . 42.3 tp -101.16 78.26 1.89 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.381 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.3 pt -103.75 31.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.308 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -126.17 121.71 33.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.985 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.477 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 18.4 t80 -74.74 -52.02 3.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.632 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.6 Cg_endo -59.94 -30.66 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.343 1.362 . . . . 1.0 112.434 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.62 -3.73 54.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.576 0.227 . . . . 1.0 111.054 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.1 -40.06 92.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.69 -32.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.291 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.432 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -58.84 -45.72 89.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.174 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -73.42 -24.45 60.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -70.15 -41.61 73.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.359 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG21 HH22 ' B' ' 68' ' ' ARG . 68.2 t -60.74 -47.93 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.83 0.348 . . . . 1.0 110.911 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.29 -31.19 71.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.267 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 89.3 m -61.34 -46.37 90.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.534 -0.466 . . . . 1.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.31 -26.61 61.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.525 ' OG1' HG12 ' A' ' 55' ' ' VAL . 44.6 p -86.08 7.34 25.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p 40.13 33.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.262 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.3 p -95.83 -45.25 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.803 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 49.38 83.72 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -46.76 89.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.755 0.312 . . . . 1.0 110.667 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.43 3.72 2.36 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.26 -50.61 72.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.0 110.507 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.541 HH11 ' CD1' ' A' ' 38' ' ' LEU . 1.4 mtt-85 -136.15 149.86 48.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -141.87 130.6 12.12 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.503 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 -172.07 0.72 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.932 1.755 . . . . 1.0 112.215 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 64' ' ' THR . 8.8 p -130.39 -144.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.046 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.879 ' H ' HG22 ' A' ' 63' ' ' VAL . 79.1 m -105.04 -41.45 5.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.669 0.271 . . . . 1.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.4 tp10 -60.82 -38.81 86.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.015 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -74.61 34.54 0.1 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 124.495 2.093 . . . . 1.0 109.943 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.71 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.19 62.52 1.51 Allowed Glycine 0 C--O 1.213 -1.214 0 CA-C-N 113.323 -1.762 . . . . 1.0 110.833 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' D' ' 50' ' ' GLU . 58.6 ttt85 -25.08 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 117.698 0.749 . . . . 1.0 110.927 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.71 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.5 mmtt -48.72 -16.38 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.005 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' GLY . 48.6 t -60.42 -45.47 96.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 119.096 -1.041 . . . . 1.0 110.08 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.27 79.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.643 0.259 . . . . 1.0 111.523 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 72' ' ' GLU . 1.5 mp0 -58.21 -43.04 87.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.052 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.33 -42.52 98.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.271 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.99 -45.15 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.117 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.555 ' SD ' HG11 ' D' ' 55' ' ' VAL . 76.1 mtm -62.03 -40.13 94.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.564 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -41.58 98.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.229 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.5 77.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.426 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.97 -40.49 97.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 1.0 110.696 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 79' ' ' ILE . 90.5 mt -71.35 -7.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.501 0.191 . . . . 1.0 111.385 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -96.08 -51.32 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.833 0.349 . . . . 1.0 110.872 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.9 m -61.61 -50.56 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.067 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 81' ' ' VAL . 38.2 m-85 -65.03 -40.58 95.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.809 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.23 86.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.724 0.297 . . . . 1.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 86' ' ' THR . 3.6 tp -62.59 -44.94 95.06 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.905 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 83.4 t -54.38 -3.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.414 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 84' ' ' LEU . 45.4 m -58.58 -42.1 87.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.84 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -41.44 -63.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.115 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.94 85.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.295 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.87 -43.94 97.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -66.12 -34.2 77.52 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.199 0.523 . . . . 1.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -76.19 -3.64 37.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.414 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.27 -48.94 77.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.434 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.0 p90 -65.47 -36.05 82.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 1.0 111.387 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.525 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -49.44 -28.78 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.229 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -71.52 -21.36 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.593 -0.276 . . . . 1.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' NH2' ' OE2' ' A' ' 97' ' ' GLU . 19.0 ptt-85 -50.91 -40.67 57.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.398 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 99' ' ' GLU . 97.5 mt-10 -75.65 168.85 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.096 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 57.84 0.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.615 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 97' ' ' GLU . 80.5 tt0 -101.5 -31.72 10.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.212 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.62 -45.41 94.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.16 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -79.9 -17.37 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.455 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.83 14.53 80.78 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.904 -1.046 . . . . 1.0 110.625 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' B' ' 2' ' ' ALA . 47.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.411 ' N ' ' OG ' ' B' ' 1' ' ' SER . . . -173.08 -109.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.487 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -132.98 -45.32 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.53 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -73.51 -31.24 63.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.673 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.02 -39.26 90.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.87 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -64.89 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.653 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.41 -43.73 88.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.5 95.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.52 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.84 -40.11 83.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.358 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.33 -34.55 78.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.75 72.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.34 -36.52 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.46 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.7 -36.27 83.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.0 110.347 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -65.22 -33.08 75.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.403 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.17 -41.67 98.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.554 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.98 -38.92 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.767 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.89 -39.65 92.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 1.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.07 -42.76 97.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.696 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.0 mt -60.54 -41.05 93.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.12 -47.89 83.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 1.0 109.887 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.13 -38.36 78.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.787 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.42 90.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 88.0 p -55.44 -43.55 75.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.234 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.58 -35.33 80.51 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.321 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -72.87 -43.41 62.59 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.196 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' B' ' 30' ' ' GLU . . . -59.27 -50.93 72.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.383 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.55 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.3 p -62.69 -46.47 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.55 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.55 ' N ' HG13 ' B' ' 27' ' ' VAL . 45.4 tp10 -67.48 -43.97 79.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.796 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.71 82.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.329 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 26' ' ' ALA . 17.6 mm-40 -64.77 -40.27 94.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.749 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -64.43 131.49 47.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.354 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.14 1.87 81.24 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.24 146.84 33.51 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.82 -0.223 . . . . 1.0 110.438 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' PRO . . . . . 0.533 ' O ' HG11 ' B' ' 63' ' ' VAL . 95.1 Cg_endo -75.56 142.46 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.322 2.015 . . . . 1.0 112.327 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.75 19.59 69.49 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.38 81.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 1.0 110.604 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.06 69.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.511 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.629 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.3 tt -89.81 119.12 29.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.27 0.557 . . . . 1.0 110.176 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.561 ' N ' HD23 ' B' ' 38' ' ' LEU . 39.1 pt -143.11 168.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.326 -0.852 . . . . 1.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.1 t 78.78 129.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.0 111.012 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.587 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 22.4 t80 -72.76 -46.78 9.13 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.026 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 26.0 Cg_endo -58.61 -31.13 93.98 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.358 1.372 . . . . 1.0 112.94 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -96.61 -11.79 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.869 0.366 . . . . 1.0 110.655 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.66 91.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.274 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.03 -30.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.024 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.468 ' CZ2' ' CB ' ' C' ' 68' ' ' ARG . 7.7 t90 -59.99 -49.36 77.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.869 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.3 OUTLIER -68.29 -34.05 75.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.303 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.459 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.3 p -67.69 54.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.706 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -147.22 -52.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.654 -0.248 . . . . 1.0 110.77 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.71 -32.8 74.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 1.0 110.613 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 51' ' ' THR . 0.0 OUTLIER -56.92 -45.15 82.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.145 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.1 -26.3 60.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.028 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.447 ' OG1' HG22 ' B' ' 55' ' ' VAL . 51.0 p -88.21 -1.43 58.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.694 0.283 . . . . 1.0 110.795 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.6 p 51.68 64.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.529 HG23 ' N ' ' B' ' 56' ' ' GLY . 21.6 m -133.66 -47.9 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.21 82.08 0.02 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.19 -42.0 98.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.707 0.289 . . . . 1.0 111.084 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.5 0.47 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.318 -0.713 . . . . 1.0 111.318 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' C' ' 61' ' ' TYR . 96.7 m-20 -48.05 -66.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 1.0 110.658 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -138.39 161.09 37.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.978 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -146.92 138.14 13.03 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.91 -172.33 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.815 1.677 . . . . 1.0 112.081 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.558 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -128.84 -143.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.019 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.558 ' H ' HG12 ' B' ' 63' ' ' VAL . 4.3 m -110.96 -42.04 4.08 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.664 0.269 . . . . 1.0 110.934 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.2 tp10 -66.2 -34.4 77.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.502 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.44 33.63 0.11 Allowed 'General case' 0 C--O 1.266 1.959 0 CA-C-O 123.961 1.838 . . . . 1.0 109.744 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.72 63.29 1.04 Allowed Glycine 0 C--O 1.214 -1.146 0 CA-C-N 113.393 -1.73 . . . . 1.0 111.175 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.605 HH22 HG21 ' A' ' 49' ' ' VAL . 59.6 ttp85 -23.57 -33.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.151 0.975 . . . . 1.0 110.763 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.7 mttp -48.29 -17.79 0.17 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' B' ' 67' ' ' GLY . 52.2 t -61.65 -49.29 84.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.97 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.94 64.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.5 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.28 -41.76 76.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.029 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.76 -43.02 99.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.307 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.94 -46.89 92.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 55' ' ' VAL . 74.4 mtm -62.62 -43.33 99.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.637 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -65.43 -42.53 92.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.156 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.86 93.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.15 -42.41 94.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.0 -43.75 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.704 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' B' ' 84' ' ' LEU . 81.0 mm-40 -59.01 -45.58 90.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.429 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.46 -49.09 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.413 ' O ' HG22 ' B' ' 85' ' ' VAL . 32.9 m-85 -70.89 -22.77 62.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.582 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.2 -22.29 19.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.301 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' B' ' 80' ' ' GLU . 6.8 tt -63.98 -40.85 97.31 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.723 0.297 . . . . 1.0 110.206 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' B' ' 87' ' ' ALA . 11.1 m -50.58 -27.85 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.749 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.415 ' C ' ' O ' ' B' ' 85' ' ' VAL . 15.6 m -33.36 -31.19 0.01 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.449 0.642 . . . . 1.0 110.016 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -52.82 -57.35 10.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.651 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -65.02 -33.81 76.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.153 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.418 HD12 ' N ' ' B' ' 89' ' ' LEU . 9.0 mp -60.04 -44.28 94.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 1.0 109.986 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.87 -19.25 60.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.925 -0.58 . . . . 1.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.527 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -98.82 -11.06 22.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.485 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.9 m-20 -62.56 -40.99 98.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.417 ' CD2' ' CB ' ' C' ' 90' ' ' ALA . 1.7 p90 -71.34 -29.27 64.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' B' ' 96' ' ' ARG . 91.4 t -60.8 -43.9 96.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.773 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -40.98 -22.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.679 0.276 . . . . 1.0 111.311 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' B' ' 94' ' ' VAL . 44.7 ptt85 -62.95 -37.25 86.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.11 -35.74 75.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.874 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.19 -36.32 83.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 1.0 110.453 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.49 -30.51 71.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -59.49 -44.31 93.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.622 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -77.21 -18.9 57.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.481 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.02 14.69 76.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.567 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -153.46 151.1 29.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.718 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' C' ' 4' ' ' HIS . 42.3 p-10 -65.4 -36.03 82.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.383 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 4' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 19.2 p80 -67.55 -38.94 84.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 5' ' ' GLU . . . . . 0.597 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.4 tt0 -63.11 -36.64 84.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.645 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.16 -40.23 95.29 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.136 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.62 -40.86 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.78 94.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.354 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.36 -32.54 74.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.366 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' C' ' 81' ' ' VAL . . . -69.23 -24.26 63.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.71 -54.2 21.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.806 0.336 . . . . 1.0 111.643 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.79 -30.51 70.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.28 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.8 -37.45 87.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.705 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.53 -36.9 85.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 1.0 110.192 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.66 -32.5 73.85 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.443 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.43 -47.47 81.81 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -64.93 -32.44 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 1.0 111.053 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' C' ' 52' ' ' ALA . 41.3 mt -60.17 -40.67 90.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.893 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.96 -43.55 98.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.77 -33.11 73.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.124 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -61.89 -41.39 97.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.647 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -61.67 -38.77 89.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.514 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -64.58 -74.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.301 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.64 -33.04 6.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.565 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 22' ' ' ALA . . . -54.37 -52.56 61.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.471 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 27' ' ' VAL . . . . . 0.439 HG22 ' HE ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -67.17 -39.67 83.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.29 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -67.09 -32.43 73.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.877 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' C' ' 66' ' ' GLU . . . -55.01 -39.57 69.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.198 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' C' ' 38' ' ' LEU . 4.3 mt-10 -95.13 -136.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.61 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' C' ' 39' ' ' ILE . 35.6 mmt180 58.82 57.64 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.115 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.33 11.16 2.27 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.861 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' ALA . . . . . 0.51 ' HB3' ' OE2' ' C' ' 66' ' ' GLU . . . -106.72 147.61 35.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.87 147.15 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.275 1.983 . . . . 1.0 111.921 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.0 14.81 61.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 141.67 57.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.706 0.289 . . . . 1.0 110.475 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.22 -21.81 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.567 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.0 tt -107.66 85.37 2.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.981 0.42 . . . . 1.0 109.917 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.525 ' O ' ' NH1' ' C' ' 31' ' ' ARG . 39.6 pt -114.37 35.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -134.52 140.9 46.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.767 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 16.9 t80 -85.3 -52.06 0.5 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.95 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.76 -32.37 95.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.394 1.396 . . . . 1.0 112.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.87 -3.76 57.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.622 -0.263 . . . . 1.0 111.101 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.89 94.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 1.0 110.639 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.04 -32.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -46.74 84.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.754 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' C' ' 48' ' ' SER . 0.1 OUTLIER -66.25 -29.93 70.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.52 ' O ' HD22 ' C' ' 19' ' ' LEU . 50.4 p -70.07 -9.3 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.973 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' C' ' 51' ' ' THR . 25.6 t -90.3 -48.77 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.147 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.07 32.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.483 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' THR . . . . . 0.478 HG23 ' N ' ' C' ' 52' ' ' ALA . 10.2 t -133.89 -41.05 0.84 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.504 0.193 . . . . 1.0 111.273 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -66.16 -14.82 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.053 -0.259 . . . . 1.0 110.771 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.479 ' OG1' HG13 ' C' ' 55' ' ' VAL . 71.0 p -98.96 8.4 45.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.937 0.399 . . . . 1.0 110.235 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.9 p 53.83 45.37 27.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.975 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.51 HG23 ' N ' ' C' ' 56' ' ' GLY . 27.7 m -103.79 -44.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.739 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 56' ' ' GLY . . . . . 0.51 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 44.29 73.26 0.27 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -44.28 96.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.599 0.237 . . . . 1.0 110.398 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.04 10.85 7.25 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.66 -49.24 78.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 1.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -147.72 162.11 39.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.846 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 61' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 t80 -163.77 136.48 4.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.39 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.75 161.4 46.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.727 1.618 . . . . 1.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' C' ' 66' ' ' GLU . 3.0 t -110.33 165.89 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.019 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' C' ' 67' ' ' GLY . 21.5 m -41.17 -66.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.178 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -46.65 -17.74 0.05 Allowed 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 63' ' ' VAL . 18.0 mt-10 -101.01 27.57 5.95 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-O 124.481 2.086 . . . . 1.0 109.24 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 67' ' ' GLY . . . . . 0.661 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 39.27 64.11 1.02 Allowed Glycine 0 C--O 1.219 -0.819 0 CA-C-N 113.26 -1.791 . . . . 1.0 111.597 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 70' ' ' VAL . 0.3 OUTLIER -24.43 -37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.054 0.927 . . . . 1.0 110.186 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.661 ' N ' ' O ' ' C' ' 67' ' ' GLY . 99.0 mttt -43.24 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.46 -1.245 . . . . 1.0 109.758 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.7 t -60.51 -46.77 94.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 118.718 -1.193 . . . . 1.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.62 -45.67 51.55 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.769 0.319 . . . . 1.0 111.707 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.58 -42.01 99.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.106 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -58.03 -49.47 76.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.285 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.24 -43.4 84.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.391 . . . . 1.0 111.253 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 48.2 ttm -59.48 -40.07 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.728 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -60.77 -38.46 85.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.739 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.96 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.692 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.61 -39.74 97.0 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.173 -0.537 . . . . 1.0 111.834 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.64 -42.97 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.774 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.85 -40.27 96.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' VAL . . . . . 0.419 HG13 ' HB1' ' C' ' 11' ' ' ALA . 53.3 t -63.68 -48.07 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.364 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -75.76 -8.08 55.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.343 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.53 -45.07 10.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.853 0.359 . . . . 1.0 110.446 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.427 ' C ' ' N ' ' C' ' 86' ' ' THR . 7.0 tt -63.21 -42.85 99.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.689 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.82 -11.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.667 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.427 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.4 m -63.76 -25.4 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -56.81 -28.57 61.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.376 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.51 -13.28 34.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.3 -32.69 22.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.072 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.83 -37.89 89.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.587 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.59 -6.0 37.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.033 -0.53 . . . . 1.0 109.949 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.454 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 40.8 t0 -63.21 -43.9 96.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -84.62 -28.15 26.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.561 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.47 -42.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -51.83 -21.9 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.223 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' ARG . . . . . 0.455 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 24.0 ptt-85 -50.6 -44.79 57.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.591 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' C' ' 99' ' ' GLU . 8.4 pt-20 -86.7 162.56 17.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.553 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 72.83 -38.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.556 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' C' ' 97' ' ' GLU . 81.8 tt0 -65.85 -50.74 63.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.132 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ARG . . . . . 0.445 HH22 ' NH2' ' C' ' 101' ' ' ARG . 73.5 ttp85 -66.59 -43.41 84.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.054 0.454 . . . . 1.0 110.46 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 101' ' ' ARG . . . . . 0.445 ' NH2' HH22 ' C' ' 100' ' ' ARG . 29.9 mmt180 -66.68 -36.79 83.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.505 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.64 18.81 29.12 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 66.8 t60 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.933 -1.032 . . . . 1.0 110.721 179.782 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.88 145.05 55.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.444 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 20.3 p80 -66.7 -40.07 88.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.1 tt0 -62.26 -38.42 89.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.495 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -61.09 -42.35 98.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.291 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.13 -41.13 97.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.47 94.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.807 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.9 -41.39 91.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.864 0.364 . . . . 1.0 110.367 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.81 -33.78 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.506 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.98 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.972 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.81 -36.3 80.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 1.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.02 -37.32 87.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -62.31 -34.83 77.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.234 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 15' ' ' LEU . . . . . 0.545 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.3 tp -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.254 -0.579 . . . . 1.0 110.306 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -56.41 -33.92 66.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.366 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.12 -44.69 96.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.596 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' D' ' 18' ' ' VAL . 4.9 m -87.37 -37.01 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.654 0.264 . . . . 1.0 111.48 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.438 HD12 ' O ' ' D' ' 19' ' ' LEU . 1.5 tp -60.9 -47.0 88.39 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -63.53 -44.75 93.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.294 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -64.2 -29.86 70.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -61.43 -39.09 89.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.625 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 85.7 p -61.57 -43.76 98.27 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.602 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -64.82 -34.05 77.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.48 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' D' ' 29' ' ' ALA . 44.8 mmtm -78.2 -44.83 24.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.294 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -58.22 -49.14 78.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.43 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 27' ' ' VAL . . . . . 0.548 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.1 p -60.07 -45.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.526 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.548 ' N ' HG13 ' D' ' 27' ' ' VAL . 11.0 tm-20 -68.13 -35.83 78.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.591 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 29' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -58.81 -51.96 67.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 14.0 mp0 -69.79 -32.27 70.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.589 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -50.22 103.35 0.05 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.051 0.453 . . . . 1.0 111.049 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.87 11.1 44.44 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.76 140.16 21.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 110.525 -0.176 . . . . 1.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.03 142.27 27.57 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.107 1.871 . . . . 1.0 112.299 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.0 26.42 63.23 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.65 140.91 56.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 1.0 110.791 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.81 -22.84 10.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.712 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' D' ' 30' ' ' GLU . 57.4 tp -104.7 121.1 42.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.925 0.393 . . . . 1.0 109.956 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' D' ' 40' ' ' SER . 34.2 pt -153.48 -164.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.372 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 40' ' ' SER . . . . . 0.452 ' O ' ' O ' ' D' ' 39' ' ' ILE . 1.3 m 58.26 141.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 1.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 7.1 m-85 -79.83 -58.42 0.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.99 -26.53 81.89 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.584 1.523 . . . . 1.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -87.98 -25.37 23.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 44' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -63.69 -39.53 94.54 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.693 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.43 -32.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.26 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -47.89 81.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 47' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' D' ' 51' ' ' THR . 0.2 OUTLIER -76.76 -22.96 53.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.21 -44.44 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.721 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.98 4.3 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 1.0 110.898 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 50.6 mm-40 -103.22 -49.86 3.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.137 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 51' ' ' THR . . . . . 0.46 ' H ' HG22 ' D' ' 51' ' ' THR . 0.0 OUTLIER -63.67 -45.61 89.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.19 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -23.51 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 1.0 110.085 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 53' ' ' THR . . . . . 0.462 ' OG1' HG13 ' D' ' 55' ' ' VAL . 43.4 p -100.45 2.22 41.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.388 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 61.6 p 45.83 70.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.452 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.555 HG11 ' SD ' ' A' ' 75' ' ' MET . 30.0 m -117.63 -42.75 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.591 -0.277 . . . . 1.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 56' ' ' GLY . . . . . 0.533 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 51.16 63.18 4.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -45.51 93.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.692 0.282 . . . . 1.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 -1.64 7.15 Favored Glycine 0 N--CA 1.466 0.648 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.63 -47.99 83.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.546 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -142.9 151.49 41.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.711 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 27.4 p90 -145.56 137.68 13.33 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.568 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.71 161.69 44.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.253 1.968 . . . . 1.0 112.152 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.947 HG22 ' H ' ' D' ' 64' ' ' THR . 8.0 p -104.76 -130.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.0 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.947 ' H ' HG22 ' D' ' 63' ' ' VAL . 23.9 m -114.18 -51.33 2.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.603 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.7 tt0 -57.11 -30.51 64.43 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.603 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.66 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 1.1 pm0 -70.66 19.43 0.05 OUTLIER 'General case' 0 C--O 1.264 1.83 0 CA-C-O 123.651 1.691 . . . . 1.0 109.4 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.64 62.19 2.99 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' D' ' 67' ' ' GLY . 59.5 ttm-85 -26.22 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.831 0.816 . . . . 1.0 110.631 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' D' ' 67' ' ' GLY . 65.0 mttm -51.02 -24.14 3.53 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.525 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.603 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.7 t -63.17 -48.4 87.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 119.769 -0.772 . . . . 1.0 110.362 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.58 -37.07 76.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.657 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -64.05 -40.46 96.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.089 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -61.43 -47.38 86.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.672 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.96 -36.35 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.309 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.47 ' SD ' HG11 ' C' ' 55' ' ' VAL . 17.9 mtm -62.54 -42.7 99.7 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.092 -0.243 . . . . 1.0 111.438 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.48 -41.64 96.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.657 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.4 -40.81 95.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.506 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 78' ' ' GLY . . . . . 0.545 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -64.44 -41.73 97.89 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.22 -43.33 98.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -63.46 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.563 -0.289 . . . . 1.0 111.132 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.5 t -62.27 -50.37 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.261 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.48 -39.86 85.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 1.0 110.476 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.552 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' D' ' 86' ' ' THR . 4.3 tt -60.92 -40.01 91.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.274 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 85' ' ' VAL . . . . . 0.481 HG12 ' O ' ' D' ' 85' ' ' VAL . 97.9 t -48.49 -10.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 1.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.519 ' N ' ' O ' ' D' ' 84' ' ' LEU . 22.6 m -49.28 -39.25 30.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.093 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -49.96 -17.94 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.392 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' D' ' 92' ' ' ASP . . . -104.87 -12.2 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.737 0.303 . . . . 1.0 110.252 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.5 mt -87.54 -64.73 1.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.36 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.13 -9.49 1.46 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.275 0.559 . . . . 1.0 109.944 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.482 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 0.5 OUTLIER -99.54 -1.12 39.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.44 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 92' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m-20 -74.57 -39.17 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.658 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 30.7 p90 -84.86 -40.39 17.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 94' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 21.2 m -43.34 -36.72 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.8 0.333 . . . . 1.0 111.401 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' D' ' 98' ' ' GLU . 95.2 mtt-85 -57.14 -27.53 61.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -39.93 -35.98 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.676 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.514 ' OE2' ' NH2' ' D' ' 101' ' ' ARG . 48.7 tp10 -66.83 -39.19 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.39 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 98' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' D' ' 95' ' ' ARG . 79.7 mm-40 -96.53 -178.79 4.39 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 67.11 -46.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.855 0.722 . . . . 1.0 110.096 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' D' ' 98' ' ' GLU . 9.0 tmm_? -63.82 -42.84 97.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.39 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 101' ' ' ARG . . . . . 0.514 ' NH2' ' OE2' ' D' ' 97' ' ' GLU . 99.6 mtt180 -64.19 -37.4 87.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.481 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.91 4.73 41.92 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 38.9 m80 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.051 -0.976 . . . . 1.0 110.515 179.734 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . -78.46 167.12 21.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.06 -45.56 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.628 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 4.0 p80 -67.3 -41.5 85.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.502 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.67 -46.02 87.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.705 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.05 -38.11 89.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.61 -38.22 90.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.197 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.52 94.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.233 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.03 -38.63 91.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.343 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.26 -41.68 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.82 85.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.996 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.91 -40.38 94.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.621 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.96 -38.15 87.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.447 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -65.6 -32.0 73.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.446 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.1 -44.81 95.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.826 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -60.69 -36.0 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.306 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.74 -40.77 96.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.087 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.25 -31.37 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.665 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -61.68 -42.12 98.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.14 -51.33 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.84 -37.46 86.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.204 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.35 83.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -59.48 -39.69 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.94 -55.1 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.612 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.68 -23.1 39.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.965 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 23' ' ' SER . 83.2 t -92.45 -50.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.929 0.395 . . . . 1.0 110.396 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.33 -42.32 93.03 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.604 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -34.73 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -78.98 -114.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 45.55 78.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.88 0.372 . . . . 1.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -6.76 41.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.12 136.14 57.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.295 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.24 140.96 25.4 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.971 1.781 . . . . 1.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . 64.27 22.13 66.97 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -60.96 -48.07 83.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.789 0.328 . . . . 1.0 110.758 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 58.89 0.6 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.697 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 38' ' ' LEU . 5.1 tt -131.48 114.59 15.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.78 0.324 . . . . 1.0 110.15 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 23.5 pt -157.96 54.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.122 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -153.48 118.19 5.0 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.856 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 47.6 m-85 -55.37 -50.33 87.36 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.119 -0.491 . . . . 1.0 112.028 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 28.8 Cg_endo -59.72 -34.08 96.22 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.546 1.497 . . . . 1.0 112.6 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB3' HH21 ' A' ' 60' ' ' ARG . 61.5 m-20 -92.52 -8.11 45.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.676 0.274 . . . . 1.0 110.82 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . . . -62.64 -45.14 94.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.0 110.386 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 46' ' ' TRP . 4.0 tt -69.41 -41.86 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.152 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.517 ' N ' HG23 ' A' ' 45' ' ' ILE . 3.3 t-105 -55.35 -43.13 74.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -66.16 -38.46 88.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 19' ' ' LEU . 3.5 t -65.05 -24.58 67.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.249 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.03 -49.76 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.605 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -75.35 -24.02 57.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.462 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 m -62.5 -45.76 91.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.529 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -62.13 -35.21 78.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.618 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 p -75.41 4.14 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 41.5 73.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 1.0 111.17 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 3.9 p -139.05 -36.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.851 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.95 76.37 0.08 OUTLIER Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CZ ' HG21 ' A' ' 55' ' ' VAL . 57.9 m-85 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 1.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.52 17.67 0.2 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -63.42 -42.26 98.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 1.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mmt180 -127.98 -170.48 2.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 51.4 m-85 -162.18 88.51 1.44 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.002 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.37 156.14 65.24 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.905 1.737 . . . . 1.0 112.221 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.995 HG22 ' H ' ' A' ' 64' ' ' THR . 7.4 p -128.16 -171.77 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.221 0.534 . . . . 1.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.995 ' H ' HG22 ' A' ' 63' ' ' VAL . 98.9 m -69.44 -43.85 72.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.8 tp10 -48.1 -49.52 31.54 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -80.79 35.55 0.37 Allowed 'General case' 0 C--O 1.258 1.511 0 CA-C-O 123.989 1.852 . . . . 1.0 109.242 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.52 66.67 0.92 Allowed Glycine 0 C--O 1.212 -1.22 0 CA-C-N 113.303 -1.771 . . . . 1.0 112.085 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' CG ' ' D' ' 59' ' ' ASP . 58.4 ttm-85 -24.24 -32.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.33 1.065 . . . . 1.0 111.15 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 67' ' ' GLY . 9.0 mtmp? -53.2 -16.48 1.25 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.81 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.2 t -63.36 -46.94 94.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 120.049 -0.661 . . . . 1.0 110.574 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -44.4 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.081 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -56.95 -43.29 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.349 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.2 -41.99 85.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.864 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.36 -45.13 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.177 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.45 -40.24 93.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.756 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -60.48 -42.63 96.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.321 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.82 82.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.492 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -39.15 93.21 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.727 -0.949 . . . . 1.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.11 -26.65 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.864 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.55 -51.83 13.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 1.0 111.2 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.6 m -61.41 -48.98 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.097 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' N ' HG23 ' A' ' 81' ' ' VAL . 16.2 m-85 -64.43 -41.65 96.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.992 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.65 -36.94 85.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.801 -0.359 . . . . 1.0 111.051 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.2 tt -63.41 -37.42 87.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.356 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 85' ' ' VAL . 90.2 t -45.45 -14.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.482 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' LEU . 41.1 m -51.08 -44.25 61.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 1.0 110.058 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.83 -21.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.69 -20.62 13.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.921 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 86' ' ' THR . 41.9 mt -84.98 -43.18 14.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.772 0.32 . . . . 1.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -59.29 -38.2 79.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.036 0.446 . . . . 1.0 110.87 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -65.67 -11.78 47.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.283 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 67.1 m-20 -59.61 -49.8 76.36 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.16 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 11.3 p90 -75.53 -22.54 57.0 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.813 0.34 . . . . 1.0 111.282 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.37 -43.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.194 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.82 -20.84 59.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -53.64 -42.66 68.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.467 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -61.17 -41.0 95.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.73 -37.46 79.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.669 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.82 -35.11 79.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.327 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -60.42 -43.68 96.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.325 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.6 -36.03 82.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.305 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.07 8.06 56.98 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.531 179.883 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . 41.6 -161.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.744 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -125.22 -25.26 3.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.766 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' HIS . . . . . 0.485 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 22.6 p-80 -78.49 -23.57 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.45 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.72 -39.45 88.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.743 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.35 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.666 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.36 -41.17 96.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.0 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 99.3 mm-40 -65.7 -38.19 88.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -61.85 -37.48 84.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.53 71.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.881 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.81 -38.76 92.31 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.554 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' B' ' 9' ' ' GLN . 1.1 mp0 -65.71 -34.82 79.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.315 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.47 -38.54 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.37 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.405 HD11 ' HB1' ' B' ' 52' ' ' ALA . 53.2 tp -62.78 -42.08 99.54 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.443 ' O ' ' OE2' ' B' ' 20' ' ' GLU . 76.3 mm-40 -63.86 -40.04 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -59.05 -42.1 89.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 1.0 110.612 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.43 -40.84 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.673 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 52' ' ' ALA . 82.5 mt -59.32 -40.94 87.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' B' ' 20' ' ' GLU . 0.3 OUTLIER -59.82 -48.93 79.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -31.01 69.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.992 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.59 90.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.496 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.9 p -59.63 -43.71 93.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.412 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -65.73 -35.48 80.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.42 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.19 -47.13 37.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.794 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.7 82.57 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' VAL . . . . . 0.546 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.9 p -62.18 -46.31 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.231 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.546 ' N ' HG13 ' B' ' 27' ' ' VAL . 83.4 tt0 -67.09 -43.78 81.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.531 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.79 83.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.337 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -70.39 -33.95 71.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.678 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.95 123.96 21.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.53 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.01 0.64 65.83 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.75 140.45 21.09 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 122.833 -0.216 . . . . 1.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.73 149.74 34.22 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.061 1.841 . . . . 1.0 112.623 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.48 2.85 23.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.68 ' O ' HG22 ' B' ' 39' ' ' ILE . . . -77.43 83.01 3.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.667 0.27 . . . . 1.0 110.699 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.5 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 1.0 110.506 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.821 HD23 ' O ' ' B' ' 38' ' ' LEU . 5.4 tt -58.99 -28.43 66.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.359 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' ILE . . . . . 0.694 HG23 ' O ' ' B' ' 39' ' ' ILE . 20.4 tt -38.26 100.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.182 0.515 . . . . 1.0 110.793 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.531 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 59.7 m -171.42 -119.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.645 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.6 m-85 -177.57 -64.88 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.014 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 21.1 Cg_endo -58.5 -33.43 98.0 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.161 1.907 . . . . 1.0 112.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.16 -4.64 51.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.665 -0.243 . . . . 1.0 111.015 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 38' ' ' LEU . . . -65.03 -40.82 95.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.181 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.76 -37.37 73.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.361 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.612 ' NE1' ' O ' ' C' ' 64' ' ' THR . 2.8 t90 -53.95 -50.99 65.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.711 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.7 t90 -66.15 -38.32 87.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.401 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . 0.443 ' O ' HD22 ' B' ' 19' ' ' LEU . 65.2 m -55.24 -45.33 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.273 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.89 -46.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.31 -31.71 72.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 98.2 m -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.157 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -55.7 -26.3 44.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.723 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' THR . . . . . 0.539 ' OG1' HG12 ' B' ' 55' ' ' VAL . 46.3 p -85.68 -2.25 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 1.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.5 p 57.08 5.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.097 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' B' ' 53' ' ' THR . 7.8 p -64.85 -43.8 96.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.784 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' GLY . . . . . 0.523 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 38.55 74.64 0.11 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' B' ' 55' ' ' VAL . 47.0 m-85 -59.92 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.663 0.268 . . . . 1.0 110.966 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.53 -0.75 2.26 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.06 -65.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 1.0 110.084 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.28 149.38 36.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 61' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 22.8 p90 -139.18 112.53 8.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.46 -171.05 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.49 1.46 . . . . 1.0 111.971 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' VAL . . . . . 0.898 HG22 ' H ' ' B' ' 64' ' ' THR . 7.2 p -133.65 -147.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.391 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' THR . . . . . 0.898 ' H ' HG22 ' B' ' 63' ' ' VAL . 97.9 m -101.79 -42.8 6.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.256 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' B' ' 67' ' ' GLY . 75.1 tt0 -54.79 -38.24 67.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.284 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -77.56 31.66 0.16 Allowed 'General case' 0 C--O 1.259 1.592 0 CA-C-O 123.788 1.756 . . . . 1.0 109.72 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.59 63.74 1.57 Allowed Glycine 0 C--O 1.212 -1.267 0 CA-C-N 113.659 -1.61 . . . . 1.0 111.629 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' B' ' 67' ' ' GLY . 55.0 ttm-85 -25.28 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.401 1.101 . . . . 1.0 110.579 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' B' ' 67' ' ' GLY . 67.5 mttm -48.49 -18.4 0.23 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.3 -47.82 91.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 119.847 -0.741 . . . . 1.0 109.691 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.36 -38.99 68.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.296 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -49.17 -43.33 41.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -66.64 -41.14 88.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -51.66 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.696 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 22.9 ptp -64.26 -41.01 97.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 1.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.14 -39.28 93.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.442 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' ALA . . . . . 0.543 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.87 -36.03 80.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 1.0 110.526 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.89 -39.88 58.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.442 -0.663 . . . . 1.0 111.442 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.21 -44.6 99.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 121.112 -0.235 . . . . 1.0 111.483 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.88 -35.29 79.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 1.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 77' ' ' ALA . 17.9 t -62.27 -71.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' PHE . . . . . 0.433 ' N ' HG12 ' B' ' 81' ' ' VAL . 69.8 m-85 -58.11 -4.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.957 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' B' ' 81' ' ' VAL . . . -97.55 -34.99 10.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.168 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -64.47 -40.79 96.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.211 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 87' ' ' ALA . 14.0 m -58.57 -16.5 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.009 -0.542 . . . . 1.0 109.621 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 52.5 m -42.43 -24.66 0.06 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.078 0.466 . . . . 1.0 109.811 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.75 -64.42 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.845 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.6 -24.06 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.2 mm? -87.81 -19.76 27.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.788 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.57 -50.55 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.459 0.647 . . . . 1.0 109.335 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' H ' ' B' ' 91' ' ' THR . 0.4 OUTLIER -54.23 -3.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.236 179.112 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 92' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' B' ' 90' ' ' ALA . 91.0 m-20 -58.69 -41.87 87.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.866 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 24.3 p90 -70.56 -27.53 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.906 -0.317 . . . . 1.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.79 -43.7 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.512 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.29 -21.35 59.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.932 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -55.09 -41.73 71.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.77 -40.95 96.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.974 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.33 -36.82 83.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.84 0.352 . . . . 1.0 110.785 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.95 -26.5 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -60.17 -43.41 95.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.319 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -64.5 -37.29 87.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.63 13.4 65.17 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.615 179.785 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.365 -0.605 . . . . 1.0 109.365 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 39.3 -106.56 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.814 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' C' ' 3' ' ' ASP . 67.8 t0 -173.74 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.924 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -80.4 -17.2 52.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.776 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.44 89.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -63.06 -39.41 94.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.0 110.281 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.5 -40.69 89.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.73 92.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.593 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.09 -39.15 89.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.337 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -62.4 -36.74 83.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.291 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.71 80.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -62.82 -40.18 96.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 1.0 111.086 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -65.84 -34.25 77.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.569 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.8 -37.94 88.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.516 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 15' ' ' LEU . . . . . 0.438 HD13 ' HA2' ' C' ' 78' ' ' GLY . 49.0 tp -61.74 -44.6 96.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.585 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 16' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' C' ' 20' ' ' GLU . 85.5 mm-40 -58.48 -32.31 68.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.82 -43.24 93.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 m -87.56 -34.65 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.592 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LEU . . . . . 0.699 HD12 ' O ' ' C' ' 19' ' ' LEU . 0.9 OUTLIER -60.49 -49.14 78.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 20' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' C' ' 16' ' ' GLN . 3.4 mp0 -61.22 -43.32 99.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.64 -29.34 66.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.473 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' C' ' 19' ' ' LEU . . . -65.17 -37.65 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 12.9 m -56.63 -44.8 81.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.356 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -64.59 -52.15 59.03 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.131 -0.628 . . . . 1.0 109.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.6 mmtt -59.48 -37.92 79.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.435 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.74 -57.74 5.86 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.832 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -64.33 -44.21 97.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.137 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -60.72 -32.81 72.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.15 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 29' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -60.77 -29.28 69.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.624 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.2 -44.73 92.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.66 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.03 130.23 41.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.46 -29.75 11.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.234 -0.747 . . . . 1.0 111.234 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.89 144.19 28.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 122.903 -0.174 . . . . 1.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.17 158.71 37.52 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.115 1.877 . . . . 1.0 112.442 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.77 36.9 14.55 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 141.86 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 1.0 110.569 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.4 -44.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.46 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.413 ' O ' HD23 ' C' ' 38' ' ' LEU . 6.4 tt -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.411 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -37.89 116.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.736 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 40' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' C' ' 41' ' ' TYR . 17.2 t -177.6 -123.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.306 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 41' ' ' TYR . . . . . 0.541 ' N ' ' OG ' ' C' ' 40' ' ' SER . 0.8 OUTLIER 171.97 -65.58 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.188 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 42' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' C' ' 41' ' ' TYR . 23.5 Cg_endo -58.81 -40.16 75.04 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.886 1.724 . . . . 1.0 112.171 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.455 ' CB ' ' NH2' ' C' ' 60' ' ' ARG . 8.5 p30 -88.37 -0.22 56.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.31 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.77 87.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 1.0 110.615 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.472 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.3 tt -67.18 -41.4 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' NE ' ' D' ' 68' ' ' ARG . 0.0 OUTLIER -52.33 -49.08 64.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.737 -179.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -65.43 -38.55 90.22 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.826 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 9.0 p -62.11 -38.79 90.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.543 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' VAL . . . . . 0.474 ' O ' HG23 ' C' ' 53' ' ' THR . 42.9 t -59.55 -47.75 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 121.181 -0.208 . . . . 1.0 111.367 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.58 -34.75 77.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.569 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -64.24 -53.7 45.07 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.55 68.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.766 0.317 . . . . 1.0 110.947 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.474 HG23 ' O ' ' C' ' 49' ' ' VAL . 58.9 p -90.81 3.63 53.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.274 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.4 p 52.06 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.47 -50.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.147 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.3 76.81 0.15 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 26.9 t80 -61.66 -43.21 99.28 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.63 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.14 12.19 5.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.6 -45.54 93.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' C' ' 43' ' ' ASP . 94.1 mtt-85 -138.45 147.99 43.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -115.66 128.88 25.6 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.762 -0.199 . . . . 1.0 110.563 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.55 157.16 61.78 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.029 1.82 . . . . 1.0 112.001 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' VAL . . . . . 0.457 ' H ' HG22 ' C' ' 63' ' ' VAL . 0.0 OUTLIER -56.2 -176.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.276 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 64' ' ' THR . . . . . 0.612 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 67.0 m -89.82 -86.25 0.2 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.643 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' C' ' 64' ' ' THR . 50.7 tp10 -28.19 -84.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.321 0.388 . . . . 1.0 111.097 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.5 mt-10 -60.95 -92.2 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.05 -56.2 0.0 OUTLIER Glycine 0 N--CA 1.478 1.457 0 O-C-N 124.376 1.047 . . . . 1.0 114.571 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 42.9 ttp85 -71.35 -47.75 54.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.289 -0.456 . . . . 1.0 110.402 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 69' ' ' LYS . . . . . 0.556 ' NZ ' HH12 ' C' ' 68' ' ' ARG . 4.5 mptp? -59.85 -41.46 91.46 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 70' ' ' VAL . . . . . 0.618 ' O ' HG23 ' C' ' 74' ' ' VAL . 58.7 t -76.64 -45.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.788 -0.765 . . . . 1.0 111.237 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.23 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.703 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' C' ' 68' ' ' ARG . 15.4 tm-20 -49.42 -40.98 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.836 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -69.25 -42.04 76.14 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.931 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.618 HG23 ' O ' ' C' ' 70' ' ' VAL . 74.0 t -66.06 -49.48 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.722 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ptp -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.693 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.34 -40.5 96.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.522 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.72 95.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 1.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.31 -41.23 96.77 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.3 -43.06 97.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 1.0 110.852 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.28 -40.6 94.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.265 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.89 -47.02 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.35 -14.62 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.168 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.18 -34.09 19.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 1.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.16 -40.53 90.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.66 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.58 -24.58 29.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' THR . . . . . 0.43 ' O ' ' N ' ' C' ' 90' ' ' ALA . 1.2 t -43.12 -33.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.168 0.509 . . . . 1.0 110.456 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -49.1 -61.74 1.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.203 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.58 -35.02 39.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.241 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' LEU . . . . . 0.562 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.4 mm? -75.35 -34.81 61.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.777 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -63.5 -36.18 82.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.181 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -4.47 37.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.08 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 92' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 88.9 m-20 -54.77 -48.95 72.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.746 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 93' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 20.8 p90 -74.83 -9.97 59.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.1 -48.3 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.679 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -65.81 -20.35 66.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.258 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -48.84 -38.8 23.35 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.412 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 97' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' C' ' 99' ' ' GLU . 17.3 pt-20 -43.55 152.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.278 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 60.42 -68.82 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.492 0.495 . . . . 1.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' C' ' 97' ' ' GLU . 79.4 mm-40 -52.11 -21.73 3.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.446 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -61.7 -43.45 98.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.34 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.75 -36.55 84.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.529 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.43 11.58 62.34 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.539 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' SER . . . . . 0.423 ' O ' ' O ' ' D' ' 2' ' ' ALA . 40.8 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 2' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' D' ' 1' ' ' SER . . . 45.3 95.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.474 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -63.75 -40.3 96.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.935 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 4' ' ' HIS . . . . . 0.501 ' CD2' ' HG3' ' D' ' 5' ' ' GLU . 3.8 p-80 -58.55 -44.92 89.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.587 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 5' ' ' GLU . . . . . 0.501 ' HG3' ' CD2' ' D' ' 4' ' ' HIS . 97.8 mt-10 -65.51 -39.6 92.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 1.0 110.581 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -65.06 -39.16 92.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.483 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.14 -37.26 86.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.931 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.76 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.846 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -63.66 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 1.0 110.306 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.98 -39.1 91.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.88 81.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.73 -41.86 87.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 1.0 110.733 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -67.14 -37.92 84.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.93 -34.83 79.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.514 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.26 -40.6 96.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.316 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -60.36 -37.05 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.43 -42.51 92.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.74 0.305 . . . . 1.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.12 -42.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.771 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.0 mt -61.13 -42.02 97.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -59.98 -46.15 90.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.341 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.25 -40.28 74.5 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.411 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.42 93.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.06 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' SER . . . . . 0.437 ' OG ' ' OG ' ' D' ' 48' ' ' SER . 16.5 m -58.54 -45.28 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.091 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' LYS . . . . . 0.48 ' O ' ' OE1' ' D' ' 28' ' ' GLU . 60.9 tttp -60.71 -59.71 4.95 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.282 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.51 -38.86 75.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 1.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 26' ' ' ALA . . . . . 0.402 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -53.76 -36.14 62.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.79 -48.73 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.525 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 28' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' D' ' 28' ' ' GLU . 47.6 mp0 -73.29 -38.2 65.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -54.55 30.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.55 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 30' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 2.0 mp0 -64.91 -35.13 80.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.576 -0.283 . . . . 1.0 110.523 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.24 128.23 35.8 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.117 0.484 . . . . 1.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.08 -16.36 61.49 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.507 -0.769 . . . . 1.0 111.465 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.27 148.17 46.59 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' PRO . . . . . 0.576 ' O ' HG11 ' D' ' 63' ' ' VAL . 76.7 Cg_endo -74.78 130.71 13.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.913 1.742 . . . . 1.0 112.396 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 17.88 71.36 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.73 173.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 1.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.42 -40.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' LEU . . . . . 0.465 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.1 tt -97.72 121.58 39.8 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' ILE . . . . . 0.451 ' N ' HD23 ' D' ' 38' ' ' LEU . 24.1 pt -152.92 54.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -149.9 119.71 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.621 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 8.5 t80 -61.08 -47.99 93.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.62 -31.73 95.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.288 1.325 . . . . 1.0 112.056 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.53 -8.26 38.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.109 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.8 81.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 1.0 110.984 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -64.48 -34.45 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.082 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -69.06 -44.12 73.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.168 179.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -62.42 -41.52 98.76 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.523 -0.471 . . . . 1.0 109.803 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.44 ' O ' HD22 ' D' ' 19' ' ' LEU . 1.2 m -72.01 57.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -145.28 -51.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.725 0.298 . . . . 1.0 110.444 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -66.46 -31.82 72.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -45.25 91.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.358 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.76 -39.05 87.31 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.118 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 8.25 21.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.075 0.464 . . . . 1.0 110.322 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 42.8 p 44.03 57.35 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' D' ' 57' ' ' TYR . 1.6 m -140.86 41.53 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.76 88.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 57' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' D' ' 55' ' ' VAL . 1.2 t80 -61.74 -44.78 96.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 1.0 110.361 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.27 27.89 0.16 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 59' ' ' ASP . . . . . 0.487 ' CG ' ' NH2' ' A' ' 68' ' ' ARG . 43.3 t0 -63.74 -48.91 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' ARG . . . . . 0.479 ' C ' ' CG ' ' D' ' 61' ' ' TYR . 0.8 OUTLIER -146.13 -178.7 6.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.166 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 1.6 m-85 -150.44 99.6 3.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.072 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.83 147.24 68.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.782 1.655 . . . . 1.0 112.101 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' VAL . . . . . 0.576 HG11 ' O ' ' D' ' 34' ' ' PRO . 2.5 t -80.74 -134.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 64' ' ' THR . . . . . 0.54 HG23 ' NH2' ' D' ' 68' ' ' ARG . 51.7 m -114.56 -54.29 2.59 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.828 0.347 . . . . 1.0 110.559 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 65' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.2 tt0 -50.88 -18.33 0.73 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 66' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' D' ' 64' ' ' THR . 0.0 OUTLIER -78.06 37.84 0.26 Allowed 'General case' 0 C--O 1.261 1.691 0 CA-C-O 123.793 1.759 . . . . 1.0 108.679 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 67' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.83 62.43 3.74 Favored Glycine 0 C--O 1.202 -1.897 0 CA-C-N 113.649 -1.614 . . . . 1.0 109.636 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 68' ' ' ARG . . . . . 0.574 ' NE ' ' CD1' ' C' ' 46' ' ' TRP . 19.0 ttm105 -22.5 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 117.663 0.732 . . . . 1.0 111.681 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.2 mmtt -65.83 -8.29 20.93 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.022 -0.99 . . . . 1.0 109.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 70' ' ' VAL . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 16.5 t -59.79 -47.49 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -76.65 -52.78 9.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.0 0.429 . . . . 1.0 110.359 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -47.9 -41.43 24.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.931 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.14 -48.92 76.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.894 -0.322 . . . . 1.0 111.784 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.82 -43.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.555 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mpp? -61.42 -43.62 98.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.624 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.03 -38.85 89.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.632 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 77' ' ' ALA . . . . . 0.566 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.15 -37.06 81.5 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.505 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.76 -40.55 58.11 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.37 -44.77 99.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.638 0.236 . . . . 1.0 111.638 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.07 -35.16 77.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.304 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 81' ' ' VAL . . . . . 0.566 HG23 ' O ' ' D' ' 77' ' ' ALA . 34.5 t -62.15 -47.47 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.166 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -72.78 -6.61 45.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.836 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.9 -32.24 11.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.198 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.5 tt -64.15 -41.47 97.17 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.338 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 m -51.31 -10.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 86' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 89' ' ' LEU . 45.9 m -51.59 -43.07 62.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.062 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -46.02 -19.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 88' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -104.76 -17.61 14.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.45 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 89' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' D' ' 86' ' ' THR . 39.6 mt -93.27 -46.06 7.55 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -54.34 -30.08 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.705 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 91' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.1 OUTLIER -74.88 -11.76 60.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.765 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -53.22 -50.67 64.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.135 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 14.0 p90 -73.19 -11.26 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.652 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.03 -35.93 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.151 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -61.91 -42.52 99.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.137 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -53.54 -30.47 41.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 1.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' D' ' 99' ' ' GLU . 30.8 tp10 -76.02 158.76 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.058 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 98' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' D' ' 100' ' ' ARG . 97.2 mt-10 58.38 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' D' ' 97' ' ' GLU . 47.2 tp10 -40.86 -25.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.302 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' D' ' 98' ' ' GLU . 2.1 ptm180 -60.14 -44.15 95.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.075 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 101' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' D' ' 98' ' ' GLU . 85.1 mtp180 -68.8 -21.75 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.635 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.46 12.03 67.9 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.073 -0.965 . . . . 1.0 110.728 179.831 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.894 0.378 . . . . 1.0 110.663 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 6' ' ' ARG . 97.7 m-20 -67.25 -14.27 62.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.525 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.552 ' ND1' ' N ' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -83.76 -35.03 24.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.895 0.379 . . . . 1.0 110.286 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.16 -44.52 88.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.808 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 3' ' ' ASP . 39.0 ptt180 -66.85 -38.51 86.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.247 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.69 -43.14 80.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.289 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -67.56 -36.93 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.245 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.44 -39.72 94.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.333 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -62.19 -38.82 90.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.28 74.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.972 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.09 -39.47 86.24 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.588 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.43 -33.76 76.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.47 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.78 -36.3 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.596 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 52' ' ' ALA . 47.3 tp -62.02 -40.87 97.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 1.0 110.339 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -33.7 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.29 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -60.62 -43.09 97.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.055 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.07 -41.53 93.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.448 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.1 mt -59.37 -41.65 89.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.121 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.34 -49.59 77.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.631 -0.427 . . . . 1.0 109.996 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.37 -38.18 86.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.024 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.83 94.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.752 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 27' ' ' VAL . 38.7 m -53.65 -36.35 61.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' VAL . 64.9 tttm -77.57 -78.29 0.14 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.835 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 74.0 mmtt -36.19 -35.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.29 87.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.612 -0.435 . . . . 1.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 1.8 m -63.08 -47.8 90.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.201 -0.6 . . . . 1.0 110.564 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.9 tm-20 -70.1 -42.92 72.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.916 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 66' ' ' GLU . . . -59.48 -31.42 69.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.931 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -97.19 -33.05 11.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.605 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 27' ' ' VAL . 23.6 tpt180 -77.55 97.63 5.1 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.286 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 -14.02 7.98 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.88 42.57 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.93 142.72 28.45 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.111 1.874 . . . . 1.0 112.318 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.18 7.69 84.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.021 -0.831 . . . . 1.0 111.021 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.33 147.28 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 1.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.38 10.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' ILE . 6.7 tt -83.8 -71.08 0.52 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.358 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 40' ' ' SER . 45.0 pt 37.51 -162.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 39' ' ' ILE . 4.0 m 55.15 128.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.361 0.601 . . . . 1.0 111.055 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 23.2 m-85 -77.66 -55.68 1.23 Allowed Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.781 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.4 Cg_endo -60.28 -20.52 62.85 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.701 1.601 . . . . 1.0 112.348 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -89.0 -24.97 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.004 -0.278 . . . . 1.0 110.951 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.85 -37.84 85.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 45' ' ' ILE . 2.5 tp -63.89 -43.51 97.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.36 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.953 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -60.13 -42.11 94.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.117 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.485 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 18.1 t90 -60.68 -41.95 96.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.409 ' C ' HD22 ' A' ' 19' ' ' LEU . 52.9 p -76.64 69.63 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.384 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -152.39 -80.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.047 0.451 . . . . 1.0 110.476 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 57' ' ' TYR . 16.7 pt-20 -60.45 -20.87 61.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 52' ' ' ALA . 15.1 t -65.18 -43.73 90.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.137 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -56.1 -50.05 72.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -79.82 37.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.362 0.601 . . . . 1.0 109.437 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 19.2 p 60.28 -117.95 0.8 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.388 -0.824 . . . . 1.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 53' ' ' THR . 2.5 t 69.87 -54.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.13 -1.91 88.27 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' ASP . 3.2 m-85 -90.58 34.49 0.89 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.45 -9.78 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 57' ' ' TYR . 11.6 t0 74.29 9.36 4.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.422 . . . . 1.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -145.08 -162.13 1.44 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 13.2 p90 -167.88 98.32 0.59 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.094 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.99 150.23 77.74 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.453 1.435 . . . . 1.0 112.122 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.99 HG22 ' H ' ' A' ' 64' ' ' THR . 14.3 p -87.64 -136.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.99 ' H ' HG22 ' A' ' 63' ' ' VAL . 29.7 m -107.19 -44.28 4.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.524 0.33 . . . . 1.0 110.907 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.0 tt0 -56.17 -41.64 75.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.807 0.337 . . . . 1.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -65.13 24.94 0.02 OUTLIER 'General case' 0 C--O 1.264 1.856 0 CA-C-O 123.625 1.679 . . . . 1.0 109.8 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 42.97 65.9 1.29 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 117.968 -1.462 . . . . 1.0 111.487 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 56.3 ttm-85 -24.33 -34.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.161 0.981 . . . . 1.0 110.833 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 67' ' ' GLY . 73.4 mmtt -48.15 -19.03 0.24 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.145 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.3 t -61.19 -47.49 93.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 119.662 -0.815 . . . . 1.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.59 -41.8 19.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.854 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -52.71 -48.29 66.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.685 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.87 -40.3 97.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 70' ' ' VAL . 95.0 t -62.97 -46.48 96.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.177 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.11 -43.22 99.06 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.99 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.81 -41.06 94.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.61 -36.34 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.386 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.18 -39.56 94.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.07 -43.73 98.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.653 0.263 . . . . 1.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -62.51 -46.17 89.65 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.33 -49.35 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.929 0.395 . . . . 1.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -69.0 -27.88 66.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.905 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -84.54 -28.03 26.94 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.006 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.41 -45.98 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.335 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HB1' ' A' ' 8' ' ' ALA . 4.4 m -57.41 -18.55 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.361 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.1 m -38.16 -31.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.101 0.477 . . . . 1.0 110.442 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -58.95 -51.1 71.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.338 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -61.88 -29.61 70.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.034 0.445 . . . . 1.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.471 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -70.86 -35.38 72.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -65.73 -50.45 64.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.088 0.47 . . . . 1.0 111.432 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -59.54 -4.54 0.64 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.0 m-20 -55.28 -66.08 0.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.305 . . . . 1.0 111.129 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.5 p90 -62.76 -39.61 94.69 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.337 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 70.9 t -43.47 -31.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.55 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.26 -22.1 66.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 1.0 111.345 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.541 ' NH2' HG11 ' B' ' 94' ' ' VAL . 29.6 ptt180 -59.95 -34.28 73.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.711 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.961 -179.749 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 4' ' ' HIS . 52.7 p-10 . . . . . 0 N--CA 1.465 0.317 0 CA-C-O 120.768 0.318 . . . . 1.0 110.726 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 3' ' ' ASP . 15.8 p-80 -83.69 -26.3 29.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.531 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.31 -42.69 87.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -64.28 -42.53 96.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.567 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.2 -40.16 84.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 1.0 109.868 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.88 97.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.729 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.69 -37.95 87.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 1.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.74 -39.48 91.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.76 -36.8 79.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.788 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.68 -36.92 85.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 1.0 110.518 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.289 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -64.08 -37.22 86.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.546 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' B' ' 52' ' ' ALA . 50.4 tp -62.89 -41.46 99.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.421 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.45 -38.12 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.791 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' B' ' 21' ' ' GLU . 25.8 ttpp -61.07 -43.1 99.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.54 -41.78 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.6 mt -59.66 -41.35 90.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.1 mt-10 -63.06 -44.05 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 47.8 mt-10 -70.08 -33.96 72.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.023 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -63.6 -39.93 95.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.413 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.1 p -59.3 -43.59 92.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.07 -63.85 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.413 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -59.88 -39.61 85.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.564 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.8 -51.38 56.92 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.941 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.99 -47.18 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.141 -0.624 . . . . 1.0 110.943 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -64.37 -39.53 94.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.763 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.11 91.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 79.5 mm-40 -67.48 -42.45 82.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.789 0.328 . . . . 1.0 111.16 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -52.62 102.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 1.0 110.805 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 113.3 -9.13 24.62 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.51 138.27 23.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.834 -0.215 . . . . 1.0 110.672 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.59 141.55 25.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.91 1.74 . . . . 1.0 112.341 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.18 26.82 68.13 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -47.16 -58.3 4.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 1.0 110.794 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' B' ' 36' ' ' ALA . . . 70.42 -20.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.383 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' B' ' 36' ' ' ALA . 24.4 tp -110.6 119.51 39.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.1 pt -154.89 168.92 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.627 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.5 OUTLIER 80.22 135.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.0 110.989 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.668 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 4.1 t80 -72.12 -41.82 8.93 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.912 -0.585 . . . . 1.0 111.564 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.5 Cg_endo -58.22 -32.7 96.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.494 1.463 . . . . 1.0 112.794 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.546 ' CG ' HH12 ' B' ' 60' ' ' ARG . 35.4 p-10 -99.05 -7.45 26.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.54 -44.11 91.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 1.0 110.406 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -64.49 -33.58 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.683 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.3 OUTLIER -61.17 -46.8 89.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.515 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.404 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.1 OUTLIER -71.01 -28.36 64.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.42 ' O ' HD22 ' B' ' 19' ' ' LEU . 3.1 t -68.49 -35.4 77.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.589 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.662 HG11 HH12 ' C' ' 68' ' ' ARG . 47.2 t -60.47 -48.4 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.856 0.317 . . . . 1.0 111.856 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.433 ' HB3' HH21 ' C' ' 68' ' ' ARG . 6.3 pt-20 -68.96 -28.84 66.99 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.472 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -62.28 -47.19 85.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.155 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.721 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.55 -36.74 69.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.502 ' C ' ' H ' ' B' ' 55' ' ' VAL . 82.1 p -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.43 HG23 ' C ' ' B' ' 53' ' ' THR . 2.7 p 66.09 -6.7 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.302 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' B' ' 57' ' ' TYR . 69.5 t -65.33 -47.34 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.922 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 67.43 -34.8 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER 61.88 -73.08 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.803 0.335 . . . . 1.0 110.604 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 57' ' ' TYR . . . 158.72 29.94 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.69 -62.41 1.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 1.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.546 HH12 ' CG ' ' B' ' 43' ' ' ASP . 81.5 mtm180 -147.43 -170.24 3.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.394 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -173.82 136.72 0.67 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.12 -171.73 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.576 1.518 . . . . 1.0 112.138 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.552 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.0 t -118.06 -135.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.155 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.953 HG23 ' CD1' ' A' ' 46' ' ' TRP . 26.2 m -114.39 -37.12 4.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.541 -0.299 . . . . 1.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.612 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.8 tt0 -66.49 -34.1 77.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.509 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -71.19 32.02 0.05 OUTLIER 'General case' 0 C--O 1.267 2.016 0 CA-C-O 123.709 1.718 . . . . 1.0 109.972 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.98 63.91 1.62 Allowed Glycine 0 C--O 1.214 -1.127 0 CA-C-N 113.916 -1.493 . . . . 1.0 111.14 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' B' ' 67' ' ' GLY . 58.8 ttm-85 -23.95 -33.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.384 1.092 . . . . 1.0 110.91 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 99.0 mttt -48.27 -18.48 0.22 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' B' ' 67' ' ' GLY . 53.6 t -61.93 -46.91 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 C-N-CA 119.953 -0.699 . . . . 1.0 109.754 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -48.16 38.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.457 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.45 -45.11 12.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.275 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.01 -46.93 87.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.686 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.0 -46.01 82.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.456 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.09 -44.12 97.34 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.72 -37.74 85.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.376 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.495 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.16 -41.23 96.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.674 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.2 -42.25 94.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.53 -43.55 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.071 -0.252 . . . . 1.0 111.075 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.76 -40.39 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 1.0 110.797 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.8 t -63.07 -46.92 94.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.151 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -74.7 0.79 14.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.018 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -106.31 -37.6 6.49 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -62.98 -39.99 96.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.057 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -52.62 -8.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.005 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.494 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.7 m -61.35 -21.54 64.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.54 -23.32 49.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.49 -10.83 18.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.533 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 38.6 mt -99.14 -25.89 14.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.953 0.406 . . . . 1.0 110.293 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -13.55 60.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.891 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.37 -4.46 29.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.122 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 89.2 m-20 -61.19 -43.56 98.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 4.7 p90 -70.5 -32.64 70.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.153 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.541 HG11 ' NH2' ' A' ' 96' ' ' ARG . 61.7 t -61.79 -27.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.711 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.61 -22.98 64.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.441 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -59.49 -37.09 77.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 1.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.986 -179.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.9 t0 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.866 0.365 . . . . 1.0 110.457 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.692 ' H ' ' CD2' ' C' ' 4' ' ' HIS . 4.5 p80 -69.04 -36.55 77.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.644 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.44 -36.32 83.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -62.91 -38.3 90.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.835 0.35 . . . . 1.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.33 -42.22 98.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.021 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.0 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.63 -39.57 93.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.398 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.12 -41.33 98.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.333 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.88 88.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.52 -39.89 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 1.0 111.106 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.69 -34.67 78.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.742 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.44 -36.16 82.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.538 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.416 HD13 ' HA2' ' C' ' 78' ' ' GLY . 51.3 tp -62.17 -41.21 98.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.345 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.26 -39.15 78.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.23 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.63 -38.48 87.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.852 0.358 . . . . 1.0 110.828 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.8 mt -58.75 -40.52 84.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.672 -0.411 . . . . 1.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.4 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.0 mm-40 -56.94 -45.43 82.79 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.96 -37.1 78.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.033 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -63.62 -39.52 94.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.415 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 90.2 p -61.41 -35.78 78.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' C' ' 26' ' ' ALA . 88.2 tttt -73.79 -77.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.106 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' C' ' 29' ' ' ALA . 14.6 mptt -38.98 -25.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' C' ' 24' ' ' LYS . . . -64.88 -41.61 95.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.74 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' C' ' 28' ' ' GLU . 1.7 m -63.73 -47.63 90.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.029 0.442 . . . . 1.0 110.366 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' C' ' 30' ' ' GLU . 96.8 mt-10 -71.64 -36.58 70.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.428 -0.805 . . . . 1.0 110.365 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' LYS . . . -70.91 29.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' C' ' 28' ' ' GLU . 3.6 tp10 -153.46 -38.98 0.1 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.954 0.407 . . . . 1.0 110.283 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -65.36 86.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.065 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.4 20.42 2.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.489 ' HB2' ' CD ' ' C' ' 66' ' ' GLU . . . -105.4 151.49 39.71 Favored Pre-proline 0 N--CA 1.466 0.373 0 O-C-N 122.886 -0.185 . . . . 1.0 110.685 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.55 115.8 4.15 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.167 1.245 . . . . 1.0 111.106 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 82.5 18.08 67.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.259 -0.736 . . . . 1.0 111.259 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.48 ' HB1' ' HG3' ' C' ' 30' ' ' GLU . . . -42.35 167.98 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.919 0.39 . . . . 1.0 110.472 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.95 -30.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.436 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.59 101.31 13.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.104 0.478 . . . . 1.0 110.225 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' C' ' 40' ' ' SER . 42.2 pt -128.83 161.25 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.217 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.8 OUTLIER 80.81 140.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 1.0 110.604 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.641 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 46.0 t80 -79.65 -41.96 1.51 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.188 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.5 Cg_endo -59.92 -29.9 90.51 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.489 1.459 . . . . 1.0 112.453 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' C' ' 44' ' ' ALA . 2.8 p-10 -93.56 -23.22 18.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.719 0.295 . . . . 1.0 111.198 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' C' ' 43' ' ' ASP . . . -63.55 -33.27 75.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.864 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.403 ' H ' HG22 ' C' ' 45' ' ' ILE . 3.1 tp -65.38 -41.11 90.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.686 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.5 OUTLIER -61.44 -42.93 99.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.811 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.535 ' NE1' ' OH ' ' B' ' 57' ' ' TYR . 3.7 t90 -59.61 -40.04 86.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' C' ' 51' ' ' THR . 15.5 m -58.27 -33.1 69.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.99 -44.89 92.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.482 ' OE1' ' NH1' ' D' ' 68' ' ' ARG . 9.0 pt-20 -87.51 73.11 9.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.693 0.282 . . . . 1.0 111.289 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' C' ' 48' ' ' SER . 0.6 OUTLIER -177.0 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.171 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.455 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -71.36 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.041 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.405 ' C ' HG23 ' C' ' 54' ' ' THR . 2.6 p -92.16 20.5 5.89 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.405 HG23 ' C ' ' C' ' 53' ' ' THR . 1.2 p 57.5 33.5 23.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.873 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.429 HG11 ' SD ' ' D' ' 75' ' ' MET . 74.2 t -132.5 87.14 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.119 0.485 . . . . 1.0 110.112 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.89 79.14 1.65 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.536 ' CZ ' ' O ' ' D' ' 60' ' ' ARG . 0.8 OUTLIER -60.08 -47.34 86.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.931 0.396 . . . . 1.0 110.523 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 147.31 -85.58 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.729 -0.949 . . . . 1.0 110.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.459 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 92.4 m-20 41.61 -89.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 1.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' C' ' 58' ' ' GLY . 84.2 mtm180 -127.8 150.85 49.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.887 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -153.41 147.51 18.81 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.74 156.94 62.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.254 1.969 . . . . 1.0 112.04 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.1 t -89.22 -132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.476 ' C ' ' H ' ' C' ' 66' ' ' GLU . 99.4 m -115.3 -56.96 2.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.833 0.349 . . . . 1.0 110.703 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -52.85 -10.08 0.15 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 10.7 mp0 -108.28 47.04 0.92 Allowed 'General case' 0 C--O 1.272 2.261 0 CA-C-O 124.747 2.213 . . . . 1.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 37.4 60.99 1.07 Allowed Glycine 0 C--O 1.218 -0.905 0 CA-C-N 112.432 -2.167 . . . . 1.0 111.128 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.662 HH12 HG11 ' B' ' 49' ' ' VAL . 60.9 ttt-85 -25.18 -32.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.738 0.769 . . . . 1.0 111.074 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.718 ' N ' ' O ' ' C' ' 67' ' ' GLY . 52.4 mtmt -55.4 -9.08 0.41 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.702 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.0 t -58.32 -45.64 89.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 118.617 -1.233 . . . . 1.0 110.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.97 38.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 1.0 111.15 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -56.89 -46.02 82.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.067 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.87 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.414 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.12 -44.02 91.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.653 -0.419 . . . . 1.0 111.395 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.14 -41.25 99.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.126 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.99 -35.49 75.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.708 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.46 74.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.357 . . . . 1.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.65 -36.63 88.18 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.07 -44.01 97.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.678 -0.307 . . . . 1.0 110.729 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.76 -43.85 87.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.814 -0.354 . . . . 1.0 111.099 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.0 -48.66 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.517 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.456 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.4 m-85 -73.98 -14.44 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.084 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.0 -32.14 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 1.0 110.171 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.2 tt -66.45 -39.61 88.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.483 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.456 HG22 ' O ' ' C' ' 82' ' ' PHE . 3.6 m -47.93 -9.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.055 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.516 ' H ' ' C ' ' C' ' 84' ' ' LEU . 27.1 m -57.4 -38.88 75.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.411 . . . . 1.0 110.024 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -51.3 -23.25 3.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.088 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.0 -11.54 26.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.85 -49.39 7.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.318 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.37 -13.97 4.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.975 0.417 . . . . 1.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.2 OUTLIER -101.02 -5.37 25.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.165 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 91.3 m-20 -61.09 -47.85 84.39 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 36.9 p90 -78.35 -36.62 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.35 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 86.9 t -46.51 -34.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.763 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -62.33 -20.65 64.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.713 0.292 . . . . 1.0 111.242 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' C' ' 96' ' ' ARG . 25.1 ptt-85 -49.48 -38.96 32.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.51 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.256 179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.902 0.382 . . . . 1.0 110.451 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -66.8 -21.93 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -41.7 94.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.267 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.45 -37.91 88.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.553 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -62.98 -42.53 99.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.354 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.51 -44.98 69.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . 0.432 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -65.47 -43.85 89.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.41 -38.01 89.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.567 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -39.18 92.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.711 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.99 73.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . 0.409 ' OE2' ' CE1' ' D' ' 82' ' ' PHE . 79.7 mm-40 -65.48 -33.73 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.23 -40.98 97.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.887 0.375 . . . . 1.0 110.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.91 -30.43 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.431 HD11 ' HB1' ' D' ' 52' ' ' ALA . 51.8 tp -61.97 -42.12 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.324 . . . . 1.0 110.486 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -62.23 -40.14 95.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.59 -41.65 92.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -60.35 -41.77 94.33 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.181 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.9 mt-10 -62.7 -48.12 80.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -69.83 -42.23 73.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 1.0 110.49 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.06 85.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.085 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -58.98 -43.58 91.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.85 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.54 -32.37 73.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.649 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -78.5 -38.26 41.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.849 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.81 75.88 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.166 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.537 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.9 p -63.11 -45.15 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 1.0 110.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.537 ' N ' HG13 ' D' ' 27' ' ' VAL . 83.7 tt0 -66.26 -42.85 87.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.511 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.44 97.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.279 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -64.98 -32.99 74.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.811 -0.356 . . . . 1.0 110.451 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.02 130.58 41.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.953 0.406 . . . . 1.0 110.454 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.07 -10.38 63.8 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.25 148.98 36.63 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.453 ' O ' HG11 ' D' ' 63' ' ' VAL . 80.9 Cg_endo -74.59 137.6 22.94 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.87 1.713 . . . . 1.0 112.208 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.57 74.42 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 138.52 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.979 0.419 . . . . 1.0 110.442 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.84 -30.98 4.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.311 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.414 ' C ' HD23 ' D' ' 38' ' ' LEU . 4.3 tt -97.38 76.39 2.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 1.0 110.166 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -101.97 -2.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.417 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 10.6 p -76.44 148.15 37.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.552 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.7 OUTLIER -104.43 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.11 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.3 Cg_endo -57.98 -31.67 93.4 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.612 1.541 . . . . 1.0 111.744 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.37 -0.79 57.7 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.195 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.7 89.21 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.819 0.343 . . . . 1.0 110.39 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.428 ' O ' HG23 ' D' ' 49' ' ' VAL . 5.1 tt -65.48 -38.39 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.468 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.44 -46.45 80.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.064 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -65.47 -38.64 90.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.17 -35.14 80.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.786 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 45' ' ' ILE . 40.9 t -60.13 -48.79 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.834 -0.347 . . . . 1.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.78 -29.35 68.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.075 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.4 m -63.04 -44.84 94.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.54 -30.39 70.61 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 23.2 p -80.76 8.93 7.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.34 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 73.1 p 41.26 70.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.444 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' D' ' 57' ' ' TYR . 0.2 OUTLIER -146.78 -42.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.334 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.56 -38.8 0.6 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' D' ' 55' ' ' VAL . 1.6 t80 66.12 -68.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 1.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . 146.0 32.21 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.0 m-20 -85.44 -58.49 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.536 ' O ' ' CZ ' ' C' ' 57' ' ' TYR . 94.1 mtt-85 -141.0 -179.39 6.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -158.01 137.09 8.13 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.697 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.66 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.3 2.0 . . . . 1.0 112.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.528 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -89.4 -140.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.814 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.686 HG23 ' CD1' ' C' ' 46' ' ' TRP . 5.1 m -114.68 -32.54 5.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' D' ' 67' ' ' GLY . 79.9 tt0 -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.926 0.394 . . . . 1.0 110.576 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.2 OUTLIER -77.49 24.88 0.19 Allowed 'General case' 0 C--O 1.262 1.758 0 CA-C-O 123.715 1.722 . . . . 1.0 109.219 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.87 62.22 3.06 Favored Glycine 0 C--O 1.213 -1.181 0 CA-C-N 113.87 -1.514 . . . . 1.0 109.439 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.482 ' NH1' ' OE1' ' C' ' 50' ' ' GLU . 58.6 ttm-85 -25.21 -30.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.216 0.598 . . . . 1.0 110.985 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.725 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.1 mttp -51.2 -24.63 4.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.351 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' D' ' 67' ' ' GLY . 74.8 t -62.37 -49.47 83.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.039 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -39.29 72.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.476 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -61.35 -37.03 81.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.848 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.01 -41.67 99.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.411 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.43 -43.24 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.267 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.429 ' SD ' HG11 ' C' ' 55' ' ' VAL . 63.4 mtt -58.82 -45.92 88.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.081 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -65.58 -38.36 89.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 1.0 110.576 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.405 ' O ' HG22 ' D' ' 81' ' ' VAL . . . -59.0 -40.26 84.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.499 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.67 -39.27 86.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.33 -43.44 97.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.414 -0.463 . . . . 1.0 111.19 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.65 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.501 HG23 ' N ' ' D' ' 82' ' ' PHE . 16.0 m -60.82 -50.31 81.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.457 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . 0.501 ' N ' HG23 ' D' ' 81' ' ' VAL . 24.6 m-85 -66.97 -41.38 86.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.11 78.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.313 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' D' ' 86' ' ' THR . 7.7 tt -61.79 -42.15 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.432 HG22 ' HB1' ' D' ' 8' ' ' ALA . 49.1 t -50.21 -15.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -54.73 -19.5 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.119 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -62.24 -62.97 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.827 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.86 75.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.139 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.06 -47.47 68.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.899 0.38 . . . . 1.0 110.732 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.457 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -61.45 -25.39 67.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 1.3 m -84.01 -3.55 58.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.319 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 87.1 m-20 -60.62 -46.76 89.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 9.0 p90 -65.54 -32.29 73.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.615 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.51 -42.74 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.181 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -52.96 -22.12 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -50.42 -37.34 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 1.0 110.459 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.876 -179.317 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.523 -0.072 0 CA-C-O 120.544 0.211 . . . . 1.0 110.568 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 59.54 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 2' ' ' ALA . 31.1 p80 -56.75 -40.2 75.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 1.0 110.663 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.441 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 43.7 tt0 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.315 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mmt-85 -64.43 -38.52 91.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.178 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.04 -40.0 90.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.68 88.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.49 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -62.21 -39.61 93.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.18 -37.67 88.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.422 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.97 79.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.59 -37.8 88.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 1.0 110.524 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -64.75 -35.97 82.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.914 0.387 . . . . 1.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.62 -33.22 75.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' HA2' ' A' ' 78' ' ' GLY . 49.6 tp -62.29 -42.0 98.98 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.628 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.34 -37.71 86.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.153 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -61.9 -41.64 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.723 0.297 . . . . 1.0 110.98 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.53 -42.03 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.467 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.0 mt -59.49 -40.94 88.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.055 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.66 -48.59 81.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.684 -0.407 . . . . 1.0 109.935 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.039 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.99 90.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.577 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -59.67 -43.05 94.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.129 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -58.28 -64.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.56 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.97 -37.8 80.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.648 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.94 -49.41 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.861 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.74 -43.18 90.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.526 -0.469 . . . . 1.0 110.179 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -61.33 -42.62 98.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.724 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -56.46 -53.37 58.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -65.02 -19.58 66.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.157 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -82.53 89.41 6.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.887 -0.325 . . . . 1.0 111.249 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.58 6.12 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 116.192 -0.458 . . . . 1.0 112.012 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.94 144.55 29.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.807 0.304 . . . . 1.0 110.287 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.45 142.03 26.06 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.954 1.77 . . . . 1.0 112.231 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.47 12.14 80.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.1 138.14 57.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 1.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.77 -58.66 1.94 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.612 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.53 99.21 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.976 0.417 . . . . 1.0 110.427 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 pt -135.5 55.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.457 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 3.4 m -156.54 132.66 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.061 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.576 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 91.6 m-85 -67.19 -44.22 47.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.578 0.584 . . . . 1.0 112.578 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.5 Cg_endo -60.04 -32.44 94.85 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 121.272 1.315 . . . . 1.0 112.76 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.9 p-10 -99.8 -1.1 38.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 121.017 -0.273 . . . . 1.0 110.948 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.429 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -66.16 -43.78 85.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 1.0 110.495 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.412 ' H ' HG22 ' A' ' 45' ' ' ILE . 5.1 tt -66.69 -38.73 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.653 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -56.52 -46.07 80.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE3' ' N ' ' A' ' 48' ' ' SER . 1.6 t90 -67.36 -39.01 85.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.906 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.492 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 m -55.74 -25.51 40.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.163 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.93 -44.81 78.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.414 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.528 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 99.5 mt-10 -79.7 69.02 5.93 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.408 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -174.65 -46.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.4 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.17 -25.4 65.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 54' ' ' THR . 33.0 p -92.44 -0.79 57.32 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 53' ' ' THR . 16.5 p 57.14 76.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.207 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' B' ' 75' ' ' MET . 89.4 t -148.77 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.688 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.4 89.85 0.8 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.546 -0.622 . . . . 1.0 111.546 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -63.93 -42.87 97.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 1.0 110.948 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.76 15.61 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.67 -68.65 0.35 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.638 0.256 . . . . 1.0 110.904 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -134.14 159.49 40.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.13 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' D' ' 57' ' ' TYR . 20.3 t80 -172.34 137.8 0.91 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.46 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.13 -172.63 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.804 1.669 . . . . 1.0 112.013 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 64' ' ' THR . 11.1 p -117.75 -121.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.746 ' N ' HG13 ' A' ' 63' ' ' VAL . 36.4 m -111.31 -61.77 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.658 0.266 . . . . 1.0 111.098 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -49.06 -20.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.149 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.627 ' CD ' HG12 ' A' ' 63' ' ' VAL . 44.9 mt-10 -87.87 36.4 0.76 Allowed 'General case' 0 C--O 1.265 1.921 0 CA-C-O 124.433 2.063 . . . . 1.0 109.032 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.65 63.43 1.21 Allowed Glycine 0 C--O 1.212 -1.261 0 CA-C-N 112.937 -1.938 . . . . 1.0 111.11 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' D' ' 59' ' ' ASP . 62.2 ttm-85 -24.92 -33.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.025 0.913 . . . . 1.0 111.055 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 67' ' ' GLY . 70.9 mmtt -49.93 -18.27 0.5 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.48 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -62.41 -47.56 92.43 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 119.288 -0.965 . . . . 1.0 110.449 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.62 69.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.307 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.32 -37.96 88.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.823 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.1 -43.99 82.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.848 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -44.57 92.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.41 -41.58 98.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.57 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.35 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.87 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.568 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -65.84 -42.52 94.99 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.4 -43.37 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.627 0.251 . . . . 1.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.71 -43.45 97.81 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.265 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.58 -49.25 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.002 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.37 -13.85 61.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.392 . . . . 1.0 111.086 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.39 -35.54 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 1.0 110.715 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.88 -42.17 97.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ALA . 11.4 m -59.42 -23.14 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.421 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.7 m -36.71 -28.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 1.0 110.624 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.35 -49.01 79.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.269 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -63.48 -32.4 73.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.284 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.2 mm? -66.48 -40.22 89.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.555 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.28 -45.12 84.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.842 0.353 . . . . 1.0 110.955 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.97 -3.22 34.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.258 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.42 -48.65 76.51 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.582 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.8 p90 -73.62 -37.06 65.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 1.0 111.451 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 95.3 t -48.29 -27.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.592 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -66.25 -21.44 66.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 . . . . . 0 C--N 1.329 -0.311 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 67.5 t0 . . . . . 0 N--CA 1.467 0.375 0 CA-C-O 120.69 0.281 . . . . 1.0 110.657 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 7.3 p80 -79.3 -22.19 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.532 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.22 -37.81 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.74 -39.85 95.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.15 -40.55 90.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.935 0.398 . . . . 1.0 110.05 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -63.05 -45.72 90.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -65.34 -41.26 94.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -63.6 -36.4 83.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.483 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.0 86.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.965 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.03 -37.25 73.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 1.0 110.613 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.3 -32.97 74.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.194 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.18 -39.52 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.389 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.9 tp -61.89 -42.79 99.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.273 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -53.95 -39.75 66.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.97 -37.77 86.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.527 -0.306 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.19 -41.83 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 1.5 tp -60.36 -48.07 83.31 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' B' ' 23' ' ' SER . 81.0 mm-40 -64.68 -41.96 95.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.233 0.539 . . . . 1.0 109.745 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.64 -26.69 68.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' LEU . . . -64.67 -37.51 87.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.248 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 97.9 p -58.86 -45.36 90.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.556 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.66 -30.75 71.49 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.45 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 29' ' ' ALA . 29.1 mmtp -79.3 -42.88 24.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.45 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.17 -47.99 77.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.441 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 28' ' ' GLU . 8.3 p -61.75 -45.88 97.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.509 . . . . 1.0 109.971 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.564 ' N ' HG13 ' B' ' 27' ' ' VAL . 79.9 tt0 -71.18 -21.22 62.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -58.49 -40.47 82.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.963 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 27.3 mp0 -65.93 -36.4 83.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 1.0 110.294 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -66.79 90.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.431 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 126.72 -15.31 6.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.28 19.17 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 87.2 Cg_endo -76.42 118.42 4.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.075 1.85 . . . . 1.0 112.235 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.8 37.68 1.13 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.89 143.34 32.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.64 -51.3 0.09 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.232 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.581 ' C ' HD23 ' B' ' 38' ' ' LEU . 5.0 tt -60.96 -60.29 4.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.981 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' B' ' 40' ' ' SER . 44.9 pt 31.56 -145.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 123.436 0.46 . . . . 1.0 110.729 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.464 ' O ' ' O ' ' B' ' 39' ' ' ILE . 19.3 m 57.39 144.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.331 0.586 . . . . 1.0 111.162 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.54 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 2.7 m-85 -100.58 -64.37 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.763 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 23.3 Cg_endo -58.85 -23.49 67.53 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.293 1.995 . . . . 1.0 112.432 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -90.76 -21.18 21.67 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.677 0.275 . . . . 1.0 110.697 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.69 88.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.841 0.353 . . . . 1.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.409 ' H ' HG22 ' B' ' 45' ' ' ILE . 5.9 tt -61.8 -36.49 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.216 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.504 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.6 OUTLIER -67.77 -43.16 80.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.421 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.464 ' CD1' ' OE2' ' B' ' 50' ' ' GLU . 19.5 t90 -61.6 -41.6 97.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.731 0.3 . . . . 1.0 110.669 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 m -60.94 -38.11 84.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.475 -0.49 . . . . 1.0 110.581 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.75 -44.41 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.464 ' OE2' ' CD1' ' B' ' 47' ' ' TRP . 5.0 pt-20 -55.78 -38.9 70.52 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.709 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.63 ' C ' ' H ' ' B' ' 53' ' ' THR . 6.0 t -87.34 -152.44 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.216 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 58.94 -9.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.475 0.179 . . . . 1.0 110.663 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.63 ' H ' ' C ' ' B' ' 51' ' ' THR . 67.0 p -113.06 15.32 19.6 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.648 0.261 . . . . 1.0 110.937 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.07 66.5 1.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.916 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.529 HG13 ' N ' ' B' ' 56' ' ' GLY . 9.9 p -147.56 -46.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.758 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 44.73 78.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -45.23 94.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.681 0.277 . . . . 1.0 110.502 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.65 3.63 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.644 -0.983 . . . . 1.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 99.5 m-20 -62.51 -41.43 98.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.363 . . . . 1.0 110.688 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -117.11 -173.17 2.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -139.57 99.4 7.77 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.615 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.12 160.52 48.39 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.375 1.383 . . . . 1.0 112.285 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.537 HG12 ' H ' ' B' ' 64' ' ' THR . 0.9 OUTLIER -79.24 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.588 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 66' ' ' GLU . 1.8 m -115.35 -67.82 0.97 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.288 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.438 ' N ' HG22 ' B' ' 64' ' ' THR . 80.7 tt0 -34.02 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.224 0.535 . . . . 1.0 110.701 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.867 ' O ' ' N ' ' B' ' 68' ' ' ARG . 91.8 mt-10 -147.85 -107.07 0.09 Allowed 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.549 -0.75 . . . . 1.0 109.359 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 23.06 -56.54 0.0 OUTLIER Glycine 0 N--CA 1.478 1.49 0 O-C-N 124.635 1.209 . . . . 1.0 114.355 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.867 ' N ' ' O ' ' B' ' 66' ' ' GLU . 36.6 ttt180 -72.13 -46.09 57.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' B' ' 66' ' ' GLU . 84.5 tttt -64.16 -34.2 77.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.832 -1.173 . . . . 1.0 107.832 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.71 -44.66 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.96 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.6 76.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.234 -0.439 . . . . 1.0 109.936 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -52.39 -50.47 62.4 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.898 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.47 -48.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.516 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 55' ' ' VAL . 78.2 mtm -61.52 -47.62 84.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.785 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' B' ' 80' ' ' GLU . 51.6 tttp -66.44 -40.51 89.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.521 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.7 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.78 94.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.55 -43.17 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.001 -0.28 . . . . 1.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -58.59 -47.39 84.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.061 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.84 -50.37 75.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.619 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -67.9 -37.21 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.689 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.03 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.32 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' B' ' 86' ' ' THR . 3.6 tt -61.59 -42.03 98.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.477 HG13 ' HB1' ' B' ' 8' ' ' ALA . 26.2 t -49.09 -21.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.406 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.5 m -48.77 -21.07 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' B' ' 91' ' ' THR . . . -58.55 -54.52 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 1.0 111.024 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.71 89.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.828 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.519 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.0 mm? -63.04 -42.75 99.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.412 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -64.35 -35.74 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.437 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -82.57 -4.36 57.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.535 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.567 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 36.6 t0 -57.93 -48.75 78.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.57 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 10.7 p90 -67.14 -32.44 73.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.008 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.68 -43.71 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.76 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -57.37 -21.62 37.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.487 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -58.97 -33.07 70.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.068 0.461 . . . . 1.0 109.936 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.836 -178.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.883 0.373 . . . . 1.0 110.328 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 15.2 p80 -66.83 -37.48 84.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.7 tt0 -62.69 -35.69 80.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.677 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.04 -39.7 95.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.01 -40.15 94.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.323 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.78 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.368 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.25 -36.54 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.371 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.42 -38.69 88.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.35 85.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.11 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.53 -39.49 93.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 1.0 111.011 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -63.55 -38.72 92.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.644 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.98 -32.38 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.546 HD11 ' HB1' ' C' ' 52' ' ' ALA . 45.5 tp -62.28 -38.52 89.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 1.0 110.315 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.62 -33.44 74.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.202 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.55 -46.95 83.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.697 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 18' ' ' VAL . 10.8 m -63.86 -37.6 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.81 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.9 mt -62.15 -41.87 98.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.0 mt-10 -64.49 -43.22 94.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.35 -39.41 71.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.313 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.4 84.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.0 p -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.413 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -65.56 -39.93 92.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.236 0.541 . . . . 1.0 109.965 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.2 mttp -66.8 -43.97 82.45 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.054 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -54.39 -53.56 52.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.748 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.433 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.3 p -58.12 -44.81 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.66 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.433 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.7 tt0 -68.34 -33.88 75.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.405 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' C' ' 26' ' ' ALA . 4.5 mp0 -81.79 -13.17 58.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.657 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.74 89.62 0.11 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.842 0.354 . . . . 1.0 110.425 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.08 20.05 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.3 140.47 72.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.438 ' O ' HG11 ' C' ' 63' ' ' VAL . 94.2 Cg_endo -76.26 141.34 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.936 1.758 . . . . 1.0 112.33 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.01 65.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.228 -0.749 . . . . 1.0 111.228 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 134.37 44.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.885 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.41 -22.73 16.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.356 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 tp -107.37 112.15 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.9 pt -139.26 -3.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.263 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -76.36 154.62 34.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.512 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 11.3 m-85 -96.18 -63.17 0.12 Allowed Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.3 Cg_endo -59.28 -36.12 95.52 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.99 1.794 . . . . 1.0 112.528 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.402 ' O ' ' NH1' ' C' ' 60' ' ' ARG . 90.8 m-20 -81.39 -7.11 59.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.257 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.47 87.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 1.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.448 HG23 ' N ' ' C' ' 46' ' ' TRP . 16.3 tt -65.5 -38.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.448 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.6 OUTLIER -54.78 -48.82 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.226 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.403 ' O ' ' N ' ' C' ' 49' ' ' VAL . 3.5 t90 -61.64 -41.18 97.14 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.682 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.454 ' O ' HD22 ' C' ' 19' ' ' LEU . 2.2 t -68.39 60.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.645 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' C' ' 47' ' ' TRP . 73.0 t -150.66 -56.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.085 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.405 ' HB3' HH12 ' D' ' 68' ' ' ARG . 9.1 pt-20 -64.36 -30.55 71.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.584 -0.446 . . . . 1.0 110.693 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 98.9 m -62.31 -46.62 87.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.25 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.713 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.48 -26.31 66.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.66 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' C' ' 54' ' ' THR . 47.3 p -91.21 5.25 49.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.96 0.41 . . . . 1.0 110.076 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 53' ' ' THR . 43.4 p 52.4 74.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.416 HG11 ' CE1' ' C' ' 57' ' ' TYR . 62.1 t -139.24 -68.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.294 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.13 75.23 0.48 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.416 ' CE1' HG11 ' C' ' 55' ' ' VAL . 37.4 m-85 -59.95 -45.98 90.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.69 0.281 . . . . 1.0 110.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.43 10.57 1.87 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' D' ' 61' ' ' TYR . 99.4 m-20 -60.02 -46.77 88.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 1.0 110.405 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' C' ' 43' ' ' ASP . 53.6 mtm180 -143.01 166.86 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.02 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -156.65 127.24 3.47 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.599 -0.44 . . . . 1.0 110.542 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.67 152.57 64.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.802 1.668 . . . . 1.0 112.236 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' C' ' 64' ' ' THR . 2.4 t -84.28 -134.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.24 -0.436 . . . . 1.0 109.949 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' C' ' 63' ' ' VAL . 72.3 m -114.59 -37.97 4.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.734 0.302 . . . . 1.0 110.721 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.2 tt0 -66.55 -28.2 68.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.469 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.445 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -72.17 26.05 0.05 Allowed 'General case' 0 C--O 1.264 1.82 0 CA-C-O 123.509 1.623 . . . . 1.0 110.36 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.44 64.06 1.93 Allowed Glycine 0 C--O 1.214 -1.095 0 CA-C-O 117.889 -1.506 . . . . 1.0 111.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' B' ' 59' ' ' ASP . 58.9 ttm-85 -24.41 -31.52 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.961 0.881 . . . . 1.0 111.368 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' C' ' 67' ' ' GLY . 14.5 mptt -49.5 -21.53 0.98 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.791 -0.641 . . . . 1.0 109.354 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 76.8 t -61.72 -49.52 83.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.9 -36.25 69.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.029 0.442 . . . . 1.0 110.696 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.34 -42.09 86.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.913 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.02 -41.1 97.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.086 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.31 -43.6 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.39 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 20.7 mtm -60.9 -44.08 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.125 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.57 -38.41 89.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.59 90.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.668 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.19 95.15 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.714 -0.554 . . . . 1.0 111.714 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.29 -43.14 97.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.51 -0.406 . . . . 1.0 110.982 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.97 -50.37 74.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.809 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' N ' ' C' ' 82' ' ' PHE . 12.0 m -61.84 -49.45 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.918 -0.313 . . . . 1.0 111.363 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.464 ' N ' HG23 ' C' ' 81' ' ' VAL . 32.5 m-85 -69.34 -40.13 77.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.019 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.519 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -64.94 -36.09 83.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 1.0 110.614 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.7 tt -62.55 -41.08 98.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.53 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -46.37 -19.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.533 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.9 m -51.94 -40.36 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -49.35 -27.48 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.243 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.58 -16.63 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.612 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' C' ' 86' ' ' THR . 55.3 mt -87.86 -44.07 11.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.164 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.15 -23.84 50.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.936 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -85.93 -4.42 59.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.898 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 94.3 m-20 -60.07 -45.27 93.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.698 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HB1' ' D' ' 90' ' ' ALA . 7.1 p90 -76.03 -28.6 57.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.067 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.81 -42.61 89.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.468 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -55.66 -21.8 19.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.198 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 42.6 ptt85 -50.74 -41.84 56.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 1.0 110.474 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 9.4 tm-20 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.694 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.446 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.866 0.365 . . . . 1.0 110.746 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 16.6 p-10 -77.01 -37.74 54.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.129 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.562 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.3 p80 -65.59 -34.83 79.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.01 -38.84 92.8 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.573 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . 0.428 ' NH1' ' O ' ' D' ' 2' ' ' ALA . 84.2 mtt85 -64.24 -38.98 92.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.598 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -66.2 -40.15 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.175 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.85 92.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.772 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.84 -40.43 91.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 1.0 110.56 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.73 -35.66 81.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.516 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.68 79.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.966 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.16 -39.53 94.2 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.683 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.22 -36.44 83.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.65 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -63.99 -36.05 82.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.427 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -62.4 -41.38 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.643 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.86 -44.78 78.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.699 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.4 -40.09 96.28 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.204 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -49.02 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.98 -30.19 62.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.415 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -66.26 -49.92 65.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.669 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.17 -40.42 95.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' D' ' 26' ' ' ALA . . . -65.45 -34.15 77.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.823 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' D' ' 48' ' ' SER . 26.0 m -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.814 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -63.68 -39.07 93.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.46 -0.496 . . . . 1.0 110.036 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.73 -18.25 44.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.135 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -58.6 -50.23 74.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.382 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' D' ' 44' ' ' ALA . 28.9 t -65.65 -43.8 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.54 -30.76 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.32 -34.11 71.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.535 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' D' ' 32' ' ' GLY . 79.0 mm-40 -63.83 -46.87 83.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -46.21 95.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.433 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 126.93 -5.7 7.38 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -105.48 146.52 32.94 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.912 0.356 . . . . 1.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.627 ' O ' HG11 ' D' ' 63' ' ' VAL . 81.2 Cg_endo -75.64 117.34 4.73 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.113 1.875 . . . . 1.0 112.49 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' D' ' 37' ' ' ALA . . . 103.52 -22.67 35.23 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' D' ' 37' ' ' ALA . . . 46.93 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.694 0.283 . . . . 1.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' D' ' 36' ' ' ALA . . . 82.44 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -73.07 53.21 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.89 0.376 . . . . 1.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.8 tt -105.16 111.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.065 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.546 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 17.3 t 179.45 -118.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.125 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.7 m-85 177.27 -66.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.298 -0.26 . . . . 1.0 110.298 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -59.03 -31.16 95.15 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.024 1.816 . . . . 1.0 111.666 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -84.21 -9.19 58.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.24 -42.32 99.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.87 0.367 . . . . 1.0 110.516 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -67.68 -39.3 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.691 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -46.95 86.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.441 ' CD2' ' C ' ' D' ' 47' ' ' TRP . 0.3 OUTLIER -70.78 -20.76 62.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.232 -0.587 . . . . 1.0 109.604 178.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' D' ' 23' ' ' SER . 22.8 t -74.56 -40.49 61.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.106 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.89 -47.76 91.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -66.78 -37.61 84.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.118 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -62.45 -44.57 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.008 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.7 -25.42 62.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.413 ' OG1' HG23 ' D' ' 55' ' ' VAL . 21.8 p -97.77 9.81 41.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.203 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p 43.88 44.62 5.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.225 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' D' ' 53' ' ' THR . 94.9 t -86.83 -54.57 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.843 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.57 57.15 3.37 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.616 ' CG ' ' CD1' ' A' ' 61' ' ' TYR . 5.6 t80 -61.91 -41.79 98.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 1.0 110.491 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.19 -14.63 0.22 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.548 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -40.43 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.886 0.375 . . . . 1.0 110.958 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -132.39 156.62 46.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.103 -0.498 . . . . 1.0 109.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.51 ' CD2' ' OD1' ' C' ' 59' ' ' ASP . 5.6 p90 -149.3 153.28 37.32 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.81 160.04 51.3 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.299 1.999 . . . . 1.0 111.993 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.627 HG11 ' O ' ' D' ' 34' ' ' PRO . 18.2 t -90.05 -116.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.578 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.499 ' N ' HG12 ' D' ' 63' ' ' VAL . 60.7 m -116.23 -77.55 0.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.815 0.341 . . . . 1.0 110.95 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' D' ' 33' ' ' ALA . 52.5 tp10 -46.92 120.77 3.21 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.064 -0.717 . . . . 1.0 109.064 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.871 ' O ' ' N ' ' D' ' 68' ' ' ARG . 96.9 mt-10 55.09 -96.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.91 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.19 -55.68 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 O-C-N 125.086 1.491 . . . . 1.0 114.085 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.871 ' N ' ' O ' ' D' ' 66' ' ' GLU . 57.7 ttm-85 -80.04 -58.5 3.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.539 . . . . 1.0 109.87 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' D' ' 66' ' ' GLU . 99.0 mttt -43.46 -40.78 3.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.71 -46.9 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.536 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -49.84 68.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -44.18 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.863 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -67.14 -40.28 86.69 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.937 -0.305 . . . . 1.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.98 -47.65 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.509 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 18.5 ptp -62.6 -39.46 93.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.264 . . . . 1.0 111.083 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.61 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.667 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.468 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.1 -38.8 92.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.597 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.87 -41.25 95.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.568 -0.613 . . . . 1.0 111.568 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.78 -43.55 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.652 0.226 . . . . 1.0 111.394 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.38 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.072 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 77' ' ' ALA . 66.9 t -63.48 -46.07 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.448 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.42 -8.41 50.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.801 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.36 -27.22 12.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.81 0.338 . . . . 1.0 110.147 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' D' ' 86' ' ' THR . 6.0 tt -65.03 -37.55 87.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.275 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.8 -5.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.462 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' D' ' 84' ' ' LEU . 65.5 m -58.82 -42.91 90.33 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.954 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' C' ' 92' ' ' ASP . . . -42.39 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.767 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -102.97 -32.33 9.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.174 0.511 . . . . 1.0 110.028 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' D' ' 86' ' ' THR . 58.2 mt -69.76 -39.34 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.715 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.576 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.28 -49.51 77.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.707 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -11.83 43.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.66 -49.33 78.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.786 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 17.2 p90 -76.24 -22.56 55.04 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.38 -42.64 94.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.776 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -50.41 -21.78 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.723 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -55.58 -43.57 76.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 C--N 1.328 -0.334 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.252 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.323 . . . . 1.0 110.476 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -162.67 -37.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.461 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -81.08 -26.6 36.14 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.605 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.62 -32.49 73.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.592 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -60.38 -42.68 96.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.192 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -63.29 -45.34 91.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.072 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -66.59 -39.71 88.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.393 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 57.2 tt0 -64.55 -39.83 94.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.59 -36.78 85.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.96 66.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.226 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 1.0 110.722 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 57.3 mp0 -66.23 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.436 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.572 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.2 tp -62.31 -42.44 99.37 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.66 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.95 -33.06 72.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.068 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 17' ' ' LYS . 5.3 ttmm -61.58 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.269 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.74 -40.94 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.52 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -59.28 -41.24 88.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.31 -47.02 87.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.624 -0.43 . . . . 1.0 109.86 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.69 -34.2 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.008 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.793 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.1 p -59.41 -44.0 92.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 1.0 109.968 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.25 -40.19 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 29' ' ' ALA . 70.1 mmtt -66.83 -42.48 85.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.14 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.922 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.2 p -62.02 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.477 -0.489 . . . . 1.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 98.2 mt-10 -67.25 -39.54 86.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.429 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -62.02 -49.24 76.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.113 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 38' ' ' LEU . 5.8 tm-20 -69.67 -41.41 75.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.059 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -54.71 90.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.604 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 121.2 3.7 10.46 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.65 122.99 45.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 122.689 -0.301 . . . . 1.0 110.55 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.44 141.96 26.0 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.881 1.721 . . . . 1.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.71 15.4 81.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.15 -162.06 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 1.0 110.545 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -171.65 -4.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.616 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 38' ' ' LEU . 4.9 tt -99.1 89.03 4.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.034 0.445 . . . . 1.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 17.4 pt -122.76 165.66 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 81.98 135.55 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.442 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.5 t80 -75.12 -45.95 4.7 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.763 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.7 Cg_endo -60.31 -27.25 84.49 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.554 1.503 . . . . 1.0 112.501 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.73 -27.95 19.72 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.011 -0.275 . . . . 1.0 110.898 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.66 -42.07 94.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.881 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.687 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.2 OUTLIER -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.109 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.539 ' CD1' ' OE2' ' A' ' 50' ' ' GLU . 26.6 t90 -60.09 -39.82 87.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.471 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.8 m -56.09 -36.7 68.43 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.55 71.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.843 0.354 . . . . 1.0 111.293 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE2' ' CD1' ' A' ' 47' ' ' TRP . 10.6 pt-20 -173.96 -40.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.175 0.512 . . . . 1.0 109.668 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.47 HG23 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -68.8 -39.74 79.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.148 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.23 -24.0 51.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.481 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 50' ' ' GLU . 72.0 p -86.41 -3.16 58.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.4 p 52.49 38.84 26.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.084 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 ' OG1' ' A' ' 53' ' ' THR . 25.2 m -102.76 -35.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.631 -0.259 . . . . 1.0 110.883 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.0 73.82 0.37 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -44.08 97.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.336 . . . . 1.0 110.415 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.66 20.38 5.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.514 -1.034 . . . . 1.0 110.514 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.7 m-20 -62.8 -40.09 96.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.297 . . . . 1.0 110.411 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -132.3 164.41 26.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 109.923 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 12.5 p90 -151.66 90.83 3.89 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.675 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.69 166.53 27.19 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.736 1.624 . . . . 1.0 112.271 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.487 HG22 ' OE2' ' A' ' 66' ' ' GLU . 16.8 m -98.75 -124.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.585 HG22 ' CD1' ' D' ' 46' ' ' TRP . 66.5 p -114.33 -37.18 4.43 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -57.94 -26.04 61.74 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.61 -0.436 . . . . 1.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.487 ' OE2' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -87.33 29.64 0.84 Allowed 'General case' 0 C--O 1.26 1.645 0 CA-C-O 123.678 1.704 . . . . 1.0 109.199 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 38.16 65.21 0.72 Allowed Glycine 0 C--O 1.212 -1.258 0 CA-C-N 113.494 -1.685 . . . . 1.0 111.714 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.632 ' NH2' ' CE3' ' D' ' 46' ' ' TRP . 0.0 OUTLIER -22.93 -31.2 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.028 0.914 . . . . 1.0 111.507 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.2 mttt -56.79 -12.3 1.84 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.241 -0.89 . . . . 1.0 108.973 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 67' ' ' GLY . 41.3 t -60.35 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 119.507 -0.877 . . . . 1.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.91 -38.4 66.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.591 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -56.19 -39.63 72.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.577 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.38 -42.2 92.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.249 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.47 HG11 HG23 ' A' ' 51' ' ' THR . 58.1 t -63.81 -46.52 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.296 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 63.0 mtm -63.35 -40.79 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.721 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.43 -45.0 96.14 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.439 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.85 -45.11 96.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -43.08 96.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.665 0.269 . . . . 1.0 110.418 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.62 -41.66 90.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.462 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.81 -55.31 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.699 -0.4 . . . . 1.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.07 -41.21 99.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.068 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.4 87.46 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.008 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.2 tt -62.99 -41.23 99.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.53 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 85' ' ' VAL . 71.6 t -49.18 -10.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.44 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' ALA . 70.8 m -51.72 -44.22 63.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.354 . . . . 1.0 110.078 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.97 -20.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.827 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.15 -33.44 8.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.857 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.8 mt -69.8 -39.24 76.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.216 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.65 -49.84 75.89 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.256 0.55 . . . . 1.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -3.38 1.48 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.686 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.25 -42.83 96.13 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.98 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.567 ' CG ' ' OG1' ' B' ' 91' ' ' THR . 31.2 p90 -85.25 -26.04 26.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.635 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -55.23 -29.51 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.239 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -65.79 -21.16 66.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 1.0 110.937 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.453 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.0 ptt-85 -50.34 -42.82 53.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.642 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.453 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 82.0 tt0 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.795 0.331 . . . . 1.0 110.648 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -65.31 -32.33 73.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.437 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.06 -35.99 82.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.881 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.07 -39.19 93.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.26 -40.65 96.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.82 99.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.614 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.77 -37.72 82.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.44 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -61.75 -38.5 88.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.65 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.54 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.33 -40.9 97.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 1.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.01 -38.62 91.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 1.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -62.69 -32.18 73.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.57 -42.03 99.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -57.88 -39.62 78.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.774 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.65 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.73 -34.3 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.905 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.3 mt -61.02 -40.39 93.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.91 -47.5 85.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -70.63 -32.09 69.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.054 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.13 80.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.265 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.9 t -60.18 -43.34 95.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.799 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.62 -55.55 33.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.137 0.494 . . . . 1.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.46 -44.11 97.19 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.082 -0.647 . . . . 1.0 110.639 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.47 -48.72 78.38 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.704 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 40' ' ' SER . 0.8 OUTLIER -65.61 -42.52 93.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.424 . . . . 1.0 110.375 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.413 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 95.5 mt-10 -69.67 -43.34 72.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.128 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.17 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -72.91 -22.4 60.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -77.88 122.25 25.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.955 0.407 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.15 2.79 57.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.377 -0.689 . . . . 1.0 111.377 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.7 149.46 37.13 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.533 -0.173 . . . . 1.0 110.533 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.27 143.41 28.21 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.073 1.849 . . . . 1.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.71 28.9 74.07 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.284 -0.726 . . . . 1.0 111.284 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 139.43 57.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 1.0 110.278 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.82 -40.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.999 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 tp -68.02 -21.73 65.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.28 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.515 HG23 ' O ' ' B' ' 39' ' ' ILE . 12.5 tt -43.27 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 1.8 p 163.85 109.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.557 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.449 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.7 m-85 -56.72 -60.27 9.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.087 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.8 Cg_endo -57.84 -35.51 98.75 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.058 1.839 . . . . 1.0 112.771 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.73 -20.53 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.526 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.36 -39.3 92.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.951 0.405 . . . . 1.0 109.988 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.405 ' H ' HG22 ' B' ' 45' ' ' ILE . 8.1 tt -67.02 -37.82 80.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.409 ' CD1' ' NE ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -46.89 79.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.422 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -62.78 -40.45 97.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.26 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' B' ' 44' ' ' ALA . 6.7 m -50.9 -22.76 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.755 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.88 -21.04 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.809 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' B' ' 55' ' ' VAL . 80.9 mm-40 -93.79 16.97 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.899 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.73 -39.02 1.65 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.744 0.307 . . . . 1.0 111.14 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.35 -29.17 70.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.294 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.54 ' OG1' HG13 ' B' ' 55' ' ' VAL . 18.7 p -90.31 9.11 30.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 1.0 110.734 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.8 p 51.32 42.04 28.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.597 HG11 ' SD ' ' C' ' 75' ' ' MET . 19.0 m -97.29 -44.78 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.673 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.566 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.31 64.57 1.3 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -60.97 -47.13 87.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 1.0 110.907 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.4 10.68 1.24 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -57.51 -66.1 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.388 . . . . 1.0 110.568 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.442 HH21 ' NH2' ' C' ' 68' ' ' ARG . 52.4 mtm180 -137.04 142.42 42.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.991 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' B' ' 61' ' ' TYR . 6.1 p90 -126.31 136.24 28.31 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.297 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.52 164.67 33.42 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.889 1.726 . . . . 1.0 112.063 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 66' ' ' GLU . 22.2 m -91.98 -140.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.223 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.687 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.4 m -114.1 -40.74 3.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.749 0.309 . . . . 1.0 111.129 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.642 ' C ' ' H ' ' B' ' 67' ' ' GLY . 79.4 tt0 -66.71 -32.72 74.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.44 ' H ' HG23 ' B' ' 63' ' ' VAL . 0.2 OUTLIER -70.38 30.35 0.04 OUTLIER 'General case' 0 C--O 1.261 1.672 0 CA-C-O 123.715 1.721 . . . . 1.0 110.03 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.42 63.94 1.27 Allowed Glycine 0 C--O 1.21 -1.344 0 CA-C-N 113.972 -1.467 . . . . 1.0 111.585 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.5 ttm-85 -25.0 -33.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.323 1.062 . . . . 1.0 110.862 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.0 mttp -48.5 -18.59 0.25 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' B' ' 67' ' ' GLY . 59.8 t -64.09 -45.55 96.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.724 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.85 -36.2 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.69 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -57.17 -41.12 78.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.947 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -64.18 -42.8 96.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.03 -47.29 88.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.251 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.668 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.03 -38.36 90.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 1.0 110.47 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.87 92.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.535 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.32 -40.92 91.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.93 -43.29 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.838 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.8 -42.45 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.384 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.24 -47.93 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.157 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.51 -11.23 60.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.912 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.08 -25.91 13.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.81 -41.53 97.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.94 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 87' ' ' ALA . 30.8 m -46.69 -26.66 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' B' ' 85' ' ' VAL . 32.4 m -34.53 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -50.49 -65.36 0.57 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.035 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.85 -20.54 35.4 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.48 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 -44.01 97.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.32 -60.93 2.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.766 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.567 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -50.21 -5.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.84 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' B' ' 90' ' ' ALA . 51.0 t0 -60.78 -40.31 92.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 93' ' ' PHE . 1.6 p90 -65.19 -33.56 76.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 1.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.77 -44.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.458 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' B' ' 97' ' ' GLU . 10.5 tpt180 -47.05 -21.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.851 -0.34 . . . . 1.0 111.207 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -46.2 -20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.377 . . . . 1.0 110.217 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' C ' ' B' ' 95' ' ' ARG . 97.0 mt-10 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.138 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.743 0.306 . . . . 1.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 7.2 p80 -172.51 -34.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.627 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 79.8 tt0 -67.31 -41.13 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.745 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -62.28 -42.59 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.55 -39.65 91.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.104 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.98 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.477 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.08 -40.69 82.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.19 -38.16 90.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.311 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.58 78.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.044 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.17 -37.72 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 1.0 110.894 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.84 -35.5 80.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.648 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.06 -36.35 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.676 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.7 tp -62.07 -41.01 97.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.342 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -62.59 -40.63 97.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.54 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.14 -38.63 89.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.815 0.341 . . . . 1.0 111.116 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.38 -40.79 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -59.29 -41.35 88.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.19 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.65 -48.7 80.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.869 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.85 -32.73 71.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.13 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.29 93.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -60.27 -44.11 95.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.508 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.11 -39.14 92.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 1.0 110.12 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -72.46 -47.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.09 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.57 73.16 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.359 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.517 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -60.8 -44.8 98.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.961 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.517 ' N ' HG13 ' C' ' 27' ' ' VAL . 42.7 tp10 -68.05 -36.98 80.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.55 86.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.3 -44.48 68.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.399 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -52.93 97.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.348 . . . . 1.0 110.701 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.63 0.15 15.63 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.176 -0.769 . . . . 1.0 111.176 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.83 140.46 21.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 1.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.2 Cg_endo -76.19 143.69 25.71 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.918 1.746 . . . . 1.0 112.338 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 24.39 69.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.51 140.82 58.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.379 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.08 -34.76 4.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.422 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' C' ' 40' ' ' SER . 1.1 mt -72.2 -2.05 17.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.213 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.545 HG23 ' O ' ' C' ' 39' ' ' ILE . 12.4 tt -46.92 90.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 1.0 110.627 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.519 ' N ' ' O ' ' C' ' 38' ' ' LEU . 70.4 m -167.04 -127.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.008 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.424 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 6.9 t80 174.39 -58.29 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.346 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.7 Cg_endo -58.86 -38.28 89.3 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.835 1.69 . . . . 1.0 112.376 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 14.6 p-10 -91.91 2.97 56.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.5 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.74 98.29 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.771 -0.371 . . . . 1.0 110.507 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.401 HG21 HD13 ' C' ' 45' ' ' ILE . 6.6 tt -68.21 -31.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.59 ' CZ2' ' O ' ' D' ' 63' ' ' VAL . 10.4 t90 -57.91 -47.17 83.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.993 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.468 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.0 OUTLIER -76.17 -22.33 55.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.0 t -67.5 -42.7 82.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.436 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.522 HG11 ' NH1' ' D' ' 68' ' ' ARG . 76.0 t -61.09 -47.9 91.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.74 -31.63 71.67 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.88 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -58.96 -44.94 91.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.2 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.98 -35.23 70.89 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.759 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.524 ' OG1' HG22 ' C' ' 55' ' ' VAL . 68.8 p -75.18 -6.81 51.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 59.33 24.15 12.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.589 HG23 ' N ' ' C' ' 56' ' ' GLY . 18.5 m -87.54 -47.5 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.611 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.589 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 38.43 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.37 -39.88 95.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.793 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.8 16.29 1.29 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.119 -0.793 . . . . 1.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.04 -41.65 99.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 1.0 110.572 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -145.44 176.3 9.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -163.67 127.7 1.87 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.593 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.27 160.02 51.0 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.918 1.745 . . . . 1.0 112.382 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 2.0 t -86.99 -140.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.092 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 54.0 m -114.81 -34.48 5.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' C' ' 67' ' ' GLY . 76.0 tt0 -67.17 -31.52 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -69.57 31.61 0.03 OUTLIER 'General case' 0 C--O 1.262 1.75 0 CA-C-O 123.48 1.61 . . . . 1.0 110.347 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.07 64.72 1.42 Allowed Glycine 0 C--O 1.212 -1.255 0 CA-C-N 114.103 -1.408 . . . . 1.0 111.234 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' C' ' 67' ' ' GLY . 49.6 ttm-85 -23.49 -33.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 117.848 0.824 . . . . 1.0 111.174 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.6 mptm? -49.66 -19.33 0.59 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' C' ' 67' ' ' GLY . 78.1 t -62.94 -46.64 95.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 119.23 -0.988 . . . . 1.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.34 69.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 1.0 110.628 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.75 -44.28 77.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.786 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.21 -43.09 99.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.518 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.73 -47.96 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.738 -0.385 . . . . 1.0 111.129 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.597 ' SD ' HG11 ' B' ' 55' ' ' VAL . 76.8 mtm -64.38 -42.64 96.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.593 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 55.2 tttm -64.68 -39.55 93.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.604 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.421 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.79 -42.49 93.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 1.0 110.47 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -66.63 -42.1 93.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.747 -0.541 . . . . 1.0 111.747 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -44.0 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.84 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 98.0 mt-10 -63.52 -40.32 96.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.279 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 77' ' ' ALA . 63.9 t -64.05 -49.05 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.094 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -67.85 -37.72 82.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.347 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.42 -36.02 81.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.0 110.644 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.7 tt -61.78 -40.05 93.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.517 ' O ' HG12 ' C' ' 85' ' ' VAL . 61.3 t -54.81 -3.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.719 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.505 ' H ' ' C ' ' C' ' 84' ' ' LEU . 66.8 m -59.33 -40.93 87.87 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.685 0.279 . . . . 1.0 110.271 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -52.45 -25.35 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.259 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.13 -11.29 38.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.69 -61.12 1.8 Allowed 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.578 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -42.93 -52.34 5.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.819 0.343 . . . . 1.0 111.045 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.38 -13.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.002 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' C' ' 90' ' ' ALA . 96.8 m-20 -63.52 -47.52 81.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.277 . . . . 1.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 2.2 p90 -67.98 -33.3 74.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 1.0 110.847 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -43.06 94.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.773 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -58.67 -22.44 56.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.394 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . 0.446 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 37.9 ptt85 -50.39 -43.11 54.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 1.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 46.9 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.362 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.878 0.37 . . . . 1.0 110.593 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 15.2 p-10 -77.73 -41.7 36.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.287 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.496 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.7 p80 -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.873 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -63.75 -37.2 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.693 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.49 -41.51 97.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.666 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -65.81 -37.46 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 1.0 110.059 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.77 -39.56 93.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.499 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.21 -37.61 87.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.554 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.93 91.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.074 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.23 -38.84 92.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 1.0 110.757 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.06 -36.35 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.626 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.78 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.581 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.5 tp -62.67 -41.57 99.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.794 -0.362 . . . . 1.0 110.418 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.05 -36.31 74.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.834 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -60.89 -41.91 96.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.715 0.293 . . . . 1.0 111.042 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.32 -37.43 79.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.0 mt -59.89 -41.65 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.19 -47.47 84.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.016 0.436 . . . . 1.0 110.149 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.48 -34.2 77.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.895 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.11 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.715 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -60.94 -45.99 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.09 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -78.08 -35.8 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 1.0 111.064 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -72.39 -44.87 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.163 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' D' ' 29' ' ' ALA . . . -62.16 -49.76 74.53 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.53 HG13 ' N ' ' D' ' 28' ' ' GLU . 11.4 p -61.44 -43.62 97.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 1.0 109.868 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.53 ' N ' HG13 ' D' ' 27' ' ' VAL . 42.1 tp10 -69.28 -20.78 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.041 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -60.33 -39.04 85.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.077 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 24.0 mp0 -63.97 -38.15 90.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.802 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -57.93 93.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.18 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -9.12 6.9 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.1 146.65 32.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.752 0.276 . . . . 1.0 110.353 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.473 ' O ' HG11 ' D' ' 63' ' ' VAL . 71.7 Cg_endo -75.72 116.47 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.766 1.644 . . . . 1.0 112.199 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.09 37.71 4.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.74 98.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.816 0.341 . . . . 1.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.63 -72.6 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.13 61.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 1.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 tt -90.38 -8.37 10.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.928 0.394 . . . . 1.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -65.69 140.13 58.44 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.543 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.8 OUTLIER -97.68 -61.44 0.12 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.67 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.5 Cg_endo -57.85 -32.04 93.97 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.558 1.505 . . . . 1.0 111.888 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.81 -3.27 58.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 1.0 110.574 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.434 HG22 ' H ' ' D' ' 45' ' ' ILE . 0.0 OUTLIER -66.3 -32.24 57.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.287 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.632 ' CE3' ' NH2' ' A' ' 68' ' ' ARG . 1.7 t-105 -61.18 -47.3 86.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.008 -178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.413 ' CE3' ' N ' ' D' ' 48' ' ' SER . 0.8 OUTLIER -69.86 -37.88 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.413 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 25.3 p -47.12 -34.57 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 1.0 110.323 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.2 -44.71 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.412 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.3 52.84 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.73 -0.471 . . . . 1.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.9 m -156.21 -48.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.468 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.597 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.91 -23.62 46.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.021 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.2 p -93.5 8.37 40.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.281 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.5 p 48.72 32.6 3.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.898 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.427 HG13 ' N ' ' D' ' 56' ' ' GLY . 7.3 p -65.47 -39.49 85.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.101 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.427 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 109.31 -91.21 0.64 Allowed Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' D' ' 57' ' ' TYR . 43.7 p90 -62.91 114.66 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.263 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' D' ' 60' ' ' ARG . . . -126.47 28.24 4.8 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t0 63.76 -6.74 0.22 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.755 0.312 . . . . 1.0 110.789 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' D' ' 58' ' ' GLY . 73.4 mtt-85 -145.87 128.41 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 8.2 p90 -118.55 141.44 29.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.852 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.81 156.78 62.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.314 2.009 . . . . 1.0 112.512 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.59 ' O ' ' CZ2' ' C' ' 46' ' ' TRP . 12.3 t -77.94 -120.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.057 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.487 ' N ' HG12 ' D' ' 63' ' ' VAL . 54.6 m -116.9 -72.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.961 0.41 . . . . 1.0 110.227 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -56.16 127.34 30.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' D' ' 68' ' ' ARG . 94.5 mt-10 58.28 -94.5 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.054 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 24.63 -57.18 0.0 OUTLIER Glycine 0 N--CA 1.48 1.57 0 O-C-N 124.483 1.114 . . . . 1.0 114.193 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.5 ttp85 -83.19 -59.48 2.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -41.08 -36.35 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.49 -46.59 80.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.949 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -66.46 -34.79 78.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.828 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.12 -48.1 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.905 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.82 -38.1 88.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.946 -0.302 . . . . 1.0 111.716 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -62.86 -46.38 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.39 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.41 ' SD ' HG11 ' C' ' 55' ' ' VAL . 77.2 mtm -63.77 -39.89 95.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.613 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.5 98.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.567 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.497 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.99 -39.11 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.91 -42.42 94.91 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.692 -0.563 . . . . 1.0 111.692 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.3 -43.43 98.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.621 0.248 . . . . 1.0 111.148 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.21 -38.63 91.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.899 -0.321 . . . . 1.0 111.36 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.497 HG23 ' O ' ' D' ' 77' ' ' ALA . 56.1 t -62.18 -49.65 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.277 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -67.17 -40.7 86.64 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.692 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.71 76.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.681 HD23 ' C ' ' D' ' 84' ' ' LEU . 7.4 tt -60.95 -41.53 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.086 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.423 ' O ' HG12 ' D' ' 85' ' ' VAL . 98.1 t -47.02 -14.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 1.0 110.258 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.489 ' N ' ' C ' ' D' ' 84' ' ' LEU . 39.6 m -49.6 -39.59 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.071 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.59 -26.98 14.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.63 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.92 -10.76 32.75 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.158 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.4 -59.85 2.1 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.181 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 92' ' ' ASP . . . -42.22 -53.74 3.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 1.0 111.056 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.746 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' D' ' 90' ' ' ALA . 80.1 m-20 -62.0 -45.11 95.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.313 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 0.1 OUTLIER -53.56 -37.14 62.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 1.0 110.489 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' D' ' 97' ' ' GLU . 61.4 t -61.05 -43.66 96.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.135 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -50.92 -21.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.745 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -55.47 -44.04 76.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.137 -0.32 . . . . 1.0 110.137 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' D' ' 97' ' ' GLU . 55.1 mp0 . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.857 0.361 . . . . 1.0 110.532 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -159.94 -61.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.416 ' CD2' ' H ' ' A' ' 4' ' ' HIS . 8.7 p80 -77.42 -23.88 50.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.836 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -67.11 -37.79 84.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.803 0.335 . . . . 1.0 110.239 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -60.76 -43.23 98.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.87 -38.89 90.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.085 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.14 99.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.331 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.09 -37.41 85.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.377 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -61.32 -41.96 97.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.283 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.2 83.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.842 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.32 -35.6 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.566 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.43 -37.16 86.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.387 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.19 -32.11 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.637 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.11 -41.73 98.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 1.0 110.504 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.22 -40.43 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.154 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -63.51 -39.85 95.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.864 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -63.11 -42.57 97.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 52' ' ' ALA . 91.9 mt -60.24 -41.41 93.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.319 -0.4 . . . . 1.0 109.944 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.81 -45.68 92.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -69.56 -34.11 73.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.107 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.79 94.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.459 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.1 p -61.77 -43.35 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.21 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.92 -59.68 5.07 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.14 -45.07 96.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.154 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.69 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.483 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 23' ' ' SER . 78.1 t -63.43 -47.23 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.257 -0.577 . . . . 1.0 110.338 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.92 -41.57 67.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.837 -0.62 . . . . 1.0 111.35 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -35.08 65.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.804 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 5.5 mp0 -89.89 -10.18 46.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.632 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -75.24 108.52 8.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.63 61.28 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.504 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.91 142.94 26.11 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.33 143.55 28.18 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.111 1.874 . . . . 1.0 112.443 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.74 -4.44 21.87 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.91 143.25 52.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.846 0.355 . . . . 1.0 110.568 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.17 -26.76 2.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.568 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.66 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.892 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 39' ' ' ILE . 14.5 tt -116.79 89.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.226 0.536 . . . . 1.0 110.439 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER 166.98 134.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.766 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 66.8 m-85 -69.58 -49.41 21.84 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.043 -0.526 . . . . 1.0 112.403 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.3 Cg_endo -60.19 -34.92 93.73 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.486 1.457 . . . . 1.0 113.188 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.7 p-10 -90.5 -24.28 20.7 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 121.062 -0.255 . . . . 1.0 111.08 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -65.1 -38.29 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 1.0 110.581 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' ILE . 2.8 tp -63.35 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.98 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CE2' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -62.49 -45.64 92.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.934 179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -57.53 -39.91 77.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -65.44 -34.78 79.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.4 -46.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.475 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.11 -8.23 56.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.062 0.458 . . . . 1.0 110.428 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -80.61 -45.63 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.328 . . . . 1.0 111.195 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -64.39 -37.57 88.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.609 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -75.12 0.29 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.71 60.98 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 56' ' ' GLY . 8.4 p -130.73 -44.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.682 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 36.12 89.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.731 -0.548 . . . . 1.0 111.731 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.89 -44.42 97.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.343 . . . . 1.0 110.704 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.12 15.76 0.68 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 98.4 m-20 -59.92 -50.39 73.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.337 . . . . 1.0 110.636 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 43' ' ' ASP . 0.9 OUTLIER -138.75 156.28 47.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.976 -0.557 . . . . 1.0 109.875 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -144.08 131.6 10.61 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.674 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.58 -171.62 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.827 1.685 . . . . 1.0 112.198 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 64' ' ' THR . 8.2 p -128.82 -136.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.222 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.855 ' H ' HG22 ' A' ' 63' ' ' VAL . 66.4 m -112.62 -40.23 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.628 0.251 . . . . 1.0 111.341 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.3 tt0 -64.48 -36.12 83.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.461 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 1.2 pp20? -72.66 32.18 0.06 Allowed 'General case' 0 C--O 1.262 1.763 0 CA-C-O 124.537 2.113 . . . . 1.0 109.721 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.25 63.98 1.43 Allowed Glycine 0 C--O 1.212 -1.242 0 CA-C-N 113.612 -1.631 . . . . 1.0 111.098 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.497 HH21 HH22 ' D' ' 60' ' ' ARG . 56.8 ttm-85 -24.12 -34.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.95 0.875 . . . . 1.0 111.334 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.8 mtmt -50.5 -14.25 0.17 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.609 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' GLY . 43.2 t -60.95 -47.68 92.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.156 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -42.48 68.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.353 . . . . 1.0 111.161 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -52.09 -39.64 60.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.85 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -68.97 -41.33 78.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.615 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.96 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.398 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.1 ptp -63.62 -39.55 94.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.773 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -62.73 -42.63 99.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.446 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.96 86.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.361 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -36.73 93.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -26.93 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.135 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.14 -49.76 18.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.724 0.297 . . . . 1.0 111.412 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 82' ' ' PHE . 18.4 m -62.21 -48.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.32 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' N ' HG23 ' A' ' 81' ' ' VAL . 13.1 m-85 -66.0 -40.79 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.707 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.61 84.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 1.0 111.064 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.6 tt -62.16 -41.59 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.346 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 85' ' ' VAL . 81.6 t -46.47 -13.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.559 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' LEU . 94.9 m -55.31 -23.83 25.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -62.28 -29.67 70.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.111 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.52 -11.84 33.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.777 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.27 -47.63 9.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.655 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.89 -24.12 49.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.959 0.409 . . . . 1.0 111.016 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -89.17 -3.73 58.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.706 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 91.5 m-20 -59.89 -46.48 89.2 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.384 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -81.76 -19.18 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.31 -28.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.405 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 97' ' ' GLU . 96.4 mtt180 -63.59 -28.91 70.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -42.41 -23.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.845 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 95' ' ' ARG . 44.1 tt0 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 1.0 110.04 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . 0.471 ' OD1' ' NH2' ' B' ' 6' ' ' ARG . 78.8 m-20 . . . . . 0 CA--C 1.529 0.165 0 CA-C-O 120.637 0.256 . . . . 1.0 110.436 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -60.97 -45.52 94.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.21 -48.99 75.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.592 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' B' ' 3' ' ' ASP . 88.7 mtm180 -65.42 -41.07 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 1.0 110.768 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.9 -40.24 87.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.166 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.44 96.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.521 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -65.49 -38.03 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.05 -39.07 93.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.684 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.44 67.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.903 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.85 -35.36 80.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 1.0 110.505 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.236 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.15 -37.55 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.599 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.49 -40.92 98.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 1.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.66 -39.34 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.812 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.37 -43.21 99.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.61 -40.84 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.49 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' B' ' 52' ' ' ALA . 32.7 mt -59.03 -42.81 91.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.46 -37.71 85.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.37 -53.11 39.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.415 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -65.93 -43.97 86.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' B' ' 48' ' ' SER . 75.2 m -56.22 -43.91 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.128 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.582 ' O ' HG22 ' B' ' 27' ' ' VAL . 14.9 tmtt? -65.34 -32.84 74.69 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.25 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.98 -34.81 50.71 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.09 -0.244 . . . . 1.0 111.239 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.43 67.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.483 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 24' ' ' LYS . 2.6 m -61.52 -49.08 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.406 -0.517 . . . . 1.0 110.496 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.527 ' N ' HG23 ' B' ' 27' ' ' VAL . 80.6 tt0 -76.35 -35.8 58.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.605 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' B' ' 66' ' ' GLU . . . -59.12 -38.97 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.215 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 40.2 mm-40 -107.82 61.41 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -141.8 80.04 1.7 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 1.0 111.105 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.06 4.41 27.54 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.7 57.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.35 139.6 23.57 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.008 1.806 . . . . 1.0 112.244 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 19.04 74.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' B' ' 30' ' ' GLU . . . -84.05 166.02 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.753 0.311 . . . . 1.0 110.458 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' B' ' 38' ' ' LEU . . . -161.07 -11.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.642 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' B' ' 47' ' ' TRP . 0.9 OUTLIER -87.6 33.26 0.7 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.223 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 pt -71.84 46.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.65 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.3 m -130.96 151.31 51.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.099 0.475 . . . . 1.0 111.065 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.525 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 3.0 m-85 -97.54 -64.5 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.015 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -58.52 -28.03 84.27 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 122.213 1.942 . . . . 1.0 112.525 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -87.56 -2.18 58.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 1.0 110.643 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.02 95.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 1.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.498 ' O ' HG23 ' B' ' 49' ' ' VAL . 6.7 tt -67.79 -39.29 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.765 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.2 OUTLIER -59.5 -49.49 77.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.415 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.479 ' CG ' HD11 ' B' ' 38' ' ' LEU . 5.3 t90 -65.06 -40.78 95.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.465 ' CB ' ' OG ' ' B' ' 23' ' ' SER . 15.2 m -63.15 -39.62 95.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.53 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 45' ' ' ILE . 25.3 t -59.5 -47.31 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.812 0.301 . . . . 1.0 111.812 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 68' ' ' ARG . 15.0 pt-20 -65.41 -30.03 70.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -64.39 -44.75 90.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.615 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.531 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.02 -25.54 61.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.286 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.51 ' OG1' HG23 ' B' ' 55' ' ' VAL . 33.3 p -90.65 4.08 52.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.805 0.336 . . . . 1.0 110.583 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 17.9 p 54.42 9.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.635 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.51 HG23 ' OG1' ' B' ' 53' ' ' THR . 67.6 t -63.97 -45.85 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.698 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.31 57.61 5.59 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -60.4 -49.29 78.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.371 . . . . 1.0 110.938 -178.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 158.73 -92.46 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 69.1 m-20 44.16 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.614 0.245 . . . . 1.0 110.611 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.593 ' NH2' ' NH2' ' C' ' 68' ' ' ARG . 1.1 mpp_? -114.87 161.52 18.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.494 ' O ' ' CD2' ' B' ' 61' ' ' TYR . 16.6 p90 -141.58 105.1 5.89 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.384 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 163.21 38.62 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.525 1.483 . . . . 1.0 112.308 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 1.052 HG22 ' H ' ' B' ' 64' ' ' THR . 9.6 p -106.03 -154.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.352 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 1.052 ' H ' HG22 ' B' ' 63' ' ' VAL . 9.9 m -88.7 -53.45 4.62 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.65 0.262 . . . . 1.0 111.632 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.3 tt0 -42.09 -36.36 1.13 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.776 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.576 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -72.73 22.85 0.06 Allowed 'General case' 0 C--O 1.267 1.974 0 CA-C-O 124.283 1.992 . . . . 1.0 109.782 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.728 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 42.99 65.46 1.41 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.704 -1.609 . . . . 1.0 111.463 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.576 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -26.66 -28.55 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.067 0.934 . . . . 1.0 110.863 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.3 mttt -45.43 -26.31 0.53 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 67' ' ' GLY . 3.8 p -63.13 -43.63 98.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.627 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -79.37 -37.91 36.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.608 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -58.59 -40.19 82.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -63.71 -44.04 94.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.502 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 95.2 t -63.17 -48.23 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.891 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.1 mtm -63.03 -43.71 97.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.281 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -64.51 -40.84 96.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.161 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -63.04 -40.23 97.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.729 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.86 95.84 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.09 -43.75 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.781 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.14 -42.99 99.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 1.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 77' ' ' ALA . 71.8 t -63.63 -46.91 93.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.908 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -74.98 -4.16 36.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.851 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.02 -31.69 10.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.881 0.372 . . . . 1.0 110.052 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -64.98 -39.52 93.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.025 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.02 -5.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.206 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' B' ' 90' ' ' ALA . 53.9 m -58.54 -41.43 85.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -42.23 -54.07 3.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.599 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.96 68.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 86' ' ' THR . 70.0 mt -88.2 -17.63 30.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -70.94 -37.15 72.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.422 HG23 ' H ' ' B' ' 91' ' ' THR . 0.0 OUTLIER -66.8 -24.86 66.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.225 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -49.42 -43.79 44.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.656 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -59.74 -46.49 88.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.946 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.75 -42.32 89.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -49.41 -21.51 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.539 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -50.29 -39.25 44.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 1.0 110.281 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 -179.615 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' C' ' 6' ' ' ARG . 55.0 m-20 . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.827 0.346 . . . . 1.0 111.074 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.491 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 7.1 p-80 -40.97 -31.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.22 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 20.4 pt-20 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 1.0 110.632 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' C' ' 3' ' ' ASP . 73.5 ttp85 -60.63 -43.1 97.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.299 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.08 -38.27 90.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.036 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.89 92.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.629 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.03 -40.98 95.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.52 -37.27 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.495 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.22 93.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.086 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.13 -38.7 89.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 1.0 110.847 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -65.82 -32.16 73.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . 0.472 ' O ' HG23 ' C' ' 18' ' ' VAL . 46.8 tp10 -61.66 -40.64 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.538 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' C' ' 52' ' ' ALA . 55.1 tp -63.29 -39.58 94.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.53 -30.93 71.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.873 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . 0.472 HG23 ' O ' ' C' ' 14' ' ' GLU . 42.3 t -63.49 -42.35 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.216 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.4 mt -59.86 -40.32 88.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.359 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.59 -48.88 71.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.849 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.78 -33.46 74.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.897 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.51 82.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -61.78 -46.95 87.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.445 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.56 -36.33 80.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.227 0.536 . . . . 1.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.72 -46.5 53.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.504 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -64.46 -48.46 75.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.395 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.529 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.3 p -59.32 -44.88 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.221 -0.591 . . . . 1.0 109.685 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.529 ' N ' HG13 ' C' ' 27' ' ' VAL . 82.4 tt0 -68.37 -26.96 65.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.37 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' C' ' 67' ' ' GLY . . . -56.16 -51.01 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.14 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 33.3 mp0 -67.54 -36.94 81.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -72.89 92.23 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.89 -19.54 5.81 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.662 . . . . 1.0 111.444 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.51 154.03 39.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.1 150.59 37.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.264 1.976 . . . . 1.0 112.193 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.28 61.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.21 143.51 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 1.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 -39.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.539 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.524 ' C ' HD23 ' C' ' 38' ' ' LEU . 3.5 tt -57.94 -79.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.994 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.617 HG22 ' N ' ' C' ' 40' ' ' SER . 95.4 mt 51.57 167.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.617 ' N ' HG22 ' C' ' 39' ' ' ILE . 1.8 t 81.65 124.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.453 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.503 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 53.4 t80 -88.28 -49.89 0.42 Allowed Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.254 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.9 Cg_endo -60.05 -28.49 87.15 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.343 1.362 . . . . 1.0 112.529 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.48 -13.2 24.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.53 0.205 . . . . 1.0 111.216 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' C' ' 40' ' ' SER . . . -66.89 -37.46 84.44 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.32 -34.69 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.2 OUTLIER -64.95 -48.11 75.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.149 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.524 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 7.6 t90 -61.18 -40.2 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.414 -0.514 . . . . 1.0 109.733 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.498 ' O ' HD22 ' C' ' 19' ' ' LEU . 63.5 p -67.09 45.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.842 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' C' ' 47' ' ' TRP . 71.0 t -137.25 -50.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.535 0.207 . . . . 1.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -69.45 -27.16 65.0 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.445 HG22 ' H ' ' C' ' 51' ' ' THR . 0.1 OUTLIER -59.84 -51.83 68.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.337 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -56.66 -25.37 53.55 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.849 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -90.94 14.21 14.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.799 0.333 . . . . 1.0 110.408 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' C' ' 54' ' ' THR . 0.1 OUTLIER 35.42 77.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.402 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -145.78 -78.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.402 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 75.54 84.73 0.37 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -63.93 -40.98 97.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.622 0.248 . . . . 1.0 110.608 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.99 22.23 0.6 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 99.8 m-20 -61.83 -43.59 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 1.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 77.7 mtt-85 -144.14 -167.58 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.617 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 89.2 m-85 -157.77 123.36 2.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.72 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.86 168.39 21.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.643 1.562 . . . . 1.0 112.255 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 63' ' ' VAL . 2.3 m -91.66 -167.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.088 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.434 ' HA ' ' HE1' ' B' ' 46' ' ' TRP . 2.4 m -101.88 -67.81 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.246 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -38.37 -31.7 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.801 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.8 mt-10 -138.62 -107.62 0.17 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' C' ' 29' ' ' ALA . . . 20.39 -54.79 0.0 OUTLIER Glycine 0 N--CA 1.479 1.567 0 O-C-N 124.513 1.133 . . . . 1.0 114.532 177.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.5 tpp180 -63.06 -58.98 5.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.106 0.562 . . . . 1.0 109.769 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.5 -38.75 88.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.416 ' O ' HG23 ' C' ' 74' ' ' VAL . 72.7 t -64.16 -49.16 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 119.467 -0.893 . . . . 1.0 110.987 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.529 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -67.86 -44.43 77.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 1.0 110.413 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -42.92 -50.62 5.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.919 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.21 -39.26 93.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.416 HG23 ' O ' ' C' ' 70' ' ' VAL . 61.4 t -63.18 -46.6 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.491 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.9 mpp? -62.3 -42.2 99.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -61.34 -36.41 80.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 1.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.01 -43.01 66.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.378 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -38.79 95.3 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' C' ' 83' ' ' ALA . 38.2 mm -61.43 -45.46 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.679 -0.307 . . . . 1.0 110.839 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.0 -44.99 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.308 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.25 -46.98 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.191 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.03 -11.53 59.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.921 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.13 -36.93 17.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 1.0 110.129 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' C' ' 86' ' ' THR . 4.9 tt -66.78 -37.58 84.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.568 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.544 ' O ' HD23 ' C' ' 89' ' ' LEU . 35.1 m -67.06 44.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 1.0 111.099 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.517 ' O ' ' N ' ' C' ' 90' ' ' ALA . 22.7 m -89.53 -42.02 11.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 1.0 110.352 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.533 ' O ' HG23 ' C' ' 91' ' ' THR . . . -52.95 -67.65 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.411 -0.516 . . . . 1.0 111.706 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.479 ' C ' HD22 ' C' ' 89' ' ' LEU . . . -48.64 -16.1 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.35 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.544 HD23 ' O ' ' C' ' 85' ' ' VAL . 3.8 mm? -100.16 -24.28 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.495 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -90.01 -65.36 1.02 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.71 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 87' ' ' ALA . 0.7 OUTLIER -45.32 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.702 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' C' ' 90' ' ' ALA . 89.9 m-20 -52.38 -42.22 63.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.368 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' C' ' 94' ' ' VAL . 2.8 p90 -61.73 -43.72 98.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.408 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 58.2 t -38.78 -27.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.785 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' C' ' 93' ' ' PHE . 95.7 mtt180 -59.89 -23.4 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.688 0.28 . . . . 1.0 111.066 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -58.79 -42.89 90.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.155 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.353 179.688 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.432 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.802 0.334 . . . . 1.0 110.559 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.15 -43.91 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.701 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 4.9 p80 -69.66 -37.93 76.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.692 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.59 -34.24 77.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.98 -43.24 91.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.457 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -64.76 -38.3 90.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.037 0.446 . . . . 1.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.31 86.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.62 -37.56 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -37.95 85.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.463 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.65 70.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.098 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -64.54 -38.85 92.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.486 -0.324 . . . . 1.0 110.644 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -40.42 93.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 1.0 110.447 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.51 -32.7 74.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.651 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.531 HD11 ' HB1' ' D' ' 52' ' ' ALA . 43.4 tp -62.98 -35.1 79.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.462 . . . . 1.0 110.29 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.13 -33.19 73.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -62.13 -45.36 93.82 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.473 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.09 -37.13 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.755 0.312 . . . . 1.0 110.935 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.1 -41.63 97.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' D' ' 23' ' ' SER . 74.0 mm-40 -66.95 -44.11 81.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 1.0 110.203 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.11 -34.03 76.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.147 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' D' ' 26' ' ' ALA . . . -63.58 -38.86 92.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.25 -43.6 95.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -61.34 -62.46 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.54 -38.11 83.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.765 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' D' ' 22' ' ' ALA . . . -52.12 -51.29 58.77 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.533 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 69.6 t -64.14 -46.26 94.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.409 -0.516 . . . . 1.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.43 -41.33 89.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.525 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' D' ' 66' ' ' GLU . . . -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.045 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 40.3 mm-40 -68.29 -41.85 80.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.822 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -62.69 87.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.014 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.12 7.61 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.332 -0.707 . . . . 1.0 111.332 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.92 135.19 20.51 Favored Pre-proline 0 CA--C 1.537 0.45 0 O-C-N 122.794 -0.239 . . . . 1.0 110.604 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.73 143.25 29.81 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.058 1.839 . . . . 1.0 112.228 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 18.84 75.84 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -61.86 143.07 56.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 1.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.73 -18.48 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.588 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.42 ' O ' HG23 ' D' ' 39' ' ' ILE . 39.2 tp -105.72 117.15 33.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 110.236 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.42 HG23 ' O ' ' D' ' 38' ' ' LEU . 5.1 pt -154.3 89.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.231 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.515 ' O ' ' N ' ' D' ' 44' ' ' ALA . 0.4 OUTLIER 169.57 112.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.98 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.493 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 13.5 m-85 -48.73 -53.96 31.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.76 -30.3 92.19 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.202 1.268 . . . . 1.0 112.013 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.13 -20.08 21.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.036 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' D' ' 40' ' ' SER . . . -61.16 -42.72 99.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.854 0.359 . . . . 1.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -65.4 -38.06 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.425 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.26 99.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.107 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.435 ' CE3' ' N ' ' D' ' 48' ' ' SER . 1.9 t90 -63.96 -40.15 95.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.466 -0.494 . . . . 1.0 109.975 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.435 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 78.6 p -60.17 -33.25 71.93 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.582 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.53 -44.33 99.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.312 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.461 ' OE2' ' CZ ' ' A' ' 68' ' ' ARG . 74.3 mt-10 -52.36 -31.96 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.575 ' C ' ' H ' ' D' ' 53' ' ' THR . 0.2 OUTLIER -83.39 -163.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . 56.35 0.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.134 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.575 ' H ' ' C ' ' D' ' 51' ' ' THR . 28.8 p -121.28 -1.2 9.74 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' D' ' 53' ' ' THR . 11.8 p 56.88 15.08 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -91.33 -53.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.705 0.288 . . . . 1.0 110.457 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.03 74.45 0.23 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.56 -47.28 86.86 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.974 -0.29 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 155.65 -90.77 0.12 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' D' ' 50' ' ' GLU . 98.0 m-20 44.05 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 1.0 110.424 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.497 HH22 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -124.62 162.54 23.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.736 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -162.75 138.95 5.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.528 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 157.53 57.24 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.893 1.729 . . . . 1.0 112.617 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.792 HG22 ' H ' ' D' ' 64' ' ' THR . 7.4 p -93.81 -121.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.495 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.792 ' H ' HG22 ' D' ' 63' ' ' VAL . 39.9 m -115.0 -35.05 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.757 0.313 . . . . 1.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 67' ' ' GLY . 51.9 tp10 -65.74 -32.09 73.44 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.232 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.519 ' CB ' ' HB1' ' D' ' 29' ' ' ALA . 0.5 OUTLIER -81.09 37.29 0.43 Allowed 'General case' 0 C--O 1.261 1.67 0 CA-C-O 123.349 1.547 . . . . 1.0 108.909 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 39.96 62.4 1.47 Allowed Glycine 0 C--O 1.214 -1.094 0 CA-C-N 113.663 -1.608 . . . . 1.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.537 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.5 ttt85 -24.5 -30.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.133 0.549 . . . . 1.0 111.323 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.5 mttm -53.12 -13.85 0.55 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.214 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.5 t -60.47 -48.73 87.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 C-N-CA 119.437 -0.905 . . . . 1.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.08 76.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.277 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.95 -38.85 92.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.329 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.25 -50.52 72.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.395 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.86 -42.93 89.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.368 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 34.4 ttm -58.08 -47.35 83.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.994 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -65.02 -40.05 94.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.614 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.04 81.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.5 94.64 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.3 -43.34 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.425 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' D' ' 84' ' ' LEU . 97.0 mt-10 -58.55 -50.73 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.836 0.309 . . . . 1.0 111.836 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.422 HG23 ' N ' ' D' ' 82' ' ' PHE . 11.4 m -60.84 -46.11 96.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.516 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . 0.422 ' N ' HG23 ' D' ' 81' ' ' VAL . 11.6 m-85 -66.24 -29.58 69.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.592 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -91.04 -20.76 21.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.575 0.226 . . . . 1.0 110.585 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 80' ' ' GLU . 8.0 tt -63.73 -42.03 97.96 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.541 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' D' ' 88' ' ' ALA . 8.7 m -60.18 -18.93 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.058 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.405 ' C ' ' O ' ' D' ' 85' ' ' VAL . 50.9 m -36.29 -28.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -62.97 -46.21 88.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.531 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -67.22 -26.35 66.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.178 0.514 . . . . 1.0 110.241 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.513 HD22 ' N ' ' D' ' 89' ' ' LEU . 4.2 mm? -73.02 -34.73 66.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.9 -45.09 93.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.95 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -4.87 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.006 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 40.7 t0 -59.4 -50.26 74.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.965 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 21.7 p90 -73.96 -26.88 60.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.008 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.98 -26.28 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.219 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -57.32 -22.51 42.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.851 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -62.2 -20.76 64.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.565 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 . . . . . 0 N--CA 1.467 0.399 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.438 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.813 0.34 . . . . 1.0 110.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 66.3 t0 -105.52 -29.04 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.577 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.6 p80 -81.02 -30.27 34.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.711 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.38 -45.69 83.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 1.0 110.813 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.46 -35.1 75.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.33 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.05 -40.32 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.213 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.75 92.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.391 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -63.31 -33.96 76.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.3 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.02 81.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.128 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.45 -39.45 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -62.25 -37.35 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.239 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.7 -31.07 71.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.572 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -42.31 98.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.438 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.99 -39.34 94.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.12 -40.27 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 1.0 111.328 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.17 -41.07 91.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.662 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.4 mt -60.61 -41.61 95.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.73 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.3 -38.39 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.308 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.4 90.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.796 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -60.14 -41.19 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.151 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.31 -30.01 70.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.37 -40.73 20.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.652 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CG ' ' A' ' 30' ' ' GLU . . . -64.83 -40.44 95.19 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.78 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.6 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.5 p -61.47 -50.29 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.608 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.6 ' N ' HG13 ' A' ' 27' ' ' VAL . 15.5 pt-20 -71.03 -43.29 68.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.545 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.99 73.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 21.7 mm-40 -67.72 -39.43 84.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.144 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -71.68 129.91 39.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.909 0.385 . . . . 1.0 110.313 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.02 -12.21 67.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.346 -0.702 . . . . 1.0 111.346 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.68 147.91 47.52 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.421 ' O ' HG11 ' A' ' 63' ' ' VAL . 97.8 Cg_endo -75.21 138.88 23.09 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.034 1.822 . . . . 1.0 112.306 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.39 69.22 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.59 54.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 1.0 110.396 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.48 -7.85 8.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.9 tt -107.13 123.1 47.76 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.064 0.459 . . . . 1.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 38' ' ' LEU . 44.3 pt -149.93 -171.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.104 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' ILE . 2.0 m 58.16 145.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.944 0.402 . . . . 1.0 110.623 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 65.0 t80 -82.7 -43.22 0.92 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.13 -0.486 . . . . 1.0 112.116 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.8 Cg_endo -60.4 -28.71 87.28 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.657 1.571 . . . . 1.0 112.829 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.7 p-10 -94.02 -28.92 15.48 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.99 -0.284 . . . . 1.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.17 83.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.271 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.82 -42.41 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.047 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.872 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.1 OUTLIER -62.88 -41.39 99.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.019 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 13.5 t90 -60.15 -39.28 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -72.87 67.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -151.99 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.007 0.432 . . . . 1.0 110.362 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.7 pm0 -48.16 -24.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.539 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -62.31 -43.67 98.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.989 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -28.09 67.77 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.236 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.4 p -84.32 5.63 26.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 48.05 76.61 0.11 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.899 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG22 ' O ' ' B' ' 54' ' ' THR . 94.5 t -138.98 -55.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.879 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.94 77.02 0.19 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.276 -0.73 . . . . 1.0 111.276 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -60.75 -42.77 98.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.46 9.92 1.32 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CG ' HH22 ' B' ' 68' ' ' ARG . 20.8 m-20 -58.1 -50.08 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -147.95 163.89 35.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.46 132.85 7.15 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.446 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.3 163.19 39.59 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.075 1.85 . . . . 1.0 112.394 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.0 t -97.78 -128.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.431 ' H ' HG12 ' A' ' 63' ' ' VAL . 8.6 m -115.01 -36.57 4.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.68 0.276 . . . . 1.0 110.979 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.692 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.4 tt0 -70.79 -39.41 73.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.748 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.79 27.53 0.02 OUTLIER 'General case' 0 C--O 1.265 1.899 0 CA-C-O 123.753 1.74 . . . . 1.0 109.925 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.16 64.35 0.96 Allowed Glycine 0 C--O 1.214 -1.117 0 CA-C-N 114.035 -1.438 . . . . 1.0 111.392 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.47 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 33.0 ttm180 -24.93 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.806 0.803 . . . . 1.0 110.969 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -50.44 -16.72 0.38 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.451 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.8 t -61.38 -48.09 90.47 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.342 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' A' ' 75' ' ' MET . . . -70.84 -42.8 69.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.007 0.432 . . . . 1.0 110.442 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.59 -43.17 46.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.474 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -62.26 -39.64 93.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.04 -43.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' A' ' 71' ' ' ALA . 3.4 mpp? -61.63 -40.2 94.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.021 -0.272 . . . . 1.0 110.503 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -61.33 -39.92 92.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.061 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 81' ' ' VAL . . . -51.4 -45.98 62.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.487 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -51.45 53.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.486 -1.046 . . . . 1.0 110.486 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 79' ' ' ILE . 95.6 mt -67.95 -4.78 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.472 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -96.17 -49.72 5.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.427 -0.352 . . . . 1.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 82' ' ' PHE . 28.3 m -70.8 -51.0 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.06 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.625 ' N ' HG23 ' A' ' 81' ' ' VAL . 45.6 m-85 -62.39 -39.18 92.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.073 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.691 ' O ' HD12 ' D' ' 89' ' ' LEU . . . -61.15 -39.57 90.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.715 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.5 tt -63.48 -40.35 96.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.505 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 85' ' ' VAL . 59.1 t -49.7 -11.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.429 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.481 ' N ' ' C ' ' A' ' 84' ' ' LEU . 54.5 m -49.28 -42.49 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 1.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.73 -13.61 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.68 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 86' ' ' THR . . . -104.75 -15.92 15.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.683 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.547 HD13 ' OD2' ' A' ' 92' ' ' ASP . 3.1 mm? -94.84 -46.68 6.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 1.0 110.677 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.03 -22.74 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -3.67 58.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.748 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD2' HD13 ' A' ' 89' ' ' LEU . 86.2 m-20 -61.65 -48.78 79.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.343 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.58 -19.57 45.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.765 0.317 . . . . 1.0 111.454 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.08 -42.73 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.904 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt-85 -58.06 -21.53 46.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.712 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -55.1 -42.85 73.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.546 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 97' ' ' GLU . 56.3 mp0 . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 1.0 110.085 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.722 0.296 . . . . 1.0 110.725 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -73.1 -35.43 66.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.714 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.26 -43.89 89.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.79 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.02 -38.89 92.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.68 -37.56 87.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.43 99.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.758 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.05 -35.73 76.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.334 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.41 -38.54 87.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.32 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.935 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.98 -34.78 78.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.562 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -62.79 -38.35 90.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.137 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.03 -33.05 74.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' B' ' 52' ' ' ALA . 47.8 tp -62.36 -41.92 98.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.506 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.11 -39.11 93.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.89 -44.23 97.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.22 -40.86 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.786 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.3 mt -60.36 -41.69 94.21 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.054 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.3 -48.17 79.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.118 0.485 . . . . 1.0 110.056 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.49 -35.85 75.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.128 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.52 86.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.35 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.5 p -56.58 -44.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.466 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.77 -36.2 82.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -67.98 -44.42 76.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.31 76.76 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.463 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.46 HG23 ' N ' ' B' ' 28' ' ' GLU . 16.9 m -62.82 -45.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.768 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.46 ' N ' HG23 ' B' ' 27' ' ' VAL . 46.2 tp10 -71.9 -42.0 67.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -43.7 -47.38 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.327 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' B' ' 38' ' ' LEU . 96.9 mt-10 -68.21 -116.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.809 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 45.67 79.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.596 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.26 17.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.413 -0.675 . . . . 1.0 111.413 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 149.7 96.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.24 121.27 6.03 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.953 1.769 . . . . 1.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 92.83 -23.06 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 49.94 175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 1.0 110.579 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.77 -85.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.552 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.529 ' N ' ' OE2' ' B' ' 30' ' ' GLU . 44.9 tp -89.93 82.3 6.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.594 HG23 ' O ' ' B' ' 39' ' ' ILE . 15.2 tt -125.97 102.07 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.963 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.516 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 73.4 m -169.94 -124.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' B' ' 40' ' ' SER . 2.3 m-85 -174.77 -65.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.0 109.995 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.15 -36.94 97.44 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.088 1.859 . . . . 1.0 112.175 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -92.98 0.91 57.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.617 -0.265 . . . . 1.0 111.145 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.06 93.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.003 0.43 . . . . 1.0 110.343 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -69.47 -36.61 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.546 ' O ' ' NH2' ' C' ' 68' ' ' ARG . 1.1 t90 -46.54 -68.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.647 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.467 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -57.16 -27.18 61.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.059 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.467 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -65.47 -41.77 92.97 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.701 -0.399 . . . . 1.0 111.347 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.572 ' CG1' HH12 ' C' ' 68' ' ' ARG . 55.5 t -60.95 -47.74 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.06 -31.59 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -60.5 -45.38 94.0 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.735 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.22 -27.57 55.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.813 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -85.43 1.52 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.723 0.297 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.6 p 53.41 15.69 0.75 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.005 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' N ' ' B' ' 56' ' ' GLY . 5.7 p -66.36 -44.69 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.02 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.496 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 46.3 65.22 2.19 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.47 -1.052 . . . . 1.0 110.47 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -58.98 -48.47 81.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 1.0 110.743 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.69 6.82 1.96 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -58.93 -45.62 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.644 0.259 . . . . 1.0 110.419 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -145.19 173.22 12.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -155.95 130.33 4.92 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.41 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.02 156.92 63.79 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.769 1.646 . . . . 1.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.51 HG12 ' H ' ' B' ' 64' ' ' THR . 1.8 t -84.03 -141.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.171 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.872 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.8 m -114.36 -46.54 2.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.24 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.9 tp10 -64.5 -29.18 70.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.355 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.3 OUTLIER -70.84 32.18 0.04 OUTLIER 'General case' 0 C--O 1.261 1.663 0 CA-C-O 123.889 1.804 . . . . 1.0 110.078 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.723 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.84 62.85 1.6 Allowed Glycine 0 C--O 1.208 -1.48 0 CA-C-N 113.827 -1.533 . . . . 1.0 111.338 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 50' ' ' GLU . 27.4 ttt85 -25.1 -31.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.075 0.937 . . . . 1.0 110.866 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -52.47 -14.97 0.55 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 67' ' ' GLY . 43.4 t -61.83 -46.43 96.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.364 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.05 67.18 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -57.18 -41.63 79.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.036 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.45 -44.35 94.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.08 -46.01 92.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.117 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 73.5 mtm -62.93 -42.72 99.89 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.432 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -63.86 -41.6 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.343 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.06 88.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -39.12 94.47 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.94 -26.78 33.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.58 -0.365 . . . . 1.0 111.293 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.9 -51.61 25.1 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.052 0.453 . . . . 1.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.446 HG23 ' N ' ' B' ' 82' ' ' PHE . 7.6 m -60.41 -47.86 90.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.17 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.446 ' N ' HG23 ' B' ' 81' ' ' VAL . 20.7 m-85 -67.81 -38.56 83.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.802 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.92 85.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.536 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.454 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.6 tt -61.72 -41.52 97.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 93.4 t -49.79 -17.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.457 ' O ' ' N ' ' B' ' 90' ' ' ALA . 75.1 m -52.38 -40.87 62.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.464 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.15 -55.06 7.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.841 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -12.69 54.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' C' ' 86' ' ' THR . 81.5 mt -98.21 -27.14 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -64.85 -24.62 67.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.382 0.61 . . . . 1.0 109.858 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.536 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.1 OUTLIER -84.52 -4.72 59.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.0 109.61 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.67 -48.93 74.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.82 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 7.9 p90 -66.56 -31.81 72.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.54 -44.32 96.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.232 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 83.7 mtt85 -60.08 -28.72 68.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.147 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -56.06 -42.23 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 . . . . . 0 CA--C 1.531 0.223 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.044 -179.826 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.931 0.396 . . . . 1.0 110.193 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.618 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 23.3 p80 -67.11 -41.07 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.618 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.6 tt0 -62.67 -39.8 95.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.719 0.295 . . . . 1.0 110.537 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -65.1 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 1.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -64.72 -39.61 93.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.92 98.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.463 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.82 -40.82 92.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.245 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.85 -35.39 80.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.327 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.89 76.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.056 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.65 -39.59 91.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 1.0 110.877 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.49 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.742 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.73 -37.81 88.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' C' ' 78' ' ' GLY . 40.8 tp -61.55 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.427 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -59.98 -31.35 69.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -61.55 -40.1 93.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.73 0.3 . . . . 1.0 111.132 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.81 -42.35 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.847 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.64 -41.7 97.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.107 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.421 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.7 mt-10 -63.31 -46.62 85.85 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.008 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 0.2 OUTLIER -70.6 -39.08 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.112 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.95 82.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.7 p -53.34 -45.77 69.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.192 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -65.08 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.215 0.531 . . . . 1.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.5 -37.9 82.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -53.51 57.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.75 0.31 . . . . 1.0 111.065 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.84 -41.45 92.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -68.14 -44.08 76.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.524 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.11 80.56 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.09 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.6 -39.4 73.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.316 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -68.38 129.09 38.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 120.943 0.401 . . . . 1.0 110.28 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.44 -0.46 65.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.334 -0.706 . . . . 1.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.37 149.9 38.31 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.43 -0.211 . . . . 1.0 110.43 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.07 139.88 22.07 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.816 1.677 . . . . 1.0 112.369 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 2.69 57.9 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.5 103.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.78 0.324 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.44 -35.46 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.393 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 15.0 tp -87.08 95.07 9.82 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.119 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 33.4 pt -138.52 49.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 1.0 110.713 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -138.66 145.3 40.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.162 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 35.9 m-85 -69.52 -50.87 17.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.3 Cg_endo -58.98 -38.54 87.43 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.727 1.618 . . . . 1.0 112.433 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.08 -11.29 59.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.221 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.86 81.71 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.788 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.405 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.3 tt -72.93 -38.89 57.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.028 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.486 ' C ' ' NH1' ' D' ' 68' ' ' ARG . 0.5 OUTLIER -63.64 -46.52 85.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.64 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' C' ' 48' ' ' SER . 3.1 t90 -61.18 -39.64 90.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 1.0 109.553 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.417 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 60.7 p -61.63 -34.53 75.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.96 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 45' ' ' ILE . 50.2 t -61.46 -48.28 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.478 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.65 -21.29 62.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.274 -0.571 . . . . 1.0 110.58 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -75.48 -42.2 53.58 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.796 0.331 . . . . 1.0 111.367 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.41 80.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.899 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.592 ' C ' HG23 ' C' ' 54' ' ' THR . 54.5 p -74.85 -11.99 60.27 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.592 HG23 ' C ' ' C' ' 53' ' ' THR . 1.3 p 69.88 0.85 3.21 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.636 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' C' ' 57' ' ' TYR . 56.0 t -65.21 -45.09 94.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.723 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.32 79.02 0.06 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.424 ' CZ ' HG11 ' C' ' 55' ' ' VAL . 52.6 m-85 -60.3 -46.64 89.16 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.811 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.04 23.27 0.69 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.49 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 21.8 t0 -61.65 -41.17 97.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 1.0 110.305 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -145.49 -161.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.961 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 13.4 p90 -172.17 112.37 0.38 Allowed Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.986 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -170.64 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.613 1.542 . . . . 1.0 112.126 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.987 HG22 ' H ' ' C' ' 64' ' ' THR . 9.9 p -139.12 -169.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.375 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.987 ' H ' HG22 ' C' ' 63' ' ' VAL . 11.4 m -77.25 -45.91 24.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 1.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' C' ' 67' ' ' GLY . 49.0 tp10 -47.49 -50.51 23.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.91 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.9 OUTLIER -72.17 35.76 0.06 Allowed 'General case' 0 C--O 1.264 1.838 0 CA-C-O 124.28 1.991 . . . . 1.0 109.859 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.85 65.88 1.46 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.76 -1.564 . . . . 1.0 111.54 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.572 HH12 ' CG1' ' B' ' 49' ' ' VAL . 8.2 ptm180 -21.33 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.775 0.798 . . . . 1.0 111.657 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.6 mmtt -43.84 -18.6 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.273 -1.331 . . . . 1.0 109.588 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' C' ' 68' ' ' ARG . 54.5 t -59.29 -44.91 93.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.453 -0.899 . . . . 1.0 110.189 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.87 63.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.966 0.412 . . . . 1.0 110.764 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.33 -35.27 79.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.955 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.93 -52.45 64.98 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.671 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.27 -43.55 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.773 0.321 . . . . 1.0 111.175 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.553 ' HG3' HG22 ' C' ' 54' ' ' THR . 19.1 ttp -59.62 -43.73 93.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 56.6 tttm -63.47 -42.49 98.59 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.583 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.482 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.14 -39.78 95.68 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.17 -44.56 93.77 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.203 -0.522 . . . . 1.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.94 -43.12 97.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.676 0.274 . . . . 1.0 110.736 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.0 mt-10 -64.63 -39.4 93.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.328 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' C' ' 77' ' ' ALA . 53.7 t -63.82 -48.72 85.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.405 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -64.18 -41.9 96.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.204 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.483 ' O ' HG22 ' C' ' 86' ' ' THR . . . -65.31 -36.0 82.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.859 0.361 . . . . 1.0 110.593 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.5 tt -61.66 -33.89 74.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.519 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.539 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.0 t -54.29 -4.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.374 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 88' ' ' ALA . 6.0 t -62.73 -39.45 94.13 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.118 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -40.09 -21.96 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.545 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -101.85 -38.35 7.87 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.215 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' C' ' 86' ' ' THR . 30.9 mt -74.03 -42.14 60.76 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.941 0.4 . . . . 1.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -55.73 -32.34 63.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.266 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.14 -4.01 45.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.095 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 87.5 m-20 -59.06 -47.8 83.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 11.6 p90 -70.15 -29.63 66.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.08 -43.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.674 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -58.7 -23.07 58.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.427 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -40.59 -37.18 0.68 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.375 -179.458 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.827 0.346 . . . . 1.0 110.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -158.78 -43.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -79.68 -20.15 47.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.811 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.27 -35.71 81.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 1.0 110.563 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.08 -40.93 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.53 -43.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 1.0 109.965 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . 0.492 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.48 -38.38 89.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.832 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 68.8 tp60 -64.45 -41.0 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.407 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.4 -38.46 89.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.733 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -28.66 65.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.095 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -62.69 -40.98 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 1.0 110.952 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' D' ' 9' ' ' GLN . 58.2 mp0 -66.32 -33.73 76.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.08 -37.79 86.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.457 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.0 tp -62.81 -41.68 99.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.78 -34.76 76.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.144 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -61.86 -44.0 97.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.835 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -64.08 -36.13 75.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.885 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' D' ' 52' ' ' ALA . 91.2 mt -60.88 -42.16 97.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.21 -47.73 72.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -66.77 -36.84 83.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.665 -0.414 . . . . 1.0 109.894 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -29.07 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.764 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' D' ' 27' ' ' VAL . 69.2 m -59.12 -45.85 89.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.997 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' D' ' 25' ' ' LYS . 13.5 ptpt -66.59 -39.12 88.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.46 ' N ' ' HG3' ' D' ' 24' ' ' LYS . 98.2 mttt -62.05 -45.34 93.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.611 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.433 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 23' ' ' SER . 90.1 t -65.6 -45.77 91.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.264 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -69.46 -42.49 74.82 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.575 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.81 91.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.631 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.455 ' OE1' ' CG2' ' D' ' 39' ' ' ILE . 11.8 tm-20 -67.2 -39.76 86.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.45 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -61.39 115.64 4.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.841 0.353 . . . . 1.0 110.652 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.98 -13.69 57.45 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.22 111.53 55.32 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.27 149.26 35.38 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.915 1.743 . . . . 1.0 112.688 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.69 73.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.73 164.32 16.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 1.0 110.478 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . 0.451 ' HB3' ' CE1' ' D' ' 61' ' ' TYR . . . -145.98 84.56 1.66 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.433 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.448 HD23 ' C ' ' D' ' 38' ' ' LEU . 3.5 tt -173.94 79.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.233 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' D' ' 40' ' ' SER . 10.1 pt -127.48 164.65 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.015 0.436 . . . . 1.0 110.606 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 81.24 123.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.438 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 54.0 m-85 -59.57 -47.07 98.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.953 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.59 -33.61 98.26 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.572 1.515 . . . . 1.0 112.267 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.7 -29.38 16.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.049 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.02 94.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.684 0.278 . . . . 1.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.488 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.5 tt -63.36 -32.17 55.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.154 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.488 ' HE3' HG23 ' D' ' 45' ' ' ILE . 0.3 OUTLIER -59.72 -46.63 88.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.884 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' D' ' 51' ' ' THR . 0.7 OUTLIER -67.29 -40.01 86.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.466 -0.493 . . . . 1.0 110.037 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 4.3 t -56.72 -40.0 74.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.459 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.79 -48.64 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.54 -31.63 71.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.911 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' D' ' 47' ' ' TRP . 87.9 m -64.29 -45.17 89.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.572 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.93 -25.98 65.58 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.599 -0.441 . . . . 1.0 110.16 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.3 p -88.37 6.08 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 1.0 110.324 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.02 67.75 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.203 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.16 -40.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.432 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.43 78.51 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.506 -1.037 . . . . 1.0 110.506 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -44.65 96.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 1.0 110.629 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.63 -0.35 3.05 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.71 -0.956 . . . . 1.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 97.5 m-20 -56.8 -50.38 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -130.95 140.78 50.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' D' ' 61' ' ' TYR . 21.3 p90 -130.47 105.25 15.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.786 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.65 154.29 68.35 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.966 1.777 . . . . 1.0 112.258 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.08 -162.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.248 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 55.1 m -87.77 -20.96 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -77.55 -13.59 59.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.665 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.411 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.8 OUTLIER -103.75 28.26 6.76 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 124.293 1.997 . . . . 1.0 108.521 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.84 60.47 4.9 Favored Glycine 0 C--O 1.211 -1.285 0 CA-C-N 113.831 -1.531 . . . . 1.0 109.761 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.49 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 42.5 ttm180 -26.93 -28.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 117.351 0.576 . . . . 1.0 111.046 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 64.0 mttm -57.33 -15.14 5.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.188 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.3 t -60.73 -47.99 90.7 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 119.417 -0.913 . . . . 1.0 109.388 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . 0.545 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -65.63 -48.69 71.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.876 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -42.87 -59.33 2.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.338 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -48.93 -39.51 26.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.717 0.266 . . . . 1.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.0 t -62.23 -42.93 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.529 -0.468 . . . . 1.0 111.614 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 2.6 mpp? -59.02 -40.03 83.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.925 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.76 -39.5 88.97 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.472 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.55 -40.28 96.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.044 -0.663 . . . . 1.0 110.716 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -73.29 -44.46 34.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.36 -44.23 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.076 -0.25 . . . . 1.0 111.397 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.94 -44.02 86.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.374 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.472 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.2 t -63.95 -48.55 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.464 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.93 -15.9 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.846 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -95.57 -25.96 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 1.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.92 -42.33 94.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.487 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.492 HG12 ' HB1' ' D' ' 8' ' ' ALA . 15.0 m -58.7 -18.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.015 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 41.2 m -36.95 -29.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.998 0.427 . . . . 1.0 110.488 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.555 ' O ' HG22 ' D' ' 91' ' ' THR . . . -58.94 -62.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.715 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.38 63.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.169 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 83' ' ' ALA . 4.2 mm? -66.03 -37.42 85.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -66.0 -66.13 0.59 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.626 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.802 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.4 OUTLIER -49.18 -4.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.879 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' D' ' 90' ' ' ALA . 25.9 t0 -67.22 -21.21 65.76 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 1.0 111.356 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.505 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 2.3 p90 -77.41 -18.21 57.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.874 0.369 . . . . 1.0 111.194 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.802 HG22 ' O ' ' D' ' 91' ' ' THR . 7.7 m -60.41 -40.05 82.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.576 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . 0.432 ' N ' HG23 ' D' ' 94' ' ' VAL . 99.8 mtt180 -49.69 -22.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.625 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -60.9 -41.97 97.11 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.889 179.71 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.801 0.334 . . . . 1.0 110.545 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 55.01 30.33 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 7.6 p80 -162.0 -37.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.925 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.637 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 44.1 tt0 -65.56 -42.45 91.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -64.09 -41.65 97.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.113 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.78 -34.24 75.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.36 -50.76 72.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -67.48 -33.32 74.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.439 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.68 -36.18 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.458 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.51 77.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.972 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -40.55 94.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.526 -0.306 . . . . 1.0 110.632 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -63.48 -33.57 75.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 1.0 110.493 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' VAL . 80.8 tt0 -62.21 -41.43 98.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.359 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 78' ' ' GLY . 54.4 tp -66.65 -39.47 88.24 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -49.62 -51.0 40.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.828 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -74.77 -31.27 61.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.495 -0.482 . . . . 1.0 112.069 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 14' ' ' GLU . 53.8 t -63.51 -48.22 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.088 -0.245 . . . . 1.0 111.588 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.03 -28.88 66.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.197 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -61.2 -46.78 89.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.4 -39.51 92.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 1.0 109.675 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.9 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.201 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.51 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 37.2 m -54.25 -40.69 67.99 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -62.73 -31.72 72.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.885 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.94 -39.3 34.96 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.902 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.58 88.58 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.6 p -61.08 -46.05 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.359 -0.536 . . . . 1.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 27' ' ' VAL . 80.5 tt0 -67.19 -42.24 84.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.229 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.38 98.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.847 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 37' ' ' ALA . 31.5 tp10 -74.01 -42.62 60.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.592 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -70.85 126.82 30.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.234 0.54 . . . . 1.0 110.819 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.48 59.63 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.387 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -103.18 151.78 38.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.599 ' O ' HG21 ' A' ' 63' ' ' VAL . 72.6 Cg_endo -75.66 117.27 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.048 1.832 . . . . 1.0 111.751 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 94.87 20.64 27.99 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -39.52 162.49 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.65 0.262 . . . . 1.0 110.629 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.572 ' H ' ' CG ' ' A' ' 30' ' ' GLU . . . -136.37 -71.84 0.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.725 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.59 128.27 35.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.08 163.12 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.028 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.7 OUTLIER 81.33 153.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.717 0.294 . . . . 1.0 110.684 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 13.3 t80 -83.15 -50.52 0.7 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.817 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.24 -28.66 87.33 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.421 1.414 . . . . 1.0 112.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 25.1 m-20 -90.25 -28.94 18.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.87 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -64.2 -36.67 84.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 tt -62.3 -37.97 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.287 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -47.81 81.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.446 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -66.09 -39.06 89.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.51 ' HG ' ' CB ' ' A' ' 23' ' ' SER . 21.5 m -57.1 -39.77 75.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.858 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 HG21 ' NH2' ' B' ' 68' ' ' ARG . 53.7 t -61.33 -46.84 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 98.9 mt-10 -65.48 -44.33 87.42 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 54' ' ' THR . 3.0 m -62.04 -43.8 98.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.269 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -48.53 -52.17 23.9 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.388 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.12 7.6 24.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.4 p 63.33 -133.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.574 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' OG1' ' A' ' 54' ' ' THR . 47.2 t 64.05 -40.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.547 0.529 . . . . 1.0 111.582 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 37.06 90.67 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 53.8 t80 -60.03 -45.84 91.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 1.0 110.462 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.19 7.59 1.09 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.24 -47.0 86.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 1.0 110.156 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -146.09 154.46 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.07 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 27.9 p90 -137.83 130.07 16.4 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.36 154.01 69.93 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.12 1.88 . . . . 1.0 112.518 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.794 HG22 ' H ' ' A' ' 64' ' ' THR . 6.2 p -75.74 -141.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.459 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.794 ' H ' HG22 ' A' ' 63' ' ' VAL . 4.7 m -116.42 -39.2 3.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.678 0.275 . . . . 1.0 111.099 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 80.2 tt0 -77.67 -11.93 59.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.225 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 63' ' ' VAL . 2.1 pp20? -71.66 23.36 0.05 OUTLIER 'General case' 0 C--O 1.259 1.605 0 CA-C-O 123.933 1.825 . . . . 1.0 109.837 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.36 69.43 1.08 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 117.561 -1.688 . . . . 1.0 112.566 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HE ' ' HA ' ' D' ' 46' ' ' TRP . 0.6 OUTLIER -24.39 -32.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.974 1.387 . . . . 1.0 110.665 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 67' ' ' GLY . 64.0 mttp -50.8 -33.72 24.66 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.316 -0.856 . . . . 1.0 109.888 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' GLY . 61.2 t -61.84 -49.75 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 119.4 -0.92 . . . . 1.0 110.576 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.41 -46.17 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CG1' ' D' ' 49' ' ' VAL . 77.5 tt0 -58.23 -38.84 77.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.735 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.57 -46.11 77.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.769 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.74 -42.24 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.269 -0.573 . . . . 1.0 111.498 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.3 mtt -52.94 -44.66 67.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.852 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.37 -46.34 83.8 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.04 92.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 15' ' ' LEU . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.58 -23.83 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.739 -0.271 . . . . 1.0 111.258 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -67.6 -45.72 74.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 81' ' ' VAL . 6.9 m -63.77 -43.99 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.837 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 78' ' ' GLY . 40.3 m-85 -67.39 -37.28 82.89 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.054 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 86' ' ' THR . . . -63.76 -40.97 97.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.046 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.411 ' C ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -63.1 -36.15 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.453 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 85' ' ' VAL . 80.8 t -53.56 -15.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.942 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.627 HG21 ' HB3' ' D' ' 89' ' ' LEU . 9.8 t -48.42 -38.01 18.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.305 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -49.86 -29.51 8.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.473 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.36 29.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.788 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.41 -58.2 2.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.856 0.36 . . . . 1.0 111.0 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.3 -22.98 33.81 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.454 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.465 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -98.28 -4.72 34.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.264 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.01 -47.17 87.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.233 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 3.8 p90 -58.07 -44.15 87.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.114 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.564 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 61.7 t -36.66 -26.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.484 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' PHE . 96.5 mtt180 -61.78 -36.13 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.988 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -49.04 -32.75 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.55 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 -179.848 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.683 0.277 . . . . 1.0 111.053 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.708 ' H ' ' CD2' ' B' ' 4' ' ' HIS . 5.3 p80 -71.47 -31.95 67.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 1.0 110.567 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.29 -36.36 83.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -63.65 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 1.0 110.622 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.4 -45.17 95.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.946 -0.391 . . . . 1.0 109.946 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -40.93 85.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.61 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.12 -40.12 94.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.52 -38.07 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.513 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.21 -35.5 75.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.004 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.66 -36.09 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.38 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.78 -34.45 78.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.128 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.01 -36.92 85.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.699 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.3 tp -63.62 -39.34 94.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.54 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.16 -38.41 86.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.978 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -62.27 -39.8 94.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 1.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.19 -41.84 91.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.649 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' B' ' 52' ' ' ALA . 90.6 mt -59.56 -41.34 89.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.608 -0.437 . . . . 1.0 109.933 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.81 -50.1 73.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.991 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.98 -33.19 75.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.008 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.6 83.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.332 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.0 t -59.85 -46.15 90.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.297 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.53 -32.59 73.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.475 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.59 -50.02 16.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.659 -0.417 . . . . 1.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.28 95.37 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.467 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.8 p -62.51 -46.67 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.156 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.541 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.0 tm-20 -70.93 -42.16 70.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.9 96.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.492 ' HG2' ' H ' ' B' ' 38' ' ' LEU . 36.3 tp10 -76.25 -41.51 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.85 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.43 111.18 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.971 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.35 -2.8 23.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.2 151.36 37.69 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 110.66 -0.126 . . . . 1.0 110.66 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' B' ' 36' ' ' ALA . 92.4 Cg_endo -74.81 146.66 33.77 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.946 1.764 . . . . 1.0 112.63 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 77.15 -24.01 2.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.646 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . 40.77 -166.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.606 0.241 . . . . 1.0 110.701 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 161.85 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.932 0.396 . . . . 1.0 110.117 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.492 ' H ' ' HG2' ' B' ' 30' ' ' GLU . 15.4 tp -154.38 108.89 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 1.0 110.743 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.8 pt -131.84 167.06 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.661 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER 80.83 127.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.624 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 9.3 t80 -72.13 -44.97 11.13 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.981 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.76 -26.62 80.76 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.609 1.54 . . . . 1.0 112.738 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -94.31 -18.92 21.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.696 0.284 . . . . 1.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.458 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.63 -41.41 88.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.562 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.538 ' CE2' ' O ' ' C' ' 64' ' ' THR . 4.2 t-105 -61.31 -46.14 91.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.374 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 2.8 t90 -63.1 -39.37 94.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.005 0.431 . . . . 1.0 110.266 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.423 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 6.3 t -62.92 -32.77 74.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.643 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 45' ' ' ILE . 42.0 t -58.85 -47.55 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.629 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.61 -30.71 69.5 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 1.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.0 m -63.33 -46.48 86.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.432 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.48 -35.96 81.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.301 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 55' ' ' VAL . 76.3 p -76.81 3.47 11.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.82 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' B' ' 53' ' ' THR . 58.8 p 51.24 53.77 12.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.426 HG21 ' SD ' ' C' ' 75' ' ' MET . 50.4 t -125.41 -60.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.544 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.13 84.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.24 -41.16 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.302 . . . . 1.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.61 26.91 0.16 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -61.65 -47.53 84.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 1.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.539 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 94.0 mtt-85 -144.1 -169.55 3.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 52.2 m-85 -159.71 110.28 1.47 Allowed Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.433 -0.317 . . . . 1.0 110.437 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.416 1.41 . . . . 1.0 112.238 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.965 HG22 ' H ' ' B' ' 64' ' ' THR . 9.9 p -95.06 -165.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.965 ' H ' HG22 ' B' ' 63' ' ' VAL . 52.4 m -91.07 -37.69 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 1.0 110.602 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 65.5 tt0 -60.79 -31.87 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.483 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -75.33 28.04 0.1 Allowed 'General case' 0 C--O 1.262 1.727 0 CA-C-O 124.028 1.87 . . . . 1.0 109.386 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.709 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 45.58 65.48 1.93 Allowed Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.786 -1.552 . . . . 1.0 111.31 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH2' HG21 ' A' ' 49' ' ' VAL . 59.5 ttp85 -24.58 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.906 0.853 . . . . 1.0 110.572 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.2 mmtt -46.2 -22.59 0.25 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 69.6 t -61.8 -44.85 99.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 119.517 -0.873 . . . . 1.0 109.585 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.524 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -72.08 -51.0 23.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.733 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -55.29 -40.25 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.59 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.0 -45.79 89.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.942 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.98 -44.78 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.4 mpp? -63.19 -41.45 99.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.35 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -63.97 -42.13 97.35 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.445 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.412 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -60.54 -41.12 93.85 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.511 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -65.22 -44.8 93.26 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.85 -43.84 99.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.881 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.34 -44.86 95.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.412 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.0 t -63.75 -48.04 88.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.138 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.441 ' O ' HG22 ' B' ' 85' ' ' VAL . 27.5 m-85 -71.63 -21.27 61.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.901 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.43 -25.14 17.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.0 110.319 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.5 -40.96 98.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.09 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' ALA . 10.7 m -46.61 -24.65 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.678 ' HA ' HD22 ' B' ' 89' ' ' LEU . 36.9 m -37.44 -24.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.377 0.608 . . . . 1.0 110.384 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -56.01 -39.41 71.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.727 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.62 -11.18 57.63 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.718 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' B' ' 86' ' ' THR . 5.0 mp -81.76 -4.26 55.91 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.468 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -94.9 -56.67 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.394 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.448 ' H ' HG22 ' B' ' 91' ' ' THR . 0.1 OUTLIER -58.89 -5.78 0.67 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.06 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' B' ' 93' ' ' PHE . 36.6 p-10 -61.35 -50.4 73.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.157 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 5.3 p90 -71.55 -8.26 52.85 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.829 0.347 . . . . 1.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.11 -26.09 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.417 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.53 -42.61 88.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.58 -0.282 . . . . 1.0 111.432 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.99 -38.03 0.91 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.907 0.384 . . . . 1.0 110.201 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.35 179.638 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.742 0.306 . . . . 1.0 110.736 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.646 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 5.8 p-80 -149.02 -47.99 0.14 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.705 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.646 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 31.5 tp10 -69.37 -36.42 76.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.885 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -64.25 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -61.34 -45.68 93.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.08 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.56 89.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.617 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -65.02 -37.84 88.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.26 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.166 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.54 87.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.038 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.23 -37.14 86.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 1.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.29 -36.33 83.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.851 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.3 tp -62.5 -40.67 97.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.342 . . . . 1.0 110.571 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.45 -39.72 88.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.1 -38.87 90.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.817 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.72 -36.22 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.9 mt -59.99 -41.66 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.136 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -60.98 -46.36 91.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.994 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -59.76 -38.9 83.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -60.78 -47.85 84.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.291 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -67.86 -36.75 80.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.443 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -78.55 -22.57 47.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.502 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -84.52 -44.7 13.34 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.251 0.344 . . . . 1.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.557 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.4 p -61.99 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 1.0 109.891 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.557 ' N ' HG13 ' C' ' 27' ' ' VAL . 2.9 pp20? -66.22 -31.39 72.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.643 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' C' ' 26' ' ' ALA . . . -49.28 -50.95 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.577 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' C' ' 32' ' ' GLY . 80.4 mm-40 -68.37 -37.66 80.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.69 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -57.34 87.58 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.803 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 30' ' ' GLU . . . 127.82 -13.06 6.48 Favored Glycine 0 N--CA 1.466 0.679 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.8 150.95 39.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.283 -0.266 . . . . 1.0 110.283 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.777 ' O ' HG21 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.77 155.93 39.53 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.097 1.864 . . . . 1.0 112.096 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' C' ' 37' ' ' ALA . . . 90.6 -17.4 54.73 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' C' ' 37' ' ' ALA . . . 40.79 -96.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 1.0 110.949 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' C' ' 36' ' ' ALA . . . 80.46 -73.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.789 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.06 122.16 43.07 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tt -149.84 4.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.03 0.443 . . . . 1.0 110.22 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -94.24 133.39 37.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.883 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.495 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 26.5 m-85 -75.04 -53.51 2.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.6 Cg_endo -59.41 -28.55 87.84 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.617 1.544 . . . . 1.0 112.246 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.59 -18.94 25.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.089 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.86 89.77 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.472 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.74 -39.8 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.698 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -45.51 92.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.252 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.508 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.6 t90 -64.62 -39.89 94.51 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.188 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.43 ' O ' HD22 ' C' ' 19' ' ' LEU . 91.1 p -59.26 -33.3 70.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.149 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.4 -48.04 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -73.7 -23.16 59.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 70.8 m -64.12 -45.6 87.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.519 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.02 -34.29 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.848 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.415 ' OG1' HG23 ' C' ' 55' ' ' VAL . 68.2 p -82.38 1.28 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 1.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.5 p 55.61 11.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.778 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' D' ' 75' ' ' MET . 79.6 t -64.37 -46.18 93.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.956 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.09 59.33 3.43 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 7.9 t80 -61.0 -47.21 87.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 1.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 169.73 -97.86 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 53.9 t0 44.92 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 1.0 110.782 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' C' ' 58' ' ' GLY . 96.9 mtt-85 -124.01 153.13 41.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' C' ' 61' ' ' TYR . 43.8 p90 -143.48 133.66 12.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.02 162.18 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.857 1.705 . . . . 1.0 112.413 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.805 HG13 ' H ' ' C' ' 64' ' ' THR . 7.2 p -83.58 -116.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.805 ' H ' HG13 ' C' ' 63' ' ' VAL . 54.8 m -116.78 -84.0 0.64 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -43.92 125.9 4.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER 57.35 -104.46 0.22 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.69 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.476 1.349 0 O-C-N 124.431 1.082 . . . . 1.0 114.901 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 54.1 ttm-85 -87.21 -46.07 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.939 0.495 . . . . 1.0 110.773 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.8 tttm -54.36 -40.19 67.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.244 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.13 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.056 -0.657 . . . . 1.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.61 -37.2 86.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -54.95 -42.4 72.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -64.93 -40.18 94.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.571 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.07 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 1.0 111.349 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.426 ' SD ' HG21 ' B' ' 55' ' ' VAL . 59.8 mtt -54.0 -44.72 71.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.887 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -63.65 -38.77 92.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 1.0 110.533 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.51 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -62.1 -25.03 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.586 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -90.46 -39.42 5.96 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.944 -0.462 . . . . 1.0 111.944 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.69 -43.47 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.082 -0.247 . . . . 1.0 111.004 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.9 -37.72 86.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.187 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.51 HG23 ' O ' ' C' ' 77' ' ' ALA . 62.1 t -63.45 -47.54 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 121.016 -0.274 . . . . 1.0 111.271 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.0 -36.81 82.99 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.306 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' B' ' 89' ' ' LEU . . . -61.82 -39.61 92.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.808 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' C' ' 86' ' ' THR . 7.3 tt -65.02 -37.56 88.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.267 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.43 HG12 ' O ' ' C' ' 85' ' ' VAL . 78.4 t -45.48 -13.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.991 -0.283 . . . . 1.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.58 ' O ' ' N ' ' C' ' 88' ' ' ALA . 8.9 m -60.29 -41.81 94.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.501 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -39.34 -18.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.005 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -103.36 -36.89 7.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' C' ' 86' ' ' THR . 36.2 mt -75.41 -43.17 51.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' C' ' 86' ' ' THR . . . -56.58 -34.18 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.762 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.67 -5.27 52.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.801 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.488 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 61.9 t0 -56.36 -47.21 79.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.41 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.9 p90 -74.35 -40.06 62.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 84.8 t -44.87 -31.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.825 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -64.12 -22.75 67.06 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.519 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . 0.417 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 47.4 ptt85 -52.95 -42.85 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 1.0 110.497 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 79.9 mm-40 . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.512 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.416 ' HB1' ' HD1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.85 0.357 . . . . 1.0 110.566 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' D' ' 4' ' ' HIS . 47.7 p-10 -65.95 -33.25 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' D' ' 3' ' ' ASP . 2.0 m80 -63.99 -45.15 90.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 1.0 110.342 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.66 -39.86 91.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -60.72 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.455 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.78 -40.02 79.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 1.0 110.09 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -63.15 -46.08 88.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' D' ' 13' ' ' GLU . 99.1 mm-40 -66.13 -37.49 85.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.566 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.29 -39.5 90.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.749 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.54 78.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.33 -39.27 86.48 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.754 0.311 . . . . 1.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' D' ' 9' ' ' GLN . 1.1 mp0 -64.12 -37.19 86.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.18 -32.51 74.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.4 tp -62.4 -41.62 98.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.511 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.93 -35.53 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.993 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . 0.52 ' NZ ' ' OE2' ' D' ' 21' ' ' GLU . 18.0 tttp -60.59 -45.82 92.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.79 -40.99 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.905 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.4 mt -59.66 -40.97 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.173 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -62.13 -46.87 87.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.318 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' D' ' 17' ' ' LYS . 98.3 mt-10 -68.67 -36.11 78.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.4 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.45 91.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.203 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.23 -44.43 92.33 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.757 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.66 -35.74 80.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.98 0.419 . . . . 1.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.056 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.93 86.52 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.035 -0.266 . . . . 1.0 111.044 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.24 -44.94 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.13 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.26 -41.5 73.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.856 0.36 . . . . 1.0 110.937 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.5 90.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.717 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.73 -34.45 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 1.0 110.219 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . 0.422 ' HG2' HD13 ' D' ' 39' ' ' ILE . 29.0 mmt180 -72.42 137.52 46.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . 0.406 ' O ' ' OE1' ' D' ' 65' ' ' GLU . . . 96.1 -11.86 67.26 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -100.26 149.51 36.11 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.455 ' O ' HG11 ' D' ' 63' ' ' VAL . 88.6 Cg_endo -74.49 142.99 30.32 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.907 1.738 . . . . 1.0 112.118 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.55 33.38 81.13 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.7 141.23 38.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.918 0.39 . . . . 1.0 110.538 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -32.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.513 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.88 31.91 0.43 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.019 0.437 . . . . 1.0 109.895 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' D' ' 40' ' ' SER . 4.5 tp -105.7 131.87 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.538 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.4 p 162.7 -102.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.2 m-85 171.44 -65.94 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.31 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.7 Cg_endo -59.15 -29.25 89.98 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.925 1.75 . . . . 1.0 111.526 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -86.92 -24.2 24.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.42 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.37 -45.13 95.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.774 -0.371 . . . . 1.0 110.868 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 46' ' ' TRP . 3.3 tp -67.51 -41.72 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.572 ' CH2' ' O ' ' A' ' 63' ' ' VAL . 1.1 t90 -60.68 -40.65 92.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.122 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' D' ' 48' ' ' SER . 6.0 t90 -61.86 -39.82 93.19 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.574 ' O ' ' N ' ' D' ' 50' ' ' GLU . 3.3 p -60.59 -145.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.002 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.593 ' H ' HD22 ' D' ' 19' ' ' LEU . 28.6 t 48.99 -81.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.13 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' D' ' 48' ' ' SER . 15.7 pt-20 -48.02 -29.47 3.52 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -61.94 -43.73 98.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.12 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.74 -37.6 84.85 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 41.3 p -72.97 0.03 12.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p 50.85 68.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.987 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.04 -52.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.607 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.65 77.32 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -44.35 96.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 1.0 110.443 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.42 14.04 0.73 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.74 -51.39 69.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.674 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.433 ' O ' ' CE1' ' C' ' 57' ' ' TYR . 34.8 mtt-85 -146.81 140.75 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 21.5 p90 -122.22 133.92 24.57 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 121.151 -0.22 . . . . 1.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.6 159.4 52.9 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.129 1.886 . . . . 1.0 112.195 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.543 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -84.91 -142.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.088 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.543 ' H ' HG12 ' D' ' 63' ' ' VAL . 46.7 m -113.46 -53.05 2.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.704 0.288 . . . . 1.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.5 tt0 -62.45 -16.43 55.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.863 0.363 . . . . 1.0 110.226 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.6 OUTLIER -74.35 26.41 0.08 Allowed 'General case' 0 C--O 1.264 1.839 0 CA-C-O 123.808 1.766 . . . . 1.0 109.087 178.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.722 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.03 61.3 3.54 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 58.2 ttm-85 -26.0 -30.31 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.297 0.645 . . . . 1.0 110.849 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.722 ' N ' ' O ' ' D' ' 67' ' ' GLY . 28.8 mmtp -53.41 -17.37 1.87 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.272 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' D' ' 67' ' ' GLY . 55.3 t -61.79 -48.36 89.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.0 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.71 -43.16 72.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.923 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -60.11 -42.21 94.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.763 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.09 -42.3 76.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.079 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.271 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.538 ' SD ' HG21 ' C' ' 55' ' ' VAL . 61.1 mtt -61.0 -42.29 98.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.327 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.23 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.479 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.02 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.396 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.14 -43.78 92.52 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -43.55 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.689 0.281 . . . . 1.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.97 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.182 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.479 HG23 ' O ' ' D' ' 77' ' ' ALA . 50.7 t -61.83 -52.31 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.341 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.91 -40.08 72.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.06 -34.94 79.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.456 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' D' ' 86' ' ' THR . 5.2 tt -61.12 -40.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' D' ' 87' ' ' ALA . 97.0 t -50.76 -16.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.611 -0.436 . . . . 1.0 109.887 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' D' ' 84' ' ' LEU . 23.7 m -42.42 -22.49 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.81 -52.97 61.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.36 -31.05 71.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.88 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.627 ' HB3' HG21 ' A' ' 86' ' ' THR . 16.0 mt -66.93 -40.97 87.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.433 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.74 -43.07 94.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.032 0.444 . . . . 1.0 110.787 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -4.28 42.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.202 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -56.93 -49.27 76.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.906 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 31.5 p90 -79.5 -42.96 24.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.172 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.527 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 60.9 t -40.44 -27.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.366 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' D' ' 93' ' ' PHE . 94.8 mtt-85 -62.78 -36.46 83.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.766 0.317 . . . . 1.0 111.105 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -47.68 -32.03 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.457 . . . . 1.0 110.285 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 45.5 tp10 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.761 -179.937 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.836 0.351 . . . . 1.0 110.519 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -173.02 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -77.84 -16.87 57.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.453 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.397 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -63.47 -37.93 89.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.299 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.62 -38.16 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.53 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.92 72.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.792 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -67.67 -35.35 78.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.57 -36.63 81.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.25 76.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.892 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.61 -37.21 83.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.552 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.79 -36.44 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -65.43 -34.47 78.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.422 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.49 -41.23 98.65 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.593 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.04 -38.83 90.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.146 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -40.57 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.5 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.2 mt -60.57 -40.96 93.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.076 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.428 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.5 mt-10 -60.58 -45.11 95.15 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.086 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.72 -37.55 76.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.91 89.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -59.77 -43.02 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 14.6 tmtt? -65.09 -36.25 83.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.833 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -76.55 -37.51 56.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.635 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.08 93.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 24' ' ' LYS . 9.1 m -61.24 -43.56 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.144 -0.622 . . . . 1.0 110.24 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -75.67 -43.25 48.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.536 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.09 -45.74 90.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.491 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.25 -44.13 92.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -71.36 133.65 46.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.58 -17.49 46.29 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.55 159.94 76.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.37 116.71 4.59 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.819 1.679 . . . . 1.0 111.924 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 82.87 -23.77 5.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . 32.69 -152.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.769 0.319 . . . . 1.0 111.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.64 -53.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.363 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.0 tp -66.22 -69.02 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.574 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 pt 36.48 25.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.103 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 38' ' ' LEU . 42.0 t -132.14 129.16 39.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.882 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 26.8 t80 -80.7 -49.05 1.13 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.982 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.36 -31.08 92.3 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.107 1.205 . . . . 1.0 112.569 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -91.17 -6.05 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.604 0.24 . . . . 1.0 111.009 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.91 95.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.916 0.389 . . . . 1.0 110.331 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 45' ' ' ILE . 7.6 tt -66.21 -40.22 86.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.155 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.59 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.96 -47.11 86.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.381 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.448 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 22.9 t90 -59.02 -39.95 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.46 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 t -76.59 66.84 2.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.698 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 48' ' ' SER . 58.3 t -156.24 -55.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.93 0.395 . . . . 1.0 110.201 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' A' ' 59' ' ' ASP . 15.3 pt-20 -64.4 -32.78 74.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.414 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -61.68 -45.95 91.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.034 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.66 -26.87 64.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.354 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -92.9 2.79 56.6 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 p 47.0 76.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 57' ' ' TYR . 32.6 t -129.07 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.7 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 97.14 -56.63 1.25 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' B' ' 61' ' ' TYR . 2.3 m-85 44.12 -89.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.883 0.373 . . . . 1.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . -166.78 -87.61 0.07 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' A' ' 50' ' ' GLU . 2.0 p-10 39.41 -105.39 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.857 0.36 . . . . 1.0 110.626 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.728 HH21 HH22 ' B' ' 68' ' ' ARG . 0.8 OUTLIER -116.96 -175.21 2.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.65 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.32 134.23 1.09 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.44 156.78 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.949 1.766 . . . . 1.0 112.454 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.454 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.5 t -98.46 -124.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.827 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.44 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 85.3 m -115.4 -40.75 3.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.592 0.235 . . . . 1.0 111.154 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.2 tt0 -67.45 -36.28 80.89 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 1.0 110.881 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.53 28.27 0.02 OUTLIER 'General case' 0 C--O 1.26 1.623 0 CA-C-O 123.289 1.519 . . . . 1.0 110.182 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.73 65.23 1.23 Allowed Glycine 0 C--O 1.212 -1.257 0 CA-C-O 117.567 -1.685 . . . . 1.0 111.437 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' D' ' 59' ' ' ASP . 60.6 ttm-85 -22.62 -35.62 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.431 1.115 . . . . 1.0 111.008 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' A' ' 67' ' ' GLY . 29.7 mmtp -48.4 -18.11 0.2 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.637 -0.711 . . . . 1.0 109.565 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -61.31 -47.97 91.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.371 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 -39.25 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 1.0 110.846 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -54.65 -42.27 71.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.674 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.52 -44.98 92.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.875 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.19 -47.19 91.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.16 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.43 -42.34 98.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.39 -42.18 96.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.346 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.17 93.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.781 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.42 95.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.28 -43.42 98.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.11 -42.09 97.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.45 -50.41 76.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -70.92 -22.41 62.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.066 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 -30.24 22.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.712 0.292 . . . . 1.0 110.781 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.65 -42.87 98.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.739 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.452 ' C ' ' N ' ' A' ' 87' ' ' ALA . 4.0 m -53.81 -16.36 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.189 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -43.16 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.268 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.452 ' N ' ' C ' ' A' ' 85' ' ' VAL . . . -63.05 -50.76 69.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.05 88.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.59 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.8 mm? -65.13 -39.0 92.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -56.4 -47.46 78.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.033 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -3.7 33.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.683 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.497 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 50.2 t0 -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.112 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.9 p90 -78.72 -44.04 24.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.827 0.346 . . . . 1.0 111.485 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 93.1 t -41.05 -25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.383 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 93' ' ' PHE . 11.1 tpt85 -58.82 -33.6 70.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.938 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -61.04 -23.05 65.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.655 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.945 179.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.711 0.291 . . . . 1.0 110.988 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.677 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.8 p80 -79.01 -31.36 44.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.566 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -66.27 -37.73 86.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.931 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -63.15 -40.18 96.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.706 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -65.66 -41.98 91.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.66 92.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.49 -40.56 93.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.11 -38.84 92.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.486 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.69 78.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.996 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.32 -35.68 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.645 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.74 -38.56 91.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 1.0 110.188 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -63.2 -34.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.7 tp -62.99 -37.91 89.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.276 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -65.57 -31.01 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.832 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.81 -47.64 82.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.378 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 18' ' ' VAL . 15.4 m -68.63 -31.38 50.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.089 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.6 mt -61.06 -41.84 97.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.94 -47.58 79.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 1.0 109.834 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -67.46 -34.36 77.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.826 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.12 89.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.139 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -60.76 -35.57 76.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.043 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' B' ' 27' ' ' VAL . 44.9 tptt -65.08 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.623 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -39.92 -28.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.611 0.243 . . . . 1.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 24' ' ' LYS . . . -62.55 -41.06 98.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.405 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' B' ' 24' ' ' LYS . 1.4 p -67.23 -41.5 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.09 0.472 . . . . 1.0 110.46 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 74.4 mm-40 -70.95 -40.3 72.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.594 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' B' ' 66' ' ' GLU . . . -71.96 58.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.906 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' B' ' 32' ' ' GLY . 0.0 OUTLIER 170.78 -16.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.004 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -68.11 56.38 0.07 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.442 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 130.8 31.28 0.55 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.734 -0.547 . . . . 1.0 111.734 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 149.56 38.04 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.72 134.38 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.902 1.735 . . . . 1.0 112.061 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.28 25.61 73.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.255 -0.738 . . . . 1.0 111.255 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.31 140.72 57.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.35 -31.34 8.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' B' ' 30' ' ' GLU . 40.1 tp -101.56 112.75 25.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.247 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.421 ' O ' ' OG ' ' B' ' 40' ' ' SER . 5.9 pt -145.11 84.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.29 -0.414 . . . . 1.0 109.89 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 62.9 m -168.73 -117.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.081 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.4 m-85 -176.09 -64.17 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.084 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -59.03 -29.33 90.35 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.147 1.898 . . . . 1.0 112.216 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.06 -8.2 58.78 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.09 86.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.0 110.396 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.423 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.5 tt -66.86 -38.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.696 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -47.51 85.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.27 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.422 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.6 t90 -63.27 -42.54 99.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 1.0 110.395 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.425 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.4 m -57.39 -39.88 77.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.119 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.65 -48.15 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.833 0.309 . . . . 1.0 111.833 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.421 ' OE1' ' NH1' ' C' ' 68' ' ' ARG . 18.1 pt-20 -76.13 -22.73 55.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.422 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 87.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.41 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.2 -24.51 55.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.286 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.517 HG21 ' OE2' ' C' ' 72' ' ' GLU . 37.9 p -83.76 4.26 29.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 1.0 110.762 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p 54.28 7.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' B' ' 53' ' ' THR . 53.8 t -62.99 -47.09 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.48 68.09 0.48 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' C' ' 60' ' ' ARG . 9.9 t80 -59.8 -46.38 89.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.678 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.66 -11.06 0.96 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.504 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 84.9 m-20 -41.63 -83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.834 0.35 . . . . 1.0 110.866 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -119.83 151.8 38.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.889 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 47.8 t80 -160.8 125.79 2.17 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.11 159.23 53.88 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.533 1.489 . . . . 1.0 112.531 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.69 -166.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.887 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.59 HG22 ' CD1' ' A' ' 46' ' ' TRP . 9.0 p -56.13 -69.45 0.15 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.522 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -47.37 -17.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 64' ' ' THR . 67.5 mt-10 -98.0 28.14 4.14 Favored 'General case' 0 C--O 1.266 1.932 0 CA-C-O 124.303 2.002 . . . . 1.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.732 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.59 62.76 1.31 Allowed Glycine 0 C--O 1.212 -1.235 0 CA-C-N 113.147 -1.842 . . . . 1.0 111.305 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.728 HH22 HH21 ' A' ' 60' ' ' ARG . 43.0 ttm180 -24.89 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.0 0.9 . . . . 1.0 111.414 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' B' ' 67' ' ' GLY . 14.7 mptt -53.19 -14.75 0.72 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' B' ' 67' ' ' GLY . 42.4 t -61.08 -45.5 98.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 119.695 -0.802 . . . . 1.0 109.698 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.0 28.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.302 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -60.48 -40.08 89.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.31 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -61.1 -46.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.48 -44.77 86.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.337 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 75.6 mtm -61.58 -41.79 97.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.614 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.86 -40.98 99.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.233 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -67.83 -41.68 87.99 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.68 -0.568 . . . . 1.0 111.68 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.88 -43.37 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.116 -0.233 . . . . 1.0 110.792 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.82 -41.32 91.01 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.231 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.67 -50.29 76.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.383 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -66.35 -36.81 83.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.579 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.1 -37.53 87.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.611 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.486 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.1 tt -62.64 -40.86 98.34 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.451 ' O ' HG12 ' B' ' 85' ' ' VAL . 85.4 t -49.4 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.513 ' O ' ' N ' ' B' ' 89' ' ' LEU . 73.6 m -58.2 -41.59 84.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -42.93 -19.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.581 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -103.19 -28.51 11.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.125 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' THR . 89.3 mt -69.41 -44.74 70.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.027 0.441 . . . . 1.0 111.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.565 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.1 -9.05 9.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.435 0.636 . . . . 1.0 109.817 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.9 OUTLIER -101.73 -5.13 25.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.081 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.445 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 96.0 m-20 -61.36 -46.95 88.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.011 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 47.8 p90 -79.29 -33.81 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.7 t -50.31 -31.71 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.335 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -64.23 -21.93 66.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.305 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.439 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 23.9 ptt-85 -51.16 -42.35 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 1.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.439 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 96.3 mt-10 . . . . . 0 C--N 1.331 -0.21 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.234 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 . . . . . 0 CA--C 1.528 0.098 0 CA-C-O 120.858 0.361 . . . . 1.0 110.691 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.711 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.8 p80 -59.25 -41.63 89.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.804 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' C' ' 95' ' ' ARG . 97.4 mt-10 -64.43 -42.42 96.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -65.21 -39.25 92.55 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.94 -39.18 87.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.155 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' C' ' 11' ' ' ALA . . . -64.47 -37.41 87.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.404 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' C' ' 12' ' ' GLU . 56.5 tt0 -60.0 -42.5 94.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 1.0 110.469 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.67 -28.79 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.437 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' C' ' 8' ' ' ALA . . . -54.17 -45.42 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.324 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' C' ' 8' ' ' ALA . 57.3 mp0 -67.0 -41.22 87.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 1.0 110.96 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.4 -38.18 88.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 1.0 110.43 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -64.98 -31.17 72.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.305 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.99 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.3 tp -62.19 -39.12 91.67 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.441 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.7 -29.81 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.215 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -77.86 -45.19 24.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . 0.484 HG23 ' N ' ' C' ' 19' ' ' LEU . 28.1 m -60.72 -46.56 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.359 0.503 . . . . 1.0 112.359 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.484 ' N ' HG23 ' C' ' 18' ' ' VAL . 3.1 pp -74.95 -26.8 59.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.742 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -63.8 -53.93 43.08 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.922 0.392 . . . . 1.0 110.032 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.92 -36.34 83.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' C' ' 74' ' ' VAL . . . -66.72 -35.43 80.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.5 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 38.6 m -53.1 -44.43 67.61 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.284 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.21 -44.87 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 1.0 109.58 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -63.22 -39.28 94.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.792 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.38 64.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.146 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.406 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.1 p -64.44 -44.91 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.194 0.521 . . . . 1.0 110.363 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.406 ' N ' HG13 ' C' ' 27' ' ' VAL . 41.0 tp10 -66.19 -35.84 81.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.816 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.34 99.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.326 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -90.23 -11.17 41.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.681 -0.236 . . . . 1.0 111.249 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -58.34 96.9 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.604 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.24 5.16 46.74 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.55 151.4 68.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.91 139.73 22.31 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.977 1.785 . . . . 1.0 112.189 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.55 25.54 63.33 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.241 -0.744 . . . . 1.0 111.241 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 140.95 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 -38.52 5.37 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.541 HD23 ' O ' ' C' ' 38' ' ' LEU . 5.7 tt -88.74 68.48 8.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.037 0.446 . . . . 1.0 109.944 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -92.11 -5.36 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.332 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.1 m -75.48 150.98 38.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.53 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 1.1 t80 -100.83 -61.95 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.98 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.6 Cg_endo -59.0 -30.07 92.39 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.782 1.654 . . . . 1.0 112.249 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.87 -2.17 57.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.054 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.51 85.3 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.392 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.43 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.6 tt -66.66 -39.36 83.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.925 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -49.49 75.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.41 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' C' ' 50' ' ' GLU . 3.5 t90 -64.38 -38.79 92.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 25.2 p -63.2 -36.54 83.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.34 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.2 t -62.39 -48.86 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 121.101 -0.24 . . . . 1.0 111.59 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' C' ' 47' ' ' TRP . 2.6 pp20? -71.08 -29.76 65.71 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.77 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.441 ' N ' ' CD ' ' C' ' 50' ' ' GLU . 69.3 m -62.36 -46.52 88.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.315 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.99 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -62.1 -23.69 66.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.809 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.604 ' OG1' HG23 ' C' ' 55' ' ' VAL . 81.1 p -90.64 3.31 54.52 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.4 p 55.5 15.55 1.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.92 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.605 HG21 ' SD ' ' D' ' 75' ' ' MET . 72.3 t -63.68 -45.65 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.677 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.35 61.86 1.69 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -45.12 95.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.664 0.269 . . . . 1.0 110.825 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.35 13.97 1.1 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.41 -50.58 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 1.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CE1' ' B' ' 57' ' ' TYR . 96.1 mtt-85 -145.91 167.19 23.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.572 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -143.7 123.03 7.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 158.65 54.36 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.798 1.665 . . . . 1.0 112.184 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.2 m -98.09 -165.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.021 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -94.03 -32.07 13.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 1.0 110.168 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' C' ' 67' ' ' GLY . 10.4 tm-20 -64.05 -32.98 74.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.047 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -75.67 28.81 0.11 Allowed 'General case' 0 C--O 1.264 1.83 0 CA-C-O 124.378 2.037 . . . . 1.0 110.008 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.33 65.78 1.77 Allowed Glycine 0 C--O 1.216 -0.976 0 CA-C-N 113.516 -1.674 . . . . 1.0 111.167 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 ttm-85 -24.92 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.148 0.974 . . . . 1.0 111.392 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' C' ' 67' ' ' GLY . 71.8 mmtt -50.08 -31.64 13.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.476 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.8 t -64.14 -49.14 82.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 119.139 -1.024 . . . . 1.0 110.6 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.25 73.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.866 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . 0.517 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.0 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.943 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.85 -43.47 85.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.954 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' C' ' 22' ' ' ALA . 70.6 t -64.18 -43.29 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.634 -0.426 . . . . 1.0 111.165 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 39.6 mtt -55.77 -45.31 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.002 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -40.83 95.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.19 86.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 1.0 110.235 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.05 -42.65 92.13 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.78 -42.77 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.71 0.29 . . . . 1.0 110.985 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' C' ' 84' ' ' LEU . 80.9 mm-40 -58.39 -41.29 84.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.244 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -49.35 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.309 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -64.93 -35.38 80.98 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.881 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.63 -28.49 30.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.751 0.31 . . . . 1.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.8 tt -63.5 -42.94 98.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.488 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.47 2.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.527 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' C' ' 84' ' ' LEU . 23.9 m -62.93 -20.65 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' C' ' 91' ' ' THR . . . -56.72 -61.06 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.39 94.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.012 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.62 -43.64 96.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.464 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.19 -23.6 66.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.401 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.529 ' OG1' ' CG ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -96.44 -3.86 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.3 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 47.2 t0 -60.42 -43.35 96.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.097 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -67.46 -30.1 69.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.03 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.93 -44.26 94.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.407 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' C' ' 5' ' ' GLU . 95.2 mtt-85 -48.04 -21.75 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.224 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.2 ptt85 -50.85 -41.28 57.77 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.39 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . 0.403 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 21.1 pt-20 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.021 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.706 0.289 . . . . 1.0 110.539 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -172.74 -64.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.82 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.621 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 3.2 p80 -59.2 -39.52 82.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.11 -39.09 93.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.43 -43.17 99.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.482 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.23 -38.3 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.297 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.799 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.52 -42.11 98.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.48 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.29 -39.07 93.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.26 81.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.116 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.97 -39.12 93.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.794 0.33 . . . . 1.0 110.791 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.36 -33.81 76.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.67 -34.84 79.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.9 tp -62.09 -42.52 99.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 1.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -64.29 -35.88 82.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.115 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -61.74 -41.83 98.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 1.0 110.99 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.61 -39.0 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.532 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.8 mt -60.16 -40.76 91.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' D' ' 23' ' ' SER . 98.5 mt-10 -61.8 -44.95 95.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 1.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.63 -34.84 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.997 0.427 . . . . 1.0 110.02 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.54 87.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.03 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -59.57 -45.07 92.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.876 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -64.11 -54.97 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.256 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.58 -40.79 96.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.743 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.13 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.834 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 72.4 t -62.36 -46.71 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.65 -41.94 83.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.47 97.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -69.35 -39.68 77.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.794 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -63.32 119.21 9.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.11 49.9 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.42 146.02 30.76 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.749 -0.265 . . . . 1.0 110.519 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' D' ' 63' ' ' VAL . 94.0 Cg_endo -74.76 144.14 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.143 1.895 . . . . 1.0 112.377 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.1 71.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.46 138.6 57.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.0 110.614 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.77 -36.44 4.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.473 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -99.28 108.23 20.72 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 pt -150.94 60.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -157.81 124.44 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.535 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 34.3 m-85 -53.1 -49.87 85.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.239 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.07 -34.99 99.07 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.1 1.2 . . . . 1.0 112.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -93.4 -8.18 42.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.716 0.293 . . . . 1.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . 0.416 ' HB2' ' CG2' ' D' ' 27' ' ' VAL . . . -65.88 -45.38 82.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 1.0 110.876 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -68.17 -39.68 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.603 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -47.82 83.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.11 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.415 ' O ' ' N ' ' D' ' 49' ' ' VAL . 6.4 t90 -62.15 -40.21 95.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' D' ' 19' ' ' LEU . 22.7 p -69.65 61.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' D' ' 47' ' ' TRP . 76.8 t -149.01 -57.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.194 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -65.72 -27.08 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.168 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.445 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -61.17 -47.49 85.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.201 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.45 -36.93 69.6 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.298 -0.561 . . . . 1.0 109.671 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.457 ' OG1' HG12 ' D' ' 55' ' ' VAL . 49.4 p -78.75 -12.68 60.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.472 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 6.1 p 60.47 10.4 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.069 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.517 HG13 ' N ' ' D' ' 56' ' ' GLY . 12.0 p -67.24 -43.43 88.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.517 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 57.3 72.61 0.56 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.448 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.3 OUTLIER -60.24 -46.94 88.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 1.0 110.465 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.0 10.62 1.51 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 68' ' ' ARG . 53.8 m-20 -58.06 -50.86 71.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -151.02 -166.11 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.7 p90 -172.07 133.44 0.78 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.831 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.48 157.74 58.11 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.999 1.8 . . . . 1.0 112.428 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.566 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -89.79 -143.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.924 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.566 ' H ' HG12 ' D' ' 63' ' ' VAL . 94.8 m -112.09 -41.68 3.91 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.744 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.1 -19.68 65.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.9 0.381 . . . . 1.0 110.448 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.1 OUTLIER -77.86 23.67 0.25 Allowed 'General case' 0 C--O 1.266 1.973 0 CA-C-O 123.842 1.782 . . . . 1.0 108.956 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.741 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.85 61.55 3.81 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' D' ' 67' ' ' GLY . 58.0 ttm-85 -26.94 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.761 0.781 . . . . 1.0 111.214 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.9 tptm -55.85 -27.34 51.17 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.107 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.4 t -61.07 -49.42 84.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 119.649 -0.82 . . . . 1.0 109.942 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.65 -37.05 73.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.179 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.57 -43.83 89.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -61.39 -40.75 95.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.213 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.09 -43.9 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.609 -0.436 . . . . 1.0 111.196 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.605 ' SD ' HG21 ' C' ' 55' ' ' VAL . 36.9 mtt -60.26 -44.34 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.902 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -65.98 -36.77 84.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.43 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -59.92 -40.28 88.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.586 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.62 -42.76 95.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.479 -0.648 . . . . 1.0 111.479 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.64 -43.46 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.021 -0.272 . . . . 1.0 111.092 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.18 -41.53 97.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.285 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 77' ' ' ALA . 61.5 t -63.21 -50.25 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 1.0 111.373 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.9 -40.26 83.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.756 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.16 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.371 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.73 -41.18 97.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.268 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.2 -17.82 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.695 -0.402 . . . . 1.0 109.919 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 56.7 m -47.46 -40.09 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.224 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -53.08 -17.29 1.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.671 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.62 20.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.563 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.51 HD13 ' OD2' ' D' ' 92' ' ' ASP . 3.7 mm? -92.53 -40.8 10.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.008 0.432 . . . . 1.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.535 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -57.14 -28.2 62.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.618 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.34 -4.36 55.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.51 ' OD2' HD13 ' D' ' 89' ' ' LEU . 89.2 m-20 -59.5 -49.92 75.92 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.145 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 21.3 p90 -73.47 -38.72 65.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.987 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.3 t -47.92 -27.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.161 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' D' ' 97' ' ' GLU . 94.5 mtt180 -64.73 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -54.31 -7.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . 0.472 ' H ' ' C ' ' D' ' 95' ' ' ARG . 24.1 tp10 . . . . . 0 N--CA 1.465 0.319 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.831 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.49 ' CB ' ' NE2' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.86 0.362 . . . . 1.0 110.638 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 11.6 p-10 -65.14 -36.64 84.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.7 ' CD2' HH12 ' D' ' 96' ' ' ARG . 6.4 p80 -75.14 -34.2 61.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.643 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 95' ' ' ARG . 96.2 mt-10 -63.54 -38.4 91.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.528 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.66 -39.71 94.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -50.87 -44.99 59.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.3 88.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.262 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.82 -45.2 90.64 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.89 -35.85 82.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.048 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -48.33 68.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.784 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.65 -42.64 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -64.03 -33.91 76.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.158 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.81 -34.92 78.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.389 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' A' ' 78' ' ' GLY . 44.8 tp -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.773 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -55.29 -40.15 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.205 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -64.37 -31.62 72.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.787 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.38 -41.98 86.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 1.0 110.683 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.2 mp -60.57 -40.64 92.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.784 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -55.96 -49.67 72.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.917 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.49 -37.14 82.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.994 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.24 86.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.634 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' VAL . 15.8 m -59.97 -40.96 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.37 -61.45 2.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.376 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.4 -44.21 95.92 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.909 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.93 -45.76 74.87 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.37 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' SER . 92.3 t -62.55 -46.49 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.25 -41.89 72.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.019 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.15 -41.12 48.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.802 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.66 -44.87 69.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.115 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -51.81 99.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.396 . . . . 1.0 110.651 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.4 -11.89 12.57 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 111.446 -0.661 . . . . 1.0 111.446 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.49 140.26 33.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 122.705 -0.291 . . . . 1.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' O ' HG11 ' A' ' 63' ' ' VAL . 94.5 Cg_endo -75.27 144.18 29.09 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.015 1.81 . . . . 1.0 112.478 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.16 27.09 68.45 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.32 140.77 58.72 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.421 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.94 -30.73 4.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -87.24 122.59 31.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' SER . 41.0 pt -153.41 163.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 79.96 134.53 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.79 0.329 . . . . 1.0 110.934 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 32.4 t80 -65.79 -44.73 64.35 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.087 -0.506 . . . . 1.0 112.127 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.3 Cg_endo -60.57 -30.86 91.5 Favored 'Trans proline' 0 N--CA 1.503 2.055 0 C-N-CA 121.562 1.508 . . . . 1.0 112.737 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.29 -27.23 18.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.706 0.288 . . . . 1.0 110.785 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.02 82.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.582 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.423 HG23 ' HE3' ' A' ' 46' ' ' TRP . 7.9 tt -62.84 -38.74 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.564 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.7 OUTLIER -65.96 -38.21 87.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.23 -0.441 . . . . 1.0 109.824 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -62.71 -42.34 99.6 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.247 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.6 p -58.09 -28.38 64.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.9 t -63.76 -45.69 96.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 1.0 110.419 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 77.5 mt-10 -80.26 -0.85 38.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.81 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -35.51 8.07 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 1.0 109.83 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.44 82.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.345 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.92 11.75 17.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' GLY . 5.1 p 64.38 -135.11 0.29 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.411 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' OG1' ' A' ' 54' ' ' THR . 46.1 t 62.73 -61.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.595 0.559 . . . . 1.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 50.36 90.92 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -60.6 -44.13 96.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.726 0.298 . . . . 1.0 110.78 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.79 17.05 0.85 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.64 -51.94 67.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 1.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' ' CZ ' ' D' ' 57' ' ' TYR . 94.8 mtt-85 -145.73 139.84 26.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.949 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 62' ' ' PRO . 77.8 t80 -130.91 127.71 22.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.536 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 60.6 Cg_endo -70.33 159.92 51.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.826 1.684 . . . . 1.0 112.62 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' THR . 2.1 t -83.68 -138.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.501 ' H ' HG12 ' A' ' 63' ' ' VAL . 51.6 m -114.72 -37.95 4.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.677 0.275 . . . . 1.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.634 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.9 tp10 -64.59 -31.21 72.33 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -70.79 30.54 0.04 OUTLIER 'General case' 0 C--O 1.263 1.786 0 CA-C-O 123.594 1.664 . . . . 1.0 109.952 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.77 64.35 1.25 Allowed Glycine 0 C--O 1.213 -1.196 0 CA-C-N 113.797 -1.547 . . . . 1.0 111.317 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.549 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 43.0 ttm180 -24.0 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.114 0.957 . . . . 1.0 111.108 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -48.86 -18.28 0.26 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.752 -0.658 . . . . 1.0 109.442 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.3 t -61.63 -47.83 91.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 119.494 -0.882 . . . . 1.0 110.131 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.19 64.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.631 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -58.92 -41.66 87.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.716 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.84 -42.03 96.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.051 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.93 -44.47 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.782 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.2 mtt -54.93 -43.91 73.77 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.748 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.08 -40.67 96.61 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.356 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.03 -41.64 98.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -67.77 -44.06 81.85 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.56 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 1.0 110.717 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.37 -40.46 96.52 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.678 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 77' ' ' ALA . 56.0 t -63.95 -50.06 78.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0 110.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' B' ' 79' ' ' ILE . 46.9 m-85 -68.33 -25.3 65.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.052 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.77 -23.51 21.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.667 0.27 . . . . 1.0 110.751 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -65.46 -35.44 80.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.2 m -43.17 -19.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.794 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' LEU . 24.9 m -40.92 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.963 0.411 . . . . 1.0 110.122 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.39 -46.68 89.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.436 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 -27.49 10.16 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.744 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' B' ' 86' ' ' THR . 44.6 tp -65.6 -37.56 86.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.627 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -70.9 -67.91 0.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 1.0 110.798 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -47.84 -8.51 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.042 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 90' ' ' ALA . 51.0 t0 -46.99 -38.73 11.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.848 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 10.1 p90 -79.45 -28.88 41.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.388 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.88 -26.15 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.427 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 96.4 mtt180 -60.1 -31.66 70.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.517 -0.311 . . . . 1.0 111.308 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' NH2' HG11 ' B' ' 94' ' ' VAL . 24.4 ptt180 -58.15 -42.32 85.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.369 . . . . 1.0 110.617 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 97.4 mt-10 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.473 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.724 0.297 . . . . 1.0 110.871 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -80.4 -34.99 35.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.504 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.48 -39.24 85.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.27 -43.49 98.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.757 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -65.08 -36.54 84.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.1 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -65.3 -41.62 93.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.464 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.04 -40.7 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.55 92.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.928 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.443 ' OE2' ' CD1' ' B' ' 82' ' ' PHE . 80.3 mm-40 -67.92 -41.6 82.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 1.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -65.05 -37.27 87.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.59 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.416 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.02 -42.96 99.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.455 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -37.58 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.6 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.02 -41.63 96.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.0 -33.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.686 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.665 HD22 ' O ' ' B' ' 48' ' ' SER . 95.3 mt -62.03 -42.1 98.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.572 -0.451 . . . . 1.0 109.922 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.48 -46.18 91.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.856 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.442 ' CG ' ' NZ ' ' B' ' 25' ' ' LYS . 83.7 tt0 -69.28 -38.65 78.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.022 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.47 -38.91 88.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.499 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -60.01 -44.29 94.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.846 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.07 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 1.0 110.258 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.442 ' NZ ' ' CG ' ' B' ' 21' ' ' GLU . 62.3 mttp -75.86 -39.51 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.364 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.97 -49.68 74.97 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.658 -0.246 . . . . 1.0 111.298 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.465 ' O ' ' OE1' ' B' ' 30' ' ' GLU . 3.8 p -63.76 -42.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.279 0.561 . . . . 1.0 110.317 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 78.8 mm-40 -70.35 -20.83 62.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.498 -0.774 . . . . 1.0 110.59 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -60.12 -37.91 81.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' B' ' 27' ' ' VAL . 29.7 mp0 -65.21 -40.23 93.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 1.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -63.16 86.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.58 -10.45 6.79 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 141.88 23.59 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.765 0.283 . . . . 1.0 110.603 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.489 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 98.9 Cg_endo -75.39 144.93 29.57 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.229 1.953 . . . . 1.0 112.38 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.87 36.3 57.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.36 150.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 1.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.12 -45.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.253 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' B' ' 60' ' ' ARG . 33.9 tp -97.02 91.9 5.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.513 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.3 pt -105.21 2.58 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.421 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -99.86 123.54 44.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.119 0.485 . . . . 1.0 110.985 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.523 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.3 t80 -77.22 -54.86 1.44 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.312 -0.858 . . . . 1.0 110.617 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -58.12 -27.0 78.34 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.803 1.669 . . . . 1.0 112.519 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -93.66 -10.25 35.13 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.926 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.08 87.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.885 0.374 . . . . 1.0 110.352 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.408 ' H ' HG22 ' B' ' 45' ' ' ILE . 6.7 tt -63.45 -33.16 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.609 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.85 75.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.707 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.666 ' CB ' ' HE ' ' B' ' 60' ' ' ARG . 1.4 t90 -62.5 -42.94 99.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.474 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.665 ' O ' HD22 ' B' ' 19' ' ' LEU . 11.9 p -45.13 -27.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.85 -25.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.443 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.66 ' CG ' HH21 ' C' ' 68' ' ' ARG . 1.5 tm-20 -66.24 -41.36 90.13 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.737 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.503 ' C ' ' H ' ' B' ' 53' ' ' THR . 8.4 t -82.44 -158.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.229 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 70.79 -38.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.474 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.541 HG21 ' OE2' ' C' ' 72' ' ' GLU . 70.8 p -91.22 6.83 43.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 44.7 p 51.61 66.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.428 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.16 -47.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.598 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.92 67.27 1.5 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.541 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 24.4 t80 -60.92 -49.14 78.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 1.0 110.908 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 160.62 -96.98 0.15 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.7 t0 52.52 -82.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.392 . . . . 1.0 110.602 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.675 ' CZ ' HD22 ' B' ' 38' ' ' LEU . 35.4 ptt85 -127.65 -160.88 1.04 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -163.55 133.32 3.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.965 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.0 179.06 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.628 1.552 . . . . 1.0 112.12 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.545 HG12 ' H ' ' B' ' 64' ' ' THR . 0.8 OUTLIER -91.33 -154.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.242 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.553 ' O ' ' NE1' ' A' ' 46' ' ' TRP . 18.0 m -113.61 -71.83 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.673 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' B' ' 64' ' ' THR . 83.4 tt0 -35.42 -31.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.966 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.907 ' O ' ' N ' ' B' ' 68' ' ' ARG . 95.2 mt-10 -141.98 -108.25 0.14 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.466 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 21.66 -56.04 0.0 OUTLIER Glycine 0 N--CA 1.476 1.345 0 O-C-N 124.492 1.12 . . . . 1.0 114.032 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.907 ' N ' ' O ' ' B' ' 66' ' ' GLU . 14.7 ttm180 -65.85 -48.61 71.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -63.58 -36.31 83.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.096 -1.075 . . . . 1.0 108.096 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.79 -45.35 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.952 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.519 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -65.88 -38.14 87.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -49.0 -45.65 42.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.176 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.36 -38.25 90.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.769 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.68 -45.55 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.552 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 3.6 mpp? -63.85 -40.29 96.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.518 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.33 -40.45 96.41 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.225 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.04 87.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.84 0.352 . . . . 1.0 110.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.77 -38.98 93.48 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.485 -0.646 . . . . 1.0 111.485 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.476 HG22 ' O ' ' B' ' 79' ' ' ILE . 95.8 mt -69.08 -11.8 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.815 -0.226 . . . . 1.0 111.559 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.57 -53.26 3.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.08 0.467 . . . . 1.0 110.931 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.687 HG23 ' H ' ' B' ' 82' ' ' PHE . 17.8 m -60.69 -55.11 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.712 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.687 ' H ' HG23 ' B' ' 81' ' ' VAL . 42.2 m-85 -62.0 -43.79 98.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.887 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.52 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.362 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.5 tt -57.62 -31.78 66.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.485 ' O ' HG12 ' B' ' 85' ' ' VAL . 46.9 t -60.1 -4.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.43 ' H ' ' C ' ' B' ' 84' ' ' LEU . 72.4 m -61.16 -44.86 96.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.574 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -51.37 -29.28 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.725 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.95 -12.69 35.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.739 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.79 -39.88 10.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.403 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.477 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.91 -25.78 57.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.231 0.539 . . . . 1.0 110.15 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -82.06 -6.31 59.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.395 -0.82 . . . . 1.0 109.891 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 96.8 m-20 -58.63 -48.77 79.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.142 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.1 p90 -77.48 -40.07 44.26 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.094 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.526 HG11 ' NH2' ' A' ' 96' ' ' ARG . 58.8 t -44.79 -31.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.586 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.05 -22.22 66.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.057 -0.257 . . . . 1.0 111.478 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.0 ptt85 -54.42 -43.45 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 1.0 110.063 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.461 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 96.4 mt-10 . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.417 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.4 t0 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.872 0.367 . . . . 1.0 110.064 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.585 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 24.8 p80 -67.02 -39.99 87.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.099 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.585 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 48.0 tp10 -65.9 -41.35 91.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.727 0.298 . . . . 1.0 110.577 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -64.78 -37.41 87.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -62.9 -40.92 99.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.128 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.31 98.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.37 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -65.64 -41.92 92.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.481 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.87 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.26 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.62 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.165 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -37.15 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.06 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -64.55 -34.47 78.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.778 0.323 . . . . 1.0 110.438 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -65.78 -35.9 82.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.22 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.706 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.4 -36.26 79.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.334 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.57 -40.23 90.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.775 0.322 . . . . 1.0 110.908 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.73 -35.46 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.522 HD22 ' O ' ' C' ' 48' ' ' SER . 94.0 mt -59.98 -41.57 92.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.709 -0.396 . . . . 1.0 109.958 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 98.4 mt-10 -62.87 -43.34 99.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.92 -36.38 75.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.279 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.64 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.434 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.47 ' O ' HG23 ' C' ' 27' ' ' VAL . 77.8 p -60.76 -43.76 97.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.824 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -60.51 -56.35 22.48 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.95 -44.24 97.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.014 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -57.1 -24.76 56.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.47 HG23 ' O ' ' C' ' 23' ' ' SER . 35.0 t -80.78 -51.77 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.191 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.83 -43.01 69.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.911 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.79 -50.57 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 3.8 mp0 -62.15 -44.92 95.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -68.01 130.32 42.61 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.94 59.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.422 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.24 151.76 41.89 Favored Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.469 ' O ' HG11 ' C' ' 63' ' ' VAL . 89.2 Cg_endo -76.17 123.54 7.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.726 1.617 . . . . 1.0 112.184 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 103.99 -23.12 33.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . 48.35 178.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 1.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.67 -93.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.63 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.43 111.54 22.82 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.839 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' C' ' 40' ' ' SER . 1.4 tp -144.18 101.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.068 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.537 ' O ' ' N ' ' C' ' 44' ' ' ALA . 0.3 OUTLIER 166.67 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.749 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.9 OUTLIER -49.11 -50.48 63.17 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.862 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.8 Cg_endo -58.9 -34.9 99.3 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.383 1.389 . . . . 1.0 112.453 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -98.74 -5.1 32.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.277 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -68.31 -41.55 80.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.809 0.338 . . . . 1.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' C' ' 45' ' ' ILE . 5.9 tt -65.04 -38.9 83.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.617 ' CZ3' ' NZ ' ' D' ' 69' ' ' LYS . 0.3 OUTLIER -58.96 -46.63 87.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.557 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.541 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.9 OUTLIER -68.31 -23.6 64.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.271 -0.571 . . . . 1.0 109.508 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.522 ' O ' HD22 ' C' ' 19' ' ' LEU . 3.4 t -75.09 -35.54 61.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.92 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.52 -44.28 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.944 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.53 -41.84 77.46 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.057 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' C' ' 52' ' ' ALA . 3.6 t -78.69 -176.28 4.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' C' ' 51' ' ' THR . . . 76.3 -12.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.569 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.453 HG21 ' OE2' ' D' ' 72' ' ' GLU . 68.9 p -115.66 14.21 16.41 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.548 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' C' ' 53' ' ' THR . 47.0 p 53.67 69.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.4 -73.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.22 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.81 81.15 0.06 OUTLIER Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.412 ' CB ' ' CD1' ' D' ' 61' ' ' TYR . 45.5 t80 -60.43 -47.66 85.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.821 -0.351 . . . . 1.0 110.789 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.0 30.15 0.54 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 40.6 t0 -61.69 -41.68 97.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 1.0 110.431 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -141.79 -161.32 1.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.895 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 20.5 p90 -171.61 120.29 0.47 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.2 158.32 56.75 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.699 1.599 . . . . 1.0 112.355 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.541 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.06 -142.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.133 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.541 ' H ' HG12 ' C' ' 63' ' ' VAL . 98.4 m -111.77 -47.44 3.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.665 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' C' ' 67' ' ' GLY . 46.3 tp10 -58.71 -25.17 62.63 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.2 OUTLIER -73.01 28.15 0.06 Allowed 'General case' 0 C--O 1.263 1.81 0 CA-C-O 123.52 1.628 . . . . 1.0 110.213 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 41.1 62.72 1.7 Allowed Glycine 0 C--O 1.216 -1.024 0 CA-C-N 113.773 -1.558 . . . . 1.0 110.673 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.66 HH21 ' CG ' ' B' ' 50' ' ' GLU . 46.5 ttt85 -24.21 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.796 0.798 . . . . 1.0 111.58 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.8 mttt -51.65 -16.5 0.65 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.704 -0.68 . . . . 1.0 109.373 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' C' ' 67' ' ' GLY . 65.9 t -62.52 -48.08 89.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 119.324 -0.95 . . . . 1.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.06 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 1.0 110.093 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.8 tp10 -64.79 -39.59 93.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.03 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.65 -42.44 75.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.245 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' C' ' 52' ' ' ALA . 82.5 t -66.0 -41.72 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.844 -0.343 . . . . 1.0 111.545 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.4 mtt -59.46 -44.75 92.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.939 -0.304 . . . . 1.0 111.216 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -63.37 -40.63 97.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.424 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.34 -41.63 89.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.84 0.352 . . . . 1.0 110.496 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -42.39 76.15 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.222 -0.513 . . . . 1.0 111.897 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.19 -43.91 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.641 -0.329 . . . . 1.0 110.752 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.54 -43.25 85.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.303 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 77' ' ' ALA . 59.0 t -64.76 -50.39 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.511 ' O ' HG22 ' C' ' 85' ' ' VAL . 38.0 m-85 -67.63 -40.76 84.59 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.22 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.23 70.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.764 0.316 . . . . 1.0 110.776 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.1 tt -62.74 -42.23 99.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.813 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.511 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.2 m -52.64 -8.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.564 -0.455 . . . . 1.0 110.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.466 ' H ' ' C ' ' C' ' 84' ' ' LEU . 43.8 m -49.43 -23.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 1.0 110.247 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -57.26 -50.58 72.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.045 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.94 85.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.454 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.38 -38.52 90.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.879 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.519 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.32 -44.26 88.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.02 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.71 44.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.233 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.415 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 56.1 t0 -56.0 -49.52 73.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.656 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -72.5 -41.12 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.08 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 93.7 t -45.71 -27.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.68 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -62.41 -22.67 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.605 -0.27 . . . . 1.0 111.414 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -55.23 -33.65 63.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.758 0.314 . . . . 1.0 110.569 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.477 179.824 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 120.937 0.398 . . . . 1.0 110.42 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' D' ' 6' ' ' ARG . 98.7 m-20 -64.48 -40.11 95.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.776 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -72.2 -19.93 61.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.202 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.01 -45.29 77.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 1.0 110.519 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . 0.463 ' NH2' ' OD1' ' D' ' 3' ' ' ASP . 95.4 mtm-85 -65.39 -36.72 84.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.66 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -61.02 -42.72 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.086 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.23 86.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.24 -42.29 99.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.94 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.75 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.486 ' HB1' HG13 ' D' ' 81' ' ' VAL . . . -58.25 -38.56 77.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.905 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.8 -42.6 90.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.735 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.64 -38.91 90.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.595 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.96 -33.58 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.4 tp -62.82 -38.54 91.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 1.0 110.075 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.59 -28.41 67.74 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -65.0 -40.15 94.51 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.824 0.345 . . . . 1.0 111.534 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.68 -31.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.429 HD22 ' O ' ' D' ' 48' ' ' SER . 29.4 mt -61.15 -44.16 97.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.412 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' D' ' 23' ' ' SER . 12.0 pt-20 -67.87 -35.33 78.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.001 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -66.49 -36.65 83.26 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.802 -0.359 . . . . 1.0 110.344 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.76 -40.32 96.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.091 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.662 ' O ' HG23 ' D' ' 27' ' ' VAL . 78.0 p -58.45 -45.69 88.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.203 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.89 -63.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -58.57 -37.57 76.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -59.8 -42.31 93.16 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.705 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 23' ' ' SER . 72.0 t -64.16 -48.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.443 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.92 -42.58 69.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.777 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.688 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.529 ' OE1' HG22 ' D' ' 39' ' ' ILE . 8.8 tm-20 -69.91 -35.41 74.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.383 . . . . 1.0 111.002 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -54.07 101.84 0.05 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.912 0.387 . . . . 1.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.69 21.34 10.5 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.617 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.49 ' CB ' ' OE2' ' D' ' 66' ' ' GLU . . . -105.33 145.1 30.14 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 122.918 -0.166 . . . . 1.0 110.711 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.86 139.36 24.58 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.037 1.824 . . . . 1.0 112.03 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 63.98 17.25 60.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . -46.83 176.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.932 0.396 . . . . 1.0 110.958 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' D' ' 38' ' ' LEU . . . -166.95 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.751 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' D' ' 30' ' ' GLU . 58.5 tp -123.04 108.74 13.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.821 0.343 . . . . 1.0 110.109 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.529 HG22 ' OE1' ' D' ' 30' ' ' GLU . 14.2 pt -136.8 159.95 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' D' ' 43' ' ' ASP . 0.5 OUTLIER 81.33 139.23 0.07 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.697 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.3 OUTLIER -77.77 -38.61 1.76 Allowed Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.695 178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.63 -32.82 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.308 1.338 . . . . 1.0 112.197 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' D' ' 40' ' ' SER . 29.6 p-10 -96.94 -6.21 36.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.578 0.228 . . . . 1.0 110.876 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.39 -40.14 67.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.948 0.404 . . . . 1.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 tt -63.91 -40.17 88.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.417 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.487 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -58.49 -45.82 87.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -63.12 -39.24 94.1 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.724 -0.472 . . . . 1.0 109.724 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.429 ' O ' HD22 ' D' ' 19' ' ' LEU . 4.8 t -58.81 -41.57 87.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.127 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.408 ' O ' HG12 ' D' ' 49' ' ' VAL . 41.8 t -76.6 68.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.009 0.433 . . . . 1.0 111.699 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -173.58 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.733 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -64.68 -43.44 93.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . -56.49 -28.69 60.48 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -84.73 -1.82 56.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.317 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p 50.95 58.86 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.025 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.584 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.2 p -128.28 -46.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.587 -0.278 . . . . 1.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.584 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 41.26 76.58 0.09 OUTLIER Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.511 ' CZ ' ' O ' ' A' ' 60' ' ' ARG . 15.1 t80 -60.94 -46.42 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.0 110.416 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.72 36.08 0.08 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 21.6 t0 -83.86 -77.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 1.0 110.69 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -130.39 147.84 52.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.412 ' CD1' ' CB ' ' C' ' 57' ' ' TYR . 46.2 t80 -149.0 135.83 10.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.33 149.23 69.41 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.011 1.807 . . . . 1.0 112.318 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.441 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 3.3 t -80.41 -125.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.009 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.415 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 76.1 m -113.7 -36.41 4.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.839 0.352 . . . . 1.0 110.888 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.7 tt0 -67.4 -30.35 70.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.2 pm0 -79.36 34.53 0.26 Allowed 'General case' 0 C--O 1.265 1.891 0 CA-C-O 123.224 1.488 . . . . 1.0 108.845 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.43 61.19 1.29 Allowed Glycine 0 C--O 1.212 -1.262 0 CA-C-N 113.767 -1.561 . . . . 1.0 109.916 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 40.0 ttm180 -24.37 -31.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.533 0.784 . . . . 1.0 111.086 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.4 mttp -54.12 -13.67 0.89 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.308 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.4 t -61.32 -47.74 92.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 119.52 -0.872 . . . . 1.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.87 80.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.96 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' C' ' 53' ' ' THR . 35.8 tp10 -57.31 -39.37 75.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.232 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -66.58 -40.47 88.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 -47.52 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.539 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.64 -40.84 96.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 1.0 111.161 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -61.51 -42.54 98.96 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.744 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.96 88.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.432 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.29 -40.43 96.57 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.53 -43.61 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.712 0.291 . . . . 1.0 111.172 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.38 -35.2 79.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.01 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.486 HG13 ' HB1' ' D' ' 11' ' ' ALA . 43.1 t -67.28 -56.12 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.519 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -62.07 -43.22 99.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.836 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.23 -37.51 87.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.292 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.2 -42.19 99.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' D' ' 87' ' ' ALA . 89.7 t -58.11 -18.34 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 75.6 m -43.96 -20.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.467 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.22 -61.01 2.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.909 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.99 61.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.254 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 2.7 mm? -78.08 -38.04 45.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.24 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.9 -35.85 71.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.31 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -4.2 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.907 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' D' ' 89' ' ' LEU . 66.6 t0 -56.66 -44.37 81.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.836 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 12.3 p90 -74.97 -42.98 56.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.923 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 88.7 t -44.17 -26.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.358 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -57.49 -25.32 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.075 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . 0.7 HH12 ' CD2' ' A' ' 4' ' ' HIS . 7.2 ptp180 -59.2 -34.8 72.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 1.0 110.358 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.057 179.834 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.906 0.384 . . . . 1.0 110.375 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -174.25 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.626 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.0 p80 -73.47 -31.07 63.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.08 -39.46 93.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -61.38 -42.09 98.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -64.0 -39.64 94.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.144 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -38.75 92.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.213 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -64.36 -41.56 96.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -63.39 -39.31 94.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.73 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HB1' HG13 ' A' ' 81' ' ' VAL . . . -59.23 -39.71 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.842 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.24 -44.23 88.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 1.0 110.635 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.72 -33.87 76.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.311 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.74 -35.16 79.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.449 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.0 tp -61.86 -42.57 99.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.392 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.24 -34.9 72.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.979 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.51 -40.76 97.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.09 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.42 -29.0 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 48' ' ' SER . 96.4 mt -62.76 -41.97 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.46 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.06 -39.8 78.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.329 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.27 93.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.029 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.5 p -60.76 -42.28 97.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 1.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.59 -30.34 71.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.926 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.9 -46.59 18.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.302 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.03 88.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.7 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 28' ' ' GLU . 11.8 m -56.71 -54.35 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.39 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.573 ' H ' HG23 ' A' ' 27' ' ' VAL . 88.2 mt-10 -67.93 -42.19 81.4 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.839 0.352 . . . . 1.0 110.701 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.32 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.063 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -98.05 14.86 25.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.557 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt85 -80.64 99.28 8.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.0 110.351 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.45 6.42 87.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.646 -0.581 . . . . 1.0 111.646 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 149.36 95.6 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.26 141.49 25.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.926 1.751 . . . . 1.0 112.245 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.05 -6.8 8.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.84 155.41 31.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.839 0.352 . . . . 1.0 110.48 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.18 10.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' SER . 6.8 tt -82.96 -10.73 58.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.476 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' LEU . 4.8 pt -37.35 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.631 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.4 m 169.21 134.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.916 -0.583 . . . . 1.0 109.888 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 55.9 m-85 -82.56 -48.33 0.86 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.448 0.536 . . . . 1.0 112.448 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.0 Cg_endo -60.56 -31.68 92.59 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 121.634 1.556 . . . . 1.0 112.657 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -91.2 -6.03 54.03 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.913 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.551 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.0 -41.0 88.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.093 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.99 96.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -62.4 -40.38 96.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.53 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.1 p -58.83 -31.9 68.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.718 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG1' ' OE1' ' B' ' 72' ' ' GLU . 94.9 t -71.59 -44.24 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.255 0.55 . . . . 1.0 110.636 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 45.7 tp10 -52.15 -42.68 63.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.376 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' THR . 4.6 t -80.78 -158.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' THR . . . 71.31 -35.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 1.0 110.141 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' THR . 62.0 p -81.31 5.43 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 p 58.17 26.7 14.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.127 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -146.95 82.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.782 0.325 . . . . 1.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 112.1 3.39 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.4 -46.05 91.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.53 27.41 0.39 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 48.7 m-20 -62.34 -42.11 99.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 1.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 38.8 mmt180 -130.87 -169.07 2.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.15 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 96.4 m-85 -159.61 91.58 1.84 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.89 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.34 157.59 60.65 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.787 1.658 . . . . 1.0 112.271 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.026 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -116.76 -165.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.987 0.423 . . . . 1.0 110.344 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 63' ' ' VAL . 61.2 m -78.66 -42.8 27.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.3 tp10 -50.74 -47.23 59.39 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -74.49 29.78 0.08 Allowed 'General case' 0 C--O 1.26 1.638 0 CA-C-O 124.212 1.958 . . . . 1.0 109.568 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.46 66.64 1.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 113.838 -1.528 . . . . 1.0 111.863 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH1' ' OE1' ' D' ' 50' ' ' GLU . 58.2 ttm-85 -24.11 -34.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.029 0.915 . . . . 1.0 110.808 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.9 mttp -47.63 -20.53 0.27 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' GLY . 57.1 t -61.29 -48.18 90.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 119.652 -0.819 . . . . 1.0 110.453 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.46 -41.73 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.673 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -59.67 -42.52 93.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.698 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.03 -41.55 83.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.821 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.1 t -65.65 -42.79 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.572 -0.451 . . . . 1.0 111.14 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.409 ' CE ' ' OH ' ' D' ' 57' ' ' TYR . 65.2 mtt -57.36 -45.33 84.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.904 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -63.59 -41.81 98.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.02 -40.6 85.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.647 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -68.24 -42.55 83.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.56 -43.92 95.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 1.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.22 -40.2 93.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.124 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.404 HG13 ' HB1' ' A' ' 11' ' ' ALA . 52.1 t -65.75 -49.74 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.07 -39.14 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.243 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.06 92.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.877 0.37 . . . . 1.0 110.998 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' C ' ' N ' ' A' ' 86' ' ' THR . 7.5 tt -62.98 -41.38 99.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.302 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 85' ' ' VAL . 81.3 t -47.4 -13.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.348 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 84' ' ' LEU . 76.8 m -58.07 -42.18 84.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.89 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -40.27 -33.77 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.561 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.61 19.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.684 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 86' ' ' THR . 52.2 mt -66.4 -38.77 88.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.53 -47.83 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.155 0.502 . . . . 1.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -4.14 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.449 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.64 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 39.6 t0 -58.41 -49.39 77.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.015 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.5 p90 -76.05 -34.41 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.439 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.1 t -43.95 -34.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.137 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -60.36 -23.04 63.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -57.48 -44.31 84.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.434 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 . . . . . 0 C--N 1.331 -0.238 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 179.554 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 64.3 t0 . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.765 0.317 . . . . 1.0 110.844 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.8 p80 -77.48 -20.56 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.372 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.39 -37.78 83.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.93 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.73 -42.72 97.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.767 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.431 . . . . 1.0 109.864 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.43 90.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.73 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.8 -43.27 96.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.146 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -63.19 -40.37 97.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.69 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -59.69 -38.51 81.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.823 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.27 -44.27 84.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 1.0 110.647 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -64.67 -36.82 85.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.129 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -62.4 -33.44 74.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.325 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 1.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.17 -38.02 72.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.96 -38.62 89.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.76 -39.84 87.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.838 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.85 -38.72 82.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' B' ' 23' ' ' SER . 96.8 mt-10 -63.05 -43.92 97.3 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -69.32 -31.18 69.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.77 86.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.006 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -60.69 -45.77 92.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 44.3 tttm -65.47 -50.09 66.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.338 0.59 . . . . 1.0 110.073 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.09 -42.63 96.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.743 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.52 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -67.71 -50.69 56.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.106 0.253 . . . . 1.0 111.531 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.9 p -60.94 -45.91 97.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.06 0.457 . . . . 1.0 110.658 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 96.7 mt-10 -68.64 -18.81 64.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.674 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.66 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -59.76 -51.23 70.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.048 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 56.0 mp0 -80.64 -110.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 1.0 110.113 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 41.81 50.22 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.151 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.77 25.82 0.9 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.786 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.08 150.47 39.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.71 130.18 12.35 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.975 1.784 . . . . 1.0 112.067 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.88 75.08 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.201 -0.76 . . . . 1.0 111.201 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 163.49 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.349 . . . . 1.0 110.53 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.24 -32.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.574 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.59 49.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.39 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.635 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -92.73 76.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.182 0.515 . . . . 1.0 110.107 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' B' ' 39' ' ' ILE . 69.1 m -168.81 98.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.087 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 53.4 t80 -58.26 -50.12 89.83 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.69 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.2 Cg_endo -58.22 -33.28 97.41 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.809 1.672 . . . . 1.0 112.608 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.406 ' HB3' HH21 ' B' ' 60' ' ' ARG . 76.5 m-20 -94.66 -4.2 48.04 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.237 -0.185 . . . . 1.0 110.958 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.88 92.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.947 0.403 . . . . 1.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.41 HG22 ' H ' ' B' ' 45' ' ' ILE . 7.7 tt -67.39 -40.23 84.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.426 ' CD1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -62.94 -42.45 99.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.469 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -61.8 -42.7 99.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.513 ' C ' ' H ' ' B' ' 50' ' ' GLU . 16.2 m -56.82 -39.11 73.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.086 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.764 HG12 ' O ' ' B' ' 49' ' ' VAL . 58.0 t -67.18 29.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.87 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' B' ' 48' ' ' SER . 79.7 mm-40 -137.07 -21.79 1.2 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.848 -0.532 . . . . 1.0 110.493 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -36.08 14.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.02 83.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.207 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.7 p -86.18 12.96 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.849 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' B' ' 53' ' ' THR . 68.0 p 50.11 73.95 0.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.624 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' C' ' 75' ' ' MET . 29.4 t -131.4 -71.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.65 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 64.76 3.25 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -46.55 89.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.779 0.323 . . . . 1.0 110.752 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.96 23.1 0.97 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.633 -0.987 . . . . 1.0 110.633 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 48.0 t0 -63.13 -41.05 99.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 1.0 110.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 35.0 mmt180 -126.57 -174.68 3.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 79.2 m-85 -159.57 83.32 2.32 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.868 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 151.97 77.94 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.545 1.497 . . . . 1.0 112.092 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 16.8 m -96.68 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.872 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' B' ' 66' ' ' GLU . 48.8 m -112.38 -55.84 2.47 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.728 0.299 . . . . 1.0 111.238 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -43.87 -16.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.86 0.362 . . . . 1.0 110.804 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.66 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -91.85 26.66 2.33 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 123.839 1.781 . . . . 1.0 109.477 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.89 64.35 1.09 Allowed Glycine 0 C--O 1.212 -1.26 0 CA-C-N 113.663 -1.608 . . . . 1.0 111.424 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 55.8 ttm-85 -24.87 -32.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.217 1.008 . . . . 1.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.6 mttt -48.0 -18.87 0.21 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 67' ' ' GLY . 65.0 t -64.28 -45.47 96.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 120.124 -0.631 . . . . 1.0 109.803 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.92 -40.97 78.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.997 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . 0.425 ' OE1' ' CG1' ' A' ' 49' ' ' VAL . 83.0 tt0 -65.39 -40.5 93.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.085 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.69 -59.44 5.43 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.087 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.2 -44.68 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.287 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 38.9 ttp -59.93 -47.52 85.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.64 -32.48 73.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.378 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.74 78.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.575 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -43.05 96.74 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.74 -43.45 97.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 122.813 -0.228 . . . . 1.0 110.87 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.13 -42.1 85.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.298 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.405 HG13 ' HB1' ' B' ' 11' ' ' ALA . 53.7 t -63.83 -50.13 78.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.344 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.39 -37.83 80.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.789 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.29 -37.85 88.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.555 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.425 ' C ' ' N ' ' B' ' 86' ' ' THR . 4.4 tt -62.66 -41.58 99.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.183 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 85' ' ' VAL . 82.7 t -51.96 -15.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.425 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.7 m -49.65 -40.81 40.96 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -50.35 -38.94 44.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.67 59.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.678 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.69 -30.33 15.61 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.203 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.521 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.75 -40.44 96.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.47 0.652 . . . . 1.0 109.93 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 -5.31 49.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.932 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 51.4 t0 -54.99 -50.45 68.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.917 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 20.7 p90 -67.87 -43.91 78.31 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.357 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 97.6 t -39.42 -27.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.709 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 93' ' ' PHE . 34.7 mmt180 -63.25 -36.03 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.041 -0.264 . . . . 1.0 111.295 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -43.91 -28.29 0.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 1.0 110.192 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.983 -179.487 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.786 0.327 . . . . 1.0 110.966 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.515 ' CD2' ' N ' ' C' ' 5' ' ' GLU . 0.3 OUTLIER -171.74 -30.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.911 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 23.8 mm-40 -83.85 -22.52 31.67 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.768 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.95 -41.57 99.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.117 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.06 -44.95 83.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.62 88.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.467 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.7 -44.5 96.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.32 -33.43 75.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.203 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.48 87.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -37.81 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.786 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -65.78 -33.45 75.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.523 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.37 -44.7 92.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.796 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' C' ' 52' ' ' ALA . 42.6 tp -63.23 -41.42 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.604 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -58.08 -42.25 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.567 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' C' ' 21' ' ' GLU . 56.4 mtmt -62.9 -40.8 98.68 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.147 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.48 -36.66 77.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.2 mt -60.81 -40.56 93.15 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.095 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.66 -50.69 72.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.146 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 12.2 mp0 -69.43 -43.0 74.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.42 93.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.475 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 20.3 m -61.76 -44.95 95.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.731 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -66.19 -36.15 82.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 1.0 109.856 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -72.98 -41.73 64.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.597 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -52.58 -52.96 52.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.537 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 4.2 p -62.8 -44.7 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.406 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 80.8 mm-40 -65.8 -37.01 85.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.48 94.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.328 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.6 mp0 -70.25 -37.85 75.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 1.0 110.69 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH2' ' OH ' ' C' ' 41' ' ' TYR . 25.5 mmt180 -56.64 100.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.721 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 116.09 -12.45 17.06 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.28 144.5 34.22 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 122.772 -0.252 . . . . 1.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.454 ' O ' HG11 ' C' ' 63' ' ' VAL . 92.6 Cg_endo -76.07 143.04 25.38 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.036 1.824 . . . . 1.0 112.414 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.17 28.9 67.39 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 141.03 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.311 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 -35.83 4.87 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.414 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.498 HD23 ' O ' ' C' ' 38' ' ' LEU . 6.5 tt -92.29 77.55 5.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.946 -0.39 . . . . 1.0 109.946 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 pt -110.41 -7.63 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.921 0.391 . . . . 1.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -81.9 134.93 35.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.46 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.2 OUTLIER -77.94 -48.57 2.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.847 178.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.5 Cg_endo -59.82 -28.73 87.91 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 121.675 1.583 . . . . 1.0 112.136 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.85 -17.28 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.383 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.66 99.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.75 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.425 ' O ' HG23 ' C' ' 49' ' ' VAL . 8.3 tt -65.27 -42.1 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.413 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.429 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.73 -46.27 86.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.538 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.459 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.0 t90 -63.91 -40.95 97.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.462 -0.495 . . . . 1.0 109.819 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 64.6 p -60.14 -35.85 76.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.134 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.3 t -61.79 -48.95 86.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.826 -0.35 . . . . 1.0 111.56 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' C' ' 59' ' ' ASP . 15.8 pt-20 -73.46 -25.81 60.65 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.549 -0.46 . . . . 1.0 110.861 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 27.4 m -62.55 -44.28 96.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.484 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -55.65 -20.41 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.696 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.542 ' C ' ' H ' ' C' ' 55' ' ' VAL . 4.9 p -84.31 -2.7 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.5 p 60.64 -3.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.726 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' C' ' 53' ' ' THR . 73.9 t -64.01 -44.84 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.795 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 70.79 -60.36 0.95 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.556 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 2.5 t80 70.6 -41.65 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 1.0 110.973 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 120.68 24.43 2.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.421 ' OD2' ' OE2' ' C' ' 50' ' ' GLU . 65.5 t0 -61.95 -48.04 82.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.984 0.421 . . . . 1.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' C' ' 61' ' ' TYR . 96.3 mtt-85 -143.54 -177.5 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 1.0 109.887 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' C' ' 60' ' ' ARG . 9.9 m-85 -155.02 106.79 2.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 120.606 -0.438 . . . . 1.0 111.01 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.16 156.42 64.99 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.725 1.616 . . . . 1.0 112.216 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.484 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.47 -140.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.061 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.484 ' H ' HG12 ' C' ' 63' ' ' VAL . 41.4 m -113.87 -38.93 4.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.836 0.351 . . . . 1.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.595 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.0 tt0 -63.64 -27.03 68.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.983 0.421 . . . . 1.0 110.008 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -73.17 30.21 0.07 Allowed 'General case' 0 C--O 1.263 1.796 0 CA-C-O 123.818 1.77 . . . . 1.0 110.109 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 40.53 64.03 1.27 Allowed Glycine 0 C--O 1.214 -1.126 0 CA-C-N 113.706 -1.588 . . . . 1.0 111.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' C' ' 67' ' ' GLY . 59.2 ttm-85 -24.09 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.768 0.784 . . . . 1.0 111.231 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.0 mttt -50.57 -16.51 0.38 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.764 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.5 t -61.44 -45.6 98.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.441 -0.904 . . . . 1.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.6 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.201 0.524 . . . . 1.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -69.53 -41.57 75.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.214 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -63.85 -48.44 76.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.748 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.496 HG13 ' N ' ' C' ' 75' ' ' MET . 7.9 p -63.93 -44.06 97.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.314 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.496 ' N ' HG13 ' C' ' 74' ' ' VAL . 71.1 mtm -64.61 -41.09 96.44 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.52 -42.6 99.62 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.366 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.463 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.19 -39.74 95.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 1.0 110.44 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.68 97.9 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.75 -0.54 . . . . 1.0 111.75 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.54 -43.3 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.277 . . . . 1.0 110.625 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.14 -40.38 86.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 77' ' ' ALA . 51.6 t -62.96 -49.95 81.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.944 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.545 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.2 m-85 -68.93 -38.87 79.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.177 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.56 -33.12 70.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.917 0.389 . . . . 1.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.7 tt -61.82 -42.36 98.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.749 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.545 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.5 m -49.31 -11.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.568 -0.453 . . . . 1.0 110.415 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.482 ' H ' ' C ' ' C' ' 84' ' ' LEU . 48.5 m -48.75 -19.66 0.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.935 0.398 . . . . 1.0 110.267 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -60.02 -35.25 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.17 -34.33 29.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.42 -39.85 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.727 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.527 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.59 -47.95 82.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.0 111.291 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -4.12 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.335 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 43.1 t0 -57.4 -48.34 79.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.557 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.527 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 22.9 p90 -76.08 -43.7 42.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.069 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 80.0 t -42.11 -27.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.747 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -61.78 -22.39 65.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.959 -0.296 . . . . 1.0 111.249 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -73.99 -7.68 53.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.816 0.341 . . . . 1.0 110.605 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.73 -178.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.501 ' C ' ' H ' ' D' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.526 0.049 0 CA-C-O 120.725 0.298 . . . . 1.0 110.568 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.17 -32.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' D' ' 2' ' ' ALA . 28.5 p80 -82.26 -19.96 38.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.91 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.04 -40.66 78.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.805 0.336 . . . . 1.0 110.624 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -65.3 -38.04 89.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.07 -44.55 96.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.066 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.17 91.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.16 -41.33 94.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.54 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -63.79 -36.33 83.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -38.28 82.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.91 -41.16 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 1.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.81 -33.24 75.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.503 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . 0.434 ' O ' HG23 ' D' ' 18' ' ' VAL . 81.6 tt0 -63.32 -38.52 91.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.53 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.449 HD13 ' HA2' ' D' ' 78' ' ' GLY . 41.9 tp -62.64 -39.84 95.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.551 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -57.97 -40.7 81.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.289 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -75.82 -18.03 59.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.957 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 14' ' ' GLU . 37.9 t -76.89 -56.48 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.04 0.448 . . . . 1.0 111.169 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' D' ' 19' ' ' LEU . 1.9 pp -62.36 -28.44 69.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.733 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.39 -44.54 91.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.229 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -66.32 -36.68 83.54 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.888 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' D' ' 74' ' ' VAL . . . -65.32 -35.04 79.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.759 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -58.12 -43.89 87.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.845 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.04 -32.71 74.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -84.84 -32.3 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -60.86 -45.37 94.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.062 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.525 HG13 ' N ' ' D' ' 28' ' ' GLU . 5.5 p -61.3 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.089 0.471 . . . . 1.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.525 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.9 tm-20 -69.26 -40.76 77.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.386 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.05 94.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.337 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' D' ' 38' ' ' LEU . 26.0 tp10 -72.12 -38.52 69.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.869 0.366 . . . . 1.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -65.35 120.49 12.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.725 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.27 55.52 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.343 -0.703 . . . . 1.0 111.343 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.595 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -101.75 149.29 36.34 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 122.899 -0.177 . . . . 1.0 110.775 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.49 131.66 15.2 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.931 1.754 . . . . 1.0 111.965 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 7.05 88.23 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.72 143.25 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 -11.29 1.72 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.497 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.7 tt -110.53 120.37 42.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.021 0.438 . . . . 1.0 109.982 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' D' ' 40' ' ' SER . 37.0 pt -143.47 -165.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.366 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 3.2 m 58.25 132.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -74.6 -48.76 5.07 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.0 Cg_endo -59.04 -30.73 94.11 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.438 1.426 . . . . 1.0 111.943 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.22 -25.93 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.3 90.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.766 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' D' ' 45' ' ' ILE . 6.2 tt -63.19 -37.21 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.248 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -65.92 -46.6 77.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.18 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.556 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 2.3 t90 -57.47 -29.77 64.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -34.65 66.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.929 0.395 . . . . 1.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.8 -48.68 87.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.481 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 12.4 pt-20 -62.8 -38.2 89.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.73 HG22 ' H ' ' D' ' 52' ' ' ALA . 20.7 m -77.64 178.57 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.73 ' H ' HG22 ' D' ' 51' ' ' THR . . . 78.47 -18.22 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.446 ' H ' ' C ' ' D' ' 51' ' ' THR . 59.0 p -106.52 9.32 31.58 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.451 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' D' ' 53' ' ' THR . 12.0 p 56.89 67.24 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.955 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.95 -80.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.724 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.4 96.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.409 ' OH ' ' CE ' ' A' ' 75' ' ' MET . 59.5 m-85 -61.72 -43.22 99.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.689 0.281 . . . . 1.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.51 12.78 1.54 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.81 -50.41 74.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 1.0 110.462 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -144.68 125.98 14.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -114.66 138.9 23.46 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.64 160.39 49.6 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.469 2.112 . . . . 1.0 111.875 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.88 HG22 ' H ' ' D' ' 64' ' ' THR . 10.0 p -97.61 -140.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.002 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.88 ' H ' HG22 ' D' ' 63' ' ' VAL . 51.8 m -114.21 -43.68 3.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.312 -0.403 . . . . 1.0 111.044 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.581 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -66.6 -19.98 65.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.58 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.3 OUTLIER -75.69 25.84 0.11 Allowed 'General case' 0 C--O 1.262 1.723 0 CA-C-O 123.993 1.854 . . . . 1.0 109.213 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.743 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.59 62.79 3.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.0 -1.454 . . . . 1.0 109.841 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 57.0 ttm-85 -25.62 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.458 0.629 . . . . 1.0 111.03 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.743 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.22 -28.06 6.97 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.24 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' D' ' 67' ' ' GLY . 78.4 t -63.05 -48.8 86.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -74.26 -51.99 13.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.47 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -49.8 -40.31 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.096 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.29 -40.37 96.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' D' ' 52' ' ' ALA . 70.5 t -62.38 -45.19 99.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.431 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' D' ' 51' ' ' THR . 3.8 mpp? -64.25 -42.08 96.66 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.066 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -63.97 -42.03 97.38 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.505 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.8 -36.53 83.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.896 0.379 . . . . 1.0 110.751 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -69.6 -40.15 77.83 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.34 -44.65 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.788 0.294 . . . . 1.0 111.708 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' D' ' 80' ' ' GLU . 9.4 pt-20 -65.92 -35.67 81.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.152 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 77' ' ' ALA . 42.0 t -62.17 -48.67 87.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.552 -0.294 . . . . 1.0 111.263 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -73.78 -4.65 35.96 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.878 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.41 -32.37 11.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.7 tt -65.11 -40.04 93.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.442 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -53.7 -6.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.191 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.502 ' O ' ' N ' ' D' ' 89' ' ' LEU . 71.1 m -58.19 -43.54 87.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.339 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.489 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -42.78 -30.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.476 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.57 -32.92 20.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.066 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' D' ' 86' ' ' THR . 90.6 mt -67.34 -39.22 85.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.228 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.01 -48.18 82.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.182 0.515 . . . . 1.0 111.101 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -73.97 -4.98 38.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.209 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 46.7 t0 -55.14 -49.36 72.0 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.102 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 26.7 p90 -73.37 -44.13 59.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.0 t -42.47 -26.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.219 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -58.4 -32.29 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.957 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -58.77 -34.32 71.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 1.0 110.418 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 . . . . . 0 C--N 1.331 -0.209 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 -179.641 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.961 0.41 . . . . 1.0 110.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 4' ' ' HIS . 31.5 p-10 -172.57 -46.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.442 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 43.0 p-80 -78.92 -29.98 44.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.53 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.71 -35.93 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -63.15 -37.81 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.291 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -64.22 -41.89 96.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.063 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.87 92.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.357 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.82 -39.26 90.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.353 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.79 -41.19 97.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.617 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.43 80.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.869 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.02 -36.82 85.24 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -34.55 78.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.487 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.567 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 39.7 tp10 -64.95 -36.35 84.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.451 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.5 tp -62.72 -42.13 99.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 1.0 110.737 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.307 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HZ1' ' CD ' ' A' ' 14' ' ' GLU . 6.8 ttpm? -62.41 -40.07 95.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.13 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.88 -35.66 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.5 mt -61.06 -42.46 98.54 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.216 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.54 -43.29 85.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.263 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.6 -39.65 77.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.389 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.48 96.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.6 m -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.391 . . . . 1.0 110.182 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.764 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.69 -46.69 13.96 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.248 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.93 -44.58 78.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.549 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 4.7 p -59.51 -46.92 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.117 -0.633 . . . . 1.0 109.694 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 94.6 mt-10 -71.55 -33.8 69.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.653 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.29 97.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.266 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -89.89 -4.34 57.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.143 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -75.37 91.08 2.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.577 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.6 -15.36 17.25 Favored Glycine 0 N--CA 1.466 0.67 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 148.67 97.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 120.786 -0.365 . . . . 1.0 110.028 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 63' ' ' VAL . 93.0 Cg_endo -75.18 139.66 24.08 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.865 1.71 . . . . 1.0 112.333 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.62 21.92 74.92 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.64 166.35 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.902 0.382 . . . . 1.0 110.554 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 38' ' ' LEU . . . -151.66 -12.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.231 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 40.2 tp -67.72 -19.07 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' LEU . 95.3 mt -33.63 89.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.273 0.559 . . . . 1.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' LEU . 8.7 t -171.66 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.561 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.405 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 22.0 t80 -179.27 -57.8 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 123.142 0.276 . . . . 1.0 111.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 45' ' ' ILE . 30.3 Cg_endo -60.09 -31.65 93.63 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 121.782 1.655 . . . . 1.0 112.5 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -82.55 -10.12 59.12 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.233 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.25 84.06 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.87 0.366 . . . . 1.0 110.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 49' ' ' VAL . 6.7 tt -67.69 -38.33 80.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.475 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.4 OUTLIER -63.96 -50.47 68.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.163 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -62.36 -42.82 99.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.751 -0.463 . . . . 1.0 109.751 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.7 m -53.64 -36.05 61.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 49' ' ' VAL . 57.8 t -82.99 -4.86 8.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.0 110.459 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -107.82 37.19 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.375 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.422 HG23 HG11 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -148.74 -35.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.57 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.31 -24.68 63.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.496 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 54' ' ' THR . 70.2 p -89.69 5.29 46.51 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 53' ' ' THR . 44.7 p 54.46 71.03 0.55 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.142 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.85 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.741 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.32 84.68 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.78 -41.72 99.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.768 0.318 . . . . 1.0 110.556 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.24 20.49 0.36 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.32 -35.36 80.6 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.697 ' NH2' HH22 ' B' ' 68' ' ' ARG . 2.1 tpp180 -134.77 179.07 6.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.348 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 75.1 m-85 -160.94 93.88 1.47 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.35 149.74 69.89 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.713 1.609 . . . . 1.0 112.216 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 34' ' ' PRO . 1.5 t -85.76 -143.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.305 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' A' ' 63' ' ' VAL . 52.1 m -110.34 -38.78 5.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.697 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.2 tt0 -61.46 -20.73 63.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.059 0.457 . . . . 1.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.14 25.77 0.22 Allowed 'General case' 0 C--O 1.267 1.995 0 CA-C-O 123.915 1.817 . . . . 1.0 109.516 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.94 65.47 1.6 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.649 -1.614 . . . . 1.0 111.12 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 55.6 ttm-85 -24.45 -32.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.975 0.888 . . . . 1.0 110.999 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 99.1 mttt -47.24 -26.25 1.15 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.422 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.4 t -63.26 -46.47 95.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.764 -0.774 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.34 62.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 1.0 111.012 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.31 -41.27 96.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.835 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -55.57 -43.82 76.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 HG23 ' A' ' 51' ' ' THR . 95.0 t -66.75 -44.72 89.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.486 -0.486 . . . . 1.0 111.005 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.508 ' SD ' HG11 ' D' ' 55' ' ' VAL . 64.3 mtt -61.87 -43.64 98.43 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.637 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.78 -41.06 92.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 1.0 110.299 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -59.76 -40.67 88.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.451 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.28 -43.74 92.24 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.07 -43.53 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 121.082 -0.247 . . . . 1.0 110.395 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -43.19 97.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.246 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' ALA . 55.6 t -64.77 -50.02 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.796 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -68.29 -37.36 80.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.68 88.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.685 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.1 tt -65.69 -37.45 86.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.24 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 t -46.06 -13.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.42 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 16.2 m -58.79 -45.17 90.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.495 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -40.93 -21.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.758 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -106.62 -25.35 11.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.73 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 86' ' ' THR . 69.6 mt -62.79 -42.22 99.6 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -72.96 -65.24 0.82 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.36 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -47.56 -10.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.229 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' ALA . 46.9 t0 -63.18 -73.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.024 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' B' ' 87' ' ' ALA . 25.1 m-85 -86.46 -27.98 23.77 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.952 0.353 . . . . 1.0 111.952 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 90' ' ' ALA . 56.3 t -40.88 -27.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.515 0.198 . . . . 1.0 111.274 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' N ' ' O ' ' A' ' 93' ' ' PHE . 95.7 mtt-85 -61.17 -32.99 72.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -39.43 -38.68 0.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.715 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.002 0.43 . . . . 1.0 109.906 179.303 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 65.7 t0 . . . . . 0 CA--C 1.528 0.104 0 CA-C-O 120.896 0.379 . . . . 1.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -80.7 -29.63 36.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.615 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.23 -44.26 84.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.89 -36.01 75.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -67.79 -40.42 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 1.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.8 98.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.85 -32.49 73.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.24 -39.46 92.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.365 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.34 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.767 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.6 -36.85 81.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.396 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -65.73 -41.18 92.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.363 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' B' ' 52' ' ' ALA . 40.6 tp -61.27 -41.86 97.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.37 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.24 -42.85 96.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.712 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -64.15 -37.93 89.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.711 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.81 -66.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.12 -31.56 61.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.837 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -63.45 -44.66 93.86 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.52 -36.63 84.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.61 75.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.854 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.466 ' O ' HG23 ' B' ' 27' ' ' VAL . 25.2 p -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.483 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.58 -56.35 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.077 -0.649 . . . . 1.0 109.856 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.1 -38.97 80.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.267 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.45 76.41 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.131 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 23' ' ' SER . 90.2 t -63.58 -48.56 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.263 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.88 -35.81 72.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.752 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.43 84.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.201 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' B' ' 38' ' ' LEU . 41.9 mm-40 -70.51 -42.56 71.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 1.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -53.6 94.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.899 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 115.85 11.25 10.33 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 111.15 -0.78 . . . . 1.0 111.15 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' OE2' ' B' ' 66' ' ' GLU . . . -102.03 137.41 19.48 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.614 0.207 . . . . 1.0 110.617 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.03 138.86 21.1 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.869 1.713 . . . . 1.0 112.407 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.4 3.4 39.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . -47.14 176.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 1.0 110.399 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.27 -28.92 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.537 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' B' ' 30' ' ' GLU . 23.0 tp -99.49 119.81 38.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.965 0.412 . . . . 1.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.34 64.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.036 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -169.26 128.99 1.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.372 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.2 OUTLIER -58.62 -51.45 81.73 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.669 -0.696 . . . . 1.0 111.176 178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.3 Cg_endo -57.85 -32.24 94.48 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.701 1.601 . . . . 1.0 112.682 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' B' ' 43' ' ' ASP . 2.4 m-20 -93.22 -23.24 18.61 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.762 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.99 94.42 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.878 0.37 . . . . 1.0 110.568 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -64.27 -37.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.41 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -44.98 86.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.44 -40.33 94.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.502 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -61.47 -36.33 80.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.171 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.99 -48.07 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 1.0 111.982 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.88 -30.5 69.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.846 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -62.51 -45.08 94.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.565 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' B' ' 15' ' ' LEU . . . -59.73 -32.15 70.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.013 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' B' ' 54' ' ' THR . 45.0 p -71.82 -6.75 43.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.799 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.38 65.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.284 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.584 HG11 ' CE1' ' B' ' 57' ' ' TYR . 92.7 t -150.37 -47.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 42.85 83.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.584 ' CE1' HG11 ' B' ' 55' ' ' VAL . 33.1 m-85 -62.83 -41.6 99.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 167.62 -90.25 0.1 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 77.1 m-20 42.56 -88.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 1.0 110.9 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' B' ' 58' ' ' GLY . 25.6 mmt180 -115.61 -173.39 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.194 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 38.7 p90 -173.77 118.54 0.37 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.246 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.35 158.12 58.65 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.565 1.51 . . . . 1.0 112.251 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.468 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.8 t -97.22 -126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.543 HG22 ' CD1' ' A' ' 46' ' ' TRP . 5.9 p -114.3 -36.56 4.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.777 0.322 . . . . 1.0 111.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.7 tt0 -65.29 -31.48 72.65 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.553 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 1.3 pm0 -79.26 30.33 0.22 Allowed 'General case' 0 C--O 1.269 2.115 0 CA-C-O 123.969 1.842 . . . . 1.0 109.797 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 37.57 61.92 1.01 Allowed Glycine 0 C--O 1.212 -1.237 0 CA-C-N 113.092 -1.867 . . . . 1.0 111.045 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.697 HH22 ' NH2' ' A' ' 60' ' ' ARG . 40.5 ttm180 -24.96 -32.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.993 . . . . 1.0 110.947 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' B' ' 67' ' ' GLY . 68.3 mttm -49.42 -16.48 0.2 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 67' ' ' GLY . 55.9 t -63.35 -46.1 96.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 119.788 -0.765 . . . . 1.0 109.578 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.58 72.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.241 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.12 -43.92 70.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.343 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.35 -44.22 88.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.825 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.34 -43.51 91.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.323 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 37.0 mtt -59.11 -44.86 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.721 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.19 -42.58 96.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.74 89.17 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.13 -36.81 93.71 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.89 -26.9 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.424 -0.457 . . . . 1.0 111.523 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.29 -50.6 37.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.042 0.449 . . . . 1.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' H ' ' B' ' 82' ' ' PHE . 5.7 m -60.04 -48.7 86.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.355 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.442 ' H ' HG23 ' B' ' 81' ' ' VAL . 20.6 m-85 -66.03 -34.55 78.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.67 37.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.2 tt -69.97 -23.43 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 1.0 110.114 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.534 ' O ' HG12 ' B' ' 85' ' ' VAL . 98.6 t -57.29 -3.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.644 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.521 ' H ' ' C ' ' B' ' 84' ' ' LEU . 14.6 t -49.32 -39.0 29.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.404 0.621 . . . . 1.0 109.585 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -46.69 -35.63 6.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.423 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.23 -10.85 51.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.585 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' B' ' 92' ' ' ASP . 85.7 mt -85.29 -56.87 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.891 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 94' ' ' VAL . . . -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.293 0.568 . . . . 1.0 109.989 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -61.11 -37.56 83.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.574 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 11.1 t0 -59.56 -44.48 93.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.617 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 0.5 OUTLIER -61.25 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.756 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 96' ' ' ARG . 95.9 t -64.93 -43.83 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.738 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.533 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 46.9 mtt85 -44.79 -20.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.459 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' B' ' 94' ' ' VAL . 52.3 ptt85 -52.85 -33.13 48.16 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.247 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.438 -179.827 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.816 0.341 . . . . 1.0 110.427 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 2.8 p80 -78.78 -27.7 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.054 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.645 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 84.7 tt0 -70.04 -32.75 71.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.739 0.304 . . . . 1.0 110.813 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -59.36 -41.58 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.58 -39.95 89.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.187 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.38 87.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -58.06 -42.45 85.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.529 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -62.6 -34.6 77.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 1.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' C' ' 84' ' ' LEU . . . -58.5 -37.95 76.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.001 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.29 -32.82 74.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.004 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.2 -41.97 94.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.705 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.44 -39.95 94.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' C' ' 52' ' ' ALA . 50.0 tp -62.39 -42.36 99.36 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.649 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.61 -41.88 92.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.6 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -63.36 -38.46 91.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.793 0.33 . . . . 1.0 111.155 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.68 -42.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.754 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' C' ' 52' ' ' ALA . 67.1 mt -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.239 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -64.5 -42.63 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.35 -39.0 74.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.492 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.53 85.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.996 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -58.27 -46.21 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.617 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.41 -35.71 81.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 1.0 109.964 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -70.6 -40.93 72.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.321 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -50.14 73.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.33 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 18.9 m -61.43 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.403 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' HG23 ' C' ' 27' ' ' VAL . 40.3 tp10 -69.6 -41.83 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.539 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.89 94.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.65 -6.76 56.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.965 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -87.74 117.47 26.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.929 0.395 . . . . 1.0 110.119 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.47 -4.02 63.94 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.3 144.09 37.75 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.93 137.79 20.11 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.9 1.734 . . . . 1.0 112.346 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.75 14.9 75.6 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 149.06 47.15 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.383 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 41.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.509 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.493 HD23 ' C ' ' C' ' 38' ' ' LEU . 3.7 tt -127.53 -67.15 0.84 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.191 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' C' ' 38' ' ' LEU . 19.2 pt 31.59 -123.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.557 0.536 . . . . 1.0 110.862 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t 47.82 -130.63 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.731 0.301 . . . . 1.0 110.754 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.466 ' HA ' HG11 ' C' ' 27' ' ' VAL . 5.9 t80 177.85 -59.37 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.1 Cg_endo -59.33 -33.95 97.74 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.927 1.751 . . . . 1.0 112.105 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -78.01 -6.04 53.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.53 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.49 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -64.3 -44.82 90.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 1.0 111.348 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.474 HG23 ' HE3' ' C' ' 46' ' ' TRP . 10.1 tt -66.14 -33.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.474 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.3 OUTLIER -64.08 -48.54 75.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.258 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.45 -42.61 95.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.272 -0.571 . . . . 1.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -52.81 -39.45 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.739 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' C' ' 51' ' ' THR . 71.2 t -65.47 -43.93 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.513 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.64 24.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.884 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.522 ' H ' ' C ' ' C' ' 49' ' ' VAL . 96.1 m -127.78 -43.85 1.52 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.674 -0.239 . . . . 1.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.93 -25.13 66.55 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.578 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.513 ' OG1' HG13 ' C' ' 55' ' ' VAL . 16.9 p -89.9 4.4 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.834 0.349 . . . . 1.0 110.12 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 44.2 p 52.19 35.76 17.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.813 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.594 HG11 ' SD ' ' D' ' 75' ' ' MET . 31.3 m -75.35 -35.87 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.212 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD2' ' B' ' 57' ' ' TYR . . . 100.11 -76.3 0.45 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' C' ' 57' ' ' TYR . 44.2 p90 -61.99 117.61 6.18 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' C' ' 60' ' ' ARG . . . -133.77 20.02 4.14 Favored Glycine 0 N--CA 1.464 0.515 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.42 ' OD2' ' CZ ' ' C' ' 60' ' ' ARG . 11.9 t0 71.12 -29.14 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.298 . . . . 1.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' C' ' 58' ' ' GLY . 21.3 mmt180 -121.22 152.4 38.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -139.35 126.85 13.06 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.63 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.84 152.49 68.91 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.764 1.643 . . . . 1.0 111.981 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.492 HG11 ' O ' ' C' ' 34' ' ' PRO . 3.4 t -92.34 -126.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.458 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 86.9 m -115.17 -38.71 3.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.909 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.669 ' C ' ' H ' ' C' ' 67' ' ' GLY . 42.7 tp10 -67.6 -38.43 83.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.647 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 0.1 OUTLIER -65.89 27.17 0.02 OUTLIER 'General case' 0 C--O 1.264 1.829 0 CA-C-O 123.176 1.465 . . . . 1.0 110.248 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.78 64.28 1.7 Allowed Glycine 0 C--O 1.216 -0.975 0 CA-C-O 118.183 -1.343 . . . . 1.0 111.192 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 56.8 ttm-85 -23.34 -32.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.05 0.925 . . . . 1.0 111.446 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.9 mttt -50.62 -16.49 0.39 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.379 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 57.0 t -60.48 -46.83 94.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.98 81.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 1.0 110.142 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -62.25 -36.72 82.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.84 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -62.55 -43.84 97.82 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.28 -45.6 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.558 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.8 -36.9 85.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.971 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -59.36 -46.26 89.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.494 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -66.25 -38.45 87.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 1.0 110.265 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.23 -48.56 73.53 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.156 -0.545 . . . . 1.0 111.809 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.15 -43.7 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.707 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -68.18 -43.02 79.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.279 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.494 HG23 ' O ' ' C' ' 77' ' ' ALA . 41.4 t -63.38 -49.16 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.083 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -68.68 -28.49 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.186 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.44 -26.41 26.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 1.0 110.412 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' C' ' 11' ' ' ALA . 4.7 tt -64.15 -42.51 96.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.625 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.8 m -62.33 -9.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.44 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 24.8 m -41.45 -20.14 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.932 0.396 . . . . 1.0 110.555 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -63.69 -66.46 0.54 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.542 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.57 64.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.48 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.638 HD12 ' O ' ' D' ' 83' ' ' ALA . 4.2 mm? -64.98 -38.43 90.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.363 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -66.99 -69.29 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.938 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.872 ' O ' HG22 ' C' ' 94' ' ' VAL . 0.5 OUTLIER -40.03 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.539 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' C' ' 90' ' ' ALA . 46.4 t0 -38.83 -33.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.677 0.275 . . . . 1.0 111.364 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 7.0 p90 -64.35 -35.64 81.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.675 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.872 HG22 ' O ' ' C' ' 91' ' ' THR . 15.1 m -48.88 -36.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.755 -0.657 . . . . 1.0 111.874 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -63.86 -21.84 66.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -59.26 -43.29 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.253 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' C' ' 97' ' ' GLU . 56.3 mp0 . . . . . 0 C--N 1.332 -0.196 0 CA-C-O 120.781 0.324 . . . . 1.0 110.788 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.667 0.27 . . . . 1.0 110.595 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -174.94 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.716 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -79.56 -17.36 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.784 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.76 -36.76 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 1.0 110.452 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -62.11 -42.95 99.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.249 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.18 -44.67 96.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.107 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' D' ' 85' ' ' VAL . . . -65.54 -39.18 91.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.785 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -64.95 -41.06 95.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.466 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -63.31 -37.56 87.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.57 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -39.3 92.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.33 -32.61 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.373 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.04 -38.34 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.61 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.6 tp -61.86 -43.41 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.522 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -56.51 -36.05 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -62.68 -36.24 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.105 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.99 -40.71 81.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 1.0 110.781 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.88 -40.81 89.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.099 -0.5 . . . . 1.0 109.98 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -55.19 -49.8 70.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.621 -0.432 . . . . 1.0 109.888 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.53 -35.06 72.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.089 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.78 85.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.138 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -60.31 -43.97 95.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 1.0 111.116 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.33 -34.32 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.654 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.03 -44.27 16.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.939 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.15 90.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.711 0.291 . . . . 1.0 110.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 2.8 p -60.43 -44.12 95.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.173 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 79.2 mm-40 -71.39 -42.9 67.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.861 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.82 99.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.423 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -65.74 -37.21 85.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.8 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -67.5 122.13 17.32 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.932 0.396 . . . . 1.0 110.553 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.65 -11.87 59.49 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.116 -0.793 . . . . 1.0 111.116 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.5 133.77 39.44 Favored Pre-proline 0 CA--C 1.538 0.515 0 O-C-N 122.798 -0.236 . . . . 1.0 110.47 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.82 142.74 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.149 1.9 . . . . 1.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.1 0.62 53.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.33 140.2 50.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.767 0.318 . . . . 1.0 110.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.93 -53.88 2.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.584 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -52.4 94.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.121 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.713 HG23 ' O ' ' D' ' 39' ' ' ILE . 21.0 tt -134.11 63.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.16 0.505 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -159.68 135.75 8.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.477 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 18.0 t80 -74.87 -49.5 4.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.72 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.8 Cg_endo -58.93 -30.71 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.321 1.347 . . . . 1.0 111.964 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -87.14 -20.2 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.076 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.93 96.25 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.867 0.365 . . . . 1.0 110.692 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.413 ' H ' HG22 ' D' ' 45' ' ' ILE . 7.3 tt -66.27 -38.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.303 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.402 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -63.86 -46.56 84.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.044 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -39.77 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.166 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.3 t -49.6 -20.25 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.564 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' D' ' 51' ' ' THR . 24.9 t -97.58 -33.64 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.0 0.429 . . . . 1.0 110.258 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -78.21 16.62 0.74 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.43 ' H ' ' C ' ' D' ' 49' ' ' VAL . 6.1 t -137.38 -34.81 0.69 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.16 -24.48 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.523 ' OG1' HG13 ' D' ' 55' ' ' VAL . 67.4 p -93.88 6.17 49.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.3 p 56.71 11.28 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.055 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.523 HG13 ' OG1' ' D' ' 53' ' ' THR . 25.8 m -63.53 -43.34 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.787 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.465 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 41.43 86.62 0.01 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -90.58 4.5 51.09 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.836 0.351 . . . . 1.0 110.159 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.03 17.3 65.46 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 30.1 m-20 -63.63 -46.18 86.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 1.0 110.593 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.39 167.08 21.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.019 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 9.6 p90 -153.56 102.48 2.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.591 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.76 162.38 42.3 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.885 1.723 . . . . 1.0 112.508 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.502 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -96.13 -140.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.502 ' H ' HG12 ' D' ' 63' ' ' VAL . 28.9 m -112.15 -39.71 4.39 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.668 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -59.53 -24.28 63.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.516 ' OE2' ' N ' ' D' ' 68' ' ' ARG . 0.1 OUTLIER -80.01 28.52 0.29 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 123.329 1.538 . . . . 1.0 108.944 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.15 62.19 2.15 Favored Glycine 0 C--O 1.216 -0.977 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.995 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.516 ' N ' ' OE2' ' D' ' 66' ' ' GLU . 48.2 ttm-85 -24.61 -32.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.401 0.707 . . . . 1.0 111.061 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.26 -18.23 0.57 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.615 ' O ' HG23 ' D' ' 74' ' ' VAL . 62.0 t -63.01 -46.84 95.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.907 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.5 -47.31 27.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.348 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -43.77 -62.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.57 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.15 -41.68 88.9 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.615 HG23 ' O ' ' D' ' 70' ' ' VAL . 89.9 t -61.72 -48.06 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.404 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.594 ' SD ' HG11 ' C' ' 55' ' ' VAL . 75.5 mtm -64.56 -41.99 95.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.697 0.284 . . . . 1.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.1 -36.16 83.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.696 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.466 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -58.3 -38.4 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.321 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.07 -42.1 94.75 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.458 -0.657 . . . . 1.0 111.458 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.64 98.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.616 0.246 . . . . 1.0 111.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.36 -38.9 92.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.133 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 77' ' ' ALA . 70.5 t -63.29 -48.29 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.091 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.05 -36.82 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.853 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.638 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -60.76 -37.75 82.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.836 -0.345 . . . . 1.0 110.266 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.8 tt -62.49 -40.34 96.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.557 ' O ' HG12 ' D' ' 85' ' ' VAL . 99.8 t -58.41 -3.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.205 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 89' ' ' LEU . 54.4 m -59.33 -44.53 92.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.649 ' O ' HG22 ' D' ' 91' ' ' THR . . . -41.71 -57.17 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 1.0 110.561 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.65 59.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' D' ' 86' ' ' THR . 83.8 mt -89.78 -16.95 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -80.71 -49.58 11.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.649 HG22 ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -50.98 -10.82 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.953 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.482 ' N ' ' C ' ' D' ' 90' ' ' ALA . 97.6 m-20 -61.54 -53.48 55.8 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -45.44 -34.02 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.01 -27.1 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.155 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -60.56 -41.27 94.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.612 -0.267 . . . . 1.0 110.895 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -50.71 -39.36 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.338 . . . . 1.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.661 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.802 0.334 . . . . 1.0 110.631 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.48 -43.06 99.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.723 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 11.2 p-80 -73.04 -32.03 64.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.626 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.27 -36.07 82.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 1.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -64.1 -39.52 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.264 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -66.84 -39.16 87.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.052 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.57 87.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.332 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.85 -45.11 94.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.114 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.21 -37.18 86.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.431 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 84' ' ' LEU . . . -54.23 -45.8 72.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.925 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.32 -41.99 93.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 1.0 110.557 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.76 -32.59 74.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.304 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.05 -36.72 84.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.685 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.2 tp -62.31 -42.4 99.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 1.0 110.594 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -57.93 -39.91 79.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.232 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.72 -42.65 99.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.077 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.71 -40.59 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.445 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 52' ' ' ALA . 89.6 mt -59.06 -40.76 86.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 1.0 109.952 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.64 -48.06 82.32 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.536 -0.465 . . . . 1.0 109.832 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.87 -33.37 75.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.972 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.86 90.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.488 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.783 ' O ' HG23 ' A' ' 27' ' ' VAL . 27.3 m -59.53 -44.86 93.08 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -66.16 -54.92 19.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.526 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.9 mttt -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.125 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.77 90.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.198 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 23' ' ' SER . 62.3 t -64.61 -46.43 92.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.042 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.35 -23.38 46.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -52.32 -49.41 64.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.251 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 63' ' ' VAL . 2.3 mm-40 -70.19 -39.74 75.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -67.55 92.91 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.785 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.44 -15.8 6.34 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.408 -0.677 . . . . 1.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.496 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -105.15 148.56 36.41 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.859 0.33 . . . . 1.0 110.285 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 97.1 Cg_endo -75.78 132.89 14.86 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.975 1.783 . . . . 1.0 112.571 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 96.94 8.16 57.07 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . -35.55 154.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.761 0.315 . . . . 1.0 110.875 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.72 -50.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.471 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.5 110.36 19.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.032 0.444 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 pt -142.84 73.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.281 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' ALA . 8.5 p -162.15 98.91 1.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 56.8 t80 -51.51 -49.43 82.56 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.089 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.6 Cg_endo -59.75 -35.3 94.93 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.262 1.308 . . . . 1.0 112.509 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.0 -6.92 34.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.9 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -65.54 -43.6 89.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 1.0 110.533 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -64.64 -34.64 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.44 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.43 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.34 -46.44 90.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.882 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.46 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 1.7 t90 -66.68 -40.48 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.498 -0.481 . . . . 1.0 109.793 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 1.2 m -54.74 -33.12 60.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.84 -46.97 95.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.024 0.44 . . . . 1.0 110.175 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' B' ' 61' ' ' TYR . 62.1 mt-10 -66.8 -33.32 75.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.387 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 96.6 m -62.2 -46.78 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.353 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.59 -36.74 81.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.149 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 55' ' ' VAL . 72.0 p -74.4 -9.83 58.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 53' ' ' THR . 3.0 p 65.1 -4.86 0.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 57' ' ' TYR . 69.5 t -64.7 -44.98 96.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.14 83.24 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.451 -0.66 . . . . 1.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.535 ' CE1' HG11 ' A' ' 55' ' ' VAL . 49.5 m-85 -61.16 -41.95 97.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 1.0 110.633 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.14 9.57 2.39 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.841 -0.903 . . . . 1.0 110.841 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 38.1 t0 -56.97 -51.53 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.361 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -134.29 126.69 30.26 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -108.09 134.21 20.23 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.775 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.05 162.69 41.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.249 1.966 . . . . 1.0 112.223 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 64' ' ' THR . 8.4 p -70.16 -145.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.445 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.939 ' H ' HG22 ' A' ' 63' ' ' VAL . 5.0 m -113.12 -73.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.958 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 64' ' ' THR . 79.9 tt0 -38.87 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.349 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.882 ' O ' ' N ' ' A' ' 68' ' ' ARG . 70.9 mt-10 -77.76 -106.63 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.553 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 18.04 -54.81 0.0 OUTLIER Glycine 0 N--CA 1.477 1.398 0 O-C-N 124.593 1.183 . . . . 1.0 114.223 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.882 ' N ' ' O ' ' A' ' 66' ' ' GLU . 10.1 tpp180 -64.05 -49.15 73.48 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.123 -0.538 . . . . 1.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 66' ' ' GLU . 68.4 mttm -64.81 -40.73 95.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.363 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.93 -45.4 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.57 83.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.99 0.424 . . . . 1.0 110.411 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -62.65 -37.66 87.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.302 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.82 -54.68 7.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.61 -46.13 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.849 -0.34 . . . . 1.0 111.09 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.2 ttp -55.97 -45.27 78.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.59 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 64.7 tttm -65.74 -33.01 74.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.368 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.62 80.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.788 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.96 -41.94 99.78 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.82 -43.67 98.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.658 0.266 . . . . 1.0 110.602 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 76' ' ' LYS . 97.8 mt-10 -60.48 -35.73 76.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.202 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.98 -74.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -45.41 -38.39 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.94 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.04 86.1 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.44 -39.47 93.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.279 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 85' ' ' VAL . 99.6 t -45.98 -13.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.427 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 76.8 m -51.33 -43.9 61.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -44.44 -20.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.554 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.11 -18.37 14.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.998 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 86' ' ' THR . 43.9 mt -92.51 -42.37 9.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.733 0.301 . . . . 1.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.95 -28.74 64.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.094 0.473 . . . . 1.0 110.863 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -80.81 -4.08 53.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.419 -179.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.2 m-20 -60.95 -47.88 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.944 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 11.1 p90 -75.89 -20.6 57.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.306 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.16 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.11 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -59.94 -22.66 62.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.964 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttp85 -57.37 -43.92 83.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.617 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 66.5 tt0 . . . . . 0 C--N 1.328 -0.339 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.771 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.8 t0 . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 120.698 0.285 . . . . 1.0 110.726 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.648 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 6.5 p80 -78.74 -24.03 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.419 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.21 -39.96 86.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.42 -38.54 91.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.54 -41.28 93.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 1.0 110.021 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.32 -41.13 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -65.49 -41.04 93.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.277 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -64.21 -36.2 83.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.531 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.27 78.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -70.74 -32.25 69.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 1.0 110.782 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.33 -49.36 72.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.884 0.373 . . . . 1.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.449 ' O ' HG23 ' B' ' 18' ' ' VAL . 13.3 pt-20 -64.91 -30.2 71.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.561 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.74 -43.2 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.03 -43.02 99.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -33.86 76.79 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.511 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 14' ' ' GLU . 49.3 t -68.3 -54.67 20.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.13 -33.89 77.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.54 -40.27 96.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.51 -40.9 96.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -63.64 -33.26 75.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.659 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' B' ' 48' ' ' SER . 2.2 m -55.54 -43.5 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.231 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.487 ' O ' HG12 ' B' ' 27' ' ' VAL . 24.9 tptp -58.74 -55.73 31.34 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.843 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -60.89 -29.33 69.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.732 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.9 67.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 24' ' ' LYS . 1.4 p -62.28 -44.17 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.069 0.461 . . . . 1.0 110.103 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.463 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 12.2 tm-20 -74.56 -33.35 62.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.271 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.07 45.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.92 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.51 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 0.5 OUTLIER 178.68 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.82 0.343 . . . . 1.0 110.777 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . 0.626 HH21 ' CG2' ' B' ' 39' ' ' ILE . 3.8 mmp_? -79.14 76.92 5.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.115 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.78 1.35 5.94 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.898 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.5 151.09 40.26 Favored Pre-proline 0 N--CA 1.465 0.304 0 O-C-N 122.767 -0.255 . . . . 1.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.07 144.26 29.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.974 1.783 . . . . 1.0 112.496 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.37 32.31 75.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -48.64 -60.57 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.0 110.75 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.52 4.32 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.341 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.426 HD23 ' O ' ' B' ' 38' ' ' LEU . 3.1 tt -145.47 55.54 1.21 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.022 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.626 ' CG2' HH21 ' B' ' 31' ' ' ARG . 33.0 pt -92.69 51.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.908 0.385 . . . . 1.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' B' ' 43' ' ' ASP . 0.3 OUTLIER -150.72 140.19 21.48 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.178 0.513 . . . . 1.0 110.94 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.8 OUTLIER -82.0 -53.99 0.66 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.278 -0.873 . . . . 1.0 110.81 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.0 Cg_endo -57.76 -28.97 84.2 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.876 1.717 . . . . 1.0 112.701 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 40' ' ' SER . 12.1 p-10 -88.91 -4.33 58.49 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.97 92.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 1.0 110.41 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 46' ' ' TRP . 20.7 tt -67.28 -37.5 79.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.517 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.511 ' NE1' ' O ' ' C' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -53.13 61.49 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -62.97 -42.69 99.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.958 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' B' ' 23' ' ' SER . 64.8 m -51.9 -38.97 58.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.711 0.291 . . . . 1.0 111.095 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.15 -50.4 73.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 1.0 111.588 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -59.77 -40.9 89.76 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.734 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -24.86 68.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.268 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 20.4 p -90.86 6.34 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 1.0 110.774 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 p 52.11 63.19 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.476 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.42 -53.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.12 81.79 0.06 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 1.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.38 3.77 12.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.69 -49.49 77.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 1.0 110.516 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -145.62 157.55 43.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.819 -0.438 . . . . 1.0 109.819 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 50' ' ' GLU . 64.2 t80 -172.46 132.52 0.7 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.7 -173.5 0.72 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.582 1.522 . . . . 1.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.592 HG22 ' N ' ' B' ' 64' ' ' THR . 3.6 p -134.15 165.72 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.422 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.592 ' N ' HG22 ' B' ' 63' ' ' VAL . 14.5 m -40.76 -61.79 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.243 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.01 -14.52 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.941 0.4 . . . . 1.0 109.94 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' B' ' 64' ' ' THR . 13.6 mm-40 -115.31 41.86 2.36 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-O 125.105 2.383 . . . . 1.0 110.392 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.46 60.04 1.48 Allowed Glycine 0 C--O 1.216 -0.978 0 CA-C-N 112.217 -2.265 . . . . 1.0 111.34 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 59' ' ' ASP . 38.5 ttm180 -28.28 -28.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.578 0.689 . . . . 1.0 110.58 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' B' ' 67' ' ' GLY . 54.4 mtpt -52.41 -12.36 0.26 Allowed 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 37.6 t -58.78 -44.95 91.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 118.902 -1.119 . . . . 1.0 109.541 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.511 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -71.1 -48.95 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 1.0 110.7 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.95 -38.25 55.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.096 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.414 ' O ' ' OE1' ' B' ' 73' ' ' GLN . 0.8 OUTLIER -58.97 -51.2 71.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.018 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 84.2 t -66.78 -43.39 89.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.506 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.2 mpp? -61.22 -41.47 96.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.662 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . 0.412 ' O ' ' OE2' ' B' ' 80' ' ' GLU . 65.9 tttm -61.49 -44.02 97.82 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.554 -0.458 . . . . 1.0 110.359 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -66.05 -40.27 90.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.91 96.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.79 -43.88 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 122.847 -0.208 . . . . 1.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.523 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 0.2 OUTLIER -62.57 -37.78 87.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 1.0 110.334 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 77' ' ' ALA . 24.9 t -60.69 -68.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.184 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -55.33 -37.37 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.776 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.94 89.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.5 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.99 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.117 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' B' ' 8' ' ' ALA . 39.0 t -53.2 -17.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 39.6 m -43.59 -35.3 1.67 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.253 0.549 . . . . 1.0 109.767 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -51.73 -61.67 2.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.9 -27.36 51.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 1.0 110.474 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.615 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.5 mm? -78.27 -32.27 49.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 1.0 110.046 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -63.03 -46.41 87.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.27 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.445 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.5 OUTLIER -73.57 -3.93 30.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.167 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.516 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 50.2 t0 -56.81 -48.77 77.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.18 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 20.9 p90 -69.5 -39.03 77.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.21 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.517 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 96.6 t -44.42 -28.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.628 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.96 -27.27 68.13 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.116 -0.234 . . . . 1.0 110.953 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.6 ptt85 -54.59 -42.6 71.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.124 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 80.4 mm-40 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.079 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . 0.509 ' OD1' ' ND1' ' C' ' 4' ' ' HIS . 35.6 p-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.698 0.285 . . . . 1.0 110.39 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.509 ' ND1' ' OD1' ' C' ' 3' ' ' ASP . 11.8 p-80 -81.6 -29.96 33.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -65.16 -44.68 87.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.789 0.328 . . . . 1.0 110.756 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -65.61 -36.83 84.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.142 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -63.78 -42.96 97.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.454 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' C' ' 85' ' ' VAL . . . -64.37 -40.32 95.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.419 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.37 -40.22 93.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.533 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.435 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.58 76.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.81 -36.19 83.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 1.0 111.072 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -63.87 -41.25 97.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 1.0 110.701 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.99 -29.48 69.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.567 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.575 HD11 ' HB1' ' C' ' 52' ' ' ALA . 43.2 tp -62.38 -39.92 94.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.379 . . . . 1.0 110.411 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -70.73 -28.59 64.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.0 -46.55 84.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.746 0.308 . . . . 1.0 111.554 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . 0.43 HG22 ' H ' ' C' ' 18' ' ' VAL . 8.6 m -64.42 -36.56 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.87 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -61.17 -41.98 97.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -60.47 -45.45 93.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.59 -33.71 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.107 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.41 94.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.463 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.507 ' O ' HG23 ' C' ' 27' ' ' VAL . 91.7 p -61.81 -46.31 90.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -63.25 -56.3 17.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.546 -0.462 . . . . 1.0 109.92 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.59 -42.61 92.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -56.09 -44.37 78.93 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.507 HG23 ' O ' ' C' ' 23' ' ' SER . 76.8 t -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.208 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.95 75.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.39 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.509 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.5 mp0 -69.54 -33.07 72.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -54.25 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.769 0.318 . . . . 1.0 110.964 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.22 -0.75 22.46 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.96 147.01 32.35 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.268 -0.271 . . . . 1.0 110.268 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.488 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.1 Cg_endo -75.96 142.5 25.11 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.863 1.709 . . . . 1.0 112.315 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.08 66.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.35 144.45 55.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.0 110.423 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.82 -22.08 0.88 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.603 HD13 ' O ' ' C' ' 38' ' ' LEU . 0.2 OUTLIER -63.6 -38.61 91.77 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.481 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -33.53 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.276 0.56 . . . . 1.0 111.1 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' ' N ' ' C' ' 44' ' ' ALA . 11.8 m -167.94 78.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.4 OUTLIER -37.72 -56.82 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.17 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.1 Cg_endo -59.38 -54.45 2.55 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.84 1.693 . . . . 1.0 112.577 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -79.66 0.18 31.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.277 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -58.56 -42.81 88.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 1.0 110.69 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.452 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.0 tt -68.42 -40.28 82.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.564 ' NE1' ' O ' ' D' ' 64' ' ' THR . 0.5 OUTLIER -55.27 -47.55 75.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.065 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.511 ' CG ' HD21 ' C' ' 38' ' ' LEU . 13.7 t90 -65.09 -40.18 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.421 -0.511 . . . . 1.0 109.771 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.474 ' O ' HD22 ' C' ' 19' ' ' LEU . 36.6 m -59.86 -41.13 90.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.429 ' O ' HG12 ' C' ' 49' ' ' VAL . 47.2 t -80.07 69.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' C' ' 51' ' ' THR . 12.4 pt-20 -166.48 -42.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.977 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.607 HG23 HG11 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -69.76 -36.97 76.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.146 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -57.2 -27.27 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.523 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' C' ' 54' ' ' THR . 43.7 p -95.25 4.57 53.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.322 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' C' ' 53' ' ' THR . 23.9 p 55.41 69.47 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.871 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -148.84 -81.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.33 96.7 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -62.2 -43.22 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 1.0 111.016 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.44 26.75 0.65 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.71 -44.52 96.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 1.0 110.545 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -141.8 161.16 38.65 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.435 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 40.2 p90 -141.76 118.86 7.41 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.764 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 157.62 59.5 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.837 1.692 . . . . 1.0 112.291 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.511 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 2.1 t -84.73 -136.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' C' ' 63' ' ' VAL . 81.8 m -114.48 -49.39 2.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.784 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' C' ' 67' ' ' GLY . 45.5 tp10 -54.38 -24.62 20.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -74.01 37.04 0.1 Allowed 'General case' 0 C--O 1.26 1.657 0 CA-C-O 123.358 1.551 . . . . 1.0 109.742 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.93 64.97 2.2 Favored Glycine 0 C--O 1.206 -1.614 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.367 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.485 ' CB ' ' NE1' ' B' ' 46' ' ' TRP . 10.8 ptp85 -21.97 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.915 0.858 . . . . 1.0 112.656 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.768 ' N ' ' O ' ' C' ' 67' ' ' GLY . 68.4 mttm -64.17 -10.14 21.22 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.291 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' C' ' 67' ' ' GLY . 43.1 t -61.89 -48.36 88.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 119.88 -0.728 . . . . 1.0 110.396 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.02 -43.56 71.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.688 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -61.59 -39.8 92.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.972 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -57.01 -43.68 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.261 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.607 HG11 HG23 ' C' ' 51' ' ' THR . 97.2 t -66.61 -43.38 90.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.739 -0.385 . . . . 1.0 111.546 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 41.6 mtt -60.72 -43.03 98.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.03 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.774 0.321 . . . . 1.0 110.69 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.36 89.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.31 -39.73 91.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.88 -0.488 . . . . 1.0 111.88 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.91 -43.13 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 122.54 -0.388 . . . . 1.0 110.668 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -53.96 51.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.645 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.495 HG23 ' N ' ' C' ' 82' ' ' PHE . 16.5 m -60.95 -47.97 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.163 -0.215 . . . . 1.0 111.544 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.495 ' N ' HG23 ' C' ' 81' ' ' VAL . 16.1 m-85 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.994 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -84.83 -25.59 28.01 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.961 -0.295 . . . . 1.0 110.59 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.601 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.4 m -59.46 -19.74 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.464 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -41.3 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.959 0.409 . . . . 1.0 110.644 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.516 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -62.84 -51.1 68.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.54 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.5 84.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.235 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.542 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -71.34 -37.84 71.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.529 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.26 -34.33 68.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.152 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -3.92 41.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.287 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 90.1 m-20 -57.08 -47.22 81.56 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.716 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 19.3 p90 -73.99 -9.37 58.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.971 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.27 -37.98 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.524 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.52 -28.68 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.268 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . 0.405 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.4 ptt85 -51.15 -41.53 60.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.55 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . 0.405 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 97.3 mt-10 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.183 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.794 0.33 . . . . 1.0 110.579 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.83 -37.55 87.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.689 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.74 -37.94 87.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.605 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 83.2 tt0 -64.47 -35.42 80.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.746 0.307 . . . . 1.0 110.515 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.56 -40.99 96.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.436 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.03 -37.51 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 1.0 109.955 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . 0.404 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -63.49 -37.22 86.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.825 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.44 -40.31 96.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.62 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.71 -41.2 98.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.28 94.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.727 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.14 -45.13 74.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 1.0 110.83 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.8 80.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -63.01 -36.67 84.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.416 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.3 tp -62.6 -41.46 98.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.82 0.343 . . . . 1.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.24 -39.29 75.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.928 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -61.91 -41.37 97.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.155 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.31 -35.01 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.711 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 52' ' ' ALA . 36.5 mt -60.98 -40.51 93.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.96 -49.32 78.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.308 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.015 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.52 94.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' D' ' 44' ' ' ALA . 1.2 m -59.93 -46.33 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.874 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.63 -52.99 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.76 -40.43 88.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.923 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -47.52 -58.27 4.42 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.77 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' D' ' 44' ' ' ALA . 23.5 t -61.27 -44.99 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.212 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.36 -32.69 64.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.302 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -56.88 -44.92 82.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.717 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 10.8 mp0 -66.63 -36.28 82.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.317 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.88 86.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.921 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.17 -6.38 7.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.9 143.73 27.3 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 122.768 -0.254 . . . . 1.0 110.775 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.708 ' O ' HG21 ' D' ' 63' ' ' VAL . 98.3 Cg_endo -74.64 153.85 43.98 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.301 2.0 . . . . 1.0 112.366 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.61 34.31 85.64 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.094 -0.803 . . . . 1.0 111.094 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.54 144.11 43.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 1.0 110.603 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.72 -19.93 1.8 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.486 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.488 HD23 ' C ' ' D' ' 38' ' ' LEU . 2.3 tt -111.13 90.64 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.837 0.351 . . . . 1.0 110.099 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -133.25 103.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.08 0.467 . . . . 1.0 110.296 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 19.0 t -174.21 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 1.0 OUTLIER 173.27 -61.88 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.072 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.79 -38.55 92.42 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.725 1.616 . . . . 1.0 111.927 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.91 -4.27 58.51 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.348 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . 0.449 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.97 -39.69 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 1.0 110.52 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.416 ' H ' HG22 ' D' ' 45' ' ' ILE . 1.1 tt -65.76 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.03 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.509 ' NE1' ' O ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -53.05 -45.91 68.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.598 -0.441 . . . . 1.0 109.903 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -63.89 -43.0 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.973 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 86.2 p -61.68 -36.2 80.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.922 -0.311 . . . . 1.0 110.674 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.06 -48.53 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.958 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.483 ' OE1' ' CZ ' ' A' ' 68' ' ' ARG . 19.0 pt-20 -83.87 31.62 0.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.983 0.42 . . . . 1.0 109.928 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 21.3 m -132.58 -46.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.178 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -57.02 -23.45 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 1.0 109.868 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' D' ' 54' ' ' THR . 43.0 p -94.62 5.35 52.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.399 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' D' ' 53' ' ' THR . 39.9 p 52.64 75.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.052 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.577 HG13 ' N ' ' D' ' 56' ' ' GLY . 6.6 p -139.72 -51.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.577 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 50.07 82.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.38 -44.39 97.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.701 0.286 . . . . 1.0 110.85 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.3 2.68 2.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.8 m-20 -59.23 -49.82 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.375 . . . . 1.0 110.357 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -146.97 154.14 40.91 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 12.0 p90 -154.37 147.89 18.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.979 -0.288 . . . . 1.0 110.58 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.43 172.24 13.67 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.418 2.079 . . . . 1.0 112.018 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.84 HG13 ' H ' ' D' ' 64' ' ' THR . 3.0 p -106.24 -105.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.84 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.4 m -118.15 -85.22 0.65 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.979 0.419 . . . . 1.0 111.058 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.402 ' N ' HG22 ' D' ' 64' ' ' THR . 51.9 tp10 -48.08 125.81 9.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' D' ' 68' ' ' ARG . 95.0 mt-10 57.94 -102.48 0.15 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.22 -57.07 0.0 OUTLIER Glycine 0 N--CA 1.474 1.179 0 O-C-N 124.487 1.117 . . . . 1.0 113.776 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.3 ttm-85 -79.84 -56.01 4.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.409 -0.395 . . . . 1.0 109.976 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -48.73 -29.19 4.2 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.458 ' O ' HG23 ' D' ' 74' ' ' VAL . 60.2 t -80.32 -27.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.245 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -78.09 -51.7 9.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.863 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' D' ' 73' ' ' GLN . 19.7 pt-20 -50.91 -42.03 59.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.653 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' D' ' 72' ' ' GLU . 56.1 tt0 -64.5 -42.73 95.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.85 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 70' ' ' VAL . 97.0 t -67.27 -44.91 87.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 78.5 mtm -63.74 -38.96 93.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.11 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' D' ' 80' ' ' GLU . 58.0 tttm -57.62 -40.37 79.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.582 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.562 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.22 -41.48 99.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.502 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' D' ' 82' ' ' PHE . . . -67.86 -40.06 89.5 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.811 -0.516 . . . . 1.0 111.811 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.16 -43.95 98.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.612 0.244 . . . . 1.0 111.27 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' D' ' 76' ' ' LYS . 97.6 mt-10 -66.3 -35.54 80.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.756 0.312 . . . . 1.0 111.104 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.562 HG23 ' O ' ' D' ' 77' ' ' ALA . 55.1 t -62.49 -46.29 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.318 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' D' ' 78' ' ' GLY . 58.4 m-85 -64.43 -31.98 73.41 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.58 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -82.93 -24.2 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.449 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.698 HD23 ' C ' ' D' ' 84' ' ' LEU . 7.0 tt -64.89 -42.98 94.35 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.404 HG12 ' HB1' ' D' ' 8' ' ' ALA . 13.5 m -62.0 -15.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.212 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.5 ' O ' ' N ' ' D' ' 90' ' ' ALA . 47.6 m -39.26 -39.84 0.68 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.066 0.46 . . . . 1.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' C' ' 92' ' ' ASP . . . -51.74 -59.98 3.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.663 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -25.56 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.128 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.484 ' N ' HD22 ' D' ' 89' ' ' LEU . 3.8 mm? -87.58 -28.45 21.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.127 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -66.35 -37.39 85.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.549 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -5.27 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.198 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -56.17 -51.38 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.276 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' D' ' 90' ' ' ALA . 24.6 p90 -75.28 -10.68 59.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.697 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.32 -32.84 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.21 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -66.38 -22.78 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 1.0 110.963 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -66.11 -19.83 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.431 . . . . 1.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.955 -179.351 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.821 0.343 . . . . 1.0 110.603 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.88 -40.85 98.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.542 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -67.04 -45.04 78.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.357 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.2 -42.01 96.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.381 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -65.25 -40.29 93.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.136 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -68.95 -43.34 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.184 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.09 89.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.464 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.81 -36.59 84.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.287 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.68 80.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.799 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.8 -38.37 85.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.52 -35.88 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.0 110.319 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.33 -34.65 78.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.438 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA2' ' A' ' 78' ' ' GLY . 47.2 tp -62.95 -38.54 91.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.111 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.72 -31.96 73.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -61.83 -49.63 75.5 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.241 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 18' ' ' VAL . 15.7 m -67.12 -32.64 58.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 52' ' ' ALA . 33.9 mt -61.56 -42.03 98.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.249 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.98 -45.26 86.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 1.0 110.232 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -71.2 -39.59 71.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.546 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.84 -50.22 74.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.841 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.502 ' HG ' ' CB ' ' A' ' 48' ' ' SER . 31.0 m -61.65 -44.38 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.421 . . . . 1.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.23 -33.64 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.16 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.5 -40.12 23.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.737 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.52 -46.39 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.634 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 28' ' ' GLU . 5.4 p -58.58 -45.98 90.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.902 -0.719 . . . . 1.0 109.68 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 27' ' ' VAL . 97.0 mt-10 -69.86 -41.6 74.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.942 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.29 90.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.9 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 79.8 mm-40 -78.84 -37.67 39.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.905 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.447 ' NH2' ' O ' ' A' ' 40' ' ' SER . 18.7 mmt85 -67.07 116.39 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 1.0 110.823 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.85 2.99 60.93 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.09 144.06 27.87 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.05 147.07 33.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.258 1.972 . . . . 1.0 112.425 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.13 2.01 57.71 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.15 146.91 52.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.716 0.293 . . . . 1.0 110.517 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.73 -13.9 5.22 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -86.89 35.06 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.998 0.427 . . . . 1.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.74 73.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.344 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 43' ' ' ASP . 53.4 p -160.64 -126.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.782 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 11.4 t80 179.26 -56.28 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.547 -0.263 . . . . 1.0 111.317 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.17 -23.41 73.7 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.7 1.6 . . . . 1.0 112.638 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 24.1 p30 -97.22 -1.84 44.05 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.009 -0.277 . . . . 1.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.13 -20.29 48.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.836 0.35 . . . . 1.0 110.274 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 46' ' ' TRP . 12.4 tt -68.81 -46.01 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.521 ' N ' HG23 ' A' ' 45' ' ' ILE . 29.0 m95 -74.93 -31.9 61.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.867 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.418 ' CZ3' ' HB2' ' A' ' 26' ' ' ALA . 25.3 t90 -54.32 -41.31 68.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.502 ' CB ' ' HG ' ' A' ' 23' ' ' SER . 61.1 m -64.22 -24.36 67.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.322 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.51 -26.27 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.951 0.405 . . . . 1.0 110.839 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -78.13 3.59 14.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.408 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -127.18 -33.54 2.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.2 -25.61 61.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.936 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.585 ' OG1' HG13 ' A' ' 55' ' ' VAL . 67.6 p -96.92 7.51 46.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.967 0.413 . . . . 1.0 109.904 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 p 59.62 10.37 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.949 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.585 HG13 ' OG1' ' A' ' 53' ' ' THR . 29.1 m -66.07 -42.21 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.333 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 55' ' ' VAL . . . 47.94 64.15 3.15 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' B' ' 50' ' ' GLU . 1.1 t80 -62.89 -21.86 66.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.328 . . . . 1.0 110.246 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.77 33.7 12.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.533 ' OD1' ' NH2' ' B' ' 68' ' ' ARG . 8.2 m-20 -62.68 -37.25 85.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 37.7 mmt180 -125.38 -161.42 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.247 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.428 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 19.9 t80 -156.51 82.41 3.4 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.66 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.66 153.35 69.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 1.0 112.478 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.008 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -108.1 -154.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 1.008 ' H ' HG22 ' A' ' 63' ' ' VAL . 76.6 m -90.68 -43.35 10.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.618 0.247 . . . . 1.0 111.283 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.1 tt0 -52.46 -37.23 56.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.234 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.6 26.34 0.08 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.321 2.01 . . . . 1.0 109.202 178.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 44.15 65.39 1.66 Allowed Glycine 0 C--O 1.211 -1.312 0 CA-C-N 113.506 -1.679 . . . . 1.0 111.359 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 53.2 ttm-85 -24.36 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.465 1.133 . . . . 1.0 111.008 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.4 mttp -49.46 -20.99 0.81 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.929 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.4 t -61.59 -46.51 96.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.432 -0.907 . . . . 1.0 110.45 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.82 -23.15 45.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.605 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.33 -43.86 54.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.961 0.41 . . . . 1.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.1 -47.62 85.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.046 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 75' ' ' MET . 10.6 p -66.6 -40.14 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.713 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.454 ' N ' HG13 ' A' ' 74' ' ' VAL . 49.8 ttm -62.89 -48.03 80.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.201 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.73 -38.49 89.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.317 . . . . 1.0 110.444 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.54 73.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.64 -43.42 92.07 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.61 -43.08 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.808 0.337 . . . . 1.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.35 -41.95 97.89 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.357 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.61 -51.23 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.741 0.305 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -65.86 -39.09 90.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.999 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.12 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.961 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.68 -39.05 92.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.167 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 85' ' ' VAL . 65.8 t -47.24 -10.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.745 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 84' ' ' LEU . 71.9 m -50.96 -43.87 60.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.87 -19.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.722 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.23 -37.64 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.61 -40.48 84.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.412 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.96 -43.31 98.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 1.0 110.95 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -73.32 -4.27 32.23 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.019 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -61.29 -43.43 98.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.812 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.6 p90 -80.31 -24.36 40.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.856 0.36 . . . . 1.0 111.395 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 -27.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.078 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.19 -20.89 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 93' ' ' PHE . 35.4 mtm105 -54.26 -32.31 55.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.692 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 . . . . . 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.0 109.799 179.516 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.698 0.285 . . . . 1.0 110.465 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 8.4 p-80 -73.87 -23.24 59.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.987 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.67 -33.58 75.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.699 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.9 -38.22 90.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.704 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -64.9 -42.0 95.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 1.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.6 -37.01 85.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.46 -42.08 77.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.326 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -63.24 -37.67 88.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.601 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.45 -42.15 63.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -41.09 92.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.606 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.72 -37.26 84.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.258 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.28 -34.89 78.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.433 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 HG21 ' B' ' 81' ' ' VAL . 46.1 tp -62.25 -41.82 98.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.93 -32.96 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.643 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.27 -42.72 99.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.617 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.96 -37.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.528 HD22 ' O ' ' B' ' 48' ' ' SER . 98.3 mt -60.31 -40.32 90.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 1.0 110.022 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.89 -38.68 76.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 1.0 109.932 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -66.66 -37.7 85.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 93.8 p -57.19 -41.3 79.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.616 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 63.3 tttm -70.32 -76.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.563 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' B' ' 29' ' ' ALA . 99.2 mttt -40.74 -35.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.204 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.25 -60.56 2.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.717 -0.219 . . . . 1.0 111.553 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.1 p -60.93 -42.05 91.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.04 0.448 . . . . 1.0 110.103 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' B' ' 24' ' ' LYS . 96.3 mt-10 -72.07 -13.25 61.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.533 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -61.0 -47.97 83.98 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.177 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 0.6 OUTLIER -81.23 -98.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 1.0 110.569 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 46.45 50.72 12.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.686 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.77 27.58 0.94 Allowed Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.359 -0.696 . . . . 1.0 111.359 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' B' ' 66' ' ' GLU . . . -93.91 153.52 40.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.68 116.72 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.912 1.741 . . . . 1.0 112.184 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 89.96 -23.59 19.82 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 44.95 -175.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 1.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 175.41 -66.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.53 121.33 34.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' B' ' 40' ' ' SER . 37.9 pt -143.04 -160.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.715 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.423 ' O ' ' O ' ' B' ' 39' ' ' ILE . 3.2 t 56.2 114.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.12 0.486 . . . . 1.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 2.3 t80 -63.54 -53.85 48.24 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.699 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 21.9 Cg_endo -57.72 -27.68 78.69 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.747 1.632 . . . . 1.0 112.566 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.37 -16.62 22.21 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 1.0 110.823 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.6 87.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.901 0.382 . . . . 1.0 110.318 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -61.7 -37.04 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.648 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.2 OUTLIER -64.16 -43.79 94.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.477 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.77 -21.35 64.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.528 ' O ' HD22 ' B' ' 19' ' ' LEU . 1.3 t -78.28 -32.63 49.56 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.421 . . . . 1.0 110.55 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.25 -45.41 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' B' ' 51' ' ' THR . 19.3 pt-20 -57.77 -42.38 83.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.724 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 3.4 t -73.47 -170.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.041 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 74.19 -24.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.538 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.503 ' H ' ' C ' ' B' ' 51' ' ' THR . 31.2 p -103.45 8.18 37.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.8 p 53.55 65.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.687 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.568 HG13 ' N ' ' B' ' 56' ' ' GLY . 4.7 p -138.34 -52.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.665 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.568 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 41.55 82.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -59.97 -43.83 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.284 . . . . 1.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.19 8.74 2.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -52.03 -67.63 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.763 0.315 . . . . 1.0 110.573 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -141.81 150.11 41.25 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 61' ' ' TYR . 7.6 p90 -141.22 128.49 11.85 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.49 148.58 73.29 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.637 1.558 . . . . 1.0 112.3 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.11 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.413 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 66' ' ' GLU . 89.4 m -113.98 -65.4 1.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.835 0.35 . . . . 1.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' B' ' 67' ' ' GLY . 85.0 tt0 -40.53 -21.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.589 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.564 ' OE2' ' N ' ' B' ' 66' ' ' GLU . 1.5 pm0 -80.24 30.27 0.28 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 123.741 1.734 . . . . 1.0 109.142 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.04 65.37 1.08 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.075 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.533 ' NH2' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -23.69 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.705 0.753 . . . . 1.0 110.788 -178.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 97.4 mttt -46.03 -21.21 0.12 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' B' ' 67' ' ' GLY . 77.4 t -63.07 -45.8 97.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.003 -0.679 . . . . 1.0 110.054 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.25 -50.36 19.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.842 0.353 . . . . 1.0 110.818 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -53.06 -46.64 68.63 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.312 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -57.63 -46.43 84.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.759 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 70' ' ' VAL . 87.1 t -65.47 -47.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.527 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.3 mtm -65.11 -43.03 93.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.673 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -66.59 -35.04 79.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.565 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.1 74.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.389 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.3 -37.1 94.05 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.577 HG22 ' O ' ' B' ' 79' ' ' ILE . 96.0 mt -70.68 -3.42 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.487 -0.42 . . . . 1.0 111.319 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.96 -54.41 3.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 1.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.431 HG21 HD13 ' B' ' 15' ' ' LEU . 0.1 OUTLIER -61.09 -51.35 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.169 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -65.38 -37.3 86.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.683 0.277 . . . . 1.0 110.725 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -62.59 -37.49 86.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.433 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.73 -40.3 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.191 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.524 HG13 ' HB1' ' B' ' 8' ' ' ALA . 47.9 t -57.34 -17.44 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 55.1 m -42.98 -37.87 2.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.1 0.476 . . . . 1.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.619 ' O ' HG22 ' B' ' 91' ' ' THR . . . -49.77 -63.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.4 32.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.27 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.505 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.1 mm? -68.94 -34.5 75.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -66.66 -66.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 110.016 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.2 OUTLIER -51.89 -7.9 0.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.614 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' B' ' 90' ' ' ALA . 41.7 t0 -57.01 -49.27 76.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.657 0.265 . . . . 1.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 11.9 p90 -73.39 -30.86 63.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.058 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.97 -32.86 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.674 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -57.81 -22.38 47.18 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.305 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -53.33 -25.48 15.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 1.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.933 -179.436 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' C' ' 3' ' ' ASP . 32.2 p-10 . . . . . 0 N--CA 1.461 0.099 0 CA-C-O 120.874 0.369 . . . . 1.0 110.385 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -88.09 -26.64 22.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.796 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.28 -39.97 89.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.5 -38.17 90.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.385 . . . . 1.0 110.276 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -65.29 -39.9 93.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.273 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.59 -39.95 94.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.602 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -62.72 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.178 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.05 -33.94 77.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.84 80.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.198 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.36 -36.79 81.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.42 -32.25 73.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.43 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.628 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.18 -42.24 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.586 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.48 -38.64 88.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.352 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -41.08 99.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 1.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.3 -38.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.794 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' C' ' 52' ' ' ALA . 97.1 mt -59.16 -40.65 86.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.066 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -56.06 -47.98 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.6 -34.56 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.317 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -40.76 97.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.759 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -59.94 -40.71 89.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.551 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -64.74 -33.7 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.487 . . . . 1.0 109.772 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.31 -41.17 34.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.09 87.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.479 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.572 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -59.66 -48.74 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 1.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.572 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.6 tt0 -68.96 -36.29 77.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.122 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.86 65.14 6.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.032 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 3.3 mm-40 163.04 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.437 0.461 . . . . 1.0 110.706 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 30' ' ' GLU . 14.5 tpt180 -108.49 67.77 0.67 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.6 0.238 . . . . 1.0 110.502 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.23 31.02 0.7 Allowed Glycine 0 N--CA 1.471 0.971 0 N-CA-C 111.928 -0.469 . . . . 1.0 111.928 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.742 ' HB2' ' OE2' ' C' ' 66' ' ' GLU . . . -103.71 161.07 24.1 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' C' ' 33' ' ' ALA . 72.2 Cg_endo -76.64 116.25 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.882 1.722 . . . . 1.0 111.47 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.66 83.54 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -56.04 149.41 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -21.14 2.25 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.478 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.0 OUTLIER -87.88 40.0 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.746 0.307 . . . . 1.0 110.242 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.27 80.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 1.0 110.587 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.7 m -156.36 -136.57 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.443 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.432 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 11.2 t80 179.75 -57.56 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.403 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.39 -34.79 97.5 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 121.736 1.624 . . . . 1.0 112.554 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' C' ' 43' ' ' ASP . 23.3 p-10 -94.24 6.42 48.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.293 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.69 90.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.81 -32.65 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.64 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.685 ' CZ2' HG23 ' D' ' 64' ' ' THR . 1.2 t-105 -60.05 -48.42 81.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.413 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.466 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.2 OUTLIER -67.31 -27.28 67.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 178.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 2.6 t -64.9 -34.74 79.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.941 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.53 -47.62 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 1.0 111.407 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.53 -28.82 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 1.0 111.07 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 86.5 m -61.9 -44.83 96.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 1.0 111.326 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.78 -35.36 70.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 1.0 110.573 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 71.4 p -73.52 -7.96 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 1.0 110.216 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.2 p 61.62 7.04 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' C' ' 57' ' ' TYR . 8.1 p -65.32 -40.68 89.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.538 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.458 ' N ' HG13 ' C' ' 55' ' ' VAL . . . 46.32 79.83 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.519 ' CE2' HG11 ' C' ' 55' ' ' VAL . 79.1 m-85 -61.67 -42.52 99.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 1.0 110.942 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.67 3.34 6.02 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -57.98 -64.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.837 0.351 . . . . 1.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 0.4 OUTLIER -135.09 147.72 49.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.154 179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' C' ' 61' ' ' TYR . 8.8 p90 -151.06 149.72 25.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.502 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.09 -175.75 1.34 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.198 1.932 . . . . 1.0 111.672 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.51 ' H ' ' HB2' ' C' ' 66' ' ' GLU . 1.1 t -135.64 -148.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.94 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.48 ' H ' HG12 ' C' ' 63' ' ' VAL . 6.2 p -88.09 -43.21 11.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -73.78 -14.02 61.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.11 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.742 ' OE2' ' HB2' ' C' ' 33' ' ' ALA . 13.8 mm-40 -99.34 32.16 2.85 Favored 'General case' 0 C--O 1.261 1.674 0 CA-C-O 123.964 1.84 . . . . 1.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 36.4 62.6 0.75 Allowed Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.114 -1.857 . . . . 1.0 111.168 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' C' ' 67' ' ' GLY . 52.7 ttm-85 -24.71 -29.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.859 0.83 . . . . 1.0 111.503 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' C' ' 67' ' ' GLY . 63.3 mttp -56.8 -11.04 1.21 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.2 t -60.67 -47.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.103 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.13 72.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.911 0.386 . . . . 1.0 110.72 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -54.04 -47.97 71.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.077 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.42 -41.49 93.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.474 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.82 -44.34 96.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.837 -0.345 . . . . 1.0 111.2 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.8 mtm -61.39 -41.05 96.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.937 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -61.61 -37.98 85.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.464 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.64 -38.25 84.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.34 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.2 -54.15 22.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.813 -0.708 . . . . 1.0 111.838 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.06 -42.73 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 1.0 110.661 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -59.47 -45.84 90.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.941 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 77' ' ' ALA . 54.6 t -65.04 -49.64 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.972 -0.291 . . . . 1.0 111.205 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -67.17 -37.35 83.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.898 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . 0.505 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -62.58 -35.33 79.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.522 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.426 ' C ' ' N ' ' C' ' 86' ' ' THR . 5.0 tt -61.96 -42.73 99.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.31 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' C' ' 8' ' ' ALA . 66.8 t -48.85 -16.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.571 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.426 ' N ' ' C ' ' C' ' 84' ' ' LEU . 63.3 m -47.74 -34.67 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.65 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.437 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -52.95 -22.04 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.96 -10.93 27.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.568 HD12 ' O ' ' D' ' 83' ' ' ALA . 3.5 mm? -86.62 -59.74 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.728 0.299 . . . . 1.0 111.049 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -44.61 -49.97 9.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.91 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -45.56 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.168 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' C' ' 90' ' ' ALA . 97.8 m-20 -60.84 -47.91 84.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.431 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 0.1 OUTLIER -58.93 -44.28 91.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 59.0 t -44.62 -39.57 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.412 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.22 -22.51 52.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.176 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -55.24 -43.92 75.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.306 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--N 1.329 -0.317 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.358 179.7 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.77 0.319 . . . . 1.0 110.537 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.91 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -68.49 -36.12 78.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.701 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.53 -40.72 96.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.793 0.33 . . . . 1.0 110.794 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -64.1 -42.66 96.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.544 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.26 -39.56 68.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 1.0 110.148 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.45 86.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.753 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.61 -23.26 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.719 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.13 -41.35 98.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.62 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' D' ' 84' ' ' LEU . . . -60.69 -37.21 80.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.923 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -58.86 -39.09 80.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 1.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.29 -33.29 75.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.01 -35.66 81.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' D' ' 52' ' ' ALA . 49.7 tp -62.61 -42.02 99.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 1.0 110.869 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -61.1 -41.19 96.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.996 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.08 -41.43 99.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 1.0 110.979 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.48 -43.38 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.828 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 52' ' ' ALA . 84.2 mt -61.28 -42.09 98.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.94 -50.99 68.65 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.58 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.8 -39.52 87.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.351 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.3 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 33.2 m -57.77 -44.92 86.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.75 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.49 -48.92 79.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 29' ' ' ALA . 5.5 mptp? -61.7 -37.86 85.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.311 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.69 59.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.324 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 m -93.74 -45.49 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.776 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.57 -40.43 96.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.709 0.29 . . . . 1.0 111.077 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 25' ' ' LYS . . . -54.41 -33.2 58.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.108 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -82.69 -113.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.05 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 44.32 75.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.634 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.46 -7.48 10.46 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -63.86 147.51 96.03 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.81 117.18 4.84 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.965 1.777 . . . . 1.0 112.044 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 84.57 -16.19 36.94 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' D' ' 37' ' ' ALA . . . 42.26 -168.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.0 110.892 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' D' ' 61' ' ' TYR . . . 175.58 -12.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.44 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.439 HD11 ' CG ' ' D' ' 47' ' ' TRP . 1.5 tt -151.8 43.67 0.73 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.897 0.38 . . . . 1.0 110.4 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -88.64 114.4 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' D' ' 41' ' ' TYR . 13.8 t 177.65 -122.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.549 ' N ' ' OG ' ' D' ' 40' ' ' SER . 2.2 m-85 -176.41 -66.2 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.543 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 22.8 Cg_endo -59.87 -29.92 90.62 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.011 1.807 . . . . 1.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -79.89 -5.57 55.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.961 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.64 84.8 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.37 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 46' ' ' TRP . 6.2 tt -73.22 -39.28 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.462 ' CE2' HG23 ' A' ' 64' ' ' THR . 2.7 t-105 -61.12 -48.22 82.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.227 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.439 ' CG ' HD11 ' D' ' 38' ' ' LEU . 18.9 t90 -62.41 -41.47 98.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -71.55 70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.11 0.481 . . . . 1.0 110.131 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.04 -64.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.468 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.437 ' OE2' ' OD2' ' D' ' 59' ' ' ASP . 22.6 pt-20 -66.02 -26.76 67.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.414 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.408 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.992 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.29 -26.57 65.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' D' ' 54' ' ' THR . 26.1 p -88.09 3.08 50.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 1.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' D' ' 53' ' ' THR . 19.4 p 53.88 73.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.084 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.0 t -151.12 -50.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.694 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 73.72 -48.42 1.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 11.7 t80 67.86 -14.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.581 0.229 . . . . 1.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 99.63 18.71 22.42 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 84.4 m-20 -62.46 -66.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.641 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.34 161.95 27.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.668 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 3.0 p90 -140.42 105.83 6.54 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.445 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . 0.529 ' O ' ' NH2' ' D' ' 68' ' ' ARG . 71.4 Cg_endo -70.72 164.09 36.72 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.575 1.517 . . . . 1.0 112.633 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' D' ' 64' ' ' THR . 11.0 p -112.08 -176.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.449 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' D' ' 63' ' ' VAL . 18.7 m -68.77 -44.06 74.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' D' ' 67' ' ' GLY . 58.7 tt0 -51.39 -46.93 62.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.021 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 14.3 pt-20 -79.82 36.66 0.34 Allowed 'General case' 0 C--O 1.264 1.842 0 CA-C-O 123.654 1.692 . . . . 1.0 109.0 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.39 61.75 1.2 Allowed Glycine 0 C--O 1.215 -1.038 0 CA-C-N 113.179 -1.828 . . . . 1.0 109.495 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' D' ' 62' ' ' PRO . 57.8 ttm-85 -25.52 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.298 0.646 . . . . 1.0 110.878 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.5 mmtt -56.38 -9.91 0.8 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.43 -0.805 . . . . 1.0 109.071 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 38.0 t -59.31 -47.77 89.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.391 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.43 79.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.064 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -60.59 -39.28 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.965 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.35 -41.05 96.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.437 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.74 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.02 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 74.7 mtm -63.16 -40.02 96.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.07 -45.97 91.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.465 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.513 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -66.35 -37.82 86.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 110.296 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.27 92.7 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.788 -0.525 . . . . 1.0 111.788 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.09 -43.59 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.584 0.23 . . . . 1.0 111.044 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.86 -40.11 94.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.75 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 77' ' ' ALA . 54.8 t -64.82 -49.58 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.774 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -61.77 -44.46 96.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.01 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.568 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -65.04 -35.14 80.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.053 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.709 ' C ' HD13 ' D' ' 84' ' ' LEU . 1.6 tm? -61.74 -53.33 57.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.338 -0.545 . . . . 1.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.541 ' N ' HD13 ' D' ' 84' ' ' LEU . 75.4 t -44.74 -15.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.574 ' O ' ' N ' ' D' ' 90' ' ' ALA . 94.4 m -51.8 -42.35 62.39 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.163 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -37.98 -65.1 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.608 0.242 . . . . 1.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.84 21.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' D' ' 86' ' ' THR . 41.4 mt -92.48 -21.87 19.91 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.451 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -72.77 -36.96 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.404 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -2.85 25.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.881 -0.599 . . . . 1.0 109.896 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.03 -48.0 79.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.953 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 19.4 p90 -72.94 -8.63 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.795 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.33 -36.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -67.27 -21.64 65.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.157 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -55.28 -32.33 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 1.0 110.346 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.465 -179.685 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.604 0.24 . . . . 1.0 110.562 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t0 64.45 -65.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.524 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 2' ' ' ALA . 34.6 p80 -57.65 -41.28 81.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.773 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.432 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 81.6 tt0 -62.93 -40.05 96.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.88 0.372 . . . . 1.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.36 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -65.53 -38.07 88.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.143 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.71 97.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.233 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.77 -40.45 88.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.354 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -62.9 -38.69 91.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.449 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.961 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.24 -38.37 88.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.729 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.69 -38.03 89.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.502 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -65.37 -32.73 74.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.542 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.18 -41.8 98.67 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.552 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.21 -38.91 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.185 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -62.55 -39.84 94.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.686 -0.405 . . . . 1.0 111.404 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.44 -33.13 59.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 1.0 110.539 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.9 mt -61.77 -40.94 96.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.08 -48.02 81.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 1.0 109.885 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.12 -32.65 73.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.119 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.84 96.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.654 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -60.74 -42.09 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -64.91 -50.51 66.22 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.203 0.525 . . . . 1.0 110.232 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.02 -42.74 99.49 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.256 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.12 49.44 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.564 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -60.99 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.192 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 70.2 mm-40 -68.28 -44.7 74.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.009 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.29 -39.32 82.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 1.0 110.203 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.438 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 52.3 mm-40 -69.51 -37.25 77.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.37 130.28 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 1.0 110.504 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.56 4.55 76.34 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.16 141.54 22.8 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 122.774 -0.251 . . . . 1.0 110.376 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.3 136.05 19.32 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.94 1.76 . . . . 1.0 112.143 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.75 30.84 70.0 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -63.05 -35.52 80.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.737 0.303 . . . . 1.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . 71.77 -39.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.334 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.8 tt -94.29 121.57 35.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.995 0.426 . . . . 1.0 109.886 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 38' ' ' LEU . 20.4 pt -155.17 60.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 m -155.36 138.22 15.34 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.385 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 27' ' ' VAL . 21.9 m-85 -76.34 -59.18 1.1 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.66 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.99 -28.83 87.93 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.807 1.671 . . . . 1.0 112.409 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -88.2 -21.26 24.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.937 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.38 81.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.6 tt -66.28 -37.46 79.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.301 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -46.01 87.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.478 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -64.42 -40.39 95.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.4 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 84.0 p -61.53 -32.75 72.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.031 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 45' ' ' ILE . 48.5 t -61.34 -49.83 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.857 0.361 . . . . 1.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH2' ' B' ' 68' ' ' ARG . 12.1 pt-20 -71.37 -25.52 62.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -63.62 -47.89 79.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.272 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.82 -36.54 77.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.465 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.3 p -75.11 -1.97 25.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.4 p 52.44 36.09 19.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.233 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.93 -49.91 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.042 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.19 84.73 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CZ ' ' O ' ' B' ' 60' ' ' ARG . 1.3 t80 -60.77 -46.28 91.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.534 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.36 7.1 0.59 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.5 m-20 -60.73 -47.61 85.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.803 0.335 . . . . 1.0 110.611 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' O ' ' CE1' ' D' ' 57' ' ' TYR . 26.5 mtm-85 -140.85 154.34 46.15 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.219 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.28 136.3 10.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.475 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.71 -175.15 1.28 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.794 1.662 . . . . 1.0 112.217 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.433 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 29.2 m -132.56 -131.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.342 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.669 HG22 ' CD1' ' D' ' 46' ' ' TRP . 7.4 p -113.87 -44.67 3.15 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.588 0.233 . . . . 1.0 111.194 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.7 tp10 -61.63 -40.44 94.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.254 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.438 ' OE1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -72.93 32.17 0.07 Allowed 'General case' 0 C--O 1.264 1.858 0 CA-C-O 123.703 1.716 . . . . 1.0 109.997 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.15 64.45 0.94 Allowed Glycine 0 C--O 1.212 -1.247 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.671 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.473 ' C ' ' O ' ' A' ' 67' ' ' GLY . 58.8 ttm-85 -23.59 -34.53 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.328 1.064 . . . . 1.0 111.264 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 44.9 mmtm -51.09 -15.81 0.38 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.624 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 67' ' ' GLY . 50.2 t -61.54 -47.55 92.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 119.617 -0.833 . . . . 1.0 110.225 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.23 62.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.691 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -50.66 -47.18 58.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.541 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.24 -41.55 94.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.229 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.71 -46.99 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.075 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.18 -40.85 98.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.764 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.21 -37.98 89.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.53 -38.09 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.37 -41.91 83.99 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 -43.47 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.659 0.266 . . . . 1.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.49 -40.41 91.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.013 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 75.5 t -65.69 -49.1 79.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.851 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -65.76 -40.48 92.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.13 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.35 84.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.006 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 86' ' ' THR . 8.0 tt -62.07 -42.04 98.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.212 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 85' ' ' VAL . 92.8 t -49.11 -13.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.308 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.47 ' N ' ' C ' ' A' ' 84' ' ' LEU . 58.0 m -51.79 -39.41 58.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.985 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -50.38 -24.94 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.03 -11.74 24.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.66 -50.01 6.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.339 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.67 -34.62 52.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 1.0 110.834 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -69.87 -12.87 61.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.401 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.91 -50.12 75.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.151 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 9.9 p90 -74.94 -23.13 58.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.314 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.48 -43.87 95.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.937 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.04 -22.57 62.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.652 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -42.68 -39.48 2.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 . . . . . 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 1.0 109.889 179.624 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t0 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.779 0.323 . . . . 1.0 110.683 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -73.41 -19.34 61.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.766 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -68.74 -36.1 77.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.511 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.72 -37.87 88.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 1.0 110.65 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.96 -40.4 80.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.579 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.5 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 1.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.08 -40.08 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.556 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.93 81.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.886 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.5 -38.76 87.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.655 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.98 -38.09 89.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.28 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.94 -31.84 73.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' B' ' 52' ' ' ALA . 41.5 tp -63.05 -37.57 87.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.406 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -68.1 -36.19 79.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.11 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.46 -47.58 83.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.797 0.332 . . . . 1.0 111.547 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.48 -34.39 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.972 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.8 mt -60.54 -39.44 87.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.39 -43.83 89.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.99 -32.93 73.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.053 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.47 80.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.902 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -44.86 95.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.592 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -62.74 -51.86 65.51 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.231 -0.588 . . . . 1.0 109.917 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.4 -42.78 98.78 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.417 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.19 70.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.524 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.9 OUTLIER -64.78 -42.01 93.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.469 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 82.5 tt0 -70.26 -43.74 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.242 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.14 86.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.15 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' B' ' 38' ' ' LEU . 33.0 mm-40 -66.0 -35.12 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 1.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.76 128.67 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.624 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.09 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.44 147.94 33.82 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.819 -0.224 . . . . 1.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' B' ' 36' ' ' ALA . 96.1 Cg_endo -75.47 142.53 26.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.18 1.92 . . . . 1.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.73 -23.29 0.4 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' B' ' 34' ' ' PRO . . . 45.3 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 1.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -178.19 -31.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.329 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.43 ' N ' ' OE1' ' B' ' 30' ' ' GLU . 14.8 tp -137.2 102.75 4.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.288 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' CB ' ' B' ' 40' ' ' SER . 4.2 pt -132.14 104.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.78 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 0.3 OUTLIER 164.89 143.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.545 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.5 m-85 -81.42 -61.66 0.37 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.983 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.0 Cg_endo -58.39 -27.05 80.17 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.187 1.925 . . . . 1.0 112.464 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -93.21 -22.12 19.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.056 -0.257 . . . . 1.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.52 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.51 -38.47 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.875 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' C' ' 68' ' ' ARG . 3.4 t-105 -60.95 -46.95 88.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.564 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.41 ' CD2' ' C ' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -66.58 -26.05 66.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.88 -36.09 75.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.017 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.08 -47.08 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.804 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -66.87 -30.77 71.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.61 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -63.7 -46.46 85.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.452 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.62 -28.77 65.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.11 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -90.01 4.23 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 1.0 110.543 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 p 46.82 66.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.971 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.409 HG21 ' SD ' ' C' ' 75' ' ' MET . 0.8 OUTLIER -148.96 11.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.317 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -39.01 105.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.26 -102.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.638 0.256 . . . . 1.0 110.591 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.23 11.13 3.56 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.19 -66.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 1.0 110.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 44.4 mtt-85 -145.73 157.25 43.96 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -150.98 140.41 13.75 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.3 170.84 15.1 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.021 1.814 . . . . 1.0 112.064 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.472 ' C ' ' OE1' ' B' ' 66' ' ' GLU . 2.7 t -100.83 -130.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.926 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' B' ' 66' ' ' GLU . 87.5 m -115.25 -42.02 3.23 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.424 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.694 ' C ' ' H ' ' B' ' 67' ' ' GLY . 45.4 tp10 -64.95 -37.68 88.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.755 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -67.14 28.44 0.02 OUTLIER 'General case' 0 C--O 1.265 1.885 0 CA-C-O 123.558 1.647 . . . . 1.0 110.06 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.53 63.5 1.17 Allowed Glycine 0 C--O 1.213 -1.162 0 CA-C-N 113.704 -1.589 . . . . 1.0 111.407 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.525 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.2 ttt85 -24.49 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.331 1.066 . . . . 1.0 111.018 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' B' ' 67' ' ' GLY . 32.1 mmtp -49.61 -18.09 0.4 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.456 -0.793 . . . . 1.0 108.885 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.48 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.699 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.27 -39.71 74.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.19 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -53.09 -44.17 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 109.999 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.77 -43.02 85.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.455 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.96 -44.39 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.047 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtt -60.31 -43.32 96.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.552 -0.294 . . . . 1.0 110.432 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.49 -38.94 93.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.323 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.93 87.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.01 62.2 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 79' ' ' ILE . 93.7 mt -68.3 -3.72 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.181 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -95.0 -52.36 4.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.05 0.452 . . . . 1.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 82' ' ' PHE . 12.7 m -60.91 -48.72 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.275 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.484 ' N ' HG23 ' B' ' 81' ' ' VAL . 44.4 m-85 -66.18 -38.83 89.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.956 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.04 83.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.561 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.0 tt -61.9 -40.69 96.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.107 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 89' ' ' LEU . 98.8 t -47.52 -19.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' B' ' 90' ' ' ALA . 81.6 m -51.41 -19.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.06 -64.71 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.433 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.93 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 1.0 110.723 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.549 HD23 HG12 ' B' ' 85' ' ' VAL . 3.6 mm? -98.17 -6.66 30.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.101 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 86' ' ' THR . . . -87.54 -27.17 22.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -3.85 45.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.271 -0.877 . . . . 1.0 109.881 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.543 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 35.9 t0 -54.48 -47.58 72.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.011 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' B' ' 90' ' ' ALA . 21.9 p90 -75.32 -30.0 60.19 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.275 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.47 -43.88 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.542 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 ttm-85 -46.29 -21.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.971 -0.292 . . . . 1.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 42.7 ptt85 -59.97 -41.41 91.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.405 . . . . 1.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 98.0 mt-10 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.159 -179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.791 0.329 . . . . 1.0 110.374 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.713 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.9 p80 -57.13 -41.67 79.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.622 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -64.87 -42.84 94.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -64.73 -41.92 95.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.76 -38.26 86.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.181 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.86 98.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -64.93 -42.36 94.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.328 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.38 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.362 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.4 -34.43 72.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.223 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.77 -38.41 90.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.714 0.292 . . . . 1.0 110.889 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -63.89 -34.36 77.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 1.0 110.347 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.66 -35.39 80.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.672 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' C' ' 78' ' ' GLY . 45.4 tp -62.29 -41.56 98.61 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.461 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -39.54 92.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.23 -40.77 97.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 1.0 111.283 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.22 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.662 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' C' ' 52' ' ' ALA . 84.7 mt -60.37 -40.66 91.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.415 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.8 -48.75 66.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.33 -32.94 73.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.152 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.68 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.78 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -58.59 -43.54 89.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.521 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -62.35 -51.08 69.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 109.568 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.05 -41.99 97.65 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.347 -0.541 . . . . 1.0 109.987 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.66 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.084 -0.247 . . . . 1.0 111.324 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 1.2 p -65.16 -41.29 91.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.538 -0.465 . . . . 1.0 109.954 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 44.3 tp10 -66.92 -44.21 81.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.611 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.38 -38.45 87.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.418 ' OE1' ' HB1' ' C' ' 36' ' ' ALA . 64.2 mm-40 -71.11 -34.2 70.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.149 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -67.79 121.8 16.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.855 0.36 . . . . 1.0 110.624 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.87 61.19 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.272 -0.731 . . . . 1.0 111.272 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.48 24.76 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 110.466 -0.198 . . . . 1.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.13 144.77 27.03 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.015 1.81 . . . . 1.0 112.359 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.73 11.82 58.19 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' OE1' ' C' ' 30' ' ' GLU . . . -60.19 92.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.323 . . . . 1.0 110.57 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.2 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.297 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.43 118.22 26.73 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.157 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' C' ' 40' ' ' SER . 40.2 pt -145.13 164.15 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.251 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.7 OUTLIER 82.13 142.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.789 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 89.8 t80 -80.36 -38.87 1.14 Allowed Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.112 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.8 Cg_endo -60.03 -32.73 95.29 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.403 1.402 . . . . 1.0 112.378 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' C' ' 39' ' ' ILE . 9.1 p-10 -95.09 -9.91 32.27 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 121.015 -0.274 . . . . 1.0 111.1 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -38.37 81.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 1.0 110.794 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 tt -64.67 -37.26 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.1 OUTLIER -60.93 -47.52 86.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.604 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.453 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.8 OUTLIER -71.69 -18.19 62.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.384 178.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.645 ' O ' HD22 ' C' ' 19' ' ' LEU . 7.5 t -81.01 48.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.009 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.544 HG11 HH12 ' D' ' 68' ' ' ARG . 92.0 t -147.21 -41.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.838 -0.345 . . . . 1.0 111.336 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.48 -34.55 78.17 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.853 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -44.7 83.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.181 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.795 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.46 -35.53 76.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.691 0.281 . . . . 1.0 110.571 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 43.3 p -88.46 3.46 50.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 110.106 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.2 p 51.66 75.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.37 -66.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.282 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 81.58 -59.1 4.86 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.445 -1.062 . . . . 1.0 110.445 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 68.74 -38.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.284 . . . . 1.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 124.53 19.6 2.53 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.09 -49.0 79.37 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.37 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -147.06 -165.57 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 42.6 p90 -170.41 113.75 0.46 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.19 -171.46 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.488 1.459 . . . . 1.0 112.104 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' C' ' 64' ' ' THR . 13.3 p -129.48 -176.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' C' ' 63' ' ' VAL . 71.3 m -79.83 -25.23 40.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.777 0.322 . . . . 1.0 110.476 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' C' ' 67' ' ' GLY . 43.1 tp10 -66.54 -43.63 84.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.399 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -77.0 31.47 0.14 Allowed 'General case' 0 C--O 1.268 2.035 0 CA-C-O 124.212 1.958 . . . . 1.0 109.586 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.83 64.38 1.92 Allowed Glycine 0 C--O 1.217 -0.914 0 CA-C-N 113.24 -1.8 . . . . 1.0 111.266 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' C' ' 67' ' ' GLY . 42.3 ttm180 -24.79 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.9 0.85 . . . . 1.0 111.049 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' C' ' 67' ' ' GLY . 29.9 mmtp -48.75 -22.35 0.78 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.595 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' C' ' 67' ' ' GLY . 80.0 t -61.95 -48.09 90.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 118.958 -1.097 . . . . 1.0 110.564 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.45 78.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 1.0 110.793 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.76 -44.78 96.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.015 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.58 -38.45 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.221 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.31 -43.15 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.455 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.409 ' SD ' HG21 ' B' ' 55' ' ' VAL . 60.2 mtt -60.99 -42.0 97.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.84 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 64.7 tttm -61.92 -41.22 97.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 1.0 110.555 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.15 -38.88 92.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 1.0 110.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.24 -41.98 91.3 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.968 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -61.12 -43.1 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.682 0.277 . . . . 1.0 110.717 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.7 mt-10 -60.13 -43.59 95.55 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.202 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.45 -49.22 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.361 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.79 -38.76 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.318 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.01 85.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 1.0 110.675 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.33 -40.59 97.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.93 -20.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.435 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 5.7 t -50.78 -22.1 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 1.0 110.515 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.543 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -56.14 -25.61 46.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.202 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.29 -16.41 19.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.694 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 58.7 mt -86.2 -47.1 9.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.82 -29.19 59.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.847 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -89.58 -3.65 58.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.968 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 53.3 t0 -56.27 -47.28 78.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.585 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 7.9 p90 -75.19 -37.5 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.105 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 95.9 t -46.64 -27.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.575 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.688 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -42.47 -37.25 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 1.0 111.078 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.653 -179.823 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.446 ' CB ' ' NE2' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.348 . . . . 1.0 110.619 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.68 -43.96 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.907 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.668 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 5.2 p80 -69.11 -37.34 78.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.85 -36.6 84.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.47 -43.4 97.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.88 -37.57 86.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.897 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . 0.441 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 59.0 tt0 -63.42 -39.93 95.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.58 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -63.91 -36.67 84.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.62 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.24 -27.56 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.282 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.52 -39.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 1.0 110.765 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' D' ' 13' ' ' GLU . 54.3 mp0 -67.06 -34.36 77.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.591 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -62.51 -37.22 85.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.651 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.7 tp -62.72 -42.0 99.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.389 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.12 -32.5 73.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -61.91 -39.19 91.14 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.045 0.45 . . . . 1.0 110.826 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.96 -38.49 72.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.637 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.3 mt -61.95 -45.92 91.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.645 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.17 -42.26 69.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 1.0 110.344 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.07 -40.28 82.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 1.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.27 83.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -55.54 -44.27 76.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.641 -0.254 . . . . 1.0 110.568 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -65.45 -32.87 74.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.631 -0.427 . . . . 1.0 110.169 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.3 -43.87 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.886 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -60.33 -49.63 76.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.533 HG13 ' N ' ' D' ' 28' ' ' GLU . 8.7 p -60.6 -44.55 97.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 109.908 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.533 ' N ' HG13 ' D' ' 27' ' ' VAL . 9.1 tm-20 -68.06 -42.51 80.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.546 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.05 91.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.628 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 3.2 mp0 -70.74 -34.18 71.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.324 . . . . 1.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -69.23 122.9 19.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 1.0 110.663 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.28 -2.06 57.62 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.574 -0.739 . . . . 1.0 111.366 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.52 35.82 Favored Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 122.847 -0.208 . . . . 1.0 110.538 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.54 143.04 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.057 1.838 . . . . 1.0 112.357 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.57 76.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.43 143.76 57.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.762 0.315 . . . . 1.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.05 -22.77 2.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 37.6 tp -70.87 -89.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.536 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.546 HG22 ' N ' ' D' ' 40' ' ' SER . 95.5 mt 54.12 161.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.188 0.518 . . . . 1.0 110.671 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.546 ' N ' HG22 ' D' ' 39' ' ' ILE . 1.1 t 76.23 130.47 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 20.8 t80 -77.22 -43.61 2.68 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.069 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.5 Cg_endo -59.2 -29.72 91.15 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.238 1.292 . . . . 1.0 112.094 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.544 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.3 m-20 -89.96 -30.91 17.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.565 -0.289 . . . . 1.0 110.993 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.72 82.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.868 0.366 . . . . 1.0 110.774 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.407 ' O ' HG23 ' D' ' 49' ' ' VAL . 7.7 tt -63.95 -37.06 78.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.059 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.669 ' CD1' HG22 ' A' ' 64' ' ' THR . 0.2 OUTLIER -67.41 -41.48 84.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.246 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CG ' ' D' ' 50' ' ' GLU . 13.5 t90 -60.08 -37.33 79.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' D' ' 19' ' ' LEU . 85.8 p -65.65 -33.1 75.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.29 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.564 ' O ' HG12 ' D' ' 49' ' ' VAL . 62.1 t -79.72 63.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.058 0.456 . . . . 1.0 111.724 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' D' ' 47' ' ' TRP . 8.3 pt-20 178.9 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.68 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.49 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 90.4 m -65.33 -42.08 93.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.637 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -55.09 -26.23 36.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 16.8 p -83.02 0.86 42.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.235 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.6 p 57.99 10.93 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.971 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' D' ' 57' ' ' TYR . 76.7 t -91.17 -54.76 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.677 0.275 . . . . 1.0 110.739 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.08 -42.1 0.61 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' D' ' 55' ' ' VAL . 0.1 OUTLIER 56.16 -74.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.763 0.316 . . . . 1.0 110.681 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . -159.15 -91.49 0.08 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' NH1' ' D' ' 60' ' ' ARG . 29.5 t70 45.41 -119.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.729 0.3 . . . . 1.0 110.345 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.544 ' NH2' ' O ' ' D' ' 43' ' ' ASP . 0.1 OUTLIER -113.78 169.24 9.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.8 p90 -137.09 136.41 20.94 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.782 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.63 154.27 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.267 1.978 . . . . 1.0 112.195 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.519 HG23 ' H ' ' D' ' 66' ' ' GLU . 18.1 m -93.42 -145.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.874 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.439 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 5.6 m -112.87 -41.04 3.85 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.694 0.283 . . . . 1.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' D' ' 67' ' ' GLY . 52.1 tp10 -66.07 -25.76 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.103 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.519 ' H ' HG23 ' D' ' 63' ' ' VAL . 1.0 OUTLIER -74.39 30.44 0.08 Allowed 'General case' 0 C--O 1.263 1.79 0 CA-C-O 123.697 1.713 . . . . 1.0 108.975 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.42 61.35 3.27 Favored Glycine 0 C--O 1.21 -1.385 0 CA-C-N 114.011 -1.449 . . . . 1.0 109.537 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.544 HH12 HG11 ' C' ' 49' ' ' VAL . 55.6 ttp85 -24.48 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 O-C-N 124.328 0.664 . . . . 1.0 110.735 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.7 mttt -51.98 -18.32 1.33 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.413 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' D' ' 67' ' ' GLY . 54.0 t -62.75 -49.63 82.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.932 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . 0.541 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -70.9 -43.27 68.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.403 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -41.84 -43.93 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.234 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -70.67 -35.66 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.665 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.1 -52.07 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.056 -0.658 . . . . 1.0 111.677 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.541 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 0.0 OUTLIER -70.89 -40.1 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 1.0 110.71 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -43.01 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.464 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.6 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.421 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -63.67 -41.53 98.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.582 -0.607 . . . . 1.0 111.582 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.21 -43.05 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.636 0.255 . . . . 1.0 111.072 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -42.03 97.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.072 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.41 -48.33 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.364 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -71.58 -12.79 61.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.787 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -94.65 -31.84 13.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.8 0.333 . . . . 1.0 110.185 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.1 tt -64.4 -41.51 96.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.459 HG12 ' HB1' ' D' ' 8' ' ' ALA . 35.0 m -58.42 -2.88 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.5 ' H ' ' C ' ' D' ' 84' ' ' LEU . 48.1 m -60.01 -22.26 62.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.056 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -59.08 -47.89 83.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.249 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.78 85.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.836 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.42 -39.52 92.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.461 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -56.8 -45.37 82.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.976 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -10.06 59.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.641 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.9 t0 -55.82 -48.52 75.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.133 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -76.11 -30.54 58.29 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.821 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.42 -26.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.305 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp85 -57.75 -32.75 67.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.883 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' D' ' 97' ' ' GLU . 36.1 ptt85 -58.17 -39.23 78.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.411 . . . . 1.0 110.037 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' D' ' 96' ' ' ARG . 81.0 tt0 . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.717 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.468 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.912 0.387 . . . . 1.0 110.704 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -106.84 -8.79 16.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.465 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.468 ' NE2' ' HB1' ' A' ' 2' ' ' ALA . 13.4 p80 -87.64 -19.74 27.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.12 -38.84 89.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.69 -38.16 90.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.233 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.1 -41.22 99.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.172 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.61 96.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 1.0 110.527 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.69 -37.16 85.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.316 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -62.46 -37.38 85.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.14 76.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.904 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.59 -38.71 92.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.597 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.2 -34.59 76.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.353 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -65.55 -34.09 77.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.392 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 52' ' ' ALA . 48.3 tp -62.92 -39.01 93.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.331 . . . . 1.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.04 -34.63 78.51 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.62 -46.77 81.16 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.6 m -63.62 -36.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.549 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.8 mt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.76 -45.81 77.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.104 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.94 -38.58 79.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.288 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.92 85.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.72 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -57.62 -44.11 85.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.087 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.3 -31.71 72.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.453 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 29' ' ' ALA . 97.2 mttt -76.57 -48.44 19.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.59 79.59 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.467 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.0 p -61.93 -44.67 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.306 -0.558 . . . . 1.0 109.669 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 27' ' ' VAL . 84.0 tt0 -69.85 -31.22 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.385 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -57.01 -38.09 72.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.261 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.24 -39.27 86.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -55.41 99.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.628 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.71 -2.45 23.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.06 142.42 24.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 O-C-N 122.753 -0.263 . . . . 1.0 110.653 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.503 ' O ' HG11 ' A' ' 63' ' ' VAL . 98.5 Cg_endo -75.07 144.19 29.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.936 1.758 . . . . 1.0 112.269 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.25 26.39 70.48 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.83 151.24 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 1.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 -53.17 0.54 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.481 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 53.93 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 39' ' ' ILE . 13.7 tt -105.64 96.81 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.225 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 71.7 m -169.34 -123.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.618 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 40' ' ' SER . 4.6 m-85 -171.66 -68.54 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.197 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 41' ' ' TYR . 28.5 Cg_endo -60.15 -32.55 94.71 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.998 1.798 . . . . 1.0 112.241 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -86.29 -20.08 28.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.102 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.87 95.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 1.0 110.353 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -67.96 -39.09 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.545 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -59.43 -44.21 92.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.902 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -59.68 -39.43 84.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -65.96 -36.96 84.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.18 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.4 -48.77 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 120.734 0.302 . . . . 1.0 110.736 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.9 -31.79 70.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.515 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 m -62.38 -45.29 93.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.313 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.46 -29.11 67.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.454 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 55' ' ' VAL . 13.9 p -90.24 11.9 19.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 1.1 p 41.42 41.9 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.276 -0.875 . . . . 1.0 111.211 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 ' SD ' ' B' ' 75' ' ' MET . 45.3 t -81.07 -51.74 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.972 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 88.07 -69.38 2.85 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.142 -0.551 . . . . 1.0 111.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.404 ' CD2' HG11 ' A' ' 55' ' ' VAL . 1.3 m-85 54.4 -83.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.932 0.396 . . . . 1.0 110.255 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . 140.48 27.84 0.21 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.27 -43.75 98.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 1.0 110.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 25.6 mmt180 -132.21 -178.72 5.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.097 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 81.7 m-85 -157.45 96.84 2.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.706 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.72 156.07 64.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.79 1.66 . . . . 1.0 112.411 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -79.69 -141.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.334 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.433 ' CA ' ' OE2' ' A' ' 66' ' ' GLU . 7.5 p -115.41 -41.76 3.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.775 0.322 . . . . 1.0 110.571 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' GLY . 15.6 tm-20 -61.6 -24.94 67.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -71.89 40.74 0.07 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 123.576 1.655 . . . . 1.0 109.167 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.765 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.82 66.71 2.3 Favored Glycine 0 C--O 1.199 -2.064 0 CA-C-N 113.708 -1.587 . . . . 1.0 111.959 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.518 ' NE ' ' CD1' ' D' ' 46' ' ' TRP . 35.7 ttm105 -24.91 -27.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.726 1.263 . . . . 1.0 112.176 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.5 mttm -76.61 -6.91 53.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.944 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.748 ' N ' ' O ' ' A' ' 67' ' ' GLY . 13.9 t -58.75 -48.53 85.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.446 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.4 -41.93 69.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.567 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.93 -36.49 79.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.582 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.79 -53.51 57.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.08 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.28 -42.19 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.7 tpp -52.23 -50.58 61.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.63 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -65.17 -41.14 94.96 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.73 -46.37 70.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.839 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -63.74 -43.43 97.78 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -43.38 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.606 0.241 . . . . 1.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.17 -43.36 99.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.47 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.38 -49.03 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.38 -8.83 57.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.979 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.64 -39.44 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.9 tt -63.21 -42.55 99.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.573 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 m -50.77 -9.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.602 -0.439 . . . . 1.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.2 m -57.98 -38.59 76.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.969 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -48.99 -33.72 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.302 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 -11.51 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' THR . 76.4 mt -91.69 -46.65 7.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.028 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.85 -24.78 53.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 1.0 110.675 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 t -86.58 -3.56 59.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.988 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.1 m-20 -62.12 -43.69 98.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.173 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 5.7 p90 -74.69 -31.59 61.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.517 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.16 -26.59 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.37 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -63.94 -21.89 66.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -60.07 -33.99 72.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 1.0 110.752 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.961 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.806 0.336 . . . . 1.0 110.745 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.49 ' CE1' HH22 ' B' ' 95' ' ' ARG . 6.0 p80 -76.13 -18.69 59.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.436 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.18 -37.26 85.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.758 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 61.0 ttt85 -60.99 -44.26 97.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.559 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -41.41 88.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.681 -0.408 . . . . 1.0 109.917 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -65.73 -37.34 86.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.646 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -62.85 -37.46 86.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.05 76.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.01 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.53 -39.77 85.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.0 110.693 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.434 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 6.3 tm-20 -65.37 -36.87 85.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.86 -32.81 74.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.552 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.33 -40.76 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.393 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -63.24 -37.03 85.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . 0.434 ' NZ ' ' OE1' ' B' ' 13' ' ' GLU . 29.2 mtmm -62.26 -41.75 98.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.0 111.054 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.08 -40.73 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.627 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' B' ' 52' ' ' ALA . 96.0 mt -61.4 -40.86 95.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.5 mt-10 -65.53 -44.01 88.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.03 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -72.03 -39.44 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.345 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.26 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.512 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.2 p -57.51 -45.41 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.77 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.81 -35.7 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.191 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.4 mttm -69.42 -45.91 68.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -54.24 -49.48 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.532 0.197 . . . . 1.0 111.532 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.432 HG13 ' N ' ' B' ' 28' ' ' GLU . 3.0 p -60.83 -46.22 96.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.432 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.7 tm-20 -68.46 -35.42 77.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.687 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -59.18 -46.99 86.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.481 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 30' ' ' GLU . 4.1 mp0 -68.02 -37.61 81.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 1.0 110.396 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -55.61 97.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.743 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.12 -7.9 16.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.481 -0.648 . . . . 1.0 111.481 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.29 146.93 34.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 122.852 -0.204 . . . . 1.0 110.487 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.522 ' O ' HG11 ' B' ' 63' ' ' VAL . 96.9 Cg_endo -75.6 142.6 26.29 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.057 1.838 . . . . 1.0 112.503 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.77 29.81 71.15 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.98 145.39 41.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 1.0 110.188 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.525 ' O ' ' NH1' ' B' ' 60' ' ' ARG . . . -126.87 -25.79 3.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.539 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.56 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.5 tt -103.1 119.49 38.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 110.09 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.465 ' N ' HD23 ' B' ' 38' ' ' LEU . 40.4 pt -153.05 -141.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.769 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.08 -127.43 1.3 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.893 0.377 . . . . 1.0 110.653 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.436 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 2.1 m-85 -164.32 -63.19 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.084 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.5 Cg_endo -58.73 -23.36 65.9 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.199 1.932 . . . . 1.0 112.122 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -89.77 -29.66 18.53 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.828 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.444 ' CB ' HD21 ' B' ' 38' ' ' LEU . . . -68.27 -40.0 82.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.0 110.596 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.6 tt -65.84 -42.94 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.703 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.481 ' N ' HG23 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -66.19 -36.96 84.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.41 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -61.65 -40.26 94.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.633 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.453 ' O ' HD22 ' B' ' 19' ' ' LEU . 10.8 p -58.4 -29.19 65.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.945 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.43 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.711 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' B' ' 59' ' ' ASP . 23.7 mt-10 -66.8 -33.93 76.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.0 m -60.09 -44.58 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.506 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.79 -24.49 57.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.974 -0.291 . . . . 1.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 56.6 p -90.29 0.83 57.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.637 -0.256 . . . . 1.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.6 p 52.65 25.57 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.441 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.571 HG13 ' N ' ' B' ' 56' ' ' GLY . 7.4 p -83.1 -46.27 18.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 72.26 -32.93 0.66 Allowed Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' B' ' 55' ' ' VAL . 1.9 m-85 41.17 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.02 0.438 . . . . 1.0 110.563 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' B' ' 56' ' ' GLY . . . 162.86 19.72 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' B' ' 50' ' ' GLU . 92.0 m-20 -63.46 -45.68 89.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.795 0.331 . . . . 1.0 110.641 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' B' ' 37' ' ' ALA . 96.9 mtt-85 -147.38 -175.36 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.24 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.533 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 13.5 p90 -162.19 113.77 1.16 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.96 153.41 72.59 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.38 1.387 . . . . 1.0 112.56 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.522 HG11 ' O ' ' B' ' 34' ' ' PRO . 2.1 t -77.82 -138.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.012 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 63' ' ' VAL . 95.2 m -114.58 -39.61 3.75 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.766 0.317 . . . . 1.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' B' ' 67' ' ' GLY . 80.1 tt0 -65.06 -24.19 67.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.329 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -74.95 27.03 0.09 Allowed 'General case' 0 C--O 1.263 1.769 0 CA-C-O 123.576 1.655 . . . . 1.0 109.719 179.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.12 63.47 1.3 Allowed Glycine 0 C--O 1.212 -1.246 0 CA-C-N 113.656 -1.611 . . . . 1.0 111.269 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.4 ttm180 -25.08 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 118.124 0.962 . . . . 1.0 110.943 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 67' ' ' GLY . 44.9 mmtm -48.62 -19.84 0.39 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' B' ' 67' ' ' GLY . 61.4 t -62.51 -47.26 93.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.607 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.89 -38.06 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.96 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -60.63 -40.85 93.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.18 -44.87 79.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.638 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.26 -43.98 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.346 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 55' ' ' VAL . 55.4 mtt -55.38 -46.9 76.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.633 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -41.96 97.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.546 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.41 ' O ' HG22 ' B' ' 81' ' ' VAL . . . -60.12 -24.54 64.75 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.54 -41.45 5.42 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.93 -43.85 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 122.416 -0.461 . . . . 1.0 111.318 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.69 -52.46 65.4 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.876 0.369 . . . . 1.0 111.383 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 82' ' ' PHE . 15.9 m -60.62 -46.27 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.479 ' N ' HG23 ' B' ' 81' ' ' VAL . 18.3 m-85 -74.15 2.7 8.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.997 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.46 -30.11 5.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.771 0.319 . . . . 1.0 110.227 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.475 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.5 tt -64.03 -40.44 96.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.256 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.468 HG12 ' HB1' ' B' ' 8' ' ' ALA . 26.9 m -48.57 -15.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.873 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.475 ' N ' ' C ' ' B' ' 84' ' ' LEU . 52.7 m -49.14 -23.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -64.64 -42.26 95.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.695 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -11.41 59.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' B' ' 92' ' ' ASP . 43.5 mt -91.0 -38.81 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -54.42 -34.86 62.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.356 0.598 . . . . 1.0 109.481 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.523 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.2 OUTLIER -79.26 -8.02 58.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.395 -0.821 . . . . 1.0 109.969 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' B' ' 89' ' ' LEU . 66.2 t0 -55.82 -51.46 67.41 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.786 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 17.4 p90 -71.84 -41.77 67.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.747 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 57.1 t -45.13 -35.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.515 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 84.5 mtt85 -63.54 -22.7 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.056 -0.257 . . . . 1.0 111.404 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' B' ' 96' ' ' ARG . 23.7 ptt-85 -46.77 -29.03 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 1.0 110.079 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 C--N 1.331 -0.204 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.045 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 t0 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.943 0.402 . . . . 1.0 110.064 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -81.83 -20.04 39.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.57 -43.04 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -75.49 -29.73 59.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -64.96 -42.74 94.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.214 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.26 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -66.74 -40.85 88.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.182 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -64.25 -35.25 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -43.16 87.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.193 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -40.55 96.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 1.0 110.968 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.518 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.82 -36.28 83.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.465 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.414 HD13 ' HA2' ' C' ' 78' ' ' GLY . 50.7 tp -62.4 -41.46 98.68 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.5 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -58.92 -40.14 83.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.388 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.66 -39.37 91.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 1.0 111.032 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.22 -32.87 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.4 mt -61.37 -41.85 97.75 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.02 -46.68 84.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.0 109.765 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.7 -40.41 72.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.433 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.75 93.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.825 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.526 ' HG ' ' CB ' ' C' ' 48' ' ' SER . 40.4 m -60.11 -45.4 93.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.655 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -66.57 -40.99 89.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.203 0.525 . . . . 1.0 110.401 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.3 mttt -66.7 -41.97 87.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.661 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.24 -51.18 69.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.361 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 7.4 p -62.37 -33.19 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.265 0.555 . . . . 1.0 110.363 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.02 -21.28 31.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.051 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -65.03 -50.83 64.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.034 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.8 pp20? -59.0 -29.36 67.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.99 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 10.8 tpt85 -62.17 118.17 7.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.794 0.33 . . . . 1.0 110.262 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.93 -9.82 63.88 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.37 148.61 34.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.496 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 87.6 Cg_endo -76.21 126.76 9.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.784 1.656 . . . . 1.0 112.299 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.02 37.47 6.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 143.06 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 1.0 110.631 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -151.73 -42.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 26.47 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.013 0.435 . . . . 1.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' C' ' 37' ' ' ALA . 12.9 tt -63.27 -24.32 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.493 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 43.3 t -59.42 129.59 42.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.518 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.507 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 52.7 t80 -86.25 -50.91 0.48 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.983 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.0 Cg_endo -60.03 -33.69 95.24 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.514 1.476 . . . . 1.0 112.426 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.77 -7.27 57.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.282 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.26 88.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.777 0.322 . . . . 1.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.459 HG23 ' HE3' ' C' ' 46' ' ' TRP . 12.0 tt -65.0 -33.72 65.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.538 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.663 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -70.18 -47.37 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.432 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -61.11 -39.64 90.75 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.382 -0.527 . . . . 1.0 109.771 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.534 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.1 m -53.18 -21.26 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.604 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.38 -43.42 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.519 ' CD ' HH21 ' D' ' 68' ' ' ARG . 9.8 pt-20 -90.27 57.81 3.85 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.74 0.305 . . . . 1.0 111.399 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.513 ' O ' ' SD ' ' C' ' 75' ' ' MET . 6.0 t -159.51 -42.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.223 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -64.32 -36.99 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 1.0 110.924 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' C' ' 54' ' ' THR . 1.5 p -94.57 19.81 9.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.871 0.367 . . . . 1.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 53' ' ' THR . 27.6 p 54.6 81.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.639 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.81 -84.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.88 44.73 45.96 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -48.22 82.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 1.0 110.66 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 165.39 -100.19 0.17 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 38.5 m-20 38.41 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.883 0.373 . . . . 1.0 111.342 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' C' ' 58' ' ' GLY . 66.5 mtm-85 -123.43 157.61 33.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.57 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -141.92 146.17 39.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.34 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.88 152.32 73.7 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.126 1.884 . . . . 1.0 112.13 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.549 HG12 ' H ' ' C' ' 64' ' ' THR . 2.1 t -64.33 -139.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 1.0 109.992 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.549 ' H ' HG12 ' C' ' 63' ' ' VAL . 17.1 m -114.5 -77.13 0.57 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.465 ' O ' ' CZ2' ' B' ' 46' ' ' TRP . 80.6 tt0 -37.28 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.932 -0.577 . . . . 1.0 110.736 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.3 mm-40 -73.89 -103.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.07 -56.38 0.0 OUTLIER Glycine 0 N--CA 1.476 1.338 0 O-C-N 124.378 1.049 . . . . 1.0 114.225 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 88.3 mtt180 -70.71 -45.59 64.65 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' C' ' 66' ' ' GLU . 68.1 mmtt -62.35 -41.72 98.81 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.298 -0.631 . . . . 1.0 109.298 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.77 -45.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 119.798 -0.761 . . . . 1.0 111.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.1 69.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 1.0 109.76 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -69.71 -38.58 76.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.628 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.58 -49.13 74.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.89 -32.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.826 -0.349 . . . . 1.0 111.104 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' C' ' 51' ' ' THR . 27.4 tpp -61.17 -43.6 98.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.818 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.43 -38.72 92.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.703 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.459 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -55.81 -46.99 77.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.633 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -63.98 -41.81 98.49 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.223 -0.513 . . . . 1.0 111.862 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.56 -43.45 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.768 0.318 . . . . 1.0 110.788 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.55 -40.98 89.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 77' ' ' ALA . 69.5 t -63.86 -50.89 75.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.365 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -67.21 -40.79 86.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.772 -0.371 . . . . 1.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.77 71.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.988 0.423 . . . . 1.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' C' ' 86' ' ' THR . 5.4 tt -62.95 -35.75 81.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.457 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' C' ' 87' ' ' ALA . 18.7 t -39.93 -23.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 1.0 110.702 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 1.3 p -41.9 -21.76 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.953 0.406 . . . . 1.0 109.988 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -48.1 -50.78 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.93 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.52 -33.27 7.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.759 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.31 -45.9 91.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.768 0.318 . . . . 1.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' C' ' 86' ' ' THR . . . -74.2 -14.45 60.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.995 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -92.97 -2.68 55.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.32 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -59.08 -43.05 91.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.69 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 5.6 p90 -66.97 -32.0 72.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.7 -43.68 91.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.271 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -57.97 -20.81 40.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -53.41 -43.31 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.979 -0.289 . . . . 1.0 110.364 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 . . . . . 0 C--N 1.33 -0.28 0 C-N-CA 120.998 -0.281 . . . . 1.0 110.377 179.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.758 0.313 . . . . 1.0 110.689 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -62.51 -40.32 96.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.665 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.75 -40.63 92.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.601 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.9 tt0 -64.66 -37.2 86.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.819 0.342 . . . . 1.0 110.43 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -60.86 -43.29 98.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.381 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.64 -41.78 98.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.045 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.38 93.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.642 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.9 -37.59 79.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.99 -39.79 91.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.419 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.78 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.886 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.612 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -64.07 -39.53 94.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.89 -36.01 82.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.74 -41.2 99.08 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.063 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -37.39 85.78 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.774 0.321 . . . . 1.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.21 -41.25 92.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.624 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' D' ' 52' ' ' ALA . 88.8 mt -59.76 -41.5 91.18 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' D' ' 23' ' ' SER . 96.9 mt-10 -61.84 -48.47 80.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.271 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.94 -32.7 73.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.0 109.908 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.57 93.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.69 -46.39 90.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.923 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.45 -34.84 76.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 1.0 110.566 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -73.05 -45.61 56.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.877 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.91 79.79 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.917 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.49 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.6 p -65.48 -42.67 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.221 0.534 . . . . 1.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.49 ' N ' HG13 ' D' ' 27' ' ' VAL . 48.1 tp10 -70.63 -41.5 72.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.7 -45.79 85.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 39' ' ' ILE . 0.3 OUTLIER -75.5 -18.38 59.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.837 0.351 . . . . 1.0 111.305 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -67.18 108.63 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 1.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.59 -8.34 51.43 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.432 -0.667 . . . . 1.0 111.432 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.02 149.17 76.34 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.54 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.6 Cg_endo -74.57 142.96 29.97 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.131 1.887 . . . . 1.0 112.424 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 22.07 67.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 143.56 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.328 . . . . 1.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -27.53 1.71 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.51 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -66.47 -16.38 64.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.493 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.638 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.5 tt -37.55 105.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.973 0.416 . . . . 1.0 111.153 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 88.9 p -173.85 -133.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.192 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' D' ' 40' ' ' SER . 2.3 m-85 -177.65 -66.28 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.413 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.1 Cg_endo -58.88 -32.31 97.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.842 1.695 . . . . 1.0 111.65 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -93.92 -7.22 43.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.23 87.28 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.848 0.356 . . . . 1.0 110.493 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -69.33 -36.59 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.317 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.518 ' CD1' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -55.6 -49.06 73.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 -178.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.67 -40.52 92.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.167 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.401 ' O ' HD22 ' D' ' 19' ' ' LEU . 54.3 p -61.42 -36.19 79.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.669 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -63.53 -48.09 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.985 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.3 44.97 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -139.06 -47.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.06 -25.95 67.29 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.3 p -89.41 9.87 24.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 53' ' ' THR . 42.9 p 51.59 70.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.802 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.78 -77.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.846 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 94.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -61.82 -41.48 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 1.0 110.843 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.92 8.51 3.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.859 -0.897 . . . . 1.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.29 -47.9 83.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -140.28 148.93 42.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 25.7 p90 -136.91 137.8 24.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.514 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.54 155.37 63.5 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.376 2.051 . . . . 1.0 112.284 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -88.81 -141.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.079 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.663 HG22 ' CD1' ' C' ' 46' ' ' TRP . 1.7 p -113.67 -42.77 3.39 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.821 0.343 . . . . 1.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.76 -19.12 65.08 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.49 26.16 0.1 Allowed 'General case' 0 C--O 1.265 1.872 0 CA-C-O 123.7 1.714 . . . . 1.0 109.443 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 43.19 59.75 3.34 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 113.907 -1.497 . . . . 1.0 109.414 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.519 HH21 ' CD ' ' C' ' 50' ' ' GLU . 51.0 ttt85 -26.49 -28.94 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.363 0.684 . . . . 1.0 110.994 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.4 mttm -53.35 -18.68 2.7 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.044 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 53.2 t -62.46 -46.97 95.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.803 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.91 76.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.302 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.89 -46.24 82.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.76 -0.655 . . . . 1.0 111.164 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.14 -41.37 99.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.38 -46.18 96.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.241 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 25.1 mtm -63.4 -41.5 98.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.846 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.71 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.438 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.17 -41.08 92.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.438 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.41 -41.89 83.8 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.523 -0.631 . . . . 1.0 111.523 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.64 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.842 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -66.82 -44.09 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.177 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 77' ' ' ALA . 74.3 t -64.8 -49.22 81.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.436 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.58 -5.55 11.91 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.872 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.95 -38.2 5.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.68 -16.81 6.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.4 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.42 -1.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.723 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 89' ' ' LEU . 19.5 m -58.31 -42.16 86.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.995 0.426 . . . . 1.0 109.91 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -48.17 -17.09 0.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.76 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -105.03 -12.95 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.775 0.322 . . . . 1.0 110.464 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.3 mt -87.67 -51.18 6.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -55.32 -28.41 53.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.136 0.493 . . . . 1.0 110.421 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.803 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.5 OUTLIER -86.9 0.53 54.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.521 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 44.4 t0 -72.04 -37.7 69.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.432 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 7.4 p90 -75.86 -42.75 48.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.803 HG22 ' O ' ' D' ' 91' ' ' THR . 17.1 m -39.97 -33.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.446 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -53.7 -22.53 9.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.741 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -55.94 -34.93 66.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 25.9 tp10 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.613 179.763 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.694 0.283 . . . . 1.0 110.474 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ALA . 99.5 m-20 -140.26 -50.32 0.47 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.518 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -82.46 -19.71 38.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.499 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.65 -38.89 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.01 -38.78 92.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.367 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.1 -39.84 93.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.78 96.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.271 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -68.52 -38.92 81.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.511 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.04 -38.88 92.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.396 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.69 78.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.792 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.1 -36.72 82.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 1.0 110.691 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.15 -34.56 78.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.153 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -64.77 -35.32 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.65 -41.79 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.433 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 87.6 mt-30 -60.24 -40.58 90.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.244 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -44.05 97.33 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.69 -42.06 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.441 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 52' ' ' ALA . 20.1 mt -60.16 -41.93 93.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.448 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -65.17 -43.07 92.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.4 -46.53 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.381 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.02 79.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.206 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 13.4 p -53.11 -42.07 65.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.035 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' ALA . 65.4 tttm -66.4 -74.08 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -35.96 -26.5 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.147 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' LYS . . . -62.61 -42.61 99.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 2.3 m -68.11 -47.05 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.178 0.513 . . . . 1.0 110.593 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 44.1 tp10 -67.09 -34.45 77.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' OE1' ' A' ' 66' ' ' GLU . . . -54.25 -29.09 45.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -67.56 -41.11 84.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.099 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.51 HH21 ' CB ' ' A' ' 36' ' ' ALA . 5.3 mmp_? -74.13 101.97 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.225 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.03 -27.19 4.61 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 152.5 40.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 110.027 -0.361 . . . . 1.0 110.027 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.5 147.66 32.4 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.382 2.054 . . . . 1.0 112.61 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.71 36.62 7.25 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.51 ' CB ' HH21 ' A' ' 31' ' ' ARG . . . -55.08 143.88 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 1.0 110.641 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.77 -58.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.11 58.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.263 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.5 pt -85.63 -5.49 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.177 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -72.79 151.65 41.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.632 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' A' ' 42' ' ' PRO . 20.1 m-85 -98.02 -63.17 0.1 Allowed Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.753 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.16 -29.63 89.54 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.969 1.779 . . . . 1.0 112.508 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 73.7 m-20 -81.85 -5.99 58.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.955 -0.298 . . . . 1.0 110.53 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . . . -63.9 -43.16 96.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.388 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.69 -39.21 81.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.505 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -59.3 -43.8 92.6 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.506 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 14.2 t90 -63.29 -40.2 96.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 58.4 p -61.64 -32.7 72.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.71 -46.53 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.239 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.63 13.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.542 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -100.21 -49.27 4.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.757 0.313 . . . . 1.0 110.56 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.22 -26.76 67.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.382 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.4 p -84.53 5.44 27.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.224 0.535 . . . . 1.0 109.628 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.36 60.5 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.312 -0.858 . . . . 1.0 111.29 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.1 p -131.65 -48.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.952 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.76 95.55 0.01 OUTLIER Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.649 -0.58 . . . . 1.0 111.649 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -74.49 -102.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.0 110.571 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.38 18.88 1.17 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' CZ ' ' B' ' 68' ' ' ARG . 99.8 m-20 -60.23 -47.29 86.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 33.9 mmt180 -134.63 -163.02 1.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 46.3 m-85 -161.34 100.59 1.24 Allowed Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.547 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 63' ' ' VAL . 62.1 Cg_endo -69.47 150.02 69.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.353 1.369 . . . . 1.0 112.568 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 62' ' ' PRO . 6.0 m -53.53 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.371 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.543 ' CG2' HH22 ' D' ' 60' ' ' ARG . 98.0 m -102.63 -71.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.535 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 84.1 tt0 -37.81 -70.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 1.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' A' ' 68' ' ' ARG . 74.2 mt-10 -83.42 -107.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -54.58 0.0 OUTLIER Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.779 1.299 . . . . 1.0 114.77 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' A' ' 66' ' ' GLU . 60.0 ttm-85 -65.74 -74.9 0.1 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.851 -0.674 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -43.55 -37.6 2.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.27 -47.32 90.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.033 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 68' ' ' ARG . . . -65.99 -36.8 84.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.644 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.22 -38.29 73.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.615 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -63.41 -43.32 97.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.594 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.91 -45.34 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.622 ' SD ' HG11 ' D' ' 55' ' ' VAL . 65.2 mtt -60.84 -42.91 98.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.95 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.62 -43.2 97.55 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.62 -39.82 95.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.612 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.69 95.61 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.54 -43.27 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.988 -0.285 . . . . 1.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.43 -42.29 98.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.249 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 59.9 t -64.73 -50.88 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -68.46 -39.51 81.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.978 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.67 85.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.222 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.461 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.7 tt -61.77 -42.54 99.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.404 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 85' ' ' VAL . 99.1 t -47.75 -16.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 1.0 110.328 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.461 ' N ' ' C ' ' A' ' 84' ' ' LEU . 92.9 m -51.59 -21.35 2.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.214 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 -35.3 78.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.243 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.57 -14.59 34.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.5 -42.7 18.11 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.932 0.345 . . . . 1.0 111.932 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.72 -30.46 67.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.844 0.354 . . . . 1.0 111.216 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.4 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.17 -50.42 73.76 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.69 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 94' ' ' VAL . 15.7 p90 -72.37 -43.92 63.3 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.268 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.575 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 57.8 t -39.72 -34.37 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.662 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -63.04 -34.96 78.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 1.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' PHE . 40.0 ptt85 -39.46 -42.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.899 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.445 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 5.2 tp10 . . . . . 0 C--N 1.328 -0.355 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.833 0.349 . . . . 1.0 111.019 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.67 -41.64 97.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.0 110.395 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.59 -33.36 75.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -62.0 -42.35 99.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.308 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.46 -44.22 83.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.361 . . . . 1.0 110.225 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -67.31 -41.54 85.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.654 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.19 -38.57 90.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.671 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.72 -37.41 86.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.21 75.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.893 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.21 -36.03 76.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 1.0 110.629 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 -37.32 87.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -64.2 -33.63 76.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.664 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.6 tp -62.43 -41.84 99.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.691 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.65 -39.92 85.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.647 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.94 -38.86 92.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.829 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.18 -41.8 94.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.754 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 94.1 mt -59.37 -41.1 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.46 -44.3 96.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 1.0 109.915 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.74 -37.78 76.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.393 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.68 88.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.415 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -58.48 -45.82 87.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -65.31 -35.0 79.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.904 0.383 . . . . 1.0 110.218 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.673 ' NZ ' HE22 ' B' ' 73' ' ' GLN . 98.7 mttt -70.95 -45.22 64.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.51 77.45 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.511 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.488 HG23 ' N ' ' B' ' 28' ' ' GLU . 24.0 m -58.59 -46.82 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.798 -0.761 . . . . 1.0 110.534 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.488 ' N ' HG23 ' B' ' 27' ' ' VAL . 89.5 mt-10 -67.91 -42.68 80.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.784 0.326 . . . . 1.0 111.027 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.37 87.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.568 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -65.09 -47.7 76.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.737 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.51 131.45 49.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.04 69.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.38 143.03 25.79 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.32 -0.252 . . . . 1.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' B' ' 63' ' ' VAL . 93.5 Cg_endo -75.45 142.6 26.71 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.151 1.901 . . . . 1.0 112.138 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.65 19.88 73.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.181 -0.767 . . . . 1.0 111.181 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.13 145.24 51.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 1.0 110.397 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.08 -34.47 0.87 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.516 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -81.75 125.5 30.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 1.0 110.588 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' SER . 35.5 pt -152.13 -166.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.408 -0.815 . . . . 1.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 39' ' ' ILE . 6.1 t 59.97 135.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 1.0 111.283 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.567 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -65.85 -48.98 61.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.369 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.45 -29.53 88.82 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.599 1.533 . . . . 1.0 112.913 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.03 -23.55 22.56 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.7 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' B' ' 27' ' ' VAL . . . -63.54 -41.63 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 1.0 110.58 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 49' ' ' VAL . 4.9 tt -65.09 -39.36 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.49 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.495 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.4 OUTLIER -59.86 -47.51 85.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.474 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -61.85 -41.91 98.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 1.0 110.267 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -64.37 -40.3 95.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.199 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 45' ' ' ILE . 44.9 t -60.49 -47.48 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.631 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.69 -32.81 74.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -64.81 -43.55 92.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.25 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -54.47 -26.3 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.915 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.6 p -88.96 2.23 54.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.716 0.293 . . . . 1.0 110.712 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' B' ' 53' ' ' THR . 69.6 p 51.59 66.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.708 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' B' ' 57' ' ' TYR . 30.5 t -133.88 -52.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.674 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.33 76.91 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.489 ' CZ ' HG11 ' B' ' 55' ' ' VAL . 81.3 m-85 -61.22 -42.6 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.912 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.89 20.73 0.83 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.527 ' CG ' HH22 ' C' ' 68' ' ' ARG . 32.7 m-20 -62.5 -41.71 99.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.816 0.341 . . . . 1.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 34.9 mmt180 -132.88 -175.83 3.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 58.9 m-85 -159.45 99.35 1.55 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.856 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.2 158.16 58.7 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.3 1.333 . . . . 1.0 112.606 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.556 HG11 ' O ' ' B' ' 34' ' ' PRO . 0.8 OUTLIER -95.11 -154.17 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.022 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.523 ' H ' HG12 ' B' ' 63' ' ' VAL . 26.8 m -101.93 -38.26 7.88 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.9 tm-20 -61.55 -32.38 72.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 1.0 110.2 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -73.01 26.52 0.06 Allowed 'General case' 0 C--O 1.263 1.784 0 CA-C-O 124.046 1.879 . . . . 1.0 109.599 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 44.31 63.95 2.2 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-O 117.492 -1.727 . . . . 1.0 110.961 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.505 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.1 ttm180 -25.08 -31.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.297 1.049 . . . . 1.0 110.904 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.5 mttt -49.82 -17.77 0.4 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 67' ' ' GLY . 45.7 t -60.32 -47.08 93.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 119.477 -0.889 . . . . 1.0 109.488 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.54 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -68.23 -54.21 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.303 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -42.82 -34.97 1.03 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.33 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . 0.673 HE22 ' NZ ' ' B' ' 25' ' ' LYS . 59.2 tt0 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.533 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 71' ' ' ALA . 45.0 t -67.03 -52.93 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.861 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 0.0 OUTLIER -65.0 -42.59 94.36 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.612 -179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.51 -43.96 93.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.119 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.428 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -64.16 -39.63 94.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.43 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.85 -42.99 92.63 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.711 -0.556 . . . . 1.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.5 -43.5 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.041 -0.264 . . . . 1.0 110.77 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 84' ' ' LEU . 80.9 mm-40 -60.28 -41.47 93.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.301 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 77' ' ' ALA . 65.3 t -64.11 -49.17 82.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.457 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -76.59 -12.16 59.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.547 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.34 -26.58 14.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.918 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 80' ' ' GLU . 4.7 tt -63.63 -41.32 98.27 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.04 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' B' ' 87' ' ' ALA . 17.3 m -47.45 -26.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.445 -0.502 . . . . 1.0 109.68 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 6.1 m -34.16 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.415 0.626 . . . . 1.0 110.211 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -53.37 -53.2 54.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.601 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -70.25 -30.18 67.17 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.333 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.445 ' N ' HD12 ' B' ' 89' ' ' LEU . 9.5 mp -61.29 -43.67 98.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.997 0.427 . . . . 1.0 109.886 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 -17.81 61.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.513 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -100.54 -11.56 20.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.241 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.6 m-20 -63.12 -41.92 99.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.076 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 1.4 p90 -64.94 -29.88 70.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.363 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.96 -43.4 92.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.519 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -48.71 -21.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.31 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -55.18 -32.22 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 1.0 110.119 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.125 -179.436 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 t0 . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.783 0.325 . . . . 1.0 110.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -58.7 -41.77 87.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.694 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.24 -37.11 86.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.72 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.9 -39.29 93.84 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.92 -39.35 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.248 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -41.01 99.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.48 -37.19 84.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.72 -38.4 87.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.661 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.5 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.2 -36.29 83.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.971 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.85 -38.71 91.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.752 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -36.02 82.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.706 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.45 -36.09 82.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 1.0 110.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.87 -33.66 76.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.184 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -61.28 -47.84 84.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.579 -0.282 . . . . 1.0 111.56 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 18' ' ' VAL . 12.5 m -65.28 -36.22 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 1.0 110.653 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' C' ' 52' ' ' ALA . 36.0 mt -60.86 -41.56 96.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.74 -42.98 99.67 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.119 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -68.89 -44.75 72.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.74 78.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.468 ' O ' ' HB1' ' C' ' 44' ' ' ALA . 72.6 m -56.75 -43.95 81.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.858 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.471 ' O ' HG22 ' C' ' 27' ' ' VAL . 8.0 tmtt? -80.65 -61.86 1.84 Allowed 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -41.89 -28.75 0.17 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.159 -0.216 . . . . 1.0 110.956 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.58 78.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.571 0.224 . . . . 1.0 110.721 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 24' ' ' LYS . 2.3 m -63.26 -43.55 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.045 0.45 . . . . 1.0 110.544 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' C' ' 27' ' ' VAL . 14.4 tm-20 -80.58 -24.22 39.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -51.01 71.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.918 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.55 78.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -53.01 90.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.564 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.12 -6.18 8.22 Favored Glycine 0 N--CA 1.47 0.911 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.14 150.73 39.14 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.255 . . . . 1.0 110.32 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.62 141.77 28.28 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.685 1.59 . . . . 1.0 111.649 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 37.35 34.27 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.64 150.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.0 110.562 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' C' ' 61' ' ' TYR . . . -132.06 -116.79 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.71 HD22 ' C ' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -55.05 163.93 0.95 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.242 0.544 . . . . 1.0 110.961 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' C' ' 40' ' ' SER . 5.7 pt -152.85 -169.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.746 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.516 ' C ' ' CG ' ' C' ' 41' ' ' TYR . 37.6 m -53.02 -165.31 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.874 0.369 . . . . 1.0 110.83 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.597 ' C ' ' H ' ' C' ' 43' ' ' ASP . 0.3 OUTLIER 76.31 161.19 0.15 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.57 5.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.564 2.176 . . . . 1.0 112.131 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' C' ' 41' ' ' TYR . 21.2 t70 -84.2 -32.3 24.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' C' ' 23' ' ' SER . . . -60.9 -44.56 96.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 1.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.53 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.4 tt -63.93 -38.0 81.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.393 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.409 . . . . 1.0 110.211 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' C' ' 48' ' ' SER . 1.4 t90 -63.25 -47.72 81.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.608 ' O ' HD22 ' C' ' 19' ' ' LEU . 1.9 t -50.42 -29.22 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.776 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' C' ' 49' ' ' VAL . 57.4 t -90.39 62.91 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.684 ' CG ' HH22 ' D' ' 68' ' ' ARG . 46.7 tp10 -173.28 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.658 -0.817 . . . . 1.0 110.825 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' C' ' 75' ' ' MET . 4.5 t -72.57 -38.97 67.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.695 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -61.23 -28.38 69.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.957 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -93.67 1.82 56.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.07 0.462 . . . . 1.0 110.282 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 57.4 p 49.8 56.9 7.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.656 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' C' ' 57' ' ' TYR . 1.7 m -145.94 45.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.422 ' H ' HG13 ' B' ' 55' ' ' VAL . . . -45.58 92.44 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.324 -1.11 . . . . 1.0 110.324 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.579 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 18.2 t80 -61.97 -43.21 99.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 1.0 110.41 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.17 16.24 0.75 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.418 ' HB2' ' HE ' ' D' ' 68' ' ' ARG . 68.0 t0 -60.98 -52.11 66.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 1.0 110.766 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -151.71 -162.28 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.493 ' O ' ' CB ' ' C' ' 37' ' ' ALA . 38.7 p90 -166.69 134.91 2.21 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.802 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 176.54 6.23 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.864 1.71 . . . . 1.0 112.362 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 63' ' ' VAL . 16.5 m -87.25 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.416 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.495 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 1.1 m -110.08 -61.49 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.574 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.455 ' N ' HG22 ' C' ' 64' ' ' THR . 81.4 tt0 -42.99 -30.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.675 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 94.1 mt-10 -144.68 -104.27 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.73 -55.28 0.0 OUTLIER Glycine 0 N--CA 1.479 1.521 0 O-C-N 124.358 1.036 . . . . 1.0 114.839 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 45.0 ttm-85 -71.12 -43.17 68.18 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.192 -0.504 . . . . 1.0 109.971 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.3 tptm -60.63 -45.16 95.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.918 -1.141 . . . . 1.0 107.918 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.53 -46.64 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.797 -0.761 . . . . 1.0 110.329 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.531 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -63.05 -39.8 95.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 1.0 110.13 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -43.73 -49.36 7.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.79 -36.35 83.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.529 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.02 -43.28 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.767 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.3 mpp? -59.36 -44.64 92.66 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.726 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -64.5 -41.18 96.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.53 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . 0.534 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.98 -24.13 65.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.786 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.29 -37.61 6.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.717 -0.553 . . . . 1.0 111.717 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.56 -43.43 98.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.07 -37.67 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.534 HG23 ' O ' ' C' ' 77' ' ' ALA . 55.1 t -62.75 -47.12 94.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.321 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -73.74 -8.01 54.32 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.299 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -40.72 12.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.876 0.369 . . . . 1.0 110.285 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.07 -42.32 99.63 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.812 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.94 -15.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.432 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.475 ' O ' ' N ' ' C' ' 89' ' ' LEU . 28.1 m -60.04 -39.87 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.43 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -39.2 -50.56 1.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.59 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.26 90.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 1.0 110.084 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' C' ' 86' ' ' THR . 44.7 mt -66.68 -38.92 87.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.401 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -60.73 -37.64 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.438 . . . . 1.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -81.99 -3.6 54.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -55.64 -49.7 72.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.569 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.2 p90 -69.06 -32.62 72.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 -27.55 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.913 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.4 -22.94 67.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.611 -0.268 . . . . 1.0 111.152 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -57.59 -31.99 66.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 1.0 110.447 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.536 -179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.764 0.316 . . . . 1.0 110.612 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -174.03 -66.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -79.21 -18.91 52.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.58 -38.79 87.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.402 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.76 -42.13 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.507 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.78 -39.42 94.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.44 99.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.818 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.18 -39.07 92.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.06 -40.82 97.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -35.42 76.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.968 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.804 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.4 -38.07 88.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.368 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.37 -31.93 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.516 HD11 ' HB1' ' D' ' 52' ' ' ALA . 45.7 tp -62.07 -39.64 93.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 1.0 110.184 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.4 -34.21 75.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -63.5 -46.78 84.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.844 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.402 ' H ' HG22 ' D' ' 18' ' ' VAL . 12.2 m -63.62 -37.45 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 1.0 110.675 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' D' ' 52' ' ' ALA . 82.7 mt -61.23 -41.45 96.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.345 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.9 -46.32 82.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.912 0.387 . . . . 1.0 110.318 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.53 -35.36 75.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.287 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.06 92.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 1.0 111.054 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -58.24 -43.65 87.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.123 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -63.96 -32.84 74.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.37 -45.19 60.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.683 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -49.23 78.38 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.54 HG13 ' N ' ' D' ' 28' ' ' GLU . 10.9 p -60.87 -45.7 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.54 ' N ' HG13 ' D' ' 27' ' ' VAL . 80.3 tt0 -67.98 -43.21 79.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.704 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.95 86.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.215 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.444 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 37.7 mm-40 -67.54 -38.23 83.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.179 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . 0.504 HH11 HD11 ' D' ' 39' ' ' ILE . 16.3 tpp180 -63.69 124.08 20.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.981 0.42 . . . . 1.0 110.726 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.5 68.83 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.68 139.4 21.88 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.539 ' O ' HG11 ' D' ' 63' ' ' VAL . 95.7 Cg_endo -74.77 144.77 31.57 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.228 1.952 . . . . 1.0 112.53 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.88 22.65 70.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -91.2 87.82 6.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.709 0.29 . . . . 1.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . 0.433 ' O ' HG22 ' D' ' 39' ' ' ILE . . . -65.14 -38.82 91.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.916 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.561 HD23 ' C ' ' D' ' 38' ' ' LEU . 4.3 tt -66.6 99.14 0.56 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.587 HG23 ' O ' ' D' ' 39' ' ' ILE . 14.3 tt -143.45 93.34 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.4 OUTLIER 168.58 150.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.572 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 10.0 m-85 -76.87 -58.79 1.02 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.562 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.1 Cg_endo -58.93 -26.78 82.47 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.648 1.565 . . . . 1.0 111.728 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.34 -35.9 27.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 1.0 111.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.79 92.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.199 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.17 -44.21 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.896 0.379 . . . . 1.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -62.8 -42.02 99.54 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.581 -0.448 . . . . 1.0 110.175 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.579 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 36.1 t90 -62.12 -40.43 95.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.269 -0.572 . . . . 1.0 109.81 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.454 ' O ' HG23 ' D' ' 49' ' ' VAL . 1.4 m -74.22 69.48 1.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.804 0.335 . . . . 1.0 110.455 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.454 HG23 ' O ' ' D' ' 48' ' ' SER . 53.3 t -155.47 -61.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 1.0 110.178 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 1.5 pm0 -63.06 -31.99 73.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.555 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.468 HG23 HG11 ' D' ' 74' ' ' VAL . 0.0 OUTLIER -60.62 -42.9 97.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.223 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.779 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.96 -35.02 75.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 1.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' D' ' 54' ' ' THR . 18.1 p -80.07 9.47 5.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.16 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' D' ' 53' ' ' THR . 44.3 p 51.93 56.33 7.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.047 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.622 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.9 p -166.81 88.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.253 0.549 . . . . 1.0 111.157 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.24 109.92 3.57 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.506 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -61.32 -45.34 94.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 1.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.52 24.78 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 64.6 m-20 -61.8 -43.71 98.31 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.991 -0.284 . . . . 1.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.543 HH22 ' CG2' ' A' ' 64' ' ' THR . 0.2 OUTLIER -144.94 -177.19 5.4 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' D' ' 60' ' ' ARG . 41.5 m-85 -156.36 128.51 4.01 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.0 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.1 -171.13 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.736 1.624 . . . . 1.0 112.064 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 1.5 t -128.96 -146.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.178 -0.465 . . . . 1.0 109.986 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.615 HG22 ' CD1' ' C' ' 46' ' ' TRP . 2.9 p -113.48 -8.7 13.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.776 -0.193 . . . . 1.0 110.847 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' D' ' 67' ' ' GLY . 50.8 tp10 -99.06 -26.67 14.15 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.838 -0.431 . . . . 1.0 109.838 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.0 OUTLIER -80.97 30.92 0.31 Allowed 'General case' 0 C--O 1.265 1.874 0 CA-C-O 123.896 1.808 . . . . 1.0 108.879 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.01 61.71 2.24 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 113.377 -1.738 . . . . 1.0 109.493 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.684 HH22 ' CG ' ' C' ' 50' ' ' GLU . 71.3 ttt-85 -26.21 -30.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.134 0.55 . . . . 1.0 110.981 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.8 mttt -52.22 -13.61 0.35 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.292 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.0 t -59.56 -47.8 89.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.525 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.59 83.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.496 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.85 -43.14 85.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.365 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -61.92 -44.72 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.209 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.468 HG11 HG23 ' D' ' 51' ' ' THR . 98.1 t -64.11 -46.51 93.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.476 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.66 -44.74 95.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.995 -0.282 . . . . 1.0 111.23 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -66.15 -41.54 90.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 1.0 110.785 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.16 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.707 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.65 -39.11 93.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.586 -0.606 . . . . 1.0 111.586 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.61 -43.53 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.906 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.14 -38.95 93.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.079 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.34 -54.19 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.719 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.88 -39.6 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.812 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.44 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.0 110.446 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.66 -40.75 96.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.525 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' D' ' 87' ' ' ALA . 48.1 t -57.6 -22.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.831 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 86.4 m -40.32 -24.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.53 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -64.51 -42.47 95.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.669 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -72.44 -15.62 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.493 ' N ' HD22 ' D' ' 89' ' ' LEU . 3.8 mm? -85.79 -41.44 15.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.033 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.87 -36.83 72.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.218 0.533 . . . . 1.0 110.244 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -15.03 62.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.9 -51.85 67.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.234 -0.587 . . . . 1.0 111.073 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 12.6 p90 -72.23 -28.51 63.21 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.057 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.97 -35.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.962 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -59.9 -22.2 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.213 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -48.66 -36.94 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.0 110.367 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.688 -179.696 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.038 0 CA-C-O 120.911 0.386 . . . . 1.0 110.693 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.53 -40.36 96.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.493 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.12 -46.23 89.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.175 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.67 -41.35 92.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 9' ' ' GLN . 8.8 tpm_? -64.1 -43.78 94.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.101 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.35 -43.76 85.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.087 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.39 92.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . 0.443 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 67.6 tp60 -64.36 -39.01 93.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.19 -41.19 96.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.91 -35.75 77.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.53 -37.8 85.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.488 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.71 -38.33 90.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.33 -32.66 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.505 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' HB1' ' A' ' 52' ' ' ALA . 49.6 tp -62.53 -38.29 89.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.079 0.466 . . . . 1.0 110.251 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.89 -33.99 74.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.12 -45.76 87.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.844 0.313 . . . . 1.0 111.844 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -63.08 -33.14 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 52' ' ' ALA . 77.3 mt -60.51 -41.94 95.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.567 -0.453 . . . . 1.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.24 -47.92 82.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.626 -0.429 . . . . 1.0 109.854 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.53 -35.62 79.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.016 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.06 84.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.614 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 p -59.56 -47.88 83.81 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -67.51 -44.86 77.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.618 . . . . 1.0 110.47 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.4 mttt -63.64 -41.93 98.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.801 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.57 -51.47 68.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.642 -0.253 . . . . 1.0 111.532 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.4 p -64.68 -42.55 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.176 0.512 . . . . 1.0 109.855 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' N ' HG13 ' A' ' 27' ' ' VAL . 44.8 tp10 -70.57 -34.04 71.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.516 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -56.14 -50.69 70.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.573 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 32' ' ' GLY . 11.4 pt-20 -67.0 -36.55 82.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.019 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -55.19 87.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.352 . . . . 1.0 110.786 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 127.74 -9.09 6.83 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.498 -0.641 . . . . 1.0 111.498 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.18 143.3 26.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 122.676 -0.308 . . . . 1.0 110.175 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.29 119.04 5.13 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.03 1.82 . . . . 1.0 112.179 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 114.02 12.64 10.91 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.066 -0.813 . . . . 1.0 111.066 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -40.47 165.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.328 . . . . 1.0 110.892 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 61' ' ' TYR . . . -146.49 -86.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.064 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -72.44 57.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.41 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 tt -63.4 -18.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 1.0 110.423 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 9.9 m -71.86 146.5 47.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.1 t80 -83.55 -51.58 0.63 Allowed Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.767 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -59.93 -30.25 91.3 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.492 1.461 . . . . 1.0 112.484 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -88.27 -23.16 23.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.625 0.25 . . . . 1.0 111.003 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -63.0 -38.71 92.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 1.0 110.111 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -65.73 -38.63 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.494 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.7 92.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.415 . . . . 1.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -60.29 -38.58 84.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.0 m -56.26 -31.67 63.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 49' ' ' VAL . 46.9 t -82.49 -5.42 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 1.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.474 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 49.5 tt0 -108.76 33.45 4.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.239 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -39.27 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.48 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.59 -25.48 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.47 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 54' ' ' THR . 45.8 p -85.65 -2.13 57.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 53' ' ' THR . 48.5 p 53.27 73.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.118 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.27 -53.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.779 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.07 63.51 4.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.62 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 1.0 110.583 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 60' ' ' ARG . . . 161.95 -87.66 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.514 ' CG ' HH22 ' B' ' 68' ' ' ARG . 10.0 m-20 41.86 -92.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 1.0 110.486 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 mpp_? -115.23 -173.52 2.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.84 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 56.1 p90 -156.08 129.78 4.63 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.355 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.31 169.33 19.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.036 1.824 . . . . 1.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.985 HG22 ' H ' ' A' ' 64' ' ' THR . 6.0 p -81.27 -155.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.28 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 63' ' ' VAL . 1.3 m -113.76 -64.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.063 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' THR . 80.6 tt0 -37.5 -39.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.027 0.442 . . . . 1.0 110.549 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.85 ' O ' ' N ' ' A' ' 68' ' ' ARG . 73.7 mm-40 -135.85 -104.28 0.21 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.524 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -57.17 0.0 OUTLIER Glycine 0 N--CA 1.479 1.516 0 O-C-N 124.563 1.164 . . . . 1.0 114.449 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.85 ' N ' ' O ' ' A' ' 66' ' ' GLU . 58.4 ttm-85 -71.56 -46.94 58.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.113 0.483 . . . . 1.0 109.965 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 66' ' ' GLU . 3.5 tmtp? -60.68 -45.33 94.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.39 -43.43 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.021 -0.672 . . . . 1.0 110.029 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.3 84.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.56 -43.03 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.151 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.5 -35.47 79.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.302 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.17 -48.84 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.137 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.4 ptp -65.07 -37.5 87.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.533 -0.303 . . . . 1.0 110.572 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.45 -42.81 92.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.345 -0.388 . . . . 1.0 110.221 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.69 -31.19 71.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.642 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -77.29 -38.05 30.26 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.57 -43.79 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.583 0.23 . . . . 1.0 110.624 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.83 -36.6 84.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.202 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' ALA . 39.3 t -63.6 -49.71 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.919 0.39 . . . . 1.0 110.631 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.34 -31.04 71.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.252 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.88 -26.65 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.986 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.89 -43.76 95.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.881 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.3 m -62.08 -16.56 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.409 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' VAL . 38.0 m -36.49 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.093 0.473 . . . . 1.0 110.444 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' O ' HG22 ' A' ' 91' ' ' THR . . . -55.72 -57.73 10.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.476 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.96 -32.94 66.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.49 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.495 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -69.31 -36.35 76.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -66.76 -55.74 13.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.985 0.422 . . . . 1.0 111.276 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -51.45 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.97 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.4 m-20 -60.36 -48.1 83.22 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.581 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 24.6 p90 -69.49 -28.05 65.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.386 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.04 -45.7 95.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.925 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -68.08 -22.25 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.706 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -44.19 -23.86 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.881 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 . . . . . 0 C--N 1.329 -0.283 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.527 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.774 0.321 . . . . 1.0 110.979 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' B' ' 5' ' ' GLU . 6.2 p80 -63.66 -29.94 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.79 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' B' ' 4' ' ' HIS . 50.2 tp10 -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.566 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -64.56 -39.22 93.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.61 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -64.09 -40.23 95.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.04 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.51 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.32 -38.36 87.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.28 -40.13 95.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.573 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.32 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.751 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.21 -35.21 79.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 1.0 110.478 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.08 -36.59 84.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.344 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.9 -37.51 87.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.54 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 ' HA2' ' B' ' 78' ' ' GLY . 48.4 tp -62.52 -40.47 96.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.29 -38.77 92.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.78 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.66 -37.96 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.941 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.68 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.575 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' B' ' 52' ' ' ALA . 95.9 mt -59.96 -41.19 91.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.1 mm-40 -57.85 -49.75 75.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.3 -37.01 77.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.202 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.59 -43.59 65.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.206 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -62.59 -40.18 96.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.719 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.29 -33.03 75.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 29' ' ' ALA . 4.4 mptp? -83.99 -50.75 7.72 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.909 -0.317 . . . . 1.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.45 72.79 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.081 -0.247 . . . . 1.0 111.33 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 3.8 p -62.17 -45.63 98.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.325 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.5 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -74.27 -32.02 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.033 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -58.93 -37.85 77.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.51 -37.85 77.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.359 . . . . 1.0 110.918 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -54.6 95.47 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.097 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.441 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 119.27 -7.71 12.53 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.1 22.32 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 122.836 -0.214 . . . . 1.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.58 147.5 31.92 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.03 1.82 . . . . 1.0 112.528 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.78 20.15 70.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.7 56.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 1.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -35.28 0.46 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.77 HD23 ' O ' ' B' ' 38' ' ' LEU . 2.6 tt -62.85 -30.63 71.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.87 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.6 HD13 ' N ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -34.48 119.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.655 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.6 ' N ' HD13 ' B' ' 39' ' ' ILE . 31.1 t -176.22 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.5 m-85 176.79 -65.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.001 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.1 -38.07 93.1 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.116 1.878 . . . . 1.0 112.228 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.536 ' O ' ' NH2' ' B' ' 60' ' ' ARG . 40.5 p30 -101.88 2.22 37.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.05 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.91 96.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.932 0.396 . . . . 1.0 110.17 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -31.91 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.713 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.556 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.5 OUTLIER -54.74 -49.83 69.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.514 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.504 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.5 OUTLIER -64.02 -39.56 94.38 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.267 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.504 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.4 p -59.45 -35.72 74.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.203 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -48.26 89.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.557 ' CG ' HH22 ' C' ' 68' ' ' ARG . 14.5 pt-20 -68.9 -30.76 69.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.699 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -62.19 -45.64 92.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.151 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.648 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -60.69 -27.99 68.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 1.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 47.0 p -86.81 3.8 43.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.68 0.276 . . . . 1.0 110.807 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 50.37 74.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 1.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.501 HG11 ' CE1' ' B' ' 57' ' ' TYR . 57.6 t -142.11 -57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.54 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.52 82.28 0.04 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.501 ' CE1' HG11 ' B' ' 55' ' ' VAL . 57.7 m-85 -61.94 -41.83 98.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.709 0.29 . . . . 1.0 110.967 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.62 9.52 1.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -60.62 -49.18 78.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 1.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.536 ' NH2' ' O ' ' B' ' 43' ' ' ASP . 0.9 OUTLIER -145.09 145.33 31.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.112 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 47.5 p90 -133.68 126.78 19.18 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.63 156.44 63.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.735 1.623 . . . . 1.0 112.282 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.455 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -83.26 -138.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.033 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.455 ' H ' HG12 ' B' ' 63' ' ' VAL . 53.9 m -114.27 -39.88 3.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.996 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.1 tt0 -65.8 -22.9 66.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.904 0.383 . . . . 1.0 110.588 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -75.35 28.2 0.1 Allowed 'General case' 0 C--O 1.268 2.031 0 CA-C-O 123.513 1.625 . . . . 1.0 109.714 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.19 64.86 1.21 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-N 113.768 -1.56 . . . . 1.0 111.556 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.514 HH22 ' CG ' ' A' ' 59' ' ' ASP . 62.9 ttm-85 -23.41 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.186 0.993 . . . . 1.0 110.866 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -45.8 -21.64 0.14 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 67' ' ' GLY . 64.7 t -63.43 -44.78 99.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.473 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -77.52 -38.43 48.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.281 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.61 -41.75 91.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.79 -44.23 93.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.956 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.0 -45.58 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.245 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.5 mtm -63.02 -43.14 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.725 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -65.35 -38.21 89.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.42 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -58.79 -43.51 90.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.693 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.1 -42.21 94.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -43.48 97.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.851 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.6 -43.02 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 1.0 110.62 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 77' ' ' ALA . 66.3 t -63.98 -47.36 90.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.283 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -74.34 0.92 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.834 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -103.47 -34.82 8.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.179 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.8 tt -64.24 -39.49 94.07 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.791 -0.363 . . . . 1.0 110.053 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.39 -13.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.304 -0.407 . . . . 1.0 109.977 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.48 ' O ' ' N ' ' B' ' 89' ' ' LEU . 55.2 m -49.33 -43.19 43.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.07 -17.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.79 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' B' ' 86' ' ' THR . . . -104.13 -19.6 14.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.742 0.306 . . . . 1.0 110.744 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 2.6 mm? -95.31 -46.09 6.88 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.919 0.39 . . . . 1.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.515 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.56 -28.08 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.277 0.56 . . . . 1.0 110.051 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -79.97 -4.15 51.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.68 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 88.5 m-20 -59.96 -49.77 76.37 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.172 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.4 p90 -70.08 -27.5 64.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.003 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.67 -44.8 99.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.315 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -64.51 -20.2 66.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttp85 -48.72 -40.26 27.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.076 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 6' ' ' ARG . 98.5 m-20 . . . . . 0 CA--C 1.528 0.111 0 CA-C-O 120.737 0.304 . . . . 1.0 110.893 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.551 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.1 p80 -40.88 -34.84 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.784 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -66.55 -37.95 86.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.903 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' C' ' 3' ' ' ASP . 83.6 mtp180 -63.79 -36.53 84.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -62.19 -40.32 95.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.43 -41.17 96.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.5 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.32 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.383 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.12 -36.44 83.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.391 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.85 77.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.199 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.722 0.296 . . . . 1.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.45 -35.76 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 1.0 110.563 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -63.88 -32.84 74.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.6 tp -62.75 -40.61 97.79 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.435 ' O ' ' CG ' ' C' ' 20' ' ' GLU . 88.8 mt-30 -70.6 -25.68 63.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.924 -0.311 . . . . 1.0 111.527 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.44 -44.63 18.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . 0.483 HG23 ' N ' ' C' ' 19' ' ' LEU . 25.9 m -61.65 -47.11 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 18' ' ' VAL . 2.8 pp -75.25 -26.27 58.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.865 0.364 . . . . 1.0 110.526 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' C' ' 16' ' ' GLN . 3.7 mm-40 -60.35 -48.33 82.19 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.666 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -65.84 -40.35 91.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.833 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -64.86 -33.63 76.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.453 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 22.3 m -56.65 -47.84 78.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.781 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.5 -39.8 92.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.561 -0.455 . . . . 1.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.7 mttt -73.55 -25.15 60.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -61.57 -45.11 95.55 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.071 -0.251 . . . . 1.0 110.684 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 42.7 t -64.82 -46.33 92.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.193 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.63 -33.65 71.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.54 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -56.68 -53.63 55.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.954 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.9 pp20? -71.2 -36.56 71.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 16.6 tpt180 -57.41 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 120.733 0.302 . . . . 1.0 110.765 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.07 -14.8 6.23 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.26 157.11 34.63 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.13 147.66 33.77 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.028 1.819 . . . . 1.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 26.37 48.92 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.14 143.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 1.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.73 -7.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.543 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -120.1 134.38 55.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.298 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 29.8 pt -153.96 -162.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.045 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.494 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 1.0 OUTLIER 59.06 126.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.09 0.471 . . . . 1.0 110.971 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 42.0 m-85 -71.56 -43.44 11.86 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.088 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.8 Cg_endo -59.34 -42.05 52.9 Favored 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 121.554 1.503 . . . . 1.0 112.959 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' C' ' 40' ' ' SER . 28.3 p-10 -84.29 -5.87 59.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.192 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.07 99.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 1.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.479 HG23 ' HE3' ' C' ' 46' ' ' TRP . 8.4 tt -65.45 -35.97 76.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.563 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.479 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.4 OUTLIER -56.51 -36.75 69.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.533 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.419 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.5 OUTLIER -84.82 -28.76 25.88 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.491 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 1.5 m -68.77 -40.09 79.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.685 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' C' ' 50' ' ' GLU . 3.9 p -60.83 -44.85 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.585 -0.28 . . . . 1.0 111.552 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' D' ' 68' ' ' ARG . 15.8 pt-20 -69.76 -33.86 73.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.823 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 70.3 m -62.57 -47.86 82.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.414 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -63.0 -23.94 67.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.752 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 59.0 p -95.07 3.28 55.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.835 0.35 . . . . 1.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' C' ' 54' ' ' THR . 17.5 p 53.79 73.66 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.63 -70.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.134 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.73 -58.3 3.44 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 70.76 -48.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.717 0.294 . . . . 1.0 110.976 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 145.24 -9.72 1.74 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 60.8 m-20 -42.93 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 1.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 81.1 mtm-85 -124.42 154.97 39.64 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.841 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 44.2 p90 -131.24 136.15 28.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.611 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.08 155.3 68.59 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.072 1.848 . . . . 1.0 112.241 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.62 -161.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.149 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.556 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 17.1 p -111.21 -66.23 1.1 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.195 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' C' ' 64' ' ' THR . 83.1 tt0 -37.81 -44.55 0.76 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.859 0.361 . . . . 1.0 110.559 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.89 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.6 mm-40 -121.52 -98.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.32 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.619 1.199 . . . . 1.0 114.438 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.89 ' N ' ' O ' ' C' ' 66' ' ' GLU . 47.7 ttm-85 -67.02 -67.08 0.48 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.892 -0.654 . . . . 1.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' C' ' 68' ' ' ARG . 1.9 mptm? -41.42 -39.42 1.48 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.72 -49.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 119.804 -0.759 . . . . 1.0 111.212 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.38 -50.7 64.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.985 0.422 . . . . 1.0 110.534 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 68' ' ' ARG . 84.2 tt0 -44.39 -44.39 8.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.601 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.69 -41.08 97.1 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.238 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.19 -42.66 94.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.6 mtt -59.1 -42.81 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.83 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -63.25 -41.99 99.13 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.645 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.59 88.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.9 -43.3 96.22 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.104 -0.569 . . . . 1.0 112.1 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.25 -42.68 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.646 0.26 . . . . 1.0 110.81 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.2 -38.91 84.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.423 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.98 -49.77 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.273 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.43 -41.02 93.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.075 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.54 -32.52 74.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 1.0 110.652 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.9 -42.13 98.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.366 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' C' ' 8' ' ' ALA . 24.6 t -58.93 -18.17 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.221 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 90' ' ' ALA . 85.9 m -43.13 -40.46 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 1.0 110.377 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' B' ' 92' ' ' ASP . . . -47.8 -63.48 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.8 -34.58 28.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 1.0 110.317 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.0 mm? -77.28 -33.42 55.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.11 -36.09 82.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.107 0.479 . . . . 1.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -4.47 37.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.142 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 86.9 m-20 -56.06 -51.55 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.049 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 19.4 p90 -68.97 -30.03 68.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.82 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.27 -42.22 89.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.443 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -57.28 -23.44 48.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.355 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -43.53 -33.53 1.15 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.856 0.36 . . . . 1.0 110.63 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.577 -179.777 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' D' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.087 0 CA-C-O 120.652 0.263 . . . . 1.0 110.75 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . 0.45 ' CB ' ' O ' ' D' ' 2' ' ' ALA . 7.0 t70 80.74 -59.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.511 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 7.5 p80 -78.39 -20.4 51.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.844 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.26 -37.98 84.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.419 . . . . 1.0 110.677 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.2 -38.41 90.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.494 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.86 -40.9 95.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.404 . . . . 1.0 109.912 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.55 96.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.749 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -67.2 -39.1 86.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.531 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -62.94 -38.21 90.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.424 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.91 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.073 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.66 -37.97 88.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 1.0 110.678 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.81 -33.97 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -65.31 -35.97 82.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.628 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.27 -41.57 98.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.372 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.69 -40.62 95.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.018 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.32 -37.4 87.12 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.997 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.87 -39.55 85.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.558 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -59.24 -40.9 87.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 1.0 109.846 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.1 mt-10 -60.85 -51.01 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 1.0 110.037 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.85 -32.32 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 109.949 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.69 95.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.1 p -58.69 -41.31 85.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.614 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.98 -32.82 74.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 44.5 mmtm -80.18 -39.3 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.333 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.5 80.07 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.886 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.578 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.1 p -62.65 -46.87 95.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.578 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.7 tm-20 -68.17 -42.75 79.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' D' ' 25' ' ' LYS . . . -86.47 71.46 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.815 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 3.1 mm-40 -157.36 -58.39 0.08 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.857 0.361 . . . . 1.0 110.337 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -79.93 124.08 28.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.152 0.501 . . . . 1.0 110.56 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.81 6.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.792 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -104.76 151.76 39.39 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.717 -0.284 . . . . 1.0 110.613 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.471 ' O ' HG11 ' D' ' 63' ' ' VAL . 72.9 Cg_endo -75.12 117.75 4.99 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.592 1.528 . . . . 1.0 112.143 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.18 29.87 8.67 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.04 140.83 52.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 1.0 110.606 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.73 -69.94 0.83 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.89 129.41 40.83 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.902 -0.406 . . . . 1.0 109.902 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -150.41 30.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.542 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 44' ' ' ALA . 1.6 p -134.25 137.61 44.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.517 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 22.5 t80 -76.17 -48.17 3.42 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.868 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.9 Cg_endo -58.9 -30.25 92.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.353 1.369 . . . . 1.0 112.096 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.77 -17.43 23.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.191 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -62.84 -38.6 91.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.34 . . . . 1.0 110.885 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.474 HG23 ' N ' ' D' ' 46' ' ' TRP . 10.2 tt -65.02 -40.58 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.502 ' CD1' HG23 ' A' ' 64' ' ' THR . 3.7 t-105 -60.42 -46.96 88.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.143 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -60.92 -33.63 73.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -66.23 -32.76 74.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.147 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.72 -48.22 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.57 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 16.1 pt-20 -69.57 -31.11 69.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.078 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -61.14 -46.55 90.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.44 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.27 -34.96 72.89 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.419 ' C ' ' H ' ' D' ' 55' ' ' VAL . 63.0 p -75.58 0.94 15.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.379 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 36.1 p 53.12 9.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.964 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.437 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.0 p -64.65 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 1.0 110.604 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.437 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 43.72 55.54 5.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -47.14 87.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 1.0 110.326 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 160.39 -103.32 0.22 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.18 -75.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.713 0.292 . . . . 1.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' D' ' 58' ' ' GLY . 69.5 mtt-85 -141.41 179.74 6.62 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.03 144.32 0.99 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.293 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.59 164.07 36.67 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.429 2.086 . . . . 1.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.471 HG11 ' O ' ' D' ' 34' ' ' PRO . 3.0 t -94.45 -128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.258 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.453 ' H ' HG12 ' D' ' 63' ' ' VAL . 55.4 m -113.96 -55.19 2.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.745 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.2 tt0 -61.68 -18.02 57.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.151 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 37.4 mm-40 -78.83 35.6 0.25 Allowed 'General case' 0 C--O 1.269 2.108 0 CA-C-O 124.025 1.869 . . . . 1.0 108.791 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 36.74 58.68 1.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.014 -1.903 . . . . 1.0 109.477 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' C' ' 50' ' ' GLU . 48.6 ttt85 -26.47 -29.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.365 0.685 . . . . 1.0 111.245 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -56.18 -12.21 1.45 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.069 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' D' ' 67' ' ' GLY . 42.6 t -62.09 -46.36 96.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 C-N-CA 119.414 -0.915 . . . . 1.0 109.745 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.26 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.183 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.02 -42.55 80.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.081 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.42 -42.94 95.78 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.758 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.24 -47.69 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.769 -0.373 . . . . 1.0 111.204 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -63.23 -41.19 99.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.101 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 79.1 tttt -61.65 -40.69 95.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.594 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.74 94.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.837 0.351 . . . . 1.0 110.476 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.94 -40.92 93.56 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.68 -43.79 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 2.6 mp0 -65.52 -43.05 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.75 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.58 -47.23 93.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.89 -0.324 . . . . 1.0 111.116 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -75.29 -8.35 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.836 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -30.33 11.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.747 0.308 . . . . 1.0 110.175 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.0 tt -64.31 -37.32 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.14 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -48.45 -9.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.523 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.4 m -49.38 -41.74 40.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.169 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.478 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -50.52 -19.3 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.529 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.68 -11.78 16.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.811 0.339 . . . . 1.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.0 -45.53 6.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.478 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.434 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.0 -16.27 12.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.111 0.482 . . . . 1.0 110.512 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.809 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.3 OUTLIER -96.06 0.33 51.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 86.7 m-20 -72.2 -27.77 62.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.555 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 5.5 p90 -79.88 -43.74 21.69 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.809 HG22 ' O ' ' D' ' 91' ' ' THR . 21.0 m -41.11 -33.39 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.004 -0.543 . . . . 1.0 111.553 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . 0.662 HH11 ' CG2' ' D' ' 94' ' ' VAL . 11.3 mpt_? -50.9 -22.53 2.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' D' ' 97' ' ' GLU . 53.5 ptt85 -54.71 -21.69 11.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' D' ' 96' ' ' ARG . 6.1 mp0 . . . . . 0 CA--C 1.533 0.319 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.826 0.346 . . . . 1.0 110.586 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 67.3 t0 -131.78 45.75 2.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.496 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.609 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 10.5 p80 -154.87 -42.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.609 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 15.1 pt-20 -65.71 -38.94 90.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -64.86 -37.79 88.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.277 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -65.77 -38.87 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.72 88.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.176 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -64.28 -41.48 96.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.338 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.07 -36.7 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.57 78.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.47 -40.44 91.28 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.14 -35.07 79.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.274 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.37 -34.55 78.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.561 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 52' ' ' ALA . 43.8 tp -62.41 -39.82 94.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.07 -34.78 75.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.233 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -63.94 -46.28 85.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.29 -36.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 1.0 110.696 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 52' ' ' ALA . 79.9 mt -61.13 -41.64 97.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 1.0 109.973 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.2 mt-10 -63.78 -42.67 97.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -39.43 79.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.31 -39.76 81.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.9 p -51.42 -41.81 61.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -62.67 -47.43 83.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.057 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.33 -42.41 91.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.695 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.12 92.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.802 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 41' ' ' TYR . 99.1 t -64.35 -47.02 91.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.456 -0.497 . . . . 1.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.91 -41.49 87.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.172 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -73.49 62.16 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.744 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -173.91 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -62.13 83.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.982 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.86 5.55 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.92 133.48 22.25 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.69 131.55 13.62 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.908 1.739 . . . . 1.0 112.778 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.14 35.91 86.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.45 129.18 54.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.887 0.375 . . . . 1.0 110.953 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.37 -166.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.215 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 47' ' ' TRP . 4.1 tt 59.35 88.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.969 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.3 tt -136.19 160.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.93 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 1.5 p 79.31 137.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 1.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -64.92 -46.79 75.06 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.235 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.9 Cg_endo -60.32 -31.6 93.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.46 1.44 . . . . 1.0 112.664 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -94.2 -31.07 14.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.672 0.272 . . . . 1.0 110.704 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.92 84.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.329 . . . . 1.0 110.683 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 46' ' ' TRP . 3.5 tt -63.83 -39.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.984 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CE2' ' O ' ' B' ' 64' ' ' THR . 4.8 t-105 -59.31 -46.13 89.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.586 ' CD2' HD11 ' A' ' 38' ' ' LEU . 2.4 t90 -59.93 -39.48 85.67 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.5 t -67.71 65.39 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.676 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 47' ' ' TRP . 75.9 t -154.39 -57.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 1.0 110.23 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' CG ' HH12 ' B' ' 68' ' ' ARG . 12.3 pt-20 -66.42 -31.69 72.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -61.83 -42.93 99.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.108 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.01 -36.79 80.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.088 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 p -80.7 16.76 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 32.14 69.25 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.597 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.42 -38.28 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.64 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.12 73.3 0.36 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.661 -0.975 . . . . 1.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 15.4 t80 -60.12 -47.18 86.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 1.0 110.507 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.6 25.76 0.44 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.032 -0.827 . . . . 1.0 111.032 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 32.6 p-10 -63.49 -41.17 98.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.317 . . . . 1.0 110.421 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.514 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 94.2 mtt-85 -151.36 -161.09 1.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.335 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 8.8 p90 -169.88 100.6 0.46 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.525 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.05 165.86 29.88 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.403 1.402 . . . . 1.0 112.399 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 64' ' ' THR . 7.8 p -100.25 -159.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 110.05 -0.352 . . . . 1.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.994 ' H ' HG22 ' A' ' 63' ' ' VAL . 51.0 m -91.98 -43.9 9.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.586 0.231 . . . . 1.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' OE2' ' N ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.75 25.1 0.07 Allowed 'General case' 0 C--O 1.265 1.899 0 CA-C-O 124.116 1.913 . . . . 1.0 109.503 178.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.717 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 46.33 67.46 1.36 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.622 -1.627 . . . . 1.0 111.723 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.535 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 59.5 ttm-85 -24.15 -32.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.404 1.102 . . . . 1.0 111.158 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.717 ' N ' ' O ' ' A' ' 67' ' ' GLY . 32.3 mmtp -48.52 -31.09 5.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.55 176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 67' ' ' GLY . 53.9 t -62.83 -49.54 83.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.28 74.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.638 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.85 -35.61 81.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -54.96 -42.85 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.683 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.537 HG11 HG23 ' A' ' 51' ' ' THR . 73.5 t -65.12 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.374 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 mmt -52.32 -56.76 12.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.378 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -36.87 85.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 1.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.53 -22.06 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.63 -28.45 8.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 36.8 mm -63.01 -43.84 99.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 121.144 -0.222 . . . . 1.0 110.484 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.07 -36.58 84.78 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.275 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.07 -72.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.145 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -51.99 -11.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.162 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -88.54 -43.8 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.788 0.328 . . . . 1.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.3 tt -63.03 -41.73 99.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.604 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 m -51.8 -8.41 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 84' ' ' LEU . 97.6 m -61.99 -25.8 67.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.275 -0.421 . . . . 1.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -57.38 -24.76 57.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.43 -11.32 24.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.859 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -90.78 -45.24 8.94 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.794 0.331 . . . . 1.0 111.416 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.06 -27.01 51.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.932 0.396 . . . . 1.0 110.987 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -4.63 58.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.55 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 87.8 m-20 -62.13 -45.02 95.33 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 7.3 p90 -76.58 -27.97 56.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.508 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.85 -40.27 82.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.296 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.82 -23.51 44.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.144 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -41.88 -40.39 2.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.797 0.332 . . . . 1.0 110.853 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.918 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.528 0.125 0 CA-C-O 120.694 0.283 . . . . 1.0 110.94 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 13.4 p-80 -78.83 -31.39 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.636 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -41.62 90.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -64.34 -40.16 95.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.762 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -65.28 -44.08 89.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.954 0.407 . . . . 1.0 109.921 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.42 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.719 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.76 -40.16 87.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.332 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.02 -39.6 92.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -57.66 -34.19 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.638 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' B' ' 16' ' ' GLN . 96.6 mt-10 -78.15 -37.81 45.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.59 -45.91 84.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 1.0 110.791 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.94 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.36 -39.99 92.66 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.036 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' B' ' 12' ' ' GLU . 8.4 mp0 -69.93 -28.05 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -62.96 -46.22 88.76 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.43 ' H ' HG22 ' B' ' 18' ' ' VAL . 14.8 m -66.3 -31.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.118 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.9 mt -60.43 -41.15 93.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.62 -48.14 83.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.11 -34.47 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.151 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -46.2 86.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.251 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . 0.555 ' O ' HG23 ' B' ' 27' ' ' VAL . 66.7 p -59.81 -46.62 88.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.928 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -61.49 -53.53 55.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.412 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.3 mttm -59.13 -43.9 92.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.008 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.419 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -59.77 -38.19 81.15 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.958 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 23' ' ' SER . 69.1 t -66.68 -44.43 89.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.712 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -83.5 -9.95 58.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.622 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.77 -39.0 90.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 32' ' ' GLY . 9.6 mp0 -68.93 -37.53 78.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 1.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.54 83.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.078 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 127.51 -14.1 6.49 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 111.397 -0.681 . . . . 1.0 111.397 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.81 143.8 27.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 O-C-N 122.795 -0.238 . . . . 1.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.78 157.11 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.054 1.836 . . . . 1.0 112.428 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.98 37.19 64.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.76 21.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.848 0.356 . . . . 1.0 110.566 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.49 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.582 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.566 ' O ' HD13 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -63.37 -30.14 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.646 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.615 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -38.5 108.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.094 0.473 . . . . 1.0 110.757 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.3 p 163.22 102.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.97 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -56.43 -47.39 99.01 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.848 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.6 Cg_endo -57.49 -36.86 98.65 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.384 1.389 . . . . 1.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' CZ ' ' B' ' 60' ' ' ARG . 46.7 p30 -100.38 -0.76 37.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.696 0.284 . . . . 1.0 110.984 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.94 89.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.947 0.403 . . . . 1.0 110.525 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 49' ' ' VAL . 7.3 tt -68.82 -40.99 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.694 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.438 ' NE1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -61.54 -45.5 93.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.408 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.513 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 9.9 t90 -63.59 -42.68 98.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.421 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' B' ' 19' ' ' LEU . 31.3 p -65.6 -25.96 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.041 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 45' ' ' ILE . 20.4 t -71.77 -25.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -98.37 -9.47 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.996 -0.282 . . . . 1.0 111.178 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -36.18 20.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 1.0 111.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -69.1 -22.84 63.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.475 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 67.3 p -83.87 0.2 48.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.661 0.267 . . . . 1.0 110.712 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 26.1 p 51.12 60.3 3.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.516 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' THR . 48.1 t -133.11 -48.13 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.519 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.35 76.44 0.18 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -60.04 -47.78 84.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.808 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.74 24.93 0.58 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 67.9 t0 -62.29 -49.14 76.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.352 . . . . 1.0 110.768 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.512 ' CZ ' ' OD2' ' B' ' 43' ' ' ASP . 91.7 mtt-85 -143.83 -164.44 1.88 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.139 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -150.99 118.96 3.42 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.108 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.25 153.35 71.42 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.366 1.378 . . . . 1.0 112.094 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.59 -169.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.5 ' O ' ' CE2' ' A' ' 46' ' ' TRP . 1.2 m -108.61 -62.56 1.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.993 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 64' ' ' THR . 79.9 tt0 -40.16 -28.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 1.0 110.769 -178.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' B' ' 68' ' ' ARG . 94.1 mt-10 -143.87 -101.32 0.12 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.256 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.02 -55.55 0.0 OUTLIER Glycine 0 N--CA 1.479 1.519 0 O-C-N 124.613 1.195 . . . . 1.0 114.223 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.905 ' N ' ' O ' ' B' ' 66' ' ' GLU . 60.4 ttm-85 -66.18 -72.48 0.16 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -42.18 -36.36 1.17 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.66 -46.03 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.809 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -70.93 -45.17 64.7 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.217 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -45.37 -48.63 13.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.064 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -61.75 -44.74 96.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -46.44 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.283 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -61.77 -38.65 88.8 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.97 85.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.325 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.42 -37.05 92.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.96 -43.85 99.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 84' ' ' LEU . 97.8 mt-10 -63.18 -38.8 92.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 1.0 110.456 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' B' ' 11' ' ' ALA . 25.1 t -62.25 -70.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.86 -14.76 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.41 -35.1 11.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.319 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' B' ' 80' ' ' GLU . 5.2 tt -63.53 -40.96 98.38 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.345 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.432 ' C ' ' N ' ' B' ' 87' ' ' ALA . 35.6 m -55.07 -16.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.737 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.4 m -44.45 -24.06 0.16 Allowed 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.159 0.504 . . . . 1.0 109.68 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.33 -45.23 94.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.522 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -12.7 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.673 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.6 mm? -92.49 -25.78 18.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.006 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -67.82 -40.49 83.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.617 . . . . 1.0 109.894 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -16.32 62.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.126 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -43.68 -65.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.138 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' B' ' 94' ' ' VAL . 30.6 p90 -64.16 -47.14 81.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.278 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 66.0 t -37.66 -28.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.713 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . 0.475 ' C ' ' N ' ' B' ' 97' ' ' GLU . 99.8 mtt180 -63.64 -37.57 87.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.902 -0.319 . . . . 1.0 111.4 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 93' ' ' PHE . 44.1 ptt85 -46.75 -15.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 1.0 110.303 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . 0.475 ' N ' ' C ' ' B' ' 95' ' ' ARG . 43.6 tp10 . . . . . 0 C--N 1.331 -0.208 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.883 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.798 0.332 . . . . 1.0 110.396 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -68.87 -38.17 79.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.839 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.26 -44.5 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.899 -179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -65.06 -39.07 92.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.864 0.364 . . . . 1.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -64.19 -41.01 97.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.15 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.39 -42.03 93.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.273 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -63.61 -38.68 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.521 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.49 71.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.66 -39.59 94.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.32 . . . . 1.0 111.009 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -63.41 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.292 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.49 -34.37 78.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.677 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.1 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.77 -39.64 94.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.244 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -61.52 -38.79 88.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.304 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.69 -42.67 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.683 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' C' ' 52' ' ' ALA . 96.0 mt -60.9 -40.15 92.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.358 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.2 -54.92 37.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 1.0 110.496 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.41 -37.5 83.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.438 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.43 89.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.386 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -65.83 -33.55 76.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.189 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' C' ' 29' ' ' ALA . 53.7 mttp -70.42 -46.61 63.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' C' ' 29' ' ' ALA . . . -55.59 -50.31 70.43 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.246 0.341 . . . . 1.0 111.446 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.494 HG13 ' N ' ' C' ' 28' ' ' GLU . 5.0 p -60.98 -46.77 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.457 -0.497 . . . . 1.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.494 ' N ' HG13 ' C' ' 27' ' ' VAL . 40.7 tp10 -69.32 -28.59 66.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -51.64 -49.84 61.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.762 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -96.78 -99.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 1.0 110.545 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' C' ' 30' ' ' GLU . 30.1 mmm-85 46.71 59.46 3.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.554 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.7 4.81 7.93 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.69 61.14 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.42 120.0 5.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.884 1.723 . . . . 1.0 111.773 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.82 13.61 62.33 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 146.09 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 1.0 110.267 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.8 -30.16 2.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.485 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.19 51.47 2.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 pt -80.0 16.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.751 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.3 t -114.0 126.28 54.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.63 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 8.1 t80 -78.12 -49.95 1.85 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.923 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 27.6 Cg_endo -60.12 -29.23 88.68 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.388 1.392 . . . . 1.0 112.402 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -89.12 -3.82 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.058 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.44 96.16 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.732 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -65.55 -40.84 89.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.494 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.433 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.07 -45.83 90.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.497 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -61.03 -41.35 96.4 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.242 -0.583 . . . . 1.0 109.482 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.422 ' O ' HD22 ' C' ' 19' ' ' LEU . 39.1 p -72.37 64.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -149.09 -51.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.503 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -66.65 -32.72 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.936 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.4 ' H ' HG22 ' C' ' 51' ' ' THR . 0.0 OUTLIER -59.17 -44.05 92.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.969 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.23 -26.46 60.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.753 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -87.31 -3.59 59.04 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.847 0.356 . . . . 1.0 110.145 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.7 p 51.7 48.75 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.082 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.73 -28.29 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.254 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.72 59.77 7.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.518 -1.033 . . . . 1.0 110.518 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -48.1 82.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 1.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.13 38.66 0.63 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' C' ' 59' ' ' ASP . 12.8 p-10 -65.27 -40.54 94.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.92 0.39 . . . . 1.0 110.601 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.464 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 30.2 mmt180 -130.4 -161.01 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.118 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.464 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 56.5 m-85 -158.59 75.54 3.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.626 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.16 156.0 66.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.058 1.839 . . . . 1.0 111.997 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 1.061 HG22 ' H ' ' C' ' 64' ' ' THR . 8.6 p -100.97 -155.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.009 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 1.061 ' H ' HG22 ' C' ' 63' ' ' VAL . 34.7 m -89.54 -46.25 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.291 . . . . 1.0 110.638 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' C' ' 67' ' ' GLY . 11.7 tm-20 -44.38 -40.18 5.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' C' ' 68' ' ' ARG . 0.1 OUTLIER -70.17 24.08 0.03 OUTLIER 'General case' 0 C--O 1.266 1.963 0 CA-C-O 123.855 1.788 . . . . 1.0 109.915 178.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.754 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 44.86 66.12 1.56 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 113.984 -1.462 . . . . 1.0 111.615 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.553 ' N ' ' OE2' ' C' ' 66' ' ' GLU . 56.1 ttm-85 -25.4 -28.31 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.17 0.985 . . . . 1.0 111.382 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.8 tppp? -52.04 -26.92 12.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.305 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.1 t -61.75 -47.19 94.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 C-N-CA 119.201 -1.0 . . . . 1.0 110.593 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -39.93 84.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.0 110.634 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.92 -38.28 88.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.721 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.2 -44.46 79.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.256 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.92 -43.76 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.229 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.1 mtt -59.54 -43.56 93.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.953 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.12 -41.34 97.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.64 90.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.834 0.35 . . . . 1.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.42 -41.53 96.39 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.761 -0.536 . . . . 1.0 111.761 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.62 -43.01 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.599 0.238 . . . . 1.0 110.761 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.56 -43.66 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.545 -0.298 . . . . 1.0 111.143 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.38 -49.23 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.136 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.296 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 1.0 110.468 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.4 tt -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.507 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.449 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.6 t -49.32 -12.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 1.0 110.491 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' C' ' 84' ' ' LEU . 85.9 m -60.82 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.268 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.46 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -59.69 -36.31 76.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.057 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 -38.3 21.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.43 -38.65 87.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.083 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -59.23 -35.45 73.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.021 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -83.0 -4.3 58.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.522 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 42.4 t0 -58.07 -47.9 81.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.672 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 8.4 p90 -66.87 -39.0 87.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.525 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 95.9 t -43.84 -36.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.511 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.21 -23.12 65.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.647 0.261 . . . . 1.0 111.179 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -57.09 -42.6 81.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.368 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.882 0.373 . . . . 1.0 110.539 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.9 -42.94 99.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.9 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.9 p-80 -73.36 -32.62 64.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.535 -0.302 . . . . 1.0 110.793 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.24 -37.42 87.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 1.0 110.551 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.26 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.47 -36.75 83.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.491 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.06 -37.72 86.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.04 79.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.021 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.24 -36.02 82.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 1.0 110.668 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.29 -38.45 91.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.665 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.36 -33.23 75.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.627 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' D' ' 52' ' ' ALA . 40.9 tp -62.01 -42.01 98.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 1.0 110.441 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.01 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.965 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -62.25 -42.99 99.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.96 0.41 . . . . 1.0 111.063 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' D' ' 22' ' ' ALA . 96.9 t -63.83 -35.56 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.689 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.9 mt -61.6 -41.81 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.679 -0.409 . . . . 1.0 109.922 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.81 -50.46 62.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.543 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.29 -39.8 86.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.379 . . . . 1.0 110.422 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' D' ' 18' ' ' VAL . . . -65.07 -37.51 87.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -57.38 -45.74 84.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.74 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -67.93 -35.33 78.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.578 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.75 -46.31 69.17 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.893 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -55.66 -51.83 65.92 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.891 -0.323 . . . . 1.0 111.204 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.506 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.5 p -62.62 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.264 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.506 ' N ' HG13 ' D' ' 27' ' ' VAL . 82.6 tt0 -64.55 -39.4 93.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.681 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 1.1 mp0 -68.31 -41.24 81.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.477 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.49 107.75 0.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.009 0.433 . . . . 1.0 110.37 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.61 -13.99 24.96 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.16 144.94 29.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.532 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.4 Cg_endo -74.79 143.63 30.05 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.157 1.905 . . . . 1.0 112.328 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 26.58 70.54 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.41 144.23 57.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 1.0 110.649 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -16.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.554 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 30.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.952 0.406 . . . . 1.0 110.08 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' D' ' 40' ' ' SER . 42.2 pt -77.34 -158.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.445 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.1 t 80.53 -137.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.606 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' D' ' 40' ' ' SER . 5.7 m-85 -168.44 -59.88 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 19.6 Cg_endo -58.55 -32.04 95.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.65 1.566 . . . . 1.0 111.95 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' D' ' 44' ' ' ALA . 18.2 p30 -87.75 -22.69 24.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.326 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' D' ' 43' ' ' ASP . . . -64.04 -41.51 97.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.349 . . . . 1.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.65 -41.83 85.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.213 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.477 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.1 OUTLIER -60.88 -36.89 80.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.114 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -62.53 -39.64 94.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.646 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.426 ' O ' HD22 ' D' ' 19' ' ' LEU . 83.3 p -65.93 -29.47 69.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.773 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.92 -48.61 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.99 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.93 69.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' D' ' 52' ' ' ALA . 28.6 m -90.65 89.09 7.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 1.0 109.838 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' D' ' 51' ' ' THR . . . 169.44 -23.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.37 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 4.2 p -110.64 29.98 7.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.981 0.419 . . . . 1.0 110.482 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 32.8 p 52.51 70.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -124.12 -66.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.717 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.01 53.13 31.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -48.76 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.321 . . . . 1.0 110.518 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.7 29.72 1.03 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.02 -43.33 99.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -140.93 169.03 18.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.917 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -141.09 111.55 6.62 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.712 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.75 156.2 63.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.747 1.632 . . . . 1.0 112.491 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.532 HG11 ' O ' ' D' ' 34' ' ' PRO . 1.8 t -80.06 -142.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.106 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.532 ' H ' HG12 ' D' ' 63' ' ' VAL . 26.5 m -113.34 -48.1 2.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.751 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' D' ' 67' ' ' GLY . 49.9 tp10 -58.62 -20.77 50.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.095 0.474 . . . . 1.0 109.9 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' D' ' 63' ' ' VAL . 0.6 OUTLIER -75.74 27.52 0.11 Allowed 'General case' 0 C--O 1.265 1.873 0 CA-C-O 123.543 1.64 . . . . 1.0 109.13 178.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.44 61.62 2.41 Favored Glycine 0 C--O 1.211 -1.287 0 CA-C-N 114.066 -1.425 . . . . 1.0 109.989 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 61.0 ttm-85 -25.18 -29.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.486 0.643 . . . . 1.0 111.42 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 72.5 mmtt -56.86 -14.27 3.32 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.659 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.2 t -62.31 -47.32 93.64 Favored 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.55 85.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.29 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.44 -37.77 81.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.141 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.49 -44.05 95.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.647 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.416 ' H ' HG23 ' D' ' 74' ' ' VAL . 3.5 t -64.75 -46.57 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.276 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.14 -40.49 94.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.238 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.67 -43.25 99.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.794 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.449 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.63 -39.06 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.537 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.37 -42.85 97.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.641 -0.583 . . . . 1.0 111.641 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.43 -43.4 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.616 0.246 . . . . 1.0 111.237 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.63 -40.96 98.2 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.39 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 77' ' ' ALA . 64.2 t -62.09 -48.07 90.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.294 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.35 -5.09 43.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.659 -0.416 . . . . 1.0 110.952 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.76 -37.01 10.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.739 0.304 . . . . 1.0 110.407 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.6 tt -62.7 -41.79 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.424 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.36 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' LEU . 57.7 m -56.88 -20.82 25.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.244 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.23 -36.73 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.347 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.4 -28.65 28.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.139 0.495 . . . . 1.0 110.062 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.78 -37.76 79.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.784 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE1' ' D' ' 93' ' ' PHE . . . -58.29 -44.68 88.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.259 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -5.79 49.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.209 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.1 t0 -58.79 -49.73 76.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.895 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -75.23 -28.86 60.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.825 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.47 -44.29 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.265 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -45.13 -28.36 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.99 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -48.79 -30.9 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 1.0 110.502 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.908 -179.322 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.866 0.365 . . . . 1.0 110.494 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -172.14 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.507 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 7.6 p80 -78.12 -24.25 47.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.495 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.9 -35.84 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.42 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.99 -38.91 92.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.085 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.42 -44.1 88.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.011 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.407 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -66.76 -39.15 87.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -65.46 -41.21 93.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 53.8 tttp -63.93 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.42 -36.04 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.894 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.45 -32.7 72.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -65.22 -37.81 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.424 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 6.6 mp0 -60.91 -42.54 98.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 52' ' ' ALA . 48.5 tp -63.26 -42.39 99.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.737 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.37 -42.12 81.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.568 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -63.71 -40.02 95.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 1.0 111.381 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.4 -36.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.2 mt -60.03 -41.16 91.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.34 -47.25 86.1 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.59 -33.2 72.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.158 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -45.7 85.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . 77.7 p -60.06 -42.4 94.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -62.57 -60.51 3.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.66 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.16 -43.72 98.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.938 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 30' ' ' GLU . . . -61.15 -40.31 93.38 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.98 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' SER . 55.0 t -63.88 -48.36 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.454 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -72.44 -23.8 61.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.523 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.504 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -49.82 -49.18 49.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.316 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 30.2 mp0 -68.65 -35.83 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -67.54 88.19 0.22 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.893 0.377 . . . . 1.0 110.962 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.65 6.25 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.63 -0.588 . . . . 1.0 111.63 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 154.05 39.49 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.85 150.61 39.16 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.253 1.969 . . . . 1.0 112.205 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 32.53 63.06 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.23 14.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 1.0 110.611 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.75 -65.09 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.628 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.421 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 51.0 tp -66.34 78.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.077 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 39' ' ' ILE . 15.8 tt -121.04 79.56 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 1.0 110.107 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 44' ' ' ALA . 18.1 m -172.02 103.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.836 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.502 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 46.5 t80 -54.87 -50.11 87.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.882 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -60.03 -34.82 94.56 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.417 1.411 . . . . 1.0 112.729 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 60.8 m-20 -92.92 -22.72 19.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.68 -0.236 . . . . 1.0 111.146 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.78 82.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 1.0 110.391 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.424 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.2 tt -60.72 -36.09 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.115 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.479 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -63.07 -46.78 85.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 2.1 t90 -62.54 -41.22 98.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.43 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 96.9 p -60.23 -35.8 76.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.074 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 45' ' ' ILE . 43.6 t -60.47 -49.36 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.943 0.401 . . . . 1.0 110.733 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 19.3 pt-20 -75.64 -23.73 56.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.51 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 95.2 m -62.49 -45.88 91.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.099 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.06 -36.59 75.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 55' ' ' VAL . 76.5 p -73.92 -0.94 17.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.1 p 53.33 5.34 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 53' ' ' THR . 7.7 p -66.4 -41.98 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.04 81.08 0.02 OUTLIER Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.41 ' OH ' ' O ' ' B' ' 60' ' ' ARG . 40.7 t80 -60.27 -45.51 93.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.855 0.359 . . . . 1.0 110.593 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.83 16.89 0.96 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.61 -46.18 90.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.944 0.402 . . . . 1.0 110.382 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -141.71 149.77 40.96 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.898 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -118.56 120.89 31.4 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.621 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 154.93 67.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.84 1.693 . . . . 1.0 112.57 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 63' ' ' VAL . 4.5 m -60.82 -168.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.154 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.537 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 1.5 m -110.29 -62.21 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.101 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -41.63 -31.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.062 0.458 . . . . 1.0 110.425 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.875 ' O ' ' N ' ' A' ' 68' ' ' ARG . 97.2 mt-10 -138.48 -105.83 0.18 Allowed 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.317 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 20.67 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.478 1.435 0 O-C-N 124.476 1.11 . . . . 1.0 114.438 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.875 ' N ' ' O ' ' A' ' 66' ' ' GLU . 33.7 ttm180 -70.78 -45.44 64.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' GLU . 27.8 tptp -62.39 -40.93 98.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.28 -45.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.82 81.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -49.2 -50.41 38.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.53 -40.63 95.96 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.05 -45.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.222 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.96 -39.67 95.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -60.25 -42.14 94.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.52 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.6 -40.29 94.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.483 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 -41.53 93.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.55 -43.78 98.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 1.0 110.274 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 84' ' ' LEU . 97.2 mt-10 -65.28 -44.7 87.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.581 -0.447 . . . . 1.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 77' ' ' ALA . 53.4 t -63.62 -47.72 90.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -68.33 -28.95 67.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.981 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -25.46 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.281 . . . . 1.0 110.888 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 80' ' ' GLU . 4.7 tt -63.65 -42.01 98.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.568 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.4 m -49.16 -22.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.253 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.671 ' HA ' HD22 ' A' ' 89' ' ' LEU . 54.0 m -36.55 -24.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.216 0.531 . . . . 1.0 110.566 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -59.57 -41.74 90.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.789 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -78.55 -21.05 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 1.0 110.969 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 86' ' ' THR . 6.7 mp -66.32 -38.54 87.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -67.38 -62.49 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 1.0 111.588 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -46.19 -9.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.321 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' ALA . 83.3 m-20 -58.51 -50.01 75.31 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.831 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 1.9 p90 -69.79 -30.18 67.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.105 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG11 ' NH2' ' D' ' 96' ' ' ARG . 89.6 t -59.5 -42.29 87.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.385 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -53.07 -21.45 4.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.704 0.288 . . . . 1.0 111.057 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -54.61 -32.94 59.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.783 0.325 . . . . 1.0 110.616 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.896 -179.523 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' B' ' 3' ' ' ASP . 5.5 p-10 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.704 0.288 . . . . 1.0 110.951 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.668 ' H ' ' CD2' ' B' ' 4' ' ' HIS . 5.2 p80 -80.57 -32.58 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 1.0 110.501 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -42.87 91.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.009 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -64.95 -39.95 94.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.635 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.84 -40.63 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.973 0.416 . . . . 1.0 110.023 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.72 94.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.659 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -66.25 -37.85 86.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.26 -40.49 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.64 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.76 78.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.912 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.31 -38.84 92.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.415 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.63 -36.4 83.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.257 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -65.68 -33.56 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.07 -42.17 99.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.14 -39.32 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.932 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -61.61 -40.14 93.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 1.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -63.02 -41.82 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.2 mt -60.61 -40.87 93.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -48.57 80.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.72 -39.42 84.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.918 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.76 82.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.315 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -54.77 -46.59 74.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -66.54 -41.93 87.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.352 0.596 . . . . 1.0 110.043 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.52 64.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.941 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.484 HG13 ' N ' ' B' ' 28' ' ' GLU . 11.6 p -69.82 -43.94 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.74 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.484 ' N ' HG13 ' B' ' 27' ' ' VAL . 41.6 tp10 -63.36 -43.87 96.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.736 -0.666 . . . . 1.0 110.775 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.75 81.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.224 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -88.41 -7.69 56.21 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.751 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -83.59 107.44 16.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.377 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.49 -3.02 53.68 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.535 -0.626 . . . . 1.0 111.535 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.58 149.64 46.84 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 110.25 -0.278 . . . . 1.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.51 142.42 26.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.161 1.907 . . . . 1.0 112.369 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.7 22.7 59.92 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.131 -0.787 . . . . 1.0 111.131 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.33 144.38 54.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.706 0.289 . . . . 1.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.54 -41.9 5.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.472 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.499 HD11 ' OD1' ' B' ' 43' ' ' ASP . 40.6 tp -92.02 74.81 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.021 0.439 . . . . 1.0 110.577 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 pt -102.26 2.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.468 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' B' ' 43' ' ' ASP . 78.6 p -75.33 -120.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.664 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.508 ' N ' ' OG ' ' B' ' 40' ' ' SER . 0.5 OUTLIER 171.5 -58.87 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.125 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -57.91 -31.77 93.45 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.869 1.713 . . . . 1.0 112.576 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' B' ' 40' ' ' SER . 3.4 p30 -91.69 0.35 57.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.653 0.263 . . . . 1.0 110.727 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.03 89.61 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.96 0.409 . . . . 1.0 110.233 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.7 -42.02 88.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.949 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.657 ' CD1' HG23 ' C' ' 64' ' ' THR . 6.2 t-105 -60.98 -46.33 91.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.263 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -61.43 -40.43 94.41 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' B' ' 19' ' ' LEU . 23.7 m -71.91 62.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.411 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.0 -50.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.153 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 56' ' ' GLY . 2.8 pp20? -66.99 -31.58 72.23 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.833 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.505 ' O ' ' SD ' ' B' ' 75' ' ' MET . 0.0 OUTLIER -59.22 -45.93 89.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.796 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.76 -27.17 62.81 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 31.9 p -89.33 4.52 48.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.641 0.258 . . . . 1.0 110.855 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 54' ' ' THR . 11.7 p 56.34 76.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.611 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' B' ' 57' ' ' TYR . 59.0 t -147.0 -82.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.693 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.493 ' N ' ' OE1' ' B' ' 50' ' ' GLU . . . 72.94 77.87 0.56 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.532 ' CE1' HG11 ' B' ' 55' ' ' VAL . 78.7 m-85 -60.97 -45.03 96.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 1.0 111.057 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.55 27.62 0.28 Allowed Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' HH22 ' C' ' 68' ' ' ARG . 67.2 t0 -63.9 -48.27 77.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 1.0 110.861 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' CG ' ' B' ' 43' ' ' ASP . 2.2 mpt_? -114.79 -167.41 1.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.133 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 17.5 t80 -164.32 78.84 1.46 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.599 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.56 156.19 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.531 1.487 . . . . 1.0 111.998 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.463 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 31.8 m -103.78 -149.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 46' ' ' TRP . 22.3 m -96.81 -38.85 9.7 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.632 -0.258 . . . . 1.0 110.842 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.0 tm-20 -56.19 -35.41 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.1 OUTLIER -74.19 26.82 0.08 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-O 123.768 1.747 . . . . 1.0 109.844 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.66 65.91 1.09 Allowed Glycine 0 C--O 1.217 -0.949 0 CA-C-N 113.62 -1.627 . . . . 1.0 111.449 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.544 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -24.82 -31.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.061 0.931 . . . . 1.0 110.897 -178.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' B' ' 67' ' ' GLY . 60.5 mttp -45.14 -23.85 0.2 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 67' ' ' GLY . 72.5 t -63.57 -47.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 C-N-CA 119.748 -0.781 . . . . 1.0 109.977 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.09 82.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.17 -39.29 92.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.016 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -47.26 -54.66 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.436 HG11 HG23 ' B' ' 51' ' ' THR . 85.8 t -65.96 -42.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 1.0 111.34 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' B' ' 51' ' ' THR . 5.6 tpp -56.73 -47.97 78.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.493 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.42 -41.07 85.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.537 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.51 74.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.688 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.31 97.81 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.438 -0.665 . . . . 1.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.38 -25.11 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.089 -0.244 . . . . 1.0 111.37 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -72.16 -53.19 13.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 1.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 82' ' ' PHE . 6.9 m -61.66 -47.09 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.355 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.429 ' N ' HG23 ' B' ' 81' ' ' VAL . 14.6 m-85 -63.63 -38.51 91.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.844 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.62 96.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.568 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.463 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.2 tt -63.96 -41.74 97.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 85' ' ' VAL . 63.5 t -51.47 -11.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 70.7 m -60.8 -38.73 86.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -38.91 -62.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.974 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.12 20.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.398 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 86' ' ' THR . 55.7 mt -98.3 -4.11 35.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -93.17 -25.16 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.622 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -84.05 -4.67 58.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.586 -0.733 . . . . 1.0 110.04 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 92' ' ' ASP . 11.6 p-10 -57.43 -47.98 80.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 8.2 p90 -67.51 -30.79 70.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 1.0 111.308 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.99 -44.38 94.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.366 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -65.91 -21.9 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -58.78 -42.98 90.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.109 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.463 0.197 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.229 -179.899 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 120.766 0.317 . . . . 1.0 110.735 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 33.2 p80 -54.37 -42.6 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.191 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.6 tt0 -64.52 -34.29 77.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.722 0.296 . . . . 1.0 110.633 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -60.78 -45.68 93.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 1.0 109.916 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.57 -42.88 98.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.072 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.09 94.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.429 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -65.0 -42.62 94.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.01 -35.53 81.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.29 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.87 83.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.85 -36.81 85.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.36 -35.24 80.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 1.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -64.77 -36.32 83.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.538 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.42 HD13 ' HA2' ' C' ' 78' ' ' GLY . 42.9 tp -62.42 -40.94 98.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.539 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -59.28 -38.84 81.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -39.69 93.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.804 0.335 . . . . 1.0 111.018 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.19 -33.77 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.3 mt -61.75 -41.83 98.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.45 -46.23 89.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.878 -0.415 . . . . 1.0 109.878 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.51 -39.84 77.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.252 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.96 -36.4 83.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 86.6 p -60.0 -46.16 90.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.68 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' C' ' 28' ' ' GLU . 14.8 tmtt? -66.41 -37.18 84.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.508 . . . . 1.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' C' ' 29' ' ' ALA . 14.5 mptt -70.26 -40.99 74.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.481 . . . . 1.0 109.927 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.04 66.81 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.102 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' C' ' 28' ' ' GLU . 10.7 p -64.6 -43.15 96.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.07 0.462 . . . . 1.0 109.962 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' C' ' 24' ' ' LYS . 82.9 tt0 -66.58 -35.14 79.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.319 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -58.01 -26.9 62.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.84 -37.62 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -70.85 101.58 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.745 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . 0.444 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 125.96 -22.53 6.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.64 143.93 27.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 97.4 Cg_endo -75.87 138.73 21.34 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.976 1.784 . . . . 1.0 112.391 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 37.07 13.08 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.02 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 1.0 110.64 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -149.32 -39.95 0.15 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 40' ' ' SER . 0.5 OUTLIER -71.45 12.49 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.021 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' C' ' 37' ' ' ALA . 21.3 tt -46.5 -13.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.516 ' N ' ' O ' ' C' ' 38' ' ' LEU . 5.4 m -65.5 146.17 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.316 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.539 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 9.8 m-85 -102.36 -63.66 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.547 ' O ' HG22 ' C' ' 45' ' ' ILE . 24.4 Cg_endo -59.35 -34.89 97.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.884 1.722 . . . . 1.0 112.256 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -83.54 -7.56 59.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.203 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.1 89.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.749 0.309 . . . . 1.0 110.917 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.547 HG22 ' O ' ' C' ' 42' ' ' PRO . 9.9 tt -64.05 -32.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.578 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.493 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.2 OUTLIER -62.81 -46.43 87.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.314 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 14.0 t90 -62.05 -40.0 94.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.354 -0.538 . . . . 1.0 109.775 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -59.17 -36.74 75.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.126 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.23 -48.22 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.418 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.0 pt-20 -72.3 -26.82 62.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.459 -0.496 . . . . 1.0 110.949 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 94.4 m -63.47 -50.11 70.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.548 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -59.47 -26.08 64.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.136 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.457 ' C ' ' H ' ' C' ' 55' ' ' VAL . 39.3 p -88.44 -0.07 56.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 55.88 6.06 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.671 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' C' ' 53' ' ' THR . 64.2 t -64.89 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.89 58.08 6.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.395 -1.082 . . . . 1.0 110.395 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 1.7 t80 -59.99 -48.83 80.08 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 164.31 -99.74 0.17 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . 0.444 ' OD1' ' NE ' ' C' ' 60' ' ' ARG . 44.4 t0 51.58 -80.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 1.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' C' ' 58' ' ' GLY . 12.9 mmt180 -118.64 -167.99 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.47 ' CE1' ' CB ' ' C' ' 37' ' ' ALA . 26.2 p90 -160.1 129.49 3.24 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.644 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.69 161.86 44.27 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.802 1.668 . . . . 1.0 111.976 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 0.5 OUTLIER -86.45 -152.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.003 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.657 HG23 ' CD1' ' B' ' 46' ' ' TRP . 19.6 m -112.15 -73.28 0.68 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' C' ' 64' ' ' THR . 78.9 tt0 -32.17 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.15 0.5 . . . . 1.0 111.125 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 78.1 mm-40 -138.96 -101.62 0.17 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.524 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.58 -56.07 0.0 OUTLIER Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.792 1.308 . . . . 1.0 114.415 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.9 ttm-85 -71.41 -70.19 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.282 -0.459 . . . . 1.0 110.28 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -46.1 -38.39 8.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.39 -44.77 86.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.262 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.83 82.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.055 0.455 . . . . 1.0 110.07 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -48.89 -48.89 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -65.59 -39.31 91.46 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.524 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.66 -45.68 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.39 -40.67 97.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.927 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -61.62 -38.15 86.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.708 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.34 83.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.348 . . . . 1.0 110.39 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.45 -42.2 89.59 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.08 -43.15 95.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 1.0 110.72 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.5 -42.38 95.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.01 -48.37 86.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.1 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . 0.538 ' O ' HG22 ' C' ' 85' ' ' VAL . 36.6 m-85 -66.01 -39.88 90.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.069 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.18 -28.18 64.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.847 0.356 . . . . 1.0 110.773 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.4 tt -63.93 -38.96 92.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.711 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . 0.538 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.8 m -51.97 -4.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.561 ' H ' ' C ' ' C' ' 84' ' ' LEU . 53.3 m -49.28 -38.9 28.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.936 0.398 . . . . 1.0 109.974 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -47.47 -18.31 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.461 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' C' ' 86' ' ' THR . . . -105.85 -14.07 15.33 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.725 0.297 . . . . 1.0 110.797 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' C' ' 86' ' ' THR . 86.7 mt -84.93 -51.84 6.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.587 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -56.91 -46.86 81.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.064 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.6 OUTLIER -77.63 -4.43 45.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.503 -179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -56.86 -48.59 77.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.451 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 14.6 p90 -73.42 -40.09 64.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . 0.49 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 92.6 t -43.56 -27.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.732 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -60.87 -22.82 64.66 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.905 -0.318 . . . . 1.0 111.247 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -63.09 -37.38 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 1.0 110.591 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.698 179.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.996 0.427 . . . . 1.0 110.622 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.42 -39.78 95.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.751 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.472 ' CE1' HH21 ' D' ' 95' ' ' ARG . 56.4 p-80 -60.02 -46.15 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.056 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.437 ' N ' ' CG ' ' D' ' 4' ' ' HIS . 81.3 tt0 -62.87 -39.43 94.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.862 0.363 . . . . 1.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -63.12 -40.71 98.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.455 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -60.19 -39.82 87.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.966 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.45 99.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.711 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -66.2 -38.67 88.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -62.62 -34.88 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.627 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.95 74.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -36.8 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.506 -0.315 . . . . 1.0 110.732 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.54 -33.21 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.416 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -40.97 97.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -53.14 -42.93 66.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.356 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -62.15 -38.98 91.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.42 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.48 -44.03 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.673 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.785 HD12 ' O ' ' D' ' 19' ' ' LEU . 0.3 OUTLIER -61.17 -46.75 89.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.18 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.48 -27.93 69.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -59.13 -46.33 88.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.15 -40.65 94.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.152 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -62.78 -34.01 76.36 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.374 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -85.93 -44.24 12.54 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.607 -0.269 . . . . 1.0 110.994 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.85 68.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.281 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.515 HG13 ' N ' ' D' ' 28' ' ' GLU . 4.6 p -60.12 -46.87 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.829 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.515 ' N ' HG13 ' D' ' 27' ' ' VAL . 44.6 tp10 -69.24 -41.24 77.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.696 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -56.56 -24.89 50.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.24 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' D' ' 32' ' ' GLY . 30.9 mm-40 -97.32 -39.73 9.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.0 111.203 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -59.82 79.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.159 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 128.86 21.85 1.33 Allowed Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.531 -0.628 . . . . 1.0 111.531 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . 0.549 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -105.92 153.37 40.16 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 110.289 -0.263 . . . . 1.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' D' ' 36' ' ' ALA . 79.2 Cg_endo -74.55 139.22 25.27 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.101 1.867 . . . . 1.0 111.904 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 69.82 -23.87 0.41 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' D' ' 34' ' ' PRO . . . 43.03 -170.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 1.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' D' ' 36' ' ' ALA . . . 175.43 -48.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.192 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.621 HD13 ' HE ' ' D' ' 60' ' ' ARG . 50.9 tp -116.35 119.68 36.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.121 0.486 . . . . 1.0 110.278 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' D' ' 40' ' ' SER . 37.3 pt -141.72 169.12 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 78.99 137.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.55 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -72.81 -46.42 8.98 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.852 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.2 Cg_endo -59.11 -30.77 94.08 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.571 1.514 . . . . 1.0 112.234 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.537 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.4 m-20 -91.65 -33.96 14.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.87 76.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.845 0.355 . . . . 1.0 110.752 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . 0.404 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.6 tt -64.26 -36.72 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.373 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.563 ' C ' HH11 ' A' ' 68' ' ' ARG . 0.4 OUTLIER -65.02 -46.02 83.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.515 ' CB ' HH21 ' D' ' 60' ' ' ARG . 2.1 t90 -62.05 -38.32 88.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 1.5 m -61.82 -37.82 85.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.822 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 45' ' ' ILE . 48.2 t -59.71 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 120.75 0.31 . . . . 1.0 110.991 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' D' ' 50' ' ' GLU . 17.4 pt-20 -68.45 -34.16 75.48 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.005 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -61.96 -46.54 88.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.556 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.56 69.28 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' D' ' 54' ' ' THR . 66.5 p -90.05 4.44 50.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.369 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 53' ' ' THR . 27.5 p 52.82 69.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -133.41 -59.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 71.85 -59.15 1.35 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 47' ' ' TRP . 0.5 OUTLIER 70.77 -37.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 1.0 110.538 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 117.07 11.11 9.27 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -61.42 -52.2 65.59 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.353 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.703 ' NH2' HH12 ' A' ' 68' ' ' ARG . 0.1 OUTLIER -145.78 144.27 30.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.762 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 13.2 p90 -136.95 122.54 13.09 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.56 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.18 -171.19 0.56 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.983 1.789 . . . . 1.0 111.898 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.863 HG22 ' H ' ' D' ' 64' ' ' THR . 8.3 p -122.26 -179.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.863 ' H ' HG22 ' D' ' 63' ' ' VAL . 97.1 m -62.3 -44.97 95.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.042 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' D' ' 67' ' ' GLY . 64.2 tt0 -52.2 -31.24 30.87 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.273 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -74.27 15.76 0.3 Allowed 'General case' 0 C--O 1.255 1.387 0 CA-C-O 124.482 2.087 . . . . 1.0 107.958 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.75 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 48.44 61.33 5.15 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 49.2 ttt85 -25.3 -27.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.535 0.668 . . . . 1.0 111.254 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.1 tptm -53.66 -21.93 7.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.587 ' O ' HG23 ' D' ' 74' ' ' VAL . 75.7 t -60.54 -44.43 96.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 119.979 -0.688 . . . . 1.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . 0.522 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -68.69 -48.02 64.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.982 0.42 . . . . 1.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.41 -64.29 0.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.832 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' D' ' 74' ' ' VAL . 10.3 pt20 -54.43 -43.25 71.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . 0.587 HG23 ' O ' ' D' ' 70' ' ' VAL . 86.7 t -61.56 -48.15 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.687 -0.405 . . . . 1.0 111.176 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mtp -63.71 -38.07 89.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.462 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 32.0 ttmt -58.81 -42.25 88.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.568 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.31 -40.19 89.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 1.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.49 -41.11 90.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.34 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.099 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' D' ' 80' ' ' GLU . 3.2 mp0 -67.65 -40.8 84.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 1.0 110.751 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 77' ' ' ALA . 47.2 t -63.2 -47.61 91.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.283 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.66 -9.31 58.06 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.622 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 -29.63 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.071 -0.344 . . . . 1.0 110.071 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.694 ' C ' HD23 ' D' ' 84' ' ' LEU . 7.3 tt -63.3 -42.88 99.09 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.243 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.04 -6.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.856 0.36 . . . . 1.0 110.163 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.506 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -60.66 -20.07 59.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.293 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.66 22.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.668 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.61 -39.11 93.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.2 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.22 -40.87 96.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.038 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.532 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -64.91 -37.19 86.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.266 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.523 ' OG1' ' CG ' ' C' ' 93' ' ' PHE . 1.0 OUTLIER -78.61 -4.75 50.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.108 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.01 -52.09 66.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.212 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 10.4 p90 -63.9 -32.23 73.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.51 -42.3 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.327 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . 0.472 HH21 ' CE1' ' D' ' 4' ' ' HIS . 95.7 mtt-85 -56.68 -24.29 47.88 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.113 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . 0.501 ' NH2' HG11 ' A' ' 94' ' ' VAL . 15.0 ptt180 -58.88 -8.71 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 1.0 110.146 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.245 -178.869 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 4' ' ' HIS . . . . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.705 0.288 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 t70 68.92 -37.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.767 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 20.7 p80 -66.64 -40.27 88.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.792 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 17.5 pt-20 -65.67 -36.32 83.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.42 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -39.63 94.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.42 -35.33 80.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.222 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -60.92 -40.53 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.974 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.61 -37.25 86.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.293 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.41 -38.78 90.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.733 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.72 86.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.31 -38.26 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.415 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.76 -34.16 77.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.343 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.83 -33.93 76.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.33 -42.31 99.28 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.528 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.38 -40.12 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.212 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.03 -42.5 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.0 110.81 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.88 -41.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.448 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.5 mt -59.87 -41.31 91.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.47 -46.57 89.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.914 0.388 . . . . 1.0 110.0 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.68 -35.2 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.73 88.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.93 -43.71 94.76 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.83 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -66.46 -36.58 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.369 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.32 -46.51 60.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.33 -0.548 . . . . 1.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.52 76.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -62.49 -46.25 96.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.085 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 27' ' ' VAL . 47.2 tp10 -66.4 -43.27 86.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.47 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.69 94.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 17.1 tp10 -73.23 -34.14 65.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.799 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -66.92 121.55 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 1.0 110.601 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 8.02 63.3 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.09 140.97 25.82 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.081 1.854 . . . . 1.0 111.982 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 6.91 60.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.58 106.49 0.05 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.863 0.363 . . . . 1.0 111.067 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.91 -29.83 21.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.541 ' CD1' HH11 ' A' ' 60' ' ' ARG . 42.3 tp -101.16 78.26 1.89 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.381 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.3 pt -103.75 31.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.308 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -126.17 121.71 33.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.985 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.477 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 18.4 t80 -74.74 -52.02 3.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.632 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.6 Cg_endo -59.94 -30.66 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.343 1.362 . . . . 1.0 112.434 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.62 -3.73 54.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.576 0.227 . . . . 1.0 111.054 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.1 -40.06 92.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.69 -32.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.291 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.432 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -58.84 -45.72 89.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.174 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -73.42 -24.45 60.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -70.15 -41.61 73.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.359 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.605 HG21 HH22 ' B' ' 68' ' ' ARG . 68.2 t -60.74 -47.93 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.83 0.348 . . . . 1.0 110.911 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.29 -31.19 71.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.267 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 89.3 m -61.34 -46.37 90.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.534 -0.466 . . . . 1.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.31 -26.61 61.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.525 ' OG1' HG12 ' A' ' 55' ' ' VAL . 44.6 p -86.08 7.34 25.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p 40.13 33.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.262 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.3 p -95.83 -45.25 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.803 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 49.38 83.72 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -46.76 89.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.755 0.312 . . . . 1.0 110.667 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.43 3.72 2.36 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.26 -50.61 72.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.0 110.507 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.541 HH11 ' CD1' ' A' ' 38' ' ' LEU . 1.4 mtt-85 -136.15 149.86 48.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -141.87 130.6 12.12 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.503 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 -172.07 0.72 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.932 1.755 . . . . 1.0 112.215 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 64' ' ' THR . 8.8 p -130.39 -144.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.046 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.879 ' H ' HG22 ' A' ' 63' ' ' VAL . 79.1 m -105.04 -41.45 5.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.669 0.271 . . . . 1.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.4 tp10 -60.82 -38.81 86.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.015 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -74.61 34.54 0.1 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 124.495 2.093 . . . . 1.0 109.943 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.71 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.19 62.52 1.51 Allowed Glycine 0 C--O 1.213 -1.214 0 CA-C-N 113.323 -1.762 . . . . 1.0 110.833 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' D' ' 50' ' ' GLU . 58.6 ttt85 -25.08 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 117.698 0.749 . . . . 1.0 110.927 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.71 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.5 mmtt -48.72 -16.38 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.005 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' GLY . 48.6 t -60.42 -45.47 96.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 119.096 -1.041 . . . . 1.0 110.08 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.27 79.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.643 0.259 . . . . 1.0 111.523 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 72' ' ' GLU . 1.5 mp0 -58.21 -43.04 87.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.052 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.33 -42.52 98.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.271 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.99 -45.15 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.117 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.555 ' SD ' HG11 ' D' ' 55' ' ' VAL . 76.1 mtm -62.03 -40.13 94.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.564 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -41.58 98.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.229 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.5 77.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.426 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.97 -40.49 97.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 1.0 110.696 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 79' ' ' ILE . 90.5 mt -71.35 -7.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.501 0.191 . . . . 1.0 111.385 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -96.08 -51.32 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.833 0.349 . . . . 1.0 110.872 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.9 m -61.61 -50.56 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.067 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 81' ' ' VAL . 38.2 m-85 -65.03 -40.58 95.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.809 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.23 86.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.724 0.297 . . . . 1.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 86' ' ' THR . 3.6 tp -62.59 -44.94 95.06 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.905 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 83.4 t -54.38 -3.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.414 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 84' ' ' LEU . 45.4 m -58.58 -42.1 87.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.84 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -41.44 -63.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.115 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.94 85.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.295 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.87 -43.94 97.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -66.12 -34.2 77.52 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.199 0.523 . . . . 1.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -76.19 -3.64 37.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.414 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.27 -48.94 77.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.434 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.0 p90 -65.47 -36.05 82.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 1.0 111.387 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.525 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -49.44 -28.78 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.229 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -71.52 -21.36 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.593 -0.276 . . . . 1.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' NH2' ' OE2' ' A' ' 97' ' ' GLU . 19.0 ptt-85 -50.91 -40.67 57.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.398 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.509 ' OE2' ' NH2' ' A' ' 96' ' ' ARG . 97.5 mt-10 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.096 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 N--CA 1.467 0.389 0 CA-C-O 120.686 0.279 . . . . 1.0 110.53 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -73.51 -31.24 63.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.673 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.02 -39.26 90.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.87 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -64.89 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.653 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.41 -43.73 88.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.5 95.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.52 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.84 -40.11 83.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.358 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.33 -34.55 78.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.75 72.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.34 -36.52 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.46 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.7 -36.27 83.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.0 110.347 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -65.22 -33.08 75.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.403 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.17 -41.67 98.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.554 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.98 -38.92 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.767 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.89 -39.65 92.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 1.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.07 -42.76 97.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.696 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.0 mt -60.54 -41.05 93.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.12 -47.89 83.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 1.0 109.887 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.13 -38.36 78.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.787 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.42 90.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 88.0 p -55.44 -43.55 75.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.234 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.58 -35.33 80.51 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.321 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -72.87 -43.41 62.59 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.196 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' B' ' 30' ' ' GLU . . . -59.27 -50.93 72.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.383 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.55 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.3 p -62.69 -46.47 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.55 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.55 ' N ' HG13 ' B' ' 27' ' ' VAL . 45.4 tp10 -67.48 -43.97 79.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.796 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.71 82.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.329 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 26' ' ' ALA . 17.6 mm-40 -64.77 -40.27 94.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.749 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -64.43 131.49 47.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.354 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.14 1.87 81.24 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.24 146.84 33.51 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.82 -0.223 . . . . 1.0 110.438 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . 0.533 ' O ' HG11 ' B' ' 63' ' ' VAL . 95.1 Cg_endo -75.56 142.46 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.322 2.015 . . . . 1.0 112.327 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.75 19.59 69.49 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.38 81.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 1.0 110.604 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.06 69.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.511 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.629 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.3 tt -89.81 119.12 29.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.27 0.557 . . . . 1.0 110.176 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.561 ' N ' HD23 ' B' ' 38' ' ' LEU . 39.1 pt -143.11 168.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.326 -0.852 . . . . 1.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.1 t 78.78 129.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.0 111.012 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.587 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 22.4 t80 -72.76 -46.78 9.13 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.026 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 26.0 Cg_endo -58.61 -31.13 93.98 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.358 1.372 . . . . 1.0 112.94 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -96.61 -11.79 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.869 0.366 . . . . 1.0 110.655 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.66 91.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.274 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.03 -30.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.024 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.468 ' CZ2' ' CB ' ' C' ' 68' ' ' ARG . 7.7 t90 -59.99 -49.36 77.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.869 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.3 OUTLIER -68.29 -34.05 75.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.303 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.459 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.3 p -67.69 54.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.706 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -147.22 -52.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.654 -0.248 . . . . 1.0 110.77 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.71 -32.8 74.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 1.0 110.613 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 51' ' ' THR . 0.0 OUTLIER -56.92 -45.15 82.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.145 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.1 -26.3 60.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.028 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.447 ' OG1' HG22 ' B' ' 55' ' ' VAL . 51.0 p -88.21 -1.43 58.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.694 0.283 . . . . 1.0 110.795 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.6 p 51.68 64.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.529 HG23 ' N ' ' B' ' 56' ' ' GLY . 21.6 m -133.66 -47.9 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.21 82.08 0.02 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.19 -42.0 98.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.707 0.289 . . . . 1.0 111.084 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.5 0.47 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.318 -0.713 . . . . 1.0 111.318 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' C' ' 61' ' ' TYR . 96.7 m-20 -48.05 -66.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 1.0 110.658 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -138.39 161.09 37.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.978 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -146.92 138.14 13.03 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.91 -172.33 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.815 1.677 . . . . 1.0 112.081 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.558 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -128.84 -143.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.019 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.558 ' H ' HG12 ' B' ' 63' ' ' VAL . 4.3 m -110.96 -42.04 4.08 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.664 0.269 . . . . 1.0 110.934 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.2 tp10 -66.2 -34.4 77.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.502 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.44 33.63 0.11 Allowed 'General case' 0 C--O 1.266 1.959 0 CA-C-O 123.961 1.838 . . . . 1.0 109.744 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.72 63.29 1.04 Allowed Glycine 0 C--O 1.214 -1.146 0 CA-C-N 113.393 -1.73 . . . . 1.0 111.175 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.605 HH22 HG21 ' A' ' 49' ' ' VAL . 59.6 ttp85 -23.57 -33.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.151 0.975 . . . . 1.0 110.763 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.7 mttp -48.29 -17.79 0.17 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' B' ' 67' ' ' GLY . 52.2 t -61.65 -49.29 84.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.97 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.94 64.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.5 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.28 -41.76 76.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.029 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.76 -43.02 99.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.307 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.94 -46.89 92.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 55' ' ' VAL . 74.4 mtm -62.62 -43.33 99.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.637 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -65.43 -42.53 92.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.156 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.86 93.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.15 -42.41 94.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.0 -43.75 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.704 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' B' ' 84' ' ' LEU . 81.0 mm-40 -59.01 -45.58 90.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.429 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.46 -49.09 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.413 ' O ' HG22 ' B' ' 85' ' ' VAL . 32.9 m-85 -70.89 -22.77 62.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.582 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.2 -22.29 19.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.301 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' B' ' 80' ' ' GLU . 6.8 tt -63.98 -40.85 97.31 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.723 0.297 . . . . 1.0 110.206 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' B' ' 87' ' ' ALA . 11.1 m -50.58 -27.85 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.749 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.415 ' C ' ' O ' ' B' ' 85' ' ' VAL . 15.6 m -33.36 -31.19 0.01 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.449 0.642 . . . . 1.0 110.016 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -52.82 -57.35 10.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.651 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -65.02 -33.81 76.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.153 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.418 HD12 ' N ' ' B' ' 89' ' ' LEU . 9.0 mp -60.04 -44.28 94.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 1.0 109.986 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.87 -19.25 60.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.925 -0.58 . . . . 1.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.527 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -98.82 -11.06 22.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.485 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.9 m-20 -62.56 -40.99 98.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.417 ' CD2' ' CB ' ' C' ' 90' ' ' ALA . 1.7 p90 -71.34 -29.27 64.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' B' ' 96' ' ' ARG . 91.4 t -60.8 -43.9 96.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.773 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -40.98 -22.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.679 0.276 . . . . 1.0 111.311 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' B' ' 94' ' ' VAL . 44.7 ptt85 -62.95 -37.25 86.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.874 -179.518 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' C' ' 4' ' ' HIS . 42.3 p-10 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.873 0.368 . . . . 1.0 110.383 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 19.2 p80 -67.55 -38.94 84.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . 0.597 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.4 tt0 -63.11 -36.64 84.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.645 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.16 -40.23 95.29 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.136 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.62 -40.86 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.78 94.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.354 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.36 -32.54 74.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.366 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' C' ' 81' ' ' VAL . . . -69.23 -24.26 63.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.71 -54.2 21.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.806 0.336 . . . . 1.0 111.643 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.79 -30.51 70.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.28 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.8 -37.45 87.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.705 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.53 -36.9 85.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 1.0 110.192 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.66 -32.5 73.85 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.443 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.43 -47.47 81.81 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -64.93 -32.44 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 1.0 111.053 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' C' ' 52' ' ' ALA . 41.3 mt -60.17 -40.67 90.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.893 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.96 -43.55 98.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.77 -33.11 73.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.124 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -61.89 -41.39 97.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.647 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -61.67 -38.77 89.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.514 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -64.58 -74.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.301 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.64 -33.04 6.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.565 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 22' ' ' ALA . . . -54.37 -52.56 61.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.471 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . 0.439 HG22 ' HE ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -67.17 -39.67 83.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.29 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -67.09 -32.43 73.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.877 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' C' ' 66' ' ' GLU . . . -55.01 -39.57 69.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.198 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' C' ' 38' ' ' LEU . 4.3 mt-10 -95.13 -136.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.61 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' C' ' 39' ' ' ILE . 35.6 mmt180 58.82 57.64 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.115 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.33 11.16 2.27 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.861 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . 0.51 ' HB3' ' OE2' ' C' ' 66' ' ' GLU . . . -106.72 147.61 35.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.87 147.15 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.275 1.983 . . . . 1.0 111.921 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.0 14.81 61.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 141.67 57.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.706 0.289 . . . . 1.0 110.475 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.22 -21.81 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.567 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.0 tt -107.66 85.37 2.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.981 0.42 . . . . 1.0 109.917 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.525 ' O ' ' NH1' ' C' ' 31' ' ' ARG . 39.6 pt -114.37 35.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -134.52 140.9 46.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.767 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 16.9 t80 -85.3 -52.06 0.5 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.95 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.76 -32.37 95.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.394 1.396 . . . . 1.0 112.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.87 -3.76 57.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.622 -0.263 . . . . 1.0 111.101 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.89 94.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 1.0 110.639 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.04 -32.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -46.74 84.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.754 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' C' ' 48' ' ' SER . 0.1 OUTLIER -66.25 -29.93 70.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.52 ' O ' HD22 ' C' ' 19' ' ' LEU . 50.4 p -70.07 -9.3 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.973 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' C' ' 51' ' ' THR . 25.6 t -90.3 -48.77 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.147 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.07 32.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.483 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . 0.478 HG23 ' N ' ' C' ' 52' ' ' ALA . 10.2 t -133.89 -41.05 0.84 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.504 0.193 . . . . 1.0 111.273 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -66.16 -14.82 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.053 -0.259 . . . . 1.0 110.771 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.479 ' OG1' HG13 ' C' ' 55' ' ' VAL . 71.0 p -98.96 8.4 45.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.937 0.399 . . . . 1.0 110.235 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.9 p 53.83 45.37 27.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.975 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.51 HG23 ' N ' ' C' ' 56' ' ' GLY . 27.7 m -103.79 -44.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.739 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . 0.51 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 44.29 73.26 0.27 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -44.28 96.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.599 0.237 . . . . 1.0 110.398 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.04 10.85 7.25 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.66 -49.24 78.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 1.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -147.72 162.11 39.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.846 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 t80 -163.77 136.48 4.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.39 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.75 161.4 46.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.727 1.618 . . . . 1.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' C' ' 66' ' ' GLU . 3.0 t -110.33 165.89 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.019 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' C' ' 67' ' ' GLY . 21.5 m -41.17 -66.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.178 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -46.65 -17.74 0.05 Allowed 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 63' ' ' VAL . 18.0 mt-10 -101.01 27.57 5.95 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-O 124.481 2.086 . . . . 1.0 109.24 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . 0.661 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 39.27 64.11 1.02 Allowed Glycine 0 C--O 1.219 -0.819 0 CA-C-N 113.26 -1.791 . . . . 1.0 111.597 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 70' ' ' VAL . 0.3 OUTLIER -24.43 -37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.054 0.927 . . . . 1.0 110.186 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.661 ' N ' ' O ' ' C' ' 67' ' ' GLY . 99.0 mttt -43.24 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.46 -1.245 . . . . 1.0 109.758 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.7 t -60.51 -46.77 94.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 118.718 -1.193 . . . . 1.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.62 -45.67 51.55 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.769 0.319 . . . . 1.0 111.707 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.58 -42.01 99.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.106 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -58.03 -49.47 76.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.285 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.24 -43.4 84.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.391 . . . . 1.0 111.253 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 48.2 ttm -59.48 -40.07 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.728 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -60.77 -38.46 85.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.739 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.96 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.692 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.61 -39.74 97.0 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.173 -0.537 . . . . 1.0 111.834 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.64 -42.97 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.774 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.85 -40.27 96.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . 0.419 HG13 ' HB1' ' C' ' 11' ' ' ALA . 53.3 t -63.68 -48.07 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.364 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -75.76 -8.08 55.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.343 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.53 -45.07 10.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.853 0.359 . . . . 1.0 110.446 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.427 ' C ' ' N ' ' C' ' 86' ' ' THR . 7.0 tt -63.21 -42.85 99.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.689 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.82 -11.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.667 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.427 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.4 m -63.76 -25.4 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -56.81 -28.57 61.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.376 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.51 -13.28 34.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.3 -32.69 22.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.072 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.83 -37.89 89.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.587 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.59 -6.0 37.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.033 -0.53 . . . . 1.0 109.949 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.454 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 40.8 t0 -63.21 -43.9 96.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -84.62 -28.15 26.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.561 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.47 -42.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -51.83 -21.9 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.223 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . 0.455 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 24.0 ptt-85 -50.6 -44.79 57.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.591 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . 0.455 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 8.4 pt-20 . . . . . 0 N--CA 1.463 0.225 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.553 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.357 . . . . 1.0 110.444 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 20.3 p80 -66.7 -40.07 88.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.1 tt0 -62.26 -38.42 89.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.495 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -61.09 -42.35 98.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.291 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.13 -41.13 97.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.47 94.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.807 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.9 -41.39 91.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.864 0.364 . . . . 1.0 110.367 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.81 -33.78 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.506 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.98 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.972 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.81 -36.3 80.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 1.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.02 -37.32 87.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -62.31 -34.83 77.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.234 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . 0.545 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.3 tp -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.254 -0.579 . . . . 1.0 110.306 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -56.41 -33.92 66.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.366 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.12 -44.69 96.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.596 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' D' ' 18' ' ' VAL . 4.9 m -87.37 -37.01 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.654 0.264 . . . . 1.0 111.48 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.438 HD12 ' O ' ' D' ' 19' ' ' LEU . 1.5 tp -60.9 -47.0 88.39 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -63.53 -44.75 93.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.294 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -64.2 -29.86 70.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -61.43 -39.09 89.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.625 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 85.7 p -61.57 -43.76 98.27 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.602 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -64.82 -34.05 77.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.48 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' D' ' 29' ' ' ALA . 44.8 mmtm -78.2 -44.83 24.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.294 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -58.22 -49.14 78.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.43 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . 0.548 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.1 p -60.07 -45.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.526 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.548 ' N ' HG13 ' D' ' 27' ' ' VAL . 11.0 tm-20 -68.13 -35.83 78.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.591 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -58.81 -51.96 67.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 14.0 mp0 -69.79 -32.27 70.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.589 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -50.22 103.35 0.05 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.051 0.453 . . . . 1.0 111.049 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.87 11.1 44.44 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.76 140.16 21.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 110.525 -0.176 . . . . 1.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.03 142.27 27.57 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.107 1.871 . . . . 1.0 112.299 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.0 26.42 63.23 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.65 140.91 56.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 1.0 110.791 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.81 -22.84 10.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.712 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' D' ' 30' ' ' GLU . 57.4 tp -104.7 121.1 42.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.925 0.393 . . . . 1.0 109.956 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' D' ' 40' ' ' SER . 34.2 pt -153.48 -164.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.372 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . 0.452 ' O ' ' O ' ' D' ' 39' ' ' ILE . 1.3 m 58.26 141.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 1.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 7.1 m-85 -79.83 -58.42 0.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.99 -26.53 81.89 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.584 1.523 . . . . 1.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -87.98 -25.37 23.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -63.69 -39.53 94.54 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.693 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.43 -32.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.26 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -47.89 81.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' D' ' 51' ' ' THR . 0.2 OUTLIER -76.76 -22.96 53.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.21 -44.44 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.721 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.98 4.3 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 1.0 110.898 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 50.6 mm-40 -103.22 -49.86 3.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.137 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . 0.46 ' H ' HG22 ' D' ' 51' ' ' THR . 0.0 OUTLIER -63.67 -45.61 89.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.19 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -23.51 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 1.0 110.085 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . 0.462 ' OG1' HG13 ' D' ' 55' ' ' VAL . 43.4 p -100.45 2.22 41.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.388 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 61.6 p 45.83 70.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.452 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.555 HG11 ' SD ' ' A' ' 75' ' ' MET . 30.0 m -117.63 -42.75 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.591 -0.277 . . . . 1.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . 0.533 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 51.16 63.18 4.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -45.51 93.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.692 0.282 . . . . 1.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 -1.64 7.15 Favored Glycine 0 N--CA 1.466 0.648 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.63 -47.99 83.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.546 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -142.9 151.49 41.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.711 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 27.4 p90 -145.56 137.68 13.33 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.568 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.71 161.69 44.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.253 1.968 . . . . 1.0 112.152 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.947 HG22 ' H ' ' D' ' 64' ' ' THR . 8.0 p -104.76 -130.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.0 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.947 ' H ' HG22 ' D' ' 63' ' ' VAL . 23.9 m -114.18 -51.33 2.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.603 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.7 tt0 -57.11 -30.51 64.43 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.603 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.66 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 1.1 pm0 -70.66 19.43 0.05 OUTLIER 'General case' 0 C--O 1.264 1.83 0 CA-C-O 123.651 1.691 . . . . 1.0 109.4 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.64 62.19 2.99 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' D' ' 67' ' ' GLY . 59.5 ttm-85 -26.22 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.831 0.816 . . . . 1.0 110.631 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' D' ' 67' ' ' GLY . 65.0 mttm -51.02 -24.14 3.53 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.525 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.603 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.7 t -63.17 -48.4 87.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 119.769 -0.772 . . . . 1.0 110.362 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.58 -37.07 76.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.657 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -64.05 -40.46 96.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.089 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -61.43 -47.38 86.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.672 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.96 -36.35 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.309 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.47 ' SD ' HG11 ' C' ' 55' ' ' VAL . 17.9 mtm -62.54 -42.7 99.7 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.092 -0.243 . . . . 1.0 111.438 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.48 -41.64 96.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.657 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.4 -40.81 95.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.506 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . 0.545 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -64.44 -41.73 97.89 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.22 -43.33 98.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -63.46 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.563 -0.289 . . . . 1.0 111.132 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.5 t -62.27 -50.37 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.261 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.48 -39.86 85.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 1.0 110.476 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.552 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' D' ' 86' ' ' THR . 4.3 tt -60.92 -40.01 91.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.274 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . 0.481 HG12 ' O ' ' D' ' 85' ' ' VAL . 97.9 t -48.49 -10.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 1.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.519 ' N ' ' O ' ' D' ' 84' ' ' LEU . 22.6 m -49.28 -39.25 30.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.093 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -49.96 -17.94 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.392 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' D' ' 92' ' ' ASP . . . -104.87 -12.2 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.737 0.303 . . . . 1.0 110.252 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.5 mt -87.54 -64.73 1.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.36 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.13 -9.49 1.46 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.275 0.559 . . . . 1.0 109.944 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.482 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 0.5 OUTLIER -99.54 -1.12 39.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.44 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m-20 -74.57 -39.17 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.658 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 30.7 p90 -84.86 -40.39 17.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 21.2 m -43.34 -36.72 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.8 0.333 . . . . 1.0 111.401 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . 0.464 ' N ' HG23 ' D' ' 94' ' ' VAL . 95.2 mtt-85 -57.14 -27.53 61.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -39.93 -35.98 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.676 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.39 -179.914 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . . . . . . 0 CA--C 1.523 -0.061 0 CA-C-O 120.857 0.36 . . . . 1.0 110.71 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.06 -45.56 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.628 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 4.0 p80 -67.3 -41.5 85.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.502 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.67 -46.02 87.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.705 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.05 -38.11 89.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.61 -38.22 90.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.197 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.52 94.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.233 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.03 -38.63 91.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.343 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.26 -41.68 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.82 85.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.996 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.91 -40.38 94.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.621 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.96 -38.15 87.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.447 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -65.6 -32.0 73.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.446 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.1 -44.81 95.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.826 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -60.69 -36.0 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.306 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.74 -40.77 96.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.087 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.25 -31.37 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.665 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -61.68 -42.12 98.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.14 -51.33 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.84 -37.46 86.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.204 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.35 83.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -59.48 -39.69 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.94 -55.1 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.612 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.68 -23.1 39.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.965 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 23' ' ' SER . 83.2 t -92.45 -50.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.929 0.395 . . . . 1.0 110.396 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.33 -42.32 93.03 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.604 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -34.73 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -78.98 -114.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 45.55 78.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.88 0.372 . . . . 1.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -6.76 41.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.12 136.14 57.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.295 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.24 140.96 25.4 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.971 1.781 . . . . 1.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . 64.27 22.13 66.97 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -60.96 -48.07 83.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.789 0.328 . . . . 1.0 110.758 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 58.89 0.6 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.697 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 38' ' ' LEU . 5.1 tt -131.48 114.59 15.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.78 0.324 . . . . 1.0 110.15 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 23.5 pt -157.96 54.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.122 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -153.48 118.19 5.0 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.856 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.511 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 47.6 m-85 -55.37 -50.33 87.36 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.119 -0.491 . . . . 1.0 112.028 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 28.8 Cg_endo -59.72 -34.08 96.22 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.546 1.497 . . . . 1.0 112.6 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB3' HH21 ' A' ' 60' ' ' ARG . 61.5 m-20 -92.52 -8.11 45.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.676 0.274 . . . . 1.0 110.82 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . . . -62.64 -45.14 94.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.0 110.386 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 46' ' ' TRP . 4.0 tt -69.41 -41.86 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.152 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.517 ' N ' HG23 ' A' ' 45' ' ' ILE . 3.3 t-105 -55.35 -43.13 74.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -66.16 -38.46 88.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 19' ' ' LEU . 3.5 t -65.05 -24.58 67.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.249 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.03 -49.76 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.605 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -75.35 -24.02 57.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.462 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 m -62.5 -45.76 91.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.529 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -62.13 -35.21 78.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.618 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 p -75.41 4.14 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 41.5 73.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 1.0 111.17 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 3.9 p -139.05 -36.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.851 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.95 76.37 0.08 OUTLIER Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CZ ' HG21 ' A' ' 55' ' ' VAL . 57.9 m-85 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 1.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.52 17.67 0.2 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -63.42 -42.26 98.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 1.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mmt180 -127.98 -170.48 2.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 51.4 m-85 -162.18 88.51 1.44 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.002 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.37 156.14 65.24 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.905 1.737 . . . . 1.0 112.221 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.995 HG22 ' H ' ' A' ' 64' ' ' THR . 7.4 p -128.16 -171.77 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.221 0.534 . . . . 1.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.995 ' H ' HG22 ' A' ' 63' ' ' VAL . 98.9 m -69.44 -43.85 72.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.8 tp10 -48.1 -49.52 31.54 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -80.79 35.55 0.37 Allowed 'General case' 0 C--O 1.258 1.511 0 CA-C-O 123.989 1.852 . . . . 1.0 109.242 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.52 66.67 0.92 Allowed Glycine 0 C--O 1.212 -1.22 0 CA-C-N 113.303 -1.771 . . . . 1.0 112.085 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' CG ' ' D' ' 59' ' ' ASP . 58.4 ttm-85 -24.24 -32.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.33 1.065 . . . . 1.0 111.15 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 67' ' ' GLY . 9.0 mtmp? -53.2 -16.48 1.25 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.81 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.2 t -63.36 -46.94 94.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 120.049 -0.661 . . . . 1.0 110.574 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -44.4 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.081 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -56.95 -43.29 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.349 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.2 -41.99 85.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.864 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.36 -45.13 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.177 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.45 -40.24 93.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.756 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -60.48 -42.63 96.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.321 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.82 82.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.492 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -39.15 93.21 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.727 -0.949 . . . . 1.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.11 -26.65 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.864 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.55 -51.83 13.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 1.0 111.2 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.6 m -61.41 -48.98 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.097 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.526 ' N ' HG23 ' A' ' 81' ' ' VAL . 16.2 m-85 -64.43 -41.65 96.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.992 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.65 -36.94 85.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.801 -0.359 . . . . 1.0 111.051 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.2 tt -63.41 -37.42 87.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.356 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 85' ' ' VAL . 90.2 t -45.45 -14.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.482 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' LEU . 41.1 m -51.08 -44.25 61.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 1.0 110.058 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.83 -21.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.69 -20.62 13.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.921 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 86' ' ' THR . 41.9 mt -84.98 -43.18 14.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.772 0.32 . . . . 1.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -59.29 -38.2 79.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.036 0.446 . . . . 1.0 110.87 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -65.67 -11.78 47.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.283 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 67.1 m-20 -59.61 -49.8 76.36 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.16 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 11.3 p90 -75.53 -22.54 57.0 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.813 0.34 . . . . 1.0 111.282 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.37 -43.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.194 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.82 -20.84 59.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -53.64 -42.66 68.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.467 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 . . . . . 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.848 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.778 0.323 . . . . 1.0 110.766 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' HIS . . . . . 0.568 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.5 p80 -78.49 -23.57 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.45 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.72 -39.45 88.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.743 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.35 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.666 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.36 -41.17 96.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.0 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 99.3 mm-40 -65.7 -38.19 88.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -61.85 -37.48 84.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.53 71.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.881 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.81 -38.76 92.31 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.554 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' B' ' 9' ' ' GLN . 1.1 mp0 -65.71 -34.82 79.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.315 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.47 -38.54 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.37 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.405 HD11 ' HB1' ' B' ' 52' ' ' ALA . 53.2 tp -62.78 -42.08 99.54 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.443 ' O ' ' OE2' ' B' ' 20' ' ' GLU . 76.3 mm-40 -63.86 -40.04 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -59.05 -42.1 89.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 1.0 110.612 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.43 -40.84 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.673 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 52' ' ' ALA . 82.5 mt -59.32 -40.94 87.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' B' ' 20' ' ' GLU . 0.3 OUTLIER -59.82 -48.93 79.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -31.01 69.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.992 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.59 90.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.496 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.9 p -59.63 -43.71 93.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.412 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -65.73 -35.48 80.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.42 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.19 -47.13 37.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.794 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.7 82.57 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' VAL . . . . . 0.546 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.9 p -62.18 -46.31 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.231 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.546 ' N ' HG13 ' B' ' 27' ' ' VAL . 83.4 tt0 -67.09 -43.78 81.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.531 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.79 83.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.337 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -70.39 -33.95 71.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.678 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.95 123.96 21.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.53 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.01 0.64 65.83 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.75 140.45 21.09 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 122.833 -0.216 . . . . 1.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.73 149.74 34.22 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.061 1.841 . . . . 1.0 112.623 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.48 2.85 23.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.68 ' O ' HG22 ' B' ' 39' ' ' ILE . . . -77.43 83.01 3.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.667 0.27 . . . . 1.0 110.699 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.5 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 1.0 110.506 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.821 HD23 ' O ' ' B' ' 38' ' ' LEU . 5.4 tt -58.99 -28.43 66.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.359 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' ILE . . . . . 0.694 HG23 ' O ' ' B' ' 39' ' ' ILE . 20.4 tt -38.26 100.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.182 0.515 . . . . 1.0 110.793 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.531 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 59.7 m -171.42 -119.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.645 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.6 m-85 -177.57 -64.88 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.014 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 21.1 Cg_endo -58.5 -33.43 98.0 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.161 1.907 . . . . 1.0 112.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.16 -4.64 51.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.665 -0.243 . . . . 1.0 111.015 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 38' ' ' LEU . . . -65.03 -40.82 95.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.181 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.76 -37.37 73.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.361 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.612 ' NE1' ' O ' ' C' ' 64' ' ' THR . 2.8 t90 -53.95 -50.99 65.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.711 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.7 t90 -66.15 -38.32 87.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.401 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . 0.443 ' O ' HD22 ' B' ' 19' ' ' LEU . 65.2 m -55.24 -45.33 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.273 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.89 -46.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.31 -31.71 72.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 98.2 m -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.157 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -55.7 -26.3 44.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.723 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' THR . . . . . 0.539 ' OG1' HG12 ' B' ' 55' ' ' VAL . 46.3 p -85.68 -2.25 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 1.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.5 p 57.08 5.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.097 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' B' ' 53' ' ' THR . 7.8 p -64.85 -43.8 96.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.784 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' GLY . . . . . 0.523 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 38.55 74.64 0.11 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' B' ' 55' ' ' VAL . 47.0 m-85 -59.92 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.663 0.268 . . . . 1.0 110.966 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.53 -0.75 2.26 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.06 -65.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 1.0 110.084 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.28 149.38 36.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 22.8 p90 -139.18 112.53 8.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.46 -171.05 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.49 1.46 . . . . 1.0 111.971 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' VAL . . . . . 0.898 HG22 ' H ' ' B' ' 64' ' ' THR . 7.2 p -133.65 -147.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.391 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' THR . . . . . 0.898 ' H ' HG22 ' B' ' 63' ' ' VAL . 97.9 m -101.79 -42.8 6.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.256 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' B' ' 67' ' ' GLY . 75.1 tt0 -54.79 -38.24 67.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.284 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -77.56 31.66 0.16 Allowed 'General case' 0 C--O 1.259 1.592 0 CA-C-O 123.788 1.756 . . . . 1.0 109.72 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.59 63.74 1.57 Allowed Glycine 0 C--O 1.212 -1.267 0 CA-C-N 113.659 -1.61 . . . . 1.0 111.629 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' B' ' 67' ' ' GLY . 55.0 ttm-85 -25.28 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.401 1.101 . . . . 1.0 110.579 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' B' ' 67' ' ' GLY . 67.5 mttm -48.49 -18.4 0.23 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.3 -47.82 91.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 119.847 -0.741 . . . . 1.0 109.691 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.36 -38.99 68.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.296 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -49.17 -43.33 41.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -66.64 -41.14 88.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -51.66 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.696 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 22.9 ptp -64.26 -41.01 97.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 1.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.14 -39.28 93.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.442 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' ALA . . . . . 0.543 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.87 -36.03 80.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 1.0 110.526 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.89 -39.88 58.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.442 -0.663 . . . . 1.0 111.442 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.21 -44.6 99.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 121.112 -0.235 . . . . 1.0 111.483 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.88 -35.29 79.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 1.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 77' ' ' ALA . 17.9 t -62.27 -71.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' PHE . . . . . 0.433 ' N ' HG12 ' B' ' 81' ' ' VAL . 69.8 m-85 -58.11 -4.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.957 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' B' ' 81' ' ' VAL . . . -97.55 -34.99 10.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.168 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -64.47 -40.79 96.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.211 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 87' ' ' ALA . 14.0 m -58.57 -16.5 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.009 -0.542 . . . . 1.0 109.621 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 52.5 m -42.43 -24.66 0.06 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.078 0.466 . . . . 1.0 109.811 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.75 -64.42 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.845 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.6 -24.06 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.2 mm? -87.81 -19.76 27.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.788 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.57 -50.55 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.459 0.647 . . . . 1.0 109.335 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' H ' ' B' ' 91' ' ' THR . 0.4 OUTLIER -54.23 -3.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.236 179.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' B' ' 90' ' ' ALA . 91.0 m-20 -58.69 -41.87 87.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.866 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 24.3 p90 -70.56 -27.53 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.906 -0.317 . . . . 1.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.79 -43.7 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.512 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.29 -21.35 59.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.932 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -55.09 -41.73 71.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.974 179.92 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' C' ' 3' ' ' ASP . 67.8 t0 . . . . . 0 C--O 1.231 0.088 0 N-CA-C 109.924 -0.399 . . . . 1.0 109.924 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -80.4 -17.2 52.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.776 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.44 89.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -63.06 -39.41 94.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.0 110.281 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.5 -40.69 89.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.73 92.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.593 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.09 -39.15 89.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.337 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -62.4 -36.74 83.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.291 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.71 80.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -62.82 -40.18 96.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 1.0 111.086 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -65.84 -34.25 77.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.569 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.8 -37.94 88.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.516 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' LEU . . . . . 0.438 HD13 ' HA2' ' C' ' 78' ' ' GLY . 49.0 tp -61.74 -44.6 96.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.585 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' C' ' 20' ' ' GLU . 85.5 mm-40 -58.48 -32.31 68.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.82 -43.24 93.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 m -87.56 -34.65 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.592 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LEU . . . . . 0.699 HD12 ' O ' ' C' ' 19' ' ' LEU . 0.9 OUTLIER -60.49 -49.14 78.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' C' ' 16' ' ' GLN . 3.4 mp0 -61.22 -43.32 99.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.64 -29.34 66.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.473 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' C' ' 19' ' ' LEU . . . -65.17 -37.65 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 12.9 m -56.63 -44.8 81.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.356 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -64.59 -52.15 59.03 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.131 -0.628 . . . . 1.0 109.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.6 mmtt -59.48 -37.92 79.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.435 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.74 -57.74 5.86 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.832 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -64.33 -44.21 97.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.137 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -60.72 -32.81 72.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.15 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -60.77 -29.28 69.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.624 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.2 -44.73 92.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.66 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.03 130.23 41.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.46 -29.75 11.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.234 -0.747 . . . . 1.0 111.234 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.89 144.19 28.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 122.903 -0.174 . . . . 1.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.17 158.71 37.52 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.115 1.877 . . . . 1.0 112.442 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.77 36.9 14.55 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 141.86 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 1.0 110.569 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.4 -44.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.46 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.413 ' O ' HD23 ' C' ' 38' ' ' LEU . 6.4 tt -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.411 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -37.89 116.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.736 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' C' ' 41' ' ' TYR . 17.2 t -177.6 -123.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.306 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' TYR . . . . . 0.541 ' N ' ' OG ' ' C' ' 40' ' ' SER . 0.8 OUTLIER 171.97 -65.58 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.188 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' C' ' 41' ' ' TYR . 23.5 Cg_endo -58.81 -40.16 75.04 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.886 1.724 . . . . 1.0 112.171 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.455 ' CB ' ' NH2' ' C' ' 60' ' ' ARG . 8.5 p30 -88.37 -0.22 56.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.31 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.77 87.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 1.0 110.615 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.472 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.3 tt -67.18 -41.4 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' NE ' ' D' ' 68' ' ' ARG . 0.0 OUTLIER -52.33 -49.08 64.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.737 -179.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -65.43 -38.55 90.22 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.826 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 9.0 p -62.11 -38.79 90.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.543 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' VAL . . . . . 0.474 ' O ' HG23 ' C' ' 53' ' ' THR . 42.9 t -59.55 -47.75 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 121.181 -0.208 . . . . 1.0 111.367 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.58 -34.75 77.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.569 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -64.24 -53.7 45.07 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.55 68.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.766 0.317 . . . . 1.0 110.947 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' THR . . . . . 0.474 HG23 ' O ' ' C' ' 49' ' ' VAL . 58.9 p -90.81 3.63 53.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.274 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.4 p 52.06 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.47 -50.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.147 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.3 76.81 0.15 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 26.9 t80 -61.66 -43.21 99.28 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.63 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.14 12.19 5.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.6 -45.54 93.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' C' ' 43' ' ' ASP . 94.1 mtt-85 -138.45 147.99 43.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -115.66 128.88 25.6 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.762 -0.199 . . . . 1.0 110.563 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.55 157.16 61.78 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.029 1.82 . . . . 1.0 112.001 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' VAL . . . . . 0.457 ' H ' HG22 ' C' ' 63' ' ' VAL . 0.0 OUTLIER -56.2 -176.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.276 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' THR . . . . . 0.612 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 67.0 m -89.82 -86.25 0.2 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.643 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' C' ' 64' ' ' THR . 50.7 tp10 -28.19 -84.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.321 0.388 . . . . 1.0 111.097 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.5 mt-10 -60.95 -92.2 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.05 -56.2 0.0 OUTLIER Glycine 0 N--CA 1.478 1.457 0 O-C-N 124.376 1.047 . . . . 1.0 114.571 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 42.9 ttp85 -71.35 -47.75 54.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.289 -0.456 . . . . 1.0 110.402 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' LYS . . . . . 0.556 ' NZ ' HH12 ' C' ' 68' ' ' ARG . 4.5 mptp? -59.85 -41.46 91.46 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' VAL . . . . . 0.618 ' O ' HG23 ' C' ' 74' ' ' VAL . 58.7 t -76.64 -45.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.788 -0.765 . . . . 1.0 111.237 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.23 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.703 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' C' ' 68' ' ' ARG . 15.4 tm-20 -49.42 -40.98 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.836 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -69.25 -42.04 76.14 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.931 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.618 HG23 ' O ' ' C' ' 70' ' ' VAL . 74.0 t -66.06 -49.48 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.722 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ptp -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.693 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.34 -40.5 96.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.522 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.72 95.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 1.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.31 -41.23 96.77 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.3 -43.06 97.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 1.0 110.852 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.28 -40.6 94.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.265 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.89 -47.02 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.35 -14.62 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.168 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.18 -34.09 19.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 1.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.16 -40.53 90.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.66 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.58 -24.58 29.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' THR . . . . . 0.43 ' O ' ' N ' ' C' ' 90' ' ' ALA . 1.2 t -43.12 -33.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.168 0.509 . . . . 1.0 110.456 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -49.1 -61.74 1.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.203 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.58 -35.02 39.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.241 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' LEU . . . . . 0.562 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.4 mm? -75.35 -34.81 61.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.777 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -63.5 -36.18 82.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.181 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -4.47 37.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.08 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 88.9 m-20 -54.77 -48.95 72.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.746 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 20.8 p90 -74.83 -9.97 59.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.1 -48.3 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.679 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -65.81 -20.35 66.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.258 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -48.84 -38.8 23.35 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.412 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.278 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.825 0.345 . . . . 1.0 110.474 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -63.75 -40.3 96.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.935 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 4' ' ' HIS . . . . . 0.708 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 2.5 p80 -58.55 -44.92 89.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.587 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.51 -39.6 92.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 1.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -65.06 -39.16 92.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.483 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.14 -37.26 86.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.931 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.76 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.846 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -63.66 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 1.0 110.306 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.98 -39.1 91.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.88 81.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.73 -41.86 87.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 1.0 110.733 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -67.14 -37.92 84.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.93 -34.83 79.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.514 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.26 -40.6 96.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.316 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -60.36 -37.05 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.43 -42.51 92.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.74 0.305 . . . . 1.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.12 -42.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.771 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.0 mt -61.13 -42.02 97.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -59.98 -46.15 90.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.341 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.25 -40.28 74.5 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.411 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.42 93.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.06 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' SER . . . . . 0.437 ' OG ' ' OG ' ' D' ' 48' ' ' SER . 16.5 m -58.54 -45.28 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.091 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' LYS . . . . . 0.48 ' O ' ' OE1' ' D' ' 28' ' ' GLU . 60.9 tttp -60.71 -59.71 4.95 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.282 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.51 -38.86 75.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 1.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' ALA . . . . . 0.402 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -53.76 -36.14 62.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.79 -48.73 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.525 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' D' ' 28' ' ' GLU . 47.6 mp0 -73.29 -38.2 65.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -54.55 30.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.55 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 2.0 mp0 -64.91 -35.13 80.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.576 -0.283 . . . . 1.0 110.523 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.24 128.23 35.8 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.117 0.484 . . . . 1.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.08 -16.36 61.49 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.507 -0.769 . . . . 1.0 111.465 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.27 148.17 46.59 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' PRO . . . . . 0.576 ' O ' HG11 ' D' ' 63' ' ' VAL . 76.7 Cg_endo -74.78 130.71 13.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.913 1.742 . . . . 1.0 112.396 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 17.88 71.36 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.73 173.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 1.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.42 -40.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' LEU . . . . . 0.465 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.1 tt -97.72 121.58 39.8 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' ILE . . . . . 0.451 ' N ' HD23 ' D' ' 38' ' ' LEU . 24.1 pt -152.92 54.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -149.9 119.71 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.621 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 8.5 t80 -61.08 -47.99 93.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.62 -31.73 95.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.288 1.325 . . . . 1.0 112.056 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.53 -8.26 38.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.109 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.8 81.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 1.0 110.984 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -64.48 -34.45 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.082 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -69.06 -44.12 73.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.168 179.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -62.42 -41.52 98.76 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.523 -0.471 . . . . 1.0 109.803 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . 0.44 ' O ' HD22 ' D' ' 19' ' ' LEU . 1.2 m -72.01 57.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -145.28 -51.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.725 0.298 . . . . 1.0 110.444 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -66.46 -31.82 72.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -45.25 91.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.358 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.76 -39.05 87.31 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.118 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 8.25 21.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.075 0.464 . . . . 1.0 110.322 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 42.8 p 44.03 57.35 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' D' ' 57' ' ' TYR . 1.6 m -140.86 41.53 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.76 88.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' D' ' 55' ' ' VAL . 1.2 t80 -61.74 -44.78 96.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 1.0 110.361 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.27 27.89 0.16 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' ASP . . . . . 0.487 ' CG ' ' NH2' ' A' ' 68' ' ' ARG . 43.3 t0 -63.74 -48.91 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' ARG . . . . . 0.479 ' C ' ' CG ' ' D' ' 61' ' ' TYR . 0.8 OUTLIER -146.13 -178.7 6.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.166 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 1.6 m-85 -150.44 99.6 3.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.072 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.83 147.24 68.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.782 1.655 . . . . 1.0 112.101 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' VAL . . . . . 0.576 HG11 ' O ' ' D' ' 34' ' ' PRO . 2.5 t -80.74 -134.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' THR . . . . . 0.54 HG23 ' NH2' ' D' ' 68' ' ' ARG . 51.7 m -114.56 -54.29 2.59 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.828 0.347 . . . . 1.0 110.559 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.2 tt0 -50.88 -18.33 0.73 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' D' ' 64' ' ' THR . 0.0 OUTLIER -78.06 37.84 0.26 Allowed 'General case' 0 C--O 1.261 1.691 0 CA-C-O 123.793 1.759 . . . . 1.0 108.679 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.83 62.43 3.74 Favored Glycine 0 C--O 1.202 -1.897 0 CA-C-N 113.649 -1.614 . . . . 1.0 109.636 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' ARG . . . . . 0.574 ' NE ' ' CD1' ' C' ' 46' ' ' TRP . 19.0 ttm105 -22.5 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 117.663 0.732 . . . . 1.0 111.681 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.2 mmtt -65.83 -8.29 20.93 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.022 -0.99 . . . . 1.0 109.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' VAL . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 16.5 t -59.79 -47.49 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -76.65 -52.78 9.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.0 0.429 . . . . 1.0 110.359 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -47.9 -41.43 24.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.931 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.14 -48.92 76.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.894 -0.322 . . . . 1.0 111.784 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.82 -43.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.555 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mpp? -61.42 -43.62 98.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.624 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.03 -38.85 89.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.632 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' ALA . . . . . 0.566 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.15 -37.06 81.5 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.505 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.76 -40.55 58.11 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.37 -44.77 99.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.638 0.236 . . . . 1.0 111.638 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.07 -35.16 77.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.304 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' VAL . . . . . 0.566 HG23 ' O ' ' D' ' 77' ' ' ALA . 34.5 t -62.15 -47.47 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.166 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -72.78 -6.61 45.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.836 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.9 -32.24 11.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.198 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.5 tt -64.15 -41.47 97.17 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.338 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 m -51.31 -10.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 89' ' ' LEU . 45.9 m -51.59 -43.07 62.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.062 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -46.02 -19.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -104.76 -17.61 14.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.45 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' D' ' 86' ' ' THR . 39.6 mt -93.27 -46.06 7.55 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -54.34 -30.08 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.705 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.1 OUTLIER -74.88 -11.76 60.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.765 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -53.22 -50.67 64.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.135 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 14.0 p90 -73.19 -11.26 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.652 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.03 -35.93 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.151 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -61.91 -42.52 99.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.137 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -53.54 -30.47 41.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 1.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.058 179.836 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.76 149.88 48.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.663 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' CZ ' ' A' ' 6' ' ' ARG . 97.7 m-20 -67.25 -14.27 62.75 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.525 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.552 ' ND1' ' N ' ' A' ' 4' ' ' HIS . 0.2 OUTLIER -83.76 -35.03 24.68 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.895 0.379 . . . . 1.0 110.286 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.16 -44.52 88.28 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.808 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.463 ' CZ ' ' OD1' ' A' ' 3' ' ' ASP . 39.0 ptt180 -66.85 -38.51 86.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.247 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -67.69 -43.14 80.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.289 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.49 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -67.56 -36.93 81.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.245 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -62.44 -39.72 94.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.333 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -62.19 -38.82 90.58 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -35.28 74.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.972 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.09 -39.47 86.24 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.588 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.43 -33.76 76.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.47 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -63.78 -36.3 83.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.596 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.477 HD11 ' HB1' ' A' ' 52' ' ' ALA . 47.3 tp -62.02 -40.87 97.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.898 0.38 . . . . 1.0 110.339 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -33.7 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.054 -0.521 . . . . 1.0 111.29 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -60.62 -43.09 97.89 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.962 -0.295 . . . . 1.0 111.055 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.6 t -63.07 -41.53 93.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.448 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.829 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.1 mt -59.37 -41.65 89.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.121 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.34 -49.59 77.22 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.631 -0.427 . . . . 1.0 109.996 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.37 -38.18 86.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.024 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.23 -40.83 94.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.752 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.406 ' O ' HG13 ' A' ' 27' ' ' VAL . 38.7 m -53.65 -36.35 61.99 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.709 -0.478 . . . . 1.0 109.709 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 27' ' ' VAL . 64.9 tttm -77.57 -78.29 0.14 Allowed 'General case' 0 C--O 1.221 -0.432 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.835 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 25' ' ' LYS . 74.0 mmtt -36.19 -35.15 0.07 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.514 -0.312 . . . . 1.0 111.483 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.29 87.92 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.612 -0.435 . . . . 1.0 111.157 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 1.8 m -63.08 -47.8 90.86 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 C-N-CA 120.201 -0.6 . . . . 1.0 110.564 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 10.9 tm-20 -70.1 -42.92 72.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.916 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.402 ' O ' ' CB ' ' A' ' 66' ' ' GLU . . . -59.48 -31.42 69.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.263 -0.426 . . . . 1.0 109.931 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.2 mm-40 -97.19 -33.05 11.63 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.605 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 27' ' ' VAL . 23.6 tpt180 -77.55 97.63 5.1 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.286 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.01 -14.02 7.98 Favored Glycine 0 N--CA 1.466 0.663 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.02 150.88 42.57 Favored Pre-proline 0 CA--C 1.532 0.287 0 N-CA-C 110.042 -0.355 . . . . 1.0 110.042 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.93 142.72 28.45 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 122.111 1.874 . . . . 1.0 112.318 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.18 7.69 84.76 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 111.021 -0.831 . . . . 1.0 111.021 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.33 147.28 51.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 1.0 110.544 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -146.38 10.09 1.1 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.477 ' O ' ' O ' ' A' ' 39' ' ' ILE . 6.7 tt -83.8 -71.08 0.52 Allowed 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.358 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.502 ' O ' ' O ' ' A' ' 40' ' ' SER . 45.0 pt 37.51 -162.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.251 -0.432 . . . . 1.0 110.808 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.502 ' O ' ' O ' ' A' ' 39' ' ' ILE . 4.0 m 55.15 128.1 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.361 0.601 . . . . 1.0 111.055 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 23.2 m-85 -77.66 -55.68 1.23 Allowed Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 116.02 -0.536 . . . . 1.0 111.781 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.4 Cg_endo -60.28 -20.52 62.85 Favored 'Trans proline' 0 N--CA 1.5 1.888 0 C-N-CA 121.701 1.601 . . . . 1.0 112.348 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -89.0 -24.97 22.25 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.004 -0.278 . . . . 1.0 110.951 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.85 -37.84 85.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.502 -0.317 . . . . 1.0 110.74 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 45' ' ' ILE . 2.5 tp -63.89 -43.51 97.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.36 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.953 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -60.13 -42.11 94.12 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.117 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.485 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 18.1 t90 -60.68 -41.95 96.13 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.527 -0.545 . . . . 1.0 109.527 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.409 ' C ' HD22 ' A' ' 19' ' ' LEU . 52.9 p -76.64 69.63 3.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.384 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 94.6 t -152.39 -80.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.047 0.451 . . . . 1.0 110.476 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.439 ' OE2' ' O ' ' A' ' 57' ' ' TYR . 16.7 pt-20 -60.45 -20.87 61.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.828 -0.624 . . . . 1.0 110.355 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.511 HG23 ' N ' ' A' ' 52' ' ' ALA . 15.1 t -65.18 -43.73 90.72 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.536 -0.466 . . . . 1.0 110.137 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.829 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -56.1 -50.05 72.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.584 ' O ' HG23 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -79.82 37.95 0.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.362 0.601 . . . . 1.0 109.437 179.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.537 ' OG1' ' N ' ' A' ' 55' ' ' VAL . 19.2 p 60.28 -117.95 0.8 Allowed 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 115.388 -0.824 . . . . 1.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 53' ' ' THR . 2.5 t 69.87 -54.86 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.084 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.13 -1.91 88.27 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.535 ' O ' ' N ' ' A' ' 59' ' ' ASP . 3.2 m-85 -90.58 34.49 0.89 Allowed 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -47.45 -9.78 0.06 OUTLIER Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 57' ' ' TYR . 11.6 t0 74.29 9.36 4.47 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.987 0.422 . . . . 1.0 110.249 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.0 mtt-85 -145.08 -162.13 1.44 Allowed 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.255 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.558 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 13.2 p90 -167.88 98.32 0.59 Allowed Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 120.544 -0.462 . . . . 1.0 111.094 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.99 150.23 77.74 Favored 'Trans proline' 0 N--CA 1.499 1.797 0 C-N-CA 121.453 1.435 . . . . 1.0 112.122 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.99 HG22 ' H ' ' A' ' 64' ' ' THR . 14.3 p -87.64 -136.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.99 ' H ' HG22 ' A' ' 63' ' ' VAL . 29.7 m -107.19 -44.28 4.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 122.524 0.33 . . . . 1.0 110.907 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.702 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.0 tt0 -56.17 -41.64 75.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.807 0.337 . . . . 1.0 110.408 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.657 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -65.13 24.94 0.02 OUTLIER 'General case' 0 C--O 1.264 1.856 0 CA-C-O 123.625 1.679 . . . . 1.0 109.8 178.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.702 ' H ' ' C ' ' A' ' 65' ' ' GLU . . . 42.97 65.9 1.29 Allowed Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 117.968 -1.462 . . . . 1.0 111.487 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 56.3 ttm-85 -24.33 -34.05 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 118.161 0.981 . . . . 1.0 110.833 -178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' A' ' 67' ' ' GLY . 73.4 mmtt -48.15 -19.03 0.24 Allowed 'General case' 0 N--CA 1.442 -0.841 0 CA-C-N 115.532 -0.758 . . . . 1.0 109.145 177.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.3 t -61.19 -47.49 93.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 C-N-CA 119.662 -0.815 . . . . 1.0 110.314 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.59 -41.8 19.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.854 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -52.71 -48.29 66.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.685 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -62.87 -40.3 97.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.73 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 70' ' ' VAL . 95.0 t -62.97 -46.48 96.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.26 -0.576 . . . . 1.0 111.177 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.11 -43.22 99.06 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.99 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -60.81 -41.06 94.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.707 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.61 -36.34 69.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.386 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.18 -39.56 94.58 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 31.3 mm -62.07 -43.73 98.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.653 0.263 . . . . 1.0 110.366 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -62.51 -46.17 89.65 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.312 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 75.1 t -64.33 -49.35 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.929 0.395 . . . . 1.0 110.905 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -69.0 -27.88 66.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.905 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.408 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -84.54 -28.03 26.94 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.006 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tp -63.41 -45.98 88.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.006 -0.278 . . . . 1.0 111.335 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.49 HG12 ' HB1' ' A' ' 8' ' ' ALA . 4.4 m -57.41 -18.55 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.352 -0.539 . . . . 1.0 110.361 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 83' ' ' ALA . 52.1 m -38.16 -31.23 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.101 0.477 . . . . 1.0 110.442 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.487 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -58.95 -51.1 71.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.723 -0.671 . . . . 1.0 110.338 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -61.88 -29.61 70.32 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.034 0.445 . . . . 1.0 110.544 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.471 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -70.86 -35.38 72.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.906 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -65.73 -50.45 64.76 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.088 0.47 . . . . 1.0 111.432 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -59.54 -4.54 0.64 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.764 -0.653 . . . . 1.0 110.714 -179.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.0 m-20 -55.28 -66.08 0.47 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.739 0.305 . . . . 1.0 111.129 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.466 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.5 p90 -62.76 -39.61 94.69 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.337 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 70.9 t -43.47 -31.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.55 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -65.26 -22.1 66.82 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.788 0.328 . . . . 1.0 111.345 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.541 ' NH2' HG11 ' B' ' 94' ' ' VAL . 29.6 ptt180 -59.95 -34.28 73.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.711 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -58.43 -41.0 84.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.961 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -68.86 -33.77 74.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.843 -0.617 . . . . 1.0 110.595 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -62.94 -34.95 78.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.356 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -60.24 -45.06 94.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.839 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.1 mmt180 -87.45 -16.12 35.75 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.36 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.81 19.29 79.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.153 -0.779 . . . . 1.0 111.153 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--O 1.22 -0.494 0 CA-C-O 118.074 -0.965 . . . . 1.0 110.614 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.432 ' O ' ' O ' ' B' ' 2' ' ' ALA . 76.5 p . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.308 -0.626 . . . . 1.0 109.308 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 45.35 -172.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.611 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' B' ' 4' ' ' HIS . 52.7 p-10 -133.16 -26.36 1.7 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.726 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.527 ' N ' ' OD1' ' B' ' 3' ' ' ASP . 15.8 p-80 -83.69 -26.3 29.93 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.531 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.31 -42.69 87.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.881 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -64.28 -42.53 96.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.567 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -59.2 -40.16 84.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 1.0 109.868 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.04 -40.88 97.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.884 -0.598 . . . . 1.0 110.729 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.69 -37.95 87.89 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.861 0.363 . . . . 1.0 110.35 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -61.74 -39.48 91.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.487 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.76 -36.8 79.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.788 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.68 -36.92 85.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 1.0 110.518 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.93 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.289 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -64.08 -37.22 86.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.546 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.413 HD11 ' HB1' ' B' ' 52' ' ' ALA . 50.4 tp -62.89 -41.46 99.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.421 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -62.45 -38.12 88.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.791 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.467 ' NZ ' ' OE1' ' B' ' 21' ' ' GLU . 25.8 ttpp -61.07 -43.1 99.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.867 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 79.1 t -63.54 -41.78 93.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.553 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.6 mt -59.66 -41.35 90.4 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.779 -0.452 . . . . 1.0 109.779 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.426 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.1 mt-10 -63.06 -44.05 96.91 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.725 -0.472 . . . . 1.0 109.725 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.467 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 47.8 mt-10 -70.08 -33.96 72.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.023 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -63.6 -39.93 95.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.413 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.1 p -59.3 -43.59 92.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.774 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -61.07 -63.85 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.413 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -59.88 -39.61 85.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.564 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.8 -51.38 56.92 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.485 -0.486 . . . . 1.0 110.941 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . . . . . . . . . 72.2 t -61.99 -47.18 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.141 -0.624 . . . . 1.0 110.943 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -64.37 -39.53 94.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.763 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.88 -40.11 91.76 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.087 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 79.5 mm-40 -67.48 -42.45 82.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.789 0.328 . . . . 1.0 111.16 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 -52.62 102.98 0.06 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.978 0.418 . . . . 1.0 110.805 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.436 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 113.3 -9.13 24.62 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.325 -0.71 . . . . 1.0 111.325 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.51 138.27 23.03 Favored Pre-proline 0 CA--C 1.537 0.459 0 O-C-N 122.834 -0.215 . . . . 1.0 110.672 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.59 141.55 25.12 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 121.91 1.74 . . . . 1.0 112.341 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.18 26.82 68.13 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.071 -0.812 . . . . 1.0 111.071 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' B' ' 38' ' ' LEU . . . -47.16 -58.3 4.2 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.637 0.256 . . . . 1.0 110.794 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' B' ' 36' ' ' ALA . . . 70.42 -20.92 0.19 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.383 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' B' ' 36' ' ' ALA . 24.4 tp -110.6 119.51 39.4 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.97 -0.381 . . . . 1.0 109.97 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.476 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.1 pt -154.89 168.92 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.904 -0.589 . . . . 1.0 109.627 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.5 OUTLIER 80.22 135.24 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.778 0.323 . . . . 1.0 110.989 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.668 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 4.1 t80 -72.12 -41.82 8.93 Favored Pre-proline 0 CA--C 1.536 0.426 0 CA-C-N 115.912 -0.585 . . . . 1.0 111.564 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.5 Cg_endo -58.22 -32.7 96.43 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 121.494 1.463 . . . . 1.0 112.794 -178.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.546 ' CG ' HH12 ' B' ' 60' ' ' ARG . 35.4 p-10 -99.05 -7.45 26.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.652 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.54 -44.11 91.83 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.986 0.422 . . . . 1.0 110.406 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.2 tt -64.49 -33.58 63.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.683 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.437 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.3 OUTLIER -61.17 -46.8 89.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.515 -179.481 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.404 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.1 OUTLIER -71.01 -28.36 64.36 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.038 -0.356 . . . . 1.0 110.038 179.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.42 ' O ' HD22 ' B' ' 19' ' ' LEU . 3.1 t -68.49 -35.4 77.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.589 -178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.662 HG11 HH12 ' C' ' 68' ' ' ARG . 47.2 t -60.47 -48.4 88.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 111.856 0.317 . . . . 1.0 111.856 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.433 ' HB3' HH21 ' C' ' 68' ' ' ARG . 6.3 pt-20 -68.96 -28.84 66.99 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.603 -0.439 . . . . 1.0 110.472 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -62.28 -47.19 85.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.155 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.721 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.55 -36.74 69.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.476 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.502 ' C ' ' H ' ' B' ' 55' ' ' VAL . 82.1 p -76.85 -9.12 58.46 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.877 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.43 HG23 ' C ' ' B' ' 53' ' ' THR . 2.7 p 66.09 -6.7 0.44 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.302 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.558 ' C ' ' H ' ' B' ' 57' ' ' TYR . 69.5 t -65.33 -47.34 87.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.922 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' B' ' 58' ' ' GLY . . . 67.43 -34.8 0.21 Allowed Glycine 0 CA--C 1.534 1.243 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' B' ' 55' ' ' VAL . 0.3 OUTLIER 61.88 -73.08 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.803 0.335 . . . . 1.0 110.604 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.492 ' N ' ' OH ' ' A' ' 57' ' ' TYR . . . 158.72 29.94 0.02 OUTLIER Glycine 0 CA--C 1.525 0.708 0 N-CA-C 110.819 -0.913 . . . . 1.0 110.819 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -79.69 -62.41 1.7 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.826 0.346 . . . . 1.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.546 HH12 ' CG ' ' B' ' 43' ' ' ASP . 81.5 mtm180 -147.43 -170.24 3.51 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.394 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -173.82 136.72 0.67 Allowed Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.065 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.12 -171.73 0.44 Allowed 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.576 1.518 . . . . 1.0 112.138 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.552 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.0 t -118.06 -135.94 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.155 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.953 HG23 ' CD1' ' A' ' 46' ' ' TRP . 26.2 m -114.39 -37.12 4.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.541 -0.299 . . . . 1.0 111.15 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.612 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.8 tt0 -66.49 -34.1 77.17 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.509 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.552 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -71.19 32.02 0.05 OUTLIER 'General case' 0 C--O 1.267 2.016 0 CA-C-O 123.709 1.718 . . . . 1.0 109.972 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.98 63.91 1.62 Allowed Glycine 0 C--O 1.214 -1.127 0 CA-C-N 113.916 -1.493 . . . . 1.0 111.14 178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' B' ' 67' ' ' GLY . 58.8 ttm-85 -23.95 -33.01 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 118.384 1.092 . . . . 1.0 110.91 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 99.0 mttt -48.27 -18.48 0.22 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.712 -0.847 . . . . 1.0 108.712 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' B' ' 67' ' ' GLY . 53.6 t -61.93 -46.91 95.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 C-N-CA 119.953 -0.699 . . . . 1.0 109.754 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.09 -48.16 38.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.457 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -45.45 -45.11 12.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.275 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -62.01 -46.93 87.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.686 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.0 -46.01 82.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.456 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.09 -44.12 97.34 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.504 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.72 -37.74 85.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.376 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.495 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.16 -41.23 96.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.674 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.2 -42.25 94.39 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 111.533 -0.627 . . . . 1.0 111.533 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -62.53 -43.55 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 121.071 -0.252 . . . . 1.0 111.075 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -63.76 -40.39 96.58 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.885 0.374 . . . . 1.0 110.797 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.495 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.8 t -63.07 -46.92 94.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.999 -0.546 . . . . 1.0 111.151 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -74.7 0.79 14.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.018 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.471 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -106.31 -37.6 6.49 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 110.221 -0.289 . . . . 1.0 110.221 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.494 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -62.98 -39.99 96.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.057 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -52.62 -8.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.005 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.494 ' H ' ' C ' ' B' ' 84' ' ' LEU . 73.7 m -61.35 -21.54 64.12 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.342 -0.614 . . . . 1.0 109.342 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.54 -23.32 49.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.573 -0.739 . . . . 1.0 110.511 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -103.49 -10.83 18.21 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.533 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 38.6 mt -99.14 -25.89 14.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.953 0.406 . . . . 1.0 110.293 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -74.74 -13.55 60.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.878 -0.601 . . . . 1.0 109.891 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.37 -4.46 29.02 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.661 -0.7 . . . . 1.0 110.122 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 89.2 m-20 -61.19 -43.56 98.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.108 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 4.7 p90 -70.5 -32.64 70.22 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.844 -0.342 . . . . 1.0 111.153 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.541 HG11 ' NH2' ' A' ' 96' ' ' ARG . 61.7 t -61.79 -27.56 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 1.0 111.711 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -60.61 -22.98 64.34 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.927 -0.309 . . . . 1.0 111.441 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 43.8 ptt85 -59.49 -37.09 77.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 1.0 110.312 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.468 ' OE2' ' NH2' ' B' ' 100' ' ' ARG . 44.8 tp10 -65.82 -40.11 91.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.986 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.25 -36.31 82.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.41 -34.78 79.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.777 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.468 ' NH2' ' OE2' ' B' ' 97' ' ' GLU . 59.8 ttp180 -60.0 -45.25 93.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.935 0.398 . . . . 1.0 110.19 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -68.64 -36.89 79.19 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 84.31 22.68 53.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.437 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 97.5 m-70 . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.052 -0.975 . . . . 1.0 110.514 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 37.4 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.463 ' CB ' ' NE2' ' C' ' 4' ' ' HIS . . . -82.93 171.33 13.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.837 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -59.38 -46.3 89.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.457 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.692 ' H ' ' CD2' ' C' ' 4' ' ' HIS . 4.5 p80 -69.04 -36.55 77.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.644 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.44 -36.32 83.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.882 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -62.91 -38.3 90.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.835 0.35 . . . . 1.0 110.414 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -63.33 -42.22 98.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.021 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.0 94.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.63 -39.57 93.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.398 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.12 -41.33 98.13 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.333 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.09 -37.88 88.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.087 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.52 -39.89 95.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.798 0.332 . . . . 1.0 111.106 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -64.69 -34.67 78.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.742 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.44 -36.16 82.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.538 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.416 HD13 ' HA2' ' C' ' 78' ' ' GLY . 51.3 tp -62.17 -41.21 98.1 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.345 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -58.26 -39.15 78.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.23 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.63 -38.48 87.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.852 0.358 . . . . 1.0 110.828 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.7 t -64.05 -37.63 80.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.644 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.8 mt -58.75 -40.52 84.09 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.672 -0.411 . . . . 1.0 109.944 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.4 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.0 mm-40 -56.94 -45.43 82.79 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -68.96 -37.1 78.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.033 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -63.62 -39.52 94.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.415 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 90.2 p -61.41 -35.78 78.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.572 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' C' ' 26' ' ' ALA . 88.2 tttt -73.79 -77.78 0.11 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.106 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.435 ' O ' ' CB ' ' C' ' 29' ' ' ALA . 14.6 mptt -38.98 -25.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 110.26 -0.274 . . . . 1.0 110.26 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' C' ' 24' ' ' LYS . . . -64.88 -41.61 95.49 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.74 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.494 ' CG2' ' N ' ' C' ' 28' ' ' GLU . 1.7 m -63.73 -47.63 90.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 121.029 0.442 . . . . 1.0 110.366 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' C' ' 30' ' ' GLU . 96.8 mt-10 -71.64 -36.58 70.78 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.428 -0.805 . . . . 1.0 110.365 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' C' ' 25' ' ' LYS . . . -70.91 29.26 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.471 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.53 ' H ' ' C ' ' C' ' 28' ' ' GLU . 3.6 tp10 -153.46 -38.98 0.1 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 120.954 0.407 . . . . 1.0 110.283 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 43.1 mmm-85 -65.36 86.43 0.07 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.065 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 124.4 20.42 2.42 Favored Glycine 0 N--CA 1.468 0.788 0 N-CA-C 111.277 -0.729 . . . . 1.0 111.277 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.489 ' HB2' ' CD ' ' C' ' 66' ' ' GLU . . . -105.4 151.49 39.71 Favored Pre-proline 0 N--CA 1.466 0.373 0 O-C-N 122.886 -0.185 . . . . 1.0 110.685 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.55 115.8 4.15 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 121.167 1.245 . . . . 1.0 111.106 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . 0.434 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 82.5 18.08 67.14 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 111.259 -0.736 . . . . 1.0 111.259 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.48 ' HB1' ' HG3' ' C' ' 30' ' ' GLU . . . -42.35 167.98 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.161 0 CA-C-O 120.919 0.39 . . . . 1.0 110.472 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.95 -30.94 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.436 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.6 tt -87.59 101.31 13.51 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.104 0.478 . . . . 1.0 110.225 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.468 ' O ' ' CB ' ' C' ' 40' ' ' SER . 42.2 pt -128.83 161.25 38.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.217 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.8 OUTLIER 80.81 140.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.109 0.48 . . . . 1.0 110.604 -179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.641 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 46.0 t80 -79.65 -41.96 1.51 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.946 -0.57 . . . . 1.0 111.188 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.5 Cg_endo -59.92 -29.9 90.51 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.489 1.459 . . . . 1.0 112.453 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' C' ' 44' ' ' ALA . 2.8 p-10 -93.56 -23.22 18.4 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.719 0.295 . . . . 1.0 111.198 -179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' C' ' 43' ' ' ASP . . . -63.55 -33.27 75.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.864 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.403 ' H ' HG22 ' C' ' 45' ' ' ILE . 3.1 tp -65.38 -41.11 90.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.91 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.686 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.5 OUTLIER -61.44 -42.93 99.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.811 -179.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.535 ' NE1' ' OH ' ' B' ' 57' ' ' TYR . 3.7 t90 -59.61 -40.04 86.22 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.419 ' O ' ' CG2' ' C' ' 51' ' ' THR . 15.5 m -58.27 -33.1 69.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.218 -0.447 . . . . 1.0 111.003 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.99 -44.89 92.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.672 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.482 ' OE1' ' NH1' ' D' ' 68' ' ' ARG . 9.0 pt-20 -87.51 73.11 9.56 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.693 0.282 . . . . 1.0 111.289 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' C' ' 48' ' ' SER . 0.6 OUTLIER -177.0 -41.16 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.327 -0.397 . . . . 1.0 111.171 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.455 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -71.36 -14.07 62.07 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.95 -0.3 . . . . 1.0 111.041 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.405 ' C ' HG23 ' C' ' 54' ' ' THR . 2.6 p -92.16 20.5 5.89 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 110.039 -0.356 . . . . 1.0 110.039 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.405 HG23 ' C ' ' C' ' 53' ' ' THR . 1.2 p 57.5 33.5 23.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.873 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.429 HG11 ' SD ' ' D' ' 75' ' ' MET . 74.2 t -132.5 87.14 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-O 121.119 0.485 . . . . 1.0 110.112 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.89 79.14 1.65 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 109.822 -1.311 . . . . 1.0 109.822 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.536 ' CZ ' ' O ' ' D' ' 60' ' ' ARG . 0.8 OUTLIER -60.08 -47.34 86.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.931 0.396 . . . . 1.0 110.523 -178.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.544 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 147.31 -85.58 0.17 Allowed Glycine 0 CA--C 1.523 0.552 0 N-CA-C 110.729 -0.949 . . . . 1.0 110.729 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.459 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 92.4 m-20 41.61 -89.46 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.926 0.393 . . . . 1.0 110.906 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.544 ' N ' ' O ' ' C' ' 58' ' ' GLY . 84.2 mtm180 -127.8 150.85 49.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.887 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -153.41 147.51 18.81 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 110.274 -0.269 . . . . 1.0 110.274 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.74 156.94 62.1 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.254 1.969 . . . . 1.0 112.04 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' C' ' 33' ' ' ALA . 2.1 t -89.22 -132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.157 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.476 ' C ' ' H ' ' C' ' 66' ' ' GLU . 99.4 m -115.3 -56.96 2.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.833 0.349 . . . . 1.0 110.703 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 30.0 tp10 -52.85 -10.08 0.15 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.595 -0.52 . . . . 1.0 109.595 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.55 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 10.7 mp0 -108.28 47.04 0.92 Allowed 'General case' 0 C--O 1.272 2.261 0 CA-C-O 124.747 2.213 . . . . 1.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.718 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 37.4 60.99 1.07 Allowed Glycine 0 C--O 1.218 -0.905 0 CA-C-N 112.432 -2.167 . . . . 1.0 111.128 177.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.662 HH12 HG11 ' B' ' 49' ' ' VAL . 60.9 ttt-85 -25.18 -32.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 117.738 0.769 . . . . 1.0 111.074 -178.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.718 ' N ' ' O ' ' C' ' 67' ' ' GLY . 52.4 mtmt -55.4 -9.08 0.41 Allowed 'General case' 0 N--CA 1.431 -1.378 0 CA-C-N 115.64 -0.709 . . . . 1.0 109.702 178.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.581 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.0 t -58.32 -45.64 89.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 118.617 -1.233 . . . . 1.0 110.34 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.26 -41.97 38.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.866 0.365 . . . . 1.0 111.15 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -56.89 -46.02 82.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.067 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.87 -41.99 99.59 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.414 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.7 t -66.12 -44.02 91.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.653 -0.419 . . . . 1.0 111.395 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.4 mtm -63.14 -41.25 99.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.126 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -59.99 -35.49 75.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.508 -0.315 . . . . 1.0 110.708 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.46 74.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.851 0.357 . . . . 1.0 110.322 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.416 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.65 -36.63 88.18 Favored Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.714 -0.555 . . . . 1.0 111.714 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 39.9 mm -61.07 -44.01 97.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 O-C-N 122.678 -0.307 . . . . 1.0 110.729 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -65.76 -43.85 87.65 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.814 -0.354 . . . . 1.0 111.099 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.0 -48.66 83.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.517 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.456 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.4 m-85 -73.98 -14.44 61.03 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.084 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.0 -32.14 20.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 1.0 110.171 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.2 tt -66.45 -39.61 88.96 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.079 -0.51 . . . . 1.0 111.483 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.456 HG22 ' O ' ' C' ' 82' ' ' PHE . 3.6 m -47.93 -9.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.055 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.516 ' H ' ' C ' ' C' ' 84' ' ' LEU . 27.1 m -57.4 -38.88 75.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.962 0.411 . . . . 1.0 110.024 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.484 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -51.3 -23.25 3.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.088 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -96.0 -11.54 26.33 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.691 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -87.85 -49.39 7.13 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.318 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.53 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.37 -13.97 4.08 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.975 0.417 . . . . 1.0 110.894 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.484 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.2 OUTLIER -101.02 -5.37 25.89 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.165 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.424 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 91.3 m-20 -61.09 -47.85 84.39 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.712 -0.395 . . . . 1.0 110.755 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.53 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 36.9 p90 -78.35 -36.62 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.356 -0.384 . . . . 1.0 111.35 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 86.9 t -46.51 -34.84 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.763 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 36.5 ttm180 -62.33 -20.65 64.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.713 0.292 . . . . 1.0 111.242 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . 0.403 HH11 ' HG2' ' C' ' 96' ' ' ARG . 25.1 ptt-85 -49.48 -38.96 32.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.525 -0.307 . . . . 1.0 110.51 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -63.24 -41.19 99.06 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.256 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.429 ' O ' ' N ' ' C' ' 102' ' ' GLY . 97.2 mt-10 -67.6 -36.18 80.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 1.0 110.327 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -67.97 -26.37 65.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.563 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -59.72 -44.95 93.51 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.619 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -108.41 -5.86 16.47 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.804 0.335 . . . . 1.0 110.614 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' C' ' 98' ' ' GLU . . . 77.8 17.03 79.3 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.603 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . 0.433 ' O ' ' O ' ' D' ' 2' ' ' ALA . 54.7 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.353 -0.61 . . . . 1.0 109.353 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' D' ' 1' ' ' SER . . . 54.05 107.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.451 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -66.8 -21.93 66.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.903 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -65.07 -41.7 94.83 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.267 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.45 -37.91 88.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.553 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -62.98 -42.53 99.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.354 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -69.51 -44.98 69.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.187 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . 0.432 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -65.47 -43.85 89.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.704 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -64.41 -38.01 89.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.567 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -62.52 -39.18 92.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.711 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.76 -35.99 73.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.982 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . 0.409 ' OE2' ' CE1' ' D' ' 82' ' ' PHE . 79.7 mm-40 -65.48 -33.73 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.737 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -62.23 -40.98 97.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.887 0.375 . . . . 1.0 110.673 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.91 -30.43 71.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.739 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.431 HD11 ' HB1' ' D' ' 52' ' ' ALA . 51.8 tp -61.97 -42.12 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.779 0.324 . . . . 1.0 110.486 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -62.23 -40.14 95.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.484 -0.325 . . . . 1.0 110.933 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 80.1 t -64.59 -41.65 92.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -60.35 -41.77 94.33 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.181 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . 0.409 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.9 mt-10 -62.7 -48.12 80.66 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.558 179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -69.83 -42.23 73.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.838 0.352 . . . . 1.0 110.49 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.65 -37.06 85.48 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.085 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -58.98 -43.58 91.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.85 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.54 -32.37 73.93 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.649 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -78.5 -38.26 41.22 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.849 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -49.81 75.88 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.166 -179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.537 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.9 p -63.11 -45.15 99.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.013 0.435 . . . . 1.0 110.024 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.537 ' N ' HG13 ' D' ' 27' ' ' VAL . 83.7 tt0 -66.26 -42.85 87.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.511 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.44 97.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.279 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 21.1 tp10 -64.98 -32.99 74.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.811 -0.356 . . . . 1.0 110.451 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -71.02 130.58 41.92 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 120.953 0.406 . . . . 1.0 110.454 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.07 -10.38 63.8 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.213 -0.755 . . . . 1.0 111.213 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -93.25 148.98 36.63 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.368 -0.234 . . . . 1.0 110.368 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.453 ' O ' HG11 ' D' ' 63' ' ' VAL . 80.9 Cg_endo -74.59 137.6 22.94 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.87 1.713 . . . . 1.0 112.208 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.42 26.57 74.42 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.21 138.52 31.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.979 0.419 . . . . 1.0 110.442 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.84 -30.98 4.03 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.967 -0.56 . . . . 1.0 110.311 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.414 ' C ' HD23 ' D' ' 38' ' ' LEU . 4.3 tt -97.38 76.39 2.58 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.013 0.435 . . . . 1.0 110.166 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 38.7 pt -101.97 -2.13 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.417 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 10.6 p -76.44 148.15 37.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.527 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.552 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.7 OUTLIER -104.43 -63.02 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.559 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.11 179.226 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.552 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.3 Cg_endo -57.98 -31.67 93.4 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 121.612 1.541 . . . . 1.0 111.744 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -91.37 -0.79 57.7 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.195 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.7 89.21 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.819 0.343 . . . . 1.0 110.39 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.428 ' O ' HG23 ' D' ' 49' ' ' VAL . 5.1 tt -65.48 -38.39 82.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.468 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -56.44 -46.45 80.29 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.064 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 3.9 t90 -65.47 -38.64 90.37 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.579 -0.526 . . . . 1.0 109.579 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 3.5 t -65.17 -35.14 80.16 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.786 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.428 HG23 ' O ' ' D' ' 45' ' ' ILE . 40.9 t -60.13 -48.79 86.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 C-N-CA 120.834 -0.347 . . . . 1.0 110.919 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -67.78 -29.35 68.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.075 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 99.4 m -63.04 -44.84 94.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.464 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.54 -30.39 70.61 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.139 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 23.2 p -80.76 8.93 7.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.34 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 73.1 p 41.26 70.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.444 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.498 ' C ' ' H ' ' D' ' 57' ' ' TYR . 0.2 OUTLIER -146.78 -42.28 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.334 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.56 -38.8 0.6 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.699 -0.96 . . . . 1.0 110.699 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.498 ' H ' ' C ' ' D' ' 55' ' ' VAL . 1.6 t80 66.12 -68.7 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.866 0.365 . . . . 1.0 110.425 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . 146.0 32.21 0.07 OUTLIER Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.914 -0.874 . . . . 1.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.0 m-20 -85.44 -58.49 2.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.805 0.336 . . . . 1.0 110.772 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.536 ' O ' ' CZ ' ' C' ' 57' ' ' TYR . 94.1 mtt-85 -141.0 -179.39 6.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -158.01 137.09 8.13 Favored Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.697 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.66 157.5 58.45 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 C-N-CA 122.3 2.0 . . . . 1.0 112.192 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.528 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -89.4 -140.91 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.056 -0.52 . . . . 1.0 109.814 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.686 HG23 ' CD1' ' C' ' 46' ' ' TRP . 5.1 m -114.68 -32.54 5.81 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.076 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' D' ' 67' ' ' GLY . 79.9 tt0 -80.88 -16.23 54.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.926 0.394 . . . . 1.0 110.576 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.441 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.2 OUTLIER -77.49 24.88 0.19 Allowed 'General case' 0 C--O 1.262 1.758 0 CA-C-O 123.715 1.722 . . . . 1.0 109.219 178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.725 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.87 62.22 3.06 Favored Glycine 0 C--O 1.213 -1.181 0 CA-C-N 113.87 -1.514 . . . . 1.0 109.439 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.482 ' NH1' ' OE1' ' C' ' 50' ' ' GLU . 58.6 ttm-85 -25.21 -30.6 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.216 0.598 . . . . 1.0 110.985 -177.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.725 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.1 mttp -51.2 -24.63 4.46 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.607 -0.724 . . . . 1.0 109.351 176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' D' ' 67' ' ' GLY . 74.8 t -62.37 -49.47 83.81 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.622 -0.831 . . . . 1.0 110.039 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.94 -39.29 72.7 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.476 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -61.35 -37.03 81.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.848 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -63.01 -41.67 99.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.523 -0.308 . . . . 1.0 111.411 -179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 89.5 t -64.43 -43.24 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.663 -0.415 . . . . 1.0 111.267 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.429 ' SD ' HG11 ' C' ' 55' ' ' VAL . 63.4 mtt -58.82 -45.92 88.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.081 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -65.58 -38.36 89.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.803 0.335 . . . . 1.0 110.576 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.405 ' O ' HG22 ' D' ' 81' ' ' VAL . . . -59.0 -40.26 84.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.499 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.67 -39.27 86.38 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.269 -0.732 . . . . 1.0 111.269 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -64.33 -43.44 97.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.414 -0.463 . . . . 1.0 111.19 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.65 -52.81 63.91 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.501 HG23 ' N ' ' D' ' 82' ' ' PHE . 16.0 m -60.82 -50.31 81.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.457 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . 0.501 ' N ' HG23 ' D' ' 81' ' ' VAL . 24.6 m-85 -66.97 -41.38 86.91 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.97 -0.292 . . . . 1.0 110.725 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.11 78.81 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.644 -0.422 . . . . 1.0 110.313 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' D' ' 86' ' ' THR . 7.7 tt -61.79 -42.15 98.63 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.279 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.432 HG22 ' HB1' ' D' ' 8' ' ' ALA . 49.1 t -50.21 -15.37 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -54.73 -19.5 6.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.119 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.459 ' O ' ' OG1' ' D' ' 91' ' ' THR . . . -62.24 -62.97 1.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.827 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.86 75.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.139 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 90.4 mt -68.06 -47.47 68.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.899 0.38 . . . . 1.0 110.732 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.457 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -61.45 -25.39 67.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.478 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.498 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 1.3 m -84.01 -3.55 58.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.826 -0.624 . . . . 1.0 110.319 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.487 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 87.1 m-20 -60.62 -46.76 89.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.147 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.457 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 9.0 p90 -65.54 -32.29 73.81 Favored 'General case' 0 C--O 1.223 -0.314 0 C-N-CA 120.74 -0.384 . . . . 1.0 110.615 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 95.8 t -60.51 -42.74 92.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.262 -0.426 . . . . 1.0 111.181 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -52.96 -22.12 5.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.522 -0.308 . . . . 1.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.9 ptt85 -50.42 -37.34 37.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 1.0 110.459 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -56.86 -44.87 82.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.876 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . 0.501 ' OE1' ' N ' ' D' ' 98' ' ' GLU . 54.1 mp0 -68.94 -39.01 79.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.917 0.389 . . . . 1.0 110.198 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.52 -37.28 84.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.226 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -61.46 -43.36 99.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.498 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 64.5 ttm-85 -64.49 -40.91 96.56 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.598 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.65 -1.53 32.26 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.904 -0.878 . . . . 1.0 110.904 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . 0.506 ' CD2' ' O ' ' D' ' 103' ' ' HIS . 25.5 p-80 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 118.103 -0.951 . . . . 1.0 110.761 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.442 ' OG ' ' NH2' ' A' ' 6' ' ' ARG . 7.3 m . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . -156.43 24.93 0.35 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.568 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 59.54 -70.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.824 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.553 ' N ' ' O ' ' A' ' 2' ' ' ALA . 31.1 p80 -56.75 -40.2 75.34 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.698 0.285 . . . . 1.0 110.663 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.441 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 43.7 tt0 -62.12 -39.49 92.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.315 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.442 ' NH2' ' OG ' ' A' ' 1' ' ' SER . 84.0 mmt-85 -64.43 -38.52 91.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.178 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -66.04 -40.0 90.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.16 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.23 -37.68 88.02 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.49 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -62.21 -39.61 93.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.253 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -63.18 -37.67 88.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.422 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.67 -35.97 79.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -63.59 -37.8 88.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 1.0 110.524 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -64.75 -35.97 82.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.914 0.387 . . . . 1.0 110.373 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.62 -33.22 75.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.684 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.403 HD13 ' HA2' ' A' ' 78' ' ' GLY . 49.6 tp -62.29 -42.0 98.98 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.853 -0.339 . . . . 1.0 110.628 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.34 -37.71 86.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.206 -0.452 . . . . 1.0 111.153 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -61.9 -41.64 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.723 0.297 . . . . 1.0 110.98 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.7 t -62.53 -42.03 94.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.467 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.0 mt -59.49 -40.94 88.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.055 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.66 -48.59 81.06 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.684 -0.407 . . . . 1.0 109.935 179.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -68.18 -34.05 75.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.039 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.99 90.59 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.577 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.7 m -59.67 -43.05 94.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.129 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -58.28 -64.22 0.99 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.56 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt -59.97 -37.8 80.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.648 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.94 -49.41 66.09 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.8 -0.36 . . . . 1.0 110.861 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.74 -43.18 90.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.526 -0.469 . . . . 1.0 110.179 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -61.33 -42.62 98.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.724 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB3' ' A' ' 66' ' ' GLU . . . -56.46 -53.37 58.26 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.786 -0.45 . . . . 1.0 109.786 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' OE1' ' OE1' ' A' ' 66' ' ' GLU . 0.8 OUTLIER -65.02 -19.58 66.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.243 -0.435 . . . . 1.0 111.157 179.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.1 tpt180 -82.53 89.41 6.67 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 120.887 -0.325 . . . . 1.0 111.249 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.05 -0.58 6.12 Favored Glycine 0 N--CA 1.469 0.848 0 CA-C-N 116.192 -0.458 . . . . 1.0 112.012 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.94 144.55 29.13 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.807 0.304 . . . . 1.0 110.287 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.45 142.03 26.06 Favored 'Trans proline' 0 N--CA 1.491 1.379 0 C-N-CA 121.954 1.77 . . . . 1.0 112.231 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.47 12.14 80.15 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.1 138.14 57.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 1.0 110.412 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.77 -58.66 1.94 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.612 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.53 99.21 2.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.976 0.417 . . . . 1.0 110.427 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 22.7 pt -135.5 55.84 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.457 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' A' ' 43' ' ' ASP . 3.4 m -156.54 132.66 9.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.962 -0.563 . . . . 1.0 111.061 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.576 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 91.6 m-85 -67.19 -44.22 47.83 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 112.578 0.584 . . . . 1.0 112.578 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.5 Cg_endo -60.04 -32.44 94.85 Favored 'Trans proline' 0 N--CA 1.499 1.822 0 C-N-CA 121.272 1.315 . . . . 1.0 112.76 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.9 p-10 -99.8 -1.1 38.46 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 121.017 -0.273 . . . . 1.0 110.948 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.429 ' O ' ' OG ' ' A' ' 48' ' ' SER . . . -66.16 -43.78 85.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 1.0 110.495 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.412 ' H ' HG22 ' A' ' 45' ' ' ILE . 5.1 tt -66.69 -38.73 82.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.653 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -56.52 -46.07 80.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 -179.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.421 ' CE3' ' N ' ' A' ' 48' ' ' SER . 1.6 t90 -67.36 -39.01 85.67 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.325 -0.55 . . . . 1.0 109.906 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.492 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 m -55.74 -25.51 40.93 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.798 -0.361 . . . . 1.0 110.163 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 75.6 t -69.93 -44.81 78.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.414 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.528 ' CD ' ' HE ' ' B' ' 68' ' ' ARG . 99.5 mt-10 -79.7 69.02 5.93 Favored 'General case' 0 N--CA 1.461 0.077 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.408 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.472 ' CG2' ' O ' ' A' ' 48' ' ' SER . 0.4 OUTLIER -174.65 -46.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.4 179.486 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.17 -25.4 65.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.352 -0.385 . . . . 1.0 110.528 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.426 ' O ' ' OG1' ' A' ' 54' ' ' THR . 33.0 p -92.44 -0.79 57.32 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 53' ' ' THR . 16.5 p 57.14 76.89 0.29 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.51 -0.768 . . . . 1.0 111.207 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG21 ' SD ' ' B' ' 75' ' ' MET . 89.4 t -148.77 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.688 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.4 89.85 0.8 Allowed Glycine 0 CA--C 1.528 0.891 0 N-CA-C 111.546 -0.622 . . . . 1.0 111.546 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -63.93 -42.87 97.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.808 0.337 . . . . 1.0 110.948 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.76 15.61 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -65.67 -68.65 0.35 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.638 0.256 . . . . 1.0 110.904 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -134.14 159.49 40.71 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.13 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' D' ' 57' ' ' TYR . 20.3 t80 -172.34 137.8 0.91 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.416 -0.357 . . . . 1.0 110.46 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.13 -172.63 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 121.804 1.669 . . . . 1.0 112.013 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.746 HG13 ' N ' ' A' ' 64' ' ' THR . 11.1 p -117.75 -121.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.425 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.432 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.746 ' N ' HG13 ' A' ' 63' ' ' VAL . 36.4 m -111.31 -61.77 1.65 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.658 0.266 . . . . 1.0 111.098 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -49.06 -20.25 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.149 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.627 ' CD ' HG12 ' A' ' 63' ' ' VAL . 44.9 mt-10 -87.87 36.4 0.76 Allowed 'General case' 0 C--O 1.265 1.921 0 CA-C-O 124.433 2.063 . . . . 1.0 109.032 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.65 63.43 1.21 Allowed Glycine 0 C--O 1.212 -1.261 0 CA-C-N 112.937 -1.938 . . . . 1.0 111.11 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.548 HH12 ' CG ' ' D' ' 59' ' ' ASP . 62.2 ttm-85 -24.92 -33.35 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 118.025 0.913 . . . . 1.0 111.055 -177.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 67' ' ' GLY . 70.9 mmtt -49.93 -18.27 0.5 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.72 -0.673 . . . . 1.0 109.48 177.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -62.41 -47.56 92.43 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 C-N-CA 119.288 -0.965 . . . . 1.0 110.449 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.03 -42.62 69.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.307 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -65.32 -37.96 88.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.823 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -57.1 -43.99 82.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.848 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -66.03 -44.57 92.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.51 -0.476 . . . . 1.0 110.892 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.41 -41.58 98.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.57 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -62.35 -42.98 99.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.487 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.03 -39.87 91.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.568 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.403 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -65.84 -42.52 94.99 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -62.4 -43.37 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.627 0.251 . . . . 1.0 110.429 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.71 -43.45 97.81 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.629 -0.428 . . . . 1.0 110.265 179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 66.1 t -64.58 -49.25 81.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.002 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -72.37 -13.85 61.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.339 -0.392 . . . . 1.0 111.086 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.39 -35.54 17.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.771 0.32 . . . . 1.0 110.715 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -63.88 -42.17 97.56 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.752 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 87' ' ' ALA . 11.4 m -59.42 -23.14 24.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 C-N-CA 120.423 -0.511 . . . . 1.0 110.421 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 54.7 m -36.71 -28.58 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.042 0.449 . . . . 1.0 110.624 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.35 -49.01 79.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.726 -0.67 . . . . 1.0 110.269 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -63.48 -32.4 73.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.803 -0.635 . . . . 1.0 110.284 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 89' ' ' LEU . 4.2 mm? -66.48 -40.22 89.21 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.305 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.555 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.28 -45.12 84.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.842 0.353 . . . . 1.0 110.955 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -75.97 -3.22 34.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.258 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -56.42 -48.65 76.51 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.582 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.555 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.8 p90 -73.62 -37.06 65.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.44 -0.345 . . . . 1.0 111.451 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 95.3 t -48.29 -27.09 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.592 -178.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 60.8 ttm-85 -66.25 -21.44 66.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.8 ptt85 -56.83 -31.22 64.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -58.85 -41.6 87.35 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.792 -0.448 . . . . 1.0 109.792 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.564 ' O ' ' N ' ' A' ' 100' ' ' ARG . 97.2 mt-10 -79.5 -168.34 1.51 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.303 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.99 -72.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.817 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.564 ' N ' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttp85 -59.34 -44.62 92.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.556 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -119.04 113.2 20.58 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.028 0.442 . . . . 1.0 109.857 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.4 0.27 23.54 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.517 ' ND1' ' OXT' ' A' ' 103' ' ' HIS . 50.1 t-80 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 117.914 -1.041 . . . . 1.0 110.588 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.481 -0.563 . . . . 1.0 109.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . 43.5 -157.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.661 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 67.5 t0 -128.2 -35.59 2.0 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.406 -0.361 . . . . 1.0 110.657 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.586 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 7.3 p80 -79.3 -22.19 44.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.532 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.22 -37.81 84.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.896 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -63.74 -39.85 95.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.65 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -66.15 -40.55 90.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.935 0.398 . . . . 1.0 110.05 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . 0.477 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -63.05 -45.72 90.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 23.3 mm100 -65.34 -41.26 94.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.517 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.9 tttm -63.6 -36.4 83.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.483 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.0 86.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.965 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -58.03 -37.25 73.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 1.0 110.613 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.1 tt0 -65.3 -32.97 74.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.194 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -61.18 -39.52 90.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.389 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 33.9 tp -61.89 -42.79 99.48 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.273 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -53.95 -39.75 66.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.845 0.355 . . . . 1.0 110.911 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.97 -37.77 86.01 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.527 -0.306 . . . . 1.0 111.162 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.19 -41.83 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.242 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' B' ' 22' ' ' ALA . 1.5 tp -60.36 -48.07 83.31 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 109.039 -0.726 . . . . 1.0 109.039 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' B' ' 23' ' ' SER . 81.0 mm-40 -64.68 -41.96 95.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.233 0.539 . . . . 1.0 109.745 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -61.64 -26.69 68.16 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' B' ' 19' ' ' LEU . . . -64.67 -37.51 87.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.248 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 97.9 p -58.86 -45.36 90.32 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.556 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.66 -30.75 71.49 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.45 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 29' ' ' ALA . 29.1 mmtp -79.3 -42.88 24.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.162 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.45 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.17 -47.99 77.19 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.634 -0.257 . . . . 1.0 111.441 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.564 HG13 ' N ' ' B' ' 28' ' ' GLU . 8.3 p -61.75 -45.88 97.72 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-O 121.17 0.509 . . . . 1.0 109.971 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.564 ' N ' HG13 ' B' ' 27' ' ' VAL . 79.9 tt0 -71.18 -21.22 62.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.721 -0.672 . . . . 1.0 110.514 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.514 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -58.49 -40.47 82.85 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.963 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 27.3 mp0 -65.93 -36.4 83.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.838 0.351 . . . . 1.0 110.294 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -66.79 90.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.535 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.431 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 126.72 -15.31 6.65 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.314 -0.714 . . . . 1.0 111.314 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.28 19.17 Favored Pre-proline 0 CA--C 1.539 0.522 0 N-CA-C 110.217 -0.29 . . . . 1.0 110.217 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.482 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 87.2 Cg_endo -76.42 118.42 4.9 Favored 'Trans proline' 0 N--CA 1.496 1.632 0 C-N-CA 122.075 1.85 . . . . 1.0 112.235 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.8 37.68 1.13 Allowed Glycine 0 N--CA 1.468 0.823 0 N-CA-C 111.134 -0.786 . . . . 1.0 111.134 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.89 143.34 32.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.948 0.404 . . . . 1.0 110.475 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.64 -51.3 0.09 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.232 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.581 ' C ' HD23 ' B' ' 38' ' ' LEU . 5.0 tt -60.96 -60.29 4.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.981 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' B' ' 40' ' ' SER . 44.9 pt 31.56 -145.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 O-C-N 123.436 0.46 . . . . 1.0 110.729 -179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.464 ' O ' ' O ' ' B' ' 39' ' ' ILE . 19.3 m 57.39 144.95 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.331 0.586 . . . . 1.0 111.162 179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.54 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 2.7 m-85 -100.58 -64.37 0.06 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 115.587 -0.733 . . . . 1.0 110.763 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 23.3 Cg_endo -58.85 -23.49 67.53 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 122.293 1.995 . . . . 1.0 112.432 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -90.76 -21.18 21.67 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.677 0.275 . . . . 1.0 110.697 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.93 -37.69 88.49 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.841 0.353 . . . . 1.0 110.579 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.409 ' H ' HG22 ' B' ' 45' ' ' ILE . 5.9 tt -61.8 -36.49 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.202 -0.454 . . . . 1.0 110.216 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.504 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.6 OUTLIER -67.77 -43.16 80.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.421 179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.464 ' CD1' ' OE2' ' B' ' 50' ' ' GLU . 19.5 t90 -61.6 -41.6 97.67 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-O 120.731 0.3 . . . . 1.0 110.669 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 10.7 m -60.94 -38.11 84.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.475 -0.49 . . . . 1.0 110.581 -178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 53.5 t -60.75 -44.41 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.262 0.467 . . . . 1.0 112.262 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.464 ' OE2' ' CD1' ' B' ' 47' ' ' TRP . 5.0 pt-20 -55.78 -38.9 70.52 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.709 -178.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.63 ' C ' ' H ' ' B' ' 53' ' ' THR . 6.0 t -87.34 -152.44 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.216 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.474 ' N ' ' OG1' ' B' ' 51' ' ' THR . . . 58.94 -9.85 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.475 0.179 . . . . 1.0 110.663 -179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.63 ' H ' ' C ' ' B' ' 51' ' ' THR . 67.0 p -113.06 15.32 19.6 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.648 0.261 . . . . 1.0 110.937 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.07 66.5 1.19 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.916 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.529 HG13 ' N ' ' B' ' 56' ' ' GLY . 9.9 p -147.56 -46.62 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.758 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 44.73 78.13 0.08 OUTLIER Glycine 0 CA--C 1.526 0.754 0 N-CA-C 110.923 -0.871 . . . . 1.0 110.923 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.98 -45.23 94.54 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.681 0.277 . . . . 1.0 110.502 -179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.36 32.65 3.63 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.644 -0.983 . . . . 1.0 110.644 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.514 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 99.5 m-20 -62.51 -41.43 98.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.863 0.363 . . . . 1.0 110.688 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -117.11 -173.17 2.35 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.933 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -139.57 99.4 7.77 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.615 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -68.12 160.52 48.39 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 121.375 1.383 . . . . 1.0 112.285 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.537 HG12 ' H ' ' B' ' 64' ' ' THR . 0.9 OUTLIER -79.24 -151.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.588 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.556 ' O ' ' N ' ' B' ' 66' ' ' GLU . 1.8 m -115.35 -67.82 0.97 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.288 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.438 ' N ' HG22 ' B' ' 64' ' ' THR . 80.7 tt0 -34.02 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.224 0.535 . . . . 1.0 110.701 -178.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.867 ' O ' ' N ' ' B' ' 68' ' ' ARG . 91.8 mt-10 -147.85 -107.07 0.09 Allowed 'General case' 0 C--O 1.217 -0.615 0 CA-C-N 115.549 -0.75 . . . . 1.0 109.359 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.514 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 23.06 -56.54 0.0 OUTLIER Glycine 0 N--CA 1.478 1.49 0 O-C-N 124.635 1.209 . . . . 1.0 114.355 178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.867 ' N ' ' O ' ' B' ' 66' ' ' GLU . 36.6 ttt180 -72.13 -46.09 57.94 Favored 'General case' 0 CA--C 1.519 -0.226 0 N-CA-C 109.124 -0.695 . . . . 1.0 109.124 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' B' ' 66' ' ' GLU . 84.5 tttt -64.16 -34.2 77.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.832 -1.173 . . . . 1.0 107.832 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 73.6 t -65.71 -44.66 93.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.698 -0.683 . . . . 1.0 109.96 179.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.6 76.15 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.234 -0.439 . . . . 1.0 109.936 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -52.39 -50.47 62.4 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.572 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.898 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -62.47 -48.5 87.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.75 -0.38 . . . . 1.0 111.516 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.481 ' SD ' HG21 ' A' ' 55' ' ' VAL . 78.2 mtm -61.52 -47.62 84.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.758 -0.377 . . . . 1.0 110.785 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . 0.44 ' O ' ' OE1' ' B' ' 80' ' ' GLU . 51.6 tttp -66.44 -40.51 89.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.521 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.35 -45.7 84.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.701 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.8 -42.78 94.93 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.49 -0.644 . . . . 1.0 111.49 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.55 -43.17 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 121.001 -0.28 . . . . 1.0 111.016 -179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.507 ' N ' ' OE1' ' B' ' 80' ' ' GLU . 1.0 OUTLIER -58.59 -47.39 84.46 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.061 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 77.3 t -64.84 -50.37 75.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.423 -0.353 . . . . 1.0 111.619 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -67.9 -37.21 81.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.689 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.18 -36.03 80.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.32 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.406 ' C ' ' N ' ' B' ' 86' ' ' THR . 3.6 tt -61.59 -42.03 98.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.477 HG13 ' HB1' ' B' ' 8' ' ' ALA . 26.2 t -49.09 -21.54 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.724 -0.473 . . . . 1.0 109.724 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.406 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.5 m -48.77 -21.07 0.55 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.077 -0.51 . . . . 1.0 109.859 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.466 ' O ' ' OG1' ' B' ' 91' ' ' THR . . . -58.55 -54.52 46.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.637 -0.711 . . . . 1.0 111.024 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.71 89.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.828 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.519 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.0 mm? -63.04 -42.75 99.81 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.695 -0.483 . . . . 1.0 109.695 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.412 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -64.35 -35.74 81.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 1.0 109.437 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -82.57 -4.36 57.51 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.421 -0.809 . . . . 1.0 110.535 -179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.567 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 36.6 t0 -57.93 -48.75 78.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.57 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.412 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 10.7 p90 -67.14 -32.44 73.55 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.008 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 94.7 t -60.68 -43.71 95.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.76 -178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 71.7 ttp85 -57.37 -21.62 37.17 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.964 -0.294 . . . . 1.0 111.487 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -58.97 -33.07 70.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.068 0.461 . . . . 1.0 109.936 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.55 -36.67 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.698 -0.683 . . . . 1.0 110.836 -178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.34 -41.07 94.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.871 0.367 . . . . 1.0 110.595 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -67.17 -39.02 86.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.91 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -62.17 -44.05 97.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.45 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -120.29 108.88 14.71 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.607 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.97 -0.89 56.35 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.3 m80 . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.001 -1.0 . . . . 1.0 110.679 179.797 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 68.1 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.406 -0.59 . . . . 1.0 109.406 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.39 149.97 46.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.78 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.76 -40.3 94.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.328 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 15.2 p80 -66.83 -37.48 84.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.996 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.7 tt0 -62.69 -35.69 80.51 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.677 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.04 -39.7 95.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.314 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -65.01 -40.15 94.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.323 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.4 -42.78 99.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.368 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.25 -36.54 83.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.371 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -61.42 -38.69 88.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.43 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.62 -37.35 85.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.11 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.53 -39.49 93.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.796 0.331 . . . . 1.0 111.011 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -63.55 -38.72 92.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.31 -0.405 . . . . 1.0 110.644 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.98 -32.38 74.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.581 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.546 HD11 ' HB1' ' C' ' 52' ' ' ALA . 45.5 tp -62.28 -38.52 89.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 1.0 110.315 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -67.62 -33.44 74.99 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.643 -0.423 . . . . 1.0 111.202 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -63.55 -46.95 83.58 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.697 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 18' ' ' VAL . 10.8 m -63.86 -37.6 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.81 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' C' ' 52' ' ' ALA . 88.9 mt -62.15 -41.87 98.71 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.279 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.418 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.0 mt-10 -64.49 -43.22 94.83 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.023 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -71.35 -39.41 71.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.313 179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.03 -37.4 84.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.693 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.0 p -58.69 -44.02 90.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.413 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 2.3 tttp -65.56 -39.93 92.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.236 0.541 . . . . 1.0 109.965 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' C' ' 29' ' ' ALA . 56.2 mttp -66.8 -43.97 82.45 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.054 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -54.39 -53.56 52.32 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.748 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.433 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.3 p -58.12 -44.81 88.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.349 -0.54 . . . . 1.0 109.66 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.433 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.7 tt0 -68.34 -33.88 75.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.405 179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.474 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -64.43 -41.09 96.79 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.602 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' C' ' 26' ' ' ALA . 4.5 mp0 -81.79 -13.17 58.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.657 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -65.74 89.62 0.11 Allowed 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 120.842 0.354 . . . . 1.0 110.425 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.72 -7.08 20.05 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.3 140.47 72.77 Favored Pre-proline 0 CA--C 1.536 0.425 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.12 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.438 ' O ' HG11 ' C' ' 63' ' ' VAL . 94.2 Cg_endo -76.26 141.34 23.03 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.936 1.758 . . . . 1.0 112.33 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.8 28.01 65.09 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.228 -0.749 . . . . 1.0 111.228 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -73.07 134.37 44.53 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.885 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.41 -22.73 16.44 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.356 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.2 tp -107.37 112.15 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 109.816 -0.438 . . . . 1.0 109.816 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.9 pt -139.26 -3.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.263 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 23.4 m -76.36 154.62 34.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.512 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 11.3 m-85 -96.18 -63.17 0.12 Allowed Pre-proline 0 CA--C 1.541 0.615 0 CA-C-N 116.033 -0.531 . . . . 1.0 110.804 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.3 Cg_endo -59.28 -36.12 95.52 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.99 1.794 . . . . 1.0 112.528 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.402 ' O ' ' NH1' ' C' ' 60' ' ' ARG . 90.8 m-20 -81.39 -7.11 59.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.257 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.24 -37.47 87.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.802 0.334 . . . . 1.0 110.832 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.448 HG23 ' N ' ' C' ' 46' ' ' TRP . 16.3 tt -65.5 -38.76 83.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.591 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.448 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.6 OUTLIER -54.78 -48.82 72.21 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.226 -179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.403 ' O ' ' N ' ' C' ' 49' ' ' VAL . 3.5 t90 -61.64 -41.18 97.14 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.335 -0.546 . . . . 1.0 109.682 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.454 ' O ' HD22 ' C' ' 19' ' ' LEU . 2.2 t -68.39 60.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.645 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' C' ' 47' ' ' TRP . 73.0 t -150.66 -56.79 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.085 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.405 ' HB3' HH12 ' D' ' 68' ' ' ARG . 9.1 pt-20 -64.36 -30.55 71.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.584 -0.446 . . . . 1.0 110.693 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 98.9 m -62.31 -46.62 87.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.439 -0.346 . . . . 1.0 111.25 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.713 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.48 -26.31 66.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.66 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.43 ' O ' ' OG1' ' C' ' 54' ' ' THR . 47.3 p -91.21 5.25 49.86 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.96 0.41 . . . . 1.0 110.076 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' C' ' 53' ' ' THR . 43.4 p 52.4 74.37 0.28 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.895 -0.593 . . . . 1.0 110.874 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.416 HG11 ' CE1' ' C' ' 57' ' ' TYR . 62.1 t -139.24 -68.19 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.294 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 67.13 75.23 0.48 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.081 -0.808 . . . . 1.0 111.081 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.416 ' CE1' HG11 ' C' ' 55' ' ' VAL . 37.4 m-85 -59.95 -45.98 90.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.69 0.281 . . . . 1.0 110.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.43 10.57 1.87 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.082 -0.807 . . . . 1.0 111.082 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.51 ' OD1' ' CD2' ' D' ' 61' ' ' TYR . 99.4 m-20 -60.02 -46.77 88.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.933 0.397 . . . . 1.0 110.405 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.402 ' NH1' ' O ' ' C' ' 43' ' ' ASP . 53.6 mtm180 -143.01 166.86 23.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.754 -0.657 . . . . 1.0 110.02 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -156.65 127.24 3.47 Favored Pre-proline 0 CA--C 1.535 0.377 0 C-N-CA 120.599 -0.44 . . . . 1.0 110.542 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -70.67 152.57 64.72 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.802 1.668 . . . . 1.0 112.236 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.495 HG12 ' H ' ' C' ' 64' ' ' THR . 2.4 t -84.28 -134.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.24 -0.436 . . . . 1.0 109.949 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.495 ' H ' HG12 ' C' ' 63' ' ' VAL . 72.3 m -114.59 -37.97 4.14 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.734 0.302 . . . . 1.0 110.721 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.569 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.2 tt0 -66.55 -28.2 68.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.469 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.445 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -72.17 26.05 0.05 Allowed 'General case' 0 C--O 1.264 1.82 0 CA-C-O 123.509 1.623 . . . . 1.0 110.36 179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.44 64.06 1.93 Allowed Glycine 0 C--O 1.214 -1.095 0 CA-C-O 117.889 -1.506 . . . . 1.0 111.106 178.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.514 ' NH1' ' OD2' ' B' ' 59' ' ' ASP . 58.9 ttm-85 -24.41 -31.52 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 CA-C-N 117.961 0.881 . . . . 1.0 111.368 -178.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' C' ' 67' ' ' GLY . 14.5 mptt -49.5 -21.53 0.98 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.791 -0.641 . . . . 1.0 109.354 176.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 76.8 t -61.72 -49.52 83.96 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 C-N-CA 119.065 -1.054 . . . . 1.0 110.607 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.9 -36.25 69.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.029 0.442 . . . . 1.0 110.696 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -58.34 -42.09 86.1 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.913 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -64.02 -41.1 97.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.086 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 89.9 t -64.31 -43.6 97.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.658 -0.417 . . . . 1.0 111.39 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 20.7 mtm -60.9 -44.08 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.125 -178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -65.57 -38.41 89.45 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.621 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.23 -39.59 90.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.668 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.72 -39.19 95.15 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.714 -0.554 . . . . 1.0 111.714 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -64.29 -43.14 97.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 O-C-N 122.51 -0.406 . . . . 1.0 110.982 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.97 -50.37 74.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.809 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' N ' ' C' ' 82' ' ' PHE . 12.0 m -61.84 -49.45 84.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.918 -0.313 . . . . 1.0 111.363 -178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.464 ' N ' HG23 ' C' ' 81' ' ' VAL . 32.5 m-85 -69.34 -40.13 77.72 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.975 -0.29 . . . . 1.0 111.019 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.519 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -64.94 -36.09 83.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.84 0.352 . . . . 1.0 110.614 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.7 tt -62.55 -41.08 98.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.53 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 82.4 t -46.37 -19.83 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.533 -179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.9 m -51.94 -40.36 60.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.402 -0.363 . . . . 1.0 110.578 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.567 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -49.35 -27.48 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.243 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.58 -16.63 25.44 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.612 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.41 ' N ' ' O ' ' C' ' 86' ' ' THR . 55.3 mt -87.86 -44.07 11.35 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.164 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.421 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.15 -23.84 50.17 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.936 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.469 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -85.93 -4.42 59.16 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.898 -179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.41 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 94.3 m-20 -60.07 -45.27 93.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.698 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.454 ' CD2' ' HB1' ' D' ' 90' ' ' ALA . 7.1 p90 -76.03 -28.6 57.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.067 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.5 t -59.81 -42.61 89.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.468 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -55.66 -21.8 19.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.599 -0.273 . . . . 1.0 111.198 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . 0.419 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 42.6 ptt85 -50.74 -41.84 56.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.808 0.337 . . . . 1.0 110.474 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.419 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 9.4 tm-20 -62.46 -41.06 98.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.694 -179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -67.07 -35.7 80.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.31 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.65 -27.35 69.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.767 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 61.5 ttp180 -59.4 -44.41 92.83 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.382 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -66.01 -37.8 86.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.307 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.47 12.56 64.72 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 110.887 -0.885 . . . . 1.0 110.887 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.04 -0.981 . . . . 1.0 110.455 179.808 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . 0.625 ' N ' HH22 ' D' ' 6' ' ' ARG . 14.8 m . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.446 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . -71.38 130.06 40.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.746 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 16.6 p-10 -77.01 -37.74 54.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.006 -0.543 . . . . 1.0 111.129 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.562 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.3 p80 -65.59 -34.83 79.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 1.0 111.042 -179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.01 -38.84 92.8 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.573 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . 0.625 HH22 ' N ' ' D' ' 1' ' ' SER . 84.2 mtt85 -64.24 -38.98 92.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.598 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -66.2 -40.15 90.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.175 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.85 92.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.772 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -65.84 -40.43 91.75 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.37 . . . . 1.0 110.56 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -63.73 -35.66 81.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.516 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.56 -36.68 79.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.966 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.16 -39.53 94.2 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.683 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.22 -36.44 83.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.65 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.2 tp10 -63.99 -36.05 82.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.427 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 32.0 tp -62.4 -41.38 98.63 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.837 -0.345 . . . . 1.0 110.643 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -55.86 -44.78 78.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.699 -179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -63.4 -40.09 96.28 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.69 -0.404 . . . . 1.0 111.204 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.79 -49.02 85.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 N-CA-C 112.114 0.413 . . . . 1.0 112.114 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.98 -30.19 62.37 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.415 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -66.26 -49.92 65.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.669 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.17 -40.42 95.95 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' D' ' 26' ' ' ALA . . . -65.45 -34.15 77.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.597 -0.728 . . . . 1.0 110.823 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' D' ' 48' ' ' SER . 26.0 m -54.1 -45.33 71.79 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.816 -0.353 . . . . 1.0 110.814 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -63.68 -39.07 93.4 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.46 -0.496 . . . . 1.0 110.036 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -81.73 -18.25 44.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.312 -0.404 . . . . 1.0 111.135 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.51 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -58.6 -50.23 74.57 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.895 -0.322 . . . . 1.0 110.382 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' D' ' 44' ' ' ALA . 28.9 t -65.65 -43.8 93.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 109.797 -0.446 . . . . 1.0 109.797 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 44.1 tp10 -61.54 -30.76 70.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.007 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.32 -34.11 71.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.535 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' D' ' 32' ' ' GLY . 79.0 mm-40 -63.83 -46.87 83.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.63 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -46.21 95.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.433 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 126.93 -5.7 7.38 Favored Glycine 0 N--CA 1.467 0.719 0 N-CA-C 111.497 -0.641 . . . . 1.0 111.497 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.406 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -105.48 146.52 32.94 Favored Pre-proline 0 N--CA 1.467 0.411 0 CA-C-N 116.912 0.356 . . . . 1.0 110.32 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.627 ' O ' HG11 ' D' ' 63' ' ' VAL . 81.2 Cg_endo -75.64 117.34 4.73 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.113 1.875 . . . . 1.0 112.49 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' D' ' 37' ' ' ALA . . . 103.52 -22.67 35.23 Favored Glycine 0 N--CA 1.467 0.706 0 N-CA-C 111.004 -0.839 . . . . 1.0 111.004 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.635 ' O ' ' HB3' ' D' ' 37' ' ' ALA . . . 46.93 -86.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.694 0.283 . . . . 1.0 111.2 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' D' ' 36' ' ' ALA . . . 82.44 -75.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.14 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.7 tp -73.07 53.21 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.89 0.376 . . . . 1.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.633 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.8 tt -105.16 111.26 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.065 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.546 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 17.3 t 179.45 -118.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.125 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.546 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.7 m-85 177.27 -66.77 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 110.298 -0.26 . . . . 1.0 110.298 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -59.03 -31.16 95.15 Favored 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.024 1.816 . . . . 1.0 111.666 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -84.21 -9.19 58.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 1.0 111.155 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.24 -42.32 99.18 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.87 0.367 . . . . 1.0 110.516 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -67.68 -39.3 81.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.691 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.07 -46.95 86.85 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.237 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.441 ' CD2' ' C ' ' D' ' 47' ' ' TRP . 0.3 OUTLIER -70.78 -20.76 62.57 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.232 -0.587 . . . . 1.0 109.604 178.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' D' ' 23' ' ' SER . 22.8 t -74.56 -40.49 61.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.106 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 68.2 t -60.89 -47.76 91.99 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.5 pt-20 -66.78 -37.61 84.91 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.711 -0.396 . . . . 1.0 110.118 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 10.3 m -62.45 -44.57 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.008 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.7 -25.42 62.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.413 ' OG1' HG23 ' D' ' 55' ' ' VAL . 21.8 p -97.77 9.81 41.67 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.203 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 1.6 p 43.88 44.62 5.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.225 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.413 HG23 ' OG1' ' D' ' 53' ' ' THR . 94.9 t -86.83 -54.57 7.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.843 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 41.57 57.15 3.37 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.616 ' CG ' ' CD1' ' A' ' 61' ' ' TYR . 5.6 t80 -61.91 -41.79 98.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.808 0.337 . . . . 1.0 110.491 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 159.19 -14.63 0.22 Allowed Glycine 0 CA--C 1.528 0.88 0 N-CA-C 111.195 -0.762 . . . . 1.0 111.195 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.548 ' CG ' HH12 ' A' ' 68' ' ' ARG . 0.9 OUTLIER -40.43 -87.87 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.886 0.375 . . . . 1.0 110.958 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mtm-85 -132.39 156.62 46.33 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.103 -0.498 . . . . 1.0 109.885 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.51 ' CD2' ' OD1' ' C' ' 59' ' ' ASP . 5.6 p90 -149.3 153.28 37.32 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.594 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.81 160.04 51.3 Favored 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.299 1.999 . . . . 1.0 111.993 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.627 HG11 ' O ' ' D' ' 34' ' ' PRO . 18.2 t -90.05 -116.57 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.938 -0.574 . . . . 1.0 110.578 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.499 ' N ' HG12 ' D' ' 63' ' ' VAL . 60.7 m -116.23 -77.55 0.57 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.815 0.341 . . . . 1.0 110.95 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.406 ' HB3' ' HB2' ' D' ' 33' ' ' ALA . 52.5 tp10 -46.92 120.77 3.21 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.064 -0.717 . . . . 1.0 109.064 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.871 ' O ' ' N ' ' D' ' 68' ' ' ARG . 96.9 mt-10 55.09 -96.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.795 -0.638 . . . . 1.0 109.91 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.19 -55.68 0.0 OUTLIER Glycine 0 N--CA 1.474 1.217 0 O-C-N 125.086 1.491 . . . . 1.0 114.085 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.871 ' N ' ' O ' ' D' ' 66' ' ' GLU . 57.7 ttm-85 -80.04 -58.5 3.13 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 115.122 -0.539 . . . . 1.0 109.87 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' D' ' 66' ' ' GLU . 99.0 mttt -43.46 -40.78 3.98 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.148 -0.686 . . . . 1.0 109.148 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 75.9 t -68.71 -46.9 78.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.815 -0.629 . . . . 1.0 110.536 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.27 -49.84 68.02 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -44.18 -42.9 6.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.684 -0.689 . . . . 1.0 110.863 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -67.14 -40.28 86.69 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.937 -0.305 . . . . 1.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.2 t -62.98 -47.65 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.739 -0.384 . . . . 1.0 111.509 -178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 18.5 ptp -62.6 -39.46 93.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.653 0.264 . . . . 1.0 111.083 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.61 -43.39 98.96 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.667 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.468 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.1 -38.8 92.36 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.597 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.87 -41.25 95.62 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.568 -0.613 . . . . 1.0 111.568 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.78 -43.55 98.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.652 0.226 . . . . 1.0 111.394 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -64.38 -38.11 89.89 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.938 -0.305 . . . . 1.0 111.072 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.468 HG23 ' O ' ' D' ' 77' ' ' ALA . 66.9 t -63.48 -46.07 96.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.448 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -70.42 -8.41 50.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.801 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.36 -27.22 12.96 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.81 0.338 . . . . 1.0 110.147 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' D' ' 86' ' ' THR . 6.0 tt -65.03 -37.55 87.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.275 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 19.8 m -51.8 -5.65 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.462 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.543 ' H ' ' C ' ' D' ' 84' ' ' LEU . 65.5 m -58.82 -42.91 90.33 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 116.301 -0.409 . . . . 1.0 109.954 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' C' ' 92' ' ' ASP . . . -42.39 -19.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.767 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -102.97 -32.33 9.79 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.174 0.511 . . . . 1.0 110.028 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' D' ' 86' ' ' THR . 58.2 mt -69.76 -39.34 76.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.715 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.576 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.28 -49.51 77.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.707 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -65.05 -11.83 43.73 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.154 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -59.66 -49.33 78.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.786 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.576 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 17.2 p90 -76.24 -22.56 55.04 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.39 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 86.5 t -61.38 -42.64 94.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.776 -179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -50.41 -21.78 1.59 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.723 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -55.58 -43.57 76.11 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.852 0.358 . . . . 1.0 110.265 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.418 ' O ' ' N ' ' D' ' 99' ' ' GLU . 96.6 mt-10 -81.38 179.71 7.73 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.703 -0.48 . . . . 1.0 109.703 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . 0.428 ' O ' ' O ' ' D' ' 101' ' ' ARG . 95.0 mt-10 65.27 -46.3 0.36 Allowed 'General case' 0 N--CA 1.469 0.478 0 O-C-N 123.75 0.656 . . . . 1.0 110.66 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' D' ' 97' ' ' GLU . 97.6 mt-10 -66.55 -43.38 85.25 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.928 0.394 . . . . 1.0 110.301 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -70.52 -37.99 74.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.574 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' D' ' 98' ' ' GLU . 70.3 ttp85 -107.63 114.34 28.25 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.165 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.73 -14.87 53.13 Favored Glycine 0 N--CA 1.465 0.608 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . 0.52 ' OXT' ' ND1' ' D' ' 103' ' ' HIS . 60.1 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.59 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 p . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.21 -103.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.476 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -162.67 -37.36 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.461 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -81.08 -26.6 36.14 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.605 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.62 -32.49 73.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.592 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.0 ttm180 -60.38 -42.68 96.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.192 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -63.29 -45.34 91.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.072 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -66.59 -39.71 88.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.393 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.44 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 57.2 tt0 -64.55 -39.83 94.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.156 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -64.59 -36.78 85.33 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.26 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.96 66.99 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.226 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -62.9 -39.81 95.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.896 0.379 . . . . 1.0 110.722 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 57.3 mp0 -66.23 -35.24 79.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.436 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.2 tm-20 -61.55 -36.83 81.71 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.734 -0.386 . . . . 1.0 110.572 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.2 tp -62.31 -42.44 99.37 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.66 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -60.95 -33.06 72.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.068 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 17' ' ' LYS . 5.3 ttmm -61.58 -44.68 96.58 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.269 -179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 83.8 t -63.74 -40.94 90.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.52 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.626 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -59.28 -41.24 88.44 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -61.31 -47.02 87.85 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.624 -0.43 . . . . 1.0 109.86 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.69 -34.2 75.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.008 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.77 88.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.793 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 92.1 p -59.41 -44.0 92.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.936 0.398 . . . . 1.0 109.968 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 ttmt -66.25 -40.19 90.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 29' ' ' ALA . 70.1 mmtt -66.83 -42.48 85.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.79 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.32 -53.14 60.53 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.922 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 5.2 p -62.02 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.477 -0.489 . . . . 1.0 109.839 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.49 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 98.2 mt-10 -67.25 -39.54 86.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.641 -0.709 . . . . 1.0 110.429 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -62.02 -49.24 76.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.113 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.424 ' OE1' ' O ' ' A' ' 38' ' ' LEU . 5.8 tm-20 -69.67 -41.41 75.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.059 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -54.71 90.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.856 -0.338 . . . . 1.0 110.604 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 121.2 3.7 10.46 Favored Glycine 0 N--CA 1.464 0.542 0 N-CA-C 111.304 -0.718 . . . . 1.0 111.304 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.65 122.99 45.72 Favored Pre-proline 0 CA--C 1.538 0.516 0 O-C-N 122.689 -0.301 . . . . 1.0 110.55 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -75.44 141.96 26.0 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.881 1.721 . . . . 1.0 112.396 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 75.71 15.4 81.32 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.15 -162.06 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.827 0.346 . . . . 1.0 110.545 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -171.65 -4.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.616 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.513 HD23 ' C ' ' A' ' 38' ' ' LEU . 4.9 tt -99.1 89.03 4.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.034 0.445 . . . . 1.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 40' ' ' SER . 17.4 pt -122.76 165.66 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.11 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 81.98 135.55 0.06 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.442 -179.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.561 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.5 t80 -75.12 -45.95 4.7 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.763 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.7 Cg_endo -60.31 -27.25 84.49 Favored 'Trans proline' 0 N--CA 1.502 1.982 0 C-N-CA 121.554 1.503 . . . . 1.0 112.501 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -89.73 -27.95 19.72 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 121.011 -0.275 . . . . 1.0 110.898 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.82 -37.74 85.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.439 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -64.66 -42.07 94.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.881 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.687 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.2 OUTLIER -63.1 -40.8 98.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.109 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.539 ' CD1' ' OE2' ' A' ' 50' ' ' GLU . 26.6 t90 -60.09 -39.82 87.45 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.572 -0.529 . . . . 1.0 109.572 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.471 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.8 m -56.09 -36.7 68.43 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.598 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 18.6 t -82.55 71.14 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-O 120.843 0.354 . . . . 1.0 111.293 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.539 ' OE2' ' CD1' ' A' ' 47' ' ' TRP . 10.6 pt-20 -173.96 -40.22 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.175 0.512 . . . . 1.0 109.668 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.47 HG23 HG11 ' A' ' 74' ' ' VAL . 0.2 OUTLIER -68.8 -39.74 79.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.707 -0.679 . . . . 1.0 110.148 -179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.626 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.23 -24.0 51.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.481 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 50' ' ' GLU . 72.0 p -86.41 -3.16 58.95 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.4 p 52.49 38.84 26.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.526 -0.761 . . . . 1.0 111.084 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.45 HG22 ' OG1' ' A' ' 53' ' ' THR . 25.2 m -102.76 -35.79 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.631 -0.259 . . . . 1.0 110.883 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 54.0 73.82 0.37 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.4 -44.08 97.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.807 0.336 . . . . 1.0 110.415 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.66 20.38 5.79 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.514 -1.034 . . . . 1.0 110.514 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.7 m-20 -62.8 -40.09 96.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.725 0.297 . . . . 1.0 110.411 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 35.7 mmt180 -132.3 164.41 26.48 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 109.923 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 12.5 p90 -151.66 90.83 3.89 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.675 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -69.69 166.53 27.19 Favored 'Trans proline' 0 N--CA 1.494 1.528 0 C-N-CA 121.736 1.624 . . . . 1.0 112.271 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.487 HG22 ' OE2' ' A' ' 66' ' ' GLU . 16.8 m -98.75 -124.11 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.231 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.585 HG22 ' CD1' ' D' ' 46' ' ' TRP . 66.5 p -114.33 -37.18 4.43 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 111.73 0.27 . . . . 1.0 111.73 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -57.94 -26.04 61.74 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.61 -0.436 . . . . 1.0 109.87 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.487 ' OE2' HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -87.33 29.64 0.84 Allowed 'General case' 0 C--O 1.26 1.645 0 CA-C-O 123.678 1.704 . . . . 1.0 109.199 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.769 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 38.16 65.21 0.72 Allowed Glycine 0 C--O 1.212 -1.258 0 CA-C-N 113.494 -1.685 . . . . 1.0 111.714 177.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.632 ' NH2' ' CE3' ' D' ' 46' ' ' TRP . 0.0 OUTLIER -22.93 -31.2 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 118.028 0.914 . . . . 1.0 111.507 -178.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.769 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.2 mttt -56.79 -12.3 1.84 Allowed 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.241 -0.89 . . . . 1.0 108.973 177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 67' ' ' GLY . 41.3 t -60.35 -48.27 88.98 Favored 'Isoleucine or valine' 0 C--N 1.346 0.455 0 C-N-CA 119.507 -0.877 . . . . 1.0 110.18 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.91 -38.4 66.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.591 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 tm-20 -56.19 -39.63 72.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.577 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -65.38 -42.2 92.93 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.249 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.47 HG11 HG23 ' A' ' 51' ' ' THR . 58.1 t -63.81 -46.52 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 C-N-CA 120.455 -0.498 . . . . 1.0 111.296 -179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 63.0 mtm -63.35 -40.79 98.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.721 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.43 -45.0 96.14 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.439 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.34 -38.99 92.99 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.421 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.85 -45.11 96.39 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.63 -43.08 96.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.665 0.269 . . . . 1.0 110.418 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -59.62 -41.66 90.93 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.683 -0.407 . . . . 1.0 110.462 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.8 t -66.81 -55.31 18.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.699 -0.4 . . . . 1.0 111.038 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.07 -41.21 99.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.42 -0.354 . . . . 1.0 111.068 -179.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.74 -37.4 87.46 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.779 -0.369 . . . . 1.0 111.008 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.493 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.2 tt -62.99 -41.23 99.51 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.259 -0.428 . . . . 1.0 111.53 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.485 HG12 ' O ' ' A' ' 85' ' ' VAL . 71.6 t -49.18 -10.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.44 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.509 ' O ' ' N ' ' A' ' 88' ' ' ALA . 70.8 m -51.72 -44.22 63.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.354 . . . . 1.0 110.078 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -41.97 -20.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.827 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.15 -33.44 8.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.857 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 40.8 mt -69.8 -39.24 76.67 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.216 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.55 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.65 -49.84 75.89 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.256 0.55 . . . . 1.0 110.92 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.68 -3.38 1.48 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.686 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -60.25 -42.83 96.13 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.621 -0.263 . . . . 1.0 110.98 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.567 ' CG ' ' OG1' ' B' ' 91' ' ' THR . 31.2 p90 -85.25 -26.04 26.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.555 -0.293 . . . . 1.0 111.635 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.9 t -55.23 -29.51 23.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.239 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -65.79 -21.16 66.48 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.803 0.335 . . . . 1.0 110.937 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.453 ' CG ' ' N ' ' A' ' 97' ' ' GLU . 24.0 ptt-85 -50.34 -42.82 53.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.642 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.453 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 82.0 tt0 -65.18 -40.21 93.94 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.533 ' O ' ' N ' ' A' ' 100' ' ' ARG . 97.7 mt-10 -83.11 -172.45 4.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.273 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 61.95 -67.31 0.07 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.529 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.533 ' N ' ' O ' ' A' ' 98' ' ' GLU . 53.9 ttp180 -55.92 -45.46 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.274 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -78.21 -17.03 57.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.458 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' O ' ' CG ' ' A' ' 103' ' ' HIS . . . 75.76 22.18 75.28 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.457 ' CG ' ' O ' ' A' ' 102' ' ' GLY . 76.3 m80 . . . . . 0 C--O 1.221 -0.418 0 CA-C-O 118.026 -0.988 . . . . 1.0 110.516 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.413 ' OG ' ' OE1' ' B' ' 5' ' ' GLU . 16.2 p . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.45 -0.574 . . . . 1.0 109.45 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.44 -104.72 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.577 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -135.85 -54.6 0.77 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.795 0.331 . . . . 1.0 110.648 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 -65.31 -32.33 73.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.437 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.413 ' OE1' ' OG ' ' B' ' 1' ' ' SER . 47.3 mt-10 -65.06 -35.99 82.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.881 -179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.07 -39.19 93.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.69 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 46.1 tp10 -62.26 -40.65 96.91 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.846 -0.427 . . . . 1.0 109.846 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.82 99.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.614 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.77 -37.72 82.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.44 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -61.75 -38.5 88.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.65 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.84 -38.54 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.955 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.33 -40.9 97.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.871 0.367 . . . . 1.0 110.665 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.01 -38.62 91.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.016 0.436 . . . . 1.0 110.434 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -62.69 -32.18 73.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.207 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 51.6 tp -62.57 -42.03 99.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.395 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -57.88 -39.62 78.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.774 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -61.65 -38.17 86.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.438 . . . . 1.0 110.95 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 99.4 t -63.73 -34.3 67.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.905 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.524 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.3 mt -61.02 -40.39 93.4 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -59.91 -47.5 85.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -70.63 -32.09 69.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.054 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.53 -47.13 80.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.265 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 45.9 t -60.18 -43.34 95.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.799 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -58.62 -55.55 33.61 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.137 0.494 . . . . 1.0 110.086 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.46 -44.11 97.19 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.082 -0.647 . . . . 1.0 110.639 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.47 -48.72 78.38 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.704 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 40' ' ' SER . 0.8 OUTLIER -65.61 -42.52 93.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.989 0.424 . . . . 1.0 110.375 -179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.413 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 95.5 mt-10 -69.67 -43.34 72.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.128 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.05 -40.63 98.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.17 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -72.91 -22.4 60.75 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.578 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -77.88 122.25 25.22 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 120.955 0.407 . . . . 1.0 110.543 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.15 2.79 57.98 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 111.377 -0.689 . . . . 1.0 111.377 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.7 149.46 37.13 Favored Pre-proline 0 N--CA 1.466 0.33 0 N-CA-C 110.533 -0.173 . . . . 1.0 110.533 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -75.27 143.41 28.21 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.073 1.849 . . . . 1.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.71 28.9 74.07 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.284 -0.726 . . . . 1.0 111.284 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.2 139.43 57.56 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.808 0.337 . . . . 1.0 110.278 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.82 -40.67 0.85 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.999 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.1 tp -68.02 -21.73 65.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.28 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.515 HG23 ' O ' ' B' ' 39' ' ' ILE . 12.5 tt -43.27 111.94 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.631 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.568 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 1.8 p 163.85 109.31 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.557 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.449 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.7 m-85 -56.72 -60.27 9.87 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.96 -0.564 . . . . 1.0 111.087 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.8 Cg_endo -57.84 -35.51 98.75 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 122.058 1.839 . . . . 1.0 112.771 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -89.73 -20.53 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.526 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.36 -39.3 92.67 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.951 0.405 . . . . 1.0 109.988 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.405 ' H ' HG22 ' B' ' 45' ' ' ILE . 8.1 tt -67.02 -37.82 80.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.663 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.409 ' CD1' ' NE ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER -64.95 -46.89 79.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.422 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 3.1 t90 -62.78 -40.45 97.37 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.875 -0.33 . . . . 1.0 110.26 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' B' ' 44' ' ' ALA . 6.7 m -50.9 -22.76 2.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.755 -178.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 86.5 t -81.88 -21.04 10.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.809 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.4 ' OE1' HG21 ' B' ' 55' ' ' VAL . 80.9 mm-40 -93.79 16.97 12.82 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.899 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.73 -39.02 1.65 Allowed 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.744 0.307 . . . . 1.0 111.14 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.524 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.35 -29.17 70.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.294 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.54 ' OG1' HG13 ' B' ' 55' ' ' VAL . 18.7 p -90.31 9.11 30.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 1.0 110.734 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' B' ' 53' ' ' THR . 72.8 p 51.32 42.04 28.66 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.51 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.597 HG11 ' SD ' ' C' ' 75' ' ' MET . 19.0 m -97.29 -44.78 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.129 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.673 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.566 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.31 64.57 1.3 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.667 -0.973 . . . . 1.0 110.667 -179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -60.97 -47.13 87.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.787 0.327 . . . . 1.0 110.907 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.4 10.68 1.24 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -57.51 -66.1 0.52 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.388 . . . . 1.0 110.568 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.442 HH21 ' NH2' ' C' ' 68' ' ' ARG . 52.4 mtm180 -137.04 142.42 42.45 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.001 -0.545 . . . . 1.0 109.991 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' B' ' 61' ' ' TYR . 6.1 p90 -126.31 136.24 28.31 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.297 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.52 164.67 33.42 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 121.889 1.726 . . . . 1.0 112.063 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.44 HG23 ' H ' ' B' ' 66' ' ' GLU . 22.2 m -91.98 -140.41 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.223 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.687 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.4 m -114.1 -40.74 3.64 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.749 0.309 . . . . 1.0 111.129 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.642 ' C ' ' H ' ' B' ' 67' ' ' GLY . 79.4 tt0 -66.71 -32.72 74.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 1.0 110.712 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.44 ' H ' HG23 ' B' ' 63' ' ' VAL . 0.2 OUTLIER -70.38 30.35 0.04 OUTLIER 'General case' 0 C--O 1.261 1.672 0 CA-C-O 123.715 1.721 . . . . 1.0 110.03 178.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.688 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.42 63.94 1.27 Allowed Glycine 0 C--O 1.21 -1.344 0 CA-C-N 113.972 -1.467 . . . . 1.0 111.585 177.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.5 ttm-85 -25.0 -33.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 CA-C-N 118.323 1.062 . . . . 1.0 110.862 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.688 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.0 mttp -48.5 -18.59 0.25 Allowed 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 176.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.615 ' N ' ' O ' ' B' ' 67' ' ' GLY . 59.8 t -64.09 -45.55 96.22 Favored 'Isoleucine or valine' 0 C--N 1.352 0.685 0 C-N-CA 119.959 -0.696 . . . . 1.0 109.724 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.85 -36.2 67.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 1.0 109.69 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 tm-20 -57.17 -41.12 78.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.943 -0.571 . . . . 1.0 109.947 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -64.18 -42.8 96.52 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.733 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.03 -47.29 88.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.251 -179.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 76.6 mtm -64.81 -40.7 95.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.668 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.03 -38.36 90.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.775 0.322 . . . . 1.0 110.47 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.87 92.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.535 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.32 -40.92 91.86 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.93 -43.29 97.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.838 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.8 -42.45 97.64 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.384 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.24 -47.93 87.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.967 -0.561 . . . . 1.0 111.157 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.51 -11.23 60.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.912 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -102.08 -25.91 13.57 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 110.004 -0.369 . . . . 1.0 110.004 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.81 -41.53 97.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.94 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.478 ' O ' ' N ' ' B' ' 87' ' ' ALA . 30.8 m -46.69 -26.66 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.521 -0.156 0 CA-C-N 116.269 -0.423 . . . . 1.0 109.962 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' B' ' 85' ' ' VAL . 32.4 m -34.53 -33.66 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 109.507 -0.553 . . . . 1.0 109.507 177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -50.49 -65.36 0.57 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.324 -0.853 . . . . 1.0 110.035 179.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.85 -20.54 35.4 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.48 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.01 -44.01 97.18 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.32 -60.93 2.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-N 115.507 -0.769 . . . . 1.0 109.766 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.567 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -50.21 -5.87 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.84 179.811 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.573 ' H ' ' C ' ' B' ' 90' ' ' ALA . 51.0 t0 -60.78 -40.31 92.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 1.0 111.147 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' B' ' 93' ' ' PHE . 1.6 p90 -65.19 -33.56 76.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 1.0 110.889 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.77 -44.3 97.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.987 -0.551 . . . . 1.0 111.458 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' B' ' 97' ' ' GLU . 10.5 tpt180 -47.05 -21.29 0.21 Allowed 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.851 -0.34 . . . . 1.0 111.207 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 53.1 ptt85 -46.2 -20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.891 0.377 . . . . 1.0 110.217 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' C ' ' B' ' 95' ' ' ARG . 97.0 mt-10 -60.18 -45.99 91.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.944 -0.571 . . . . 1.0 111.138 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.17 -40.27 78.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.815 0.34 . . . . 1.0 110.666 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -70.78 -25.72 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.727 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.435 HH12 ' NH2' ' B' ' 101' ' ' ARG . 79.2 ttt-85 -59.72 -44.35 93.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.576 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . 0.435 ' NH2' HH12 ' B' ' 100' ' ' ARG . 35.5 mmt180 -98.36 -7.85 28.09 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.413 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.67 10.1 86.45 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.171 -0.772 . . . . 1.0 111.171 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 . . . . . 0 C--O 1.219 -0.529 0 CA-C-O 118.072 -0.966 . . . . 1.0 110.546 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.485 ' HB1' ' NE2' ' C' ' 4' ' ' HIS . . . -78.27 -4.93 50.35 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.934 -0.575 . . . . 1.0 110.44 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 56.97 29.87 17.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.432 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.627 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 7.2 p80 -172.51 -34.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.9 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.627 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 79.8 tt0 -67.31 -41.13 85.86 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.54 -0.3 . . . . 1.0 110.745 -179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -62.28 -42.59 99.48 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.199 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -65.55 -39.65 91.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.104 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.21 -42.98 96.37 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.477 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.08 -40.69 82.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.493 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -63.19 -38.16 90.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.311 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.8 -35.58 78.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.044 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.17 -37.72 88.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.748 0.308 . . . . 1.0 110.894 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.84 -35.5 80.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.648 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.06 -36.35 83.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.676 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.7 tp -62.07 -41.01 97.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.342 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -62.59 -40.63 97.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.54 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -62.14 -38.63 89.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.815 0.341 . . . . 1.0 111.116 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 84.9 t -64.38 -40.79 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.766 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -59.29 -41.35 88.73 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.864 -0.334 . . . . 1.0 110.19 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -59.65 -48.7 80.62 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.869 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.85 -32.73 71.27 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.13 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.67 -44.29 93.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.632 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 17.5 m -60.27 -44.11 95.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.508 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.11 -39.14 92.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.189 0.519 . . . . 1.0 110.12 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -72.46 -47.68 46.93 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 120.484 -0.486 . . . . 1.0 110.09 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.32 -50.57 73.16 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.41 -0.359 . . . . 1.0 111.359 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.517 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -60.8 -44.8 98.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.39 -0.524 . . . . 1.0 109.961 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.517 ' N ' HG13 ' C' ' 27' ' ' VAL . 42.7 tp10 -68.05 -36.98 80.76 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 1.0 110.414 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 -37.55 86.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.555 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -70.3 -44.48 68.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.443 -0.344 . . . . 1.0 111.399 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -52.93 97.02 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.832 0.348 . . . . 1.0 110.701 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.63 0.15 15.63 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 111.176 -0.769 . . . . 1.0 111.176 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.83 140.46 21.57 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 110.385 -0.228 . . . . 1.0 110.385 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.2 Cg_endo -76.19 143.69 25.71 Favored 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 121.918 1.746 . . . . 1.0 112.338 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 24.39 69.23 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.245 -0.742 . . . . 1.0 111.245 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.51 140.82 58.02 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.834 -0.346 . . . . 1.0 110.379 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -117.08 -34.76 4.28 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.422 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' C' ' 40' ' ' SER . 1.1 mt -72.2 -2.05 17.37 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.213 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.545 HG23 ' O ' ' C' ' 39' ' ' ILE . 12.4 tt -46.92 90.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.089 0.471 . . . . 1.0 110.627 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.519 ' N ' ' O ' ' C' ' 38' ' ' LEU . 70.4 m -167.04 -127.18 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.008 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.424 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 6.9 t80 174.39 -58.29 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.346 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.7 Cg_endo -58.86 -38.28 89.3 Favored 'Trans proline' 0 N--CA 1.5 1.907 0 C-N-CA 121.835 1.69 . . . . 1.0 112.376 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 14.6 p-10 -91.91 2.97 56.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.5 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.74 98.29 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.771 -0.371 . . . . 1.0 110.507 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.401 HG21 HD13 ' C' ' 45' ' ' ILE . 6.6 tt -68.21 -31.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.378 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.59 ' CZ2' ' O ' ' D' ' 63' ' ' VAL . 10.4 t90 -57.91 -47.17 83.6 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.993 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.468 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.0 OUTLIER -76.17 -22.33 55.48 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 178.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.0 t -67.5 -42.7 82.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.436 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.522 HG11 ' NH1' ' D' ' 68' ' ' ARG . 76.0 t -61.09 -47.9 91.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.038 0.384 . . . . 1.0 112.038 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -67.74 -31.63 71.67 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.88 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -58.96 -44.94 91.56 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.2 -179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.98 -35.23 70.89 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.759 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.524 ' OG1' HG22 ' C' ' 55' ' ' VAL . 68.8 p -75.18 -6.81 51.6 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.632 -0.427 . . . . 1.0 110.381 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 13.2 p 59.33 24.15 12.67 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.829 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.589 HG23 ' N ' ' C' ' 56' ' ' GLY . 18.5 m -87.54 -47.5 15.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.611 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.589 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 38.43 86.54 0.01 OUTLIER Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.106 -0.798 . . . . 1.0 111.106 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -63.37 -39.88 95.75 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.928 -0.309 . . . . 1.0 110.793 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.8 16.29 1.29 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.119 -0.793 . . . . 1.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -63.04 -41.65 99.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 1.0 110.572 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 61.8 mtt-85 -145.44 176.3 9.69 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 1.0 109.963 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -163.67 127.7 1.87 Allowed Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.593 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -70.27 160.02 51.0 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.918 1.745 . . . . 1.0 112.382 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.525 HG12 ' H ' ' C' ' 64' ' ' THR . 2.0 t -86.99 -140.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.092 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.525 ' H ' HG12 ' C' ' 63' ' ' VAL . 54.0 m -114.81 -34.48 5.12 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.799 0.333 . . . . 1.0 110.607 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.632 ' C ' ' H ' ' C' ' 67' ' ' GLY . 76.0 tt0 -67.17 -31.52 71.99 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.129 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' C ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -69.57 31.61 0.03 OUTLIER 'General case' 0 C--O 1.262 1.75 0 CA-C-O 123.48 1.61 . . . . 1.0 110.347 179.236 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.07 64.72 1.42 Allowed Glycine 0 C--O 1.212 -1.255 0 CA-C-N 114.103 -1.408 . . . . 1.0 111.234 177.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.466 ' C ' ' O ' ' C' ' 67' ' ' GLY . 49.6 ttm-85 -23.49 -33.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 117.848 0.824 . . . . 1.0 111.174 -178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.6 mptm? -49.66 -19.33 0.59 Allowed 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 177.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' C' ' 67' ' ' GLY . 78.1 t -62.94 -46.64 95.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 C-N-CA 119.23 -0.988 . . . . 1.0 110.44 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.34 69.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.905 0.383 . . . . 1.0 110.628 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -55.75 -44.28 77.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.786 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.21 -43.09 99.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.518 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -63.73 -47.96 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.738 -0.385 . . . . 1.0 111.129 -179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.597 ' SD ' HG11 ' B' ' 55' ' ' VAL . 76.8 mtm -64.38 -42.64 96.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.593 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . 0.524 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 55.2 tttm -64.68 -39.55 93.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.604 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.421 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.79 -42.49 93.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.819 0.342 . . . . 1.0 110.47 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -66.63 -42.1 93.58 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.747 -0.541 . . . . 1.0 111.747 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.0 -44.0 98.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.84 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.524 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 98.0 mt-10 -63.52 -40.32 96.73 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.279 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 77' ' ' ALA . 63.9 t -64.05 -49.05 83.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 C-N-CA 120.741 -0.384 . . . . 1.0 111.094 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -67.85 -37.72 82.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.469 -0.332 . . . . 1.0 111.347 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.42 -36.02 81.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.884 0.373 . . . . 1.0 110.644 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' C' ' 86' ' ' THR . 6.7 tt -61.78 -40.05 93.83 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.489 -179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.517 ' O ' HG12 ' C' ' 85' ' ' VAL . 61.3 t -54.81 -3.11 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.719 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.505 ' H ' ' C ' ' C' ' 84' ' ' LEU . 66.8 m -59.33 -40.93 87.87 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.685 0.279 . . . . 1.0 110.271 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.449 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -52.45 -25.35 9.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.22 -0.445 . . . . 1.0 110.259 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.13 -11.29 38.95 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.661 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 94.9 mt -86.69 -61.12 1.8 Allowed 'General case' 0 C--O 1.224 -0.289 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.578 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.542 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -42.93 -52.34 5.2 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.819 0.343 . . . . 1.0 111.045 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -45.38 -13.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.002 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.542 ' N ' ' O ' ' C' ' 90' ' ' ALA . 96.8 m-20 -63.52 -47.52 81.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.681 0.277 . . . . 1.0 110.957 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 2.2 p90 -67.98 -33.3 74.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 1.0 110.847 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -60.82 -43.06 94.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.773 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -58.67 -22.44 56.96 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 1.0 111.394 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . 0.446 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 37.9 ptt85 -50.39 -43.11 54.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 1.0 110.52 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.446 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 46.9 tp10 -59.68 -45.06 93.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.362 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.42 -42.18 88.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.382 . . . . 1.0 110.496 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -68.09 -37.82 81.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.495 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 ttp85 -60.92 -42.99 99.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.474 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -64.78 -36.54 84.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.571 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.85 18.94 57.32 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.987 -0.845 . . . . 1.0 110.987 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 59.3 t-80 . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.95 -1.024 . . . . 1.0 110.584 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.328 -0.619 . . . . 1.0 109.328 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.46 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . -154.62 149.71 26.91 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.593 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' D' ' 3' ' ' ASP . 15.2 p-10 -77.73 -41.7 36.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.963 -0.562 . . . . 1.0 111.287 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.496 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 6.7 p80 -66.27 -34.96 79.18 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.873 -179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -63.75 -37.2 86.49 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.782 -0.367 . . . . 1.0 110.693 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -61.49 -41.51 97.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.666 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.8 tp10 -65.81 -37.46 86.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.88 0.371 . . . . 1.0 110.059 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.64 -38.08 89.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.89 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -64.77 -39.56 93.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.499 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.21 -37.61 87.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.554 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.48 -38.93 91.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.074 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.23 -38.84 92.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 1.0 110.757 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.06 -36.35 83.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.626 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.78 -34.28 77.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.581 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.471 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.5 tp -62.67 -41.57 99.15 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.794 -0.362 . . . . 1.0 110.418 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -59.05 -36.31 74.82 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.834 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 71.6 tttt -60.89 -41.91 96.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.715 0.293 . . . . 1.0 111.042 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.32 -37.43 79.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.697 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.0 mt -59.89 -41.65 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.19 -47.47 84.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.016 0.436 . . . . 1.0 110.149 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -66.48 -34.2 77.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.189 -0.46 . . . . 1.0 109.895 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.11 82.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.715 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -60.94 -45.99 92.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.09 -179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 3.2 tmmt? -78.08 -35.8 48.95 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.975 0.417 . . . . 1.0 111.064 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -72.39 -44.87 61.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.163 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.52 ' O ' ' HB3' ' D' ' 29' ' ' ALA . . . -62.16 -49.76 74.53 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.475 -0.33 . . . . 1.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.53 HG13 ' N ' ' D' ' 28' ' ' GLU . 11.4 p -61.44 -43.62 97.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 121.02 0.438 . . . . 1.0 109.868 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.53 ' N ' HG13 ' D' ' 27' ' ' VAL . 42.1 tp10 -69.28 -20.78 63.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.683 -0.689 . . . . 1.0 110.041 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -60.33 -39.04 85.65 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.077 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 24.0 mp0 -63.97 -38.15 90.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.802 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -57.93 93.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.18 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.56 -9.12 6.9 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.1 146.65 32.96 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.752 0.276 . . . . 1.0 110.353 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.473 ' O ' HG11 ' D' ' 63' ' ' VAL . 71.7 Cg_endo -75.72 116.47 4.46 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.766 1.644 . . . . 1.0 112.199 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.09 37.71 4.55 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -38.74 98.91 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.816 0.341 . . . . 1.0 110.968 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -90.63 -72.6 0.57 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.546 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 3.6 tt -71.13 61.65 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.361 -0.381 . . . . 1.0 109.991 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 20.9 tt -90.38 -8.37 10.65 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 CA-C-O 120.928 0.394 . . . . 1.0 110.425 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 4.1 m -65.69 140.13 58.44 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.241 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.543 ' H ' ' HD2' ' D' ' 42' ' ' PRO . 0.8 OUTLIER -97.68 -61.44 0.12 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.67 179.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.543 ' HD2' ' H ' ' D' ' 41' ' ' TYR . 19.5 Cg_endo -57.85 -32.04 93.97 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 121.558 1.505 . . . . 1.0 111.888 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -88.81 -3.27 58.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.25 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.09 -39.91 96.11 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.757 0.313 . . . . 1.0 110.574 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.434 HG22 ' H ' ' D' ' 45' ' ' ILE . 0.0 OUTLIER -66.3 -32.24 57.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.287 179.072 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.632 ' CE3' ' NH2' ' A' ' 68' ' ' ARG . 1.7 t-105 -61.18 -47.3 86.77 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.008 -178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.413 ' CE3' ' N ' ' D' ' 48' ' ' SER . 0.8 OUTLIER -69.86 -37.88 76.26 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.913 -0.403 . . . . 1.0 109.913 178.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.413 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 25.3 p -47.12 -34.57 6.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 1.0 110.323 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 83.6 t -65.2 -44.71 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.412 179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -83.3 52.84 2.31 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.73 -0.471 . . . . 1.0 109.73 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 23.9 m -156.21 -48.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.905 -0.589 . . . . 1.0 110.468 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.597 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.91 -23.62 46.28 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.562 -0.455 . . . . 1.0 110.021 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 21.2 p -93.5 8.37 40.92 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.281 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.5 p 48.72 32.6 3.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.898 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.427 HG13 ' N ' ' D' ' 56' ' ' GLY . 7.3 p -65.47 -39.49 85.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.101 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.427 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 109.31 -91.21 0.64 Allowed Glycine 0 N--CA 1.467 0.743 0 N-CA-C 110.614 -0.994 . . . . 1.0 110.614 -179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.528 ' CD2' ' O ' ' D' ' 57' ' ' TYR . 43.7 p90 -62.91 114.66 3.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.263 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.538 ' C ' ' H ' ' D' ' 60' ' ' ARG . . . -126.47 28.24 4.8 Favored Glycine 0 N--CA 1.465 0.582 0 N-CA-C 111.107 -0.797 . . . . 1.0 111.107 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 36.8 t0 63.76 -6.74 0.22 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.755 0.312 . . . . 1.0 110.789 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.538 ' H ' ' C ' ' D' ' 58' ' ' GLY . 73.4 mtt-85 -145.87 128.41 16.05 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.088 -0.708 . . . . 1.0 109.088 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.493 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 8.2 p90 -118.55 141.44 29.82 Favored Pre-proline 0 N--CA 1.467 0.381 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.852 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.81 156.78 62.35 Favored 'Trans proline' 0 N--CA 1.495 1.587 0 C-N-CA 122.314 2.009 . . . . 1.0 112.512 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.59 ' O ' ' CZ2' ' C' ' 46' ' ' TRP . 12.3 t -77.94 -120.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.057 179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.487 ' N ' HG12 ' D' ' 63' ' ' VAL . 54.6 m -116.9 -72.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.961 0.41 . . . . 1.0 110.227 179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -56.16 127.34 30.21 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' D' ' 68' ' ' ARG . 94.5 mt-10 58.28 -94.5 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.054 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 24.63 -57.18 0.0 OUTLIER Glycine 0 N--CA 1.48 1.57 0 O-C-N 124.483 1.114 . . . . 1.0 114.193 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.5 ttp85 -83.19 -59.48 2.46 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.85 -0.426 . . . . 1.0 109.85 178.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -41.08 -36.35 0.69 Allowed 'General case' 0 N--CA 1.466 0.335 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . . . . . . . . . 79.7 t -68.49 -46.59 80.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.531 -0.759 . . . . 1.0 109.949 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -66.46 -34.79 78.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.893 -0.594 . . . . 1.0 109.828 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -54.12 -48.1 71.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.905 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.82 -38.1 88.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.946 -0.302 . . . . 1.0 111.716 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 90.2 t -62.86 -46.38 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.39 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.41 ' SD ' HG11 ' C' ' 55' ' ' VAL . 77.2 mtm -63.77 -39.89 95.37 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.613 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -60.87 -42.5 98.04 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.567 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.497 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.99 -39.11 93.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.471 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.91 -42.42 94.91 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.692 -0.563 . . . . 1.0 111.692 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -62.3 -43.43 98.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.621 0.248 . . . . 1.0 111.148 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.21 -38.63 91.05 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.899 -0.321 . . . . 1.0 111.36 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.497 HG23 ' O ' ' D' ' 77' ' ' ALA . 56.1 t -62.18 -49.65 83.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 120.85 -0.34 . . . . 1.0 111.277 -179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -67.17 -40.7 86.64 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.692 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.92 -33.71 76.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.234 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.681 HD23 ' C ' ' D' ' 84' ' ' LEU . 7.4 tt -60.95 -41.53 96.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.086 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.423 ' O ' HG12 ' D' ' 85' ' ' VAL . 98.1 t -47.02 -14.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.846 0.355 . . . . 1.0 110.258 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.489 ' N ' ' C ' ' D' ' 84' ' ' LEU . 39.6 m -49.6 -39.59 35.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.071 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.59 -26.98 14.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.63 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.92 -10.76 32.75 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.158 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.4 -59.85 2.1 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.181 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' D' ' 92' ' ' ASP . . . -42.22 -53.74 3.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.767 0.318 . . . . 1.0 111.056 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -42.33 -22.79 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.746 -179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' D' ' 90' ' ' ALA . 80.1 m-20 -62.0 -45.11 95.06 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.465 -0.334 . . . . 1.0 111.313 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.462 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 0.1 OUTLIER -53.56 -37.14 62.62 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 120.889 0.376 . . . . 1.0 110.489 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.431 ' O ' ' OE1' ' D' ' 97' ' ' GLU . 61.4 t -61.05 -43.66 96.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.945 -0.57 . . . . 1.0 111.135 -178.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 92.3 mtt-85 -50.92 -21.48 1.75 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.385 -0.371 . . . . 1.0 110.745 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -55.47 -44.04 76.06 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.137 -0.32 . . . . 1.0 110.137 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.514 ' N ' ' OE1' ' D' ' 97' ' ' GLU . 55.1 mp0 -70.16 -38.92 75.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.981 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.84 -37.04 85.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.916 0.389 . . . . 1.0 110.174 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -63.7 -31.36 72.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.345 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -55.64 -43.54 76.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 22.8 mmt85 -63.5 -37.97 89.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.264 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.72 21.1 64.46 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.175 -0.77 . . . . 1.0 111.175 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 78.8 m80 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.034 -0.984 . . . . 1.0 110.55 179.938 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.3 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.397 -0.594 . . . . 1.0 109.397 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.4 -76.15 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.532 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.6 t0 -159.94 -61.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.439 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.416 ' CD2' ' H ' ' A' ' 4' ' ' HIS . 8.7 p80 -77.42 -23.88 50.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.836 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -67.11 -37.79 84.52 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 120.803 0.335 . . . . 1.0 110.239 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 61.1 ttt85 -60.76 -43.23 98.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.215 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -65.87 -38.89 90.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.085 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.16 -41.14 99.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.331 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.09 -37.41 85.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.377 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 38.9 tptt -61.32 -41.96 97.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.283 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.2 83.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.842 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.32 -35.6 81.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.566 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.43 -37.16 86.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.387 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -66.19 -32.11 73.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.637 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -62.11 -41.73 98.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.866 0.365 . . . . 1.0 110.504 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -63.22 -40.43 97.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.07 -0.514 . . . . 1.0 111.154 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -63.51 -39.85 95.51 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.864 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.1 t -63.11 -42.57 97.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.44 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 52' ' ' ALA . 91.9 mt -60.24 -41.41 93.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.319 -0.4 . . . . 1.0 109.944 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.81 -45.68 92.79 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.895 -0.409 . . . . 1.0 109.895 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -69.56 -34.11 73.71 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.107 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.79 94.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.459 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.1 p -61.77 -43.35 99.03 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.21 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -58.92 -59.68 5.07 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.356 -0.538 . . . . 1.0 109.974 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -61.14 -45.07 96.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.931 -0.577 . . . . 1.0 111.154 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.56 -43.69 89.46 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.574 -0.45 . . . . 1.0 111.483 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 23' ' ' SER . 78.1 t -63.43 -47.23 92.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.257 -0.577 . . . . 1.0 110.338 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.92 -41.57 67.71 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.837 -0.62 . . . . 1.0 111.35 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.52 -35.08 65.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 1.0 109.804 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 5.5 mp0 -89.89 -10.18 46.2 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.632 178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -75.24 108.52 8.06 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.644 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.41 3.63 61.28 Favored Glycine 0 CA--C 1.522 0.482 0 CA-C-N 115.673 -0.694 . . . . 1.0 111.504 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.91 142.94 26.11 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.33 143.55 28.18 Favored 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.111 1.874 . . . . 1.0 112.443 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.74 -4.44 21.87 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.91 143.25 52.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.846 0.355 . . . . 1.0 110.568 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.17 -26.76 2.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.568 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -72.66 70.64 0.95 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.607 -0.437 . . . . 1.0 109.892 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.579 HG23 ' O ' ' A' ' 39' ' ' ILE . 14.5 tt -116.79 89.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-O 121.226 0.536 . . . . 1.0 110.439 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.565 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.3 OUTLIER 166.98 134.05 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.766 -179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.514 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 66.8 m-85 -69.58 -49.41 21.84 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 116.043 -0.526 . . . . 1.0 112.403 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.3 Cg_endo -60.19 -34.92 93.73 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 121.486 1.457 . . . . 1.0 113.188 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 44' ' ' ALA . 14.7 p-10 -90.5 -24.28 20.7 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 121.062 -0.255 . . . . 1.0 111.08 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -65.1 -38.29 90.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.889 0.376 . . . . 1.0 110.581 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.4 ' H ' HG22 ' A' ' 45' ' ' ILE . 2.8 tp -63.35 -40.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.042 -0.527 . . . . 1.0 109.98 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.606 ' CE2' HG23 ' B' ' 64' ' ' THR . 0.3 OUTLIER -62.49 -45.64 92.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.293 -0.412 . . . . 1.0 109.934 179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -57.53 -39.91 77.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.493 -0.558 . . . . 1.0 109.493 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.1 t -65.44 -34.78 79.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.995 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.8 t -60.4 -46.96 94.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.475 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -76.11 -8.23 56.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.062 0.458 . . . . 1.0 110.428 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -80.61 -45.63 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.79 0.328 . . . . 1.0 111.195 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -64.39 -37.57 88.0 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.609 -179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.6 p -75.12 0.29 16.69 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.617 -0.512 . . . . 1.0 109.617 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 p 47.71 60.98 3.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.385 -0.825 . . . . 1.0 111.339 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 56' ' ' GLY . 8.4 p -130.73 -44.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.562 -0.29 . . . . 1.0 110.682 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.494 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 36.12 89.05 0.01 OUTLIER Glycine 0 CA--C 1.53 1.003 0 N-CA-C 111.731 -0.548 . . . . 1.0 111.731 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -60.89 -44.42 97.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.819 0.343 . . . . 1.0 110.704 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.12 15.76 0.68 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 111.074 -0.81 . . . . 1.0 111.074 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 98.4 m-20 -59.92 -50.39 73.95 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.809 0.337 . . . . 1.0 110.636 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH1' ' OD2' ' A' ' 43' ' ' ASP . 0.9 OUTLIER -138.75 156.28 47.5 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.976 -0.557 . . . . 1.0 109.875 179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 33.2 p90 -144.08 131.6 10.61 Favored Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.674 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.58 -171.62 0.56 Allowed 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 121.827 1.685 . . . . 1.0 112.198 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.855 HG22 ' H ' ' A' ' 64' ' ' THR . 8.2 p -128.82 -136.35 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.776 -0.647 . . . . 1.0 110.222 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.855 ' H ' HG22 ' A' ' 63' ' ' VAL . 66.4 m -112.62 -40.23 4.12 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.628 0.251 . . . . 1.0 111.341 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.605 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.3 tt0 -64.48 -36.12 83.14 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.461 -179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.504 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 1.2 pp20? -72.66 32.18 0.06 Allowed 'General case' 0 C--O 1.262 1.763 0 CA-C-O 124.537 2.113 . . . . 1.0 109.721 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.25 63.98 1.43 Allowed Glycine 0 C--O 1.212 -1.242 0 CA-C-N 113.612 -1.631 . . . . 1.0 111.098 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.497 HH21 HH22 ' D' ' 60' ' ' ARG . 56.8 ttm-85 -24.12 -34.79 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 117.95 0.875 . . . . 1.0 111.334 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.674 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.8 mtmt -50.5 -14.25 0.17 Allowed 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.609 176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 67' ' ' GLY . 43.2 t -60.95 -47.68 92.42 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 C-N-CA 119.379 -0.928 . . . . 1.0 110.156 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.41 -42.48 68.26 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.84 0.353 . . . . 1.0 111.161 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -52.09 -39.64 60.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.85 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -68.97 -41.33 78.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.615 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.96 -49.19 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 120.594 -0.442 . . . . 1.0 111.398 -178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 25.1 ptp -63.62 -39.55 94.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.773 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -62.73 -42.63 99.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.446 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.75 -38.96 86.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.361 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -36.73 93.42 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.67 -0.972 . . . . 1.0 110.67 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.77 -26.93 26.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 120.923 -0.311 . . . . 1.0 111.135 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -75.14 -49.76 18.5 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.724 0.297 . . . . 1.0 111.412 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' N ' ' A' ' 82' ' ' PHE . 18.4 m -62.21 -48.41 88.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.32 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' N ' HG23 ' A' ' 81' ' ' VAL . 13.1 m-85 -66.0 -40.79 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.409 -0.359 . . . . 1.0 110.707 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.61 84.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 1.0 111.064 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.6 tt -62.16 -41.59 98.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.376 -0.374 . . . . 1.0 111.346 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.434 HG12 ' O ' ' A' ' 85' ' ' VAL . 81.6 t -46.47 -13.75 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.559 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 84' ' ' LEU . 94.9 m -55.31 -23.83 25.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.292 -0.413 . . . . 1.0 109.955 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.462 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -62.28 -29.67 70.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.111 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -92.52 -11.84 33.49 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.777 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 68.7 mt -86.27 -47.63 9.24 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.485 -0.325 . . . . 1.0 111.655 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.89 -24.12 49.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.959 0.409 . . . . 1.0 111.016 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -89.17 -3.73 58.5 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.706 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' B' ' 87' ' ' ALA . 91.5 m-20 -59.89 -46.48 89.2 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.728 -0.389 . . . . 1.0 111.384 -178.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -81.76 -19.18 41.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 1.0 111.282 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 86.2 t -64.31 -28.88 45.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.405 -178.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' O ' ' N ' ' A' ' 97' ' ' GLU . 96.4 mtt180 -63.59 -28.91 70.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.038 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.6 ptt85 -42.41 -23.98 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.845 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 95' ' ' ARG . 44.1 tt0 -64.73 -38.24 90.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 1.0 110.04 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' A' ' 102' ' ' GLY . 97.4 mt-10 -66.82 -39.93 87.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.343 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -68.75 -32.59 72.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.364 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.8 ttt-85 -58.39 -45.6 88.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.705 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -107.14 -1.87 21.51 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.858 0.361 . . . . 1.0 110.515 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 98' ' ' GLU . . . 67.79 24.67 74.22 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.048 -0.821 . . . . 1.0 111.048 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.445 ' O ' ' CG ' ' A' ' 103' ' ' HIS . 85.5 t60 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.939 -1.029 . . . . 1.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 38.5 m . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.422 -0.585 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.21 154.88 31.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.531 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.471 ' OD1' ' NH2' ' B' ' 6' ' ' ARG . 78.8 m-20 -63.1 -40.98 99.21 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.96 -0.564 . . . . 1.0 110.436 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -60.97 -45.52 94.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.21 -48.99 75.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.592 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.471 ' NH2' ' OD1' ' B' ' 3' ' ' ASP . 88.7 mtm180 -65.42 -41.07 93.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.888 0.375 . . . . 1.0 110.768 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -66.9 -40.24 87.67 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 1.0 110.166 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.53 -44.44 96.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.521 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -65.49 -38.03 88.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.258 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.05 -39.07 93.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.684 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.75 -32.44 67.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.903 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.85 -35.36 80.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 1.0 110.505 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.03 -35.67 81.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.236 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.15 -37.55 87.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.599 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.49 -40.92 98.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.913 0.387 . . . . 1.0 110.435 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -62.66 -39.34 93.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.812 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -62.37 -43.21 99.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.93 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.61 -40.84 89.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.49 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.531 HD21 ' HB2' ' B' ' 52' ' ' ALA . 32.7 mt -59.03 -42.81 91.08 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.858 -0.423 . . . . 1.0 109.858 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.46 -37.71 85.73 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -66.37 -53.11 39.81 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.415 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.502 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -65.93 -43.97 86.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.733 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.465 ' OG ' ' CB ' ' B' ' 48' ' ' SER . 75.2 m -56.22 -43.91 79.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.128 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.582 ' O ' HG22 ' B' ' 27' ' ' VAL . 14.9 tmtt? -65.34 -32.84 74.69 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.25 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -77.98 -34.81 50.71 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.09 -0.244 . . . . 1.0 111.239 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.05 -29.43 67.3 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.51 -0.313 . . . . 1.0 111.483 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.582 HG22 ' O ' ' B' ' 24' ' ' LYS . 2.6 m -61.52 -49.08 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 120.406 -0.517 . . . . 1.0 110.496 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.527 ' N ' HG23 ' B' ' 27' ' ' VAL . 80.6 tt0 -76.35 -35.8 58.53 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.605 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.498 ' HB1' ' HB2' ' B' ' 66' ' ' GLU . . . -59.12 -38.97 80.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.215 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.464 ' OE1' ' HB1' ' B' ' 36' ' ' ALA . 40.2 mm-40 -107.82 61.41 0.61 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.762 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -141.8 80.04 1.7 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.944 0.402 . . . . 1.0 111.105 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 111.06 4.41 27.54 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 111.421 -0.672 . . . . 1.0 111.421 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.85 153.7 57.86 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 110.226 -0.287 . . . . 1.0 110.226 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.35 139.6 23.57 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.008 1.806 . . . . 1.0 112.244 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.71 19.04 74.58 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.464 ' HB1' ' OE1' ' B' ' 30' ' ' GLU . . . -84.05 166.02 18.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.753 0.311 . . . . 1.0 110.458 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' B' ' 38' ' ' LEU . . . -161.07 -11.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.642 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.479 HD11 ' CG ' ' B' ' 47' ' ' TRP . 0.9 OUTLIER -87.6 33.26 0.7 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.223 -179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 34.7 pt -71.84 46.71 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.65 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 58.3 m -130.96 151.31 51.51 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.099 0.475 . . . . 1.0 111.065 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.525 ' H ' ' HD2' ' B' ' 42' ' ' PRO . 3.0 m-85 -97.54 -64.5 0.09 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 CA-C-N 115.499 -0.773 . . . . 1.0 111.015 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' H ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -58.52 -28.03 84.27 Favored 'Trans proline' 0 N--CA 1.499 1.847 0 C-N-CA 122.213 1.942 . . . . 1.0 112.525 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -87.56 -2.18 58.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.7 0.286 . . . . 1.0 110.643 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.02 95.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.873 0.368 . . . . 1.0 110.183 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.498 ' O ' HG23 ' B' ' 49' ' ' VAL . 6.7 tt -67.79 -39.29 81.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.765 179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.434 ' HE1' ' HA ' ' C' ' 64' ' ' THR . 0.2 OUTLIER -59.5 -49.49 77.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.415 -179.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.479 ' CG ' HD11 ' B' ' 38' ' ' LEU . 5.3 t90 -65.06 -40.78 95.21 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.465 ' CB ' ' OG ' ' B' ' 23' ' ' SER . 15.2 m -63.15 -39.62 95.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.53 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 45' ' ' ILE . 25.3 t -59.5 -47.31 91.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 N-CA-C 111.812 0.301 . . . . 1.0 111.812 -178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.491 ' CD ' HH12 ' C' ' 68' ' ' ARG . 15.0 pt-20 -65.41 -30.03 70.79 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.603 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 96.7 m -64.39 -44.75 90.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.615 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.531 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.02 -25.54 61.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.624 -0.262 . . . . 1.0 111.286 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.51 ' OG1' HG23 ' B' ' 55' ' ' VAL . 33.3 p -90.65 4.08 52.39 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.805 0.336 . . . . 1.0 110.583 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 17.9 p 54.42 9.09 0.23 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.635 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.51 HG23 ' OG1' ' B' ' 53' ' ' THR . 67.6 t -63.97 -45.85 95.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.698 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.31 57.61 5.59 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.524 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 1.0 OUTLIER -60.4 -49.29 78.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.878 0.371 . . . . 1.0 110.938 -178.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 158.73 -92.46 0.12 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.551 -1.02 . . . . 1.0 110.551 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.52 ' OD2' ' NH1' ' C' ' 68' ' ' ARG . 69.1 m-20 44.16 -86.78 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.614 0.245 . . . . 1.0 110.611 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.593 ' NH2' ' NH2' ' C' ' 68' ' ' ARG . 1.1 mpp_? -114.87 161.52 18.14 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.291 -0.633 . . . . 1.0 109.291 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.494 ' O ' ' CD2' ' B' ' 61' ' ' TYR . 16.6 p90 -141.58 105.1 5.89 Favored Pre-proline 0 CA--C 1.536 0.429 0 CA-C-N 116.198 -0.456 . . . . 1.0 110.384 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 163.21 38.62 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 121.525 1.483 . . . . 1.0 112.308 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 1.052 HG22 ' H ' ' B' ' 64' ' ' THR . 9.6 p -106.03 -154.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.571 -0.286 . . . . 1.0 110.352 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 1.052 ' H ' HG22 ' B' ' 63' ' ' VAL . 9.9 m -88.7 -53.45 4.62 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.65 0.262 . . . . 1.0 111.632 -179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.3 tt0 -42.09 -36.36 1.13 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.776 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.576 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -72.73 22.85 0.06 Allowed 'General case' 0 C--O 1.267 1.974 0 CA-C-O 124.283 1.992 . . . . 1.0 109.782 178.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.728 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 42.99 65.46 1.41 Allowed Glycine 0 N--CA 1.44 -1.087 0 CA-C-O 117.704 -1.609 . . . . 1.0 111.463 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.576 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -26.66 -28.55 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 118.067 0.934 . . . . 1.0 110.863 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.728 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.3 mttt -45.43 -26.31 0.53 Allowed 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 108.596 -0.89 . . . . 1.0 108.596 175.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' B' ' 67' ' ' GLY . 3.8 p -63.13 -43.63 98.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.236 -0.986 . . . . 1.0 109.627 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -79.37 -37.91 36.23 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.608 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -58.59 -40.19 82.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 1.0 109.851 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tp60 -63.71 -44.04 94.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.44 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.502 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 95.2 t -63.17 -48.23 88.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.473 -0.491 . . . . 1.0 110.891 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.1 mtm -63.03 -43.71 97.95 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.281 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -64.51 -40.84 96.38 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.161 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.447 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -63.04 -40.23 97.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.729 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.6 -41.86 95.84 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.373 -0.691 . . . . 1.0 111.373 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.09 -43.75 99.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 C-N-CA 120.989 -0.284 . . . . 1.0 110.781 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -62.14 -42.99 99.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.9 0.381 . . . . 1.0 110.544 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.447 HG23 ' O ' ' B' ' 77' ' ' ALA . 71.8 t -63.63 -46.91 93.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.908 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 32.2 m-85 -74.98 -4.16 36.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.851 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.413 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -102.02 -31.69 10.53 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.881 0.372 . . . . 1.0 110.052 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.497 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.4 tt -64.98 -39.52 93.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.025 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 27.0 m -55.02 -5.0 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.206 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' B' ' 90' ' ' ALA . 53.9 m -58.54 -41.43 85.53 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.501 -0.555 . . . . 1.0 109.501 179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.506 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -42.23 -54.07 3.84 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.599 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.96 68.8 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.181 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' B' ' 86' ' ' THR . 70.0 mt -88.2 -17.63 30.44 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.654 -0.499 . . . . 1.0 109.654 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -70.94 -37.15 72.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.156 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.422 HG23 ' H ' ' B' ' 91' ' ' THR . 0.0 OUTLIER -66.8 -24.86 66.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.225 -179.316 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -49.42 -43.79 44.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.992 -0.549 . . . . 1.0 110.656 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.616 ' CD1' ' N ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -59.74 -46.49 88.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.659 -0.7 . . . . 1.0 110.946 -178.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.9 t -66.75 -42.32 89.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.434 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -49.41 -21.51 0.92 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.539 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 9.7 ptm85 -50.29 -39.25 44.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 1.0 110.281 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.75 -40.92 96.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.611 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.542 ' O ' ' N ' ' B' ' 100' ' ' ARG . 48.1 mt-10 -71.61 -169.86 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.472 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 56.31 -76.01 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.072 -0.513 . . . . 1.0 111.166 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.542 ' N ' ' O ' ' B' ' 98' ' ' GLU . 71.6 ttt-85 -57.14 -44.45 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 1.0 110.383 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -120.26 106.44 11.9 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.856 0.36 . . . . 1.0 110.051 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.13 -6.17 34.45 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.22 -0.493 0 CA-C-O 117.987 -1.006 . . . . 1.0 110.516 179.918 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' C' ' 2' ' ' ALA . 14.5 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.401 -0.592 . . . . 1.0 109.401 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.547 ' O ' ' N ' ' C' ' 4' ' ' HIS . . . 71.94 -40.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.521 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.461 ' O ' ' N ' ' C' ' 6' ' ' ARG . 55.0 m-20 59.53 -70.01 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.029 -0.532 . . . . 1.0 111.074 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' C' ' 2' ' ' ALA . 7.1 p-80 -40.97 -31.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.426 . . . . 1.0 111.22 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.491 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 20.4 pt-20 -66.3 -39.54 89.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.9 0.381 . . . . 1.0 110.632 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . 0.461 ' N ' ' O ' ' C' ' 3' ' ' ASP . 73.5 ttp85 -60.63 -43.1 97.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.299 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -64.08 -38.27 90.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.036 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 -38.89 92.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.629 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -65.03 -40.98 95.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.431 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.52 -37.27 86.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.495 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.33 -40.22 93.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.027 -0.533 . . . . 1.0 111.086 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.13 -38.7 89.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.858 0.361 . . . . 1.0 110.847 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -65.82 -32.16 73.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . 0.472 ' O ' HG23 ' C' ' 18' ' ' VAL . 46.8 tp10 -61.66 -40.64 95.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.538 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.428 HD21 ' HB1' ' C' ' 52' ' ' ALA . 55.1 tp -63.29 -39.58 94.98 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.87 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -59.67 -51.03 71.55 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.379 0.511 . . . . 1.0 112.379 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -64.53 -30.93 71.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.873 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . 0.472 HG23 ' O ' ' C' ' 14' ' ' GLU . 42.3 t -63.49 -42.35 95.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.216 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.4 mt -59.86 -40.32 88.2 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.359 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -54.59 -48.88 71.62 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.533 -0.467 . . . . 1.0 109.849 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.78 -33.46 74.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 1.0 109.897 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.87 -37.51 82.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.476 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 91.0 p -61.78 -46.95 87.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.445 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.56 -36.33 80.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.227 0.536 . . . . 1.0 110.423 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -72.72 -46.5 53.27 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.85 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.504 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -64.46 -48.46 75.19 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.355 -0.384 . . . . 1.0 111.395 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.529 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.3 p -59.32 -44.88 93.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.221 -0.591 . . . . 1.0 109.685 -179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.529 ' N ' HG13 ' C' ' 27' ' ' VAL . 82.4 tt0 -68.37 -26.96 65.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.37 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.49 ' HB1' ' H ' ' C' ' 67' ' ' GLY . . . -56.16 -51.01 69.52 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.14 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 33.3 mp0 -67.54 -36.94 81.95 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.239 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -72.89 92.23 1.6 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.636 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.89 -19.54 5.81 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.444 -0.662 . . . . 1.0 111.444 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.51 154.03 39.4 Favored Pre-proline 0 N--CA 1.467 0.413 0 N-CA-C 109.919 -0.4 . . . . 1.0 109.919 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.1 150.59 37.93 Favored 'Trans proline' 0 N--CA 1.495 1.59 0 C-N-CA 122.264 1.976 . . . . 1.0 112.193 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 79.31 24.28 61.45 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.145 -0.782 . . . . 1.0 111.145 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.21 143.51 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.772 0.32 . . . . 1.0 110.533 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.6 -39.42 0.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.539 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.524 ' C ' HD23 ' C' ' 38' ' ' LEU . 3.5 tt -57.94 -79.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.325 -0.398 . . . . 1.0 109.994 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.617 HG22 ' N ' ' C' ' 40' ' ' SER . 95.4 mt 51.57 167.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.973 -0.38 . . . . 1.0 109.973 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.617 ' N ' HG22 ' C' ' 39' ' ' ILE . 1.8 t 81.65 124.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.453 179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.503 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 53.4 t80 -88.28 -49.89 0.42 Allowed Pre-proline 0 CA--C 1.543 0.694 0 CA-C-N 115.739 -0.664 . . . . 1.0 111.254 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.9 Cg_endo -60.05 -28.49 87.15 Favored 'Trans proline' 0 N--CA 1.501 1.945 0 C-N-CA 121.343 1.362 . . . . 1.0 112.529 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -95.48 -13.2 24.75 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.53 0.205 . . . . 1.0 111.216 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' C' ' 40' ' ' SER . . . -66.89 -37.46 84.44 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.896 -0.322 . . . . 1.0 110.532 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.0 tt -58.32 -34.69 50.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.335 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.428 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.2 OUTLIER -64.95 -48.11 75.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.149 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.524 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 7.6 t90 -61.18 -40.2 93.01 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.414 -0.514 . . . . 1.0 109.733 178.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.498 ' O ' HD22 ' C' ' 19' ' ' LEU . 63.5 p -67.09 45.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.842 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.413 ' H ' ' C ' ' C' ' 47' ' ' TRP . 71.0 t -137.25 -50.99 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.535 0.207 . . . . 1.0 110.783 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -69.45 -27.16 65.0 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.92 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.445 HG22 ' H ' ' C' ' 51' ' ' THR . 0.1 OUTLIER -59.84 -51.83 68.04 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.896 -0.322 . . . . 1.0 111.337 -179.243 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -56.66 -25.37 53.55 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.769 -0.373 . . . . 1.0 110.849 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 69.5 p -90.94 14.21 14.44 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.799 0.333 . . . . 1.0 110.408 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' C' ' 54' ' ' THR . 0.1 OUTLIER 35.42 77.66 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.785 -0.643 . . . . 1.0 111.681 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.402 HG23 ' H ' ' C' ' 56' ' ' GLY . 0.0 OUTLIER -145.78 -78.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.052 179.309 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.402 ' H ' HG23 ' C' ' 55' ' ' VAL . . . 75.54 84.73 0.37 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.244 -0.742 . . . . 1.0 111.244 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -63.93 -40.98 97.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.622 0.248 . . . . 1.0 110.608 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.99 22.23 0.6 Allowed Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 99.8 m-20 -61.83 -43.59 98.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.913 0.387 . . . . 1.0 110.469 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 77.7 mtt-85 -144.14 -167.58 2.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 1.0 109.617 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 89.2 m-85 -157.77 123.36 2.39 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 120.596 -0.441 . . . . 1.0 110.72 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.86 168.39 21.83 Favored 'Trans proline' 0 N--CA 1.494 1.541 0 C-N-CA 121.643 1.562 . . . . 1.0 112.255 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.416 HG22 ' H ' ' C' ' 63' ' ' VAL . 2.3 m -91.66 -167.52 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.088 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.434 ' HA ' ' HE1' ' B' ' 46' ' ' TRP . 2.4 m -101.88 -67.81 0.85 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 1.0 111.246 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -38.37 -31.7 0.06 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.801 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.8 mt-10 -138.62 -107.62 0.17 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.577 -0.738 . . . . 1.0 109.221 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.49 ' H ' ' HB1' ' C' ' 29' ' ' ALA . . . 20.39 -54.79 0.0 OUTLIER Glycine 0 N--CA 1.479 1.567 0 O-C-N 124.513 1.133 . . . . 1.0 114.532 177.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.5 tpp180 -63.06 -58.98 5.44 Favored 'General case' 0 CA--C 1.511 -0.538 0 C-N-CA 123.106 0.562 . . . . 1.0 109.769 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 17.9 tptp -61.5 -38.75 88.46 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.797 -0.816 . . . . 1.0 108.797 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.416 ' O ' HG23 ' C' ' 74' ' ' VAL . 72.7 t -64.16 -49.16 82.55 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 119.467 -0.893 . . . . 1.0 110.987 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.529 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -67.86 -44.43 77.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 1.0 110.413 179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -42.92 -50.62 5.77 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.881 -0.6 . . . . 1.0 110.919 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -64.21 -39.26 93.6 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.474 -0.33 . . . . 1.0 111.238 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.416 HG23 ' O ' ' C' ' 70' ' ' VAL . 61.4 t -63.18 -46.6 95.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 C-N-CA 120.81 -0.356 . . . . 1.0 111.491 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.529 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.9 mpp? -62.3 -42.2 99.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.579 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -61.34 -36.41 80.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.719 0.295 . . . . 1.0 110.844 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.01 -43.01 66.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.378 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.41 -38.79 95.3 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' C' ' 83' ' ' ALA . 38.2 mm -61.43 -45.46 98.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 O-C-N 122.679 -0.307 . . . . 1.0 110.839 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.0 -44.99 83.17 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.308 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 79.2 t -64.25 -46.98 91.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.191 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -77.03 -11.53 59.82 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.921 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.472 ' O ' ' OG1' ' C' ' 86' ' ' THR . . . -87.13 -36.93 17.8 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.867 0.365 . . . . 1.0 110.129 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' C' ' 86' ' ' THR . 4.9 tt -66.78 -37.58 84.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 1.0 111.568 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.544 ' O ' HD23 ' C' ' 89' ' ' LEU . 35.1 m -67.06 44.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 CA-C-O 120.799 0.333 . . . . 1.0 111.099 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.517 ' O ' ' N ' ' C' ' 90' ' ' ALA . 22.7 m -89.53 -42.02 11.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.031 0.443 . . . . 1.0 110.352 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.533 ' O ' HG23 ' C' ' 91' ' ' THR . . . -52.95 -67.65 0.23 Allowed 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 120.411 -0.516 . . . . 1.0 111.706 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.479 ' C ' HD22 ' C' ' 89' ' ' LEU . . . -48.64 -16.1 0.11 Allowed 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.35 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.544 HD23 ' O ' ' C' ' 85' ' ' VAL . 3.8 mm? -100.16 -24.28 14.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.495 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.56 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -90.01 -65.36 1.02 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.71 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.533 HG23 ' O ' ' C' ' 87' ' ' ALA . 0.7 OUTLIER -45.32 -11.82 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.702 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' C' ' 90' ' ' ALA . 89.9 m-20 -52.38 -42.22 63.79 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.368 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.597 ' CD1' ' N ' ' C' ' 94' ' ' VAL . 2.8 p90 -61.73 -43.72 98.31 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.17 -0.468 . . . . 1.0 111.408 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.597 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 58.2 t -38.78 -27.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.055 -0.521 . . . . 1.0 111.785 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' C' ' 93' ' ' PHE . 95.7 mtt180 -59.89 -23.4 63.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.688 0.28 . . . . 1.0 111.066 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.6 ttp85 -58.79 -42.89 90.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.155 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.518 ' O ' ' NH1' ' C' ' 100' ' ' ARG . 96.9 mt-10 -67.21 -31.81 72.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.353 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -88.55 -8.22 55.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.466 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.68 -41.65 87.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 1.0 110.73 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' C' ' 97' ' ' GLU . 34.7 ptt-85 -65.79 -37.3 85.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.04 0.448 . . . . 1.0 110.184 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -63.04 -37.26 86.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.749 -0.66 . . . . 1.0 110.648 -179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.97 25.47 40.83 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.057 -0.817 . . . . 1.0 111.057 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 80.0 m80 . . . . . 0 C--O 1.219 -0.51 0 CA-C-O 118.058 -0.972 . . . . 1.0 110.535 179.923 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 77.3 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.437 -0.579 . . . . 1.0 109.437 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.432 ' HB1' ' NE2' ' D' ' 4' ' ' HIS . . . -79.52 167.25 21.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.559 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.15 -43.91 97.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.939 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.701 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 4.9 p80 -69.66 -37.93 76.89 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.692 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.59 -34.24 77.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.696 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -58.98 -43.24 91.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.457 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -64.76 -38.3 90.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.037 0.446 . . . . 1.0 109.946 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.96 -37.31 86.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.765 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -60.62 -37.56 81.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.501 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.28 -37.95 85.02 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.463 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.63 -47.65 70.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 1.0 111.098 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -64.54 -38.85 92.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.486 -0.324 . . . . 1.0 110.644 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -40.42 93.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.025 0.44 . . . . 1.0 110.447 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -66.51 -32.7 74.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.651 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.531 HD11 ' HB1' ' D' ' 52' ' ' ALA . 43.4 tp -62.98 -35.1 79.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.069 0.462 . . . . 1.0 110.29 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.13 -33.19 73.06 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.255 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 40.9 mtmt -62.13 -45.36 93.82 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 120.592 -0.443 . . . . 1.0 111.473 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 14.3 m -66.09 -37.13 79.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.755 0.312 . . . . 1.0 110.935 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 38.1 mt -61.1 -41.63 97.02 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.881 -0.414 . . . . 1.0 109.881 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . 0.433 ' O ' ' OG ' ' D' ' 23' ' ' SER . 74.0 mm-40 -66.95 -44.11 81.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 1.0 110.203 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.11 -34.03 76.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.147 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' D' ' 26' ' ' ALA . . . -63.58 -38.86 92.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.433 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.25 -43.6 95.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.44 -0.346 . . . . 1.0 110.93 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -61.34 -62.46 1.82 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.229 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -60.54 -38.11 83.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.95 -0.568 . . . . 1.0 110.765 -179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' D' ' 22' ' ' ALA . . . -52.12 -51.29 58.77 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.59 -0.444 . . . . 1.0 110.533 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 69.6 t -64.14 -46.26 94.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 C-N-CA 120.409 -0.516 . . . . 1.0 110.171 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.43 -41.33 89.3 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.525 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.519 ' HB1' ' CB ' ' D' ' 66' ' ' GLU . . . -60.87 -41.72 96.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.045 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.53 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 40.3 mm-40 -68.29 -41.85 80.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.822 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -62.69 87.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.014 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.09 0.12 7.61 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 111.332 -0.707 . . . . 1.0 111.332 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.92 135.19 20.51 Favored Pre-proline 0 CA--C 1.537 0.45 0 O-C-N 122.794 -0.239 . . . . 1.0 110.604 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.73 143.25 29.81 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.058 1.839 . . . . 1.0 112.228 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.53 18.84 75.84 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 111.054 -0.818 . . . . 1.0 111.054 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.53 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -61.86 143.07 56.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 1.0 110.389 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.73 -18.48 7.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.588 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.42 ' O ' HG23 ' D' ' 39' ' ' ILE . 39.2 tp -105.72 117.15 33.28 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.539 -0.3 . . . . 1.0 110.236 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.42 HG23 ' O ' ' D' ' 38' ' ' LEU . 5.1 pt -154.3 89.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.231 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.515 ' O ' ' N ' ' D' ' 44' ' ' ALA . 0.4 OUTLIER 169.57 112.38 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.98 179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.493 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 13.5 m-85 -48.73 -53.96 31.79 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.748 178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.76 -30.3 92.19 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.202 1.268 . . . . 1.0 112.013 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -92.13 -20.08 21.61 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.548 -0.296 . . . . 1.0 111.036 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' D' ' 40' ' ' SER . . . -61.16 -42.72 99.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.854 0.359 . . . . 1.0 110.677 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -65.4 -38.06 81.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.425 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.82 -43.26 99.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.459 -0.337 . . . . 1.0 110.107 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.435 ' CE3' ' N ' ' D' ' 48' ' ' SER . 1.9 t90 -63.96 -40.15 95.78 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.466 -0.494 . . . . 1.0 109.975 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.435 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 78.6 p -60.17 -33.25 71.93 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.582 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.53 -44.33 99.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.312 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.461 ' OE2' ' CZ ' ' A' ' 68' ' ' ARG . 74.3 mt-10 -52.36 -31.96 36.14 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.753 -0.462 . . . . 1.0 109.753 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.575 ' C ' ' H ' ' D' ' 53' ' ' THR . 0.2 OUTLIER -83.39 -163.18 0.71 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 108.944 -0.761 . . . . 1.0 108.944 179.141 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . 56.35 0.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.134 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.575 ' H ' ' C ' ' D' ' 51' ' ' THR . 28.8 p -121.28 -1.2 9.74 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.296 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' D' ' 53' ' ' THR . 11.8 p 56.88 15.08 2.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.924 -0.58 . . . . 1.0 110.948 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 40.4 t -91.33 -53.35 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-O 120.705 0.288 . . . . 1.0 110.457 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.03 74.45 0.23 Allowed Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.878 -0.889 . . . . 1.0 110.878 -179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -60.56 -47.28 86.86 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 120.974 -0.29 . . . . 1.0 110.605 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 155.65 -90.77 0.12 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.884 -0.886 . . . . 1.0 110.884 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.449 ' OD2' ' OE2' ' D' ' 50' ' ' GLU . 98.0 m-20 44.05 -91.96 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.703 0.287 . . . . 1.0 110.424 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.497 HH22 HH21 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -124.62 162.54 23.88 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.736 179.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -162.75 138.95 5.66 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.528 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.14 157.53 57.24 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.893 1.729 . . . . 1.0 112.617 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.792 HG22 ' H ' ' D' ' 64' ' ' THR . 7.4 p -93.81 -121.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.495 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.792 ' H ' HG22 ' D' ' 63' ' ' VAL . 39.9 m -115.0 -35.05 4.87 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.757 0.313 . . . . 1.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' D' ' 67' ' ' GLY . 51.9 tp10 -65.74 -32.09 73.44 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.232 -179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.519 ' CB ' ' HB1' ' D' ' 29' ' ' ALA . 0.5 OUTLIER -81.09 37.29 0.43 Allowed 'General case' 0 C--O 1.261 1.67 0 CA-C-O 123.349 1.547 . . . . 1.0 108.909 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 39.96 62.4 1.47 Allowed Glycine 0 C--O 1.214 -1.094 0 CA-C-N 113.663 -1.608 . . . . 1.0 109.747 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.537 ' NH1' ' OD2' ' C' ' 59' ' ' ASP . 51.5 ttt85 -24.5 -30.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 O-C-N 124.133 0.549 . . . . 1.0 111.323 -176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.5 mttm -53.12 -13.85 0.55 Allowed 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.214 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.5 t -60.47 -48.73 87.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 C-N-CA 119.437 -0.905 . . . . 1.0 109.552 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.2 -36.08 76.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.277 178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -64.95 -38.85 92.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.764 -0.653 . . . . 1.0 111.329 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -61.25 -50.52 72.7 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.395 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 82.7 t -66.86 -42.93 89.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.368 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 34.4 ttm -58.08 -47.35 83.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.994 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -65.02 -40.05 94.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.614 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.97 -37.04 81.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -37.5 94.64 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 111.306 -0.718 . . . . 1.0 111.306 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 95.6 mt -65.3 -43.34 95.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.425 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' D' ' 84' ' ' LEU . 97.0 mt-10 -58.55 -50.73 72.71 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.836 0.309 . . . . 1.0 111.836 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.422 HG23 ' N ' ' D' ' 82' ' ' PHE . 11.4 m -60.84 -46.11 96.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.516 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . 0.422 ' N ' HG23 ' D' ' 81' ' ' VAL . 11.6 m-85 -66.24 -29.58 69.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.592 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.402 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -91.04 -20.76 21.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.575 0.226 . . . . 1.0 110.585 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' D' ' 80' ' ' GLU . 8.0 tt -63.73 -42.03 97.96 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.819 -0.352 . . . . 1.0 110.541 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.525 ' O ' ' N ' ' D' ' 88' ' ' ALA . 8.7 m -60.18 -18.93 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.058 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.405 ' C ' ' O ' ' D' ' 85' ' ' VAL . 50.9 m -36.29 -28.88 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.634 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -62.97 -46.21 88.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.531 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.525 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -67.22 -26.35 66.55 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.178 0.514 . . . . 1.0 110.241 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.513 HD22 ' N ' ' D' ' 89' ' ' LEU . 4.2 mm? -73.02 -34.73 66.54 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.275 179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.534 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -59.9 -45.09 93.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.95 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -74.08 -4.87 38.19 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.006 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.462 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 40.7 t0 -59.4 -50.26 74.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.965 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.534 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 21.7 p90 -73.96 -26.88 60.72 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.367 -0.379 . . . . 1.0 111.008 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 98.9 t -59.98 -26.28 35.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.219 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -57.32 -22.51 42.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.851 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.2 ptt85 -62.2 -20.76 64.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.565 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' D' ' 99' ' ' GLU . 60.7 tt0 -120.45 164.88 15.72 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 109.604 -0.517 . . . . 1.0 109.604 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 58.23 -73.64 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.841 0.353 . . . . 1.0 110.728 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' D' ' 97' ' ' GLU . 80.2 mm-40 -56.15 -48.82 75.55 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.37 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -65.38 -43.05 91.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.317 179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 85.1 mtp180 -120.23 108.79 14.63 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.25 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 94.23 29.08 9.9 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.382 -0.687 . . . . 1.0 111.382 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 48.5 p-80 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 118.047 -0.978 . . . . 1.0 110.849 179.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 2' ' ' ALA . 23.3 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 50.25 174.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 66.3 t0 -105.52 -29.04 10.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.653 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.577 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.6 p80 -81.02 -30.27 34.96 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.711 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.38 -45.69 83.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.902 0.382 . . . . 1.0 110.813 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -69.46 -35.1 75.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.33 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -68.05 -40.32 82.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.213 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.75 92.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.391 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -63.31 -33.96 76.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.3 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.73 -42.85 99.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.645 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -37.02 81.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 1.0 111.128 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.45 -39.45 90.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 1.0 110.605 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -62.25 -37.35 85.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.239 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.7 -31.07 71.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.572 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 42.6 tp -61.86 -42.31 98.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.438 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -62.99 -39.34 94.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.148 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -62.12 -40.27 95.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.762 0.315 . . . . 1.0 111.328 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.0 t -63.17 -41.07 91.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.662 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.4 mt -60.61 -41.61 95.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.805 -0.442 . . . . 1.0 109.805 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -62.73 -43.33 99.08 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -70.3 -38.39 74.97 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.308 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.66 -38.4 90.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.796 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -60.14 -41.19 92.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.946 0.403 . . . . 1.0 110.151 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.31 -30.01 70.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.101 -0.5 . . . . 1.0 110.663 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -82.37 -40.73 20.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.652 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.412 ' O ' ' CG ' ' A' ' 30' ' ' GLU . . . -64.83 -40.44 95.19 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.78 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.6 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.5 p -61.47 -50.29 80.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.361 -0.536 . . . . 1.0 110.608 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.6 ' N ' HG13 ' A' ' 27' ' ' VAL . 15.5 pt-20 -71.03 -43.29 68.2 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.545 179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.61 -49.99 73.04 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.077 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' A' ' 26' ' ' ALA . 21.7 mm-40 -67.72 -39.43 84.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.144 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 -71.68 129.91 39.85 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 120.909 0.385 . . . . 1.0 110.313 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.02 -12.21 67.15 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.346 -0.702 . . . . 1.0 111.346 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.68 147.91 47.52 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 110.219 -0.289 . . . . 1.0 110.219 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' O ' HG11 ' A' ' 63' ' ' VAL . 97.8 Cg_endo -75.21 138.88 23.09 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.034 1.822 . . . . 1.0 112.306 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.93 15.39 69.22 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.008 -0.837 . . . . 1.0 111.008 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 143.59 54.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.734 0.302 . . . . 1.0 110.396 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.48 -7.85 8.62 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.645 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.9 tt -107.13 123.1 47.76 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.064 0.459 . . . . 1.0 110.24 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 38' ' ' LEU . 44.3 pt -149.93 -171.34 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.104 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 39' ' ' ILE . 2.0 m 58.16 145.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.944 0.402 . . . . 1.0 110.623 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 65.0 t80 -82.7 -43.22 0.92 Allowed Pre-proline 0 CA--C 1.542 0.671 0 CA-C-N 116.13 -0.486 . . . . 1.0 112.116 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.8 Cg_endo -60.4 -28.71 87.28 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 121.657 1.571 . . . . 1.0 112.829 -179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.441 ' OD1' ' O ' ' A' ' 40' ' ' SER . 30.7 p-10 -94.02 -28.92 15.48 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.99 -0.284 . . . . 1.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.92 -36.17 83.51 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.485 -0.325 . . . . 1.0 110.271 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 tp -63.82 -42.41 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.047 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.872 ' CD1' HG23 ' B' ' 64' ' ' THR . 0.1 OUTLIER -62.88 -41.39 99.39 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.019 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.444 ' O ' ' OE2' ' A' ' 50' ' ' GLU . 13.5 t90 -60.15 -39.28 85.79 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.475 -0.565 . . . . 1.0 109.475 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 35.5 m -72.87 67.88 0.85 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.389 -0.369 . . . . 1.0 110.913 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 95.3 t -151.99 -82.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-O 121.007 0.432 . . . . 1.0 110.362 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.66 ' H ' ' CD ' ' A' ' 50' ' ' GLU . 3.7 pm0 -48.16 -24.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.833 -0.621 . . . . 1.0 110.539 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.432 ' H ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -62.31 -43.67 98.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.285 -0.416 . . . . 1.0 109.989 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -60.25 -28.09 67.77 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.236 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.4 p -84.32 5.63 26.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 109.4 -0.593 . . . . 1.0 109.4 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p 48.05 76.61 0.11 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.398 -0.819 . . . . 1.0 110.899 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG22 ' O ' ' B' ' 54' ' ' THR . 94.5 t -138.98 -55.72 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.463 -0.335 . . . . 1.0 110.879 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 58.94 77.02 0.19 Allowed Glycine 0 CA--C 1.527 0.825 0 N-CA-C 111.276 -0.73 . . . . 1.0 111.276 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -60.75 -42.77 98.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.774 0.321 . . . . 1.0 110.614 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.46 9.92 1.32 Allowed Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.983 -0.847 . . . . 1.0 110.983 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' CG ' HH22 ' B' ' 68' ' ' ARG . 20.8 m-20 -58.1 -50.08 74.7 Favored 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 120.915 -0.314 . . . . 1.0 110.556 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 61.0 mtt-85 -147.95 163.89 35.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.1 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -153.46 132.85 7.15 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.446 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -70.3 163.19 39.59 Favored 'Trans proline' 0 N--CA 1.499 1.804 0 C-N-CA 122.075 1.85 . . . . 1.0 112.394 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.47 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.0 t -97.78 -128.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.431 ' H ' HG12 ' A' ' 63' ' ' VAL . 8.6 m -115.01 -36.57 4.39 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.68 0.276 . . . . 1.0 110.979 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.692 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.4 tt0 -70.79 -39.41 73.17 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.748 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.552 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -66.79 27.53 0.02 OUTLIER 'General case' 0 C--O 1.265 1.899 0 CA-C-O 123.753 1.74 . . . . 1.0 109.925 178.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.7 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.16 64.35 0.96 Allowed Glycine 0 C--O 1.214 -1.117 0 CA-C-N 114.035 -1.438 . . . . 1.0 111.392 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.47 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 33.0 ttm180 -24.93 -32.11 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 CA-C-N 117.806 0.803 . . . . 1.0 110.969 -178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.7 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -50.44 -16.72 0.38 Allowed 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 115.749 -0.66 . . . . 1.0 109.451 176.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.599 ' N ' ' O ' ' A' ' 67' ' ' GLY . 52.8 t -61.38 -48.09 90.47 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 C-N-CA 119.759 -0.776 . . . . 1.0 110.342 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' A' ' 75' ' ' MET . . . -70.84 -42.8 69.67 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.007 0.432 . . . . 1.0 110.442 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -49.59 -43.17 46.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.474 -179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -62.26 -39.64 93.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.872 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.7 t -64.04 -43.85 97.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.511 -0.476 . . . . 1.0 111.215 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' A' ' 71' ' ' ALA . 3.4 mpp? -61.63 -40.2 94.03 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 121.021 -0.272 . . . . 1.0 110.503 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -61.33 -39.92 92.33 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.626 -0.43 . . . . 1.0 110.061 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.402 ' O ' HG22 ' A' ' 81' ' ' VAL . . . -51.4 -45.98 62.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.487 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.84 -51.45 53.49 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.486 -1.046 . . . . 1.0 110.486 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 79' ' ' ILE . 95.6 mt -67.95 -4.78 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.776 0.322 . . . . 1.0 110.472 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 76.2 tt0 -96.17 -49.72 5.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.427 -0.352 . . . . 1.0 110.293 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.625 HG23 ' N ' ' A' ' 82' ' ' PHE . 28.3 m -70.8 -51.0 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.06 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.625 ' N ' HG23 ' A' ' 81' ' ' VAL . 45.6 m-85 -62.39 -39.18 92.38 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.073 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.691 ' O ' HD12 ' D' ' 89' ' ' LEU . . . -61.15 -39.57 90.57 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.669 -0.412 . . . . 1.0 110.715 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.481 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.5 tt -63.48 -40.35 96.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 1.0 111.505 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 85' ' ' VAL . 59.1 t -49.7 -11.1 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.696 -0.401 . . . . 1.0 110.429 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.481 ' N ' ' C ' ' A' ' 84' ' ' LEU . 54.5 m -49.28 -42.49 41.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 1.0 110.144 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -50.73 -13.61 0.15 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.68 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 86' ' ' THR . . . -104.75 -15.92 15.09 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.683 -179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.547 HD13 ' OD2' ' A' ' 92' ' ' ASP . 3.1 mm? -94.84 -46.68 6.78 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 1.0 110.677 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.03 -22.74 28.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.372 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.37 -3.67 58.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.748 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.547 ' OD2' HD13 ' A' ' 89' ' ' LEU . 86.2 m-20 -61.65 -48.78 79.31 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.343 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -80.58 -19.57 45.26 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.765 0.317 . . . . 1.0 111.454 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 72.5 t -60.08 -42.73 90.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.904 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.455 ' O ' ' O ' ' A' ' 98' ' ' GLU . 95.9 mtt-85 -58.06 -21.53 46.11 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.712 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -55.1 -42.85 73.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.572 -0.285 . . . . 1.0 110.546 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.507 ' OE1' ' N ' ' A' ' 97' ' ' GLU . 56.3 mp0 -74.74 0.33 15.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.104 0.478 . . . . 1.0 110.085 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.48 ' C ' ' H ' ' A' ' 100' ' ' ARG . 96.9 mt-10 -129.18 168.7 15.77 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.091 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 66.73 -43.05 0.42 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 123.767 0.667 . . . . 1.0 110.393 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.48 ' H ' ' C ' ' A' ' 98' ' ' GLU . 70.6 ttp85 -61.71 -43.89 97.98 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.591 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -97.18 -1.23 45.45 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.572 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.2 18.55 79.25 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.05 -0.82 . . . . 1.0 111.05 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.1 t60 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 118.033 -0.984 . . . . 1.0 110.57 -179.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.97 165.53 22.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.653 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -61.82 -43.37 98.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.725 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -73.1 -35.43 66.6 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.714 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.26 -43.89 89.82 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.79 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -65.02 -38.89 92.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.67 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -63.68 -37.56 87.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 1.0 109.938 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.24 -42.43 99.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.758 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -69.05 -35.73 76.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.377 -0.374 . . . . 1.0 110.334 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.41 -38.54 87.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.568 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.63 -36.32 76.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.935 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.98 -34.78 78.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.562 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -62.79 -38.35 90.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.0 110.137 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.03 -33.05 74.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.448 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.465 HD11 ' HB1' ' B' ' 52' ' ' ALA . 47.8 tp -62.36 -41.92 98.99 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.506 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -63.11 -39.11 93.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.89 -44.23 97.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 91.2 t -64.22 -40.86 90.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.907 -0.588 . . . . 1.0 110.786 -179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.3 mt -60.36 -41.69 94.21 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.744 -0.382 . . . . 1.0 110.054 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.3 -48.17 79.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.118 0.485 . . . . 1.0 110.056 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -69.49 -35.85 75.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.128 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.01 -37.52 86.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.35 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 91.5 p -56.58 -44.68 81.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.466 -179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.77 -36.2 82.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.121 0.486 . . . . 1.0 110.677 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 69.1 mmtt -67.98 -44.42 76.7 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.833 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.53 -49.31 76.76 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 121.024 -0.27 . . . . 1.0 111.463 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.46 HG23 ' N ' ' B' ' 28' ' ' GLU . 16.9 m -62.82 -45.38 99.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.768 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.46 ' N ' HG23 ' B' ' 27' ' ' VAL . 46.2 tp10 -71.9 -42.0 67.28 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.85 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -43.7 -47.38 7.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.327 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.529 ' OE2' ' N ' ' B' ' 38' ' ' LEU . 96.9 mt-10 -68.21 -116.83 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.809 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 37.4 mmm-85 45.67 79.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.596 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.88 -7.26 17.29 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 111.413 -0.675 . . . . 1.0 111.413 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.9 149.7 96.46 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.528 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.24 121.27 6.03 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.953 1.769 . . . . 1.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 92.83 -23.06 30.56 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 111.084 -0.806 . . . . 1.0 111.084 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 49.94 175.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 1.0 110.579 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.77 -85.84 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.552 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.529 ' N ' ' OE2' ' B' ' 30' ' ' GLU . 44.9 tp -89.93 82.3 6.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.558 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.594 HG23 ' O ' ' B' ' 39' ' ' ILE . 15.2 tt -125.97 102.07 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 115.911 -0.586 . . . . 1.0 109.963 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.516 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 73.4 m -169.94 -124.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.706 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.516 ' CD2' ' O ' ' B' ' 40' ' ' SER . 2.3 m-85 -174.77 -65.08 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.092 -0.503 . . . . 1.0 109.995 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.15 -36.94 97.44 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.088 1.859 . . . . 1.0 112.175 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -92.98 0.91 57.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.617 -0.265 . . . . 1.0 111.145 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.92 -45.06 93.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.003 0.43 . . . . 1.0 110.343 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 21.4 tt -69.47 -36.61 72.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.606 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.546 ' O ' ' NH2' ' C' ' 68' ' ' ARG . 1.1 t90 -46.54 -68.75 0.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.647 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.467 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.0 OUTLIER -57.16 -27.18 61.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.059 179.509 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.467 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 3.1 t -65.47 -41.77 92.97 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.701 -0.399 . . . . 1.0 111.347 -178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.572 ' CG1' HH12 ' C' ' 68' ' ' ARG . 55.5 t -60.95 -47.74 92.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 N-CA-C 111.815 0.302 . . . . 1.0 111.815 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -68.06 -31.59 71.34 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.641 -0.424 . . . . 1.0 110.571 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.2 m -60.5 -45.38 94.0 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.818 -0.353 . . . . 1.0 111.174 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.735 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -56.22 -27.57 55.28 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.813 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 61.1 p -85.43 1.52 48.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.723 0.297 . . . . 1.0 110.755 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.455 ' O ' HG22 ' A' ' 55' ' ' VAL . 4.6 p 53.41 15.69 0.75 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.005 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.496 HG13 ' N ' ' B' ' 56' ' ' GLY . 5.7 p -66.36 -44.69 90.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.02 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.496 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 46.3 65.22 2.19 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.47 -1.052 . . . . 1.0 110.47 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -58.98 -48.47 81.45 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.746 0.308 . . . . 1.0 110.743 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.69 6.82 1.96 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -58.93 -45.62 89.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.644 0.259 . . . . 1.0 110.419 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 67.0 mtt-85 -145.19 173.22 12.12 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.181 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -155.95 130.33 4.92 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.456 -0.338 . . . . 1.0 110.41 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.02 156.92 63.79 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 121.769 1.646 . . . . 1.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.51 HG12 ' H ' ' B' ' 64' ' ' THR . 1.8 t -84.03 -141.08 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.171 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.872 HG23 ' CD1' ' A' ' 46' ' ' TRP . 3.8 m -114.36 -46.54 2.97 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.24 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.627 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.9 tp10 -64.5 -29.18 70.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.355 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.3 OUTLIER -70.84 32.18 0.04 OUTLIER 'General case' 0 C--O 1.261 1.663 0 CA-C-O 123.889 1.804 . . . . 1.0 110.078 178.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.723 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.84 62.85 1.6 Allowed Glycine 0 C--O 1.208 -1.48 0 CA-C-N 113.827 -1.533 . . . . 1.0 111.338 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.558 ' HE ' ' CD ' ' A' ' 50' ' ' GLU . 27.4 ttt85 -25.1 -31.37 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 118.075 0.937 . . . . 1.0 110.866 -178.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.723 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -52.47 -14.97 0.55 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.611 -0.885 . . . . 1.0 108.611 176.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.661 ' N ' ' O ' ' B' ' 67' ' ' GLY . 43.4 t -61.83 -46.43 96.53 Favored 'Isoleucine or valine' 0 C--N 1.353 0.718 0 C-N-CA 119.876 -0.73 . . . . 1.0 109.364 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.86 -38.05 67.18 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -57.18 -41.63 79.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.868 -0.606 . . . . 1.0 110.036 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.45 -44.35 94.73 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.888 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.08 -46.01 92.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 C-N-CA 120.847 -0.341 . . . . 1.0 111.117 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 73.5 mtm -62.93 -42.72 99.89 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.432 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -63.86 -41.6 97.74 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.343 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.41 -38.06 88.22 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.442 -0.345 . . . . 1.0 110.546 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.14 -39.12 94.47 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -68.94 -26.78 33.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 122.58 -0.365 . . . . 1.0 111.293 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -70.9 -51.61 25.1 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.052 0.453 . . . . 1.0 111.169 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.446 HG23 ' N ' ' B' ' 82' ' ' PHE . 7.6 m -60.41 -47.86 90.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.686 -0.688 . . . . 1.0 111.17 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.446 ' N ' HG23 ' B' ' 81' ' ' VAL . 20.7 m-85 -67.81 -38.56 83.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.802 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.07 -36.92 85.85 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.536 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.454 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.6 tt -61.72 -41.52 97.74 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.198 -0.456 . . . . 1.0 109.93 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 93.4 t -49.79 -17.06 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.557 -0.534 . . . . 1.0 109.557 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.457 ' O ' ' N ' ' B' ' 90' ' ' ALA . 75.1 m -52.38 -40.87 62.6 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.464 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.15 -55.06 7.57 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.841 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.42 -12.69 54.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.83 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.405 ' HB3' HG21 ' C' ' 86' ' ' THR . 81.5 mt -98.21 -27.14 14.3 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.457 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -64.85 -24.62 67.6 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.382 0.61 . . . . 1.0 109.858 179.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.536 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.1 OUTLIER -84.52 -4.72 59.11 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.186 -0.915 . . . . 1.0 109.61 -179.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -55.67 -48.93 74.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.82 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.463 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 7.9 p90 -66.56 -31.81 72.75 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.274 -0.421 . . . . 1.0 111.165 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 84.9 t -60.54 -44.32 96.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.232 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.536 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 83.7 mtt85 -60.08 -28.72 68.04 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.867 -0.333 . . . . 1.0 111.147 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 72.7 ttp85 -56.06 -42.23 76.32 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -63.55 -40.5 97.15 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.044 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.25 -36.11 82.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.749 0.309 . . . . 1.0 110.596 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -66.13 -38.59 88.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.634 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -63.09 -43.37 98.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.46 -0.337 . . . . 1.0 110.507 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 25.1 mmt85 -112.22 112.76 24.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.484 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.2 -18.83 47.87 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.989 -0.844 . . . . 1.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.977 -1.011 . . . . 1.0 110.561 179.829 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 60.6 m . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.357 -0.608 . . . . 1.0 109.357 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.452 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -68.56 145.27 54.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.827 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -61.98 -40.99 97.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.193 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.618 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 23.3 p80 -67.11 -41.07 86.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.019 -0.537 . . . . 1.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.618 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.6 tt0 -62.67 -39.8 95.07 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.719 0.295 . . . . 1.0 110.537 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 34.5 mmt180 -65.1 -38.99 92.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.87 0.367 . . . . 1.0 110.257 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -64.72 -39.61 93.94 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.154 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.09 -41.92 98.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.463 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -65.82 -40.82 92.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.245 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -63.85 -35.39 80.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.327 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 -35.89 76.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.056 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.65 -39.59 91.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 1.0 110.877 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.49 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.742 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -63.73 -37.81 88.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.77 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.436 HD13 ' HA2' ' C' ' 78' ' ' GLY . 40.8 tp -61.55 -43.35 99.03 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.446 -0.502 . . . . 1.0 110.427 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -59.98 -31.35 69.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.085 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -61.55 -40.1 93.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.73 0.3 . . . . 1.0 111.132 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 71.2 t -67.81 -42.35 85.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.847 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . . . . . . . . . 6.7 mp -61.64 -41.7 97.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.411 -0.359 . . . . 1.0 110.107 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.421 ' O ' ' OG ' ' C' ' 23' ' ' SER . 97.7 mt-10 -63.31 -46.62 85.85 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.008 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.537 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 0.2 OUTLIER -70.6 -39.08 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.112 179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.95 82.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.799 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.7 p -53.34 -45.77 69.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.192 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -65.08 -46.55 80.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.215 0.531 . . . . 1.0 109.84 178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -60.5 -37.9 82.6 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.852 -0.613 . . . . 1.0 109.961 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.14 -53.51 57.46 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.75 0.31 . . . . 1.0 111.065 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 m -62.84 -41.45 92.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.47 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -68.14 -44.08 76.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.524 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.11 80.56 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.09 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -70.6 -39.4 73.84 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.316 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -68.38 129.09 38.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 120.943 0.401 . . . . 1.0 110.28 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.44 -0.46 65.78 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.334 -0.706 . . . . 1.0 111.334 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.37 149.9 38.31 Favored Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 110.43 -0.211 . . . . 1.0 110.43 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.07 139.88 22.07 Favored 'Trans proline' 0 N--CA 1.492 1.385 0 C-N-CA 121.816 1.677 . . . . 1.0 112.369 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 2.69 57.9 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.229 -0.748 . . . . 1.0 111.229 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.5 103.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.78 0.324 . . . . 1.0 110.393 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.44 -35.46 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 1.0 110.393 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 15.0 tp -87.08 95.07 9.82 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.119 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 33.4 pt -138.52 49.13 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.89 0.376 . . . . 1.0 110.713 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -138.66 145.3 40.26 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.162 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.555 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 35.9 m-85 -69.52 -50.87 17.74 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 115.901 -0.591 . . . . 1.0 110.86 179.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.3 Cg_endo -58.98 -38.54 87.43 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 121.727 1.618 . . . . 1.0 112.433 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 25.8 m-20 -81.08 -11.29 59.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.221 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.32 -46.86 81.71 Favored 'General case' 0 N--CA 1.463 0.225 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.788 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.405 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.3 tt -72.93 -38.89 57.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 1.0 111.028 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.486 ' C ' ' NH1' ' D' ' 68' ' ' ARG . 0.5 OUTLIER -63.64 -46.52 85.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.64 -178.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.417 ' CE3' ' N ' ' C' ' 48' ' ' SER . 3.1 t90 -61.18 -39.64 90.92 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.241 -0.583 . . . . 1.0 109.553 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.417 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 60.7 p -61.63 -34.53 75.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.96 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 45' ' ' ILE . 50.2 t -61.46 -48.28 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.478 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -70.65 -21.29 62.63 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.274 -0.571 . . . . 1.0 110.58 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 64.9 m -75.48 -42.2 53.58 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.796 0.331 . . . . 1.0 111.367 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.26 -37.41 80.35 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.899 -178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.592 ' C ' HG23 ' C' ' 54' ' ' THR . 54.5 p -74.85 -11.99 60.27 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.023 -0.362 . . . . 1.0 110.023 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.592 HG23 ' C ' ' C' ' 53' ' ' THR . 1.3 p 69.88 0.85 3.21 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.636 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' C' ' 57' ' ' TYR . 56.0 t -65.21 -45.09 94.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.723 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 44.32 79.02 0.06 OUTLIER Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.684 -0.966 . . . . 1.0 110.684 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.424 ' CZ ' HG11 ' C' ' 55' ' ' VAL . 52.6 m-85 -60.3 -46.64 89.16 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.811 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.04 23.27 0.69 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 110.969 -0.853 . . . . 1.0 110.969 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.49 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 21.8 t0 -61.65 -41.17 97.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 1.0 110.305 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 74.2 mtt-85 -145.49 -161.91 1.4 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.261 -0.427 . . . . 1.0 109.961 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.537 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 13.4 p90 -172.17 112.37 0.38 Allowed Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 120.32 -0.552 . . . . 1.0 110.986 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.14 -170.64 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 121.613 1.542 . . . . 1.0 112.126 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.987 HG22 ' H ' ' C' ' 64' ' ' THR . 9.9 p -139.12 -169.59 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.375 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.987 ' H ' HG22 ' C' ' 63' ' ' VAL . 11.4 m -77.25 -45.91 24.87 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.996 0.427 . . . . 1.0 110.716 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' C' ' 67' ' ' GLY . 49.0 tp10 -47.49 -50.51 23.06 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.061 -0.518 . . . . 1.0 109.91 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.485 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 0.9 OUTLIER -72.17 35.76 0.06 Allowed 'General case' 0 C--O 1.264 1.838 0 CA-C-O 124.28 1.991 . . . . 1.0 109.859 178.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.85 65.88 1.46 Allowed Glycine 0 CA--C 1.525 0.688 0 CA-C-N 113.76 -1.564 . . . . 1.0 111.54 177.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.572 HH12 ' CG1' ' B' ' 49' ' ' VAL . 8.2 ptm180 -21.33 -38.75 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 CA-C-O 121.775 0.798 . . . . 1.0 111.657 -178.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.67 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.6 mmtt -43.84 -18.6 0.02 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.273 -1.331 . . . . 1.0 109.588 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' C' ' 68' ' ' ARG . 54.5 t -59.29 -44.91 93.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 C-N-CA 119.453 -0.899 . . . . 1.0 110.189 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.51 -44.87 63.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.966 0.412 . . . . 1.0 110.764 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -63.33 -35.27 79.82 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.955 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.93 -52.45 64.98 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.828 -0.349 . . . . 1.0 111.671 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.27 -43.55 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-O 120.773 0.321 . . . . 1.0 111.175 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.553 ' HG3' HG22 ' C' ' 54' ' ' THR . 19.1 ttp -59.62 -43.73 93.69 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 1.0 111.179 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 56.6 tttm -63.47 -42.49 98.59 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.583 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.482 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.14 -39.78 95.68 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.467 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.436 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.17 -44.56 93.77 Favored Glycine 0 CA--C 1.524 0.604 0 C-N-CA 121.203 -0.522 . . . . 1.0 111.917 -179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.1 mt -61.94 -43.12 97.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.676 0.274 . . . . 1.0 110.736 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.0 mt-10 -64.63 -39.4 93.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.403 -0.362 . . . . 1.0 111.328 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.482 HG23 ' O ' ' C' ' 77' ' ' ALA . 53.7 t -63.82 -48.72 85.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.735 -0.386 . . . . 1.0 111.405 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -64.18 -41.9 96.9 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.782 -0.367 . . . . 1.0 111.204 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.483 ' O ' HG22 ' C' ' 86' ' ' THR . . . -65.31 -36.0 82.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.859 0.361 . . . . 1.0 110.593 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.512 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.5 tt -61.66 -33.89 74.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.057 -0.519 . . . . 1.0 111.519 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.539 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.0 t -54.29 -4.83 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.374 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.536 ' O ' ' N ' ' C' ' 88' ' ' ALA . 6.0 t -62.73 -39.45 94.13 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.118 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.461 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -40.09 -21.96 0.01 OUTLIER 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.545 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.536 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -101.85 -38.35 7.87 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.215 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' C' ' 86' ' ' THR . 30.9 mt -74.03 -42.14 60.76 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 120.941 0.4 . . . . 1.0 110.888 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -55.73 -32.34 63.27 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.266 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.14 -4.01 45.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.095 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.546 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 87.5 m-20 -59.06 -47.8 83.92 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.753 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.539 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 11.6 p90 -70.15 -29.63 66.59 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.923 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -61.08 -43.16 95.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.152 -0.476 . . . . 1.0 111.674 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' C' ' 98' ' ' GLU . 95.4 mtt180 -58.7 -23.07 58.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.589 -0.278 . . . . 1.0 111.427 -179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.8 ptt-85 -40.59 -37.18 0.68 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.31 -40.58 93.92 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.375 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' C' ' 95' ' ' ARG . 97.4 mt-10 -66.99 -42.3 85.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.94 0.4 . . . . 1.0 110.457 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.77 -47.52 71.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.44 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -65.31 -42.79 92.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.89 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -109.95 114.12 27.39 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.401 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 105.38 -10.62 46.75 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.499 ' ND1' ' OXT' ' C' ' 103' ' ' HIS . 59.0 t-80 . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.984 -1.008 . . . . 1.0 110.588 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 86.9 p . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.385 -0.598 . . . . 1.0 109.385 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -50.0 -92.48 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.508 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -158.78 -43.77 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.867 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -79.68 -20.15 47.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.811 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.27 -35.71 81.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 1.0 110.563 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.08 -40.93 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.51 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -66.53 -43.91 83.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 1.0 109.965 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . 0.492 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.48 -38.38 89.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.832 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 68.8 tp60 -64.45 -41.0 96.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.407 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.4 -38.46 89.73 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.733 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -28.66 65.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.095 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -62.69 -40.98 98.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 1.0 110.952 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.449 ' OE1' ' O ' ' D' ' 9' ' ' GLN . 58.2 mp0 -66.32 -33.73 76.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.547 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -62.08 -37.79 86.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.457 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.418 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.0 tp -62.81 -41.68 99.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.929 0.395 . . . . 1.0 110.458 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -61.78 -34.76 76.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.144 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttmt -61.86 -44.0 97.71 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.835 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 88.9 t -64.08 -36.13 75.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.885 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' D' ' 52' ' ' ALA . 91.2 mt -60.88 -42.16 97.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.79 -0.448 . . . . 1.0 109.79 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -66.21 -47.73 72.9 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.271 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -66.77 -36.84 83.35 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.665 -0.414 . . . . 1.0 109.894 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.37 -29.07 64.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.764 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.434 ' O ' HG23 ' D' ' 27' ' ' VAL . 69.2 m -59.12 -45.85 89.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.997 -179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.46 ' HG3' ' N ' ' D' ' 25' ' ' LYS . 13.5 ptpt -66.59 -39.12 88.26 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.546 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.46 ' N ' ' HG3' ' D' ' 24' ' ' LYS . 98.2 mttt -62.05 -45.34 93.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.611 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.77 92.96 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.715 -0.394 . . . . 1.0 110.433 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 23' ' ' SER . 90.1 t -65.6 -45.77 91.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.264 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -69.46 -42.49 74.82 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 115.841 -0.618 . . . . 1.0 110.575 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.81 91.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.631 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.455 ' OE1' ' CG2' ' D' ' 39' ' ' ILE . 11.8 tm-20 -67.2 -39.76 86.37 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.45 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 5.9 tpp85 -61.39 115.64 4.02 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.841 0.353 . . . . 1.0 110.652 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.98 -13.69 57.45 Favored Glycine 0 N--CA 1.461 0.315 0 N-CA-C 111.013 -0.835 . . . . 1.0 111.013 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.22 111.53 55.32 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.208 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.27 149.26 35.38 Favored 'Trans proline' 0 N--CA 1.492 1.387 0 C-N-CA 121.915 1.743 . . . . 1.0 112.688 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.76 1.69 73.21 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -87.73 164.32 16.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.713 0.292 . . . . 1.0 110.478 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . 0.451 ' HB3' ' CE1' ' D' ' 61' ' ' TYR . . . -145.98 84.56 1.66 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.433 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.448 HD23 ' C ' ' D' ' 38' ' ' LEU . 3.5 tt -173.94 79.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.233 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.471 ' O ' ' CB ' ' D' ' 40' ' ' SER . 10.1 pt -127.48 164.65 28.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 121.015 0.436 . . . . 1.0 110.606 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 81.24 123.51 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.438 -179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.59 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 54.0 m-85 -59.57 -47.07 98.54 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.953 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.59 -33.61 98.26 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.572 1.515 . . . . 1.0 112.267 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -91.7 -29.38 16.88 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.532 -0.304 . . . . 1.0 111.049 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.75 -40.02 94.61 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.684 0.278 . . . . 1.0 110.855 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.488 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.5 tt -63.36 -32.17 55.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.154 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.488 ' HE3' HG23 ' D' ' 45' ' ' ILE . 0.3 OUTLIER -59.72 -46.63 88.53 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 1.0 109.884 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' D' ' 51' ' ' THR . 0.7 OUTLIER -67.29 -40.01 86.05 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.466 -0.493 . . . . 1.0 110.037 178.366 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.466 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 4.3 t -56.72 -40.0 74.89 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.459 -178.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.79 -48.64 87.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.495 -0.32 . . . . 1.0 110.789 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.54 -31.63 71.86 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 120.635 -0.426 . . . . 1.0 109.911 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' D' ' 47' ' ' TRP . 87.9 m -64.29 -45.17 89.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.572 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.93 -25.98 65.58 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.599 -0.441 . . . . 1.0 110.16 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 9.3 p -88.37 6.08 39.05 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 1.0 110.324 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.02 67.75 0.54 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.233 -0.439 . . . . 1.0 111.203 179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 m -135.16 -40.24 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.609 -0.269 . . . . 1.0 110.432 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.43 78.51 0.09 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.506 -1.037 . . . . 1.0 110.506 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.71 -44.65 96.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 1.0 110.629 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.63 -0.35 3.05 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.71 -0.956 . . . . 1.0 110.71 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.47 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 97.5 m-20 -56.8 -50.38 72.54 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.347 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 -130.95 140.78 50.21 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.496 -0.557 . . . . 1.0 109.496 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' D' ' 61' ' ' TYR . 21.3 p90 -130.47 105.25 15.95 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.786 -179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.65 154.29 68.35 Favored 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.966 1.777 . . . . 1.0 112.258 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 13.8 m -108.08 -162.67 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.248 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.412 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 55.1 m -87.77 -20.96 25.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.597 -0.274 . . . . 1.0 110.732 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -77.55 -13.59 59.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.665 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.411 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.8 OUTLIER -103.75 28.26 6.76 Favored 'General case' 0 C--O 1.263 1.809 0 CA-C-O 124.293 1.997 . . . . 1.0 108.521 178.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.708 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.84 60.47 4.9 Favored Glycine 0 C--O 1.211 -1.285 0 CA-C-N 113.831 -1.531 . . . . 1.0 109.761 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.49 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 42.5 ttm180 -26.93 -28.71 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 117.351 0.576 . . . . 1.0 111.046 -178.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 64.0 mttm -57.33 -15.14 5.61 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.637 -0.71 . . . . 1.0 109.188 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.653 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.3 t -60.73 -47.99 90.7 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 C-N-CA 119.417 -0.913 . . . . 1.0 109.388 179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . 0.545 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -65.63 -48.69 71.37 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.876 178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -42.87 -59.33 2.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.883 -0.598 . . . . 1.0 111.338 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -48.93 -39.51 26.54 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.717 0.266 . . . . 1.0 111.717 -178.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 85.0 t -62.23 -42.93 97.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.529 -0.468 . . . . 1.0 111.614 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.545 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 2.6 mpp? -59.02 -40.03 83.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.925 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.76 -39.5 88.97 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.575 -0.45 . . . . 1.0 110.29 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.472 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.55 -40.28 96.58 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.044 -0.663 . . . . 1.0 110.716 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -73.29 -44.46 34.5 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.36 -44.23 98.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 121.076 -0.25 . . . . 1.0 111.397 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.94 -44.02 86.3 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.767 -0.373 . . . . 1.0 111.374 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.472 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.2 t -63.95 -48.55 85.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.464 -0.334 . . . . 1.0 111.464 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -72.93 -15.9 61.56 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.846 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.412 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -95.57 -25.96 15.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 1.0 110.22 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -64.92 -42.33 94.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.487 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.492 HG12 ' HB1' ' D' ' 8' ' ' ALA . 15.0 m -58.7 -18.73 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.015 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 41.2 m -36.95 -29.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.998 0.427 . . . . 1.0 110.488 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.555 ' O ' HG22 ' D' ' 91' ' ' THR . . . -58.94 -62.43 1.89 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.727 -0.67 . . . . 1.0 110.715 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -53.99 -37.38 63.93 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.169 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 83' ' ' ALA . 4.2 mm? -66.03 -37.42 85.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.929 -0.578 . . . . 1.0 109.759 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.563 ' C ' ' H ' ' D' ' 92' ' ' ASP . . . -66.0 -66.13 0.59 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.626 -179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.802 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.4 OUTLIER -49.18 -4.98 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.879 179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.563 ' H ' ' C ' ' D' ' 90' ' ' ALA . 25.9 t0 -67.22 -21.21 65.76 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.549 0.214 . . . . 1.0 111.356 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.505 ' CD1' ' C ' ' D' ' 93' ' ' PHE . 2.3 p90 -77.41 -18.21 57.47 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.874 0.369 . . . . 1.0 111.194 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.802 HG22 ' O ' ' D' ' 91' ' ' THR . 7.7 m -60.41 -40.05 82.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.935 -0.575 . . . . 1.0 111.576 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.432 ' N ' HG23 ' D' ' 94' ' ' VAL . 99.8 mtt180 -49.69 -22.79 1.46 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.625 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 mtm105 -60.9 -41.97 97.11 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.138 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -92.06 -34.68 14.29 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.889 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . 0.56 ' O ' ' N ' ' D' ' 100' ' ' ARG . 80.0 mm-40 -94.6 -176.1 3.8 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 109.937 -0.394 . . . . 1.0 109.937 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 58.94 -71.7 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.65 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.56 ' N ' ' O ' ' D' ' 98' ' ' GLU . 77.5 ttt-85 -58.11 -43.65 87.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.222 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -119.49 108.28 14.34 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.285 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' D' ' 103' ' ' HIS . . . 104.52 -4.02 43.25 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.315 -0.714 . . . . 1.0 111.315 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . 0.529 ' CG ' ' O ' ' D' ' 102' ' ' GLY . 26.5 p80 . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.074 -0.965 . . . . 1.0 110.921 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.497 ' C ' ' H ' ' A' ' 3' ' ' ASP . 29.8 t . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 4' ' ' HIS . . . 51.88 8.62 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.545 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 1' ' ' SER . 98.2 m-20 55.01 30.33 13.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.52 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.637 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 7.6 p80 -162.0 -37.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.925 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.637 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 44.1 tt0 -65.56 -42.45 91.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.428 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -64.09 -41.65 97.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.113 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -68.78 -34.24 75.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.253 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.36 -50.76 72.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 17.8 pt20 -67.48 -33.32 74.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.439 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.68 -36.18 82.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.458 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -35.51 77.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.972 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -40.55 94.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.526 -0.306 . . . . 1.0 110.632 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -63.48 -33.57 75.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.933 0.397 . . . . 1.0 110.493 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 18' ' ' VAL . 80.8 tt0 -62.21 -41.43 98.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.359 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.475 HD22 ' HA2' ' A' ' 78' ' ' GLY . 54.4 tp -66.65 -39.47 88.24 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.027 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -49.62 -51.0 40.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.247 -0.433 . . . . 1.0 111.828 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -74.77 -31.27 61.73 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.495 -0.482 . . . . 1.0 112.069 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 14' ' ' GLU . 53.8 t -63.51 -48.22 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 121.088 -0.245 . . . . 1.0 111.588 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pp -69.03 -28.88 66.96 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.197 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -61.2 -46.78 89.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.995 -0.372 . . . . 1.0 109.995 178.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -65.4 -39.51 92.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.143 0.497 . . . . 1.0 109.675 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.3 -35.9 81.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.201 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.51 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 37.2 m -54.25 -40.69 67.99 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.49 -0.559 . . . . 1.0 109.49 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -62.73 -31.72 72.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.064 -0.516 . . . . 1.0 109.885 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.94 -39.3 34.96 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.902 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.58 88.58 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 111.85 0.315 . . . . 1.0 111.85 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.565 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.6 p -61.08 -46.05 97.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.359 -0.536 . . . . 1.0 109.689 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 27' ' ' VAL . 80.5 tt0 -67.19 -42.24 84.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.229 179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.45 -42.38 98.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.847 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.572 ' CG ' ' H ' ' A' ' 37' ' ' ALA . 31.5 tp10 -74.01 -42.62 60.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.592 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 71.1 ttp85 -70.85 126.82 30.64 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.234 0.54 . . . . 1.0 110.819 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.6 -0.48 59.63 Favored Glycine 0 CA--C 1.523 0.589 0 CA-C-N 115.403 -0.817 . . . . 1.0 111.387 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' CB ' HG11 ' A' ' 63' ' ' VAL . . . -103.18 151.78 38.55 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.231 -0.285 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.599 ' O ' HG21 ' A' ' 63' ' ' VAL . 72.6 Cg_endo -75.66 117.27 4.7 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.048 1.832 . . . . 1.0 111.751 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 94.87 20.64 27.99 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.431 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -39.52 162.49 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.65 0.262 . . . . 1.0 110.629 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' H ' ' CG ' ' A' ' 30' ' ' GLU . . . -136.37 -71.84 0.45 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.725 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.6 pp -87.59 128.27 35.26 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.503 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 40' ' ' SER . 0.1 OUTLIER -132.08 163.12 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.028 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.473 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 0.7 OUTLIER 81.33 153.84 0.12 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.717 0.294 . . . . 1.0 110.684 -179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.498 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 13.3 t80 -83.15 -50.52 0.7 Allowed Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 116.167 -0.47 . . . . 1.0 111.817 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.24 -28.66 87.33 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 121.421 1.414 . . . . 1.0 112.541 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.52 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 25.1 m-20 -90.25 -28.94 18.49 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.87 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -64.2 -36.67 84.81 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.86 0.362 . . . . 1.0 110.333 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 tt -62.3 -37.97 79.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.287 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.58 -47.81 81.06 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.816 -0.439 . . . . 1.0 109.816 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.446 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -66.09 -39.06 89.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.771 -0.455 . . . . 1.0 109.771 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.51 ' HG ' ' CB ' ' A' ' 23' ' ' SER . 21.5 m -57.1 -39.77 75.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.858 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 HG21 ' NH2' ' B' ' 68' ' ' ARG . 53.7 t -61.33 -46.84 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.056 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 98.9 mt-10 -65.48 -44.33 87.42 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.739 -0.384 . . . . 1.0 110.395 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.43 ' C ' ' H ' ' A' ' 54' ' ' THR . 3.0 m -62.04 -43.8 98.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.269 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -48.53 -52.17 23.9 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.627 -0.429 . . . . 1.0 110.388 -179.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -86.12 7.6 24.19 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.004 -0.739 . . . . 1.0 109.004 178.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.486 ' O ' ' N ' ' A' ' 56' ' ' GLY . 6.4 p 63.33 -133.9 0.41 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.332 -0.849 . . . . 1.0 110.574 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.485 ' N ' ' OG1' ' A' ' 54' ' ' THR . 47.2 t 64.05 -40.33 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 O-C-N 123.547 0.529 . . . . 1.0 111.582 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 37.06 90.67 0.01 OUTLIER Glycine 0 CA--C 1.529 0.945 0 N-CA-C 111.176 -0.77 . . . . 1.0 111.176 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.505 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 53.8 t80 -60.03 -45.84 91.48 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 1.0 110.462 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.19 7.59 1.09 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.163 -0.775 . . . . 1.0 111.163 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.24 -47.0 86.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.351 . . . . 1.0 110.156 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -146.09 154.46 41.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.07 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.462 ' O ' ' CB ' ' A' ' 37' ' ' ALA . 27.9 p90 -137.83 130.07 16.4 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.574 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.36 154.01 69.93 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 122.12 1.88 . . . . 1.0 112.518 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.794 HG22 ' H ' ' A' ' 64' ' ' THR . 6.2 p -75.74 -141.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.459 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.794 ' H ' HG22 ' A' ' 63' ' ' VAL . 4.7 m -116.42 -39.2 3.39 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.678 0.275 . . . . 1.0 111.099 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 80.2 tt0 -77.67 -11.93 59.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.225 -178.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' HB3' HG12 ' A' ' 63' ' ' VAL . 2.1 pp20? -71.66 23.36 0.05 OUTLIER 'General case' 0 C--O 1.259 1.605 0 CA-C-O 123.933 1.825 . . . . 1.0 109.837 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.36 69.43 1.08 Allowed Glycine 0 N--CA 1.434 -1.462 0 CA-C-O 117.561 -1.688 . . . . 1.0 112.566 175.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' HE ' ' HA ' ' D' ' 46' ' ' TRP . 0.6 OUTLIER -24.39 -32.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 118.974 1.387 . . . . 1.0 110.665 -179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' A' ' 67' ' ' GLY . 64.0 mttp -50.8 -33.72 24.66 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 115.316 -0.856 . . . . 1.0 109.888 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' N ' ' O ' ' A' ' 67' ' ' GLY . 61.2 t -61.84 -49.75 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 119.4 -0.92 . . . . 1.0 110.576 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.41 -46.17 64.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.353 -0.385 . . . . 1.0 111.014 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' OE2' ' CG1' ' D' ' 49' ' ' VAL . 77.5 tt0 -58.23 -38.84 77.61 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.735 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.57 -46.11 77.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.705 -0.398 . . . . 1.0 110.769 -179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.74 -42.24 86.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 120.269 -0.573 . . . . 1.0 111.498 -179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 62.3 mtt -52.94 -44.66 67.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.521 -0.309 . . . . 1.0 110.852 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -64.37 -46.34 83.8 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 1.0 110.398 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.22 -40.04 92.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.656 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.475 ' HA2' HD22 ' A' ' 15' ' ' LEU . . . -65.91 -41.14 95.58 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.598 -1.001 . . . . 1.0 110.598 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.58 -23.83 19.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 122.739 -0.271 . . . . 1.0 111.258 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.1 mm-40 -67.6 -45.72 74.66 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.53 -0.304 . . . . 1.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.44 ' H ' HG22 ' A' ' 81' ' ' VAL . 6.9 m -63.77 -43.99 98.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.837 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD2' ' O ' ' A' ' 78' ' ' GLY . 40.3 m-85 -67.39 -37.28 82.89 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 1.0 111.054 -179.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 86' ' ' THR . . . -63.76 -40.97 97.99 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.825 -0.35 . . . . 1.0 111.046 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.411 ' C ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -63.1 -36.15 82.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.453 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.408 ' O ' HG12 ' A' ' 85' ' ' VAL . 80.8 t -53.56 -15.25 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.942 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.627 HG21 ' HB3' ' D' ' 89' ' ' LEU . 9.8 t -48.42 -38.01 18.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.305 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 91' ' ' THR . . . -49.86 -29.51 8.21 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.473 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.36 29.31 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.396 -0.365 . . . . 1.0 110.788 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -94.41 -58.2 2.27 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.856 0.36 . . . . 1.0 111.0 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.3 -22.98 33.81 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.454 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.465 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -98.28 -4.72 34.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.264 -179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -61.01 -47.17 87.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.233 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.564 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 3.8 p90 -58.07 -44.15 87.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.424 -0.353 . . . . 1.0 111.114 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.564 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 61.7 t -36.66 -26.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.049 -0.523 . . . . 1.0 111.484 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 93' ' ' PHE . 96.5 mtt180 -61.78 -36.13 80.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.988 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -49.04 -32.75 9.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.55 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -61.94 -41.74 98.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -68.12 -42.14 80.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.457 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -68.46 -34.08 75.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.269 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.4 ttp85 -59.02 -43.79 91.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.439 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.44 -37.91 88.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.439 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.57 57.64 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.093 -0.803 . . . . 1.0 111.093 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 117.951 -1.023 . . . . 1.0 110.603 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.417 -0.586 . . . . 1.0 109.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.46 ' CB ' ' NE2' ' B' ' 4' ' ' HIS . . . -80.63 177.19 9.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.647 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.01 -42.86 99.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.053 -179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.708 ' H ' ' CD2' ' B' ' 4' ' ' HIS . 5.3 p80 -71.47 -31.95 67.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 1.0 110.567 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -65.29 -36.36 83.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.85 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -63.65 -39.21 93.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 1.0 110.622 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.4 -45.17 95.46 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.946 -0.391 . . . . 1.0 109.946 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.48 -40.93 85.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.61 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -65.12 -40.12 94.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.5 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -62.52 -38.07 88.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.513 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.21 -35.5 75.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.972 -0.558 . . . . 1.0 111.004 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.66 -36.09 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.38 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.78 -34.45 78.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.128 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.01 -36.92 85.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.699 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.3 tp -63.62 -39.34 94.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.54 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -61.16 -38.41 86.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.978 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -62.27 -39.8 94.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.862 0.363 . . . . 1.0 110.781 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.0 t -61.19 -41.84 91.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.649 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.641 HD21 ' HB2' ' B' ' 52' ' ' ALA . 90.6 mt -59.56 -41.34 89.94 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.608 -0.437 . . . . 1.0 109.933 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -61.81 -50.1 73.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.108 0.48 . . . . 1.0 109.991 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.98 -33.19 75.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.008 179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.1 -38.6 83.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.332 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.0 t -59.85 -46.15 90.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.297 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -67.53 -32.59 73.48 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.475 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -75.59 -50.02 16.79 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.659 -0.417 . . . . 1.0 111.124 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.09 -45.28 95.37 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.467 -179.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.541 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.8 p -62.51 -46.67 95.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.499 -0.48 . . . . 1.0 110.156 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.541 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.0 tm-20 -70.93 -42.16 70.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.91 -0.586 . . . . 1.0 111.155 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.86 -41.9 96.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.398 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.492 ' HG2' ' H ' ' B' ' 38' ' ' LEU . 36.3 tp10 -76.25 -41.51 48.84 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.693 -0.403 . . . . 1.0 110.85 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -63.43 111.18 2.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.971 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.35 -2.8 23.68 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.222 -0.751 . . . . 1.0 111.222 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.2 151.36 37.69 Favored Pre-proline 0 N--CA 1.465 0.311 0 N-CA-C 110.66 -0.126 . . . . 1.0 110.66 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' B' ' 36' ' ' ALA . 92.4 Cg_endo -74.81 146.66 33.77 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 C-N-CA 121.946 1.764 . . . . 1.0 112.63 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 77.15 -24.01 2.12 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.237 -0.745 . . . . 1.0 111.237 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.646 ' O ' ' HB2' ' B' ' 37' ' ' ALA . . . 40.77 -166.54 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 120.606 0.241 . . . . 1.0 110.701 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.646 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 161.85 -6.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.932 0.396 . . . . 1.0 110.117 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.492 ' H ' ' HG2' ' B' ' 30' ' ' GLU . 15.4 tp -154.38 108.89 3.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.246 0.546 . . . . 1.0 110.743 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.48 ' O ' ' CB ' ' B' ' 40' ' ' SER . 36.8 pt -131.84 167.06 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.623 -0.717 . . . . 1.0 109.661 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 0.7 OUTLIER 80.83 127.48 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.0 110.805 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.624 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 9.3 t80 -72.13 -44.97 11.13 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.981 178.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.76 -26.62 80.76 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.609 1.54 . . . . 1.0 112.738 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -94.31 -18.92 21.14 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.696 0.284 . . . . 1.0 110.739 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.91 -39.2 93.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.325 . . . . 1.0 110.664 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.458 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.63 -41.41 88.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.562 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.538 ' CE2' ' O ' ' C' ' 64' ' ' THR . 4.2 t-105 -61.31 -46.14 91.53 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.374 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.505 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 2.8 t90 -63.1 -39.37 94.51 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.005 0.431 . . . . 1.0 110.266 178.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.423 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 6.3 t -62.92 -32.77 74.13 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.643 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 45' ' ' ILE . 42.0 t -58.85 -47.55 89.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.629 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.61 -30.71 69.5 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.441 -0.503 . . . . 1.0 110.797 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 99.0 m -63.33 -46.48 86.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 1.0 111.432 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -62.48 -35.96 81.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.503 -0.317 . . . . 1.0 111.301 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.422 ' O ' HG23 ' B' ' 55' ' ' VAL . 76.3 p -76.81 3.47 11.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.82 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' B' ' 53' ' ' THR . 58.8 p 51.24 53.77 12.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.631 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.426 HG21 ' SD ' ' C' ' 75' ' ' MET . 50.4 t -125.41 -60.39 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.544 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.13 84.12 0.02 OUTLIER Glycine 0 CA--C 1.527 0.803 0 N-CA-C 110.939 -0.864 . . . . 1.0 110.939 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -62.24 -41.16 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.302 . . . . 1.0 110.887 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.61 26.91 0.16 Allowed Glycine 0 CA--C 1.526 0.745 0 N-CA-C 110.966 -0.854 . . . . 1.0 110.966 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -61.65 -47.53 84.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.795 0.331 . . . . 1.0 110.72 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.539 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 94.0 mtt-85 -144.1 -169.55 3.14 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.031 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.539 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 52.2 m-85 -159.71 110.28 1.47 Allowed Pre-proline 0 CA--C 1.539 0.544 0 CA-C-O 119.433 -0.317 . . . . 1.0 110.437 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 157.15 62.52 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.416 1.41 . . . . 1.0 112.238 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.965 HG22 ' H ' ' B' ' 64' ' ' THR . 9.9 p -95.06 -165.24 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.152 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.965 ' H ' HG22 ' B' ' 63' ' ' VAL . 52.4 m -91.07 -37.69 13.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.736 0.303 . . . . 1.0 110.602 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 65.5 tt0 -60.79 -31.87 71.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.483 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -75.33 28.04 0.1 Allowed 'General case' 0 C--O 1.262 1.727 0 CA-C-O 124.028 1.87 . . . . 1.0 109.386 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.709 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 45.58 65.48 1.93 Allowed Glycine 0 C--O 1.215 -1.087 0 CA-C-N 113.786 -1.552 . . . . 1.0 111.31 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.509 ' NH2' HG21 ' A' ' 49' ' ' VAL . 59.5 ttp85 -24.58 -33.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 117.906 0.853 . . . . 1.0 110.572 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.709 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.2 mmtt -46.2 -22.59 0.25 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 108.931 -0.766 . . . . 1.0 108.931 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 69.6 t -61.8 -44.85 99.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 C-N-CA 119.517 -0.873 . . . . 1.0 109.585 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.524 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -72.08 -51.0 23.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.733 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -55.29 -40.25 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.59 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -59.0 -45.79 89.78 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.942 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 84.7 t -66.98 -44.78 88.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.841 -0.344 . . . . 1.0 111.346 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.524 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.4 mpp? -63.19 -41.45 99.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.35 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.9 tttp -63.97 -42.13 97.35 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.445 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.412 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -60.54 -41.12 93.85 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.511 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -65.22 -44.8 93.26 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.305 -0.718 . . . . 1.0 111.305 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.85 -43.84 99.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.881 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.34 -44.86 95.5 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.565 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.412 HG23 ' O ' ' B' ' 77' ' ' ALA . 53.0 t -63.75 -48.04 88.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.138 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.441 ' O ' HG22 ' B' ' 85' ' ' VAL . 27.5 m-85 -71.63 -21.27 61.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.901 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.43 -25.14 17.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.0 110.319 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 6.1 tt -63.5 -40.96 98.44 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.09 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.566 ' O ' ' N ' ' B' ' 87' ' ' ALA . 10.7 m -46.61 -24.65 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.678 ' HA ' HD22 ' B' ' 89' ' ' LEU . 36.9 m -37.44 -24.14 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 121.377 0.608 . . . . 1.0 110.384 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.566 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -56.01 -39.41 71.87 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.712 -0.676 . . . . 1.0 109.727 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.62 -11.18 57.63 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.718 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' B' ' 86' ' ' THR . 5.0 mp -81.76 -4.26 55.91 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.452 -0.573 . . . . 1.0 109.452 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.468 ' CB ' ' CD2' ' A' ' 93' ' ' PHE . . . -94.9 -56.67 2.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.771 -0.649 . . . . 1.0 109.394 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.448 ' H ' HG22 ' B' ' 91' ' ' THR . 0.1 OUTLIER -58.89 -5.78 0.67 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.773 -0.649 . . . . 1.0 110.06 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' B' ' 93' ' ' PHE . 36.6 p-10 -61.35 -50.4 73.06 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.157 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.513 ' N ' ' OD1' ' B' ' 92' ' ' ASP . 5.3 p90 -71.55 -8.26 52.85 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.829 0.347 . . . . 1.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 97.1 t -90.11 -26.09 5.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.378 -0.374 . . . . 1.0 111.417 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 42.6 ttm180 -58.53 -42.61 88.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.58 -0.282 . . . . 1.0 111.432 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -40.99 -38.03 0.91 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 120.907 0.384 . . . . 1.0 110.201 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' B' ' 99' ' ' GLU . 97.4 mt-10 -72.21 -167.54 0.33 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.35 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 56.87 -76.75 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.91 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' B' ' 97' ' ' GLU . 1.1 pp20? -52.06 -19.36 1.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.613 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -60.59 -44.89 95.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.347 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -99.13 -2.34 37.17 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.399 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.59 16.66 77.26 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.123 -0.791 . . . . 1.0 111.123 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.426 ' OXT' ' ND1' ' B' ' 103' ' ' HIS . 59.0 t-80 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 117.925 -1.036 . . . . 1.0 110.569 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . 0.582 ' O ' ' HB3' ' C' ' 2' ' ' ALA . 38.8 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.702 ' HB1' ' ND1' ' C' ' 4' ' ' HIS . . . 75.18 -31.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.454 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' C' ' 1' ' ' SER . 99.0 m-20 56.61 36.83 28.21 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.736 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.702 ' ND1' ' HB1' ' C' ' 2' ' ' ALA . 5.8 p-80 -149.02 -47.99 0.14 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.705 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.646 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 31.5 tp10 -69.37 -36.42 76.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.885 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -64.25 -39.16 93.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.184 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 -61.34 -45.68 93.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.08 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.23 -39.56 89.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.617 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 12.0 tp-100 -65.02 -37.84 88.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.26 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -60.76 -41.62 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.166 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.69 -37.54 87.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.093 -0.503 . . . . 1.0 111.13 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -66.17 -34.94 79.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.038 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.23 -37.14 86.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.773 0.32 . . . . 1.0 110.937 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.29 -36.33 83.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.851 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' C' ' 78' ' ' GLY . 48.3 tp -62.5 -40.67 97.45 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.342 . . . . 1.0 110.571 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -60.45 -39.72 88.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.1 -38.87 90.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.817 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 87.2 t -63.72 -36.22 75.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.644 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.656 HD21 ' HB2' ' C' ' 52' ' ' ALA . 94.9 mt -59.99 -41.66 92.54 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.136 -179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -60.98 -46.36 91.04 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.653 -0.499 . . . . 1.0 109.653 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -68.3 -35.36 77.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 1.0 109.994 179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -59.76 -38.9 83.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.584 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 15.7 m -60.78 -47.85 84.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.291 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmmm? -67.86 -36.75 80.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.443 179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -78.55 -22.57 47.04 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.11 -0.496 . . . . 1.0 110.502 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -84.52 -44.7 13.34 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.251 0.344 . . . . 1.0 111.309 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.557 HG13 ' N ' ' C' ' 28' ' ' GLU . 8.4 p -61.99 -45.95 97.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.1 0.476 . . . . 1.0 109.891 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.557 ' N ' HG13 ' C' ' 27' ' ' VAL . 2.9 pp20? -66.22 -31.39 72.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.613 -0.721 . . . . 1.0 110.643 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' C' ' 26' ' ' ALA . . . -49.28 -50.95 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.577 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' C' ' 32' ' ' GLY . 80.4 mm-40 -68.37 -37.66 80.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.69 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -57.34 87.58 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.803 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' C' ' 30' ' ' GLU . . . 127.82 -13.06 6.48 Favored Glycine 0 N--CA 1.466 0.679 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.8 150.95 39.77 Favored Pre-proline 0 CA--C 1.535 0.39 0 N-CA-C 110.283 -0.266 . . . . 1.0 110.283 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.777 ' O ' HG21 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.77 155.93 39.53 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 122.097 1.864 . . . . 1.0 112.096 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . 0.411 ' O ' ' N ' ' C' ' 37' ' ' ALA . . . 90.6 -17.4 54.73 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.167 -0.773 . . . . 1.0 111.167 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.633 ' O ' ' HB3' ' C' ' 37' ' ' ALA . . . 40.79 -96.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.656 0.265 . . . . 1.0 110.949 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' C' ' 36' ' ' ALA . . . 80.46 -73.63 0.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.789 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -101.06 122.16 43.07 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 10.9 tt -149.84 4.75 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.03 0.443 . . . . 1.0 110.22 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 1.2 t -94.24 133.39 37.82 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.61 . . . . 1.0 110.883 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.495 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 26.5 m-85 -75.04 -53.51 2.87 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 1.0 110.77 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.6 Cg_endo -59.41 -28.55 87.84 Favored 'Trans proline' 0 N--CA 1.498 1.786 0 C-N-CA 121.617 1.544 . . . . 1.0 112.246 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -89.59 -18.94 25.59 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.089 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.84 -38.86 89.77 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.829 -0.348 . . . . 1.0 110.472 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.8 tt -66.74 -39.8 84.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.299 -0.41 . . . . 1.0 110.698 179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -45.51 92.69 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.472 -0.331 . . . . 1.0 110.252 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.508 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.6 t90 -64.62 -39.89 94.51 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.188 178.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.43 ' O ' HD22 ' C' ' 19' ' ' LEU . 91.1 p -59.26 -33.3 70.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.149 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.4 -48.04 90.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.673 -0.411 . . . . 1.0 111.286 -179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -73.7 -23.16 59.77 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.456 -0.498 . . . . 1.0 110.992 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 70.8 m -64.12 -45.6 87.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.453 -0.34 . . . . 1.0 111.519 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.656 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.02 -34.29 73.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.419 -0.355 . . . . 1.0 110.848 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.415 ' OG1' HG23 ' C' ' 55' ' ' VAL . 68.2 p -82.38 1.28 37.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.927 0.394 . . . . 1.0 110.003 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.5 p 55.61 11.09 0.58 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.899 -0.591 . . . . 1.0 110.778 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' D' ' 75' ' ' MET . 79.6 t -64.37 -46.18 93.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.956 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 43.09 59.33 3.43 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.615 -0.994 . . . . 1.0 110.615 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 7.9 t80 -61.0 -47.21 87.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.81 0.338 . . . . 1.0 110.599 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.539 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 169.73 -97.86 0.13 Allowed Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.65 -0.98 . . . . 1.0 110.65 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 53.9 t0 44.92 -87.71 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.766 0.317 . . . . 1.0 110.782 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.539 ' N ' ' O ' ' C' ' 58' ' ' GLY . 96.9 mtt-85 -124.01 153.13 41.76 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 109.414 -0.587 . . . . 1.0 109.414 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.522 ' O ' ' CD1' ' C' ' 61' ' ' TYR . 43.8 p90 -143.48 133.66 12.05 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 120.812 -0.355 . . . . 1.0 110.342 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.02 162.18 43.57 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 121.857 1.705 . . . . 1.0 112.413 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.805 HG13 ' H ' ' C' ' 64' ' ' THR . 7.2 p -83.58 -116.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.658 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.805 ' H ' HG13 ' C' ' 63' ' ' VAL . 54.8 m -116.78 -84.0 0.64 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.443 -0.344 . . . . 1.0 110.443 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -43.92 125.9 4.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.122 -0.49 . . . . 1.0 109.914 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 0.2 OUTLIER 57.35 -104.46 0.22 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.134 -0.691 . . . . 1.0 109.134 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.69 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.476 1.349 0 O-C-N 124.431 1.082 . . . . 1.0 114.901 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 54.1 ttm-85 -87.21 -46.07 10.07 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.939 0.495 . . . . 1.0 110.773 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.55 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.8 tttm -54.36 -40.19 67.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.693 -0.685 . . . . 1.0 109.244 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 77.3 t -65.13 -44.82 95.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.056 -0.657 . . . . 1.0 110.308 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.61 -37.2 86.43 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.946 0.403 . . . . 1.0 110.352 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -54.95 -42.4 72.3 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.873 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -64.93 -40.18 94.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.493 -0.322 . . . . 1.0 111.571 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 98.4 t -64.07 -43.91 97.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.748 0.309 . . . . 1.0 111.349 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.426 ' SD ' HG21 ' B' ' 55' ' ' VAL . 59.8 mtt -54.0 -44.72 71.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.887 -179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -63.65 -38.77 92.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.796 0.331 . . . . 1.0 110.533 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.51 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -62.1 -25.03 67.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.586 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -90.46 -39.42 5.96 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.944 -0.462 . . . . 1.0 111.944 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -61.69 -43.47 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 121.082 -0.247 . . . . 1.0 111.004 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -65.9 -37.72 86.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.549 -0.296 . . . . 1.0 111.187 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.51 HG23 ' O ' ' C' ' 77' ' ' ALA . 62.1 t -63.45 -47.54 91.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 121.016 -0.274 . . . . 1.0 111.271 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -67.0 -36.81 82.99 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.809 -0.356 . . . . 1.0 111.306 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' B' ' 89' ' ' LEU . . . -61.82 -39.61 92.38 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.808 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' C' ' 86' ' ' THR . 7.3 tt -65.02 -37.56 88.03 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.267 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.43 HG12 ' O ' ' C' ' 85' ' ' VAL . 78.4 t -45.48 -13.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.991 -0.283 . . . . 1.0 110.7 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.58 ' O ' ' N ' ' C' ' 88' ' ' ALA . 8.9 m -60.29 -41.81 94.15 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.86 -0.422 . . . . 1.0 109.86 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.501 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -39.34 -18.33 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.005 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.58 ' N ' ' O ' ' C' ' 86' ' ' THR . . . -103.36 -36.89 7.86 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.843 -0.428 . . . . 1.0 109.843 178.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.534 ' N ' ' O ' ' C' ' 86' ' ' THR . 36.2 mt -75.41 -43.17 51.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.202 -0.454 . . . . 1.0 111.481 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.572 ' HB2' HG22 ' C' ' 86' ' ' THR . . . -56.58 -34.18 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.012 -0.54 . . . . 1.0 110.762 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.501 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -78.67 -5.27 52.59 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.157 -0.474 . . . . 1.0 109.801 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.488 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 61.9 t0 -56.36 -47.21 79.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.41 -179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.543 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.9 p90 -74.35 -40.06 62.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.953 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 84.8 t -44.87 -31.09 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.825 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -64.12 -22.75 67.06 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.519 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . 0.417 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 47.4 ptt85 -52.95 -42.85 65.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.818 0.342 . . . . 1.0 110.497 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.417 ' N ' ' CG ' ' C' ' 96' ' ' ARG . 79.9 mm-40 -65.27 -43.49 91.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.512 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.65 -34.35 75.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.423 . . . . 1.0 110.404 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -61.83 -26.81 68.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.609 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 60.8 ttp180 -60.15 -44.5 94.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.435 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 26.9 mmt85 -70.83 -21.56 62.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.397 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.89 18.07 66.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.128 -0.789 . . . . 1.0 111.128 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 117.992 -1.004 . . . . 1.0 110.59 179.879 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 57.8 m . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.416 ' HB1' ' HD1' ' D' ' 4' ' ' HIS . . . -68.4 141.86 55.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.566 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' D' ' 4' ' ' HIS . 47.7 p-10 -65.95 -33.25 75.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.055 -0.52 . . . . 1.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.518 ' N ' ' OD1' ' D' ' 3' ' ' ASP . 2.0 m80 -63.99 -45.15 90.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.804 0.335 . . . . 1.0 110.342 -179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -65.66 -39.86 91.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.537 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -60.72 -43.65 97.59 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.455 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -68.78 -40.02 79.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.902 0.382 . . . . 1.0 110.09 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . 0.426 ' HB1' HG22 ' D' ' 85' ' ' VAL . . . -63.15 -46.08 88.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.861 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.436 ' O ' ' OE2' ' D' ' 13' ' ' GLU . 99.1 mm-40 -66.13 -37.49 85.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.566 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.29 -39.5 90.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.749 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.0 -35.54 78.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 1.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -60.33 -39.27 86.48 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.754 0.311 . . . . 1.0 110.837 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.436 ' OE2' ' O ' ' D' ' 9' ' ' GLN . 1.1 mp0 -64.12 -37.19 86.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.805 0.336 . . . . 1.0 110.581 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -64.18 -32.51 74.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.563 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.4 tp -62.4 -41.62 98.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.821 0.343 . . . . 1.0 110.511 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -61.93 -35.53 78.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.993 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . 0.52 ' NZ ' ' OE2' ' D' ' 21' ' ' GLU . 18.0 tttp -60.59 -45.82 92.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.073 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 92.1 t -63.79 -40.99 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.905 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.4 mt -59.66 -40.97 89.51 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.173 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 75.6 mt-10 -62.13 -46.87 87.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.417 -0.356 . . . . 1.0 110.318 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . 0.52 ' OE2' ' NZ ' ' D' ' 17' ' ' LYS . 98.3 mt-10 -68.67 -36.11 78.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.4 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.45 91.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.203 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.23 -44.43 92.33 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.757 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -66.66 -35.74 80.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.98 0.419 . . . . 1.0 110.503 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -74.24 -40.28 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.484 -0.326 . . . . 1.0 111.056 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.77 -44.93 86.52 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 121.035 -0.266 . . . . 1.0 111.044 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.24 -44.94 99.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 120.387 -0.525 . . . . 1.0 110.13 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -70.26 -41.5 73.38 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.856 0.36 . . . . 1.0 110.937 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.75 -38.5 90.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.717 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -60.73 -34.45 74.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.811 0.339 . . . . 1.0 110.219 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . 0.422 ' HG2' HD13 ' D' ' 39' ' ' ILE . 29.0 mmt180 -72.42 137.52 46.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.725 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . 0.406 ' O ' ' OE1' ' D' ' 65' ' ' GLU . . . 96.1 -11.86 67.26 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 111.193 -0.763 . . . . 1.0 111.193 179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.448 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -100.26 149.51 36.11 Favored Pre-proline 0 N--CA 1.465 0.3 0 N-CA-C 110.537 -0.171 . . . . 1.0 110.537 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.455 ' O ' HG11 ' D' ' 63' ' ' VAL . 88.6 Cg_endo -74.49 142.99 30.32 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.907 1.738 . . . . 1.0 112.118 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.55 33.38 81.13 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -55.7 141.23 38.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.918 0.39 . . . . 1.0 110.538 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.0 -32.17 0.31 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.954 -0.566 . . . . 1.0 110.513 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -82.88 31.91 0.43 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.019 0.437 . . . . 1.0 109.895 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' CB ' ' D' ' 40' ' ' SER . 4.5 tp -105.7 131.87 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.054 -0.521 . . . . 1.0 110.538 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.4 p 162.7 -102.95 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.107 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.562 ' CD2' ' O ' ' D' ' 40' ' ' SER . 1.2 m-85 171.44 -65.94 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.31 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.445 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.7 Cg_endo -59.15 -29.25 89.98 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 121.925 1.75 . . . . 1.0 111.526 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -86.92 -24.2 24.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 1.0 111.42 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.37 -45.13 95.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.774 -0.371 . . . . 1.0 110.868 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.426 HG23 ' N ' ' D' ' 46' ' ' TRP . 3.3 tp -67.51 -41.72 86.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.16 179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.572 ' CH2' ' O ' ' A' ' 63' ' ' VAL . 1.1 t90 -60.68 -40.65 92.91 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.122 -179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.438 ' O ' ' O ' ' D' ' 48' ' ' SER . 6.0 t90 -61.86 -39.82 93.19 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 109.89 -0.411 . . . . 1.0 109.89 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.574 ' O ' ' N ' ' D' ' 50' ' ' GLU . 3.3 p -60.59 -145.8 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.402 -0.519 . . . . 1.0 110.002 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.593 ' H ' HD22 ' D' ' 19' ' ' LEU . 28.6 t 48.99 -81.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.13 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.574 ' N ' ' O ' ' D' ' 48' ' ' SER . 15.7 pt-20 -48.02 -29.47 3.52 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 78.4 m -61.94 -43.73 98.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.12 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.692 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.74 -37.6 84.85 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 41.3 p -72.97 0.03 12.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.214 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p 50.85 68.2 0.82 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.987 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 23.9 t -128.04 -52.18 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.607 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.65 77.32 0.11 Allowed Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.826 -0.91 . . . . 1.0 110.826 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.21 -44.35 96.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.748 0.309 . . . . 1.0 110.443 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.42 14.04 0.73 Allowed Glycine 0 CA--C 1.527 0.816 0 N-CA-C 110.927 -0.869 . . . . 1.0 110.927 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -59.74 -51.39 69.98 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.924 -0.31 . . . . 1.0 110.674 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.433 ' O ' ' CE1' ' C' ' 57' ' ' TYR . 34.8 mtt-85 -146.81 140.75 26.02 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.181 -0.674 . . . . 1.0 109.181 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 21.5 p90 -122.22 133.92 24.57 Favored Pre-proline 0 N--CA 1.468 0.463 0 C-N-CA 121.151 -0.22 . . . . 1.0 110.903 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.6 159.4 52.9 Favored 'Trans proline' 0 N--CA 1.497 1.685 0 C-N-CA 122.129 1.886 . . . . 1.0 112.195 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.543 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -84.91 -142.29 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.088 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.543 ' H ' HG12 ' D' ' 63' ' ' VAL . 46.7 m -113.46 -53.05 2.73 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.704 0.288 . . . . 1.0 110.869 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.5 tt0 -62.45 -16.43 55.16 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.863 0.363 . . . . 1.0 110.226 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.415 ' CD ' ' O ' ' D' ' 66' ' ' GLU . 0.6 OUTLIER -74.35 26.41 0.08 Allowed 'General case' 0 C--O 1.264 1.839 0 CA-C-O 123.808 1.766 . . . . 1.0 109.087 178.36 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.722 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.03 61.3 3.54 Favored Glycine 0 C--O 1.211 -1.325 0 N-CA-C 109.386 -1.486 . . . . 1.0 109.386 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 58.2 ttm-85 -26.0 -30.31 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.074 0 O-C-N 124.297 0.645 . . . . 1.0 110.849 -177.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.722 ' N ' ' O ' ' D' ' 67' ' ' GLY . 28.8 mmtp -53.41 -17.37 1.87 Allowed 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.315 -0.857 . . . . 1.0 109.272 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' D' ' 67' ' ' GLY . 55.3 t -61.79 -48.36 89.03 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.506 -0.878 . . . . 1.0 110.0 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.71 -43.16 72.95 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.923 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -60.11 -42.21 94.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 1.0 110.763 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.09 -42.3 76.55 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.079 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 84.3 t -65.72 -44.64 93.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.624 -0.43 . . . . 1.0 111.271 -179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.538 ' SD ' HG21 ' C' ' 55' ' ' VAL . 61.1 mtt -61.0 -42.29 98.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.327 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -63.23 -42.84 99.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.326 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.479 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -64.02 -38.16 90.06 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.396 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.407 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.14 -43.78 92.52 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 111.703 -0.559 . . . . 1.0 111.703 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.31 -43.55 98.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.689 0.281 . . . . 1.0 111.065 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -62.97 -39.62 95.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.501 -0.318 . . . . 1.0 111.182 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.479 HG23 ' O ' ' D' ' 77' ' ' ALA . 50.7 t -61.83 -52.31 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 C-N-CA 120.756 -0.378 . . . . 1.0 111.341 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -70.91 -40.08 72.34 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.645 -0.422 . . . . 1.0 110.562 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.06 -34.94 79.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.456 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.421 ' C ' ' N ' ' D' ' 86' ' ' THR . 5.2 tt -61.12 -40.82 95.2 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.035 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' D' ' 87' ' ' ALA . 97.0 t -50.76 -16.84 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.611 -0.436 . . . . 1.0 109.887 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.421 ' N ' ' C ' ' D' ' 84' ' ' LEU . 23.7 m -42.42 -22.49 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.379 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.488 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.81 -52.97 61.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.574 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.36 -31.05 71.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.88 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.627 ' HB3' HG21 ' A' ' 86' ' ' THR . 16.0 mt -66.93 -40.97 87.76 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.715 -0.675 . . . . 1.0 111.433 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.74 -43.07 94.39 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.032 0.444 . . . . 1.0 110.787 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.88 -4.28 42.93 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.858 -0.61 . . . . 1.0 110.202 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -56.93 -49.27 76.14 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.906 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.542 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 31.5 p90 -79.5 -42.96 24.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.411 -0.359 . . . . 1.0 111.172 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.527 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 60.9 t -40.44 -27.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.366 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' D' ' 93' ' ' PHE . 94.8 mtt-85 -62.78 -36.46 83.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.766 0.317 . . . . 1.0 111.105 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 42.2 ptt85 -47.68 -32.03 5.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.059 0.457 . . . . 1.0 110.285 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.519 ' OE2' ' NH1' ' D' ' 100' ' ' ARG . 45.5 tp10 -78.07 -34.91 50.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.85 -0.614 . . . . 1.0 110.761 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -67.88 -46.32 72.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.915 0.388 . . . . 1.0 110.849 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.42 -17.33 64.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.472 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.519 ' NH1' ' OE2' ' D' ' 97' ' ' GLU . 51.6 ttp180 -58.85 -45.68 89.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.299 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -81.35 -10.87 59.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.509 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.04 17.34 72.45 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.058 -0.817 . . . . 1.0 111.058 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . 0.444 ' O ' ' ND1' ' D' ' 103' ' ' HIS . 64.1 t-80 . . . . . 0 C--O 1.22 -0.471 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.538 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.8 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.32 -72.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.519 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -173.02 -52.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.516 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -77.84 -16.87 57.97 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.453 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.397 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -63.47 -37.93 89.17 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.152 -0.477 . . . . 1.0 110.299 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -70.62 -38.16 73.9 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.194 -0.457 . . . . 1.0 110.53 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.07 -50.92 72.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.792 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -67.67 -35.35 78.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.33 -0.396 . . . . 1.0 110.401 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.57 -36.63 81.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.311 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -35.25 76.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.892 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.61 -37.21 83.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.51 -0.314 . . . . 1.0 110.552 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -63.79 -36.44 83.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.343 -0.39 . . . . 1.0 110.396 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -65.43 -34.47 78.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.422 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.4 tp -62.49 -41.23 98.65 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.593 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -62.04 -38.83 90.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 1.0 111.146 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -61.98 -40.57 96.08 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.967 -0.293 . . . . 1.0 110.992 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.5 -42.48 96.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.605 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.606 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.2 mt -60.57 -40.96 93.57 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.784 -0.366 . . . . 1.0 110.076 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.428 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.5 mt-10 -60.58 -45.11 95.15 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.839 -0.344 . . . . 1.0 110.086 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.72 -37.55 76.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.133 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.8 -37.91 89.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.044 -0.525 . . . . 1.0 110.896 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 77.9 p -59.77 -43.02 94.55 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' O ' ' CG2' ' A' ' 27' ' ' VAL . 14.6 tmtt? -65.09 -36.25 83.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.833 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -76.55 -37.51 56.5 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.635 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.08 93.45 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.621 -178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.417 ' CG2' ' O ' ' A' ' 24' ' ' LYS . 9.1 m -61.24 -43.56 96.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.144 -0.622 . . . . 1.0 110.24 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -75.67 -43.25 48.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.536 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.09 -45.74 90.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.042 -0.526 . . . . 1.0 110.491 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -64.25 -44.13 92.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.764 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -71.36 133.65 46.13 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 120.935 -0.306 . . . . 1.0 110.448 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.58 -17.49 46.29 Favored Glycine 0 CA--C 1.529 0.947 0 N-CA-C 111.251 -0.739 . . . . 1.0 111.251 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.55 159.94 76.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.855 -0.424 . . . . 1.0 109.855 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.37 116.71 4.59 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 121.819 1.679 . . . . 1.0 111.924 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 82.87 -23.77 5.63 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . 32.69 -152.71 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 120.769 0.319 . . . . 1.0 111.376 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 179.64 -53.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.363 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.552 ' O ' ' N ' ' A' ' 40' ' ' SER . 15.0 tp -66.22 -69.02 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.574 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 44.0 pt 36.48 25.63 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.103 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 38' ' ' LEU . 42.0 t -132.14 129.16 39.48 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.882 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 26.8 t80 -80.7 -49.05 1.13 Allowed Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.982 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.36 -31.08 92.3 Favored 'Trans proline' 0 N--CA 1.499 1.849 0 C-N-CA 121.107 1.205 . . . . 1.0 112.569 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -91.17 -6.05 54.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.604 0.24 . . . . 1.0 111.009 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.15 -40.91 95.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.916 0.389 . . . . 1.0 110.331 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.404 ' H ' HG22 ' A' ' 45' ' ' ILE . 7.6 tt -66.21 -40.22 86.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.155 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.59 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.96 -47.11 86.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.381 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.448 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 22.9 t90 -59.02 -39.95 83.48 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.476 -0.565 . . . . 1.0 109.476 179.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.46 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.1 t -76.59 66.84 2.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.698 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 48' ' ' SER . 58.3 t -156.24 -55.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.93 0.395 . . . . 1.0 110.201 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' A' ' 59' ' ' ASP . 15.3 pt-20 -64.4 -32.78 74.54 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.414 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 51' ' ' THR . 0.0 OUTLIER -61.68 -45.95 91.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.034 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.66 -26.87 64.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.354 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 43.7 p -92.9 2.79 56.6 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.531 -0.544 . . . . 1.0 109.531 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.5 p 47.0 76.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.521 -0.763 . . . . 1.0 110.922 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 57' ' ' TYR . 32.6 t -129.07 -59.64 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.7 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 97.14 -56.63 1.25 Allowed Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.604 -0.598 . . . . 1.0 111.604 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.571 ' CD2' ' CE1' ' B' ' 61' ' ' TYR . 2.3 m-85 44.12 -89.8 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.883 0.373 . . . . 1.0 110.522 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . -166.78 -87.61 0.07 OUTLIER Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.643 -0.983 . . . . 1.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' A' ' 50' ' ' GLU . 2.0 p-10 39.41 -105.39 0.05 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.857 0.36 . . . . 1.0 110.626 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.728 HH21 HH22 ' B' ' 68' ' ' ARG . 0.8 OUTLIER -116.96 -175.21 2.73 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.65 179.75 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -170.32 134.23 1.09 Allowed Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.378 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.44 156.78 60.84 Favored 'Trans proline' 0 N--CA 1.496 1.668 0 C-N-CA 121.949 1.766 . . . . 1.0 112.454 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.454 ' C ' ' OE1' ' A' ' 66' ' ' GLU . 3.5 t -98.46 -124.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.827 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.44 ' N ' ' OE1' ' A' ' 66' ' ' GLU . 85.3 m -115.4 -40.75 3.37 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 120.592 0.235 . . . . 1.0 111.154 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.661 ' C ' ' H ' ' A' ' 67' ' ' GLY . 79.2 tt0 -67.45 -36.28 80.89 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.741 0.305 . . . . 1.0 110.881 -179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 66' ' ' GLU . 0.1 OUTLIER -66.53 28.27 0.02 OUTLIER 'General case' 0 C--O 1.26 1.623 0 CA-C-O 123.289 1.519 . . . . 1.0 110.182 179.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.73 65.23 1.23 Allowed Glycine 0 C--O 1.212 -1.257 0 CA-C-O 117.567 -1.685 . . . . 1.0 111.437 177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.557 HH12 ' CG ' ' D' ' 59' ' ' ASP . 60.6 ttm-85 -22.62 -35.62 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 118.431 1.115 . . . . 1.0 111.008 -178.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' A' ' 67' ' ' GLY . 29.7 mmtp -48.4 -18.11 0.2 Allowed 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.637 -0.711 . . . . 1.0 109.565 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.5 t -61.31 -47.97 91.07 Favored 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 119.717 -0.793 . . . . 1.0 110.371 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.89 -39.25 69.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.831 0.348 . . . . 1.0 110.846 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -54.65 -42.27 71.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.674 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -63.52 -44.98 92.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.875 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.4 t -64.19 -47.19 91.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 C-N-CA 120.395 -0.522 . . . . 1.0 111.16 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.0 mtm -63.43 -42.34 98.7 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.39 -42.18 96.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.346 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.68 -39.17 93.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.209 -0.451 . . . . 1.0 110.781 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.42 95.46 Favored Glycine 0 CA--C 1.523 0.567 0 N-CA-C 111.067 -0.813 . . . . 1.0 111.067 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.28 -43.42 98.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.702 0.287 . . . . 1.0 110.531 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.11 -42.09 97.89 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.419 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.0 t -64.45 -50.41 76.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.407 -0.361 . . . . 1.0 111.088 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -70.92 -22.41 62.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.066 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.28 -30.24 22.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.712 0.292 . . . . 1.0 110.781 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.2 tt -63.65 -42.87 98.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.426 -0.352 . . . . 1.0 111.739 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.452 ' C ' ' N ' ' A' ' 87' ' ' ALA . 4.0 m -53.81 -16.36 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.189 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.6 m -43.16 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.268 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.452 ' N ' ' C ' ' A' ' 85' ' ' VAL . . . -63.05 -50.76 69.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.89 -0.596 . . . . 1.0 110.643 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.35 -38.05 88.93 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.59 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 89' ' ' LEU . 3.8 mm? -65.13 -39.0 92.43 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.535 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.489 ' O ' ' CE1' ' A' ' 93' ' ' PHE . . . -56.4 -47.46 78.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.033 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -74.83 -3.7 33.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.683 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.497 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 50.2 t0 -56.82 -47.86 79.33 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.112 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.514 ' CG ' ' N ' ' A' ' 94' ' ' VAL . 22.9 p90 -78.72 -44.04 24.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.827 0.346 . . . . 1.0 111.485 -179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.514 ' N ' ' CG ' ' A' ' 93' ' ' PHE . 93.1 t -41.05 -25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.383 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 93' ' ' PHE . 11.1 tpt85 -58.82 -33.6 70.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.938 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -61.04 -23.05 65.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.655 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -63.69 -37.79 88.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.945 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -67.1 -36.83 82.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.558 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -63.76 -34.68 78.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.369 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -59.9 -44.23 94.38 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.343 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -92.78 -3.87 54.02 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.431 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.21 21.11 76.45 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.22 -0.752 . . . . 1.0 111.22 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.6 t60 . . . . . 0 C--O 1.22 -0.454 0 CA-C-O 117.989 -1.005 . . . . 1.0 110.57 -179.907 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 37.3 p . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.376 -0.602 . . . . 1.0 109.376 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.413 ' CB ' ' NE2' ' B' ' 4' ' ' HIS . . . -156.43 169.58 24.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.652 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -64.16 -36.98 85.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.988 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.677 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 5.8 p80 -79.01 -31.36 44.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.566 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -66.27 -37.73 86.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.931 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 18.2 mmm180 -63.15 -40.18 96.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.706 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -65.66 -41.98 91.91 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.82 -0.437 . . . . 1.0 109.82 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.66 92.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.827 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.49 -40.56 93.22 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.46 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.11 -38.84 92.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.486 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.27 -35.69 78.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.996 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -63.32 -35.68 81.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.645 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -64.74 -38.56 91.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 1.0 110.188 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -63.2 -34.03 76.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.248 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.7 tp -62.99 -37.91 89.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.276 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 77.6 mm-40 -65.57 -31.01 71.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.832 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.81 -47.64 82.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.529 -0.305 . . . . 1.0 111.378 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.418 ' H ' HG22 ' B' ' 18' ' ' VAL . 15.4 m -68.63 -31.38 50.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.089 -179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.772 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.6 mt -61.06 -41.84 97.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.632 -0.507 . . . . 1.0 109.632 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -63.94 -47.58 79.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.029 0.442 . . . . 1.0 109.834 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -67.46 -34.36 77.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.867 -0.606 . . . . 1.0 109.826 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.38 -40.12 89.7 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.139 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -60.76 -35.57 76.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.043 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.456 ' O ' ' N ' ' B' ' 27' ' ' VAL . 44.9 tptt -65.08 -82.29 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.319 -0.552 . . . . 1.0 110.623 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -39.92 -28.02 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.611 0.243 . . . . 1.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' B' ' 24' ' ' LYS . . . -62.55 -41.06 98.66 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.405 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.456 ' N ' ' O ' ' B' ' 24' ' ' LYS . 1.4 p -67.23 -41.5 86.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-O 121.09 0.472 . . . . 1.0 110.46 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.42 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 74.4 mm-40 -70.95 -40.3 72.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.594 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.44 ' O ' ' OE1' ' B' ' 66' ' ' GLU . . . -71.96 58.64 0.35 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 1.0 109.906 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' B' ' 32' ' ' GLY . 0.0 OUTLIER 170.78 -16.84 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.004 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 23.1 tpt85 -68.11 56.38 0.07 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 120.855 -0.338 . . . . 1.0 111.442 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 130.8 31.28 0.55 Allowed Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.734 -0.547 . . . . 1.0 111.734 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 149.56 38.04 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.909 -0.404 . . . . 1.0 109.909 178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.72 134.38 16.58 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 121.902 1.735 . . . . 1.0 112.061 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.28 25.61 73.56 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.255 -0.738 . . . . 1.0 111.255 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.31 140.72 57.31 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.42 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.35 -31.34 8.23 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.637 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.424 ' O ' ' CD ' ' B' ' 30' ' ' GLU . 40.1 tp -101.56 112.75 25.4 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.471 -0.332 . . . . 1.0 110.247 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.421 ' O ' ' OG ' ' B' ' 40' ' ' SER . 5.9 pt -145.11 84.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.29 -0.414 . . . . 1.0 109.89 179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.553 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 62.9 m -168.73 -117.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.081 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.553 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.4 m-85 -176.09 -64.17 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.084 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.435 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 22.6 Cg_endo -59.03 -29.33 90.35 Favored 'Trans proline' 0 N--CA 1.498 1.756 0 C-N-CA 122.147 1.898 . . . . 1.0 112.216 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -85.06 -8.2 58.78 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.658 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.09 86.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.965 0.412 . . . . 1.0 110.396 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.423 HG22 ' H ' ' B' ' 45' ' ' ILE . 6.5 tt -66.86 -38.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.037 -0.528 . . . . 1.0 110.696 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -60.05 -47.51 85.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.27 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.422 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.6 t90 -63.27 -42.54 99.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 1.0 110.395 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.425 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.4 m -57.39 -39.88 77.01 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.119 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -59.65 -48.15 88.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.833 0.309 . . . . 1.0 111.833 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.421 ' OE1' ' NH1' ' C' ' 68' ' ' ARG . 18.1 pt-20 -76.13 -22.73 55.14 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.989 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.422 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 87.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.41 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.772 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.2 -24.51 55.01 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.286 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.517 HG21 ' OE2' ' C' ' 72' ' ' GLU . 37.9 p -83.76 4.26 29.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.678 0.275 . . . . 1.0 110.762 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p 54.28 7.43 0.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.586 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' B' ' 53' ' ' THR . 53.8 t -62.99 -47.09 94.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.717 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.48 68.09 0.48 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.763 -0.935 . . . . 1.0 110.763 -179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' C' ' 60' ' ' ARG . 9.9 t80 -59.8 -46.38 89.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.767 0.318 . . . . 1.0 110.678 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 149.66 -11.06 0.96 Allowed Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.504 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 84.9 m-20 -41.63 -83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.834 0.35 . . . . 1.0 110.866 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -119.83 151.8 38.27 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.031 -0.531 . . . . 1.0 109.889 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.571 ' CE1' ' CD2' ' A' ' 57' ' ' TYR . 47.8 t80 -160.8 125.79 2.17 Favored Pre-proline 0 CA--C 1.536 0.424 0 N-CA-C 110.089 -0.337 . . . . 1.0 110.089 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.11 159.23 53.88 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 121.533 1.489 . . . . 1.0 112.531 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 34.8 m -107.69 -166.25 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.887 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.59 HG22 ' CD1' ' A' ' 46' ' ' TRP . 9.0 p -56.13 -69.45 0.15 Allowed 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.522 -178.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 33.5 tp10 -47.37 -17.06 0.06 Allowed 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.953 -0.388 . . . . 1.0 109.953 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.442 ' N ' ' O ' ' B' ' 64' ' ' THR . 67.5 mt-10 -98.0 28.14 4.14 Favored 'General case' 0 C--O 1.266 1.932 0 CA-C-O 124.303 2.002 . . . . 1.0 109.386 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.732 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.59 62.76 1.31 Allowed Glycine 0 C--O 1.212 -1.235 0 CA-C-N 113.147 -1.842 . . . . 1.0 111.305 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.728 HH22 HH21 ' A' ' 60' ' ' ARG . 43.0 ttm180 -24.89 -30.18 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 118.0 0.9 . . . . 1.0 111.414 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.732 ' N ' ' O ' ' B' ' 67' ' ' GLY . 14.7 mptt -53.19 -14.75 0.72 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.463 -0.94 . . . . 1.0 108.463 176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.618 ' N ' ' O ' ' B' ' 67' ' ' GLY . 42.4 t -61.08 -45.5 98.45 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 119.695 -0.802 . . . . 1.0 109.698 179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.8 -44.0 28.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.278 -0.419 . . . . 1.0 111.302 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -60.48 -40.08 89.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.31 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -61.1 -46.09 92.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.642 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 65.6 t -67.48 -44.77 86.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.836 -0.346 . . . . 1.0 111.337 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.429 ' SD ' HG21 ' A' ' 55' ' ' VAL . 75.6 mtm -61.58 -41.79 97.92 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.614 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -62.86 -40.98 99.14 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.624 -0.43 . . . . 1.0 110.233 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.6 -39.13 90.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.563 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -67.83 -41.68 87.99 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.68 -0.568 . . . . 1.0 111.68 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -61.88 -43.37 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 121.116 -0.233 . . . . 1.0 110.792 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.82 -41.32 91.01 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.543 -0.463 . . . . 1.0 110.231 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 66.2 t -64.67 -50.29 76.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.383 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -66.35 -36.81 83.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.579 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.4 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -65.1 -37.53 87.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.429 -0.35 . . . . 1.0 110.611 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.486 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.1 tt -62.64 -40.86 98.34 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.824 -0.35 . . . . 1.0 110.218 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.451 ' O ' HG12 ' B' ' 85' ' ' VAL . 85.4 t -49.4 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 109.775 -0.454 . . . . 1.0 109.775 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.513 ' O ' ' N ' ' B' ' 89' ' ' LEU . 73.6 m -58.2 -41.59 84.33 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.336 -0.616 . . . . 1.0 109.336 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.497 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -42.93 -19.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.581 179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' B' ' 86' ' ' THR . . . -103.19 -28.51 11.87 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.125 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.513 ' N ' ' O ' ' B' ' 86' ' ' THR . 89.3 mt -69.41 -44.74 70.79 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.027 0.441 . . . . 1.0 111.184 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.565 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.1 -9.05 9.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.435 0.636 . . . . 1.0 109.817 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.419 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.9 OUTLIER -101.73 -5.13 25.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.491 -0.777 . . . . 1.0 109.081 -179.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.445 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 96.0 m-20 -61.36 -46.95 88.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.89 -0.596 . . . . 1.0 111.011 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.565 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 47.8 p90 -79.29 -33.81 43.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.7 t -50.31 -31.71 8.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.335 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -64.23 -21.93 66.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.626 -0.261 . . . . 1.0 111.305 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.439 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 23.9 ptt-85 -51.16 -42.35 60.76 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 1.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.543 ' O ' ' N ' ' B' ' 99' ' ' GLU . 96.3 mt-10 -64.72 -164.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.94 -0.573 . . . . 1.0 110.234 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 57.46 -74.51 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.901 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.543 ' N ' ' O ' ' B' ' 97' ' ' GLU . 97.8 mt-10 -59.78 -42.97 94.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.502 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.8 tmm_? -65.4 -43.62 90.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.805 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -114.66 113.07 23.85 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.01 0.434 . . . . 1.0 110.006 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 112.1 -15.01 25.9 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.004 -0.838 . . . . 1.0 111.004 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 77.9 t60 . . . . . 0 C--O 1.22 -0.5 0 CA-C-O 118.048 -0.977 . . . . 1.0 110.61 179.838 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.554 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -157.14 121.35 4.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.633 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -68.84 -44.64 73.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.691 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.711 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.8 p80 -59.25 -41.63 89.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.059 -0.518 . . . . 1.0 110.804 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.501 ' OE2' ' NH2' ' C' ' 95' ' ' ARG . 97.4 mt-10 -64.43 -42.42 96.03 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.861 -0.336 . . . . 1.0 110.693 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -65.21 -39.25 92.55 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.221 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -66.94 -39.18 87.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.155 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' C' ' 11' ' ' ALA . . . -64.47 -37.41 87.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.404 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . 0.423 ' O ' ' OE1' ' C' ' 12' ' ' GLU . 56.5 tt0 -60.0 -42.5 94.39 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 1.0 110.469 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -64.67 -28.79 69.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.437 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.5 ' HB3' ' O ' ' C' ' 8' ' ' ALA . . . -54.17 -45.42 72.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.957 -0.565 . . . . 1.0 111.324 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . 0.458 ' OE1' ' O ' ' C' ' 8' ' ' ALA . 57.3 mp0 -67.0 -41.22 87.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.849 0.357 . . . . 1.0 110.96 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -62.4 -38.18 88.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.879 0.371 . . . . 1.0 110.43 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -64.98 -31.17 72.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.305 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.99 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.3 tp -62.19 -39.12 91.67 Favored 'General case' 0 C--O 1.224 -0.24 0 C-N-CA 120.89 -0.324 . . . . 1.0 110.441 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.7 -29.81 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.762 -0.375 . . . . 1.0 111.215 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -77.86 -45.19 24.97 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . 0.484 HG23 ' N ' ' C' ' 19' ' ' LEU . 28.1 m -60.72 -46.56 95.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 112.359 0.503 . . . . 1.0 112.359 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.484 ' N ' HG23 ' C' ' 18' ' ' VAL . 3.1 pp -74.95 -26.8 59.87 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.742 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -63.8 -53.93 43.08 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.922 0.392 . . . . 1.0 110.032 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -63.92 -36.34 83.61 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.468 ' CB ' ' CG2' ' C' ' 74' ' ' VAL . . . -66.72 -35.43 80.11 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.5 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.47 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 38.6 m -53.1 -44.43 67.61 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.284 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 16.4 ttmt -63.21 -44.87 94.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 1.0 109.58 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -63.22 -39.28 94.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.792 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -52.38 64.86 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.146 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.406 HG13 ' N ' ' C' ' 28' ' ' GLU . 3.1 p -64.44 -44.91 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-O 121.194 0.521 . . . . 1.0 110.363 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.406 ' N ' HG13 ' C' ' 27' ' ' VAL . 41.0 tp10 -66.19 -35.84 81.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.597 -0.729 . . . . 1.0 110.816 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.55 -43.34 99.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.326 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -90.23 -11.17 41.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.681 -0.236 . . . . 1.0 111.249 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 -58.34 96.9 0.03 OUTLIER 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.604 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.24 5.16 46.74 Favored Glycine 0 N--CA 1.466 0.683 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.55 151.4 68.46 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 109.993 -0.373 . . . . 1.0 109.993 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.91 139.73 22.31 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.977 1.785 . . . . 1.0 112.189 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.55 25.54 63.33 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.241 -0.744 . . . . 1.0 111.241 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.49 140.95 55.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.761 0.315 . . . . 1.0 110.476 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -109.74 -38.52 5.37 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.535 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.541 HD23 ' O ' ' C' ' 38' ' ' LEU . 5.7 tt -88.74 68.48 8.57 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.037 0.446 . . . . 1.0 109.944 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 2.3 pp -92.11 -5.36 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.332 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 72.1 m -75.48 150.98 38.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.889 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.53 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 1.1 t80 -100.83 -61.95 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.98 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' H ' ' C' ' 41' ' ' TYR . 26.6 Cg_endo -59.0 -30.07 92.39 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.782 1.654 . . . . 1.0 112.249 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -84.87 -2.17 57.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.533 -0.303 . . . . 1.0 111.054 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.51 85.3 Favored 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.392 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.43 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.6 tt -66.66 -39.36 83.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.925 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -49.49 75.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.519 -0.309 . . . . 1.0 110.41 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.441 ' O ' ' OE2' ' C' ' 50' ' ' GLU . 3.5 t90 -64.38 -38.79 92.28 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.497 -0.557 . . . . 1.0 109.497 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.47 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 25.2 p -63.2 -36.54 83.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.064 -0.516 . . . . 1.0 111.34 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.2 t -62.39 -48.86 86.35 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 C-N-CA 121.101 -0.24 . . . . 1.0 111.59 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' C' ' 47' ' ' TRP . 2.6 pp20? -71.08 -29.76 65.71 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.77 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.441 ' N ' ' CD ' ' C' ' 50' ' ' GLU . 69.3 m -62.36 -46.52 88.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.364 -0.38 . . . . 1.0 111.315 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.99 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -62.1 -23.69 66.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.809 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.604 ' OG1' HG23 ' C' ' 55' ' ' VAL . 81.1 p -90.64 3.31 54.52 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.212 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 17.4 p 55.5 15.55 1.51 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.92 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.605 HG21 ' SD ' ' D' ' 75' ' ' MET . 72.3 t -63.68 -45.65 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.677 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 40.35 61.86 1.69 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.005 -0.838 . . . . 1.0 111.005 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.87 -45.12 95.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.664 0.269 . . . . 1.0 110.825 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.35 13.97 1.1 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 110.91 -0.876 . . . . 1.0 110.91 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -59.41 -50.58 73.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.921 0.391 . . . . 1.0 110.656 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CE1' ' B' ' 57' ' ' TYR . 96.1 mtt-85 -145.91 167.19 23.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.982 -0.554 . . . . 1.0 109.572 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -143.7 123.03 7.38 Favored Pre-proline 0 CA--C 1.538 0.482 0 C-N-CA 120.685 -0.406 . . . . 1.0 110.823 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -71.15 158.65 54.36 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 121.798 1.665 . . . . 1.0 112.184 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.439 ' H ' ' HG2' ' C' ' 66' ' ' GLU . 2.2 m -98.09 -165.31 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.021 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . . . . . . . . . 24.5 m -94.03 -32.07 13.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.33 . . . . 1.0 110.168 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.557 ' C ' ' H ' ' C' ' 67' ' ' GLY . 10.4 tm-20 -64.05 -32.98 74.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.047 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.439 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -75.67 28.81 0.11 Allowed 'General case' 0 C--O 1.264 1.83 0 CA-C-O 124.378 2.037 . . . . 1.0 110.008 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.733 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.33 65.78 1.77 Allowed Glycine 0 C--O 1.216 -0.976 0 CA-C-N 113.516 -1.674 . . . . 1.0 111.167 177.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.504 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 ttm-85 -24.92 -30.79 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 118.148 0.974 . . . . 1.0 111.392 -178.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.733 ' N ' ' O ' ' C' ' 67' ' ' GLY . 71.8 mmtt -50.08 -31.64 13.68 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 115.675 -0.693 . . . . 1.0 109.476 177.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.461 ' N ' ' O ' ' C' ' 67' ' ' GLY . 73.8 t -64.14 -49.14 82.66 Favored 'Isoleucine or valine' 0 C--N 1.351 0.656 0 C-N-CA 119.139 -1.024 . . . . 1.0 110.6 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.46 -40.25 73.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.866 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . 0.517 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.0 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.943 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.85 -43.47 85.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.954 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.468 ' CG2' ' CB ' ' C' ' 22' ' ' ALA . 70.6 t -64.18 -43.29 97.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 C-N-CA 120.634 -0.426 . . . . 1.0 111.165 -179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 39.6 mtt -55.77 -45.31 78.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.547 -0.297 . . . . 1.0 111.002 -178.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -64.9 -40.83 95.69 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.573 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.19 86.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.866 0.365 . . . . 1.0 110.235 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.05 -42.65 92.13 Favored Glycine 0 CA--C 1.525 0.717 0 CA-C-N 116.076 -0.511 . . . . 1.0 111.91 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.78 -42.77 97.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.71 0.29 . . . . 1.0 110.985 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' C' ' 84' ' ' LEU . 80.9 mm-40 -58.39 -41.29 84.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.338 -0.392 . . . . 1.0 111.244 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -49.35 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.637 -0.425 . . . . 1.0 111.309 -179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -64.93 -35.38 80.98 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.624 -0.431 . . . . 1.0 110.881 -179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -82.63 -28.49 30.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.751 0.31 . . . . 1.0 110.937 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.8 tt -63.5 -42.94 98.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.488 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 17.8 m -61.47 2.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.527 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.535 ' H ' ' C ' ' C' ' 84' ' ' LEU . 23.9 m -62.93 -20.65 65.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.362 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.458 ' O ' ' OG1' ' C' ' 91' ' ' THR . . . -56.72 -61.06 2.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.995 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.1 -39.39 94.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.012 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 80.4 mt -63.62 -43.64 96.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.464 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.19 -23.6 66.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.401 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.529 ' OG1' ' CG ' ' B' ' 93' ' ' PHE . 0.2 OUTLIER -96.44 -3.86 42.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.3 -179.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.448 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 47.2 t0 -60.42 -43.35 96.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.097 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -67.46 -30.1 69.73 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.201 -0.454 . . . . 1.0 111.03 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 71.1 t -59.93 -44.26 94.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.0 111.407 -178.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . 0.501 ' NH2' ' OE2' ' C' ' 5' ' ' GLU . 95.2 mtt-85 -48.04 -21.75 0.51 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.224 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . 0.403 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.2 ptt85 -50.85 -41.28 57.77 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.934 -0.306 . . . . 1.0 110.39 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' C' ' 99' ' ' GLU . 21.1 pt-20 -51.69 149.04 4.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.021 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' C' ' 102' ' ' GLY . 97.1 mt-10 62.74 -60.04 0.13 Allowed 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.826 0.704 . . . . 1.0 110.673 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.0 mt-10 -54.95 -40.16 69.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.453 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -63.53 -44.79 93.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.622 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -82.34 -15.04 54.26 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.67 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' C' ' 98' ' ' GLU . . . 81.74 14.55 77.57 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.92 -0.872 . . . . 1.0 110.92 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.474 ' O ' ' CG ' ' C' ' 103' ' ' HIS . 86.1 t60 . . . . . 0 C--O 1.22 -0.49 0 CA-C-O 117.965 -1.017 . . . . 1.0 110.598 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 63.6 p . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.416 -0.587 . . . . 1.0 109.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.03 -74.27 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.539 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -172.74 -64.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.82 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.621 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 3.2 p80 -59.2 -39.52 82.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.621 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -63.11 -39.09 93.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 1.0 110.619 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 77.8 ttt-85 -61.43 -43.17 99.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.482 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -66.23 -38.3 87.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.297 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.43 -42.75 99.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.799 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -61.52 -42.11 98.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.48 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.29 -39.07 93.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.776 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.2 -36.26 81.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.116 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.97 -39.12 93.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.794 0.33 . . . . 1.0 110.791 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.36 -33.81 76.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.499 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -65.67 -34.84 79.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.795 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.423 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.9 tp -62.09 -42.52 99.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.813 0.34 . . . . 1.0 110.663 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -64.29 -35.88 82.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.257 -0.429 . . . . 1.0 111.115 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -61.74 -41.83 98.17 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.812 0.339 . . . . 1.0 110.99 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 86.9 t -63.61 -39.0 83.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.532 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.516 HD21 ' HB2' ' D' ' 52' ' ' ALA . 95.8 mt -60.16 -40.76 91.05 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.852 -0.425 . . . . 1.0 109.852 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' D' ' 23' ' ' SER . 98.5 mt-10 -61.8 -44.95 95.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.942 0.401 . . . . 1.0 109.965 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.63 -34.84 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.997 0.427 . . . . 1.0 110.02 179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -37.54 87.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.883 -0.599 . . . . 1.0 111.03 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.2 p -59.57 -45.07 92.91 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.773 -0.371 . . . . 1.0 110.876 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -64.11 -54.97 25.56 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.256 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.58 -40.79 96.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.743 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.56 -47.13 80.16 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.834 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.416 ' CG2' ' HB2' ' D' ' 44' ' ' ALA . 72.4 t -62.36 -46.71 95.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 C-N-CA 120.38 -0.528 . . . . 1.0 110.374 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -67.65 -41.94 83.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.08 -41.47 97.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.384 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -69.35 -39.68 77.96 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.794 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -63.32 119.21 9.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.792 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.97 -5.11 49.9 Favored Glycine 0 N--CA 1.465 0.614 0 N-CA-C 111.43 -0.668 . . . . 1.0 111.43 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.42 146.02 30.76 Favored Pre-proline 0 CA--C 1.534 0.33 0 O-C-N 122.749 -0.265 . . . . 1.0 110.519 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' D' ' 63' ' ' VAL . 94.0 Cg_endo -74.76 144.14 30.79 Favored 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.143 1.895 . . . . 1.0 112.377 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 61.63 29.1 71.04 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.46 138.6 57.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.734 0.302 . . . . 1.0 110.614 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.77 -36.44 4.51 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.473 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 16.6 tp -99.28 108.23 20.72 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 110.109 -0.33 . . . . 1.0 110.109 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 17.3 pt -150.94 60.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.789 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 6.4 t -157.81 124.44 4.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.285 -0.416 . . . . 1.0 111.108 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.535 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 34.3 m-85 -53.1 -49.87 85.22 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 116.071 -0.513 . . . . 1.0 111.239 178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.07 -34.99 99.07 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 121.1 1.2 . . . . 1.0 112.382 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -93.4 -8.18 42.5 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.716 0.293 . . . . 1.0 110.669 -179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . 0.416 ' HB2' ' CG2' ' D' ' 27' ' ' VAL . . . -65.88 -45.38 82.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.946 0.403 . . . . 1.0 110.876 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -68.17 -39.68 81.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.926 -0.579 . . . . 1.0 110.603 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -61.56 -47.82 83.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.11 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.415 ' O ' ' N ' ' D' ' 49' ' ' VAL . 6.4 t90 -62.15 -40.21 95.2 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.521 -0.548 . . . . 1.0 109.521 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' D' ' 19' ' ' LEU . 22.7 p -69.65 61.65 0.16 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.191 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.415 ' N ' ' O ' ' D' ' 47' ' ' TRP . 76.8 t -149.01 -57.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.194 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -65.72 -27.08 68.06 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.716 -0.394 . . . . 1.0 110.168 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.445 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -61.17 -47.49 85.95 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.201 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.516 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -56.45 -36.93 69.6 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.298 -0.561 . . . . 1.0 109.671 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.457 ' OG1' HG12 ' D' ' 55' ' ' VAL . 49.4 p -78.75 -12.68 60.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.472 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 6.1 p 60.47 10.4 2.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.023 -0.535 . . . . 1.0 111.069 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.517 HG13 ' N ' ' D' ' 56' ' ' GLY . 12.0 p -67.24 -43.43 88.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.252 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.517 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 57.3 72.61 0.56 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.357 -1.097 . . . . 1.0 110.357 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.448 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.3 OUTLIER -60.24 -46.94 88.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 1.0 110.465 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.0 10.62 1.51 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.557 ' CG ' HH12 ' A' ' 68' ' ' ARG . 53.8 m-20 -58.06 -50.86 71.98 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.488 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -151.02 -166.11 2.45 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.67 -0.493 . . . . 1.0 109.67 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.469 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.7 p90 -172.07 133.44 0.78 Allowed Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 120.483 -0.487 . . . . 1.0 110.831 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -70.48 157.74 58.11 Favored 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.999 1.8 . . . . 1.0 112.428 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.566 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -89.79 -143.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 116.07 -0.514 . . . . 1.0 109.924 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.566 ' H ' HG12 ' D' ' 63' ' ' VAL . 94.8 m -112.09 -41.68 3.91 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.744 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.1 -19.68 65.68 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.9 0.381 . . . . 1.0 110.448 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.414 ' OE2' ' O ' ' D' ' 66' ' ' GLU . 0.1 OUTLIER -77.86 23.67 0.25 Allowed 'General case' 0 C--O 1.266 1.973 0 CA-C-O 123.842 1.782 . . . . 1.0 108.956 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.741 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.85 61.55 3.81 Favored Glycine 0 C--O 1.209 -1.435 0 N-CA-C 109.344 -1.503 . . . . 1.0 109.344 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' D' ' 67' ' ' GLY . 58.0 ttm-85 -26.94 -27.0 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 117.761 0.781 . . . . 1.0 111.214 -177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.741 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.9 tptm -55.85 -27.34 51.17 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 115.305 -0.861 . . . . 1.0 109.107 177.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.611 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.4 t -61.07 -49.42 84.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 C-N-CA 119.649 -0.82 . . . . 1.0 109.942 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.65 -37.05 73.68 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.179 178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.57 -43.83 89.55 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.017 -0.538 . . . . 1.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -61.39 -40.75 95.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.213 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.09 -43.9 97.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 120.609 -0.436 . . . . 1.0 111.196 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.605 ' SD ' HG21 ' C' ' 55' ' ' VAL . 36.9 mtt -60.26 -44.34 95.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.445 -0.343 . . . . 1.0 110.902 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -65.98 -36.77 84.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.478 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.43 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -59.92 -40.28 88.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.586 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.423 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -65.62 -42.76 95.32 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.479 -0.648 . . . . 1.0 111.479 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.64 -43.46 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 121.021 -0.272 . . . . 1.0 111.092 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.18 -41.53 97.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.285 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.43 HG23 ' O ' ' D' ' 77' ' ' ALA . 61.5 t -63.21 -50.25 79.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 120.815 -0.354 . . . . 1.0 111.373 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -67.9 -40.26 83.49 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.756 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.16 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.371 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.3 tt -61.73 -41.18 97.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.268 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 60.2 t -54.2 -17.82 2.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.695 -0.402 . . . . 1.0 109.919 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 56.7 m -47.46 -40.09 17.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.224 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.448 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -53.08 -17.29 1.46 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.671 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.75 -12.62 20.77 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.563 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.51 HD13 ' OD2' ' D' ' 92' ' ' ASP . 3.7 mm? -92.53 -40.8 10.61 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.008 0.432 . . . . 1.0 110.393 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.535 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -57.14 -28.2 62.54 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.618 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.34 -4.36 55.45 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.345 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.51 ' OD2' HD13 ' D' ' 89' ' ' LEU . 89.2 m-20 -59.5 -49.92 75.92 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.907 -0.317 . . . . 1.0 111.145 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.535 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 21.3 p90 -73.47 -38.72 65.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.987 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.3 t -47.92 -27.64 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 1.0 111.161 -179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.472 ' C ' ' H ' ' D' ' 97' ' ' GLU . 94.5 mtt180 -64.73 -22.41 66.98 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.974 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 47.3 ptt85 -54.31 -7.31 0.14 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' D' ' 99' ' ' GLU . 24.1 tp10 -133.53 158.16 43.83 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.093 -0.503 . . . . 1.0 109.831 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 57.36 -76.2 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.422 -0.353 . . . . 1.0 110.721 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.546 ' N ' ' O ' ' D' ' 97' ' ' GLU . 49.0 tp10 -57.01 -28.94 62.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.173 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.427 ' NH2' ' HE ' ' D' ' 101' ' ' ARG . 73.2 ttp85 -59.53 -43.03 93.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.351 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . 0.427 ' HE ' ' NH2' ' D' ' 100' ' ' ARG . 3.2 mpt_? -64.89 -38.22 90.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.401 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.23 20.63 62.21 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . 0.407 ' OXT' ' CG ' ' D' ' 103' ' ' HIS . 85.2 t60 . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.096 -0.955 . . . . 1.0 110.612 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.49 ' CB ' ' NE2' ' A' ' 4' ' ' HIS . . . -81.64 169.81 16.57 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.638 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 3' ' ' ASP . 11.6 p-10 -65.14 -36.64 84.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.595 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.7 ' CD2' HH12 ' D' ' 96' ' ' ARG . 6.4 p80 -75.14 -34.2 61.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.643 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.464 ' OE2' ' NH2' ' A' ' 95' ' ' ARG . 96.2 mt-10 -63.54 -38.4 91.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.528 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -64.66 -39.71 94.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.321 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -50.87 -44.99 59.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.097 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.64 -38.3 88.99 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.262 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -63.82 -45.2 90.64 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.427 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -63.89 -35.85 82.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.048 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -48.33 68.52 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.784 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.65 -42.64 99.18 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.816 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -64.03 -33.91 76.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.158 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -62.81 -34.92 78.29 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.389 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.476 HD13 ' HA2' ' A' ' 78' ' ' GLY . 44.8 tp -62.38 -44.31 96.75 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.63 -0.428 . . . . 1.0 110.773 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -55.29 -40.15 70.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.205 -179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -64.37 -31.62 72.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.787 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.38 -41.98 86.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.868 0.366 . . . . 1.0 110.683 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 19' ' ' LEU . 7.2 mp -60.57 -40.64 92.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.784 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -55.96 -49.67 72.92 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.56 -0.456 . . . . 1.0 109.917 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 21' ' ' GLU . 0.3 OUTLIER -67.49 -37.14 82.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 1.0 109.994 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.61 -38.24 86.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.634 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.643 ' O ' HG23 ' A' ' 27' ' ' VAL . 15.8 m -59.97 -40.96 90.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.37 -61.45 2.57 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.376 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -60.4 -44.21 95.92 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.909 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.93 -45.76 74.87 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.974 -0.29 . . . . 1.0 111.37 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 23' ' ' SER . 92.3 t -62.55 -46.49 96.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.368 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -70.25 -41.89 72.93 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.283 -0.417 . . . . 1.0 111.019 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.15 -41.12 48.47 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.172 -0.467 . . . . 1.0 109.802 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -69.66 -44.87 69.66 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.882 -0.327 . . . . 1.0 111.115 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -51.81 99.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.933 0.396 . . . . 1.0 110.651 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 118.4 -11.89 12.57 Favored Glycine 0 N--CA 1.467 0.72 0 N-CA-C 111.446 -0.661 . . . . 1.0 111.446 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.49 140.26 33.88 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 122.705 -0.291 . . . . 1.0 110.35 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' O ' HG11 ' A' ' 63' ' ' VAL . 94.5 Cg_endo -75.27 144.18 29.09 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.015 1.81 . . . . 1.0 112.478 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 62.16 27.09 68.45 Favored Glycine 0 CA--C 1.523 0.57 0 N-CA-C 111.08 -0.808 . . . . 1.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -65.32 140.77 58.72 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.421 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -121.94 -30.73 4.04 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.402 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 7.0 tt -87.24 122.59 31.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.384 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 40' ' ' SER . 41.0 pt -153.41 163.52 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.237 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.453 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 0.9 OUTLIER 79.96 134.53 0.06 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.79 0.329 . . . . 1.0 110.934 179.658 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.564 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 32.4 t80 -65.79 -44.73 64.35 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.087 -0.506 . . . . 1.0 112.127 179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.3 Cg_endo -60.57 -30.86 91.5 Favored 'Trans proline' 0 N--CA 1.503 2.055 0 C-N-CA 121.562 1.508 . . . . 1.0 112.737 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -91.29 -27.23 18.55 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.706 0.288 . . . . 1.0 110.785 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.91 -38.02 82.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.582 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.423 HG23 ' HE3' ' A' ' 46' ' ' TRP . 7.9 tt -62.84 -38.74 82.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.564 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 64' ' ' THR . 0.7 OUTLIER -65.96 -38.21 87.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.23 -0.441 . . . . 1.0 109.824 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 1.7 t90 -62.71 -42.34 99.6 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.247 178.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.6 p -58.09 -28.38 64.54 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.986 -0.285 . . . . 1.0 110.634 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 84.9 t -63.76 -45.69 96.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.77 0.319 . . . . 1.0 110.419 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 54' ' ' THR . 77.5 mt-10 -80.26 -0.85 38.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.81 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -104.02 -35.51 8.07 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.038 0.447 . . . . 1.0 109.83 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.7 -46.44 82.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.007 -0.542 . . . . 1.0 111.345 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.436 ' O ' ' OG1' ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.92 11.75 17.24 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.175 -0.676 . . . . 1.0 109.175 179.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 56' ' ' GLY . 5.1 p 64.38 -135.11 0.29 Allowed 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.411 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.512 ' N ' ' OG1' ' A' ' 54' ' ' THR . 46.1 t 62.73 -61.27 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 O-C-N 123.595 0.559 . . . . 1.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 54' ' ' THR . . . 50.36 90.92 0.01 OUTLIER Glycine 0 CA--C 1.53 0.976 0 N-CA-C 111.129 -0.788 . . . . 1.0 111.129 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -60.6 -44.13 96.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.726 0.298 . . . . 1.0 110.78 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.79 17.05 0.85 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -60.64 -51.94 67.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.807 0.337 . . . . 1.0 110.772 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.511 ' O ' ' CZ ' ' D' ' 57' ' ' TYR . 94.8 mtt-85 -145.73 139.84 26.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.097 -0.501 . . . . 1.0 109.949 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.536 ' CE2' ' O ' ' A' ' 62' ' ' PRO . 77.8 t80 -130.91 127.71 22.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 110.255 -0.276 . . . . 1.0 110.255 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.536 ' O ' ' CE2' ' A' ' 61' ' ' TYR . 60.6 Cg_endo -70.33 159.92 51.31 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 C-N-CA 121.826 1.684 . . . . 1.0 112.62 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.501 HG12 ' H ' ' A' ' 64' ' ' THR . 2.1 t -83.68 -138.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.361 -0.382 . . . . 1.0 110.21 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.501 ' H ' HG12 ' A' ' 63' ' ' VAL . 51.6 m -114.72 -37.95 4.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.677 0.275 . . . . 1.0 110.997 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.634 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.9 tp10 -64.59 -31.21 72.33 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.935 -0.395 . . . . 1.0 109.935 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.443 ' HG3' ' H ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -70.79 30.54 0.04 OUTLIER 'General case' 0 C--O 1.263 1.786 0 CA-C-O 123.594 1.664 . . . . 1.0 109.952 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.77 64.35 1.25 Allowed Glycine 0 C--O 1.213 -1.196 0 CA-C-N 113.797 -1.547 . . . . 1.0 111.317 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.549 ' NH2' ' OD2' ' D' ' 59' ' ' ASP . 43.0 ttm180 -24.0 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.114 0.957 . . . . 1.0 111.108 -178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.3 mttm -48.86 -18.28 0.26 Allowed 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.752 -0.658 . . . . 1.0 109.442 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.3 t -61.63 -47.83 91.56 Favored 'Isoleucine or valine' 0 C--N 1.351 0.639 0 C-N-CA 119.494 -0.882 . . . . 1.0 110.131 179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.19 64.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.631 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.8 tm-20 -58.92 -41.66 87.84 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.064 -0.517 . . . . 1.0 110.716 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.84 -42.03 96.99 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.051 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.93 -44.47 92.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 120.671 -0.411 . . . . 1.0 110.782 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.2 mtt -54.93 -43.91 73.77 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.748 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 77.5 tttt -62.08 -40.67 96.61 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.356 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.03 -41.64 98.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.901 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.476 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -67.77 -44.06 81.85 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.916 -0.874 . . . . 1.0 110.916 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.6 mt -62.56 -43.63 98.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.617 0.246 . . . . 1.0 110.717 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -62.37 -40.46 96.52 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.703 -0.399 . . . . 1.0 110.678 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 77' ' ' ALA . 56.0 t -63.95 -50.06 78.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.917 0.389 . . . . 1.0 110.96 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.446 ' CD1' HG21 ' B' ' 79' ' ' ILE . 46.9 m-85 -68.33 -25.3 65.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.121 -0.491 . . . . 1.0 111.052 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -89.77 -23.51 21.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.667 0.27 . . . . 1.0 110.751 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' O ' ' N ' ' A' ' 86' ' ' THR . 3.9 tt -65.46 -35.44 80.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.303 -0.408 . . . . 1.0 111.303 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.2 m -43.17 -19.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.794 -179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 84' ' ' LEU . 24.9 m -40.92 -22.17 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.963 0.411 . . . . 1.0 110.122 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -60.39 -46.68 89.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.436 179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 -27.49 10.16 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.744 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.408 HD11 ' HB ' ' B' ' 86' ' ' THR . 44.6 tp -65.6 -37.56 86.97 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.627 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -70.9 -67.91 0.47 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.921 0.391 . . . . 1.0 110.798 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.426 ' H ' HG22 ' A' ' 91' ' ' THR . 0.0 OUTLIER -47.84 -8.51 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 1.0 111.042 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 90' ' ' ALA . 51.0 t0 -46.99 -38.73 11.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.611 -0.268 . . . . 1.0 110.848 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.419 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 10.1 p90 -79.45 -28.88 41.63 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.888 -0.325 . . . . 1.0 111.388 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.88 -26.15 34.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.427 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.464 ' NH2' ' OE2' ' A' ' 5' ' ' GLU . 96.4 mtt180 -60.1 -31.66 70.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.517 -0.311 . . . . 1.0 111.308 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' NH2' HG11 ' B' ' 94' ' ' VAL . 24.4 ptt180 -58.15 -42.32 85.67 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.876 0.369 . . . . 1.0 110.617 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.46 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 97.4 mt-10 -72.64 151.27 42.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.473 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.439 ' CB ' ' O ' ' A' ' 97' ' ' GLU . 3.6 tm-20 77.02 -52.24 0.56 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.647 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -65.41 -36.87 85.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.194 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -62.01 -35.39 78.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.536 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.63 -37.23 86.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.486 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.0 12.5 61.9 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 31.2 m170 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.986 -1.007 . . . . 1.0 110.481 179.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.335 -0.617 . . . . 1.0 109.335 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.403 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . -77.86 172.0 14.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.486 . . . . 1.0 110.687 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -62.3 -43.82 97.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.871 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.403 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 7.2 p-80 -80.4 -34.99 35.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.504 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.48 -39.24 85.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.947 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.27 -43.49 98.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.757 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -65.08 -36.54 84.66 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.804 -0.443 . . . . 1.0 109.804 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.29 -39.1 93.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 5.6 tm0? -65.3 -41.62 93.9 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.363 -0.381 . . . . 1.0 110.464 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -63.04 -40.7 98.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.667 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -42.55 92.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.928 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.443 ' OE2' ' CD1' ' B' ' 82' ' ' PHE . 80.3 mm-40 -67.92 -41.6 82.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.836 0.351 . . . . 1.0 110.516 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -65.05 -37.27 87.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.0 110.008 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -63.59 -32.41 73.87 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.033 -0.53 . . . . 1.0 110.416 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.02 -42.96 99.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.455 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -58.5 -37.58 75.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.6 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -61.02 -41.63 96.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.84 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.0 -33.73 64.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.686 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.665 HD22 ' O ' ' B' ' 48' ' ' SER . 95.3 mt -62.03 -42.1 98.81 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.572 -0.451 . . . . 1.0 109.922 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.48 -46.18 91.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.437 . . . . 1.0 109.856 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.442 ' CG ' ' NZ ' ' B' ' 25' ' ' LYS . 83.7 tt0 -69.28 -38.65 78.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.022 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.47 -38.91 88.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.499 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 39.2 m -60.01 -44.29 94.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.846 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.07 -35.92 81.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.896 0.379 . . . . 1.0 110.258 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.442 ' NZ ' ' CG ' ' B' ' 21' ' ' GLU . 62.3 mttp -75.86 -39.51 56.43 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.364 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.463 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -56.97 -49.68 74.97 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.658 -0.246 . . . . 1.0 111.298 -178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.465 ' O ' ' OE1' ' B' ' 30' ' ' GLU . 3.8 p -63.76 -42.99 97.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 121.279 0.561 . . . . 1.0 110.317 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.457 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 78.8 mm-40 -70.35 -20.83 62.95 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.498 -0.774 . . . . 1.0 110.59 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.466 ' HB1' ' H ' ' B' ' 67' ' ' GLY . . . -60.12 -37.91 81.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.511 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' B' ' 27' ' ' VAL . 29.7 mp0 -65.21 -40.23 93.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.895 0.379 . . . . 1.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 mmm180 -63.16 86.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.036 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.58 -10.45 6.79 Favored Glycine 0 CA--C 1.528 0.874 0 N-CA-C 111.476 -0.65 . . . . 1.0 111.476 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 141.88 23.59 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 116.765 0.283 . . . . 1.0 110.603 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.489 ' O ' ' CG1' ' B' ' 63' ' ' VAL . 98.9 Cg_endo -75.39 144.93 29.57 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.229 1.953 . . . . 1.0 112.38 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.87 36.3 57.7 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.01 -0.836 . . . . 1.0 111.01 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.36 150.37 0.91 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 1.0 110.269 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.12 -45.77 0.71 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.253 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.675 HD22 ' CZ ' ' B' ' 60' ' ' ARG . 33.9 tp -97.02 91.9 5.81 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.513 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 39.3 pt -105.21 2.58 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.421 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 14.8 t -99.86 123.54 44.21 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.119 0.485 . . . . 1.0 110.985 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.523 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.3 t80 -77.22 -54.86 1.44 Allowed Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.312 -0.858 . . . . 1.0 110.617 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -58.12 -27.0 78.34 Favored 'Trans proline' 0 N--CA 1.498 1.752 0 C-N-CA 121.803 1.669 . . . . 1.0 112.519 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.5 m-20 -93.66 -10.25 35.13 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.926 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.16 -38.08 87.21 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.885 0.374 . . . . 1.0 110.352 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.408 ' H ' HG22 ' B' ' 45' ' ' ILE . 6.7 tt -63.45 -33.16 59.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.609 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -48.85 75.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.707 -179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.666 ' CB ' ' HE ' ' B' ' 60' ' ' ARG . 1.4 t90 -62.5 -42.94 99.84 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.709 -0.396 . . . . 1.0 110.474 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.665 ' O ' HD22 ' B' ' 19' ' ' LEU . 11.9 p -45.13 -27.95 0.67 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.814 -0.354 . . . . 1.0 110.586 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 93.6 t -79.85 -25.85 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.443 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.66 ' CG ' HH21 ' C' ' 68' ' ' ARG . 1.5 tm-20 -66.24 -41.36 90.13 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.737 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.503 ' C ' ' H ' ' B' ' 53' ' ' THR . 8.4 t -82.44 -158.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.229 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 70.79 -38.36 0.42 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.474 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.541 HG21 ' OE2' ' C' ' 72' ' ' GLU . 70.8 p -91.22 6.83 43.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.784 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 44.7 p 51.61 66.3 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.428 . . . . 1.0 110.428 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.16 -47.7 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.598 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.92 67.27 1.5 Allowed Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.605 -0.998 . . . . 1.0 110.605 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.541 ' OH ' ' CD1' ' C' ' 47' ' ' TRP . 24.4 t80 -60.92 -49.14 78.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.679 0.276 . . . . 1.0 110.908 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 160.62 -96.98 0.15 Allowed Glycine 0 CA--C 1.523 0.569 0 N-CA-C 110.916 -0.873 . . . . 1.0 110.916 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 67.7 t0 52.52 -82.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.922 0.392 . . . . 1.0 110.602 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.675 ' CZ ' HD22 ' B' ' 38' ' ' LEU . 35.4 ptt85 -127.65 -160.88 1.04 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.325 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 28.2 p90 -163.55 133.32 3.15 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-N 116.262 -0.426 . . . . 1.0 109.965 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.0 179.06 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.628 1.552 . . . . 1.0 112.12 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.545 HG12 ' H ' ' B' ' 64' ' ' THR . 0.8 OUTLIER -91.33 -154.39 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.242 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.553 ' O ' ' NE1' ' A' ' 46' ' ' TRP . 18.0 m -113.61 -71.83 0.73 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.339 -0.391 . . . . 1.0 111.673 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' B' ' 64' ' ' THR . 83.4 tt0 -35.42 -31.49 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.966 -178.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.907 ' O ' ' N ' ' B' ' 68' ' ' ARG . 95.2 mt-10 -141.98 -108.25 0.14 Allowed 'General case' 0 C--O 1.217 -0.63 0 CA-C-N 115.482 -0.781 . . . . 1.0 109.203 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.466 ' H ' ' HB1' ' B' ' 29' ' ' ALA . . . 21.66 -56.04 0.0 OUTLIER Glycine 0 N--CA 1.476 1.345 0 O-C-N 124.492 1.12 . . . . 1.0 114.032 178.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.907 ' N ' ' O ' ' B' ' 66' ' ' GLU . 14.7 ttm180 -65.85 -48.61 71.01 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.247 -0.649 . . . . 1.0 109.247 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 37.5 tptt -63.58 -36.31 83.37 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.096 -1.075 . . . . 1.0 108.096 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 74.6 t -65.79 -45.35 91.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.59 -0.732 . . . . 1.0 109.952 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.519 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -65.88 -38.14 87.99 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.56 -0.533 . . . . 1.0 109.56 179.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -49.0 -45.65 42.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.176 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.36 -38.25 90.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.769 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 60.0 t -63.68 -45.55 97.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.552 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.519 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 3.6 mpp? -63.85 -40.29 96.24 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.518 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.33 -40.45 96.41 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.225 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.82 -40.04 87.06 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.84 0.352 . . . . 1.0 110.503 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.77 -38.98 93.48 Favored Glycine 0 CA--C 1.529 0.918 0 N-CA-C 111.485 -0.646 . . . . 1.0 111.485 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.476 HG22 ' O ' ' B' ' 79' ' ' ILE . 95.8 mt -69.08 -11.8 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.815 -0.226 . . . . 1.0 111.559 -179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -94.57 -53.26 3.96 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.08 0.467 . . . . 1.0 110.931 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.687 HG23 ' H ' ' B' ' 82' ' ' PHE . 17.8 m -60.69 -55.11 26.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.712 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.687 ' H ' HG23 ' B' ' 81' ' ' VAL . 42.2 m-85 -62.0 -43.79 98.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.887 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.67 -36.82 85.52 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.615 -0.434 . . . . 1.0 110.362 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.43 ' C ' ' H ' ' B' ' 86' ' ' THR . 6.5 tt -57.62 -31.78 66.58 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.125 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.485 ' O ' HG12 ' B' ' 85' ' ' VAL . 46.9 t -60.1 -4.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.662 -0.496 . . . . 1.0 109.662 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.43 ' H ' ' C ' ' B' ' 84' ' ' LEU . 72.4 m -61.16 -44.86 96.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 120.262 -0.575 . . . . 1.0 109.574 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.512 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -51.37 -29.28 14.96 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.632 -0.713 . . . . 1.0 110.725 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.95 -12.69 35.23 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.501 -0.318 . . . . 1.0 110.739 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 84.9 mt -93.79 -39.88 10.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.403 179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.477 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.91 -25.78 57.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.231 0.539 . . . . 1.0 110.15 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.466 ' CG2' ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -82.06 -6.31 59.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.395 -0.82 . . . . 1.0 109.891 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.491 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 96.8 m-20 -58.63 -48.77 79.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.142 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.1 p90 -77.48 -40.07 44.26 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.094 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.526 HG11 ' NH2' ' A' ' 96' ' ' ARG . 58.8 t -44.79 -31.25 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 1.0 111.586 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -64.05 -22.22 66.84 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 121.057 -0.257 . . . . 1.0 111.478 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.461 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.0 ptt85 -54.42 -43.45 71.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 1.0 110.063 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.552 ' O ' ' N ' ' B' ' 99' ' ' GLU . 96.4 mt-10 -64.87 177.8 0.91 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.877 -0.601 . . . . 1.0 110.417 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 mp0 56.99 -75.17 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.552 ' N ' ' O ' ' B' ' 97' ' ' GLU . 83.6 tt0 -51.4 -20.32 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.505 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 69.9 ttp85 -60.19 -44.95 94.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.546 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 -86.91 -11.26 51.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.307 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.15 18.12 77.04 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.165 -0.774 . . . . 1.0 111.165 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.475 ' CG ' ' O ' ' B' ' 103' ' ' HIS . 86.4 t60 . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.591 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 37.7 m . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.34 -0.615 . . . . 1.0 109.34 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.491 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -69.05 150.09 48.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.926 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -62.38 -38.8 90.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.064 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.585 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 24.8 p80 -67.02 -39.99 87.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.099 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.585 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 48.0 tp10 -65.9 -41.35 91.6 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.727 0.298 . . . . 1.0 110.577 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 80.0 mtp85 -64.78 -37.41 87.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -62.9 -40.92 99.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.128 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -41.31 98.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 1.0 110.37 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -65.64 -41.92 92.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.481 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -64.87 -37.94 89.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.26 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.92 -37.62 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 1.0 111.165 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -37.15 86.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.526 -0.307 . . . . 1.0 111.06 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -64.55 -34.47 78.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.778 0.323 . . . . 1.0 110.438 -179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -65.78 -35.9 82.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.682 -179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 51.5 tp -62.22 -42.2 99.08 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.704 -0.398 . . . . 1.0 110.706 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -61.4 -36.26 79.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 1.0 111.334 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.57 -40.23 90.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.775 0.322 . . . . 1.0 110.908 -179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.73 -35.46 73.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.745 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.522 HD22 ' O ' ' C' ' 48' ' ' SER . 94.0 mt -59.98 -41.57 92.3 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.709 -0.396 . . . . 1.0 109.958 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' C' ' 23' ' ' SER . 98.4 mt-10 -62.87 -43.34 99.05 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -69.92 -36.38 75.3 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.279 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.42 -40.64 97.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.434 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.47 ' O ' HG23 ' C' ' 27' ' ' VAL . 77.8 p -60.76 -43.76 97.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.824 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -60.51 -56.35 22.48 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.389 -0.524 . . . . 1.0 110.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.95 -44.24 97.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.014 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.462 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -57.1 -24.76 56.34 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.686 -0.406 . . . . 1.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.47 HG23 ' O ' ' C' ' 23' ' ' SER . 35.0 t -80.78 -51.77 15.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.191 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -70.83 -43.01 69.44 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.911 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.79 -50.57 65.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.332 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.52 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 3.8 mp0 -62.15 -44.92 95.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.625 -0.261 . . . . 1.0 110.716 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 50.9 ttp180 -68.01 130.32 42.61 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 120.488 -0.485 . . . . 1.0 110.125 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.2 -8.94 59.28 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-N 115.67 -0.695 . . . . 1.0 111.422 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.24 151.76 41.89 Favored Pre-proline 0 N--CA 1.465 0.308 0 N-CA-C 110.111 -0.329 . . . . 1.0 110.111 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.469 ' O ' HG11 ' C' ' 63' ' ' VAL . 89.2 Cg_endo -76.17 123.54 7.29 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.726 1.617 . . . . 1.0 112.184 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' C' ' 36' ' ' ALA . . . 103.99 -23.12 33.14 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.971 -0.852 . . . . 1.0 110.971 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.442 ' O ' ' O ' ' C' ' 35' ' ' GLY . . . 48.35 178.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.771 0.32 . . . . 1.0 110.694 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -177.67 -93.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.63 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 12.5 tp -90.43 111.54 22.82 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.839 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.436 ' O ' ' CB ' ' C' ' 40' ' ' SER . 1.4 tp -144.18 101.24 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.817 -0.629 . . . . 1.0 110.068 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.537 ' O ' ' N ' ' C' ' 44' ' ' ALA . 0.3 OUTLIER 166.67 106.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.749 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.532 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.9 OUTLIER -49.11 -50.48 63.17 Favored Pre-proline 0 CA--C 1.538 0.492 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.862 178.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.8 Cg_endo -58.9 -34.9 99.3 Favored 'Trans proline' 0 N--CA 1.5 1.88 0 C-N-CA 121.383 1.389 . . . . 1.0 112.453 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -98.74 -5.1 32.05 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.277 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -68.31 -41.55 80.71 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.809 0.338 . . . . 1.0 111.153 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' C' ' 45' ' ' ILE . 5.9 tt -65.04 -38.9 83.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.728 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.617 ' CZ3' ' NZ ' ' D' ' 69' ' ' LYS . 0.3 OUTLIER -58.96 -46.63 87.59 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.557 -178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.541 ' CD1' ' OH ' ' B' ' 57' ' ' TYR . 0.9 OUTLIER -68.31 -23.6 64.75 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.271 -0.571 . . . . 1.0 109.508 179.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.522 ' O ' HD22 ' C' ' 19' ' ' LEU . 3.4 t -75.09 -35.54 61.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.92 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.52 -44.28 96.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 111.944 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.53 -41.84 77.46 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.681 -0.408 . . . . 1.0 111.057 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.598 ' O ' ' HB3' ' C' ' 52' ' ' ALA . 3.6 t -78.69 -176.28 4.82 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' C' ' 51' ' ' THR . . . 76.3 -12.19 1.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.569 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.453 HG21 ' OE2' ' D' ' 72' ' ' GLU . 68.9 p -115.66 14.21 16.41 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.548 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.416 ' OG1' ' O ' ' C' ' 53' ' ' THR . 47.0 p 53.67 69.4 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.879 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 17.4 t -144.4 -73.16 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.17 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.22 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 51.81 81.15 0.06 OUTLIER Glycine 0 CA--C 1.523 0.537 0 N-CA-C 110.777 -0.929 . . . . 1.0 110.777 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.412 ' CB ' ' CD1' ' D' ' 61' ' ' TYR . 45.5 t80 -60.43 -47.66 85.14 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.821 -0.351 . . . . 1.0 110.789 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.0 30.15 0.54 Allowed Glycine 0 N--CA 1.466 0.668 0 N-CA-C 110.961 -0.856 . . . . 1.0 110.961 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.509 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 40.6 t0 -61.69 -41.68 97.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.829 0.347 . . . . 1.0 110.431 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 94.5 mtt-85 -141.79 -161.32 1.21 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.895 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.476 ' CG ' ' O ' ' C' ' 61' ' ' TYR . 20.5 p90 -171.61 120.29 0.47 Allowed Pre-proline 0 CA--C 1.538 0.5 0 C-N-CA 120.367 -0.533 . . . . 1.0 110.743 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.2 158.32 56.75 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.699 1.599 . . . . 1.0 112.355 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.541 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.06 -142.88 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.029 -0.532 . . . . 1.0 110.133 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.541 ' H ' HG12 ' C' ' 63' ' ' VAL . 98.4 m -111.77 -47.44 3.15 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.498 -0.319 . . . . 1.0 110.665 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.583 ' C ' ' H ' ' C' ' 67' ' ' GLY . 46.3 tp10 -58.71 -25.17 62.63 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.943 -0.391 . . . . 1.0 109.943 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.433 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.2 OUTLIER -73.01 28.15 0.06 Allowed 'General case' 0 C--O 1.263 1.81 0 CA-C-O 123.52 1.628 . . . . 1.0 110.213 179.077 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 41.1 62.72 1.7 Allowed Glycine 0 C--O 1.216 -1.024 0 CA-C-N 113.773 -1.558 . . . . 1.0 110.673 178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.66 HH21 ' CG ' ' B' ' 50' ' ' GLU . 46.5 ttt85 -24.21 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.796 0.798 . . . . 1.0 111.58 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.8 mttt -51.65 -16.5 0.65 Allowed 'General case' 0 N--CA 1.437 -1.089 0 CA-C-N 115.704 -0.68 . . . . 1.0 109.373 176.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.591 ' N ' ' O ' ' C' ' 67' ' ' GLY . 65.9 t -62.52 -48.08 89.93 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 119.324 -0.95 . . . . 1.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.88 -39.06 87.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.359 . . . . 1.0 110.093 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . 0.541 ' OE2' HG21 ' B' ' 53' ' ' THR . 37.8 tp10 -64.79 -39.59 93.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.043 -0.526 . . . . 1.0 111.03 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -55.65 -42.44 75.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.51 -0.314 . . . . 1.0 111.245 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' C' ' 52' ' ' ALA . 82.5 t -66.0 -41.72 90.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 120.844 -0.343 . . . . 1.0 111.545 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.4 mtt -59.46 -44.75 92.93 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.939 -0.304 . . . . 1.0 111.216 -178.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -63.37 -40.63 97.79 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.874 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.424 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -59.34 -41.63 89.64 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.84 0.352 . . . . 1.0 110.496 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.18 -42.39 76.15 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 121.222 -0.513 . . . . 1.0 111.897 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 91.1 mt -61.19 -43.91 97.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 O-C-N 122.641 -0.329 . . . . 1.0 110.752 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -66.54 -43.25 85.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.463 -0.335 . . . . 1.0 111.303 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.424 HG23 ' O ' ' C' ' 77' ' ' ALA . 59.0 t -64.76 -50.39 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 C-N-CA 120.704 -0.398 . . . . 1.0 111.349 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.511 ' O ' HG22 ' C' ' 85' ' ' VAL . 38.0 m-85 -67.63 -40.76 84.59 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.764 -0.374 . . . . 1.0 111.22 -179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.23 -31.23 70.58 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.764 0.316 . . . . 1.0 110.776 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.466 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.1 tt -62.74 -42.23 99.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 1.0 111.813 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.511 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.2 m -52.64 -8.92 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.564 -0.455 . . . . 1.0 110.61 -179.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.466 ' H ' ' C ' ' C' ' 84' ' ' LEU . 43.8 m -49.43 -23.87 1.72 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.849 0.357 . . . . 1.0 110.247 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.491 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -57.26 -50.58 72.45 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.045 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.97 -37.94 85.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 1.0 110.454 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.38 -38.52 90.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.903 -0.59 . . . . 1.0 110.879 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.519 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.32 -44.26 88.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.02 -179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -4.71 44.18 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.233 -179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.415 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 56.1 t0 -56.0 -49.52 73.41 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.656 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.519 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -72.5 -41.12 66.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.08 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.469 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 93.7 t -45.71 -27.34 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.926 -0.579 . . . . 1.0 111.68 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -62.41 -22.67 66.35 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.605 -0.27 . . . . 1.0 111.414 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 50.3 ptt85 -55.23 -33.65 63.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.758 0.314 . . . . 1.0 110.569 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.84 -42.31 95.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.477 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -71.56 -39.56 70.56 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.864 0.364 . . . . 1.0 110.625 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -67.39 -18.37 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.273 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.429 ' NH1' ' CZ ' ' C' ' 101' ' ' ARG . 79.7 ttt-85 -59.34 -44.67 92.62 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.652 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . 0.429 ' CZ ' ' NH1' ' C' ' 100' ' ' ARG . 85.0 mtt85 -105.96 -6.57 18.71 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.8 0.333 . . . . 1.0 110.398 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 72.69 16.77 77.87 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.07 -0.812 . . . . 1.0 111.07 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.221 -0.441 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.592 -179.907 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.455 -0.572 . . . . 1.0 109.455 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.617 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -67.39 143.98 56.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.479 . . . . 1.0 110.42 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . 0.463 ' OD1' ' NH2' ' D' ' 6' ' ' ARG . 98.7 m-20 -64.48 -40.11 95.07 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.776 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -72.2 -19.93 61.65 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.202 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.01 -45.29 77.97 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.768 0.318 . . . . 1.0 110.519 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . 0.463 ' NH2' ' OD1' ' D' ' 3' ' ' ASP . 95.4 mtm-85 -65.39 -36.72 84.83 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.66 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -61.02 -42.72 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.086 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.69 -37.23 86.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.724 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -63.24 -42.29 99.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.479 -0.328 . . . . 1.0 110.661 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.94 -40.07 96.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.75 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.486 ' HB1' HG13 ' D' ' 81' ' ' VAL . . . -58.25 -38.56 77.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.905 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.8 -42.6 90.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.735 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.64 -38.91 90.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.595 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -63.96 -33.58 76.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' D' ' 52' ' ' ALA . 46.4 tp -62.82 -38.54 91.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.049 0.452 . . . . 1.0 110.075 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -67.59 -28.41 67.74 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.81 -0.356 . . . . 1.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -65.0 -40.15 94.51 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.824 0.345 . . . . 1.0 111.534 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.68 -31.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.383 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.429 HD22 ' O ' ' D' ' 48' ' ' SER . 29.4 mt -61.15 -44.16 97.76 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.412 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . 0.412 ' O ' ' OG ' ' D' ' 23' ' ' SER . 12.0 pt-20 -67.87 -35.33 78.34 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.001 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -66.49 -36.65 83.26 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.802 -0.359 . . . . 1.0 110.344 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.408 ' O ' ' CB ' ' D' ' 26' ' ' ALA . . . -63.76 -40.32 96.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.324 -0.398 . . . . 1.0 111.091 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.662 ' O ' HG23 ' D' ' 27' ' ' VAL . 78.0 p -58.45 -45.69 88.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.203 -179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -59.89 -63.47 1.29 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.71 -0.396 . . . . 1.0 110.336 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -58.57 -37.57 76.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.556 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.408 ' CB ' ' O ' ' D' ' 22' ' ' ALA . . . -59.8 -42.31 93.16 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.533 -0.467 . . . . 1.0 110.705 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.662 HG23 ' O ' ' D' ' 23' ' ' SER . 72.0 t -64.16 -48.7 84.54 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.283 -0.567 . . . . 1.0 110.443 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -70.92 -42.58 69.71 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.777 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.5 -51.18 60.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.744 -0.662 . . . . 1.0 109.688 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.529 ' OE1' HG22 ' D' ' 39' ' ' ILE . 8.8 tm-20 -69.91 -35.41 74.57 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.356 -0.383 . . . . 1.0 111.002 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -54.07 101.84 0.05 Allowed 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 120.912 0.387 . . . . 1.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.69 21.34 10.5 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.822 -0.626 . . . . 1.0 111.617 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.49 ' CB ' ' OE2' ' D' ' 66' ' ' GLU . . . -105.33 145.1 30.14 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 122.918 -0.166 . . . . 1.0 110.711 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -74.86 139.36 24.58 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.037 1.824 . . . . 1.0 112.03 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 63.98 17.25 60.73 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.217 -0.753 . . . . 1.0 111.217 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.429 ' O ' ' O ' ' D' ' 35' ' ' GLY . . . -46.83 176.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.932 0.396 . . . . 1.0 110.958 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . 0.42 ' H ' ' H ' ' D' ' 38' ' ' LEU . . . -166.95 -1.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.751 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.436 ' O ' ' OE1' ' D' ' 30' ' ' GLU . 58.5 tp -123.04 108.74 13.24 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.821 0.343 . . . . 1.0 110.109 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.529 HG22 ' OE1' ' D' ' 30' ' ' GLU . 14.2 pt -136.8 159.95 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.377 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.496 ' O ' ' OD1' ' D' ' 43' ' ' ASP . 0.5 OUTLIER 81.33 139.23 0.07 Allowed 'General case' 0 C--O 1.224 -0.255 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.697 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.3 OUTLIER -77.77 -38.61 1.76 Allowed Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.695 178.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.1 Cg_endo -58.63 -32.82 97.54 Favored 'Trans proline' 0 N--CA 1.497 1.684 0 C-N-CA 121.308 1.338 . . . . 1.0 112.197 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.496 ' OD1' ' O ' ' D' ' 40' ' ' SER . 29.6 p-10 -96.94 -6.21 36.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.578 0.228 . . . . 1.0 110.876 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.39 -40.14 67.44 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.948 0.404 . . . . 1.0 110.929 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.2 tt -63.91 -40.17 88.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.417 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.487 ' O ' ' NH1' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -58.49 -45.82 87.93 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.673 -0.491 . . . . 1.0 109.673 -179.613 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -63.12 -39.24 94.1 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 109.724 -0.472 . . . . 1.0 109.724 178.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.429 ' O ' HD22 ' D' ' 19' ' ' LEU . 4.8 t -58.81 -41.57 87.1 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.443 -0.503 . . . . 1.0 110.127 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.408 ' O ' HG12 ' D' ' 49' ' ' VAL . 41.8 t -76.6 68.04 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.009 0.433 . . . . 1.0 111.699 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -173.58 -40.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.057 -0.519 . . . . 1.0 109.733 178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -64.68 -43.44 93.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.41 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' D' ' 15' ' ' LEU . . . -56.49 -28.69 60.48 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 44.2 p -84.73 -1.82 56.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.317 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 46.4 p 50.95 58.86 5.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 1.0 111.025 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.584 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.2 p -128.28 -46.45 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 116.587 -0.278 . . . . 1.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.584 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 41.26 76.58 0.09 OUTLIER Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.511 ' CZ ' ' O ' ' A' ' 60' ' ' ARG . 15.1 t80 -60.94 -46.42 90.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.76 0.314 . . . . 1.0 110.416 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.72 36.08 0.08 OUTLIER Glycine 0 N--CA 1.466 0.645 0 N-CA-C 110.912 -0.875 . . . . 1.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 21.6 t0 -83.86 -77.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.812 0.339 . . . . 1.0 110.69 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 17.4 mmt180 -130.39 147.84 52.14 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.412 ' CD1' ' CB ' ' C' ' 57' ' ' TYR . 46.2 t80 -149.0 135.83 10.55 Favored Pre-proline 0 CA--C 1.533 0.322 0 C-N-CA 120.759 -0.376 . . . . 1.0 110.628 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.33 149.23 69.41 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 122.011 1.807 . . . . 1.0 112.318 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.441 ' H ' ' CG ' ' D' ' 66' ' ' GLU . 3.3 t -80.41 -125.84 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.009 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.415 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 76.1 m -113.7 -36.41 4.88 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.839 0.352 . . . . 1.0 110.888 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' D' ' 67' ' ' GLY . 78.7 tt0 -67.4 -30.35 70.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.352 -0.386 . . . . 1.0 110.223 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.575 ' OE1' ' N ' ' D' ' 66' ' ' GLU . 1.2 pm0 -79.36 34.53 0.26 Allowed 'General case' 0 C--O 1.265 1.891 0 CA-C-O 123.224 1.488 . . . . 1.0 108.845 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.43 61.19 1.29 Allowed Glycine 0 C--O 1.212 -1.262 0 CA-C-N 113.767 -1.561 . . . . 1.0 109.916 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.509 ' NH2' ' OD2' ' C' ' 59' ' ' ASP . 40.0 ttm180 -24.37 -31.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.533 0.784 . . . . 1.0 111.086 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 60.4 mttp -54.12 -13.67 0.89 Allowed 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 115.758 -0.656 . . . . 1.0 109.308 176.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.638 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.4 t -61.32 -47.74 92.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 C-N-CA 119.52 -0.872 . . . . 1.0 109.59 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.87 80.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.945 -0.571 . . . . 1.0 109.96 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . 0.453 ' OE2' HG21 ' C' ' 53' ' ' THR . 35.8 tp10 -57.31 -39.37 75.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.766 -0.652 . . . . 1.0 111.232 -179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 16.0 tm0? -66.58 -40.47 88.94 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.877 -0.329 . . . . 1.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 -47.52 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 C-N-CA 120.602 -0.439 . . . . 1.0 111.539 -178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 20.2 ptp -64.64 -40.84 96.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 1.0 111.161 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -61.51 -42.54 98.96 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.899 -0.32 . . . . 1.0 110.744 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.31 -37.96 88.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.432 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.29 -40.43 96.57 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.612 -0.595 . . . . 1.0 111.612 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.3 mt -62.53 -43.61 98.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.712 0.291 . . . . 1.0 111.172 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.38 -35.2 79.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.01 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.486 HG13 ' HB1' ' D' ' 11' ' ' ALA . 43.1 t -67.28 -56.12 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.519 -179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -62.07 -43.22 99.3 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.725 -0.39 . . . . 1.0 110.836 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -64.23 -37.51 87.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.292 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.4 tt -62.2 -42.19 99.06 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.822 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.471 ' O ' ' N ' ' D' ' 87' ' ' ALA . 89.7 t -58.11 -18.34 10.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 83' ' ' ALA . 75.6 m -43.96 -20.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.467 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -61.22 -61.01 2.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.909 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.93 -27.99 61.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.254 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.548 ' N ' ' CD2' ' D' ' 89' ' ' LEU . 2.7 mm? -78.08 -38.04 45.18 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.882 -0.599 . . . . 1.0 110.24 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.495 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.9 -35.85 71.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.31 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.11 -4.2 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.94 -0.573 . . . . 1.0 109.907 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' D' ' 89' ' ' LEU . 66.6 t0 -56.66 -44.37 81.27 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.836 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 12.3 p90 -74.97 -42.98 56.53 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.863 -0.335 . . . . 1.0 110.923 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 88.7 t -44.17 -26.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.105 -0.498 . . . . 1.0 111.358 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -57.49 -25.32 59.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.602 -0.272 . . . . 1.0 111.075 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . 0.7 HH12 ' CD2' ' A' ' 4' ' ' HIS . 7.2 ptp180 -59.2 -34.8 72.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.987 0.422 . . . . 1.0 110.358 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.576 ' O ' ' N ' ' D' ' 99' ' ' GLU . 97.6 mt-10 -70.97 -167.53 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.057 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 32.8 mp0 57.39 -73.77 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.807 0.336 . . . . 1.0 110.706 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.576 ' N ' ' O ' ' D' ' 97' ' ' GLU . 79.6 mm-40 -55.24 -43.85 74.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.38 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -61.36 -42.1 98.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.437 . . . . 1.0 110.329 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 24.9 mmt85 -63.24 -36.51 83.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.443 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.66 15.32 56.92 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.185 -0.766 . . . . 1.0 111.185 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 33.0 m80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.957 -1.02 . . . . 1.0 110.357 179.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.412 -0.588 . . . . 1.0 109.412 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.27 -74.64 0.09 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.375 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -174.25 -53.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.412 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.626 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 6.0 p80 -73.47 -31.07 63.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -65.08 -39.46 93.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -61.38 -42.09 98.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.144 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -64.0 -39.64 94.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.468 . . . . 1.0 110.144 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.53 -38.75 92.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.213 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -64.36 -41.56 96.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.413 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -63.39 -39.31 94.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.73 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.404 ' HB1' HG13 ' A' ' 81' ' ' VAL . . . -59.23 -39.71 83.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.842 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -65.24 -44.23 88.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 1.0 110.635 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -64.72 -33.87 76.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 1.0 110.311 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.9 tt0 -63.74 -35.16 79.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.449 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.0 tp -61.86 -42.57 99.21 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.731 -0.388 . . . . 1.0 110.392 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -59.24 -34.9 72.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.979 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.51 -40.76 97.79 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.744 -0.382 . . . . 1.0 111.09 -179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 77.8 t -65.42 -29.0 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.682 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 48' ' ' SER . 96.4 mt -62.76 -41.97 99.47 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.46 -42.88 99.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.864 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.06 -39.8 78.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.329 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.27 93.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.393 -0.367 . . . . 1.0 111.029 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.435 ' O ' HG22 ' A' ' 27' ' ' VAL . 77.5 p -60.76 -42.28 97.11 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 1.0 110.177 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.59 -30.34 71.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.926 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -78.9 -46.59 18.15 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.302 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.47 -43.03 88.78 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.7 -178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.573 HG23 ' H ' ' A' ' 28' ' ' GLU . 11.8 m -56.71 -54.35 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.39 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.573 ' H ' HG23 ' A' ' 27' ' ' VAL . 88.2 mt-10 -67.93 -42.19 81.4 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.839 0.352 . . . . 1.0 110.701 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.04 -39.32 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.063 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -98.05 14.86 25.96 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.425 -0.352 . . . . 1.0 111.557 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 25.3 tpt85 -80.64 99.28 8.07 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-O 120.72 0.295 . . . . 1.0 110.351 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.45 6.42 87.6 Favored Glycine 0 CA--C 1.523 0.56 0 N-CA-C 111.646 -0.581 . . . . 1.0 111.646 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.48 149.36 95.6 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.26 141.49 25.98 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 121.926 1.751 . . . . 1.0 112.245 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.05 -6.8 8.96 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.992 -0.843 . . . . 1.0 110.992 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -77.84 155.41 31.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.839 0.352 . . . . 1.0 110.48 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -148.18 10.61 0.89 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.518 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' A' ' 40' ' ' SER . 6.8 tt -82.96 -10.73 58.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.476 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.403 ' C ' ' O ' ' A' ' 38' ' ' LEU . 4.8 pt -37.35 90.56 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.631 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.4 m 169.21 134.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.916 -0.583 . . . . 1.0 109.888 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.52 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 55.9 m-85 -82.56 -48.33 0.86 Allowed Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 112.448 0.536 . . . . 1.0 112.448 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.0 Cg_endo -60.56 -31.68 92.59 Favored 'Trans proline' 0 N--CA 1.502 1.992 0 C-N-CA 121.634 1.556 . . . . 1.0 112.657 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.4 p-10 -91.2 -6.03 54.03 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.913 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.86 -44.48 73.24 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.551 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.5 tt -66.0 -41.0 88.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.093 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.99 96.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 31.9 t90 -62.4 -40.38 96.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.53 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.1 p -58.83 -31.9 68.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.141 -0.482 . . . . 1.0 110.718 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.425 ' CG1' ' OE1' ' B' ' 72' ' ' GLU . 94.9 t -71.59 -44.24 70.35 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-O 121.255 0.55 . . . . 1.0 110.636 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.432 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 45.7 tp10 -52.15 -42.68 63.59 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.264 -0.88 . . . . 1.0 110.376 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 53' ' ' THR . 4.6 t -80.78 -158.17 0.19 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.965 -0.754 . . . . 1.0 108.965 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 51' ' ' THR . . . 71.31 -35.8 0.34 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.866 0.365 . . . . 1.0 110.141 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 51' ' ' THR . 62.0 p -81.31 5.43 17.3 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.214 -0.662 . . . . 1.0 109.214 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.7 p 58.17 26.7 14.08 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.497 -0.774 . . . . 1.0 111.127 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 84.6 t -146.95 82.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 120.782 0.325 . . . . 1.0 110.649 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 112.1 3.39 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 110.63 -0.988 . . . . 1.0 110.63 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.4 -46.05 91.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 1.0 110.419 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.53 27.41 0.39 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.531 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 48.7 m-20 -62.34 -42.11 99.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.978 0.418 . . . . 1.0 110.473 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 38.8 mmt180 -130.87 -169.07 2.09 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.15 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.531 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 96.4 m-85 -159.61 91.58 1.84 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.89 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.34 157.59 60.65 Favored 'Trans proline' 0 N--CA 1.498 1.789 0 C-N-CA 121.787 1.658 . . . . 1.0 112.271 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.026 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -116.76 -165.96 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 120.987 0.423 . . . . 1.0 110.344 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 1.026 ' H ' HG22 ' A' ' 63' ' ' VAL . 61.2 m -78.66 -42.8 27.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.067 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 67' ' ' GLY . 48.3 tp10 -50.74 -47.23 59.39 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.769 -0.456 . . . . 1.0 109.769 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.1 OUTLIER -74.49 29.78 0.08 Allowed 'General case' 0 C--O 1.26 1.638 0 CA-C-O 124.212 1.958 . . . . 1.0 109.568 178.657 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.46 66.64 1.18 Allowed Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 113.838 -1.528 . . . . 1.0 111.863 176.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.506 ' NH1' ' OE1' ' D' ' 50' ' ' GLU . 58.2 ttm-85 -24.11 -34.21 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.029 0.915 . . . . 1.0 110.808 -178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.9 mttp -47.63 -20.53 0.27 Allowed 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 109.756 -0.461 . . . . 1.0 109.756 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 67' ' ' GLY . 57.1 t -61.29 -48.18 90.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.688 0 C-N-CA 119.652 -0.819 . . . . 1.0 110.453 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.46 -41.73 60.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.673 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -59.67 -42.52 93.04 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.698 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -58.03 -41.55 83.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.821 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 84.1 t -65.65 -42.79 93.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 120.572 -0.451 . . . . 1.0 111.14 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.409 ' CE ' ' OH ' ' D' ' 57' ' ' TYR . 65.2 mtt -57.36 -45.33 84.49 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.832 -0.347 . . . . 1.0 110.904 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -63.59 -41.81 98.32 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.83 -0.348 . . . . 1.0 110.533 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.02 -40.6 85.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.647 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.417 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -68.24 -42.55 83.0 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.024 -0.831 . . . . 1.0 111.024 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.56 -43.92 95.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.702 0.287 . . . . 1.0 110.593 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -61.22 -40.2 93.13 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 120.462 -0.495 . . . . 1.0 110.124 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.404 HG13 ' HB1' ' A' ' 11' ' ' ALA . 52.1 t -65.75 -49.74 75.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.914 179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -66.07 -39.14 89.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 1.0 111.243 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.5 -39.06 92.29 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.877 0.37 . . . . 1.0 110.998 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' C ' ' N ' ' A' ' 86' ' ' THR . 7.5 tt -62.98 -41.38 99.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.209 -0.451 . . . . 1.0 111.302 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.439 ' O ' HG12 ' A' ' 85' ' ' VAL . 81.3 t -47.4 -13.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.858 -0.337 . . . . 1.0 110.348 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.483 ' N ' ' C ' ' A' ' 84' ' ' LEU . 76.8 m -58.07 -42.18 84.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 1.0 109.89 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.504 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -40.27 -33.77 0.27 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.211 -0.449 . . . . 1.0 110.561 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.61 19.56 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.684 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 86' ' ' THR . 52.2 mt -66.4 -38.77 88.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.992 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.53 -47.83 82.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.155 0.502 . . . . 1.0 111.062 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -4.14 32.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.872 -0.604 . . . . 1.0 110.449 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.64 ' CG ' ' HB2' ' B' ' 87' ' ' ALA . 39.6 t0 -58.41 -49.39 77.44 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.015 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 22.5 p90 -76.05 -34.41 59.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.439 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 79.1 t -43.95 -34.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 1.0 111.137 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.1 mtt-85 -60.36 -23.04 63.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.573 -0.285 . . . . 1.0 110.934 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -57.48 -44.31 84.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.434 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.8 tp10 -89.73 -68.25 0.79 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.781 -0.451 . . . . 1.0 109.781 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.531 ' C ' ' H ' ' A' ' 100' ' ' ARG . 47.7 mt-10 -75.01 162.38 28.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.491 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 71.28 -33.87 0.28 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.309 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 98' ' ' GLU . 69.2 ttp85 -60.99 -44.36 97.51 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.471 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -94.88 -7.71 39.35 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.494 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.27 22.47 77.57 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.529 -179.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.402 ' O ' ' O ' ' B' ' 2' ' ' ALA . 7.8 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.309 -0.626 . . . . 1.0 109.309 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.402 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 44.59 -169.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.607 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 64.3 t0 -131.03 -29.98 1.81 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.844 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.447 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.8 p80 -77.48 -20.56 54.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.372 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.39 -37.78 83.67 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.93 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -63.73 -42.72 97.86 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.767 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -67.03 -40.88 87.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.004 0.431 . . . . 1.0 109.864 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -38.43 90.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.74 -0.664 . . . . 1.0 110.73 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.9 tp60 -63.8 -43.27 96.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.146 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -63.19 -40.37 97.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.69 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.405 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -59.69 -38.51 81.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.823 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -66.27 -44.27 84.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 1.0 110.647 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -64.67 -36.82 85.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.129 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -62.4 -33.44 74.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.325 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.3 tp -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 1.0 110.537 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -57.17 -38.02 72.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.575 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -61.96 -38.62 89.18 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.994 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 61.9 t -64.76 -39.84 87.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.838 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 29.8 mt -59.85 -38.72 82.89 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.367 -0.605 . . . . 1.0 109.367 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' B' ' 23' ' ' SER . 96.8 mt-10 -63.05 -43.92 97.3 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.519 -0.548 . . . . 1.0 109.519 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -69.32 -31.18 69.47 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.873 -0.603 . . . . 1.0 109.94 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -42.77 86.64 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.006 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -60.69 -45.77 92.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.846 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.462 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 44.3 tttm -65.47 -50.09 66.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.338 0.59 . . . . 1.0 110.073 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -64.09 -42.63 96.86 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.743 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.52 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -67.71 -50.69 56.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.106 0.253 . . . . 1.0 111.531 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.482 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.9 p -60.94 -45.91 97.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 121.06 0.457 . . . . 1.0 110.658 -179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.482 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 96.7 mt-10 -68.64 -18.81 64.36 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.744 -0.662 . . . . 1.0 110.674 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.66 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -59.76 -51.23 70.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.254 -0.43 . . . . 1.0 111.048 -179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' O ' ' B' ' 26' ' ' ALA . 56.0 mp0 -80.64 -110.65 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.072 0.463 . . . . 1.0 110.113 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 38.6 mmt180 41.81 50.22 4.02 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.9 -0.591 . . . . 1.0 111.151 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.77 25.82 0.9 Allowed Glycine 0 N--CA 1.467 0.73 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.786 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.08 150.47 39.35 Favored Pre-proline 0 CA--C 1.535 0.385 0 N-CA-C 110.263 -0.273 . . . . 1.0 110.263 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -75.71 130.18 12.35 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 121.975 1.784 . . . . 1.0 112.067 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 69.22 25.88 75.08 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.201 -0.76 . . . . 1.0 111.201 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.9 163.49 25.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.834 0.349 . . . . 1.0 110.53 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.24 -32.08 0.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.574 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 1.8 tt -73.59 49.16 0.29 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.442 . . . . 1.0 110.39 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.635 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -92.73 76.96 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 121.182 0.515 . . . . 1.0 110.107 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' B' ' 39' ' ' ILE . 69.1 m -168.81 98.23 0.38 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.943 -0.571 . . . . 1.0 111.087 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 53.4 t80 -58.26 -50.12 89.83 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.708 -0.678 . . . . 1.0 110.69 178.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.2 Cg_endo -58.22 -33.28 97.41 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 C-N-CA 121.809 1.672 . . . . 1.0 112.608 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.406 ' HB3' HH21 ' B' ' 60' ' ' ARG . 76.5 m-20 -94.66 -4.2 48.04 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.237 -0.185 . . . . 1.0 110.958 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -38.88 92.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.947 0.403 . . . . 1.0 110.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.41 HG22 ' H ' ' B' ' 45' ' ' ILE . 7.7 tt -67.39 -40.23 84.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.635 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.426 ' CD1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -62.94 -42.45 99.81 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.469 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -61.8 -42.7 99.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.513 ' C ' ' H ' ' B' ' 50' ' ' GLU . 16.2 m -56.82 -39.11 73.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.292 -0.413 . . . . 1.0 111.086 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.764 HG12 ' O ' ' B' ' 49' ' ' VAL . 58.0 t -67.18 29.78 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.371 -0.377 . . . . 1.0 111.87 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.513 ' H ' ' C ' ' B' ' 48' ' ' SER . 79.7 mm-40 -137.07 -21.79 1.2 Allowed 'General case' 0 N--CA 1.464 0.235 0 O-C-N 121.848 -0.532 . . . . 1.0 110.493 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.3 -36.08 14.88 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.974 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.02 83.5 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.207 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.7 p -86.18 12.96 8.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.849 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' B' ' 53' ' ' THR . 68.0 p 50.11 73.95 0.24 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.624 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.407 HG21 ' SD ' ' C' ' 75' ' ' MET . 29.4 t -131.4 -71.99 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.65 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.56 64.76 3.25 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.843 -0.903 . . . . 1.0 110.843 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.37 -46.55 89.74 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.779 0.323 . . . . 1.0 110.752 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.96 23.1 0.97 Allowed Glycine 0 CA--C 1.528 0.885 0 N-CA-C 110.633 -0.987 . . . . 1.0 110.633 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.45 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 48.0 t0 -63.13 -41.05 99.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.898 0.38 . . . . 1.0 110.583 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.521 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 35.0 mmt180 -126.57 -174.68 3.19 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.531 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.521 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 79.2 m-85 -159.57 83.32 2.32 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.868 -179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.81 151.97 77.94 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 121.545 1.497 . . . . 1.0 112.092 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.442 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 16.8 m -96.68 -127.37 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.872 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' B' ' 66' ' ' GLU . 48.8 m -112.38 -55.84 2.47 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-O 120.728 0.299 . . . . 1.0 111.238 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 71.0 tt0 -43.87 -16.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.86 0.362 . . . . 1.0 110.804 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.66 ' CB ' ' HB1' ' B' ' 29' ' ' ALA . 0.0 OUTLIER -91.85 26.66 2.33 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 123.839 1.781 . . . . 1.0 109.477 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.701 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.89 64.35 1.09 Allowed Glycine 0 C--O 1.212 -1.26 0 CA-C-N 113.663 -1.608 . . . . 1.0 111.424 177.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.531 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 55.8 ttm-85 -24.87 -32.98 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.217 1.008 . . . . 1.0 110.737 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.701 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.6 mttt -48.0 -18.87 0.21 Allowed 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.917 -0.772 . . . . 1.0 108.917 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.628 ' N ' ' O ' ' B' ' 67' ' ' GLY . 65.0 t -64.28 -45.47 96.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 C-N-CA 120.124 -0.631 . . . . 1.0 109.803 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.92 -40.97 78.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 1.0 109.997 179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . 0.425 ' OE1' ' CG1' ' A' ' 49' ' ' VAL . 83.0 tt0 -65.39 -40.5 93.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.085 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 54.0 tp60 -59.69 -59.44 5.43 Favored 'General case' 0 N--CA 1.461 0.104 0 C-N-CA 120.721 -0.391 . . . . 1.0 111.087 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 98.2 t -65.2 -44.68 95.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.817 -0.353 . . . . 1.0 111.287 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 38.9 ttp -59.93 -47.52 85.43 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.921 -0.312 . . . . 1.0 110.798 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -67.64 -32.48 73.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.378 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -39.74 78.57 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.575 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.8 -43.05 96.74 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 92.2 mt -61.74 -43.45 97.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 O-C-N 122.813 -0.228 . . . . 1.0 110.87 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.13 -42.1 85.08 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.619 -0.433 . . . . 1.0 110.298 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.405 HG13 ' HB1' ' B' ' 11' ' ' ALA . 53.7 t -63.83 -50.13 78.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.033 -0.53 . . . . 1.0 111.344 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -68.39 -37.83 80.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.789 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.29 -37.85 88.95 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.555 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.425 ' C ' ' N ' ' B' ' 86' ' ' THR . 4.4 tt -62.66 -41.58 99.15 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.183 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.4 ' O ' HG12 ' B' ' 85' ' ' VAL . 82.7 t -51.96 -15.62 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.537 -0.542 . . . . 1.0 109.537 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.425 ' N ' ' C ' ' B' ' 84' ' ' LEU . 54.7 m -49.65 -40.81 40.96 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.611 -0.515 . . . . 1.0 109.611 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.64 ' HB2' ' CG ' ' A' ' 92' ' ' ASP . . . -50.35 -38.94 44.7 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.322 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.62 -11.67 59.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 1.0 110.678 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . . . . . . . . . 76.7 mt -92.69 -30.33 15.61 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.203 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.521 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -63.75 -40.44 96.72 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.47 0.652 . . . . 1.0 109.93 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.51 -5.31 49.57 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.246 -0.888 . . . . 1.0 109.932 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.524 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 51.4 t0 -54.99 -50.45 68.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.917 -178.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 20.7 p90 -67.87 -43.91 78.31 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.836 -0.345 . . . . 1.0 111.357 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 97.6 t -39.42 -27.46 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 1.0 111.709 -179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' B' ' 93' ' ' PHE . 34.7 mmt180 -63.25 -36.03 82.29 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.041 -0.264 . . . . 1.0 111.295 -179.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 48.7 ptt85 -43.91 -28.29 0.44 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 1.0 110.192 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.38 -45.78 92.3 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.87 -0.605 . . . . 1.0 110.983 -179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' B' ' 102' ' ' GLY . 97.0 mt-10 -70.22 -31.91 69.54 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.75 0.31 . . . . 1.0 110.685 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.17 -34.85 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.849 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.9 -44.61 96.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.958 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . 0.48 ' O ' ' CE1' ' B' ' 103' ' ' HIS . 95.8 mtt-85 -99.08 -0.9 40.86 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.896 0.379 . . . . 1.0 110.35 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' B' ' 98' ' ' GLU . . . 78.08 3.71 85.26 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.077 -0.809 . . . . 1.0 111.077 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' B' ' 101' ' ' ARG . 40.0 p-80 . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 118.038 -0.982 . . . . 1.0 110.529 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.851 ' HB3' ' CD2' ' C' ' 4' ' ' HIS . . . -155.15 12.03 0.35 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 56.85 53.2 8.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.966 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.851 ' CD2' ' HB3' ' C' ' 2' ' ' ALA . 0.3 OUTLIER -171.74 -30.31 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.911 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.515 ' N ' ' CD2' ' C' ' 4' ' ' HIS . 23.8 mm-40 -83.85 -22.52 31.67 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.768 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -62.95 -41.57 99.54 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.117 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -66.06 -44.95 83.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.31 179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.59 -37.62 88.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.467 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.7 -44.5 96.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.328 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.32 -33.43 75.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.203 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.34 -38.48 87.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.06 -0.518 . . . . 1.0 111.24 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -60.42 -37.81 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.786 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -65.78 -33.45 75.88 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.523 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -59.37 -44.7 92.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.473 -0.33 . . . . 1.0 110.796 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.447 HD21 ' HB1' ' C' ' 52' ' ' ALA . 42.6 tp -63.23 -41.42 99.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.604 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -58.08 -42.25 85.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.31 -0.405 . . . . 1.0 111.567 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.433 ' O ' ' OE1' ' C' ' 21' ' ' GLU . 56.4 mtmt -62.9 -40.8 98.68 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.952 -0.299 . . . . 1.0 111.147 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.48 -36.66 77.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.808 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' C' ' 52' ' ' ALA . 91.2 mt -60.81 -40.56 93.15 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.848 -0.341 . . . . 1.0 110.095 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -59.66 -50.69 72.87 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.701 -0.399 . . . . 1.0 110.146 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' C' ' 21' ' ' GLU . 12.2 mp0 -69.43 -43.0 74.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.29 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.51 -45.42 93.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.473 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.475 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 20.3 m -61.76 -44.95 95.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.731 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -66.19 -36.15 82.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.041 0.448 . . . . 1.0 109.856 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -72.98 -41.73 64.06 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.597 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.417 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -52.58 -52.96 52.67 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.471 -0.331 . . . . 1.0 111.537 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.474 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 4.2 p -62.8 -44.7 99.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.496 -0.482 . . . . 1.0 110.406 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.474 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 80.8 mm-40 -65.8 -37.01 85.12 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.575 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.41 -40.48 94.56 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.328 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.53 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.6 mp0 -70.25 -37.85 75.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.923 0.392 . . . . 1.0 110.69 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH2' ' OH ' ' C' ' 41' ' ' TYR . 25.5 mmt180 -56.64 100.79 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.721 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 116.09 -12.45 17.06 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 111.257 -0.737 . . . . 1.0 111.257 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.28 144.5 34.22 Favored Pre-proline 0 CA--C 1.533 0.322 0 O-C-N 122.772 -0.252 . . . . 1.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.454 ' O ' HG11 ' C' ' 63' ' ' VAL . 92.6 Cg_endo -76.07 143.04 25.38 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.036 1.824 . . . . 1.0 112.414 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.17 28.9 67.39 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.8 141.03 57.85 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.311 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -114.26 -35.83 4.87 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.414 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.498 HD23 ' O ' ' C' ' 38' ' ' LEU . 6.5 tt -92.29 77.55 5.18 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 109.946 -0.39 . . . . 1.0 109.946 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 25.7 pt -110.41 -7.63 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.921 0.391 . . . . 1.0 110.466 179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 3.9 m -81.9 134.93 35.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.46 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.558 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.2 OUTLIER -77.94 -48.57 2.11 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.965 -0.561 . . . . 1.0 110.847 178.658 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.5 Cg_endo -59.82 -28.73 87.91 Favored 'Trans proline' 0 N--CA 1.504 2.091 0 C-N-CA 121.675 1.583 . . . . 1.0 112.136 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -87.85 -17.28 31.83 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.383 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.87 -42.66 99.33 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.75 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.425 ' O ' HG23 ' C' ' 49' ' ' VAL . 8.3 tt -65.27 -42.1 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.413 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.429 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.73 -46.27 86.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.538 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.459 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 5.0 t90 -63.91 -40.95 97.67 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.462 -0.495 . . . . 1.0 109.819 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.475 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 64.6 p -60.14 -35.85 76.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.134 -178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.425 HG23 ' O ' ' C' ' 45' ' ' ILE . 42.3 t -61.79 -48.95 86.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.826 -0.35 . . . . 1.0 111.56 -179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.421 ' OE2' ' OD2' ' C' ' 59' ' ' ASP . 15.8 pt-20 -73.46 -25.81 60.65 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.549 -0.46 . . . . 1.0 110.861 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.459 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 27.4 m -62.55 -44.28 96.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 1.0 111.484 -179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -55.65 -20.41 13.9 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.696 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.542 ' C ' ' H ' ' C' ' 55' ' ' VAL . 4.9 p -84.31 -2.7 57.47 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.905 -0.318 . . . . 1.0 110.274 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 6.5 p 60.64 -3.62 0.14 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.999 -0.546 . . . . 1.0 110.726 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' C' ' 53' ' ' THR . 73.9 t -64.01 -44.84 97.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.795 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 70.79 -60.36 0.95 Allowed Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.479 -1.048 . . . . 1.0 110.479 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.556 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 2.5 t80 70.6 -41.65 0.5 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.72 0.295 . . . . 1.0 110.973 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 120.68 24.43 2.58 Favored Glycine 0 CA--C 1.527 0.809 0 N-CA-C 111.017 -0.833 . . . . 1.0 111.017 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.421 ' OD2' ' OE2' ' C' ' 50' ' ' GLU . 65.5 t0 -61.95 -48.04 82.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.984 0.421 . . . . 1.0 110.465 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.495 ' C ' ' CG ' ' C' ' 61' ' ' TYR . 96.3 mtt-85 -143.54 -177.5 5.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.039 -0.528 . . . . 1.0 109.887 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' C ' ' C' ' 60' ' ' ARG . 9.9 m-85 -155.02 106.79 2.29 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 120.606 -0.438 . . . . 1.0 111.01 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.16 156.42 64.99 Favored 'Trans proline' 0 N--CA 1.498 1.777 0 C-N-CA 121.725 1.616 . . . . 1.0 112.216 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.484 HG12 ' H ' ' C' ' 64' ' ' THR . 1.8 t -82.47 -140.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.061 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.484 ' H ' HG12 ' C' ' 63' ' ' VAL . 41.4 m -113.87 -38.93 4.1 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.836 0.351 . . . . 1.0 110.714 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.595 ' C ' ' H ' ' C' ' 67' ' ' GLY . 44.0 tt0 -63.64 -27.03 68.95 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.983 0.421 . . . . 1.0 110.008 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.44 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -73.17 30.21 0.07 Allowed 'General case' 0 C--O 1.263 1.796 0 CA-C-O 123.818 1.77 . . . . 1.0 110.109 179.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.703 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 40.53 64.03 1.27 Allowed Glycine 0 C--O 1.214 -1.126 0 CA-C-N 113.706 -1.588 . . . . 1.0 111.151 178.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.463 ' C ' ' O ' ' C' ' 67' ' ' GLY . 59.2 ttm-85 -24.09 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.768 0.784 . . . . 1.0 111.231 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.703 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.0 mttt -50.57 -16.51 0.38 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 120.328 -0.549 . . . . 1.0 109.764 176.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.558 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.5 t -61.44 -45.6 98.29 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 C-N-CA 119.441 -0.904 . . . . 1.0 110.34 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -28.6 61.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.201 0.524 . . . . 1.0 110.157 179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -69.53 -41.57 75.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.214 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 tm0? -63.85 -48.44 76.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.4 -0.364 . . . . 1.0 111.748 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.496 HG13 ' N ' ' C' ' 75' ' ' MET . 7.9 p -63.93 -44.06 97.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.314 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.496 ' N ' HG13 ' C' ' 74' ' ' VAL . 71.1 mtm -64.61 -41.09 96.44 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.991 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -62.52 -42.6 99.62 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.366 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.463 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -63.19 -39.74 95.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.862 0.363 . . . . 1.0 110.44 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.16 -42.68 97.9 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.75 -0.54 . . . . 1.0 111.75 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -62.54 -43.3 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.681 0.277 . . . . 1.0 110.625 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -67.14 -40.38 86.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.0 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 77' ' ' ALA . 51.6 t -62.96 -49.95 81.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.944 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.545 ' O ' HG22 ' C' ' 85' ' ' VAL . 42.2 m-85 -68.93 -38.87 79.78 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.82 -0.352 . . . . 1.0 111.177 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.56 -33.12 70.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.917 0.389 . . . . 1.0 110.857 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.482 ' C ' ' H ' ' C' ' 86' ' ' THR . 4.7 tt -61.82 -42.36 98.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 1.0 111.749 -179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.545 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.5 m -49.31 -11.55 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.568 -0.453 . . . . 1.0 110.415 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.482 ' H ' ' C ' ' C' ' 84' ' ' LEU . 48.5 m -48.75 -19.66 0.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.935 0.398 . . . . 1.0 110.267 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.524 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -60.02 -35.25 74.67 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.899 -0.591 . . . . 1.0 109.934 179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -82.17 -34.33 29.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.47 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 97.7 mt -65.42 -39.85 92.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.727 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.527 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -58.59 -47.95 82.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.081 0.467 . . . . 1.0 111.291 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.52 -4.12 34.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.036 -0.529 . . . . 1.0 110.335 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.489 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 43.1 t0 -57.4 -48.34 79.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.447 -0.342 . . . . 1.0 110.557 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.527 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 22.9 p90 -76.08 -43.7 42.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.069 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.511 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 80.0 t -42.11 -27.03 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.747 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -61.78 -22.39 65.39 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.959 -0.296 . . . . 1.0 111.249 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -73.99 -7.68 53.3 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.816 0.341 . . . . 1.0 110.605 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -57.76 -51.26 70.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.73 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -68.57 -35.19 77.06 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.986 0.422 . . . . 1.0 110.565 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -61.45 -24.3 66.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.428 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 78.9 ttt-85 -60.23 -44.39 95.24 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.266 -0.424 . . . . 1.0 110.579 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -105.4 -4.88 20.91 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.518 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.79 8.82 87.56 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 m170 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.047 -0.977 . . . . 1.0 110.508 -179.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' D' ' 2' ' ' ALA . 75.7 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.365 -0.606 . . . . 1.0 109.365 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' D' ' 1' ' ' SER . . . 72.15 -50.7 0.7 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.568 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 71.17 -32.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 1.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' D' ' 2' ' ' ALA . 28.5 p80 -82.26 -19.96 38.52 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.91 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -69.04 -40.66 78.46 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.805 0.336 . . . . 1.0 110.624 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -65.3 -38.04 89.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 1.0 110.511 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -62.07 -44.55 96.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.066 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.62 -39.17 91.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.035 -0.53 . . . . 1.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.16 -41.33 94.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.54 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -63.79 -36.33 83.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.599 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -38.28 82.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.0 111.048 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.91 -41.16 97.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.855 0.36 . . . . 1.0 110.692 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -65.81 -33.24 75.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.503 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . 0.434 ' O ' HG23 ' D' ' 18' ' ' VAL . 81.6 tt0 -63.32 -38.52 91.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.53 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.449 HD13 ' HA2' ' D' ' 78' ' ' GLY . 41.9 tp -62.64 -39.84 95.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.807 -0.357 . . . . 1.0 110.551 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -57.97 -40.7 81.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.161 -0.472 . . . . 1.0 111.289 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 21.1 pttt -75.82 -18.03 59.62 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.957 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.434 HG23 ' O ' ' D' ' 14' ' ' GLU . 37.9 t -76.89 -56.48 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.04 0.448 . . . . 1.0 111.169 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.426 ' H ' ' HG ' ' D' ' 19' ' ' LEU . 1.9 pp -62.36 -28.44 69.77 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.921 -0.581 . . . . 1.0 109.733 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 73.6 mt-10 -64.39 -44.54 91.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.229 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -66.32 -36.68 83.54 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.888 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' D' ' 74' ' ' VAL . . . -65.32 -35.04 79.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.759 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -58.12 -43.89 87.47 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.958 -0.297 . . . . 1.0 110.845 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.04 -32.71 74.15 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.49 -0.484 . . . . 1.0 110.06 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -84.84 -32.3 23.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.81 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.423 ' N ' ' O ' ' D' ' 22' ' ' ALA . . . -60.86 -45.37 94.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.673 -0.239 . . . . 1.0 111.062 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.525 HG13 ' N ' ' D' ' 28' ' ' GLU . 5.5 p -61.3 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.089 0.471 . . . . 1.0 109.918 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.525 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.9 tm-20 -69.26 -40.76 77.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.827 -0.624 . . . . 1.0 110.386 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.4 -45.05 94.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.592 . . . . 1.0 110.337 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' D' ' 38' ' ' LEU . 26.0 tp10 -72.12 -38.52 69.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.869 0.366 . . . . 1.0 110.944 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -65.35 120.49 12.88 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.725 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.48 2.27 55.52 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.343 -0.703 . . . . 1.0 111.343 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.595 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -101.75 149.29 36.34 Favored Pre-proline 0 CA--C 1.532 0.259 0 O-C-N 122.899 -0.177 . . . . 1.0 110.775 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -74.49 131.66 15.2 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.931 1.754 . . . . 1.0 111.965 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.22 7.05 88.23 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -45.72 143.25 2.1 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.909 0.385 . . . . 1.0 110.451 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -137.03 -11.29 1.72 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.436 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.497 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.7 tt -110.53 120.37 42.19 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.021 0.438 . . . . 1.0 109.982 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' D' ' 40' ' ' SER . 37.0 pt -143.47 -165.72 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.366 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 3.2 m 58.25 132.67 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.516 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.573 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -74.6 -48.76 5.07 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.0 -0.546 . . . . 1.0 110.611 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.0 Cg_endo -59.04 -30.73 94.11 Favored 'Trans proline' 0 N--CA 1.498 1.782 0 C-N-CA 121.438 1.426 . . . . 1.0 111.943 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.22 -25.93 23.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.307 -0.406 . . . . 1.0 111.171 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.3 90.52 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.568 -0.287 . . . . 1.0 110.766 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.408 HG22 ' H ' ' D' ' 45' ' ' ILE . 6.2 tt -63.19 -37.21 78.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.248 179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.4 OUTLIER -65.92 -46.6 77.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.18 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.556 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 2.3 t90 -57.47 -29.77 64.52 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.264 -0.643 . . . . 1.0 109.264 178.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.83 -34.65 66.97 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.929 0.395 . . . . 1.0 110.814 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 59.7 t -60.8 -48.68 87.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.481 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 12.4 pt-20 -62.8 -38.2 89.76 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.656 -0.498 . . . . 1.0 109.656 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.73 HG22 ' H ' ' D' ' 52' ' ' ALA . 20.7 m -77.64 178.57 7.19 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.663 -0.866 . . . . 1.0 108.663 178.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.73 ' H ' HG22 ' D' ' 51' ' ' THR . . . 78.47 -18.22 0.52 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 -179.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.446 ' H ' ' C ' ' D' ' 51' ' ' THR . 59.0 p -106.52 9.32 31.58 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.451 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.406 ' OG1' ' O ' ' D' ' 53' ' ' THR . 12.0 p 56.89 67.24 1.02 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.955 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 83.8 t -150.95 -80.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.724 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 60.4 96.67 0.01 OUTLIER Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.813 -0.915 . . . . 1.0 110.813 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.409 ' OH ' ' CE ' ' A' ' 75' ' ' MET . 59.5 m-85 -61.72 -43.22 99.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.689 0.281 . . . . 1.0 110.814 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.51 12.78 1.54 Allowed Glycine 0 CA--C 1.526 0.777 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.81 -50.41 74.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.905 0.383 . . . . 1.0 110.462 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 88.7 mtt-85 -144.68 125.98 14.78 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 109.244 -0.65 . . . . 1.0 109.244 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -114.66 138.9 23.46 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 116.608 -0.269 . . . . 1.0 110.956 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -70.64 160.39 49.6 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.469 2.112 . . . . 1.0 111.875 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.88 HG22 ' H ' ' D' ' 64' ' ' THR . 10.0 p -97.61 -140.93 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.002 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.88 ' H ' HG22 ' D' ' 63' ' ' VAL . 51.8 m -114.21 -43.68 3.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.312 -0.403 . . . . 1.0 111.044 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.581 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -66.6 -19.98 65.9 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 120.827 -0.349 . . . . 1.0 110.58 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.428 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.3 OUTLIER -75.69 25.84 0.11 Allowed 'General case' 0 C--O 1.262 1.723 0 CA-C-O 123.993 1.854 . . . . 1.0 109.213 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.743 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 45.59 62.79 3.07 Favored Glycine 0 N--CA 1.437 -1.284 0 CA-C-N 114.0 -1.454 . . . . 1.0 109.841 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 57.0 ttm-85 -25.62 -29.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 117.458 0.629 . . . . 1.0 111.03 -178.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.743 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.22 -28.06 6.97 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 115.603 -0.726 . . . . 1.0 109.24 176.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.578 ' N ' ' O ' ' D' ' 67' ' ' GLY . 78.4 t -63.05 -48.8 86.18 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 C-N-CA 119.653 -0.819 . . . . 1.0 110.121 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . 0.516 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -74.26 -51.99 13.68 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.47 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.6 tp10 -49.8 -40.31 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.082 -0.508 . . . . 1.0 111.096 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -62.29 -40.37 96.06 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.354 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.452 ' CG1' ' HB2' ' D' ' 52' ' ' ALA . 70.5 t -62.38 -45.19 99.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.481 -0.488 . . . . 1.0 111.431 -179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' D' ' 51' ' ' THR . 3.8 mpp? -64.25 -42.08 96.66 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.947 -0.301 . . . . 1.0 111.066 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -63.97 -42.03 97.38 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.843 -0.343 . . . . 1.0 110.836 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.505 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -62.8 -36.53 83.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.896 0.379 . . . . 1.0 110.751 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.449 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -69.6 -40.15 77.83 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.639 -0.585 . . . . 1.0 111.639 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 89.5 mt -62.34 -44.65 99.43 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.788 0.294 . . . . 1.0 111.708 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' D' ' 80' ' ' GLU . 9.4 pt-20 -65.92 -35.67 81.27 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.745 -0.382 . . . . 1.0 111.152 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.505 HG23 ' O ' ' D' ' 77' ' ' ALA . 42.0 t -62.17 -48.67 87.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.552 -0.294 . . . . 1.0 111.263 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -73.78 -4.65 35.96 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.878 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.41 -32.37 11.89 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.022 179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.7 tt -65.11 -40.04 93.96 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.442 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 16.9 m -53.7 -6.69 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.191 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.502 ' O ' ' N ' ' D' ' 89' ' ' LEU . 71.1 m -58.19 -43.54 87.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.339 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.489 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -42.78 -30.46 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.476 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -86.57 -32.92 20.41 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.066 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' D' ' 86' ' ' THR . 90.6 mt -67.34 -39.22 85.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.228 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -59.01 -48.18 82.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.182 0.515 . . . . 1.0 111.101 -179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.428 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -73.97 -4.98 38.53 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.209 -179.109 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.504 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 46.7 t0 -55.14 -49.36 72.0 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.534 -0.303 . . . . 1.0 111.102 -179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 26.7 p90 -73.37 -44.13 59.25 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.87 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.508 ' N ' ' CG ' ' D' ' 93' ' ' PHE . 59.0 t -42.47 -26.65 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.219 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 17.6 tpt85 -58.4 -32.29 68.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.957 -179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -58.77 -34.32 71.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.93 0.395 . . . . 1.0 110.418 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.483 ' C ' ' H ' ' D' ' 99' ' ' GLU . 67.2 tt0 -72.7 162.84 28.97 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.159 -0.682 . . . . 1.0 109.159 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 68.23 -41.83 0.45 Allowed 'General case' 0 N--CA 1.465 0.28 0 O-C-N 123.782 0.676 . . . . 1.0 110.49 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.483 ' H ' ' C ' ' D' ' 97' ' ' GLU . 80.1 mm-40 -66.21 -36.37 82.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.398 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -60.82 -44.32 97.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.0 110.127 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -76.74 -14.76 59.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.583 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.57 8.84 85.58 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . 0.433 ' OXT' ' CG ' ' D' ' 103' ' ' HIS . 85.9 t60 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 117.963 -1.017 . . . . 1.0 110.487 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.9 p . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.311 -0.625 . . . . 1.0 109.311 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -46.2 -73.81 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.485 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 4' ' ' HIS . 31.5 p-10 -172.57 -46.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.55 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.442 ' N ' ' OD1' ' A' ' 3' ' ' ASP . 43.0 p-80 -78.92 -29.98 44.51 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.53 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.71 -35.93 81.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.598 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.0 mtp180 -63.15 -37.81 88.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.291 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -64.22 -41.89 96.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.063 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.86 -38.87 92.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.357 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -65.82 -39.26 90.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.353 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.79 -41.19 97.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.617 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.52 -36.43 80.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.869 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.02 -36.82 85.24 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.66 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.29 -34.55 78.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.487 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.567 ' CD ' ' HZ1' ' A' ' 17' ' ' LYS . 39.7 tp10 -64.95 -36.35 84.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.451 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.451 HD13 ' HA2' ' A' ' 78' ' ' GLY . 51.5 tp -62.72 -42.13 99.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.877 0.37 . . . . 1.0 110.737 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.49 -39.61 94.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 1.0 111.307 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.567 ' HZ1' ' CD ' ' A' ' 14' ' ' GLU . 6.8 ttpm? -62.41 -40.07 95.33 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.786 -0.365 . . . . 1.0 111.13 -179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 80.7 t -62.88 -35.66 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.429 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.546 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.5 mt -61.06 -42.46 98.54 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.783 -0.367 . . . . 1.0 110.216 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -66.54 -43.29 85.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.263 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -69.6 -39.65 77.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.389 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.96 -40.48 96.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.967 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.6 m -61.09 -42.83 99.23 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.922 0.391 . . . . 1.0 110.182 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -66.41 -33.45 75.73 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.764 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -81.69 -46.69 13.96 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.248 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.93 -44.58 78.49 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.549 -178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' CG1' ' N ' ' A' ' 28' ' ' GLU . 4.7 p -59.51 -46.92 92.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.117 -0.633 . . . . 1.0 109.694 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 94.6 mt-10 -71.55 -33.8 69.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.653 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.29 97.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.266 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -89.89 -4.34 57.59 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.305 -0.407 . . . . 1.0 111.143 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -75.37 91.08 2.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.577 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.6 -15.36 17.25 Favored Glycine 0 N--CA 1.466 0.67 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.14 148.67 97.72 Favored Pre-proline 0 C--N 1.327 -0.389 0 C-N-CA 120.786 -0.365 . . . . 1.0 110.028 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' HG11 ' A' ' 63' ' ' VAL . 93.0 Cg_endo -75.18 139.66 24.08 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.865 1.71 . . . . 1.0 112.333 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.62 21.92 74.92 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.64 166.35 16.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.902 0.382 . . . . 1.0 110.554 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.415 ' H ' ' H ' ' A' ' 38' ' ' LEU . . . -151.66 -12.35 0.2 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.231 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.546 ' O ' ' N ' ' A' ' 40' ' ' SER . 40.2 tp -67.72 -19.07 65.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.087 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' LEU . 95.3 mt -33.63 89.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-O 121.273 0.559 . . . . 1.0 110.954 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' LEU . 8.7 t -171.66 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.535 -0.757 . . . . 1.0 110.561 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.405 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 22.0 t80 -179.27 -57.8 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.726 0 O-C-N 123.142 0.276 . . . . 1.0 111.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.425 ' O ' HG22 ' A' ' 45' ' ' ILE . 30.3 Cg_endo -60.09 -31.65 93.63 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 121.782 1.655 . . . . 1.0 112.5 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.0 p30 -82.55 -10.12 59.12 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.233 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.25 84.06 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.87 0.366 . . . . 1.0 110.246 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 49' ' ' VAL . 6.7 tt -67.69 -38.33 80.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.475 178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.543 ' CD1' HG22 ' B' ' 64' ' ' THR . 0.4 OUTLIER -63.96 -50.47 68.48 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.163 -179.424 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 8.4 t90 -62.36 -42.82 99.71 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.751 -0.463 . . . . 1.0 109.751 178.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 74.7 m -53.64 -36.05 61.63 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.676 -179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' A' ' 49' ' ' VAL . 57.8 t -82.99 -4.86 8.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.831 0.348 . . . . 1.0 110.459 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -107.82 37.19 2.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.375 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.422 HG23 HG11 ' A' ' 74' ' ' VAL . 0.8 OUTLIER -148.74 -35.84 0.19 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.57 179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.546 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.31 -24.68 63.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.496 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 54' ' ' THR . 70.2 p -89.69 5.29 46.51 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 109.564 -0.532 . . . . 1.0 109.564 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 53' ' ' THR . 44.7 p 54.46 71.03 0.55 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.546 -0.752 . . . . 1.0 111.142 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 53.2 t -143.85 -95.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.741 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.32 84.68 1.01 Allowed Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.536 -0.626 . . . . 1.0 111.536 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -62.78 -41.72 99.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.768 0.318 . . . . 1.0 110.556 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 140.24 20.49 0.36 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.001 -0.84 . . . . 1.0 111.001 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -64.32 -35.36 80.6 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.697 ' NH2' HH22 ' B' ' 68' ' ' ARG . 2.1 tpp180 -134.77 179.07 6.53 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.348 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.551 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 75.1 m-85 -160.94 93.88 1.47 Allowed Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 115.883 -0.598 . . . . 1.0 110.739 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.35 149.74 69.89 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.713 1.609 . . . . 1.0 112.216 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.51 HG11 ' O ' ' A' ' 34' ' ' PRO . 1.5 t -85.76 -143.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.305 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' A' ' 63' ' ' VAL . 52.1 m -110.34 -38.78 5.15 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.697 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.526 ' C ' ' H ' ' A' ' 67' ' ' GLY . 84.2 tt0 -61.46 -20.73 63.47 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.059 0.457 . . . . 1.0 109.822 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.45 ' OE2' ' O ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -78.14 25.77 0.22 Allowed 'General case' 0 C--O 1.267 1.995 0 CA-C-O 123.915 1.817 . . . . 1.0 109.516 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 43.94 65.47 1.6 Allowed Glycine 0 N--CA 1.44 -1.06 0 CA-C-N 113.649 -1.614 . . . . 1.0 111.12 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.48 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 55.6 ttm-85 -24.45 -32.94 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 117.975 0.888 . . . . 1.0 110.999 -178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 99.1 mttt -47.24 -26.25 1.15 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 115.767 -0.651 . . . . 1.0 109.422 176.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.4 t -63.26 -46.47 95.61 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 119.764 -0.774 . . . . 1.0 110.618 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.34 62.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.31 -0.404 . . . . 1.0 111.012 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -61.31 -41.27 96.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.835 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 21.1 tm0? -55.57 -43.82 76.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.821 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.422 HG11 HG23 ' A' ' 51' ' ' THR . 95.0 t -66.75 -44.72 89.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 C-N-CA 120.486 -0.486 . . . . 1.0 111.005 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.508 ' SD ' HG11 ' D' ' 55' ' ' VAL . 64.3 mtt -61.87 -43.64 98.43 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.938 -0.305 . . . . 1.0 110.637 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -65.78 -41.06 92.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.831 0.348 . . . . 1.0 110.299 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -59.76 -40.67 88.96 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.629 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.451 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.28 -43.74 92.24 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.838 -0.905 . . . . 1.0 110.838 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.07 -43.53 97.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 121.082 -0.247 . . . . 1.0 110.395 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -63.74 -43.19 97.2 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.617 -0.433 . . . . 1.0 110.246 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 77' ' ' ALA . 55.6 t -64.77 -50.02 77.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.328 -0.397 . . . . 1.0 110.796 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -68.29 -37.36 80.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.24 -0.436 . . . . 1.0 110.95 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.12 -37.68 88.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.685 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.1 tt -65.69 -37.45 86.49 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.234 -0.439 . . . . 1.0 111.24 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 85' ' ' VAL . 71.3 t -46.06 -13.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 C-N-CA 120.754 -0.379 . . . . 1.0 110.42 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 16.2 m -58.79 -45.17 90.47 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.727 -0.471 . . . . 1.0 109.727 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.495 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -40.93 -21.09 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.758 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -106.62 -25.35 11.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.544 -0.298 . . . . 1.0 111.73 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 86' ' ' THR . 69.6 mt -62.79 -42.22 99.6 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.728 0.27 . . . . 1.0 111.728 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.576 ' O ' HG23 ' A' ' 94' ' ' VAL . . . -72.96 -65.24 0.82 Allowed 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.647 -0.421 . . . . 1.0 111.36 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.495 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -47.56 -10.64 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.942 -0.572 . . . . 1.0 110.229 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 90' ' ' ALA . 46.9 t0 -63.18 -73.95 0.1 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.25 -0.432 . . . . 1.0 111.024 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.553 ' CE1' ' HB2' ' B' ' 87' ' ' ALA . 25.1 m-85 -86.46 -27.98 23.77 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 111.952 0.353 . . . . 1.0 111.952 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 90' ' ' ALA . 56.3 t -40.88 -27.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-O 120.515 0.198 . . . . 1.0 111.274 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 98' ' ' GLU . 95.7 mtt-85 -61.17 -32.99 72.72 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.981 -0.288 . . . . 1.0 111.005 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.8 ptt-85 -39.43 -38.68 0.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.715 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.43 -41.8 75.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.002 0.43 . . . . 1.0 109.906 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 95' ' ' ARG . 80.1 mm-40 -68.16 -35.79 78.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.492 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.27 -43.86 97.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.41 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.427 HH21 ' NH2' ' A' ' 101' ' ' ARG . 42.2 ttp-105 -65.57 -42.72 91.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.309 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' NH2' HH21 ' A' ' 100' ' ' ARG . 89.5 mtm180 -130.91 102.22 5.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.505 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.77 27.73 5.06 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 34.0 p80 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 117.945 -1.026 . . . . 1.0 110.683 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 10.9 t . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.439 -0.578 . . . . 1.0 109.439 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.515 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . -160.94 171.4 18.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.669 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' B' ' 3' ' ' ASP . 65.7 t0 -63.56 -39.02 93.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.903 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.515 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 16.1 p-80 -80.7 -29.63 36.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 1.0 110.615 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -66.23 -44.26 84.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.135 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 35.4 ptt180 -69.89 -36.01 75.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.83 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -67.79 -40.42 83.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.986 0.422 . . . . 1.0 110.162 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.22 -43.8 98.0 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.583 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 -67.85 -32.49 73.05 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.335 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 41.7 tptt -62.24 -39.46 92.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.365 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.1 -40.34 80.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.767 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.6 -36.85 81.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.396 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -65.73 -41.18 92.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.0 110.242 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.63 -30.88 71.65 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.977 -0.556 . . . . 1.0 110.363 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.668 HD11 ' HB1' ' B' ' 52' ' ' ALA . 40.6 tp -61.27 -41.86 97.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.37 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -60.24 -42.85 96.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.712 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -64.15 -37.93 89.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.54 -0.3 . . . . 1.0 111.711 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 75.5 t -62.81 -66.78 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.214 0.45 . . . . 1.0 112.214 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pp -55.12 -31.56 61.36 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.837 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -63.45 -44.66 93.86 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -64.52 -36.63 84.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.631 -0.507 . . . . 1.0 109.631 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.61 75.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.902 -0.59 . . . . 1.0 109.854 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.466 ' O ' HG23 ' B' ' 27' ' ' VAL . 25.2 p -55.73 -44.45 77.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.483 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -58.58 -56.35 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.077 -0.649 . . . . 1.0 109.856 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.1 -38.97 80.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.267 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.42 -41.45 76.41 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.131 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.466 HG23 ' O ' ' B' ' 23' ' ' SER . 90.2 t -63.58 -48.56 86.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.263 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -70.88 -35.81 72.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.752 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.6 -46.43 84.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.0 110.201 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.452 ' CB ' ' O ' ' B' ' 38' ' ' LEU . 41.9 mm-40 -70.51 -42.56 71.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.877 0.37 . . . . 1.0 110.904 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -53.6 94.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.899 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.434 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 115.85 11.25 10.33 Favored Glycine 0 N--CA 1.465 0.622 0 N-CA-C 111.15 -0.78 . . . . 1.0 111.15 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.427 ' CB ' ' OE2' ' B' ' 66' ' ' GLU . . . -102.03 137.41 19.48 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.614 0.207 . . . . 1.0 110.617 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -76.03 138.86 21.1 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 121.869 1.713 . . . . 1.0 112.407 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.4 3.4 39.25 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.208 -0.757 . . . . 1.0 111.208 179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . -47.14 176.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.884 0.373 . . . . 1.0 110.399 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.27 -28.92 0.26 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.537 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.452 ' O ' ' CB ' ' B' ' 30' ' ' GLU . 23.0 tp -99.49 119.81 38.61 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.965 0.412 . . . . 1.0 110.26 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.34 64.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.859 -0.609 . . . . 1.0 110.036 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 2.5 p -169.26 128.99 1.05 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 1.0 111.372 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.572 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.2 OUTLIER -58.62 -51.45 81.73 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.669 -0.696 . . . . 1.0 111.176 178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.3 Cg_endo -57.85 -32.24 94.48 Favored 'Trans proline' 0 N--CA 1.497 1.699 0 C-N-CA 121.701 1.601 . . . . 1.0 112.682 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.434 ' N ' ' OD1' ' B' ' 43' ' ' ASP . 2.4 m-20 -93.22 -23.24 18.61 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.762 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.99 94.42 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.878 0.37 . . . . 1.0 110.568 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 tt -64.27 -37.54 80.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.0 110.41 179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -44.98 86.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.441 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.44 -40.33 94.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.502 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 1.1 m -61.47 -36.33 80.12 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.842 -0.343 . . . . 1.0 111.171 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.99 -48.07 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 N-CA-C 111.982 0.364 . . . . 1.0 111.982 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -67.88 -30.5 69.87 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.846 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -62.51 -45.08 94.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.325 -0.398 . . . . 1.0 111.565 -179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.668 ' HB1' HD11 ' B' ' 15' ' ' LEU . . . -59.73 -32.15 70.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.013 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' B' ' 54' ' ' THR . 45.0 p -71.82 -6.75 43.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.503 -0.317 . . . . 1.0 110.799 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' B' ' 53' ' ' THR . 12.2 p 56.38 65.28 1.46 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.284 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.584 HG11 ' CE1' ' B' ' 57' ' ' TYR . 92.7 t -150.37 -47.55 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.584 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 42.85 83.38 0.02 OUTLIER Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.934 -0.867 . . . . 1.0 110.934 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.584 ' CE1' HG11 ' B' ' 55' ' ' VAL . 33.1 m-85 -62.83 -41.6 99.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.786 0.327 . . . . 1.0 110.928 -179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.54 ' O ' ' N ' ' B' ' 60' ' ' ARG . . . 167.62 -90.25 0.1 OUTLIER Glycine 0 CA--C 1.523 0.581 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 77.1 m-20 42.56 -88.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.84 0.352 . . . . 1.0 110.9 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.54 ' N ' ' O ' ' B' ' 58' ' ' GLY . 25.6 mmt180 -115.61 -173.39 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.194 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.491 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 38.7 p90 -173.77 118.54 0.37 Allowed Pre-proline 0 CA--C 1.541 0.611 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.246 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.35 158.12 58.65 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.565 1.51 . . . . 1.0 112.251 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.468 ' H ' ' CG ' ' B' ' 66' ' ' GLU . 2.8 t -97.22 -126.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.039 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.543 HG22 ' CD1' ' A' ' 46' ' ' TRP . 5.9 p -114.3 -36.56 4.63 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.777 0.322 . . . . 1.0 111.144 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.538 ' C ' ' H ' ' B' ' 67' ' ' GLY . 77.7 tt0 -65.29 -31.48 72.65 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.553 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.528 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 1.3 pm0 -79.26 30.33 0.22 Allowed 'General case' 0 C--O 1.269 2.115 0 CA-C-O 123.969 1.842 . . . . 1.0 109.797 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 37.57 61.92 1.01 Allowed Glycine 0 C--O 1.212 -1.237 0 CA-C-N 113.092 -1.867 . . . . 1.0 111.045 178.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.697 HH22 ' NH2' ' A' ' 60' ' ' ARG . 40.5 ttm180 -24.96 -32.75 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 118.186 0.993 . . . . 1.0 110.947 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' B' ' 67' ' ' GLY . 68.3 mttm -49.42 -16.48 0.2 Allowed 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 108.835 -0.802 . . . . 1.0 108.835 176.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.629 ' N ' ' O ' ' B' ' 67' ' ' GLY . 55.9 t -63.35 -46.1 96.36 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 C-N-CA 119.788 -0.765 . . . . 1.0 109.578 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.58 72.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.241 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -54.12 -43.92 70.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.343 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.35 -44.22 88.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.825 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -66.34 -43.51 91.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.323 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 37.0 mtt -59.11 -44.86 92.0 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.82 -0.352 . . . . 1.0 110.721 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -64.19 -42.58 96.6 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.599 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.58 -39.74 89.17 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.65 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.13 -36.81 93.71 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 110.919 -0.873 . . . . 1.0 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.89 -26.9 28.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 122.424 -0.457 . . . . 1.0 111.523 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.29 -50.6 37.79 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.042 0.449 . . . . 1.0 111.206 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' H ' ' B' ' 82' ' ' PHE . 5.7 m -60.04 -48.7 86.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.618 -0.719 . . . . 1.0 111.355 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.442 ' H ' HG23 ' B' ' 81' ' ' VAL . 20.6 m-85 -66.03 -34.55 78.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.835 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.47 -23.67 37.26 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.697 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.521 ' C ' ' H ' ' B' ' 86' ' ' THR . 5.2 tt -69.97 -23.43 63.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.379 . . . . 1.0 110.114 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.534 ' O ' HG12 ' B' ' 85' ' ' VAL . 98.6 t -57.29 -3.7 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 C-N-CA 120.409 -0.516 . . . . 1.0 109.644 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.521 ' H ' ' C ' ' B' ' 84' ' ' LEU . 14.6 t -49.32 -39.0 29.71 Favored 'General case' 0 CA--C 1.522 -0.106 0 CA-C-O 121.404 0.621 . . . . 1.0 109.585 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.553 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -46.69 -35.63 6.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.155 -0.93 . . . . 1.0 110.423 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -87.23 -10.85 51.42 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.585 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' B' ' 92' ' ' ASP . 85.7 mt -85.29 -56.87 3.32 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.891 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.471 ' HB1' HG22 ' A' ' 94' ' ' VAL . . . -42.38 -43.37 3.53 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.293 0.568 . . . . 1.0 109.989 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.533 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.0 OUTLIER -61.11 -37.56 83.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.574 -179.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.588 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 11.1 t0 -59.56 -44.48 93.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.617 -179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.461 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 0.5 OUTLIER -61.25 -48.95 79.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.756 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.402 ' O ' ' N ' ' B' ' 96' ' ' ARG . 95.9 t -64.93 -43.83 96.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.738 -178.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.533 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 46.9 mtt85 -44.79 -20.9 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.459 -179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.402 ' N ' ' O ' ' B' ' 94' ' ' VAL . 52.3 ptt85 -52.85 -33.13 48.16 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.247 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.51 ' O ' ' N ' ' B' ' 99' ' ' GLU . 7.5 pt-20 -112.76 -169.11 1.42 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.438 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 39.87 22.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.334 -0.394 . . . . 1.0 111.157 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.51 ' N ' ' O ' ' B' ' 97' ' ' GLU . 82.0 tt0 -132.15 -48.34 0.93 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.796 0.332 . . . . 1.0 110.735 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 34.8 ptt-85 -60.15 -36.54 77.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.371 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.43 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.508 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.45 25.17 44.09 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.339 -0.705 . . . . 1.0 111.339 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 84.3 t60 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.555 179.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . 0.411 ' O ' ' O ' ' C' ' 2' ' ' ALA . 42.8 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.403 -0.591 . . . . 1.0 109.403 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' C' ' 1' ' ' SER . . . 59.99 136.87 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.82 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.85 -21.29 40.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.427 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.645 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 2.8 p80 -78.78 -27.7 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 1.0 111.054 -179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.645 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 84.7 tt0 -70.04 -32.75 71.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.739 0.304 . . . . 1.0 110.813 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -59.36 -41.58 89.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.116 -179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 46.5 tp10 -60.58 -39.95 89.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.187 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.87 -37.38 87.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.308 -0.406 . . . . 1.0 110.525 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -58.06 -42.45 85.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.398 -0.364 . . . . 1.0 110.529 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -62.6 -34.6 77.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.997 0.427 . . . . 1.0 110.464 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.48 ' HB2' HD22 ' C' ' 84' ' ' LEU . . . -58.5 -37.95 76.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.922 -0.581 . . . . 1.0 111.001 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.29 -32.82 74.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.004 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -60.2 -41.97 94.12 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.705 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -64.44 -39.95 94.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.062 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.457 HD11 ' HB1' ' C' ' 52' ' ' ALA . 50.0 tp -62.39 -42.36 99.36 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.86 -0.336 . . . . 1.0 110.649 -179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -65.61 -41.88 92.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 1.0 111.6 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -63.36 -38.46 91.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.793 0.33 . . . . 1.0 111.155 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.68 -42.77 97.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.165 -0.47 . . . . 1.0 110.754 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' C' ' 52' ' ' ALA . 67.1 mt -60.0 -41.73 92.71 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.239 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.425 ' O ' ' OG ' ' C' ' 23' ' ' SER . 96.6 mt-10 -64.5 -42.63 95.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.91 -0.404 . . . . 1.0 109.91 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -70.35 -39.0 74.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.492 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.29 -37.53 85.64 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.996 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -58.27 -46.21 86.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.617 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -66.41 -35.71 81.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.281 0.562 . . . . 1.0 109.964 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -70.6 -40.93 72.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.958 -0.565 . . . . 1.0 110.321 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.82 -50.14 73.29 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.33 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' C' ' 44' ' ' ALA . 18.9 m -61.43 -44.43 98.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.494 -0.482 . . . . 1.0 110.403 -179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' HG23 ' C' ' 27' ' ' VAL . 40.3 tp10 -69.6 -41.83 75.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.539 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.89 94.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 1.0 110.439 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -78.65 -6.76 56.58 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.965 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -87.74 117.47 26.6 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 120.929 0.395 . . . . 1.0 110.119 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.47 -4.02 63.94 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.233 -0.747 . . . . 1.0 111.233 179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.3 144.09 37.75 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 110.2 -0.296 . . . . 1.0 110.2 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.492 ' O ' HG11 ' C' ' 63' ' ' VAL . 97.6 Cg_endo -75.93 137.79 20.11 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.9 1.734 . . . . 1.0 112.346 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.75 14.9 75.6 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.159 -0.776 . . . . 1.0 111.159 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.55 149.06 47.15 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.281 . . . . 1.0 110.383 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -147.62 41.8 1.05 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.509 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.493 HD23 ' C ' ' C' ' 38' ' ' LEU . 3.7 tt -127.53 -67.15 0.84 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.435 -0.348 . . . . 1.0 110.191 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.436 ' C ' ' O ' ' C' ' 38' ' ' LEU . 19.2 pt 31.59 -123.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 O-C-N 123.557 0.536 . . . . 1.0 110.862 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 4.8 t 47.82 -130.63 1.59 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.731 0.301 . . . . 1.0 110.754 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.466 ' HA ' HG11 ' C' ' 27' ' ' VAL . 5.9 t80 177.85 -59.37 0.0 OUTLIER Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.013 -0.54 . . . . 1.0 110.454 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.1 Cg_endo -59.33 -33.95 97.74 Favored 'Trans proline' 0 N--CA 1.499 1.839 0 C-N-CA 121.927 1.751 . . . . 1.0 112.105 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -78.01 -6.04 53.22 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.226 -0.443 . . . . 1.0 111.53 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.49 ' HB2' ' CG1' ' C' ' 27' ' ' VAL . . . -64.3 -44.82 90.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.879 0.371 . . . . 1.0 111.348 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.474 HG23 ' HE3' ' C' ' 46' ' ' TRP . 10.1 tt -66.14 -33.9 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.474 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.3 OUTLIER -64.08 -48.54 75.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.258 -179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -64.45 -42.61 95.86 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.272 -0.571 . . . . 1.0 109.965 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -52.81 -39.45 62.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.739 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.522 ' C ' ' H ' ' C' ' 51' ' ' THR . 71.2 t -65.47 -43.93 94.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.46 -0.336 . . . . 1.0 111.513 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -71.64 24.84 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.633 -0.427 . . . . 1.0 110.884 -178.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.522 ' H ' ' C ' ' C' ' 49' ' ' VAL . 96.1 m -127.78 -43.85 1.52 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 116.674 -0.239 . . . . 1.0 111.108 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.93 -25.13 66.55 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.578 -179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.513 ' OG1' HG13 ' C' ' 55' ' ' VAL . 16.9 p -89.9 4.4 50.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.834 0.349 . . . . 1.0 110.12 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 44.2 p 52.19 35.76 17.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.813 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.594 HG11 ' SD ' ' D' ' 75' ' ' MET . 31.3 m -75.35 -35.87 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 1.0 111.212 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.516 ' O ' ' CD2' ' B' ' 57' ' ' TYR . . . 100.11 -76.3 0.45 Allowed Glycine 0 N--CA 1.466 0.655 0 N-CA-C 110.694 -0.962 . . . . 1.0 110.694 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.515 ' CD2' ' O ' ' C' ' 57' ' ' TYR . 44.2 p90 -61.99 117.61 6.18 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.605 -0.438 . . . . 1.0 110.435 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.532 ' C ' ' H ' ' C' ' 60' ' ' ARG . . . -133.77 20.02 4.14 Favored Glycine 0 N--CA 1.464 0.515 0 N-CA-C 110.685 -0.966 . . . . 1.0 110.685 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.42 ' OD2' ' CZ ' ' C' ' 60' ' ' ARG . 11.9 t0 71.12 -29.14 0.19 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.727 0.298 . . . . 1.0 111.103 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.532 ' H ' ' C ' ' C' ' 58' ' ' GLY . 21.3 mmt180 -121.22 152.4 38.88 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.179 -0.674 . . . . 1.0 109.179 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 49.8 p90 -139.35 126.85 13.06 Favored Pre-proline 0 CA--C 1.537 0.457 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.63 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.84 152.49 68.91 Favored 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 121.764 1.643 . . . . 1.0 111.981 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.492 HG11 ' O ' ' C' ' 34' ' ' PRO . 3.4 t -92.34 -126.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.773 -0.454 . . . . 1.0 109.773 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.458 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 86.9 m -115.17 -38.71 3.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.909 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.669 ' C ' ' H ' ' C' ' 67' ' ' GLY . 42.7 tp10 -67.6 -38.43 83.96 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.647 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.539 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 0.1 OUTLIER -65.89 27.17 0.02 OUTLIER 'General case' 0 C--O 1.264 1.829 0 CA-C-O 123.176 1.465 . . . . 1.0 110.248 179.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.735 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 42.78 64.28 1.7 Allowed Glycine 0 C--O 1.216 -0.975 0 CA-C-O 118.183 -1.343 . . . . 1.0 111.192 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.537 ' NH2' ' OD2' ' B' ' 59' ' ' ASP . 56.8 ttm-85 -23.34 -32.46 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 CA-C-N 118.05 0.925 . . . . 1.0 111.446 -178.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.735 ' N ' ' O ' ' C' ' 67' ' ' GLY . 98.9 mttt -50.62 -16.49 0.39 Allowed 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.818 -0.628 . . . . 1.0 109.379 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.556 ' N ' ' O ' ' C' ' 67' ' ' GLY . 57.0 t -60.48 -46.83 94.75 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 C-N-CA 119.135 -1.026 . . . . 1.0 110.098 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.88 -36.98 81.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.991 0.424 . . . . 1.0 110.142 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -62.25 -36.72 82.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.802 -0.636 . . . . 1.0 110.84 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 65.5 tp60 -62.55 -43.84 97.82 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.734 -0.386 . . . . 1.0 111.335 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.28 -45.6 89.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.532 -0.467 . . . . 1.0 111.558 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 78.0 mtm -64.8 -36.9 85.82 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.971 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -59.36 -46.26 89.15 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.728 -0.389 . . . . 1.0 110.652 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.494 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -66.25 -38.45 87.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 1.0 110.265 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.424 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.23 -48.56 73.53 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 121.156 -0.545 . . . . 1.0 111.809 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -62.15 -43.7 98.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.931 -0.307 . . . . 1.0 110.707 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -68.18 -43.02 79.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.279 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.494 HG23 ' O ' ' C' ' 77' ' ' ALA . 41.4 t -63.38 -49.16 83.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 111.083 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -68.68 -28.49 66.91 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.186 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.44 -26.41 26.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.946 0.403 . . . . 1.0 110.412 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.48 HD22 ' HB2' ' C' ' 11' ' ' ALA . 4.7 tt -64.15 -42.51 96.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.091 -0.504 . . . . 1.0 111.625 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.8 m -62.33 -9.48 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.446 -0.501 . . . . 1.0 110.44 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 24.8 m -41.45 -20.14 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.932 0.396 . . . . 1.0 110.555 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -63.69 -66.46 0.54 Allowed 'General case' 0 C--O 1.224 -0.274 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.542 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.12 -37.57 64.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.48 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.638 HD12 ' O ' ' D' ' 83' ' ' ALA . 4.2 mm? -64.98 -38.43 90.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.363 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -66.99 -69.29 0.32 Allowed 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.938 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.872 ' O ' HG22 ' C' ' 94' ' ' VAL . 0.5 OUTLIER -40.03 -23.08 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.539 -179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.515 ' N ' ' O ' ' C' ' 90' ' ' ALA . 46.4 t0 -38.83 -33.88 0.13 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.677 0.275 . . . . 1.0 111.364 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 7.0 p90 -64.35 -35.64 81.52 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.675 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.872 HG22 ' O ' ' C' ' 91' ' ' THR . 15.1 m -48.88 -36.01 7.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.755 -0.657 . . . . 1.0 111.874 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -63.86 -21.84 66.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.804 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 74.2 ttp85 -59.26 -43.29 92.47 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.253 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.524 ' OE1' ' N ' ' C' ' 97' ' ' GLU . 56.3 mp0 -82.59 168.76 17.02 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.781 0.324 . . . . 1.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 56.86 17.76 3.45 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.459 -179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -135.9 -23.04 1.38 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.671 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' C' ' 100' ' ' ARG . 45.9 mtm180 -61.8 -44.6 96.54 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.821 0.343 . . . . 1.0 110.724 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 95.8 mtt-85 -67.23 -36.84 82.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.65 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.38 57.06 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.055 -0.818 . . . . 1.0 111.055 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 61.0 m-70 . . . . . 0 C--O 1.22 -0.48 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.548 179.873 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 4.1 m . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.383 -0.599 . . . . 1.0 109.383 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.76 -50.76 72.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.424 . . . . 1.0 110.595 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -174.94 -64.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.716 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -79.56 -17.36 54.14 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.784 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.76 -36.76 85.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.9 0.381 . . . . 1.0 110.452 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.2 ttp85 -62.11 -42.95 99.74 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.249 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -62.18 -44.67 96.08 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.745 -0.382 . . . . 1.0 110.107 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . 0.466 ' HB1' HG13 ' D' ' 85' ' ' VAL . . . -65.54 -39.18 91.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.785 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -64.95 -41.06 95.82 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.466 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -63.31 -37.56 87.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.026 -0.534 . . . . 1.0 110.567 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.14 -36.57 80.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.956 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -39.3 92.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.632 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.33 -32.61 74.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.373 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -63.04 -38.34 90.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.61 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.6 tp -61.86 -43.41 98.9 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.623 -0.431 . . . . 1.0 110.522 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -56.51 -36.05 68.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 25.8 ttpp -62.68 -36.24 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.374 -0.375 . . . . 1.0 111.105 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -68.99 -40.71 81.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.873 0.368 . . . . 1.0 110.781 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . . . . . . . . . 7.5 mp -59.88 -40.81 89.95 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.099 -0.5 . . . . 1.0 109.98 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -55.19 -49.8 70.98 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.621 -0.432 . . . . 1.0 109.888 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.53 -35.06 72.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.089 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.13 -46.78 85.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.138 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 16.1 m -60.31 -43.97 95.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 1.0 111.116 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -63.33 -34.32 77.44 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.654 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -82.03 -44.27 16.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.939 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.15 90.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.711 0.291 . . . . 1.0 110.838 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.456 ' CG1' ' N ' ' D' ' 28' ' ' GLU . 2.8 p -60.43 -44.12 95.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.173 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.456 ' N ' ' CG1' ' D' ' 27' ' ' VAL . 79.2 mm-40 -71.39 -42.9 67.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.78 -0.645 . . . . 1.0 110.861 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.88 -42.82 99.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.423 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -65.74 -37.21 85.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.8 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.8 tpt85 -67.5 122.13 17.32 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-O 120.932 0.396 . . . . 1.0 110.553 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.65 -11.87 59.49 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.116 -0.793 . . . . 1.0 111.116 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.5 133.77 39.44 Favored Pre-proline 0 CA--C 1.538 0.515 0 O-C-N 122.798 -0.236 . . . . 1.0 110.47 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.82 142.74 28.85 Favored 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 122.149 1.9 . . . . 1.0 112.476 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.1 0.62 53.25 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.33 140.2 50.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.767 0.318 . . . . 1.0 110.729 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -107.93 -53.88 2.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.584 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 42.9 tp -52.4 94.99 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.121 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.713 HG23 ' O ' ' D' ' 39' ' ' ILE . 21.0 tt -134.11 63.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-O 121.16 0.505 . . . . 1.0 110.447 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -159.68 135.75 8.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.477 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.537 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 18.0 t80 -74.87 -49.5 4.4 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.72 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.8 Cg_endo -58.93 -30.71 93.88 Favored 'Trans proline' 0 N--CA 1.496 1.673 0 C-N-CA 121.321 1.347 . . . . 1.0 111.964 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -87.14 -20.2 27.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.399 -0.364 . . . . 1.0 111.076 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.93 96.25 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.867 0.365 . . . . 1.0 110.692 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.413 ' H ' HG22 ' D' ' 45' ' ' ILE . 7.3 tt -66.27 -38.24 81.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.303 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.402 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.2 OUTLIER -63.86 -46.56 84.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.044 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -65.06 -39.77 93.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.594 -0.442 . . . . 1.0 110.166 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 5.3 t -49.6 -20.25 0.74 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.569 -0.287 . . . . 1.0 110.564 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.43 ' C ' ' H ' ' D' ' 51' ' ' THR . 24.9 t -97.58 -33.64 4.44 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.0 0.429 . . . . 1.0 110.258 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -78.21 16.62 0.74 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.431 -0.581 . . . . 1.0 109.431 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.43 ' H ' ' C ' ' D' ' 49' ' ' VAL . 6.1 t -137.38 -34.81 0.69 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.378 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.16 -24.48 67.2 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.045 -0.354 . . . . 1.0 110.045 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.523 ' OG1' HG13 ' D' ' 55' ' ' VAL . 67.4 p -93.88 6.17 49.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.441 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 16.3 p 56.71 11.28 0.87 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.055 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.523 HG13 ' OG1' ' D' ' 53' ' ' THR . 25.8 m -63.53 -43.34 98.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.492 -0.322 . . . . 1.0 110.787 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.465 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 41.43 86.62 0.01 OUTLIER Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.018 -0.833 . . . . 1.0 111.018 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 9.4 t80 -90.58 4.5 51.09 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.836 0.351 . . . . 1.0 110.159 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.03 17.3 65.46 Favored Glycine 0 CA--C 1.526 0.757 0 N-CA-C 111.019 -0.832 . . . . 1.0 111.019 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 30.1 m-20 -63.63 -46.18 86.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.875 0.369 . . . . 1.0 110.593 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -134.39 167.08 21.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.019 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 9.6 p90 -153.56 102.48 2.55 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.591 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -69.76 162.38 42.3 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 121.885 1.723 . . . . 1.0 112.508 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.502 HG12 ' H ' ' D' ' 64' ' ' THR . 1.9 t -96.13 -140.92 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.211 -0.45 . . . . 1.0 110.097 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.502 ' H ' HG12 ' D' ' 63' ' ' VAL . 28.9 m -112.15 -39.71 4.39 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.668 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.502 ' C ' ' H ' ' D' ' 67' ' ' GLY . 80.5 tt0 -59.53 -24.28 63.55 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.857 -0.423 . . . . 1.0 109.857 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.516 ' OE2' ' N ' ' D' ' 68' ' ' ARG . 0.1 OUTLIER -80.01 28.52 0.29 Allowed 'General case' 0 C--O 1.266 1.922 0 CA-C-O 123.329 1.538 . . . . 1.0 108.944 178.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.719 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.15 62.19 2.15 Favored Glycine 0 C--O 1.216 -0.977 0 CA-C-N 114.134 -1.394 . . . . 1.0 109.995 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.516 ' N ' ' OE2' ' D' ' 66' ' ' GLU . 48.2 ttm-85 -24.61 -32.06 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 O-C-N 124.401 0.707 . . . . 1.0 111.061 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.719 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -50.26 -18.23 0.57 Allowed 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 176.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.615 ' O ' HG23 ' D' ' 74' ' ' VAL . 62.0 t -63.01 -46.84 95.25 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 C-N-CA 119.525 -0.87 . . . . 1.0 109.907 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.5 -47.31 27.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.348 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -43.77 -62.6 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.824 -0.625 . . . . 1.0 111.57 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.15 -41.68 88.9 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 112.012 0.375 . . . . 1.0 112.012 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.615 HG23 ' O ' ' D' ' 70' ' ' VAL . 89.9 t -61.72 -48.06 90.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.493 -0.483 . . . . 1.0 111.404 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.594 ' SD ' HG11 ' C' ' 55' ' ' VAL . 75.5 mtm -64.56 -41.99 95.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.697 0.284 . . . . 1.0 111.181 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 78.2 tttt -64.1 -36.16 83.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.696 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.466 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -58.3 -38.4 76.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.321 -179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -66.07 -42.1 94.75 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.458 -0.657 . . . . 1.0 111.458 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.38 -43.64 98.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.616 0.246 . . . . 1.0 111.356 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -63.36 -38.9 92.95 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.898 -0.321 . . . . 1.0 111.133 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.466 HG23 ' O ' ' D' ' 77' ' ' ALA . 70.5 t -63.29 -48.29 88.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.091 -179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -68.05 -36.82 80.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.853 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.638 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -60.76 -37.75 82.88 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.836 -0.345 . . . . 1.0 110.266 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.8 tt -62.49 -40.34 96.39 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.652 -0.419 . . . . 1.0 110.235 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.557 ' O ' HG12 ' D' ' 85' ' ' VAL . 99.8 t -58.41 -3.0 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.205 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.498 ' O ' ' N ' ' D' ' 89' ' ' LEU . 54.4 m -59.33 -44.53 92.61 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.34 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.649 ' O ' HG22 ' D' ' 91' ' ' THR . . . -41.71 -57.17 2.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 1.0 110.561 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.36 -25.65 59.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.333 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.498 ' N ' ' O ' ' D' ' 86' ' ' THR . 83.8 mt -89.78 -16.95 29.14 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.444 -0.576 . . . . 1.0 109.444 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.483 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -80.71 -49.58 11.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.485 179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.649 HG22 ' O ' ' D' ' 87' ' ' ALA . 0.2 OUTLIER -50.98 -10.82 0.08 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.067 -0.515 . . . . 1.0 109.953 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.482 ' N ' ' C ' ' D' ' 90' ' ' ALA . 97.6 m-20 -61.54 -53.48 55.8 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.493 ' CD1' ' HB3' ' A' ' 90' ' ' ALA . 0.6 OUTLIER -45.44 -34.02 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.437 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 3.9 t -90.01 -27.1 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.155 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 77.2 ttt-85 -60.56 -41.27 94.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.612 -0.267 . . . . 1.0 110.895 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 48.0 ptt85 -50.71 -39.36 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.811 0.338 . . . . 1.0 110.157 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.48 -37.11 86.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.661 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.55 -31.77 72.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.982 0.42 . . . . 1.0 110.372 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -61.64 -37.87 85.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.134 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 66.2 mtp180 -61.54 -43.67 98.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.584 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 23.5 mmt85 -68.95 -24.99 64.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.046 -0.525 . . . . 1.0 110.439 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.07 11.41 76.31 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.079 -0.808 . . . . 1.0 111.079 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.219 -0.509 0 CA-C-O 118.031 -0.985 . . . . 1.0 110.55 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.422 -0.584 . . . . 1.0 109.422 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.419 ' HB1' ' CE1' ' A' ' 4' ' ' HIS . . . -58.04 176.35 0.16 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.631 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -62.48 -43.06 99.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.723 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.419 ' CE1' ' HB1' ' A' ' 2' ' ' ALA . 11.2 p-80 -73.04 -32.03 64.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.626 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -65.27 -36.07 82.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.99 0.424 . . . . 1.0 110.638 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -64.1 -39.52 94.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.264 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -66.84 -39.16 87.53 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.052 179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -37.57 87.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.332 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 68.0 tp60 -62.85 -45.11 94.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.114 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -63.21 -37.18 86.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.431 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.422 ' HB2' HD22 ' A' ' 84' ' ' LEU . . . -54.23 -45.8 72.37 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.925 -179.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.32 -41.99 93.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.826 0.346 . . . . 1.0 110.557 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.76 -32.59 74.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.304 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -64.05 -36.72 84.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.685 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' A' ' 78' ' ' GLY . 52.2 tp -62.31 -42.4 99.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.884 0.373 . . . . 1.0 110.594 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -57.93 -39.91 79.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.126 -0.488 . . . . 1.0 111.232 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -61.72 -42.65 99.23 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.832 -0.347 . . . . 1.0 111.077 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 61.2 t -64.71 -40.59 89.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.445 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 52' ' ' ALA . 89.6 mt -59.06 -40.76 86.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 1.0 109.952 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -58.64 -48.06 82.32 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.536 -0.465 . . . . 1.0 109.832 179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.87 -33.37 75.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.441 . . . . 1.0 109.972 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.86 90.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.081 -0.509 . . . . 1.0 110.488 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.783 ' O ' HG23 ' A' ' 27' ' ' VAL . 27.3 m -59.53 -44.86 93.08 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.659 -0.417 . . . . 1.0 110.104 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -66.16 -54.92 19.51 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.407 -0.517 . . . . 1.0 110.526 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.485 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.9 mttt -59.6 -45.66 91.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.967 -0.56 . . . . 1.0 111.125 -179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.08 -38.77 90.08 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.991 -0.284 . . . . 1.0 111.198 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.783 HG23 ' O ' ' A' ' 23' ' ' SER . 62.3 t -64.61 -46.43 92.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 C-N-CA 120.412 -0.515 . . . . 1.0 110.042 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.35 -23.38 46.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.837 -0.62 . . . . 1.0 110.543 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -52.32 -49.41 64.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.251 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 63' ' ' VAL . 2.3 mm-40 -70.19 -39.74 75.04 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.895 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -67.55 92.91 0.33 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.785 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.44 -15.8 6.34 Favored Glycine 0 N--CA 1.467 0.743 0 N-CA-C 111.408 -0.677 . . . . 1.0 111.408 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.496 ' HB3' HG11 ' A' ' 63' ' ' VAL . . . -105.15 148.56 36.41 Favored Pre-proline 0 N--CA 1.465 0.325 0 CA-C-N 116.859 0.33 . . . . 1.0 110.285 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.51 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 97.1 Cg_endo -75.78 132.89 14.86 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 121.975 1.783 . . . . 1.0 112.571 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 36' ' ' ALA . . . 96.94 8.16 57.07 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 35' ' ' GLY . . . -35.55 154.84 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.761 0.315 . . . . 1.0 110.875 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -154.72 -50.03 0.09 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.471 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.5 110.36 19.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.032 0.444 . . . . 1.0 110.568 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.0 pt -142.84 73.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.996 -0.547 . . . . 1.0 110.281 179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.479 ' O ' ' N ' ' A' ' 44' ' ' ALA . 8.5 p -162.15 98.91 1.06 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.026 -0.534 . . . . 1.0 111.138 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.496 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 56.8 t80 -51.51 -49.43 82.56 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 116.241 -0.436 . . . . 1.0 112.089 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.6 Cg_endo -59.75 -35.3 94.93 Favored 'Trans proline' 0 N--CA 1.501 1.919 0 C-N-CA 121.262 1.308 . . . . 1.0 112.509 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -97.0 -6.92 34.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.689 -0.232 . . . . 1.0 110.9 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -65.54 -43.6 89.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.923 0.392 . . . . 1.0 110.533 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 tt -64.64 -34.64 71.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.44 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.43 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -61.34 -46.44 90.21 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.173 -0.467 . . . . 1.0 109.882 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.46 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 1.7 t90 -66.68 -40.48 88.57 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.498 -0.481 . . . . 1.0 109.793 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 44' ' ' ALA . 1.2 m -54.74 -33.12 60.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.547 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.7 t -60.84 -46.97 95.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.024 0.44 . . . . 1.0 110.175 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.536 ' OE2' ' CZ ' ' B' ' 61' ' ' TYR . 62.1 mt-10 -66.8 -33.32 75.36 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.387 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.46 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 96.6 m -62.2 -46.78 87.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.353 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.59 -36.74 81.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 1.0 110.149 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 55' ' ' VAL . 72.0 p -74.4 -9.83 58.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.337 -0.616 . . . . 1.0 109.337 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 53' ' ' THR . 3.0 p 65.1 -4.86 0.46 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.55 -0.75 . . . . 1.0 110.855 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.535 HG11 ' CE1' ' A' ' 57' ' ' TYR . 69.5 t -64.7 -44.98 96.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.266 -0.425 . . . . 1.0 111.182 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.14 83.24 0.01 OUTLIER Glycine 0 CA--C 1.53 0.988 0 N-CA-C 111.451 -0.66 . . . . 1.0 111.451 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.535 ' CE1' HG11 ' A' ' 55' ' ' VAL . 49.5 m-85 -61.16 -41.95 97.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.723 0.297 . . . . 1.0 110.633 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.14 9.57 2.39 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.841 -0.903 . . . . 1.0 110.841 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.536 ' OD2' ' NH2' ' B' ' 68' ' ' ARG . 38.1 t0 -56.97 -51.53 68.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.813 -0.355 . . . . 1.0 110.361 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -134.29 126.69 30.26 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 109.269 -0.641 . . . . 1.0 109.269 179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -108.09 134.21 20.23 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.775 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -70.05 162.69 41.26 Favored 'Trans proline' 0 N--CA 1.496 1.674 0 C-N-CA 122.249 1.966 . . . . 1.0 112.223 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.939 HG22 ' H ' ' A' ' 64' ' ' THR . 8.4 p -70.16 -145.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.445 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.939 ' H ' HG22 ' A' ' 63' ' ' VAL . 5.0 m -113.12 -73.99 0.64 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.958 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 64' ' ' THR . 79.9 tt0 -38.87 -80.36 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.524 -0.307 . . . . 1.0 110.349 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.882 ' O ' ' N ' ' A' ' 68' ' ' ARG . 70.9 mt-10 -77.76 -106.63 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.168 -0.678 . . . . 1.0 109.168 178.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.553 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 18.04 -54.81 0.0 OUTLIER Glycine 0 N--CA 1.477 1.398 0 O-C-N 124.593 1.183 . . . . 1.0 114.223 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.882 ' N ' ' O ' ' A' ' 66' ' ' GLU . 10.1 tpp180 -64.05 -49.15 73.48 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.123 -0.538 . . . . 1.0 109.694 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 66' ' ' GLU . 68.4 mttm -64.81 -40.73 95.69 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.55 -0.75 . . . . 1.0 109.363 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.93 -45.4 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 120.208 -0.597 . . . . 1.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.77 -36.57 83.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.99 0.424 . . . . 1.0 110.411 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -62.65 -37.66 87.22 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.302 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -73.82 -54.68 7.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.782 0.29 . . . . 1.0 111.782 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 93.9 t -62.61 -46.13 97.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 C-N-CA 120.849 -0.34 . . . . 1.0 111.09 -179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 34.2 ttp -55.97 -45.27 78.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.489 -0.323 . . . . 1.0 110.59 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.515 ' NZ ' ' OE2' ' A' ' 80' ' ' GLU . 64.7 tttm -65.74 -33.01 74.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.368 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.62 80.05 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.788 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -62.96 -41.94 99.78 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 66.9 mt -62.82 -43.67 98.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.658 0.266 . . . . 1.0 110.602 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 76' ' ' LYS . 97.8 mt-10 -60.48 -35.73 76.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.202 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 64.6 t -68.98 -74.58 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -45.41 -38.39 5.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.982 -0.553 . . . . 1.0 110.94 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.39 -37.04 86.1 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.907 -0.317 . . . . 1.0 110.928 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.44 -39.47 93.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.279 -179.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 85' ' ' VAL . 99.6 t -45.98 -13.94 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.427 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.525 ' N ' ' O ' ' A' ' 84' ' ' LEU . 76.8 m -51.33 -43.9 61.87 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.903 -0.406 . . . . 1.0 109.903 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.421 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -44.44 -20.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.554 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -105.11 -18.37 14.17 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.998 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 86' ' ' THR . 43.9 mt -92.51 -42.37 9.75 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.733 0.301 . . . . 1.0 110.849 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.465 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -57.95 -28.74 64.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.094 0.473 . . . . 1.0 110.863 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.421 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -80.81 -4.08 53.38 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.99 -0.55 . . . . 1.0 110.419 -179.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.484 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.2 m-20 -60.95 -47.88 84.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.944 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.465 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 11.1 p90 -75.89 -20.6 57.93 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.394 -0.367 . . . . 1.0 111.306 -179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.16 -43.52 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.11 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 84.6 mtt85 -59.94 -22.66 62.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.483 -0.326 . . . . 1.0 110.964 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.8 ttp85 -57.37 -43.92 83.96 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.617 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.479 ' C ' ' H ' ' A' ' 99' ' ' GLU . 66.5 tt0 -76.38 162.16 28.09 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' O ' ' O ' ' A' ' 101' ' ' ARG . 56.1 mm-40 68.49 -41.48 0.46 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.379 0.424 . . . . 1.0 110.73 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 97' ' ' GLU . 84.0 tt0 -64.83 -49.96 68.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.794 0.33 . . . . 1.0 110.404 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.4 mtp180 -65.9 -39.97 91.08 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.624 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.424 ' O ' ' O ' ' A' ' 98' ' ' GLU . 30.1 mmt180 -108.84 113.46 26.41 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.212 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.09 -8.57 49.61 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.964 -0.854 . . . . 1.0 110.964 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.422 ' OXT' ' ND1' ' A' ' 103' ' ' HIS . 56.4 t-80 . . . . . 0 C--O 1.22 -0.458 0 CA-C-O 118.049 -0.977 . . . . 1.0 110.533 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.424 ' O ' ' O ' ' B' ' 2' ' ' ALA . 94.2 p . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.296 -0.631 . . . . 1.0 109.296 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' B' ' 1' ' ' SER . . . 45.93 -174.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.486 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -137.87 -34.77 0.66 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.233 -0.439 . . . . 1.0 110.726 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.648 ' H ' ' CD2' ' B' ' 4' ' ' HIS . 6.5 p80 -78.74 -24.03 45.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.419 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -67.21 -39.96 86.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.9 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.0 mtm180 -64.42 -38.54 91.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.589 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.54 -41.28 93.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.006 0.432 . . . . 1.0 110.021 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.32 -41.13 94.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.81 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -65.49 -41.04 93.71 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.277 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -64.21 -36.2 83.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.531 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.91 -38.27 78.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.841 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -70.74 -32.25 69.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.816 0.341 . . . . 1.0 110.782 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.33 -49.36 72.01 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.884 0.373 . . . . 1.0 110.629 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.449 ' O ' HG23 ' B' ' 18' ' ' VAL . 13.3 pt-20 -64.91 -30.2 71.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.561 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 32.5 tp -59.74 -43.2 94.35 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.815 -0.354 . . . . 1.0 110.612 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.03 -43.02 99.73 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.343 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.97 -33.86 76.79 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.879 -0.328 . . . . 1.0 111.511 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 14' ' ' GLU . 49.3 t -68.3 -54.67 20.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 112.053 0.39 . . . . 1.0 112.053 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . . . . . . . . . 2.7 pp -65.13 -33.89 77.09 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -63.54 -40.27 96.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.776 -0.647 . . . . 1.0 109.782 179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -64.51 -40.9 96.5 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.567 -0.531 . . . . 1.0 109.567 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.448 ' CB ' ' CG2' ' B' ' 74' ' ' VAL . . . -63.64 -33.26 75.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.659 179.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.463 ' HG ' ' CB ' ' B' ' 48' ' ' SER . 2.2 m -55.54 -43.5 75.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.231 -179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.487 ' O ' HG12 ' B' ' 27' ' ' VAL . 24.9 tptp -58.74 -55.73 31.34 Favored 'General case' 0 C--O 1.219 -0.534 0 C-N-CA 120.252 -0.579 . . . . 1.0 109.843 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -60.89 -29.33 69.5 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.732 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.55 -36.9 67.29 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.912 -0.315 . . . . 1.0 110.797 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.487 HG12 ' O ' ' B' ' 24' ' ' LYS . 1.4 p -62.28 -44.17 98.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 CA-C-O 121.069 0.461 . . . . 1.0 110.103 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.463 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 12.2 tm-20 -74.56 -33.35 62.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.271 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.07 45.12 0.07 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.643 -0.708 . . . . 1.0 109.92 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.51 ' HB2' ' HB1' ' B' ' 36' ' ' ALA . 0.5 OUTLIER 178.68 -13.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.82 0.343 . . . . 1.0 110.777 -179.236 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.626 HH21 ' CG2' ' B' ' 39' ' ' ILE . 3.8 mmp_? -79.14 76.92 5.65 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.129 -0.487 . . . . 1.0 111.115 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.78 1.35 5.94 Favored Glycine 0 N--CA 1.469 0.841 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.898 178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.5 151.09 40.26 Favored Pre-proline 0 N--CA 1.465 0.304 0 O-C-N 122.767 -0.255 . . . . 1.0 110.662 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -75.07 144.26 29.79 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.974 1.783 . . . . 1.0 112.496 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.37 32.31 75.43 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.061 -0.816 . . . . 1.0 111.061 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' B' ' 30' ' ' GLU . . . -48.64 -60.57 2.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.752 0.31 . . . . 1.0 110.75 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . 61.52 4.32 0.98 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.341 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.426 HD23 ' O ' ' B' ' 38' ' ' LEU . 3.1 tt -145.47 55.54 1.21 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.307 -0.406 . . . . 1.0 110.022 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.626 ' CG2' HH21 ' B' ' 31' ' ' ARG . 33.0 pt -92.69 51.51 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 120.908 0.385 . . . . 1.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.438 ' O ' ' OD1' ' B' ' 43' ' ' ASP . 0.3 OUTLIER -150.72 140.19 21.48 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-O 121.178 0.513 . . . . 1.0 110.94 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.528 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 0.8 OUTLIER -82.0 -53.99 0.66 Allowed Pre-proline 0 CA--C 1.539 0.551 0 CA-C-N 115.278 -0.873 . . . . 1.0 110.81 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.0 Cg_endo -57.76 -28.97 84.2 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.876 1.717 . . . . 1.0 112.701 -178.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' B' ' 40' ' ' SER . 12.1 p-10 -88.91 -4.33 58.49 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.52 -38.97 92.85 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.9 0.381 . . . . 1.0 110.41 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.428 HG23 ' N ' ' B' ' 46' ' ' TRP . 20.7 tt -67.28 -37.5 79.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.517 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.511 ' NE1' ' O ' ' C' ' 63' ' ' VAL . 0.1 OUTLIER -56.97 -53.13 61.49 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.827 -0.435 . . . . 1.0 109.827 -178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 4.1 t90 -62.97 -42.69 99.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.958 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.463 ' CB ' ' HG ' ' B' ' 23' ' ' SER . 64.8 m -51.9 -38.97 58.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.711 0.291 . . . . 1.0 111.095 -178.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.48 -43.77 94.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.582 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -61.15 -50.4 73.33 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.839 -0.344 . . . . 1.0 111.588 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 2.0 t -59.77 -40.9 89.76 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.878 -0.329 . . . . 1.0 110.734 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.32 -24.86 68.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.329 . . . . 1.0 111.268 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 20.4 p -90.86 6.34 44.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 1.0 110.774 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 11.7 p 52.11 63.19 2.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.341 -0.39 . . . . 1.0 110.476 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 5.5 t -138.42 -53.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.562 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 55.12 81.79 0.06 OUTLIER Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -63.18 -39.89 95.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.618 0.247 . . . . 1.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.38 3.77 12.58 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.459 -1.056 . . . . 1.0 110.459 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -58.69 -49.49 77.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.72 0.295 . . . . 1.0 110.516 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 11.9 mtt-85 -145.62 157.55 43.96 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.819 -0.438 . . . . 1.0 109.819 -179.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.536 ' CZ ' ' OE2' ' A' ' 50' ' ' GLU . 64.2 t80 -172.46 132.52 0.7 Allowed Pre-proline 0 CA--C 1.536 0.431 0 N-CA-C 110.202 -0.296 . . . . 1.0 110.202 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -69.7 -173.5 0.72 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 121.582 1.522 . . . . 1.0 111.737 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.592 HG22 ' N ' ' B' ' 64' ' ' THR . 3.6 p -134.15 165.72 30.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-N 115.964 -0.562 . . . . 1.0 110.422 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.592 ' N ' HG22 ' B' ' 63' ' ' VAL . 14.5 m -40.76 -61.79 0.9 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.372 -0.376 . . . . 1.0 111.243 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -46.01 -14.52 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.941 0.4 . . . . 1.0 109.94 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' B' ' 64' ' ' THR . 13.6 mm-40 -115.31 41.86 2.36 Favored 'General case' 0 C--O 1.277 2.501 0 CA-C-O 125.105 2.383 . . . . 1.0 110.392 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.721 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.46 60.04 1.48 Allowed Glycine 0 C--O 1.216 -0.978 0 CA-C-N 112.217 -2.265 . . . . 1.0 111.34 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.536 ' NH2' ' OD2' ' A' ' 59' ' ' ASP . 38.5 ttm180 -28.28 -28.29 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 117.578 0.689 . . . . 1.0 110.58 -178.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.721 ' N ' ' O ' ' B' ' 67' ' ' GLY . 54.4 mtpt -52.41 -12.36 0.26 Allowed 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 176.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.589 ' N ' ' O ' ' B' ' 67' ' ' GLY . 37.6 t -58.78 -44.95 91.4 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 118.902 -1.119 . . . . 1.0 109.541 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.511 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -71.1 -48.95 49.4 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.827 0.346 . . . . 1.0 110.7 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -51.95 -38.25 55.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.096 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.414 ' O ' ' OE1' ' B' ' 73' ' ' GLN . 0.8 OUTLIER -58.97 -51.2 71.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 1.0 111.018 -179.291 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.448 ' CG2' ' CB ' ' B' ' 22' ' ' ALA . 84.2 t -66.78 -43.39 89.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.76 -0.376 . . . . 1.0 111.506 -179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 1.2 mpp? -61.22 -41.47 96.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.662 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . 0.412 ' O ' ' OE2' ' B' ' 80' ' ' GLU . 65.9 tttm -61.49 -44.02 97.82 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.554 -0.458 . . . . 1.0 110.359 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.442 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -66.05 -40.27 90.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.895 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -42.91 96.64 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 111.41 -0.676 . . . . 1.0 111.41 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 89.3 mt -63.79 -43.88 98.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 O-C-N 122.847 -0.208 . . . . 1.0 111.352 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' B' ' 80' ' ' GLU . 0.2 OUTLIER -62.57 -37.78 87.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.929 0.395 . . . . 1.0 110.334 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.442 HG23 ' O ' ' B' ' 77' ' ' ALA . 24.9 t -60.69 -68.98 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.95 -0.568 . . . . 1.0 111.184 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -55.33 -37.37 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.918 -0.583 . . . . 1.0 110.776 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.94 89.27 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.5 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 tt -62.99 -41.11 99.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.881 -0.328 . . . . 1.0 110.117 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' B' ' 8' ' ' ALA . 39.0 t -53.2 -17.58 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.605 -0.517 . . . . 1.0 109.605 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 39.6 m -43.59 -35.3 1.67 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.253 0.549 . . . . 1.0 109.767 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -51.73 -61.67 2.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.747 -0.66 . . . . 1.0 111.034 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.9 -27.36 51.65 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.907 0.384 . . . . 1.0 110.474 -179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.615 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.5 mm? -78.27 -32.27 49.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 1.0 110.046 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.546 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -63.03 -46.41 87.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.27 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.445 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.5 OUTLIER -73.57 -3.93 30.88 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 1.0 110.167 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.516 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 50.2 t0 -56.81 -48.77 77.21 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.346 -0.388 . . . . 1.0 111.18 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.546 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 20.9 p90 -69.5 -39.03 77.84 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.904 -0.319 . . . . 1.0 111.21 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.517 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 96.6 t -44.42 -28.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.0 111.628 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.96 -27.27 68.13 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.116 -0.234 . . . . 1.0 110.953 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.44 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 46.6 ptt85 -54.59 -42.6 71.27 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.719 -0.392 . . . . 1.0 110.124 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.44 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 80.4 mm-40 -60.43 -45.93 91.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 111.079 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' B' ' 102' ' ' GLY . 97.5 mt-10 -68.46 -40.29 81.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.783 0.325 . . . . 1.0 110.809 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -67.44 -34.11 76.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.696 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -61.04 -44.75 96.92 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.479 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -95.49 -9.63 31.99 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.938 0.399 . . . . 1.0 110.415 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' B' ' 98' ' ' GLU . . . 73.9 15.8 79.56 Favored Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.161 -0.776 . . . . 1.0 111.161 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.421 ' OXT' ' ND1' ' B' ' 103' ' ' HIS . 56.9 t-80 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.0 -1.0 . . . . 1.0 110.603 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.405 -0.591 . . . . 1.0 109.405 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.454 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -81.03 177.17 9.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 1.0 110.738 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.509 ' OD1' ' ND1' ' C' ' 4' ' ' HIS . 35.6 p-10 -64.05 -36.42 83.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.037 -0.529 . . . . 1.0 110.39 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.509 ' ND1' ' OD1' ' C' ' 3' ' ' ASP . 11.8 p-80 -81.6 -29.96 33.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.246 -0.433 . . . . 1.0 110.814 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -65.16 -44.68 87.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.789 0.328 . . . . 1.0 110.756 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -65.61 -36.83 84.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.317 -0.402 . . . . 1.0 110.142 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -63.78 -42.96 97.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.454 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . 0.446 ' HB1' HG12 ' C' ' 85' ' ' VAL . . . -64.37 -40.32 95.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.419 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.37 -40.22 93.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.083 -0.508 . . . . 1.0 110.533 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -34.37 77.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.435 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.6 -36.58 76.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.977 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.81 -36.19 83.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.779 0.323 . . . . 1.0 111.072 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -63.87 -41.25 97.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.831 0.348 . . . . 1.0 110.701 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.99 -29.48 69.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.567 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.575 HD11 ' HB1' ' C' ' 52' ' ' ALA . 43.2 tp -62.38 -39.92 94.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.895 0.379 . . . . 1.0 110.411 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -70.73 -28.59 64.83 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.912 -0.315 . . . . 1.0 111.39 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -64.0 -46.55 84.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.746 0.308 . . . . 1.0 111.554 -179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . 0.43 HG22 ' H ' ' C' ' 18' ' ' VAL . 8.6 m -64.42 -36.56 77.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.87 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.558 HD21 ' HB2' ' C' ' 52' ' ' ALA . 90.2 mt -61.17 -41.98 97.75 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.589 -0.444 . . . . 1.0 110.079 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -60.47 -45.45 93.67 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.562 -0.533 . . . . 1.0 109.562 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.59 -33.71 71.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.107 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.41 94.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.463 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.507 ' O ' HG23 ' C' ' 27' ' ' VAL . 91.7 p -61.81 -46.31 90.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.797 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 59.7 tttp -63.25 -56.3 17.71 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.546 -0.462 . . . . 1.0 109.92 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -59.59 -42.61 92.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.426 ' O ' ' OE1' ' C' ' 30' ' ' GLU . . . -56.09 -44.37 78.93 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.662 -0.244 . . . . 1.0 110.885 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.507 HG23 ' O ' ' C' ' 23' ' ' SER . 76.8 t -64.0 -45.45 96.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.535 -0.466 . . . . 1.0 110.208 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -69.08 -34.91 75.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.449 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.15 -46.95 75.74 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.39 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' C' ' 30' ' ' GLU . 5.5 mp0 -69.54 -33.07 72.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.701 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -54.25 95.04 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 120.769 0.318 . . . . 1.0 110.964 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 115.22 -0.75 22.46 Favored Glycine 0 N--CA 1.468 0.818 0 N-CA-C 111.298 -0.721 . . . . 1.0 111.298 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.96 147.01 32.35 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.268 -0.271 . . . . 1.0 110.268 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.488 ' O ' HG11 ' C' ' 63' ' ' VAL . 95.1 Cg_endo -75.96 142.5 25.11 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.863 1.709 . . . . 1.0 112.315 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.89 29.08 66.98 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.116 -0.794 . . . . 1.0 111.116 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.35 144.45 55.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.968 0.413 . . . . 1.0 110.423 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.82 -22.08 0.88 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.294 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.603 HD13 ' O ' ' C' ' 38' ' ' LEU . 0.2 OUTLIER -63.6 -38.61 91.77 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.847 -0.427 . . . . 1.0 109.847 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.481 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -33.53 95.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 121.276 0.56 . . . . 1.0 111.1 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.547 ' O ' ' N ' ' C' ' 44' ' ' ALA . 11.8 m -167.94 78.3 0.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.877 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.473 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 0.4 OUTLIER -37.72 -56.82 1.71 Allowed Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 116.384 -0.371 . . . . 1.0 111.17 179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 24.1 Cg_endo -59.38 -54.45 2.55 Favored 'Trans proline' 0 N--CA 1.498 1.767 0 C-N-CA 121.84 1.693 . . . . 1.0 112.577 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -79.66 0.18 31.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.277 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.547 ' N ' ' O ' ' C' ' 40' ' ' SER . . . -58.56 -42.81 88.79 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.762 0.315 . . . . 1.0 110.69 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.452 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.0 tt -68.42 -40.28 82.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.564 ' NE1' ' O ' ' D' ' 64' ' ' THR . 0.5 OUTLIER -55.27 -47.55 75.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.065 -179.52 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.511 ' CG ' HD21 ' C' ' 38' ' ' LEU . 13.7 t90 -65.09 -40.18 94.23 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.421 -0.511 . . . . 1.0 109.771 178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.474 ' O ' HD22 ' C' ' 19' ' ' LEU . 36.6 m -59.86 -41.13 90.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.986 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.429 HG12 ' O ' ' C' ' 49' ' ' VAL . 47.2 t -80.07 69.05 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.449 -0.341 . . . . 1.0 111.743 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.438 ' CG ' ' N ' ' C' ' 51' ' ' THR . 12.4 pt-20 -166.48 -42.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.411 -0.515 . . . . 1.0 110.977 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.607 HG23 HG11 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -69.76 -36.97 76.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.146 -179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.575 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -57.2 -27.27 61.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.523 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.429 ' O ' ' OG1' ' C' ' 54' ' ' THR . 43.7 p -95.25 4.57 53.38 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.753 0.311 . . . . 1.0 110.322 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' C' ' 53' ' ' THR . 23.9 p 55.41 69.47 0.73 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.978 -0.555 . . . . 1.0 110.871 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 45.7 t -148.84 -81.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.309 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.33 96.7 0.01 OUTLIER Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.692 -0.963 . . . . 1.0 110.692 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -62.2 -43.22 99.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 1.0 111.016 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 132.44 26.75 0.65 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.897 -0.881 . . . . 1.0 110.897 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.71 -44.52 96.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 1.0 110.545 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 93.7 mtt-85 -141.8 161.16 38.65 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.616 -0.513 . . . . 1.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.435 ' CD2' ' O ' ' C' ' 61' ' ' TYR . 40.2 p90 -141.76 118.86 7.41 Favored Pre-proline 0 CA--C 1.54 0.577 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.764 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.9 157.62 59.5 Favored 'Trans proline' 0 N--CA 1.497 1.68 0 C-N-CA 121.837 1.692 . . . . 1.0 112.291 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.511 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 2.1 t -84.73 -136.98 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.488 ' H ' HG12 ' C' ' 63' ' ' VAL . 81.8 m -114.48 -49.39 2.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.867 0.365 . . . . 1.0 110.784 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' C' ' 67' ' ' GLY . 45.5 tp10 -54.38 -24.62 20.4 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.548 -0.538 . . . . 1.0 109.548 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.447 ' OE2' ' O ' ' C' ' 63' ' ' VAL . 0.0 OUTLIER -74.01 37.04 0.1 Allowed 'General case' 0 C--O 1.26 1.657 0 CA-C-O 123.358 1.551 . . . . 1.0 109.742 179.093 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.768 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 45.93 64.97 2.2 Favored Glycine 0 C--O 1.206 -1.614 0 CA-C-N 114.123 -1.399 . . . . 1.0 111.367 177.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.485 ' CB ' ' NE1' ' B' ' 46' ' ' TRP . 10.8 ptp85 -21.97 -31.56 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.915 0.858 . . . . 1.0 112.656 -177.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.768 ' N ' ' O ' ' C' ' 67' ' ' GLY . 68.4 mttm -64.17 -10.14 21.22 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.062 -0.972 . . . . 1.0 110.291 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.632 ' N ' ' O ' ' C' ' 67' ' ' GLY . 43.1 t -61.89 -48.36 88.95 Favored 'Isoleucine or valine' 0 C--N 1.348 0.52 0 C-N-CA 119.88 -0.728 . . . . 1.0 110.396 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.02 -43.56 71.09 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.505 -0.478 . . . . 1.0 110.688 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -61.59 -39.8 92.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.972 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -57.01 -43.68 82.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.464 -0.335 . . . . 1.0 111.261 -179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.607 HG11 HG23 ' C' ' 51' ' ' THR . 97.2 t -66.61 -43.38 90.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.739 -0.385 . . . . 1.0 111.546 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 41.6 mtt -60.72 -43.03 98.37 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.584 -0.28 . . . . 1.0 111.03 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -63.42 -39.66 95.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.774 0.321 . . . . 1.0 110.69 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.01 -39.36 89.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.349 -0.387 . . . . 1.0 110.432 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.31 -39.73 91.91 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.88 -0.488 . . . . 1.0 111.88 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.91 -43.13 97.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 122.54 -0.388 . . . . 1.0 110.668 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.81 -53.96 51.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.645 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.495 HG23 ' N ' ' C' ' 82' ' ' PHE . 16.5 m -60.95 -47.97 91.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 121.163 -0.215 . . . . 1.0 111.544 -179.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.495 ' N ' HG23 ' C' ' 81' ' ' VAL . 16.1 m-85 -67.67 -32.09 72.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.994 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.615 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -84.83 -25.59 28.01 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.961 -0.295 . . . . 1.0 110.59 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -63.1 -41.76 99.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.601 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' C' ' 87' ' ' ALA . 3.4 m -59.46 -19.74 17.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.555 -0.458 . . . . 1.0 110.464 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 91.6 m -41.3 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.959 0.409 . . . . 1.0 110.644 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.516 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -62.84 -51.1 68.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.54 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.5 84.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.235 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.542 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.5 mm? -71.34 -37.84 71.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.873 -0.603 . . . . 1.0 110.563 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.529 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -57.26 -34.33 68.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 1.0 111.152 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.99 -3.92 41.43 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.287 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.55 ' CB ' ' HB2' ' D' ' 87' ' ' ALA . 90.1 m-20 -57.08 -47.22 81.56 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.553 -0.459 . . . . 1.0 110.716 -178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.529 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 19.3 p90 -73.99 -9.37 58.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.971 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.27 -37.98 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.524 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -58.52 -28.68 65.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.528 -0.306 . . . . 1.0 111.268 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . 0.405 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 48.4 ptt85 -51.15 -41.53 60.18 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.55 -179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.519 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.3 mt-10 -64.35 164.3 11.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.369 . . . . 1.0 110.183 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 63.08 -64.13 0.11 Allowed 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.557 0.535 . . . . 1.0 110.632 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.519 ' N ' ' O ' ' C' ' 97' ' ' GLU . 81.0 tt0 -53.93 -41.17 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.386 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -63.57 -43.28 97.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.426 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -136.2 100.8 4.5 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.987 0.423 . . . . 1.0 110.699 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.55 31.96 3.55 Favored Glycine 0 N--CA 1.467 0.705 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.52 ' OXT' ' CG ' ' C' ' 103' ' ' HIS . 51.7 p-80 . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 117.972 -1.013 . . . . 1.0 110.574 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 34.9 t . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.82 142.31 57.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.579 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -63.83 -37.55 87.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.689 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.605 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.74 -37.94 87.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.857 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.605 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 83.2 tt0 -64.47 -35.42 80.87 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 120.746 0.307 . . . . 1.0 110.515 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -61.56 -40.99 96.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.436 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -65.03 -37.51 87.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.972 0.415 . . . . 1.0 109.955 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . 0.404 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -63.49 -37.22 86.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.568 . . . . 1.0 110.825 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -62.44 -40.31 96.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.465 -0.334 . . . . 1.0 110.62 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.9 mmtt -63.71 -41.2 98.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.589 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.28 94.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.727 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.14 -45.13 74.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.872 0.368 . . . . 1.0 110.83 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -67.03 -35.8 80.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.602 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -63.01 -36.67 84.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.416 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.407 HD13 ' HA2' ' D' ' 78' ' ' GLY . 45.3 tp -62.6 -41.46 98.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.82 0.343 . . . . 1.0 110.409 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -57.24 -39.29 75.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.928 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmmm? -61.91 -41.37 97.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.458 -0.337 . . . . 1.0 111.155 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 94.0 t -63.31 -35.01 70.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.711 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' D' ' 52' ' ' ALA . 36.5 mt -60.98 -40.51 93.68 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.688 -0.486 . . . . 1.0 109.688 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.96 -49.32 78.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.308 179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -67.67 -34.29 76.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.015 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -63.58 -39.52 94.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.838 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.427 ' O ' ' HB1' ' D' ' 44' ' ' ALA . 1.2 m -59.93 -46.33 89.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.874 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -65.63 -52.99 47.61 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.199 -0.6 . . . . 1.0 110.299 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -59.76 -40.43 88.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.923 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -47.52 -58.27 4.42 Favored 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.785 -0.366 . . . . 1.0 110.77 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.449 HG23 ' HB2' ' D' ' 44' ' ' ALA . 23.5 t -61.27 -44.99 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.585 -0.446 . . . . 1.0 110.212 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -56.36 -32.69 64.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.302 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' D' ' 26' ' ' ALA . . . -56.88 -44.92 82.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.717 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.526 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 10.8 mp0 -66.63 -36.28 82.19 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.317 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 24.3 mmt85 -60.88 86.49 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.921 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 126.17 -6.38 7.7 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.9 143.73 27.3 Favored Pre-proline 0 CA--C 1.537 0.454 0 O-C-N 122.768 -0.254 . . . . 1.0 110.775 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.708 ' O ' HG21 ' D' ' 63' ' ' VAL . 98.3 Cg_endo -74.64 153.85 43.98 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.301 2.0 . . . . 1.0 112.366 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.61 34.31 85.64 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.094 -0.803 . . . . 1.0 111.094 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.54 144.11 43.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.846 0.355 . . . . 1.0 110.603 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.72 -19.93 1.8 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.486 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.488 ' C ' HD23 ' D' ' 38' ' ' LEU . 2.3 tt -111.13 90.64 3.39 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.837 0.351 . . . . 1.0 110.099 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -133.25 103.28 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 121.08 0.467 . . . . 1.0 110.296 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 19.0 t -174.21 -118.45 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.59 . . . . 1.0 110.272 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.437 ' CD1' ' C ' ' D' ' 41' ' ' TYR . 1.0 OUTLIER 173.27 -61.88 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.072 -179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.79 -38.55 92.42 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 121.725 1.616 . . . . 1.0 111.927 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.91 -4.27 58.51 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.215 -0.448 . . . . 1.0 111.348 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . 0.449 ' HB2' HG23 ' D' ' 27' ' ' VAL . . . -63.97 -39.69 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 1.0 110.52 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.416 ' H ' HG22 ' D' ' 45' ' ' ILE . 1.1 tt -65.76 -40.64 88.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.03 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.509 ' NE1' ' O ' ' A' ' 64' ' ' THR . 0.8 OUTLIER -53.05 -45.91 68.26 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.598 -0.441 . . . . 1.0 109.903 -178.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 8.2 t90 -63.89 -43.0 97.34 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.366 -0.534 . . . . 1.0 109.973 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 86.2 p -61.68 -36.2 80.17 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.922 -0.311 . . . . 1.0 110.674 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.06 -48.53 88.06 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 CA-C-N 116.49 -0.323 . . . . 1.0 110.958 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.483 ' OE1' ' CZ ' ' A' ' 68' ' ' ARG . 19.0 pt-20 -83.87 31.62 0.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.983 0.42 . . . . 1.0 109.928 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 21.3 m -132.58 -46.27 0.89 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 115.861 -0.609 . . . . 1.0 110.178 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -57.02 -23.45 46.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.612 -0.435 . . . . 1.0 109.868 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.411 ' O ' ' OG1' ' D' ' 54' ' ' THR . 43.0 p -94.62 5.35 52.09 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.099 -0.501 . . . . 1.0 110.399 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' D' ' 53' ' ' THR . 39.9 p 52.64 75.77 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.997 -0.547 . . . . 1.0 111.052 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.577 HG13 ' N ' ' D' ' 56' ' ' GLY . 6.6 p -139.72 -51.44 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.394 -0.366 . . . . 1.0 110.892 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.577 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 50.07 82.41 0.04 OUTLIER Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.728 -0.949 . . . . 1.0 110.728 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -61.38 -44.39 97.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.701 0.286 . . . . 1.0 110.85 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.3 2.68 2.6 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.974 -0.851 . . . . 1.0 110.974 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 98.8 m-20 -59.23 -49.82 76.38 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.761 -0.375 . . . . 1.0 110.357 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -146.97 154.14 40.91 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.441 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 12.0 p90 -154.37 147.89 18.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 C-N-CA 120.979 -0.288 . . . . 1.0 110.58 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -70.43 172.24 13.67 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.418 2.079 . . . . 1.0 112.018 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.84 HG13 ' H ' ' D' ' 64' ' ' THR . 3.0 p -106.24 -105.54 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.641 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.84 ' H ' HG13 ' D' ' 63' ' ' VAL . 53.4 m -118.15 -85.22 0.65 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.979 0.419 . . . . 1.0 111.058 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.402 ' N ' HG22 ' D' ' 64' ' ' THR . 51.9 tp10 -48.08 125.81 9.76 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.538 -0.541 . . . . 1.0 109.538 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.894 ' O ' ' N ' ' D' ' 68' ' ' ARG . 95.0 mt-10 57.94 -102.48 0.15 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.51 -0.768 . . . . 1.0 110.066 -178.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.22 -57.07 0.0 OUTLIER Glycine 0 N--CA 1.474 1.179 0 O-C-N 124.487 1.117 . . . . 1.0 113.776 178.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.894 ' N ' ' O ' ' D' ' 66' ' ' GLU . 51.3 ttm-85 -79.84 -56.01 4.58 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.409 -0.395 . . . . 1.0 109.976 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' D' ' 66' ' ' GLU . 68.4 mttm -48.73 -29.19 4.2 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.029 -0.73 . . . . 1.0 109.029 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.458 ' O ' HG23 ' D' ' 74' ' ' VAL . 60.2 t -80.32 -27.96 11.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.779 -0.646 . . . . 1.0 110.245 179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . 0.519 ' N ' ' O ' ' D' ' 68' ' ' ARG . . . -78.09 -51.7 9.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.863 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . 0.415 ' CG ' ' N ' ' D' ' 73' ' ' GLN . 19.7 pt-20 -50.91 -42.03 59.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.947 -0.569 . . . . 1.0 110.653 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' D' ' 72' ' ' GLU . 56.1 tt0 -64.5 -42.73 95.66 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.85 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.458 HG23 ' O ' ' D' ' 70' ' ' VAL . 97.0 t -67.27 -44.91 87.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 120.665 -0.414 . . . . 1.0 111.507 -179.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 78.5 mtm -63.74 -38.96 93.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.11 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . 0.497 ' NZ ' ' OE2' ' D' ' 80' ' ' GLU . 58.0 tttm -57.62 -40.37 79.01 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.999 -0.28 . . . . 1.0 110.582 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.562 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.22 -41.48 99.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.502 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.509 ' O ' ' CD2' ' D' ' 82' ' ' PHE . . . -67.86 -40.06 89.5 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.811 -0.516 . . . . 1.0 111.811 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.4 mt -62.16 -43.95 98.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.612 0.244 . . . . 1.0 111.27 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.497 ' OE2' ' NZ ' ' D' ' 76' ' ' LYS . 97.6 mt-10 -66.3 -35.54 80.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.756 0.312 . . . . 1.0 111.104 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.562 HG23 ' O ' ' D' ' 77' ' ' ALA . 55.1 t -62.49 -46.29 96.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.318 -0.401 . . . . 1.0 111.318 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . 0.509 ' CD2' ' O ' ' D' ' 78' ' ' GLY . 58.4 m-85 -64.43 -31.98 73.41 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.788 -0.365 . . . . 1.0 110.58 -179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -82.93 -24.2 33.17 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.872 -0.331 . . . . 1.0 110.449 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.698 ' C ' HD23 ' D' ' 84' ' ' LEU . 7.0 tt -64.89 -42.98 94.35 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.601 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.404 HG12 ' HB1' ' D' ' 8' ' ' ALA . 13.5 m -62.0 -15.13 13.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.212 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.5 ' O ' ' N ' ' D' ' 90' ' ' ALA . 47.6 m -39.26 -39.84 0.68 Allowed 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 121.066 0.46 . . . . 1.0 110.45 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.55 ' HB2' ' CB ' ' C' ' 92' ' ' ASP . . . -51.74 -59.98 3.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.663 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -54.2 -25.56 23.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.128 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.484 HD22 ' N ' ' D' ' 89' ' ' LEU . 3.8 mm? -87.58 -28.45 21.92 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.001 -0.545 . . . . 1.0 110.127 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -66.35 -37.39 85.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.549 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.52 -5.27 31.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.842 -0.617 . . . . 1.0 110.198 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -56.17 -51.38 68.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.276 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.469 ' CD1' ' O ' ' D' ' 90' ' ' ALA . 24.6 p90 -75.28 -10.68 59.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.464 -0.335 . . . . 1.0 110.697 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 6.2 t -90.32 -32.84 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 116.326 -0.397 . . . . 1.0 111.21 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -66.38 -22.78 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.727 0.298 . . . . 1.0 110.963 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 38.9 ptt85 -66.11 -19.83 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.006 0.431 . . . . 1.0 110.206 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -58.43 -23.41 57.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.639 . . . . 1.0 110.955 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -98.33 -28.1 13.81 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 120.926 0.393 . . . . 1.0 110.208 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -68.33 -36.89 79.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.269 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 51.5 ptt85 -61.34 -35.9 78.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.116 -0.493 . . . . 1.0 110.261 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.42 -38.36 90.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.506 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.76 22.86 59.04 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.946 -0.862 . . . . 1.0 110.946 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 84.4 t60 . . . . . 0 C--O 1.221 -0.407 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.648 -179.95 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.348 -0.612 . . . . 1.0 109.348 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.52 155.24 31.63 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.603 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -62.88 -40.85 98.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.542 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -67.04 -45.04 78.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.0 110.357 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.2 -42.01 96.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.381 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 34.3 mmt180 -65.25 -40.29 93.81 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.015 -0.538 . . . . 1.0 110.136 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -68.95 -43.34 75.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.184 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.16 -39.09 89.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.464 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -64.23 -40.58 96.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.238 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.81 -36.59 84.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.287 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.24 -36.68 80.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.799 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -60.8 -38.37 85.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.761 0.315 . . . . 1.0 110.627 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.52 -35.88 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.927 0.394 . . . . 1.0 110.319 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -63.33 -34.65 78.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.438 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.47 HD13 ' HA2' ' A' ' 78' ' ' GLY . 47.2 tp -62.95 -38.54 91.5 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.675 -0.41 . . . . 1.0 110.111 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -63.72 -31.96 73.3 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.193 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -61.83 -49.63 75.5 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 120.856 -0.338 . . . . 1.0 111.241 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' H ' HG22 ' A' ' 18' ' ' VAL . 15.7 m -67.12 -32.64 58.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.889 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 52' ' ' ALA . 33.9 mt -61.56 -42.03 98.24 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.249 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.98 -45.26 86.38 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.872 0.368 . . . . 1.0 110.232 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -71.2 -39.59 71.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.546 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.84 -50.22 74.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.454 . . . . 1.0 110.841 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.502 ' HG ' ' CB ' ' A' ' 48' ' ' SER . 31.0 m -61.65 -44.38 97.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.985 0.421 . . . . 1.0 110.357 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -61.23 -33.64 73.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.792 -0.64 . . . . 1.0 110.16 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -81.5 -40.12 23.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.737 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.418 ' HB2' ' CZ3' ' A' ' 47' ' ' TRP . . . -58.52 -46.39 86.85 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 121.104 -0.238 . . . . 1.0 111.634 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 28' ' ' GLU . 5.4 p -58.58 -45.98 90.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 119.902 -0.719 . . . . 1.0 109.68 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.489 ' N ' HG13 ' A' ' 27' ' ' VAL . 97.0 mt-10 -69.86 -41.6 74.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.942 179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.29 90.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.0 109.9 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 79.8 mm-40 -78.84 -37.67 39.91 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.905 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.447 ' NH2' ' O ' ' A' ' 40' ' ' SER . 18.7 mmt85 -67.07 116.39 7.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.078 0.466 . . . . 1.0 110.823 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.85 2.99 60.93 Favored Glycine 0 CA--C 1.522 0.478 0 N-CA-C 111.328 -0.709 . . . . 1.0 111.328 179.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.09 144.06 27.87 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 110.362 -0.236 . . . . 1.0 110.362 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.05 147.07 33.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.258 1.972 . . . . 1.0 112.425 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.13 2.01 57.71 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.15 146.91 52.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.716 0.293 . . . . 1.0 110.517 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.73 -13.9 5.22 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -86.89 35.06 0.67 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-O 120.998 0.427 . . . . 1.0 110.13 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.74 73.78 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.344 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.453 ' OG ' ' OD1' ' A' ' 43' ' ' ASP . 53.4 p -160.64 -126.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.782 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 11.4 t80 179.26 -56.28 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 119.547 -0.263 . . . . 1.0 111.317 -179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 31.6 Cg_endo -60.17 -23.41 73.7 Favored 'Trans proline' 0 N--CA 1.5 1.872 0 C-N-CA 121.7 1.6 . . . . 1.0 112.638 -179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.519 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 24.1 p30 -97.22 -1.84 44.05 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 121.009 -0.277 . . . . 1.0 110.814 -179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.13 -20.29 48.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 120.836 0.35 . . . . 1.0 110.274 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.521 HG23 ' N ' ' A' ' 46' ' ' TRP . 12.4 tt -68.81 -46.01 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.887 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.521 ' N ' HG23 ' A' ' 45' ' ' ILE . 29.0 m95 -74.93 -31.9 61.63 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.482 -0.487 . . . . 1.0 110.867 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.418 ' CZ3' ' HB2' ' A' ' 26' ' ' ALA . 25.3 t90 -54.32 -41.31 68.86 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.502 ' CB ' ' HG ' ' A' ' 23' ' ' SER . 61.1 m -64.22 -24.36 67.64 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.322 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.51 -26.27 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.951 0.405 . . . . 1.0 110.839 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -78.13 3.59 14.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.982 -0.554 . . . . 1.0 110.408 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.3 t -127.18 -33.54 2.39 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.458 -0.337 . . . . 1.0 110.606 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.69 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -58.2 -25.61 61.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.936 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.585 ' OG1' HG13 ' A' ' 55' ' ' VAL . 67.6 p -96.92 7.51 46.48 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.967 0.413 . . . . 1.0 109.904 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.0 p 59.62 10.37 1.93 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.5 -0.773 . . . . 1.0 110.949 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.585 HG13 ' OG1' ' A' ' 53' ' ' THR . 29.1 m -66.07 -42.21 91.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.386 -0.37 . . . . 1.0 111.333 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 55' ' ' VAL . . . 47.94 64.15 3.15 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 110.954 -0.858 . . . . 1.0 110.954 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.432 ' OH ' ' OE2' ' B' ' 50' ' ' GLU . 1.1 t80 -62.89 -21.86 66.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.788 0.328 . . . . 1.0 110.246 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.77 33.7 12.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.984 -0.847 . . . . 1.0 110.984 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.533 ' OD1' ' NH2' ' B' ' 68' ' ' ARG . 8.2 m-20 -62.68 -37.25 85.7 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 110.144 -0.317 . . . . 1.0 110.144 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 37.7 mmt180 -125.38 -161.42 1.03 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.247 -179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.428 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 19.9 t80 -156.51 82.41 3.4 Favored Pre-proline 0 CA--C 1.533 0.326 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.66 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.66 153.35 69.51 Favored 'Trans proline' 0 N--CA 1.493 1.477 0 C-N-CA 121.587 1.525 . . . . 1.0 112.478 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.008 HG22 ' H ' ' A' ' 64' ' ' THR . 8.9 p -108.1 -154.61 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.302 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 1.008 ' H ' HG22 ' A' ' 63' ' ' VAL . 76.6 m -90.68 -43.35 10.19 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.618 0.247 . . . . 1.0 111.283 -179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.607 ' C ' ' H ' ' A' ' 67' ' ' GLY . 77.1 tt0 -52.46 -37.23 56.59 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.234 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.458 ' OE2' ' O ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER -74.6 26.34 0.08 Allowed 'General case' 0 C--O 1.261 1.675 0 CA-C-O 124.321 2.01 . . . . 1.0 109.202 178.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.696 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 44.15 65.39 1.66 Allowed Glycine 0 C--O 1.211 -1.312 0 CA-C-N 113.506 -1.679 . . . . 1.0 111.359 177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.5 ' NH1' ' OD2' ' D' ' 59' ' ' ASP . 53.2 ttm-85 -24.36 -33.58 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 118.465 1.133 . . . . 1.0 111.008 -178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.696 ' N ' ' O ' ' A' ' 67' ' ' GLY . 62.4 mttp -49.46 -20.99 0.81 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.988 -0.551 . . . . 1.0 109.929 176.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.567 ' N ' ' O ' ' A' ' 67' ' ' GLY . 60.4 t -61.59 -46.51 96.4 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.432 -0.907 . . . . 1.0 110.45 179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.82 -23.15 45.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.605 179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -74.33 -43.86 54.89 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.961 0.41 . . . . 1.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -61.1 -47.62 85.44 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.063 -0.517 . . . . 1.0 111.046 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.454 HG13 ' N ' ' A' ' 75' ' ' MET . 10.6 p -66.6 -40.14 85.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 120.238 -0.585 . . . . 1.0 110.713 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.454 ' N ' HG13 ' A' ' 74' ' ' VAL . 49.8 ttm -62.89 -48.03 80.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.492 -0.322 . . . . 1.0 111.201 -179.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -65.73 -38.49 89.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.317 . . . . 1.0 110.444 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.28 -36.54 73.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.281 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.47 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -66.64 -43.42 92.07 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 94.6 mt -61.61 -43.08 96.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.808 0.337 . . . . 1.0 110.292 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -61.35 -41.95 97.89 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.357 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.9 t -65.61 -51.23 65.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.741 0.305 . . . . 1.0 111.028 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -65.86 -39.09 90.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.999 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.12 86.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.565 -0.288 . . . . 1.0 110.961 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.538 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.0 tt -62.68 -39.05 92.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.269 -0.423 . . . . 1.0 111.167 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 85' ' ' VAL . 65.8 t -47.24 -10.46 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.745 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.538 ' N ' ' O ' ' A' ' 84' ' ' LEU . 71.9 m -50.96 -43.87 60.47 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.87 -19.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.722 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.485 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.23 -37.64 7.2 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.63 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -67.61 -40.48 84.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.412 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.578 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -60.96 -43.31 98.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 1.0 110.95 -179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.4 OUTLIER -73.32 -4.27 32.23 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.019 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -61.29 -43.43 98.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.494 -0.321 . . . . 1.0 110.812 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.578 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.6 p90 -80.31 -24.36 40.02 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.856 0.36 . . . . 1.0 111.395 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.0 t -61.97 -27.52 42.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.078 -178.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -68.19 -20.89 64.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.029 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' A' ' 93' ' ' PHE . 35.4 mtm105 -54.26 -32.31 55.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.692 -178.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.44 ' CG ' ' N ' ' A' ' 98' ' ' GLU . 14.4 pt-20 -61.62 -40.83 96.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.076 0.465 . . . . 1.0 109.799 179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 102' ' ' GLY . 97.7 mt-10 -66.2 -41.65 89.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 1.0 110.644 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -66.55 -35.77 81.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.327 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -60.04 -45.07 94.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.545 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -98.21 -4.29 35.73 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.492 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 98' ' ' GLU . . . 71.36 22.05 78.58 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.066 -0.814 . . . . 1.0 111.066 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.481 ' ND1' ' O ' ' A' ' 102' ' ' GLY . 79.4 m80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 117.996 -1.002 . . . . 1.0 110.54 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.332 -0.618 . . . . 1.0 109.332 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.473 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . -72.82 155.1 40.27 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.632 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.53 -41.01 98.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.973 -0.558 . . . . 1.0 110.465 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.473 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 8.4 p-80 -73.87 -23.24 59.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.493 -0.322 . . . . 1.0 110.987 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.67 -33.58 75.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.474 -0.33 . . . . 1.0 110.699 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -62.9 -38.22 90.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.395 . . . . 1.0 110.704 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -64.9 -42.0 95.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.979 0.418 . . . . 1.0 109.949 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' B' ' 85' ' ' VAL . . . -65.6 -37.01 85.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.789 -0.641 . . . . 1.0 110.747 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -56.46 -42.08 77.58 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.326 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -63.24 -37.67 88.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.601 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.45 -42.15 63.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.884 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -65.86 -41.09 92.09 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.887 -0.325 . . . . 1.0 110.606 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -66.72 -37.26 84.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.258 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -63.28 -34.89 78.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.433 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 HG21 ' B' ' 81' ' ' VAL . 46.1 tp -62.25 -41.82 98.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.418 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -60.93 -32.96 72.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.643 -179.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.27 -42.72 99.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.617 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.96 -37.69 79.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 1.0 110.636 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.528 HD22 ' O ' ' B' ' 48' ' ' SER . 98.3 mt -60.31 -40.32 90.15 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.839 -0.43 . . . . 1.0 109.839 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.65 -44.89 96.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.924 0.393 . . . . 1.0 110.022 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -69.89 -38.68 76.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.209 -0.451 . . . . 1.0 109.932 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' B' ' 26' ' ' ALA . . . -66.66 -37.7 85.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.874 -0.603 . . . . 1.0 110.675 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 93.8 p -57.19 -41.3 79.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.616 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.45 ' NZ ' ' OE1' ' B' ' 28' ' ' GLU . 63.3 tttm -70.32 -76.27 0.1 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.491 -0.484 . . . . 1.0 110.563 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.507 ' O ' ' N ' ' B' ' 29' ' ' ALA . 99.2 mttt -40.74 -35.65 0.52 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.866 -0.334 . . . . 1.0 111.204 -179.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' B' ' 22' ' ' ALA . . . -51.25 -60.56 2.98 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.717 -0.219 . . . . 1.0 111.553 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.416 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 2.1 p -60.93 -42.05 91.28 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.106 0 CA-C-O 121.04 0.448 . . . . 1.0 110.103 -179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.45 ' OE1' ' NZ ' ' B' ' 24' ' ' LYS . 96.3 mt-10 -72.07 -13.25 61.54 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.731 -0.668 . . . . 1.0 111.067 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.533 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -61.0 -47.97 83.98 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.586 -0.279 . . . . 1.0 111.177 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' B' ' 30' ' ' GLU . 0.6 OUTLIER -81.23 -98.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.853 0.358 . . . . 1.0 110.569 -179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 18.4 mmm180 46.45 50.72 12.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.686 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.77 27.58 0.94 Allowed Glycine 0 N--CA 1.468 0.814 0 N-CA-C 111.359 -0.696 . . . . 1.0 111.359 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.496 ' CB ' ' OE1' ' B' ' 66' ' ' GLU . . . -93.91 153.52 40.92 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.123 -0.325 . . . . 1.0 110.123 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -75.68 116.72 4.54 Favored 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 121.912 1.741 . . . . 1.0 112.184 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 89.96 -23.59 19.82 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.04 -0.824 . . . . 1.0 111.04 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' B' ' 35' ' ' GLY . . . 44.95 -175.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.803 0.335 . . . . 1.0 110.558 -179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' B' ' 36' ' ' ALA . . . 175.41 -66.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.345 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.53 121.33 34.83 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.251 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.423 ' O ' ' O ' ' B' ' 40' ' ' SER . 37.9 pt -143.04 -160.74 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.835 -0.62 . . . . 1.0 109.715 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.423 ' O ' ' O ' ' B' ' 39' ' ' ILE . 3.2 t 56.2 114.28 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.12 0.486 . . . . 1.0 111.007 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.519 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 2.3 t80 -63.54 -53.85 48.24 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.563 -0.744 . . . . 1.0 110.699 178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 21.9 Cg_endo -57.72 -27.68 78.69 Favored 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 121.747 1.632 . . . . 1.0 112.566 -179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -95.37 -16.62 22.21 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 1.0 110.823 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.89 -37.6 87.59 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.901 0.382 . . . . 1.0 110.318 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -61.7 -37.04 77.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.648 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.461 ' CH2' ' NZ ' ' C' ' 69' ' ' LYS . 0.2 OUTLIER -64.16 -43.79 94.07 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.477 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -61.77 -21.35 64.49 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.757 -0.46 . . . . 1.0 109.757 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.528 ' O ' HD22 ' B' ' 19' ' ' LEU . 1.3 t -78.28 -32.63 49.56 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.983 0.421 . . . . 1.0 110.55 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.25 -45.41 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 112.568 0.581 . . . . 1.0 112.568 -178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.439 ' CG ' ' N ' ' B' ' 51' ' ' THR . 19.3 pt-20 -57.77 -42.38 83.92 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.724 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.567 ' O ' ' HB3' ' B' ' 52' ' ' ALA . 3.4 t -73.47 -170.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.041 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' B' ' 51' ' ' THR . . . 74.19 -24.01 0.22 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.538 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.503 ' H ' ' C ' ' B' ' 51' ' ' THR . 31.2 p -103.45 8.18 37.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.813 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.8 p 53.55 65.15 1.6 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.357 -0.383 . . . . 1.0 110.687 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.568 HG13 ' N ' ' B' ' 56' ' ' GLY . 4.7 p -138.34 -52.49 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.665 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.568 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 41.55 82.24 0.02 OUTLIER Glycine 0 CA--C 1.527 0.844 0 N-CA-C 110.761 -0.936 . . . . 1.0 110.761 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -59.97 -43.83 94.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.695 0.284 . . . . 1.0 110.863 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.19 8.74 2.01 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.941 -0.864 . . . . 1.0 110.941 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -52.03 -67.63 0.24 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.763 0.315 . . . . 1.0 110.573 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -141.81 150.11 41.25 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 109.825 -0.435 . . . . 1.0 109.825 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.465 ' CD1' ' N ' ' B' ' 61' ' ' TYR . 7.6 p90 -141.22 128.49 11.85 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 110.063 -0.347 . . . . 1.0 110.063 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.49 148.58 73.29 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 121.637 1.558 . . . . 1.0 112.3 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 3.2 t -76.11 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 C-N-CA 120.662 -0.415 . . . . 1.0 110.413 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.529 ' O ' ' N ' ' B' ' 66' ' ' GLU . 89.4 m -113.98 -65.4 1.19 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.835 0.35 . . . . 1.0 111.098 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.517 ' C ' ' H ' ' B' ' 67' ' ' GLY . 85.0 tt0 -40.53 -21.98 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.066 -0.516 . . . . 1.0 110.589 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.564 ' OE2' ' N ' ' B' ' 66' ' ' GLU . 1.5 pm0 -80.24 30.27 0.28 Allowed 'General case' 0 C--O 1.261 1.699 0 CA-C-O 123.741 1.734 . . . . 1.0 109.142 178.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.04 65.37 1.08 Allowed Glycine 0 N--CA 1.44 -1.084 0 CA-C-N 113.515 -1.675 . . . . 1.0 111.075 177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.533 ' NH2' ' OD1' ' A' ' 59' ' ' ASP . 0.8 OUTLIER -23.69 -32.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 117.705 0.753 . . . . 1.0 110.788 -178.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' B' ' 67' ' ' GLY . 97.4 mttt -46.03 -21.21 0.12 Allowed 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 109.037 -0.727 . . . . 1.0 109.037 175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' B' ' 67' ' ' GLY . 77.4 t -63.07 -45.8 97.78 Favored 'Isoleucine or valine' 0 C--N 1.354 0.798 0 C-N-CA 120.003 -0.679 . . . . 1.0 110.054 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.25 -50.36 19.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.842 0.353 . . . . 1.0 110.818 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -53.06 -46.64 68.63 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.312 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -57.63 -46.43 84.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.759 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 70' ' ' VAL . 87.1 t -65.47 -47.88 85.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.64 -0.424 . . . . 1.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.527 ' SD ' HG11 ' A' ' 55' ' ' VAL . 74.3 mtm -65.11 -43.03 93.32 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.721 -0.392 . . . . 1.0 110.673 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -66.59 -35.04 79.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.565 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.15 -39.1 74.58 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.301 -0.408 . . . . 1.0 110.389 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.3 -37.1 94.05 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 111.316 -0.714 . . . . 1.0 111.316 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.577 HG22 ' O ' ' B' ' 79' ' ' ILE . 96.0 mt -70.68 -3.42 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 122.487 -0.42 . . . . 1.0 111.319 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -97.96 -54.41 3.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.77 0.319 . . . . 1.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.431 HG21 HD13 ' B' ' 15' ' ' LEU . 0.1 OUTLIER -61.09 -51.35 74.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.169 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -65.38 -37.3 86.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.683 0.277 . . . . 1.0 110.725 -179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' B' ' 86' ' ' THR . . . -62.59 -37.49 86.41 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.838 -0.345 . . . . 1.0 110.433 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.9 tt -62.73 -40.3 96.78 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.191 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.524 HG13 ' HB1' ' B' ' 8' ' ' ALA . 47.9 t -57.34 -17.44 6.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.149 -0.478 . . . . 1.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 55.1 m -42.98 -37.87 2.04 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.1 0.476 . . . . 1.0 109.868 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.619 ' O ' HG22 ' B' ' 91' ' ' THR . . . -49.77 -63.47 1.1 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.53 179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -49.68 -38.4 32.66 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.27 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.505 HD12 ' O ' ' C' ' 83' ' ' ALA . 3.1 mm? -68.94 -34.5 75.46 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.647 -0.501 . . . . 1.0 109.647 178.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.497 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -66.66 -66.14 0.59 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.265 0.555 . . . . 1.0 110.016 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.2 OUTLIER -51.89 -7.9 0.06 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.805 -0.634 . . . . 1.0 110.614 179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' B' ' 90' ' ' ALA . 41.7 t0 -57.01 -49.27 76.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.657 0.265 . . . . 1.0 111.034 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 11.9 p90 -73.39 -30.86 63.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.058 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 85.8 t -60.97 -32.86 53.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.167 -0.469 . . . . 1.0 111.674 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.417 ' O ' ' OE1' ' B' ' 99' ' ' GLU . 79.8 mtp85 -57.81 -22.38 47.18 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.933 -0.307 . . . . 1.0 111.305 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 46.9 ptt85 -53.33 -25.48 15.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 1.0 110.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.7 -35.53 80.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.826 -0.625 . . . . 1.0 110.933 -179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.08 -43.28 98.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 1.0 110.746 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.417 ' OE1' ' O ' ' B' ' 95' ' ' ARG . 57.6 mp0 -69.66 -34.71 74.38 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.721 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -60.45 -44.28 96.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.337 -0.392 . . . . 1.0 110.556 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 25.5 mmt85 -95.97 -9.25 31.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.329 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.46 15.51 80.36 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.135 -0.786 . . . . 1.0 111.135 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 117.962 -1.018 . . . . 1.0 110.518 -179.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . 0.443 ' O ' ' O ' ' C' ' 2' ' ' ALA . 9.1 m . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.368 -0.604 . . . . 1.0 109.368 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.625 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . 56.25 117.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.962 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' C' ' 3' ' ' ASP . 32.2 p-10 -90.97 -4.77 56.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.385 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.625 ' CE1' ' HB1' ' C' ' 2' ' ' ALA . 10.0 p-80 -88.09 -26.64 22.42 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.796 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.28 -39.97 89.76 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.497 -0.319 . . . . 1.0 110.855 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -64.5 -38.17 90.1 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.736 -0.385 . . . . 1.0 110.276 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -65.29 -39.9 93.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.273 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . 0.451 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.59 -39.95 94.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.602 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -62.72 -43.42 98.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.178 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.8 tptt -65.05 -33.94 77.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.242 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.44 -39.84 80.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.014 -0.539 . . . . 1.0 111.198 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -61.36 -36.79 81.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.9 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.42 -32.25 73.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.579 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -64.43 -38.5 91.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.628 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 56.9 tp -62.18 -42.24 99.1 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.606 -0.438 . . . . 1.0 110.586 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 99.2 mt-30 -61.48 -38.64 88.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.415 -0.357 . . . . 1.0 111.352 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.93 -41.08 99.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.809 0.337 . . . . 1.0 111.086 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 83.6 t -63.3 -38.41 82.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.794 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.553 HD21 ' HB2' ' C' ' 52' ' ' ALA . 97.1 mt -59.16 -40.65 86.25 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.755 -0.378 . . . . 1.0 110.066 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.408 ' O ' ' OG ' ' C' ' 23' ' ' SER . 80.3 mm-40 -56.06 -47.98 76.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.737 -0.468 . . . . 1.0 109.737 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -68.6 -34.56 75.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.317 178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.46 -40.76 97.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.759 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' C' ' 20' ' ' GLU . 78.1 p -59.94 -40.71 89.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.551 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -64.74 -33.7 76.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.124 0.487 . . . . 1.0 109.772 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -78.31 -41.17 34.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.115 -0.493 . . . . 1.0 109.937 179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.6 -47.09 87.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.479 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.572 HG13 ' N ' ' C' ' 28' ' ' GLU . 7.4 p -59.66 -48.74 86.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.081 0.467 . . . . 1.0 110.079 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.572 ' N ' HG13 ' C' ' 27' ' ' VAL . 80.6 tt0 -68.96 -36.29 77.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.714 -0.675 . . . . 1.0 110.122 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.86 65.14 6.61 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.706 -0.679 . . . . 1.0 110.032 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.562 ' N ' ' OE1' ' C' ' 66' ' ' GLU . 3.3 mm-40 163.04 13.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.437 0.461 . . . . 1.0 110.706 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' C' ' 30' ' ' GLU . 14.5 tpt180 -108.49 67.77 0.67 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.6 0.238 . . . . 1.0 110.502 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.23 31.02 0.7 Allowed Glycine 0 N--CA 1.471 0.971 0 N-CA-C 111.928 -0.469 . . . . 1.0 111.928 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.742 ' HB2' ' OE2' ' C' ' 66' ' ' GLU . . . -103.71 161.07 24.1 Favored Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 109.687 -0.486 . . . . 1.0 109.687 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' HB1' ' C' ' 33' ' ' ALA . 72.2 Cg_endo -76.64 116.25 4.24 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.882 1.722 . . . . 1.0 111.47 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.1 10.66 83.54 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.443 -0.663 . . . . 1.0 111.443 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' C' ' 33' ' ' ALA . . . -56.04 149.41 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 1.0 110.523 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -21.14 2.25 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.429 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.478 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 1.0 OUTLIER -87.88 40.0 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.746 0.307 . . . . 1.0 110.242 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 7.4 pt -80.27 80.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.16 0.505 . . . . 1.0 110.587 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 67.7 m -156.36 -136.57 0.05 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.857 -0.61 . . . . 1.0 110.443 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.432 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 11.2 t80 179.75 -57.56 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 116.453 -0.34 . . . . 1.0 110.403 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.39 -34.79 97.5 Favored 'Trans proline' 0 N--CA 1.501 1.913 0 C-N-CA 121.736 1.624 . . . . 1.0 112.554 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' C' ' 43' ' ' ASP . 23.3 p-10 -94.24 6.42 48.68 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.482 -0.326 . . . . 1.0 111.293 -179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.12 -39.69 90.99 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.531 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 13.8 tt -67.81 -32.65 57.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.64 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.685 ' CZ2' HG23 ' D' ' 64' ' ' THR . 1.2 t-105 -60.05 -48.42 81.79 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.413 -178.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.466 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.2 OUTLIER -67.31 -27.28 67.03 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.231 -0.655 . . . . 1.0 109.231 178.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' C' ' 47' ' ' TRP . 2.6 t -64.9 -34.74 79.11 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.923 -0.58 . . . . 1.0 110.941 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.53 -47.62 92.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.513 -0.312 . . . . 1.0 111.407 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -70.53 -28.82 65.23 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.642 -0.423 . . . . 1.0 111.07 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.435 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 86.5 m -61.9 -44.83 96.0 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.005 -0.278 . . . . 1.0 111.326 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.553 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.78 -35.36 70.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 1.0 110.573 -179.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 71.4 p -73.52 -7.96 53.96 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.836 -0.346 . . . . 1.0 110.216 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 8.2 p 61.62 7.04 1.71 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.44 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.519 HG11 ' CE2' ' C' ' 57' ' ' TYR . 8.1 p -65.32 -40.68 89.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.235 -0.439 . . . . 1.0 110.538 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.458 ' N ' HG13 ' C' ' 55' ' ' VAL . . . 46.32 79.83 0.06 OUTLIER Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.519 ' CE2' HG11 ' C' ' 55' ' ' VAL . 79.1 m-85 -61.67 -42.52 99.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 1.0 110.942 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.67 3.34 6.02 Favored Glycine 0 N--CA 1.467 0.739 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -57.98 -64.38 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.837 0.351 . . . . 1.0 110.158 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 0.4 OUTLIER -135.09 147.72 49.63 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.154 179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.453 ' CD1' ' N ' ' C' ' 61' ' ' TYR . 8.8 p90 -151.06 149.72 25.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.502 -179.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -70.09 -175.75 1.34 Allowed 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 122.198 1.932 . . . . 1.0 111.672 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.51 ' H ' ' HB2' ' C' ' 66' ' ' GLU . 1.1 t -135.64 -148.19 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.94 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.48 ' H ' HG12 ' C' ' 63' ' ' VAL . 6.2 p -88.09 -43.21 11.85 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 1.0 110.574 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -73.78 -14.02 61.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.11 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.742 ' OE2' ' HB2' ' C' ' 33' ' ' ALA . 13.8 mm-40 -99.34 32.16 2.85 Favored 'General case' 0 C--O 1.261 1.674 0 CA-C-O 123.964 1.84 . . . . 1.0 110.18 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 36.4 62.6 0.75 Allowed Glycine 0 C--O 1.215 -1.088 0 CA-C-N 113.114 -1.857 . . . . 1.0 111.168 177.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.433 ' C ' ' O ' ' C' ' 67' ' ' GLY . 52.7 ttm-85 -24.71 -29.79 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 117.859 0.83 . . . . 1.0 111.503 -177.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' C' ' 67' ' ' GLY . 63.3 mttp -56.8 -11.04 1.21 Allowed 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 109.513 -0.551 . . . . 1.0 109.513 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.2 t -60.67 -47.47 92.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 118.735 -1.186 . . . . 1.0 110.103 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -35.13 72.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.911 0.386 . . . . 1.0 110.72 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 43.9 tp10 -54.04 -47.97 71.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 1.0 111.077 -179.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -65.42 -41.49 93.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.478 -0.328 . . . . 1.0 111.474 -179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 51.7 t -64.82 -44.34 96.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.837 -0.345 . . . . 1.0 111.2 -179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 75.8 mtm -61.39 -41.05 96.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.416 -0.356 . . . . 1.0 110.937 -178.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -61.61 -37.98 85.91 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.279 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.464 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.64 -38.25 84.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.34 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.2 -54.15 22.16 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.813 -0.708 . . . . 1.0 111.838 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 95.4 mt -63.06 -42.73 97.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.812 0.339 . . . . 1.0 110.661 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -59.47 -45.84 90.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.941 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.464 HG23 ' O ' ' C' ' 77' ' ' ALA . 54.6 t -65.04 -49.64 78.54 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 C-N-CA 120.972 -0.291 . . . . 1.0 111.205 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -67.17 -37.35 83.57 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.799 -0.36 . . . . 1.0 110.898 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . 0.505 ' O ' HD12 ' B' ' 89' ' ' LEU . . . -62.58 -35.33 79.15 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.55 -0.295 . . . . 1.0 110.522 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.426 ' C ' ' N ' ' C' ' 86' ' ' THR . 5.0 tt -61.96 -42.73 99.45 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 1.0 111.31 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.451 HG13 ' HB1' ' C' ' 8' ' ' ALA . 66.8 t -48.85 -16.85 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 C-N-CA 120.5 -0.48 . . . . 1.0 110.571 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.426 ' N ' ' C ' ' C' ' 84' ' ' LEU . 63.3 m -47.74 -34.67 8.7 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.65 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.437 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -52.95 -22.04 5.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 1.0 110.454 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -95.96 -10.93 27.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.853 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.568 HD12 ' O ' ' D' ' 83' ' ' ALA . 3.5 mm? -86.62 -59.74 2.19 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.728 0.299 . . . . 1.0 111.049 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' C' ' 92' ' ' ASP . . . -44.61 -49.97 9.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.91 -179.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.437 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -45.56 -15.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.168 -179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' C' ' 90' ' ' ALA . 97.8 m-20 -60.84 -47.91 84.2 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.429 -0.508 . . . . 1.0 110.431 -179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.486 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 0.1 OUTLIER -58.93 -44.28 91.33 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.867 -0.606 . . . . 1.0 110.852 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.486 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 59.0 t -44.62 -39.57 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.412 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -58.22 -22.51 52.27 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 121.023 -0.271 . . . . 1.0 111.176 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 77.0 ttt-85 -55.24 -43.92 75.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.559 -0.291 . . . . 1.0 110.306 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.5 mt-10 -80.31 -178.0 6.41 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.925 -0.31 . . . . 1.0 110.358 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 59.66 -69.48 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 O-C-N 123.555 0.535 . . . . 1.0 110.837 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.5 mt-10 -55.87 -46.01 78.39 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.672 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 40.4 tpt85 -64.08 -44.13 93.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.28 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -115.99 110.22 18.63 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.654 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 113.67 -11.78 23.2 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 110.921 -0.872 . . . . 1.0 110.921 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.501 ' O ' ' CG ' ' C' ' 103' ' ' HIS . 56.8 t-80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.008 -0.996 . . . . 1.0 110.686 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.372 -0.603 . . . . 1.0 109.372 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -81.61 172.21 13.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.537 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.91 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.504 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.1 p-80 -68.49 -36.12 78.49 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.701 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -64.53 -40.72 96.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.793 0.33 . . . . 1.0 110.794 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -64.1 -42.66 96.81 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.544 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.26 -39.56 68.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.151 0.501 . . . . 1.0 110.148 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.81 -37.45 86.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.67 -0.696 . . . . 1.0 110.753 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -76.61 -23.26 53.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.719 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.13 -41.35 98.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.62 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . 0.506 ' CB ' HD12 ' D' ' 84' ' ' LEU . . . -60.69 -37.21 80.87 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.923 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -58.86 -39.09 80.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.52 -0.309 . . . . 1.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.29 -33.29 75.48 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.326 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -65.01 -35.66 81.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.881 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.496 HD11 ' HB1' ' D' ' 52' ' ' ALA . 49.7 tp -62.61 -42.02 99.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.832 0.349 . . . . 1.0 110.869 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -61.1 -41.19 96.23 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.996 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -63.08 -41.43 99.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.758 0.313 . . . . 1.0 110.979 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 79.5 t -63.48 -43.38 98.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.828 -179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.748 HD21 ' HB2' ' D' ' 52' ' ' ALA . 84.2 mt -61.28 -42.09 98.05 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.317 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.94 -50.99 68.65 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.58 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.8 -39.52 87.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.351 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.13 -36.3 83.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.12 -0.491 . . . . 1.0 111.023 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' D' ' 19' ' ' LEU . 33.2 m -57.77 -44.92 86.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.418 -0.355 . . . . 1.0 110.75 -179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.49 -48.92 79.66 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.357 -0.537 . . . . 1.0 110.06 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.415 ' O ' ' CB ' ' D' ' 29' ' ' ALA . 5.5 mptp? -61.7 -37.86 85.7 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.311 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.67 -34.69 59.55 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.948 -0.301 . . . . 1.0 111.324 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 6.2 m -93.74 -45.49 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 C-N-CA 121.04 -0.264 . . . . 1.0 110.776 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.57 -40.43 96.95 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.709 0.29 . . . . 1.0 111.077 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' D' ' 25' ' ' LYS . . . -54.41 -33.2 58.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.108 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -82.69 -113.27 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.05 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 43.3 mmm-85 44.32 75.48 0.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.634 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 121.46 -7.48 10.46 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.344 -0.702 . . . . 1.0 111.344 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.568 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -63.86 147.51 96.03 Favored Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.246 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.81 117.18 4.84 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 C-N-CA 121.965 1.777 . . . . 1.0 112.044 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 84.57 -16.19 36.94 Favored Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.929 -0.868 . . . . 1.0 110.929 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' D' ' 37' ' ' ALA . . . 42.26 -168.54 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.772 0.32 . . . . 1.0 110.892 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' D' ' 61' ' ' TYR . . . 175.58 -12.85 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.026 -0.533 . . . . 1.0 110.44 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.439 HD11 ' CG ' ' D' ' 47' ' ' TRP . 1.5 tt -151.8 43.67 0.73 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.897 0.38 . . . . 1.0 110.4 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 pt -88.64 114.4 26.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.453 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.549 ' OG ' ' N ' ' D' ' 41' ' ' TYR . 13.8 t 177.65 -122.63 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.025 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.549 ' N ' ' OG ' ' D' ' 40' ' ' SER . 2.2 m-85 -176.41 -66.2 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 121.229 -0.188 . . . . 1.0 110.543 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 22.8 Cg_endo -59.87 -29.92 90.62 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 122.011 1.807 . . . . 1.0 112.011 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 38.4 p-10 -79.89 -5.57 55.79 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.78 -0.368 . . . . 1.0 110.961 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.46 -47.64 84.8 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.54 -0.464 . . . . 1.0 110.37 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.442 HG23 ' N ' ' D' ' 46' ' ' TRP . 6.2 tt -73.22 -39.28 56.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.888 -0.596 . . . . 1.0 110.643 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.462 ' CE2' HG23 ' A' ' 64' ' ' THR . 2.7 t-105 -61.12 -48.22 82.63 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.979 -0.555 . . . . 1.0 110.227 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.439 ' CG ' HD11 ' D' ' 38' ' ' LEU . 18.9 t90 -62.41 -41.47 98.72 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.785 -0.45 . . . . 1.0 109.785 178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 2.1 t -71.55 70.78 0.67 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.11 0.481 . . . . 1.0 110.131 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 94.0 t -151.04 -64.11 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.468 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.437 ' OE2' ' OD2' ' D' ' 59' ' ' ASP . 22.6 pt-20 -66.02 -26.76 67.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.414 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.408 ' H ' HG22 ' D' ' 51' ' ' THR . 0.1 OUTLIER -60.8 -44.71 96.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.992 -179.761 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.748 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.29 -26.57 65.08 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.822 -0.436 . . . . 1.0 109.822 179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.405 ' O ' ' OG1' ' D' ' 54' ' ' THR . 26.1 p -88.09 3.08 50.36 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.992 0.425 . . . . 1.0 110.312 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' D' ' 53' ' ' THR . 19.4 p 53.88 73.54 0.38 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.86 -0.609 . . . . 1.0 111.084 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.0 t -151.12 -50.95 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.694 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.518 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 73.72 -48.42 1.6 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.688 -0.965 . . . . 1.0 110.688 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 11.7 t80 67.86 -14.82 0.21 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.581 0.229 . . . . 1.0 110.864 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 99.63 18.71 22.42 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.164 -0.774 . . . . 1.0 111.164 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' NH1' ' A' ' 68' ' ' ARG . 84.4 m-20 -62.46 -66.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.846 -0.342 . . . . 1.0 110.641 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt85 -127.34 161.95 27.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.053 -0.521 . . . . 1.0 109.668 -179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 3.0 p90 -140.42 105.83 6.54 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.445 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . 0.529 ' O ' ' NH2' ' D' ' 68' ' ' ARG . 71.4 Cg_endo -70.72 164.09 36.72 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 121.575 1.517 . . . . 1.0 112.633 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' D' ' 64' ' ' THR . 11.0 p -112.08 -176.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 116.185 -0.461 . . . . 1.0 110.449 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' D' ' 63' ' ' VAL . 18.7 m -68.77 -44.06 74.47 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.845 179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' D' ' 67' ' ' GLY . 58.7 tt0 -51.39 -46.93 62.99 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.565 -0.454 . . . . 1.0 110.021 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.483 ' CD ' ' H ' ' D' ' 63' ' ' VAL . 14.3 pt-20 -79.82 36.66 0.34 Allowed 'General case' 0 C--O 1.264 1.842 0 CA-C-O 123.654 1.692 . . . . 1.0 109.0 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.738 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 38.39 61.75 1.2 Allowed Glycine 0 C--O 1.215 -1.038 0 CA-C-N 113.179 -1.828 . . . . 1.0 109.495 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.529 ' NH2' ' O ' ' D' ' 62' ' ' PRO . 57.8 ttm-85 -25.52 -29.59 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.106 0 O-C-N 124.298 0.646 . . . . 1.0 110.878 -177.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.738 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.5 mmtt -56.38 -9.91 0.8 Allowed 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.43 -0.805 . . . . 1.0 109.071 177.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 38.0 t -59.31 -47.77 89.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.23 -0.988 . . . . 1.0 109.391 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.3 -35.43 79.44 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.064 178.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -60.59 -39.28 87.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.823 -0.626 . . . . 1.0 110.965 -179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -64.35 -41.05 96.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.432 -0.349 . . . . 1.0 111.437 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.74 -46.0 97.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.571 -0.452 . . . . 1.0 111.02 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 74.7 mtm -63.16 -40.02 96.34 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.462 -0.336 . . . . 1.0 111.003 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -60.07 -45.97 91.11 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.714 -0.394 . . . . 1.0 110.465 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.513 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -66.35 -37.82 86.21 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.826 0.346 . . . . 1.0 110.296 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.71 -44.27 92.7 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 111.788 -0.525 . . . . 1.0 111.788 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 90.3 mt -62.09 -43.59 97.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.584 0.23 . . . . 1.0 111.044 -179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -64.86 -40.11 94.62 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.75 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.513 HG23 ' O ' ' D' ' 77' ' ' ALA . 54.8 t -64.82 -49.58 79.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.406 -0.361 . . . . 1.0 111.774 -179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -61.77 -44.46 96.85 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 120.3 -0.56 . . . . 1.0 110.01 -179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.568 ' O ' HD12 ' C' ' 89' ' ' LEU . . . -65.04 -35.14 80.21 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.658 -0.417 . . . . 1.0 110.053 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.709 ' C ' HD13 ' D' ' 84' ' ' LEU . 1.6 tm? -61.74 -53.33 57.42 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 120.338 -0.545 . . . . 1.0 109.867 179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.541 ' N ' HD13 ' D' ' 84' ' ' LEU . 75.4 t -44.74 -15.26 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 C-N-CA 120.667 -0.413 . . . . 1.0 110.381 179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.574 ' O ' ' N ' ' D' ' 90' ' ' ALA . 94.4 m -51.8 -42.35 62.39 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.163 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -37.98 -65.1 0.35 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.608 0.242 . . . . 1.0 111.592 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.39 -22.84 21.55 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.742 -0.383 . . . . 1.0 110.241 -179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' D' ' 86' ' ' THR . 41.4 mt -92.48 -21.87 19.91 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.451 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' D' ' 86' ' ' THR . . . -72.77 -36.96 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.404 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.82 -2.85 25.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.881 -0.599 . . . . 1.0 109.896 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -57.03 -48.0 79.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.953 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 19.4 p90 -72.94 -8.63 56.51 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.803 -0.359 . . . . 1.0 110.795 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.33 -36.36 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.526 -0.306 . . . . 1.0 111.088 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 62.0 ttm-85 -67.27 -21.64 65.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.294 -0.412 . . . . 1.0 111.157 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 44.3 ptt85 -55.28 -32.33 62.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.952 0.406 . . . . 1.0 110.346 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -61.36 147.13 45.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.465 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 48.04 23.76 0.54 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.812 0.339 . . . . 1.0 110.387 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -138.48 -35.44 0.6 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.164 -0.471 . . . . 1.0 109.951 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 52.9 ptt85 -69.38 -23.58 63.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.479 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.93 -36.6 84.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.464 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.39 16.05 57.74 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.937 -0.865 . . . . 1.0 110.937 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 56.5 t-80 . . . . . 0 C--O 1.221 -0.42 0 CA-C-O 117.96 -1.019 . . . . 1.0 110.52 179.798 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 28.0 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.48 -0.563 . . . . 1.0 109.48 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.491 ' O ' ' N ' ' A' ' 4' ' ' HIS . . . -63.62 -38.8 92.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.562 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.2 t0 64.45 -65.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.524 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 2' ' ' ALA . 34.6 p80 -57.65 -41.28 81.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.773 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.432 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 81.6 tt0 -62.93 -40.05 96.47 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.88 0.372 . . . . 1.0 110.435 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -64.36 -38.44 91.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.064 -0.516 . . . . 1.0 110.229 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.9 tp10 -65.53 -38.07 88.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.068 -0.515 . . . . 1.0 110.143 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.27 -41.71 97.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.339 -0.391 . . . . 1.0 110.233 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -66.77 -40.45 88.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.354 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -62.9 -38.69 91.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.449 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.93 -37.37 84.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.961 -179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -62.24 -38.37 88.98 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.884 -0.326 . . . . 1.0 110.729 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -63.69 -38.03 89.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.502 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -65.37 -32.73 74.52 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.542 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.8 tp -62.18 -41.8 98.67 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 120.831 -0.348 . . . . 1.0 110.552 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -61.21 -38.91 88.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.185 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmmm? -62.55 -39.84 94.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.686 -0.405 . . . . 1.0 111.404 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.44 -33.13 59.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 1.0 110.539 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 52' ' ' ALA . 95.9 mt -61.77 -40.94 96.92 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.925 -0.398 . . . . 1.0 109.925 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -58.08 -48.02 81.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 1.0 109.885 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -68.12 -32.65 73.1 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.119 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.84 96.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.654 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.9 p -60.74 -42.09 96.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.245 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -64.91 -50.51 66.22 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.203 0.525 . . . . 1.0 110.232 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -62.02 -42.74 99.49 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.399 -0.52 . . . . 1.0 110.256 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.21 -53.12 49.44 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.564 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.465 HG11 ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -60.99 -44.0 97.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.123 -0.631 . . . . 1.0 110.192 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.455 ' N ' ' CG1' ' A' ' 27' ' ' VAL . 70.2 mm-40 -68.28 -44.7 74.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.818 -0.628 . . . . 1.0 111.009 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.29 -39.32 82.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 1.0 110.203 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.438 ' OE2' ' OE1' ' A' ' 66' ' ' GLU . 52.3 mm-40 -69.51 -37.25 77.08 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.478 . . . . 1.0 111.075 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -68.37 130.28 42.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.003 0.43 . . . . 1.0 110.504 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.56 4.55 76.34 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 111.214 -0.755 . . . . 1.0 111.214 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.16 141.54 22.8 Favored Pre-proline 0 CA--C 1.534 0.346 0 O-C-N 122.774 -0.251 . . . . 1.0 110.376 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.3 136.05 19.32 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 121.94 1.76 . . . . 1.0 112.143 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.75 30.84 70.0 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 111.064 -0.815 . . . . 1.0 111.064 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' ALA . . . -63.05 -35.52 80.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.737 0.303 . . . . 1.0 110.719 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 36' ' ' ALA . . . 71.77 -39.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.475 . . . . 1.0 110.334 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 38' ' ' LEU . 6.8 tt -94.29 121.57 35.94 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.995 0.426 . . . . 1.0 109.886 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.56 ' N ' HD23 ' A' ' 38' ' ' LEU . 20.4 pt -155.17 60.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.494 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 2.6 m -155.36 138.22 15.34 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.385 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.465 ' CE2' HG11 ' A' ' 27' ' ' VAL . 21.9 m-85 -76.34 -59.18 1.1 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.143 -0.48 . . . . 1.0 111.66 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.99 -28.83 87.93 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 121.807 1.671 . . . . 1.0 112.409 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -88.2 -21.26 24.65 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.937 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.38 81.48 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.864 -0.421 . . . . 1.0 109.864 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.412 ' O ' HG23 ' A' ' 49' ' ' VAL . 5.6 tt -66.28 -37.46 79.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.301 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -46.01 87.34 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.885 -0.413 . . . . 1.0 109.885 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.478 ' HB2' ' HE ' ' A' ' 60' ' ' ARG . 2.8 t90 -64.42 -40.39 95.66 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.4 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 84.0 p -61.53 -32.75 72.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.398 -0.365 . . . . 1.0 111.031 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 45' ' ' ILE . 48.5 t -61.34 -49.83 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.857 0.361 . . . . 1.0 110.782 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH2' ' B' ' 68' ' ' ARG . 12.1 pt-20 -71.37 -25.52 62.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.449 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 98.2 m -63.62 -47.89 79.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.272 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.589 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.82 -36.54 77.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.465 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 44.3 p -75.11 -1.97 25.47 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.27 -0.641 . . . . 1.0 109.27 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.4 p 52.44 36.09 19.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.561 -0.745 . . . . 1.0 111.233 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -102.93 -49.91 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.436 -0.347 . . . . 1.0 111.042 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 45.19 84.73 0.01 OUTLIER Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.954 -0.859 . . . . 1.0 110.954 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.534 ' CZ ' ' O ' ' B' ' 60' ' ' ARG . 1.3 t80 -60.77 -46.28 91.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.799 0.333 . . . . 1.0 110.534 -179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 143.36 7.1 0.59 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.525 ' OD2' ' NH1' ' B' ' 68' ' ' ARG . 99.5 m-20 -60.73 -47.61 85.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.803 0.335 . . . . 1.0 110.611 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' O ' ' CE1' ' D' ' 57' ' ' TYR . 26.5 mtm-85 -140.85 154.34 46.15 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.219 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -150.28 136.3 10.58 Favored Pre-proline 0 CA--C 1.535 0.375 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.475 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.71 -175.15 1.28 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 C-N-CA 121.794 1.662 . . . . 1.0 112.217 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.433 ' H ' ' HG2' ' A' ' 66' ' ' GLU . 29.2 m -132.56 -131.61 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 115.976 -0.556 . . . . 1.0 110.342 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.669 HG22 ' CD1' ' D' ' 46' ' ' TRP . 7.4 p -113.87 -44.67 3.15 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.588 0.233 . . . . 1.0 111.194 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.597 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.7 tp10 -61.63 -40.44 94.87 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.254 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.438 ' OE1' ' OE2' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -72.93 32.17 0.07 Allowed 'General case' 0 C--O 1.264 1.858 0 CA-C-O 123.703 1.716 . . . . 1.0 109.997 179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.711 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 39.15 64.45 0.94 Allowed Glycine 0 C--O 1.212 -1.247 0 CA-C-N 113.53 -1.668 . . . . 1.0 111.671 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.473 ' C ' ' O ' ' A' ' 67' ' ' GLY . 58.8 ttm-85 -23.59 -34.53 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 118.328 1.064 . . . . 1.0 111.264 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.711 ' N ' ' O ' ' A' ' 67' ' ' GLY . 44.9 mmtm -51.09 -15.81 0.38 Allowed 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.716 -0.675 . . . . 1.0 109.624 177.185 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' ' O ' ' A' ' 67' ' ' GLY . 50.2 t -61.54 -47.55 92.85 Favored 'Isoleucine or valine' 0 C--N 1.35 0.602 0 C-N-CA 119.617 -0.833 . . . . 1.0 110.225 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.74 -38.23 62.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.691 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.0 tp10 -50.66 -47.18 58.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.541 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -65.24 -41.55 94.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.421 -0.354 . . . . 1.0 111.229 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.4 t -63.71 -46.99 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 C-N-CA 120.47 -0.492 . . . . 1.0 111.075 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -63.18 -40.85 98.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.764 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -63.21 -37.98 89.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.398 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.53 -38.09 86.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.633 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.37 -41.91 83.99 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 110.967 -0.853 . . . . 1.0 110.967 179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.62 -43.47 97.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.659 0.266 . . . . 1.0 110.444 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -60.49 -40.41 91.23 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.545 -0.462 . . . . 1.0 110.013 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 75.5 t -65.69 -49.1 79.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.851 179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -65.76 -40.48 92.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.13 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.35 84.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.006 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.47 ' C ' ' N ' ' A' ' 86' ' ' THR . 8.0 tt -62.07 -42.04 98.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.212 -179.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 85' ' ' VAL . 92.8 t -49.11 -13.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.628 -0.429 . . . . 1.0 110.308 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.47 ' N ' ' C ' ' A' ' 84' ' ' LEU . 58.0 m -51.79 -39.41 58.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.165 -0.47 . . . . 1.0 109.985 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -50.38 -24.94 3.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.367 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.03 -11.74 24.11 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.821 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 67.7 mt -89.66 -50.01 6.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.339 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.548 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -52.67 -34.62 52.69 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.961 0.41 . . . . 1.0 110.834 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.465 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -69.87 -12.87 61.95 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.196 -0.457 . . . . 1.0 110.401 -179.299 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -58.91 -50.12 75.21 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.686 -0.406 . . . . 1.0 111.151 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.548 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 9.9 p90 -74.94 -23.13 58.27 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.314 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 77.4 t -60.48 -43.87 95.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.937 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' O ' ' N ' ' A' ' 98' ' ' GLU . 99.7 mtt180 -60.04 -22.57 62.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.556 -0.293 . . . . 1.0 110.652 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 73.4 ttp85 -42.68 -39.48 2.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.48 -0.327 . . . . 1.0 110.867 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -61.62 -41.94 98.19 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.047 0.451 . . . . 1.0 109.889 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.424 ' N ' ' O ' ' A' ' 95' ' ' ARG . 97.3 mt-10 -70.59 -38.18 74.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.566 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.66 -30.04 70.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.506 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.6 ttt-85 -59.28 -44.12 92.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.341 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -65.54 -37.78 87.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.503 ' O ' ' ND1' ' A' ' 103' ' ' HIS . . . 78.05 25.88 61.17 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.503 ' ND1' ' O ' ' A' ' 102' ' ' GLY . 78.7 m80 . . . . . 0 C--O 1.22 -0.448 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.617 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.526 ' O ' ' ND1' ' B' ' 4' ' ' HIS . . . -156.97 32.73 0.3 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.7 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.5 t0 66.28 -65.49 0.19 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.903 -0.589 . . . . 1.0 110.683 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.526 ' ND1' ' O ' ' B' ' 2' ' ' ALA . 14.1 p-80 -73.41 -19.34 61.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.766 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -68.74 -36.1 77.95 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.511 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -62.72 -37.87 88.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.791 0.329 . . . . 1.0 110.65 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -57.96 -40.4 80.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.94 89.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.579 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.5 -37.02 84.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 1.0 110.464 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -61.08 -40.08 92.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.556 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.21 -38.93 81.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.886 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.5 -38.76 87.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.431 -0.35 . . . . 1.0 110.655 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -63.98 -38.09 89.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.333 -0.394 . . . . 1.0 110.28 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.94 -31.84 73.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.274 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.447 HD11 ' HB1' ' B' ' 52' ' ' ALA . 41.5 tp -63.05 -37.57 87.73 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.406 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -68.1 -36.19 79.36 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.258 -0.428 . . . . 1.0 111.11 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -62.46 -47.58 83.39 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.797 0.332 . . . . 1.0 111.547 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.48 -34.39 69.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.972 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 35.8 mt -60.54 -39.44 87.93 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.29 -0.633 . . . . 1.0 109.29 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.39 -43.83 89.43 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -67.99 -32.93 73.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.053 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -38.47 80.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 1.0 109.902 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 11.6 t -60.54 -44.86 95.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.13 -0.486 . . . . 1.0 110.592 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 52.9 tttm -62.74 -51.86 65.51 Favored 'General case' 0 N--CA 1.463 0.176 0 C-N-CA 120.231 -0.588 . . . . 1.0 109.917 179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -63.4 -42.78 98.78 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.316 -0.554 . . . . 1.0 110.417 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.8 -51.19 70.37 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.871 -0.332 . . . . 1.0 111.524 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.41 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 0.9 OUTLIER -64.78 -42.01 93.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 C-N-CA 120.546 -0.462 . . . . 1.0 110.469 -179.643 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.41 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 82.5 tt0 -70.26 -43.74 69.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.702 -0.681 . . . . 1.0 111.242 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.41 -37.14 86.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.15 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.43 ' OE1' ' N ' ' B' ' 38' ' ' LEU . 33.0 mm-40 -66.0 -35.12 79.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.905 0.383 . . . . 1.0 110.775 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.76 128.67 37.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.209 -0.45 . . . . 1.0 110.624 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.54 3.09 63.02 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.258 -0.737 . . . . 1.0 111.258 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.44 147.94 33.82 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.819 -0.224 . . . . 1.0 110.505 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.528 ' C ' ' H ' ' B' ' 36' ' ' ALA . 96.1 Cg_endo -75.47 142.53 26.57 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.18 1.92 . . . . 1.0 112.318 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . 0.437 ' O ' ' O ' ' B' ' 36' ' ' ALA . . . 69.73 -23.29 0.4 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.528 ' H ' ' C ' ' B' ' 34' ' ' PRO . . . 45.3 -174.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.837 0.351 . . . . 1.0 110.581 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -178.19 -31.86 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.329 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.43 ' N ' ' OE1' ' B' ' 30' ' ' GLU . 14.8 tp -137.2 102.75 4.91 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.288 179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.462 ' O ' ' CB ' ' B' ' 40' ' ' SER . 4.2 pt -132.14 104.17 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.78 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.758 ' O ' ' HB2' ' B' ' 44' ' ' ALA . 0.3 OUTLIER 164.89 143.97 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.545 -179.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 3.5 m-85 -81.42 -61.66 0.37 Allowed Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.983 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.0 Cg_endo -58.39 -27.05 80.17 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.187 1.925 . . . . 1.0 112.464 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -93.21 -22.12 19.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 121.056 -0.257 . . . . 1.0 110.918 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.758 ' HB2' ' O ' ' B' ' 40' ' ' SER . . . -62.52 -40.64 97.4 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 110.049 -0.352 . . . . 1.0 110.049 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.1 tt -66.51 -38.47 81.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.875 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.435 ' HE1' ' HB2' ' C' ' 68' ' ' ARG . 3.4 t-105 -60.95 -46.95 88.67 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.564 -178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.41 ' CD2' ' C ' ' B' ' 47' ' ' TRP . 0.2 OUTLIER -66.58 -26.05 66.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -69.88 -36.09 75.17 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.754 -0.378 . . . . 1.0 111.017 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 58.1 t -61.08 -47.08 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.164 0 CA-C-N 116.491 -0.322 . . . . 1.0 111.804 -178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -66.87 -30.77 71.02 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.61 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -63.7 -46.46 85.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.452 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -58.62 -28.77 65.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.517 -0.31 . . . . 1.0 111.11 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.9 p -90.01 4.23 50.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.786 0.327 . . . . 1.0 110.543 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.9 p 46.82 66.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.971 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.409 HG21 ' SD ' ' C' ' 75' ' ' MET . 0.8 OUTLIER -148.96 11.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.317 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . -39.01 105.71 0.05 OUTLIER Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -74.26 -102.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.638 0.256 . . . . 1.0 110.591 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.23 11.13 3.56 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 110.955 -0.858 . . . . 1.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.19 -66.81 0.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.752 0.31 . . . . 1.0 110.501 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.534 ' O ' ' CZ ' ' A' ' 57' ' ' TYR . 44.4 mtt-85 -145.73 157.25 43.96 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 109.915 -0.402 . . . . 1.0 109.915 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -150.98 140.41 13.75 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 110.002 -0.37 . . . . 1.0 110.002 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.3 170.84 15.1 Favored 'Trans proline' 0 N--CA 1.496 1.619 0 C-N-CA 122.021 1.814 . . . . 1.0 112.064 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.472 ' C ' ' OE1' ' B' ' 66' ' ' GLU . 2.7 t -100.83 -130.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-N 116.289 -0.414 . . . . 1.0 109.926 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.503 ' N ' ' OE1' ' B' ' 66' ' ' GLU . 87.5 m -115.25 -42.02 3.23 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.424 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.694 ' C ' ' H ' ' B' ' 67' ' ' GLY . 45.4 tp10 -64.95 -37.68 88.46 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.755 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -67.14 28.44 0.02 OUTLIER 'General case' 0 C--O 1.265 1.885 0 CA-C-O 123.558 1.647 . . . . 1.0 110.06 178.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 39.53 63.5 1.17 Allowed Glycine 0 C--O 1.213 -1.162 0 CA-C-N 113.704 -1.589 . . . . 1.0 111.407 178.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.525 ' NH1' ' OD2' ' A' ' 59' ' ' ASP . 58.2 ttt85 -24.49 -32.59 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.331 1.066 . . . . 1.0 111.018 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' B' ' 67' ' ' GLY . 32.1 mmtp -49.61 -18.09 0.4 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.456 -0.793 . . . . 1.0 108.885 176.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.637 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.48 -47.85 91.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.699 179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.27 -39.71 74.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.19 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -53.09 -44.17 67.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 109.999 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -57.77 -43.02 85.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.455 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 56.2 t -66.96 -44.39 88.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 120.649 -0.42 . . . . 1.0 111.047 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 36.3 mtt -60.31 -43.32 96.46 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.552 -0.294 . . . . 1.0 110.432 -179.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -63.49 -38.94 93.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.515 -0.311 . . . . 1.0 110.323 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.34 -40.93 87.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.673 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.66 -49.01 62.2 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.544 -0.622 . . . . 1.0 111.544 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . 0.576 HG22 ' O ' ' B' ' 79' ' ' ILE . 93.7 mt -68.3 -3.72 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 C-N-CA 120.804 -0.358 . . . . 1.0 111.181 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -95.0 -52.36 4.26 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.05 0.452 . . . . 1.0 110.545 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.484 HG23 ' N ' ' B' ' 82' ' ' PHE . 12.7 m -60.91 -48.72 87.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.7 -0.682 . . . . 1.0 111.275 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.484 ' N ' HG23 ' B' ' 81' ' ' VAL . 44.4 m-85 -66.18 -38.83 89.0 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.956 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.1 -36.04 83.02 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.561 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.444 ' C ' ' N ' ' B' ' 86' ' ' THR . 6.0 tt -61.9 -40.69 96.29 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.107 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.549 HG12 HD23 ' B' ' 89' ' ' LEU . 98.8 t -47.52 -19.37 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 109.6 -0.519 . . . . 1.0 109.6 179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' B' ' 90' ' ' ALA . 81.6 m -51.41 -19.88 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.486 -0.561 . . . . 1.0 109.486 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.06 -64.71 0.8 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.709 -0.678 . . . . 1.0 111.433 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -69.4 -11.93 61.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.81 0.338 . . . . 1.0 110.723 -179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.549 HD23 HG12 ' B' ' 85' ' ' VAL . 3.6 mm? -98.17 -6.66 30.96 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.101 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' B' ' 86' ' ' THR . . . -87.54 -27.17 22.76 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.11 -0.7 . . . . 1.0 109.11 178.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.46 -3.85 45.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.271 -0.877 . . . . 1.0 109.881 179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.543 ' CG ' ' HB2' ' C' ' 87' ' ' ALA . 35.9 t0 -54.48 -47.58 72.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.038 -0.528 . . . . 1.0 111.011 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.447 ' CE1' ' O ' ' B' ' 90' ' ' ALA . 21.9 p90 -75.32 -30.0 60.19 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.955 -0.298 . . . . 1.0 111.275 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.4 t -60.47 -43.88 95.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.421 . . . . 1.0 111.542 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 64.6 ttm-85 -46.29 -21.45 0.16 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.971 -0.292 . . . . 1.0 111.176 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.441 ' CG ' ' N ' ' B' ' 97' ' ' GLU . 42.7 ptt85 -59.97 -41.41 91.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.405 . . . . 1.0 110.213 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.441 ' N ' ' CG ' ' B' ' 96' ' ' ARG . 98.0 mt-10 -62.0 -39.26 91.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.74 -0.664 . . . . 1.0 111.159 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.43 ' O ' ' O ' ' B' ' 101' ' ' ARG . 80.1 mm-40 -65.99 -39.09 90.01 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.971 -0.292 . . . . 1.0 110.651 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.411 ' O ' ' O ' ' B' ' 103' ' ' HIS . 97.7 mt-10 -65.83 -47.7 74.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.681 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -66.56 -42.67 86.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.425 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . 0.43 ' O ' ' O ' ' B' ' 98' ' ' GLU . 24.6 mmt85 -102.3 114.88 29.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.315 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.5 -14.07 56.61 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.871 -0.891 . . . . 1.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' B' ' 99' ' ' GLU . 47.7 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.093 -0.956 . . . . 1.0 110.658 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.503 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . 54.06 92.1 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.855 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -62.7 -40.19 96.37 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.132 -0.485 . . . . 1.0 110.374 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.713 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.9 p80 -57.13 -41.67 79.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.622 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -64.87 -42.84 94.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 1.0 110.912 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -64.73 -41.92 95.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.971 -0.381 . . . . 1.0 109.971 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -66.76 -38.26 86.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.984 -0.553 . . . . 1.0 110.181 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.72 -41.86 98.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -64.93 -42.36 94.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.303 -0.408 . . . . 1.0 110.328 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 65.4 tttm -64.38 -37.19 86.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.362 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.4 -34.43 72.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.009 -0.541 . . . . 1.0 111.223 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -62.77 -38.41 90.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.714 0.292 . . . . 1.0 110.889 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -63.89 -34.36 77.78 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 1.0 110.347 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.66 -35.39 80.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.672 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.409 HD13 ' HA2' ' C' ' 78' ' ' GLY . 45.4 tp -62.29 -41.56 98.61 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.857 -0.337 . . . . 1.0 110.461 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -61.79 -39.54 92.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.288 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -62.23 -40.77 97.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.833 0.349 . . . . 1.0 111.283 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.4 t -63.22 -40.15 87.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.662 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.795 HD21 ' HB2' ' C' ' 52' ' ' ALA . 84.7 mt -60.37 -40.66 91.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.415 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -52.8 -48.75 66.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.52 -0.548 . . . . 1.0 109.52 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.33 -32.94 73.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.152 178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.89 -43.68 98.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.78 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.6 p -58.59 -43.54 89.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.521 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -62.35 -51.08 69.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.263 0.554 . . . . 1.0 109.568 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.05 -41.99 97.65 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.347 -0.541 . . . . 1.0 109.987 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.88 -52.66 62.22 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 121.084 -0.247 . . . . 1.0 111.324 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' C' ' 28' ' ' GLU . 1.2 p -65.16 -41.29 91.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 C-N-CA 120.538 -0.465 . . . . 1.0 109.954 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.4 ' N ' ' CG1' ' C' ' 27' ' ' VAL . 44.3 tp10 -66.92 -44.21 81.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.611 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.38 -38.45 87.57 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.685 -0.487 . . . . 1.0 109.685 178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.418 ' OE1' ' HB1' ' C' ' 36' ' ' ALA . 64.2 mm-40 -71.11 -34.2 70.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.094 -0.503 . . . . 1.0 111.149 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 11.1 tpt180 -67.79 121.8 16.76 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.855 0.36 . . . . 1.0 110.624 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.39 3.87 61.19 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.272 -0.731 . . . . 1.0 111.272 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.08 142.48 24.76 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 110.466 -0.198 . . . . 1.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.13 144.77 27.03 Favored 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 122.015 1.81 . . . . 1.0 112.359 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.73 11.82 58.19 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.202 -0.759 . . . . 1.0 111.202 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . 0.418 ' HB1' ' OE1' ' C' ' 30' ' ' GLU . . . -60.19 92.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.777 0.323 . . . . 1.0 110.57 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.42 -37.2 86.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.297 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 24.7 tp -87.43 118.22 26.73 Favored 'General case' 0 C--O 1.226 -0.171 0 CA-C-N 116.259 -0.428 . . . . 1.0 110.157 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.485 ' O ' ' CB ' ' C' ' 40' ' ' SER . 40.2 pt -145.13 164.15 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.251 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' C' ' 39' ' ' ILE . 0.7 OUTLIER 82.13 142.3 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.789 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.678 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 89.8 t80 -80.36 -38.87 1.14 Allowed Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 115.799 -0.637 . . . . 1.0 111.112 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 25.8 Cg_endo -60.03 -32.73 95.29 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 121.403 1.402 . . . . 1.0 112.378 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.433 ' OD2' ' O ' ' C' ' 39' ' ' ILE . 9.1 p-10 -95.09 -9.91 32.27 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 121.015 -0.274 . . . . 1.0 111.1 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -38.37 81.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.908 0.385 . . . . 1.0 110.794 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 tt -64.67 -37.26 79.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.594 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' D' ' 64' ' ' THR . 0.1 OUTLIER -60.93 -47.52 86.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.604 -179.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.453 ' CD2' ' C ' ' C' ' 47' ' ' TRP . 0.8 OUTLIER -71.69 -18.19 62.18 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.188 -0.605 . . . . 1.0 109.384 178.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.645 ' O ' HD22 ' C' ' 19' ' ' LEU . 7.5 t -81.01 48.98 1.17 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.009 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.544 HG11 HH12 ' D' ' 68' ' ' ARG . 92.0 t -147.21 -41.33 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 C-N-CA 120.838 -0.345 . . . . 1.0 111.336 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.48 -34.55 78.17 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.853 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.01 -44.7 83.98 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.495 -0.32 . . . . 1.0 111.181 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.795 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -60.46 -35.53 76.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.691 0.281 . . . . 1.0 110.571 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 43.3 p -88.46 3.46 50.02 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.814 0.34 . . . . 1.0 110.106 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.2 p 51.66 75.43 0.21 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.967 -0.561 . . . . 1.0 110.788 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 46.9 t -142.37 -66.77 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.282 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' C' ' 58' ' ' GLY . . . 81.58 -59.1 4.86 Favored Glycine 0 CA--C 1.521 0.409 0 N-CA-C 110.445 -1.062 . . . . 1.0 110.445 -179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 68.74 -38.4 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.632 -0.284 . . . . 1.0 110.978 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.494 ' H ' ' C ' ' C' ' 56' ' ' GLY . . . 124.53 19.6 2.53 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.787 -0.925 . . . . 1.0 110.787 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -60.09 -49.0 79.37 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.805 -0.358 . . . . 1.0 110.37 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 75.8 mtt-85 -147.06 -165.57 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.916 -0.402 . . . . 1.0 109.916 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.524 ' O ' ' CD2' ' C' ' 61' ' ' TYR . 42.6 p90 -170.41 113.75 0.46 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 120.447 -0.501 . . . . 1.0 110.636 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.19 -171.46 0.51 Allowed 'Trans proline' 0 N--CA 1.497 1.726 0 C-N-CA 121.488 1.459 . . . . 1.0 112.104 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.861 HG22 ' H ' ' C' ' 64' ' ' THR . 13.3 p -129.48 -176.41 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.236 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.861 ' H ' HG22 ' C' ' 63' ' ' VAL . 71.3 m -79.83 -25.23 40.87 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.777 0.322 . . . . 1.0 110.476 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.562 ' C ' ' H ' ' C' ' 67' ' ' GLY . 43.1 tp10 -66.54 -43.63 84.62 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 1.0 110.399 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' C' ' 63' ' ' VAL . 1.1 pp20? -77.0 31.47 0.14 Allowed 'General case' 0 C--O 1.268 2.035 0 CA-C-O 124.212 1.958 . . . . 1.0 109.586 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.699 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 43.83 64.38 1.92 Allowed Glycine 0 C--O 1.217 -0.914 0 CA-C-N 113.24 -1.8 . . . . 1.0 111.266 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' C' ' 67' ' ' GLY . 42.3 ttm180 -24.79 -32.47 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.9 0.85 . . . . 1.0 111.049 -178.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.699 ' N ' ' O ' ' C' ' 67' ' ' GLY . 29.9 mmtp -48.75 -22.35 0.78 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 115.647 -0.706 . . . . 1.0 109.595 177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.547 ' N ' ' O ' ' C' ' 67' ' ' GLY . 80.0 t -61.95 -48.09 90.2 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 C-N-CA 118.958 -1.097 . . . . 1.0 110.564 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.17 -39.45 78.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.916 0.389 . . . . 1.0 110.793 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.76 -44.78 96.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 1.0 111.015 -179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.58 -38.45 72.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.446 -0.343 . . . . 1.0 111.221 -179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 53.3 t -64.31 -43.15 97.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.816 -0.354 . . . . 1.0 111.455 -179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.409 ' SD ' HG21 ' B' ' 55' ' ' VAL . 60.2 mtt -60.99 -42.0 97.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.84 -178.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . 0.517 ' NZ ' ' OE2' ' C' ' 80' ' ' GLU . 64.7 tttm -61.92 -41.22 97.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.718 0.294 . . . . 1.0 110.555 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.15 -38.88 92.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.736 0.303 . . . . 1.0 110.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.409 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.24 -41.98 91.3 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 116.146 -0.479 . . . . 1.0 111.968 -179.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -61.12 -43.1 95.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.682 0.277 . . . . 1.0 110.717 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . 0.517 ' OE2' ' NZ ' ' C' ' 76' ' ' LYS . 97.7 mt-10 -60.13 -43.59 95.55 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.93 -0.308 . . . . 1.0 111.202 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -64.45 -49.22 81.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.664 -0.414 . . . . 1.0 111.361 -179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -67.79 -38.76 83.77 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.901 -0.32 . . . . 1.0 111.318 -179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.27 -37.01 85.85 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.867 0.365 . . . . 1.0 110.675 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.33 -40.59 97.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.657 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -50.93 -20.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.435 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . . . . . . . . . 5.7 t -50.78 -22.1 1.97 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.985 0.421 . . . . 1.0 110.515 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.543 ' HB2' ' CG ' ' B' ' 92' ' ' ASP . . . -56.14 -25.61 46.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.806 -0.634 . . . . 1.0 110.202 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -98.29 -16.41 19.39 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.694 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 58.7 mt -86.2 -47.1 9.76 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.408 -0.36 . . . . 1.0 111.279 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.82 -29.19 59.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.847 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -89.58 -3.65 58.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.143 -0.48 . . . . 1.0 109.968 -179.67 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.438 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 53.3 t0 -56.27 -47.28 78.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.585 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.427 ' CG ' ' N ' ' C' ' 94' ' ' VAL . 7.9 p90 -75.19 -37.5 61.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.467 -0.333 . . . . 1.0 111.105 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.427 ' N ' ' CG ' ' C' ' 93' ' ' PHE . 95.9 t -46.64 -27.32 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.575 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' C' ' 98' ' ' GLU . 96.4 mtt180 -69.49 -23.59 63.65 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.688 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -42.47 -37.25 1.55 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 1.0 111.078 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -82.06 -24.72 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.653 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.503 ' N ' ' O ' ' C' ' 95' ' ' ARG . 96.6 mt-10 -97.31 38.52 1.25 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.872 0.367 . . . . 1.0 110.5 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.35 -42.68 0.41 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.489 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.926 0.393 . . . . 1.0 110.594 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 33.9 mmt180 -65.38 -36.71 84.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.883 -0.599 . . . . 1.0 110.521 -179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.69 15.7 51.67 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.984 -0.846 . . . . 1.0 110.984 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 118.083 -0.961 . . . . 1.0 110.499 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 61.2 m . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.483 -0.562 . . . . 1.0 109.483 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.446 ' CB ' ' NE2' ' D' ' 4' ' ' HIS . . . -83.52 170.05 14.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 1.0 110.619 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -61.68 -43.96 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.907 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.668 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 5.2 p80 -69.11 -37.34 78.33 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.723 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -64.85 -36.6 84.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.573 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 72.8 ttt180 -62.28 -42.2 99.14 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.4 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -63.47 -43.4 97.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.086 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . 0.459 ' HB1' HG12 ' D' ' 85' ' ' VAL . . . -65.88 -37.57 86.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.897 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . 0.441 ' O ' ' OE1' ' D' ' 13' ' ' GLU . 59.0 tt0 -63.42 -39.93 95.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.374 -0.375 . . . . 1.0 110.58 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 38.3 tptt -63.91 -36.67 84.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.62 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.24 -27.56 65.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.125 -0.488 . . . . 1.0 111.282 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.52 -39.24 93.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 1.0 110.765 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' D' ' 13' ' ' GLU . 54.3 mp0 -67.06 -34.36 77.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.591 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 11.9 tm-20 -62.51 -37.22 85.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.42 -0.355 . . . . 1.0 110.651 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.418 HD13 ' HA2' ' D' ' 78' ' ' GLY . 42.7 tp -62.72 -42.0 99.44 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.64 -0.424 . . . . 1.0 110.389 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -62.12 -32.5 73.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 1.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 70.7 tttt -61.91 -39.19 91.14 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.045 0.45 . . . . 1.0 110.826 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 57.8 t -70.96 -38.49 72.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 116.367 -0.379 . . . . 1.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.637 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.3 mt -61.95 -45.92 91.59 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.645 -178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -71.17 -42.26 69.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.382 . . . . 1.0 110.344 179.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -68.07 -40.28 82.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 1.0 110.253 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.23 -37.27 83.28 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.838 -0.619 . . . . 1.0 111.067 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -55.54 -44.27 76.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.641 -0.254 . . . . 1.0 110.568 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -65.45 -32.87 74.72 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 120.631 -0.427 . . . . 1.0 110.169 179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -76.3 -43.87 39.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.886 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.451 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -60.33 -49.63 76.83 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.533 HG13 ' N ' ' D' ' 28' ' ' GLU . 8.7 p -60.6 -44.55 97.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.443 -0.503 . . . . 1.0 109.908 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.533 ' N ' HG13 ' D' ' 27' ' ' VAL . 9.1 tm-20 -68.06 -42.51 80.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.913 -0.585 . . . . 1.0 110.546 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.05 91.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.628 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.52 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 3.2 mp0 -70.74 -34.18 71.61 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.779 0.324 . . . . 1.0 110.309 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 34.2 mmm-85 -69.23 122.9 19.77 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.079 0.466 . . . . 1.0 110.663 -179.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.28 -2.06 57.62 Favored Glycine 0 CA--C 1.523 0.535 0 CA-C-N 115.574 -0.739 . . . . 1.0 111.366 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.52 149.52 35.82 Favored Pre-proline 0 N--CA 1.464 0.261 0 O-C-N 122.847 -0.208 . . . . 1.0 110.538 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.54 143.04 30.2 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.057 1.838 . . . . 1.0 112.357 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 71.41 24.57 76.74 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.11 -0.796 . . . . 1.0 111.11 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.43 143.76 57.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.762 0.315 . . . . 1.0 110.628 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.05 -22.77 2.01 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.58 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' D' ' 39' ' ' ILE . 37.6 tp -70.87 -89.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.536 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.546 HG22 ' N ' ' D' ' 40' ' ' SER . 95.5 mt 54.12 161.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 121.188 0.518 . . . . 1.0 110.671 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.546 ' N ' HG22 ' D' ' 39' ' ' ILE . 1.1 t 76.23 130.47 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.585 -0.734 . . . . 1.0 110.67 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 20.8 t80 -77.22 -43.61 2.68 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.069 178.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.5 Cg_endo -59.2 -29.72 91.15 Favored 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 121.238 1.292 . . . . 1.0 112.094 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.544 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.3 m-20 -89.96 -30.91 17.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.565 -0.289 . . . . 1.0 110.993 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.96 -36.72 82.27 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.868 0.366 . . . . 1.0 110.774 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.407 ' O ' HG23 ' D' ' 49' ' ' VAL . 7.7 tt -63.95 -37.06 78.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.059 179.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.669 ' CD1' HG22 ' A' ' 64' ' ' THR . 0.2 OUTLIER -67.41 -41.48 84.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.577 -0.283 . . . . 1.0 110.246 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.412 ' O ' ' CG ' ' D' ' 50' ' ' GLU . 13.5 t90 -60.08 -37.33 79.61 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.563 -0.532 . . . . 1.0 109.563 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.484 ' O ' HD22 ' D' ' 19' ' ' LEU . 85.8 p -65.65 -33.1 75.11 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.449 -0.501 . . . . 1.0 110.29 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.564 ' O ' HG12 ' D' ' 49' ' ' VAL . 62.1 t -79.72 63.46 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.058 0.456 . . . . 1.0 111.724 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.412 ' CG ' ' O ' ' D' ' 47' ' ' TRP . 8.3 pt-20 178.9 -33.71 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.976 -0.556 . . . . 1.0 109.68 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.49 ' CG2' ' SD ' ' D' ' 75' ' ' MET . 90.4 m -65.33 -42.08 93.29 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.079 -0.509 . . . . 1.0 110.114 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.637 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -55.09 -26.23 36.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.776 -0.453 . . . . 1.0 109.776 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 16.8 p -83.02 0.86 42.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.235 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 17.6 p 57.99 10.93 1.29 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.971 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.483 ' C ' ' H ' ' D' ' 57' ' ' TYR . 76.7 t -91.17 -54.76 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.677 0.275 . . . . 1.0 110.739 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.566 ' O ' ' N ' ' D' ' 58' ' ' GLY . . . 71.08 -42.1 0.61 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.74 -0.944 . . . . 1.0 110.74 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.483 ' H ' ' C ' ' D' ' 55' ' ' VAL . 0.1 OUTLIER 56.16 -74.04 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.763 0.316 . . . . 1.0 110.681 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' D' ' 56' ' ' GLY . . . -159.15 -91.49 0.08 OUTLIER Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.629 -0.988 . . . . 1.0 110.629 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' NH1' ' D' ' 60' ' ' ARG . 29.5 t70 45.41 -119.53 0.81 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.729 0.3 . . . . 1.0 110.345 -179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.544 ' NH2' ' O ' ' D' ' 43' ' ' ASP . 0.1 OUTLIER -113.78 169.24 9.14 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.44 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 53.8 p90 -137.09 136.41 20.94 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.782 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -70.63 154.27 64.39 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.267 1.978 . . . . 1.0 112.195 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.519 HG23 ' H ' ' D' ' 66' ' ' GLU . 18.1 m -93.42 -145.82 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.0 -0.545 . . . . 1.0 109.874 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.439 ' HA ' ' HE1' ' C' ' 46' ' ' TRP . 5.6 m -112.87 -41.04 3.85 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.694 0.283 . . . . 1.0 110.447 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.599 ' C ' ' H ' ' D' ' 67' ' ' GLY . 52.1 tp10 -66.07 -25.76 67.18 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.845 -0.342 . . . . 1.0 110.103 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.519 ' H ' HG23 ' D' ' 63' ' ' VAL . 1.0 OUTLIER -74.39 30.44 0.08 Allowed 'General case' 0 C--O 1.263 1.79 0 CA-C-O 123.697 1.713 . . . . 1.0 108.975 178.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.706 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.42 61.35 3.27 Favored Glycine 0 C--O 1.21 -1.385 0 CA-C-N 114.011 -1.449 . . . . 1.0 109.537 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.544 HH12 HG11 ' C' ' 49' ' ' VAL . 55.6 ttp85 -24.48 -33.05 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 O-C-N 124.328 0.664 . . . . 1.0 110.735 -177.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.706 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.7 mttt -51.98 -18.32 1.33 Allowed 'General case' 0 N--CA 1.438 -1.058 0 CA-C-N 115.618 -0.719 . . . . 1.0 109.413 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' D' ' 67' ' ' GLY . 54.0 t -62.75 -49.63 82.93 Favored 'Isoleucine or valine' 0 C--N 1.353 0.753 0 C-N-CA 119.577 -0.849 . . . . 1.0 109.932 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . 0.541 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -70.9 -43.27 68.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.403 179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -41.84 -43.93 3.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 1.0 111.234 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -70.67 -35.66 72.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 120.9 -0.32 . . . . 1.0 111.665 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -60.1 -52.07 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 C-N-CA 120.056 -0.658 . . . . 1.0 111.677 -177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.541 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 0.0 OUTLIER -70.89 -40.1 72.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.782 0.325 . . . . 1.0 110.71 179.775 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.05 -43.01 99.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.464 -179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.66 -36.6 84.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.983 0.421 . . . . 1.0 110.221 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.418 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -63.67 -41.53 98.99 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.582 -0.607 . . . . 1.0 111.582 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 94.1 mt -62.21 -43.05 97.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.636 0.255 . . . . 1.0 111.072 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.19 -42.03 97.86 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.824 -0.35 . . . . 1.0 111.072 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.41 -48.33 87.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.43 -0.35 . . . . 1.0 111.364 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -71.58 -12.79 61.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.671 -0.412 . . . . 1.0 110.787 -179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' D' ' 86' ' ' THR . . . -94.65 -31.84 13.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.8 0.333 . . . . 1.0 110.185 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.5 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.1 tt -64.4 -41.51 96.6 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.337 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.459 HG12 ' HB1' ' D' ' 8' ' ' ALA . 35.0 m -58.42 -2.88 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.142 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.5 ' H ' ' C ' ' D' ' 84' ' ' LEU . 48.1 m -60.01 -22.26 62.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.056 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.438 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -59.08 -47.89 83.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.249 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.94 -36.78 85.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.027 -0.533 . . . . 1.0 109.836 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.42 -39.52 92.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.795 -0.639 . . . . 1.0 110.461 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.537 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -56.8 -45.37 82.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 1.0 110.976 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.18 -10.06 59.37 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.086 -0.507 . . . . 1.0 110.1 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.641 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.9 t0 -55.82 -48.52 75.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.363 -0.381 . . . . 1.0 111.133 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.537 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -76.11 -30.54 58.29 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.821 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 46.9 t -62.42 -26.18 39.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.305 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp85 -57.75 -32.75 67.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.883 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . 0.414 ' CG ' ' N ' ' D' ' 97' ' ' GLU . 36.1 ptt85 -58.17 -39.23 78.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.411 . . . . 1.0 110.037 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.414 ' N ' ' CG ' ' D' ' 96' ' ' ARG . 81.0 tt0 -63.49 -40.65 97.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.836 -0.62 . . . . 1.0 110.717 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.66 -42.61 86.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.889 0.376 . . . . 1.0 110.255 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -67.76 -38.17 83.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.157 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -60.56 -47.24 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.435 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 25.7 mmt85 -69.9 -36.93 75.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.101 -0.499 . . . . 1.0 110.593 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.4 28.24 30.73 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.924 -0.87 . . . . 1.0 110.924 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 76.8 m80 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.041 -0.98 . . . . 1.0 110.622 179.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.444 ' O ' ' O ' ' A' ' 2' ' ' ALA . 73.5 m . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.344 -0.613 . . . . 1.0 109.344 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.468 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . 56.26 154.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.704 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -106.84 -8.79 16.59 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.245 -0.434 . . . . 1.0 110.465 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.468 ' NE2' ' HB1' ' A' ' 2' ' ' ALA . 13.4 p80 -87.64 -19.74 27.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.527 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -66.12 -38.84 89.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.559 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.69 -38.16 90.05 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.118 -0.492 . . . . 1.0 110.233 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -63.1 -41.22 99.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.172 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.53 -41.61 96.27 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.852 0.358 . . . . 1.0 110.527 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -65.69 -37.16 85.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.316 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -62.46 -37.38 85.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.372 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.14 76.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.904 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.59 -38.71 92.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.563 -0.289 . . . . 1.0 110.597 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -62.2 -34.59 76.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.353 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -65.55 -34.09 77.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.392 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.503 HD11 ' HB1' ' A' ' 52' ' ' ALA . 48.3 tp -62.92 -39.01 93.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.331 . . . . 1.0 110.417 -179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -66.04 -34.63 78.51 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.444 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -64.62 -46.77 81.16 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.921 0.341 . . . . 1.0 111.921 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' A' ' 18' ' ' VAL . 10.6 m -63.62 -36.0 74.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.584 -0.28 . . . . 1.0 110.549 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.684 HD21 ' HB2' ' A' ' 52' ' ' ALA . 85.8 mt -62.47 -42.76 99.71 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.161 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.76 -45.81 77.35 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.104 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -68.94 -38.58 79.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.288 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.43 -36.92 85.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.72 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.1 m -57.62 -44.11 85.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.373 -0.376 . . . . 1.0 110.087 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -66.3 -31.71 72.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.453 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.442 ' O ' ' N ' ' A' ' 29' ' ' ALA . 97.2 mttt -76.57 -48.44 19.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.225 -0.443 . . . . 1.0 111.215 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.7 -47.59 79.59 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.515 -0.311 . . . . 1.0 111.467 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.509 HG13 ' N ' ' A' ' 28' ' ' GLU . 9.0 p -61.93 -44.67 99.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.306 -0.558 . . . . 1.0 109.669 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.509 ' N ' HG13 ' A' ' 27' ' ' VAL . 84.0 tt0 -69.85 -31.22 68.95 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.385 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.442 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -57.01 -38.09 72.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.261 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -67.24 -39.27 86.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.419 -0.355 . . . . 1.0 111.076 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 47.6 mmm-85 -55.41 99.69 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.628 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.71 -2.45 23.18 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.275 -0.73 . . . . 1.0 111.275 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -101.06 142.42 24.58 Favored Pre-proline 0 CA--C 1.534 0.363 0 O-C-N 122.753 -0.263 . . . . 1.0 110.653 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.503 ' O ' HG11 ' A' ' 63' ' ' VAL . 98.5 Cg_endo -75.07 144.19 29.72 Favored 'Trans proline' 0 N--CA 1.492 1.432 0 C-N-CA 121.936 1.758 . . . . 1.0 112.269 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.25 26.39 70.48 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.83 151.24 0.92 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.796 0.331 . . . . 1.0 110.483 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.61 -53.17 0.54 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.481 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.97 53.93 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.186 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 39' ' ' ILE . 13.7 tt -105.64 96.81 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.04 -0.527 . . . . 1.0 110.225 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.521 ' O ' ' CD2' ' A' ' 41' ' ' TYR . 71.7 m -169.34 -123.14 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.253 -0.431 . . . . 1.0 110.618 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.521 ' CD2' ' O ' ' A' ' 40' ' ' SER . 4.6 m-85 -171.66 -68.54 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 120.823 -0.351 . . . . 1.0 111.197 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.446 ' CD ' ' CB ' ' A' ' 41' ' ' TYR . 28.5 Cg_endo -60.15 -32.55 94.71 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 121.998 1.798 . . . . 1.0 112.241 -179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -86.29 -20.08 28.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.102 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.87 95.63 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.881 0.372 . . . . 1.0 110.353 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -67.96 -39.09 81.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.535 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.545 ' CH2' ' NZ ' ' B' ' 69' ' ' LYS . 0.2 OUTLIER -59.43 -44.21 92.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.243 -0.435 . . . . 1.0 109.902 -179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -59.68 -39.43 84.46 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.573 -0.529 . . . . 1.0 109.573 178.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.5 t -65.96 -36.96 84.76 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.172 -0.467 . . . . 1.0 111.18 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 62.8 t -59.4 -48.77 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-O 120.734 0.302 . . . . 1.0 110.736 -179.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -68.9 -31.79 70.96 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.515 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 77.0 m -62.38 -45.29 93.83 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.313 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.684 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.46 -29.11 67.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.454 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.558 ' OG1' HG23 ' A' ' 55' ' ' VAL . 13.9 p -90.24 11.9 19.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.381 -0.6 . . . . 1.0 109.381 179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.408 ' O ' ' OG1' ' A' ' 54' ' ' THR . 1.1 p 41.42 41.9 1.7 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.276 -0.875 . . . . 1.0 111.211 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG21 ' SD ' ' B' ' 75' ' ' MET . 45.3 t -81.07 -51.74 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.972 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.509 ' O ' ' N ' ' A' ' 58' ' ' GLY . . . 88.07 -69.38 2.85 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 121.142 -0.551 . . . . 1.0 111.776 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.404 ' CD2' HG11 ' A' ' 55' ' ' VAL . 1.3 m-85 54.4 -83.85 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 120.932 0.396 . . . . 1.0 110.255 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 56' ' ' GLY . . . 140.48 27.84 0.21 Allowed Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.86 -0.896 . . . . 1.0 110.86 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -62.27 -43.75 98.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.779 0.323 . . . . 1.0 110.499 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.517 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 25.6 mmt180 -132.21 -178.72 5.03 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.137 -0.483 . . . . 1.0 110.097 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.517 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 81.7 m-85 -157.45 96.84 2.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.706 -179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.72 156.07 64.39 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.79 1.66 . . . . 1.0 112.411 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -79.69 -141.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.2 -0.455 . . . . 1.0 110.334 -179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.433 ' CA ' ' OE2' ' A' ' 66' ' ' GLU . 7.5 p -115.41 -41.76 3.23 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.775 0.322 . . . . 1.0 110.571 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.591 ' C ' ' H ' ' A' ' 67' ' ' GLY . 15.6 tm-20 -61.6 -24.94 67.02 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 109.272 -0.64 . . . . 1.0 109.272 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.457 ' O ' ' CG2' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -71.89 40.74 0.07 Allowed 'General case' 0 C--O 1.254 1.338 0 CA-C-O 123.576 1.655 . . . . 1.0 109.167 178.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.765 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 50.82 66.71 2.3 Favored Glycine 0 C--O 1.199 -2.064 0 CA-C-N 113.708 -1.587 . . . . 1.0 111.959 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.518 ' NE ' ' CD1' ' D' ' 46' ' ' TRP . 35.7 ttm105 -24.91 -27.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.726 1.263 . . . . 1.0 112.176 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.765 ' N ' ' O ' ' A' ' 67' ' ' GLY . 68.5 mttm -76.61 -6.91 53.98 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.575 -0.739 . . . . 1.0 110.944 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.748 ' N ' ' O ' ' A' ' 67' ' ' GLY . 13.9 t -58.75 -48.53 85.74 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 C-N-CA 120.322 -0.551 . . . . 1.0 110.446 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.4 -41.93 69.0 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.567 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -60.93 -36.49 79.46 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.582 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -58.79 -53.51 57.59 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.442 -0.345 . . . . 1.0 111.08 -179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.28 -42.19 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.68 -0.408 . . . . 1.0 111.033 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 7.7 tpp -52.23 -50.58 61.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.63 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -65.17 -41.14 94.96 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.823 -0.351 . . . . 1.0 110.589 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.73 -46.37 70.8 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.839 -179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -63.74 -43.43 97.78 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 97.0 mt -62.12 -43.38 97.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.606 0.241 . . . . 1.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -61.17 -43.36 99.0 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.718 -0.393 . . . . 1.0 110.47 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 67.9 t -64.38 -49.03 82.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.442 -0.344 . . . . 1.0 111.034 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -73.38 -8.83 57.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 1.0 110.979 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.64 -39.44 12.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.328 . . . . 1.0 110.689 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.488 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.9 tt -63.21 -42.55 99.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 1.0 111.573 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 32.4 m -50.77 -9.49 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 120.602 -0.439 . . . . 1.0 110.506 -179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 84' ' ' LEU . 71.2 m -57.98 -38.59 76.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.459 . . . . 1.0 109.969 179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -48.99 -33.72 11.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.302 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -84.51 -11.51 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.825 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.436 ' N ' ' O ' ' A' ' 86' ' ' THR . 76.4 mt -91.69 -46.65 7.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.24 -0.436 . . . . 1.0 111.028 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.445 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.85 -24.78 53.92 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.036 0.446 . . . . 1.0 110.675 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 1.7 t -86.58 -3.56 59.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.988 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 86.1 m-20 -62.12 -43.69 98.27 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.173 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.446 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 5.7 p90 -74.69 -31.59 61.94 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.486 -0.324 . . . . 1.0 111.517 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -58.16 -26.59 29.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.213 -0.449 . . . . 1.0 111.37 -178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -63.94 -21.89 66.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.566 -0.288 . . . . 1.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.0 ptt85 -60.07 -33.99 72.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.841 0.353 . . . . 1.0 110.752 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.46 -40.86 88.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.961 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -64.44 -47.02 80.63 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.48 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -70.39 -34.04 72.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.444 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 71.2 ttt180 -60.04 -44.79 94.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.593 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -90.06 -13.77 35.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.936 0.398 . . . . 1.0 110.38 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 66.35 26.6 72.69 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 111.073 -0.811 . . . . 1.0 111.073 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.2 t60 . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.045 -0.979 . . . . 1.0 110.619 -179.941 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.602 ' N ' ' N ' ' B' ' 6' ' ' ARG . 3.9 t . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.415 -0.587 . . . . 1.0 109.415 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.38 95.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.634 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -173.14 -80.23 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.745 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.49 ' CE1' HH22 ' B' ' 95' ' ' ARG . 6.0 p80 -76.13 -18.69 59.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.436 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.18 -37.26 85.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.758 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . 0.602 ' N ' ' N ' ' B' ' 1' ' ' SER . 61.0 ttt85 -60.99 -44.26 97.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.559 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.26 -41.41 88.76 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.681 -0.408 . . . . 1.0 109.917 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . 0.468 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -65.73 -37.34 86.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.86 -0.609 . . . . 1.0 110.646 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -62.3 -42.1 99.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.433 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -62.85 -37.46 86.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.085 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.68 -43.05 76.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 1.0 111.01 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -67.53 -39.77 85.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.837 0.351 . . . . 1.0 110.693 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.434 ' OE1' ' NZ ' ' B' ' 17' ' ' LYS . 6.3 tm-20 -65.37 -36.87 85.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.228 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -65.86 -32.81 74.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.552 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 44.5 tp -62.33 -40.76 97.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.393 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -63.24 -37.03 85.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.015 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . 0.434 ' NZ ' ' OE1' ' B' ' 13' ' ' GLU . 29.2 mtmm -62.26 -41.75 98.73 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.0 111.054 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.08 -40.73 90.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.627 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' B' ' 52' ' ' ALA . 96.0 mt -61.4 -40.86 95.93 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.74 -0.467 . . . . 1.0 109.74 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.452 ' O ' ' OG ' ' B' ' 23' ' ' SER . 97.5 mt-10 -65.53 -44.01 88.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.03 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -72.03 -39.44 69.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.284 -0.417 . . . . 1.0 110.345 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.08 -36.26 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.862 -0.608 . . . . 1.0 110.512 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.2 p -57.51 -45.41 84.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.77 -179.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.81 -35.7 81.42 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.612 -0.435 . . . . 1.0 110.191 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.4 mttm -69.42 -45.91 68.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.797 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -54.24 -49.48 69.38 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.532 0.197 . . . . 1.0 111.532 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.432 HG13 ' N ' ' B' ' 28' ' ' GLU . 3.0 p -60.83 -46.22 96.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 C-N-CA 120.454 -0.499 . . . . 1.0 110.231 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.432 ' N ' HG13 ' B' ' 27' ' ' VAL . 13.7 tm-20 -68.46 -35.42 77.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.713 -0.676 . . . . 1.0 110.687 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -59.18 -46.99 86.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.481 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.513 ' OE1' ' N ' ' B' ' 30' ' ' GLU . 4.1 mp0 -68.02 -37.61 81.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.913 0.387 . . . . 1.0 110.396 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.0 mmt85 -55.61 97.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.743 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 117.12 -7.9 16.4 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.481 -0.648 . . . . 1.0 111.481 179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.29 146.93 34.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 O-C-N 122.852 -0.204 . . . . 1.0 110.487 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.522 ' O ' HG11 ' B' ' 63' ' ' VAL . 96.9 Cg_endo -75.6 142.6 26.29 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.057 1.838 . . . . 1.0 112.503 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.77 29.81 71.15 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.266 -0.734 . . . . 1.0 111.266 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.98 145.39 41.89 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.941 -0.304 . . . . 1.0 110.188 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.525 ' O ' ' NH1' ' B' ' 60' ' ' ARG . . . -126.87 -25.79 3.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.264 -0.426 . . . . 1.0 110.539 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.56 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.5 tt -103.1 119.49 38.95 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.984 0.421 . . . . 1.0 110.09 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.465 ' N ' HD23 ' B' ' 38' ' ' LEU . 40.4 pt -153.05 -141.69 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-N 115.664 -0.698 . . . . 1.0 109.769 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t 59.08 -127.43 1.3 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.893 0.377 . . . . 1.0 110.653 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.436 ' CB ' ' CD ' ' B' ' 42' ' ' PRO . 2.1 m-85 -164.32 -63.19 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.084 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.5 Cg_endo -58.73 -23.36 65.9 Favored 'Trans proline' 0 N--CA 1.496 1.629 0 C-N-CA 122.199 1.932 . . . . 1.0 112.122 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -89.77 -29.66 18.53 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.034 -0.266 . . . . 1.0 110.828 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.444 ' CB ' HD21 ' B' ' 38' ' ' LEU . . . -68.27 -40.0 82.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.818 0.342 . . . . 1.0 110.596 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.481 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.6 tt -65.84 -42.94 93.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.703 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.481 ' N ' HG23 ' B' ' 45' ' ' ILE . 0.0 OUTLIER -66.19 -36.96 84.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.41 179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -61.65 -40.26 94.26 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.018 -0.273 . . . . 1.0 110.633 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.453 ' O ' HD22 ' B' ' 19' ' ' LEU . 10.8 p -58.4 -29.19 65.86 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.766 -0.374 . . . . 1.0 110.945 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.43 -46.07 97.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.711 -179.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.424 ' OE2' ' OD2' ' B' ' 59' ' ' ASP . 23.7 mt-10 -66.8 -33.93 76.7 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 32.0 m -60.09 -44.58 94.69 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.498 -0.319 . . . . 1.0 111.506 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.79 -24.49 57.49 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.974 -0.291 . . . . 1.0 110.683 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 56.6 p -90.29 0.83 57.05 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.637 -0.256 . . . . 1.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 3.6 p 52.65 25.57 3.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.441 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.571 HG13 ' N ' ' B' ' 56' ' ' GLY . 7.4 p -83.1 -46.27 18.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.668 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.571 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 72.26 -32.93 0.66 Allowed Glycine 0 CA--C 1.53 0.993 0 N-CA-C 111.12 -0.792 . . . . 1.0 111.12 -179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.489 ' H ' ' C ' ' B' ' 55' ' ' VAL . 1.9 m-85 41.17 -89.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.02 0.438 . . . . 1.0 110.563 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' B' ' 56' ' ' GLY . . . 162.86 19.72 0.02 OUTLIER Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.103 -0.799 . . . . 1.0 111.103 -179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.424 ' OD2' ' OE2' ' B' ' 50' ' ' GLU . 92.0 m-20 -63.46 -45.68 89.74 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.795 0.331 . . . . 1.0 110.641 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' B' ' 37' ' ' ALA . 96.9 mtt-85 -147.38 -175.36 4.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.24 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.533 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 13.5 p90 -162.19 113.77 1.16 Allowed Pre-proline 0 CA--C 1.543 0.688 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.254 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -68.96 153.41 72.59 Favored 'Trans proline' 0 N--CA 1.496 1.65 0 C-N-CA 121.38 1.387 . . . . 1.0 112.56 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.522 HG11 ' O ' ' B' ' 34' ' ' PRO . 2.1 t -77.82 -138.94 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.012 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.503 ' H ' HG12 ' B' ' 63' ' ' VAL . 95.2 m -114.58 -39.61 3.75 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.766 0.317 . . . . 1.0 111.18 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.589 ' C ' ' H ' ' B' ' 67' ' ' GLY . 80.1 tt0 -65.06 -24.19 67.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.329 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -74.95 27.03 0.09 Allowed 'General case' 0 C--O 1.263 1.769 0 CA-C-O 123.576 1.655 . . . . 1.0 109.719 179.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.73 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 40.12 63.47 1.3 Allowed Glycine 0 C--O 1.212 -1.246 0 CA-C-N 113.656 -1.611 . . . . 1.0 111.269 178.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.488 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.4 ttm180 -25.08 -31.75 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 118.124 0.962 . . . . 1.0 110.943 -178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.73 ' N ' ' O ' ' B' ' 67' ' ' GLY . 44.9 mmtm -48.62 -19.84 0.39 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.878 -0.786 . . . . 1.0 108.878 175.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.584 ' N ' ' O ' ' B' ' 67' ' ' GLY . 61.4 t -62.51 -47.26 93.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 119.743 -0.783 . . . . 1.0 109.607 179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.89 -38.06 79.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.96 178.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -60.63 -40.85 93.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.998 -0.546 . . . . 1.0 110.282 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -56.18 -44.87 79.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.638 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.26 -43.98 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.891 -0.324 . . . . 1.0 111.346 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.566 ' SD ' HG21 ' A' ' 55' ' ' VAL . 55.4 mtt -55.38 -46.9 76.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.602 -0.272 . . . . 1.0 110.633 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -63.98 -41.96 97.38 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.906 -0.318 . . . . 1.0 110.546 179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.41 ' O ' HG22 ' B' ' 81' ' ' VAL . . . -60.12 -24.54 64.75 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.329 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.54 -41.45 5.42 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -64.93 -43.85 96.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 122.416 -0.461 . . . . 1.0 111.318 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -59.69 -52.46 65.4 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 120.876 0.369 . . . . 1.0 111.383 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.479 HG23 ' N ' ' B' ' 82' ' ' PHE . 15.9 m -60.62 -46.27 96.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.0 111.326 -179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.479 ' N ' HG23 ' B' ' 81' ' ' VAL . 18.3 m-85 -74.15 2.7 8.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.518 -0.31 . . . . 1.0 110.997 -179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.46 -30.11 5.63 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.771 0.319 . . . . 1.0 110.227 179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.475 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.5 tt -64.03 -40.44 96.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.256 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.468 HG12 ' HB1' ' B' ' 8' ' ' ALA . 26.9 m -48.57 -15.83 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 116.279 -0.419 . . . . 1.0 109.873 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.475 ' N ' ' C ' ' B' ' 84' ' ' LEU . 52.7 m -49.14 -23.14 1.14 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.37 -0.604 . . . . 1.0 109.37 179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.437 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -64.64 -42.26 95.57 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.436 -0.802 . . . . 1.0 110.695 179.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -80.59 -11.41 59.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.592 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.433 ' O ' ' CB ' ' B' ' 92' ' ' ASP . 43.5 mt -91.0 -38.81 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.455 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -54.42 -34.86 62.18 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.356 0.598 . . . . 1.0 109.481 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.523 ' OG1' ' NH1' ' B' ' 95' ' ' ARG . 0.2 OUTLIER -79.26 -8.02 58.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.395 -0.821 . . . . 1.0 109.969 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.433 ' CB ' ' O ' ' B' ' 89' ' ' LEU . 66.2 t0 -55.82 -51.46 67.41 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 116.302 -0.408 . . . . 1.0 110.786 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' B' ' 94' ' ' VAL . 17.4 p90 -71.84 -41.77 67.74 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.661 -0.416 . . . . 1.0 111.747 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.559 ' N ' ' CD1' ' B' ' 93' ' ' PHE . 57.1 t -45.13 -35.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.044 -0.525 . . . . 1.0 111.515 -179.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' OG1' ' B' ' 91' ' ' THR . 84.5 mtt85 -63.54 -22.7 67.04 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.056 -0.257 . . . . 1.0 111.404 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' B' ' 96' ' ' ARG . 23.7 ptt-85 -46.77 -29.03 1.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.998 0.428 . . . . 1.0 110.079 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -64.17 -43.95 93.56 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.854 -0.612 . . . . 1.0 111.045 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -67.85 -39.04 83.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.809 0.337 . . . . 1.0 110.797 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -66.75 -31.66 72.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.683 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -58.61 -46.87 86.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.432 -0.349 . . . . 1.0 110.506 -179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -77.76 -20.54 53.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.421 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.6 13.59 83.33 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.14 -0.784 . . . . 1.0 111.14 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 118.018 -0.992 . . . . 1.0 110.625 -179.974 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.271 -0.64 . . . . 1.0 109.271 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . -57.14 -106.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.043 -0.526 . . . . 1.0 110.483 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -135.89 -45.71 0.65 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -81.83 -20.04 39.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.845 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.57 -43.04 81.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 17.5 ptm180 -75.49 -29.73 59.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.477 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -64.96 -42.74 94.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.535 . . . . 1.0 110.214 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.49 -43.26 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 1.0 110.475 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -66.74 -40.85 88.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.216 -0.447 . . . . 1.0 110.182 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -64.25 -35.25 80.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.242 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.24 -43.16 87.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.021 -0.536 . . . . 1.0 111.193 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.35 -40.55 96.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 1.0 110.968 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -64.56 -32.91 74.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.518 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.82 -36.28 83.39 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.465 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.414 HD13 ' HA2' ' C' ' 78' ' ' GLY . 50.7 tp -62.4 -41.46 98.68 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.5 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -58.92 -40.14 83.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.388 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -61.66 -39.37 91.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.721 0.296 . . . . 1.0 111.032 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.7 t -64.22 -32.87 59.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.8 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.4 mt -61.37 -41.85 97.75 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.674 -0.411 . . . . 1.0 110.175 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.02 -46.68 84.91 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.553 -0.459 . . . . 1.0 109.765 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -70.7 -40.41 72.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.433 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.21 -39.75 93.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.825 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.526 ' HG ' ' CB ' ' C' ' 48' ' ' SER . 40.4 m -60.11 -45.4 93.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.655 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -66.57 -40.99 89.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.203 0.525 . . . . 1.0 110.401 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.3 mttt -66.7 -41.97 87.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.875 -0.602 . . . . 1.0 110.661 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.24 -51.18 69.07 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.361 -179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.432 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 7.4 p -62.37 -33.19 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-O 121.265 0.555 . . . . 1.0 110.363 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -84.02 -21.28 31.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.455 -0.793 . . . . 1.0 110.051 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -65.03 -50.83 64.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.319 -0.4 . . . . 1.0 111.034 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.467 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.8 pp20? -59.0 -29.36 67.17 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.99 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.467 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 10.8 tpt85 -62.17 118.17 7.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 120.794 0.33 . . . . 1.0 110.262 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 97.93 -9.82 63.88 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.155 -0.778 . . . . 1.0 111.155 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -97.37 148.61 34.67 Favored Pre-proline 0 N--CA 1.466 0.331 0 N-CA-C 110.044 -0.354 . . . . 1.0 110.044 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.496 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 87.6 Cg_endo -76.21 126.76 9.41 Favored 'Trans proline' 0 N--CA 1.493 1.475 0 C-N-CA 121.784 1.656 . . . . 1.0 112.299 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.02 37.47 6.31 Favored Glycine 0 CA--C 1.525 0.706 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.25 143.06 24.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.849 0.357 . . . . 1.0 110.631 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -151.73 -42.48 0.11 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.501 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.27 26.47 0.16 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.013 0.435 . . . . 1.0 110.081 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' C' ' 37' ' ' ALA . 12.9 tt -63.27 -24.32 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.493 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 43.3 t -59.42 129.59 42.74 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.29 -0.414 . . . . 1.0 110.518 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.507 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 52.7 t80 -86.25 -50.91 0.48 Allowed Pre-proline 0 CA--C 1.539 0.525 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.983 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.0 Cg_endo -60.03 -33.69 95.24 Favored 'Trans proline' 0 N--CA 1.5 1.909 0 C-N-CA 121.514 1.476 . . . . 1.0 112.426 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -87.77 -7.27 57.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.536 -0.302 . . . . 1.0 111.282 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.9 -38.26 88.25 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.777 0.322 . . . . 1.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.459 HG23 ' HE3' ' C' ' 46' ' ' TRP . 12.0 tt -65.0 -33.72 65.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.538 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.663 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -70.18 -47.37 61.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.432 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 10.9 t90 -61.11 -39.64 90.75 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.382 -0.527 . . . . 1.0 109.771 179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.534 ' O ' HD22 ' C' ' 19' ' ' LEU . 6.1 m -53.18 -21.26 4.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.189 -0.459 . . . . 1.0 110.604 -179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 61.3 t -75.38 -43.42 42.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 111.988 0.366 . . . . 1.0 111.988 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.519 ' CD ' HH21 ' D' ' 68' ' ' ARG . 9.8 pt-20 -90.27 57.81 3.85 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.74 0.305 . . . . 1.0 111.399 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.513 ' O ' ' SD ' ' C' ' 75' ' ' MET . 6.0 t -159.51 -42.28 0.05 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.457 -0.338 . . . . 1.0 111.223 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -64.32 -36.99 85.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.69 0.281 . . . . 1.0 110.924 -179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.427 ' O ' ' OG1' ' C' ' 54' ' ' THR . 1.5 p -94.57 19.81 9.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.871 0.367 . . . . 1.0 110.243 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' C' ' 53' ' ' THR . 27.6 p 54.6 81.55 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.639 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.1 t -123.81 -84.99 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.344 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 71.88 44.73 45.96 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 110.638 -0.985 . . . . 1.0 110.638 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.91 -48.22 82.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.84 0.352 . . . . 1.0 110.66 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.583 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 165.39 -100.19 0.17 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.507 -1.037 . . . . 1.0 110.507 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.518 ' OD2' ' NH1' ' D' ' 68' ' ' ARG . 38.5 m-20 38.41 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.883 0.373 . . . . 1.0 111.342 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.583 ' N ' ' O ' ' C' ' 58' ' ' GLY . 66.5 mtm-85 -123.43 157.61 33.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.912 -0.585 . . . . 1.0 109.57 179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -141.92 146.17 39.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.34 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -68.88 152.32 73.7 Favored 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 122.126 1.884 . . . . 1.0 112.13 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.549 HG12 ' H ' ' C' ' 64' ' ' THR . 2.1 t -64.33 -139.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.024 -0.535 . . . . 1.0 109.992 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.549 ' H ' HG12 ' C' ' 63' ' ' VAL . 17.1 m -114.5 -77.13 0.57 Allowed 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.409 -0.36 . . . . 1.0 110.788 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.465 ' O ' ' CZ2' ' B' ' 46' ' ' TRP . 80.6 tt0 -37.28 -84.61 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.932 -0.577 . . . . 1.0 110.736 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.3 mm-40 -73.89 -103.77 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.0 -0.741 . . . . 1.0 109.0 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.07 -56.38 0.0 OUTLIER Glycine 0 N--CA 1.476 1.338 0 O-C-N 124.378 1.049 . . . . 1.0 114.225 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 88.3 mtt180 -70.71 -45.59 64.65 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 109.744 -0.465 . . . . 1.0 109.744 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' C' ' 66' ' ' GLU . 68.1 mmtt -62.35 -41.72 98.81 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.298 -0.631 . . . . 1.0 109.298 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 84.3 t -72.77 -45.11 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 119.798 -0.761 . . . . 1.0 111.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -28.1 69.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 1.0 109.76 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -69.71 -38.58 76.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.886 -0.597 . . . . 1.0 110.628 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -63.58 -49.13 74.58 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 111.942 0.349 . . . . 1.0 111.942 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 10.9 p -63.89 -32.53 57.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.826 -0.349 . . . . 1.0 111.104 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.513 ' SD ' ' O ' ' C' ' 51' ' ' THR . 27.4 tpp -61.17 -43.6 98.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.818 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -63.43 -38.72 92.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.703 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.459 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -55.81 -46.99 77.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.633 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -63.98 -41.81 98.49 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 121.223 -0.513 . . . . 1.0 111.862 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.56 -43.45 96.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.768 0.318 . . . . 1.0 110.788 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.55 -40.98 89.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.31 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.459 HG23 ' O ' ' C' ' 77' ' ' ALA . 69.5 t -63.86 -50.89 75.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.812 -0.355 . . . . 1.0 111.365 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -67.21 -40.79 86.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.772 -0.371 . . . . 1.0 111.072 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.84 -31.77 71.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.988 0.423 . . . . 1.0 110.551 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' C' ' 86' ' ' THR . 5.4 tt -62.95 -35.75 81.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.013 -0.54 . . . . 1.0 111.457 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' C' ' 87' ' ' ALA . 18.7 t -39.93 -23.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 1.0 110.702 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.533 ' O ' ' HB3' ' C' ' 90' ' ' ALA . 1.3 p -41.9 -21.76 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.953 0.406 . . . . 1.0 109.988 178.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.513 ' N ' ' O ' ' C' ' 85' ' ' VAL . . . -48.1 -50.78 27.18 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.949 -0.569 . . . . 1.0 109.93 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.52 -33.27 7.09 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.424 -0.353 . . . . 1.0 110.759 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 37.5 tp -62.31 -45.9 91.14 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 120.768 0.318 . . . . 1.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' C' ' 86' ' ' THR . . . -74.2 -14.45 60.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.32 -0.4 . . . . 1.0 110.995 -179.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' C' ' 87' ' ' ALA . 0.5 OUTLIER -92.97 -2.68 55.54 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.286 -0.416 . . . . 1.0 110.32 -179.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 31.9 t0 -59.08 -43.05 91.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.69 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.48 ' C ' ' CD1' ' C' ' 93' ' ' PHE . 5.6 p90 -66.97 -32.0 72.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.314 -0.403 . . . . 1.0 111.282 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 95.1 t -59.7 -43.68 91.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.056 -0.52 . . . . 1.0 111.271 -178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -57.97 -20.81 40.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.539 -0.301 . . . . 1.0 111.034 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.1 ttp85 -53.41 -43.31 67.83 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.979 -0.289 . . . . 1.0 110.364 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.538 ' O ' ' N ' ' C' ' 99' ' ' GLU . 97.5 mt-10 -62.88 167.64 4.54 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.998 -0.281 . . . . 1.0 110.377 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.41 ' C ' ' N ' ' C' ' 100' ' ' ARG . 96.7 mt-10 58.4 -73.44 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.241 -0.436 . . . . 1.0 110.658 -179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.538 ' N ' ' O ' ' C' ' 97' ' ' GLU . 97.3 mt-10 -51.59 -13.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.963 -0.562 . . . . 1.0 110.501 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.41 ' N ' ' C ' ' C' ' 98' ' ' GLU . 41.5 ttp180 -59.45 -52.22 66.53 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.8 0.333 . . . . 1.0 110.505 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -70.84 -36.92 73.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.591 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . 0.423 ' O ' ' OXT' ' C' ' 103' ' ' HIS . . . 85.67 21.0 55.11 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.956 -0.858 . . . . 1.0 110.956 -179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.423 ' OXT' ' O ' ' C' ' 102' ' ' GLY . 96.6 m-70 . . . . . 0 C--O 1.22 -0.491 0 CA-C-O 118.087 -0.959 . . . . 1.0 110.621 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.35 147.29 53.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.689 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -62.51 -40.32 96.34 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.218 -0.446 . . . . 1.0 110.665 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.601 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 13.8 p80 -65.75 -40.63 92.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.364 -0.38 . . . . 1.0 110.925 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.601 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.9 tt0 -64.66 -37.2 86.78 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.819 0.342 . . . . 1.0 110.43 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 60.5 ttm-85 -60.86 -43.29 98.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.381 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -63.64 -41.78 98.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.045 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.38 93.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.642 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -68.9 -37.59 79.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.561 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -60.99 -39.79 91.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.419 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.94 -35.78 77.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.886 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -63.68 -36.16 82.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.612 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -64.07 -39.53 94.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.496 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.89 -36.01 82.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 1.0 110.595 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.74 -41.2 99.08 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.862 -0.335 . . . . 1.0 110.367 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -60.13 -38.06 81.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 1.0 111.063 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -37.39 85.78 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.774 0.321 . . . . 1.0 111.011 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 83.9 t -63.21 -41.25 92.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.624 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.61 HD21 ' HB2' ' D' ' 52' ' ' ALA . 88.8 mt -59.76 -41.5 91.18 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.876 -0.416 . . . . 1.0 109.876 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . 0.429 ' O ' ' OG ' ' D' ' 23' ' ' SER . 96.9 mt-10 -61.84 -48.47 80.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.271 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 41.9 tp10 -67.94 -32.7 73.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.3 -0.409 . . . . 1.0 109.908 179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.31 -39.57 93.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.937 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 77.9 p -60.69 -46.39 90.56 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.923 -179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -68.45 -34.84 76.68 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 1.0 110.566 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -73.05 -45.61 56.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.877 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.9 -48.91 79.79 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.91 -0.316 . . . . 1.0 110.917 -179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.49 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.6 p -65.48 -42.67 93.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.221 0.534 . . . . 1.0 109.998 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.49 ' N ' HG13 ' D' ' 27' ' ' VAL . 48.1 tp10 -70.63 -41.5 72.11 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.831 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.7 -45.79 85.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 1.0 111.047 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 39' ' ' ILE . 0.3 OUTLIER -75.5 -18.38 59.84 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.837 0.351 . . . . 1.0 111.305 -179.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 11.6 mmt180 -67.18 108.63 2.75 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 1.0 110.266 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.59 -8.34 51.43 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 111.432 -0.667 . . . . 1.0 111.432 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -78.02 149.17 76.34 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.313 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.54 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.6 Cg_endo -74.57 142.96 29.97 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.131 1.887 . . . . 1.0 112.424 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.43 22.07 67.23 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.02 -0.832 . . . . 1.0 111.02 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.0 143.56 56.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.788 0.328 . . . . 1.0 110.562 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -132.62 -27.53 1.71 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.51 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 6.6 tt -66.47 -16.38 64.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.493 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.638 HG23 ' O ' ' D' ' 39' ' ' ILE . 18.5 tt -37.55 105.45 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 120.973 0.416 . . . . 1.0 111.153 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.524 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 88.9 p -173.85 -133.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.891 -0.595 . . . . 1.0 110.192 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.524 ' CD2' ' O ' ' D' ' 40' ' ' SER . 2.3 m-85 -177.65 -66.28 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.413 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' D' ' 41' ' ' TYR . 19.1 Cg_endo -58.88 -32.31 97.07 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 121.842 1.695 . . . . 1.0 111.65 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -93.92 -7.22 43.66 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.224 -0.444 . . . . 1.0 111.336 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.78 -38.23 87.28 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.848 0.356 . . . . 1.0 110.493 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 15.1 tt -69.33 -36.59 72.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.317 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.518 ' CD1' ' NE ' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -55.6 -49.06 73.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.746 -0.464 . . . . 1.0 109.746 -178.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -60.67 -40.52 92.41 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.684 -0.406 . . . . 1.0 110.167 178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.401 ' O ' HD22 ' D' ' 19' ' ' LEU . 54.3 p -61.42 -36.19 79.65 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.669 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 50.9 t -63.53 -48.09 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.985 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -84.3 44.97 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.972 -0.381 . . . . 1.0 109.972 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 22.4 m -139.06 -47.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.326 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.61 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -61.06 -25.95 67.29 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.154 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.404 ' O ' ' OG1' ' D' ' 54' ' ' THR . 49.3 p -89.41 9.87 24.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.329 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' D' ' 53' ' ' THR . 42.9 p 51.59 70.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.802 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 62.0 t -141.78 -77.72 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.846 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 64.78 94.74 0.02 OUTLIER Glycine 0 CA--C 1.525 0.659 0 N-CA-C 110.657 -0.977 . . . . 1.0 110.657 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -61.82 -41.48 97.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 1.0 110.843 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 130.92 8.51 3.01 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.859 -0.897 . . . . 1.0 110.859 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -59.29 -47.9 83.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.766 0.317 . . . . 1.0 110.426 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 74.8 mtt-85 -140.28 148.93 42.18 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.4 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 25.7 p90 -136.91 137.8 24.18 Favored Pre-proline 0 CA--C 1.538 0.499 0 C-N-CA 120.982 -0.287 . . . . 1.0 110.514 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.54 155.37 63.5 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 C-N-CA 122.376 2.051 . . . . 1.0 112.284 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 2.0 t -88.81 -141.67 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.079 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.663 HG22 ' CD1' ' C' ' 46' ' ' TRP . 1.7 p -113.67 -42.77 3.39 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.821 0.343 . . . . 1.0 110.273 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.58 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.1 tt0 -67.76 -19.12 65.08 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.695 -0.402 . . . . 1.0 110.204 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' D' ' 67' ' ' GLY . 0.3 OUTLIER -75.49 26.16 0.1 Allowed 'General case' 0 C--O 1.265 1.872 0 CA-C-O 123.7 1.714 . . . . 1.0 109.443 178.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.724 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 43.19 59.75 3.34 Favored Glycine 0 N--CA 1.436 -1.338 0 CA-C-N 113.907 -1.497 . . . . 1.0 109.414 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.519 HH21 ' CD ' ' C' ' 50' ' ' GLU . 51.0 ttt85 -26.49 -28.94 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 O-C-N 124.363 0.684 . . . . 1.0 110.994 -177.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.724 ' N ' ' O ' ' D' ' 67' ' ' GLY . 68.4 mttm -53.35 -18.68 2.7 Favored 'General case' 0 N--CA 1.437 -1.125 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.044 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.621 ' N ' ' O ' ' D' ' 67' ' ' GLY . 53.2 t -62.46 -46.97 95.14 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 119.589 -0.844 . . . . 1.0 109.803 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.91 76.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.936 -0.575 . . . . 1.0 110.302 179.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -56.89 -46.24 82.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.76 -0.655 . . . . 1.0 111.164 -179.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.14 -41.37 99.28 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 116.612 -0.267 . . . . 1.0 111.636 -179.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -63.38 -46.18 96.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.648 -0.421 . . . . 1.0 111.241 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 25.1 mtm -63.4 -41.5 98.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.846 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -63.71 -38.59 91.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.497 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.438 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.17 -41.08 92.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.321 -0.4 . . . . 1.0 110.438 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.41 -41.89 83.8 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.523 -0.631 . . . . 1.0 111.523 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 92.0 mt -61.64 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.94 -0.304 . . . . 1.0 110.842 -179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -66.82 -44.09 82.05 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.778 -0.369 . . . . 1.0 111.177 -179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 77' ' ' ALA . 74.3 t -64.8 -49.22 81.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.383 -0.372 . . . . 1.0 111.436 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -66.58 -5.55 11.91 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.872 -179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -109.95 -38.2 5.4 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.051 -0.351 . . . . 1.0 110.051 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.68 -16.81 6.98 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.524 -0.47 . . . . 1.0 110.4 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 17.6 m -75.42 -1.33 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 120.666 -0.414 . . . . 1.0 110.723 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.466 ' O ' ' N ' ' D' ' 89' ' ' LEU . 19.5 m -58.31 -42.16 86.06 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-O 120.995 0.426 . . . . 1.0 109.91 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.485 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -48.17 -17.09 0.11 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.76 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.42 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -105.03 -12.95 15.92 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.775 0.322 . . . . 1.0 110.464 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.3 mt -87.67 -51.18 6.03 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.939 -0.573 . . . . 1.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -55.32 -28.41 53.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.136 0.493 . . . . 1.0 110.421 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.803 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.5 OUTLIER -86.9 0.53 54.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.804 -0.635 . . . . 1.0 109.521 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.444 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 44.4 t0 -72.04 -37.7 69.65 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.432 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.608 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 7.4 p90 -75.86 -42.75 48.48 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.124 0.416 . . . . 1.0 112.124 -178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.803 HG22 ' O ' ' D' ' 91' ' ' THR . 17.1 m -39.97 -33.24 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.064 -0.517 . . . . 1.0 111.446 -178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -53.7 -22.53 9.24 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.013 -0.539 . . . . 1.0 110.741 -179.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 53.5 ptt85 -55.94 -34.93 66.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.208 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.555 ' C ' ' H ' ' D' ' 99' ' ' GLU . 25.9 tp10 -73.38 155.68 39.11 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.975 -0.557 . . . . 1.0 109.613 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 66.75 -37.57 0.3 Allowed 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.493 0.496 . . . . 1.0 110.418 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' D' ' 97' ' ' GLU . 51.8 tp10 -67.95 -33.07 73.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 1.0 110.224 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -59.44 -37.03 77.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.277 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -64.94 -37.56 88.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.563 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.99 7.93 63.78 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.051 -0.82 . . . . 1.0 111.051 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 33.7 m80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.079 -0.962 . . . . 1.0 110.496 179.687 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.422 ' O ' ' OD1' ' A' ' 3' ' ' ASP . . . -58.83 -104.07 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.09 -0.505 . . . . 1.0 110.474 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 2' ' ' ALA . 99.5 m-20 -140.26 -50.32 0.47 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.393 -0.367 . . . . 1.0 110.518 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -82.46 -19.71 38.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.499 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.65 -38.89 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.396 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.01 -38.78 92.31 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.367 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -65.1 -39.84 93.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.287 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.27 -41.78 96.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.271 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -68.52 -38.92 81.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.511 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -63.04 -38.88 92.95 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.396 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.48 -35.69 78.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.941 -0.572 . . . . 1.0 110.792 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.1 -36.72 82.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.755 0.312 . . . . 1.0 110.691 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -65.15 -34.56 78.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.153 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -64.77 -35.32 80.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.637 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 50.4 tp -62.65 -41.79 99.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.782 0.325 . . . . 1.0 110.433 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' O ' ' OE2' ' A' ' 20' ' ' GLU . 87.6 mt-30 -60.24 -40.58 90.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 1.0 111.244 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -62.47 -44.05 97.33 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.787 -0.365 . . . . 1.0 110.861 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.69 -42.06 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.517 -0.31 . . . . 1.0 110.441 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 52' ' ' ALA . 20.1 mt -60.16 -41.93 93.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.448 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -65.17 -43.07 92.92 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.054 -0.35 . . . . 1.0 110.054 179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -69.4 -46.53 66.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.381 179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.53 -37.02 79.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.059 -0.518 . . . . 1.0 111.206 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 20' ' ' GLU . 13.4 p -53.11 -42.07 65.63 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 120.767 -0.373 . . . . 1.0 110.035 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 26' ' ' ALA . 65.4 tttm -66.4 -74.08 0.12 Allowed 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.35 -0.54 . . . . 1.0 109.727 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.8 mptt -35.96 -26.5 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.147 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 24' ' ' LYS . . . -62.61 -42.61 99.68 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 120.502 -0.479 . . . . 1.0 110.681 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.493 ' CG2' ' N ' ' A' ' 28' ' ' GLU . 2.3 m -68.11 -47.05 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 CA-C-O 121.178 0.513 . . . . 1.0 110.593 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.493 ' N ' ' CG2' ' A' ' 27' ' ' VAL . 44.1 tp10 -67.09 -34.45 77.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.458 -0.792 . . . . 1.0 110.575 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.405 ' O ' ' OE1' ' A' ' 66' ' ' GLU . . . -54.25 -29.09 45.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.1 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -67.56 -41.11 84.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.099 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.51 HH21 ' CB ' ' A' ' 36' ' ' ALA . 5.3 mmp_? -74.13 101.97 4.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 1.0 111.225 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.03 -27.19 4.61 Favored Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.62 152.5 40.07 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 110.027 -0.361 . . . . 1.0 110.027 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.5 147.66 32.4 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.382 2.054 . . . . 1.0 112.61 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.71 36.62 7.25 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.015 -0.834 . . . . 1.0 111.015 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' CB ' HH21 ' A' ' 31' ' ' ARG . . . -55.08 143.88 25.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.831 0.348 . . . . 1.0 110.641 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -162.77 -58.19 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.905 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 tp -73.11 58.37 0.5 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.263 -179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 36.5 pt -85.63 -5.49 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.177 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 26.8 m -72.79 151.65 41.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.808 -0.633 . . . . 1.0 110.632 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.483 ' H ' ' HD2' ' A' ' 42' ' ' PRO . 20.1 m-85 -98.02 -63.17 0.1 Allowed Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 116.253 -0.43 . . . . 1.0 111.753 -179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.483 ' HD2' ' H ' ' A' ' 41' ' ' TYR . 30.4 Cg_endo -60.16 -29.63 89.54 Favored 'Trans proline' 0 N--CA 1.5 1.874 0 C-N-CA 121.969 1.779 . . . . 1.0 112.508 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.529 ' OD2' ' NH2' ' A' ' 60' ' ' ARG . 73.7 m-20 -81.85 -5.99 58.7 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.955 -0.298 . . . . 1.0 110.53 -179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.463 ' HB2' ' CG1' ' A' ' 27' ' ' VAL . . . -63.9 -43.16 96.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.388 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.7 tt -67.69 -39.21 81.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.505 ' O ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -59.3 -43.8 92.6 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.758 -0.46 . . . . 1.0 109.758 179.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.506 ' NE1' ' OH ' ' D' ' 57' ' ' TYR . 14.2 t90 -63.29 -40.2 96.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.693 -0.484 . . . . 1.0 109.693 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.425 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 58.4 p -61.64 -32.7 72.86 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.385 -0.37 . . . . 1.0 110.796 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 61.5 t -59.71 -46.53 93.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.58 -0.448 . . . . 1.0 110.239 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -82.63 13.2 3.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.513 -0.312 . . . . 1.0 110.542 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -100.21 -49.27 4.33 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.757 0.313 . . . . 1.0 110.56 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.22 -26.76 67.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.462 -0.335 . . . . 1.0 110.382 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.4 p -84.53 5.44 27.61 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.224 0.535 . . . . 1.0 109.628 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.4 p 42.36 60.5 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.312 -0.858 . . . . 1.0 111.29 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.1 p -131.65 -48.2 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 CA-C-N 116.434 -0.348 . . . . 1.0 110.952 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.574 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.76 95.55 0.01 OUTLIER Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.649 -0.58 . . . . 1.0 111.649 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -74.49 -102.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.859 0.361 . . . . 1.0 110.571 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.38 18.88 1.17 Allowed Glycine 0 CA--C 1.524 0.61 0 N-CA-C 110.87 -0.892 . . . . 1.0 110.87 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.48 ' OD2' ' CZ ' ' B' ' 68' ' ' ARG . 99.8 m-20 -60.23 -47.29 86.62 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.818 -0.353 . . . . 1.0 110.515 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' NH2' ' OD2' ' A' ' 43' ' ' ASP . 33.9 mmt180 -134.63 -163.02 1.32 Allowed 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.523 -0.547 . . . . 1.0 109.523 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 46.3 m-85 -161.34 100.59 1.24 Allowed Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.547 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' O ' ' O ' ' A' ' 63' ' ' VAL . 62.1 Cg_endo -69.47 150.02 69.46 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 121.353 1.369 . . . . 1.0 112.568 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' O ' ' O ' ' A' ' 62' ' ' PRO . 6.0 m -53.53 -170.2 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.52 -0.206 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.371 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.543 ' CG2' HH22 ' D' ' 60' ' ' ARG . 98.0 m -102.63 -71.17 0.73 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 1.0 110.899 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.535 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 84.1 tt0 -37.81 -70.26 0.1 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.919 0.39 . . . . 1.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.874 ' O ' ' N ' ' A' ' 68' ' ' ARG . 74.2 mt-10 -83.42 -107.66 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.199 -1.037 . . . . 1.0 108.199 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -54.58 0.0 OUTLIER Glycine 0 N--CA 1.479 1.558 0 O-C-N 124.779 1.299 . . . . 1.0 114.77 176.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.874 ' N ' ' O ' ' A' ' 66' ' ' GLU . 60.0 ttm-85 -65.74 -74.9 0.1 Allowed 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 114.851 -0.674 . . . . 1.0 109.416 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -43.55 -37.6 2.56 Favored 'General case' 0 CA--C 1.519 -0.232 0 N-CA-C 109.468 -0.567 . . . . 1.0 109.468 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.8 t -64.27 -47.32 90.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 119.572 -0.851 . . . . 1.0 110.033 178.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 68' ' ' ARG . . . -65.99 -36.8 84.29 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.644 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -57.22 -38.29 73.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.97 -0.559 . . . . 1.0 110.615 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -63.41 -43.32 97.86 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.594 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 73.9 t -63.91 -45.34 97.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.622 ' SD ' HG11 ' D' ' 55' ' ' VAL . 65.2 mtt -60.84 -42.91 98.68 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.95 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -63.62 -43.2 97.55 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.797 -0.361 . . . . 1.0 110.345 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -62.62 -39.82 95.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.612 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.94 -43.69 95.61 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.833 -0.907 . . . . 1.0 110.833 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.54 -43.27 98.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.988 -0.285 . . . . 1.0 110.336 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.43 -42.29 98.52 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.595 -0.442 . . . . 1.0 110.249 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 77' ' ' ALA . 59.9 t -64.73 -50.88 73.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.473 -0.33 . . . . 1.0 111.009 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -68.46 -39.51 81.41 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.978 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.67 85.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.354 -0.384 . . . . 1.0 111.222 179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.461 ' C ' ' N ' ' A' ' 86' ' ' THR . 5.7 tt -61.77 -42.54 99.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.502 -0.317 . . . . 1.0 111.404 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.405 ' O ' HG12 ' A' ' 85' ' ' VAL . 99.1 t -47.75 -16.16 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 C-N-CA 120.62 -0.432 . . . . 1.0 110.328 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.461 ' N ' ' C ' ' A' ' 84' ' ' LEU . 92.9 m -51.59 -21.35 2.5 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.214 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.28 -35.3 78.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.243 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -89.57 -14.59 34.74 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.926 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 46.5 mt -82.5 -42.7 18.11 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 111.932 0.345 . . . . 1.0 111.932 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -58.72 -30.46 67.46 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.844 0.354 . . . . 1.0 111.216 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -4.4 55.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.161 -0.472 . . . . 1.0 110.514 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -60.17 -50.42 73.76 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.512 -0.475 . . . . 1.0 110.69 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 94' ' ' VAL . 15.7 p90 -72.37 -43.92 63.3 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.675 -0.41 . . . . 1.0 111.268 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.575 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 57.8 t -39.72 -34.37 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.662 -178.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -63.04 -34.96 78.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.89 0.376 . . . . 1.0 110.805 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 93' ' ' PHE . 40.0 ptt85 -39.46 -42.45 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.899 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 99' ' ' GLU . 5.2 tp10 -70.29 -165.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.657 -0.497 . . . . 1.0 109.657 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 55.08 -79.94 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.759 0.314 . . . . 1.0 110.702 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.548 ' N ' ' O ' ' A' ' 97' ' ' GLU . 97.8 mt-10 -55.21 -17.04 3.78 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.537 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 60.0 ttp180 -60.79 -44.91 96.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.559 -179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -89.54 -16.18 31.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.295 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 78.31 11.78 84.97 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 1.0 111.085 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.573 180.0 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 35.1 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.225 -0.658 . . . . 1.0 109.225 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.98 147.97 24.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.388 -0.369 . . . . 1.0 110.582 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.76 -39.52 94.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.109 -0.496 . . . . 1.0 111.019 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -61.67 -41.64 97.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.967 0.413 . . . . 1.0 110.395 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -65.59 -33.36 75.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.936 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 41.6 mmm-85 -62.0 -42.35 99.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.47 -0.332 . . . . 1.0 110.308 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -66.46 -44.22 83.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.857 0.361 . . . . 1.0 110.225 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . 0.507 ' HB1' HG12 ' B' ' 85' ' ' VAL . . . -67.31 -41.54 85.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.654 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -65.19 -38.57 90.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.671 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -62.72 -37.41 86.43 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.678 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.49 -36.21 75.6 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.893 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.21 -36.03 76.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.881 0.372 . . . . 1.0 110.629 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -65.12 -37.32 87.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.478 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -64.2 -33.63 76.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.097 -0.501 . . . . 1.0 110.664 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.432 HD13 ' HA2' ' B' ' 78' ' ' GLY . 46.6 tp -62.43 -41.84 99.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.265 -0.425 . . . . 1.0 110.691 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -59.65 -39.92 85.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.647 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -62.94 -38.86 92.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.829 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 92.7 t -63.18 -41.8 94.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.155 -0.475 . . . . 1.0 110.754 -179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.688 HD21 ' HB2' ' B' ' 52' ' ' ALA . 94.1 mt -59.37 -41.1 88.54 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.653 -0.419 . . . . 1.0 110.091 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.46 -44.3 96.73 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.969 0.414 . . . . 1.0 109.915 179.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.74 -37.78 76.59 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.393 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.68 88.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.415 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 9.7 t -58.48 -45.82 87.91 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.364 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -65.31 -35.0 79.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.904 0.383 . . . . 1.0 110.218 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.673 ' NZ ' HE22 ' B' ' 73' ' ' GLN . 98.7 mttt -70.95 -45.22 64.54 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.899 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.78 -49.51 77.45 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 120.747 -0.381 . . . . 1.0 111.511 -179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.488 HG23 ' N ' ' B' ' 28' ' ' GLU . 24.0 m -58.59 -46.82 89.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 119.798 -0.761 . . . . 1.0 110.534 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.488 ' N ' HG23 ' B' ' 27' ' ' VAL . 89.5 mt-10 -67.91 -42.68 80.73 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.784 0.326 . . . . 1.0 111.027 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.41 -37.37 87.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.568 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -65.09 -47.7 76.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.737 179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -62.51 131.45 49.16 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.648 -0.421 . . . . 1.0 110.055 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.86 -0.04 69.33 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.188 -0.765 . . . . 1.0 111.188 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -103.38 143.03 25.79 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 110.32 -0.252 . . . . 1.0 110.32 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.556 ' O ' HG11 ' B' ' 63' ' ' VAL . 93.5 Cg_endo -75.45 142.6 26.71 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 C-N-CA 122.151 1.901 . . . . 1.0 112.138 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 68.65 19.88 73.46 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.181 -0.767 . . . . 1.0 111.181 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.13 145.24 51.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 1.0 110.397 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.08 -34.47 0.87 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.516 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 38.0 tp -81.75 125.5 30.71 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.182 0.515 . . . . 1.0 110.588 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.431 ' O ' ' O ' ' B' ' 40' ' ' SER . 35.5 pt -152.13 -166.91 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.408 -0.815 . . . . 1.0 109.906 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.431 ' O ' ' O ' ' B' ' 39' ' ' ILE . 6.1 t 59.97 135.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.978 0.418 . . . . 1.0 111.283 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.567 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -65.85 -48.98 61.11 Favored Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.826 -0.625 . . . . 1.0 111.369 178.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 24.8 Cg_endo -58.45 -29.53 88.82 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 121.599 1.533 . . . . 1.0 112.913 -179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -89.03 -23.55 22.56 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.7 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' B' ' 27' ' ' VAL . . . -63.54 -41.63 98.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.043 0.449 . . . . 1.0 110.58 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.477 ' O ' HG23 ' B' ' 49' ' ' VAL . 4.9 tt -65.09 -39.36 85.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.49 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.495 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.4 OUTLIER -59.86 -47.51 85.44 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.474 -179.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 8.0 t90 -61.85 -41.91 98.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.972 0.415 . . . . 1.0 110.267 179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 5.2 t -64.37 -40.3 95.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.0 111.199 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 45' ' ' ILE . 44.9 t -60.49 -47.48 92.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.481 -0.327 . . . . 1.0 111.631 -178.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.69 -32.81 74.37 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.655 -0.418 . . . . 1.0 110.842 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 97.2 m -64.81 -43.55 92.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.227 -0.442 . . . . 1.0 111.25 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.688 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -54.47 -26.3 30.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.915 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.42 ' O ' ' OG1' ' B' ' 54' ' ' THR . 68.6 p -88.96 2.23 54.23 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.716 0.293 . . . . 1.0 110.712 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' B' ' 53' ' ' THR . 69.6 p 51.59 66.2 1.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 1.0 110.708 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.489 HG11 ' CZ ' ' B' ' 57' ' ' TYR . 30.5 t -133.88 -52.2 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.427 -0.351 . . . . 1.0 110.674 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 48.33 76.91 0.13 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.772 -0.931 . . . . 1.0 110.772 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.489 ' CZ ' HG11 ' B' ' 55' ' ' VAL . 81.3 m-85 -61.22 -42.6 98.88 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.024 -0.27 . . . . 1.0 110.912 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 133.89 20.73 0.83 Allowed Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.527 ' CG ' HH22 ' C' ' 68' ' ' ARG . 32.7 m-20 -62.5 -41.71 99.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.816 0.341 . . . . 1.0 110.692 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.495 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 34.9 mmt180 -132.88 -175.83 3.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.153 -0.476 . . . . 1.0 110.198 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.495 ' CG ' ' O ' ' B' ' 60' ' ' ARG . 58.9 m-85 -159.45 99.35 1.55 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.856 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.2 158.16 58.7 Favored 'Trans proline' 0 N--CA 1.498 1.771 0 C-N-CA 121.3 1.333 . . . . 1.0 112.606 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.556 HG11 ' O ' ' B' ' 34' ' ' PRO . 0.8 OUTLIER -95.11 -154.17 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.022 -179.967 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.523 ' H ' HG12 ' B' ' 63' ' ' VAL . 26.8 m -101.93 -38.26 7.88 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.468 -0.333 . . . . 1.0 110.767 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.602 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.9 tm-20 -61.55 -32.38 72.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.971 0.415 . . . . 1.0 110.2 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -73.01 26.52 0.06 Allowed 'General case' 0 C--O 1.263 1.784 0 CA-C-O 124.046 1.879 . . . . 1.0 109.599 178.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 44.31 63.95 2.2 Favored Glycine 0 N--CA 1.439 -1.141 0 CA-C-O 117.492 -1.727 . . . . 1.0 110.961 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.505 ' NH1' ' O ' ' A' ' 46' ' ' TRP . 42.1 ttm180 -25.08 -31.76 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.297 1.049 . . . . 1.0 110.904 -178.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' B' ' 67' ' ' GLY . 98.5 mttt -49.82 -17.77 0.4 Allowed 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 176.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.616 ' N ' ' O ' ' B' ' 67' ' ' GLY . 45.7 t -60.32 -47.08 93.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 C-N-CA 119.477 -0.889 . . . . 1.0 109.488 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.54 ' O ' ' SD ' ' B' ' 75' ' ' MET . . . -68.23 -54.21 19.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.324 -0.398 . . . . 1.0 110.303 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -42.82 -34.97 1.03 Allowed 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.255 -0.429 . . . . 1.0 110.33 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . 0.673 HE22 ' NZ ' ' B' ' 25' ' ' LYS . 59.2 tt0 -67.05 -40.14 87.05 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.099 -0.5 . . . . 1.0 110.533 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.462 ' N ' ' O ' ' B' ' 71' ' ' ALA . 45.0 t -67.03 -52.93 38.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 120.662 -0.415 . . . . 1.0 111.861 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.54 ' SD ' ' O ' ' B' ' 71' ' ' ALA . 0.0 OUTLIER -65.0 -42.59 94.36 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.997 -0.281 . . . . 1.0 110.612 -179.537 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.51 -43.96 93.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.663 -0.415 . . . . 1.0 110.119 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.428 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -64.16 -39.63 94.42 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.711 -0.395 . . . . 1.0 110.43 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.432 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.85 -42.99 92.63 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 111.711 -0.556 . . . . 1.0 111.711 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 93.2 mt -62.5 -43.5 98.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 121.041 -0.264 . . . . 1.0 110.77 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' B' ' 84' ' ' LEU . 80.9 mm-40 -60.28 -41.47 93.42 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.301 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.428 HG23 ' O ' ' B' ' 77' ' ' ALA . 65.3 t -64.11 -49.17 82.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.457 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -76.59 -12.16 59.98 Favored 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.547 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -99.34 -26.58 14.11 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.314 -0.403 . . . . 1.0 109.918 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 80' ' ' GLU . 4.7 tt -63.63 -41.32 98.27 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.04 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.573 ' O ' ' N ' ' B' ' 87' ' ' ALA . 17.3 m -47.45 -26.15 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 120.445 -0.502 . . . . 1.0 109.68 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 6.1 m -34.16 -28.48 0.01 OUTLIER 'General case' 0 C--N 1.346 0.418 0 CA-C-O 121.415 0.626 . . . . 1.0 110.211 178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.573 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -53.37 -53.2 54.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.601 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.537 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -70.25 -30.18 67.17 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.333 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.445 ' N ' HD12 ' B' ' 89' ' ' LEU . 9.5 mp -61.29 -43.67 98.49 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.997 0.427 . . . . 1.0 109.886 -179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -72.8 -17.81 61.53 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.409 -0.589 . . . . 1.0 109.409 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.513 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.2 OUTLIER -100.54 -11.56 20.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.66 -0.7 . . . . 1.0 110.241 -179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.6 m-20 -63.12 -41.92 99.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.217 -0.447 . . . . 1.0 111.076 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.453 ' CD1' ' C ' ' B' ' 93' ' ' PHE . 1.4 p90 -64.94 -29.88 70.84 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.438 -0.346 . . . . 1.0 111.363 -179.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 90.2 t -59.96 -43.4 92.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.519 -178.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -48.71 -21.7 0.66 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.108 -0.237 . . . . 1.0 111.31 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.48 HH11 HH21 ' B' ' 100' ' ' ARG . 45.6 ptt85 -55.18 -32.22 62.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.083 0.468 . . . . 1.0 110.119 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 -61.83 -35.42 78.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.726 -0.67 . . . . 1.0 111.125 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' B' ' 98' ' ' GLU . 2.9 pp20? -120.95 22.94 10.9 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 120.661 0.267 . . . . 1.0 110.887 -179.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -132.26 -29.13 1.63 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.892 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.48 HH21 HH11 ' B' ' 96' ' ' ARG . 18.5 ttm105 -61.15 -46.18 91.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.024 0.44 . . . . 1.0 110.295 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -94.28 -3.16 51.1 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 115.816 -0.629 . . . . 1.0 110.664 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.522 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 82.52 8.7 85.8 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.522 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 80.7 m80 . . . . . 0 C--O 1.22 -0.479 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.598 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.299 -0.63 . . . . 1.0 109.299 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.545 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -155.68 108.7 2.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -63.87 -40.91 97.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.473 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.545 ' CE1' ' HB1' ' C' ' 2' ' ' ALA . 3.8 p-80 -58.7 -41.77 87.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.694 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.24 -37.11 86.21 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.72 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.9 -39.29 93.84 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.761 -0.376 . . . . 1.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -62.92 -39.35 94.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.174 -0.467 . . . . 1.0 110.248 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.1 -41.01 99.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.48 -37.19 84.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.531 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.72 -38.4 87.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.275 -0.42 . . . . 1.0 110.661 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.43 -34.5 74.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.882 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.2 -36.29 83.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.971 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.85 -38.71 91.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.752 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -64.17 -36.02 82.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.706 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.45 -36.09 82.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 1.0 110.405 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.87 -33.66 76.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.422 -0.354 . . . . 1.0 111.184 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -61.28 -47.84 84.15 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.579 -0.282 . . . . 1.0 111.56 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 18' ' ' VAL . 12.5 m -65.28 -36.22 77.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.873 0.368 . . . . 1.0 110.653 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.695 HD21 ' HB2' ' C' ' 52' ' ' ALA . 36.0 mt -60.86 -41.56 96.13 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.74 -42.98 99.67 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.119 179.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -68.89 -44.75 72.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.366 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.74 78.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.701 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.468 ' O ' ' HB1' ' C' ' 44' ' ' ALA . 72.6 m -56.75 -43.95 81.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.858 -179.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.471 ' O ' HG22 ' C' ' 27' ' ' VAL . 8.0 tmtt? -80.65 -61.86 1.84 Allowed 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 109.138 -0.69 . . . . 1.0 109.138 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -41.89 -28.75 0.17 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 121.159 -0.216 . . . . 1.0 110.956 179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.8 -34.58 78.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.571 0.224 . . . . 1.0 110.721 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 24' ' ' LYS . 2.3 m -63.26 -43.55 98.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 121.045 0.45 . . . . 1.0 110.544 -178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' C' ' 27' ' ' VAL . 14.4 tm-20 -80.58 -24.22 39.34 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.555 -0.748 . . . . 1.0 110.301 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.59 -51.01 71.23 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.932 -0.576 . . . . 1.0 110.918 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.55 78.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.154 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 39.1 mmm-85 -53.01 90.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.479 -0.328 . . . . 1.0 111.564 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.12 -6.18 8.22 Favored Glycine 0 N--CA 1.47 0.911 0 N-CA-C 111.115 -0.794 . . . . 1.0 111.115 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.14 150.73 39.14 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.69 -0.255 . . . . 1.0 110.32 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.62 141.77 28.28 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 C-N-CA 121.685 1.59 . . . . 1.0 111.649 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 76.79 37.35 34.27 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.29 -0.724 . . . . 1.0 111.29 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -46.64 150.66 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.06 0.457 . . . . 1.0 110.562 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' C' ' 61' ' ' TYR . . . -132.06 -116.79 0.22 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.689 -0.687 . . . . 1.0 110.163 -179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.71 HD22 ' C ' ' C' ' 38' ' ' LEU . 0.0 OUTLIER -55.05 163.93 0.95 Allowed 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.242 0.544 . . . . 1.0 110.961 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' C' ' 40' ' ' SER . 5.7 pt -152.85 -169.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.094 -0.503 . . . . 1.0 109.746 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.516 ' C ' ' CG ' ' C' ' 41' ' ' TYR . 37.6 m -53.02 -165.31 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.302 0 CA-C-O 120.874 0.369 . . . . 1.0 110.83 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.597 ' C ' ' H ' ' C' ' 43' ' ' ASP . 0.3 OUTLIER 76.31 161.19 0.15 Allowed Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.57 5.81 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.564 2.176 . . . . 1.0 112.131 -179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.597 ' H ' ' C ' ' C' ' 41' ' ' TYR . 21.2 t70 -84.2 -32.3 24.61 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 116.203 -0.453 . . . . 1.0 111.062 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' C' ' 23' ' ' SER . . . -60.9 -44.56 96.98 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.865 0.364 . . . . 1.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.53 ' O ' HG23 ' C' ' 49' ' ' VAL . 6.4 tt -63.93 -38.0 81.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.393 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.615 ' CD1' HG22 ' D' ' 64' ' ' THR . 0.3 OUTLIER -55.25 -48.91 73.29 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.679 -0.409 . . . . 1.0 110.211 -179.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' C' ' 48' ' ' SER . 1.4 t90 -63.25 -47.72 81.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.608 ' O ' HD22 ' C' ' 19' ' ' LEU . 1.9 t -50.42 -29.22 9.71 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.586 -0.734 . . . . 1.0 111.776 -179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.532 ' O ' HG12 ' C' ' 49' ' ' VAL . 57.4 t -90.39 62.91 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 N-CA-C 110.19 -0.3 . . . . 1.0 110.19 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.684 ' CG ' HH22 ' D' ' 68' ' ' ARG . 46.7 tp10 -173.28 -37.88 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 119.658 -0.817 . . . . 1.0 110.825 -178.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.513 ' OG1' ' SD ' ' C' ' 75' ' ' MET . 4.5 t -72.57 -38.97 67.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.505 -0.316 . . . . 1.0 110.928 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.695 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -61.23 -28.38 69.11 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.957 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 13.9 p -93.67 1.82 56.49 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.07 0.462 . . . . 1.0 110.282 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 57.4 p 49.8 56.9 7.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.721 -0.672 . . . . 1.0 111.656 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' C' ' 57' ' ' TYR . 1.7 m -145.94 45.89 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 109.8 -0.445 . . . . 1.0 109.8 179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.422 ' H ' HG13 ' B' ' 55' ' ' VAL . . . -45.58 92.44 0.01 OUTLIER Glycine 0 CA--C 1.522 0.525 0 N-CA-C 110.324 -1.11 . . . . 1.0 110.324 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.579 ' HH ' ' HE1' ' D' ' 47' ' ' TRP . 18.2 t80 -61.97 -43.21 99.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.823 0.344 . . . . 1.0 110.41 -179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.17 16.24 0.75 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.386 -0.686 . . . . 1.0 111.386 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.418 ' HB2' ' HE ' ' D' ' 68' ' ' ARG . 68.0 t0 -60.98 -52.11 66.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.94 0.4 . . . . 1.0 110.766 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -151.71 -162.28 1.49 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.016 -0.538 . . . . 1.0 109.607 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.493 ' O ' ' CB ' ' C' ' 37' ' ' ALA . 38.7 p90 -166.69 134.91 2.21 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 120.359 -0.536 . . . . 1.0 110.802 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.22 176.54 6.23 Favored 'Trans proline' 0 N--CA 1.496 1.643 0 C-N-CA 121.864 1.71 . . . . 1.0 112.362 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.406 HG22 ' H ' ' C' ' 63' ' ' VAL . 16.5 m -87.25 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.416 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.495 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 1.1 m -110.08 -61.49 1.65 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.574 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.455 ' N ' HG22 ' C' ' 64' ' ' THR . 81.4 tt0 -42.99 -30.26 0.4 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.11 -0.495 . . . . 1.0 110.675 -178.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 94.1 mt-10 -144.68 -104.27 0.11 Allowed 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 116.127 -0.488 . . . . 1.0 109.845 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.73 -55.28 0.0 OUTLIER Glycine 0 N--CA 1.479 1.521 0 O-C-N 124.358 1.036 . . . . 1.0 114.839 177.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 45.0 ttm-85 -71.12 -43.17 68.18 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 115.192 -0.504 . . . . 1.0 109.971 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.445 ' N ' ' O ' ' C' ' 66' ' ' GLU . 18.3 tptm -60.63 -45.16 95.11 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 107.918 -1.141 . . . . 1.0 107.918 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 92.8 t -65.53 -46.64 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 119.797 -0.761 . . . . 1.0 110.329 179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.531 ' O ' ' SD ' ' C' ' 75' ' ' MET . . . -63.05 -39.8 95.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 1.0 110.13 179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -43.73 -49.36 7.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.579 . . . . 1.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -63.79 -36.35 83.6 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.597 -0.441 . . . . 1.0 110.529 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 95.2 t -64.02 -43.28 97.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 C-N-CA 120.858 -0.337 . . . . 1.0 111.767 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.531 ' SD ' ' O ' ' C' ' 71' ' ' ALA . 3.3 mpp? -59.36 -44.64 92.66 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 120.618 -0.433 . . . . 1.0 110.726 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -64.5 -41.18 96.59 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.425 -0.51 . . . . 1.0 110.53 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . 0.534 ' O ' HG23 ' C' ' 81' ' ' VAL . . . -60.98 -24.13 65.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.554 . . . . 1.0 110.786 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -90.29 -37.61 6.59 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.717 -0.553 . . . . 1.0 111.717 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 86.6 mt -62.56 -43.43 98.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 C-N-CA 120.778 -0.369 . . . . 1.0 110.786 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 18.3 pt-20 -66.07 -37.67 86.38 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.969 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.534 HG23 ' O ' ' C' ' 77' ' ' ALA . 55.1 t -62.75 -47.12 94.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.494 -0.321 . . . . 1.0 111.321 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -73.74 -8.01 54.32 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.501 -0.48 . . . . 1.0 111.299 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.19 -40.72 12.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.876 0.369 . . . . 1.0 110.285 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 5.6 tt -63.07 -42.32 99.63 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.812 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 31.9 m -53.94 -15.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.444 -0.502 . . . . 1.0 110.432 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.475 ' O ' ' N ' ' C' ' 89' ' ' LEU . 28.1 m -60.04 -39.87 87.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.43 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.453 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -39.2 -50.56 1.94 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.297 -0.41 . . . . 1.0 110.59 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.19 -38.26 90.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.148 0.499 . . . . 1.0 110.084 179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' C' ' 86' ' ' THR . 44.7 mt -66.68 -38.92 87.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.853 -0.612 . . . . 1.0 111.401 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.464 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -60.73 -37.64 82.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.235 -0.438 . . . . 1.0 111.011 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 1.8 t -81.99 -3.6 54.81 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.325 -0.398 . . . . 1.0 110.28 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -55.64 -49.7 72.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.569 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.464 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 12.2 p90 -69.06 -32.62 72.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 1.0 111.082 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 91.1 t -60.0 -27.55 39.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.913 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.4 -22.94 67.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.611 -0.268 . . . . 1.0 111.152 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 41.0 ptt85 -57.59 -31.99 66.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 1.0 110.447 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -61.36 -34.06 74.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.536 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -82.52 -24.78 33.93 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.897 -0.321 . . . . 1.0 110.44 179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -67.58 -44.72 77.5 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.284 -0.416 . . . . 1.0 111.104 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -65.55 -36.95 85.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.312 -0.404 . . . . 1.0 110.357 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -64.16 -37.36 87.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.586 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 84.43 27.26 36.59 Favored Glycine 0 CA--C 1.524 0.605 0 N-CA-C 110.966 -0.853 . . . . 1.0 110.966 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 80.1 m80 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.61 179.906 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.626 0 N-CA-C 109.345 -0.613 . . . . 1.0 109.345 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.22 -48.94 79.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.612 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -174.03 -66.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.736 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -79.21 -18.91 52.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.758 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.58 -38.79 87.8 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.374 -0.376 . . . . 1.0 110.402 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -60.76 -42.13 96.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.507 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -63.78 -39.42 94.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.196 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.44 99.23 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.818 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -65.18 -39.07 92.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.689 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -62.06 -40.82 97.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.672 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.82 -35.42 76.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.968 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.88 -37.6 87.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.804 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -62.4 -38.07 88.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.368 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -65.37 -31.93 73.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.622 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.516 HD11 ' HB1' ' D' ' 52' ' ' ALA . 45.7 tp -62.07 -39.64 93.11 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.004 0.431 . . . . 1.0 110.184 -179.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.4 -34.21 75.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -63.5 -46.78 84.53 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.844 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.402 ' H ' HG22 ' D' ' 18' ' ' VAL . 12.2 m -63.62 -37.45 79.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.711 0.291 . . . . 1.0 110.675 -179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' D' ' 52' ' ' ALA . 82.7 mt -61.23 -41.45 96.91 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.528 -0.469 . . . . 1.0 110.345 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.9 -46.32 82.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.912 0.387 . . . . 1.0 110.318 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 45.7 tp10 -69.53 -35.36 75.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.287 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.06 92.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.921 -0.582 . . . . 1.0 111.054 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 33.1 m -58.24 -43.65 87.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.123 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -63.96 -32.84 74.52 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.624 -0.51 . . . . 1.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.37 -45.19 60.9 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.281 -0.567 . . . . 1.0 110.683 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.58 -49.23 78.38 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 120.635 -0.426 . . . . 1.0 111.412 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.54 HG13 ' N ' ' D' ' 28' ' ' GLU . 10.9 p -60.87 -45.7 97.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.266 -0.574 . . . . 1.0 110.178 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.54 ' N ' HG13 ' D' ' 27' ' ' VAL . 80.3 tt0 -67.98 -43.21 79.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.912 -0.586 . . . . 1.0 110.704 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.33 -37.95 86.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.215 179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.444 ' OE1' ' HB1' ' D' ' 36' ' ' ALA . 37.7 mm-40 -67.54 -38.23 83.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.179 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . 0.504 HH11 HD11 ' D' ' 39' ' ' ILE . 16.3 tpp180 -63.69 124.08 20.5 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 120.981 0.42 . . . . 1.0 110.726 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.2 -6.5 68.83 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -95.68 139.4 21.88 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 110.313 -0.254 . . . . 1.0 110.313 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.539 ' O ' HG11 ' D' ' 63' ' ' VAL . 95.7 Cg_endo -74.77 144.77 31.57 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.228 1.952 . . . . 1.0 112.53 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 65.88 22.65 70.47 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.191 -0.764 . . . . 1.0 111.191 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.444 ' HB1' ' OE1' ' D' ' 30' ' ' GLU . . . -91.2 87.82 6.67 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.709 0.29 . . . . 1.0 110.869 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . 0.433 ' O ' HG22 ' D' ' 39' ' ' ILE . . . -65.14 -38.82 91.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.916 179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.561 HD23 ' C ' ' D' ' 38' ' ' LEU . 4.3 tt -66.6 99.14 0.56 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.458 -0.571 . . . . 1.0 109.458 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.587 HG23 ' O ' ' D' ' 39' ' ' ILE . 14.3 tt -143.45 93.34 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.421 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.4 OUTLIER 168.58 150.87 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.017 -0.538 . . . . 1.0 110.572 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.431 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 10.0 m-85 -76.87 -58.79 1.02 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.562 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.1 Cg_endo -58.93 -26.78 82.47 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 121.648 1.565 . . . . 1.0 111.728 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -82.34 -35.9 27.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.755 0.312 . . . . 1.0 111.106 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.79 92.46 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.433 -0.349 . . . . 1.0 111.199 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.17 -44.21 97.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.896 0.379 . . . . 1.0 110.188 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.535 ' NE1' ' O ' ' A' ' 65' ' ' GLU . 0.7 OUTLIER -62.8 -42.02 99.54 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.581 -0.448 . . . . 1.0 110.175 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.579 ' HE1' ' HH ' ' C' ' 57' ' ' TYR . 36.1 t90 -62.12 -40.43 95.88 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.269 -0.572 . . . . 1.0 109.81 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.454 ' O ' HG23 ' D' ' 49' ' ' VAL . 1.4 m -74.22 69.48 1.56 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.804 0.335 . . . . 1.0 110.455 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.454 HG23 ' O ' ' D' ' 48' ' ' SER . 53.3 t -155.47 -61.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 1.0 110.178 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.481 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 1.5 pm0 -63.06 -31.99 73.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 1.0 110.555 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.468 HG23 HG11 ' D' ' 74' ' ' VAL . 0.0 OUTLIER -60.62 -42.9 97.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.223 -179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.779 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.96 -35.02 75.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.894 0.378 . . . . 1.0 110.026 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.401 ' O ' ' OG1' ' D' ' 54' ' ' THR . 18.1 p -80.07 9.47 5.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.555 . . . . 1.0 110.16 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.401 ' OG1' ' O ' ' D' ' 53' ' ' THR . 44.3 p 51.93 56.33 7.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.771 -0.65 . . . . 1.0 111.047 179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.622 HG11 ' SD ' ' A' ' 75' ' ' MET . 5.9 p -166.81 88.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.253 0.549 . . . . 1.0 111.157 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.24 109.92 3.57 Favored Glycine 0 CA--C 1.522 0.519 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.506 ' OH ' ' NE1' ' A' ' 47' ' ' TRP . 0.2 OUTLIER -61.32 -45.34 94.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.81 0.338 . . . . 1.0 110.298 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.52 24.78 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.805 -0.918 . . . . 1.0 110.805 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 64.6 m-20 -61.8 -43.71 98.31 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.991 -0.284 . . . . 1.0 110.532 -179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.543 HH22 ' CG2' ' A' ' 64' ' ' THR . 0.2 OUTLIER -144.94 -177.19 5.4 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.807 -0.442 . . . . 1.0 109.807 179.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' D' ' 60' ' ' ARG . 41.5 m-85 -156.36 128.51 4.01 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 120.942 -0.303 . . . . 1.0 111.0 179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.1 -171.13 0.47 Allowed 'Trans proline' 0 N--CA 1.496 1.662 0 C-N-CA 121.736 1.624 . . . . 1.0 112.064 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.544 HG12 ' H ' ' D' ' 64' ' ' THR . 1.5 t -128.96 -146.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-N 116.178 -0.465 . . . . 1.0 109.986 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.615 HG22 ' CD1' ' C' ' 46' ' ' TRP . 2.9 p -113.48 -8.7 13.37 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.776 -0.193 . . . . 1.0 110.847 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.533 ' C ' ' H ' ' D' ' 67' ' ' GLY . 50.8 tp10 -99.06 -26.67 14.15 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.838 -0.431 . . . . 1.0 109.838 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' D' ' 63' ' ' VAL . 0.0 OUTLIER -80.97 30.92 0.31 Allowed 'General case' 0 C--O 1.265 1.874 0 CA-C-O 123.896 1.808 . . . . 1.0 108.879 178.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.705 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.01 61.71 2.24 Favored Glycine 0 C--O 1.218 -0.863 0 CA-C-N 113.377 -1.738 . . . . 1.0 109.493 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.684 HH22 ' CG ' ' C' ' 50' ' ' GLU . 71.3 ttt-85 -26.21 -30.51 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.857 0 O-C-N 124.134 0.55 . . . . 1.0 110.981 -177.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.705 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.8 mttt -52.22 -13.61 0.35 Allowed 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.554 -0.748 . . . . 1.0 109.292 176.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.602 ' N ' ' O ' ' D' ' 67' ' ' GLY . 44.0 t -59.56 -47.8 89.62 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 119.118 -1.033 . . . . 1.0 109.525 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.34 -36.59 83.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.496 178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 82.8 tt0 -57.85 -43.14 85.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.778 -0.646 . . . . 1.0 111.365 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -61.92 -44.72 96.19 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.799 -0.36 . . . . 1.0 111.209 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.468 HG11 HG23 ' D' ' 51' ' ' THR . 98.1 t -64.11 -46.51 93.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 120.398 -0.521 . . . . 1.0 111.476 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 73.9 mtm -62.66 -44.74 95.49 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.995 -0.282 . . . . 1.0 111.23 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -66.15 -41.54 90.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.77 0.319 . . . . 1.0 110.785 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.44 -39.16 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.707 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.65 -39.11 93.69 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.586 -0.606 . . . . 1.0 111.586 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 93.6 mt -62.61 -43.53 98.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.906 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -63.14 -38.95 93.21 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.52 -0.309 . . . . 1.0 111.079 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 55.4 t -64.34 -54.19 33.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 120.795 -0.362 . . . . 1.0 111.719 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.88 -39.6 90.82 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.743 -0.383 . . . . 1.0 110.812 -179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.44 79.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 1.0 110.446 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -61.66 -40.75 96.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.306 -0.407 . . . . 1.0 110.525 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.5 ' O ' ' N ' ' D' ' 87' ' ' ALA . 48.1 t -57.6 -22.13 17.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.587 -0.445 . . . . 1.0 109.831 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . . . . . . . . . 86.4 m -40.32 -24.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.53 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -64.51 -42.47 95.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.669 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' D' ' 85' ' ' VAL . . . -72.44 -15.62 61.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.319 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.493 ' N ' HD22 ' D' ' 89' ' ' LEU . 3.8 mm? -85.79 -41.44 15.05 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.0 -0.545 . . . . 1.0 111.033 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.597 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -57.87 -36.83 72.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.218 0.533 . . . . 1.0 110.244 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -15.03 62.83 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -57.9 -51.85 67.92 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.234 -0.587 . . . . 1.0 111.073 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.597 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 12.6 p90 -72.23 -28.51 63.21 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.361 -0.381 . . . . 1.0 111.057 -179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -60.97 -35.74 67.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.962 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 95.5 mtt-85 -59.9 -22.2 62.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.484 -0.325 . . . . 1.0 111.213 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -48.66 -36.94 17.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.963 0.411 . . . . 1.0 110.367 -179.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -62.75 -29.28 70.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.688 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -88.1 -22.49 24.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.899 0.381 . . . . 1.0 110.374 179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.16 -44.19 80.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.698 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 53.0 ptt85 -66.19 -33.32 75.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.285 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 26.8 mmt180 -62.47 -36.79 83.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.777 -0.647 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.51 22.01 52.23 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 110.909 -0.877 . . . . 1.0 110.909 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 84.5 t60 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.01 -0.995 . . . . 1.0 110.339 179.925 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.428 -0.582 . . . . 1.0 109.428 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.32 145.02 55.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.693 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -62.53 -40.36 96.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.493 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -62.12 -46.23 89.95 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.175 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.67 -41.35 92.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.408 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.443 ' NH2' ' CG ' ' A' ' 9' ' ' GLN . 8.8 tpm_? -64.1 -43.78 94.3 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.101 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -66.35 -43.76 85.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.123 -0.489 . . . . 1.0 110.087 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.21 -39.39 92.73 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.399 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.443 ' CG ' ' NH2' ' A' ' 6' ' ' ARG . 67.6 tp60 -64.36 -39.01 93.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.047 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -61.19 -41.19 96.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.91 -35.75 77.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.008 -0.542 . . . . 1.0 110.888 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.53 -37.8 85.05 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.902 -0.319 . . . . 1.0 110.488 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.71 -38.33 90.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.33 -32.66 74.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.505 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 ' HB1' ' A' ' 52' ' ' ALA . 49.6 tp -62.53 -38.29 89.4 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.079 0.466 . . . . 1.0 110.251 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -68.89 -33.99 74.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.38 -0.373 . . . . 1.0 111.315 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -64.12 -45.76 87.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.844 0.313 . . . . 1.0 111.844 -178.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 m -63.08 -33.14 59.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.933 -0.307 . . . . 1.0 110.836 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 52' ' ' ALA . 77.3 mt -60.51 -41.94 95.4 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.567 -0.453 . . . . 1.0 109.977 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.24 -47.92 82.24 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.626 -0.429 . . . . 1.0 109.854 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -67.53 -35.62 79.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.016 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.27 -37.06 84.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.053 -0.521 . . . . 1.0 110.614 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.9 p -59.56 -47.88 83.81 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.726 -0.39 . . . . 1.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.3 tttm -67.51 -44.86 77.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.397 0.618 . . . . 1.0 110.47 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 29' ' ' ALA . 98.4 mttt -63.64 -41.93 98.19 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.801 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.57 -51.47 68.43 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.642 -0.253 . . . . 1.0 111.532 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 28' ' ' GLU . 13.4 p -64.68 -42.55 95.36 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 CA-C-O 121.176 0.512 . . . . 1.0 109.855 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' N ' HG13 ' A' ' 27' ' ' VAL . 44.8 tp10 -70.57 -34.04 71.77 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.704 -0.68 . . . . 1.0 110.516 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 25' ' ' LYS . . . -56.14 -50.69 70.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.573 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 32' ' ' GLY . 11.4 pt-20 -67.0 -36.55 82.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.096 -0.502 . . . . 1.0 111.019 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -55.19 87.85 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.352 . . . . 1.0 110.786 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 30' ' ' GLU . . . 127.74 -9.09 6.83 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 111.498 -0.641 . . . . 1.0 111.498 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.18 143.3 26.46 Favored Pre-proline 0 CA--C 1.535 0.391 0 O-C-N 122.676 -0.308 . . . . 1.0 110.175 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -76.29 119.04 5.13 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.03 1.82 . . . . 1.0 112.179 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 36' ' ' ALA . . . 114.02 12.64 10.91 Favored Glycine 0 N--CA 1.467 0.74 0 N-CA-C 111.066 -0.813 . . . . 1.0 111.066 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 35' ' ' GLY . . . -40.47 165.33 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.79 0.328 . . . . 1.0 110.892 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 61' ' ' TYR . . . -146.49 -86.29 0.1 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.341 -0.39 . . . . 1.0 111.064 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.556 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -72.44 57.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.41 -179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 20.8 tt -63.4 -18.96 22.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.013 0.435 . . . . 1.0 110.423 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 44' ' ' ALA . 9.9 m -71.86 146.5 47.89 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.848 -0.615 . . . . 1.0 110.602 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.485 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 37.1 t80 -83.55 -51.58 0.63 Allowed Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.767 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -59.93 -30.25 91.3 Favored 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 121.492 1.461 . . . . 1.0 112.484 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -88.27 -23.16 23.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.625 0.25 . . . . 1.0 111.003 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 40' ' ' SER . . . -63.0 -38.71 92.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.866 0.365 . . . . 1.0 110.111 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.9 tt -65.73 -38.63 82.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.494 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 -45.7 92.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.288 -0.415 . . . . 1.0 109.916 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -60.29 -38.58 84.05 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.672 -0.492 . . . . 1.0 109.672 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' A' ' 19' ' ' LEU . 15.0 m -56.26 -31.67 63.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.497 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' O ' HG12 ' A' ' 49' ' ' VAL . 46.9 t -82.49 -5.42 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.961 0.41 . . . . 1.0 110.196 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.474 ' OE1' ' NH1' ' B' ' 68' ' ' ARG . 49.5 tt0 -108.76 33.45 4.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.239 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.65 -39.27 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.48 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.59 -25.48 64.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.47 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.432 ' O ' ' OG1' ' A' ' 54' ' ' THR . 45.8 p -85.65 -2.13 57.87 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.463 -0.569 . . . . 1.0 109.463 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 53' ' ' THR . 48.5 p 53.27 73.67 0.35 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.506 -0.77 . . . . 1.0 111.118 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.27 -53.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.779 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 62.07 63.51 4.69 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.242 -0.743 . . . . 1.0 111.242 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -60.62 -48.69 80.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.951 0.405 . . . . 1.0 110.583 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' N ' ' A' ' 60' ' ' ARG . . . 161.95 -87.66 0.11 Allowed Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.625 -0.99 . . . . 1.0 110.625 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.514 ' CG ' HH22 ' B' ' 68' ' ' ARG . 10.0 m-20 41.86 -92.63 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.941 0.4 . . . . 1.0 110.486 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' N ' ' O ' ' A' ' 58' ' ' GLY . 1.5 mpp_? -115.23 -173.52 2.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.095 -0.502 . . . . 1.0 109.84 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 61' ' ' TYR . 56.1 p90 -156.08 129.78 4.63 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.355 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.31 169.33 19.86 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 C-N-CA 122.036 1.824 . . . . 1.0 112.502 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.985 HG22 ' H ' ' A' ' 64' ' ' THR . 6.0 p -81.27 -155.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.28 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 63' ' ' VAL . 1.3 m -113.76 -64.66 1.28 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.063 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' THR . 80.6 tt0 -37.5 -39.87 0.34 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.027 0.442 . . . . 1.0 110.549 -178.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.85 ' O ' ' N ' ' A' ' 68' ' ' ARG . 73.7 mm-40 -135.85 -104.28 0.21 Allowed 'General case' 0 C--O 1.22 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.0 109.524 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 20.51 -57.17 0.0 OUTLIER Glycine 0 N--CA 1.479 1.516 0 O-C-N 124.563 1.164 . . . . 1.0 114.449 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.85 ' N ' ' O ' ' A' ' 66' ' ' GLU . 58.4 ttm-85 -71.56 -46.94 58.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.113 0.483 . . . . 1.0 109.965 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.459 ' N ' ' O ' ' A' ' 66' ' ' GLU . 3.5 tmtp? -60.68 -45.33 94.55 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.464 -0.939 . . . . 1.0 108.464 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -67.39 -43.43 87.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.021 -0.672 . . . . 1.0 110.029 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.28 -37.3 84.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.25 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -53.56 -43.03 68.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.004 -0.543 . . . . 1.0 110.151 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -67.5 -35.47 79.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.302 179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.3 t -62.17 -48.84 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 120.717 -0.393 . . . . 1.0 111.137 -179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 19.4 ptp -65.07 -37.5 87.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.533 -0.303 . . . . 1.0 110.572 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.45 -42.81 92.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.345 -0.388 . . . . 1.0 110.221 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.69 -31.19 71.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.276 -0.42 . . . . 1.0 110.642 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' A' ' 15' ' ' LEU . . . -77.29 -38.05 30.26 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 88.4 mt -61.57 -43.79 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.583 0.23 . . . . 1.0 110.624 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.83 -36.6 84.85 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.506 -0.477 . . . . 1.0 110.202 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 77' ' ' ALA . 39.3 t -63.6 -49.71 81.24 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 CA-C-O 120.919 0.39 . . . . 1.0 110.631 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -66.34 -31.04 71.57 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.252 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.88 -26.65 29.23 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.986 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -63.89 -43.76 95.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.402 -0.363 . . . . 1.0 111.881 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' O ' ' N ' ' A' ' 87' ' ' ALA . 4.3 m -62.08 -16.56 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.409 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' VAL . 38.0 m -36.49 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 121.093 0.473 . . . . 1.0 110.444 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' O ' HG22 ' A' ' 91' ' ' THR . . . -55.72 -57.73 10.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.724 -0.671 . . . . 1.0 110.476 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -56.96 -32.94 66.54 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.128 -0.487 . . . . 1.0 110.49 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.495 HD12 ' O ' ' B' ' 83' ' ' ALA . 3.8 mm? -69.31 -36.35 76.9 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.849 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 92' ' ' ASP . . . -66.76 -55.74 13.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.985 0.422 . . . . 1.0 111.276 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 87' ' ' ALA . 0.5 OUTLIER -51.45 -4.83 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.074 -0.512 . . . . 1.0 110.97 -179.656 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.542 ' H ' ' C ' ' A' ' 90' ' ' ALA . 86.4 m-20 -60.36 -48.1 83.22 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 120.893 -0.323 . . . . 1.0 110.581 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 24.6 p90 -69.49 -28.05 65.73 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.386 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 75.1 t -60.04 -45.7 95.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.356 . . . . 1.0 110.925 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 98' ' ' GLU . 99.7 mtt180 -68.08 -22.25 64.93 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.95 -0.3 . . . . 1.0 110.706 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 68.7 ttp85 -44.19 -23.86 0.13 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 1.0 110.881 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -65.12 -38.54 90.97 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.793 -0.447 . . . . 1.0 109.793 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 95' ' ' ARG . 98.3 mt-10 -66.57 -36.05 81.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.725 -0.67 . . . . 1.0 110.592 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.23 -36.06 82.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.464 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -60.15 -46.97 87.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.47 -179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -71.05 -25.12 62.5 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.33 9.64 72.48 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.22 -0.489 0 CA-C-O 118.094 -0.955 . . . . 1.0 110.539 179.918 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 29.4 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.381 -0.599 . . . . 1.0 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.52 139.91 55.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.247 -0.433 . . . . 1.0 110.667 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.3 -40.47 93.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.979 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' B' ' 5' ' ' GLU . 6.2 p80 -63.66 -29.94 71.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.278 -0.419 . . . . 1.0 110.79 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.616 ' N ' ' ND1' ' B' ' 4' ' ' HIS . 50.2 tp10 -65.99 -38.86 89.59 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.467 -0.333 . . . . 1.0 110.566 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -64.56 -39.22 93.36 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.916 -0.314 . . . . 1.0 110.61 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -64.09 -40.23 95.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.04 179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.15 -40.51 97.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.885 -0.598 . . . . 1.0 110.743 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -66.32 -38.36 87.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.319 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -62.28 -40.13 95.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.573 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.68 -36.32 80.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.751 -179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -63.21 -35.21 79.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 1.0 110.478 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.08 -36.59 84.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.344 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -62.9 -37.51 87.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.54 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.431 HD13 ' HA2' ' B' ' 78' ' ' GLY . 48.4 tp -62.52 -40.47 96.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.222 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -63.29 -38.77 92.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.466 . . . . 1.0 110.78 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -62.66 -37.96 88.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.941 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.68 -40.44 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.575 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.648 HD21 ' HB2' ' B' ' 52' ' ' ALA . 95.9 mt -59.96 -41.19 91.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.831 -0.433 . . . . 1.0 109.831 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.423 ' O ' ' OG ' ' B' ' 23' ' ' SER . 80.1 mm-40 -57.85 -49.75 75.61 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.669 -0.493 . . . . 1.0 109.669 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.3 -37.01 77.6 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.202 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.59 -43.59 65.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 1.0 110.206 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' B' ' 20' ' ' GLU . 78.3 p -62.59 -40.18 96.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.719 179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -65.29 -33.03 75.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.731 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 29' ' ' ALA . 4.4 mptp? -83.99 -50.75 7.72 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.909 -0.317 . . . . 1.0 110.519 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.07 -42.45 72.79 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.081 -0.247 . . . . 1.0 111.33 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' B' ' 28' ' ' GLU . 3.8 p -62.17 -45.63 98.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.325 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.5 ' N ' ' CG1' ' B' ' 27' ' ' VAL . 79.9 tt0 -74.27 -32.02 62.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.792 -0.64 . . . . 1.0 111.033 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.43 ' HB1' ' CB ' ' B' ' 66' ' ' GLU . . . -58.93 -37.85 77.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.43 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -69.51 -37.85 77.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.853 0.359 . . . . 1.0 110.918 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -54.6 95.47 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.177 -0.465 . . . . 1.0 111.097 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.441 ' O ' ' OE1' ' B' ' 65' ' ' GLU . . . 119.27 -7.71 12.53 Favored Glycine 0 N--CA 1.465 0.628 0 N-CA-C 111.381 -0.688 . . . . 1.0 111.381 179.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.33 139.1 22.32 Favored Pre-proline 0 CA--C 1.536 0.408 0 O-C-N 122.836 -0.214 . . . . 1.0 110.859 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.58 147.5 31.92 Favored 'Trans proline' 0 N--CA 1.493 1.466 0 C-N-CA 122.03 1.82 . . . . 1.0 112.528 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.78 20.15 70.09 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.261 -0.736 . . . . 1.0 111.261 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.26 144.7 56.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.804 0.335 . . . . 1.0 110.348 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -35.28 0.46 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.538 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.77 HD23 ' O ' ' B' ' 38' ' ' LEU . 2.6 tt -62.85 -30.63 71.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.12 -0.491 . . . . 1.0 109.87 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.6 HD13 ' N ' ' B' ' 40' ' ' SER . 0.2 OUTLIER -34.48 119.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.469 -0.332 . . . . 1.0 110.655 179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.6 ' N ' HD13 ' B' ' 39' ' ' ILE . 31.1 t -176.22 -126.27 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.5 m-85 176.79 -65.51 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 1.0 110.001 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.453 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 20.6 Cg_endo -58.1 -38.07 93.1 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.116 1.878 . . . . 1.0 112.228 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.536 ' O ' ' NH2' ' B' ' 60' ' ' ARG . 40.5 p30 -101.88 2.22 37.85 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.608 -0.269 . . . . 1.0 111.05 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.9 -41.91 96.99 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.932 0.396 . . . . 1.0 110.17 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.66 -31.91 50.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.713 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.556 ' NE1' ' O ' ' C' ' 64' ' ' THR . 0.5 OUTLIER -54.74 -49.83 69.86 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.514 -178.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.504 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.5 OUTLIER -64.02 -39.56 94.38 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.267 179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.504 ' N ' ' CE3' ' B' ' 47' ' ' TRP . 38.4 p -59.45 -35.72 74.58 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.428 -0.351 . . . . 1.0 111.203 -178.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 60.7 t -61.14 -48.26 89.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 111.831 0.308 . . . . 1.0 111.831 -178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.557 ' CG ' HH22 ' C' ' 68' ' ' ARG . 14.5 pt-20 -68.9 -30.76 69.32 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.699 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 88.4 m -62.19 -45.64 92.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 1.0 111.151 -179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.648 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -60.69 -27.99 68.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.551 -0.295 . . . . 1.0 111.024 -179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 47.0 p -86.81 3.8 43.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.68 0.276 . . . . 1.0 110.807 -179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 72.9 p 50.37 74.84 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.795 0.331 . . . . 1.0 110.583 -179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.501 HG11 ' CE1' ' B' ' 57' ' ' TYR . 57.6 t -142.11 -57.37 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.54 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 47.52 82.28 0.04 OUTLIER Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.968 -0.853 . . . . 1.0 110.968 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.501 ' CE1' HG11 ' B' ' 55' ' ' VAL . 57.7 m-85 -61.94 -41.83 98.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.709 0.29 . . . . 1.0 110.967 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 137.62 9.52 1.15 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.986 -0.846 . . . . 1.0 110.986 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -60.62 -49.18 78.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.82 0.343 . . . . 1.0 110.433 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.536 ' NH2' ' O ' ' B' ' 43' ' ' ASP . 0.9 OUTLIER -145.09 145.33 31.38 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.112 179.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.494 ' CD2' ' O ' ' B' ' 61' ' ' TYR . 47.5 p90 -133.68 126.78 19.18 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.155 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.63 156.44 63.68 Favored 'Trans proline' 0 N--CA 1.496 1.653 0 C-N-CA 121.735 1.623 . . . . 1.0 112.282 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.455 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -83.26 -138.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.033 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.455 ' H ' HG12 ' B' ' 63' ' ' VAL . 53.9 m -114.27 -39.88 3.78 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.996 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' B' ' 67' ' ' GLY . 78.1 tt0 -65.8 -22.9 66.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.904 0.383 . . . . 1.0 110.588 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' B' ' 66' ' ' GLU . 0.0 OUTLIER -75.35 28.2 0.1 Allowed 'General case' 0 C--O 1.268 2.031 0 CA-C-O 123.513 1.625 . . . . 1.0 109.714 179.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.19 64.86 1.21 Allowed Glycine 0 C--O 1.215 -1.05 0 CA-C-N 113.768 -1.56 . . . . 1.0 111.556 177.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.514 HH22 ' CG ' ' A' ' 59' ' ' ASP . 62.9 ttm-85 -23.41 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 118.186 0.993 . . . . 1.0 110.866 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 73.0 mmtt -45.8 -21.64 0.14 Allowed 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.82 -0.807 . . . . 1.0 108.82 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' B' ' 67' ' ' GLY . 64.7 t -63.43 -44.78 99.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.618 0 C-N-CA 119.873 -0.731 . . . . 1.0 109.473 179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -77.52 -38.43 48.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.281 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -59.61 -41.75 91.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.186 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -63.79 -44.23 93.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.956 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.0 -45.58 94.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.835 -0.346 . . . . 1.0 111.245 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 75.5 mtm -63.02 -43.14 99.53 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.738 -0.385 . . . . 1.0 110.725 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -65.35 -38.21 89.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.295 -0.411 . . . . 1.0 110.529 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.42 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -58.79 -43.51 90.5 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.693 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . 0.431 ' HA2' HD13 ' B' ' 15' ' ' LEU . . . -66.1 -42.21 94.62 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.22 -43.48 97.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 121.064 -0.254 . . . . 1.0 110.851 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.6 -43.02 98.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.856 0.36 . . . . 1.0 110.62 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.42 HG23 ' O ' ' B' ' 77' ' ' ALA . 66.3 t -63.98 -47.36 90.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 1.0 111.283 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -74.34 0.92 12.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.834 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.495 ' O ' HD12 ' A' ' 89' ' ' LEU . . . -103.47 -34.82 8.57 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.517 -0.311 . . . . 1.0 110.179 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.464 ' C ' ' N ' ' B' ' 86' ' ' THR . 5.8 tt -64.24 -39.49 94.07 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.791 -0.363 . . . . 1.0 110.053 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . . . . . . . . . 35.3 m -48.39 -13.91 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 116.304 -0.407 . . . . 1.0 109.977 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.48 ' O ' ' N ' ' B' ' 89' ' ' LEU . 55.2 m -49.33 -43.19 43.43 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.558 -0.534 . . . . 1.0 109.558 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.07 -17.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.783 -0.644 . . . . 1.0 110.79 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' B' ' 86' ' ' THR . . . -104.13 -19.6 14.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.742 0.306 . . . . 1.0 110.744 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.503 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 2.6 mm? -95.31 -46.09 6.88 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-O 120.919 0.39 . . . . 1.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.515 ' O ' ' CE2' ' B' ' 93' ' ' PHE . . . -56.56 -28.08 59.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.277 0.56 . . . . 1.0 110.051 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 1.2 t -79.97 -4.15 51.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.542 -0.754 . . . . 1.0 110.68 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' C' ' 87' ' ' ALA . 88.5 m-20 -59.96 -49.77 76.37 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.472 -0.331 . . . . 1.0 111.172 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.515 ' CE2' ' O ' ' B' ' 90' ' ' ALA . 16.4 p90 -70.08 -27.5 64.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.379 . . . . 1.0 111.003 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 86.1 t -61.67 -44.8 99.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.135 -0.484 . . . . 1.0 111.315 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -64.51 -20.2 66.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.53 -0.305 . . . . 1.0 111.187 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.1 ttp85 -48.72 -40.26 27.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.493 ' C ' HH21 ' B' ' 101' ' ' ARG . 80.8 mm-40 -64.6 -41.76 96.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.076 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.05 -35.79 78.82 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.801 0.334 . . . . 1.0 110.734 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -65.34 -30.88 71.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.752 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 70.6 ttp85 -59.36 -44.2 92.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.78 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . 0.493 HH21 ' C ' ' B' ' 97' ' ' GLU . 0.4 OUTLIER -78.34 -16.15 57.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.383 -0.372 . . . . 1.0 110.168 179.698 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 82.89 11.94 80.61 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.038 -0.825 . . . . 1.0 111.038 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 51.8 p-80 . . . . . 0 C--O 1.22 -0.451 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.927 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . 0.478 ' N ' ' OE1' ' C' ' 5' ' ' GLU . 63.3 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.501 ' O ' ' CD2' ' C' ' 4' ' ' HIS . . . -75.36 80.08 2.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.496 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' C' ' 6' ' ' ARG . 98.5 m-20 41.58 -91.71 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.971 -0.559 . . . . 1.0 110.893 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.551 ' CD2' ' H ' ' C' ' 4' ' ' HIS . 2.1 p80 -40.88 -34.84 0.44 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.784 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.478 ' OE1' ' N ' ' C' ' 1' ' ' SER . 96.9 mt-10 -66.55 -37.95 86.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.903 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' C' ' 3' ' ' ASP . 83.6 mtp180 -63.79 -36.53 84.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.323 -0.399 . . . . 1.0 110.249 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 41.6 tp10 -62.19 -40.32 95.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.055 -0.52 . . . . 1.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . 0.471 ' HB1' HG13 ' C' ' 85' ' ' VAL . . . -64.43 -41.17 96.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.5 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.59 -41.32 96.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.383 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -63.12 -36.44 83.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.391 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.93 -35.85 77.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 1.0 111.199 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -61.26 -42.48 98.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.722 0.296 . . . . 1.0 110.956 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.45 -35.76 78.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.803 0.335 . . . . 1.0 110.563 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -63.88 -32.84 74.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.471 . . . . 1.0 110.336 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.888 HD11 ' HB1' ' C' ' 52' ' ' ALA . 46.6 tp -62.75 -40.61 97.79 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 120.871 -0.332 . . . . 1.0 110.489 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.435 ' O ' ' CG ' ' C' ' 20' ' ' GLU . 88.8 mt-30 -70.6 -25.68 63.16 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.924 -0.311 . . . . 1.0 111.527 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -80.44 -44.63 18.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . 0.483 HG23 ' N ' ' C' ' 19' ' ' LEU . 25.9 m -61.65 -47.11 94.83 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.328 0.492 . . . . 1.0 112.328 -177.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.483 ' N ' HG23 ' C' ' 18' ' ' VAL . 2.8 pp -75.25 -26.27 58.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.865 0.364 . . . . 1.0 110.526 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' C' ' 16' ' ' GLN . 3.7 mm-40 -60.35 -48.33 82.19 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.076 -0.511 . . . . 1.0 109.666 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 47.2 tp10 -65.84 -40.35 91.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.148 -0.478 . . . . 1.0 109.833 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.479 ' O ' ' N ' ' C' ' 26' ' ' ALA . . . -64.86 -33.63 76.46 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.453 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' C' ' 48' ' ' SER . 22.3 m -56.65 -47.84 78.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.781 -179.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 14.8 tmtt? -65.5 -39.8 92.29 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.561 -0.455 . . . . 1.0 110.159 179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' C' ' 29' ' ' ALA . 98.7 mttt -73.55 -25.15 60.26 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.462 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' C' ' 22' ' ' ALA . . . -61.57 -45.11 95.55 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 121.071 -0.251 . . . . 1.0 110.684 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.437 ' O ' ' OE2' ' C' ' 30' ' ' GLU . 42.7 t -64.82 -46.33 92.3 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.181 0 C-N-CA 120.521 -0.472 . . . . 1.0 110.193 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -70.63 -33.65 71.23 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.108 -0.496 . . . . 1.0 110.54 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.44 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -56.68 -53.63 55.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.049 -0.523 . . . . 1.0 110.954 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' C' ' 31' ' ' ARG . 2.9 pp20? -71.2 -36.56 71.96 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.889 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' C' ' 30' ' ' GLU . 16.6 tpt180 -57.41 90.44 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-O 120.733 0.302 . . . . 1.0 110.765 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.07 -14.8 6.23 Favored Glycine 0 N--CA 1.468 0.804 0 N-CA-C 111.403 -0.679 . . . . 1.0 111.403 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.26 157.11 34.63 Favored Pre-proline 0 N--CA 1.467 0.406 0 N-CA-C 109.869 -0.419 . . . . 1.0 109.869 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.13 147.66 33.77 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 C-N-CA 122.028 1.819 . . . . 1.0 112.186 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.08 26.37 48.92 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.151 -0.78 . . . . 1.0 111.151 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.14 143.16 39.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.804 0.335 . . . . 1.0 110.492 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -159.73 -7.25 0.06 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.543 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.8 tt -120.1 134.38 55.27 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 116.185 -0.462 . . . . 1.0 110.298 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.452 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 29.8 pt -153.96 -162.75 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.045 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.494 ' O ' ' OD1' ' C' ' 43' ' ' ASP . 1.0 OUTLIER 59.06 126.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.09 0.471 . . . . 1.0 110.971 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.63 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 42.0 m-85 -71.56 -43.44 11.86 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 115.873 -0.603 . . . . 1.0 111.088 178.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 26.8 Cg_endo -59.34 -42.05 52.9 Favored 'Trans proline' 0 N--CA 1.5 1.912 0 C-N-CA 121.554 1.503 . . . . 1.0 112.959 -179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' O ' ' C' ' 40' ' ' SER . 28.3 p-10 -84.29 -5.87 59.32 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.564 -0.289 . . . . 1.0 111.192 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.07 99.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.819 0.342 . . . . 1.0 110.487 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.479 HG23 ' HE3' ' C' ' 46' ' ' TRP . 8.4 tt -65.45 -35.97 76.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.563 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.479 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.4 OUTLIER -56.51 -36.75 69.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.533 -179.264 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.419 ' HB2' ' HE ' ' C' ' 60' ' ' ARG . 0.5 OUTLIER -84.82 -28.76 25.88 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 109.288 -0.634 . . . . 1.0 109.288 178.75 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.491 ' CB ' ' OG ' ' C' ' 23' ' ' SER . 1.5 m -68.77 -40.09 79.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.281 -0.418 . . . . 1.0 111.685 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.462 ' CG1' ' N ' ' C' ' 50' ' ' GLU . 3.9 p -60.83 -44.85 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.122 0 CA-C-N 116.585 -0.28 . . . . 1.0 111.552 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.545 ' CD ' HH21 ' D' ' 68' ' ' ARG . 15.8 pt-20 -69.76 -33.86 73.0 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.657 -0.417 . . . . 1.0 110.823 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 70.3 m -62.57 -47.86 82.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.391 -0.368 . . . . 1.0 111.414 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.888 ' HB1' HD11 ' C' ' 15' ' ' LEU . . . -63.0 -23.94 67.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.551 -0.295 . . . . 1.0 110.752 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 59.0 p -95.07 3.28 55.0 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.835 0.35 . . . . 1.0 110.132 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.403 ' O ' ' OG1' ' C' ' 54' ' ' THR . 17.5 p 53.79 73.66 0.37 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.994 -0.548 . . . . 1.0 110.894 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 77.6 t -137.63 -70.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.134 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 76.73 -58.3 3.44 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.441 -1.063 . . . . 1.0 110.441 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER 70.76 -48.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.717 0.294 . . . . 1.0 110.976 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 145.24 -9.72 1.74 Allowed Glycine 0 CA--C 1.526 0.726 0 N-CA-C 110.821 -0.912 . . . . 1.0 110.821 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.513 ' OD2' ' NH2' ' D' ' 68' ' ' ARG . 60.8 m-20 -42.93 -82.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.968 0.413 . . . . 1.0 110.655 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 47' ' ' TRP . 81.1 mtm-85 -124.42 154.97 39.64 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 115.768 -0.651 . . . . 1.0 109.841 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.463 ' CD1' ' O ' ' C' ' 61' ' ' TYR . 44.2 p90 -131.24 136.15 28.28 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 116.53 -0.305 . . . . 1.0 110.611 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.08 155.3 68.59 Favored 'Trans proline' 0 N--CA 1.495 1.586 0 C-N-CA 122.072 1.848 . . . . 1.0 112.241 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -68.62 -161.12 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.149 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.556 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 17.1 p -111.21 -66.23 1.1 Allowed 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 116.512 -0.313 . . . . 1.0 111.195 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.413 ' C ' ' O ' ' C' ' 64' ' ' THR . 83.1 tt0 -37.81 -44.55 0.76 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.859 0.361 . . . . 1.0 110.559 -179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.89 ' O ' ' N ' ' C' ' 68' ' ' ARG . 80.6 mm-40 -121.52 -98.38 0.44 Allowed 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.874 -0.787 . . . . 1.0 108.874 178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 18.32 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.619 1.199 . . . . 1.0 114.438 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.89 ' N ' ' O ' ' C' ' 66' ' ' GLU . 47.7 ttm-85 -67.02 -67.08 0.48 Allowed 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 114.892 -0.654 . . . . 1.0 110.11 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' C' ' 68' ' ' ARG . 1.9 mptm? -41.42 -39.42 1.48 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.553 -0.536 . . . . 1.0 109.553 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 58.5 t -76.72 -49.07 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 119.804 -0.759 . . . . 1.0 111.212 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.38 -50.7 64.53 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 120.985 0.422 . . . . 1.0 110.534 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 68' ' ' ARG . 84.2 tt0 -44.39 -44.39 8.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.784 -0.644 . . . . 1.0 110.601 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.69 -41.08 97.1 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.238 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 79.6 t -65.19 -42.66 94.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.977 -0.289 . . . . 1.0 111.359 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 36.6 mtt -59.1 -42.81 91.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.83 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -63.25 -41.99 99.13 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.825 -0.35 . . . . 1.0 110.645 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.68 -37.59 88.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.453 -0.339 . . . . 1.0 110.477 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.402 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -64.9 -43.3 96.22 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 121.104 -0.569 . . . . 1.0 112.1 -179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 98.0 mt -63.25 -42.68 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.646 0.26 . . . . 1.0 110.81 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.2 -38.91 84.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.407 -0.36 . . . . 1.0 111.423 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 70.6 t -62.98 -49.77 82.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.636 -0.426 . . . . 1.0 111.273 -179.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -65.43 -41.02 93.96 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.651 -0.42 . . . . 1.0 111.075 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.54 -32.52 74.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 1.0 110.652 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 tt -61.9 -42.13 98.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 1.0 111.366 -179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.471 HG13 ' HB1' ' C' ' 8' ' ' ALA . 24.6 t -58.93 -18.17 12.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.529 -0.468 . . . . 1.0 110.221 -179.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.459 ' O ' ' N ' ' C' ' 90' ' ' ALA . 85.9 m -43.13 -40.46 3.26 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.846 0.355 . . . . 1.0 110.377 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.417 ' HB2' ' CB ' ' B' ' 92' ' ' ASP . . . -47.8 -63.48 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.891 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -50.8 -34.58 28.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.03 0.443 . . . . 1.0 110.317 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.502 ' CD2' ' N ' ' C' ' 89' ' ' LEU . 3.0 mm? -77.28 -33.42 55.82 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.736 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.514 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.11 -36.09 82.89 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.107 0.479 . . . . 1.0 110.997 -179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.64 -4.47 37.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.142 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 86.9 m-20 -56.06 -51.55 67.43 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.698 -0.401 . . . . 1.0 111.049 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 19.4 p90 -68.97 -30.03 68.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.82 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.27 -42.22 89.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.047 -0.524 . . . . 1.0 111.443 -178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . 0.426 ' O ' ' N ' ' C' ' 98' ' ' GLU . 97.0 mtt180 -57.28 -23.44 48.45 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.032 -0.267 . . . . 1.0 111.355 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 27.4 ptt-85 -43.53 -33.53 1.15 Allowed 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.856 0.36 . . . . 1.0 110.63 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -65.97 -38.25 88.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.577 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' C' ' 95' ' ' ARG . 71.4 mm-40 -65.86 -40.82 92.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.279 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -67.47 -39.32 85.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 1.0 110.354 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 61.4 ttt85 -64.82 -43.69 92.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.685 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 70.5 mtt180 -135.88 100.5 4.46 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.608 -179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.88 34.89 3.36 Favored Glycine 0 N--CA 1.466 0.658 0 N-CA-C 111.078 -0.809 . . . . 1.0 111.078 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.515 ' OXT' ' CG ' ' C' ' 103' ' ' HIS . 53.7 p-80 . . . . . 0 C--O 1.219 -0.524 0 CA-C-O 117.972 -1.013 . . . . 1.0 110.512 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . 0.458 ' C ' ' H ' ' D' ' 3' ' ' ASP . 58.0 m . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 109.331 -0.618 . . . . 1.0 109.331 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.477 ' O ' ' CD2' ' D' ' 4' ' ' HIS . . . -76.6 29.79 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.75 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' D' ' 1' ' ' SER . 7.0 t70 80.74 -59.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.79 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.511 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 7.5 p80 -78.39 -20.4 51.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.439 -0.346 . . . . 1.0 110.844 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.26 -37.98 84.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.981 0.419 . . . . 1.0 110.677 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.2 -38.41 90.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.494 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -64.86 -40.9 95.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.312 -0.404 . . . . 1.0 109.912 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.55 96.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.749 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -67.2 -39.1 86.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.382 -0.372 . . . . 1.0 110.531 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 21.3 tptp -62.94 -38.21 90.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 1.0 110.424 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.91 78.57 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.073 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -62.66 -37.97 88.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.781 0.324 . . . . 1.0 110.678 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.81 -33.97 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -65.31 -35.97 82.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.628 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 48.4 tp -62.27 -41.57 98.59 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.372 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -61.69 -40.62 95.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.018 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -63.32 -37.4 87.12 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.438 -0.346 . . . . 1.0 110.997 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 70.9 t -62.87 -39.55 85.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.558 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.676 HD21 ' HB2' ' D' ' 52' ' ' ALA . 92.5 mt -59.24 -40.9 87.38 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.554 -0.458 . . . . 1.0 109.846 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . 0.413 ' O ' ' OG ' ' D' ' 23' ' ' SER . 97.1 mt-10 -60.85 -51.01 71.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.18 0.514 . . . . 1.0 110.037 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.85 -32.32 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 1.0 109.949 179.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.69 95.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.018 -0.537 . . . . 1.0 110.937 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' D' ' 20' ' ' GLU . 78.1 p -58.69 -41.31 85.96 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.412 -0.358 . . . . 1.0 110.614 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -63.98 -32.82 74.5 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.378 -0.529 . . . . 1.0 110.252 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' D' ' 29' ' ' ALA . 44.5 mmtm -80.18 -39.3 29.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.333 179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.31 -46.5 80.07 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.886 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.578 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.1 p -62.65 -46.87 95.31 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.872 -0.418 . . . . 1.0 109.872 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.578 ' N ' HG13 ' D' ' 27' ' ' VAL . 10.7 tm-20 -68.17 -42.75 79.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.876 -0.602 . . . . 1.0 110.0 179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' D' ' 25' ' ' LYS . . . -86.47 71.46 10.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 1.0 109.815 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 3.1 mm-40 -157.36 -58.39 0.08 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.857 0.361 . . . . 1.0 110.337 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -79.93 124.08 28.35 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.152 0.501 . . . . 1.0 110.56 -179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.81 6.63 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 115.368 -0.833 . . . . 1.0 111.792 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' D' ' 65' ' ' GLU . . . -104.76 151.76 39.39 Favored Pre-proline 0 N--CA 1.467 0.405 0 O-C-N 122.717 -0.284 . . . . 1.0 110.613 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.471 ' O ' HG11 ' D' ' 63' ' ' VAL . 72.9 Cg_endo -75.12 117.75 4.99 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.592 1.528 . . . . 1.0 112.143 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 95.18 29.87 8.67 Favored Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.426 -0.669 . . . . 1.0 111.426 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -70.04 140.83 52.9 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.799 0.333 . . . . 1.0 110.606 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -115.73 -69.94 0.83 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.473 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 32.3 tp -61.89 129.41 40.83 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 109.902 -0.406 . . . . 1.0 109.902 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . . . . . . . . . 34.5 pt -150.41 30.34 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.542 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' D' ' 44' ' ' ALA . 1.6 p -134.25 137.61 44.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.002 -0.544 . . . . 1.0 110.517 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.569 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 22.5 t80 -76.17 -48.17 3.42 Favored Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 115.755 -0.657 . . . . 1.0 110.868 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.9 Cg_endo -58.9 -30.25 92.53 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.353 1.369 . . . . 1.0 112.096 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.77 -17.43 23.14 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.47 -0.332 . . . . 1.0 111.191 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -62.84 -38.6 91.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.815 0.34 . . . . 1.0 110.885 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.474 HG23 ' N ' ' D' ' 46' ' ' TRP . 10.2 tt -65.02 -40.58 89.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.944 -0.391 . . . . 1.0 109.944 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.502 ' CD1' HG23 ' A' ' 64' ' ' THR . 3.7 t-105 -60.42 -46.96 88.15 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.143 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -60.92 -33.63 73.43 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 178.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 4.7 t -66.23 -32.76 74.37 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.248 -0.433 . . . . 1.0 111.147 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 78.4 t -59.72 -48.22 88.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.57 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.531 ' OE1' ' NH1' ' A' ' 68' ' ' ARG . 16.1 pt-20 -69.57 -31.11 69.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.493 -0.483 . . . . 1.0 110.078 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 97.3 m -61.14 -46.55 90.11 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.44 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.676 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -59.27 -34.96 72.89 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.458 -0.497 . . . . 1.0 110.153 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.419 ' C ' ' H ' ' D' ' 55' ' ' VAL . 63.0 p -75.58 0.94 15.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 1.0 110.379 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 36.1 p 53.12 9.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 1.0 110.964 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.437 HG13 ' N ' ' D' ' 56' ' ' GLY . 10.0 p -64.65 -40.55 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 1.0 110.604 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.437 ' N ' HG13 ' D' ' 55' ' ' VAL . . . 43.72 55.54 5.38 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -61.28 -47.14 87.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.776 0.322 . . . . 1.0 110.326 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' D' ' 60' ' ' ARG . . . 160.39 -103.32 0.22 Allowed Glycine 0 CA--C 1.52 0.368 0 N-CA-C 110.28 -1.128 . . . . 1.0 110.28 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 39.6 t0 54.18 -75.96 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.713 0.292 . . . . 1.0 110.662 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' D' ' 58' ' ' GLY . 69.5 mtt-85 -141.41 179.74 6.62 Favored 'General case' 0 N--CA 1.462 0.13 0 N-CA-C 109.848 -0.427 . . . . 1.0 109.848 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -174.03 144.32 0.99 Allowed Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 120.984 -0.286 . . . . 1.0 110.293 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.59 164.07 36.67 Favored 'Trans proline' 0 N--CA 1.498 1.744 0 C-N-CA 122.429 2.086 . . . . 1.0 112.075 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.471 HG11 ' O ' ' D' ' 34' ' ' PRO . 3.0 t -94.45 -128.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.275 -0.421 . . . . 1.0 110.258 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.453 ' H ' HG12 ' D' ' 63' ' ' VAL . 55.4 m -113.96 -55.19 2.53 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.516 -0.311 . . . . 1.0 110.745 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.561 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.2 tt0 -61.68 -18.02 57.89 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.151 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' D' ' 30' ' ' GLU . 37.4 mm-40 -78.83 35.6 0.25 Allowed 'General case' 0 C--O 1.269 2.108 0 CA-C-O 124.025 1.869 . . . . 1.0 108.791 178.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 36.74 58.68 1.14 Allowed Glycine 0 C--O 1.213 -1.164 0 CA-C-N 113.014 -1.903 . . . . 1.0 109.477 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.545 HH21 ' CD ' ' C' ' 50' ' ' GLU . 48.6 ttt85 -26.47 -29.57 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.951 0 O-C-N 124.365 0.685 . . . . 1.0 111.245 -177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' D' ' 67' ' ' GLY . 98.6 mttt -56.18 -12.21 1.45 Allowed 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 115.432 -0.804 . . . . 1.0 109.069 176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.648 ' N ' ' O ' ' D' ' 67' ' ' GLY . 42.6 t -62.09 -46.36 96.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 C-N-CA 119.414 -0.915 . . . . 1.0 109.745 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.1 -37.26 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.183 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -57.02 -42.55 80.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.97 -0.559 . . . . 1.0 111.081 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -64.42 -42.94 95.78 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.758 -179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.24 -47.69 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 C-N-CA 120.769 -0.373 . . . . 1.0 111.204 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -63.23 -41.19 99.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 1.0 111.101 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . 0.439 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 79.1 tttt -61.65 -40.69 95.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 110.594 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.74 94.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.837 0.351 . . . . 1.0 110.476 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.94 -40.92 93.56 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.508 -0.637 . . . . 1.0 111.508 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.68 -43.79 98.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.667 0.27 . . . . 1.0 111.159 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.518 ' N ' ' OE1' ' D' ' 80' ' ' GLU . 2.6 mp0 -65.52 -43.05 91.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.575 -0.284 . . . . 1.0 110.75 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.58 -47.23 93.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 C-N-CA 120.89 -0.324 . . . . 1.0 111.116 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -75.29 -8.35 56.41 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.806 -0.358 . . . . 1.0 110.836 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.19 -30.33 11.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 120.747 0.308 . . . . 1.0 110.175 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.523 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.0 tt -64.31 -37.32 87.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.404 -0.362 . . . . 1.0 110.14 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -48.45 -9.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.523 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.4 m -49.38 -41.74 40.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.169 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.478 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -50.52 -19.3 0.85 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.529 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -104.68 -11.78 16.71 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.811 0.339 . . . . 1.0 110.497 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 52.4 mt -96.0 -45.53 6.88 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.224 -0.444 . . . . 1.0 110.478 179.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.434 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.0 -16.27 12.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.111 0.482 . . . . 1.0 110.512 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.809 ' O ' HG22 ' D' ' 94' ' ' VAL . 0.3 OUTLIER -96.06 0.33 51.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.014 -0.539 . . . . 1.0 109.786 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.453 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 86.7 m-20 -72.2 -27.77 62.77 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.808 -0.357 . . . . 1.0 111.555 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 5.5 p90 -79.88 -43.74 21.69 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 111.992 0.367 . . . . 1.0 111.992 -178.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.809 HG22 ' O ' ' D' ' 91' ' ' THR . 21.0 m -41.11 -33.39 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 CA-C-N 116.004 -0.543 . . . . 1.0 111.553 -178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.662 HH11 ' CG2' ' D' ' 94' ' ' VAL . 11.3 mpt_? -50.9 -22.53 2.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.109 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . 0.462 ' CZ ' ' OE2' ' D' ' 97' ' ' GLU . 53.5 ptt85 -54.71 -21.69 11.63 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.085 -0.339 . . . . 1.0 110.085 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.462 ' OE2' ' CZ ' ' D' ' 96' ' ' ARG . 6.1 mp0 -73.42 -58.09 3.55 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.866 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -69.0 -36.65 78.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.962 0.411 . . . . 1.0 110.484 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.44 -19.8 65.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.848 -0.614 . . . . 1.0 110.452 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 62.0 ttp180 -60.25 -44.58 95.14 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.265 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -94.96 -5.68 44.15 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.493 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.27 4.42 89.87 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.18 -0.768 . . . . 1.0 111.18 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 60.7 m170 . . . . . 0 C--O 1.221 -0.436 0 CA-C-O 118.021 -0.99 . . . . 1.0 110.435 179.931 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.421 ' O ' ' O ' ' A' ' 2' ' ' ALA . 8.1 t . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.377 -0.601 . . . . 1.0 109.377 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.421 ' O ' ' O ' ' A' ' 1' ' ' SER . . . 45.17 -171.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.586 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' ASP . 67.3 t0 -131.78 45.75 2.74 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.496 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.609 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 10.5 p80 -154.87 -42.0 0.09 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.883 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.609 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 15.1 pt-20 -65.71 -38.94 90.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 110.606 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -64.86 -37.79 88.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.277 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -65.77 -38.87 90.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 1.0 109.949 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.72 88.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.176 179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.3 tm0? -64.28 -41.48 96.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.338 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -64.07 -36.7 84.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.389 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -35.57 78.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.002 -0.545 . . . . 1.0 110.978 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.47 -40.44 91.28 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.579 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.14 -35.07 79.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.298 -0.41 . . . . 1.0 110.274 179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -65.37 -34.55 78.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.561 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.576 HD11 ' HB1' ' A' ' 52' ' ' ALA . 43.8 tp -62.41 -39.82 94.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.378 -0.374 . . . . 1.0 110.303 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -69.07 -34.78 75.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.357 -0.383 . . . . 1.0 111.233 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -63.94 -46.28 85.43 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.806 0.298 . . . . 1.0 111.806 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.5 m -63.29 -36.41 75.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 1.0 110.696 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.775 HD21 ' HB2' ' A' ' 52' ' ' ALA . 79.9 mt -61.13 -41.64 97.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.313 -0.403 . . . . 1.0 109.973 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.437 ' O ' ' OG ' ' A' ' 23' ' ' SER . 97.2 mt-10 -63.78 -42.67 97.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.755 -0.461 . . . . 1.0 109.755 179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -69.01 -39.43 79.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.047 179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.31 -39.76 81.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.109 -0.496 . . . . 1.0 110.932 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 27' ' ' VAL . 78.9 p -51.42 -41.81 61.04 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.853 -0.425 . . . . 1.0 109.853 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.7 tttp -62.67 -47.43 83.69 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.057 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.33 -42.41 91.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.695 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.27 -41.12 92.65 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.847 -0.341 . . . . 1.0 110.802 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.472 HG11 ' CE2' ' A' ' 41' ' ' TYR . 99.1 t -64.35 -47.02 91.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 120.456 -0.497 . . . . 1.0 110.155 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -66.91 -41.49 87.02 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.172 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -73.49 62.16 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 1.0 109.744 179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.0 tm-20 -173.91 -44.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 1.0 110.552 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -62.13 83.58 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 1.0 110.982 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.38 3.86 5.55 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 111.478 -0.649 . . . . 1.0 111.478 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.92 133.48 22.25 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 110.034 -0.358 . . . . 1.0 110.034 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.69 131.55 13.62 Favored 'Trans proline' 0 N--CA 1.494 1.53 0 C-N-CA 121.908 1.739 . . . . 1.0 112.778 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 59.14 35.91 86.28 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.209 -0.756 . . . . 1.0 111.209 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -106.45 129.18 54.46 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.887 0.375 . . . . 1.0 110.953 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -94.37 -166.12 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.003 -0.544 . . . . 1.0 110.215 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.586 HD11 ' CD2' ' A' ' 47' ' ' TRP . 4.1 tt 59.35 88.06 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.156 -0.475 . . . . 1.0 109.969 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 40' ' ' SER . 5.3 tt -136.19 160.1 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.1 -0.5 . . . . 1.0 109.93 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' ILE . 1.5 p 79.31 137.37 0.06 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.945 0.402 . . . . 1.0 110.731 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.548 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 0.4 OUTLIER -64.92 -46.79 75.06 Favored Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 115.808 -0.633 . . . . 1.0 112.235 179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 29.9 Cg_endo -60.32 -31.6 93.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 121.46 1.44 . . . . 1.0 112.664 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -94.2 -31.07 14.28 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.672 0.272 . . . . 1.0 110.704 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.54 -38.92 84.88 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.329 . . . . 1.0 110.683 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.483 HG23 ' N ' ' A' ' 46' ' ' TRP . 3.5 tt -63.83 -39.77 86.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 1.0 109.984 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.5 ' CE2' ' O ' ' B' ' 64' ' ' THR . 4.8 t-105 -59.31 -46.13 89.42 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.586 ' CD2' HD11 ' A' ' 38' ' ' LEU . 2.4 t90 -59.93 -39.48 85.67 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.364 -0.606 . . . . 1.0 109.364 178.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HD22 ' A' ' 19' ' ' LEU . 1.5 t -67.71 65.39 0.08 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.676 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 47' ' ' TRP . 75.9 t -154.39 -57.69 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.928 0.394 . . . . 1.0 110.23 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' CG ' HH12 ' B' ' 68' ' ' ARG . 12.3 pt-20 -66.42 -31.69 72.6 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.958 -0.564 . . . . 1.0 110.479 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.537 HG23 HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -61.83 -42.93 99.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.108 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -61.01 -36.79 80.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.214 -0.448 . . . . 1.0 110.088 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.7 p -80.7 16.76 1.3 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.515 -0.55 . . . . 1.0 109.515 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 52' ' ' ALA . 0.3 OUTLIER 32.14 69.25 0.12 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.429 -0.805 . . . . 1.0 111.597 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.42 -38.28 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.64 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.12 73.3 0.36 Allowed Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.661 -0.975 . . . . 1.0 110.661 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.513 ' OH ' ' CD1' ' B' ' 47' ' ' TRP . 15.4 t80 -60.12 -47.18 86.99 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 1.0 110.507 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.6 25.76 0.44 Allowed Glycine 0 CA--C 1.526 0.759 0 N-CA-C 111.032 -0.827 . . . . 1.0 111.032 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 60' ' ' ARG . 32.6 p-10 -63.49 -41.17 98.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.767 0.317 . . . . 1.0 110.421 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.514 ' N ' ' OD1' ' A' ' 59' ' ' ASP . 94.2 mtt-85 -151.36 -161.09 1.26 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.335 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.586 ' CG ' ' O ' ' A' ' 61' ' ' TYR . 8.8 p90 -169.88 100.6 0.46 Allowed Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 120.775 -0.37 . . . . 1.0 110.525 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.05 165.86 29.88 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 C-N-CA 121.403 1.402 . . . . 1.0 112.399 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.994 HG22 ' H ' ' A' ' 64' ' ' THR . 7.8 p -100.25 -159.76 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 N-CA-C 110.05 -0.352 . . . . 1.0 110.05 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.994 ' H ' HG22 ' A' ' 63' ' ' VAL . 51.0 m -91.98 -43.9 9.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.586 0.231 . . . . 1.0 110.91 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.596 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.9 tp10 -50.18 -34.91 24.19 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 109.677 -0.49 . . . . 1.0 109.677 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' OE2' ' N ' ' A' ' 68' ' ' ARG . 0.1 OUTLIER -73.75 25.1 0.07 Allowed 'General case' 0 C--O 1.265 1.899 0 CA-C-O 124.116 1.913 . . . . 1.0 109.503 178.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.717 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 46.33 67.46 1.36 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 113.622 -1.627 . . . . 1.0 111.723 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.535 ' N ' ' OE2' ' A' ' 66' ' ' GLU . 59.5 ttm-85 -24.15 -32.29 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.404 1.102 . . . . 1.0 111.158 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.717 ' N ' ' O ' ' A' ' 67' ' ' GLY . 32.3 mmtp -48.52 -31.09 5.95 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.817 -0.629 . . . . 1.0 109.55 176.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.496 ' N ' ' O ' ' A' ' 67' ' ' GLY . 53.9 t -62.83 -49.54 83.27 Favored 'Isoleucine or valine' 0 C--N 1.35 0.622 0 C-N-CA 119.395 -0.922 . . . . 1.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.76 -42.28 74.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.638 179.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.9 tm-20 -64.85 -35.61 81.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 1.0 110.657 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -54.96 -42.85 72.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.335 -0.393 . . . . 1.0 110.683 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.537 HG11 HG23 ' A' ' 51' ' ' THR . 73.5 t -65.12 -42.19 93.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 C-N-CA 120.414 -0.514 . . . . 1.0 111.374 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 16.3 mmt -52.32 -56.76 12.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.466 -0.334 . . . . 1.0 111.378 -178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -63.28 -36.87 85.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.833 0.349 . . . . 1.0 110.469 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.53 -22.06 4.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.472 . . . . 1.0 110.497 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -97.63 -28.45 8.4 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.944 -0.862 . . . . 1.0 110.944 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' ALA . 36.8 mm -63.01 -43.84 99.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 121.144 -0.222 . . . . 1.0 110.484 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.07 -36.58 84.78 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.52 -0.472 . . . . 1.0 110.275 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.1 t -67.07 -72.75 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 1.0 111.145 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -51.99 -11.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.0 111.162 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 79' ' ' ILE . . . -88.54 -43.8 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.788 0.328 . . . . 1.0 110.891 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 86' ' ' THR . 6.3 tt -63.03 -41.73 99.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 1.0 111.604 -179.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 m -51.8 -8.41 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.447 -179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.496 ' H ' ' C ' ' A' ' 84' ' ' LEU . 97.6 m -61.99 -25.8 67.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.275 -0.421 . . . . 1.0 109.984 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' HB2' ' CG ' ' D' ' 92' ' ' ASP . . . -57.38 -24.76 57.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.308 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -97.43 -11.32 24.03 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.273 -0.421 . . . . 1.0 110.859 -179.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 60.1 mt -90.78 -45.24 8.94 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.794 0.331 . . . . 1.0 111.416 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.467 ' O ' ' CE2' ' A' ' 93' ' ' PHE . . . -56.06 -27.01 51.67 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.932 0.396 . . . . 1.0 110.987 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.28 -4.63 58.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.55 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 87.8 m-20 -62.13 -45.02 95.33 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 120.801 -0.359 . . . . 1.0 110.927 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.467 ' CE2' ' O ' ' A' ' 90' ' ' ALA . 7.3 p90 -76.58 -27.97 56.03 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.417 -0.356 . . . . 1.0 111.508 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.1 t -59.85 -40.27 82.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.232 -0.44 . . . . 1.0 111.296 -178.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -56.82 -23.51 44.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.557 -0.292 . . . . 1.0 111.144 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -41.88 -40.39 2.11 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.797 0.332 . . . . 1.0 110.853 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -62.97 -45.68 91.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.258 -0.428 . . . . 1.0 109.918 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.46 -41.45 80.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.653 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -67.6 -41.6 83.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.579 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -61.65 -44.24 97.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.598 -179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -65.97 -37.34 85.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.532 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 21.88 42.58 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.069 -0.812 . . . . 1.0 111.069 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 80.4 m80 . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 118.013 -0.994 . . . . 1.0 110.56 179.88 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.442 -0.577 . . . . 1.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.45 ' HB1' ' CE1' ' B' ' 4' ' ' HIS . . . -80.97 174.05 12.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.18 -0.463 . . . . 1.0 110.785 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -61.58 -41.91 98.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 1.0 110.94 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.45 ' CE1' ' HB1' ' B' ' 2' ' ' ALA . 13.4 p-80 -78.83 -31.39 45.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.636 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -66.08 -41.62 90.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.219 -0.446 . . . . 1.0 111.047 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 79.7 mtp85 -64.34 -40.16 95.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.762 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -65.28 -44.08 89.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.954 0.407 . . . . 1.0 109.921 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.61 -36.42 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.719 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -59.76 -40.16 87.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 1.0 110.332 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -62.02 -39.6 92.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 1.0 110.517 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' B' ' 81' ' ' VAL . . . -57.66 -34.19 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.638 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.525 ' O ' ' NE2' ' B' ' 16' ' ' GLN . 96.6 mt-10 -78.15 -37.81 45.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.805 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -64.59 -45.91 84.95 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.913 0.387 . . . . 1.0 110.791 -179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -64.94 -28.42 69.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 1.0 110.306 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 52.2 tp -61.36 -39.99 92.66 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.308 -0.405 . . . . 1.0 110.036 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' B' ' 12' ' ' GLU . 8.4 mp0 -69.93 -28.05 65.27 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.42 -0.512 . . . . 1.0 110.896 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -62.96 -46.22 88.76 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.57 -0.286 . . . . 1.0 111.46 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.43 ' H ' HG22 ' B' ' 18' ' ' VAL . 14.8 m -66.3 -31.98 56.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.394 -0.366 . . . . 1.0 111.118 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.609 HD21 ' HB2' ' B' ' 52' ' ' ALA . 84.9 mt -60.43 -41.15 93.42 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.866 -0.42 . . . . 1.0 109.866 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -60.62 -48.14 83.09 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.784 -0.45 . . . . 1.0 109.784 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.11 -34.47 75.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 1.0 110.151 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.37 -46.2 86.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 1.0 110.251 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.555 ' O ' HG23 ' B' ' 27' ' ' VAL . 66.7 p -59.81 -46.62 88.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 1.0 110.928 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -61.49 -53.53 55.17 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.374 -0.53 . . . . 1.0 110.412 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' B' ' 29' ' ' ALA . 68.3 mttm -59.13 -43.9 92.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 1.0 111.008 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.419 ' O ' ' OE1' ' B' ' 30' ' ' GLU . . . -59.77 -38.19 81.15 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.961 -0.296 . . . . 1.0 110.958 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 23' ' ' SER . 69.1 t -66.68 -44.43 89.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 C-N-CA 120.643 -0.423 . . . . 1.0 110.712 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -83.5 -9.95 58.64 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.622 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' B' ' 25' ' ' LYS . . . -61.77 -39.0 90.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.524 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.501 ' O ' ' N ' ' B' ' 32' ' ' GLY . 9.6 mp0 -68.93 -37.53 78.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 1.0 110.516 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -55.54 83.71 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.04 -0.527 . . . . 1.0 111.078 -179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' B' ' 30' ' ' GLU . . . 127.51 -14.1 6.49 Favored Glycine 0 N--CA 1.466 0.698 0 N-CA-C 111.397 -0.681 . . . . 1.0 111.397 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.81 143.8 27.6 Favored Pre-proline 0 CA--C 1.535 0.396 0 O-C-N 122.795 -0.238 . . . . 1.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.78 157.11 39.64 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.054 1.836 . . . . 1.0 112.428 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.98 37.19 64.55 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.317 -0.713 . . . . 1.0 111.317 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.47 142.76 21.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.848 0.356 . . . . 1.0 110.566 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -161.49 -44.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 1.0 110.582 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.566 ' O ' HD13 ' B' ' 38' ' ' LEU . 0.2 OUTLIER -63.37 -30.14 71.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.965 -0.562 . . . . 1.0 109.646 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.615 HG23 ' O ' ' B' ' 39' ' ' ILE . 18.7 tt -38.5 108.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-O 121.094 0.473 . . . . 1.0 110.757 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.3 p 163.22 102.95 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.849 -0.614 . . . . 1.0 110.97 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.585 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 1.1 t80 -56.43 -47.39 99.01 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 115.722 -0.672 . . . . 1.0 111.848 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 23.6 Cg_endo -57.49 -36.86 98.65 Favored 'Trans proline' 0 N--CA 1.498 1.743 0 C-N-CA 121.384 1.389 . . . . 1.0 113.263 -178.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.512 ' OD2' ' CZ ' ' B' ' 60' ' ' ARG . 46.7 p30 -100.38 -0.76 37.6 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.696 0.284 . . . . 1.0 110.984 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.34 -44.94 89.92 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.947 0.403 . . . . 1.0 110.525 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.47 ' O ' HG23 ' B' ' 49' ' ' VAL . 7.3 tt -68.82 -40.99 82.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.904 -0.589 . . . . 1.0 110.694 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.438 ' NE1' HG23 ' C' ' 64' ' ' THR . 0.1 OUTLIER -61.54 -45.5 93.89 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.408 -179.839 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.513 ' CD1' ' OH ' ' A' ' 57' ' ' TYR . 9.9 t90 -63.59 -42.68 98.25 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.753 -0.379 . . . . 1.0 110.421 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.45 ' O ' HD22 ' B' ' 19' ' ' LEU . 31.3 p -65.6 -25.96 67.63 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.852 -0.339 . . . . 1.0 111.041 -179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.47 HG23 ' O ' ' B' ' 45' ' ' ILE . 20.4 t -71.77 -25.32 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 111.745 0.276 . . . . 1.0 111.745 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -98.37 -9.47 25.24 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 120.996 -0.282 . . . . 1.0 111.178 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.56 -36.18 20.6 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.782 0.325 . . . . 1.0 111.209 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.609 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -69.1 -22.84 63.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 1.0 111.475 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.401 ' O ' HG23 ' B' ' 55' ' ' VAL . 67.3 p -83.87 0.2 48.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.661 0.267 . . . . 1.0 110.712 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 26.1 p 51.12 60.3 3.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.516 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 53' ' ' THR . 48.1 t -133.11 -48.13 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.272 -0.422 . . . . 1.0 110.519 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . . . . . . . . . . . 53.35 76.44 0.18 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.602 -0.999 . . . . 1.0 110.602 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 13.2 t80 -60.04 -47.78 84.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.797 0.332 . . . . 1.0 110.808 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.74 24.93 0.58 Allowed Glycine 0 CA--C 1.527 0.844 0 N-CA-C 111.031 -0.827 . . . . 1.0 111.031 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.517 ' OD2' ' NH2' ' C' ' 68' ' ' ARG . 67.9 t0 -62.29 -49.14 76.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.84 0.352 . . . . 1.0 110.768 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.512 ' CZ ' ' OD2' ' B' ' 43' ' ' ASP . 91.7 mtt-85 -143.83 -164.44 1.88 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.179 -0.464 . . . . 1.0 110.139 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -150.99 118.96 3.42 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.108 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -69.25 153.35 71.42 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.366 1.378 . . . . 1.0 112.094 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 4.8 m -62.59 -169.03 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.914 -0.584 . . . . 1.0 110.213 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.5 ' O ' ' CE2' ' A' ' 46' ' ' TRP . 1.2 m -108.61 -62.56 1.45 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.37 -0.377 . . . . 1.0 110.993 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.444 ' N ' HG22 ' B' ' 64' ' ' THR . 79.9 tt0 -40.16 -28.51 0.06 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.036 0.446 . . . . 1.0 110.769 -178.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.905 ' O ' ' N ' ' B' ' 68' ' ' ARG . 94.1 mt-10 -143.87 -101.32 0.12 Allowed 'General case' 0 C--O 1.22 -0.466 0 CA-C-N 115.763 -0.653 . . . . 1.0 109.256 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.02 -55.55 0.0 OUTLIER Glycine 0 N--CA 1.479 1.519 0 O-C-N 124.613 1.195 . . . . 1.0 114.223 177.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.905 ' N ' ' O ' ' B' ' 66' ' ' GLU . 60.4 ttm-85 -66.18 -72.48 0.16 Allowed 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 108.998 -0.741 . . . . 1.0 108.998 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -42.18 -36.36 1.17 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 109.097 -0.705 . . . . 1.0 109.097 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . . . . . . . . . 72.4 t -67.66 -46.03 83.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.775 -0.648 . . . . 1.0 109.809 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.516 ' N ' ' O ' ' B' ' 68' ' ' ARG . . . -70.93 -45.17 64.7 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.217 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -45.37 -48.63 13.39 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.877 -0.602 . . . . 1.0 110.064 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -61.75 -44.74 96.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.687 -0.405 . . . . 1.0 110.729 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 66.5 t -66.21 -46.44 87.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 120.865 -0.334 . . . . 1.0 111.198 -179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.44 -40.11 96.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.523 -0.308 . . . . 1.0 110.283 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -61.77 -38.65 88.8 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.873 -0.331 . . . . 1.0 110.31 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.27 -37.97 85.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.325 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.42 -37.05 92.41 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.555 -0.618 . . . . 1.0 111.555 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.1 mt -62.96 -43.85 99.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.93 -0.308 . . . . 1.0 110.838 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' B' ' 84' ' ' LEU . 97.8 mt-10 -63.18 -38.8 92.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 1.0 110.456 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' B' ' 11' ' ' ALA . 25.1 t -62.25 -70.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.769 -0.651 . . . . 1.0 110.737 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -54.86 -14.76 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.834 -0.621 . . . . 1.0 111.123 -178.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.41 -35.1 11.29 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.484 -0.326 . . . . 1.0 110.319 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.405 ' N ' ' O ' ' B' ' 80' ' ' GLU . 5.2 tt -63.53 -40.96 98.38 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.294 -0.412 . . . . 1.0 110.345 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.432 ' C ' ' N ' ' B' ' 87' ' ' ALA . 35.6 m -55.07 -16.83 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.737 179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . . . . . . . . . 33.4 m -44.45 -24.06 0.16 Allowed 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.159 0.504 . . . . 1.0 109.68 179.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.33 -45.23 94.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.413 -0.812 . . . . 1.0 110.522 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -71.83 -12.7 61.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.673 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.468 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.6 mm? -92.49 -25.78 18.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.006 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.539 ' O ' ' CE1' ' B' ' 93' ' ' PHE . . . -67.82 -40.49 83.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.397 0.617 . . . . 1.0 109.894 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.75 -16.32 62.81 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.36 -0.836 . . . . 1.0 110.126 -179.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -43.68 -65.42 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 1.0 111.138 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.544 ' CG ' ' N ' ' B' ' 94' ' ' VAL . 30.6 p90 -64.16 -47.14 81.03 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.368 -0.378 . . . . 1.0 111.278 -179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.544 ' N ' ' CG ' ' B' ' 93' ' ' PHE . 66.0 t -37.66 -28.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.304 -0.407 . . . . 1.0 111.713 -179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . 0.475 ' C ' ' N ' ' B' ' 97' ' ' GLU . 99.8 mtt180 -63.64 -37.57 87.85 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.902 -0.319 . . . . 1.0 111.4 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.414 ' N ' ' O ' ' B' ' 93' ' ' PHE . 44.1 ptt85 -46.75 -15.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 1.0 110.303 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . 0.529 ' OE2' ' NH2' ' B' ' 100' ' ' ARG . 43.6 tp10 -63.31 -41.82 98.97 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.937 -0.574 . . . . 1.0 110.883 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.3 -40.58 86.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.817 0.341 . . . . 1.0 110.775 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' B' ' 99' ' ' GLU . 59.0 mp0 -69.44 -36.46 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 1.0 110.899 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.529 ' NH2' ' OE2' ' B' ' 97' ' ' GLU . 55.0 ttp180 -60.62 -45.22 94.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.914 0.388 . . . . 1.0 110.295 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -79.76 -14.83 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.111 -0.495 . . . . 1.0 110.529 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . 0.524 ' O ' ' CG ' ' B' ' 103' ' ' HIS . . . 77.43 21.48 72.58 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.097 -0.801 . . . . 1.0 111.097 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . 0.524 ' CG ' ' O ' ' B' ' 102' ' ' GLY . 33.7 p80 . . . . . 0 C--O 1.219 -0.508 0 CA-C-O 117.998 -1.001 . . . . 1.0 110.877 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.35 -0.611 . . . . 1.0 109.35 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.485 ' HB1' ' CE1' ' C' ' 4' ' ' HIS . . . -157.62 170.52 22.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 1.0 110.701 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -56.45 -50.7 70.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.396 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.485 ' CE1' ' HB1' ' C' ' 2' ' ' ALA . 6.8 p-80 -68.87 -38.17 79.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.839 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.412 ' HB2' ' H ' ' C' ' 2' ' ' ALA . 96.4 mt-10 -64.26 -44.5 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.331 . . . . 1.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 79.2 mtp85 -65.06 -39.07 92.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.864 0.364 . . . . 1.0 110.201 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 43.7 tp10 -64.19 -41.01 97.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.025 -0.534 . . . . 1.0 110.114 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.15 95.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.428 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -65.39 -42.03 93.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.273 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 12.1 ttmm -63.61 -38.68 92.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.521 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.49 71.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.981 -0.554 . . . . 1.0 111.086 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.66 -39.59 94.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.32 . . . . 1.0 111.009 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -63.41 -33.5 75.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.372 -0.377 . . . . 1.0 110.292 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -65.49 -34.37 78.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.677 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 45.5 tp -62.1 -42.3 99.08 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.765 -0.374 . . . . 1.0 110.6 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -62.77 -39.64 94.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.244 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . 0.501 ' HZ3' ' HB3' ' C' ' 17' ' ' LYS . 0.0 OUTLIER -61.52 -38.79 88.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.305 . . . . 1.0 111.304 -179.672 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 95.3 t -62.69 -42.67 97.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.683 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' C' ' 52' ' ' ALA . 96.0 mt -60.9 -40.15 92.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.31 -0.404 . . . . 1.0 110.358 -179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -55.2 -54.92 37.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.825 0.345 . . . . 1.0 110.496 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -67.41 -37.5 83.18 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.414 -0.357 . . . . 1.0 110.438 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.39 -38.43 89.6 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.883 -0.327 . . . . 1.0 110.767 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 95.1 p -59.2 -42.31 90.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.386 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -65.83 -33.55 76.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.189 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' C' ' 29' ' ' ALA . 53.7 mttp -70.42 -46.61 63.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.511 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' C' ' 29' ' ' ALA . . . -55.59 -50.31 70.43 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.246 0.341 . . . . 1.0 111.446 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.494 HG13 ' N ' ' C' ' 28' ' ' GLU . 5.0 p -60.98 -46.77 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 C-N-CA 120.457 -0.497 . . . . 1.0 109.926 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.494 ' N ' HG13 ' C' ' 27' ' ' VAL . 40.7 tp10 -69.32 -28.59 66.38 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.468 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -51.64 -49.84 61.49 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.187 -0.46 . . . . 1.0 110.762 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.433 ' CG ' ' H ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -96.78 -99.51 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.857 0.361 . . . . 1.0 110.545 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.433 ' H ' ' CG ' ' C' ' 30' ' ' GLU . 30.1 mmm-85 46.71 59.46 3.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.554 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.7 4.81 7.93 Favored Glycine 0 N--CA 1.469 0.893 0 N-CA-C 111.33 -0.708 . . . . 1.0 111.33 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.91 155.69 61.14 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 110.075 -0.343 . . . . 1.0 110.075 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -76.42 120.0 5.45 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 C-N-CA 121.884 1.723 . . . . 1.0 111.773 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.82 13.61 62.33 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.075 -0.81 . . . . 1.0 111.075 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.85 146.09 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.726 0.298 . . . . 1.0 110.267 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -129.8 -30.16 2.07 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.351 -0.386 . . . . 1.0 110.485 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.19 51.47 2.2 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.254 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . . . . . . . . . 38.6 pt -80.0 16.9 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 1.0 110.751 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 7.3 t -114.0 126.28 54.95 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 1.0 110.63 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.529 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 8.1 t80 -78.12 -49.95 1.85 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 115.811 -0.631 . . . . 1.0 110.923 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 27.6 Cg_endo -60.12 -29.23 88.68 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.388 1.392 . . . . 1.0 112.402 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -89.12 -3.82 58.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.577 -0.283 . . . . 1.0 111.058 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.14 -40.44 96.16 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 120.84 -0.344 . . . . 1.0 110.732 -179.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 7.9 tt -65.55 -40.84 89.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.494 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.433 ' CD1' HG23 ' D' ' 64' ' ' THR . 0.1 OUTLIER -63.07 -45.83 90.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.156 -0.475 . . . . 1.0 110.497 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 25.7 t90 -61.03 -41.35 96.4 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.242 -0.583 . . . . 1.0 109.482 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.422 ' O ' HD22 ' C' ' 19' ' ' LEU . 39.1 p -72.37 64.86 0.6 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.524 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 89.1 t -149.09 -51.0 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 120.911 -0.316 . . . . 1.0 111.503 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -66.65 -32.72 74.22 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.692 -0.403 . . . . 1.0 110.936 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.4 ' H ' HG22 ' C' ' 51' ' ' THR . 0.0 OUTLIER -59.17 -44.05 92.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.43 -0.35 . . . . 1.0 110.969 -179.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.448 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -57.23 -26.46 60.76 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.729 -0.388 . . . . 1.0 110.753 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . . . . . . . . . 62.8 p -87.31 -3.59 59.04 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.847 0.356 . . . . 1.0 110.145 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 43.7 p 51.7 48.75 22.24 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.94 -0.573 . . . . 1.0 111.082 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 34.2 m -110.73 -28.29 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.254 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 49.72 59.77 7.03 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.518 -1.033 . . . . 1.0 110.518 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -61.26 -48.1 82.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.818 0.342 . . . . 1.0 110.705 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.13 38.66 0.63 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.042 -0.823 . . . . 1.0 111.042 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' C' ' 59' ' ' ASP . 12.8 p-10 -65.27 -40.54 94.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.92 0.39 . . . . 1.0 110.601 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.464 ' O ' ' CG ' ' C' ' 61' ' ' TYR . 30.2 mmt180 -130.4 -161.01 1.08 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.118 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.464 ' CG ' ' O ' ' C' ' 60' ' ' ARG . 56.5 m-85 -158.59 75.54 3.53 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.496 -0.32 . . . . 1.0 110.626 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -69.16 156.0 66.22 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.058 1.839 . . . . 1.0 111.997 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 1.061 HG22 ' H ' ' C' ' 64' ' ' THR . 8.6 p -100.97 -155.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.009 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 1.061 ' H ' HG22 ' C' ' 63' ' ' VAL . 34.7 m -89.54 -46.25 8.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.712 0.291 . . . . 1.0 110.638 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' C' ' 67' ' ' GLY . 11.7 tm-20 -44.38 -40.18 5.2 Favored 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 109.93 -0.396 . . . . 1.0 109.93 -179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.553 ' OE2' ' N ' ' C' ' 68' ' ' ARG . 0.1 OUTLIER -70.17 24.08 0.03 OUTLIER 'General case' 0 C--O 1.266 1.963 0 CA-C-O 123.855 1.788 . . . . 1.0 109.915 178.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.754 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 44.86 66.12 1.56 Allowed Glycine 0 N--CA 1.438 -1.183 0 CA-C-N 113.984 -1.462 . . . . 1.0 111.615 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.553 ' N ' ' OE2' ' C' ' 66' ' ' GLU . 56.1 ttm-85 -25.4 -28.31 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 118.17 0.985 . . . . 1.0 111.382 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.754 ' N ' ' O ' ' C' ' 67' ' ' GLY . 1.8 tppp? -52.04 -26.92 12.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.634 -0.712 . . . . 1.0 109.305 176.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.543 ' N ' ' O ' ' C' ' 67' ' ' GLY . 69.1 t -61.75 -47.19 94.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.674 0 C-N-CA 119.201 -1.0 . . . . 1.0 110.593 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -39.93 84.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.0 110.634 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -65.92 -38.28 88.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.721 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -56.2 -44.46 79.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.431 -0.35 . . . . 1.0 111.256 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 74.2 t -64.92 -43.76 96.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.779 -0.368 . . . . 1.0 111.229 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.1 mtt -59.54 -43.56 93.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.557 -0.292 . . . . 1.0 110.953 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.12 -41.34 97.27 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.88 -0.328 . . . . 1.0 110.813 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.64 90.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.834 0.35 . . . . 1.0 110.497 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.42 -41.53 96.39 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.761 -0.536 . . . . 1.0 111.761 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.2 mt -61.62 -43.01 96.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.599 0.238 . . . . 1.0 110.761 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -60.56 -43.66 97.0 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.545 -0.298 . . . . 1.0 111.143 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 76.8 t -64.38 -49.23 81.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.628 -0.429 . . . . 1.0 111.136 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -68.53 -38.5 80.9 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.763 -0.375 . . . . 1.0 111.296 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.61 84.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.845 0.355 . . . . 1.0 110.468 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.455 ' C ' ' N ' ' C' ' 86' ' ' THR . 6.4 tt -62.88 -41.89 99.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.031 -0.531 . . . . 1.0 111.507 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.449 ' O ' HG12 ' C' ' 85' ' ' VAL . 98.6 t -49.32 -12.51 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.697 0.284 . . . . 1.0 110.491 -179.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.455 ' N ' ' C ' ' C' ' 84' ' ' LEU . 85.9 m -60.82 -20.7 62.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.361 -0.381 . . . . 1.0 110.268 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.46 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -59.69 -36.31 76.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.057 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.71 -38.3 21.61 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 49.0 mt -66.43 -38.65 87.88 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.133 -0.485 . . . . 1.0 111.083 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -59.23 -35.45 73.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 1.0 111.021 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.46 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.1 OUTLIER -83.0 -4.3 58.16 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.678 -0.49 . . . . 1.0 109.678 -179.495 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.522 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 42.4 t0 -58.07 -47.9 81.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.672 -179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 8.4 p90 -66.87 -39.0 87.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.525 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 95.9 t -43.84 -36.89 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.0 111.511 -178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -61.21 -23.12 65.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.647 0.261 . . . . 1.0 111.179 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 73.7 ttp85 -57.09 -42.6 81.02 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.457 -0.338 . . . . 1.0 110.355 -179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.66 -39.29 93.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.5 -0.318 . . . . 1.0 110.368 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -67.06 -39.61 86.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.851 0.358 . . . . 1.0 110.344 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -66.78 -35.43 80.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.449 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 71.6 ttp85 -60.22 -44.75 94.92 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.243 -0.435 . . . . 1.0 110.678 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -66.67 -37.38 84.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.287 -0.415 . . . . 1.0 110.582 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' C' ' 103' ' ' HIS . . . 83.85 22.58 55.18 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . 0.445 ' CG ' ' O ' ' C' ' 102' ' ' GLY . 81.0 m80 . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.007 -0.997 . . . . 1.0 110.641 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.393 -0.595 . . . . 1.0 109.393 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.439 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . -79.57 174.5 11.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.539 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -61.9 -42.94 99.67 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.9 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.439 ' CE1' ' HB1' ' D' ' 2' ' ' ALA . 9.9 p-80 -73.36 -32.62 64.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.535 -0.302 . . . . 1.0 110.793 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -65.24 -37.42 87.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.83 0.348 . . . . 1.0 110.551 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -60.12 -44.12 95.13 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.346 -179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -64.45 -38.3 90.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.0 110.081 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.95 -42.26 98.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.675 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -66.47 -36.75 83.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.38 -0.373 . . . . 1.0 110.491 179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -62.06 -37.72 86.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 1.0 110.521 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 -36.04 79.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.222 -0.444 . . . . 1.0 111.021 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.24 -36.02 82.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 1.0 110.668 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -64.29 -38.45 91.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.665 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -63.36 -33.23 75.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 1.0 110.627 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.574 HD11 ' HB1' ' D' ' 52' ' ' ALA . 40.9 tp -62.01 -42.01 98.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.778 0.323 . . . . 1.0 110.441 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -63.01 -32.81 74.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.965 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -62.25 -42.99 99.82 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.96 0.41 . . . . 1.0 111.063 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.412 ' O ' ' CB ' ' D' ' 22' ' ' ALA . 96.9 t -63.83 -35.56 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.689 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' D' ' 52' ' ' ALA . 96.9 mt -61.6 -41.81 97.97 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.679 -0.409 . . . . 1.0 109.922 -179.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -66.81 -50.46 62.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.273 -0.422 . . . . 1.0 110.543 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -67.29 -39.8 86.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.379 . . . . 1.0 110.422 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' D' ' 18' ' ' VAL . . . -65.07 -37.51 87.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.085 -0.507 . . . . 1.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 94.5 p -57.38 -45.74 84.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.499 -0.319 . . . . 1.0 110.74 -178.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -67.93 -35.33 78.25 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.635 -0.426 . . . . 1.0 110.578 179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -68.75 -46.31 69.17 Favored 'General case' 0 C--O 1.22 -0.461 0 C-N-CA 120.779 -0.368 . . . . 1.0 110.893 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.421 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -55.66 -51.83 65.92 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 120.891 -0.323 . . . . 1.0 111.204 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.506 HG13 ' N ' ' D' ' 28' ' ' GLU . 7.5 p -62.62 -45.72 98.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 120.57 -0.452 . . . . 1.0 110.264 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.506 ' N ' HG13 ' D' ' 27' ' ' VAL . 82.6 tt0 -64.55 -39.4 93.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.0 110.681 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.33 -37.1 82.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.127 -0.488 . . . . 1.0 110.445 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.421 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 1.1 mp0 -68.31 -41.24 81.14 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.014 -0.274 . . . . 1.0 110.477 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -57.49 107.75 0.47 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.009 0.433 . . . . 1.0 110.37 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 112.61 -13.99 24.96 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 111.47 -0.652 . . . . 1.0 111.47 179.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.16 144.94 29.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 121.047 -0.261 . . . . 1.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.532 ' O ' HG11 ' D' ' 63' ' ' VAL . 92.4 Cg_endo -74.79 143.63 30.05 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.157 1.905 . . . . 1.0 112.328 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 64.18 26.58 70.54 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.122 -0.791 . . . . 1.0 111.122 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.41 144.23 57.15 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.761 0.315 . . . . 1.0 110.649 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -141.51 -16.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.242 -0.435 . . . . 1.0 110.554 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -85.1 30.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.952 0.406 . . . . 1.0 110.08 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' D' ' 40' ' ' SER . 42.2 pt -77.34 -158.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.989 -0.55 . . . . 1.0 110.445 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.467 ' O ' ' CD2' ' D' ' 41' ' ' TYR . 1.1 t 80.53 -137.75 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.313 -0.403 . . . . 1.0 110.606 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.467 ' CD2' ' O ' ' D' ' 40' ' ' SER . 5.7 m-85 -168.44 -59.88 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.626 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.416 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 19.6 Cg_endo -58.55 -32.04 95.72 Favored 'Trans proline' 0 N--CA 1.494 1.554 0 C-N-CA 121.65 1.566 . . . . 1.0 111.95 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' D' ' 44' ' ' ALA . 18.2 p30 -87.75 -22.69 24.42 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 1.0 111.326 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . 0.526 ' N ' ' OD1' ' D' ' 43' ' ' ASP . . . -64.04 -41.51 97.38 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.834 0.349 . . . . 1.0 110.766 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 8.5 tt -67.65 -41.83 85.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 1.0 110.213 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.477 ' CD1' HG23 ' A' ' 64' ' ' THR . 0.1 OUTLIER -60.88 -36.89 80.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.114 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 15.0 t90 -62.53 -39.64 94.22 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.15 -0.62 . . . . 1.0 109.646 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.426 ' O ' HD22 ' D' ' 19' ' ' LEU . 83.3 p -65.93 -29.47 69.89 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.56 -0.456 . . . . 1.0 110.773 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 71.0 t -60.92 -48.61 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 C-N-CA 120.923 -0.311 . . . . 1.0 110.99 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -29.93 69.49 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.791 -0.448 . . . . 1.0 109.791 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' D' ' 52' ' ' ALA . 28.6 m -90.65 89.09 7.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.714 -0.676 . . . . 1.0 109.838 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' D' ' 51' ' ' THR . . . 169.44 -23.8 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.281 -0.418 . . . . 1.0 110.37 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' D' ' 54' ' ' THR . 4.2 p -110.64 29.98 7.24 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.981 0.419 . . . . 1.0 110.482 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' D' ' 53' ' ' THR . 32.8 p 52.51 70.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.808 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -124.12 -66.23 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.422 -0.354 . . . . 1.0 110.717 179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . 52.01 53.13 31.81 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.474 -1.05 . . . . 1.0 110.474 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -59.9 -48.76 80.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.773 0.321 . . . . 1.0 110.518 -179.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.7 29.72 1.03 Allowed Glycine 0 CA--C 1.526 0.77 0 N-CA-C 110.775 -0.93 . . . . 1.0 110.775 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.02 -43.33 99.05 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.34 . . . . 1.0 110.585 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 96.9 mtt-85 -140.93 169.03 18.38 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.232 -0.44 . . . . 1.0 109.917 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -141.09 111.55 6.62 Favored Pre-proline 0 CA--C 1.537 0.473 0 C-N-CA 120.901 -0.32 . . . . 1.0 110.712 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.75 156.2 63.99 Favored 'Trans proline' 0 N--CA 1.497 1.692 0 C-N-CA 121.747 1.632 . . . . 1.0 112.491 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.532 HG11 ' O ' ' D' ' 34' ' ' PRO . 1.8 t -80.06 -142.35 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.106 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.532 ' H ' HG12 ' D' ' 63' ' ' VAL . 26.5 m -113.34 -48.1 2.97 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.383 -0.371 . . . . 1.0 110.751 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.584 ' C ' ' H ' ' D' ' 67' ' ' GLY . 49.9 tp10 -58.62 -20.77 50.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.095 0.474 . . . . 1.0 109.9 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' D' ' 63' ' ' VAL . 0.6 OUTLIER -75.74 27.52 0.11 Allowed 'General case' 0 C--O 1.265 1.873 0 CA-C-O 123.543 1.64 . . . . 1.0 109.13 178.336 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.731 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 42.44 61.62 2.41 Favored Glycine 0 C--O 1.211 -1.287 0 CA-C-N 114.066 -1.425 . . . . 1.0 109.989 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.44 ' C ' ' O ' ' D' ' 67' ' ' GLY . 61.0 ttm-85 -25.18 -29.83 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 CA-C-N 117.486 0.643 . . . . 1.0 111.42 -177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.731 ' N ' ' O ' ' D' ' 67' ' ' GLY . 72.5 mmtt -56.86 -14.27 3.32 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 108.939 -0.763 . . . . 1.0 108.939 177.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.659 ' N ' ' O ' ' D' ' 67' ' ' GLY . 45.2 t -62.31 -47.32 93.64 Favored 'Isoleucine or valine' 0 C--N 1.351 0.646 0 C-N-CA 119.511 -0.876 . . . . 1.0 109.454 179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.56 -37.55 85.2 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.005 -0.543 . . . . 1.0 110.29 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.44 -37.77 81.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 1.0 111.141 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.49 -44.05 95.47 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 120.917 -0.313 . . . . 1.0 111.647 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.416 ' H ' HG23 ' D' ' 74' ' ' VAL . 3.5 t -64.75 -46.57 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 C-N-CA 120.499 -0.481 . . . . 1.0 111.276 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.14 -40.49 94.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.341 -0.391 . . . . 1.0 111.238 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.67 -43.25 99.28 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.495 -0.321 . . . . 1.0 110.794 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.449 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -63.63 -39.06 93.39 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.537 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.37 -42.85 97.52 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.641 -0.583 . . . . 1.0 111.641 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.1 mt -63.43 -43.4 98.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.616 0.246 . . . . 1.0 111.237 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.63 -40.96 98.2 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 121.019 -0.272 . . . . 1.0 111.39 -179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' D' ' 77' ' ' ALA . 64.2 t -62.09 -48.07 90.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.559 -0.291 . . . . 1.0 111.294 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.35 -5.09 43.04 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.659 -0.416 . . . . 1.0 110.952 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.76 -37.01 10.04 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.739 0.304 . . . . 1.0 110.407 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.491 ' C ' ' H ' ' D' ' 86' ' ' THR . 5.6 tt -62.7 -41.79 99.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.424 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 27.2 m -49.36 -11.82 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 C-N-CA 120.757 -0.377 . . . . 1.0 110.191 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.491 ' H ' ' C ' ' D' ' 84' ' ' LEU . 57.7 m -56.88 -20.82 25.22 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.151 -0.477 . . . . 1.0 110.244 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -61.23 -36.73 80.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.863 -0.608 . . . . 1.0 110.347 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.4 -28.65 28.74 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.139 0.495 . . . . 1.0 110.062 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 44.2 mt -68.78 -37.76 79.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.921 -0.581 . . . . 1.0 110.784 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.528 ' O ' ' CE1' ' D' ' 93' ' ' PHE . . . -58.29 -44.68 88.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.83 -0.623 . . . . 1.0 111.259 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.68 -5.79 49.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.039 -0.528 . . . . 1.0 110.209 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.562 ' CG ' ' HB2' ' A' ' 87' ' ' ALA . 37.1 t0 -58.79 -49.73 76.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.895 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.528 ' CE1' ' O ' ' D' ' 90' ' ' ALA . 16.9 p90 -75.23 -28.86 60.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.481 -0.327 . . . . 1.0 110.825 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 90.1 t -60.47 -44.29 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 1.0 111.265 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.449 ' O ' ' OE1' ' D' ' 99' ' ' GLU . 17.5 tpp180 -45.13 -28.36 0.73 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.504 -0.316 . . . . 1.0 110.99 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 45.9 ptt85 -48.79 -30.9 6.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.962 0.41 . . . . 1.0 110.502 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.536 ' OE2' ' NH2' ' D' ' 100' ' ' ARG . 80.3 mm-40 -58.54 -23.39 58.15 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.857 -0.611 . . . . 1.0 110.908 -179.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -82.53 -41.06 20.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.882 0.372 . . . . 1.0 110.624 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.487 ' N ' ' OE1' ' D' ' 99' ' ' GLU . 51.4 mp0 -67.19 -41.75 85.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.621 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.536 ' NH2' ' OE2' ' D' ' 97' ' ' GLU . 15.0 ttm180 -60.84 -46.72 89.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.161 -179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 -68.35 -36.03 78.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.864 -0.607 . . . . 1.0 110.357 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.65 19.54 47.91 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.076 -0.809 . . . . 1.0 111.076 -179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 43.5 t60 . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.004 -0.998 . . . . 1.0 110.67 179.791 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.67 -73.68 0.25 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.494 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -172.14 -49.57 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.016 -0.538 . . . . 1.0 110.458 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.507 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 7.6 p80 -78.12 -24.25 47.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.495 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -65.9 -35.84 81.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 1.0 110.42 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.99 -38.91 92.81 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.085 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -65.42 -44.1 88.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 1.0 110.011 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.407 ' HB1' HG12 ' A' ' 85' ' ' VAL . . . -66.76 -39.15 87.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.256 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -65.46 -41.21 93.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.154 -0.476 . . . . 1.0 110.401 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 53.8 tttp -63.93 -38.59 91.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.446 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.42 -36.04 66.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 1.0 110.894 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.45 -32.7 72.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.398 -0.365 . . . . 1.0 110.414 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -65.22 -37.81 88.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.424 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.495 ' OE1' ' N ' ' A' ' 14' ' ' GLU . 6.6 mp0 -60.91 -42.54 98.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.331 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.448 HD21 ' HB1' ' A' ' 52' ' ' ALA . 48.5 tp -63.26 -42.39 99.16 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.596 -0.442 . . . . 1.0 110.737 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -57.37 -42.12 81.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.315 -0.402 . . . . 1.0 111.568 -179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -63.71 -40.02 95.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.736 0.303 . . . . 1.0 111.381 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.4 -36.23 75.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.512 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.2 mt -60.03 -41.16 91.64 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.887 -0.412 . . . . 1.0 109.887 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -59.34 -47.25 86.1 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.734 -0.469 . . . . 1.0 109.734 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -69.59 -33.2 72.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.158 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.86 -45.7 85.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.45 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.781 ' O ' HG23 ' A' ' 27' ' ' VAL . 77.7 p -60.06 -42.4 94.42 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.6 -0.44 . . . . 1.0 110.27 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.9 tttp -62.57 -60.51 3.42 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.381 -0.528 . . . . 1.0 110.66 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -61.16 -43.72 98.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.938 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.464 ' O ' ' OE1' ' A' ' 30' ' ' GLU . . . -61.15 -40.31 93.38 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.98 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.781 HG23 ' O ' ' A' ' 23' ' ' SER . 55.0 t -63.88 -48.36 86.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.454 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -72.44 -23.8 61.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.523 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.504 ' HB1' ' H ' ' A' ' 67' ' ' GLY . . . -49.82 -49.18 49.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.316 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.5 ' H ' ' CD ' ' A' ' 30' ' ' GLU . 30.2 mp0 -68.65 -35.83 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.726 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -67.54 88.19 0.22 Allowed 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 120.893 0.377 . . . . 1.0 110.962 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.08 -14.65 6.25 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 111.63 -0.588 . . . . 1.0 111.63 179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.65 154.05 39.49 Favored Pre-proline 0 N--CA 1.467 0.385 0 N-CA-C 109.905 -0.406 . . . . 1.0 109.905 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -74.85 150.61 39.16 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 122.253 1.969 . . . . 1.0 112.205 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.09 32.53 63.06 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.101 -0.8 . . . . 1.0 111.101 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -53.78 146.23 14.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.848 0.356 . . . . 1.0 110.611 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.75 -65.09 0.14 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.628 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.421 ' O ' ' OE1' ' A' ' 30' ' ' GLU . 51.0 tp -66.34 78.84 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.684 -0.407 . . . . 1.0 110.077 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 39' ' ' ILE . 15.8 tt -121.04 79.56 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.283 0.563 . . . . 1.0 110.107 179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 44' ' ' ALA . 18.1 m -172.02 103.3 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.887 -0.597 . . . . 1.0 110.836 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.502 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 46.5 t80 -54.87 -50.11 87.97 Favored Pre-proline 0 CA--C 1.539 0.541 0 CA-C-N 116.333 -0.394 . . . . 1.0 111.882 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.2 Cg_endo -60.03 -34.82 94.56 Favored 'Trans proline' 0 N--CA 1.502 2.004 0 C-N-CA 121.417 1.411 . . . . 1.0 112.729 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' NH2' ' A' ' 60' ' ' ARG . 60.8 m-20 -92.92 -22.72 19.06 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.68 -0.236 . . . . 1.0 111.146 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 40' ' ' SER . . . -59.71 -38.78 82.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 1.0 110.391 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.424 ' O ' ' OG ' ' A' ' 48' ' ' SER . 6.2 tt -60.72 -36.09 68.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.115 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.479 ' C ' ' NH1' ' B' ' 68' ' ' ARG . 0.2 OUTLIER -63.07 -46.78 85.86 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.729 -0.471 . . . . 1.0 109.729 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.51 ' CE2' ' OG1' ' A' ' 51' ' ' THR . 2.1 t90 -62.54 -41.22 98.74 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.43 ' N ' ' CE3' ' A' ' 47' ' ' TRP . 96.9 p -60.23 -35.8 76.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.193 -0.458 . . . . 1.0 111.074 -178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 45' ' ' ILE . 43.6 t -60.47 -49.36 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.943 0.401 . . . . 1.0 110.733 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.402 ' H ' ' HG2' ' A' ' 50' ' ' GLU . 19.3 pt-20 -75.64 -23.73 56.34 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.697 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.51 ' OG1' ' CE2' ' A' ' 47' ' ' TRP . 95.2 m -62.49 -45.88 91.01 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.099 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.655 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -59.06 -36.59 75.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.421 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 55' ' ' VAL . 76.5 p -73.92 -0.94 17.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.349 -0.612 . . . . 1.0 109.349 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 69.1 p 53.33 5.34 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.414 -0.812 . . . . 1.0 110.928 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 53' ' ' THR . 7.7 p -66.4 -41.98 89.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.509 -0.314 . . . . 1.0 111.039 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.469 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 38.04 81.08 0.02 OUTLIER Glycine 0 CA--C 1.529 0.953 0 N-CA-C 111.252 -0.739 . . . . 1.0 111.252 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.41 ' OH ' ' O ' ' B' ' 60' ' ' ARG . 40.7 t80 -60.27 -45.51 93.07 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.855 0.359 . . . . 1.0 110.593 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.83 16.89 0.96 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.044 -0.822 . . . . 1.0 111.044 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.61 -46.18 90.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.944 0.402 . . . . 1.0 110.382 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.532 ' NH2' ' O ' ' A' ' 43' ' ' ASP . 0.4 OUTLIER -141.71 149.77 40.96 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.042 -0.526 . . . . 1.0 109.898 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -118.56 120.89 31.4 Favored Pre-proline 0 CA--C 1.539 0.538 0 CA-C-N 116.343 -0.389 . . . . 1.0 110.621 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.56 154.93 67.89 Favored 'Trans proline' 0 N--CA 1.496 1.621 0 C-N-CA 121.84 1.693 . . . . 1.0 112.57 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.426 HG22 ' H ' ' A' ' 63' ' ' VAL . 4.5 m -60.82 -168.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 1.0 110.154 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.537 ' O ' ' NE1' ' D' ' 46' ' ' TRP . 1.5 m -110.29 -62.21 1.55 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.434 -0.348 . . . . 1.0 111.101 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -41.63 -31.36 0.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.062 0.458 . . . . 1.0 110.425 -178.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.875 ' O ' ' N ' ' A' ' 68' ' ' ARG . 97.2 mt-10 -138.48 -105.83 0.18 Allowed 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.652 -0.704 . . . . 1.0 109.317 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' H ' ' HB1' ' A' ' 29' ' ' ALA . . . 20.67 -55.92 0.0 OUTLIER Glycine 0 N--CA 1.478 1.435 0 O-C-N 124.476 1.11 . . . . 1.0 114.438 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.875 ' N ' ' O ' ' A' ' 66' ' ' GLU . 33.7 ttm180 -70.78 -45.44 64.7 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 109.665 -0.494 . . . . 1.0 109.665 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 66' ' ' GLU . 27.8 tptp -62.39 -40.93 98.09 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.031 -0.729 . . . . 1.0 109.031 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 75.5 t -65.28 -45.08 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 120.085 -0.646 . . . . 1.0 110.308 179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.92 -35.82 81.67 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.113 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -49.2 -50.41 38.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.88 -0.6 . . . . 1.0 110.467 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -64.53 -40.63 95.96 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.843 -0.343 . . . . 1.0 111.221 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.05 -45.55 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 120.792 -0.363 . . . . 1.0 111.222 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 75.2 mtm -62.96 -39.67 95.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.647 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -60.25 -42.14 94.7 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.828 -0.349 . . . . 1.0 110.52 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.401 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -61.6 -40.29 94.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.483 -179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.78 -41.53 93.58 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 110.841 -0.904 . . . . 1.0 110.841 179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.55 -43.78 98.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.698 0.285 . . . . 1.0 110.274 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.419 ' O ' ' N ' ' A' ' 84' ' ' LEU . 97.2 mt-10 -65.28 -44.7 87.16 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.581 -0.447 . . . . 1.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 77' ' ' ALA . 53.4 t -63.62 -47.72 90.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 1.0 110.758 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -68.33 -28.95 67.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.078 -0.51 . . . . 1.0 110.981 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.87 -25.46 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.691 0.281 . . . . 1.0 110.888 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.419 ' N ' ' O ' ' A' ' 80' ' ' GLU . 4.7 tt -63.65 -42.01 98.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.387 -0.37 . . . . 1.0 111.568 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' ' N ' ' A' ' 87' ' ' ALA . 33.4 m -49.16 -22.36 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 C-N-CA 120.441 -0.504 . . . . 1.0 110.253 -179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.671 ' HA ' HD22 ' A' ' 89' ' ' LEU . 54.0 m -36.55 -24.99 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.216 0.531 . . . . 1.0 110.566 178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -59.57 -41.74 90.89 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.111 -0.495 . . . . 1.0 109.789 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 85' ' ' VAL . . . -78.55 -21.05 49.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.863 0.363 . . . . 1.0 110.969 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 86' ' ' THR . 6.7 mp -66.32 -38.54 87.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.297 -0.411 . . . . 1.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.54 ' O ' ' N ' ' A' ' 92' ' ' ASP . . . -67.38 -62.49 1.4 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 1.0 111.588 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 91' ' ' THR . 0.5 OUTLIER -46.19 -9.74 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.035 -0.529 . . . . 1.0 111.321 -179.119 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 90' ' ' ALA . 83.3 m-20 -58.51 -50.01 75.31 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 120.943 -0.303 . . . . 1.0 110.831 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.449 ' CD1' ' C ' ' A' ' 93' ' ' PHE . 1.9 p90 -69.79 -30.18 67.67 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.486 -0.325 . . . . 1.0 111.105 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG11 ' NH2' ' D' ' 96' ' ' ARG . 89.6 t -59.5 -42.29 87.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.359 -0.382 . . . . 1.0 111.385 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 64.2 ttm-85 -53.07 -21.45 4.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.704 0.288 . . . . 1.0 111.057 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -54.61 -32.94 59.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.783 0.325 . . . . 1.0 110.616 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.41 -41.78 81.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 1.0 109.896 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.42 -34.59 76.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 1.0 110.449 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -64.7 -30.12 71.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.079 -0.51 . . . . 1.0 110.491 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 72.8 ttp85 -58.56 -45.09 89.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.206 -0.452 . . . . 1.0 110.396 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -66.73 -37.85 85.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 1.0 110.449 179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 92.67 9.75 60.99 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.121 -0.791 . . . . 1.0 111.121 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.066 -0.969 . . . . 1.0 110.561 179.795 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 46.0 t . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.324 -0.621 . . . . 1.0 109.324 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.416 ' CB ' ' NE2' ' B' ' 4' ' ' HIS . . . -82.02 172.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 1.0 110.669 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -63.8 -36.22 83.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.951 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.668 ' H ' ' CD2' ' B' ' 4' ' ' HIS . 5.2 p80 -80.57 -32.58 36.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.838 0.351 . . . . 1.0 110.501 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.56 -42.87 91.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.176 -0.466 . . . . 1.0 111.009 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -64.95 -39.95 94.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.635 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.84 -40.63 91.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.973 0.416 . . . . 1.0 110.023 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.98 -39.72 94.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.868 -0.605 . . . . 1.0 110.659 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 67.8 tp60 -66.25 -37.85 86.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.332 -0.394 . . . . 1.0 110.28 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -61.26 -40.49 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.64 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.09 -36.76 78.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.103 -0.499 . . . . 1.0 110.912 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -64.31 -38.84 92.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.437 -0.347 . . . . 1.0 110.415 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -63.63 -36.4 83.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.257 179.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -65.68 -33.56 76.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 1.0 110.221 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 48.3 tp -63.07 -42.17 99.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.59 -179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -64.14 -39.32 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.932 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -61.61 -40.14 93.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 1.0 110.822 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 84.0 t -63.02 -41.82 94.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.63 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.518 HD21 ' HB2' ' B' ' 52' ' ' ALA . 93.2 mt -60.61 -40.87 93.4 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.713 -0.477 . . . . 1.0 109.713 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -48.57 80.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.667 -0.494 . . . . 1.0 109.667 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -67.72 -39.42 84.31 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 1.0 109.918 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.11 -35.76 82.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.0 110.315 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 29.3 m -54.77 -46.59 74.42 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.053 -0.522 . . . . 1.0 110.445 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -66.54 -41.93 87.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.352 0.596 . . . . 1.0 110.043 179.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -62.84 -41.31 99.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.197 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.32 -52.52 64.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.498 -0.481 . . . . 1.0 110.941 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.484 HG13 ' N ' ' B' ' 28' ' ' GLU . 11.6 p -69.82 -43.94 79.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.698 -0.401 . . . . 1.0 110.74 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.484 ' N ' HG13 ' B' ' 27' ' ' VAL . 41.6 tp10 -63.36 -43.87 96.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.736 -0.666 . . . . 1.0 110.775 -179.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.75 81.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.986 -0.552 . . . . 1.0 110.224 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -88.41 -7.69 56.21 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.751 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -83.59 107.44 16.05 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 120.665 -0.414 . . . . 1.0 110.377 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 101.49 -3.02 53.68 Favored Glycine 0 N--CA 1.465 0.593 0 N-CA-C 111.535 -0.626 . . . . 1.0 111.535 178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.58 149.64 46.84 Favored Pre-proline 0 CA--C 1.536 0.407 0 N-CA-C 110.25 -0.278 . . . . 1.0 110.25 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.51 142.42 26.35 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.161 1.907 . . . . 1.0 112.369 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.7 22.7 59.92 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.131 -0.787 . . . . 1.0 111.131 179.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -68.33 144.38 54.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.706 0.289 . . . . 1.0 110.367 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -106.54 -41.9 5.15 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.472 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.499 HD11 ' OD1' ' B' ' 43' ' ' ASP . 40.6 tp -92.02 74.81 5.55 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.021 0.439 . . . . 1.0 110.577 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . . . . . . . . . 44.2 pt -102.26 2.73 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.767 -0.651 . . . . 1.0 110.468 179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.548 ' HG ' ' CG ' ' B' ' 43' ' ' ASP . 78.6 p -75.33 -120.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.664 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.508 ' N ' ' OG ' ' B' ' 40' ' ' SER . 0.5 OUTLIER 171.5 -58.87 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 115.972 -0.558 . . . . 1.0 110.125 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 22.7 Cg_endo -57.91 -31.77 93.45 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 121.869 1.713 . . . . 1.0 112.576 -179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.548 ' CG ' ' HG ' ' B' ' 40' ' ' SER . 3.4 p30 -91.69 0.35 57.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.653 0.263 . . . . 1.0 110.727 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.43 -38.03 89.61 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.96 0.409 . . . . 1.0 110.233 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.461 HG23 ' N ' ' B' ' 46' ' ' TRP . 12.0 tt -66.7 -42.02 88.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.949 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.657 ' CD1' HG23 ' C' ' 64' ' ' THR . 6.2 t-105 -60.98 -46.33 91.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.263 -178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . . . . . . . . . 32.9 t90 -61.43 -40.43 94.41 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 109.988 -0.375 . . . . 1.0 109.988 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.441 ' O ' HD22 ' B' ' 19' ' ' LEU . 23.7 m -71.91 62.41 0.44 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.411 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 97.8 t -150.0 -50.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 120.94 -0.304 . . . . 1.0 111.153 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . 0.493 ' OE1' ' N ' ' B' ' 56' ' ' GLY . 2.8 pp20? -66.99 -31.58 72.23 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.747 -0.381 . . . . 1.0 110.833 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.505 ' O ' ' SD ' ' B' ' 75' ' ' MET . 0.0 OUTLIER -59.22 -45.93 89.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.0 110.796 -179.08 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.518 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.76 -27.17 62.81 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.985 -0.286 . . . . 1.0 110.816 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 31.9 p -89.33 4.52 48.59 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.641 0.258 . . . . 1.0 110.855 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' B' ' 54' ' ' THR . 11.7 p 56.34 76.26 0.3 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.611 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.532 HG11 ' CE1' ' B' ' 57' ' ' TYR . 59.0 t -147.0 -82.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.693 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.493 ' N ' ' OE1' ' B' ' 50' ' ' GLU . . . 72.94 77.87 0.56 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.83 -0.908 . . . . 1.0 110.83 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.532 ' CE1' HG11 ' B' ' 55' ' ' VAL . 78.7 m-85 -60.97 -45.03 96.4 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.679 0.276 . . . . 1.0 111.057 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 138.55 27.62 0.28 Allowed Glycine 0 N--CA 1.468 0.801 0 N-CA-C 111.053 -0.819 . . . . 1.0 111.053 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.409 ' HB2' HH22 ' C' ' 68' ' ' ARG . 67.2 t0 -63.9 -48.27 77.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 1.0 110.861 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . 0.498 ' NH2' ' CG ' ' B' ' 43' ' ' ASP . 2.2 mpt_? -114.79 -167.41 1.22 Allowed 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.133 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.499 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 17.5 t80 -164.32 78.84 1.46 Allowed Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.05 -0.523 . . . . 1.0 110.599 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.56 156.19 66.4 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 121.531 1.487 . . . . 1.0 111.998 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.463 ' O ' ' OE2' ' B' ' 66' ' ' GLU . 31.8 m -103.78 -149.87 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-N 116.291 -0.413 . . . . 1.0 110.341 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.411 HG23 ' CE2' ' A' ' 46' ' ' TRP . 22.3 m -96.81 -38.85 9.7 Favored 'General case' 0 CA--C 1.528 0.118 0 CA-C-N 116.632 -0.258 . . . . 1.0 110.842 -179.614 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' B' ' 67' ' ' GLY . 10.0 tm-20 -56.19 -35.41 67.24 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.826 -0.435 . . . . 1.0 109.826 -179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' B' ' 68' ' ' ARG . 0.1 OUTLIER -74.19 26.82 0.08 Allowed 'General case' 0 C--O 1.266 1.954 0 CA-C-O 123.768 1.747 . . . . 1.0 109.844 179.049 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.72 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.66 65.91 1.09 Allowed Glycine 0 C--O 1.217 -0.949 0 CA-C-N 113.62 -1.627 . . . . 1.0 111.449 177.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.544 ' N ' ' OE2' ' B' ' 66' ' ' GLU . 40.6 ttm180 -24.82 -31.99 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 118.061 0.931 . . . . 1.0 110.897 -178.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.72 ' N ' ' O ' ' B' ' 67' ' ' GLY . 60.5 mttp -45.14 -23.85 0.2 Allowed 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.838 -0.801 . . . . 1.0 108.838 176.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.5 ' N ' ' O ' ' B' ' 67' ' ' GLY . 72.5 t -63.57 -47.08 93.06 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 C-N-CA 119.748 -0.781 . . . . 1.0 109.977 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.79 -42.09 82.18 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.038 -0.528 . . . . 1.0 110.191 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -65.17 -39.29 92.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.052 -0.522 . . . . 1.0 110.016 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -47.26 -54.66 10.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.573 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.436 HG11 HG23 ' B' ' 51' ' ' THR . 85.8 t -65.96 -42.6 92.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 C-N-CA 120.727 -0.389 . . . . 1.0 111.34 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' B' ' 51' ' ' THR . 5.6 tpp -56.73 -47.97 78.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.801 -0.36 . . . . 1.0 110.493 -178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -67.42 -41.07 85.46 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.537 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.76 -39.51 74.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.36 -0.382 . . . . 1.0 110.688 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.32 -42.31 97.81 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.438 -0.665 . . . . 1.0 111.438 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 95.7 mt -65.38 -25.11 36.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 C-N-CA 121.089 -0.244 . . . . 1.0 111.37 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -72.16 -53.19 13.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 1.0 111.055 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.429 HG23 ' N ' ' B' ' 82' ' ' PHE . 6.9 m -61.66 -47.09 94.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.825 -0.625 . . . . 1.0 111.355 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.429 ' N ' HG23 ' B' ' 81' ' ' VAL . 14.6 m-85 -63.63 -38.51 91.38 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.256 -0.429 . . . . 1.0 110.844 -179.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.28 -40.62 96.34 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.681 -0.408 . . . . 1.0 110.568 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.463 ' C ' ' N ' ' B' ' 86' ' ' THR . 7.2 tt -63.96 -41.74 97.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.892 -0.323 . . . . 1.0 110.273 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 85' ' ' VAL . 63.5 t -51.47 -11.33 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 N-CA-C 109.71 -0.478 . . . . 1.0 109.71 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.522 ' O ' ' N ' ' B' ' 89' ' ' LEU . 70.7 m -60.8 -38.73 86.33 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.361 -0.607 . . . . 1.0 109.361 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -38.91 -62.48 0.62 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.853 -0.612 . . . . 1.0 110.974 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.12 20.38 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.359 -0.382 . . . . 1.0 110.398 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' B' ' 86' ' ' THR . 55.7 mt -98.3 -4.11 35.78 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.556 -0.535 . . . . 1.0 109.556 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.478 ' O ' ' CD2' ' B' ' 93' ' ' PHE . . . -93.17 -25.16 17.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.622 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' O ' ' B' ' 87' ' ' ALA . 0.1 OUTLIER -84.05 -4.67 58.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.586 -0.733 . . . . 1.0 110.04 -179.886 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' B' ' 92' ' ' ASP . 11.6 p-10 -57.43 -47.98 80.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 1.0 111.201 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.478 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 8.2 p90 -67.51 -30.79 70.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.883 0.373 . . . . 1.0 111.308 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -59.99 -44.38 94.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 1.0 111.366 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -65.91 -21.9 66.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.949 -0.3 . . . . 1.0 110.675 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.674 ' NH1' HH21 ' B' ' 100' ' ' ARG . 68.8 ttp85 -58.78 -42.98 90.27 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.109 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -48.83 -57.26 6.67 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.229 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . 0.426 ' O ' ' O ' ' B' ' 101' ' ' ARG . 14.6 pt-20 -67.04 -33.38 75.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.767 0.318 . . . . 1.0 110.723 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 tm-20 -61.49 -44.69 96.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.198 -0.455 . . . . 1.0 110.487 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.674 HH21 ' NH1' ' B' ' 96' ' ' ARG . 16.4 ttm105 -70.15 -43.19 71.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.578 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' B' ' 98' ' ' GLU . 89.4 mtt180 -107.21 117.39 33.96 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.229 -0.441 . . . . 1.0 110.319 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.6 -21.81 13.92 Favored Glycine 0 N--CA 1.468 0.781 0 N-CA-C 111.095 -0.802 . . . . 1.0 111.095 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 85.2 t60 . . . . . 0 C--O 1.22 -0.457 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.533 179.806 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . 0.53 ' O ' ' N ' ' C' ' 3' ' ' ASP . 9.8 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.294 -0.632 . . . . 1.0 109.294 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' C' ' 4' ' ' HIS . . . 43.09 17.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.863 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.53 ' N ' ' O ' ' C' ' 1' ' ' SER . 97.1 m-20 56.76 -73.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.735 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.572 ' N ' ' O ' ' C' ' 2' ' ' ALA . 33.2 p80 -54.37 -42.6 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 1.0 111.191 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 81.6 tt0 -64.52 -34.29 77.88 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 120.722 0.296 . . . . 1.0 110.633 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -60.78 -45.68 93.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.016 0.436 . . . . 1.0 109.916 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -63.57 -42.88 98.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.072 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.88 -40.09 94.57 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.172 -0.467 . . . . 1.0 110.429 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -65.0 -42.62 94.34 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.314 -0.403 . . . . 1.0 110.346 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -64.01 -35.53 81.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 1.0 110.29 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.87 83.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.153 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -63.85 -36.81 85.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.583 -0.28 . . . . 1.0 110.806 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.36 -35.24 80.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.833 0.349 . . . . 1.0 110.578 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -64.77 -36.32 83.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.538 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.42 HD13 ' HA2' ' C' ' 78' ' ' GLY . 42.9 tp -62.42 -40.94 98.16 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.794 -0.363 . . . . 1.0 110.539 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -59.28 -38.84 81.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.218 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.25 -39.69 93.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.804 0.335 . . . . 1.0 111.018 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 96.0 t -63.19 -33.77 62.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.675 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' C' ' 52' ' ' ALA . 92.3 mt -61.75 -41.83 98.19 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.672 -0.411 . . . . 1.0 110.148 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.45 -46.23 89.48 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.878 -0.415 . . . . 1.0 109.878 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -69.51 -39.84 77.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.156 -0.474 . . . . 1.0 110.252 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.96 -36.4 83.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.685 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 86.6 p -60.0 -46.16 90.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.68 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . 0.511 ' NZ ' ' OE1' ' C' ' 28' ' ' GLU . 14.8 tmtt? -66.41 -37.18 84.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.168 0.508 . . . . 1.0 110.068 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' C' ' 29' ' ' ALA . 14.5 mptt -70.26 -40.99 74.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.141 -0.481 . . . . 1.0 109.927 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.04 66.81 Favored 'General case' 0 C--O 1.226 -0.137 0 CA-C-N 116.489 -0.323 . . . . 1.0 111.102 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.489 HG13 ' N ' ' C' ' 28' ' ' GLU . 10.7 p -64.6 -43.15 96.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.07 0.462 . . . . 1.0 109.962 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . 0.511 ' OE1' ' NZ ' ' C' ' 24' ' ' LYS . 82.9 tt0 -66.58 -35.14 79.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.653 -0.703 . . . . 1.0 110.319 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.444 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -58.01 -26.9 62.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.789 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.84 -37.62 86.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 44.7 mmm-85 -70.85 101.58 2.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.745 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . 0.444 ' O ' ' OE1' ' C' ' 65' ' ' GLU . . . 125.96 -22.53 6.03 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.64 143.93 27.22 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 110.247 -0.279 . . . . 1.0 110.247 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . 0.511 ' O ' ' CG1' ' C' ' 63' ' ' VAL . 97.4 Cg_endo -75.87 138.73 21.34 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 121.976 1.784 . . . . 1.0 112.391 -179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.18 37.07 13.08 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.098 -0.801 . . . . 1.0 111.098 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -57.95 146.02 33.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 1.0 110.64 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' C' ' 39' ' ' ILE . . . -149.32 -39.95 0.15 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.119 -0.492 . . . . 1.0 110.519 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' C' ' 40' ' ' SER . 0.5 OUTLIER -71.45 12.49 0.34 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.367 -0.378 . . . . 1.0 110.021 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.491 ' H ' ' C ' ' C' ' 37' ' ' ALA . 21.3 tt -46.5 -13.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.304 -0.407 . . . . 1.0 110.58 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.516 ' N ' ' O ' ' C' ' 38' ' ' LEU . 5.4 m -65.5 146.17 55.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.316 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.539 ' H ' ' HD2' ' C' ' 42' ' ' PRO . 9.8 m-85 -102.36 -63.66 0.06 OUTLIER Pre-proline 0 CA--C 1.54 0.582 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.685 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.547 ' O ' HG22 ' C' ' 45' ' ' ILE . 24.4 Cg_endo -59.35 -34.89 97.72 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 121.884 1.722 . . . . 1.0 112.256 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -83.54 -7.56 59.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.398 -0.364 . . . . 1.0 111.203 -179.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.83 -38.1 89.82 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.749 0.309 . . . . 1.0 110.917 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.547 HG22 ' O ' ' C' ' 42' ' ' PRO . 9.9 tt -64.05 -32.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.578 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.493 ' HE3' HG23 ' C' ' 45' ' ' ILE . 0.2 OUTLIER -62.81 -46.43 87.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.253 -0.43 . . . . 1.0 110.314 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.52 ' CE2' ' OG1' ' C' ' 51' ' ' THR . 14.0 t90 -62.05 -40.0 94.28 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.354 -0.538 . . . . 1.0 109.775 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 4.8 t -59.17 -36.74 75.84 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.877 -0.601 . . . . 1.0 111.126 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . . . . . . . . . 50.5 t -60.23 -48.22 89.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 120.785 -0.366 . . . . 1.0 111.418 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . 0.516 ' OE1' ' NH2' ' D' ' 68' ' ' ARG . 15.0 pt-20 -72.3 -26.82 62.11 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.459 -0.496 . . . . 1.0 110.949 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.52 ' OG1' ' CE2' ' C' ' 47' ' ' TRP . 94.4 m -63.47 -50.11 70.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.379 -0.373 . . . . 1.0 111.548 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.566 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -59.47 -26.08 64.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.741 -0.383 . . . . 1.0 111.136 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.457 ' C ' ' H ' ' C' ' 55' ' ' VAL . 39.3 p -88.44 -0.07 56.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.02 -0.363 . . . . 1.0 110.02 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 55.88 6.06 0.19 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.088 -0.505 . . . . 1.0 110.671 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' C' ' 53' ' ' THR . 64.2 t -64.89 -43.94 96.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.611 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 46.89 58.08 6.42 Favored Glycine 0 CA--C 1.522 0.531 0 N-CA-C 110.395 -1.082 . . . . 1.0 110.395 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.44 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 1.7 t80 -59.99 -48.83 80.08 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . 0.584 ' O ' ' N ' ' C' ' 60' ' ' ARG . . . 164.31 -99.74 0.17 Allowed Glycine 0 CA--C 1.52 0.39 0 N-CA-C 110.66 -0.976 . . . . 1.0 110.66 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . 0.444 ' OD1' ' NE ' ' C' ' 60' ' ' ARG . 44.4 t0 51.58 -80.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.762 0.315 . . . . 1.0 110.865 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.584 ' N ' ' O ' ' C' ' 58' ' ' GLY . 12.9 mmt180 -118.64 -167.99 1.47 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.46 -0.57 . . . . 1.0 109.46 -179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.47 ' CE1' ' CB ' ' C' ' 37' ' ' ALA . 26.2 p90 -160.1 129.49 3.24 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 120.557 -0.457 . . . . 1.0 110.644 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.69 161.86 44.27 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.802 1.668 . . . . 1.0 111.976 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' C' ' 34' ' ' PRO . 0.5 OUTLIER -86.45 -152.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.92 -0.582 . . . . 1.0 110.003 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.657 HG23 ' CD1' ' B' ' 46' ' ' TRP . 19.6 m -112.15 -73.28 0.68 Allowed 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.902 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' C' ' 64' ' ' THR . 78.9 tt0 -32.17 -33.89 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.15 0.5 . . . . 1.0 111.125 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.859 ' O ' ' N ' ' C' ' 68' ' ' ARG . 78.1 mm-40 -138.96 -101.62 0.17 Allowed 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 115.521 -0.763 . . . . 1.0 109.524 178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 23.58 -56.07 0.0 OUTLIER Glycine 0 N--CA 1.479 1.526 0 O-C-N 124.792 1.308 . . . . 1.0 114.415 178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.859 ' N ' ' O ' ' C' ' 66' ' ' GLU . 56.9 ttm-85 -71.41 -70.19 0.33 Allowed 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 115.282 -0.459 . . . . 1.0 110.28 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -46.1 -38.39 8.02 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.203 -0.666 . . . . 1.0 109.203 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.39 -44.77 86.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 119.802 -0.759 . . . . 1.0 110.262 178.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.59 -35.83 82.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.055 0.455 . . . . 1.0 110.07 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -48.89 -48.89 41.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 1.0 110.617 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -65.59 -39.31 91.46 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.716 -0.394 . . . . 1.0 111.524 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 55.1 t -63.66 -45.68 96.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.461 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 77.4 mtm -62.39 -40.67 97.26 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.927 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -61.62 -38.15 86.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.488 -0.324 . . . . 1.0 110.708 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -43.34 83.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.832 0.348 . . . . 1.0 110.39 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.42 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -67.45 -42.2 89.59 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.837 -0.505 . . . . 1.0 111.837 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 94.5 mt -61.08 -43.15 95.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 120.694 0.283 . . . . 1.0 110.72 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -64.5 -42.38 95.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.431 -0.349 . . . . 1.0 111.142 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 62.1 t -64.01 -48.37 86.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.883 -0.327 . . . . 1.0 111.1 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . 0.538 ' O ' HG22 ' C' ' 85' ' ' VAL . 36.6 m-85 -66.01 -39.88 90.65 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.806 -0.358 . . . . 1.0 111.069 -179.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.18 -28.18 64.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.847 0.356 . . . . 1.0 110.773 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.561 ' C ' ' H ' ' C' ' 86' ' ' THR . 5.4 tt -63.93 -38.96 92.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.711 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . 0.538 HG22 ' O ' ' C' ' 82' ' ' PHE . 1.8 m -51.97 -4.3 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 120.741 -0.384 . . . . 1.0 110.82 -179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.561 ' H ' ' C ' ' C' ' 84' ' ' LEU . 53.3 m -49.28 -38.9 28.89 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.936 0.398 . . . . 1.0 109.974 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' C' ' 91' ' ' THR . . . -47.47 -18.31 0.12 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.461 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . 0.423 ' N ' ' C ' ' C' ' 86' ' ' THR . . . -105.85 -14.07 15.33 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 120.725 0.297 . . . . 1.0 110.797 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' C' ' 86' ' ' THR . 86.7 mt -84.93 -51.84 6.42 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.362 -0.381 . . . . 1.0 111.587 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.536 ' O ' ' CE2' ' C' ' 93' ' ' PHE . . . -56.91 -46.86 81.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 1.0 111.064 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' C' ' 87' ' ' ALA . 0.6 OUTLIER -77.63 -4.43 45.92 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.222 -0.444 . . . . 1.0 110.503 -179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -56.86 -48.59 77.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.451 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' C' ' 90' ' ' ALA . 14.6 p90 -73.42 -40.09 64.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.323 -0.399 . . . . 1.0 111.126 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . 0.49 ' N ' ' CD1' ' C' ' 93' ' ' PHE . 92.6 t -43.56 -27.22 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 1.0 111.732 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 11.0 tpp85 -60.87 -22.82 64.66 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.905 -0.318 . . . . 1.0 111.247 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -63.09 -37.38 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.845 0.355 . . . . 1.0 110.591 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -65.19 -33.09 75.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.698 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . 0.417 ' O ' ' N ' ' C' ' 100' ' ' ARG . 98.5 mt-10 -106.64 -176.36 3.05 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.874 -0.417 . . . . 1.0 109.874 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 66.4 -56.14 0.39 Allowed 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.532 0.52 . . . . 1.0 110.613 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.586 HH22 ' NH2' ' C' ' 101' ' ' ARG . 70.9 ttp85 -59.38 -43.67 92.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.534 -0.303 . . . . 1.0 110.634 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . 0.586 ' NH2' HH22 ' C' ' 100' ' ' ARG . 1.8 mpt_? -64.42 -36.95 85.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.209 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.5 23.46 33.8 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.812 -0.915 . . . . 1.0 110.812 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.447 179.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.319 -0.623 . . . . 1.0 109.319 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' D' ' 4' ' ' HIS . . . 44.07 88.56 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.996 0.427 . . . . 1.0 110.622 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -63.42 -39.78 95.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.751 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.472 ' CE1' HH21 ' D' ' 95' ' ' ARG . 56.4 p-80 -60.02 -46.15 90.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.301 -0.409 . . . . 1.0 111.056 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.437 ' N ' ' CG ' ' D' ' 4' ' ' HIS . 81.3 tt0 -62.87 -39.43 94.41 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 120.862 0.363 . . . . 1.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 73.3 ttp85 -63.12 -40.71 98.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.455 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 45.6 tp10 -60.19 -39.82 87.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 1.0 109.966 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.09 -41.45 99.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 1.0 110.711 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -66.2 -38.67 88.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.415 -0.357 . . . . 1.0 110.431 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 51.9 tttp -62.62 -34.88 77.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.168 -0.469 . . . . 1.0 110.627 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.78 -37.95 74.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.947 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -60.72 -36.8 79.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.506 -0.315 . . . . 1.0 110.732 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -64.54 -33.21 75.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.399 -0.364 . . . . 1.0 110.416 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -61.81 -40.97 97.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.572 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 41.3 tp -62.34 -41.78 98.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.677 -0.409 . . . . 1.0 110.518 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -53.14 -42.93 66.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.487 -0.324 . . . . 1.0 111.356 -179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -62.15 -38.98 91.06 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.42 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 89.0 t -82.48 -44.03 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.372 -0.377 . . . . 1.0 111.673 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.785 HD12 ' O ' ' D' ' 19' ' ' LEU . 0.3 OUTLIER -61.17 -46.75 89.21 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 109.629 -0.508 . . . . 1.0 109.629 179.871 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -57.98 -41.36 82.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.18 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -63.48 -27.93 69.61 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.726 -0.472 . . . . 1.0 109.726 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -59.13 -46.33 88.63 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.212 -0.449 . . . . 1.0 110.913 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -61.15 -40.65 94.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.152 -179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -62.78 -34.01 76.36 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 120.664 -0.415 . . . . 1.0 110.374 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -85.93 -44.24 12.54 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.607 -0.269 . . . . 1.0 110.994 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -42.85 68.83 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.5 -0.318 . . . . 1.0 111.281 -178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.515 HG13 ' N ' ' D' ' 28' ' ' GLU . 4.6 p -60.12 -46.87 93.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.446 -0.502 . . . . 1.0 109.829 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.515 ' N ' HG13 ' D' ' 27' ' ' VAL . 44.6 tp10 -69.24 -41.24 77.22 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.696 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.45 ' HB1' ' HA ' ' D' ' 66' ' ' GLU . . . -56.56 -24.89 50.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.829 -0.623 . . . . 1.0 110.24 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.473 ' O ' ' N ' ' D' ' 32' ' ' GLY . 30.9 mm-40 -97.32 -39.73 9.08 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.808 0.337 . . . . 1.0 111.203 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 22.0 mmt85 -59.82 79.76 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.163 -0.471 . . . . 1.0 111.159 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' D' ' 30' ' ' GLU . . . 128.86 21.85 1.33 Allowed Glycine 0 N--CA 1.467 0.755 0 N-CA-C 111.531 -0.628 . . . . 1.0 111.531 178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . 0.549 ' HB1' HG11 ' D' ' 63' ' ' VAL . . . -105.92 153.37 40.16 Favored Pre-proline 0 CA--C 1.536 0.436 0 N-CA-C 110.289 -0.263 . . . . 1.0 110.289 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' D' ' 36' ' ' ALA . 79.2 Cg_endo -74.55 139.22 25.27 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.101 1.867 . . . . 1.0 111.904 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . 0.439 ' O ' ' O ' ' D' ' 36' ' ' ALA . . . 69.82 -23.87 0.41 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . 0.535 ' H ' ' C ' ' D' ' 34' ' ' PRO . . . 43.03 -170.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.775 0.321 . . . . 1.0 110.984 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' D' ' 36' ' ' ALA . . . 175.43 -48.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.192 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.621 HD13 ' HE ' ' D' ' 60' ' ' ARG . 50.9 tp -116.35 119.68 36.47 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.121 0.486 . . . . 1.0 110.278 179.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.449 ' O ' ' CB ' ' D' ' 40' ' ' SER . 37.3 pt -141.72 169.12 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 115.707 -0.678 . . . . 1.0 110.633 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.449 ' CB ' ' O ' ' D' ' 39' ' ' ILE . 0.7 OUTLIER 78.99 137.62 0.07 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.917 -0.583 . . . . 1.0 110.55 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.605 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 0.2 OUTLIER -72.81 -46.42 8.98 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 1.0 110.852 178.705 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 21.2 Cg_endo -59.11 -30.77 94.08 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.571 1.514 . . . . 1.0 112.234 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.537 ' O ' ' NH2' ' D' ' 60' ' ' ARG . 13.4 m-20 -91.65 -33.96 14.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.537 -0.301 . . . . 1.0 110.89 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.82 -34.87 76.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.845 0.355 . . . . 1.0 110.752 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . 0.404 HG23 ' HE3' ' D' ' 46' ' ' TRP . 9.6 tt -64.26 -36.72 77.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.373 179.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.563 ' C ' HH11 ' A' ' 68' ' ' ARG . 0.4 OUTLIER -65.02 -46.02 83.11 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.938 -0.393 . . . . 1.0 109.938 -179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.515 ' CB ' HH21 ' D' ' 60' ' ' ARG . 2.1 t90 -62.05 -38.32 88.32 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.469 -0.567 . . . . 1.0 109.469 178.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.407 ' N ' ' CE3' ' D' ' 47' ' ' TRP . 1.5 m -61.82 -37.82 85.84 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.39 -0.368 . . . . 1.0 110.822 -179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . 0.403 HG23 ' O ' ' D' ' 45' ' ' ILE . 48.2 t -59.71 -49.9 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 CA-C-O 120.75 0.31 . . . . 1.0 110.991 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.403 ' H ' ' HG2' ' D' ' 50' ' ' GLU . 17.4 pt-20 -68.45 -34.16 75.48 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.542 -0.463 . . . . 1.0 110.005 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 76.9 m -61.96 -46.54 88.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 1.0 110.556 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.6 -29.56 69.28 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.789 -0.364 . . . . 1.0 110.211 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' D' ' 54' ' ' THR . 66.5 p -90.05 4.44 50.25 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.191 -0.458 . . . . 1.0 110.369 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' D' ' 53' ' ' THR . 27.5 p 52.82 69.52 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.103 -0.499 . . . . 1.0 111.086 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -133.41 -59.12 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.514 -0.312 . . . . 1.0 110.577 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.512 ' C ' ' H ' ' D' ' 58' ' ' GLY . . . 71.85 -59.15 1.35 Allowed Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.865 -0.894 . . . . 1.0 110.865 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.492 ' OH ' ' CD1' ' A' ' 47' ' ' TRP . 0.5 OUTLIER 70.77 -37.21 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.787 0.327 . . . . 1.0 110.538 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . 0.512 ' H ' ' C ' ' D' ' 56' ' ' GLY . . . 117.07 11.11 9.27 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.656 -0.978 . . . . 1.0 110.656 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -61.42 -52.2 65.59 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.706 -0.398 . . . . 1.0 110.353 -179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.703 ' NH2' HH12 ' A' ' 68' ' ' ARG . 0.1 OUTLIER -145.78 144.27 30.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 1.0 109.762 179.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 13.2 p90 -136.95 122.54 13.09 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.56 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.18 -171.19 0.56 Allowed 'Trans proline' 0 N--CA 1.497 1.677 0 C-N-CA 121.983 1.789 . . . . 1.0 111.898 -179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.863 HG22 ' H ' ' D' ' 64' ' ' THR . 8.3 p -122.26 -179.03 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.55 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.863 ' H ' HG22 ' D' ' 63' ' ' VAL . 97.1 m -62.3 -44.97 95.29 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.263 -0.426 . . . . 1.0 111.042 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.551 ' C ' ' H ' ' D' ' 67' ' ' GLY . 64.2 tt0 -52.2 -31.24 30.87 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.68 -0.408 . . . . 1.0 110.273 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.472 ' CG ' ' O ' ' D' ' 66' ' ' GLU . 0.0 OUTLIER -74.27 15.76 0.3 Allowed 'General case' 0 C--O 1.255 1.387 0 CA-C-O 124.482 2.087 . . . . 1.0 107.958 177.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.75 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 48.44 61.33 5.15 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 178.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.516 ' NH2' ' OE1' ' C' ' 50' ' ' GLU . 49.2 ttt85 -25.3 -27.98 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 117.535 0.668 . . . . 1.0 111.254 -177.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.75 ' N ' ' O ' ' D' ' 67' ' ' GLY . 13.1 tptm -53.66 -21.93 7.86 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.742 -0.836 . . . . 1.0 108.742 176.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.587 ' O ' HG23 ' D' ' 74' ' ' VAL . 75.7 t -60.54 -44.43 96.61 Favored 'Isoleucine or valine' 0 C--N 1.352 0.715 0 C-N-CA 119.979 -0.688 . . . . 1.0 109.473 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . 0.522 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -68.69 -48.02 64.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.982 0.42 . . . . 1.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -48.41 -64.29 0.84 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.889 -0.596 . . . . 1.0 111.832 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . 0.428 ' CG ' ' N ' ' D' ' 74' ' ' VAL . 10.3 pt20 -54.43 -43.25 71.41 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.899 0.333 . . . . 1.0 111.899 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . 0.587 HG23 ' O ' ' D' ' 70' ' ' VAL . 86.7 t -61.56 -48.15 90.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.687 -0.405 . . . . 1.0 111.176 -178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.522 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mtp -63.71 -38.07 89.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.263 -0.426 . . . . 1.0 110.462 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . 0.436 ' O ' ' OE1' ' D' ' 80' ' ' GLU . 32.0 ttmt -58.81 -42.25 88.68 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.733 -0.387 . . . . 1.0 110.568 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.439 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -60.31 -40.19 89.65 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.906 0.384 . . . . 1.0 110.373 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.49 -41.11 90.92 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.653 -0.579 . . . . 1.0 111.653 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -62.34 -43.98 98.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 120.967 -0.293 . . . . 1.0 111.099 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . 0.492 ' OE1' ' N ' ' D' ' 80' ' ' GLU . 3.2 mp0 -67.65 -40.8 84.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.853 0.359 . . . . 1.0 110.751 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.439 HG23 ' O ' ' D' ' 77' ' ' ALA . 47.2 t -63.2 -47.61 91.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.317 -0.401 . . . . 1.0 111.283 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 31.2 m-85 -71.66 -9.31 58.06 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.699 -0.4 . . . . 1.0 110.622 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.34 -29.63 13.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.071 -0.344 . . . . 1.0 110.071 179.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.694 ' C ' HD23 ' D' ' 84' ' ' LEU . 7.3 tt -63.3 -42.88 99.09 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.833 -0.347 . . . . 1.0 110.243 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 15.9 m -54.04 -6.96 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.856 0.36 . . . . 1.0 110.163 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.506 ' H ' ' C ' ' D' ' 84' ' ' LEU . 53.0 m -60.66 -20.07 59.96 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 116.145 -0.48 . . . . 1.0 110.293 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.07 -55.66 22.09 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.668 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.61 -39.11 93.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.2 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . . . . . . . . . 40.9 mt -64.22 -40.87 96.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.038 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.532 ' O ' ' CD2' ' D' ' 93' ' ' PHE . . . -64.91 -37.19 86.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.799 -0.637 . . . . 1.0 110.266 179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.523 ' OG1' ' CG ' ' C' ' 93' ' ' PHE . 1.0 OUTLIER -78.61 -4.75 50.44 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.946 -0.57 . . . . 1.0 110.108 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -60.01 -52.09 66.85 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.012 -0.54 . . . . 1.0 111.212 -179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.532 ' CD2' ' O ' ' D' ' 90' ' ' ALA . 10.4 p90 -63.9 -32.23 73.69 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.835 -0.346 . . . . 1.0 110.922 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 88.2 t -59.51 -42.3 87.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.321 -0.4 . . . . 1.0 111.327 -178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.472 HH21 ' CE1' ' D' ' 4' ' ' HIS . 95.7 mtt-85 -56.68 -24.29 47.88 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 121.002 -0.279 . . . . 1.0 111.113 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . 0.501 ' NH2' HG11 ' A' ' 94' ' ' VAL . 15.0 ptt180 -58.88 -8.71 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.894 0.378 . . . . 1.0 110.146 -179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -85.7 -1.44 57.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.245 -178.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -132.56 -23.61 2.07 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.814 0.34 . . . . 1.0 110.385 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.51 -41.41 93.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 1.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . . . . . . . . . 55.1 mtm180 -61.39 -48.83 79.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.485 . . . . 1.0 110.461 -179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -69.67 -36.59 76.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.465 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.64 24.66 27.53 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.979 -0.848 . . . . 1.0 110.979 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.991 -1.004 . . . . 1.0 110.641 179.893 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.38 -0.6 . . . . 1.0 109.38 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 4' ' ' HIS . . . -164.31 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.596 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 14.6 t70 68.92 -37.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.022 -0.536 . . . . 1.0 110.767 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.624 ' ND1' ' N ' ' A' ' 5' ' ' GLU . 20.7 p80 -66.64 -40.27 88.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.527 -0.306 . . . . 1.0 110.792 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' ND1' ' A' ' 4' ' ' HIS . 17.5 pt-20 -65.67 -36.32 83.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 1.0 110.42 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -64.08 -39.63 94.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.452 . . . . 1.0 110.223 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -66.42 -35.33 80.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.086 -0.506 . . . . 1.0 110.222 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HB1' HG13 ' A' ' 85' ' ' VAL . . . -60.92 -40.53 93.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 1.0 109.974 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -64.61 -37.25 86.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.487 . . . . 1.0 110.293 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -62.41 -38.78 90.99 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 1.0 110.733 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.72 -38.72 86.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 1.0 111.088 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -63.31 -38.26 90.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.415 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.76 -34.16 77.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.343 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.6 tp10 -65.83 -33.93 76.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.497 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.33 -42.31 99.28 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.781 -0.367 . . . . 1.0 110.528 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.7 mt-30 -61.38 -40.12 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.253 -0.431 . . . . 1.0 111.212 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -62.03 -42.5 99.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.873 0.368 . . . . 1.0 110.81 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.7 t -63.88 -41.1 91.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.448 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.672 HD21 ' HB2' ' A' ' 52' ' ' ALA . 93.5 mt -59.87 -41.31 91.23 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.822 -0.351 . . . . 1.0 110.245 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -61.47 -46.57 89.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.914 0.388 . . . . 1.0 110.0 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -69.68 -35.2 74.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.125 -0.488 . . . . 1.0 110.096 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.05 -37.73 88.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.844 -0.616 . . . . 1.0 110.746 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 78.1 p -59.93 -43.71 94.76 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.489 -0.484 . . . . 1.0 109.83 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.7 tmtm? -66.46 -36.58 83.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.369 179.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -71.32 -46.51 60.46 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.33 -0.548 . . . . 1.0 110.676 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -49.52 76.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.477 -0.329 . . . . 1.0 111.464 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.556 HG13 ' N ' ' A' ' 28' ' ' GLU . 7.4 p -62.49 -46.25 96.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.263 -0.575 . . . . 1.0 110.085 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 27' ' ' VAL . 47.2 tp10 -66.4 -43.27 86.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.47 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.33 -39.69 94.41 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.648 -0.501 . . . . 1.0 109.648 179.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.43 ' HG3' ' HB1' ' A' ' 36' ' ' ALA . 17.1 tp10 -73.23 -34.14 65.72 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.799 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.8 mmt85 -66.92 121.55 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.896 0.379 . . . . 1.0 110.601 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.24 8.02 63.3 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.515 -0.634 . . . . 1.0 111.515 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.66 151.08 39.22 Favored Pre-proline 0 N--CA 1.466 0.345 0 N-CA-C 110.246 -0.279 . . . . 1.0 110.246 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -75.09 140.97 25.82 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.081 1.854 . . . . 1.0 111.982 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 70.76 6.91 60.5 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.023 -0.831 . . . . 1.0 111.023 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 30' ' ' GLU . . . -38.58 106.49 0.05 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.863 0.363 . . . . 1.0 111.067 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -86.91 -29.83 21.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.104 -0.498 . . . . 1.0 110.514 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.541 ' CD1' HH11 ' A' ' 60' ' ' ARG . 42.3 tp -101.16 78.26 1.89 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.4 -0.364 . . . . 1.0 110.381 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 38.3 pt -103.75 31.28 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.308 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.9 m -126.17 121.71 33.58 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.015 -0.539 . . . . 1.0 110.985 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.477 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 18.4 t80 -74.74 -52.02 3.71 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.137 -0.483 . . . . 1.0 111.632 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 30.6 Cg_endo -59.94 -30.66 92.23 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.343 1.362 . . . . 1.0 112.434 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -92.62 -3.73 54.5 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.576 0.227 . . . . 1.0 111.054 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.1 -40.06 92.32 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.875 -0.417 . . . . 1.0 109.875 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 tt -66.69 -32.78 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.291 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.432 ' HE1' ' HA ' ' B' ' 64' ' ' THR . 0.2 OUTLIER -58.84 -45.72 89.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.334 -0.393 . . . . 1.0 110.174 -179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.426 ' O ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -73.42 -24.45 60.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.613 -0.514 . . . . 1.0 109.613 178.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.6 t -70.15 -41.61 73.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.13 -0.486 . . . . 1.0 111.359 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.605 HG21 HH22 ' B' ' 68' ' ' ARG . 68.2 t -60.74 -47.93 90.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 120.83 0.348 . . . . 1.0 110.911 -179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -67.29 -31.19 71.34 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.267 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.426 ' OG1' ' O ' ' A' ' 47' ' ' TRP . 89.3 m -61.34 -46.37 90.53 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.534 -0.466 . . . . 1.0 110.308 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.672 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -57.31 -26.61 61.17 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.72 -0.392 . . . . 1.0 110.547 -179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.525 ' OG1' HG12 ' A' ' 55' ' ' VAL . 44.6 p -86.08 7.34 25.09 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.313 -0.625 . . . . 1.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.4 p 40.13 33.1 0.14 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.262 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG13 ' N ' ' A' ' 56' ' ' GLY . 11.3 p -95.83 -45.25 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.451 -0.341 . . . . 1.0 110.803 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 49.38 83.72 0.03 OUTLIER Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.118 -0.793 . . . . 1.0 111.118 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.11 -46.76 89.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.755 0.312 . . . . 1.0 110.667 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 136.43 3.72 2.36 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.817 -0.913 . . . . 1.0 110.817 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.26 -50.61 72.96 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 120.876 0.369 . . . . 1.0 110.507 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.541 HH11 ' CD1' ' A' ' 38' ' ' LEU . 1.4 mtt-85 -136.15 149.86 48.82 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.467 -0.568 . . . . 1.0 109.467 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -141.87 130.6 12.12 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.539 -0.301 . . . . 1.0 110.503 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.43 -172.07 0.72 Allowed 'Trans proline' 0 N--CA 1.496 1.627 0 C-N-CA 121.932 1.755 . . . . 1.0 112.215 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.879 HG22 ' H ' ' A' ' 64' ' ' THR . 8.8 p -130.39 -144.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.975 -0.557 . . . . 1.0 110.046 179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.879 ' H ' HG22 ' A' ' 63' ' ' VAL . 79.1 m -105.04 -41.45 5.58 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.669 0.271 . . . . 1.0 111.148 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.558 ' C ' ' H ' ' A' ' 67' ' ' GLY . 52.4 tp10 -60.82 -38.81 86.73 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.015 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.48 ' HG2' ' H ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER -74.61 34.54 0.1 Allowed 'General case' 0 C--O 1.266 1.972 0 CA-C-O 124.495 2.093 . . . . 1.0 109.943 179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.71 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 40.19 62.52 1.51 Allowed Glycine 0 C--O 1.213 -1.214 0 CA-C-N 113.323 -1.762 . . . . 1.0 110.833 178.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.516 ' HE ' ' CG ' ' D' ' 50' ' ' GLU . 58.6 ttt85 -25.08 -32.67 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 117.698 0.749 . . . . 1.0 110.927 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.71 ' N ' ' O ' ' A' ' 67' ' ' GLY . 72.5 mmtt -48.72 -16.38 0.12 Allowed 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.46 -0.791 . . . . 1.0 109.005 176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' N ' ' O ' ' A' ' 67' ' ' GLY . 48.6 t -60.42 -45.47 96.69 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 C-N-CA 119.096 -1.041 . . . . 1.0 110.08 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.31 -42.27 79.65 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.643 0.259 . . . . 1.0 111.523 179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 72' ' ' GLU . 1.5 mp0 -58.21 -43.04 87.48 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.405 -0.361 . . . . 1.0 111.052 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -63.33 -42.52 98.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.271 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.99 -45.15 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 C-N-CA 120.88 -0.328 . . . . 1.0 111.117 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.555 ' SD ' HG11 ' D' ' 55' ' ' VAL . 76.1 mtm -62.03 -40.13 94.65 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.255 -0.43 . . . . 1.0 110.564 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.12 -41.58 98.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.403 -0.362 . . . . 1.0 110.229 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.5 77.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.426 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.97 -40.49 97.19 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 110.696 -0.962 . . . . 1.0 110.696 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 79' ' ' ILE . 90.5 mt -71.35 -7.48 9.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.501 0.191 . . . . 1.0 111.385 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -96.08 -51.32 4.48 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.833 0.349 . . . . 1.0 110.872 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.9 m -61.61 -50.56 79.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.429 . . . . 1.0 111.067 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.568 ' N ' HG23 ' A' ' 81' ' ' VAL . 38.2 m-85 -65.03 -40.58 95.04 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.452 -0.34 . . . . 1.0 110.809 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.01 -37.23 86.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.724 0.297 . . . . 1.0 110.977 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.556 ' C ' ' H ' ' A' ' 86' ' ' THR . 3.6 tp -62.59 -44.94 95.06 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.888 -0.325 . . . . 1.0 110.905 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 83.4 t -54.38 -3.36 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 C-N-CA 120.529 -0.469 . . . . 1.0 110.414 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.556 ' H ' ' C ' ' A' ' 84' ' ' LEU . 45.4 m -58.58 -42.1 87.28 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 116.182 -0.463 . . . . 1.0 109.84 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.561 ' HB2' ' CB ' ' D' ' 92' ' ' ASP . . . -41.44 -63.04 0.76 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.051 -0.522 . . . . 1.0 111.115 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.43 -38.94 85.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.295 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.87 -43.94 97.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.309 -0.405 . . . . 1.0 110.862 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.551 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -66.12 -34.2 77.52 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.199 0.523 . . . . 1.0 109.903 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.478 ' OG1' ' CB ' ' D' ' 93' ' ' PHE . 0.2 OUTLIER -76.19 -3.64 37.44 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.732 -0.667 . . . . 1.0 110.414 -179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.27 -48.94 77.61 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.144 -0.48 . . . . 1.0 111.434 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 14.0 p90 -65.47 -36.05 82.73 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.887 0.375 . . . . 1.0 111.387 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.525 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 61.1 t -49.44 -28.78 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.216 -0.447 . . . . 1.0 111.229 -178.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 36.2 ttm180 -71.52 -21.36 61.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.593 -0.276 . . . . 1.0 111.085 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' NH2' ' OE2' ' A' ' 97' ' ' GLU . 19.0 ptt-85 -50.91 -40.67 57.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.398 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.514 ' C ' ' H ' ' A' ' 99' ' ' GLU . 97.5 mt-10 -75.65 168.85 19.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.096 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 57.84 0.85 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.615 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.514 ' H ' ' C ' ' A' ' 97' ' ' GLU . 80.5 tt0 -101.5 -31.72 10.75 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.212 179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -61.62 -45.41 94.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 1.0 110.16 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -79.9 -17.37 53.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.935 -0.575 . . . . 1.0 110.455 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.83 14.53 80.78 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.024 -0.83 . . . . 1.0 111.024 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 86.5 t60 . . . . . 0 C--O 1.22 -0.476 0 CA-C-O 117.904 -1.046 . . . . 1.0 110.625 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . 0.411 ' OG ' ' N ' ' B' ' 2' ' ' ALA . 47.6 t . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.375 -0.602 . . . . 1.0 109.375 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.411 ' N ' ' OG ' ' B' ' 1' ' ' SER . . . -173.08 -109.4 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.487 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -132.98 -45.32 0.86 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.547 -0.297 . . . . 1.0 110.53 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . . . . . . . . . 25.4 p-80 -73.51 -31.24 63.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.264 -0.425 . . . . 1.0 110.673 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -66.02 -39.26 90.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 1.0 110.87 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -64.89 -38.28 90.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.0 110.653 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -58.41 -43.73 88.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.782 -0.451 . . . . 1.0 109.782 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.63 -42.5 95.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.52 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -67.84 -40.11 83.76 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.358 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.33 -34.55 78.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 1.0 110.562 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.64 -36.75 72.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 1.0 110.796 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -61.34 -36.52 80.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.46 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -64.7 -36.27 83.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.922 0.392 . . . . 1.0 110.347 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -65.22 -33.08 75.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.514 . . . . 1.0 110.403 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.17 -41.67 98.54 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.554 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -61.98 -38.92 90.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.767 -179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -61.89 -39.65 92.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.794 0.331 . . . . 1.0 110.851 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 97.2 t -63.07 -42.76 97.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 1.0 110.696 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.512 HD21 ' HB2' ' B' ' 52' ' ' ALA . 97.0 mt -60.54 -41.05 93.7 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.04 -0.356 . . . . 1.0 110.04 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -59.12 -47.89 83.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.088 0.47 . . . . 1.0 109.887 179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.13 -38.36 78.81 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.0 -0.546 . . . . 1.0 109.787 179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.27 -38.42 90.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.032 -0.531 . . . . 1.0 110.836 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 88.0 p -55.44 -43.55 75.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.293 -0.412 . . . . 1.0 110.234 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -65.58 -35.33 80.51 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.321 179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -72.87 -43.41 62.59 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.694 -0.402 . . . . 1.0 110.196 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . 0.408 ' O ' ' CG ' ' B' ' 30' ' ' GLU . . . -59.27 -50.93 72.1 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.61 -0.436 . . . . 1.0 111.383 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.55 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.3 p -62.69 -46.47 96.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 120.31 -0.556 . . . . 1.0 110.55 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.55 ' N ' HG13 ' B' ' 27' ' ' VAL . 45.4 tp10 -67.48 -43.97 79.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.217 -0.447 . . . . 1.0 110.796 -179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.23 -38.71 82.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.102 -0.499 . . . . 1.0 110.329 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.408 ' CG ' ' O ' ' B' ' 26' ' ' ALA . 17.6 mm-40 -64.77 -40.27 94.99 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.425 -0.352 . . . . 1.0 110.749 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -64.43 131.49 47.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.354 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.14 1.87 81.24 Favored Glycine 0 CA--C 1.527 0.838 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -105.24 146.84 33.51 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.82 -0.223 . . . . 1.0 110.438 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . 0.533 ' O ' HG11 ' B' ' 63' ' ' VAL . 95.1 Cg_endo -75.56 142.46 26.25 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 C-N-CA 122.322 2.015 . . . . 1.0 112.327 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.75 19.59 69.49 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.143 -0.783 . . . . 1.0 111.143 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.38 81.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.815 0.34 . . . . 1.0 110.604 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.68 -28.06 69.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 1.0 110.511 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.629 ' C ' HD23 ' B' ' 38' ' ' LEU . 6.3 tt -89.81 119.12 29.92 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.27 0.557 . . . . 1.0 110.176 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.561 ' N ' HD23 ' B' ' 38' ' ' LEU . 39.1 pt -143.11 168.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.326 -0.852 . . . . 1.0 109.765 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' B' ' 39' ' ' ILE . 1.1 t 78.78 129.6 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.0 111.012 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.587 ' N ' ' HD2' ' B' ' 42' ' ' PRO . 22.4 t80 -72.76 -46.78 9.13 Favored Pre-proline 0 CA--C 1.539 0.53 0 CA-C-N 115.603 -0.726 . . . . 1.0 111.026 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' B' ' 41' ' ' TYR . 26.0 Cg_endo -58.61 -31.13 93.98 Favored 'Trans proline' 0 N--CA 1.498 1.75 0 C-N-CA 121.358 1.372 . . . . 1.0 112.94 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -96.61 -11.79 24.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.869 0.366 . . . . 1.0 110.655 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.11 -38.66 91.87 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.274 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 tt -65.03 -30.21 49.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.024 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.468 ' CZ2' ' CB ' ' C' ' 68' ' ' ARG . 7.7 t90 -59.99 -49.36 77.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 1.0 110.869 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.449 ' CE3' ' N ' ' B' ' 48' ' ' SER . 0.3 OUTLIER -68.29 -34.05 75.45 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.891 -0.323 . . . . 1.0 110.303 179.216 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.459 ' O ' HD22 ' B' ' 19' ' ' LEU . 38.3 p -67.69 54.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.305 -0.407 . . . . 1.0 110.706 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 70.3 t -147.22 -52.55 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.654 -0.248 . . . . 1.0 110.77 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -66.71 -32.8 74.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.833 0.349 . . . . 1.0 110.613 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.443 ' H ' HG22 ' B' ' 51' ' ' THR . 0.0 OUTLIER -56.92 -45.15 82.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.366 -0.379 . . . . 1.0 111.145 -179.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.512 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -57.1 -26.3 60.21 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.028 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.447 ' OG1' HG22 ' B' ' 55' ' ' VAL . 51.0 p -88.21 -1.43 58.01 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 120.694 0.283 . . . . 1.0 110.795 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 15.6 p 51.68 64.75 1.72 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.962 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.529 HG23 ' N ' ' B' ' 56' ' ' GLY . 21.6 m -133.66 -47.9 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.092 0 CA-C-N 116.386 -0.37 . . . . 1.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.529 ' N ' HG23 ' B' ' 55' ' ' VAL . . . 41.21 82.08 0.02 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.03 -0.828 . . . . 1.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -62.19 -42.0 98.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.707 0.289 . . . . 1.0 111.084 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 150.7 -2.5 0.47 Allowed Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.318 -0.713 . . . . 1.0 111.318 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . 0.524 ' OD2' ' CE2' ' C' ' 61' ' ' TYR . 96.7 m-20 -48.05 -66.39 0.41 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.811 0.339 . . . . 1.0 110.658 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 52.9 mtt-85 -138.39 161.09 37.86 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.34 -0.391 . . . . 1.0 109.978 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -146.92 138.14 13.03 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.287 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.91 -172.33 0.48 Allowed 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.815 1.677 . . . . 1.0 112.081 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.558 HG12 ' H ' ' B' ' 64' ' ' THR . 1.9 t -128.84 -143.06 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.991 -0.549 . . . . 1.0 110.019 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.558 ' H ' HG12 ' B' ' 63' ' ' VAL . 4.3 m -110.96 -42.04 4.08 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.664 0.269 . . . . 1.0 110.934 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.576 ' C ' ' H ' ' B' ' 67' ' ' GLY . 46.2 tp10 -66.2 -34.4 77.94 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 110.061 -0.348 . . . . 1.0 110.061 -179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.502 ' CG ' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -75.44 33.63 0.11 Allowed 'General case' 0 C--O 1.266 1.959 0 CA-C-O 123.961 1.838 . . . . 1.0 109.744 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.726 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 38.72 63.29 1.04 Allowed Glycine 0 C--O 1.214 -1.146 0 CA-C-N 113.393 -1.73 . . . . 1.0 111.175 178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.605 HH22 HG21 ' A' ' 49' ' ' VAL . 59.6 ttp85 -23.57 -33.23 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.151 0.975 . . . . 1.0 110.763 -178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.726 ' N ' ' O ' ' B' ' 67' ' ' GLY . 63.7 mttp -48.29 -17.79 0.17 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 109.277 -0.638 . . . . 1.0 109.277 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.588 ' N ' ' O ' ' B' ' 67' ' ' GLY . 52.2 t -61.65 -49.29 84.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.887 0 C-N-CA 119.482 -0.887 . . . . 1.0 109.97 179.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.9 -37.94 64.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.5 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -56.28 -41.76 76.38 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.029 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -61.76 -43.02 99.68 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.978 -0.556 . . . . 1.0 110.307 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 79.7 t -63.94 -46.89 92.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 120.682 -0.407 . . . . 1.0 111.162 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.439 ' SD ' HG21 ' A' ' 55' ' ' VAL . 74.4 mtm -62.62 -43.33 99.09 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.774 -0.37 . . . . 1.0 110.637 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -65.43 -42.53 92.36 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.156 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.86 93.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.58 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.15 -42.41 94.41 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 111.362 -0.695 . . . . 1.0 111.362 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.0 -43.75 99.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 121.019 -0.272 . . . . 1.0 110.704 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' B' ' 84' ' ' LEU . 81.0 mm-40 -59.01 -45.58 90.32 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.66 -0.416 . . . . 1.0 110.429 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.46 -49.09 85.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.344 -0.389 . . . . 1.0 111.269 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.413 ' O ' HG22 ' B' ' 85' ' ' VAL . 32.9 m-85 -70.89 -22.77 62.23 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.031 -0.532 . . . . 1.0 110.582 -179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.2 -22.29 19.13 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.507 -0.315 . . . . 1.0 110.301 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.48 ' N ' ' O ' ' B' ' 80' ' ' GLU . 6.8 tt -63.98 -40.85 97.31 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-O 120.723 0.297 . . . . 1.0 110.206 179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' B' ' 87' ' ' ALA . 11.1 m -50.58 -27.85 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 120.458 -0.497 . . . . 1.0 109.749 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.415 ' C ' ' O ' ' B' ' 85' ' ' VAL . 15.6 m -33.36 -31.19 0.01 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-O 121.449 0.642 . . . . 1.0 110.016 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.553 ' N ' ' O ' ' B' ' 85' ' ' VAL . . . -52.82 -57.35 10.5 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.355 -0.839 . . . . 1.0 109.651 179.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . 0.539 ' O ' ' N ' ' B' ' 92' ' ' ASP . . . -65.02 -33.81 76.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.252 -0.431 . . . . 1.0 111.153 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.418 HD12 ' N ' ' B' ' 89' ' ' LEU . 9.0 mp -60.04 -44.28 94.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.922 0.392 . . . . 1.0 109.986 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . . . . . . . . . . . -73.87 -19.25 60.78 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.925 -0.58 . . . . 1.0 109.864 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.527 ' OG1' ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -98.82 -11.06 22.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.62 -0.718 . . . . 1.0 110.485 -179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.539 ' N ' ' O ' ' B' ' 88' ' ' ALA . 89.9 m-20 -62.56 -40.99 98.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.139 -0.482 . . . . 1.0 110.75 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.417 ' CD2' ' CB ' ' C' ' 90' ' ' ALA . 1.7 p90 -71.34 -29.27 64.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 1.0 111.082 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . 0.48 ' O ' ' N ' ' B' ' 96' ' ' ARG . 91.4 t -60.8 -43.9 96.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 1.0 111.773 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -40.98 -22.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.679 0.276 . . . . 1.0 111.311 -179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' B' ' 94' ' ' VAL . 44.7 ptt85 -62.95 -37.25 86.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.064 0.459 . . . . 1.0 110.336 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -60.11 -35.74 75.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.64 -0.709 . . . . 1.0 110.874 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.19 -36.32 83.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.864 0.364 . . . . 1.0 110.453 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.49 -30.51 71.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 72.6 ttp85 -59.49 -44.31 93.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.328 -0.396 . . . . 1.0 110.622 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 84.1 mtt85 -77.21 -18.9 57.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.369 -0.378 . . . . 1.0 110.481 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.02 14.69 76.64 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.139 -0.784 . . . . 1.0 111.139 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 . . . . . 0 C--O 1.221 -0.445 0 CA-C-O 117.99 -1.005 . . . . 1.0 110.567 -179.971 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.473 -0.566 . . . . 1.0 109.473 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . 0.474 ' HB1' ' CD2' ' C' ' 4' ' ' HIS . . . -153.46 151.1 29.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.718 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' C' ' 4' ' ' HIS . 42.3 p-10 -65.4 -36.03 82.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.072 -0.513 . . . . 1.0 110.383 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . 0.597 ' ND1' ' N ' ' C' ' 5' ' ' GLU . 19.2 p80 -67.55 -38.94 84.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.036 -0.529 . . . . 1.0 111.029 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . 0.597 ' N ' ' ND1' ' C' ' 4' ' ' HIS . 80.4 tt0 -63.11 -36.64 84.28 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.387 -0.37 . . . . 1.0 110.645 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -62.16 -40.23 95.29 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.855 -0.338 . . . . 1.0 110.136 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -65.62 -40.86 93.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.0 110.282 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.6 -39.78 94.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.044 -0.526 . . . . 1.0 110.354 179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -65.36 -32.54 74.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.366 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.67 -37.99 88.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.16 -0.473 . . . . 1.0 110.399 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . 0.419 ' HB1' HG13 ' C' ' 81' ' ' VAL . . . -69.23 -24.26 63.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.341 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -67.71 -54.2 21.32 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.806 0.336 . . . . 1.0 111.643 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.79 -30.51 70.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.28 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -63.8 -37.45 87.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.705 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . . . . . . . . . 47.1 tp -63.53 -36.9 85.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.081 0.467 . . . . 1.0 110.192 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.66 -32.5 73.85 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.703 -0.399 . . . . 1.0 111.443 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.43 -47.47 81.81 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.806 0.299 . . . . 1.0 111.806 -179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 12.5 m -64.93 -32.44 58.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.903 0.382 . . . . 1.0 111.053 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.689 HD21 ' HB2' ' C' ' 52' ' ' ALA . 41.3 mt -60.17 -40.67 90.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.146 -0.479 . . . . 1.0 109.893 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -60.96 -43.55 98.6 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.494 -0.558 . . . . 1.0 109.494 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -68.77 -33.11 73.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.0 110.124 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.556 ' O ' ' HB2' ' C' ' 26' ' ' ALA . . . -61.89 -41.39 97.84 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.508 . . . . 1.0 110.647 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 77.4 p -61.67 -38.77 89.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.514 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -64.58 -74.69 0.1 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.301 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -47.64 -33.04 6.22 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.507 -0.477 . . . . 1.0 110.565 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . 0.556 ' HB2' ' O ' ' C' ' 22' ' ' ALA . . . -54.37 -52.56 61.26 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.725 -0.216 . . . . 1.0 111.471 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . 0.439 HG22 ' HE ' ' C' ' 31' ' ' ARG . 1.0 OUTLIER -67.17 -39.67 83.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 C-N-CA 120.474 -0.49 . . . . 1.0 110.29 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -67.09 -32.43 73.59 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.562 -0.745 . . . . 1.0 110.877 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' C' ' 66' ' ' GLU . . . -55.01 -39.57 69.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.198 -179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.45 ' OE1' ' N ' ' C' ' 38' ' ' LEU . 4.3 mt-10 -95.13 -136.37 0.22 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.61 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . 0.525 ' NH1' ' O ' ' C' ' 39' ' ' ILE . 35.6 mmt180 58.82 57.64 3.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.881 -0.6 . . . . 1.0 111.115 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 131.33 11.16 2.27 Favored Glycine 0 N--CA 1.47 0.942 0 CA-C-N 116.001 -0.545 . . . . 1.0 111.861 178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . 0.51 ' HB3' ' OE2' ' C' ' 66' ' ' GLU . . . -106.72 147.61 35.34 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 109.888 -0.412 . . . . 1.0 109.888 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -75.87 147.15 30.43 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.275 1.983 . . . . 1.0 111.921 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.0 14.81 61.77 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.132 -0.787 . . . . 1.0 111.132 179.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.17 141.67 57.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.706 0.289 . . . . 1.0 110.475 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.22 -21.81 5.77 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.23 -0.441 . . . . 1.0 110.567 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.45 ' N ' ' OE1' ' C' ' 30' ' ' GLU . 5.0 tt -107.66 85.37 2.11 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.981 0.42 . . . . 1.0 109.917 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.525 ' O ' ' NH1' ' C' ' 31' ' ' ARG . 39.6 pt -114.37 35.1 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 115.793 -0.64 . . . . 1.0 110.523 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . . . . . . . . . 5.1 m -134.52 140.9 46.5 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.069 -0.514 . . . . 1.0 110.767 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.471 ' N ' ' HD2' ' C' ' 42' ' ' PRO . 16.9 t80 -85.3 -52.06 0.5 Allowed Pre-proline 0 CA--C 1.539 0.529 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.95 179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' C' ' 41' ' ' TYR . 28.4 Cg_endo -59.76 -32.37 95.5 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 121.394 1.396 . . . . 1.0 112.314 179.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -89.87 -3.76 57.92 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.622 -0.263 . . . . 1.0 111.101 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.42 -39.89 94.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.821 0.343 . . . . 1.0 110.639 -179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 tt -66.04 -32.67 59.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.321 -0.399 . . . . 1.0 110.802 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -63.41 -46.74 84.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 1.0 110.754 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . 0.457 ' CE3' ' N ' ' C' ' 48' ' ' SER . 0.1 OUTLIER -66.25 -29.93 70.27 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.319 -0.622 . . . . 1.0 109.319 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.52 ' O ' HD22 ' C' ' 19' ' ' LEU . 50.4 p -70.07 -9.3 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.192 -0.458 . . . . 1.0 110.973 -178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' C' ' 51' ' ' THR . 25.6 t -90.3 -48.77 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.994 -0.282 . . . . 1.0 111.147 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -76.07 32.32 0.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.715 -0.394 . . . . 1.0 111.483 -179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . 0.478 HG23 ' N ' ' C' ' 52' ' ' ALA . 10.2 t -133.89 -41.05 0.84 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.504 0.193 . . . . 1.0 111.273 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.689 ' HB2' HD21 ' C' ' 19' ' ' LEU . . . -66.16 -14.82 62.46 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.053 -0.259 . . . . 1.0 110.771 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.479 ' OG1' HG13 ' C' ' 55' ' ' VAL . 71.0 p -98.96 8.4 45.05 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.937 0.399 . . . . 1.0 110.235 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.9 p 53.83 45.37 27.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.83 -0.623 . . . . 1.0 110.975 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.51 HG23 ' N ' ' C' ' 56' ' ' GLY . 27.7 m -103.79 -44.95 9.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.739 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . 0.51 ' N ' HG23 ' C' ' 55' ' ' VAL . . . 44.29 73.26 0.27 Allowed Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -44.28 96.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.599 0.237 . . . . 1.0 110.398 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.04 10.85 7.25 Favored Glycine 0 N--CA 1.465 0.606 0 N-CA-C 110.874 -0.89 . . . . 1.0 110.874 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.66 -49.24 78.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.905 0.383 . . . . 1.0 110.378 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . . . . . . . . . 90.2 mtm-85 -147.72 162.11 39.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.855 -0.611 . . . . 1.0 109.846 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . 0.524 ' CE2' ' OD2' ' B' ' 59' ' ' ASP . 48.7 t80 -163.77 136.48 4.05 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 120.79 -0.364 . . . . 1.0 110.39 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.75 161.4 46.09 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 121.727 1.618 . . . . 1.0 112.565 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' C' ' 66' ' ' GLU . 3.0 t -110.33 165.89 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 116.258 -0.428 . . . . 1.0 110.019 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.532 ' O ' ' N ' ' C' ' 67' ' ' GLY . 21.5 m -41.17 -66.53 0.32 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.562 -0.29 . . . . 1.0 111.178 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -46.65 -17.74 0.05 Allowed 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 120.517 -0.473 . . . . 1.0 110.319 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' C' ' 63' ' ' VAL . 18.0 mt-10 -101.01 27.57 5.95 Favored 'General case' 0 C--O 1.269 2.119 0 CA-C-O 124.481 2.086 . . . . 1.0 109.24 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . 0.661 ' O ' ' N ' ' C' ' 69' ' ' LYS . . . 39.27 64.11 1.02 Allowed Glycine 0 C--O 1.219 -0.819 0 CA-C-N 113.26 -1.791 . . . . 1.0 111.597 177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' C' ' 70' ' ' VAL . 0.3 OUTLIER -24.43 -37.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 118.054 0.927 . . . . 1.0 110.186 -178.011 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.661 ' N ' ' O ' ' C' ' 67' ' ' GLY . 99.0 mttt -43.24 -19.08 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-N 114.46 -1.245 . . . . 1.0 109.758 178.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' C' ' 67' ' ' GLY . 55.7 t -60.51 -46.77 94.9 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 118.718 -1.193 . . . . 1.0 110.25 179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.62 -45.67 51.55 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.769 0.319 . . . . 1.0 111.707 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -62.58 -42.01 99.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.331 -0.395 . . . . 1.0 111.106 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -58.03 -49.47 76.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.35 -0.387 . . . . 1.0 111.285 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.24 -43.4 84.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.724 -0.391 . . . . 1.0 111.253 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 48.2 ttm -59.48 -40.07 85.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.354 -0.385 . . . . 1.0 110.728 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 31.9 ttmt -60.77 -38.46 85.31 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.739 -179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.26 -36.96 81.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.44 . . . . 1.0 110.692 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.61 -39.74 97.0 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 121.173 -0.537 . . . . 1.0 111.834 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.64 -42.97 98.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 120.913 -0.315 . . . . 1.0 110.774 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -62.85 -40.27 96.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.348 -0.387 . . . . 1.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . 0.419 HG13 ' HB1' ' C' ' 11' ' ' ALA . 53.3 t -63.68 -48.07 88.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.943 -0.303 . . . . 1.0 111.364 -179.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -75.76 -8.08 55.98 Favored 'General case' 0 C--N 1.33 -0.239 0 C-N-CA 120.692 -0.403 . . . . 1.0 111.343 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.53 -45.07 10.8 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.853 0.359 . . . . 1.0 110.446 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.427 ' C ' ' N ' ' C' ' 86' ' ' THR . 7.0 tt -63.21 -42.85 99.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.113 -0.494 . . . . 1.0 111.689 -179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 34.9 m -51.82 -11.93 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.558 -0.457 . . . . 1.0 110.667 -179.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.427 ' N ' ' C ' ' C' ' 84' ' ' LEU . 25.4 m -63.76 -25.4 68.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.316 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -56.81 -28.57 61.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.022 -0.535 . . . . 1.0 110.376 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -90.51 -13.28 34.98 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.269 -0.423 . . . . 1.0 110.561 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . . . . . . . . . 85.9 mt -85.3 -32.69 22.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.276 -0.42 . . . . 1.0 111.072 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.541 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -64.83 -37.89 89.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 1.0 110.587 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.59 -6.0 37.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.033 -0.53 . . . . 1.0 109.949 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.454 ' CG ' ' HB2' ' D' ' 87' ' ' ALA . 40.8 t0 -63.21 -43.9 96.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.286 -0.415 . . . . 1.0 111.06 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 18.9 p90 -84.62 -28.15 26.69 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.342 -0.39 . . . . 1.0 111.561 -179.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 60.0 t -59.47 -42.51 88.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.221 -0.445 . . . . 1.0 111.213 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -51.83 -21.9 3.26 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.929 -0.308 . . . . 1.0 111.223 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . 0.455 ' CG ' ' N ' ' C' ' 97' ' ' GLU . 24.0 ptt-85 -50.6 -44.79 57.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 120.889 -0.324 . . . . 1.0 110.591 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.506 ' C ' ' H ' ' C' ' 99' ' ' GLU . 8.4 pt-20 -86.7 162.56 17.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.267 -0.424 . . . . 1.0 110.553 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 72.83 -38.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.556 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' C' ' 97' ' ' GLU . 81.8 tt0 -65.85 -50.74 63.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.924 -0.58 . . . . 1.0 111.132 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . 0.445 HH22 ' NH2' ' C' ' 101' ' ' ARG . 73.5 ttp85 -66.59 -43.41 84.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.054 0.454 . . . . 1.0 110.46 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . 0.445 ' NH2' HH22 ' C' ' 100' ' ' ARG . 29.9 mmt180 -66.68 -36.79 83.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 1.0 110.505 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 96.64 18.81 29.12 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.8 -0.92 . . . . 1.0 110.8 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 66.8 t60 . . . . . 0 C--O 1.221 -0.435 0 CA-C-O 117.933 -1.032 . . . . 1.0 110.721 179.782 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . . . . . . . . . 32.1 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.4 -0.592 . . . . 1.0 109.4 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . . . . . . . . . . . -66.88 145.05 55.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.444 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -62.5 -41.04 98.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.54 ' ND1' ' N ' ' D' ' 5' ' ' GLU . 20.3 p80 -66.7 -40.07 88.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.365 -0.38 . . . . 1.0 110.948 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . 0.54 ' N ' ' ND1' ' D' ' 4' ' ' HIS . 81.1 tt0 -62.26 -38.42 89.21 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.495 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 63.2 ttm-85 -61.09 -42.35 98.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.291 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -64.13 -41.13 97.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.34 -0.391 . . . . 1.0 110.099 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.26 -40.47 94.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.807 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -65.9 -41.39 91.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.864 0.364 . . . . 1.0 110.367 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -63.81 -33.78 76.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.506 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.28 -35.98 72.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.076 -0.511 . . . . 1.0 110.972 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.81 -36.3 80.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.726 0.298 . . . . 1.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -65.02 -37.32 87.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.927 0.394 . . . . 1.0 110.619 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 tp10 -62.31 -34.83 77.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 1.0 110.234 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . 0.545 HD13 ' HA2' ' D' ' 78' ' ' GLY . 43.3 tp -62.34 -44.69 95.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.254 -0.579 . . . . 1.0 110.306 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -56.41 -33.92 66.24 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.992 -0.283 . . . . 1.0 111.366 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -61.12 -44.69 96.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.84 -0.344 . . . . 1.0 111.596 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . 0.408 ' H ' HG22 ' D' ' 18' ' ' VAL . 4.9 m -87.37 -37.01 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.654 0.264 . . . . 1.0 111.48 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.438 HD12 ' O ' ' D' ' 19' ' ' LEU . 1.5 tp -60.9 -47.0 88.39 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 109.322 -0.621 . . . . 1.0 109.322 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -63.53 -44.75 93.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.173 -0.467 . . . . 1.0 110.294 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -64.2 -29.86 70.95 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.714 -0.476 . . . . 1.0 109.714 178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' D' ' 19' ' ' LEU . . . -61.43 -39.09 89.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.625 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . . . . . . . . . 85.7 p -61.57 -43.76 98.27 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.793 -0.363 . . . . 1.0 110.602 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -64.82 -34.05 77.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.48 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . 0.419 ' O ' ' N ' ' D' ' 29' ' ' ALA . 44.8 mmtm -78.2 -44.83 24.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.708 -0.397 . . . . 1.0 110.294 179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.476 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -58.22 -49.14 78.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 1.0 111.43 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . 0.548 HG13 ' N ' ' D' ' 28' ' ' GLU . 9.1 p -60.07 -45.31 95.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.249 -0.58 . . . . 1.0 109.526 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.548 ' N ' HG13 ' D' ' 27' ' ' VAL . 11.0 tm-20 -68.13 -35.83 78.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.703 -0.681 . . . . 1.0 110.591 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . 0.419 ' N ' ' O ' ' D' ' 25' ' ' LYS . . . -58.81 -51.96 67.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.476 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 14.0 mp0 -69.79 -32.27 70.66 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.589 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 14.7 tpt180 -50.22 103.35 0.05 Allowed 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 121.051 0.453 . . . . 1.0 111.049 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.87 11.1 44.44 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.671 -0.695 . . . . 1.0 111.475 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.76 140.16 21.36 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 110.525 -0.176 . . . . 1.0 110.525 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.03 142.27 27.57 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 122.107 1.871 . . . . 1.0 112.299 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 60.0 26.42 63.23 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.031 -0.828 . . . . 1.0 111.031 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.65 140.91 56.85 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.809 0.338 . . . . 1.0 110.791 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.81 -22.84 10.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.215 -0.448 . . . . 1.0 110.712 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.407 ' O ' ' CB ' ' D' ' 30' ' ' GLU . 57.4 tp -104.7 121.1 42.89 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.925 0.393 . . . . 1.0 109.956 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.452 ' O ' ' O ' ' D' ' 40' ' ' SER . 34.2 pt -153.48 -164.07 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.955 -0.566 . . . . 1.0 110.372 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . 0.452 ' O ' ' O ' ' D' ' 39' ' ' ILE . 1.3 m 58.26 141.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 1.0 110.687 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.435 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 7.1 m-85 -79.83 -58.42 0.62 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.862 -0.608 . . . . 1.0 111.053 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.99 -26.53 81.89 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 121.584 1.523 . . . . 1.0 111.998 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -87.98 -25.37 23.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.511 -0.313 . . . . 1.0 110.893 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' D' ' 40' ' ' SER . . . -63.69 -39.53 94.54 Favored 'General case' 0 C--N 1.333 -0.126 0 C-N-CA 120.749 -0.38 . . . . 1.0 110.693 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 5.5 tt -60.43 -32.67 51.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.26 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -47.89 81.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.331 -0.395 . . . . 1.0 110.462 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . 0.431 ' CH2' HG21 ' D' ' 51' ' ' THR . 0.2 OUTLIER -76.76 -22.96 53.01 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.73 -0.47 . . . . 1.0 109.73 178.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 6.7 t -62.21 -44.44 96.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.363 -0.38 . . . . 1.0 110.721 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.98 4.3 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.821 0.343 . . . . 1.0 110.898 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . 0.516 ' CG ' ' HE ' ' A' ' 68' ' ' ARG . 50.6 mm-40 -103.22 -49.86 3.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.407 -0.36 . . . . 1.0 110.137 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . 0.46 ' H ' HG22 ' D' ' 51' ' ' THR . 0.0 OUTLIER -63.67 -45.61 89.34 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 1.0 110.19 179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.1 -23.51 47.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.914 0.387 . . . . 1.0 110.085 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . 0.462 ' OG1' HG13 ' D' ' 55' ' ' VAL . 43.4 p -100.45 2.22 41.96 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.985 -0.552 . . . . 1.0 110.388 179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 61.6 p 45.83 70.21 0.39 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.065 -0.516 . . . . 1.0 111.452 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.555 HG11 ' SD ' ' A' ' 75' ' ' MET . 30.0 m -117.63 -42.75 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.591 -0.277 . . . . 1.0 110.702 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . 0.533 ' N ' HG23 ' D' ' 55' ' ' VAL . . . 51.16 63.18 4.8 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 110.678 -0.969 . . . . 1.0 110.678 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -45.51 93.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.692 0.282 . . . . 1.0 110.675 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 127.23 -1.64 7.15 Favored Glycine 0 N--CA 1.466 0.648 0 N-CA-C 110.627 -0.989 . . . . 1.0 110.627 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . . . . . . . . . 42.1 m-20 -60.63 -47.99 83.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.863 0.363 . . . . 1.0 110.546 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . . . . . . . . . 92.8 mtt-85 -142.9 151.49 41.07 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 1.0 109.711 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.438 ' O ' ' CD1' ' D' ' 61' ' ' TYR . 27.4 p90 -145.56 137.68 13.33 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 120.866 -0.334 . . . . 1.0 110.568 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.71 161.69 44.42 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.253 1.968 . . . . 1.0 112.152 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.947 HG22 ' H ' ' D' ' 64' ' ' THR . 8.0 p -104.76 -130.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 CA-C-N 116.105 -0.498 . . . . 1.0 110.0 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.947 ' H ' HG22 ' D' ' 63' ' ' VAL . 23.9 m -114.18 -51.33 2.78 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 111.66 0.245 . . . . 1.0 111.66 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.603 ' C ' ' H ' ' D' ' 67' ' ' GLY . 76.7 tt0 -57.11 -30.51 64.43 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 116.318 -0.401 . . . . 1.0 110.603 -178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.66 ' N ' ' OE1' ' D' ' 66' ' ' GLU . 1.1 pm0 -70.66 19.43 0.05 OUTLIER 'General case' 0 C--O 1.264 1.83 0 CA-C-O 123.651 1.691 . . . . 1.0 109.4 178.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.727 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 44.64 62.19 2.99 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.719 -1.352 . . . . 1.0 109.719 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.458 ' C ' ' O ' ' D' ' 67' ' ' GLY . 59.5 ttm-85 -26.22 -30.07 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 117.831 0.816 . . . . 1.0 110.631 -177.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.727 ' N ' ' O ' ' D' ' 67' ' ' GLY . 65.0 mttm -51.02 -24.14 3.53 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.574 -0.739 . . . . 1.0 109.525 176.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.603 ' N ' ' O ' ' D' ' 67' ' ' GLY . 70.7 t -63.17 -48.4 87.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 C-N-CA 119.769 -0.772 . . . . 1.0 110.362 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.58 -37.07 76.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.657 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -64.05 -40.46 96.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.471 . . . . 1.0 111.089 -179.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -61.43 -47.38 86.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.298 -0.41 . . . . 1.0 111.672 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.96 -36.35 76.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 120.676 -0.41 . . . . 1.0 111.309 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.47 ' SD ' HG11 ' C' ' 55' ' ' VAL . 17.9 mtm -62.54 -42.7 99.7 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 121.092 -0.243 . . . . 1.0 111.438 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.48 -41.64 96.35 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.682 -0.407 . . . . 1.0 110.657 -179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.413 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.4 -40.81 95.72 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.789 -0.365 . . . . 1.0 110.506 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . 0.545 ' HA2' HD13 ' D' ' 15' ' ' LEU . . . -64.44 -41.73 97.89 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.436 -0.666 . . . . 1.0 111.436 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 97.5 mt -63.22 -43.33 98.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 121.04 -0.264 . . . . 1.0 111.051 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -63.46 -39.31 94.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.563 -0.289 . . . . 1.0 111.132 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.413 HG23 ' O ' ' D' ' 77' ' ' ALA . 53.5 t -62.27 -50.37 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.781 -0.368 . . . . 1.0 111.261 -179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -67.48 -39.86 85.24 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.468 -0.493 . . . . 1.0 110.476 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.11 -34.95 79.62 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 1.0 110.552 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' D' ' 86' ' ' THR . 4.3 tt -60.92 -40.01 91.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.438 -0.347 . . . . 1.0 110.274 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . 0.481 HG12 ' O ' ' D' ' 85' ' ' VAL . 97.9 t -48.49 -10.11 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.844 0.354 . . . . 1.0 110.389 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.519 ' N ' ' O ' ' D' ' 84' ' ' LEU . 22.6 m -49.28 -39.25 30.17 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.093 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.454 ' HB2' ' CG ' ' C' ' 92' ' ' ASP . . . -49.96 -17.94 0.46 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.02 -0.536 . . . . 1.0 110.392 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.456 ' O ' ' OD1' ' D' ' 92' ' ' ASP . . . -104.87 -12.2 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.737 0.303 . . . . 1.0 110.252 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.458 ' N ' ' O ' ' D' ' 86' ' ' THR . 87.5 mt -87.54 -64.73 1.1 Allowed 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.336 -0.393 . . . . 1.0 111.36 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.542 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -58.13 -9.49 1.46 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.275 0.559 . . . . 1.0 109.944 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.482 ' OG1' ' CB ' ' C' ' 93' ' ' PHE . 0.5 OUTLIER -99.54 -1.12 39.11 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.673 -0.694 . . . . 1.0 110.44 -179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . 0.561 ' CB ' ' HB2' ' A' ' 87' ' ' ALA . 97.5 m-20 -74.57 -39.17 62.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.815 -0.63 . . . . 1.0 111.658 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.573 ' CD1' ' N ' ' D' ' 94' ' ' VAL . 30.7 p90 -84.86 -40.39 17.16 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.666 0.617 . . . . 1.0 112.666 -178.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . 0.573 ' N ' ' CD1' ' D' ' 93' ' ' PHE . 21.2 m -43.34 -36.72 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.8 0.333 . . . . 1.0 111.401 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' D' ' 98' ' ' GLU . 95.2 mtt-85 -57.14 -27.53 61.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -39.93 -35.98 0.41 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.676 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.514 ' OE2' ' NH2' ' D' ' 101' ' ' ARG . 48.7 tp10 -66.83 -39.19 87.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.075 -0.511 . . . . 1.0 110.39 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' D' ' 95' ' ' ARG . 79.7 mm-40 -96.53 -178.79 4.39 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 109.936 -0.394 . . . . 1.0 109.936 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 67.11 -46.11 0.47 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.855 0.722 . . . . 1.0 110.096 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.427 ' H ' ' C ' ' D' ' 98' ' ' GLU . 9.0 tmm_? -63.82 -42.84 97.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.39 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . 0.514 ' NH2' ' OE2' ' D' ' 97' ' ' GLU . 99.6 mtt180 -64.19 -37.4 87.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 1.0 110.481 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.91 4.73 41.92 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.063 -0.815 . . . . 1.0 111.063 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.051 -0.976 . . . . 1.0 110.515 179.734 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.366 -0.605 . . . . 1.0 109.366 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HB1' ' NE2' ' A' ' 4' ' ' HIS . . . -78.46 167.12 21.78 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.07 -0.514 . . . . 1.0 110.71 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -61.06 -45.56 94.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.196 -0.456 . . . . 1.0 110.54 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.628 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 4.0 p80 -67.3 -41.5 85.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.384 -0.371 . . . . 1.0 110.502 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -63.67 -46.02 87.47 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.326 -0.397 . . . . 1.0 110.705 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -65.05 -38.11 89.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.085 -0.507 . . . . 1.0 110.344 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -63.61 -38.22 90.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.197 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.55 -39.52 94.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.0 110.233 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -65.03 -38.63 91.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 1.0 110.343 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -61.26 -41.68 97.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 1.0 110.536 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.58 -38.82 85.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.114 -0.494 . . . . 1.0 110.996 -179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -64.91 -40.38 94.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.621 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.96 -38.15 87.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.332 -0.395 . . . . 1.0 110.447 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 36.2 tp10 -65.6 -32.0 73.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.446 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 47.2 tp -62.1 -44.81 95.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.475 -0.329 . . . . 1.0 110.826 -179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 91.7 mm-40 -60.69 -36.0 77.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 1.0 111.306 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -61.74 -40.77 96.27 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.589 -0.444 . . . . 1.0 111.087 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.4 t -64.25 -31.37 53.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.665 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 52' ' ' ALA . 96.0 mt -61.68 -42.12 98.49 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.81 -0.441 . . . . 1.0 109.81 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -63.14 -51.33 66.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.355 -0.384 . . . . 1.0 110.268 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -65.84 -37.46 86.25 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.435 . . . . 1.0 110.204 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.58 -36.35 83.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.01 -0.541 . . . . 1.0 110.772 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 27' ' ' VAL . 0.0 OUTLIER -59.48 -39.69 84.55 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.958 -0.386 . . . . 1.0 109.958 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -61.94 -55.1 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.523 -0.471 . . . . 1.0 110.538 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -60.69 -43.31 97.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 1.0 110.612 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.68 -23.1 39.57 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.809 -0.356 . . . . 1.0 110.965 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 23' ' ' SER . 83.2 t -92.45 -50.53 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 CA-C-O 120.929 0.395 . . . . 1.0 110.396 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -65.33 -42.32 93.03 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.604 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -50.85 -34.73 29.17 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.797 -0.445 . . . . 1.0 109.797 179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 64.8 mm-40 -78.98 -114.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.478 -0.328 . . . . 1.0 110.486 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 45.55 78.99 0.06 Allowed 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.88 0.372 . . . . 1.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 105.82 -6.76 41.12 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 111.437 -0.665 . . . . 1.0 111.437 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.12 136.14 57.68 Favored Pre-proline 0 CA--C 1.537 0.467 0 C-N-CA 120.766 -0.373 . . . . 1.0 110.295 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -75.24 140.96 25.4 Favored 'Trans proline' 0 N--CA 1.495 1.573 0 C-N-CA 121.971 1.781 . . . . 1.0 112.286 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 61' ' ' TYR . . . 64.27 22.13 66.97 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.046 -0.822 . . . . 1.0 111.046 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 38' ' ' LEU . . . -60.96 -48.07 83.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.789 0.328 . . . . 1.0 110.758 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . 58.89 0.6 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.082 -0.508 . . . . 1.0 110.697 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.593 HD23 ' C ' ' A' ' 38' ' ' LEU . 5.1 tt -131.48 114.59 15.1 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.78 0.324 . . . . 1.0 110.15 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.552 ' N ' HD23 ' A' ' 38' ' ' LEU . 23.5 pt -157.96 54.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.122 179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 6.2 m -153.48 118.19 5.0 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.856 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.511 ' N ' ' HD2' ' A' ' 42' ' ' PRO . 47.6 m-85 -55.37 -50.33 87.36 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.119 -0.491 . . . . 1.0 112.028 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 41' ' ' TYR . 28.8 Cg_endo -59.72 -34.08 96.22 Favored 'Trans proline' 0 N--CA 1.502 1.985 0 C-N-CA 121.546 1.497 . . . . 1.0 112.6 -179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.409 ' HB3' HH21 ' A' ' 60' ' ' ARG . 61.5 m-20 -92.52 -8.11 45.41 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.676 0.274 . . . . 1.0 110.82 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' HB2' ' CG2' ' A' ' 27' ' ' VAL . . . -62.64 -45.14 94.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.848 0.356 . . . . 1.0 110.386 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 46' ' ' TRP . 4.0 tt -69.41 -41.86 80.87 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 CA-C-N 116.011 -0.541 . . . . 1.0 110.152 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.517 ' N ' HG23 ' A' ' 45' ' ' ILE . 3.3 t-105 -55.35 -43.13 74.72 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.665 -0.495 . . . . 1.0 109.665 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -66.16 -38.46 88.14 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.715 -0.476 . . . . 1.0 109.715 177.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.4 ' O ' HD22 ' A' ' 19' ' ' LEU . 3.5 t -65.05 -24.58 67.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.101 -0.5 . . . . 1.0 111.249 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.03 -49.76 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 120.811 -0.355 . . . . 1.0 110.605 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -75.35 -24.02 57.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.0 110.462 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 m -62.5 -45.76 91.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.392 -0.367 . . . . 1.0 110.529 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 19' ' ' LEU . . . -62.13 -35.21 78.06 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.327 -0.397 . . . . 1.0 110.618 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 45.2 p -75.41 4.14 7.87 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 p 41.5 73.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.527 -0.761 . . . . 1.0 111.17 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.433 HG21 ' CZ ' ' A' ' 57' ' ' TYR . 3.9 p -139.05 -36.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.851 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 38.95 76.37 0.08 OUTLIER Glycine 0 CA--C 1.53 1.006 0 N-CA-C 111.335 -0.706 . . . . 1.0 111.335 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CZ ' HG21 ' A' ' 55' ' ' VAL . 57.9 m-85 -60.58 -45.21 94.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.851 0.358 . . . . 1.0 110.745 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 144.52 17.67 0.2 Allowed Glycine 0 CA--C 1.529 0.912 0 N-CA-C 111.187 -0.765 . . . . 1.0 111.187 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -63.42 -42.26 98.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 1.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 61' ' ' TYR . 35.7 mmt180 -127.98 -170.48 2.25 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.095 -0.502 . . . . 1.0 110.251 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.525 ' CG ' ' O ' ' A' ' 60' ' ' ARG . 51.4 m-85 -162.18 88.51 1.44 Allowed Pre-proline 0 CA--C 1.536 0.423 0 C-N-CA 120.787 -0.365 . . . . 1.0 111.002 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -69.37 156.14 65.24 Favored 'Trans proline' 0 N--CA 1.497 1.733 0 C-N-CA 121.905 1.737 . . . . 1.0 112.221 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.995 HG22 ' H ' ' A' ' 64' ' ' THR . 7.4 p -128.16 -171.77 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-O 121.221 0.534 . . . . 1.0 110.629 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.995 ' H ' HG22 ' A' ' 63' ' ' VAL . 98.9 m -69.44 -43.85 72.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.824 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 67' ' ' GLY . 46.8 tp10 -48.1 -49.52 31.54 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.635 -0.505 . . . . 1.0 109.635 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.575 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -80.79 35.55 0.37 Allowed 'General case' 0 C--O 1.258 1.511 0 CA-C-O 123.989 1.852 . . . . 1.0 109.242 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.716 ' O ' ' N ' ' A' ' 69' ' ' LYS . . . 41.52 66.67 0.92 Allowed Glycine 0 C--O 1.212 -1.22 0 CA-C-N 113.303 -1.771 . . . . 1.0 112.085 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.487 ' NH2' ' CG ' ' D' ' 59' ' ' ASP . 58.4 ttm-85 -24.24 -32.84 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.28 0 CA-C-N 118.33 1.065 . . . . 1.0 111.15 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.716 ' N ' ' O ' ' A' ' 67' ' ' GLY . 9.0 mtmp? -53.2 -16.48 1.25 Allowed 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.9 -0.591 . . . . 1.0 109.81 177.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.63 ' N ' ' O ' ' A' ' 67' ' ' GLY . 54.2 t -63.36 -46.94 94.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.539 0 C-N-CA 120.049 -0.661 . . . . 1.0 110.574 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -44.4 54.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 1.0 111.081 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -56.95 -43.29 81.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.183 -0.462 . . . . 1.0 110.349 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -58.2 -41.99 85.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.864 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.4 t -65.36 -45.13 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 C-N-CA 120.578 -0.449 . . . . 1.0 111.177 -179.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 61.9 mtt -61.45 -40.24 93.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.322 -0.399 . . . . 1.0 110.756 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 45.1 tttp -60.48 -42.63 96.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.41 -0.359 . . . . 1.0 110.321 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.75 -38.82 82.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.436 -0.347 . . . . 1.0 110.492 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -66.96 -39.15 93.21 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.727 -0.949 . . . . 1.0 110.727 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.11 -26.65 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.944 -0.302 . . . . 1.0 110.864 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -74.55 -51.83 13.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.819 0.342 . . . . 1.0 111.2 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG23 ' N ' ' A' ' 82' ' ' PHE . 16.6 m -61.41 -48.98 86.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.124 -0.489 . . . . 1.0 111.097 -179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' N ' HG23 ' A' ' 81' ' ' VAL . 16.2 m-85 -64.43 -41.65 96.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.992 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 86' ' ' THR . . . -64.65 -36.94 85.88 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.801 -0.359 . . . . 1.0 111.051 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' O ' ' N ' ' A' ' 86' ' ' THR . 7.2 tt -63.41 -37.42 87.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.194 -0.457 . . . . 1.0 111.356 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 85' ' ' VAL . 90.2 t -45.45 -14.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 C-N-CA 120.772 -0.371 . . . . 1.0 110.482 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 84' ' ' LEU . 41.1 m -51.08 -44.25 61.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 1.0 110.058 179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.446 ' O ' ' CG2' ' A' ' 91' ' ' THR . . . -42.83 -21.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 1.0 110.672 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 86' ' ' THR . . . -104.69 -20.62 13.57 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.921 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 86' ' ' THR . 41.9 mt -84.98 -43.18 14.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.772 0.32 . . . . 1.0 111.222 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.558 ' O ' ' CD2' ' A' ' 93' ' ' PHE . . . -59.29 -38.2 79.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.036 0.446 . . . . 1.0 110.87 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 87' ' ' ALA . 0.1 OUTLIER -65.67 -11.78 47.86 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.997 -0.547 . . . . 1.0 110.283 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.54 ' CB ' ' HB2' ' B' ' 87' ' ' ALA . 67.1 m-20 -59.61 -49.8 76.36 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 120.881 -0.328 . . . . 1.0 111.16 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.558 ' CD2' ' O ' ' A' ' 90' ' ' ALA . 11.3 p90 -75.53 -22.54 57.0 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 120.813 0.34 . . . . 1.0 111.282 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 95.0 t -62.37 -43.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.166 -0.47 . . . . 1.0 111.194 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.82 -20.84 59.36 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.395 -0.366 . . . . 1.0 110.951 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -53.64 -42.66 68.04 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.992 -0.283 . . . . 1.0 110.467 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.3 tp10 -61.17 -41.0 95.99 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.574 -0.528 . . . . 1.0 109.574 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -68.73 -37.46 79.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.669 179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.82 -35.11 79.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.08 -0.509 . . . . 1.0 110.327 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -60.42 -43.68 96.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.051 -0.522 . . . . 1.0 110.325 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 84.9 mtp180 -64.6 -36.03 82.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.282 -0.417 . . . . 1.0 110.305 -179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 97.07 8.06 56.98 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 83.8 t60 . . . . . 0 C--O 1.221 -0.425 0 CA-C-O 117.978 -1.01 . . . . 1.0 110.531 179.883 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.258 -0.645 . . . . 1.0 109.258 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.412 ' HB1' ' CD2' ' B' ' 4' ' ' HIS . . . 41.6 -161.95 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.175 -0.466 . . . . 1.0 110.744 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -125.22 -25.26 3.83 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.368 -0.378 . . . . 1.0 110.766 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' HIS . . . . . 0.568 ' CD2' ' H ' ' B' ' 4' ' ' HIS . 8.5 p80 -78.49 -23.57 46.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.421 -0.354 . . . . 1.0 110.45 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -66.72 -39.45 88.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.226 -0.443 . . . . 1.0 110.743 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ARG . . . . . . . . . . . . . 95.6 mtt-85 -64.35 -38.2 90.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.666 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . . . . . . . . . 81.0 tt0 -61.36 -41.17 96.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.0 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.74 -40.05 94.66 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.045 -0.525 . . . . 1.0 110.839 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 13' ' ' GLU . 99.3 mm-40 -65.7 -38.19 88.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 1.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -61.85 -37.48 84.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 1.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.53 71.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.084 -0.507 . . . . 1.0 110.881 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -63.81 -38.76 92.31 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.908 -0.317 . . . . 1.0 110.554 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' B' ' 9' ' ' GLN . 1.1 mp0 -65.71 -34.82 79.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 1.0 110.315 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 43.2 tp10 -65.47 -38.54 90.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 1.0 110.37 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.405 HD11 ' HB1' ' B' ' 52' ' ' ALA . 53.2 tp -62.78 -42.08 99.54 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.867 -0.333 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.443 ' O ' ' OE2' ' B' ' 20' ' ' GLU . 76.3 mm-40 -63.86 -40.04 95.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 1.0 110.885 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -59.05 -42.1 89.46 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.857 0.36 . . . . 1.0 110.612 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . . . . . . . . . 88.8 t -65.43 -40.84 89.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.968 -0.56 . . . . 1.0 110.673 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' B' ' 52' ' ' ALA . 82.5 mt -59.32 -40.94 87.9 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.829 -0.434 . . . . 1.0 109.829 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' B' ' 20' ' ' GLU . 0.3 OUTLIER -59.82 -48.93 79.69 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.214 -0.661 . . . . 1.0 109.214 178.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.1 -31.01 69.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.922 -0.581 . . . . 1.0 109.992 178.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.81 -44.59 90.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 1.0 110.496 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 75.9 p -59.63 -43.71 93.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 1.0 110.412 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -65.73 -35.48 80.87 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.465 -0.494 . . . . 1.0 110.42 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.19 -47.13 37.67 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.744 -0.383 . . . . 1.0 110.794 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.7 82.57 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 116.558 -0.292 . . . . 1.0 111.086 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' VAL . . . . . 0.546 HG13 ' N ' ' B' ' 28' ' ' GLU . 9.9 p -62.18 -46.31 96.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 120.329 -0.548 . . . . 1.0 110.231 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.546 ' N ' HG13 ' B' ' 27' ' ' VAL . 83.4 tt0 -67.09 -43.78 81.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.531 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.97 -39.79 83.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.066 -0.515 . . . . 1.0 110.337 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -70.39 -33.95 71.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.195 -0.457 . . . . 1.0 110.678 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -66.95 123.96 21.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.014 -0.539 . . . . 1.0 110.53 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.01 0.64 65.83 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.224 -0.75 . . . . 1.0 111.224 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -104.75 140.45 21.09 Favored Pre-proline 0 CA--C 1.535 0.387 0 O-C-N 122.833 -0.216 . . . . 1.0 110.783 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.73 149.74 34.22 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.061 1.841 . . . . 1.0 112.623 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.48 2.85 23.07 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.105 -0.798 . . . . 1.0 111.105 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.68 ' O ' HG22 ' B' ' 39' ' ' ILE . . . -77.43 83.01 3.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.667 0.27 . . . . 1.0 110.699 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.92 -32.5 73.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.951 0.405 . . . . 1.0 110.506 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.821 HD23 ' O ' ' B' ' 38' ' ' LEU . 5.4 tt -58.99 -28.43 66.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.909 -0.587 . . . . 1.0 110.359 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' ILE . . . . . 0.694 HG23 ' O ' ' B' ' 39' ' ' ILE . 20.4 tt -38.26 100.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.182 0.515 . . . . 1.0 110.793 179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.531 ' O ' ' CD2' ' B' ' 41' ' ' TYR . 59.7 m -171.42 -119.72 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.922 -0.581 . . . . 1.0 110.645 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' B' ' 40' ' ' SER . 1.6 m-85 -177.57 -64.88 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.121 -0.49 . . . . 1.0 110.014 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' B' ' 41' ' ' TYR . 21.1 Cg_endo -58.5 -33.43 98.0 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.161 1.907 . . . . 1.0 112.3 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.16 -4.64 51.78 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.665 -0.243 . . . . 1.0 111.015 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ALA . . . . . 0.628 ' HA ' HD21 ' B' ' 38' ' ' LEU . . . -65.03 -40.82 95.39 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.656 -0.418 . . . . 1.0 110.181 179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 6.3 tt -69.76 -37.37 73.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 1.0 110.361 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.612 ' NE1' ' O ' ' C' ' 64' ' ' THR . 2.8 t90 -53.95 -50.99 65.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.301 -0.409 . . . . 1.0 110.711 -178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' TRP . . . . . 0.529 ' CE2' ' OG1' ' B' ' 51' ' ' THR . 3.7 t90 -66.15 -38.32 87.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.428 -0.351 . . . . 1.0 110.401 178.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . 0.443 ' O ' HD22 ' B' ' 19' ' ' LEU . 65.2 m -55.24 -45.33 76.03 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.694 -0.402 . . . . 1.0 111.273 -178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.89 -46.34 94.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 111.807 0.299 . . . . 1.0 111.807 -179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.31 -31.71 72.66 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.611 -0.436 . . . . 1.0 110.6 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' THR . . . . . 0.529 ' OG1' ' CE2' ' B' ' 47' ' ' TRP . 98.2 m -61.93 -44.05 97.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.459 -0.337 . . . . 1.0 111.157 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' B' ' 19' ' ' LEU . . . -55.7 -26.3 44.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.919 -0.312 . . . . 1.0 110.723 -179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . 0.539 ' OG1' HG12 ' B' ' 55' ' ' VAL . 46.3 p -85.68 -2.25 58.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.748 0.309 . . . . 1.0 110.845 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' THR . . . . . . . . . . . . . 12.5 p 57.08 5.53 0.25 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.097 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.539 HG12 ' OG1' ' B' ' 53' ' ' THR . 7.8 p -64.85 -43.8 96.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 1.0 110.784 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' GLY . . . . . 0.523 ' N ' HG13 ' B' ' 55' ' ' VAL . . . 38.55 74.64 0.11 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 111.144 -0.782 . . . . 1.0 111.144 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' TYR . . . . . 0.452 ' CE2' HG21 ' B' ' 55' ' ' VAL . 47.0 m-85 -59.92 -45.84 91.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.663 0.268 . . . . 1.0 110.966 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . 139.53 -0.75 2.26 Favored Glycine 0 CA--C 1.526 0.723 0 N-CA-C 110.828 -0.909 . . . . 1.0 110.828 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -51.06 -65.81 0.49 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.847 0.356 . . . . 1.0 110.084 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -114.28 149.38 36.01 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 109.849 -0.426 . . . . 1.0 109.849 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' TYR . . . . . 0.545 ' O ' ' CG ' ' B' ' 61' ' ' TYR . 22.8 p90 -139.18 112.53 8.03 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 116.204 -0.453 . . . . 1.0 110.602 -179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.46 -171.05 0.41 Allowed 'Trans proline' 0 N--CA 1.496 1.649 0 C-N-CA 121.49 1.46 . . . . 1.0 111.971 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . 0.898 HG22 ' H ' ' B' ' 64' ' ' THR . 7.2 p -133.65 -147.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.093 -0.503 . . . . 1.0 110.391 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' THR . . . . . 0.898 ' H ' HG22 ' B' ' 63' ' ' VAL . 97.9 m -101.79 -42.8 6.03 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.296 -0.411 . . . . 1.0 111.256 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' GLU . . . . . 0.534 ' C ' ' H ' ' B' ' 67' ' ' GLY . 75.1 tt0 -54.79 -38.24 67.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.891 -0.324 . . . . 1.0 110.284 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.45 ' HG2' ' H ' ' B' ' 63' ' ' VAL . 0.0 OUTLIER -77.56 31.66 0.16 Allowed 'General case' 0 C--O 1.259 1.592 0 CA-C-O 123.788 1.756 . . . . 1.0 109.72 178.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' GLY . . . . . 0.692 ' O ' ' N ' ' B' ' 69' ' ' LYS . . . 41.59 63.74 1.57 Allowed Glycine 0 C--O 1.212 -1.267 0 CA-C-N 113.659 -1.61 . . . . 1.0 111.629 177.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ARG . . . . . 0.47 ' C ' ' O ' ' B' ' 67' ' ' GLY . 55.0 ttm-85 -25.28 -33.44 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 118.401 1.101 . . . . 1.0 110.579 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' B' ' 67' ' ' GLY . 67.5 mttm -48.49 -18.4 0.23 Allowed 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.177 -0.675 . . . . 1.0 109.177 176.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.625 ' N ' ' O ' ' B' ' 67' ' ' GLY . 56.1 t -62.3 -47.82 91.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 119.847 -0.741 . . . . 1.0 109.691 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.36 -38.99 68.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.296 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 tp10 -49.17 -43.33 41.94 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.986 -0.552 . . . . 1.0 109.927 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -66.64 -41.14 88.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 1.0 110.985 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.66 -51.66 59.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 C-N-CA 120.37 -0.532 . . . . 1.0 111.696 -178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 22.9 ptp -64.26 -41.01 97.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.739 0.304 . . . . 1.0 110.676 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.14 -39.28 93.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 1.0 110.442 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' ALA . . . . . 0.543 ' O ' HG23 ' B' ' 81' ' ' VAL . . . -61.87 -36.03 80.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.382 . . . . 1.0 110.526 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.89 -39.88 58.53 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.442 -0.663 . . . . 1.0 111.442 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.21 -44.6 99.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 121.112 -0.235 . . . . 1.0 111.483 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -66.88 -35.29 79.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.965 0.412 . . . . 1.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 77' ' ' ALA . 17.9 t -62.27 -71.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.772 -0.649 . . . . 1.0 110.974 -179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' PHE . . . . . 0.433 ' N ' HG12 ' B' ' 81' ' ' VAL . 69.8 m-85 -58.11 -4.8 0.38 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.944 -0.571 . . . . 1.0 110.957 -178.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' B' ' 81' ' ' VAL . . . -97.55 -34.99 10.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.397 -0.365 . . . . 1.0 110.168 179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 4.3 tt -64.47 -40.79 96.36 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.7 -0.4 . . . . 1.0 110.211 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' B' ' 87' ' ' ALA . 14.0 m -58.57 -16.5 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.009 -0.542 . . . . 1.0 109.621 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' B' ' 83' ' ' ALA . 52.5 m -42.43 -24.66 0.06 Allowed 'General case' 0 C--N 1.334 -0.097 0 CA-C-O 121.078 0.466 . . . . 1.0 109.811 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.54 ' HB2' ' CB ' ' A' ' 92' ' ' ASP . . . -62.75 -64.42 0.92 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.611 -0.722 . . . . 1.0 110.845 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.6 -24.06 30.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.397 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' LEU . . . . . 0.496 ' CD2' ' N ' ' B' ' 89' ' ' LEU . 3.2 mm? -87.81 -19.76 27.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.065 -0.516 . . . . 1.0 109.788 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ALA . . . . . 0.562 ' C ' ' H ' ' B' ' 92' ' ' ASP . . . -74.57 -50.55 17.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.459 0.647 . . . . 1.0 109.335 178.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' THR . . . . . 0.406 HG22 ' H ' ' B' ' 91' ' ' THR . 0.4 OUTLIER -54.23 -3.06 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.274 -0.875 . . . . 1.0 110.236 179.112 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' ASP . . . . . 0.562 ' H ' ' C ' ' B' ' 90' ' ' ALA . 91.0 m-20 -58.69 -41.87 87.22 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.454 -0.339 . . . . 1.0 110.866 -179.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' PHE . . . . . 0.512 ' CD2' ' O ' ' B' ' 90' ' ' ALA . 24.3 p90 -70.56 -27.53 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.906 -0.317 . . . . 1.0 111.496 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 65.0 t -60.79 -43.7 95.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.506 -0.315 . . . . 1.0 111.512 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -59.29 -21.35 59.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.558 -0.292 . . . . 1.0 110.932 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 74.3 ttp85 -55.09 -41.73 71.95 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.882 -0.414 . . . . 1.0 109.882 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -61.77 -40.95 96.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.28 -0.418 . . . . 1.0 110.974 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.33 -36.82 83.89 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.84 0.352 . . . . 1.0 110.785 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -65.95 -26.5 67.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.041 -0.527 . . . . 1.0 110.763 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 8.5 tmm_? -60.17 -43.41 95.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.401 -0.363 . . . . 1.0 110.319 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 84.7 mtp180 -64.5 -37.29 87.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.227 -0.442 . . . . 1.0 110.53 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.63 13.4 65.17 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.108 -0.797 . . . . 1.0 111.108 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' HIS . . . . . . . . . . . . . 74.8 m80 . . . . . 0 C--O 1.221 -0.439 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.615 179.785 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' SER . . . . . . . . . . . . . 33.5 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.365 -0.605 . . . . 1.0 109.365 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' ALA . . . . . . . . . . . . . . . 39.3 -106.56 0.06 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.184 -0.462 . . . . 1.0 110.814 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' ASP . . . . . 0.415 ' O ' ' OD1' ' C' ' 3' ' ' ASP . 67.8 t0 -173.74 -33.99 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.202 -0.454 . . . . 1.0 109.924 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -80.4 -17.2 52.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.931 -0.577 . . . . 1.0 110.776 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.23 -39.44 89.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.45 -0.341 . . . . 1.0 110.802 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ARG . . . . . . . . . . . . . 89.7 mtm180 -63.06 -39.41 94.63 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.876 0.369 . . . . 1.0 110.281 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.5 -40.69 89.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.059 -0.519 . . . . 1.0 110.249 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 -41.73 92.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.593 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.09 -39.15 89.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.337 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -62.4 -36.74 83.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.257 -0.429 . . . . 1.0 110.291 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.66 -35.71 80.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 1.0 111.206 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -62.82 -40.18 96.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.732 0.301 . . . . 1.0 111.086 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' GLU . . . . . . . . . . . . . 45.2 tp10 -65.84 -34.25 77.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.491 -0.322 . . . . 1.0 110.569 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -62.8 -37.94 88.7 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.371 -0.377 . . . . 1.0 110.516 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' LEU . . . . . 0.438 HD13 ' HA2' ' C' ' 78' ' ' GLY . 49.0 tp -61.74 -44.6 96.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.608 -0.437 . . . . 1.0 110.585 -179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' GLN . . . . . 0.465 ' O ' ' OE1' ' C' ' 20' ' ' GLU . 85.5 mm-40 -58.48 -32.31 68.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.587 -0.279 . . . . 1.0 111.567 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -64.82 -43.24 93.74 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.625 -0.43 . . . . 1.0 111.68 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' VAL . . . . . . . . . . . . . 6.4 m -87.56 -34.65 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-N 116.15 -0.477 . . . . 1.0 111.592 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LEU . . . . . 0.699 HD12 ' O ' ' C' ' 19' ' ' LEU . 0.9 OUTLIER -60.49 -49.14 78.75 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' C' ' 16' ' ' GLN . 3.4 mp0 -61.22 -43.32 99.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.307 -0.627 . . . . 1.0 109.307 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . . . . . . . . . 45.1 tp10 -58.64 -29.34 66.46 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.886 -0.597 . . . . 1.0 109.473 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' C' ' 19' ' ' LEU . . . -65.17 -37.65 88.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.136 -0.484 . . . . 1.0 110.655 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' SER . . . . . . . . . . . . . 12.9 m -56.63 -44.8 81.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.346 -0.388 . . . . 1.0 110.356 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -64.59 -52.15 59.03 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.131 -0.628 . . . . 1.0 109.694 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' LYS . . . . . 0.433 ' O ' ' N ' ' C' ' 29' ' ' ALA . 70.6 mmtt -59.48 -37.92 79.48 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.517 -0.765 . . . . 1.0 110.435 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.74 -57.74 5.86 Favored 'General case' 0 N--CA 1.463 0.213 0 C-N-CA 121.013 -0.275 . . . . 1.0 110.832 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -64.33 -44.21 97.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.572 -0.451 . . . . 1.0 110.137 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -60.72 -32.81 72.06 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.277 -0.42 . . . . 1.0 110.15 -179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' C' ' 25' ' ' LYS . . . -60.77 -29.28 69.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.011 -0.54 . . . . 1.0 110.624 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -59.2 -44.73 92.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.311 -0.404 . . . . 1.0 110.66 -179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -70.03 130.23 41.6 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.031 -0.531 . . . . 1.0 110.153 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.46 -29.75 11.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.234 -0.747 . . . . 1.0 111.234 179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' ALA . . . . . . . . . . . . . . . -106.89 144.19 28.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 O-C-N 122.903 -0.174 . . . . 1.0 110.742 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.17 158.71 37.52 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 C-N-CA 122.115 1.877 . . . . 1.0 112.442 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.77 36.9 14.55 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 111.351 -0.7 . . . . 1.0 111.351 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.21 141.86 55.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.328 . . . . 1.0 110.569 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' ALA . . . . . . . . . . . . . . . -160.4 -44.73 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.479 . . . . 1.0 110.46 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.413 ' O ' HD23 ' C' ' 38' ' ' LEU . 6.4 tt -68.7 -16.15 63.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.098 -0.501 . . . . 1.0 110.475 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.411 HG23 ' O ' ' C' ' 39' ' ' ILE . 2.6 tp -37.89 116.51 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.122 -0.49 . . . . 1.0 110.736 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' SER . . . . . 0.541 ' OG ' ' N ' ' C' ' 41' ' ' TYR . 17.2 t -177.6 -123.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.112 -0.494 . . . . 1.0 110.306 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' TYR . . . . . 0.541 ' N ' ' OG ' ' C' ' 40' ' ' SER . 0.8 OUTLIER 171.97 -65.58 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.188 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' C' ' 41' ' ' TYR . 23.5 Cg_endo -58.81 -40.16 75.04 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.886 1.724 . . . . 1.0 112.171 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.455 ' CB ' ' NH2' ' C' ' 60' ' ' ARG . 8.5 p30 -88.37 -0.22 56.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.191 -0.459 . . . . 1.0 111.31 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.57 -37.77 87.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 1.0 110.615 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.472 HG23 ' N ' ' C' ' 46' ' ' TRP . 20.3 tt -67.18 -41.4 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.213 -0.449 . . . . 1.0 110.829 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.574 ' CD1' ' NE ' ' D' ' 68' ' ' ARG . 0.0 OUTLIER -52.33 -49.08 64.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.487 -0.324 . . . . 1.0 110.737 -179.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' TRP . . . . . . . . . . . . . 29.7 t90 -65.43 -38.55 90.22 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.381 -0.528 . . . . 1.0 109.826 178.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 9.0 p -62.11 -38.79 90.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.045 -0.525 . . . . 1.0 111.543 -179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' VAL . . . . . 0.474 ' O ' HG23 ' C' ' 53' ' ' THR . 42.9 t -59.55 -47.75 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 121.181 -0.208 . . . . 1.0 111.367 -178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -67.58 -34.75 77.66 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.107 -0.637 . . . . 1.0 110.569 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' THR . . . . . . . . . . . . . 44.7 m -64.24 -53.7 45.07 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 111.939 0.348 . . . . 1.0 111.939 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.55 68.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.766 0.317 . . . . 1.0 110.947 -178.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.474 HG23 ' O ' ' C' ' 49' ' ' VAL . 58.9 p -90.81 3.63 53.92 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.319 -0.401 . . . . 1.0 110.274 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' C' ' 53' ' ' THR . 50.4 p 52.06 68.99 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.006 -0.543 . . . . 1.0 110.748 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -135.47 -50.63 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.306 -0.406 . . . . 1.0 110.147 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' GLY . . . . . . . . . . . . . . . 50.3 76.81 0.15 Allowed Glycine 0 CA--C 1.522 0.498 0 N-CA-C 110.706 -0.958 . . . . 1.0 110.706 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' D' ' 60' ' ' ARG . 26.9 t80 -61.66 -43.21 99.28 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.869 -0.332 . . . . 1.0 110.63 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.14 12.19 5.41 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.978 -0.849 . . . . 1.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -61.6 -45.54 93.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.805 0.336 . . . . 1.0 110.884 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' ARG . . . . . 0.455 ' NH2' ' CB ' ' C' ' 43' ' ' ASP . 94.1 mtt-85 -138.45 147.99 43.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.301 -0.629 . . . . 1.0 109.301 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -115.66 128.88 25.6 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-N 116.762 -0.199 . . . . 1.0 110.563 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -69.55 157.16 61.78 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.029 1.82 . . . . 1.0 112.001 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . 0.457 ' H ' HG22 ' C' ' 63' ' ' VAL . 0.0 OUTLIER -56.2 -176.54 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.839 -0.619 . . . . 1.0 110.276 179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' THR . . . . . 0.612 ' O ' ' NE1' ' B' ' 46' ' ' TRP . 67.0 m -89.82 -86.25 0.2 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 115.933 -0.576 . . . . 1.0 110.643 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' GLU . . . . . 0.469 ' C ' ' O ' ' C' ' 64' ' ' THR . 50.7 tp10 -28.19 -84.92 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.321 0.388 . . . . 1.0 111.097 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' GLU . . . . . 0.879 ' O ' ' N ' ' C' ' 68' ' ' ARG . 97.5 mt-10 -60.95 -92.2 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 109.191 -0.67 . . . . 1.0 109.191 178.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' GLY . . . . . . . . . . . . . . . 21.05 -56.2 0.0 OUTLIER Glycine 0 N--CA 1.478 1.457 0 O-C-N 124.376 1.047 . . . . 1.0 114.571 177.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' ARG . . . . . 0.879 ' N ' ' O ' ' C' ' 66' ' ' GLU . 42.9 ttp85 -71.35 -47.75 54.52 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.289 -0.456 . . . . 1.0 110.402 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' LYS . . . . . 0.556 ' NZ ' HH12 ' C' ' 68' ' ' ARG . 4.5 mptp? -59.85 -41.46 91.46 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.975 -0.75 . . . . 1.0 108.975 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' VAL . . . . . 0.618 ' O ' HG23 ' C' ' 74' ' ' VAL . 58.7 t -76.64 -45.81 32.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 C-N-CA 119.788 -0.765 . . . . 1.0 111.237 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -53.23 28.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.953 -0.299 . . . . 1.0 110.703 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' GLU . . . . . 0.455 ' CB ' ' O ' ' C' ' 68' ' ' ARG . 15.4 tm-20 -49.42 -40.98 38.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.836 -179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -69.25 -42.04 76.14 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.598 -0.441 . . . . 1.0 111.931 -179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.618 HG23 ' O ' ' C' ' 70' ' ' VAL . 74.0 t -66.06 -49.48 76.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.801 -0.36 . . . . 1.0 111.722 -178.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 25.5 ptp -59.69 -37.34 78.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.476 -0.329 . . . . 1.0 110.693 -178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -62.34 -40.5 96.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.29 -0.413 . . . . 1.0 110.522 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.52 -39.72 95.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.762 0.315 . . . . 1.0 110.585 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' C' ' 15' ' ' LEU . . . -65.31 -41.23 96.77 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.817 -0.513 . . . . 1.0 111.817 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 97.8 mt -62.3 -43.06 97.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.741 0.305 . . . . 1.0 110.852 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -61.28 -40.6 94.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.373 -0.376 . . . . 1.0 111.265 -179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' VAL . . . . . . . . . . . . . 75.5 t -63.89 -47.02 92.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.951 -0.3 . . . . 1.0 111.274 -179.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -71.35 -14.62 62.25 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.924 -0.31 . . . . 1.0 111.168 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.18 -34.09 19.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.928 0.394 . . . . 1.0 110.244 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 tt -66.16 -40.53 90.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.119 -0.491 . . . . 1.0 111.66 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.58 -24.58 29.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 C-N-CA 120.654 -0.418 . . . . 1.0 110.672 -179.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' THR . . . . . 0.43 ' O ' ' N ' ' C' ' 90' ' ' ALA . 1.2 t -43.12 -33.88 0.97 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.168 0.509 . . . . 1.0 110.456 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.519 ' HB2' ' HB3' ' B' ' 92' ' ' ASP . . . -49.1 -61.74 1.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.733 -0.667 . . . . 1.0 110.203 -179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -51.58 -35.02 39.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.046 -0.524 . . . . 1.0 110.241 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' LEU . . . . . 0.562 HD22 ' N ' ' C' ' 89' ' ' LEU . 3.4 mm? -75.35 -34.81 61.21 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.969 -0.559 . . . . 1.0 110.777 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' ALA . . . . . 0.504 ' O ' ' CD2' ' C' ' 93' ' ' PHE . . . -63.5 -36.18 82.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.097 -0.501 . . . . 1.0 111.181 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -4.47 37.55 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.08 -179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' ASP . . . . . 0.417 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 88.9 m-20 -54.77 -48.95 72.03 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.77 -0.372 . . . . 1.0 110.746 -178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' PHE . . . . . 0.504 ' CD2' ' O ' ' C' ' 90' ' ' ALA . 20.8 p90 -74.83 -9.97 59.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.27 -0.423 . . . . 1.0 110.837 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' VAL . . . . . . . . . . . . . 61.9 t -90.1 -48.3 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.453 -0.339 . . . . 1.0 111.679 -178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -65.81 -20.35 66.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.392 -0.367 . . . . 1.0 111.258 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' ARG . . . . . . . . . . . . . 51.7 ptt85 -48.84 -38.8 23.35 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.964 -0.294 . . . . 1.0 110.412 -179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' GLU . . . . . 0.554 ' O ' ' N ' ' C' ' 99' ' ' GLU . 17.3 pt-20 -43.55 152.91 0.13 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.477 -0.329 . . . . 1.0 110.278 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 60.42 -68.82 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 O-C-N 123.492 0.495 . . . . 1.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLU . . . . . 0.554 ' N ' ' O ' ' C' ' 97' ' ' GLU . 79.4 mm-40 -52.11 -21.73 3.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.181 -0.463 . . . . 1.0 110.446 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ARG . . . . . . . . . . . . . 27.9 ttp-105 -61.7 -43.45 98.83 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.431 -0.349 . . . . 1.0 110.34 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -64.75 -36.55 84.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.529 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' GLY . . . . . . . . . . . . . . . 90.43 11.58 62.34 Favored Glycine 0 CA--C 1.525 0.663 0 N-CA-C 111.083 -0.807 . . . . 1.0 111.083 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' HIS . . . . . . . . . . . . . 86.4 t60 . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 117.982 -1.009 . . . . 1.0 110.539 179.851 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' SER . . . . . 0.423 ' O ' ' O ' ' D' ' 2' ' ' ALA . 40.8 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.42 -0.585 . . . . 1.0 109.42 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' D' ' 1' ' ' SER . . . 45.3 95.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.474 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -63.75 -40.3 96.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.09 -0.504 . . . . 1.0 110.935 -179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' HIS . . . . . 0.708 ' H ' ' CD2' ' D' ' 4' ' ' HIS . 2.5 p80 -58.55 -44.92 89.81 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.442 -0.344 . . . . 1.0 110.587 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -65.51 -39.6 92.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.8 0.333 . . . . 1.0 110.581 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ARG . . . . . . . . . . . . . 31.8 mmt180 -65.06 -39.16 92.88 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 1.0 110.483 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -65.14 -37.26 86.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.257 -0.429 . . . . 1.0 109.931 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.25 -38.76 90.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.934 -0.576 . . . . 1.0 110.846 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -63.66 -38.77 92.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.866 0.365 . . . . 1.0 110.306 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.98 -39.1 91.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.047 -0.524 . . . . 1.0 110.559 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.32 -38.88 81.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 1.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -66.73 -41.86 87.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 1.0 110.733 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -67.14 -37.92 84.63 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.288 -0.415 . . . . 1.0 110.469 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -64.93 -34.83 79.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 1.0 110.514 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' LEU . . . . . . . . . . . . . 38.7 tp -62.26 -40.6 96.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.446 -0.343 . . . . 1.0 110.316 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -60.36 -37.05 79.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.133 -0.485 . . . . 1.0 110.917 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.43 -42.51 92.05 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.74 0.305 . . . . 1.0 111.094 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' VAL . . . . . . . . . . . . . 72.9 t -63.12 -42.49 96.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.262 -0.426 . . . . 1.0 110.771 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LEU . . . . . 0.663 HD21 ' HB2' ' D' ' 52' ' ' ALA . 97.0 mt -61.13 -42.02 97.77 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.833 -0.432 . . . . 1.0 109.833 -179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -59.98 -46.15 90.38 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.288 -0.414 . . . . 1.0 110.341 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -70.25 -40.28 74.5 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.795 -0.362 . . . . 1.0 110.411 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.42 93.18 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.122 -0.49 . . . . 1.0 111.06 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' SER . . . . . 0.437 ' OG ' ' OG ' ' D' ' 48' ' ' SER . 16.5 m -58.54 -45.28 89.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.427 -0.351 . . . . 1.0 111.091 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' LYS . . . . . 0.48 ' O ' ' OE1' ' D' ' 28' ' ' GLU . 60.9 tttp -60.71 -59.71 4.95 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.477 -0.489 . . . . 1.0 110.282 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.51 -38.86 75.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 1.0 111.006 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' ALA . . . . . 0.402 ' O ' ' OE1' ' D' ' 30' ' ' GLU . . . -53.76 -36.14 62.05 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.762 -0.375 . . . . 1.0 110.873 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' VAL . . . . . . . . . . . . . 88.5 t -63.79 -48.73 85.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 C-N-CA 120.561 -0.456 . . . . 1.0 110.525 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' GLU . . . . . 0.535 ' OE1' ' N ' ' D' ' 28' ' ' GLU . 47.6 mp0 -73.29 -38.2 65.97 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.065 -0.516 . . . . 1.0 110.539 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.31 -54.55 30.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.436 . . . . 1.0 110.55 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' GLU . . . . . 0.402 ' OE1' ' O ' ' D' ' 26' ' ' ALA . 2.0 mp0 -64.91 -35.13 80.17 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.576 -0.283 . . . . 1.0 110.523 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -68.24 128.23 35.8 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.117 0.484 . . . . 1.0 110.126 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.08 -16.36 61.49 Favored Glycine 0 CA--C 1.525 0.695 0 CA-C-N 115.507 -0.769 . . . . 1.0 111.465 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.27 148.17 46.59 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 110.358 -0.238 . . . . 1.0 110.358 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' PRO . . . . . 0.576 ' O ' HG11 ' D' ' 63' ' ' VAL . 76.7 Cg_endo -74.78 130.71 13.78 Favored 'Trans proline' 0 N--CA 1.492 1.423 0 C-N-CA 121.913 1.742 . . . . 1.0 112.396 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.92 17.88 71.36 Favored Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.133 -0.787 . . . . 1.0 111.133 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' ALA . . . . . . . . . . . . . . . -47.73 173.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.851 0.358 . . . . 1.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.42 -40.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.17 -0.468 . . . . 1.0 110.616 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' LEU . . . . . 0.465 HD23 ' C ' ' D' ' 38' ' ' LEU . 6.1 tt -97.72 121.58 39.8 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 109.962 -0.384 . . . . 1.0 109.962 -179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' ILE . . . . . 0.451 ' N ' HD23 ' D' ' 38' ' ' LEU . 24.1 pt -152.92 54.72 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-N 116.135 -0.484 . . . . 1.0 110.651 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' SER . . . . . . . . . . . . . 2.6 m -149.9 119.71 7.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.142 -0.481 . . . . 1.0 110.621 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' TYR . . . . . 0.57 ' N ' ' HD2' ' D' ' 42' ' ' PRO . 8.5 t80 -61.08 -47.99 93.5 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.027 -0.533 . . . . 1.0 110.942 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' D' ' 41' ' ' TYR . 20.4 Cg_endo -58.62 -31.73 95.25 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 121.288 1.325 . . . . 1.0 112.056 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.53 -8.26 38.82 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.454 -0.339 . . . . 1.0 111.109 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.13 -41.8 81.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.84 0.352 . . . . 1.0 110.984 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 tt -64.48 -34.45 69.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.082 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 64' ' ' THR . 0.2 OUTLIER -69.06 -44.12 73.23 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.168 179.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' TRP . . . . . . . . . . . . . 35.1 t90 -62.42 -41.52 98.76 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.523 -0.471 . . . . 1.0 109.803 179.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.44 ' O ' HD22 ' D' ' 19' ' ' LEU . 1.2 m -72.01 57.35 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 1.0 110.172 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' VAL . . . . . . . . . . . . . 45.9 t -145.28 -51.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.265 0 CA-C-O 120.725 0.298 . . . . 1.0 110.444 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -66.46 -31.82 72.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.106 -0.497 . . . . 1.0 109.954 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.46 -45.25 91.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 1.0 110.358 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.663 ' HB2' HD21 ' D' ' 19' ' ' LEU . . . -60.76 -39.05 87.31 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.792 -0.363 . . . . 1.0 110.118 179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' THR . . . . . . . . . . . . . 4.0 p -86.0 8.25 21.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.075 0.464 . . . . 1.0 110.322 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' THR . . . . . . . . . . . . . 42.8 p 44.03 57.35 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.01 -0.541 . . . . 1.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' D' ' 57' ' ' TYR . 1.6 m -140.86 41.53 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 110.062 -0.347 . . . . 1.0 110.062 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' GLY . . . . . . . . . . . . . . . -45.76 88.05 0.01 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.737 -0.945 . . . . 1.0 110.737 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' D' ' 55' ' ' VAL . 1.2 t80 -61.74 -44.78 96.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.875 0.369 . . . . 1.0 110.361 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.27 27.89 0.16 Allowed Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.95 -0.86 . . . . 1.0 110.95 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' ASP . . . . . 0.487 ' CG ' ' NH2' ' A' ' 68' ' ' ARG . 43.3 t0 -63.74 -48.91 75.09 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.796 -0.362 . . . . 1.0 110.454 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' ARG . . . . . 0.479 ' C ' ' CG ' ' D' ' 61' ' ' TYR . 0.8 OUTLIER -146.13 -178.7 6.27 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.319 -0.4 . . . . 1.0 110.166 179.478 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' TYR . . . . . 0.521 ' CD1' ' N ' ' D' ' 61' ' ' TYR . 1.6 m-85 -150.44 99.6 3.19 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 116.28 -0.418 . . . . 1.0 111.072 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -68.83 147.24 68.4 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 121.782 1.655 . . . . 1.0 112.101 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . 0.576 HG11 ' O ' ' D' ' 34' ' ' PRO . 2.5 t -80.74 -134.95 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.342 -0.39 . . . . 1.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' THR . . . . . 0.54 HG23 ' NH2' ' D' ' 68' ' ' ARG . 51.7 m -114.56 -54.29 2.59 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.828 0.347 . . . . 1.0 110.559 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' GLU . . . . . 0.53 ' C ' ' H ' ' D' ' 67' ' ' GLY . 84.2 tt0 -50.88 -18.33 0.73 Allowed 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 109.644 -0.502 . . . . 1.0 109.644 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' GLU . . . . . 0.422 ' N ' ' C ' ' D' ' 64' ' ' THR . 0.0 OUTLIER -78.06 37.84 0.26 Allowed 'General case' 0 C--O 1.261 1.691 0 CA-C-O 123.793 1.759 . . . . 1.0 108.679 178.244 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' GLY . . . . . 0.736 ' O ' ' N ' ' D' ' 69' ' ' LYS . . . 46.83 62.43 3.74 Favored Glycine 0 C--O 1.202 -1.897 0 CA-C-N 113.649 -1.614 . . . . 1.0 109.636 179.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' ARG . . . . . 0.574 ' NE ' ' CD1' ' C' ' 46' ' ' TRP . 19.0 ttm105 -22.5 -32.89 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 117.663 0.732 . . . . 1.0 111.681 -177.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' LYS . . . . . 0.736 ' N ' ' O ' ' D' ' 67' ' ' GLY . 71.2 mmtt -65.83 -8.29 20.93 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.022 -0.99 . . . . 1.0 109.877 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' VAL . . . . . 0.708 ' N ' ' O ' ' D' ' 67' ' ' GLY . 16.5 t -59.79 -47.49 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 120.177 -0.609 . . . . 1.0 109.555 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' ALA . . . . . 0.517 ' O ' ' SD ' ' D' ' 75' ' ' MET . . . -76.65 -52.78 9.01 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.0 0.429 . . . . 1.0 110.359 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -47.9 -41.43 24.48 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.851 -0.613 . . . . 1.0 110.931 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -63.14 -48.92 76.44 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 120.894 -0.322 . . . . 1.0 111.784 -179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' VAL . . . . . . . . . . . . . 74.5 t -64.82 -43.76 96.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 C-N-CA 120.655 -0.418 . . . . 1.0 111.555 -179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' D' ' 71' ' ' ALA . 1.3 mpp? -61.42 -43.62 98.56 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.391 -0.368 . . . . 1.0 110.624 -178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -66.03 -38.85 89.44 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.642 -0.423 . . . . 1.0 110.632 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' ALA . . . . . 0.566 ' O ' HG23 ' D' ' 81' ' ' VAL . . . -61.15 -37.06 81.5 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.3 -0.409 . . . . 1.0 110.505 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.76 -40.55 58.11 Favored Glycine 0 CA--C 1.529 0.962 0 N-CA-C 111.628 -0.589 . . . . 1.0 111.628 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 91.0 mt -62.37 -44.77 99.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 111.638 0.236 . . . . 1.0 111.638 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -68.07 -35.16 77.76 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.798 -0.361 . . . . 1.0 111.304 -179.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' VAL . . . . . 0.566 HG23 ' O ' ' D' ' 77' ' ' ALA . 34.5 t -62.15 -47.47 92.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.437 -0.347 . . . . 1.0 111.166 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -72.78 -6.61 45.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.526 -0.47 . . . . 1.0 110.836 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.9 -32.24 11.78 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.451 -0.34 . . . . 1.0 110.198 179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' LEU . . . . . 0.476 ' C ' ' H ' ' D' ' 86' ' ' THR . 7.5 tt -64.15 -41.47 97.17 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.808 -0.357 . . . . 1.0 110.338 179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' VAL . . . . . . . . . . . . . 33.2 m -51.31 -10.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.408 -0.36 . . . . 1.0 110.098 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' THR . . . . . 0.495 ' O ' ' N ' ' D' ' 89' ' ' LEU . 45.9 m -51.59 -43.07 62.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 1.0 110.062 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.482 ' O ' ' CG2' ' D' ' 91' ' ' THR . . . -46.02 -19.16 0.06 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.073 -0.512 . . . . 1.0 110.657 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . 0.408 ' N ' ' C ' ' D' ' 86' ' ' THR . . . -104.76 -17.61 14.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.405 -0.362 . . . . 1.0 110.45 -179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' D' ' 86' ' ' THR . 39.6 mt -93.27 -46.06 7.55 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.175 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' ALA . . . . . 0.524 ' O ' ' CE2' ' D' ' 93' ' ' PHE . . . -54.34 -30.08 50.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 1.0 110.705 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' THR . . . . . 0.482 ' CG2' ' O ' ' D' ' 87' ' ' ALA . 0.1 OUTLIER -74.88 -11.76 60.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.154 -0.476 . . . . 1.0 109.765 -179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -53.22 -50.67 64.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.377 -0.374 . . . . 1.0 111.135 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' PHE . . . . . 0.524 ' CE2' ' O ' ' D' ' 90' ' ' ALA . 14.0 p90 -73.19 -11.26 60.46 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.817 -0.353 . . . . 1.0 110.652 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' VAL . . . . . . . . . . . . . 38.0 t -91.03 -35.93 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.235 -0.439 . . . . 1.0 111.151 -179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -61.91 -42.52 99.19 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.335 -0.393 . . . . 1.0 111.137 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' ARG . . . . . . . . . . . . . 49.8 ptt85 -53.54 -30.47 41.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.745 0.307 . . . . 1.0 110.279 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' D' ' 99' ' ' GLU . 30.8 tp10 -76.02 158.76 31.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.058 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' GLU . . . . . 0.462 ' O ' ' N ' ' D' ' 100' ' ' ARG . 97.2 mt-10 58.38 -74.15 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.348 -0.387 . . . . 1.0 110.817 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLU . . . . . 0.536 ' N ' ' O ' ' D' ' 97' ' ' GLU . 47.2 tp10 -40.86 -25.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 1.0 110.302 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' D' ' 98' ' ' GLU . 2.1 ptm180 -60.14 -44.15 95.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.075 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' D' ' 98' ' ' GLU . 85.1 mtp180 -68.8 -21.75 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 1.0 110.635 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.46 12.03 67.9 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.029 -0.828 . . . . 1.0 111.029 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 . . . . . 0 C--O 1.22 -0.475 0 CA-C-O 118.073 -0.965 . . . . 1.0 110.728 179.831 . . . . . . . . 0 0 . 1 stop_ save_